Citrus Sinensis ID: 008893

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------55
Protein Sequence
MMLLLEKVLIIVLIQVICSDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR
Secondary Structure (PSIPRED)
cccccccccEEEEccEEcccccccHHHHHcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccEEccccccccHHHHHHHHcccccccEEEEcccccEEEEEEccccEEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEEcccccEEEEcccccccHHHHHcccccccHHHHHHHHHHHHHHHHHccccccccccccccccccEEccccccEEEccccccccccccccEEcccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccEEcccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHccccccEEEcccccccccccHHHHHHHHcccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHHcccccEcccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHccccccccccccccccccEEcHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEcccccEEcccccccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHccccHHHEcccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccHHHHcccccccccccccccccccccccccccccccEEEccccc
Coil and Loop (DISEMBL)
MMLLLEKVLIIVLIQVICsdgvffsfgrllqnnnisghiptEIGKLSKLLTldlsnnfftgpipstvshLETLQYLRLNnnsltgaippslsnmsqlAFLDlsynnlsgpvpsfhaktfnitgnslicatgaeedcfgtapmplsfalnnspnskpsgmpkGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLgnlkrfhfkelqsatsnfssknlvgkggfgnvykgylqdgTVVAVKRLkdgnaiggeiqFQTEVEMISLAVHRNLLRLIGFCMttterllvypymsngsvasrlkakpsldwATRKRIALGAARGLLYlheqcdpkiiHRDVKAANILLDEYYEAVVGDFGLAKLLdhcdshvttavrgtvghiapeylstgqssektdvFGFGILLLELISGLralefgktanqkGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTqylpslrpkMSEVVRMLEGDGLAEKWAASQKAEATRSranefssserysdltddsSLLVQAMELSGPR
Flexible Loop (DISEMBL)
MMLLLEKVLIIVLIQVICSDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKelqsatsnfssknlVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSngsvasrlkakpsldwATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEylstgqsseKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQkaeatrsranefssserysdltddsslLVQAMELSGPR
Low Complexity Region (SEG)
MMlllekvliivliqviCSDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIalalgsslgcisllilgfgfllWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR
Disordered region (IsUnstruct)
**LLLEKVLIIVLIQVICSDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPL********************IALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML***************************************************
Disordered Region (DISOPRED)
MMLLLEKVLIIVLIQVICSDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGA********************************IALALGSSLGCISLLILGFGFLLWWR*********************GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRL*************TEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD************************************************
Disordered Region (DISEMBL)
MMLLLEKVLIIVLIQVICSDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPN********GQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA***************************LTDDSSLLVQAMELSGPR
Disordered Region (DISPRO)
MMLLLEKVLIIVLIQVICSDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMP******************GQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD************************************LLVQ**EL****
Transmembrane Helix (TMHMM)
oooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MMLLLEKVLIIVLIQVICSDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	549	2.2.26 [Sep-21-2011]
Q8RY65	635	Protein NSP-INTERACTING K	yes	no	0.948	0.820	0.794	0.0
Q9LFS4	638	Protein NSP-INTERACTING K	no	no	0.948	0.816	0.757	0.0
Q0WVM4	634	Probable LRR receptor-lik	no	no	0.934	0.809	0.633	0.0
Q8VYT3	648	Probable LRR receptor-lik	no	no	0.868	0.736	0.668	0.0
Q93ZS4	632	Protein NSP-INTERACTING K	no	no	0.943	0.819	0.637	0.0
Q94AG2	625	Somatic embryogenesis rec	no	no	0.939	0.825	0.590	1e-160
C0LGU5	614	Probable LRR receptor-lik	no	no	0.910	0.814	0.554	1e-159
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.901	0.798	0.546	1e-146
Q94F62	615	BRASSINOSTEROID INSENSITI	no	no	0.919	0.821	0.517	1e-144
Q9XIC7	628	Somatic embryogenesis rec	no	no	0.655	0.573	0.670	1e-139

>sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1

 Score =  857 bits (2215), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 417/525 (79%), Positives = 462/525 (88%), Gaps = 4/525 (0%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           LLQNN I+G+IP EIGKL KL TLDLS N FTG IP T+S+ + LQYLR+NNNSLTG IP
Sbjct: 111 LLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQYLRVNNNSLTGTIP 170

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
            SL+NM+QL FLDLSYNNLSGPVP   AKTFN+ GNS IC TG E+DC GT P P+S  L
Sbjct: 171 SSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNSQICPTGTEKDCNGTQPKPMSITL 230

Query: 149 NNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQI-FFDVNEQRRE 207
           N+S N    G  K +KIA+  G SL C+ LLI+GFGFLLWWR+RHN+Q+ FFD+NEQ +E
Sbjct: 231 NSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLWWRRRHNKQVLFFDINEQNKE 290

Query: 208 EVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 267
           E+CLGNL+RF+FKELQSATSNFSSKNLVGKGGFGNVYKG L DG+++AVKRLKD N  GG
Sbjct: 291 EMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAVKRLKDINNGGG 350

Query: 268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
           E+QFQTE+EMISLAVHRNLLRL GFC T++ERLLVYPYMSNGSVASRLKAKP LDW TRK
Sbjct: 351 EVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLKAKPVLDWGTRK 410

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
           RIALGA RGLLYLHEQCDPKIIHRDVKAANILLD+Y+EAVVGDFGLAKLLDH +SHVTTA
Sbjct: 411 RIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGLAKLLDHEESHVTTA 470

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
           VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+GLRALEFGK ANQ+GA+LDWVKK+
Sbjct: 471 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKAANQRGAILDWVKKL 530

Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKW 507
            QEKKLE +VDKDLK+NYDRIE+EEMVQVALLCTQYLP  RPKMSEVVRMLEGDGL EKW
Sbjct: 531 QQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKMSEVVRMLEGDGLVEKW 590

Query: 508 -AASQKAEATR--SRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
            A+SQ+AE  R  S+ NEFSSSERYSDLTDDSS+LVQAMELSGPR
Sbjct: 591 EASSQRAETNRSYSKPNEFSSSERYSDLTDDSSVLVQAMELSGPR 635

Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1

 Score =  811 bits (2096), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 400/528 (75%), Positives = 450/528 (85%), Gaps = 7/528 (1%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           LLQNNNI G IP EIG+L++L TLDLS+NFF G IP +V +L++LQYLRLNNNSL+G  P
Sbjct: 111 LLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFP 170

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
            SLSNM+QLAFLDLSYNNLSGPVP F AKTF+I GN LIC TG E DC GT  +P+S  L
Sbjct: 171 LSLSNMTQLAFLDLSYNNLSGPVPRFAAKTFSIVGNPLICPTGTEPDCNGTTLIPMSMNL 230

Query: 149 NNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNE-QRRE 207
           N +     +G  +  K+A+A+GSS+G +SL+ +  G  LWWRQRHNQ  FFDV +    E
Sbjct: 231 NQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHE 290

Query: 208 EVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 267
           EV LGNL+RF F+ELQ AT+NFSSKNL+GKGG+GNVYKG L D TVVAVKRLKDG A+GG
Sbjct: 291 EVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGG 350

Query: 268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
           EIQFQTEVEMISLAVHRNLLRL GFC+T TE+LLVYPYMSNGSVASR+KAKP LDW+ RK
Sbjct: 351 EIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMKAKPVLDWSIRK 410

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
           RIA+GAARGL+YLHEQCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTA
Sbjct: 411 RIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTA 470

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
           VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL++G RA EFGK ANQKG MLDWVKKI
Sbjct: 471 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDWVKKI 530

Query: 448 HQEKKLEMLVDKDL--KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAE 505
           HQEKKLE+LVDK+L  K +YD IEL+EMV+VALLCTQYLP  RPKMSEVVRMLEGDGLAE
Sbjct: 531 HQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAE 590

Query: 506 KWAASQKAEAT---RSRANEF-SSSERYSDLTDDSSLLVQAMELSGPR 549
           KW ASQ++++     +R NE  SSS+RYSDLTDDSSLLVQAMELSGPR
Sbjct: 591 KWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSSLLVQAMELSGPR 638

Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1

 Score =  669 bits (1726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/537 (63%), Positives = 408/537 (75%), Gaps = 24/537 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           LQNNNISG IP EI  L KL TLDLSNN F+G IP +V+ L  LQYLRLNNNSL+G  P 
Sbjct: 105 LQNNNISGKIPPEICSLPKLQTLDLSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPA 164

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGT-APMPLSFAL 148
           SLS +  L+FLDLSYNNL GPVP F A+TFN+ GN LIC     E C G+ +  PLS +L
Sbjct: 165 SLSQIPHLSFLDLSYNNLRGPVPKFPARTFNVAGNPLICKNSLPEICSGSISASPLSVSL 224

Query: 149 NNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREE 208
            +S   + +       +A+ALG SLG    +IL  GF+ W+R++  +     +++++ E 
Sbjct: 225 RSSSGRRTN------ILAVALGVSLGFAVSVILSLGFI-WYRKKQRRLTMLRISDKQEEG 277

Query: 209 VC-LGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 267
           +  LGNL+ F F+EL  AT  FSSK+++G GGFGNVY+G   DGTVVAVKRLKD N   G
Sbjct: 278 LLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSG 337

Query: 268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
             QF+TE+EMISLAVHRNLLRLIG+C +++ERLLVYPYMSNGSVASRLKAKP+LDW TRK
Sbjct: 338 NSQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAKPALDWNTRK 397

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
           +IA+GAARGL YLHEQCDPKIIHRDVKAANILLDEY+EAVVGDFGLAKLL+H DSHVTTA
Sbjct: 398 KIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTA 457

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
           VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+G+RALEFGK+ +QKGAML+WV+K+
Sbjct: 458 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKL 517

Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKW 507
           H+E K+E LVD++L   YDRIE+ EM+QVALLCTQ+LP+ RPKMSEVV+MLEGDGLAE+W
Sbjct: 518 HKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLAERW 577

Query: 508 AASQK---------------AEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
           AAS                 +    ++      S  + D  D+ +L   AMELSGPR
Sbjct: 578 AASHDHSHFYHANMSYRTITSTDGNNQTKHLFGSSGFEDEDDNQALDSFAMELSGPR 634

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1

 Score =  652 bits (1681), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/483 (66%), Positives = 387/483 (80%), Gaps = 6/483 (1%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           LQNNNISG IP E+G L KL TLDLSNN F+G IP ++  L +LQYLRLNNNSL+G  P 
Sbjct: 108 LQNNNISGKIPPELGFLPKLQTLDLSNNRFSGDIPVSIDQLSSLQYLRLNNNSLSGPFPA 167

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALN 149
           SLS +  L+FLDLSYNNLSGPVP F A+TFN+ GN LIC +   E C G+       A  
Sbjct: 168 SLSQIPHLSFLDLSYNNLSGPVPKFPARTFNVAGNPLICRSNPPEICSGSIN-----ASP 222

Query: 150 NSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEV 209
            S +   S   +  ++A+AL  SLG + +L+L  G   W+R++  + +  ++N+++ E +
Sbjct: 223 LSVSLSSSSGRRSNRLAIALSVSLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQEEGL 282

Query: 210 -CLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE 268
             LGNL+ F F+EL   T  FSSKN++G GGFGNVY+G L DGT+VAVKRLKD N   G+
Sbjct: 283 QGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGD 342

Query: 269 IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR 328
            QF+ E+EMISLAVH+NLLRLIG+C T+ ERLLVYPYM NGSVAS+LK+KP+LDW  RKR
Sbjct: 343 SQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKSKPALDWNMRKR 402

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           IA+GAARGLLYLHEQCDPKIIHRDVKAANILLDE +EAVVGDFGLAKLL+H DSHVTTAV
Sbjct: 403 IAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHADSHVTTAV 462

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+GLRALEFGKT +QKGAML+WV+K+H
Sbjct: 463 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAMLEWVRKLH 522

Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWA 508
           +E K+E L+D++L  NYD+IE+ EM+QVALLCTQYLP+ RPKMSEVV MLEGDGLAE+WA
Sbjct: 523 EEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLMLEGDGLAERWA 582

Query: 509 ASQ 511
           AS 
Sbjct: 583 ASH 585

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  640 bits (1651), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/532 (63%), Positives = 406/532 (76%), Gaps = 14/532 (2%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           +LQNN I+G IP  IG+L KL +LDLSNN FTG IP+++  L+ L YLRLNNNSL G  P
Sbjct: 104 VLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCP 163

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
            SLS +  L  +D+SYNNLSG +P   A+TF + GN+LIC   A  +C    P PL+   
Sbjct: 164 ESLSKIEGLTLVDISYNNLSGSLPKVSARTFKVIGNALICGPKAVSNC-SAVPEPLTLPQ 222

Query: 149 NNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREE 208
           +    S       G  +ALA  +S      +    G  LWWR R N+QIFFDVNEQ   E
Sbjct: 223 DGPDES--GTRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPE 280

Query: 209 VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE 268
           V LG+LKR+ FKEL+SAT++F+SKN++G+GG+G VYKG+L DGT+VAVKRLKD N  GGE
Sbjct: 281 VSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGE 340

Query: 269 IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----AKPSLDWA 324
           +QFQTEVE ISLA+HRNLLRL GFC +  ER+LVYPYM NGSVASRLK     +P+LDW+
Sbjct: 341 VQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWS 400

Query: 325 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 384
            RK+IA+G ARGL+YLHEQCDPKIIHRDVKAANILLDE +EAVVGDFGLAKLLDH DSHV
Sbjct: 401 RRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 460

Query: 385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
           TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+G +AL+FG++A+QKG MLDWV
Sbjct: 461 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWV 520

Query: 445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 504
           KK+HQE KL+ L+DKDL + +DR+ELEE+VQVALLCTQ+ PS RPKMSEV++MLEGDGLA
Sbjct: 521 KKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLA 580

Query: 505 EKWAASQKAEATRS----RANEFSSSER---YSDLTDDSSLLVQAMELSGPR 549
           E+W A+Q                SSS R   YSD   +SSL+V+A+ELSGPR
Sbjct: 581 ERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQESSLVVEAIELSGPR 632

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2

 Score =  567 bits (1460), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 313/530 (59%), Positives = 375/530 (70%), Gaps = 14/530 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L +NNI+G IP+ +G L+ L++LDL  N F+GPIP ++  L  L++LRLNNNSLTG+IP 
Sbjct: 100 LYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPM 159

Query: 90  SLSNMSQLAFLDLSYNNLSGPVP---SFHAKT-FNITGNSLICA-TGAEEDCFGTAPMPL 144
           SL+N++ L  LDLS N LSG VP   SF   T  +   N  +C    +          P 
Sbjct: 160 SLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPP 219

Query: 145 SFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQ 204
              +   P S PSG   G   A+A G + G   L         WWR+R    IFFDV  +
Sbjct: 220 PPFIQPPPVSTPSGY--GITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPAE 277

Query: 205 RREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA 264
              EV LG LKRF  +ELQ A+  FS+KN++G+GGFG VYKG L DGT+VAVKRLK+   
Sbjct: 278 EDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT 337

Query: 265 IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----AKPS 320
            GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L+    ++P 
Sbjct: 338 PGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPP 397

Query: 321 LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 380
           LDW TRKRIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGLAKL+D+ 
Sbjct: 398 LDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 457

Query: 381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELI+G RA +  + AN    M
Sbjct: 458 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVM 517

Query: 441 -LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            LDWVK + +EKKLEMLVD DL+ NY+  ELE+++QVALLCTQ  P  RPKMSEVVRMLE
Sbjct: 518 LLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRMLE 577

Query: 500 GDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
           GDGLAEKW   QK E  R   +   S    SD   DS+  + A+ELSGPR
Sbjct: 578 GDGLAEKWDEWQKVEILREEID--LSPNPNSDWILDSTYNLHAVELSGPR 625

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1

 Score =  562 bits (1448), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 290/523 (55%), Positives = 378/523 (72%), Gaps = 23/523 (4%)

Query: 31  QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 90
           QNN ++G IP+E+G+LS+L TLDLS N F+G IP+++  L  L YLRL+ N L+G +P  
Sbjct: 111 QNNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQVPHL 170

Query: 91  LSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNN 150
           ++ +S L+FLDLS+NNLSGP P+  AK + I GN+ +C   ++E C    P+  +  L+ 
Sbjct: 171 VAGLSGLSFLDLSFNNLSGPTPNISAKDYRIVGNAFLCGPASQELCSDATPVRNATGLSE 230

Query: 151 SPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVC 210
             NSK   +     ++ A G  +  I  L+  F ++LW R R ++      + Q+  E  
Sbjct: 231 KDNSKHHSL----VLSFAFGIVVAFIISLMFLFFWVLWHRSRLSRS-----HVQQDYEFE 281

Query: 211 LGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ 270
           +G+LKRF F+E+Q+ATSNFS KN++G+GGFG VYKGYL +GTVVAVKRLKD     GE+Q
Sbjct: 282 IGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKD-PIYTGEVQ 340

Query: 271 FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----AKPSLDWATR 326
           FQTEVEMI LAVHRNLLRL GFCMT  ER+LVYPYM NGSVA RL+     KPSLDW  R
Sbjct: 341 FQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRR 400

Query: 327 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
             IALGAARGL+YLHEQC+PKIIHRDVKAANILLDE +EA+VGDFGLAKLLD  DSHVTT
Sbjct: 401 ISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHVTT 460

Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           AVRGT+GHIAPEYLSTGQSSEKTDVFGFG+L+LELI+G + ++ G    +KG +L WV+ 
Sbjct: 461 AVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRT 520

Query: 447 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEK 506
           +  EK+   +VD+DLK  +D + LEE+V++ALLCTQ  P+LRP+MS+V+++LE  GL E+
Sbjct: 521 LKAEKRFAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVLE--GLVEQ 578

Query: 507 WAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
                +A A        S S  YS+  ++ S +++A+ELSGPR
Sbjct: 579 CEGGYEARAP-------SVSRNYSNGHEEQSFIIEAIELSGPR 614

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  520 bits (1338), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 295/540 (54%), Positives = 364/540 (67%), Gaps = 45/540 (8%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L +NNI+G IP E+G L +L++LDL  N  +GPIPS++  L  L++LRLNNNSL+G IP 
Sbjct: 106 LYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKLRFLRLNNNSLSGEIPM 165

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN-SLICATGAEEDCFGTAPMPLSFAL 148
           +L+++ QL  LD+S N LSG +P        + G+ SL                P+SFA 
Sbjct: 166 TLTSV-QLQVLDISNNRLSGDIP--------VNGSFSLFT--------------PISFA- 201

Query: 149 NNSPNSKPSGMPK-----------GQKIALALGSSLGCISLL--ILGFGFLLWWRQRHNQ 195
           NNS    P   P            GQ  A   G      +LL  +    F  WW +R  Q
Sbjct: 202 NNSLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFA-WWLRRKPQ 260

Query: 196 QIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVA 255
             FFDV  +   EV LG LKRF  +EL  AT NFS+KN++G+GGFG VYKG L DG +VA
Sbjct: 261 DHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVA 320

Query: 256 VKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL 315
           VKRLK+    GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L
Sbjct: 321 VKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 380

Query: 316 KAKP----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 371
           + +P    +LDW  RK IALG+ARGL YLH+ CD KIIHRDVKAANILLDE +EAVVGDF
Sbjct: 381 RERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDF 440

Query: 372 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 431
           GLAKL+++ DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELI+G +A +  
Sbjct: 441 GLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLA 500

Query: 432 KTANQKGAM-LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK 490
           + AN    M LDWVK++ +EKKLE LVD +L+  Y   E+E+++Q+ALLCTQ     RPK
Sbjct: 501 RLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPK 560

Query: 491 MSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSD-LTDDSSLLVQAMELSGPR 549
           MSEVVRMLEGDGLAE+W   QK E      N  +     +D L   S+ L++    SGPR
Sbjct: 561 MSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 620

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  513 bits (1320), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 288/556 (51%), Positives = 364/556 (65%), Gaps = 51/556 (9%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L N N+SG +  ++G+L  L  L+L +N  TG IP  + +L  L  L L  N+L+G IP 
Sbjct: 75  LGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNLSGPIPS 134

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPS-----FHAKTFNITGNSLICATGAEEDCFGTAPM-- 142
           +L  + +L FL L+ N+LSG +P         +  +++ N L           G  P+  
Sbjct: 135 TLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLT----------GDIPVNG 184

Query: 143 ------PLSFALNNSPNSKPSGMPK---------------GQKIALALGSSLGCISLLIL 181
                 P+SFA     N+K + +P                  +I  A+   +   + L+ 
Sbjct: 185 SFSLFTPISFA-----NTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLF 239

Query: 182 GFGF--LLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGG 239
                 L WWR++  Q  FFDV  +   EV LG LKRF  +ELQ A+ NFS+KN++G+GG
Sbjct: 240 AVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGG 299

Query: 240 FGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 299
           FG VYKG L DGT+VAVKRLK+    GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TER
Sbjct: 300 FGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 359

Query: 300 LLVYPYMSNGSVAS----RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKA 355
           LLVYPYM+NGSVAS    R +++P LDW  R+RIALG+ARGL YLH+ CDPKIIHRDVKA
Sbjct: 360 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 419

Query: 356 ANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 415
           ANILLDE +EAVVGDFGLAKL+D+ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G
Sbjct: 420 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 479

Query: 416 ILLLELISGLRALEFGKTANQKGAM-LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMV 474
           ++LLELI+G RA +  + AN    M LDWVK + +EKKLE LVD DL+ NY   E+E+++
Sbjct: 480 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLI 539

Query: 475 QVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSD-LT 533
           QVALLCTQ  P  RPKMSEVVRMLEGDGLAE+W   QK E  R   N  +     S  + 
Sbjct: 540 QVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPTHHPAVSGWII 599

Query: 534 DDSSLLVQAMELSGPR 549
            DS+  ++    SGPR
Sbjct: 600 GDSTSQIENEYPSGPR 615

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1

 Score =  495 bits (1275), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 246/367 (67%), Positives = 289/367 (78%), Gaps = 7/367 (1%)

Query: 188 WWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY 247
           WWR+R  Q+ FFDV  +   EV LG LKRF  +ELQ AT +FS+KN++G+GGFG VYKG 
Sbjct: 264 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 323

Query: 248 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 307
           L DGT+VAVKRLK+    GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+
Sbjct: 324 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 383

Query: 308 NGSVASRLKAKP----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 363
           NGSVAS L+ +P     L W+ R++IALG+ARGL YLH+ CDPKIIHRDVKAANILLDE 
Sbjct: 384 NGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443

Query: 364 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           +EAVVGDFGLA+L+D+ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELI+
Sbjct: 444 FEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 503

Query: 424 GLRALEFGKTANQKGAM-LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQ 482
           G RA +  + AN    M LDWVK + +EKKLEMLVD DL++NY   E+E+++QVALLCTQ
Sbjct: 504 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQ 563

Query: 483 YLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQA 542
             P  RPKMSEVVRMLEGDGLAEKW   QK E  R       SS   SD   DS+  + A
Sbjct: 564 SSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVE--LSSHPTSDWILDSTDNLHA 621

Query: 543 MELSGPR 549
           MELSGPR
Sbjct: 622 MELSGPR 628

Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	549
224099221	622	predicted protein [Populus trichocarpa]	0.945	0.834	0.861	0.0
147815751	609	hypothetical protein VITISV_025883 [Viti	0.948	0.855	0.862	0.0
225425033	625	PREDICTED: protein NSP-INTERACTING KINAS	0.948	0.833	0.862	0.0
110432095	622	leucine-rich repeat receptor-like kinase	0.945	0.834	0.852	0.0
224108601	627	predicted protein [Populus trichocarpa]	0.945	0.827	0.834	0.0
449434692	623	PREDICTED: protein NSP-INTERACTING KINAS	0.947	0.834	0.827	0.0
255546957	576	BRASSINOSTEROID INSENSITIVE 1-associated	0.945	0.901	0.848	0.0
356502688	770	PREDICTED: protein NSP-INTERACTING KINAS	0.945	0.674	0.833	0.0
356498122	621	PREDICTED: protein NSP-INTERACTING KINAS	0.945	0.835	0.827	0.0
225451885	624	PREDICTED: protein NSP-INTERACTING KINAS	0.948	0.834	0.813	0.0

>gi|224099221|ref|XP_002311408.1| predicted protein [Populus trichocarpa] gi|222851228|gb|EEE88775.1| predicted protein [Populus trichocarpa]

 Score =  923 bits (2386), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 449/521 (86%), Positives = 478/521 (91%), Gaps = 2/521 (0%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           LLQ+NNISGHIP+E+G+LSKL T+DLS+N F+G IPS +S+L +LQYLRLNNNSL GAIP
Sbjct: 104 LLQDNNISGHIPSELGRLSKLKTIDLSSNNFSGQIPSALSNLNSLQYLRLNNNSLDGAIP 163

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
            SL NM+QL FLDLSYN+LS PVP  HAKTFNI GN LIC  G E+ C GT P+P S AL
Sbjct: 164 ASLVNMTQLTFLDLSYNDLSTPVPPVHAKTFNIVGNPLIC--GTEQGCAGTTPVPQSVAL 221

Query: 149 NNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREE 208
           NNS NS+PSG  K  KIALA GSSLGCI LL+LGFGF+LWWRQRHNQQIFFDVNEQ  EE
Sbjct: 222 NNSQNSQPSGNNKSHKIALAFGSSLGCICLLVLGFGFILWWRQRHNQQIFFDVNEQHNEE 281

Query: 209 VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE 268
           + LGNL+ F FKELQ AT+NFSSKNL+GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE
Sbjct: 282 LNLGNLRSFQFKELQVATNNFSSKNLIGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE 341

Query: 269 IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR 328
           IQFQTEVEMISLAVHRNLLRL GFCMTTTERLLVYPYMSNGSVA+RLKAKP+LDW TRKR
Sbjct: 342 IQFQTEVEMISLAVHRNLLRLYGFCMTTTERLLVYPYMSNGSVATRLKAKPALDWGTRKR 401

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           IALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAV
Sbjct: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAV 461

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK+ NQKGA+LDWVKKIH
Sbjct: 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKSTNQKGALLDWVKKIH 521

Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWA 508
           QEKKLE+LVDKDLKNNYDRIELEE+VQVALLCTQYLPS RPKMSEVVRMLEGDGLAEKW 
Sbjct: 522 QEKKLELLVDKDLKNNYDRIELEEIVQVALLCTQYLPSHRPKMSEVVRMLEGDGLAEKWE 581

Query: 509 ASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
           ASQ+AE TRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR
Sbjct: 582 ASQRAEETRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 622

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147815751|emb|CAN63733.1| hypothetical protein VITISV_025883 [Vitis vinifera]

 Score =  911 bits (2354), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 450/522 (86%), Positives = 484/522 (92%), Gaps = 1/522 (0%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           LLQ+N+ISG IP+E+GKLSKL  LDLSNNFF G IP+++SHL++LQYLRLNNNSL+GAIP
Sbjct: 88  LLQDNSISGPIPSELGKLSKLHLLDLSNNFFNGEIPTSLSHLKSLQYLRLNNNSLSGAIP 147

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFG-TAPMPLSFA 147
            SL+NM+ LAFLD+SYNNLSGPVP F A+TFNI GN LIC TG E+DCFG   P+P+S +
Sbjct: 148 SSLANMTHLAFLDMSYNNLSGPVPGFAARTFNIVGNPLICPTGTEKDCFGRPTPLPVSIS 207

Query: 148 LNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRRE 207
           +NNS +S+PS  PK  K+ALA GSSLGCI LLILGFGFLLWWRQRHNQQIFFDVNEQ RE
Sbjct: 208 MNNSQSSQPSARPKSHKVALAFGSSLGCICLLILGFGFLLWWRQRHNQQIFFDVNEQYRE 267

Query: 208 EVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 267
           EVCLGNL+RF FKELQ AT+NFSSKN++GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG
Sbjct: 268 EVCLGNLRRFPFKELQIATNNFSSKNILGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 327

Query: 268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
            IQFQTEVEMISLAVHRNLLRL GFCMTTTERLLVYPYMSNGSVA RLKAKP+LDW+TRK
Sbjct: 328 VIQFQTEVEMISLAVHRNLLRLYGFCMTTTERLLVYPYMSNGSVAYRLKAKPALDWSTRK 387

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
           RIALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTA
Sbjct: 388 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHRDSHVTTA 447

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
           VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+G RALEFGK ANQKGAMLDWVKKI
Sbjct: 448 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEFGKAANQKGAMLDWVKKI 507

Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKW 507
           HQEKKL+MLVDKDLK NYDRIELEEMVQVALLCTQYLPS RPKMSEVVRMLEGDGLAEKW
Sbjct: 508 HQEKKLDMLVDKDLKANYDRIELEEMVQVALLCTQYLPSHRPKMSEVVRMLEGDGLAEKW 567

Query: 508 AASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
            A+Q+AEATR +ANEFSSSERYSDLTDDSSLLVQAMELSGPR
Sbjct: 568 EATQRAEATRCKANEFSSSERYSDLTDDSSLLVQAMELSGPR 609

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225425033|ref|XP_002269902.1| PREDICTED: protein NSP-INTERACTING KINASE 1 [Vitis vinifera] gi|297738231|emb|CBI27432.3| unnamed protein product [Vitis vinifera]

 Score =  910 bits (2353), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 450/522 (86%), Positives = 484/522 (92%), Gaps = 1/522 (0%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           LLQ+N+ISG IP+E+GKLSKL  LDLSNNFF G IP+++SHL++LQYLRLNNNSL+GAIP
Sbjct: 104 LLQDNSISGPIPSELGKLSKLHLLDLSNNFFNGEIPTSLSHLKSLQYLRLNNNSLSGAIP 163

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFG-TAPMPLSFA 147
            SL+NM+ LAFLD+SYNNLSGPVP F A+TFNI GN LIC TG E+DCFG   P+P+S +
Sbjct: 164 SSLANMTHLAFLDMSYNNLSGPVPGFAARTFNIVGNPLICPTGTEKDCFGRPTPLPVSIS 223

Query: 148 LNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRRE 207
           +NNS +S+PS  PK  K+ALA GSSLGCI LLILGFGFLLWWRQRHNQQIFFDVNEQ RE
Sbjct: 224 MNNSQSSQPSARPKSHKVALAFGSSLGCICLLILGFGFLLWWRQRHNQQIFFDVNEQYRE 283

Query: 208 EVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 267
           EVCLGNL+RF FKELQ AT+NFSSKN++GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG
Sbjct: 284 EVCLGNLRRFPFKELQIATNNFSSKNILGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 343

Query: 268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
            IQFQTEVEMISLAVHRNLLRL GFCMTTTERLLVYPYMSNGSVA RLKAKP+LDW+TRK
Sbjct: 344 VIQFQTEVEMISLAVHRNLLRLYGFCMTTTERLLVYPYMSNGSVAYRLKAKPALDWSTRK 403

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
           RIALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTA
Sbjct: 404 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHRDSHVTTA 463

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
           VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+G RALEFGK ANQKGAMLDWVKKI
Sbjct: 464 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEFGKAANQKGAMLDWVKKI 523

Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKW 507
           HQEKKL+MLVDKDLK NYDRIELEEMVQVALLCTQYLPS RPKMSEVVRMLEGDGLAEKW
Sbjct: 524 HQEKKLDMLVDKDLKANYDRIELEEMVQVALLCTQYLPSHRPKMSEVVRMLEGDGLAEKW 583

Query: 508 AASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
            A+Q+AEATR +ANEFSSSERYSDLTDDSSLLVQAMELSGPR
Sbjct: 584 EATQRAEATRCKANEFSSSERYSDLTDDSSLLVQAMELSGPR 625

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110432095|gb|ABG73621.1| leucine-rich repeat receptor-like kinase [Populus tomentosa]

 Score =  909 bits (2350), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 444/521 (85%), Positives = 473/521 (90%), Gaps = 2/521 (0%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           LLQ+NNISGHIP+E+G+L KL T+DLS+N F+G IPS +S+L  LQYLRLNNNSL GAIP
Sbjct: 104 LLQDNNISGHIPSELGRLPKLKTIDLSSNNFSGQIPSALSNLNNLQYLRLNNNSLDGAIP 163

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
            SL NM+QL FLDLSYN+LS PVP  HAKTFNI GN  IC  G E+ C GT P+P S AL
Sbjct: 164 ASLVNMTQLTFLDLSYNDLSTPVPPVHAKTFNIVGNPQIC--GTEQGCAGTTPVPQSVAL 221

Query: 149 NNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREE 208
           NNS NS+PSG  K  KIALA GSSLGCI LL+LGFGF+LWWRQRHNQQIFFDVNEQ  EE
Sbjct: 222 NNSQNSQPSGNNKSHKIALAFGSSLGCICLLVLGFGFILWWRQRHNQQIFFDVNEQHNEE 281

Query: 209 VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE 268
           + LGNL+ F FKELQ AT+NFSSKNL+GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 
Sbjct: 282 LSLGNLRSFQFKELQVATNNFSSKNLIGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGV 341

Query: 269 IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR 328
           IQFQTEVEMISLAVHRNLLRL GFCMTTTERLLVYPYMSNGSVA+RLKAKP+LDW TRKR
Sbjct: 342 IQFQTEVEMISLAVHRNLLRLHGFCMTTTERLLVYPYMSNGSVATRLKAKPALDWGTRKR 401

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           IALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAV
Sbjct: 402 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHRDSHVTTAV 461

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK+ NQKGA+LDWVKKIH
Sbjct: 462 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKSTNQKGALLDWVKKIH 521

Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWA 508
            EKKLE+LVDKDLKNNYDRIELEE+VQVALLCTQYLPS RPKMSEVVRMLEGDGLAEKW 
Sbjct: 522 LEKKLELLVDKDLKNNYDRIELEEIVQVALLCTQYLPSHRPKMSEVVRMLEGDGLAEKWE 581

Query: 509 ASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
           ASQ+AE +RSRANEFSSSERYSDLTDDSSLLVQAMELSGPR
Sbjct: 582 ASQRAEESRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 622

Source: Populus tomentosa

Species: Populus tomentosa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108601|ref|XP_002314905.1| predicted protein [Populus trichocarpa] gi|222863945|gb|EEF01076.1| predicted protein [Populus trichocarpa]

 Score =  898 bits (2320), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/526 (83%), Positives = 472/526 (89%), Gaps = 7/526 (1%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL-----RLNNNSL 83
           LLQ+NNISGHIP E+GKL KL T+DLS+N F+G IPST+S+L +L YL     RLNNNSL
Sbjct: 104 LLQDNNISGHIPAELGKLPKLKTIDLSSNNFSGQIPSTLSNLNSLHYLGIWIRRLNNNSL 163

Query: 84  TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMP 143
            GAIP SL+NM+QL FLDLSYNNL+ PVP  HAKTFNI GN+LIC  G E+ C GT P+P
Sbjct: 164 NGAIPASLANMTQLTFLDLSYNNLNTPVPPVHAKTFNIVGNTLIC--GTEQGCAGTTPVP 221

Query: 144 LSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNE 203
            S A++NS NS+PSG  K  KIALA GSSLGCI LL+LGFGF+LWWRQRHNQQIFFD+NE
Sbjct: 222 QSLAVHNSQNSQPSGNSKSHKIALAFGSSLGCICLLVLGFGFILWWRQRHNQQIFFDINE 281

Query: 204 QRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGN 263
           Q  EE+ LGNL+RF FKELQ ATSNFSSKNL+GKGGFGNVYKG+LQDGTVVAVKRLKDGN
Sbjct: 282 QHHEELNLGNLRRFQFKELQIATSNFSSKNLIGKGGFGNVYKGHLQDGTVVAVKRLKDGN 341

Query: 264 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW 323
           AIGGEIQFQTEVEMISLAVHRNLLRL G CMTTTERLLVYPYMSNGSVA+RLKAKP LDW
Sbjct: 342 AIGGEIQFQTEVEMISLAVHRNLLRLYGLCMTTTERLLVYPYMSNGSVATRLKAKPVLDW 401

Query: 324 ATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 383
            TRKR+ALGA RGLLYLHEQCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSH
Sbjct: 402 GTRKRVALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSH 461

Query: 384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 443
           VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK+ NQKGA+LDW
Sbjct: 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKSTNQKGALLDW 521

Query: 444 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL 503
           VKKIHQEKKLE+LVDKDLKNNYD IEL+E VQVALLCTQ LPS RPKMSEVVRMLEGDGL
Sbjct: 522 VKKIHQEKKLELLVDKDLKNNYDPIELDETVQVALLCTQNLPSHRPKMSEVVRMLEGDGL 581

Query: 504 AEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
           AEKW ASQ+AEATR+R  EFSSSERYSDLTDDSSLLVQAMELSGPR
Sbjct: 582 AEKWEASQRAEATRTRTIEFSSSERYSDLTDDSSLLVQAMELSGPR 627

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449434692|ref|XP_004135130.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Cucumis sativus] gi|449478323|ref|XP_004155284.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Cucumis sativus]

 Score =  896 bits (2316), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 432/522 (82%), Positives = 475/522 (90%), Gaps = 2/522 (0%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           LLQ+NNISG IP E+G +  L TLDLS+N F G IP+++SHL++LQYLRLNNNSL+GAIP
Sbjct: 103 LLQDNNISGTIPMELGNIPSLDTLDLSSNGFHGEIPTSLSHLKSLQYLRLNNNSLSGAIP 162

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
            SL+NM+QLA LDLS+NNLSGP+P   AKT+N+ GNSLIC+ G+E  C GTAP PL FA+
Sbjct: 163 SSLANMTQLALLDLSFNNLSGPLPRLLAKTYNLAGNSLICSPGSEHSCNGTAP-PLLFAV 221

Query: 149 NNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVN-EQRRE 207
           N S NS+PSG  KG K+ALA GSSLGC+ LL +GFGF +WWRQRHNQQIFFDVN +QR E
Sbjct: 222 NTSQNSQPSGRSKGHKLALAFGSSLGCVFLLTIGFGFFIWWRQRHNQQIFFDVNNDQRFE 281

Query: 208 EVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 267
           EVCLGNL+ F F+ELQ+AT+NFSSKNLVGKGGFGNVYKGYLQDGT++AVKRLKDGNA+ G
Sbjct: 282 EVCLGNLRIFQFRELQAATNNFSSKNLVGKGGFGNVYKGYLQDGTIIAVKRLKDGNAMRG 341

Query: 268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
           EIQFQTEVEMISLAVHRNLLRL GFCMTTTERLLVYPYMSNGSVASRLKAKP+LDW+TRK
Sbjct: 342 EIQFQTEVEMISLAVHRNLLRLYGFCMTTTERLLVYPYMSNGSVASRLKAKPALDWSTRK 401

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
           RIALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTA
Sbjct: 402 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHRDSHVTTA 461

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
           VRGTVGHIAPEYLSTGQSSEKTDVFG+GILLLELI+G RALEFGK  NQKGAMLDWVKKI
Sbjct: 462 VRGTVGHIAPEYLSTGQSSEKTDVFGYGILLLELITGQRALEFGKAVNQKGAMLDWVKKI 521

Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKW 507
           HQEKKLE+LVDKDL++NYDRIELEEMVQVALLCTQYLP+ RPKMSEVVRMLEGDGLAEKW
Sbjct: 522 HQEKKLEILVDKDLRSNYDRIELEEMVQVALLCTQYLPTTRPKMSEVVRMLEGDGLAEKW 581

Query: 508 AASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
            ASQ+A+A R R NEFSSSERYSDLTDDSSLL QAMELSGPR
Sbjct: 582 EASQRADANRYRVNEFSSSERYSDLTDDSSLLAQAMELSGPR 623

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255546957|ref|XP_002514536.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223546140|gb|EEF47642.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  887 bits (2292), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 443/522 (84%), Positives = 476/522 (91%), Gaps = 3/522 (0%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           LLQNNN SG IP+EIGKLSKL TLDLSNNFF   IP+T S L+ LQYLRLNNNSL+G IP
Sbjct: 57  LLQNNNFSGQIPSEIGKLSKLKTLDLSNNFFNSQIPTTFSTLKNLQYLRLNNNSLSGVIP 116

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
           PSL+NMSQL F+DLS+NNL+ P+P+FHAKTFNI GN LIC T  +E C G    PLS  L
Sbjct: 117 PSLANMSQLTFVDLSFNNLTAPLPAFHAKTFNIVGNPLICRT--QEQCSGAIQSPLSMNL 174

Query: 149 NNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREE 208
           NNS NS+PSG  KG KIALA GSSLGCI LLILGFGFLLWWRQRHNQQIFFDVNEQR+EE
Sbjct: 175 NNSQNSQPSGSGKGHKIALAFGSSLGCICLLILGFGFLLWWRQRHNQQIFFDVNEQRQEE 234

Query: 209 VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGN-AIGG 267
           + LGNLKRF FKELQ AT NFSSKNL+G+GGFGNVYKG+LQDG+VVAVKRLKDGN +IGG
Sbjct: 235 LNLGNLKRFQFKELQVATKNFSSKNLIGQGGFGNVYKGHLQDGSVVAVKRLKDGNGSIGG 294

Query: 268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
           E QFQTEVEMISLAVHRNLLRL GFCMT+TERLLVYPYMSNGSVASRLKAKP+LDW+TRK
Sbjct: 295 ETQFQTEVEMISLAVHRNLLRLYGFCMTSTERLLVYPYMSNGSVASRLKAKPALDWSTRK 354

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
           RIALG ARGLLYLHEQCDPKIIHRDVKAANILLDEY EAVVGDFGLAKLLDH DSHVTTA
Sbjct: 355 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEYCEAVVGDFGLAKLLDHRDSHVTTA 414

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
           VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL+ GLRALEFGK+ANQKGAMLDW+KKI
Sbjct: 415 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVHGLRALEFGKSANQKGAMLDWIKKI 474

Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKW 507
           HQ+KKLE+LVDK+LKNNYD IELEE+V+VALLCTQ++P  RPKMSEVVRMLEGDGLAEKW
Sbjct: 475 HQDKKLELLVDKNLKNNYDPIELEEIVRVALLCTQFIPGHRPKMSEVVRMLEGDGLAEKW 534

Query: 508 AASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
            ASQ+AEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR
Sbjct: 535 EASQRAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 576

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356502688|ref|XP_003520149.1| PREDICTED: protein NSP-INTERACTING KINASE 2-like [Glycine max]

 Score =  876 bits (2264), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 434/521 (83%), Positives = 470/521 (90%), Gaps = 2/521 (0%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           LLQ+NNI+G IP EIG+L KL TLDLS+NFFTG +P T+S+++ L YLRLNNNSLTG IP
Sbjct: 252 LLQDNNITGPIPFEIGRLQKLQTLDLSDNFFTGQLPDTLSYMKGLHYLRLNNNSLTGPIP 311

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
            SL+NM+QLAFLD+SYNNLS PVP  +AKTFNI GN  ICATG E++CF T  +P   A 
Sbjct: 312 SSLANMTQLAFLDISYNNLSEPVPRINAKTFNIIGNPQICATGVEKNCFRTTSIP--SAP 369

Query: 149 NNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREE 208
           NNS +S+ +  PK  K ALA  SSL CI LLILG GFL+WWRQR+N+QIFFDVNEQ REE
Sbjct: 370 NNSQDSQSTKRPKSHKFALAFASSLSCICLLILGLGFLIWWRQRYNKQIFFDVNEQHREE 429

Query: 209 VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE 268
           VCLGNLK+FHF+ELQ AT+NFSSKNL+GKGGFGNVYKGY+QDGTV+AVKRLKDGNAIGGE
Sbjct: 430 VCLGNLKKFHFRELQLATNNFSSKNLIGKGGFGNVYKGYVQDGTVIAVKRLKDGNAIGGE 489

Query: 269 IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR 328
           IQFQTEVEMISLAVHRNLLRL GFCMT TERLLVYPYMSNGSVASRLKAKP+LDWATRKR
Sbjct: 490 IQFQTEVEMISLAVHRNLLRLYGFCMTATERLLVYPYMSNGSVASRLKAKPALDWATRKR 549

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           IALGA RGLLYLHEQCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAV
Sbjct: 550 IALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHRDSHVTTAV 609

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG RALEFGK ANQKGAMLDWVKKIH
Sbjct: 610 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGQRALEFGKAANQKGAMLDWVKKIH 669

Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWA 508
           QEKK+++LVDKDLKNNYDRIEL+E+VQVALLCTQYLPS RPKMSEVVRMLEGDGLAEKW 
Sbjct: 670 QEKKIDLLVDKDLKNNYDRIELDEIVQVALLCTQYLPSHRPKMSEVVRMLEGDGLAEKWE 729

Query: 509 ASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
           ASQ AE+TRSR NE SSSERYSDLTDDSSLL QAMELSGPR
Sbjct: 730 ASQSAESTRSRGNELSSSERYSDLTDDSSLLAQAMELSGPR 770

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356498122|ref|XP_003517902.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Glycine max]

 Score =  873 bits (2256), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 431/521 (82%), Positives = 469/521 (90%), Gaps = 2/521 (0%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           LLQ+NNI+G IP+EIG+L KL TLDLS+NFFTG +P ++SH++ L YLRLNNNSLTG IP
Sbjct: 103 LLQDNNITGPIPSEIGRLQKLQTLDLSDNFFTGQLPDSLSHMKGLHYLRLNNNSLTGPIP 162

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
            SL+NM+QLAFLD+SYNNLS PVP  +AKTFNI GN  IC TG E++C  T  +P   A 
Sbjct: 163 SSLANMTQLAFLDISYNNLSEPVPRINAKTFNIVGNPQICVTGVEKNCSRTTSIP--SAP 220

Query: 149 NNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREE 208
           NNS +S+ +  PK  K+ALA  SSL CI LLILG GFL+WWRQR+N+QIFF VNEQ REE
Sbjct: 221 NNSQDSQSTKRPKSHKVALAFASSLSCICLLILGLGFLIWWRQRYNKQIFFVVNEQHREE 280

Query: 209 VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE 268
           VCLGNLK+FHF+ELQ AT+NFSSKNL+GKGGFGNVYKGYLQDGTV+AVKRLKDGNAIGGE
Sbjct: 281 VCLGNLKKFHFRELQLATNNFSSKNLIGKGGFGNVYKGYLQDGTVIAVKRLKDGNAIGGE 340

Query: 269 IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR 328
           IQFQTEVEMISLAVHRNLLRL GFCMT TERLLVYPYMSNGSVASRLKAKP+LDW TRKR
Sbjct: 341 IQFQTEVEMISLAVHRNLLRLYGFCMTATERLLVYPYMSNGSVASRLKAKPALDWPTRKR 400

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           IALGA RGLLYLHEQCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAV
Sbjct: 401 IALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHRDSHVTTAV 460

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG RALEFGK ANQKGAMLDWVKKIH
Sbjct: 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGQRALEFGKAANQKGAMLDWVKKIH 520

Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWA 508
           QEKK+++LVDKDLKNNYDRIEL+E+VQVALLCTQYLPS RPKMSEVVRMLEGDGLAEKW 
Sbjct: 521 QEKKIDLLVDKDLKNNYDRIELDEIVQVALLCTQYLPSYRPKMSEVVRMLEGDGLAEKWE 580

Query: 509 ASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
           ASQ+AE+TRSR NE SSSERYSDLTDDSSLL QAMELSGPR
Sbjct: 581 ASQRAESTRSRGNELSSSERYSDLTDDSSLLAQAMELSGPR 621

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225451885|ref|XP_002278965.1| PREDICTED: protein NSP-INTERACTING KINASE 1 [Vitis vinifera]

 Score =  868 bits (2244), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/521 (81%), Positives = 467/521 (89%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           LLQNNNI+G IP E+G+LSKL TLDLSNNFFT  +PS++ HL +LQYLRLNNNSL+G  P
Sbjct: 104 LLQNNNITGPIPQELGRLSKLHTLDLSNNFFTDEVPSSLGHLTSLQYLRLNNNSLSGPFP 163

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
            SL+NM+QLAFLDLS+NNLSGPVP F AKTFNI GN LICATG+E++C+GT  MP+S  L
Sbjct: 164 VSLANMTQLAFLDLSFNNLSGPVPRFPAKTFNIVGNPLICATGSEQECYGTTLMPMSMTL 223

Query: 149 NNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREE 208
           N+S  + P+   K  K+ALA G+SLGCI LLI G G LLWWRQRHNQQ+FFDVN++  EE
Sbjct: 224 NSSQTALPTRRSKNHKLALAFGTSLGCICLLIFGGGLLLWWRQRHNQQMFFDVNDRHHEE 283

Query: 209 VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE 268
           V LGNLKRF F+ELQ AT NFSSKN++GKGGFGNVYKGYLQDGT+VAVKRLKDGNA+GGE
Sbjct: 284 VSLGNLKRFQFRELQIATDNFSSKNILGKGGFGNVYKGYLQDGTIVAVKRLKDGNAVGGE 343

Query: 269 IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR 328
           IQFQTEVEMISLAVHRNLLRL GFC+TT+ERLLVYPYMSNGSVASRLK KP LDW TRKR
Sbjct: 344 IQFQTEVEMISLAVHRNLLRLYGFCITTSERLLVYPYMSNGSVASRLKGKPVLDWGTRKR 403

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           IALGAARGLLYLHEQCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAV
Sbjct: 404 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAV 463

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+G RALEFGK ANQKGAMLDWVKKIH
Sbjct: 464 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALEFGKAANQKGAMLDWVKKIH 523

Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWA 508
           QEK+LE+LVDKDLK+ YDR+ELEEMVQVALLCTQYLP  RPKMSEVV+MLEGDGLAE+W 
Sbjct: 524 QEKRLEILVDKDLKHFYDRVELEEMVQVALLCTQYLPGHRPKMSEVVQMLEGDGLAERWE 583

Query: 509 ASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
           ASQ+ E T+ + +E SSSERYSDLTDDSSLLVQAMELSGPR
Sbjct: 584 ASQRGEVTKCKPHELSSSERYSDLTDDSSLLVQAMELSGPR 624

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	549
TAIR|locus:2146102	638	NIK1 "NSP-interacting kinase 1	0.948	0.816	0.738	1.2e-202
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.943	0.819	0.625	1.7e-171
TAIR|locus:2118811	648	SARK "SENESCENCE-ASSOCIATED RE	0.865	0.733	0.658	1.3e-167
TAIR|locus:2061466	634	AT2G23950 [Arabidopsis thalian	0.932	0.807	0.624	1.1e-165
TAIR|locus:2013021	625	SERK1 "somatic embryogenesis r	0.938	0.824	0.587	3.3e-150
TAIR|locus:2026097	628	SERK2 "somatic embryogenesis r	0.934	0.816	0.577	2.4e-147
TAIR|locus:2171973	614	AT5G45780 [Arabidopsis thalian	0.914	0.817	0.544	1.1e-140
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.918	0.812	0.551	4.7e-135
TAIR|locus:2145407	613	AT5G10290 [Arabidopsis thalian	0.912	0.817	0.516	2.3e-126
TAIR|locus:2040471	601	SERK5 "somatic embryogenesis r	0.945	0.863	0.510	5.7e-123

TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1961 (695.4 bits), Expect = 1.2e-202, P = 1.2e-202
 Identities = 390/528 (73%), Positives = 434/528 (82%)

Query:    29 LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
             LLQNNNI G IP EIG+L++L TLDLS+NFF G IP +V +L++LQYLRLNNNSL+G  P
Sbjct:   111 LLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFP 170

Query:    89 PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
              SLSNM+QLAFLDLSYNNLSGPVP F AKTF+I GN LIC TG E DC GT  +P+S  L
Sbjct:   171 LSLSNMTQLAFLDLSYNNLSGPVPRFAAKTFSIVGNPLICPTGTEPDCNGTTLIPMSMNL 230

Query:   149 NNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXXXWWRQRHNQQIFFDVNE-QRRE 207
             N +     +G  +  K+                      WWRQRHNQ  FFDV +    E
Sbjct:   231 NQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHE 290

Query:   208 EVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 267
             EV LGNL+RF F+ELQ AT+NFSSKNL+GKGG+GNVYKG L D TVVAVKRLKDG A+GG
Sbjct:   291 EVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGG 350

Query:   268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
             EIQFQTEVEMISLAVHRNLLRL GFC+T TE+LLVYPYMSNGSVASR+KAKP LDW+ RK
Sbjct:   351 EIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMKAKPVLDWSIRK 410

Query:   328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
             RIA+GAARGL+YLHEQCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTA
Sbjct:   411 RIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTA 470

Query:   388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
             VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL++G RA EFGK ANQKG MLDWVKKI
Sbjct:   471 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDWVKKI 530

Query:   448 HQEKKLEMLVDKDL--KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAE 505
             HQEKKLE+LVDK+L  K +YD IEL+EMV+VALLCTQYLP  RPKMSEVVRMLEGDGLAE
Sbjct:   531 HQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAE 590

Query:   506 KWAASQKAEATR---SRANEF-SSSERYSDLTDDSSLLVQAMELSGPR 549
             KW ASQ++++     +R NE  SSS+RYSDLTDDSSLLVQAMELSGPR
Sbjct:   591 KWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSSLLVQAMELSGPR 638

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0051607 "defense response to virus" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009736 "cytokinin mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1667 (591.9 bits), Expect = 1.7e-171, P = 1.7e-171
 Identities = 333/532 (62%), Positives = 400/532 (75%)

Query:    29 LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
             +LQNN I+G IP  IG+L KL +LDLSNN FTG IP+++  L+ L YLRLNNNSL G  P
Sbjct:   104 VLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCP 163

Query:    89 PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
              SLS +  L  +D+SYNNLSG +P   A+TF + GN+LIC   A  +C    P PL+   
Sbjct:   164 ESLSKIEGLTLVDISYNNLSGSLPKVSARTFKVIGNALICGPKAVSNC-SAVPEPLTLP- 221

Query:   149 NNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXXXWWRQRHNQQIFFDVNEQRREE 208
              + P+   +    G  +                      WWR R N+QIFFDVNEQ   E
Sbjct:   222 QDGPDESGT-RTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPE 280

Query:   209 VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE 268
             V LG+LKR+ FKEL+SAT++F+SKN++G+GG+G VYKG+L DGT+VAVKRLKD N  GGE
Sbjct:   281 VSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGE 340

Query:   269 IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----AKPSLDWA 324
             +QFQTEVE ISLA+HRNLLRL GFC +  ER+LVYPYM NGSVASRLK     +P+LDW+
Sbjct:   341 VQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWS 400

Query:   325 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 384
              RK+IA+G ARGL+YLHEQCDPKIIHRDVKAANILLDE +EAVVGDFGLAKLLDH DSHV
Sbjct:   401 RRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 460

Query:   385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
             TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+G +AL+FG++A+QKG MLDWV
Sbjct:   461 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWV 520

Query:   445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 504
             KK+HQE KL+ L+DKDL + +DR+ELEE+VQVALLCTQ+ PS RPKMSEV++MLEGDGLA
Sbjct:   521 KKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLA 580

Query:   505 EKWAASQKAEATRSRA----NEFSSSER---YSDLTDDSSLLVQAMELSGPR 549
             E+W A+Q                SSS R   YSD   +SSL+V+A+ELSGPR
Sbjct:   581 ERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQESSLVVEAIELSGPR 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)]

 Score = 1605 (570.0 bits), Expect = 1.3e-167, Sum P(2) = 1.3e-167
 Identities = 318/483 (65%), Positives = 380/483 (78%)

Query:    30 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             LQNNNISG IP E+G L KL TLDLSNN F+G IP ++  L +LQYLRLNNNSL+G  P 
Sbjct:   108 LQNNNISGKIPPELGFLPKLQTLDLSNNRFSGDIPVSIDQLSSLQYLRLNNNSLSGPFPA 167

Query:    90 SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTA-PMPLSFAL 148
             SLS +  L+FLDLSYNNLSGPVP F A+TFN+ GN LIC +   E C G+    PLS +L
Sbjct:   168 SLSQIPHLSFLDLSYNNLSGPVPKFPARTFNVAGNPLICRSNPPEICSGSINASPLSVSL 227

Query:   149 NNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXXXWWRQRHNQQIFFDVNEQRREE 208
             ++S     SG  +  ++                      W+R++  + +  ++N+++ E 
Sbjct:   228 SSS-----SGR-RSNRLAIALSVSLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQEEG 281

Query:   209 VC-LGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 267
             +  LGNL+ F F+EL   T  FSSKN++G GGFGNVY+G L DGT+VAVKRLKD N   G
Sbjct:   282 LQGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSG 341

Query:   268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
             + QF+ E+EMISLAVH+NLLRLIG+C T+ ERLLVYPYM NGSVAS+LK+KP+LDW  RK
Sbjct:   342 DSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKSKPALDWNMRK 401

Query:   328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
             RIA+GAARGLLYLHEQCDPKIIHRDVKAANILLDE +EAVVGDFGLAKLL+H DSHVTTA
Sbjct:   402 RIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHADSHVTTA 461

Query:   388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
             VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+GLRALEFGKT +QKGAML+WV+K+
Sbjct:   462 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAMLEWVRKL 521

Query:   448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKW 507
             H+E K+E L+D++L  NYD+IE+ EM+QVALLCTQYLP+ RPKMSEVV MLEGDGLAE+W
Sbjct:   522 HEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLMLEGDGLAERW 581

Query:   508 AAS 510
             AAS
Sbjct:   582 AAS 584

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010150 "leaf senescence" evidence=IMP

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

GO:0048438 "floral whorl development" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)]

 Score = 1612 (572.5 bits), Expect = 1.1e-165, P = 1.1e-165
 Identities = 336/538 (62%), Positives = 397/538 (73%)

Query:    30 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             LQNNNISG IP EI  L KL TLDLSNN F+G IP +V+ L  LQYLRLNNNSL+G  P 
Sbjct:   105 LQNNNISGKIPPEICSLPKLQTLDLSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPA 164

Query:    90 SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGT-APMPLSFAL 148
             SLS +  L+FLDLSYNNL GPVP F A+TFN+ GN LIC     E C G+ +  PLS +L
Sbjct:   165 SLSQIPHLSFLDLSYNNLRGPVPKFPARTFNVAGNPLICKNSLPEICSGSISASPLSVSL 224

Query:   149 NNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXXXWWRQRHNQQIFFDVNEQRREE 208
              +S     SG  +   I                      W+R++  +     +++++ E 
Sbjct:   225 RSS-----SG--RRTNILAVALGVSLGFAVSVILSLGFIWYRKKQRRLTMLRISDKQEEG 277

Query:   209 VC-LGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG 267
             +  LGNL+ F F+EL  AT  FSSK+++G GGFGNVY+G   DGTVVAVKRLKD N   G
Sbjct:   278 LLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSG 337

Query:   268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
               QF+TE+EMISLAVHRNLLRLIG+C +++ERLLVYPYMSNGSVASRLKAKP+LDW TRK
Sbjct:   338 NSQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAKPALDWNTRK 397

Query:   328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
             +IA+GAARGL YLHEQCDPKIIHRDVKAANILLDEY+EAVVGDFGLAKLL+H DSHVTTA
Sbjct:   398 KIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTA 457

Query:   388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
             VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+G+RALEFGK+ +QKGAML+WV+K+
Sbjct:   458 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKL 517

Query:   448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKW 507
             H+E K+E LVD++L   YDRIE+ EM+QVALLCTQ+LP+ RPKMSEVV+MLEGDGLAE+W
Sbjct:   518 HKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLAERW 577

Query:   508 AASQKAE-----------ATRSRANE-----FSSSERYSDLTDDSSLLVQAMELSGPR 549
             AAS                T +  N      F SS  + D  D+ +L   AMELSGPR
Sbjct:   578 AASHDHSHFYHANMSYRTITSTDGNNQTKHLFGSSG-FEDEDDNQALDSFAMELSGPR 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1466 (521.1 bits), Expect = 3.3e-150, P = 3.3e-150
 Identities = 312/531 (58%), Positives = 372/531 (70%)

Query:    30 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             L +NNI+G IP+ +G L+ L++LDL  N F+GPIP ++  L  L++LRLNNNSLTG+IP 
Sbjct:   100 LYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPM 159

Query:    90 SLSNMSQLAFLDLSYNNLSGPVP---SFHAKT-FNITGNSLICATGAEEDCFGTAPM--P 143
             SL+N++ L  LDLS N LSG VP   SF   T  +   N  +C       C G+ P   P
Sbjct:   160 SLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPP 219

Query:   144 LSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXXXWWRQRHNQQIFFDVNE 203
               F +   P S PSG   G                         WWR+R    IFFDV  
Sbjct:   220 PPF-IQPPPVSTPSGY--GITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPA 276

Query:   204 QRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGN 263
             +   EV LG LKRF  +ELQ A+  FS+KN++G+GGFG VYKG L DGT+VAVKRLK+  
Sbjct:   277 EEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 336

Query:   264 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----AKP 319
               GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L+    ++P
Sbjct:   337 TPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQP 396

Query:   320 SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 379
              LDW TRKRIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGLAKL+D+
Sbjct:   397 PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 456

Query:   380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA 439
              D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELI+G RA +  + AN    
Sbjct:   457 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 516

Query:   440 ML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
             ML DWVK + +EKKLEMLVD DL+ NY+  ELE+++QVALLCTQ  P  RPKMSEVVRML
Sbjct:   517 MLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRML 576

Query:   499 EGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
             EGDGLAEKW   QK E  R   +   S    SD   DS+  + A+ELSGPR
Sbjct:   577 EGDGLAEKWDEWQKVEILREEID--LSPNPNSDWILDSTYNLHAVELSGPR 625

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0043234 "protein complex" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI;IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0007030 "Golgi organization" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IGI

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0009880 "embryonic pattern specification" evidence=RCA

GO:0010072 "primary shoot apical meristem specification" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0010431 "seed maturation" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045595 "regulation of cell differentiation" evidence=RCA

GO:0051301 "cell division" evidence=RCA

TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1439 (511.6 bits), Expect = 2.4e-147, P = 2.4e-147
 Identities = 308/533 (57%), Positives = 370/533 (69%)

Query:    30 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             L +NNI+G +P+++G L+ L++LDL  N FTGPIP ++  L  L++LRLNNNSLTG IP 
Sbjct:   103 LYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLRFLRLNNNSLTGPIPM 162

Query:    90 SLSNMSQLAFLDLSYNNLSGPVP---SFHAKT-FNITGNSLICATGAEEDCFGTAPM--P 143
             SL+N+  L  LDLS N LSG VP   SF   T  +   N  +C       C G+ P   P
Sbjct:   163 SLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGSPPFSPP 222

Query:   144 LSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXX--XXXXWWRQRHNQQIFFDV 201
               F     P   P+  P G                           WWR+R  Q+ FFDV
Sbjct:   223 PPFI---PPPIVPT--PGGYSATGAIAGGVAAGAALLFAAPALAFAWWRRRKPQEFFFDV 277

Query:   202 NEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKD 261
               +   EV LG LKRF  +ELQ AT +FS+KN++G+GGFG VYKG L DGT+VAVKRLK+
Sbjct:   278 PAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 337

Query:   262 GNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS- 320
                 GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L+ +P  
Sbjct:   338 ERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS 397

Query:   321 ---LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 377
                L W+ R++IALG+ARGL YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGLA+L+
Sbjct:   398 QLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLM 457

Query:   378 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK 437
             D+ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELI+G RA +  + AN  
Sbjct:   458 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD 517

Query:   438 GAML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
               ML DWVK + +EKKLEMLVD DL++NY   E+E+++QVALLCTQ  P  RPKMSEVVR
Sbjct:   518 DVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVR 577

Query:   497 MLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
             MLEGDGLAEKW   QK E  R    E SS    SD   DS+  + AMELSGPR
Sbjct:   578 MLEGDGLAEKWDEWQKVEVLRQEV-ELSSHPT-SDWILDSTDNLHAMELSGPR 628

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)]

 Score = 1376 (489.4 bits), Expect = 1.1e-140, P = 1.1e-140
 Identities = 286/525 (54%), Positives = 369/525 (70%)

Query:    29 LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
             LLQNN ++G IP+E+G+LS+L TLDLS N F+G IP+++  L  L YLRL+ N L+G +P
Sbjct:   109 LLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQVP 168

Query:    89 PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
               ++ +S L+FLDLS+NNLSGP P+  AK + I GN+ +C   ++E C    P+  +  L
Sbjct:   169 HLVAGLSGLSFLDLSFNNLSGPTPNISAKDYRIVGNAFLCGPASQELCSDATPVRNATGL 228

Query:   149 NNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXXXWWRQRHNQQIFFDVNEQRREE 208
             +   NSK   +     +                      W R R ++      + Q+  E
Sbjct:   229 SEKDNSKHHSLV----LSFAFGIVVAFIISLMFLFFWVLWHRSRLSRS-----HVQQDYE 279

Query:   209 VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE 268
               +G+LKRF F+E+Q+ATSNFS KN++G+GGFG VYKGYL +GTVVAVKRLKD     GE
Sbjct:   280 FEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKDP-IYTGE 338

Query:   269 IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----AKPSLDWA 324
             +QFQTEVEMI LAVHRNLLRL GFCMT  ER+LVYPYM NGSVA RL+     KPSLDW 
Sbjct:   339 VQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWN 398

Query:   325 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 384
              R  IALGAARGL+YLHEQC+PKIIHRDVKAANILLDE +EA+VGDFGLAKLLD  DSHV
Sbjct:   399 RRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHV 458

Query:   385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
             TTAVRGT+GHIAPEYLSTGQSSEKTDVFGFG+L+LELI+G + ++ G    +KG +L WV
Sbjct:   459 TTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWV 518

Query:   445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 504
             + +  EK+   +VD+DLK  +D + LEE+V++ALLCTQ  P+LRP+MS+V+++LEG  L 
Sbjct:   519 RTLKAEKRFAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVLEG--LV 576

Query:   505 EKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
             E+     +A A        S S  YS+  ++ S +++A+ELSGPR
Sbjct:   577 EQCEGGYEARAP-------SVSRNYSNGHEEQSFIIEAIELSGPR 614

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009560 "embryo sac egg cell differentiation" evidence=RCA

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1323 (470.8 bits), Expect = 4.7e-135, P = 4.7e-135
 Identities = 293/531 (55%), Positives = 359/531 (67%)

Query:    30 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             L +NNI+G IP E+G L +L++LDL  N  +GPIPS++  L  L++LRLNNNSL+G IP 
Sbjct:   106 LYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKLRFLRLNNNSLSGEIPM 165

Query:    90 SLSNMSQLAFLDLSYNNLSGPVP---SFHAKT-FNITGNSLICATGAEEDCFGTAPMPLS 145
             +L+++ QL  LD+S N LSG +P   SF   T  +   NSL   T   E      P P S
Sbjct:   166 TLTSV-QLQVLDISNNRLSGDIPVNGSFSLFTPISFANNSL---TDLPE------PPPTS 215

Query:   146 FALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXX-XXXXXWWRQRHNQQIFFDVNEQ 204
              +    P   PSG   GQ                         WW +R  Q  FFDV  +
Sbjct:   216 TSPTPPP---PSG---GQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHFFDVPAE 269

Query:   205 RREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA 264
                EV LG LKRF  +EL  AT NFS+KN++G+GGFG VYKG L DG +VAVKRLK+   
Sbjct:   270 EDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERT 329

Query:   265 IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP----S 320
              GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L+ +P    +
Sbjct:   330 KGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPA 389

Query:   321 LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 380
             LDW  RK IALG+ARGL YLH+ CD KIIHRDVKAANILLDE +EAVVGDFGLAKL+++ 
Sbjct:   390 LDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYN 449

Query:   381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
             DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELI+G +A +  + AN    M
Sbjct:   450 DSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIM 509

Query:   441 L-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             L DWVK++ +EKKLE LVD +L+  Y   E+E+++Q+ALLCTQ     RPKMSEVVRMLE
Sbjct:   510 LLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLE 569

Query:   500 GDGLAEKWAASQKAEATRSRANEFSSSERYSD-LTDDSSLLVQAMELSGPR 549
             GDGLAE+W   QK E      N  +     +D L   S+ L++    SGPR
Sbjct:   570 GDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 620

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)]

 Score = 1241 (441.9 bits), Expect = 2.3e-126, P = 2.3e-126
 Identities = 275/532 (51%), Positives = 348/532 (65%)

Query:    30 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             L+ N I+G IP + G L+ L +LDL +N  TG IPST+ +L+ LQ+L L+ N L G IP 
Sbjct:   101 LKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPE 160

Query:    90 SLSNMSQLAFLDLSYNNLSGPVPS--FHAKTFNITGNSLICATGAEEDCFGTAPMP-LSF 146
             SL+ +  L  L L  N+LSG +P   F    +N T N+L        +C G  P P +S 
Sbjct:   161 SLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNL--------NCGGRQPHPCVSA 212

Query:   147 ALNNSPNSKP-SGMPKGQKIXXXXXXXXXXXXXXXXXXXXXXWWRQRHN---QQIFFDVN 202
               ++  +SKP +G+  G                         + + RH    + +F DV 
Sbjct:   213 VAHSGDSSKPKTGIIAG---------VVAGVTVVLFGILLFLFCKDRHKGYRRDVFVDVA 263

Query:   203 EQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDG 262
              +    +  G LKRF ++ELQ AT NFS KN++G+GGFG VYKG L D T VAVKRL D 
Sbjct:   264 GEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDF 323

Query:   263 NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----AK 318
              + GG+  FQ EVEMIS+AVHRNLLRLIGFC T TERLLVYP+M N S+A RL+      
Sbjct:   324 ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGD 383

Query:   319 PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 378
             P LDW TRKRIALGAARG  YLHE C+PKIIHRDVKAAN+LLDE +EAVVGDFGLAKL+D
Sbjct:   384 PVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 443

Query:   379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG 438
                ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL++G RA++F +   +  
Sbjct:   444 VRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 503

Query:   439 AML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 497
              +L D VKK+ +EK+L  +VDK+L   Y + E+E M+QVALLCTQ  P  RP MSEVVRM
Sbjct:   504 VLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRM 563

Query:   498 LEGDGLAEKWAASQKAEATRSRANEFSSSERYSDLTDDSSLLVQAMELSGPR 549
             LEG+GLAE+W   Q  E TR   +EF   +R  D  +DS     A+ELSG R
Sbjct:   564 LEGEGLAERWEEWQNVEVTRR--HEFERLQRRFDWGEDSMHNQDAIELSGGR 613

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1209 (430.6 bits), Expect = 5.7e-123, P = 5.7e-123
 Identities = 274/537 (51%), Positives = 341/537 (63%)

Query:    25 SFGRL-LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 83
             S  RL L + N+SG +  ++ +L  L  L+L NN  TG IP  +  L  L  L L  N++
Sbjct:    71 SVTRLDLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNI 130

Query:    84 TGAIPPSLSNMSQLAFLDLSYNNLSGPVP-SFHAKTFNIT--GNSLICATGAEEDCFGTA 140
             +G IP SL  + +L FL L  N+LSG +P S  A   ++    N+ +         F   
Sbjct:   131 SGPIPSSLGKLGKLRFLRLYNNSLSGEIPRSLTALPLDVLDISNNRLSGDIPVNGSFSQF 190

Query:   141 PMPLSFALNN-SPN-SKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXXXWWRQRHNQQIF 198
                +SFA N   P  + PS  P G                         WW +R  Q  F
Sbjct:   191 TS-MSFANNKLRPRPASPSPSPSG-----TSAAIVVGVAAGAALLFALAWWLRRKLQGHF 244

Query:   199 FDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKR 258
              DV  +   EV LG  KRF  +EL  AT  FS +N++GKG FG +YKG L D T+VAVKR
Sbjct:   245 LDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKR 304

Query:   259 LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK 318
             L +    GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L+ +
Sbjct:   305 LNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 364

Query:   319 P----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 374
             P    +LDW  RK IALG+ARGL YLH+ CD KIIH DVKAANILLDE +EAVVGDFGLA
Sbjct:   365 PEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLA 424

Query:   375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTA 434
             KL+++ DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELI+G +A +  + A
Sbjct:   425 KLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLA 484

Query:   435 NQKGAML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSE 493
             N    ML DWVK++ +EKKLE LVD +L+  Y   E+E+++Q+ALLCTQ     RPKMSE
Sbjct:   485 NDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSE 544

Query:   494 VVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSD-LTDDSSLLVQAMELSGPR 549
             VVRMLEGDGLAE+W   QK E      N  +     +D L   S+ L++    SGPR
Sbjct:   545 VVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 601

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8RY65	NIK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.7942	0.9489	0.8204	yes	no
Q9LFS4	NIK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.7575	0.9489	0.8166	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pg.C_LG_VIII0972 hypothetical protein (622 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	549
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-46
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-46
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-45
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-43
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-29
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-25
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-24
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-21
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-21
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-18
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-15
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-15
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-06
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-05
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.001
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.002
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.002
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	0.002
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.002
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  161 bits (409), Expect = 2e-46
 Identities = 67/191 (35%), Positives = 95/191 (49%), Gaps = 8/191 (4%)

Query: 235 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+GGFG VY     + G  VA+K +K  ++     +   E+E++    H N+++L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
                  LV  Y   GS+   LK     L      RI L    GL YLH      IIHRD
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117

Query: 353 VKAANILLDE-YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTD 410
           +K  NILLD    +  + DFGL+KLL   D  +   + GT  ++APE L      SEK+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 411 VFGFGILLLEL 421
           ++  G++L EL
Sbjct: 177 IWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  161 bits (411), Expect = 6e-46
 Identities = 87/294 (29%), Positives = 127/294 (43%), Gaps = 59/294 (20%)

Query: 233 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
             +G+G FG VYKG L+      T VAVK LK+  +      F  E   M  L  H N++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVV 59

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKA---------KPSLDWATRKRIALGAARGLL 338
           RL+G C       LV  YM  G +   L+          K +L        A+  A+G+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI--- 395
           YL  +   K +HRD+ A N L+ E     + DFGL++ +   D +      G    I   
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWM 174

Query: 396 APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQE 450
           APE L  G  + K+DV+ FG+LL E+ +       G T     +N+              
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFT------LGATPYPGLSNE-------------- 214

Query: 451 KKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              E+L  + L+  Y R+       +E+ ++ L C Q  P  RP  SE+V  LE
Sbjct: 215 ---EVL--EYLRKGY-RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  172 bits (438), Expect = 8e-46
 Identities = 140/493 (28%), Positives = 249/493 (50%), Gaps = 48/493 (9%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N  SG +P ++G LS+L+ L LS N  +G IP  +S  + L  L L++N L+G IP 
Sbjct: 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA 541

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITG-NSLICATGAEEDCFGTAPMPLSF-A 147
           S S M  L+ LDLS N LSG +P       N+    SL+    +     G+ P   +F A
Sbjct: 542 SFSEMPVLSQLDLSQNQLSGEIPK------NLGNVESLVQVNISHNHLHGSLPSTGAFLA 595

Query: 148 LNNSP---------NSKPSGMPKGQKIA------LALGSSLGC-ISLLILGFGFLLWWRQ 191
           +N S              SG+P  +++         +  +LG  + L ++ FGF ++ R 
Sbjct: 596 INASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGF-VFIRG 654

Query: 192 RHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKG-YLQD 250
           R+N ++    NE    E+   + K      +    S+   +N++ +G  G  YKG  +++
Sbjct: 655 RNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKN 714

Query: 251 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 310
           G    VK + D N+I       +E+  +    H N+++LIG C +     L++ Y+   +
Sbjct: 715 GMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769

Query: 311 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 370
           ++  L+   +L W  R++IA+G A+ L +LH +C P ++  ++    I++D   E  +  
Sbjct: 770 LSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-R 825

Query: 371 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA--L 428
             L  LL  C     T    +  ++APE   T   +EK+D++GFG++L+EL++G      
Sbjct: 826 LSLPGLL--C---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880

Query: 429 EFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN--YDRIELEEMVQVALLCTQYLPS 486
           EFG      G++++W +  + +  L+M +D  ++ +   ++ E+ E++ +AL CT   P+
Sbjct: 881 EFG----VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPT 936

Query: 487 LRPKMSEVVRMLE 499
            RP  ++V++ LE
Sbjct: 937 ARPCANDVLKTLE 949

Length = 968

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  161 bits (409), Expect = 1e-45
 Identities = 77/269 (28%), Positives = 124/269 (46%), Gaps = 25/269 (9%)

Query: 236 GKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           G+G FG VYKG L+         VAVK LK+  +     +F  E  ++    H N+++L+
Sbjct: 8   GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G C       +V  YM  G + S L+  +P L  +     AL  ARG+ YL  +     I
Sbjct: 68  GVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFI 124

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           HRD+ A N L+ E     + DFGL++ L   D +     +  +  +APE L  G+ + K+
Sbjct: 125 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKS 184

Query: 410 DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 469
           DV+ FG+LL E+ +       G +  +   +L+++K  ++  +                 
Sbjct: 185 DVWSFGVLLWEIFTLGEQPYPGMSNEE---VLEYLKNGYRLPQPPNCPP----------- 230

Query: 470 LEEMVQVALLCTQYLPSLRPKMSEVVRML 498
             E+  + L C    P  RP  SE+V +L
Sbjct: 231 --ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  157 bits (400), Expect = 2e-44
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 26/270 (9%)

Query: 236 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           G+G FG VYKG L+         VAVK LK+  +     +F  E  ++    H N+++L+
Sbjct: 8   GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           G C      ++V  YM  G +   L+      L  +     AL  ARG+ YL  +     
Sbjct: 68  GVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NF 124

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
           IHRD+ A N L+ E     + DFGL++ L   D +     +  +  +APE L  G+ + K
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSK 184

Query: 409 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           +DV+ FG+LL E+ +       G +  +   +L+++KK ++  K                
Sbjct: 185 SDVWSFGVLLWEIFTLGEEPYPGMSNAE---VLEYLKKGYRLPKPPNCPP---------- 231

Query: 469 ELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
              E+ ++ L C    P  RP  SE+V +L
Sbjct: 232 ---ELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  154 bits (393), Expect = 2e-43
 Identities = 76/277 (27%), Positives = 123/277 (44%), Gaps = 40/277 (14%)

Query: 236 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           G+G FG VYKG L        T VAVK LK+G +     +F  E  ++    H N++RL+
Sbjct: 8   GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G C       +V  YM  G +   L+     L      ++AL  A+G+ YL  +     +
Sbjct: 68  GVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK---NFV 124

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 404
           HRD+ A N L+ E     + DFGL++ +   D +         ++      APE L  G+
Sbjct: 125 HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESLKDGK 180

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKT--ANQKGA-MLDWVKKIHQEKKLEMLVDKDL 461
            + K+DV+ FG+LL E+ +       G+          +L+ ++  ++   L    +   
Sbjct: 181 FTSKSDVWSFGVLLWEIFT------LGEQPYPGMSNEEVLELLEDGYR---LPRPENCP- 230

Query: 462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
                    +E+ ++ L C  Y P  RP  SE+V  L
Sbjct: 231 ---------DELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  153 bits (388), Expect = 7e-43
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 6/197 (3%)

Query: 229 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +     +G+G FG VY     + G +VA+K +K         +   E++++    H N++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           RL        +  LV  Y   G +   LK +  L     +         L YLH +    
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK---G 117

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
           I+HRD+K  NILLDE     + DFGLA+ LD     +TT V GT  ++APE L      +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFV-GTPEYMAPEVLLGKGYGK 175

Query: 408 KTDVFGFGILLLELISG 424
             D++  G++L EL++G
Sbjct: 176 AVDIWSLGVILYELLTG 192

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  153 bits (388), Expect = 1e-42
 Identities = 72/193 (37%), Positives = 93/193 (48%), Gaps = 7/193 (3%)

Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRL-KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           +G G FG VYK   +  G +VAVK L K       +   + E+ ++    H N++RLI  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
                   LV  Y   G +   L     L     K+IAL   RGL YLH      IIHRD
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHRD 123

Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           +K  NILLDE     + DFGLAK L    S   T   GT  ++APE L  G     K DV
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182

Query: 412 FGFGILLLELISG 424
           +  G++L EL++G
Sbjct: 183 WSLGVILYELLTG 195

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (332), Expect = 8e-35
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 8/197 (4%)

Query: 233 NLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLI 290
            L+G+G FG+VY    +D G ++AVK ++       E+   + E+ ++S   H N++R  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 291 GFCMTTTER-LLVY-PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           G      +  L ++  Y+S GS++S LK    L     ++       GL YLH      I
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GI 122

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
           +HRD+K ANIL+D      + DFG AK L D      T +VRGT   +APE +   +   
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182

Query: 408 KTDVFGFGILLLELISG 424
             D++  G  ++E+ +G
Sbjct: 183 AADIWSLGCTVIEMATG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 4e-30
 Identities = 68/199 (34%), Positives = 98/199 (49%), Gaps = 14/199 (7%)

Query: 232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKD-GNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
              +GKG FG+V  G  + G  VAVK LKD   A      F  E  +++   H NL++L+
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLL 66

Query: 291 GFCMTTTERLLVYPYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           G  +      +V  YM+ GS+    R + +  +  A +   AL    G+ YL E+     
Sbjct: 67  GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
           +HRD+ A N+L+ E   A V DFGLAK  +        + +  V   APE L   + S K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQ--DSGKLPVKWTAPEALREKKFSTK 179

Query: 409 TDVFGFGILLLELISGLRA 427
           +DV+ FGILL E+ S  R 
Sbjct: 180 SDVWSFGILLWEIYSFGRV 198

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  115 bits (290), Expect = 4e-29
 Identities = 66/204 (32%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 229 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISLAV 282
           F     +GKGGFG VYK  + + G  VA+K +K         I  EIQ   + +      
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------ 55

Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLH 341
           H N+++  G  +   E  +V  + S GS+   LK+   +L  +    +     +GL YLH
Sbjct: 56  HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYL 400
                 IIHRD+KAANILL    E  + DFGL+  L D    +      GT   +APE +
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVI 169

Query: 401 STGQSSEKTDVFGFGILLLELISG 424
           +      K D++  GI  +EL  G
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEG 193

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 6e-29
 Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 6/199 (3%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRN 285
           N+   +L+G+G FG VYKG  L+ G  VA+K++         ++    E++++    H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           +++ IG   T+    ++  Y  NGS+   +K       +          +GL YLHEQ  
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ-- 118

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +IHRD+KAANIL  +     + DFG+A  L+   S    +V GT   +APE +    +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 406 SEKTDVFGFGILLLELISG 424
           S  +D++  G  ++EL++G
Sbjct: 177 STASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  108 bits (271), Expect = 1e-26
 Identities = 85/269 (31%), Positives = 127/269 (47%), Gaps = 26/269 (9%)

Query: 234 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           L+GKG FG V+KG L+D T VAVK  K+      +I+F +E  ++    H N+++LIG C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 294 MTTTERLLVYPYM---SNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
              T+R  +Y  M     G   S L K K  L      + AL AA G+ YL  +     I
Sbjct: 62  ---TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           HRD+ A N L+ E     + DFG+++  D      +   +  +   APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 410 DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 469
           DV+ +GILL E  S L    +    NQ+        +   EK   M   +          
Sbjct: 176 DVWSYGILLWETFS-LGVCPYPGMTNQQA-------REQVEKGYRMSCPQKCP------- 220

Query: 470 LEEMVQVALLCTQYLPSLRPKMSEVVRML 498
            +++ +V   C  Y P  RPK SE+ + L
Sbjct: 221 -DDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  107 bits (269), Expect = 3e-26
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 7/199 (3%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
             F+ +  +G G FG V++G  ++   VA+K LK  + +  +  FQ EV+ +    H++L
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHL 64

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQC 344
           + L   C       ++   M  GS+ + L++     L  A+   +A   A G+ YL EQ 
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ- 123

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
               IHRD+ A NIL+ E     V DFGLA+L+   D ++++  +      APE  S G 
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASHGT 180

Query: 405 SSEKTDVFGFGILLLELIS 423
            S K+DV+ FGILL E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 27/271 (9%)

Query: 234 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
            +GKG FG+VYKG L+  T VAVK  +       + +F  E E++    H N+++LIG C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 294 MTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
           +      +V   +  GS+ + L K K  L      +++L AA G+ YL  +     IHRD
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118

Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT----VGHIAPEYLSTGQSSEK 408
           + A N L+ E     + DFG+++     +  + T   G     +   APE L+ G+ + +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175

Query: 409 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           +DV+ +GILL E  S       G +  Q                    ++   +    ++
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRER----------------IESGYRMPAPQL 219

Query: 469 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             EE+ ++ L C  Y P  RP  SE+   L+
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  102 bits (257), Expect = 1e-24
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 14/201 (6%)

Query: 233 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
            ++GKG FG VY G L D        AVK L     +    QF  E  ++    H N+L 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 289 LIGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCD 345
           L+G C+ +    L+V PYM +G + + ++   + +   +  I  G   A+G+ YL  +  
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIR-SETHNPTVKDLIGFGLQVAKGMEYLASK-- 117

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLST 402
            K +HRD+ A N +LDE +   V DFGLA+ +   ++   H  T  +  V  +A E L T
Sbjct: 118 -KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 403 GQSSEKTDVFGFGILLLELIS 423
            + + K+DV+ FG+LL EL++
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  104 bits (260), Expect = 2e-24
 Identities = 75/283 (26%), Positives = 114/283 (40%), Gaps = 25/283 (8%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI--QFQTEVE-MISLAVHR 284
           ++     +G+G FG VY     D  +VA+K L        +   +F  E++ + SL    
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLH 341
           N+++L  F        LV  Y+  GS+   LK       L  +    I       L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 342 EQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDSHV-----TTAVRGTVGHI 395
            +    IIHRD+K  NILLD       + DFGLAKLL    S        +   GT G++
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 396 APEYL---STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
           APE L   S   +S  +D++  GI L EL++GL   E  K ++     L  + ++     
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
                   L  +   +  +    +        P  R   S  +
Sbjct: 236 A-----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (256), Expect = 3e-24
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 31/285 (10%)

Query: 233 NLVGKGGFGNVYKGY---LQDGT--VVAVKRLKDGNAIGGEIQ---FQTEVEMISLAVHR 284
             +G+G FG V       L D T   VAVK L   N  G E     F+ E+E++    H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL---NHSGEEQHRSDFEREIEILRTLDHE 66

Query: 285 NLLRLIGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLH 341
           N+++  G C     R   L+  Y+ +GS+   L + +  ++       +    +G+ YL 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEY 399
            Q   + IHRD+ A NIL++      + DFGLAK+L     +      G   +   APE 
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 459
           L T + S  +DV+ FG+ L EL +         + +     L  +     +  +  L++ 
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGD-----PSQSPPAEFLRMIGIAQGQMIVTRLLEL 238

Query: 460 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            LK   +R+       +E+  +  LC +  P  RP  ++++ +++
Sbjct: 239 -LKEG-ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 3e-24
 Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 35/278 (12%)

Query: 233 NLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
            ++G G FG V +G L+        VA+K LK G++    + F TE  ++    H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPK 347
           L G    +   +++  YM NGS+   L+             +  G A G+ YL E     
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLST 402
            +HRD+ A NIL++      V DFGL++ L+  ++  TT      +R T    APE ++ 
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182

Query: 403 GQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 461
            + +  +DV+ FGI++ E++S G R   +   +NQ     D +K +    +L   +D   
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP--YWDMSNQ-----DVIKAVEDGYRLPPPMDCP- 234

Query: 462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                      + Q+ L C Q   + RP  S++V  L+
Sbjct: 235 ---------SALYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 4e-24
 Identities = 77/275 (28%), Positives = 125/275 (45%), Gaps = 30/275 (10%)

Query: 235 VGKGGFGNVYKGYLQ--DGTV--VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G G FG+V KG      G    VAVK LK  +   G+ +F  E  +++   H  ++RLI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
           G C      +LV      G +   LK +  +  +  K +A   A G+ YL  +     +H
Sbjct: 63  GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVH 118

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--VTTAVRGTVGHIAPEYLSTGQSSEK 408
           RD+ A N+LL   ++A + DFG+++ L     +   TTA R  +   APE ++ G+ S K
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK 178

Query: 409 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           +DV+ +G+ L E  S   A  +G+         + +  +   ++L             R 
Sbjct: 179 SDVWSYGVTLWEAFS-YGAKPYGEMKGA-----EVIAMLESGERLP------------RP 220

Query: 469 EL--EEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           E   +E+  + L C +Y P  RP  SE+      D
Sbjct: 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =   99 bits (249), Expect = 1e-23
 Identities = 63/192 (32%), Positives = 100/192 (52%), Gaps = 10/192 (5%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VA+K LK G+       F  E  ++    H  L+RL  + +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRL--YAV 69

Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K I + A  A G+ ++  +     IHR
Sbjct: 70  VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 412 FGFGILLLELIS 423
           + FGILL E+++
Sbjct: 187 WSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 65/193 (33%), Positives = 94/193 (48%), Gaps = 13/193 (6%)

Query: 236 GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 295
           G G FG V+ G     T VAVK LK G        F  E +++    H  L++L   C  
Sbjct: 15  GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 296 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHRDV 353
                +V  YMS GS+   LK+         + + + A  A G+ YL  +     IHRD+
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129

Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT---VGHIAPEYLSTGQSSEKTD 410
            A NIL+ E     + DFGLA+L++  D    TA  G    +   APE  + G+ + K+D
Sbjct: 130 AARNILVGENLVCKIADFGLARLIE--DDEY-TAREGAKFPIKWTAPEAANYGRFTIKSD 186

Query: 411 VFGFGILLLELIS 423
           V+ FGILL E+++
Sbjct: 187 VWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.9 bits (246), Expect = 3e-23
 Identities = 56/190 (29%), Positives = 93/190 (48%), Gaps = 6/190 (3%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY  +   VA+K +++G     E  F  E +++    H  L++L G C 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 295 TTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
             +   LV+ +M +G ++  L+A+       T   + L    G+ YL       +IHRD+
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126

Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
            A N L+ E     V DFG+ + +       +T  +  V   +PE  S  + S K+DV+ 
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 414 FGILLLELIS 423
           FG+L+ E+ S
Sbjct: 187 FGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 97.6 bits (244), Expect = 9e-23
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 53/285 (18%)

Query: 232 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRL 289
              +GKG FG VY      DG +  +K +   N    E +    EV+++    H N+++ 
Sbjct: 5   IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPS----------LDWATRKRIALGAARGLLY 339
                   +  +V  Y   G ++ ++K +            LDW  +  + L     L Y
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKY 118

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           LH +   KI+HRD+K  NI L       +GDFG++K+L        T V GT  +++PE 
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE- 173

Query: 400 LSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 458
           L   +  + K+D++  G +L EL +      F                  + + L  L  
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHP--F------------------EGENLLELAL 213

Query: 459 KDLKNNYDRI------ELEEMVQVALLCTQYLPSLRPKMSEVVRM 497
           K LK  Y  I      EL  +V  +LL     P  RP ++++++ 
Sbjct: 214 KILKGQYPPIPSQYSSELRNLVS-SLLQKD--PEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 94.9 bits (237), Expect = 6e-22
 Identities = 62/195 (31%), Positives = 86/195 (44%), Gaps = 9/195 (4%)

Query: 235 VGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIG 291
           +GKG FG V        G + A+K LK    I         TE  ++S   H  +++L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 292 FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
           +   T E+L LV  Y   G + S L  +        +  A      L YLH      II+
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIY 116

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 410
           RD+K  NILLD      + DFGLAK L    S   T   GT  ++APE L      +  D
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKAVD 175

Query: 411 VFGFGILLLELISGL 425
            +  G+LL E+++G 
Sbjct: 176 WWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 94.7 bits (235), Expect = 8e-22
 Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 9/192 (4%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG V+ GY  + T VAVK LK G      +Q F  E  ++    H  L+RL    
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
                  ++  YM+ GS+   LK+         K I   A  A G+ Y+  +     IHR
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AAN+L+ E     + DFGLA++++  +       +  +   APE ++ G  + K+DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 412 FGFGILLLELIS 423
           + FGILL E+++
Sbjct: 188 WSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 67/201 (33%), Positives = 93/201 (46%), Gaps = 14/201 (6%)

Query: 229 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR--LKDGNAIGGEIQF-QTEVEMISLAVHR 284
           F+    +GKG FG VYK    +   VVA+K   L++      EI+  Q E++ +S     
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED---EIEDIQQEIQFLSQCRSP 59

Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            + +  G       +L ++  Y   GS    LK    LD      I      GL YLHE+
Sbjct: 60  YITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEE 117

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
                IHRD+KAANILL E  +  + DFG++  L    S   T V GT   +APE +   
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQS 173

Query: 404 QSSEKTDVFGFGILLLELISG 424
              EK D++  GI  +EL  G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 21/207 (10%)

Query: 233 NLVGKGGFGNVYKGY-LQDGTVVAVK--RLKDGN-AIGGEIQFQTEVEMISLAVHRNLLR 288
           N +G G FG VY    L  G ++AVK  R++D +     EI    E++++ L  H NL++
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA--DEMKVLELLKHPNLVK 63

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
             G  +   +  +   Y S G++   L+    LD    +   L    GL YLH      I
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------GTVGHIAPEYLST 402
           +HRD+K ANI LD      +GDFG A  L    ++ TT         GT  ++APE ++ 
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 403 GQSSEK---TDVFGFGILLLELISGLR 426
           G+        D++  G ++LE+ +G R
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 36/282 (12%)

Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VY+G  +        T VA+K + +  ++   I+F  E  ++      +++R
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAK-------PSLDWATRKRI---ALGAARGLL 338
           L+G   T    L+V   M+ G + S L+++       P L   T ++    A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAP 397
           YL  +   K +HRD+ A N ++ E     +GDFG+ + +   D +         V  +AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 398 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
           E L  G  + K+DV+ FG++L E ++ L    +   +N              E+ L+ ++
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWE-MATLAEQPYQGLSN--------------EEVLKFVI 235

Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           D    +  +    ++++++  +C QY P +RP   E+V  L+
Sbjct: 236 DGGHLDLPENCP-DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 97.6 bits (243), Expect = 2e-21
 Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 28/171 (16%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L N  + G IP +I KL  L +++LS N   G IP ++  + +L+ L L+ NS  G+IP 
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPS------FHAKTFNITGNSLICATGAEEDCFGTAPMP 143
           SL  ++ L  L+L+ N+LSG VP+       H  +FN T N+ +C       C       
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC------- 537

Query: 144 LSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHN 194
                          +  G KI +A G S+  + L+I     + WW++R N
Sbjct: 538 ------------GPHLSVGAKIGIAFGVSVAFLFLVICA---MCWWKRRQN 573

Length = 623

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 81/296 (27%), Positives = 132/296 (44%), Gaps = 55/296 (18%)

Query: 234 LVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGE-IQFQTEVEMI-SLAVHRN 285
            +G+G FG V K            + VAVK LKD +A   +     +E+EM+  +  H+N
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--------KPSLDWATRKRI-------- 329
           ++ L+G C       +V  Y ++G++   L+A         P       + +        
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
           A   ARG+ +L  +   K IHRD+ A N+L+ E +   + DFGLA+ + H D +  TT  
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           R  V  +APE L     + ++DV+ FG+LL E+ +       G +              +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGSP-------------Y 235

Query: 449 QEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
               +E L  K LK  Y R+E      +E+  +   C   +PS RP   ++V  L+
Sbjct: 236 PGIPVEELF-KLLKEGY-RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 73/267 (27%), Positives = 123/267 (46%), Gaps = 22/267 (8%)

Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G FG V+ G L+ D T VAVK  ++      + +F  E  ++    H N++RLIG C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 294 MTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
                  +V   +  G   + L+ + P L      ++   AA G+ YL  +     IHRD
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119

Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-VGHIAPEYLSTGQSSEKTDV 411
           + A N L+ E     + DFG+++  +      T  ++   V   APE L+ G+ S ++DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179

Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 471
           + FGILL E  S L A+ +   +NQ+        +   E+ + +   +           +
Sbjct: 180 WSFGILLWEAFS-LGAVPYANLSNQQ-------TREAIEQGVRLPCPELCP--------D 223

Query: 472 EMVQVALLCTQYLPSLRPKMSEVVRML 498
            + ++   C +Y P  RP  S V + L
Sbjct: 224 AVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.7 bits (230), Expect = 5e-21
 Identities = 72/281 (25%), Positives = 137/281 (48%), Gaps = 28/281 (9%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
           S+ + + ++G G FG V++G L+        VA+K LK G        F +E  ++    
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYL 340
           H N++RL G        +++  YM NG++   L+     ++++ + + +  G A G+ YL
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYL 123

Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 398
               D   +HRD+ A NIL++   E  V DFGL+++L  D   ++ T+  +  +   APE
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180

Query: 399 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 458
            ++  + +  +DV+ FGI++ E++S      FG+      +  + +K I+   +L   +D
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMS------FGERPYWDMSNHEVMKAINDGFRLPAPMD 234

Query: 459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                         + Q+ L C Q   + RP+  ++V +L+
Sbjct: 235 CP----------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 92.9 bits (231), Expect = 5e-21
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 29/210 (13%)

Query: 236 GKGGFGNVYKGY-LQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           G G FG VYKG  + +G      VA+K L++  +     +   E  +++   H +++RL+
Sbjct: 16  GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75

Query: 291 GFCMTTTERLLVYPYMSNGSV-------ASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
           G C+++    L+   M  G +          + ++  L+W  +       A+G+ YL E+
Sbjct: 76  GICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEEK 128

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
              +++HRD+ A N+L+       + DFGLAKLLD  +        +  +  +A E +  
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFGK 432
              + K+DV+ +G+ + EL      + FG 
Sbjct: 186 RIYTHKSDVWSYGVTVWEL------MTFGA 209

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 92.1 bits (229), Expect = 7e-21
 Identities = 59/191 (30%), Positives = 89/191 (46%), Gaps = 7/191 (3%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V++G   + T VAVK LK G     +  F  E +++    H  L++L   C 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHRD 352
                 +V   M  GS+   L+          + I + A  A G+ YL  Q     IHRD
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRD 128

Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 412
           + A N+L+ E     V DFGLA+++           +  +   APE     + S K+DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188

Query: 413 GFGILLLELIS 423
            FGILL E+++
Sbjct: 189 SFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 91.9 bits (229), Expect = 9e-21
 Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 14/195 (7%)

Query: 236 GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG-FC 293
           G+G  G VYK   +  G + A+K++          Q   E++ +       +++  G F 
Sbjct: 10  GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69

Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 + V  YM  GS+A  LK    +       IA    +GL YLH      IIHRD+
Sbjct: 70  KEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDI 126

Query: 354 KAANILLDEYYEAVVGDFGLAKLL----DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           K +N+L++   E  + DFG++K+L    D C++ V     GTV +++PE +     S   
Sbjct: 127 KPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPERIQGESYSYAA 181

Query: 410 DVFGFGILLLELISG 424
           D++  G+ LLE   G
Sbjct: 182 DIWSLGLTLLECALG 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 19/203 (9%)

Query: 229 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 286
           F     +G+G +G+VYK  + + G VVA+K +     +  ++Q    E+ ++       +
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPYI 60

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 345
           ++  G     T+  +V  Y   GSV+  +K    +L       I     +GL YLH    
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN-- 118

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV-G---HIAPEYLS 401
            K IHRD+KA NILL+E  +A + DFG++  L       T A R TV G    +APE + 
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMAPEVIQ 172

Query: 402 TGQSSEKTDVFGFGILLLELISG 424
               + K D++  GI  +E+  G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 90.7 bits (225), Expect = 2e-20
 Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 10/199 (5%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++ + K+ +G G +G VY+G  +     VAVK LK+      E  F  E  ++    H N
Sbjct: 6   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 63

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQ 343
           L++L+G C       ++  +M+ G++   L+   +  ++      +A   +  + YL ++
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTVGHIAPEYLST 402
                IHRD+ A N L+ E +   V DFGL++L+   D++   A  +  +   APE L+ 
Sbjct: 124 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAY 179

Query: 403 GQSSEKTDVFGFGILLLEL 421
            + S K+DV+ FG+LL E+
Sbjct: 180 NKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 16/206 (7%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRL--------KDGNAIGGEIQ-FQTEVEMISLAVH 283
           L+GKG +G VY    +  G ++AVK++        +  +     ++  ++E+E +    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            N+++ +GF  T     +   Y+  GS+ S L+     +    +        GL YLH +
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLST 402
               I+HRD+KA N+L+D      + DFG++K  D   D+    +++G+V  +APE + +
Sbjct: 128 ---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184

Query: 403 GQS--SEKTDVFGFGILLLELISGLR 426
                S K D++  G ++LE+ +G R
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 82/283 (28%), Positives = 128/283 (45%), Gaps = 55/283 (19%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEI--QFQTEVEMISLAVHRNLLR 288
           L+G G FG+VY+G  L DG   AVK   L D    G E   Q + E+ ++S   H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 289 LIGFCMTTTERLLVY-PYMSNGSVASRLKAKPSLDWA-----TRKRIALGAARGLLYLHE 342
            +G      + L ++   +  GS+A  LK   S         TR+ +      GL YLH+
Sbjct: 67  YLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHD 120

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-----AVRGTVGHIAP 397
           +     +HRD+K ANIL+D      + DFG+AK        V       + +G+   +AP
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMAP 170

Query: 398 EYL-STGQSSEKTDVFGFGILLLELISG---LRALEFGKTANQKGAMLDWVKKIHQEKKL 453
           E +   G      D++  G  +LE+ +G      LE         A+     KI + K+L
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE------GVAAVF----KIGRSKEL 220

Query: 454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
             + D  L +     E ++ +   L C Q  PSLRP  +E++ 
Sbjct: 221 PPIPD-HLSD-----EAKDFI---LKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.1 bits (221), Expect = 7e-20
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 18/207 (8%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRL---KDGNAIGGEI-QFQTEVEMISLAV 282
           N+    L+G+G FG VY  Y  D G  +AVK++    D      E+   + E++++    
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 283 HRNLLRLIGFCMTTTERLLVY-PYMSNGSVASRLKAKPSL-DWATRK--RIALGAARGLL 338
           H  +++  G C+   E L ++  YM  GSV  +LKA  +L +  TRK  R  L    G+ 
Sbjct: 63  HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL---EGVE 118

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIA 396
           YLH      I+HRD+K ANIL D      +GDFG +K L    S  T   +V GT   ++
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 397 PEYLSTGQSSEKTDVFGFGILLLELIS 423
           PE +S      K DV+  G  ++E+++
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.0 bits (221), Expect = 8e-20
 Identities = 62/199 (31%), Positives = 88/199 (44%), Gaps = 13/199 (6%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRLIGF 292
           +G G    VY    L +   VA+KR+ D       +   + EV+ +S   H N+++    
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQCDPKII 349
            +   E  LV PY+S GS+   +K+           IA       +GL YLH       I
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQI 124

Query: 350 HRDVKAANILLDEYYEAVVGDFGL-AKLLDH--CDSHVTTAVRGTVGHIAPEYLSTGQS- 405
           HRD+KA NILL E     + DFG+ A L D       V     GT   +APE +      
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184

Query: 406 SEKTDVFGFGILLLELISG 424
             K D++ FGI  +EL +G
Sbjct: 185 DFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)

Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKR--LKDGNAIGGEIQF---QTEVEMISLAVHRNLL 287
            ++GKG +G VY G    G ++AVK+  L   N +  E ++   Q EV+++    H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           + +G C+      +   ++  GS++S L     L      +       G+ YLH  C   
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-----TAVRGTVGHIAPEYLST 402
           ++HRD+K  N++L       + DFG A+ L     H T      ++ GT   +APE ++ 
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182

Query: 403 GQSSEKTDVFGFGILLLELISG 424
                K+D++  G  + E+ +G
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATG 204

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 70/272 (25%), Positives = 116/272 (42%), Gaps = 36/272 (13%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ G  +    VA+K +++G     E  F  E +++    H NL++L G C 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA----RGLLYLHEQCDPKIIH 350
                 +V  YM+NG + + L+ +            L         + YL        IH
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGK---LGTEWLLDMCSDVCEAMEYLESNG---FIH 123

Query: 351 RDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGT---VGHIAPEYLSTGQSS 406
           RD+ A N L+ E     V DFGLA+ +LD  D +  T+ +GT   V    PE     + S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLD--DQY--TSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 466
            K+DV+ FG+L+ E+ S       GK   ++ +  + V+ +    +L             
Sbjct: 180 SKSDVWSFGVLMWEVFSE------GKMPYERFSNSEVVESVSAGYRLYR----------P 223

Query: 467 RIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
           ++   E+  +   C    P  RP   +++  L
Sbjct: 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 84/286 (29%), Positives = 134/286 (46%), Gaps = 35/286 (12%)

Query: 234 LVGKGGFGNVYK-GY--LQD--GTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 287
            +GKG FG+V    Y  LQD  G VVAVK+L+   A    ++ F+ E+E++    H N++
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIV 68

Query: 288 RLIGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQC 344
           +  G C +   R   LV  Y+  GS+   L K +  LD       A    +G+ YL  + 
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK- 127

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH---VTTAVRGTVGHIAPEYLS 401
             + +HRD+   NIL++      +GDFGL K+L   D     V       +   APE L+
Sbjct: 128 --RYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFWYAPESLT 184

Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV---D 458
             + S  +DV+ FG++L EL        F  +        ++++ +  +K+ +M+V    
Sbjct: 185 ESKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236

Query: 459 KDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           + LKNN  R+        E+  +   C    PS RP  SE+   +E
Sbjct: 237 ELLKNNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 36/222 (16%)

Query: 235 VGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG V+ G         D  +VAVK LK+  +      F+ E E+++   H N+++
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKR-------------IALGAA 334
             G C      ++V+ YM +G +   L++  P   +                  IA+  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--- 391
            G++YL  Q     +HRD+   N L+       +GDFG+++ +   D +    V G    
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGHTML 186

Query: 392 -VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 432
            +  + PE +   + + ++DV+ FG++L E+ +      +GK
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT------YGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)

Query: 234 LVGKGGFGNVYKGYL-QDGTV---VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLR 288
           ++G+G FG+V +G L QD      VAVK +K       EI+ F +E   +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 289 LIGFCMTTTER------LLVYPYMSNGSV-----ASRLKAKP-SLDWATRKRIALGAARG 336
           LIG C   +        +++ P+M +G +      SRL   P  L   T  +  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-AVRGTVGHI 395
           + YL  +     IHRD+ A N +L E     V DFGL+K +   D +      +  V  I
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 396 APEYLSTGQSSEKTDVFGFGILLLELIS 423
           A E L+    + K+DV+ FG+ + E+ +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 29/214 (13%)

Query: 233 NLVGKGGFGNVYKGYLQD----GT---VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           N +G G FG VY+G   D    G+    VAVK L+ G     + +F  E  ++S   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLL 338
           +++L+G C+    + ++   M  G + S L+         P L       I L  A+G +
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 339 YLHEQCDPKIIHRDVKAANILLDEY-YEA----VVGDFGLAKLLDHCDSHVTTAVRG--- 390
           YL        IHRD+ A N L+ E  Y+A     +GDFGLA+ +   D +      G   
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174

Query: 391 -TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             V  +APE L  G+ + ++DV+ FG+L+ E+++
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 90.3 bits (224), Expect = 6e-19
 Identities = 45/89 (50%), Positives = 60/89 (67%)

Query: 33  NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLS 92
           NN+SG IP EIG L+ L  LDL  N  TGPIPS++ +L+ LQYL L  N L+G IPPS+ 
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281

Query: 93  NMSQLAFLDLSYNNLSGPVPSFHAKTFNI 121
           ++ +L  LDLS N+LSG +P    +  N+
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNL 310

Length = 968

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 8e-19
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 24/203 (11%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLK------DGNAIGGEIQFQTEVEMISLAVHRNL 286
           L+G+G +G VY+G  +  G VVA+K +       D + I  E+   ++   +  +   N+
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQ---LRQSQPPNI 64

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL----YLHE 342
            +  G  +      ++  Y   GSV + +KA P       K I++   R +L    Y+H+
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKYISV-IIREVLVALKYIHK 119

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
                +IHRD+KAANIL+       + DFG+A LL+   S  +T V GT   +APE ++ 
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITE 175

Query: 403 GQSSE-KTDVFGFGILLLELISG 424
           G+  + K D++  GI + E+ +G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 25/229 (10%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHR 284
           +F   N +GKG FG V+K   + D  V A+K+  L   N    E     E  +++     
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP------SLDWATRKRIALGAARGLL 338
            ++R     +   +  +V  Y  NG +   LK +          W    R  +    GL 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLA 115

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
           +LH +   KI+HRD+K+ N+ LD Y    +GD G+AKLL    +   T V GT  +++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPE 171

Query: 399 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
                  +EK+DV+  G++L E  +G    +    AN +GA+   + KI
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGAL---ILKI 213

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 73/289 (25%), Positives = 135/289 (46%), Gaps = 46/289 (15%)

Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VY+G  +D       T VAVK + +  ++   I+F  E  ++      +++R
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA------------KPSLDWATRKRIALGA--A 334
           L+G        L+V   M++G + S L++             P+L    ++ I + A  A
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL----QEMIQMAAEIA 129

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TV 392
            G+ YL+ +   K +HRD+ A N ++   +   +GDFG+ + +   D +     +G   V
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPV 185

Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             +APE L  G  +  +D++ FG++L E I+ L    +   +N              E+ 
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSN--------------EQV 230

Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           L+ ++D    +  D    E +  +  +C Q+ P +RP   E+V +L+ D
Sbjct: 231 LKFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 20/197 (10%)

Query: 235 VGKGGFGNVYKG-YLQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +G G +G+VYK   +  G +VA+K  +L+ G+        Q E+ M+    H N++   G
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE---IIQQEISMLKECRHPNIVAYFG 67

Query: 292 FCMTTTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
             +   +  +V  Y   GS+    +        L  A   R  L   +GL YLHE     
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHET---G 121

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL---STGQ 404
            IHRD+K ANILL E  +  + DFG++  L    +   + + GT   +APE       G 
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGG 180

Query: 405 SSEKTDVFGFGILLLEL 421
              K D++  GI  +EL
Sbjct: 181 YDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 82/281 (29%), Positives = 117/281 (41%), Gaps = 43/281 (15%)

Query: 234 LVGKGGFGNVYKGYLQD--GTV--VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 288
            +G G FG V +G      G V  VAVK LK          F  E   M SL  H NL+R
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIR 60

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           L G  +T    ++V      GS+  RL+  A      +T    A+  A G+ YL  +   
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--- 116

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV--GHIAPEYLSTGQ 404
           + IHRD+ A NILL    +  +GDFGL + L   + H        V     APE L T  
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 405 SSEKTDVFGFGILLLELIS-------GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG+ L E+ +       GL   +              +KKI  +K+ E L 
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI-------------LKKI--DKEGERLE 221

Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
             +          +++  V L C  + P+ RP  + +   L
Sbjct: 222 RPEACP-------QDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 79/277 (28%), Positives = 121/277 (43%), Gaps = 39/277 (14%)

Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 287
           F+    +GKG FG V+KG       V   ++ D      EI+  Q E+ ++S      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           +  G  +  T+  ++  Y+  GS    L+  P LD      I     +GL YLH +   K
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE---K 121

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRGTVGHIAPEYLSTGQSS 406
            IHRD+KAAN+LL E+ E  + DFG+A  L   D+ +      GT   +APE +      
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE---KKLEMLVDKD--- 460
            K D++  GI  +EL  G                    +  H E    K+  L+ K+   
Sbjct: 180 SKADIWSLGITAIELAKG--------------------EPPHSELHPMKVLFLIPKNNPP 219

Query: 461 -LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
            L+ NY +  L+E V+    C    PS RP   E+++
Sbjct: 220 TLEGNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 66/197 (33%), Positives = 101/197 (51%), Gaps = 18/197 (9%)

Query: 235 VGKGGFGNVYKG-YLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           +G+G FG V +G Y   G  VAVK +K D  A      F  E  +++   H+NL+RL+G 
Sbjct: 14  IGEGEFGAVLQGEYT--GQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGV 67

Query: 293 CMTTTERLLVYPYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
            +      +V   MS G++ +  R + +  +      + +L  A G+ YL  +   K++H
Sbjct: 68  ILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 410
           RD+ A NIL+ E   A V DFGLA++     S      +  V   APE L   + S K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSD 179

Query: 411 VFGFGILLLELISGLRA 427
           V+ +G+LL E+ S  RA
Sbjct: 180 VWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 74/277 (26%), Positives = 130/277 (46%), Gaps = 32/277 (11%)

Query: 234 LVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G G FG V +G L+        VA+K LK G        F +E  ++    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCDPK 347
            G    +   +++  +M NG++ S L+      +   + + +  G A G+ YL E     
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEM---N 126

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGT--VGHIAPEYLSTG 403
            +HRD+ A NIL++      V DFGL++ L  D  D   T+++ G   +   APE ++  
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 404 QSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 462
           + +  +DV+ +GI++ E++S G R   +   +NQ     D +  I Q+ +L   +D    
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQ-----DVINAIEQDYRLPPPMDCP-- 237

Query: 463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                     + Q+ L C Q   + RPK  ++V  L+
Sbjct: 238 --------TALHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 83.6 bits (206), Expect = 7e-18
 Identities = 63/197 (31%), Positives = 91/197 (46%), Gaps = 6/197 (3%)

Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 287
           F+    +GKG FG VYKG       V   ++ D      EI+  Q E+ ++S      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           R  G  +  T+  ++  Y+  GS    LK  P L+      I     +GL YLH +   +
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSE---R 121

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
            IHRD+KAAN+LL E  +  + DFG+A  L        T V GT   +APE +       
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDF 180

Query: 408 KTDVFGFGILLLELISG 424
           K D++  GI  +EL  G
Sbjct: 181 KADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 10/195 (5%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 69

Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 126

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 412 FGFGILLLELISGLR 426
           + FGILL EL +  R
Sbjct: 187 WSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 17/205 (8%)

Query: 234 LVGKGGFGNVYKG-YLQDGTVVAVKRLK-DGNAIGGEIQ-------FQTEVEMISLAVHR 284
           L+G G FG+VY G     G ++AVK+++    +   + +          E+ ++    H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           N+++ +G  +      +   Y+  GSVA+ L    + +    +       +GL YLH + 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR- 125

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-----AVRGTVGHIAPEY 399
              IIHRD+K ANIL+D      + DFG++K L+       T     +++G+V  +APE 
Sbjct: 126 --GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +     + K D++  G L++E+++G
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 12/206 (5%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLA 281
           +N+    L+G+G FG VY  Y  D G  +AVK+++   +      E+   + E++++   
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 282 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
           +H  +++  G      ER L     +M  GS+  +LK+  +L     ++       G+ Y
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-CDSHV-TTAVRGTVGHIAP 397
           LH      I+HRD+K ANIL D      +GDFG +K L   C S     +V GT   ++P
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 398 EYLSTGQSSEKTDVFGFGILLLELIS 423
           E +S      K D++  G  ++E+++
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 69/224 (30%), Positives = 106/224 (47%), Gaps = 22/224 (9%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +GKG FG+V  G  + G  VAVK +K D  A      F  E  +++   H NL++L+G  
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVI 68

Query: 294 MTTTERL-LVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
           +     L +V  YM+ GS+   L+++    L      + +L     + YL        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 410
           RD+ A N+L+ E   A V DFGL K            V+ T    APE L   + S K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSD 181

Query: 411 VFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
           V+ FGILL E+ S      FG+    +  + D V ++ +  K++
Sbjct: 182 VWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMD 219

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 18/200 (9%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           +G+G +G VYK    + G +VA+K+++ +    G  I    E++++    H N++RL   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK-- 64

Query: 293 CMTTTERL----LVYPYMSN--GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            + T++      +V+ YM +    +    + K +      K        GL YLH     
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES--QIKCYMKQLLEGLQYLHSN--- 119

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--STGQ 404
            I+HRD+K +NIL++      + DFGLA+     +S   T    T+ +  PE L  +T +
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT-R 178

Query: 405 SSEKTDVFGFGILLLELISG 424
              + D++  G +L EL  G
Sbjct: 179 YGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 72/297 (24%), Positives = 132/297 (44%), Gaps = 54/297 (18%)

Query: 235 VGKGGFGNVYK----GYL--QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG V++    G L  +  T+VAVK LK+  +   +  FQ E  +++   H N+++
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA----------------------KPSLDWATR 326
           L+G C       L++ YM+ G +   L+                          L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 327 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK---LLDHCDSH 383
             IA   A G+ YL E+   K +HRD+   N L+ E     + DFGL++     D+  + 
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLD 442
              A+   +  + PE +   + + ++DV+ +G++L E+ S G++   +G           
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY-YGMA--------- 237

Query: 443 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                  E+ +  + D ++ +  D   L E+  +  LC   LPS RP  + + R+L+
Sbjct: 238 ------HEEVIYYVRDGNVLSCPDNCPL-ELYNLMRLCWSKLPSDRPSFASINRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 81.3 bits (200), Expect = 4e-17
 Identities = 66/200 (33%), Positives = 97/200 (48%), Gaps = 12/200 (6%)

Query: 229 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 286
           F+    +GKG FG V+KG   +   VVA+K + D      EI+  Q E+ ++S      +
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQC 344
            +  G  +  T+  ++  Y+  GS    L+A P      AT  +  L   +GL YLH + 
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE- 120

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
             K IHRD+KAAN+LL E  +  + DFG+A  L        T V GT   +APE +    
Sbjct: 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSA 177

Query: 405 SSEKTDVFGFGILLLELISG 424
              K D++  GI  +EL  G
Sbjct: 178 YDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 20/204 (9%)

Query: 235 VGKGGFGNVYKGYL-QDGTV--VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V +G L QD ++  VAVK +K       E++ F +E   +    H N++RLI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 291 GFCMTTTER------LLVYPYMSNGSVAS-----RLKAKPS-LDWATRKRIALGAARGLL 338
           G C+ T E       +++ P+M +G + S     RL   P  L      +     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV-RGTVGHIAP 397
           YL  +     IHRD+ A N +L+E     V DFGL+K + + D +    + +  V  IA 
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 398 EYLSTGQSSEKTDVFGFGILLLEL 421
           E L+    + K+DV+ FG+ + E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.5 bits (209), Expect = 5e-17
 Identities = 38/83 (45%), Positives = 52/83 (62%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L NN +SG IP +IG  S L  LDL  N   G IP+++++L +L++L L +N L G IP 
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206

Query: 90  SLSNMSQLAFLDLSYNNLSGPVP 112
            L  M  L ++ L YNNLSG +P
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIP 229

Length = 968

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 11/193 (5%)

Query: 236 GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQ--TEVEMISLAVHRNLLRLIGF 292
           G G  G V K   +  G ++AVK ++    I   IQ Q   E++++       ++   G 
Sbjct: 10  GAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 293 CMTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
                +  +   YM  GS+   LK  +  +      +IA+   +GL YLHE+   KIIHR
Sbjct: 68  FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHR 125

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           DVK +NIL++   +  + DFG++  L   +S   T V GT  ++APE +     S K+D+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182

Query: 412 FGFGILLLELISG 424
           +  G+ L+EL +G
Sbjct: 183 WSLGLSLIELATG 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 34/216 (15%)

Query: 235 VGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VYKG L         T VA+K LK+      + +F+ E E++S   H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRL----------------KAKPSLDWATRKRIALG 332
           L+G C       +++ Y+++G +   L                  K SLD +    IA+ 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-----SHVTTA 387
            A G+ YL        +HRD+ A N L+ E     + DFGL++ +   D     S     
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           VR     + PE +  G+ + ++D++ FG++L E+ S
Sbjct: 190 VR----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 80.5 bits (198), Expect = 7e-17
 Identities = 66/270 (24%), Positives = 124/270 (45%), Gaps = 30/270 (11%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+       T VAVK +K G+       F  E  ++    H  L++L    +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKL--HAV 69

Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  +M+ GS+   LK+         K I   A  A G+ ++ ++     IHR
Sbjct: 70  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 126

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+       + DFGLA++++  +       +  +   APE ++ G  + K+DV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL- 470
           + FGILL+E+++      +G+      +  + ++ + +  ++             R E  
Sbjct: 187 WSFGILLMEIVT------YGRIPYPGMSNPEVIRALERGYRMP------------RPENC 228

Query: 471 -EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            EE+  + + C +  P  RP    +  +L+
Sbjct: 229 PEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 80.3 bits (198), Expect = 7e-17
 Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 30/282 (10%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
           S    + ++G G FG V  G L+        VA+K LK G        F +E  ++    
Sbjct: 4   SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63

Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYL 340
           H N++ L G    +   ++V  YM NGS+ + L+ K    +   + + +  G A G+ YL
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLRGIASGMKYL 122

Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 398
               D   +HRD+ A NIL++      V DFGL+++L  D   ++ T   +  +   APE
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 399 YLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            ++  + +  +DV+ +GI++ E++S G R   + + +NQ     D +K I +  +L   +
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERP--YWEMSNQ-----DVIKAIEEGYRLPAPM 232

Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 233 DCPAA----------LHQLMLDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 80.0 bits (198), Expect = 9e-17
 Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 11/200 (5%)

Query: 235 VGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGE-IQFQTEVEMISLAVHRNLLRLIG- 291
           +GKG FG V K     DG ++  K +  GN    E  Q  +EV ++    H N++R    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 292 FCMTTTERL-LVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARGLLYLH--EQC 344
               + + L +V  Y   G +A  +    K +  ++     RI       L   H     
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
              ++HRD+K ANI LD      +GDFGLAK+L H  S   T V GT  +++PE L+   
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMS 186

Query: 405 SSEKTDVFGFGILLLELISG 424
             EK+D++  G L+ EL + 
Sbjct: 187 YDEKSDIWSLGCLIYELCAL 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 83.4 bits (206), Expect = 1e-16
 Identities = 38/84 (45%), Positives = 50/84 (59%), Gaps = 2/84 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L NNN +G IP   G +  L TLDLSNN  +G IP+ +    +L+ L L  N L G IP 
Sbjct: 125 LSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPS 113
           SL+N++ L FL L+ N L G +P 
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPR 206

Length = 968

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 30/223 (13%)

Query: 223 QSATSNFSSKNLVGKGGFGNVYKG---YLQDGTV---VAVKRLKDGNAIGGEIQFQTEVE 276
           +    + +    +G G FG VY+G         V   VAVK L +  +   E  F  E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKR------I 329
           ++S   H+N++RLIG       R ++   M+ G + S L+  +P  +  +          
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHCDSHVTT 386
           A   A+G  YL E      IHRD+ A N LL        A + DFG+A+     D +  +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRAS 173

Query: 387 AVRG------TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             R        +  + PE    G  + KTDV+ FG+LL E+ S
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 61/195 (31%), Positives = 96/195 (49%), Gaps = 10/195 (5%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ G     T VAVK LK G        F  E +++    H  L++L  + +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQL--YAV 69

Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK            + + A  A G+ Y+        IHR
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHR 126

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D+++ANIL+ +     + DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 412 FGFGILLLELISGLR 426
           + FGILL EL++  R
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 19/204 (9%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLK--DGNAIGGEIQFQT---EVEMISLAVHRNLL 287
            +G G F + Y+   ++ GT++AVK++      +   E   +    E+ +++   H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           R++G     +   L   +M+ GSV+  L    +   A          RGL YLHE    +
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---Q 123

Query: 348 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTA------VRGTVGHIAPEYL 400
           IIHRDVK AN+L+D   + + + DFG A  L    +  T A      + GT+  +APE L
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 401 STGQSSEKTDVFGFGILLLELISG 424
              Q     DV+  G +++E+ + 
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATA 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 29/215 (13%)

Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K        VAVK LKD           +E+EM+ +   H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRI--- 329
           ++ L+G C       ++  Y S G++   L+A+  P +D++           T K +   
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
           A   ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ + + D +  TT  
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+LL E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 12/205 (5%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLAV 282
           N+    L+G+G FG VY  Y  D G  +AVK++    D      E+   + E++++    
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 283 HRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
           H  +++  G      E+ L     YM  GS+  +LKA  +L     +R      +G+ YL
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-CDSHV-TTAVRGTVGHIAPE 398
           H      I+HRD+K ANIL D      +GDFG +K +   C S     +V GT   ++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 399 YLSTGQSSEKTDVFGFGILLLELIS 423
            +S      K DV+     ++E+++
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 79/302 (26%), Positives = 140/302 (46%), Gaps = 55/302 (18%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAV 282
           ++   ++++G+G FG V K  + +DG  +  A+KR+K+  +      F  E+E++  L  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNGSV-----ASR-LKAKPSLDWATRKRIALGA--- 333
           H N++ L+G C       L   Y  +G++      SR L+  P+   A      L +   
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 334 -------ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
                  ARG+ YL ++   + IHRD+ A NIL+ E Y A + DFGL++  +        
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------V 176

Query: 387 AVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 441
            V+ T+G +     A E L+    +  +DV+ +G+LL E++S       G T        
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCA 230

Query: 442 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV----RM 497
           +  +K+ Q  +LE  ++ D          +E+  +   C +  P  RP  ++++    RM
Sbjct: 231 ELYEKLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRM 280

Query: 498 LE 499
           LE
Sbjct: 281 LE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 78.4 bits (194), Expect = 4e-16
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 28/222 (12%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMIS-LAV 282
            +F    ++G+G F  V     +      A+K L     I        + E E+++ L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 283 HRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           H  +++L  +     E L  V  Y  NG +   ++   SLD    +  A      L YLH
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------------ 389
            +    IIHRD+K  NILLD+     + DFG AK+LD   S  +                
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 390 -------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
                  GT  +++PE L+   + + +D++  G ++ ++++G
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 77.8 bits (191), Expect = 6e-16
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 12/205 (5%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLAV 282
           N+    L+G+G FG VY  Y  D G  +A K+++   +      E+   + E++++    
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 283 HRNLLRLIGFCMTTTERLLV--YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
           H  +++  G      E+ L     YM  GSV  +LKA  +L  +  ++       G+ YL
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122

Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-CDSHV-TTAVRGTVGHIAPE 398
           H      I+HRD+K ANIL D      +GDFG +K L   C S     +V GT   ++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 399 YLSTGQSSEKTDVFGFGILLLELIS 423
            +S      K DV+  G  ++E+++
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)

Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRI--- 329
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 51/300 (17%)

Query: 232 KNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           K  +G+G FG V+          +D  +VAVK LKD   +     FQ E E+++   H +
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEH 68

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRI 329
           +++  G C      ++V+ YM +G +   L+A                K  L  +    I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-----SHV 384
           A   A G++YL  Q     +HRD+   N L+       +GDFG+++ +   D      H 
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
              +R     + PE +   + + ++DV+ FG++L E+ +      +GK    + +  + +
Sbjct: 186 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNTEVI 235

Query: 445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 504
           + I Q + LE            R+  +E+  + L C Q  P  R  + E+ ++L   G A
Sbjct: 236 ECITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 7e-16
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 16/199 (8%)

Query: 234 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT---EVEMISLAVHRNLLRL 289
           +VG+G +G V K   +  G +VA+K+ K+  +   E   +T   EV+++    H N++ L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKI 348
                      LV+ Y+   ++   L+A P  L     +       + + Y H      I
Sbjct: 66  KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NI 121

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAPEYL-STGQS 405
           IHRD+K  NIL+ E     + DFG A+ L      S +T  V  T  + APE L      
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARAL-RARPASPLTDYV-ATRWYRAPELLVGDTNY 179

Query: 406 SEKTDVFGFGILLLELISG 424
            +  DV+  G ++ EL+ G
Sbjct: 180 GKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 10/195 (5%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G  +     F  E +++    H  L+ L  + +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE--AFLQEAQIMKKLRHDKLVPL--YAV 69

Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  +M  GS+   LK          + + + A  A G+ Y+        IHR
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHR 126

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 412 FGFGILLLELISGLR 426
           + FGILL EL++  R
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 58/300 (19%)

Query: 235 VGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG V K            T VAVK LK+  +        +E  ++    H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK----------------AKPSLDWATRKRIALG 332
           L G C      LL+  Y   GS+ S L+                    LD    + + +G
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 333 --------AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 384
                    +RG+ YL E    K++HRD+ A N+L+ E  +  + DFGL++ +   DS+V
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 385 TTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 443
             +  R  V  +A E L     + ++DV+ FG+LL E+++ L    +   A ++   L  
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-LGGNPYPGIAPERLFNL-- 241

Query: 444 VKKIHQEKKLEMLVDKDLKNNY--DRIE--LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                            LK  Y  +R E   EEM  + L C +  P  RP  +++ + LE
Sbjct: 242 -----------------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 10/196 (5%)

Query: 234 LVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHRNLLRL 289
           ++GKG FG V    L + G + AVK LK  + I  +   +   TE  ++SLA +   L  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 290 IGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +  C  T +RL  V  +++ G +   ++     D A  +  A      L++LH++    I
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GI 117

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
           I+RD+K  N+LLD      + DFG+ K     +   T+   GT  +IAPE L        
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176

Query: 409 TDVFGFGILLLELISG 424
            D +  G+LL E++ G
Sbjct: 177 VDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG V   Y  D      G +VAVK LK          ++ E+ ++    H N+++
Sbjct: 12  LGEGHFGKVSL-YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 289 LIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
             G C     +   L+  Y+  GS+   L  K  L+ A     A     G+ YLH Q   
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQ--- 126

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLST 402
             IHRD+ A N+LLD      +GDFGLAK +   + H    VR      V   A E L  
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 403 GQSSEKTDVFGFGILLLELIS 423
            + S  +DV+ FG+ L EL++
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 66/196 (33%), Positives = 87/196 (44%), Gaps = 20/196 (10%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRL----KDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +G G FG VY    ++   VVA+K++    K  N    +I    EV  +    H N +  
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQQLRHPNTIEY 80

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
            G  +      LV  Y   GS +  L+  K  L       I  GA +GL YLH       
Sbjct: 81  KGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---R 136

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---LSTGQS 405
           IHRD+KA NILL E     + DFG A L+   +S V     GT   +APE    +  GQ 
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQY 191

Query: 406 SEKTDVFGFGILLLEL 421
             K DV+  GI  +EL
Sbjct: 192 DGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 34/226 (15%)

Query: 229 FSSKNLV-----GKGGFGNVYK--GY-----LQDGTV-VAVKRLKDGNAIGGEIQFQTEV 275
           F    LV     G+G FG V +   Y       D TV VAVK LKD           +E+
Sbjct: 9   FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68

Query: 276 EMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA---TRK-- 327
           E++ L   H+N++ L+G C       ++  Y + G++   L+A+  P  D+    T+   
Sbjct: 69  ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128

Query: 328 ---------RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 378
                      A   ARG+ YL  +   + IHRD+ A N+L+ E     + DFGLA+ + 
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 379 HCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             D +  T+  R  V  +APE L     + ++DV+ FGIL+ E+ +
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 78.7 bits (194), Expect = 3e-15
 Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 1/94 (1%)

Query: 21  GVFFSFGRL-LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 79
           G F S   L L  N + G IP  +  L+ L  L L++N   G IP  +  +++L+++ L 
Sbjct: 161 GSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220

Query: 80  NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 113
            N+L+G IP  +  ++ L  LDL YNNL+GP+PS
Sbjct: 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254

Length = 968

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 77.6 bits (191), Expect = 3e-15
 Identities = 68/218 (31%), Positives = 94/218 (43%), Gaps = 28/218 (12%)

Query: 250 DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG-------FCMTTTE-RLL 301
               V VK +  G   G EI     ++ IS   HR ++ LI         CM   + +  
Sbjct: 118 QRKKVIVKAVTGGKTPGREIDI---LKTIS---HRAIINLIHAYRWKSTVCMVMPKYKCD 171

Query: 302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 361
           ++ Y+       R    P     T +R  L A   L YLH +    IIHRDVK  NI LD
Sbjct: 172 LFTYVD------RSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLD 219

Query: 362 EYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 420
           E   AV+GDFG A KL  H D+       GT+   +PE L+      KTD++  G++L E
Sbjct: 220 EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279

Query: 421 LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 458
           +      L FGK      + L  + +  Q   LE   +
Sbjct: 280 MSVKNVTL-FGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316

Length = 392

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 69/279 (24%), Positives = 130/279 (46%), Gaps = 38/279 (13%)

Query: 235 VGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E  ++      +++R
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA-------KPSLDWATRKRIALGA---ARGLL 338
           L+G        L++   M+ G + S L++        P     + K++   A   A G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIA 396
           YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D +     +G   V  ++
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMS 189

Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 456
           PE L  G  +  +DV+ FG++L E I+ L    +   +N              E+ L  +
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWE-IATLAEQPYQGMSN--------------EQVLRFV 234

Query: 457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
           ++  L +  D    + + ++  +C QY P +RP   E++
Sbjct: 235 MEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 76.3 bits (187), Expect = 3e-15
 Identities = 57/207 (27%), Positives = 107/207 (51%), Gaps = 31/207 (14%)

Query: 234 LVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           ++G G FG VYKG ++ +G  V    A+K L +       ++F  E  +++   H +L+R
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 289 LIGFCMTTTERL----------LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 338
           L+G C++ T +L          L Y +    ++ S+L     L+W  +       A+G++
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLL----LNWCVQ------IAKGMM 123

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIA 396
           YL E+   +++HRD+ A N+L+       + DFGLA+LL+  D     A  G   +  +A
Sbjct: 124 YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG-DEKEYNADGGKMPIKWMA 179

Query: 397 PEYLSTGQSSEKTDVFGFGILLLELIS 423
            E +   + + ++DV+ +G+ + EL++
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 25/218 (11%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN----AIGGEIQFQTEVEMISL 280
              + +   +G+G  G VYK      G  VA+K+++        I  EI       M   
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILI-----MKDC 72

Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLY 339
             H N++      +   E  +V  YM  GS+   +      ++      +     +GL Y
Sbjct: 73  -KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEY 131

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           LH Q    +IHRD+K+ NILL +     + DFG A  L    S   + V GT   +APE 
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEV 187

Query: 400 LSTGQSSEKTDVFGFGILLLELISG---------LRAL 428
           +       K D++  GI+ +E+  G         LRAL
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 78.4 bits (193), Expect = 4e-15
 Identities = 39/93 (41%), Positives = 55/93 (59%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N +SG IP  I  L KL++LDLS+N  +G IP  V  L+ L+ L L +N+ TG IP 
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT 122
           +L+++ +L  L L  N  SG +P    K  N+T
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT 359

Length = 968

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 29/215 (13%)

Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K      T VAVK LK            +E+EM+ +   H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRK--------------RI 329
           ++ L+G C       ++  Y S G++   L+A+  P +++                    
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
           A   ARG+ YL  +   K IHRD+ A N+L+ E     + DFGLA+ + H D +  TT  
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+LL E+ +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 10/195 (5%)

Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +GKGGFG V    ++  G + A K+L  K      GE     E +++     R ++ L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 292 FCMTTTERLLVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
              T  +  LV   M+ G +   +    +P    A     A     GL +LH++   +I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           +RD+K  N+LLD++    + D GLA  ++           GT G++APE L         
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 410 DVFGFGILLLELISG 424
           D F  G  L E+I+G
Sbjct: 176 DWFALGCTLYEMIAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 35/276 (12%)

Query: 228 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQ-TEVEMISLAVHRN 285
           +F     +GKG +G+VYK   L D    A+K +  G+    E +    E+ +++   H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVA----SRLKAKPSLDWATRKRIALGAARGLLYLH 341
           ++      +   +  +V  Y   G ++     R K +  +      RI +   RGL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
           EQ   KI+HRD+K+ANILL       +GD G++K+L     ++     GT  ++APE   
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWK 174

Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 461
               S K+D++  G LL E+ +   A  F                  + + ++ L  K  
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATF--APPF------------------EARSMQDLRYKVQ 214

Query: 462 KNNYDRIEL---EEMVQVALLCTQYLPSLRPKMSEV 494
           +  Y  I     +++        Q  P LRP   ++
Sbjct: 215 RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 56/212 (26%), Positives = 80/212 (37%), Gaps = 28/212 (13%)

Query: 228 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +F    ++GKG FG V          + A+K           +  Q  VE  S+    N 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMK----------YMNKQKCVEKGSVRNVLNE 50

Query: 287 LR---------LIGFCMTTTER---LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA 334
            R         L+    +  +     LV   +  G +   L  K        K       
Sbjct: 51  RRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIV 110

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             L YLH +    IIHRD+K  NILLDE     + DF +A  +      +TT+  GT G+
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTSGTPGY 165

Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLR 426
           +APE L     S   D +  G+   E + G R
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.1 bits (182), Expect = 9e-15
 Identities = 52/217 (23%), Positives = 103/217 (47%), Gaps = 24/217 (11%)

Query: 221 ELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMI 278
           E +        + ++GKG +G VY    L     +A+K + + ++    +Q    E+ + 
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALH 59

Query: 279 SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--------PSLDWATRKRIA 330
           S   HRN+++ +G         +    +  GS+++ L++K         ++ + T++ + 
Sbjct: 60  SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL- 118

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVR 389
                GL YLH+    +I+HRD+K  N+L++ Y   V + DFG +K L   +   T    
Sbjct: 119 ----EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFT 170

Query: 390 GTVGHIAPEYLSTGQS--SEKTDVFGFGILLLELISG 424
           GT+ ++APE +  G        D++  G  ++E+ +G
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 235 VGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +G+  FG +YKG+L         +VA+K LKD N      +FQ E  +++   H N++ L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRL-----------------KAKPSLDWATRKRIALG 332
           +G         +++ Y++ G +   L                   K SLD      IA+ 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGT 391
            A G+ YL        +H+D+ A NIL+ E     + D GL++ +   D + V       
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           +  + PE +  G+ S  +D++ FG++L E+ S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 69/288 (23%), Positives = 126/288 (43%), Gaps = 33/288 (11%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 280
           SN      +G+G FG V+    +        T+V VK L+       + +F+ E++M   
Sbjct: 5   SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64

Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW-------ATRKRIALGA 333
             H+N++RL+G C       ++  Y   G +   L+A  S D        +T++++AL  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 334 --ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
             A G+ +L      + +HRD+ A N L+    E  V    L+K + + + +        
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181

Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 451
           +  +APE +     S K+DV+ FG+L+ E+ +    L F   +++     + + ++ Q  
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDE-----EVLNRL-QAG 234

Query: 452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           KLE+ V +   +   ++           C    P  RP  SE+V  L 
Sbjct: 235 KLELPVPEGCPSRLYKLMTR--------CWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 29/223 (13%)

Query: 222 LQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMI- 278
           L   T  F    ++G+G +G VYK  + + G +VA+K +   + I  E +  + E  ++ 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILR 57

Query: 279 SLAVHRNLLRLIGFCMTTTERL------LVYPYMSNGSVASRLKAKPSLDWATRKR---- 328
             + H N+    G  +            LV      GSV + L  K       R +    
Sbjct: 58  KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-TDL-VKGLRKKGKRLKEEWI 115

Query: 329 --IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
             I     RGL YLHE    K+IHRD+K  NILL +  E  + DFG++  LD       T
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172

Query: 387 AVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELISG 424
            + GT   +APE ++  +  + +     DV+  GI  +EL  G
Sbjct: 173 FI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 37/179 (20%)

Query: 224 SATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRL-----KDGNAIGGEIQFQTEVEM 277
           S   ++     +G+G FG VYK   ++ G VVA+K++     KDG  I        E+++
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA----LREIKI 60

Query: 278 ISLAVHRNLLRLIGFCM-----TTTERLLVY---PYM--------SNGSVASRLKAKPSL 321
           +    H N++ LI   +     +  +R  VY   PYM         N SV         L
Sbjct: 61  LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--------KL 112

Query: 322 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 380
             +  K   L    G+ YLHE     I+HRD+KAANIL+D      + DFGLA+  D  
Sbjct: 113 TESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 10/192 (5%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V  G  +    VA+K +K+G+    E +F  E +++    H  L++L G C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 295 TTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 +V  YMSNG + + L+        +    +      G+ YL  +   + IHRD+
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDL 126

Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV--RGTVGHIAPEYLSTGQSSEKTDV 411
            A N L+D+     V DFGL++ +   D   T++V  +  V    PE L   + S K+DV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184

Query: 412 FGFGILLLELIS 423
           + FG+L+ E+ S
Sbjct: 185 WAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 70/296 (23%), Positives = 128/296 (43%), Gaps = 48/296 (16%)

Query: 228 NFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           N   K  +G+G FG V+          QD  +VAVK LKD +       F  E E+++  
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNL 64

Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-------------PSLDWATRKR 328
            H ++++  G C+     ++V+ YM +G +   L+A                L  +    
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-----SH 383
           IA   A G++YL  Q     +HRD+   N L+ E     +GDFG+++ +   D      H
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 443
               +R     + PE +   + + ++DV+  G++L E+ +      +GK    + +  + 
Sbjct: 182 TMLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFT------YGKQPWYQLSNNEV 231

Query: 444 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           ++ I Q + L+            R   +E+  + L C Q  P +R  + E+  +L+
Sbjct: 232 IECITQGRVLQR----------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 21/213 (9%)

Query: 229 FSSKNLVGKGGFGNVYKGYL--QDGTV--VAVKRLK-DGNAIGGEIQFQTEVEMISLAVH 283
           F+   ++GKG FG+V +  L  +DG+   VAVK LK D  +     +F  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 284 RNLLRLIGFCMTTTER------LLVYPYMSNGSV-----ASRLKAKP-SLDWATRKRIAL 331
            N+++LIG  + +  +      +++ P+M +G +      SR+  +P +L   T  R  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRG 390
             A G+ YL  +     IHRD+ A N +L+E     V DFGL+K +   D +    A + 
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
            V  +A E L+    +  +DV+ FG+ + E+++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 17/200 (8%)

Query: 234 LVGKGGFGNVYKG-YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAV--HRN 285
           L+G G FG V+KG ++ +G      VA+K ++D +   G   FQ   + M+++    H  
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAY 70

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQC 344
           ++RL+G C   + +L V      GS+   + + + SLD        +  A+G+ YL E  
Sbjct: 71  IVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTG 403
              ++HR++ A NILL       + DFG+A LL   D  +  +  +  +  +A E +  G
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + ++DV+ +G+ + E++S
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 58/242 (23%), Positives = 109/242 (45%), Gaps = 32/242 (13%)

Query: 235 VGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG V+          QD  +VAVK LK+ +       FQ E E++++  H++++R
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVR 71

Query: 289 LIGFCMTTTERLLVYPYMSNGSV---------------ASRLKAKPSLDWATRKRIALGA 333
             G C      L+V+ YM +G +                    A   L       IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTV 392
           A G++YL        +HRD+   N L+ +     +GDFG+++ +   D + V       +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE +   + + ++D++ FG++L E+ +      +GK    + +  + ++ I Q ++
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT------YGKQPWYQLSNTEAIECITQGRE 242

Query: 453 LE 454
           LE
Sbjct: 243 LE 244

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 76/296 (25%), Positives = 137/296 (46%), Gaps = 55/296 (18%)

Query: 233 NLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLR 288
           +++G+G FG V K  ++ DG  +  A+KR+K+  +      F  E+E++  L  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLD--------------WATRK--RIALG 332
           L+G C       L   Y  +G++   L+    L+               ++++    A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
            ARG+ YL ++   + IHRD+ A NIL+ E Y A + DFGL++  +         V+ T+
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 170

Query: 393 GHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
           G +     A E L+    +  +DV+ +G+LL E++S       G T        +  +K+
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYEKL 224

Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV----RMLE 499
            Q  +LE  ++ D          +E+  +   C +  P  RP  ++++    RMLE
Sbjct: 225 PQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 35/278 (12%)

Query: 232 KNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
              +G+G FG+VY+G           VAVK  K+  +     +F  E  ++    H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +LIG   T     +V      G + S L+  K SLD A+    +   +  L YL  +   
Sbjct: 71  KLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK--- 126

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           + +HRD+ A N+L+       +GDFGL++ L+    +  +  +  +  +APE ++  + +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186

Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 466
             +DV+ FG+ + E++        G    Q       VK      ++E         N +
Sbjct: 187 SASDVWMFGVCMWEILM------LGVKPFQ------GVKNNDVIGRIE---------NGE 225

Query: 467 RIELEEMVQVAL-----LCTQYLPSLRPKMSEVVRMLE 499
           R+ +       L      C  Y PS RP+ +E+   L 
Sbjct: 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 66/303 (21%), Positives = 121/303 (39%), Gaps = 40/303 (13%)

Query: 212 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQ 270
           G     H  E          ++   K    N       D  V VAVK L+   +      
Sbjct: 16  GQFGEVHLCE------ADGLQDFSEKAFAENDNA----DAPVLVAVKVLRPDASDNARED 65

Query: 271 FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-----------KP 319
           F  EV+++S     N+ RL+G C       ++  YM NG +   L+              
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 320 SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 379
           SL ++T   +A   A G+ YL        +HRD+   N L+ + Y   + DFG+++ L  
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 380 CDSHVTTAVRG-TVGHI---APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN 435
            D +    V+G     I   A E +  G+ + K+DV+ FG+ L E+++  R   +    +
Sbjct: 183 SDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239

Query: 436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
           Q+  +++      ++   ++ + +           +++ ++ L C +     RP   E+ 
Sbjct: 240 QQ--VIENAGHFFRDDGRQIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREIH 291

Query: 496 RML 498
             L
Sbjct: 292 LFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 36/272 (13%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ G  +    VA+K + +G     E  F  E +++    H  L++L G C 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR----GLLYLHEQCDPKIIH 350
                 +V  +M NG + + L+ +        K + L   +    G+ YL        IH
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIH 123

Query: 351 RDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTA-VRGTVGHIAPEYLSTGQSSEK 408
           RD+ A N L+       V DFG+ + +LD  D + +++  +  V    PE  +  + S K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 409 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           +DV+ FG+L+ E+ +       GK   +K +  + V+ I +  +L             R 
Sbjct: 182 SDVWSFGVLMWEVFTE------GKMPFEKKSNYEVVEMISRGFRLY------------RP 223

Query: 469 ELEEMV--QVALLCTQYLPSLRPKMSEVVRML 498
           +L  M   +V   C    P  RP  +E++R +
Sbjct: 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 15/197 (7%)

Query: 236 GKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           G+G  G+V K  L   G + A+K +        + Q   E+E+        +++  G  +
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69

Query: 295 --TTTERLLVYPYMSNGSVASRLKAKPSLDWATRK----RIALGAARGLLYLHEQCDPKI 348
             +++   +   Y   GS+ S  K          +    +IA    +GL YLH +   KI
Sbjct: 70  DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KI 126

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
           IHRD+K +NILL    +  + DFG++ +L++      T    GT  ++APE +     S 
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPERIQGKPYSI 182

Query: 408 KTDVFGFGILLLELISG 424
            +DV+  G+ LLE+   
Sbjct: 183 TSDVWSLGLTLLEVAQN 199

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 18/201 (8%)

Query: 229 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHR 284
           FS    +G G FG VY    +++  VVA+K++        E ++Q    EV  +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQ 343
           N ++  G  +      LV  Y   GS +  L+  K  L       +  GA +GL YLH  
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---L 400
               +IHRDVKA NILL E     +GDFG A ++   +  V     GT   +APE    +
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 186

Query: 401 STGQSSEKTDVFGFGILLLEL 421
             GQ   K DV+  GI  +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 21/204 (10%)

Query: 235 VGKGGFGNVYKGYLQDGTVVA---VKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +G G FG V  G    G   A   VK L+       ++ F  EV+      H N+L+ +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSL-----DWATRKRIALGAARGLLYLHEQCDP 346
            C+ +   LLV  +   G + + L++   +          +R+A   A GLL+LH+    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG--HIAPEYLSTGQ 404
             IH D+   N  L       +GD+GLA L  + + +  T     V    +APE +    
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 405 S-------SEKTDVFGFGILLLEL 421
                   ++K++++  G+ + EL
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 72/298 (24%), Positives = 134/298 (44%), Gaps = 55/298 (18%)

Query: 232 KNLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLL 287
           ++++G+G FG V +  ++ DG  +  A+K LK+  +      F  E+E++  L  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLD--------------WATRK--RIAL 331
            L+G C       +   Y   G++   L+    L+                +++  + A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
             A G+ YL E+   + IHRD+ A N+L+ E   + + DFGL++  +         V+ T
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKT 176

Query: 392 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +G +     A E L+    + K+DV+ FG+LL E++S       G T        +  +K
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS------LGGTPYCGMTCAELYEK 230

Query: 447 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV----RMLEG 500
           + Q  ++E   + D          +E+ ++   C +  P  RP  +++     RMLE 
Sbjct: 231 LPQGYRMEKPRNCD----------DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 10/195 (5%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVHRNLLRLIG 291
           +G+G  G V+K    + G  VA+K++      GG I  Q   E++ +    H  +++L+ 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-IPNQALREIKALQACQHPYVVKLLD 66

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
                +  +LV  YM    ++  L+ +   L  A  K       +G+ Y+H      I+H
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMH 122

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKT 409
           RD+K AN+L+       + DFGLA+L    +  + +    T  + APE L   +      
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV 182

Query: 410 DVFGFGILLLELISG 424
           D++  G +  EL++G
Sbjct: 183 DLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 72.2 bits (177), Expect = 3e-13
 Identities = 36/83 (43%), Positives = 51/83 (61%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L +N++SG IP  + +L  L  L L +N FTG IP  ++ L  LQ L+L +N  +G IP 
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Query: 90  SLSNMSQLAFLDLSYNNLSGPVP 112
           +L   + L  LDLS NNL+G +P
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIP 373

Length = 968

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 20/221 (9%)

Query: 219 FKELQSATSNFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 277
            + L   T  +     +GKG +G VYK    +DG++ AVK L   + +  EI+ +  + +
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72

Query: 278 ISLAVHRNLLRLIGFCMTTTERL-----LVYPYMSNGSVASR----LKAKPSLDWATRKR 328
            SL  H N+++  G      + +     LV    + GSV       L     LD A    
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           I  GA  GL +LH     +IIHRDVK  NILL       + DFG++  L        T+V
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 389 RGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELISG 424
            GT   +APE ++  Q  +     + DV+  GI  +EL  G
Sbjct: 190 -GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 75/296 (25%), Positives = 122/296 (41%), Gaps = 56/296 (18%)

Query: 229 FSSKNL-----VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
           F++++L     +G+G FG V K  +   GT++AVKR++       + +   +++++  + 
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 283 H-RNLLRLIG---------FCM----TTTERLLVYPYMS-NGSVASRLKAKPSLDWATRK 327
               +++  G          CM     + ++   Y Y      +   +  K         
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK--------- 111

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
            IA+   + L YL E  + KIIHRDVK +NILLD      + DFG++  L   DS   T 
Sbjct: 112 -IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTR 166

Query: 388 VRGTVGHIAPEYLSTGQSSE---KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
             G   ++APE +          ++DV+  GI L E+ +G       K    K     W 
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG-------KFPYPK-----WN 214

Query: 445 KKIHQEKKLEMLVDKD---LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 497
               Q   L  +V  D   L N+ +R      V    LC     S RPK  E++  
Sbjct: 215 SVFDQ---LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.4 bits (169), Expect = 4e-13
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 23/219 (10%)

Query: 222 LQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 279
           L+     F    LVG G +G VYKG +++ G + A+K +   +  G E +  + E+ M+ 
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLK 57

Query: 280 -LAVHRNLLRLIGFCMTTT------ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIA 330
             + HRN+    G  +         +  LV  +   GSV   +K     +L       I 
Sbjct: 58  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 390
               RGL +LH+    K+IHRD+K  N+LL E  E  + DFG++  LD       T + G
Sbjct: 118 REILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 173

Query: 391 TVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELISG 424
           T   +APE ++  ++ +     K+D++  GI  +E+  G
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 20/228 (8%)

Query: 235 VGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +G G FG V KG  +       VA+K LK+ N      +   E E++    +  ++R+IG
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQCDPKI 348
            C      +LV    S G +   L  K   D  T   +       + G+ YL  +     
Sbjct: 63  VCEAEA-LMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NF 116

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L   DS+    +A +  +   APE ++  + S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            ++DV+ +GI + E      A  +G+   +K    + +  I Q K+L+
Sbjct: 177 SRSDVWSYGITMWE------AFSYGQKPYKKMKGPEVMSFIEQGKRLD 218

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 25/211 (11%)

Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSV-------ASRLKAKPSLDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L +   M  G +          + ++  L+W  +       A
Sbjct: 67  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 119

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV-- 392
           +G+ YL E+   +++HRD+ A N+L+       + DFGLAKLL   D     A  G V  
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-ADEKEYHAEGGKVPI 175

Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 25/204 (12%)

Query: 234 LVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           ++G G FG VYKG ++ DG      VA+K L++  +     +   E  +++      + R
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 289 LIGFCMTTTERLLVYPYMSNGSV-------ASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           L+G C+T+T +L V   M  G +         R+ ++  L+W  +       A+G+ YL 
Sbjct: 74  LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV--GHIAPEY 399
           E    +++HRD+ A N+L+       + DFGLA+LLD  D     A  G V    +A E 
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADGGKVPIKWMALES 182

Query: 400 LSTGQSSEKTDVFGFGILLLELIS 423
           +   + + ++DV+ +G+ + EL++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 28/215 (13%)

Query: 229 FSSKNLV-----GKGGFGNVYK----GYLQDGTV--VAVKRLKDGNAIGGEIQ-FQTEVE 276
           F   NL      G G FG V +    G  +   V  VAVK LK   A   E +   +E++
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP-TAHSSEREALMSELK 90

Query: 277 MIS-LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS--RLKAKPSLDWATRKRIALGA 333
           ++S L  H N++ L+G C      L++  Y   G + +  R K +  L        +   
Sbjct: 91  IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150

Query: 334 ARGLLYL-HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT- 391
           A+G+ +L  + C    IHRD+ A N+LL       + DFGLA+ + +  ++V   V+G  
Sbjct: 151 AKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNA 203

Query: 392 ---VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
              V  +APE +     + ++DV+ +GILL E+ S
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 68.7 bits (169), Expect = 8e-13
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 25/208 (12%)

Query: 229 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL---AVHR 284
           +     +G+G +G VYK    + G +VA+K+++  N   G I   T +  ISL     H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-IP-STALREISLLKELKHP 58

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQ 343
           N+++L+    T  +  LV+ Y     +   L  +P  L     K I     RGL Y H  
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSH--VTTAVRGTVGHIAPE 398
              +I+HRD+K  NIL++      + DFGLA+         +H  VT   R      APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR------APE 168

Query: 399 YL--STGQSSEKTDVFGFGILLLELISG 424
            L  S   S+   D++  G +  E+I+G
Sbjct: 169 ILLGSKHYSTA-VDIWSVGCIFAEMITG 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.0 bits (168), Expect = 9e-13
 Identities = 65/201 (32%), Positives = 91/201 (45%), Gaps = 18/201 (8%)

Query: 229 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHR 284
           F+    +G G FG VY    ++   VVA+K++        E ++Q    EV+ +    H 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVKFLQRIKHP 85

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQ 343
           N +   G  +      LV  Y   GS +  L+  K  L       I  GA +GL YLH  
Sbjct: 86  NSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---L 400
               +IHRD+KA NILL E  +  + DFG A +    +S V     GT   +APE    +
Sbjct: 145 ---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAM 196

Query: 401 STGQSSEKTDVFGFGILLLEL 421
             GQ   K DV+  GI  +EL
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 65/194 (33%), Positives = 85/194 (43%), Gaps = 16/194 (8%)

Query: 235 VGKGGFGNVY-KGYLQDGTVVAVKRLK-DGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIG 291
           +G G FG VY         VVAVK++   G     + Q    EV+ +    H N +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
             +      LV  Y   GS +  L+  K  L       I  GA +GL YLH      +IH
Sbjct: 89  CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIH 144

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---LSTGQSSE 407
           RD+KA NILL E  +  + DFG A      +S V     GT   +APE    +  GQ   
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYDG 199

Query: 408 KTDVFGFGILLLEL 421
           K DV+  GI  +EL
Sbjct: 200 KVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 70.6 bits (173), Expect = 1e-12
 Identities = 35/83 (42%), Positives = 49/83 (59%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L +N + G IP E+G++  L  + L  N  +G IP  +  L +L +L L  N+LTG IP 
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254

Query: 90  SLSNMSQLAFLDLSYNNLSGPVP 112
           SL N+  L +L L  N LSGP+P
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIP 277

Length = 968

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 10/195 (5%)

Query: 235 VGKGGFGNVYKGYLQ---DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G G FG V KG  +       VAVK LK D N    + +   E  ++    +  ++R+I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
           G C      +LV      G +   L+    +       +    + G+ YL E      +H
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVH 118

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSSEK 408
           RD+ A N+LL   + A + DFGL+K L   +++      G   V   APE ++  + S K
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178

Query: 409 TDVFGFGILLLELIS 423
           +DV+ FG+L+ E  S
Sbjct: 179 SDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 60/198 (30%), Positives = 87/198 (43%), Gaps = 14/198 (7%)

Query: 234 LVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++GKG FG V     KG      + AVK LK    +  +    T  E   LA+      L
Sbjct: 2   VLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 290 IGF--CMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
                C  T +RL  V  Y++ G +   ++     D    +  A     GL +LHE+   
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER--- 115

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
            II+RD+K  N+LLD      + DFG+ K         T+   GT  +IAPE LS     
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVTTSTFCGTPDYIAPEILSYQPYG 174

Query: 407 EKTDVFGFGILLLELISG 424
              D +  G+LL E+++G
Sbjct: 175 PAVDWWALGVLLYEMLAG 192

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 26/214 (12%)

Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-----VAVKRLKDGNAIGGEIQ---FQTEVEMISL 280
            +  +L+ +G FG ++ G L D        V VK +KD  +   EIQ      E  ++  
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS---EIQVTLLLQESCLLYG 64

Query: 281 AVHRNLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKR---------IA 330
             H+N+L ++  C+   E   V YPYM+ G++   L+ +  L  A   +         +A
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ-QCRLGEANNPQALSTQQLVHMA 123

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVR 389
           +  A G+ YLH++    +IH+D+ A N ++DE  +  + D  L++ L   D H +     
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180

Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             V  +A E L   + S  +DV+ FG+LL EL++
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 8/206 (3%)

Query: 228 NFSSKNLVGKGGFGNVY--KGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 284
            +    +VG+G FG V+  +    D  +V +K++  +       +  Q E +++ L  H 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           N++      +     ++V  Y   G++A     K          I     + LL LH   
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLA-EYIQKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 345 DPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              I+HRD+K  NILLD++   V +GDFG++K+L    S   T V GT  +I+PE     
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELCEGK 176

Query: 404 QSSEKTDVFGFGILLLELISGLRALE 429
             ++K+D++  G +L EL S  RA E
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 20/265 (7%)

Query: 232 KNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           + ++G G  G VYK Y L    ++AVK +     +  + Q  +E+E++       ++   
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
           G         +   +M  GS    L     +      RIA+   +GL YL      KI+H
Sbjct: 66  GAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGRIAVAVVKGLTYLWSL---KILH 118

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 410
           RDVK +N+L++   +  + DFG++  L   +S   T V GT  ++APE +S  Q    +D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISGEQYGIHSD 175

Query: 411 VFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 470
           V+  GI  +EL  G     + +    +G+++         + L+ +VD+D          
Sbjct: 176 VWSLGISFMELALG--RFPYPQIQKNQGSLMPL-------QLLQCIVDEDPPVLPVGQFS 226

Query: 471 EEMVQVALLCTQYLPSLRPKMSEVV 495
           E+ V     C +  P  RP    ++
Sbjct: 227 EKFVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 25/206 (12%)

Query: 235 VGKGGFGNVY---KGYLQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHRNLLR 288
           + KG +G V+   K     G + A+K +K  + I  + Q     TE +++S A    +++
Sbjct: 1   ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVK 57

Query: 289 LIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           L  +     ++   LV  Y+  G +AS L+   SLD    +         L YLH     
Sbjct: 58  L--YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN--- 112

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKL---LDHCDSHVTTA----VRGTVGHIAPEY 399
            IIHRD+K  NIL+D      + DFGL+K+       + +        + GT  +IAPE 
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 400 LSTGQSSEKT-DVFGFGILLLELISG 424
           +  GQ   KT D +  G +L E + G
Sbjct: 173 I-LGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 16/195 (8%)

Query: 236 GKGGFGNVYKG-YLQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           G G FG VYK  + + G   A K   ++    +     F  E++++S   H N++ L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE---DFMVEIDILSECKHPNIVGLYEA 70

Query: 293 CMTTTERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
                +  ++  +   G++ S  L+ +  L     + +       L +LH     K+IHR
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHR 127

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE---- 407
           D+KA NILL    +  + DFG++           T + GT   +APE ++     +    
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYD 186

Query: 408 -KTDVFGFGILLLEL 421
            K D++  GI L+EL
Sbjct: 187 YKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)

Query: 229 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNL 286
           F    +VG G +G VYKG +++ G + A+K +        EI+   E+ M+   + HRN+
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL--EINMLKKYSHHRNI 75

Query: 287 LRLIGFCMTTT------ERLLVYPYMSNGSVASRLKAKP----SLDWATRKRIALGAARG 336
               G  +  +      +  LV  +   GSV   +K         DW     I     RG
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRG 133

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L +LH     K+IHRD+K  N+LL E  E  + DFG++  LD       T + GT   +A
Sbjct: 134 LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 189

Query: 397 PEYLSTGQSSEKT-----DVFGFGILLLELISG 424
           PE ++  ++ + T     D++  GI  +E+  G
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 69/284 (24%), Positives = 125/284 (44%), Gaps = 37/284 (13%)

Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-----LKDGNAIGGEIQFQTEVEMISL 280
           +NF  +  +G+G F  VY+   L DG  VA+K+     L D  A    I+   E++++  
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQ 58

Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARG 336
             H N+++     +   E  +V      G ++  +    K K  +   T  +  +     
Sbjct: 59  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG--- 393
           L ++H +   +++HRD+K AN+ +       +GD GL +      S  TTA    VG   
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPY 171

Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 453
           +++PE +     + K+D++  G LL E+ + L++  +G   N    +    KKI Q    
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMN----LYSLCKKIEQCDYP 226

Query: 454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 497
            +  D     +Y     EE+ Q+  +C    P  RP ++ V  +
Sbjct: 227 PLPSD-----HYS----EELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 30/222 (13%)

Query: 233 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISLAVHR 284
             +G+G +G VYK   L  G  VA+K+++   +  G       EI    ++E      H 
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---HP 61

Query: 285 NLLRLIGFCMT-TTER----LLVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGL 337
           N++RL+  C    T+R     LV+ ++    +A+ L    KP L   T K +     RG+
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGV 120

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
            +LH      I+HRD+K  NIL+    +  + DFGLA++    +  +T+ V  T+ + AP
Sbjct: 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVV-TLWYRAP 175

Query: 398 EYLSTGQSSEKT--DVFGFGILLLELISGLRALEFGKT-ANQ 436
           E L   QSS  T  D++  G +  EL    R L  G + A+Q
Sbjct: 176 EVLL--QSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQ 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 72/283 (25%), Positives = 125/283 (44%), Gaps = 39/283 (13%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMIS 279
             NF  +  +GKG F  VYK   L DG VVA+K+++     D  A    ++   E++++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57

Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL-----KAKPSLDWATRKRIALGAA 334
              H N+++ +   +   E  +V      G + SR+     K K  +   T  +  +   
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG- 393
             L ++H +   +I+HRD+K AN+ +       +GD GL +      S  TTA    VG 
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGT 169

Query: 394 --HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 451
             +++PE +     + K+D++  G LL E+ + L++  +G   N    +    KKI +  
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMN----LYSLCKKIEKCD 224

Query: 452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV 494
                    L  ++   EL ++V     C    P  RP +S V
Sbjct: 225 Y------PPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 13/196 (6%)

Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRL---KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G +G V+K   ++ G +VA+K+    +D   I  +I  + E+ M+    H NL+ LI
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALR-EIRMLKQLKHPNLVNLI 66

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKII 349
                  +  LV+ Y  + +V + L+  P  +     K+I     + + + H+      I
Sbjct: 67  EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCI 122

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL-STGQSSEK 408
           HRDVK  NIL+ +  +  + DFG A++L       T  V  T  + APE L    Q    
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGPP 181

Query: 409 TDVFGFGILLLELISG 424
            DV+  G +  EL++G
Sbjct: 182 VDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 66.4 bits (163), Expect = 5e-12
 Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 30/159 (18%)

Query: 233 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----------EIQFQTEVEMISLA 281
             +G+G +  VYK    + G +VA+K++K G               EI+   E++     
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK----- 60

Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-----KPSLDWATRKRIALGAARG 336
            H N++ L+      +   LV+ +M      + L+         L  A  K   L   RG
Sbjct: 61  -HPNIIGLLDVFGHKSNINLVFEFME-----TDLEKVIKDKSIVLTPADIKSYMLMTLRG 114

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
           L YLH      I+HRD+K  N+L+       + DFGLA+
Sbjct: 115 LEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.9 bits (161), Expect = 7e-12
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 51/217 (23%)

Query: 236 GKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           G+G +G V K  ++  GT++AVKR++                 ++    + LL  +   M
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIR---------------ATVNSQEQKRLLMDLDISM 54

Query: 295 TTTERLLVYPYM--------SNGSVASRLKA-KPSLDWATRK--------------RIAL 331
            + +     PY           G V   ++    SLD   +K              +IA+
Sbjct: 55  RSVD----CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV 110

Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
              + L YLH +    +IHRDVK +N+L++   +  + DFG++  L   DS   T   G 
Sbjct: 111 SIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGC 166

Query: 392 VGHIAPEYLSTGQSSE----KTDVFGFGILLLELISG 424
             ++APE ++   + +    K+DV+  GI ++EL +G
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 66.2 bits (162), Expect = 7e-12
 Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 45/247 (18%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-----KDGNAIGG--EIQFQTEVEMI 278
           + F   N +G+G +G VY+      G +VA+K++     +DG  I    EI     +   
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-- 64

Query: 279 SLAVHRNLLRLIGFCMTTTERL----LVYPYMSNGSVASRLKAKPS-LDWATRKRIALGA 333
               H N++ L    +   + L    LV  Y     +AS L   P+    +  K + L  
Sbjct: 65  ----HPNIVELKE--VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQL 117

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 393
            RGL YLHE     IIHRD+K +N+LL +     + DFGLA+        +T  V  T+ 
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLW 173

Query: 394 HIAPEYL--STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 451
           + APE L   T   +   D++  G +L EL++  + L  GK+            +I Q  
Sbjct: 174 YRAPELLLGCTTY-TTAIDMWAVGCILAELLAH-KPLLPGKS------------EIEQ-- 217

Query: 452 KLEMLVD 458
            L++++ 
Sbjct: 218 -LDLIIQ 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 19/201 (9%)

Query: 234 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI---GGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+GGFG VY     D G + A+K L D   I    GE     E  M+SL    +   +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 290 IGFCMT----TTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           +  CM+    T ++L  +   M+ G +   L        A  +  A     GL ++H + 
Sbjct: 60  V--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF 117

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
              +++RD+K ANILLDE+    + D GLA        H +    GT G++APE L  G 
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171

Query: 405 SSEKT-DVFGFGILLLELISG 424
           + + + D F  G +L +L+ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.0 bits (161), Expect = 8e-12
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 24/203 (11%)

Query: 235 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR----- 288
           +GKG FG V    +  DG   AVK L+        I  + E + I     RN+L      
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKA-----ILKKKEQKHI--MAERNVLLKNVKH 55

Query: 289 --LIG--FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L+G  +   T ++L  V  Y++ G +   L+ + S      +  A   A  L YLH  
Sbjct: 56  PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRGTVGHIAPEYLST 402
               II+RD+K  NILLD     V+ DFGL K  ++H  +  T+   GT  ++APE L  
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRK 170

Query: 403 GQSSEKTDVFGFGILLLELISGL 425
                  D +  G +L E++ GL
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 67.6 bits (165), Expect = 9e-12
 Identities = 32/80 (40%), Positives = 47/80 (58%)

Query: 33  NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLS 92
           NN++G IP+ +G L  L  L L  N  +GPIP ++  L+ L  L L++NSL+G IP  + 
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305

Query: 93  NMSQLAFLDLSYNNLSGPVP 112
            +  L  L L  NN +G +P
Sbjct: 306 QLQNLEILHLFSNNFTGKIP 325

Length = 968

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 5/89 (5%)

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
            GL YLH Q   +IIHRDVK  NI +++  +  +GD G A+      +     + GTV  
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVET 222

Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELIS 423
            APE L+  + + K D++  GI+L E+++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.2 bits (159), Expect = 9e-12
 Identities = 64/270 (23%), Positives = 113/270 (41%), Gaps = 29/270 (10%)

Query: 235 VGKGGFGN--VYKGYLQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +GKG FG   +Y+   +D ++V  K   L   +          E+ ++SL  H N++   
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDA-LNEIVILSLLQHPNIIAYY 65

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCDPKI 348
              M     L+   Y + G++  ++  +    +     +         + Y+H+     I
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GI 122

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
           +HRD+K  NI L +     +GDFG++K+L    S   T V GT  +++PE     + + K
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNFK 181

Query: 409 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           +D++  G +L EL++  R  +     N     L+ V KI Q      +V       Y   
Sbjct: 182 SDIWALGCVLYELLTLKRTFD---ATNP----LNLVVKIVQ-GNYTPVVSV-----YS-- 226

Query: 469 ELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
              E++ +     Q  P  RP   EV+   
Sbjct: 227 --SELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 67.6 bits (165), Expect = 1e-11
 Identities = 36/84 (42%), Positives = 44/84 (52%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L +N  SG IP  +GK + L  LDLS N  TG IP  +     L  L L +NSL G IP 
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPS 113
           SL     L  + L  N+ SG +PS
Sbjct: 399 SLGACRSLRRVRLQDNSFSGELPS 422

Length = 968

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 19/203 (9%)

Query: 235 VGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +G G FG V  G +  G     V VK L+   ++  +++F  E +      H NLL+ +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKP-----SLDWATRKRIALGAARGLLYLHEQCDP 346
            C   T  LLV  +   G +   L++       + D  T +R+A   A GLL+LH+    
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-VGHIAPEYLSTGQS 405
             IH D+   N LL       +GD+GL+      D +VT       +  IAPE +     
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 406 -------SEKTDVFGFGILLLEL 421
                  +++++V+  G+ + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 17/212 (8%)

Query: 234 LVGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           ++G+GGFG VY     D G + A+K L  K      GE     E  M+SL    +   ++
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 291 GFCMT----TTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
             CMT    T ++L  +   M+ G +   L           +  A     GL ++H +  
Sbjct: 61  --CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF- 117

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +++RD+K ANILLDE+    + D GLA        H +    GT G++APE L  G +
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTA 172

Query: 406 SEKT-DVFGFGILLLELISGLRALEFGKTANQ 436
            + + D F  G +L +L+ G       KT ++
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 22/202 (10%)

Query: 234 LVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQ--------TEVEMISLAVH 283
           ++GKG FG V    L+ GT  V A+K LK       ++  Q        TE  +++LA  
Sbjct: 2   VLGKGSFGKVMLAELK-GTDEVYAIKVLKK------DVILQDDDVDCTMTEKRILALAAK 54

Query: 284 RNLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 342
              L  +  C  T +RL  V  Y++ G +  +++     D    +  A      L++LH 
Sbjct: 55  HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
                +I+RD+K  NILLD      + DFG+ K     +   TT   GT  +IAPE L  
Sbjct: 115 H---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQE 170

Query: 403 GQSSEKTDVFGFGILLLELISG 424
            +     D +  G+L+ E+++G
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 37/208 (17%)

Query: 236 GKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI----------SLA 281
           G+G FG V    YK     G + A+K LK G+ I  +     EVE +          +  
Sbjct: 8   GRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARD-----EVESLMCEKRIFETANSE 59

Query: 282 VHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR---GL 337
            H  L+ L   C  T + +  V  Y + G +   +      D  +  R    AA    GL
Sbjct: 60  RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGL 114

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRGTVGHIA 396
            YLHE    KI++RD+K  N+LLD      + DFGL K  +   D   T+   GT   +A
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLA 169

Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE L+    +   D +G G+L+ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 27/224 (12%)

Query: 223 QSATSNFSS---KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 278
            SA  + S     N +G G  G VYK  +   G + A+K +   +      Q   E+E++
Sbjct: 67  PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126

Query: 279 SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGL 337
               H N+++         E  ++  +M  GS+  + +  +  L    R+ ++     G+
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-----GI 181

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG----LAKLLDHCDSHVTTAVRGTVG 393
            YLH +    I+HRD+K +N+L++      + DFG    LA+ +D C+S V     GT+ 
Sbjct: 182 AYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIA 233

Query: 394 HIAPEYLSTGQSSEK-----TDVFGFGILLLELISGLRALEFGK 432
           +++PE ++T  +         D++  G+ +LE   G      G+
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 8/178 (4%)

Query: 251 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER--LLVYPYMSN 308
           G  VAVK LK  +        + E+E++    H N+++  G C         L+  ++ +
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 309 GSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 367
           GS+   L + K  ++   + + A+   +G+ YL  +   + +HRD+ A N+L++  ++  
Sbjct: 93  GSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 149

Query: 368 VGDFGLAKLLDHCDSHVTTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           +GDFGL K ++    + T    +   V   APE L   +    +DV+ FG+ L EL++
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 18/197 (9%)

Query: 305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 364
           +M  GS+    K    +      +IA+    GL YL+     +I+HRD+K +NIL++   
Sbjct: 84  FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRG 141

Query: 365 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           +  + DFG++  L   +S   T V GT  +++PE +  G+ + K+DV+  GI ++EL  G
Sbjct: 142 QIKLCDFGVSGEL--INSIADTFV-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198

Query: 425 LRALEFGKTANQKGA----MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLC 480
                F    +        +LD +++I QE    +      +      +L + V   LL 
Sbjct: 199 KFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE------DLRDFVDACLLK 252

Query: 481 TQYLPSLRPKMSEVVRM 497
               P+ RP   ++  M
Sbjct: 253 D---PTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 66.0 bits (161), Expect = 3e-11
 Identities = 41/104 (39%), Positives = 60/104 (57%), Gaps = 8/104 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL-ETLQYLRLNNNSLTGAIP 88
           L   NISG I + I +L  + T++LSNN  +GPIP  +     +L+YL L+NN+ TG+IP
Sbjct: 76  LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPS-----FHAKTFNITGNSLI 127
               ++  L  LDLS N LSG +P+        K  ++ GN L+
Sbjct: 136 R--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177

Length = 968

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 11/196 (5%)

Query: 234 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDG--NAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           LVG+G +G V K   ++ G +VA+K+  +   + +  +I  + E+ M+    H NL+ LI
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKII 349
                     LV+ ++ + +V   L+  P+ LD +  ++      RG+ + H      II
Sbjct: 67  EVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NII 122

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK- 408
           HRD+K  NIL+ +     + DFG A+ L       T  V  T  + APE L       + 
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKYGRA 181

Query: 409 TDVFGFGILLLELISG 424
            D++  G L+ E+++G
Sbjct: 182 VDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 10/202 (4%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN- 285
           +F+   ++GKG FG V     +    + A+K LK    I  +    T VE   LA+    
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  +  C  T +RL  V  Y++ G +   ++             A   + GL +LH +
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLST 402
               II+RD+K  N++LD      + DFG+ K  +H    VTT    GT  +IAPE ++ 
Sbjct: 121 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAY 175

Query: 403 GQSSEKTDVFGFGILLLELISG 424
               +  D + +G+LL E+++G
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 18/197 (9%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG VYK   ++  V+A  ++ D  +      +  E+++++   H N+++L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 295 TTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 ++  + + G+V A  L+ +  L     + +       L YLHE    KIIHRD+
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129

Query: 354 KAANILLDEYYEAVVGDFGLA----KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 407
           KA NIL     +  + DFG++    + +   DS +     GT   +APE +    S +  
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKDRP 184

Query: 408 ---KTDVFGFGILLLEL 421
              K DV+  GI L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQTEVE--MISLAVH 283
           +F+   ++GKG FG V     + GT  + A+K LK    I  +    T VE  +++L+  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59

Query: 284 RNLLRLIGFCMTTTERL-LVYPYMSNGSV------ASRLKAKPSLDWATRKRIALGAARG 336
              L  +  C  T +RL  V  Y++ G +        R K   ++ +A    I      G
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------G 113

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L +LH +    II+RD+K  N++LD      + DFG+ K  +  D   T    GT  +IA
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIA 169

Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE ++     +  D + FG+LL E+++G
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 16/204 (7%)

Query: 229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 285
           F    ++GKGGFG V    ++  G + A KRL  K      GE     E +++     + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRL--KAKPSLDWATRKRIALGAAR---GLLYL 340
           ++ L     T     LV   M+ G +   +     P  +    +R    AA    GL  L
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE---EERALFYAAEILCGLEDL 118

Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
           H +     ++RD+K  NILLD+Y    + D GLA  +   +S       GTVG++APE L
Sbjct: 119 HRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVL 173

Query: 401 STGQSSEKTDVFGFGILLLELISG 424
           +  + +   D +G G L+ E+I G
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 26/206 (12%)

Query: 234 LVGKGGFGNVYKG-YLQDGTVVAVKRL-KDGNAIGGE-IQFQTEVEMISLAVHR--NLLR 288
            +G G  G VYK  + + G V+AVK++ + GN    + I    +V + S   H    +++
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVK 78

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAK-----PSLDWATRKRIALGAARGLLYLHEQ 343
             G+ +T ++  +    MS  +   +L  +     P        ++ +   + L YL E+
Sbjct: 79  CYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPE---DILGKMTVAIVKALHYLKEK 133

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +IHRDVK +NILLD      + DFG++  L   DS   T   G   ++APE +   
Sbjct: 134 --HGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYMAPERIDPP 189

Query: 404 QSSEK----TDVFGFGILLLELISGL 425
             + K     DV+  GI L+EL +G 
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 8/195 (4%)

Query: 234 LVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQ-FQTEVEMISLAVHRNLLRLI 290
           ++GKG FG V    L+  G   AVK LK D   I  +++    E  +++LA     L  +
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 291 GFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
                T E L  V  +++ G +   ++ K   D       A     GL +LH +    II
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GII 118

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           +RD+K  N++LD      + DFG+ K     D+  +T   GT  +IAPE L   + +   
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSV 177

Query: 410 DVFGFGILLLELISG 424
           D + FG+LL E++ G
Sbjct: 178 DWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 63/268 (23%), Positives = 113/268 (42%), Gaps = 28/268 (10%)

Query: 234 LVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G G FG + +G L+        VA+  L+ G +      F  E   +    H N++RL
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
            G        ++V  YMSNG++ S L K +  L       +  G A G+ YL E      
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GY 128

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIAPEYLSTGQSS 406
           +H+ + A  +L++      +  F   +L +     + T + G   V   APE +     S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 466
             +DV+ FGI++ E++S      +G+      +  D +K +  E    +   ++  N   
Sbjct: 187 SASDVWSFGIVMWEVMS------YGERPYWDMSGQDVIKAV--EDGFRLPAPRNCPNLLH 238

Query: 467 RIELEEMVQVALLCTQYLPSLRPKMSEV 494
           ++ L+        C Q     RP+ S++
Sbjct: 239 QLMLD--------CWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 8/195 (4%)

Query: 234 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE--MISLAVHRNLLRLI 290
           ++GKG FG V+   L+      A+K LK    +  +    T VE  ++SLA     L  +
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 291 GFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
                T E L  V  Y++ G +   +++    D       A     GL +LH +    I+
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIV 118

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           +RD+K  NILLD      + DFG+ K     D+   T   GT  +IAPE L   + +   
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNTSV 177

Query: 410 DVFGFGILLLELISG 424
           D + FG+LL E++ G
Sbjct: 178 DWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 16/219 (7%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           +G+G +G VYK      G +VA+K++K    + G       E++++    H N+++L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 293 CMTTTERLLVYPYM-SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
                +  LV+ +M ++     + + +  L  +  K       +GL + H      I+HR
Sbjct: 67  FRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSH---GILHR 122

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTD 410
           D+K  N+L++      + DFGLA+          T    T  + APE L      S   D
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLGDKGYSTPVD 181

Query: 411 VFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 449
           ++  G +  EL+S  R L  GK+       +D + KI +
Sbjct: 182 IWSVGCIFAELLSR-RPLFPGKSE------IDQLFKIFR 213

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 37/223 (16%)

Query: 232 KNLVGKGGFGNVY-------KGYLQDGT--------VVAVKRLKDGNAIGGEIQFQTEVE 276
           K  +G+G FG V+         +L +G         +VAVK L+          F  E++
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK------------PSLDWA 324
           ++S   + N++RL+G C++     ++  YM NG +   L  +            PS+  A
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 325 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 384
               +A+  A G+ YL        +HRD+   N L+  +Y   + DFG+++ L   D + 
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY- 185

Query: 385 TTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
              ++G     +  +A E +  G+ +  +DV+ FG+ L E+ +
Sbjct: 186 --RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 43/135 (31%), Positives = 69/135 (51%), Gaps = 14/135 (10%)

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           I  CM          +M  GS+   LK    +      +I++   RGL YL E+   KI+
Sbjct: 74  ISICME---------HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIM 122

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           HRDVK +NIL++   E  + DFG++  L   DS   + V GT  +++PE L     + ++
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYTVQS 179

Query: 410 DVFGFGILLLELISG 424
           D++  G+ L+E+  G
Sbjct: 180 DIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 7/194 (3%)

Query: 235 VGKGGFGNVYKGYLQDGT-VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGF 292
           +GKG FG V +   +D   + A+K ++  + +       T  E   LA V+   +  + F
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 293 CMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
              + E+L LV  +++ G +   L+ +   D  +R R     A  L  L       +I+R
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFD-LSRARFY--TAELLCALENLHKFNVIYR 117

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D+K  NILLD      + DFGL K L+  D   T    GT  ++APE L     ++  D 
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 412 FGFGILLLELISGL 425
           +  G+LL E+++GL
Sbjct: 177 WTLGVLLYEMLTGL 190

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 27/210 (12%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQT---------EV 275
           T+ +     VG G FG V     Q  G  VA+K++           F T         E+
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK--------PFSTPVLAKRTYREL 60

Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 335
           +++    H N++ L    ++  E +     +    +   L ++P L+    +       R
Sbjct: 61  KLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILR 119

Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           GL Y+H      ++HRD+K +NIL++E  +  + DFGLA++ D     +T  V  T  + 
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYV-STRYYR 172

Query: 396 APEYLSTGQS-SEKTDVFGFGILLLELISG 424
           APE + T Q    + D++  G +  E++ G
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 37/232 (15%)

Query: 235 VGKGGFGNVYKG--YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---------- 282
           +G+G +G V+K       G  VA+KR          ++ QT  E + L+           
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKR----------VRVQTGEEGMPLSTIREVAVLRHL 58

Query: 283 ----HRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALG 332
               H N++RL   C  +     T+  LV+ ++         K  +P +   T K +   
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118

Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL +LH     +++HRD+K  NIL+    +  + DFGLA++         T+V  T+
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTL 173

Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
            + APE L     +   D++  G +  E+             +Q G +LD +
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 8/196 (4%)

Query: 234 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLI 290
           ++GKG FG V     + DG   AVK L+    +  + Q     E  ++   V    L  +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 291 GFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
            +   TTE+L  V  +++ G +   L+ + S      +  A   A  L YLH      I+
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIV 118

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           +RD+K  NILLD     V+ DFGL K      S  TT   GT  ++APE +         
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177

Query: 410 DVFGFGILLLELISGL 425
           D +  G +L E++ GL
Sbjct: 178 DWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 40/120 (33%), Positives = 66/120 (55%), Gaps = 5/120 (4%)

Query: 305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 364
           +M  GS+   LK    +      ++++   RGL YL E+   +I+HRDVK +NIL++   
Sbjct: 84  HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRG 141

Query: 365 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           E  + DFG++  L   DS   + V GT  +++PE L     S ++D++  G+ L+EL  G
Sbjct: 142 EIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 66/287 (22%)

Query: 235 VGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLR---- 288
           VGKG +G V    +  DG    +K+L   NA   E +  + E +++S   H N++     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 289 ----------LIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--------LDWATRKRIA 330
                     ++GFC               G +  +LK +          ++W  +    
Sbjct: 68  WEGEDGLLYIVMGFC-------------EGGDLYHKLKEQKGKLLPENQVVEWFVQ---- 110

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVR 389
              A  L YLHE+    I+HRD+K  N+ L       VGD G+A++L+  CD  + + + 
Sbjct: 111 --IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLI 163

Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 449
           GT  +++PE  S    + K+DV+  G  + E+ +   A       N K  M   V +I +
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF------NAKD-MNSLVYRIIE 216

Query: 450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
            K   M  D      Y   EL E++   +L  +  P  RP +  ++R
Sbjct: 217 GKLPPMPKD------YSP-ELGELIA-TMLSKR--PEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 21/197 (10%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           VG G +G+VYK   L  G + AVK  +L+ G+        Q E+ M+    H N++   G
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS---LIQQEIFMVKECKHCNIVAYFG 73

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
             ++  +  +   Y   GS+         L       +     +GL YLH +     +HR
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHR 130

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLS---TGQ 404
           D+K ANILL +  +  + DFG+A  +       T A R    GT   +APE  +    G 
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 405 SSEKTDVFGFGILLLEL 421
            ++  D++  GI  +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 6/196 (3%)

Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +  VYKG  + +G +VA+K ++     G       E  ++    H N++ L    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
            T     LV+ Y+         K    L     K       RGL Y+H++    I+HRD+
Sbjct: 73  HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDL 129

Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVF 412
           K  N+L+ +  E  + DFGLA+      SH  +    T+ +  P+  L + + S   D++
Sbjct: 130 KPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMW 188

Query: 413 GFGILLLELISGLRAL 428
           G G + +E+I G+ A 
Sbjct: 189 GVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 15/208 (7%)

Query: 228 NFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISL-A 281
           NF    ++G G +G V+     G    G + A+K LK    +   +    T  E   L A
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 282 VHRN--LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA-ARGLL 338
           V R   L+ L     T T+  L+  Y++ G + + L  +     +   R+ +      L 
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAEIVLALD 119

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
           +LH+     II+RD+K  NILLD     V+ DFGL+K     +     +  GT+ ++APE
Sbjct: 120 HLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176

Query: 399 YLSTGQS--SEKTDVFGFGILLLELISG 424
            +  G     +  D +  G+L  EL++G
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 16/198 (8%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV---HRNLLRL 289
           +G G +G VYK      G  VA+K ++   N  G  +    EV ++       H N++RL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 290 IGFCMTT-----TERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQ 343
           +  C T+     T+  LV+ ++         K   P L   T K +     RGL +LH  
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
           C   I+HRD+K  NIL+    +  + DFGLA++   C   +T  V  T+ + APE L   
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVV-TLWYRAPEVLLQS 182

Query: 404 QSSEKTDVFGFGILLLEL 421
             +   D++  G +  E+
Sbjct: 183 TYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.5 bits (152), Expect = 4e-10
 Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 46/227 (20%)

Query: 234 LVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNLL 287
           L+GKGG G VY  Y  D      VA+K++++ +     +   +F  E ++ +  +H  ++
Sbjct: 9   LIGKGGMGEVYLAY--DPVCSRRVALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 288 RLIGFCMTTTERLLVY---PYMSNGSVASRLKA---KPSLDWATRKRIALGA-------- 333
            +   C   ++   VY   PY+   ++ S LK+   K SL     ++ ++GA        
Sbjct: 66  PVYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK--------LLD------- 378
              + Y+H +    ++HRD+K  NILL  + E V+ D+G A         LLD       
Sbjct: 123 CATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 379 HCDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
            C S +T    + GT  ++APE L    +SE TD++  G++L ++++
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 12/203 (5%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +F+   ++GKG FG V     + GT  + A+K LK    I  +    T VE   LA+   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59

Query: 286 --LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 342
              L  +  C  T +RL  V  Y++ G +   ++             A   A GL +LH 
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLS 401
           +    II+RD+K  N++LD      + DFG+ K  ++     TT    GT  +IAPE ++
Sbjct: 120 K---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIA 174

Query: 402 TGQSSEKTDVFGFGILLLELISG 424
                +  D + FG+LL E+++G
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 14/229 (6%)

Query: 229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 285
           F    ++GKGGFG V    ++  G + A K+L  K      GE     E +++     R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR---GLLYLHE 342
           ++ L     T     LV   M+ G +   +       +    R    AA    GL  LH+
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDLHQ 120

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLS 401
           +   +I++RD+K  NILLD++    + D GLA    H     T   R GTVG++APE + 
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVK 174

Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
             + +   D +  G LL E+I+G    +  K   ++  +   VK++ +E
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 20/205 (9%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF- 292
           +GKG +G V+K    ++G+  AVK L   + I  EI+ +  + + +L+ H N+++  G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHPNVVKFYGMY 84

Query: 293 ----CMTTTERLLVYPYMSNGSVASR----LKAKPSLDWATRKRIALGAARGLLYLHEQC 344
                    +  LV    + GSV       LK    ++      I   A  GL +LH   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
             K IHRDVK  NILL       + DFG++  L        T+V GT   +APE ++  Q
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200

Query: 405 S-----SEKTDVFGFGILLLELISG 424
                   + DV+  GI  +EL  G
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)

Query: 234 LVGKGGFGNVYKGYLQDGT-VVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRL 289
           ++GKG FG V    L+      A+K LK    +  +    T VE   LA+   H  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 290 IGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
             FC   T+  L  V  Y++ G +   +++    D A  +  A     GL +LH++    
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---G 116

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
           II+RD+K  N+LLD+     + DFG+ K   + +   +T   GT  +IAPE L   + +E
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNE 175

Query: 408 KTDVFGFGILLLELISG 424
             D + FG+LL E++ G
Sbjct: 176 SVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 36/214 (16%)

Query: 229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL-------KDGNAIG-GEIQFQTEVE--- 276
           F    ++GKGGFG V    ++  G + A K+L       + G A+   E Q   +V    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 277 MISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLK--AKPSLDWATRKRIALGA 333
           ++SLA          +   T + L LV   M+ G +   +     P  D    +R    A
Sbjct: 62  VVSLA----------YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYA 108

Query: 334 AR---GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 390
           A    GL  LH +   +I++RD+K  NILLD+Y    + D GLA  +   +        G
Sbjct: 109 AEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIRGRVG 163

Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           TVG++APE +   + +   D +G G L+ E+I G
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 60.6 bits (148), Expect = 5e-10
 Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 48/220 (21%)

Query: 232 KNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EVEMISLA 281
              +G G +G V      + G  VA+K++   N       F           E++++   
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLLRHL 56

Query: 282 VHRNLLRLIGFCMTTTERL------LVYPYMSN--GSVASRLKAKPSLDWATRKRIALGA 333
            H N++ L+   +            +V   M      V   +K+   L     +      
Sbjct: 57  RHENIIGLLDI-LRPPSPEDFNDVYIVTELMETDLHKV---IKSPQPLTDDHIQYFLYQI 112

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--------VT 385
            RGL YLH      +IHRD+K +NIL++   +  + DFGLA+ +D  +          VT
Sbjct: 113 LRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169

Query: 386 TAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
              R      APE  LS+ + ++  D++  G +  EL++ 
Sbjct: 170 RWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 10/195 (5%)

Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +GKGGFG V    +++ G + A K+L  K      GE     E E++       ++ L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKII 349
              + T   LV   M+ G +   +           + I   A    G+L+LH      I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIV 117

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           +RD+K  N+LLD+     + D GLA  L   D    T   GT G++APE L     S   
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 410 DVFGFGILLLELISG 424
           D F  G  + E+++G
Sbjct: 176 DWFAMGCSIYEMVAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.8 bits (150), Expect = 7e-10
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 17/199 (8%)

Query: 249 QDGTVVAVKRLKDGNAIGGEIQ---FQTEVEMISLAVHRNLLRLIGFCMTTTERLL-VYP 304
             G  VA+K L+  +A   E Q   F+ E  + +   H N++ L+         L  V+ 
Sbjct: 1   MTGHEVAIKLLRT-DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFE 59

Query: 305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---D 361
           Y+   ++   L A  +L      R+ L     L   H Q    I+HRD+K  NI++    
Sbjct: 60  YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116

Query: 362 EYYEAVVGDFGLAKLL-DHCDSHVTTAVR-----GTVGHIAPEYLSTGQSSEKTDVFGFG 415
               A V DFG+  LL    D+ V T  R     GT  + APE L     +  +D++ +G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 416 ILLLELISGLRALEFGKTA 434
           ++ LE ++G R ++    A
Sbjct: 177 LIFLECLTGQRVVQGASVA 195

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 70/278 (25%), Positives = 113/278 (40%), Gaps = 37/278 (13%)

Query: 235 VGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +G+G F  ++KG  ++         T V +K L   +    E  F     M+S   H++L
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE-SFFEAASMMSQLSHKHL 61

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY-LHEQCD 345
           +   G C+   E ++V  Y+  GS+ + LK   +L   + K   L  A+ L + LH   D
Sbjct: 62  VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK---LEVAKQLAWALHFLED 118

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLST 402
             + H +V A N+LL    +   G+    KL D   S         +  I    PE +  
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN 178

Query: 403 GQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH-QEKKLEMLVDKD 460
            Q+ S   D + FG  L E+ SG          ++  + LD  KK+   E + ++   K 
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFSG---------GDKPLSALDSQKKLQFYEDRHQLPAPK- 228

Query: 461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
                   EL  ++     C  Y P  RP    ++R L
Sbjct: 229 ------WTELANLINQ---CMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 14/215 (6%)

Query: 234 LVGKGGFGNVY---KGYLQD-GTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLR 288
           ++G+G FG V+   K    D G + A+K LK     +   ++ + E ++++   H  +++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           L     T  +  L+  ++  G + +RL  +        K      A  L +LH      I
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GI 119

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
           I+RD+K  NILLDE     + DFGL+K  +DH       +  GTV ++APE ++    ++
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQ 177

Query: 408 KTDVFGFGILLLELISGLRALEF-GKTANQKGAML 441
             D + FG+L+ E+++G  +L F GK   +   M+
Sbjct: 178 SADWWSFGVLMFEMLTG--SLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 18/197 (9%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG VYK   ++   +A  ++ +  +      +  E+E+++   H  +++L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 295 TTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
              +  ++  +   G+V A  L+    L     + I       L YLH     KIIHRD+
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDL 136

Query: 354 KAANILLDEYYEAVVGDFGLA----KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 407
           KA N+LL    +  + DFG++    K L   DS +     GT   +APE +      +  
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMKDTP 191

Query: 408 ---KTDVFGFGILLLEL 421
              K D++  GI L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.5 bits (146), Expect = 1e-09
 Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 17/175 (9%)

Query: 257 KRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL--------IGFCMTTTERLLVYPYMSN 308
           KR+K G+     IQ + E+  +    H N+L++          + +T      +Y +M +
Sbjct: 198 KRVKAGSRAA--IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255

Query: 309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV 368
              A   K +P L   TR  I       + Y+H   D K+IHRD+K  NI L+   + V+
Sbjct: 256 E--AFDWKDRPLL-KQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVL 308

Query: 369 GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           GDFG A   +           GTV   +PE L+     E TD++  G++LL+++S
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 59/198 (29%), Positives = 90/198 (45%), Gaps = 12/198 (6%)

Query: 234 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE---MISLAVHRNLLRL 289
           ++GKG FG V     + DG+  AVK L+    +  + Q     E   ++    H  L+ L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 290 IGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
             +   T E+L  V  Y++ G +   L+ +        +  A   A  + YLH      I
Sbjct: 62  -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NI 117

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLSTGQSSE 407
           I+RD+K  NILLD     V+ DFGL K  +  +   TT+   GT  ++APE L       
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 408 KTDVFGFGILLLELISGL 425
             D +  G +L E++ GL
Sbjct: 176 TVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 36/214 (16%)

Query: 229 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT---------EVEMI 278
           + + + VG G +G V   +    G  VA+K+L           FQ+         E+ ++
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR--------PFQSAIHAKRTYRELRLL 68

Query: 279 SLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKRIAL 331
               H N++ L+    T    L       LV   M  G+  + +     L     + +  
Sbjct: 69  KHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVY 125

Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
              RGL Y+H      IIHRD+K +NI ++E  E  + DFGLA+   H D  +T  V  T
Sbjct: 126 QILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYV-AT 178

Query: 392 VGHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
             + APE  L+    ++  D++  G ++ EL++G
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 39/120 (32%), Positives = 66/120 (55%), Gaps = 5/120 (4%)

Query: 305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 364
           +M  GS+   LK    +      ++++   +GL YL E+   KI+HRDVK +NIL++   
Sbjct: 84  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRG 141

Query: 365 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           E  + DFG++  L   DS   + V GT  +++PE L     S ++D++  G+ L+E+  G
Sbjct: 142 EIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 34/211 (16%)

Query: 234 LVGKGGFGNVYKGYLQDG--TVVAVKRLKDGNAIGGEIQFQ---------TEVEMISLAV 282
            +G G FG VYK   ++    ++A+K +   N   G+ + +         +EV +I   +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 283 -HRNLLRLIGFCMTTTERLLVYPYM------SNGSVASRLKAK-----PSLDWATRKRIA 330
            H N++R   +  T  E   +Y  M        G   + LK K         W    ++ 
Sbjct: 67  RHPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 390
           L     L YLH++   +I+HRD+   NI+L E  +  + DFGLAK     +S +T+ V G
Sbjct: 124 LA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTSVV-G 175

Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 421
           T+ +  PE +      EK DV+ FG +L ++
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 37/105 (35%), Positives = 57/105 (54%), Gaps = 12/105 (11%)

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL-----DHCDSHVTTAVR 389
           RGL Y+H      +IHRD+K +N+L++E  E  +GDFG+A+ L     +H    +T  V 
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-YFMTEYV- 172

Query: 390 GTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 433
            T  + APE  LS  + +   D++  G +  E++ G R L  GK 
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKN 216

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 30/168 (17%)

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHI 395
           LL +H      +IHRD+K+ANILL       +GDFG +K+     S  V     GT  ++
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 396 APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 455
           APE       S+K D+F  G+LL EL++                    +K+    + +E 
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLT--------------------LKRPFDGENMEE 252

Query: 456 LVDKDLKNNYDRI------ELEEMVQVALLCTQYLPSLRPKMSEVVRM 497
           ++ K L   YD +      E++E+V  ALL +   P  RP  S+++ M
Sbjct: 253 VMHKTLAGRYDPLPPSISPEMQEIVT-ALLSSD--PKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 39/214 (18%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF-----------QTEVE 276
            +     +G+G FG +Y         +A  +    + +  EI             + EV 
Sbjct: 1   RYEIIKKIGEGSFGKIY---------LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI 51

Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--------LDWATRKR 328
           +++   H N++             +V  Y   G +  R+  +          L W  +  
Sbjct: 52  LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ-- 109

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDHCDSHVTTA 387
           I+LG    L ++H   D KI+HRD+K+ NI L +    A +GDFG+A+ L+       T 
Sbjct: 110 ISLG----LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC 162

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 421
           V GT  +++PE       + KTD++  G +L EL
Sbjct: 163 V-GTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 4e-09
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 2/98 (2%)

Query: 17  ICSDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 76
           +CS G  F    +L +N++ G IP  +G    L  + L +N F+G +PS  + L  + +L
Sbjct: 376 LCSSGNLFKL--ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433

Query: 77  RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 114
            ++NN+L G I     +M  L  L L+ N   G +P  
Sbjct: 434 DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS 471

Length = 968

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 42/277 (15%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-------HRNL 286
           +G+G  G VY    +  G  VA+K++         +Q Q + E+I   +       H N+
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMN--------LQQQPKKELIINEILVMRENKHPNI 78

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +  +   +   E  +V  Y++ GS+ + +  +  +D      +     + L +LH     
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 134

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           ++IHRD+K+ NILL       + DFG    +    S  +T V GT   +APE ++     
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193

Query: 407 EKTDVFGFGILLLELISG---------LRALEF----GKTANQKGAMLDWVKKIHQEKKL 453
            K D++  GI+ +E++ G         LRAL      G    Q    L  + +    + L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253

Query: 454 EMLVDKDLKNNYDRIELEEMVQVALL-CTQYLPSLRP 489
           EM V+K       R   +E++Q   L   + L SL P
Sbjct: 254 EMDVEK-------RGSAKELLQHPFLKIAKPLSSLTP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 32/219 (14%)

Query: 242 NVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 301
           NV KG      +VAVK L+          F  EV+++S     N++RL+G C+      +
Sbjct: 40  NVRKGR---PLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCM 96

Query: 302 VYPYMSNGSVASRLKAK-------------------PSLDWATRKRIALGAARGLLYLHE 342
           +  YM NG +   L +                    P++ +++   +AL  A G+ YL  
Sbjct: 97  ITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG----TVGHIAPE 398
                 +HRD+   N L+ E     + DFG+++ L   D +    ++G     +  +A E
Sbjct: 157 L---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWE 210

Query: 399 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK 437
            +  G+ +  +DV+ FG+ L E++   +   +G+  +++
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 18/205 (8%)

Query: 229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 285
           F    ++GKGGFG V    ++  G + A K+L  K      GE     E  ++     R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 286 LLRLIGFCMTTTERL-LVYPYMSNGSVASRL--KAKPSLDWATRKRIALGAAR---GLLY 339
           ++ L  +   T + L LV   M+ G +   +     P  D    +R    AA    GL  
Sbjct: 62  VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD---EQRAIFYAAELCCGLED 117

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           L  +   +I++RD+K  NILLD+     + D GLA  +   +        GTVG++APE 
Sbjct: 118 LQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGRVGTVGYMAPEV 172

Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           ++  + +   D +G G L+ E+I G
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 64/204 (31%), Positives = 88/204 (43%), Gaps = 27/204 (13%)

Query: 235 VGKGGFGNVY------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VH-RNL 286
           +GKGGFG V        G L     +  KRLK      G +     VE   LA VH R +
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM-----VEKRILAKVHSRFI 55

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAAR---GLLY 339
           + L     T T+  LV   M+ G +   +    +  P        R     A+   GL +
Sbjct: 56  VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISGLEH 112

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           LH++   +II+RD+K  N+LLD      + D GLA  L    S  T    GT G +APE 
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPEL 168

Query: 400 LSTGQSSEKTDVFGFGILLLELIS 423
           L   +     D F  G+ L E+I+
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIA 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 10/197 (5%)

Query: 234 LVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLI 290
           ++GKG FG V    +  +    AVK L+    +    E    +E  ++   V    L  +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 291 GFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
            F   T ++L  V  Y++ G +   L+ +        +  A   A  L YLH      I+
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIV 118

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLSTGQSSEK 408
           +RD+K  NILLD     V+ DFGL K  ++ + + TT+   GT  ++APE L        
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176

Query: 409 TDVFGFGILLLELISGL 425
            D +  G +L E++ GL
Sbjct: 177 VDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 20/164 (12%)

Query: 273 TEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL- 331
           TE  ++    H ++++L G         L+ P         R K       A ++ IA+ 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILP---------RYKTDLYCYLAAKRNIAIC 182

Query: 332 -------GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 384
                     R + YLHE    +IIHRD+KA NI ++   +  +GDFG A      +++ 
Sbjct: 183 DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239

Query: 385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRAL 428
                GT+   APE L+        D++  GI+L E+ +   +L
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 56.8 bits (138), Expect = 6e-09
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 32/209 (15%)

Query: 235 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQT--------EVE-MISLAVHR 284
           +G G FG+VY     + G +VA+K++K         +F +        EV+ +  L  H 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKK--------KFYSWEECMNLREVKSLRKLNEHP 58

Query: 285 NLLRLIGFCMTTTERLLVYPYMSN---GSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           N+++L        E   V+ YM       +  R K KP    +  + I     +GL ++H
Sbjct: 59  NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-KGKP-FSESVIRSIIYQILQGLAHIH 116

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL- 400
           +       HRD+K  N+L+       + DFGLA+ +     + T  V  T  + APE L 
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILL 171

Query: 401 -STGQSSEKTDVFGFGILLLELISGLRAL 428
            ST  SS   D++  G ++ EL + LR L
Sbjct: 172 RSTSYSS-PVDIWALGCIMAELYT-LRPL 198

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 9/206 (4%)

Query: 235 VGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           +G+G +  VYKG   L D  +VA+K ++  +  G       EV ++    H N++ L   
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
             T     LV+ Y+             S++    K       RGL Y H +   K++HRD
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRD 129

Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDV 411
           +K  N+L++E  E  + DFGLA+         +  V  T+ +  P+  L +   S + D+
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDM 188

Query: 412 FGFGILLLELISGLRALEFGKTANQK 437
           +G G +  E+ +G R L  G T  ++
Sbjct: 189 WGVGCIFYEMSTG-RPLFPGSTVEEQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 27/158 (17%)

Query: 235 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGF 292
           +G+G FG V+K  + +   +VA+K++   N   G  I    E++++ L  H N++ LI  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 293 CMTTTERLLVYPYMSNGSVAS-------------RLKAKPSLDW--ATRKRIALGAARGL 337
           C T            N    S              L +  ++ +  +  K++      GL
Sbjct: 80  CRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
            Y+H     KI+HRD+KAANIL+ +     + DFGLA+
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 14/139 (10%)

Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
            L ++H   D KI+HRD+K+ NI L +     +GDFG+A++L+       T + GT  ++
Sbjct: 113 ALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYL 168

Query: 396 APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK------KIHQ 449
           +PE       + K+D++  G +L E+ +   A E G   N K  +L  ++        H 
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRGSYPPVSSHY 225

Query: 450 EKKLEMLVDKDLKNNY-DR 467
              L  LV +  K N  DR
Sbjct: 226 SYDLRNLVSQLFKRNPRDR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 34/229 (14%)

Query: 221 ELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTE 274
           E+  +T  F  +  +G+  FG VYKG+L      +    VA+K LKD        +F+ E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN----------------GSVASRLKAK 318
             M S   H N++ L+G         +++ Y S+                GS       K
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 319 PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 378
            +L+ A    I    A G+ +L       ++H+D+   N+L+ +     + D GL + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 379 HCDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             D +    + G     +  ++PE +  G+ S  +D++ +G++L E+ S
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 15/208 (7%)

Query: 228 NFSSKNLVGKGGFGNVY-----KGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMIS 279
           NF    ++G G +G V+      G+   G + A+K LK    +         +TE +++ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59

Query: 280 LAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 338
                  L  + +   T  +L L+  Y++ G + + L  +        + + + +   +L
Sbjct: 60  HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF---KEQEVQIYSGEIVL 116

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
            L       II+RD+K  NILLD     V+ DFGL+K     +     +  GT+ ++AP+
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176

Query: 399 YLSTGQS--SEKTDVFGFGILLLELISG 424
            +  G     +  D +  G+L+ EL++G
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           NF     +G+G +  VYKG  +  G +VA+K +      G       E+ ++    H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLK-------AKPSLDWATRKRIALGAARGLLY 339
           +RL     T  + +LV+ YM        LK        + +LD  T K       +G+ +
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKD-----LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            HE    +++HRD+K  N+L+++  E  + DFGLA+      +  +  V  T+ + AP+ 
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171

Query: 400 LSTGQS-SEKTDVFGFGILLLELISGL 425
           L   ++ S   D++  G ++ E+I+G 
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 19/207 (9%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
            +   N + +G +G VY+    + G +VA+K+LK +    G  I    E+ ++    H N
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65

Query: 286 LLRLIGFCMTTTER--LLVYPYMSNGSVASRLKA-----KPSLDWATRKRIALGAARGLL 338
           ++ +    + +      +V  Y+ +      LK+     K     +  K + L    G+ 
Sbjct: 66  IVTVKEVVVGSNLDKIYMVMEYVEH-----DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
           +LH+     I+HRD+K +N+LL+      + DFGLA+         T  V  T+ + APE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176

Query: 399 -YLSTGQSSEKTDVFGFGILLLELISG 424
             L   + S   D++  G +  EL++ 
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 8/187 (4%)

Query: 272 QTEVEMISLAVHRNLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIA 330
           QTE  +   A +   L  +  C  T  RL  V  Y++ G +   ++ +  L     +  +
Sbjct: 43  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 102

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVR 389
              +  L YLHE+    II+RD+K  N+LLD      + D+G+ K  L   D+  T+   
Sbjct: 103 AEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFC 157

Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF-GKTANQKGAMLDWVKKIH 448
           GT  +IAPE L         D +  G+L+ E+++G    +  G + N      D++ ++ 
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217

Query: 449 QEKKLEM 455
            EK++ +
Sbjct: 218 LEKQIRI 224

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 56.3 bits (135), Expect = 1e-08
 Identities = 72/277 (25%), Positives = 120/277 (43%), Gaps = 42/277 (15%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 286
           +G+G  G VY    +  G  VA+K++         +Q Q + E+I   + V R     N+
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMN--------LQQQPKKELIINEILVMRENKNPNI 78

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +  +   +   E  +V  Y++ GS+ + +  +  +D      +     + L +LH     
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSN--- 134

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           ++IHRD+K+ NILL       + DFG    +    S  +T V GT   +APE ++     
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193

Query: 407 EKTDVFGFGILLLELISG---------LRALEF----GKTANQKGAMLDWVKKIHQEKKL 453
            K D++  GI+ +E++ G         LRAL      G    Q    L  V +    + L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253

Query: 454 EMLVDKDLKNNYDRIELEEMVQVALL-CTQYLPSLRP 489
           EM VD+       R   +E++Q   L   + L SL P
Sbjct: 254 EMDVDR-------RGSAKELLQHPFLKLAKPLSSLTP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 32/166 (19%)

Query: 235 VGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA---VHRNLLR 288
           +G+G +G VYK   +   DG   A+K+ K        I  Q+    I+L     H N++ 
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS-QSACREIALLRELKHENVVS 66

Query: 289 LIGFCMTTTERL--LVYPYMSNGSVAS----------RLKAKPSLDWATRKRIALGAARG 336
           L+   +   ++   L++ Y      A           R   + S+  +  K +      G
Sbjct: 67  LVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 337 LLYLHEQCDPKIIHRDVKAANILL--DEYYEAVV--GDFGLAKLLD 378
           + YLH      ++HRD+K ANIL+  +     VV  GD GLA+L +
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 54/236 (22%), Positives = 108/236 (45%), Gaps = 28/236 (11%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISL 280
           +NF  +  +G+G F  VY+   L D   VA+K+++     D  A    ++   E++++  
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQ 58

Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARG 336
             H N+++ +   +   E  +V      G ++  +    K K  +   T  +  +     
Sbjct: 59  LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG--- 393
           + ++H +   +++HRD+K AN+ +       +GD GL +      S  TTA    VG   
Sbjct: 119 VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPY 171

Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 449
           +++PE +     + K+D++  G LL E+ + L++  +G   N    +    +KI Q
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMN----LFSLCQKIEQ 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 18/202 (8%)

Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLI 290
           + KG FG+VY    +  G   A+K LK  + I        + E   + +      + +L 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 291 GFCMTTTERL-LVYPYMSNGSVASRLKAKPSL--DWATRKRIALGAARGLLYLHEQCDPK 347
            +   + + L LV  Y++ G  AS +K    L  DWA  K+       G+  LH++    
Sbjct: 64  -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWA--KQYIAEVVLGVEDLHQR---G 117

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
           IIHRD+K  N+L+D+     + DFGL++              GT  ++APE +      +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDK 172

Query: 408 KTDVFGFGILLLELISGLRALE 429
            +D +  G ++ E + G     
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 20/206 (9%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIG--GEIQFQTEVEMISLA 281
            +      VG G FG V+   ++D       A+K +     I    E     E  ++   
Sbjct: 1   DDLERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV 58

Query: 282 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
            H  ++RL  F     +R L  +  Y+  G + S L+       +T    A      L Y
Sbjct: 59  SHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPE 398
           LH +   +I++RD+K  NILLD+     + DFG AK L D      T  + GT  ++APE
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPE 168

Query: 399 YLSTGQSSEKTDVFGFGILLLELISG 424
            + +   ++  D +  GIL+ E++ G
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 34/221 (15%)

Query: 233 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE------------IQFQT--EVEM 277
             +G+G +G V K Y    G +VA+K++K    I  +            I F T  E+++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKI-IEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
           ++   H N++ L+   +      LV   M+   +   +  K  L  +  K I L    GL
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGL 132

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK------LLDHCDSHVTTAVRG- 390
             LH+      +HRD+  ANI ++      + DFGLA+        D      T   R  
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 391 ------TVGHIAPEYL-STGQSSEKTDVFGFGILLLELISG 424
                 T+ + APE L    +     D++  G +  EL++G
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 12/206 (5%)

Query: 228 NFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISL 280
           NF    ++G G +G V+          G + A+K L+    +         +TE  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 281 AVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
                 L  + +   T  +L L+  Y+S G + + L  +   D  +   +   +   +L 
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILA 117

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           L       I++RD+K  NILLD     V+ DFGL+K     +   T +  GT+ ++APE 
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 400 L-STGQSSEKTDVFGFGILLLELISG 424
           +   G   +  D +  GIL+ EL++G
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 55.2 bits (134), Expect = 2e-08
 Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 26/209 (12%)

Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVH 283
            +F     +G G FG V    +   G   A+K L     +          E  ++    H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLL--- 338
             L+ L G     +   LV  Y+  G + S L+   +     A        AA+ +L   
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-----FYAAQVVLALE 115

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
           YLH      I++RD+K  N+LLD      + DFG AK +       T  + GT  ++APE
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCGTPEYLAPE 168

Query: 399 YLST---GQSSEKTDVFGFGILLLELISG 424
            + +   G++    D +  GIL+ E+++G
Sbjct: 169 IILSKGYGKAV---DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 27/220 (12%)

Query: 220 KELQSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVE 276
           ++LQ    ++    ++G+G FG V    +     V A+K L     I       F  E +
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 277 MISLAVHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLD-WATRKRIALGA 333
           +++ A    +++L  FC    ++ L  V  YM  G + + +      + WA         
Sbjct: 96  IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYT 148

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAV 388
           A  +L L       +IHRDVK  N+LLD++    + DFG    +D      CD+ V    
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV---- 204

Query: 389 RGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELISG 424
            GT  +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 25/210 (11%)

Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +  V+KG  +    +VA+K ++  +  G       EV ++    H N++ L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 294 MTTTERLLVYPYMSN---------GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
            T     LV+ Y+           G++ S    K  L             RGL Y H + 
Sbjct: 74  HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---------YQILRGLAYCHRR- 123

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTG 403
             K++HRD+K  N+L++E  E  + DFGLA+         +  V  T+ +  P+  L + 
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180

Query: 404 QSSEKTDVFGFGILLLELISGLRALEFGKT 433
           + S + D++G G +  E+ SG R L  G T
Sbjct: 181 EYSTQIDMWGVGCIFFEMASG-RPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 32/205 (15%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GE------IQFQTEVEMIS-------L 280
           +GKG FG VY   ++D   VA +RLK    I  GE      +Q   E +++S       +
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 281 AVHRNLLRLIGFCMTTT---ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
             H + L    FC+ T     R L             L      +W  +  +      G+
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTAVRGTVGHIA 396
            Y+H++   +I+HRD+KA NI L       +GDFG+++LL   CD  + T   GT  +++
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD--LATTFTGTPYYMS 173

Query: 397 PEYLSTGQSSEKTDVFGFGILLLEL 421
           PE L       K+D++  G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 7/155 (4%)

Query: 272 QTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIA 330
           QTE  +   A     L  +  C  TT RL LV  Y++ G +   ++ +  L     +  A
Sbjct: 43  QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYA 102

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVR 389
                 L +LHE+    II+RD+K  N+LLD      + D+G+ K  L   D+  T+   
Sbjct: 103 AEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFC 157

Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           GT  +IAPE L   +     D +  G+L+ E+++G
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.0 bits (135), Expect = 4e-08
 Identities = 32/83 (38%), Positives = 44/83 (53%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L +NN +G IP  +  L +L  L L +N F+G IP  +     L  L L+ N+LTG IP 
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374

Query: 90  SLSNMSQLAFLDLSYNNLSGPVP 112
            L +   L  L L  N+L G +P
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIP 397

Length = 968

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 52/226 (23%), Positives = 102/226 (45%), Gaps = 18/226 (7%)

Query: 200 DVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR 258
           ++ E+ R  V +G+ K+            ++    +G+G  G V+    +  G  VA+K+
Sbjct: 3   EIMEKLRTIVSIGDPKK-----------KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQ 51

Query: 259 LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK 318
           +        E+     + M  L  + N++  +   +   E  +V  Y++ GS+ + +  +
Sbjct: 52  INLQKQPKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFVVMEYLAGGSL-TDVVTE 109

Query: 319 PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 378
             +D A    +     + L +LH     ++IHRD+K+ N+LL       + DFG    + 
Sbjct: 110 TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166

Query: 379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
              S  +T V GT   +APE ++      K D++  GI+ +E++ G
Sbjct: 167 PEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 25/204 (12%)

Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR----- 288
           +GKG FG VY+   +D   + A+K L        EI  + EV        RN+L      
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVA--HTIGERNILVRTLLD 53

Query: 289 ----LIGF---CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
               ++G      T ++  LV  YMS G +   L+ +         R     A  +L L 
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALE 110

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
                 I++RD+K  NILLD      + DFGL+K  +  D+  T    GT  ++APE L 
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLL 169

Query: 402 TGQSSEK-TDVFGFGILLLELISG 424
             +   K  D +  G+L+ E+  G
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 7/205 (3%)

Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +  V+KG  +    +VA+K ++  +  G       EV ++    H N++ L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
            T     LV+ Y+ +            +     K       RGL Y H++   KI+HRD+
Sbjct: 73  HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDL 129

Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVF 412
           K  N+L++E  E  + DFGLA+         +  V  T+ +  P+  L + + S   D++
Sbjct: 130 KPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMW 188

Query: 413 GFGILLLELISGLRALEFGKTANQK 437
           G G +L E+ +G R +  G T  ++
Sbjct: 189 GVGCILYEMATG-RPMFPGSTVKEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 4/86 (4%)

Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           G+ ++HE+   +++HRD+K+ NI L +  +  +GDFG A+LL    ++  T V GT  ++
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167

Query: 396 APEYLSTGQSSEKTDVFGFGILLLEL 421
            PE       + K+D++  G +L EL
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 53.8 bits (130), Expect = 6e-08
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 14/196 (7%)

Query: 235 VGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLIG 291
           +G GGFG V            A+K +K  + +    Q    +E E++    H  +++L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 292 FCMTTTERLLVY---PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
              T  ++  +Y    Y   G + + L+ +   D  T +           YLH +    I
Sbjct: 60  --RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GI 114

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
           I+RD+K  N+LLD      + DFG AK L       T    GT  ++APE +        
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAPEIILNKGYDFS 172

Query: 409 TDVFGFGILLLELISG 424
            D +  GILL EL++G
Sbjct: 173 VDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 45/186 (24%), Positives = 91/186 (48%), Gaps = 21/186 (11%)

Query: 253 VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV- 311
           +VAVK L++         F  E++++S     N++RL+  C+T+    ++  YM NG + 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 312 --ASRLKAK--------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 361
              SR + +         ++ ++T   +A   A G+ YL        +HRD+   N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164

Query: 362 EYYEAVVGDFGLAKLLDHCDSHVTTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGIL 417
           + Y   + DFG+++ L   D +    ++G     +  ++ E +  G+ +  +DV+ FG+ 
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221

Query: 418 LLELIS 423
           L E+++
Sbjct: 222 LWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.4 bits (128), Expect = 9e-08
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 13/206 (6%)

Query: 224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
           +ATS  + + L G+G +  VYKG  + +G +VA+K +      G       E  ++    
Sbjct: 3   AATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61

Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLH 341
           H N++ L     T      V+ YM    +A  +   P  L     +       RGL Y+H
Sbjct: 62  HANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAPEYL 400
            Q    I+HRD+K  N+L+    E  + DFGLA+       ++ +  V  T+ +  P+ L
Sbjct: 121 GQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175

Query: 401 --STGQSSEKTDVFGFGILLLELISG 424
             +T  SS   D++G G + +E++ G
Sbjct: 176 LGATDYSSA-LDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 7/194 (3%)

Query: 234 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIG 291
           L+GKG FG V     +  G   A+K LK    I  +    T  E   L   R+  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 292 FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
           +   T +RL  V  Y++ G +   L  +        +         L YLH     KI++
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVY 118

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 410
           RD+K  N++LD+     + DFGL K     D+       GT  ++APE L         D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177

Query: 411 VFGFGILLLELISG 424
            +G G+++ E++ G
Sbjct: 178 WWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 26/235 (11%)

Query: 229 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNL 286
           F     +G+G +G VYK   +D G +VA+K+++ D    G  I    E++++    HRN+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 287 LRL----------IGFCMTTTERLLVYPYMSN---GSVASRLKAKPSLDWATRKRIALGA 333
           + L          + F        LV+ YM +   G + S L         +  +  L  
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL-- 126

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 393
             GL Y H++     +HRD+K +NILL+   +  + DFGLA+L +  +S   T    T+ 
Sbjct: 127 -EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182

Query: 394 HIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
           +  PE  L   +     DV+  G +L EL +  +   F   ANQ+ A L+ + ++
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFT--KKPIF--QANQELAQLELISRL 233

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 21/197 (10%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +G G +G+VYK   +  G + A+K  +L+ G         Q E+ M+    H N++   G
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA---VVQQEIIMMKDCKHSNIVAYFG 73

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
             +   +  +   +   GS+         L  +    ++    +GL YLH +     +HR
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHR 130

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLST---GQ 404
           D+K ANILL +     + DFG++  +       T A R    GT   +APE  +    G 
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQIT-----ATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 405 SSEKTDVFGFGILLLEL 421
            ++  D++  GI  +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 21/198 (10%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 286
           +G+G  G VY    +  G  VA++++         +Q Q + E+I   + V R     N+
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMRENKNPNI 79

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +  +   +   E  +V  Y++ GS+ + +  +  +D      +     + L +LH     
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 135

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           ++IHRD+K+ NILL       + DFG    +    S  +T V GT   +APE ++     
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194

Query: 407 EKTDVFGFGILLLELISG 424
            K D++  GI+ +E+I G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 59/232 (25%), Positives = 89/232 (38%), Gaps = 46/232 (19%)

Query: 236 GKGGFGNVYKG-YLQDGTVVAVKRLKDG-------NAIGGEIQFQTEVEMISLAVHRNLL 287
           G+G F  V K    + G   A+K +K         N +  EIQ      +  L+ H N+L
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQ-----ALRRLSPHPNIL 61

Query: 288 RLIGF-------CMTTTERLL---VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
           RLI          +     L+   +Y  +           K  L     K       + L
Sbjct: 62  RLIEVLFDRKTGRLALVFELMDMNLYELIKG--------RKRPLPEKRVKSYMYQLLKSL 113

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
            ++H      I HRD+K  NIL+ +     + DFG  + +        T    T  + AP
Sbjct: 114 DHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGI--YSKPPYTEYISTRWYRAP 167

Query: 398 E-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           E  L+ G    K D++  G +  E++S L  L  G   N+    LD + KIH
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGT--NE----LDQIAKIH 212

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 27/206 (13%)

Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLK---DGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +GKG +G+VYK   +  G  +A+K ++   D +     I    E++++  AV   ++   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM---ELDILHKAVSPYIVDFY 65

Query: 291 GFCMTTTERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           G         +   YM  GS+        A   +     +RI     +GL +L E+ +  
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYLSTGQ 404
           IIHRDVK  N+L++   +  + DFG++  L      V +  +  +G   ++APE + +G 
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177

Query: 405 SSE------KTDVFGFGILLLELISG 424
            ++      ++DV+  G+ +LE+  G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 11/200 (5%)

Query: 232 KNLVGKGGFGNVYKGYLQDGT----VVAVKRLKDGNAIGGE---IQFQTEVEMISLAVHR 284
             ++GKGG+G V++     G     + A+K LK    +  +      + E  ++    H 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
            ++ LI    T  +  L+  Y+S G +   L+ +      T        +  L +LH+Q 
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ- 119

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
              II+RD+K  NILLD      + DFGL K   H  + VT    GT+ ++APE L    
Sbjct: 120 --GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSG 176

Query: 405 SSEKTDVFGFGILLLELISG 424
             +  D +  G L+ ++++G
Sbjct: 177 HGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 4/88 (4%)

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L YLH      +++RD+K  N++LD+     + DFGL K     D        GT  ++A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163

Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE L         D +G G+++ E++ G
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 36/208 (17%)

Query: 235 VGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQT---------EVEMISLAVHR 284
           VG G +G V      + G  VA+K+L           FQ+         E+ ++    H 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYR--------PFQSELFAKRAYRELRLLKHMKHE 74

Query: 285 NLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
           N++ L+    T    L       LV P+M  G+   +L     L     + +     +GL
Sbjct: 75  NVIGLLD-VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
            Y+H      IIHRD+K  N+ ++E  E  + DFGLA+     DS +T  V  T  + AP
Sbjct: 132 KYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWYRAP 184

Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISG 424
           E  L+    ++  D++  G ++ E+++G
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTG 212

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 25/68 (36%), Positives = 41/68 (60%), Gaps = 1/68 (1%)

Query: 47  SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMS-QLAFLDLSYN 105
           S+++++DLS    +G I S +  L  +Q + L+NN L+G IP  +   S  L +L+LS N
Sbjct: 69  SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNN 128

Query: 106 NLSGPVPS 113
           N +G +P 
Sbjct: 129 NFTGSIPR 136

Length = 968

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 4/91 (4%)

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTV 392
           ARG+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R  +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +APE +     + ++DV+ FG+LL E+ S
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 36/143 (25%), Positives = 68/143 (47%), Gaps = 5/143 (3%)

Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           +G+G +G V+K   ++   +VA+KR++ D +  G       E+ ++    H+N++RL   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
             +  +  LV+ Y               +D    K       +GL + H      ++HRD
Sbjct: 68  LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRD 124

Query: 353 VKAANILLDEYYEAVVGDFGLAK 375
           +K  N+L+++  E  + DFGLA+
Sbjct: 125 LKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 23/212 (10%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK      G VVA+K+++ D    G       E+ ++    H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GL 337
           +++L+    T  +  LV+ ++           K  +D +    I L   +        GL
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQ-------DLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
            + H     +++HRD+K  N+L++      + DFGLA+         T  V  T+ + AP
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 169

Query: 398 E-YLSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 32/86 (37%), Positives = 45/86 (52%), Gaps = 7/86 (8%)

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
           YLH   D  II+RD+K  N+LLD      V DFG AK +       T  + GT  ++APE
Sbjct: 133 YLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185

Query: 399 YLSTGQSSEKTDVFGFGILLLELISG 424
            + +    +  D +  G+LL E I+G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 13/196 (6%)

Query: 235 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLI 290
           +G+G +G VYKG   + G +VA+K+++  +   G     T +  ISL     H N++ L 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPS--TAIREISLLKELQHPNIVCLQ 65

Query: 291 GFCMTTTERLLVYPYMSNG--SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
              M  +   L++ ++S         L     +D    K       +G+L+ H +   ++
Sbjct: 66  DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SE 407
           +HRD+K  N+L+D      + DFGLA+        V T    T+ + APE L      S 
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTHEVVTLWYRAPEVLLGSPRYST 181

Query: 408 KTDVFGFGILLLELIS 423
             D++  G +  E+ +
Sbjct: 182 PVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.0 bits (122), Expect = 7e-07
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 21/221 (9%)

Query: 228 NFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLA 281
           +F  K+LVG+G FG V     K     G + A+K +K    +  E    F+ E +++S++
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 282 VHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLY 339
               + +L  +     + L LV  Y   G + S L + +   D           A  +L 
Sbjct: 59  NSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD---EDMAQFYLAELVLA 114

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           +H       +HRD+K  N+L+D      + DFG A  L       +    GT  +IAPE 
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Query: 400 LSTGQSSEKT------DVFGFGILLLELISGLRALEFGKTA 434
           L+T     K       D +  G++  E+I G      G +A
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           S   +   +G+G  G V        G  VAVK++        E+ F  EV ++    H N
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPN 77

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRKRIALGAARGLLYL 340
           ++ +    +   E  +V  ++  G++      +R+  +  +  AT     L A   L +L
Sbjct: 78  IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQI--ATVCLAVLKA---LSFL 131

Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV---RGTVGH--- 394
           H Q    +IHRD+K+ +ILL       + DFG       C + V+  V   +  VG    
Sbjct: 132 HAQ---GVIHRDIKSDSILLTSDGRVKLSDFGF------C-AQVSKEVPRRKSLVGTPYW 181

Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           +APE +S      + D++  GI+++E++ G
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 9/127 (7%)

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 393
           RGL Y+H      ++HRD+K AN+ ++ E     +GDFGLA+++D   SH      G V 
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 394 --HIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTA-NQKGAMLDWVKKIHQ 449
             + +P   LS    ++  D++  G +  E+++G + L  G     Q   +L+ V  + +
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILESVPVVRE 240

Query: 450 EKKLEML 456
           E + E+L
Sbjct: 241 EDRNELL 247

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.4 bits (123), Expect = 8e-07
 Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 6/145 (4%)

Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIG 291
           + +G FG VY G  + +  + AVK +K  + I   +  Q + E  +LA+ ++  ++ L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
              +     LV  Y+  G V S L      D     +     A  L YLH      IIHR
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHR 128

Query: 352 DVKAANILLDEYYEAVVGDFGLAKL 376
           D+K  N+L+       + DFGL+K+
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 57/240 (23%), Positives = 91/240 (37%), Gaps = 45/240 (18%)

Query: 236 GKGGFGNVYKGYL-QDGTVVAVKRLKD--------GNAIGGEIQFQTEVEMISLAVHRNL 286
           G+G F N+YKG L     +  V   ++        G+     + F     ++S   H++L
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL-GAARGLLYLHEQCD 345
           ++L G C+   E ++V  Y+  G +   L  + +      K       A  L YL ++  
Sbjct: 64  VKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK-- 120

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH----------I 395
            K++H +V   NIL+   Y    G     KL D         +  TV            I
Sbjct: 121 -KLVHGNVCGKNILVAR-YGLNEGYVPFIKLSD-------PGIPITVLSREERVERIPWI 171

Query: 396 APEYLSTGQSS--EKTDVFGFGILLLELISG----------LRALEFGKTANQKGAMLDW 443
           APE +  GQ+S     D + FG  LLE+ S                F +  ++   M D 
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL-PMPDC 230

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 22/175 (12%)

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-AVRGTV 392
           ARG+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V   + R  +
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF-GKTANQKGAMLDWVKKIHQEK 451
             +APE +     + ++DV+ FG+LL E+ S L A  + G   N+     ++ +++    
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-LGASPYPGVQINE-----EFCQRLKDGT 294

Query: 452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEK 506
           ++                  E+ ++ L C Q  P  RP  S +V +L GD L E 
Sbjct: 295 RMRA----------PENATPEIYRIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 45/191 (23%), Positives = 89/191 (46%), Gaps = 7/191 (3%)

Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G  G V    ++  G +VAVK++        E+ F  EV ++    H N++ +    
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86

Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +   E  +V  ++  G++ + +     ++      + L   + L  LH Q    +IHRD+
Sbjct: 87  LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDI 142

Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
           K+ +ILL       + DFG    +   +     ++ GT   +APE +S      + D++ 
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWS 201

Query: 414 FGILLLELISG 424
            GI+++E++ G
Sbjct: 202 LGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 44/173 (25%), Positives = 83/173 (47%), Gaps = 19/173 (10%)

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTT 386
           R +   A+G+ +L  +     IHRDV A N+LL +   A + DFGLA+ +++  +  V  
Sbjct: 216 RFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
             R  V  +APE +     + ++DV+ +GILL E+ S       GK+    G +++    
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGKSP-YPGILVN---- 321

Query: 447 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                K   +V +  + +       E+  +  +C    P+ RP  S++ ++++
Sbjct: 322 ----SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 40/127 (31%), Positives = 67/127 (52%), Gaps = 4/127 (3%)

Query: 300 LLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 357
           LL+  Y S G +  ++K   K  L +   + + L   + +L L E    K++HRD+K+AN
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYE-VGLLFYQIVLALDEVHSRKMMHRDLKSAN 199

Query: 358 ILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 416
           I L       +GDFG +K   D     V ++  GT  ++APE     + S+K D++  G+
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259

Query: 417 LLLELIS 423
           +L EL++
Sbjct: 260 ILYELLT 266

Length = 478

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.2 bits (108), Expect = 1e-06
 Identities = 24/57 (42%), Positives = 30/57 (52%)

Query: 51  TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 107
           +LDLSNN  T         L  L+ L L+ N+LT   P + S +  L  LDLS NNL
Sbjct: 4   SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 6/174 (3%)

Query: 251 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 310
           G  VAVK++        E+ F  EV ++    H N++ +    +   E  +V  ++  G+
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 311 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 370
           + + +     ++      + L   R L YLH Q    +IHRD+K+ +ILL       + D
Sbjct: 106 L-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSD 161

Query: 371 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           FG    +   +     ++ GT   +APE +S      + D++  GI+++E+I G
Sbjct: 162 FGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
           RGL YLH      I+HRD+K  N+L++      + DFGLA++ +  +S   T    T  +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 395 IAPEYLSTGQS-SEKTDVFGFGILLLELISG 424
            APE L   +  +   D++  G +  EL+  
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 34/210 (16%)

Query: 235 VGKGGFGNVYKGYLQDGTVVA---VKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +G G FG V    +   T VA   VK LK   +   + +F  + +   +  H N+L+ +G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR-------KRIALGAARGLLYLHEQC 344
            C+     LLV+ Y   G + S L  +    W  R       +R+A   A G+ ++H+  
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQE---QWHRRNSQLLLLQRMACEIAAGVTHMHKH- 118

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT------AVRGTVGHIAPE 398
               +H D+   N  L       VGD+G+     + + ++ T       +R      APE
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWL----APE 171

Query: 399 YLSTGQ----SSEKT---DVFGFGILLLEL 421
            +        ++E+T   +V+  G+ L EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 8/91 (8%)

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
           RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T  +
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183

Query: 395 IAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            APE  L+    ++  D++  G ++ EL++G
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 5/154 (3%)

Query: 272 QTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIA 330
           QTE  +   A +   L  +  C  T  RL  V  ++S G +   ++ +  L     +  +
Sbjct: 43  QTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYS 102

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 390
              +  L +LHE+    II+RD+K  N+LLD      + D+G+ K         T+   G
Sbjct: 103 AEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCG 158

Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           T  +IAPE L         D +  G+L+ E+++G
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 19/166 (11%)

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTV 392
           A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R  +
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             +APE +     + ++DV+ FG+LL E+ S L A  +                +  +++
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPY--------------PGVKIDEE 290

Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
               + +  +         EM Q  L C    PS RP  SE+V  L
Sbjct: 291 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 20/199 (10%)

Query: 236 GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           G+G +  VYKG  +  G +VA+K ++  +  G       E  ++    H N++ L     
Sbjct: 14  GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH 73

Query: 295 TTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           T     LV+ Y+    +   +      L     +       RGL Y H++   +++HRD+
Sbjct: 74  TKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDL 129

Query: 354 KAANILLDEYYEAVVGDFGLAK---LLDHCDSH--VTTAVRGTVGHIAPEYL--STGQSS 406
           K  N+L+ E  E  + DFGLA+   +     S+  VT   R       P+ L  ST  S+
Sbjct: 130 KPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR------PPDVLLGSTEYST 183

Query: 407 EKTDVFGFGILLLELISGL 425
              D++G G +  E+ +G 
Sbjct: 184 S-LDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 48.7 bits (117), Expect = 3e-06
 Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 9/143 (6%)

Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 342
           + N ++L     T    +L+  Y+ +G +   LK +  L  A  K+I       L  LH+
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 343 QCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
                IIH D+K  N+L D   + + + D+GL K++     +      GT+ + +PE + 
Sbjct: 128 H---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKIK 179

Query: 402 TGQSSEKTDVFGFGILLLELISG 424
                   D +  G+L  EL++G
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 49.1 bits (117), Expect = 3e-06
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 35/213 (16%)

Query: 229 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEV-------EMISL 280
           ++S   VG G +G+V      + G  VA+K+L           FQ+E+       E+  L
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR--------PFQSEIFAKRAYRELTLL 68

Query: 281 A--VHRNLLRLIGFCMTTT------ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
               H N++ L+    +        +  LV PYM       ++   P L     + +   
Sbjct: 69  KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHP-LSEDKVQYLVYQ 125

Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
              GL Y+H      IIHRD+K  N+ ++E  E  + DFGLA+   H D+ +T  V  T 
Sbjct: 126 MLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TR 178

Query: 393 GHIAPEY-LSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ E+++G
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 30/207 (14%)

Query: 239 GFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           GF N+   YL      GT+V V+     N     ++  Q EV +     H N++      
Sbjct: 9   GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF 68

Query: 294 MTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
            T +   ++ P+M+ GS  S LK      +  A    I  GA RGL YLH+      IHR
Sbjct: 69  TTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHR 125

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ---SSE- 407
           ++KA++IL+    + +V   GL+    H  S V    +  V +  P++ ++     S E 
Sbjct: 126 NIKASHILISG--DGLVSLSGLS----HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179

Query: 408 ----------KTDVFGFGILLLELISG 424
                     K+D++  GI   EL +G
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 38/160 (23%)

Query: 235 VGKGGFGNVYKG-YLQDGTVVAVKRLK-----DG---NAIGGEIQFQTEVEMISLAVHRN 285
           +G+G +G VYK      G +VA+K+++     +G    AI  EI    E+       H N
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELN------HPN 59

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA----------R 335
           ++RL+    +  +  LV+ ++        L  K  +D  +     L             +
Sbjct: 60  IVRLLDVVHSENKLYLVFEFLD-------LDLKKYMD--SSPLTGLDPPLIKSYLYQLLQ 110

Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
           G+ Y H     +++HRD+K  N+L+D      + DFGLA+
Sbjct: 111 GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 4e-06
 Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 54/239 (22%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI-GGEIQ-FQTEVEMISLAVH 283
            +F    ++G+G FG V+       G V A+K L+  + I   +I   + E ++++ A  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 284 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLD--WATRKRIA-LGAARGLLY 339
             +++L  +     E L LV  YM  G + + L  K       A R  IA L  A  L  
Sbjct: 61  PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIAELVLA--LDS 116

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD--------------------- 378
           +H+      IHRD+K  NIL+D      + DFGL K ++                     
Sbjct: 117 VHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 379 ------------HCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 424
                         +S V     GT  +IAPE L  G     + D +  G++L E++ G
Sbjct: 174 LVRRRDHKQRRVRANSTV-----GTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 20/206 (9%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           VG+G +G+VYK   +DG       LK     G  +    E+ ++    H N++ L    +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 295 TTTER--LLVYPYMSNG-------SVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQC 344
           + ++R   L++ Y  +          AS+   KP  L  +  K +      G+ YLH   
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 345 DPKIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPE 398
              ++HRD+K ANIL+     E     + D G A+L +     +     V  T  + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 399 YLSTGQSSEKT-DVFGFGILLLELIS 423
            L   +   K  D++  G +  EL++
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 14/85 (16%)

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAVRGTVGHIAPEYLST- 402
           IHRDVK  N+LLD+     + DFG    +D      CD    TAV GT  +I+PE L + 
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD----TAV-GTPDYISPEVLKSQ 218

Query: 403 ---GQSSEKTDVFGFGILLLELISG 424
              G    + D +  G+ L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 51/194 (26%), Positives = 81/194 (41%), Gaps = 7/194 (3%)

Query: 234 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIG 291
           L+GKG FG V     +  G   A+K L+    I  +    T  E   L   R+  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 292 FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
           +   T +RL  V  Y + G +   L  +        +         L YLH +    +++
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVY 118

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 410
           RD+K  N++LD+     + DFGL K     D        GT  ++APE L         D
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177

Query: 411 VFGFGILLLELISG 424
            +G G+++ E++ G
Sbjct: 178 WWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 47.4 bits (113), Expect = 9e-06
 Identities = 52/267 (19%), Positives = 106/267 (39%), Gaps = 35/267 (13%)

Query: 243 VYKGYLQDGTVVAVKRLK-DGNAIGGEI-QFQTEVEMISLAVHRNLLRLIGFCMTTTERL 300
           +YKG   +   V ++  K         I   + E++ +      N+L++ GF +   + L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 301 ----LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAA 356
               L+  Y + G +   L  +  L + T+  +A+   +GL  L++       ++++ + 
Sbjct: 95  PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSV 152

Query: 357 NILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAV---RGTVGHIAPEYLSTGQSSEKTDVF 412
           + L+ E Y+  +   GL K+L      +V   V      +  I  EY        K D++
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYT------IKDDIY 206

Query: 413 GFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEE 472
             G++L E+ +G   + F +    K      + K +   KL +    ++K   +      
Sbjct: 207 SLGVVLWEIFTG--KIPF-ENLTTKEIYDLIINKNNSL-KLPLDCPLEIKCIVEA----- 257

Query: 473 MVQVALLCTQYLPSLRPKMSEVVRMLE 499
                  CT +    RP + E++  L 
Sbjct: 258 -------CTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 6/93 (6%)

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD--HCDSHVTTAVRGTV 392
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++ D  H  +   T    T 
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L++   ++  D++  G +L E++S 
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 38/207 (18%)

Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQ--------TEVEMISLAVHRN 285
           VG+GG+G V+    +D G +VA+KR+K        + F+        TE ++++      
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKK------SLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 286 LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLD------WATRKRIALGAARGLL 338
           L++L+ +     E L L   Y+  G   + L     L       +      A+ A     
Sbjct: 63  LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA----- 116

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAP 397
            LHE      IHRD+K  N L+D      + DFGL+K ++ + +S V     G+  ++AP
Sbjct: 117 -LHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAP 167

Query: 398 EYLSTGQSSEKTDVFGFGILLLELISG 424
           E L         D +  G +L E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 53/210 (25%), Positives = 82/210 (39%), Gaps = 39/210 (18%)

Query: 238 GGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRLIGFCMTT 296
               ++ K +    T+VAVK++   +    +++  Q E+       H N+L         
Sbjct: 13  LMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVTSFIV 70

Query: 297 TERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQCDPKIIHRD 352
              L +V P M+ GS    L      +      IA         L Y+H +     IHR 
Sbjct: 71  DSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRS 126

Query: 353 VKAANILLDEYYEAVVGDFGLAKL--LDHCDSHVTTAVRGTVGH------------IAPE 398
           VKA++ILL        GD G   L  L +  S +    R  V H            ++PE
Sbjct: 127 VKASHILLS-------GD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178

Query: 399 YLSTGQS----SEKTDVFGFGILLLELISG 424
            L   Q+    +EK+D++  GI   EL +G
Sbjct: 179 VLQ--QNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 20/206 (9%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           VG+G +G+VYK   +DG       LK     G  +    E+ ++    H N++ L    +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 295 TTTER--LLVYPYMSNG-------SVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQC 344
           +  +R   L++ Y  +          AS+   KP  L     K +      G+ YLH   
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 345 DPKIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPE 398
              ++HRD+K ANIL+     E     + D G A+L +     +     V  T  + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 399 YLSTGQSSEKT-DVFGFGILLLELIS 423
            L   +   K  D++  G +  EL++
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 28/86 (32%), Positives = 46/86 (53%), Gaps = 3/86 (3%)

Query: 28  RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAI 87
            L  +NN    + + +  L  L  L+LSNN     +P ++ +L  L+ L L+NN ++   
Sbjct: 213 ELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--S 269

Query: 88  PPSLSNMSQLAFLDLSYNNLSGPVPS 113
             SL +++ L  LDLS N+LS  +P 
Sbjct: 270 ISSLGSLTNLRELDLSGNSLSNALPL 295

Length = 394

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 8/92 (8%)

Query: 334 ARGLL----YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAV 388
           AR LL    Y+H +    IIHRD+K  N+L++   +  +GDFG A        +     +
Sbjct: 266 ARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 420
            GTV   APE L+    +   D++  G+++ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 42/174 (24%), Positives = 82/174 (47%), Gaps = 6/174 (3%)

Query: 251 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 310
           G  VAVK +        E+ F  EV ++    H+N++ +    +   E  ++  ++  G+
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 311 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 370
           + + + ++  L+      +     + L YLH Q    +IHRD+K+ +ILL       + D
Sbjct: 105 L-TDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSD 160

Query: 371 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           FG    +   D     ++ GT   +APE +S      + D++  GI+++E++ G
Sbjct: 161 FGFCAQISK-DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 51/194 (26%), Positives = 80/194 (41%), Gaps = 6/194 (3%)

Query: 234 LVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIG 291
           L+GKG FG V        G   A+K LK    +  +    T  E   L   R+  L  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 292 FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
           +   T +RL  V  Y + G +   L  +        +         L YLH +    +++
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVY 119

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 410
           RD+K  N++LD+     + DFGL K     D        GT  ++APE L         D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178

Query: 411 VFGFGILLLELISG 424
            +G G+++ E++ G
Sbjct: 179 WWGLGVVMYEMMCG 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 4/91 (4%)

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTV 392
           A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     R  V
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +APE +     + ++DV+ +GILL E+ S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 10/94 (10%)

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-- 391
           ARG+ +L  +     +HRD+ A N+LL +     + DFGLA+ + H  ++V+   +G+  
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300

Query: 392 --VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             V  +APE +     +  +DV+ +GILL E+ S
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 8/91 (8%)

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
           RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+     D  +T  V  T  +
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYV-ATRWY 181

Query: 395 IAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            APE  L+    ++  D++  G ++ EL+ G
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 9/91 (9%)

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA+        +T  V  T  +
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174

Query: 395 IAPEYLSTGQSSEKT---DVFGFGILLLELI 422
            APE L     SE T   DV+  G +  EL+
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELL 203

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 25/202 (12%)

Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLK--------DGNAIGGEIQFQTEVEMISLAVHRN 285
           +G+G +G VYK   +     +A+K+++           AI  EI    E++      H N
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQ------HGN 62

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR--KRIALGAARGLLYLHEQ 343
           ++RL     +     LV+ Y+ +  +   + + P      R  K       RG+ Y H  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 344 CDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLS 401
              +++HRD+K  N+L+D    A+ + DFGLA+         T  V  T+ + APE  L 
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLG 177

Query: 402 TGQSSEKTDVFGFGILLLELIS 423
           +   S   D++  G +  E+++
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 29/228 (12%)

Query: 227 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA 281
            +F +  L+  G +G VY    K   Q     A+K++   N I   +IQ Q  VE   L 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQR---FAMKKINKQNLILRNQIQ-QVFVERDILT 56

Query: 282 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              N   +  FC   T+R L  V  Y+  G  A+ LK   +L     +         L Y
Sbjct: 57  FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEY 116

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL------LDHCDSHVTTAVR---- 389
           LH      I+HRD+K  N+L+       + DFGL+K+       +  + H+    R    
Sbjct: 117 LHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 390 ----GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 433
               GT  +IAPE +      +  D +  GI+L E + G     FG T
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF-FGDT 220

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 3/86 (3%)

Query: 24  FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL-ETLQYLRLNNNS 82
                L  N N      +E+ +L+ L +LDL NN  T  IP  +  L   L+ L L++N 
Sbjct: 93  LPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK 151

Query: 83  LTGAIPPSLSNMSQLAFLDLSYNNLS 108
           +  ++P  L N+  L  LDLS+N+LS
Sbjct: 152 IE-SLPSPLRNLPNLKNLDLSFNDLS 176

Length = 394

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 44.5 bits (106), Expect = 8e-05
 Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 35/222 (15%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKD--GNAIGG-----EIQFQTEVEMISLAVHRNL 286
           +GKG +G V+K    +   VVA+K++ D   NA        EI F  E     L  H N+
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE-----LGDHPNI 69

Query: 287 LRLIGFCMTTTER--LLVYPYMSNGSVASRLKA---KPSLDWATRKRIALGAARGLLYLH 341
           ++L+       ++   LV+ YM      + L A      L+   ++ I     + L Y+H
Sbjct: 70  VKLLNVIKAENDKDIYLVFEYME-----TDLHAVIRANILEDVHKRYIMYQLLKALKYIH 124

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAP 397
                 +IHRD+K +NILL+      + DFGLA+ L   + +    V      T  + AP
Sbjct: 125 SG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181

Query: 398 EYL--STGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 436
           E L  ST + ++  D++  G +L E++ G + L  G  T NQ
Sbjct: 182 EILLGST-RYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQ 221

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 10/102 (9%)

Query: 32  NNNISGHIPTEIGKLSKLLT-LDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 90
           NNNI+  IP  IG L   L  LDLS+N     +PS + +L  L+ L L+ N L+  +P  
Sbjct: 125 NNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKL 181

Query: 91  LSNMSQLAFLDLSYNNLSGPVPSF-----HAKTFNITGNSLI 127
           LSN+S L  LDLS N +S  +P         +  +++ NS+I
Sbjct: 182 LSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII 222

Length = 394

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 27/77 (35%), Positives = 42/77 (54%), Gaps = 4/77 (5%)

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
           I++RD+K  N+LLD+     + DFG AK++D      T  + GT  +IAPE L      +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLNVGHGK 207

Query: 408 KTDVFGFGILLLELISG 424
             D +  GI + E++ G
Sbjct: 208 AADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 3/78 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L +N I   +P+ +  L  L  LDLS N  +  +P  +S+L  L  L L+ N ++  +PP
Sbjct: 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPP 203

Query: 90  SLSNMSQLAFLDLSYNNL 107
            +  +S L  LDLS N++
Sbjct: 204 EIELLSALEELDLSNNSI 221

Length = 394

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 64/231 (27%), Positives = 92/231 (39%), Gaps = 50/231 (21%)

Query: 234 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGE---IQFQTEVEMISLAVHRNLLRL 289
           L+GKG  G V+   L+  G + A+K L D   +       +  TE E+++   H  L  L
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 341
                T T   LV  Y   G +   L+ +P       K ++   AR         L YLH
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLLQRQP------GKCLSEEVARFYAAEVLLALEYLH 120

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------------ 389
                 I++RD+K  NILL E    ++ DF L+K  D     V+ A+R            
Sbjct: 121 LL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 390 ----------------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
                           GT  +IAPE +S        D +  GILL E++ G
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 14/85 (16%)

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAVRGTVGHIAPEYLST- 402
           IHRDVK  N+LLD+     + DFG    ++      CD+ V     GT  +I+PE L + 
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQ 218

Query: 403 ---GQSSEKTDVFGFGILLLELISG 424
              G    + D +  G+ L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 7e-04
 Identities = 21/55 (38%), Positives = 27/55 (49%), Gaps = 2/55 (3%)

Query: 30 LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 83
          L NN ++  IP      L  L  LDLS N  T   P   S L +L+ L L+ N+L
Sbjct: 7  LSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 8/150 (5%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +F S  ++G+G FG V     +D G V A+K L+  + +  E       E   + V  + 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAER-DILVEADS 60

Query: 287 LRLIGFCMTTTERL---LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
           L ++    +  ++L   L+  ++  G + + L  K +L   T +      A  +L +   
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL---TEEETQFYIAETVLAIDSI 117

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGL 373
                IHRD+K  N+LLD      + DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 5/89 (5%)

Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           G+ +LH      IIHRD+K +NI++       + DFGLA+    C + + T    T  + 
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189

Query: 396 APEYLSTGQSSEKTDVFGFGILLLELISG 424
           APE +      E  D++  G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 29/126 (23%), Positives = 59/126 (46%), Gaps = 10/126 (7%)

Query: 302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 361
           +          + +   P+L +      +   A G+ +L  +     +HRD+ A N+L+ 
Sbjct: 217 LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273

Query: 362 EYYEAVVGDFGLAKLLDHCDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGIL 417
           E     + DFGLA+ +    ++++   +G+    +  +APE +     +  +DV+ FGIL
Sbjct: 274 EGKLVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGIL 330

Query: 418 LLELIS 423
           L E+ +
Sbjct: 331 LWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 9/95 (9%)

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD----HCDSHVTTAVRG 390
            GL Y+H      ++HRD+K  N+L++   E  + DFGLA+            +T  V  
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171

Query: 391 TVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
           T  + APE + + QS  K  DV+  G +L EL+  
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.9 bits (84), Expect = 0.002
 Identities = 17/36 (47%), Positives = 24/36 (66%), Gaps = 2/36 (5%)

Query: 73  LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
           L+ L L+NN +T  +PP LSN+  L  LDLS N ++
Sbjct: 3   LETLDLSNNQITD-LPP-LSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 9/202 (4%)

Query: 227 SNFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVH 283
           + F    +VG+G +G V K  + +   +VA+K+ KD      E++  T  E++M+     
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQ 59

Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL-GAARGLLYLHE 342
            N++ L        +  LV+ Y+   ++   L+  P+     + R  +    + + + H+
Sbjct: 60  ENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
                I+HRD+K  N+L+       + DFG A+ L    +   T    T  + +PE L  
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175

Query: 403 GQSSEKTDVFGFGILLLELISG 424
               +  D++  G +L EL  G
Sbjct: 176 APYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 14/102 (13%)

Query: 349 IHRDVKAANILLDEYYEAVVGDFG-LAKLLDHCDSHVTTAVRGTVGHIAPEYLST----- 402
           +HRD+K  NIL+D      + DFG   KL++      + AV GT  +I+PE L       
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEDGK 182

Query: 403 GQSSEKTDVFGFGILLLELISGLRAL-------EFGKTANQK 437
           G+   + D +  G+ + E++ G            +GK  N K
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 7/97 (7%)

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG-LAKLLDHCDSHVTTAVRGTV 392
           A  +L +H       +HRD+K  N+LLD      + DFG   K+        + AV GT 
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTP 167

Query: 393 GHIAPEYLST-----GQSSEKTDVFGFGILLLELISG 424
            +I+PE L       G+   + D +  G+ + E++ G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	549
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
PRK10345	210	hypothetical protein; Provisional	99.79
smart00090	237	RIO RIO-like kinase.	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.72
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.72
PLN03150	623	hypothetical protein; Provisional	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.34
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.32
KOG1243	690	consensus Protein kinase [General function predict	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.21
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.2
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.15
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.11
PLN03150	623	hypothetical protein; Provisional	99.08
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.07
KOG3087	229	consensus Serine/threonine protein kinase [General	99.04
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.96
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.95
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.91
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.9
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.83
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.82
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.79
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.75
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.73
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.7
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.7
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.66
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.66
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.65
COG4248	637	Uncharacterized protein with protein kinase and he	98.64
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.6
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.58
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.52
PRK09902	216	hypothetical protein; Provisional	98.51
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.5
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.45
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.43
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.41
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.29
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.27
PF01636	239	APH: Phosphotransferase enzyme family This family	98.26
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.25
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.24
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.23
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.18
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.18
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.16
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.15
PLN02876	822	acyl-CoA dehydrogenase	98.14
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.13
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.12
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.1
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.05
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.02
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	97.98
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.94
PRK10593	297	hypothetical protein; Provisional	97.91
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.91
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	97.89
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.86
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.85
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.85
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.83

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-57  Score=457.58  Aligned_cols=285  Identities=51%  Similarity=0.859  Sum_probs=254.2

Q ss_pred             CccccCHHHHHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEE
Q 008893          213 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF  292 (549)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  292 (549)
                      ..+.|+++++..||++|...+.||+|+||.||+|.+.+|+.||||++....... ..+|..|+.++++++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            567899999999999999999999999999999999999999999887655433 5569999999999999999999999


Q ss_pred             EecCC-ceeeEeeccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEe
Q 008893          293 CMTTT-ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG  369 (549)
Q Consensus       293 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  369 (549)
                      |.+.+ +.+||||||++|+|.++++...  +++|.+|.+||.++|+||+|||+.+.|+|+||||||+|||+|+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99998 5999999999999999998654  89999999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCC-CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          370 DFGLAKLLDH-CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       370 Dfg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      |||+|+..+. ........ .||.+|+|||++..+..++|+|||||||+|+||+||+.+.+... ......+.+|+....
T Consensus       220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHH
Confidence            9999976654 22222111 79999999999999999999999999999999999999887654 222334899999888


Q ss_pred             hccchhhhcccccc-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          449 QEKKLEMLVDKDLK-NNYDR-IELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       449 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....+.+++|+.+. ..+.. .+...+..++.+|++.+|++||+|.||+++|+.
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            88899999999987 66665 678889999999999999999999999999955

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.9e-57  Score=518.36  Aligned_cols=452  Identities=28%  Similarity=0.469  Sum_probs=319.7

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|++++.+|..|.++++|+.|+|++|+++|.+|..+.++++|+.|+|++|.++|.+|..|..+++|+.|+|++|+
T Consensus       479 ~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  558 (968)
T PLN00113        479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ  558 (968)
T ss_pred             EEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCc
Confidence            46788888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             CCCCCCccc-----cccccccCCccccCCCCCCccccCCCCCCccccCCC------CCCCCCC--CCCCceeeeeecchh
Q 008893          107 LSGPVPSFH-----AKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNS------PNSKPSG--MPKGQKIALALGSSL  173 (549)
Q Consensus       107 l~~~~p~~~-----~~~~~l~~N~~~~~~~~~~~c~~~~~~p~s~~~~~~------~~~~~~~--~~~~~~~~~~~~~~~  173 (549)
                      ++|.+|..+     ...+++++|++.+.-+..... .. ....++..+..      ....+++  ......+.+++++++
T Consensus       559 l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~-~~-~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~  636 (968)
T PLN00113        559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAF-LA-INASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTL  636 (968)
T ss_pred             ccccCChhHhcCcccCEEeccCCcceeeCCCcchh-cc-cChhhhcCCccccCCccccCCCCCccccccceeeeehhHHH
Confidence            888887643     256788888876532211000 00 00000111100      0000111  111223344444444


Q ss_pred             hhHHHHHhhhhheeccccccccce-eecchhhhhhhhh-c--CCccccCHHHHHHHhcCCCCCCeeeeeCCeEEEEEEE-
Q 008893          174 GCISLLILGFGFLLWWRQRHNQQI-FFDVNEQRREEVC-L--GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL-  248 (549)
Q Consensus       174 g~i~~~~~~~~~~~~~r~~~~~~~-~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-  248 (549)
                      ++++++++++++++++|++++.+. ..+... ...+.. .  .....++++++   ...|...+.||+|+||.||+|.. 
T Consensus       637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~  712 (968)
T PLN00113        637 GAFLVLALVAFGFVFIRGRNNLELKRVENED-GTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSI  712 (968)
T ss_pred             HHHHHHHHHHHHHHHHHhhhccccccccccc-ccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEEC
Confidence            444443333333334443322111 000000 000000 0  01122333333   35677889999999999999997 


Q ss_pred             CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHH
Q 008893          249 QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR  328 (549)
Q Consensus       249 ~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~  328 (549)
                      .++..||||++......     ...|++.+++++||||++++|+|...+..++||||+++|+|.++++   .++|..+.+
T Consensus       713 ~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~  784 (968)
T PLN00113        713 KNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRK  784 (968)
T ss_pred             CCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---cCCHHHHHH
Confidence            47899999998654321     2346888999999999999999999999999999999999999996   389999999


Q ss_pred             HHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCc
Q 008893          329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK  408 (549)
Q Consensus       329 i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  408 (549)
                      ++.|||+||+|||..+.++|+||||||+||+++.++.+++. ||........     ....+|..|+|||++.+..++.+
T Consensus       785 i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~  858 (968)
T PLN00113        785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEK  858 (968)
T ss_pred             HHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcc
Confidence            99999999999997767799999999999999999988875 6665433211     12357899999999999999999


Q ss_pred             ccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC--CCCHHHHHHHHHHHHHhcccCCC
Q 008893          409 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN--NYDRIELEEMVQVALLCTQYLPS  486 (549)
Q Consensus       409 ~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~cl~~dP~  486 (549)
                      +|||||||++|||+||+.||+...  .....+..|.+...........+|+.+..  ..+..+..++.+++.+||+.+|+
T Consensus       859 sDv~S~Gvvl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~  936 (968)
T PLN00113        859 SDIYGFGLILIELLTGKSPADAEF--GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPT  936 (968)
T ss_pred             cchhhHHHHHHHHHhCCCCCCccc--CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCch
Confidence            999999999999999999985432  22345777877665555556666666543  23456677889999999999999


Q ss_pred             CCCCHHHHHHHHhc
Q 008893          487 LRPKMSEVVRMLEG  500 (549)
Q Consensus       487 ~RPs~~evl~~L~~  500 (549)
                      +||+|+||++.|+.
T Consensus       937 ~RPt~~evl~~L~~  950 (968)
T PLN00113        937 ARPCANDVLKTLES  950 (968)
T ss_pred             hCcCHHHHHHHHHH
Confidence            99999999999987

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=375.54  Aligned_cols=251  Identities=26%  Similarity=0.353  Sum_probs=213.2

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC-ceeeEeecc
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-ERLLVYPYM  306 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  306 (549)
                      ++..+.||+|..|+|||+.++ +++.+|+|.+.........+++.+|+++++..+||+||.++|.|.... +..++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            345688999999999999987 689999999976665566678999999999999999999999999988 599999999


Q ss_pred             CCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      ++|+|.+++...+.+++...-+|+.+|++||.|||+ .   +||||||||+|||++..|++||||||.++.+...   ..
T Consensus       161 DgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a  234 (364)
T KOG0581|consen  161 DGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA  234 (364)
T ss_pred             CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence            999999999988889999999999999999999996 5   9999999999999999999999999999877543   44


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....||..|||||.+.+..|+.++||||||+.++|+++|+.|+....  .....+.+.+..+..+..          ...
T Consensus       235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~Iv~~pp----------P~l  302 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCAIVDEPP----------PRL  302 (364)
T ss_pred             ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHHHhcCCC----------CCC
Confidence            56779999999999999999999999999999999999999997641  112223333333322111          112


Q ss_pred             CH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          466 DR-IELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       466 ~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +. ..++++..++..|+++||.+||+++|+++|
T Consensus       303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            22 356789999999999999999999999864

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=390.32  Aligned_cols=251  Identities=34%  Similarity=0.486  Sum_probs=209.0

Q ss_pred             CCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCc-HHHHHHHHHHHhhccCCCccceEEEEecCC-ceeeEeeccC
Q 008893          230 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMTTT-ERLLVYPYMS  307 (549)
Q Consensus       230 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~  307 (549)
                      ...+.||+|+||+||+|.++....||||++........ ...|.+|+.++.+++|||||+++|+|.+.. ..++||||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            34456999999999999998544599999986542222 458999999999999999999999999988 7999999999


Q ss_pred             CCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCc-eEecccCcCeeeecCCC-ceEEeecccccccCCCCCc
Q 008893          308 NGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPK-IIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       308 ~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +|+|.++++.  ...+++..+..++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++...... .
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            9999999987  67899999999999999999999999   7 99999999999999997 99999999998765432 2


Q ss_pred             eeeccccccCccCchhhc--cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          384 VTTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      ..+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....       ...+..         ++....
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~---------v~~~~~  263 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASA---------VVVGGL  263 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHH---------HHhcCC
Confidence            233367999999999999  66999999999999999999999999975332       111111         111222


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +...+..+...+..++.+||+.||++||++.+++..|+.
T Consensus       264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~  302 (362)
T KOG0192|consen  264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES  302 (362)
T ss_pred             CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence            233334456789999999999999999999999999885

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-47  Score=384.89  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=214.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ..|...++||+|||+.||.++. ..|+.||+|++.+..  .......+.+||++.+.++|||||+++++|.+.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688999999999999999997 789999999997643  2334557899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      |+|++++|..+++..+++++.+++.++.||+.||.|||+.   +|+|||||..|+|++++.++||+|||+|..+... ..
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-GE  173 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-cc
Confidence            9999999999999889999999999999999999999999   9999999999999999999999999999988753 33


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ...+.+|||.|+|||++.....+..+||||+||++|.||+|++||+.....+..       ..+...           .-
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-------~~Ik~~-----------~Y  235 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-------NKIKLN-----------EY  235 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-------HHHHhc-----------Cc
Confidence            456678999999999999999999999999999999999999999743322111       111110           01


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..|...+....+||.++|+++|.+|||+++|+.+
T Consensus       236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1233445778899999999999999999999964

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-47  Score=363.11  Aligned_cols=250  Identities=23%  Similarity=0.357  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+.... .....+.+..|+.+|+.++|||||.+++++..++..++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357888889999999999999976 58999999997654 2333456889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC------CceEEeeccccccc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY------YEAVVGDFGLAKLL  377 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~------~~~kl~Dfg~~~~~  377 (549)
                      |||.+|+|.++++..+.+++.....++.|+|.||++||++   +||||||||+||||+..      -.+||+|||+|+.+
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            9999999999999998999999999999999999999999   99999999999999864      56899999999988


Q ss_pred             CCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          378 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ..  +......+|++.|||||+++..+|+.|+|+||+|+++|++++|+.||+.....       +....+.+...     
T Consensus       166 ~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~-------eL~~~~~k~~~-----  231 (429)
T KOG0595|consen  166 QP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK-------ELLLYIKKGNE-----  231 (429)
T ss_pred             Cc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH-------HHHHHHhcccc-----
Confidence            73  34456678999999999999999999999999999999999999999743321       22222222211     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV  495 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  495 (549)
                         +....+......+.+++...++.+|.+|-+..+-.
T Consensus       232 ---~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  232 ---IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             ---ccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence               11122222334455667777777777777666654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-48  Score=369.47  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=208.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC------cHHHHHHHHHHHhhccCCCccceEEEEecCCce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  299 (549)
                      +.|.+.+.||+|+||.|-+|..+ +|+.||||++++.....      ....+++|+++|++++|||||++.+++...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45778899999999999999954 79999999997653222      223467999999999999999999999999999


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC---CceEEeecccccc
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY---YEAVVGDFGLAKL  376 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~~~~  376 (549)
                      |+||||++||+|.+.+-..+.+.+.....+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+|||+|++
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            99999999999999998888899999999999999999999999   99999999999999765   7899999999998


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCC---CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccch
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      .+  ......+.+||+.|.|||++.+..+   ..++|+||+||+||-+++|.+||.......   .+.+.+.    .++.
T Consensus       329 ~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---sl~eQI~----~G~y  399 (475)
T KOG0615|consen  329 SG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---SLKEQIL----KGRY  399 (475)
T ss_pred             cc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---cHHHHHh----cCcc
Confidence            76  3445667899999999999987653   348899999999999999999998543322   1111111    0110


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       454 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .      ..........++..++|.+||..||++|||+.|++++
T Consensus       400 ~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  400 A------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             c------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            0      0112234556889999999999999999999999863

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-47  Score=377.43  Aligned_cols=251  Identities=28%  Similarity=0.422  Sum_probs=213.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccC
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      .+...+.||+|-||+||.|.++....||+|.++...  .....|.+|++++++++|+|||+++|+|...+..+||||||+
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            344668899999999999999988899999998764  334578999999999999999999999999889999999999


Q ss_pred             CCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          308 NGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       308 ~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      .|+|.++|+.  +..+...+.+.++.|||+|++||+++   ++|||||.++||||+++..+||+|||+|+..........
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence            9999999985  56799999999999999999999999   999999999999999999999999999996554444344


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      ....-...|.|||.+..+.++.|||||||||+||||+| |+.|+..       ....+.+..+.+.          .+-.
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-------msn~ev~~~le~G----------yRlp  424 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-------MSNEEVLELLERG----------YRLP  424 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-------CCHHHHHHHHhcc----------CcCC
Confidence            44445678999999999999999999999999999999 6666543       2233333333333          2333


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .|..++..+.+++..||+.+|++|||++.+...|++
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~  460 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED  460 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence            456677899999999999999999999999888876

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.5e-46  Score=345.56  Aligned_cols=266  Identities=20%  Similarity=0.261  Sum_probs=211.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      +.|+....+|+|+||+|||.+++ +|+.||||++...... ...+-..+|+++|++++|+|+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45778889999999999999987 4999999999765542 223347899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |++..-|.++-+....++.....+++.|++.|+.|+|++   +++||||||+||||+.++.+||||||+|+.+.. .+..
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~  157 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN  157 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence            999866655555556799999999999999999999999   999999999999999999999999999998875 4455


Q ss_pred             eeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh--------hccchhh
Q 008893          385 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH--------QEKKLEM  455 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~  455 (549)
                      .+..+.|.+|+|||++.+ .+|...+||||+||++.||++|.+.|.+....++-..+...+..+.        .......
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            666778999999999988 6799999999999999999999999886555444322222222111        1111111


Q ss_pred             h-----cccc-ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 L-----VDKD-LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ~-----~d~~-l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +     -++. +...++ ....-+.+++..|++.||++|++-+|++.+
T Consensus       238 v~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            1     1111 111122 223468899999999999999999999854

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-47  Score=345.48  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=206.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEE-ECCCCEEEEEEcccCCCCCc-HHHHHHHHHHHhhccCCCccceEEE-EecCCc-eeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGF-CMTTTE-RLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~lv  302 (549)
                      .+|.+.+.||+|.||+||++. ..+|..||.|.++-+..... ......|+.+|++++|||||+++++ +.++.+ .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            356778899999999999998 56899999999984432222 3358899999999999999999994 444445 8899


Q ss_pred             eeccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-ceEecccCcCeeeecCCCceEEeeccccccc
Q 008893          303 YPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDP-KIIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       303 ~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      |||+..|+|...++    ++..+++..+++++.|++.||.++|++.++ -|+||||||.||+++.+|.+|++|||+++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999986    456799999999999999999999995332 2889999999999999999999999999998


Q ss_pred             CCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          378 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ..... .....+|||.||+||.+....|+.|+||||+||++|||+.-.+||.+.       .+....+.+.+. .     
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~~KI~qg-d-----  244 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLCKKIEQG-D-----  244 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHHHHHHcC-C-----
Confidence            75433 334567999999999999999999999999999999999999999753       222222222221 1     


Q ss_pred             cccccCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          458 DKDLKNNYD-RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       458 d~~l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         . ...+ ...++++..|+..|+..||+.||+.-.+++.++.
T Consensus       245 ---~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  245 ---Y-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ---C-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence               1 1122 5667899999999999999999995555554443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=350.15  Aligned_cols=244  Identities=27%  Similarity=0.310  Sum_probs=207.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .++|++.++||+|+||+||.++.+ +++.+|+|++++......  ......|..+|..++||.||+++-.+.+.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999965 599999999987653333  45688999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      +||+.||.|..+|++.+.+++..+.-++.+|+.||.|||++   +||||||||+|||+|.+|+++|+|||+++..-. .+
T Consensus       104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-~~  179 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-DG  179 (357)
T ss_pred             EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc-CC
Confidence            99999999999999999999999999999999999999999   999999999999999999999999999986433 23


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ..+...+||+.|||||++....|+..+|.||+|+++|||++|.+||......       .+...+...+          .
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------~~~~~I~~~k----------~  242 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------KMYDKILKGK----------L  242 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-------HHHHHHhcCc----------C
Confidence            3455678999999999999999999999999999999999999999754321       2222222222          0


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPK  490 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs  490 (549)
                      ...+.....+..+++.+.++.||++|..
T Consensus       243 ~~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  243 PLPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence            1112223467889999999999999974

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.1e-45  Score=379.52  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=214.2

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      ...+....+.||+|.||+||+|...      +...||||.+++........+|++|++++..++|||||+++|+|.+++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3455667789999999999999842      3568999999988766567789999999999999999999999999999


Q ss_pred             eeeEeeccCCCchhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC
Q 008893          299 RLLVYPYMSNGSVASRLKA--------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY  364 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  364 (549)
                      .++|+|||..|||.++|..              ..+++..+.+.||.|||.|+.||-++   .+|||||..+|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence            9999999999999999961              12388999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCCcee-eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHH
Q 008893          365 EAVVGDFGLAKLLDHCDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLD  442 (549)
Q Consensus       365 ~~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~  442 (549)
                      .+||+|||+++..-..+.... ....-..+|||||.+..++||++||||||||+|||++| |+.|+.+-...        
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--------  712 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--------  712 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--------
Confidence            999999999986543333222 12334679999999999999999999999999999999 88887642221        


Q ss_pred             HHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          443 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       443 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                              +.++.+-+..+ -..++.++.++..|+..||+.+|++||+++||-..|+.
T Consensus       713 --------EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~  761 (774)
T KOG1026|consen  713 --------EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA  761 (774)
T ss_pred             --------HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence                    11222223333 34567778999999999999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-44  Score=354.88  Aligned_cols=266  Identities=23%  Similarity=0.312  Sum_probs=213.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEE-ECCCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecC--CceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  302 (549)
                      +.|+..+.||+|.||.||+|+ ..+|+.||+|+++.+. .........+||.+|+++.||||+++.+...+.  ...|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            346667889999999999999 4579999999998655 334445678999999999999999999998876  689999


Q ss_pred             eeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      +|||++ +|.-++.. .-.+++.++..++.|++.||+|+|++   +|+|||||.+|||||.+|.+||+|||+|+++....
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999987 88888775 44799999999999999999999999   99999999999999999999999999999988777


Q ss_pred             CceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccch-hhhcc-
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL-EMLVD-  458 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d-  458 (549)
                      ....+..+.|..|+|||++.+. .|+.++|+||.|||+.||++|++.|.+....++-..+.........+.+. ..+.. 
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence            6667777799999999999875 69999999999999999999999998766555443343333222221111 01110 


Q ss_pred             --ccccCCCCHH-------HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          459 --KDLKNNYDRI-------ELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       459 --~~l~~~~~~~-------~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                        ......|.+.       .+...++|+..+|..||.+|.|+.++++
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              0001112221       2356788999999999999999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=356.22  Aligned_cols=266  Identities=22%  Similarity=0.261  Sum_probs=212.5

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCC-ceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT-ERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~lv  302 (549)
                      .++|...+.||.|+||.||+|+.. +|+.||||+++.....-++-.-.+|++.|+++. ||||+++.+++.+.+ ..++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            457888899999999999999954 699999999987643322333578999999998 999999999999888 89999


Q ss_pred             eeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||||+. +|+++++. ...+++..+..|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+|+.+..  
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--  162 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS--  162 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc--
Confidence            999975 99999975 45799999999999999999999999   999999999999999999999999999998764  


Q ss_pred             CceeeccccccCccCchhhc-cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc-----hhh
Q 008893          382 SHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK-----LEM  455 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~  455 (549)
                      ....+..+.|..|+|||++. .+-|+.+.||||+|||++|+.+-++.|.+....++-..+.+.+..-....+     +..
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence            33456677999999999874 567999999999999999999999999876655544333333322111111     111


Q ss_pred             hc--------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          456 LV--------DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       456 ~~--------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                      .+        ...+..-.+ ..+.+..+++.+|++.||++|||+.|++++-
T Consensus       243 ~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            11        111111112 2567899999999999999999999999753

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=346.34  Aligned_cols=255  Identities=27%  Similarity=0.383  Sum_probs=207.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC--ceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  303 (549)
                      .++...+.||+|+||+||++...+ |+..|||.+....... ...+.+|+.+|++++|||||+++|......  .++++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            356678999999999999999764 8999999987653322 456899999999999999999999855544  689999


Q ss_pred             eccCCCchhhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-CCceEEeecccccccCC--
Q 008893          304 PYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDH--  379 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~--  379 (549)
                      ||+++|+|.+++...+ .+++..+..++.||+.||.|||++   +|+||||||+|||++. ++.+||+|||+++....  
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999998655 799999999999999999999999   9999999999999999 79999999999987663  


Q ss_pred             CCCceeeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ..........||+.|||||++..+. ...++|||||||++.||+||+.||..-      .....++..+....       
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~-------  239 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGRED-------  239 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccC-------
Confidence            1222334567999999999998643 345999999999999999999999742      11112222221111       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        ....++...+.+..+++..|+..+|++|||+++++++..-
T Consensus       240 --~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  240 --SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             --CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence              1123445566789999999999999999999999987665

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-44  Score=351.97  Aligned_cols=256  Identities=23%  Similarity=0.287  Sum_probs=212.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhc-cCCCccceEEEEecCCcee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  300 (549)
                      ...+|..++.||+|+|++|++|+.. .++.||||++.+.....+  .+.+..|-..|.++ .||.|++++--|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3467889999999999999999955 699999999865432222  23467788888888 8999999999999999999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +|+||+++|+|.++++..+.+++...+.++.+|+.||+|||++   |||||||||+|||+|+|+++||+|||.|+.+...
T Consensus       151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            9999999999999999999999999999999999999999999   9999999999999999999999999999987532


Q ss_pred             CCc------------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          381 DSH------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       381 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      ...            ....++||..|.+||++..+..++.+|+|+|||+||.|+.|.+||.........       +.+.
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF-------qkI~  300 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF-------QKIQ  300 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH-------HHHH
Confidence            211            114478999999999999999999999999999999999999999754321110       1110


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                            . ++-    .+++..++.+.+|+.+.|..||.+|+|..+|.+|.--.
T Consensus       301 ------~-l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~  342 (604)
T KOG0592|consen  301 ------A-LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE  342 (604)
T ss_pred             ------H-hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence                  0 111    22333337789999999999999999999998876543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=353.38  Aligned_cols=240  Identities=25%  Similarity=0.396  Sum_probs=207.6

Q ss_pred             CCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCc
Q 008893          231 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS  310 (549)
Q Consensus       231 ~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  310 (549)
                      ..+-||+|+.|.||.|+++ ++.||||+++...        ..+|+-|++++||||+.+.|+|....-++||||||..|-
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            4578999999999999997 6889999987543        367889999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecccc
Q 008893          311 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG  390 (549)
Q Consensus       311 L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  390 (549)
                      |+.+|+...++.......+..+||.|+.|||.+   .|||||||.-||||..+..+||+|||-++.....  .....++|
T Consensus       199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG  273 (904)
T KOG4721|consen  199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG  273 (904)
T ss_pred             HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence            999999999999999999999999999999999   9999999999999999999999999999876543  33345789


Q ss_pred             ccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHH
Q 008893          391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL  470 (549)
Q Consensus       391 t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  470 (549)
                      |..|||||++.+.+.++|+||||||||||||+||..|+..-+....                +-.+-...+.-..+..++
T Consensus       274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----------------IwGVGsNsL~LpvPstcP  337 (904)
T KOG4721|consen  274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----------------IWGVGSNSLHLPVPSTCP  337 (904)
T ss_pred             hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----------------EEeccCCcccccCcccCc
Confidence            9999999999999999999999999999999999999863221110                001111223334566778


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          471 EEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       471 ~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +.+.-|++.||+..|..||++++++.||+-
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            889999999999999999999999999975

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.7e-43  Score=354.34  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=203.2

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEE------CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCC
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT  297 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  297 (549)
                      ..++|.+.+.||+|+||.||+|.+      .+++.||||+++..........+.+|+.++..+ +||||+++++++...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            456789999999999999999974      235689999997654333445789999999999 8999999999987654


Q ss_pred             -ceeeEeeccCCCchhhhhccC----------------------------------------------------------
Q 008893          298 -ERLLVYPYMSNGSVASRLKAK----------------------------------------------------------  318 (549)
Q Consensus       298 -~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------------  318 (549)
                       ..+++|||+++|+|.+++...                                                          
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             578999999999999888632                                                          


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc-eeeccccccC
Q 008893          319 ----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVG  393 (549)
Q Consensus       319 ----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~  393 (549)
                          .++++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++........ ......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                2478889999999999999999998   9999999999999999999999999999865432221 1222346678


Q ss_pred             ccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHH
Q 008893          394 HIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEE  472 (549)
Q Consensus       394 y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  472 (549)
                      |+|||++.+..++.++|||||||++|||++ |..||.......      ........ ...         ...+...+..
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~-~~~---------~~~~~~~~~~  305 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKD-GTR---------MRAPENATPE  305 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhc-CCC---------CCCCCCCCHH
Confidence            999999999999999999999999999997 999986432211      11111111 100         0112233467


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          473 MVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       473 l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +.+++.+||+.||++|||+.|+++.|+.
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            8999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.5e-43  Score=318.23  Aligned_cols=265  Identities=24%  Similarity=0.327  Sum_probs=208.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCc-HHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .+|...+.+|+|.||.||+|+. ++|+.||||+++.....++ .....+|++.|+.++|+||+.+++++...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            3577788999999999999994 5799999999987654433 3468899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+. +|+..++.. ..++..++..++.++++|++|||++   .|+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9975 899999854 4789999999999999999999999   9999999999999999999999999999988754433


Q ss_pred             eeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc----------
Q 008893          384 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK----------  452 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------  452 (549)
                      . ...+.|..|+|||.+.+. .|+..+||||.|||+.||+-|.+-|.+....++-..+..-+..-..+.+          
T Consensus       158 ~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  158 Q-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             c-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            2 223579999999998775 5899999999999999999987766654433332222211111111111          


Q ss_pred             -hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          453 -LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       453 -~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       +.....+.+ ...-.....+..+++..++..||.+|+++.|++++
T Consensus       237 ~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  237 KIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence             111111111 11223345677999999999999999999999863

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8.9e-43  Score=344.41  Aligned_cols=249  Identities=20%  Similarity=0.269  Sum_probs=210.7

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ...++|+....||+|+||.||.++-+ +|..+|+|++++...  ..+.+.+..|-++|....+|+||+++..|.+.+.+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            35688999999999999999999965 599999999987643  233456889999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC-
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-  379 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~-  379 (549)
                      |||||++||++..+|.....|++.....++.+++.|+..+|+.   |+|||||||+|+|||..|++||+|||++.-+.. 
T Consensus       218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999999999999999999999999999999999999999   999999999999999999999999999853211 


Q ss_pred             ---------------------CCCc-----e-------------------eeccccccCccCchhhccCCCCCcccchhH
Q 008893          380 ---------------------CDSH-----V-------------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGF  414 (549)
Q Consensus       380 ---------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~  414 (549)
                                           .+..     .                   ....+|||.|||||++.+..|+..+|.||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 0000     0                   012349999999999999999999999999


Q ss_pred             hHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 008893          415 GILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK  490 (549)
Q Consensus       415 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs  490 (549)
                      |||+||||.|.+||....+......+..|...+.....              .....+..+||.+|+. ||++|..
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999999999977766666666666554432111              1122678899999999 9999997

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=322.54  Aligned_cols=237  Identities=22%  Similarity=0.303  Sum_probs=205.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|+..+.||.|+||.|..++.+ +|..+|+|++.....  ..+.+...+|..+|+.+.||+++++.+.+.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46788899999999999999976 588999999976542  223345788999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||++||.|.++++..+.+++..++.+|.||+.||+|||+.   +|++|||||+|||+|.+|.+||+|||+|+.+..    
T Consensus       124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----  196 (355)
T ss_pred             eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence            9999999999999999999999999999999999999999   999999999999999999999999999997753    


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      .+.+.+||+.|+|||.+.+..+...+|.|||||++|||+.|..||.........                +.++...  -
T Consensus       197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY----------------~KI~~~~--v  258 (355)
T KOG0616|consen  197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY----------------EKILEGK--V  258 (355)
T ss_pred             cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH----------------HHHHhCc--c
Confidence            256678999999999999999999999999999999999999999754431111                1111111  1


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCC
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLR  488 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~R  488 (549)
                      .+|+....++.+|+...++.|-.+|
T Consensus       259 ~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            2455556789999999999999999

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3e-43  Score=347.53  Aligned_cols=248  Identities=24%  Similarity=0.354  Sum_probs=215.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|.+.+.||+|+||.||||+-+ +.+.||+|.+.+... ......+.+|+++++.++||||+.++++|....+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46788899999999999999965 589999999865443 3334569999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+.+ +|..++...+.++++.+..++.+++.||.|||+.   +|.|||+||+|||++..+.+|+||||+|+.+... ...
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~v  156 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSV  156 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-cee
Confidence            9977 9999999999999999999999999999999999   9999999999999999999999999999987753 345


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      .+.+.||+.|||||+..+.+|+..+|+||+||++||+++|++||..       ..+...++.+..+.           ..
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~I~~d~-----------v~  218 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKSILKDP-----------VK  218 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHHHhcCC-----------CC
Confidence            5667899999999999999999999999999999999999999963       23445555444322           11


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ++......+.+++...+.+||.+|.+-.+++.|
T Consensus       219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            233556789999999999999999999998864

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-42  Score=332.60  Aligned_cols=261  Identities=25%  Similarity=0.342  Sum_probs=208.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||.|..++||+|+. ..++.||||++..+........+.+|+..++.++||||++++..|..+...|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            35788999999999999999995 46899999999887766667789999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||.+|++.+++..  ...+++..+..|..++++||.|||++   |.||||||+.||||+.+|.+||+|||.+..+.....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            9999999999974  33599999999999999999999999   999999999999999999999999999876644332


Q ss_pred             ce--e-eccccccCccCchhhcc--CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          383 HV--T-TAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       383 ~~--~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ..  . ....||++|||||+++.  ..|+.|+||||||++..||++|..||..-.+..      -.+..+........  
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~pp~~~--  253 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQNDPPTLL--  253 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCCCCCcc--
Confidence            11  1 44579999999999644  358999999999999999999999997322111      11111111110000  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+..+-.......+.+++..|+++||++|||+++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            0001111112234578999999999999999999999853

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-42  Score=345.79  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=208.7

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC----CcHHHHHHHHHHHhhcc-CCCccceEEEEecCCc
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTE  298 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  298 (549)
                      ..++|...+.||+|+||+|+.|... +|+.||+|++......    .....+.+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4568999999999999999999864 6899999977654211    23446778999999999 9999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC-CceEEeeccccccc
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLL  377 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~  377 (549)
                      .++||||+.+|+|.+++...+.+.+....+++.|++.|++|+|+.   +|+||||||+|||+|.+ +++||+|||++...
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            999999999999999999888999999999999999999999999   99999999999999999 99999999999987


Q ss_pred             CCCCCceeeccccccCccCchhhccCC-CC-CcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          378 DHCDSHVTTAVRGTVGHIAPEYLSTGQ-SS-EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      . .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.....       .....+...     
T Consensus       172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-------~l~~ki~~~-----  238 (370)
T KOG0583|consen  172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-------NLYRKIRKG-----  238 (370)
T ss_pred             C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-------HHHHHHhcC-----
Confidence            4 2333455678999999999999977 75 7899999999999999999999852211       111111111     


Q ss_pred             hccccccCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          456 LVDKDLKNNYDRIE-LEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       456 ~~d~~l~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                          .  -.++... +.++..++.+|+..+|.+|+++.+|+.
T Consensus       239 ----~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  239 ----E--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ----C--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                0  0112222 578999999999999999999999984

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=340.02  Aligned_cols=250  Identities=28%  Similarity=0.372  Sum_probs=214.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ..|+..+.||+|.||.||+|... .++.||+|++..+...+....+++|+.++..++++||.+++|.+..+...+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777799999999999999954 68999999999887777778899999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +.+|++.+.+..+..+++.....++.+++.|+.|||.+   +.+|||||+.|||+..+|.+|++|||++..+...... .
T Consensus        93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r  168 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-R  168 (467)
T ss_pred             hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc-c
Confidence            99999999999888789999999999999999999999   9999999999999999999999999999877654333 3


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ...+||+.|||||++....|+.|+||||||++.+||++|.+|+..-.+...                 .-++.+......
T Consensus       169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----------------lflIpk~~PP~L  231 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----------------LFLIPKSAPPRL  231 (467)
T ss_pred             ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----------------EEeccCCCCCcc
Confidence            667899999999999988999999999999999999999999875433211                 111111111222


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .......+.+++..|+.++|+.||++.+++++
T Consensus       232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            22334679999999999999999999999864

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-43  Score=349.11  Aligned_cols=264  Identities=27%  Similarity=0.426  Sum_probs=209.9

Q ss_pred             HHHHHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCC
Q 008893          219 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT  297 (549)
Q Consensus       219 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  297 (549)
                      .+++++..+.+.+...||+|.||+||+|.|..  .||||+++...... ..+.|++|+..+++-+|.||+-++|||..+.
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            35566666777889999999999999999863  59999998665433 3456999999999999999999999999887


Q ss_pred             ceeeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          298 ERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      . .||+.+|++-+|+.+++. ...++..+...||.|||+|+.|||.+   +|||||||..||++.++++|||+|||++..
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence            7 999999999999999984 34688999999999999999999999   999999999999999999999999999975


Q ss_pred             cCCCC-CceeeccccccCccCchhhccC---CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc
Q 008893          377 LDHCD-SHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK  452 (549)
Q Consensus       377 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (549)
                      -..-. ........|...|||||++...   +|++.+||||||+++|||+||..|+..... ++-  +  |  ..-+.  
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dqI--i--f--mVGrG--  608 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQI--I--F--MVGRG--  608 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hhe--E--E--Eeccc--
Confidence            43221 1122233478899999999754   689999999999999999999999973221 110  0  0  00000  


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       453 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                       ....|.   ......+..++.+|+..||..++++||.+.+|+..|+..
T Consensus       609 -~l~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l  653 (678)
T KOG0193|consen  609 -YLMPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL  653 (678)
T ss_pred             -ccCccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence             000111   011233457899999999999999999999999988873

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=343.06  Aligned_cols=250  Identities=22%  Similarity=0.304  Sum_probs=209.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEE-ECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ..|.....||+|..|.||.|. ..+++.||||++.... ....+-+.+|+.+++..+|+|||++++.|...++.|+||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            456777899999999999998 4568999999997654 33445688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      |++|+|.+.+.... +++.++..|+.++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+..... .+
T Consensus       352 m~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR  426 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR  426 (550)
T ss_pred             cCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence            99999999987654 99999999999999999999999   999999999999999999999999999988765443 45


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....||+.|||||+.....|.+|+||||||++++||+-|.+||-....       ..-++.+...+.      +.  -..
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyLIa~ng~------P~--lk~  491 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGT------PK--LKN  491 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHHHhhcCC------CC--cCC
Confidence            666799999999999999999999999999999999999999864221       111111111111      11  122


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +...+..+.+++.+||+.||++||++.|+++|
T Consensus       492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            34456789999999999999999999999974

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.8e-41  Score=334.81  Aligned_cols=263  Identities=17%  Similarity=0.243  Sum_probs=208.5

Q ss_pred             hcCCccccCHHHHHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhccCCCcc
Q 008893          210 CLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLL  287 (549)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv  287 (549)
                      +..+++.++.+++     +......||+|++|.||+|.+ +|+.||||.++.......  ...+.+|+.++.+++||||+
T Consensus         8 ~~~~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv   81 (283)
T PHA02988          8 YINDIKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNIL   81 (283)
T ss_pred             hcCcceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEE
Confidence            3445566666665     233346899999999999998 588999999976532221  34688999999999999999


Q ss_pred             ceEEEEec----CCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC
Q 008893          288 RLIGFCMT----TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY  363 (549)
Q Consensus       288 ~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  363 (549)
                      +++|++.+    ....++||||+++|+|.+++.....+++.....++.|++.||.|||+..  +++||||||+||+++++
T Consensus        82 ~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~  159 (283)
T PHA02988         82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN  159 (283)
T ss_pred             EEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC
Confidence            99999876    3467899999999999999988888999999999999999999999732  78899999999999999


Q ss_pred             CceEEeecccccccCCCCCceeeccccccCccCchhhcc--CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH
Q 008893          364 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML  441 (549)
Q Consensus       364 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~  441 (549)
                      +.+||+|||+++......    ....|+..|+|||++.+  ..++.++|||||||++|||+||+.||.....       .
T Consensus       160 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-------~  228 (283)
T PHA02988        160 YKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-------K  228 (283)
T ss_pred             CcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-------H
Confidence            999999999998654321    22358899999999976  6789999999999999999999999974321       1


Q ss_pred             HHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          442 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       442 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +.........         .....+...+..+.+++.+||+.||++|||++|+++.|+.
T Consensus       229 ~~~~~i~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        229 EIYDLIINKN---------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             HHHHHHHhcC---------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            1111111111         0111222345679999999999999999999999998875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=361.47  Aligned_cols=253  Identities=28%  Similarity=0.402  Sum_probs=216.0

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ...+.++||.|.||.||+|+++-    ...||||.++.........+|..|..++.++.||||+++.|+.......+||+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            34578999999999999999762    45899999999887777778999999999999999999999999999999999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||++|+|..+|+. .+.+++.+...+..+||.|+.||-+.   ++|||||.++|||++.+..+|++|||+++++++...
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            99999999999974 45799999999999999999999999   999999999999999999999999999998876553


Q ss_pred             ceeeccc--cccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          383 HVTTAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       383 ~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ...+...  -..+|.|||.+.-.++|.++||||||+++||.++ |..|+...       .-.+.++.+.+          
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-------SNQdVIkaIe~----------  849 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------SNQDVIKAIEQ----------  849 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc-------chHHHHHHHHh----------
Confidence            3333332  3468999999999999999999999999999887 77776522       22233333333          


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..+-..+..++..|.+|++.||++|-.+||.+.+|+..|..
T Consensus       850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk  890 (996)
T KOG0196|consen  850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK  890 (996)
T ss_pred             ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence            33334456677899999999999999999999999999986

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.8e-42  Score=320.64  Aligned_cols=267  Identities=22%  Similarity=0.281  Sum_probs=208.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc-HHHHHHHHHHHhhccCCCccceEEEEecC--Cceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  301 (549)
                      .++|+..+.|++|+||.||+|+.+ +++.||+|+++-+....+ .....+||.+|.+.+|||||.+-.+....  +..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            356778899999999999999965 689999999986543222 33568999999999999999999988754  57999


Q ss_pred             EeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      |||||+. +|..++..- .++...++..++.|+++|++|||..   .|+|||||++|+|+++.|.+||+|||+|+.+...
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999987 888888753 4799999999999999999999999   9999999999999999999999999999988765


Q ss_pred             CCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc-----hh
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK-----LE  454 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~  454 (549)
                      .. ..+..+.|..|+|||++.+. .|++.+||||+|||+.||+++++.|.+....++-..+...+..-....+     +.
T Consensus       231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence            33 34556689999999998875 5899999999999999999999998876555443333332221111110     00


Q ss_pred             --------hhccccccCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 --------MLVDKDLKNNYDRI-ELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 --------~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                              ......++..+... ..+.-++++...+..||.+|-|++|.+++
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                    00011111222222 34667899999999999999999999863

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.7e-41  Score=330.66  Aligned_cols=255  Identities=24%  Similarity=0.316  Sum_probs=205.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC----CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++..........+.+|+.++.+++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999863    3668999999865443444578999999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999875 35789999999999999999999999   9999999999999999999999999987654322


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .........++..|+|||.+.+..++.++|||||||++||+++ |+.||.....       .+.........        
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~~~--------  225 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAVEDGF--------  225 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCCC--------
Confidence            1111122335678999999999999999999999999999875 9999864221       11111111110        


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        ....+...+..+.+++.+||+.+|++||+++++.+.|..
T Consensus       226 --~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         226 --RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence              011122344678999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.6e-41  Score=336.09  Aligned_cols=268  Identities=19%  Similarity=0.221  Sum_probs=205.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|++.+.||+|+||.||+|..+ +++.||+|+++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999976 5889999999754322 234468899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |++++.+..+......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..........
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            999987776665556799999999999999999999998   99999999999999999999999999998765433323


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHH--------HHHHHhhccchhhh
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--------WVKKIHQEKKLEML  456 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  456 (549)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||...........+..        +.............
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            3345689999999999988899999999999999999999999975332111100100        00000000000000


Q ss_pred             cccccc------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          457 VDKDLK------NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       457 ~d~~l~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..+...      ..+....+..+.+++.+|++.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000      00111234679999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.6e-41  Score=346.84  Aligned_cols=256  Identities=26%  Similarity=0.377  Sum_probs=203.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE------CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  298 (549)
                      .++|++.+.||+|+||.||+|.+      .++..||||+++..........+.+|+.++..+ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788899999999999999973      235689999997554444455788999999999 89999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccC------------------------------------------------------------
Q 008893          299 RLLVYPYMSNGSVASRLKAK------------------------------------------------------------  318 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~------------------------------------------------------------  318 (549)
                      .++||||+++|+|.++++..                                                            
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            99999999999999888532                                                            


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          319 ---------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       319 ---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                                     ..+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           2478899999999999999999998   9999999999999999999999999999866432221


Q ss_pred             e-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          384 V-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       384 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      . .....++..|+|||.+.+..++.++|||||||++|||+| |..||......   ..+..++.   ...          
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~~---~~~----------  334 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMIK---EGY----------  334 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHHH---hCc----------
Confidence            1 122335668999999999999999999999999999998 88887532211   11111111   110          


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....+...+.++.+++.+||+.||++||++.||++.|+.
T Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            000111223678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4e-41  Score=336.19  Aligned_cols=261  Identities=22%  Similarity=0.344  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC-----------------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD-----------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL  289 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  289 (549)
                      ++|.+.+.||+|+||.||++.+++                 +..||+|.+...........+.+|+.++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            468888999999999999998532                 347999998765433344579999999999999999999


Q ss_pred             EEEEecCCceeeEeeccCCCchhhhhccC-------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEe
Q 008893          290 IGFCMTTTERLLVYPYMSNGSVASRLKAK-------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIH  350 (549)
Q Consensus       290 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  350 (549)
                      ++++...+..++||||+++|+|.+++...                   ..+++..+.+++.||+.||.|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            99999999999999999999999987532                   2468889999999999999999999   9999


Q ss_pred             cccCcCeeeecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhC--Ccc
Q 008893          351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG--LRA  427 (549)
Q Consensus       351 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg--~~p  427 (549)
                      |||||+|||+++++.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999865433221 12223457889999999988999999999999999999975  445


Q ss_pred             cccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          428 LEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      |.....    ......+...........      ....+..++..+.+++.+||+.+|++|||+.||.+.|++
T Consensus       242 ~~~~~~----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTD----EQVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCH----HHHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            542211    112222221111110000      001112234678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.5e-41  Score=345.54  Aligned_cols=256  Identities=26%  Similarity=0.384  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  298 (549)
                      .++|++.+.||+|+||.||+|...      ++..||+|+++..........+.+|+++++.+ +|+||+++++++...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457889999999999999999842      24589999997654444445688999999999 89999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccC------------------------------------------------------------
Q 008893          299 RLLVYPYMSNGSVASRLKAK------------------------------------------------------------  318 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~------------------------------------------------------------  318 (549)
                      .++||||+++|+|.++++..                                                            
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            99999999999999887421                                                            


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc-eeec
Q 008893          319 ----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTA  387 (549)
Q Consensus       319 ----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~  387 (549)
                                .++++..+.+++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++........ ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      2478889999999999999999998   9999999999999999999999999999865432221 1122


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCC
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD  466 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  466 (549)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||.......   .+.   ... ...         .....+
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~---~~~-~~~---------~~~~~~  337 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFY---KMV-KRG---------YQMSRP  337 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHH---HHH-Hcc---------cCccCC
Confidence            335678999999998899999999999999999998 999986422111   011   111 000         000111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          467 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       467 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...+.++.+++.+||+.||++||++.++++.|+.
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1123678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.7e-41  Score=330.87  Aligned_cols=250  Identities=25%  Similarity=0.341  Sum_probs=200.2

Q ss_pred             CCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          229 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      |...+.||+|+||.||+|.. .+|+.||+|.+.....  ......+.+|+.++..++|+|++++++++...+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66788999999999999996 4699999999864332  22234578899999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++|+|.+.+..  ...+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            999999887753  34689999999999999999999999   99999999999999999999999999998754322  


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||..........   ...... ..          ...
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~-~~----------~~~  222 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRV-KE----------DQE  222 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHh-hc----------ccc
Confidence            2233468999999999999999999999999999999999999997543211110   000000 00          001


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  497 (549)
                      .++...+..+.+++.+||+.||++||+     +++++++
T Consensus       223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            122223467899999999999999997     6777753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=335.62  Aligned_cols=246  Identities=23%  Similarity=0.237  Sum_probs=203.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999976 689999999864321  123446889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++.....++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.....   
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---  154 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---  154 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence            9999999999998888899999999999999999999999   9999999999999999999999999999865432   


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                       .....||+.|+|||.+.+..++.++|||||||++|||+||+.||......       ..........           .
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~-----------~  215 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-------GIYEKILAGK-----------L  215 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC-----------c
Confidence             12345899999999999988999999999999999999999999643211       1111111110           0


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  497 (549)
                      .++......+.+++.+|++.||.+||+     ++|++++
T Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            112222467899999999999999995     7777754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-41  Score=341.80  Aligned_cols=251  Identities=22%  Similarity=0.284  Sum_probs=211.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .-|+.++.||+|+.|.|-.|++. +|+.+|||++.+..  .......+.+|+.+|+.+.|||++++++++.+..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45778899999999999999964 79999999997652  2222346889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|.|.+++..++++++.+..+++.||+.|+.|+|..   +|+||||||+|+|+|..+++||+|||+|....  .+.
T Consensus        92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gk  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGK  166 (786)
T ss_pred             EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--CCc
Confidence            9999999999999999999999999999999999999999   99999999999999999999999999998654  234


Q ss_pred             eeeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      .-.+.||++.|.|||++.+.+| ..++||||.|||||.|+||+.||+...       +...+..+.+ +..         
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~-G~f---------  229 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQR-GVF---------  229 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHc-Ccc---------
Confidence            4566789999999999999998 578999999999999999999997321       2222222211 111         


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       +.+...+.+..+|+.+|+..||++|.|++||++|--=
T Consensus       230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l  266 (786)
T KOG0588|consen  230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL  266 (786)
T ss_pred             -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence             1223345778999999999999999999999986543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.9e-41  Score=338.86  Aligned_cols=264  Identities=21%  Similarity=0.281  Sum_probs=207.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||++... +|..||+|.+...........+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367899999999999999999976 5889999998765433334579999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+++|+|.+++.....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||++......   .
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~  158 (331)
T cd06649          84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M  158 (331)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---c
Confidence            9999999999988778999999999999999999999851  5999999999999999999999999998765432   1


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh---c-----------
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ---E-----------  450 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~-----------  450 (549)
                      .....||..|+|||++.+..++.++|||||||++|||+||+.||.......    +.........   .           
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhcccccccccCCccccCcccc
Confidence            233458999999999999999999999999999999999999996432110    0000000000   0           


Q ss_pred             --------------------cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          451 --------------------KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       451 --------------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                                          .....+...............++.+++.+||+.||++|||++|++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                000000000000000112346799999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-41  Score=340.36  Aligned_cols=254  Identities=20%  Similarity=0.271  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||+|... +++.||+|+++....  ......+..|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 589999999975421  223446888999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....    
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence            9999999999998877899999999999999999999999   999999999999999999999999999976543    


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..|       .   .........
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------~---~~~~~~~~~  223 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-------K---ETLQRPVYD  223 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-------c---ccccCCCCC
Confidence            223446899999999999999999999999999999999999999743321111111111       0   000000000


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ......+.++.+++.+|+..+|++||++++++++
T Consensus       224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0011234678899999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=364.73  Aligned_cols=256  Identities=30%  Similarity=0.444  Sum_probs=211.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC--CC----EEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD--GT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~--g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  299 (549)
                      ..+.+..+.||+|.||.||.|...+  |.    .||||.++.........+|.+|..+++.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4456677899999999999999653  43    49999999887777778899999999999999999999999999999


Q ss_pred             eeEeeccCCCchhhhhccC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecc
Q 008893          300 LLVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG  372 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  372 (549)
                      ++++|||++|+|..+|++.       ..++-.+.+.++.|||+|+.||+++   ++|||||..+|+|++....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999854       3688999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecc-ccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhc
Q 008893          373 LAKLLDHCDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQE  450 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (549)
                      +|+.+...+....... .-...|||||.+..+.++.|+|||||||++||++| |..|+.....       .+.+..+...
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------~~v~~~~~~g  920 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------FEVLLDVLEG  920 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-------HHHHHHHHhC
Confidence            9995433322222211 23368999999999999999999999999999999 7777753221       1111112222


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       451 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      +          +-..++.+++.+.+++..||+.+|++||++..+++.+...
T Consensus       921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            2          2234566778999999999999999999999999977653

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-42  Score=304.75  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=210.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      -++|++.+.||+|.||.||.|+.+ ++-.||+|++.+...  .....++.+|+++-+.++||||+++++++.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            357899999999999999999965 578999999975432  22345789999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          303 YPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       303 ~e~~~~g~L~~~l~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +||...|+++..|+  ....+++.....++.|+|.||.|+|.+   +|+||||||+|+|++.++..||+|||.+..-+  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999998  556799999999999999999999999   99999999999999999999999999986543  


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                       .......+||..|.|||+..+...+..+|+|++|++.||++.|.+||......+.    ..   .+.         .- 
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et----Yk---rI~---------k~-  237 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET----YK---RIR---------KV-  237 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH----HH---HHH---------Hc-
Confidence             3456678899999999999999999999999999999999999999974331111    11   111         01 


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       .-.++...+....++|.+|+..+|.+|.+..|++.+
T Consensus       238 -~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  238 -DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence             112233445778999999999999999999999874

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-41  Score=340.03  Aligned_cols=283  Identities=23%  Similarity=0.313  Sum_probs=222.9

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhc-cCCCccceEEEEecCCce
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  299 (549)
                      ..-++|...++||+|.||+|+.+..+ +++.+|||+++++...  +..+..+.|..++... +||.+++++..+...++.
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34568999999999999999999976 5889999999987543  3345677888888776 599999999999999999


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+.||++..+ .....+++..+..++..|+.||+|||++   +|||||||.+|||+|.+|.+||+|||+++..-.
T Consensus       445 ~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence            999999999994433 3445799999999999999999999999   999999999999999999999999999986432


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                       .+..+.+.+||+.|||||++.+..|+..+|.|||||+||||++|..||.+.+.++.                    +|.
T Consensus       521 -~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~--------------------Fds  579 (694)
T KOG0694|consen  521 -QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV--------------------FDS  579 (694)
T ss_pred             -CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH--------------------HHH
Confidence             33467788999999999999999999999999999999999999999985443221                    111


Q ss_pred             ccc--CCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHHhcCCCcchhhhhhHHHhhhcccccccCCCCCCCC
Q 008893          460 DLK--NNYDRIELEEMVQVALLCTQYLPSLRPKM-----SEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYSDL  532 (549)
Q Consensus       460 ~l~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (549)
                      .+.  ..||...+.+...++.+++.++|++|..+     .+|..+---.  .-+|......+...+-...+.+.+.++++
T Consensus       580 I~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr--~i~w~~L~~r~i~PPf~P~i~~~~D~snF  657 (694)
T KOG0694|consen  580 IVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR--SIDWDDLLNRRIKPPFVPTIKGPEDVSNF  657 (694)
T ss_pred             HhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc--cCCHHHHhhccCCCCCCcccCChhhhccc
Confidence            111  23566667889999999999999999977     3333321111  12466665555544433444444545544


Q ss_pred             C
Q 008893          533 T  533 (549)
Q Consensus       533 ~  533 (549)
                      .
T Consensus       658 d  658 (694)
T KOG0694|consen  658 D  658 (694)
T ss_pred             c
Confidence            4

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-40  Score=328.72  Aligned_cols=254  Identities=27%  Similarity=0.442  Sum_probs=205.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|++.+.||+|+||.||+|....      ...||+|.++..........+.+|+..+..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999998643      25799999875543334456899999999999999999999999989999


Q ss_pred             eEeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC
Q 008893          301 LVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY  364 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  364 (549)
                      ++|||+++++|.+++...                ..+++..+..++.|++.||.|||+.   +++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999988643                4588899999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCC-ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHH
Q 008893          365 EAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLD  442 (549)
Q Consensus       365 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~  442 (549)
                      .+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||+| |..||......    .+..
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----~~~~  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----EVIE  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH
Confidence            999999999976533221 12223346788999999998899999999999999999998 99998643211    1111


Q ss_pred             HHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          443 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       443 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         .+..          ......+...+.++.+++.+||+.+|++||++.||+++|+.
T Consensus       238 ---~i~~----------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 ---MIRS----------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHc----------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence               1111          11111233445789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.6e-41  Score=339.25  Aligned_cols=246  Identities=22%  Similarity=0.275  Sum_probs=202.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||+|... +++.||+|+++...  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999976 58999999987532  1223446889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+.+.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999998664321  


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                        ....||+.|+|||.+.+..++.++|||||||++|||+||+.||.....       ......... ..        +  
T Consensus       173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~-~~--------~--  232 (329)
T PTZ00263        173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILA-GR--------L--  232 (329)
T ss_pred             --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhc-CC--------c--
Confidence              234689999999999999999999999999999999999999964221       111111111 10        0  


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  497 (549)
                      .++......+.+++.+||+.||++||+     +++++.+
T Consensus       233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            111122356889999999999999997     5666654

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.6e-41  Score=331.43  Aligned_cols=266  Identities=20%  Similarity=0.282  Sum_probs=200.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|...+.||+|+||+||+|..+ +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999975 68999999997554334445678999999999999999999999998899999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++ +|.+++.. ...+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++....... .
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~  159 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T  159 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence            975 88888864 34579999999999999999999999   999999999999999999999999999976543222 1


Q ss_pred             eeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHH--------HHhhccchhh
Q 008893          385 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK--------KIHQEKKLEM  455 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~  455 (549)
                      .....+++.|+|||.+.+ ..++.++||||+||++|||+||+.||...........+.....        ..........
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            233458899999999865 5689999999999999999999999975332211100100000        0000000000


Q ss_pred             hccccccCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 LVDKDLKNN----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ~~d~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+.....    .......+..+++.+|++.||.+|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000000    001123567899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.8e-41  Score=337.24  Aligned_cols=243  Identities=23%  Similarity=0.251  Sum_probs=198.7

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      +.||+|+||.||++... +|+.||+|+++....  ......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 689999999975421  222346788999999999999999999999999999999999999


Q ss_pred             chhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccc
Q 008893          310 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR  389 (549)
Q Consensus       310 ~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  389 (549)
                      +|.+.+.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... ........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~  156 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFC  156 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCccccee
Confidence            9999998878899999999999999999999999   9999999999999999999999999998753221 12223456


Q ss_pred             cccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHH
Q 008893          390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE  469 (549)
Q Consensus       390 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  469 (549)
                      ||+.|+|||.+.+..++.++|||||||++|||+||+.||......    .+.   ......       +    ..++...
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~---~~~~~~-------~----~~~p~~~  218 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLF---ELILME-------E----IRFPRTL  218 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----HHH---HHHHcC-------C----CCCCCCC
Confidence            999999999999999999999999999999999999999642211    111   111100       0    1122233


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          470 LEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       470 ~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                      ..++.+++.+||+.||++||     ++.+++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            46789999999999999999     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-41  Score=328.67  Aligned_cols=248  Identities=29%  Similarity=0.486  Sum_probs=195.0

Q ss_pred             CCCeeeeeCCeEEEEEEEC-----CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          231 SKNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       231 ~~~~iG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ..+.||.|.||.||+|.+.     .+..|+||.++..........|.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999976     25789999997644333456899999999999999999999999988889999999


Q ss_pred             cCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++|+|.+++...  ..+++..+..|+.||+.||.|||+.   +++|+||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999999865  6899999999999999999999999   9999999999999999999999999999876322221


Q ss_pred             -eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          384 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       384 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                       ..........|+|||.+....++.++||||||+++|||+| |+.|+....       ..++...+......        
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------~~~~~~~~~~~~~~--------  224 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------NEEIIEKLKQGQRL--------  224 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------HHHHHHHHHTTEET--------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccccccc--------
Confidence             2233447788999999999999999999999999999999 678875321       12222222222111        


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                        ..+...+..+.+++..||+.+|++||++.++++.|
T Consensus       225 --~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 --PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              11122346789999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.9e-40  Score=335.54  Aligned_cols=253  Identities=23%  Similarity=0.293  Sum_probs=201.2

Q ss_pred             CCCCCCeeeeeCCeEEEEEEE----CCCCEEEEEEcccCC---CCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCce
Q 008893          228 NFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGN---AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  299 (549)
                      +|++.+.||+|+||.||++..    .+++.||+|++....   .......+..|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999885    358899999986432   112234578899999999 599999999999999999


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            99999999999999998777899999999999999999999999   999999999999999999999999999986544


Q ss_pred             CCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ..........||..|+|||.+.+. .++.++|||||||++|||+||+.||.........   .........       .+
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~-------~~  227 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILK-------CD  227 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhc-------CC
Confidence            333333445699999999999765 4788999999999999999999999643222111   111111111       01


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                      +.    ++......+.+++.+|++.||++||     ++++++++
T Consensus       228 ~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         228 PP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            11    1222346788999999999999999     66676654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=324.45  Aligned_cols=268  Identities=29%  Similarity=0.402  Sum_probs=200.8

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhh--ccCCCccceEEEEecCC----ceee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCMTTT----ERLL  301 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~l  301 (549)
                      .....++||+|.||.||||.+. ++.||||++...    ..+.|..|-++.+.  ++|+||++++++-....    +++|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            3445678999999999999997 589999999743    34568888888764  58999999999876655    8999


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc------CCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      |++|.+.|+|.++|... .++|....+|+..+++||+|||+.      ..|+|+|||||++||||..|+++.|+|||+|.
T Consensus       286 Vt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             EeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999999999876 599999999999999999999976      35789999999999999999999999999998


Q ss_pred             ccCCCCCc-eeeccccccCccCchhhccCC-CC-----CcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          376 LLDHCDSH-VTTAVRGTVGHIAPEYLSTGQ-SS-----EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       376 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      .+...... .....+||.+|||||++.+.. +.     .+.||||+|.|||||++....+..+...+....+..-+..-.
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            87644332 233467999999999997653 22     367999999999999998766643222221111111111000


Q ss_pred             hccch-hhhccccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          449 QEKKL-EMLVDKDLKNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       449 ~~~~~-~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      .-+.+ ..++.+..+..++     ...+..+.+.+..||..||+.|.|+.=|.+++...
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            00001 1111122222111     12356789999999999999999999998887763

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=342.21  Aligned_cols=260  Identities=30%  Similarity=0.396  Sum_probs=208.1

Q ss_pred             HHHHhcCCCCCCeeeeeCCeEEEEEEECC--C--CE-EEEEEcccC--CCCCcHHHHHHHHHHHhhccCCCccceEEEEe
Q 008893          222 LQSATSNFSSKNLVGKGGFGNVYKGYLQD--G--TV-VAVKRLKDG--NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM  294 (549)
Q Consensus       222 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--g--~~-vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  294 (549)
                      ++...++....+.||+|+||.||+|.++.  +  .. ||||..+..  .......+|.+|.+++++++|||||+++|++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33445566677999999999999999653  2  23 899998852  23344557999999999999999999999999


Q ss_pred             cCCceeeEeeccCCCchhhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccc
Q 008893          295 TTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL  373 (549)
Q Consensus       295 ~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  373 (549)
                      .....++|||+|.||+|.++|+..+ .++..++..++.+.|.||+|||++   +++||||.++|+|++.++.+||+|||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence            9999999999999999999998766 599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccc
Q 008893          374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKK  452 (549)
Q Consensus       374 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (549)
                      ++....... ......-...|+|||.+..+.+++++|||||||++||+++ |..|+.+....    ....+   +...  
T Consensus       309 s~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~k---I~~~--  378 (474)
T KOG0194|consen  309 SRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAK---IVKN--  378 (474)
T ss_pred             ccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHH---HHhc--
Confidence            875431111 1111134578999999999999999999999999999999 78887643321    11111   1111  


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       453 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                             ..+-..+...+..+..++..||..+|++||+|.++.+.++..
T Consensus       379 -------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~  420 (474)
T KOG0194|consen  379 -------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL  420 (474)
T ss_pred             -------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence                   111222334457788999999999999999999999988863

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.9e-40  Score=321.41  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=203.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      ++|+..+.||+|+||.||+|.++++..+|+|.+....  .....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            4577889999999999999999888899999886443  23457889999999999999999999999999999999999


Q ss_pred             CCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      ++|+|.++++. ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||.++..........
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence            99999999874 34689999999999999999999999   999999999999999999999999999986543222222


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+...........          .
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~~----------~  221 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGFRL----------Y  221 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCCC----------C
Confidence            22335668999999988889999999999999999999 8888864221       1111222111110          0


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                      .+...+..+.+++.+||+.+|++||++.++++.|
T Consensus       222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            1112235789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-40  Score=322.05  Aligned_cols=254  Identities=28%  Similarity=0.389  Sum_probs=206.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ..++|++.+.||+|++|.||+|...+++.||+|.++...  .....+.+|+.++++++|||++++++++...+..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            345688899999999999999998878899999987543  234578899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999987543  689999999999999999999999   999999999999999999999999999987653222


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      ........+..|+|||++.+..++.++||||||+++|||+| |+.||......    ...   .......          
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~---~~~~~~~----------  221 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVL---QQVDQGY----------  221 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHH---HHHHcCC----------
Confidence            21222223457999999998899999999999999999999 88888632211    111   1111110          


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....+...+..+.+++.+|++.+|++||++.++++.|++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            011122234779999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-41  Score=321.62  Aligned_cols=247  Identities=20%  Similarity=0.360  Sum_probs=210.4

Q ss_pred             CCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcH--HHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      +|++.+.||+|.||.|-+|+. ..|+.||||.++++...+..  ..+.+|+++++.++||||+.++++|.+.+..++|||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            567778999999999999995 67999999999876543332  358999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |..+|.|++++...+.+++.....++.||..|+.|+|.+   +++|||||.+|||+|+++++||+|||++..+..  ...
T Consensus       134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~kf  208 (668)
T KOG0611|consen  134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KKF  208 (668)
T ss_pred             ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc--ccH
Confidence            999999999999999999999999999999999999999   999999999999999999999999999988763  334


Q ss_pred             eeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ..+++|++-|.+||+..+.+| .+.+|-|||||+||.|+.|.-||++.+-       -..++++... ...         
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~G-aYr---------  271 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISRG-AYR---------  271 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhcc-ccc---------
Confidence            567889999999999999998 5899999999999999999999985321       1122222211 111         


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                        .+..+....-||.+|+..+|++|-|+.+|..+-
T Consensus       272 --EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  272 --EPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             --CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence              122235577899999999999999999998754

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-40  Score=330.34  Aligned_cols=247  Identities=22%  Similarity=0.252  Sum_probs=199.0

Q ss_pred             eeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCch
Q 008893          235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV  311 (549)
Q Consensus       235 iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  311 (549)
                      ||+|+||.||+|... +++.||+|+++...  .......+..|+.++..++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999976 58899999986432  122334678899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccc
Q 008893          312 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT  391 (549)
Q Consensus       312 ~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt  391 (549)
                      .+++.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++...... .......||
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt  156 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT  156 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence            99998777899999999999999999999999   99999999999999999999999999997543222 223345699


Q ss_pred             cCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHH
Q 008893          392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE  471 (549)
Q Consensus       392 ~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  471 (549)
                      +.|+|||.+.+..++.++|||||||++|||+||+.||.....       ..........         .  ..++.....
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~~~---------~--~~~~~~~~~  218 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKILQE---------P--LRFPDGFDR  218 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcC---------C--CCCCCcCCH
Confidence            999999999999999999999999999999999999964221       1111111111         0  011222346


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 008893          472 EMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL  503 (549)
Q Consensus       472 ~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  503 (549)
                      .+.+++.+||+.||++||++..+.+.|+...+
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~  250 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF  250 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCc
Confidence            78899999999999999876555555544433

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-41  Score=320.71  Aligned_cols=259  Identities=23%  Similarity=0.325  Sum_probs=200.3

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC-----ceee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----ERLL  301 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  301 (549)
                      .|...+++|.|+||.||+|... +++.||||+...+....     .+|.++|+.+.|||||++.-++....     ...+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            4566789999999999999965 57999999987654322     36889999999999999998886432     2358


Q ss_pred             EeeccCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC-CceEEeecccccc
Q 008893          302 VYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKL  376 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~  376 (549)
                      |||||+. +|.+.++.    +..++...+.-+..||.+||.|||+.   +|+||||||+|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999987 89888873    56788999999999999999999998   99999999999999955 9999999999998


Q ss_pred             cCCCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc-----
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE-----  450 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  450 (549)
                      +..+...  .....|..|+|||++.+. .|+.+.||||.|||+.||+-|+..|.+....++-..+...++.-.++     
T Consensus       176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            8755443  344578899999998775 69999999999999999999999998654444433333322211110     


Q ss_pred             -cchhhhcccccc-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          451 -KKLEMLVDKDLK-----NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       451 -~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       ....+.-.+.+.     .-+......++.+++.++++.+|.+|.++.|++.+
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence             000111112221     11233445789999999999999999999999864

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-41  Score=324.36  Aligned_cols=257  Identities=23%  Similarity=0.298  Sum_probs=204.2

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-------------CCCcHHHHHHHHHHHhhccCCCccceE
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-------------AIGGEIQFQTEVEMISLAVHRNLLRLI  290 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~niv~l~  290 (549)
                      .-+.|++.+.||+|.||.|-+|+.. +++.||||++.+..             .....+...+|+.++++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            4468999999999999999999965 69999999996432             112234789999999999999999999


Q ss_pred             EEEecC--CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEE
Q 008893          291 GFCMTT--TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV  368 (549)
Q Consensus       291 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  368 (549)
                      ++..+.  +..|||+|||..|.+...=.....+++.++++|+.+++.||+|||.+   +|+||||||+|+|++++|++||
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEe
Confidence            998764  57899999999888765444444499999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCCc----eeeccccccCccCchhhccCC----CCCcccchhHhHHHHHHHhCCcccccCccccccccH
Q 008893          369 GDFGLAKLLDHCDSH----VTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM  440 (549)
Q Consensus       369 ~Dfg~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~  440 (549)
                      +|||.+.........    ......||+.|+|||...++.    .+.+.||||+||+||-|+.|+.||.....       
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-------  324 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-------  324 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-------
Confidence            999999866332111    123357999999999987743    35678999999999999999999974322       


Q ss_pred             HHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       441 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....         +.++...+.-.-.++..+.+.+||+++|.+||++|.+..+|..|..-
T Consensus       325 ~~l~---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  325 LELF---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             HHHH---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence            1111         12222333222233456889999999999999999999999877654

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-41  Score=301.86  Aligned_cols=259  Identities=26%  Similarity=0.319  Sum_probs=207.7

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEE-ECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC-----Cc
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TE  298 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  298 (549)
                      ..++|.+.+.+|+|||+-||.+. ..+++.+|+|++.... ..+.+..++|++..++++|||++++++++..+     .+
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            45678999999999999999998 5678999999998766 45566789999999999999999999887543     45


Q ss_pred             eeeEeeccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccc
Q 008893          299 RLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA  374 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  374 (549)
                      .|++++|...|+|.+.+.    ++..+++.+.+.|+.+|++||.+||+. .|+++||||||.|||+.+++.+++.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            899999999999999886    445799999999999999999999997 446999999999999999999999999998


Q ss_pred             cccCCCCCc--------eeeccccccCccCchhhcc---CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHH
Q 008893          375 KLLDHCDSH--------VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW  443 (549)
Q Consensus       375 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~  443 (549)
                      ....-.-..        .......|..|+|||++.-   ...++++|||||||++|+|+.|..||+....  .       
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--~-------  247 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--Q-------  247 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--c-------
Confidence            755321111        1123347899999999853   4578999999999999999999999974322  1       


Q ss_pred             HHHHhhccchhhhc-cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          444 VKKIHQEKKLEMLV-DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       444 ~~~~~~~~~~~~~~-d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                            .+.+.-.+ ...+.-.-....++.+.+++.+|++.||.+||++.+++.++++
T Consensus       248 ------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  248 ------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             ------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                  11111111 1112111122356889999999999999999999999998875

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4e-40  Score=321.34  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .++|++.+.||+|+||.||+|...++..||+|.+....  .....+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            35788899999999999999998888899999986533  2345789999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++++|.+++..  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999999864  34689999999999999999999998   9999999999999999999999999999876543222


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......++..|+|||++....++.++||||||+++|+|+| |+.||......    ....   ......      ...  
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~---~~~~~~------~~~--  224 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMS---ALQRGY------RMP--  224 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHH---HHHcCC------CCC--
Confidence            2223346678999999998889999999999999999999 88888632211    1111   111110      000  


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        .....+..+.+++.+|++.+|++||+++++.+.|++
T Consensus       225 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 --RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             --CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              111223678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=319.26  Aligned_cols=267  Identities=21%  Similarity=0.309  Sum_probs=206.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccC-CCCCcHHHHHHHHHHHhhccCCCccceEEEEec-----CC
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-----TT  297 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~  297 (549)
                      ....|...+.||+|+||.|+.+..+ +|+.||||++... ......++-.+|+++|+.++|+||+.+.+.+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3445666789999999999999965 6999999998732 223334567899999999999999999998865     35


Q ss_pred             ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      ..|+|+|+| ..+|...++.+..++......+++|+++||.|+|+.   +|+||||||+|+|++.+..+||+|||+|+..
T Consensus       100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeec
Confidence            689999999 559999999988899999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCC-CceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          378 DHCD-SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       378 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      .... ....+....|..|.|||++.+ ..|+..+||||.|||+.||++|+..|.+.+...+-..+...+... .+..+..
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e~l~~  254 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEEDLQK  254 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHHHHHH
Confidence            5431 112245568999999998754 579999999999999999999999998765544332222221110 0000100


Q ss_pred             --------hcc-------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 --------LVD-------KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 --------~~d-------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                              .+.       ..+..-+ +......++|+.+|+..||.+|+|++|++++
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                    100       0000011 1234678999999999999999999999864

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.1e-40  Score=326.19  Aligned_cols=263  Identities=22%  Similarity=0.315  Sum_probs=198.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||+|... +++.||+|+++..........+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367999999999999999999976 6899999999765443444567889999999999999999999999999999999


Q ss_pred             ccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      |+. ++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++...... .
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  158 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H  158 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence            996 577777654 45689999999999999999999999   99999999999999999999999999987543222 1


Q ss_pred             eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc---------ch
Q 008893          384 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK---------KL  453 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~  453 (549)
                      ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||........   ....+.......         ..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD---QLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhCCCChhhccchhhc
Confidence            2233458899999999865 4578899999999999999999999974321110   001010000000         00


Q ss_pred             hhhccccccCCCC---H------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          454 EMLVDKDLKNNYD---R------IELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       454 ~~~~d~~l~~~~~---~------~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ............+   .      .....+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000000000000   0      01246789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.8e-40  Score=331.90  Aligned_cols=254  Identities=22%  Similarity=0.382  Sum_probs=202.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCC----EEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      .+|+..+.||+|+||.||+|.+. +++    .||+|.++..........+.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46889999999999999999864 333    48999987544334455788999999999999999999998764 5789


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ++||+++|+|.+++.. ...+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence            9999999999999975 34689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcee-eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          381 DSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       381 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ..... ....++..|+|||++.+..++.++||||||+++|||+| |+.||.....       ..+.......        
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-------~~~~~~~~~~--------  227 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------SEISSILEKG--------  227 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHhCC--------
Confidence            32211 22234678999999999999999999999999999998 9999863211       1111111111        


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                        .....+..+..++.+++.+||+.+|++||++.+++..+...
T Consensus       228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              00111122346788999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-40  Score=320.34  Aligned_cols=254  Identities=27%  Similarity=0.412  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|++.+.||+|+||+||+|.+..    ...||+|.++..........|..|+..++.++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578899999999999999999752    4589999987655444455788999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||+++......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            999999999999865 34689999999999999999999998   99999999999999999999999999998775222


Q ss_pred             Cc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          382 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       382 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |..||......    ....   .......       
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~---~~~~~~~-------  226 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIK---AVEDGYR-------  226 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHH---HHHcCCC-------
Confidence            22 2222335678999999998899999999999999999998 98888532111    1111   1111100       


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         ...+...+..+.+++.+|++.+|++||++.|++++|+.
T Consensus       227 ---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         227 ---LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence               01112234678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-40  Score=336.28  Aligned_cols=246  Identities=21%  Similarity=0.222  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC--CCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD--GTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|++.+.||+|+||.||+|..+.  +..||+|.+....  .......+..|+.++..++||||+++++++...+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468889999999999999998643  3689999986432  122344688899999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||+++|+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....  
T Consensus       110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            99999999999998878899999999999999999999999   9999999999999999999999999999865432  


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                        .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......       ........         .  
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~---------~--  244 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEG---------I--  244 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcC---------C--
Confidence              223469999999999999889999999999999999999999997432110       01111110         0  


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                      ..++......+.+++.+|++.||++|+     ++++++++
T Consensus       245 ~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            011222235688999999999999995     78888764

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.8e-40  Score=319.41  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=203.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      ++|...+.||+|+||+||+|.+.++..+|+|.+....  .....+.+|+.++.+++||||+++++++......+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            3577889999999999999998877789999987543  23457899999999999999999999999888999999999


Q ss_pred             CCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      .+|+|.+++.. ...+++..++.++.||+.||.|||+.   +++|+||||+||++++++.+||+|||.++..........
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            99999999875 34689999999999999999999999   999999999999999999999999999986543322222


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      ....++..|+|||.+.+..++.++||||||+++|||+| |+.||......       ...........          ..
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~----------~~  221 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------ETVEKVSQGLR----------LY  221 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHhcCCC----------CC
Confidence            22345678999999998889999999999999999999 98888632211       11111111110          01


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      .+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11122467899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-40  Score=337.39  Aligned_cols=260  Identities=20%  Similarity=0.242  Sum_probs=200.5

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ..+|++.+.||+|+||.||++... +++.||+|....       ..+.+|+++++.++||||+++++++......++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            357999999999999999999965 688999997532       246789999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      ++. ++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       164 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        164 RYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            995 68888887777899999999999999999999999   99999999999999999999999999997543322223


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccc----cHHHHHHHHhh---c------c
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG----AMLDWVKKIHQ---E------K  451 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~---~------~  451 (549)
                      .....||+.|+|||++.+..++.++|||||||++|||+||+.|+..........    .+...+.....   +      .
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            344569999999999999999999999999999999999998876433211110    01100000000   0      0


Q ss_pred             chhhhc---------cccccCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          452 KLEMLV---------DKDLKNNY--DRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       452 ~~~~~~---------d~~l~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .+....         .+......  ....+.++.+++.+||+.||++|||++|+++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000         00000000  0123457899999999999999999999985

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-39  Score=329.53  Aligned_cols=200  Identities=25%  Similarity=0.348  Sum_probs=177.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||++... ++..+|+|.+...........+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999976 5889999988765433334578999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+++|+|.+++.....+++.....++.|++.||.|||+..  +|+||||||+|||+++++.+||+|||++......   .
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~  158 (333)
T cd06650          84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M  158 (333)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---c
Confidence            9999999999987778999999999999999999999741  6999999999999999999999999999765322   1


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCccccc
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF  430 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  430 (549)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            2234589999999999988899999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=339.80  Aligned_cols=254  Identities=23%  Similarity=0.284  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||+||+|... +|+.||+|+++....  ......+..|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999976 689999999975421  233456889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC--
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD--  381 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  381 (549)
                      ||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.......  
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            9999999999998777899999999999999999999998   99999999999999999999999999998665432  


Q ss_pred             --------------------------CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccc
Q 008893          382 --------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN  435 (549)
Q Consensus       382 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~  435 (549)
                                                ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                      012233458999999999999999999999999999999999999997533211


Q ss_pred             ccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHH
Q 008893          436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK-MSEVVRML  498 (549)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L  498 (549)
                      .       ...+....       ..+........+..+.+++.+|++ +|.+||+ ++|++++-
T Consensus       238 ~-------~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         238 T-------YNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             H-------HHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            1       11111100       000000001134678899999998 9999999 99999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.8e-40  Score=319.42  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=204.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .+|...+.||+|+||.||+|..+ .++.||+|.+....  .....+.+|+++++.++|+|++++++++...+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            45778899999999999999975 58899999987432  2345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++++|.+++..  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999999864  34689999999999999999999998   9999999999999999999999999999876543222


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......++..|+|||.+.+..++.++||||||+++|||+| |..||.....       .+........          ..
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~----------~~  223 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKG----------YR  223 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCC----------CC
Confidence            2222234668999999998999999999999999999998 8888864221       1111111111          11


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            11222234679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.7e-40  Score=323.19  Aligned_cols=253  Identities=25%  Similarity=0.423  Sum_probs=204.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|.+.+.||+|+||.||+|...+      ++.||+|.++..........+.+|+++++.++|+|++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457788999999999999998643      47899999976554334567999999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCce
Q 008893          301 LVYPYMSNGSVASRLKAK--------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA  366 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  366 (549)
                      ++|||+++++|.+++...              ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            999999999999998643              3478999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHH
Q 008893          367 VVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWV  444 (549)
Q Consensus       367 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  444 (549)
                      ||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......    ..... 
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~~~~~-  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIEC-  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH-
Confidence            99999999765322211 1123345788999999999999999999999999999999 99998643221    11111 


Q ss_pred             HHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       445 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                        .. ....         ...+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus       237 --~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 --IT-QGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --HH-cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence              11 1110         1111223467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.1e-40  Score=324.28  Aligned_cols=257  Identities=23%  Similarity=0.392  Sum_probs=203.4

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT  297 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  297 (549)
                      .++++|+..+.||+|+||.||+|...      .+..||+|.+...........+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999999753      256799999865443333456889999999999999999999999999


Q ss_pred             ceeeEeeccCCCchhhhhccC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceE
Q 008893          298 ERLLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV  367 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  367 (549)
                      ..++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence            999999999999999988642          2367889999999999999999998   999999999999999999999


Q ss_pred             EeecccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHH
Q 008893          368 VGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       368 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      |+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....       .....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~~~  232 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLR  232 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence            99999987654322211 112235778999999998899999999999999999999 6778753221       11111


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...... .         ...+...+..+.+++.+|++.+|++|||+.|++++|++
T Consensus       233 ~~~~~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 FVMEGG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHcCC-c---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            111111 0         01122234678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.4e-40  Score=337.10  Aligned_cols=255  Identities=20%  Similarity=0.219  Sum_probs=202.8

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ..++|++.+.||+|+||.||++... +++.||+|++....  .......+.+|+.+++.++||||+++++++...+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4568999999999999999999975 58899999986432  11223457889999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||||+++|+|.+++... .+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||++.......
T Consensus       121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999999999988754 488899999999999999999999   99999999999999999999999999998664332


Q ss_pred             CceeeccccccCccCchhhccC----CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ........||+.|+|||.+.+.    .++.++|||||||++|||++|+.||......       .....+.....     
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~-----  264 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMDHKN-----  264 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCCC-----
Confidence            2223345699999999998653    4789999999999999999999999743211       11111111100     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  497 (549)
                        .+.-......+..+.+++.+|++.+|++  ||+++|++++
T Consensus       265 --~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 --SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             --cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence              0000001123467889999999999988  9999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.2e-40  Score=332.30  Aligned_cols=243  Identities=22%  Similarity=0.250  Sum_probs=197.8

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      +.||+|+||.||++... +|+.||+|+++....  ......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999965 689999999975422  122345778999999999999999999999999999999999999


Q ss_pred             chhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccc
Q 008893          310 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR  389 (549)
Q Consensus       310 ~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  389 (549)
                      +|..++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~  156 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC  156 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccccc
Confidence            9999998777899999999999999999999999   99999999999999999999999999987532211 1223356


Q ss_pred             cccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHH
Q 008893          390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE  469 (549)
Q Consensus       390 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  469 (549)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.......       .......         ..  ..++...
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~---------~~--~~~p~~~  218 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILM---------EE--IRFPRTL  218 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhc---------CC--CCCCCCC
Confidence            9999999999999999999999999999999999999996432110       0111110         00  0112223


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          470 LEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       470 ~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                      ...+.+++.+|++.||++||     ++.+++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            46788999999999999998     78888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7e-40  Score=337.45  Aligned_cols=257  Identities=23%  Similarity=0.340  Sum_probs=204.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCC
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT  297 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  297 (549)
                      ..++|.+.+.||+|+||.||+|...      .+..||||+++..........+.+|+++++.+. ||||+++++++....
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3567889999999999999999853      134799999976544444557899999999996 999999999999999


Q ss_pred             ceeeEeeccCCCchhhhhccC-----------------------------------------------------------
Q 008893          298 ERLLVYPYMSNGSVASRLKAK-----------------------------------------------------------  318 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~-----------------------------------------------------------  318 (549)
                      ..++||||+++|+|.++++..                                                           
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            999999999999999887531                                                           


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec
Q 008893          319 -------------------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD  361 (549)
Q Consensus       319 -------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  361 (549)
                                                           ..+++..+..++.||+.||.|||+.   +|+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence                                                 2478888999999999999999998   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCcccccccc
Q 008893          362 EYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGA  439 (549)
Q Consensus       362 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~  439 (549)
                      +++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---~  348 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---T  348 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---H
Confidence            9999999999999865432221 1222346788999999999899999999999999999997 888886422110   0


Q ss_pred             HHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          440 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +.   .... ..         .....+...+..+.+++.+||+.+|++||++.++.++|+.
T Consensus       349 ~~---~~~~-~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         349 FY---NKIK-SG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             HH---HHHh-cC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence            11   1111 10         0011122334678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.8e-40  Score=335.26  Aligned_cols=248  Identities=21%  Similarity=0.336  Sum_probs=194.7

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      +|+..+.||+|+||.||+|... +|+.||||++...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4556788999999999999965 689999999975543333457899999999999999999999999999999999999


Q ss_pred             CCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceee
Q 008893          307 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT  386 (549)
Q Consensus       307 ~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  386 (549)
                      ++|+|.+..    ..++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus       155 ~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~  226 (353)
T PLN00034        155 DGGSLEGTH----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCN  226 (353)
T ss_pred             CCCcccccc----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccc
Confidence            999986532    356778889999999999999999   999999999999999999999999999987643221 223


Q ss_pred             ccccccCccCchhhccC-----CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          387 AVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      ...||..|+|||++...     ..+.++|||||||++|||++|+.||.......    ............          
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~~----------  292 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WASLMCAICMSQ----------  292 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhccC----------
Confidence            34689999999987432     24568999999999999999999997322111    111111111000          


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ....+.....++.+++.+||+.||++||++.|++++
T Consensus       293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            011122334678999999999999999999999874

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5e-40  Score=331.47  Aligned_cols=243  Identities=24%  Similarity=0.260  Sum_probs=198.8

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      +.||+|+||.||++... +|+.||+|++.....  ......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 689999999975432  223346788999999999999999999999999999999999999


Q ss_pred             chhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccc
Q 008893          310 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR  389 (549)
Q Consensus       310 ~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  389 (549)
                      +|...+.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~  156 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFC  156 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccccc
Confidence            9999998777899999999999999999999999   99999999999999999999999999987543221 1223456


Q ss_pred             cccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHH
Q 008893          390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE  469 (549)
Q Consensus       390 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  469 (549)
                      ||+.|+|||.+.+..++.++|||||||++|||+||+.||......       .........       +.    .++...
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~~~~~~~~~-------~~----~~p~~~  218 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILME-------DI----KFPRTL  218 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-------HHHHHhccC-------Cc----cCCCCC
Confidence            999999999999999999999999999999999999999642211       111111100       00    112223


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          470 LEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       470 ~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                      ..++.+++.+|++.||++||     ++.|++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            46788999999999999997     88888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.1e-40  Score=332.41  Aligned_cols=256  Identities=27%  Similarity=0.421  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC-C
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT-T  297 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  297 (549)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++..........+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457889999999999999999632      25789999997654333345678899999999 899999999988754 5


Q ss_pred             ceeeEeeccCCCchhhhhccC-----------------------------------------------------------
Q 008893          298 ERLLVYPYMSNGSVASRLKAK-----------------------------------------------------------  318 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~-----------------------------------------------------------  318 (549)
                      ..++++||+++++|.+++...                                                           
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            678999999999999887521                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce-eeccccccCcc
Q 008893          319 --PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHI  395 (549)
Q Consensus       319 --~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~  395 (549)
                        ..++|..+.+++.||+.||.|||+.   +|+||||||+||++++++.++|+|||+++.+....... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              2589999999999999999999999   99999999999999999999999999998764333222 12234567899


Q ss_pred             CchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHH
Q 008893          396 APEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMV  474 (549)
Q Consensus       396 aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  474 (549)
                      |||++.+..++.++|||||||++|||++ |..||.......      ...... ....         ....+.....++.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~-~~~~---------~~~~~~~~~~~~~  306 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRL-KEGT---------RMRAPEYATPEIY  306 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHH-hccC---------CCCCCccCCHHHH
Confidence            9999999999999999999999999998 999986422111      011111 1110         0111122346789


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          475 QVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       475 ~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +++.+||+.+|++||++.|++++|+.
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.4e-40  Score=325.13  Aligned_cols=264  Identities=23%  Similarity=0.335  Sum_probs=195.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC--CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhc---cCCCccceEEEEec-----
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLIGFCMT-----  295 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----  295 (549)
                      .+|++.+.||+|+||+||+|...  +++.||+|.++...... ....+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  46889999987543222 233566777776655   69999999999852     


Q ss_pred             CCceeeEeeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccc
Q 008893          296 TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL  373 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  373 (549)
                      ....++||||++ ++|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            346889999997 588888864  34589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccch
Q 008893          374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       374 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      ++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.+...........
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            9866432  22334568999999999998899999999999999999999999997543322111111111000000000


Q ss_pred             h------hhccccccC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          454 E------MLVDKDLKN---NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       454 ~------~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .      .........   ...+.....+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0      000000000   001122356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=317.57  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=201.8

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccC
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      +|++.+.||+|+||.||+|.++++..+|+|.+.....  ....+.+|+++++.++||||+++++++...+..++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            5778899999999999999988778899999864332  34468889999999999999999999999999999999999


Q ss_pred             CCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceee
Q 008893          308 NGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT  386 (549)
Q Consensus       308 ~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  386 (549)
                      +++|.+++.. ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++...........
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            9999999864 34689999999999999999999999   9999999999999999999999999999765432221112


Q ss_pred             ccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ...++..|+|||.+.+..++.++||||||+++|||+| |+.||......    ..   .......          .....
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~---~~~~~~~----------~~~~~  222 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EV---VESVSAG----------YRLYR  222 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HH---HHHHHcC----------CcCCC
Confidence            2224567999999999999999999999999999999 78888642211    11   1111110          00111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      +...+..+.+++.+|++.+|++|||+.|+++.|.
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            2223567999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-39  Score=321.84  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-----CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++|++.+.||+|+||+||+|.+     .++..|++|.++..........+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999984     24678999999754433334578899999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhccC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC
Q 008893          302 VYPYMSNGSVASRLKAK-----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY  364 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  364 (549)
                      +|||+++++|.+++...                 ..+++.....++.|++.||.|||++   +++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            99999999999988421                 2478899999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCC-ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHH
Q 008893          365 EAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLD  442 (549)
Q Consensus       365 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~  442 (549)
                      .+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.....       ..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~  234 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QE  234 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence            999999999986543221 11223345678999999988889999999999999999999 8888853211       01


Q ss_pred             HHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          443 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       443 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ......... .         ...+...+..+.+++.+|++.+|++||++.++.++|..
T Consensus       235 ~~~~~~~~~-~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVRKRQ-L---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCC-c---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111111111 0         01112234678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.4e-40  Score=337.19  Aligned_cols=253  Identities=19%  Similarity=0.236  Sum_probs=198.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .|+..+.||+|+||+||+|... +++.||+|++......  .....+..|+.++..++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999865 5889999999754321  223468899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC--
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS--  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  382 (549)
                      |+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+.....  
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            999999999998877899999999999999999999998   999999999999999999999999999764321000  


Q ss_pred             --------------------------------------------ceeeccccccCccCchhhccCCCCCcccchhHhHHH
Q 008893          383 --------------------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL  418 (549)
Q Consensus       383 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il  418 (549)
                                                                  .......||+.|+|||.+.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                        001234699999999999988999999999999999


Q ss_pred             HHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHH--hcccCCCCCCCHHHHHH
Q 008893          419 LELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALL--CTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       419 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~evl~  496 (549)
                      |||+||+.||.........       .......       ..+..........++.+++.+  |+..+|..||++.|++.
T Consensus       239 ~elltG~~Pf~~~~~~~~~-------~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQ-------LKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHH-------HHHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            9999999999753321110       0110000       000000001123567788877  55667777999999987


Q ss_pred             H
Q 008893          497 M  497 (549)
Q Consensus       497 ~  497 (549)
                      +
T Consensus       305 h  305 (381)
T cd05626         305 H  305 (381)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.1e-39  Score=327.13  Aligned_cols=245  Identities=23%  Similarity=0.270  Sum_probs=194.3

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||.||+|... +++.||+|+++....  ......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 588999999975432  12234577888888766 799999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|..++.....+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~  156 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTF  156 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccccc
Confidence            99999988777899999999999999999999999   99999999999999999999999999987543211 122345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccc-cccHHHHHHHHhhccchhhhccccccCCCCH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ-KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR  467 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  467 (549)
                      .||..|+|||++.+..++.++|||||||++|||+||+.||........ ......++........          ..++.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p~  226 (329)
T cd05618         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIPR  226 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CCCCC
Confidence            689999999999999999999999999999999999999963221111 1111222222111111          11222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCH
Q 008893          468 IELEEMVQVALLCTQYLPSLRPKM  491 (549)
Q Consensus       468 ~~~~~l~~l~~~cl~~dP~~RPs~  491 (549)
                      .....+.+++.+|++.||++||+.
T Consensus       227 ~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         227 SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCHHHHHHHHHHhcCCHHHcCCC
Confidence            334678899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.1e-40  Score=334.81  Aligned_cols=253  Identities=22%  Similarity=0.251  Sum_probs=203.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||+||++... +|+.||+|+++....  ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999965 689999999975432  223446889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+++|+|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999765 6799999999999999999999999   999999999999999999999999999987654333


Q ss_pred             ceeeccccccCccCchhhc------cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          383 HVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      .......||+.|+|||++.      ...++.++|||||||++|||++|+.||......       .....+.........
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~  230 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNFQRFLKF  230 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcCCCccCC
Confidence            3333456899999999986      456789999999999999999999999643221       111111111110000


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .       .....+..+.+++..|++ +|++||++.+++.+
T Consensus       231 ~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         231 P-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             C-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            0       011123668899999998 99999999998753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=338.43  Aligned_cols=253  Identities=20%  Similarity=0.266  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||++.....  ......+..|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999975 589999999975321  122345788999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+......
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            9999999999998877899999999999999999999999   9999999999999999999999999998754321100


Q ss_pred             -------------------------------------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCc
Q 008893          384 -------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR  426 (549)
Q Consensus       384 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~  426 (549)
                                                           ......||+.|+|||++....++.++|||||||++|||++|+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                 0012358999999999999999999999999999999999999


Q ss_pred             ccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 008893          427 ALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK---MSEVVRM  497 (549)
Q Consensus       427 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~  497 (549)
                      ||.......       ..........       .+........+..+.+++.+|+. +|.+|++   +.|++++
T Consensus       238 Pf~~~~~~~-------~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         238 PFCSDNPQE-------TYRKIINWKE-------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCHHH-------HHHHHHcCCC-------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            997432211       1111111000       00000001123567889999996 9999998   7777654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.4e-40  Score=319.42  Aligned_cols=254  Identities=29%  Similarity=0.419  Sum_probs=208.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      +..+|+..+.||+|+||.||+|...+++.+++|.+..... .....+..|+.+++.++|+|++++++++...+..++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            3457888999999999999999988899999999876542 234568899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||.+........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999974  34689999999999999999999998   999999999999999999999999999986643221


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                       ......++..|+|||.+....++.++||||||+++|+|++ |+.||.....    .......   ..          ..
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~~---~~----------~~  221 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQI---TA----------GY  221 (261)
T ss_pred             -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHH---Hh----------CC
Confidence             1223346778999999988899999999999999999999 8888864321    1111111   11          11


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....+...+..+.+++.+|++.+|++|||+.++++.|++
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            111223344778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-39  Score=321.64  Aligned_cols=266  Identities=25%  Similarity=0.352  Sum_probs=203.1

Q ss_pred             CCCCCeeeeeCCeEEEEEEE-----CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC--Cceee
Q 008893          229 FSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL  301 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  301 (549)
                      |...+.||+|+||+||.+..     .+++.||+|.++..........+.+|+++++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37789999999999988653     357899999997654333455788999999999999999999988654  35789


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      +|||+++++|.+++... .+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||+++......
T Consensus        86 v~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             EecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            99999999999998764 499999999999999999999999   99999999999999999999999999998765332


Q ss_pred             Cce--eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          382 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       382 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ...  .....++..|+|||.+.+..++.++||||||+++|||+||+.|+........  ....+..............+.
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE--EMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh--hhhcccccccchhhhhhhhhc
Confidence            211  1222356679999999888899999999999999999999999764321100  000000000000111111122


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ......+...+..+.+++..||+.+|++|||++++++.|+.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            11122233345789999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-40  Score=328.61  Aligned_cols=250  Identities=25%  Similarity=0.355  Sum_probs=211.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcH-HHHHHHHHHHhhccCCCccceEEEEecCCc-eeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGE-IQFQTEVEMISLAVHRNLLRLIGFCMTTTE-RLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  303 (549)
                      ++|...+.+|+|+||.++..+++ +++.+++|.+.-....... .....|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888999999999999999876 5789999999765433333 357899999999999999999999998888 99999


Q ss_pred             eccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          304 PYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       304 e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      +|++||++.+.+...  ..++++.+.+++.|++.|+.|||++   .|+|||||+.||+++.+..+||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            999999999999743  4689999999999999999999998   99999999999999999999999999999987654


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      . ....+.||+.|+.||.+.+.+|..|+|||||||++|||++-+++|...+.       ...+..+.+.          .
T Consensus       161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ki~~~----------~  222 (426)
T KOG0589|consen  161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELILKINRG----------L  222 (426)
T ss_pred             h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-------HHHHHHHhhc----------c
Confidence            3 34456799999999999999999999999999999999999999975332       1122222111          1


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ....+..++.++..++..|++.+|+.||++.+++.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            233455566889999999999999999999999875

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.1e-40  Score=329.03  Aligned_cols=243  Identities=26%  Similarity=0.316  Sum_probs=197.4

Q ss_pred             CeeeeeCCeEEEEEEE----CCCCEEEEEEcccCCC---CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          233 NLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +.||+|+||.||++..    .+++.||+|+++....   ......+..|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    3578999999875321   12234578899999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+.+.....+.+..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  157 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT  157 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence            99999999998877889999999999999999999999   999999999999999999999999999875432221 22


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......       .........         .  ...
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~~~~~---------~--~~~  219 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDKILKG---------K--LNL  219 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC---------C--CCC
Confidence            3356999999999999888999999999999999999999999743211       111111111         0  011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                      +......+.+++.+|++.+|++||     ++.+++++
T Consensus       220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            222346788999999999999999     78887764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-39  Score=327.66  Aligned_cols=243  Identities=26%  Similarity=0.321  Sum_probs=195.9

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||.||+|... +++.||+|+++....  ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999976 578999999875421  22234567788888765 799999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|...+.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~  156 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTF  156 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccc
Confidence            99999998777899999999999999999999999   99999999999999999999999999987543222 222345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||++.+..++.++|||||||++|||+||+.||......       ..........         .  .++..
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~~~~~i~~~~---------~--~~p~~  218 (321)
T cd05591         157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-------DLFESILHDD---------V--LYPVW  218 (321)
T ss_pred             ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC---------C--CCCCC
Confidence            6899999999999989999999999999999999999999743211       1111111110         0  01112


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 008893          469 ELEEMVQVALLCTQYLPSLRP-------KMSEVVRM  497 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RP-------s~~evl~~  497 (549)
                      ...++.+++.+|++.||++||       ++.+++++
T Consensus       219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            236788999999999999999       67777754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-39  Score=321.31  Aligned_cols=255  Identities=26%  Similarity=0.374  Sum_probs=202.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECC------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      .+++|.+.+.||+|+||.||+|.+.+      +..||+|.+...........+..|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35678899999999999999999753      568999988754433334568999999999999999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCC-------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC---ceEE
Q 008893          299 RLLVYPYMSNGSVASRLKAKP-------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVV  368 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl  368 (549)
                      .+++|||+++++|.+++....       .+++..+..++.||+.||.|||+.   +++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            999999999999999986432       589999999999999999999999   999999999999998654   6999


Q ss_pred             eecccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHH
Q 008893          369 GDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKK  446 (549)
Q Consensus       369 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  446 (549)
                      +|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||......       .....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~~~~~  233 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEF  233 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence            9999998663221111 111223568999999999999999999999999999997 88888642211       11111


Q ss_pred             HhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          447 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       447 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      .....          ....+...+..+.+++.+|++.+|++||++.+|+++|+
T Consensus       234 ~~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11111          11122233467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-40  Score=313.00  Aligned_cols=266  Identities=21%  Similarity=0.280  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCC-ccceEEEEecCC------
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTT------  297 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------  297 (549)
                      ..|...+.||+|+||+||+|+.+ +|+.||+|+++..... .......+|+.+++.++|+| |+++.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34556678999999999999965 6899999999866542 23335678999999999999 999999998877      


Q ss_pred             ceeeEeeccCCCchhhhhccCC----CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAKP----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL  373 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  373 (549)
                      ..++||||++. +|..++....    .++...+..++.||+.||+|||++   +|+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            78899999976 8988886433    577789999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc
Q 008893          374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK  452 (549)
Q Consensus       374 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (549)
                      |+....... ..+...+|..|+|||++.+. .|+...||||+|||++||++++..|.+....++...+...+..-....+
T Consensus       167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            996653322 34556689999999999887 6899999999999999999998888765553333333322222111111


Q ss_pred             hhhhccccccCCC-----C----HHH---HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          453 LEMLVDKDLKNNY-----D----RIE---LEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       453 ~~~~~d~~l~~~~-----~----~~~---~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .....-++....+     +    ...   .....+++.+|++.+|.+|.|++.+++|
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1111111111011     1    111   1368899999999999999999999986

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-39  Score=313.21  Aligned_cols=247  Identities=31%  Similarity=0.456  Sum_probs=199.5

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCchh
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVA  312 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  312 (549)
                      +.||+|+||.||+|...+++.+|+|.++..........+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999999876543333446889999999999999999999999999999999999999999


Q ss_pred             hhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccc
Q 008893          313 SRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT  391 (549)
Q Consensus       313 ~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt  391 (549)
                      +++.. ...+++..+..++.|++.||.|+|+.   +++||||||+||++++++.+|++|||++...............++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            98864 34689999999999999999999998   999999999999999999999999999875433221111222346


Q ss_pred             cCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHH
Q 008893          392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL  470 (549)
Q Consensus       392 ~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  470 (549)
                      ..|+|||++.+..++.++||||||+++|++++ |..||.......       ........          .....+...+
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~----------~~~~~~~~~~  220 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKG----------YRMSCPQKCP  220 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcC----------CCCCCCCCCC
Confidence            68999999998999999999999999999999 888986422110       01111110          0111122234


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          471 EEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       471 ~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      ..+.+++.+|++.+|++||++.|+++.|.
T Consensus       221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         221 DDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            67999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-39  Score=327.98  Aligned_cols=265  Identities=19%  Similarity=0.304  Sum_probs=197.8

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecC-----Ccee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TERL  300 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  300 (549)
                      +|++.+.||+|+||.||+|... +|+.||||+++... .......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999965 68999999987432 222344688999999999999999999988643     2479


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +||||+. ++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            9999995 68999988777899999999999999999999999   9999999999999999999999999999765322


Q ss_pred             CC--ceeeccccccCccCchhhcc--CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH--------HHHHHHh
Q 008893          381 DS--HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKIH  448 (549)
Q Consensus       381 ~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~  448 (549)
                      ..  .......||..|+|||++.+  ..++.++|||||||++|||+||+.||...........+.        .+.....
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            11  11233468999999999876  678999999999999999999999996533211100000        0000000


Q ss_pred             hccchhhhc---cccccCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          449 QEKKLEMLV---DKDLKNNYD---RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       449 ~~~~~~~~~---d~~l~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .. ......   .+.......   ......+.+++.+|++.||++|||++|++++
T Consensus       237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         237 NE-KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hh-hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00 000000   000000000   0123567899999999999999999999863

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.3e-39  Score=314.36  Aligned_cols=247  Identities=28%  Similarity=0.423  Sum_probs=197.6

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCch
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV  311 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  311 (549)
                      +.||+|+||.||+|... +++.||+|.+...........+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999975 68999999987554334455789999999999999999999999999999999999999999


Q ss_pred             hhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee-eccc
Q 008893          312 ASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVR  389 (549)
Q Consensus       312 ~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~  389 (549)
                      .+++.. ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........... ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            999865 34689999999999999999999999   999999999999999999999999999875442211111 1112


Q ss_pred             cccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       390 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      ++..|+|||.+.++.++.++||||||+++|||++ |..||......       .......          .......+..
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~----------~~~~~~~~~~  220 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIE----------QGVRLPCPEL  220 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHH----------cCCCCCCccc
Confidence            3457999999999999999999999999999998 88887532111       0000010          1111112223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      .+..+.+++.+|++.+|++||++.++++.|+
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.7e-39  Score=326.39  Aligned_cols=250  Identities=22%  Similarity=0.269  Sum_probs=198.2

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||.||++... +++.||+|+++....  ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999975 588999999975432  12234578899998888 799999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|.+++.....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++..... .......
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~  156 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTF  156 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccc
Confidence            99999988777899999999999999999999999   9999999999999999999999999998743211 1223345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccc-cccHHHHHHHHhhccchhhhccccccCCCCH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ-KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR  467 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  467 (549)
                      .||+.|+|||++.+..++.++|||||||++|||+||+.||........ .....++..........          ..+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~p~  226 (329)
T cd05588         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------RIPR  226 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------CCCC
Confidence            699999999999999999999999999999999999999974322111 11122222222111111          1122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 008893          468 IELEEMVQVALLCTQYLPSLRPK------MSEVVR  496 (549)
Q Consensus       468 ~~~~~l~~l~~~cl~~dP~~RPs------~~evl~  496 (549)
                      ..+..+.+++.+|++.||.+||+      +.++++
T Consensus       227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            23467899999999999999998      556654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=327.64  Aligned_cols=265  Identities=23%  Similarity=0.352  Sum_probs=215.7

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      +.+...+.+.||+|-||.|.......+..||||+++.+........|..|+++|.+++||||++++|+|..++..++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            34556788999999999999999988899999999988777777889999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||++|+|.+++...  +.++......|+.|||.|++||.+.   ++|||||.++|+|+|.++++||+|||+++-+-..+.
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999999754  3446667778999999999999999   999999999999999999999999999996544443


Q ss_pred             c-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh--CCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          383 H-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       383 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      + ......-..+|||||.+..++++.++|||+||+++||+++  ...|+.....    ...++-...........     
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~~~-----  763 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQGRQ-----  763 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCCcc-----
Confidence            3 2333445679999999999999999999999999999876  4566643211    11111111111111111     


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG  502 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  502 (549)
                       .....++.++.++.+++.+||..|.++||+++++...|+++.
T Consensus       764 -~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  764 -VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             -eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence             112235667789999999999999999999999999998753

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.8e-39  Score=314.33  Aligned_cols=251  Identities=27%  Similarity=0.414  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      ++|++.+.||+|+||.||+|..+++..+|+|.++....  ....+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            46788899999999999999988888999999875432  3457899999999999999999999875 45689999999


Q ss_pred             CCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          307 SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       307 ~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      ++++|.+++..  ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            99999999874  34589999999999999999999999   99999999999999999999999999998765432222


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....    ....+   .....          ...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~---~~~~~----------~~~  222 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----REVLE---QVERG----------YRM  222 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHHHH---HHHcC----------CCC
Confidence            222335678999999988899999999999999999999 8888853221    11111   11111          011


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..+...+..+.+++.+|++.+|++|||+.++.+.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1122334679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-39  Score=333.32  Aligned_cols=201  Identities=22%  Similarity=0.330  Sum_probs=176.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|+..+.||+|+||+||++... +++.||+|++.....  ......+..|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999865 589999999975321  122346788999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  382 (549)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.+..... 
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            9999999999998888899999999999999999999999   999999999999999999999999999875432110 


Q ss_pred             ---------------------------------ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccc
Q 008893          383 ---------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE  429 (549)
Q Consensus       383 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  429 (549)
                                                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             00123469999999999999999999999999999999999999997


Q ss_pred             c
Q 008893          430 F  430 (549)
Q Consensus       430 ~  430 (549)
                      .
T Consensus       238 ~  238 (363)
T cd05628         238 S  238 (363)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=329.02  Aligned_cols=258  Identities=25%  Similarity=0.393  Sum_probs=216.1

Q ss_pred             HHHHhcCCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          222 LQSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       222 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++-...+....+.||-|.||.||.|+|+. .-.||||.++.+..  ...+|..|..+++.++|||+|+++|+|.....+|
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            33344566778999999999999999975 67899999987653  3567999999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          301 LVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      ||+|||.+|+|.++|++  +..++.-..+.++.||+.|+.||..+   ++|||||..+|.|+.++..+|++|||+++++.
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            99999999999999984  34577778889999999999999999   99999999999999999999999999999987


Q ss_pred             CCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ...........-.+.|.|||-+....++.|+|||+|||+|||+.| |..|+.+-+..        .+         -+++
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------qV---------Y~LL  479 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QV---------YGLL  479 (1157)
T ss_pred             CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------HH---------HHHH
Confidence            554333333334568999999999999999999999999999999 77887642211        11         1233


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      .+..+-+.+..+++.+.+|+..||+.+|.+||++.|+-+.++..
T Consensus       480 EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  480 EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            33344445677889999999999999999999999999888864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-39  Score=325.63  Aligned_cols=242  Identities=25%  Similarity=0.335  Sum_probs=192.8

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhh-ccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||.||+|... +++.||+|+++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 588999999975421  1223345556666654 4899999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~  156 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF  156 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence            99999998777899999999999999999999998   99999999999999999999999999997643322 223345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||......       .........           ...++..
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~-----------~~~~~~~  218 (316)
T cd05592         157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-------ELFDSILND-----------RPHFPRW  218 (316)
T ss_pred             cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC-----------CCCCCCC
Confidence            6999999999999989999999999999999999999999743211       111111110           0112222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKMS-EVVR  496 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~~-evl~  496 (549)
                      ...++.+++.+||+.+|++||++. ++++
T Consensus       219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            346788999999999999999986 4443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-39  Score=327.55  Aligned_cols=237  Identities=27%  Similarity=0.348  Sum_probs=192.6

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||+||+|..+ +++.||+|+++...  .......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 58899999987532  122334567788888766 699999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~  156 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTF  156 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccc
Confidence            99999998777899999999999999999999999   99999999999999999999999999987543221 122345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||.....       ...........           ...+..
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~-----------~~~~~~  218 (320)
T cd05590         157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDE-----------VVYPTW  218 (320)
T ss_pred             ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCC-----------CCCCCC
Confidence            699999999999999999999999999999999999999974321       11111111110           011222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKM  491 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~  491 (549)
                      ...++.+++.+|++.||++||++
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         219 LSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCC
Confidence            34678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2e-39  Score=331.85  Aligned_cols=258  Identities=21%  Similarity=0.239  Sum_probs=202.0

Q ss_pred             HHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          222 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       222 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      +....++|++.+.||+|+||.||++... +++.||+|++....  .......+.+|+.+++.++||||+++++++.....
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3345578999999999999999999976 58899999986432  11223458889999999999999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++||||+++|+|.+++... .+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++....
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999999998755 589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceeeccccccCccCchhhccCC----CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      ...........||+.|+|||.+.+..    ++.++|||||||++|||+||+.||......       .....+.....  
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~~~~i~~~~~--  264 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GTYSKIMDHKN--  264 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCc--
Confidence            33322233456999999999987543    788999999999999999999999743211       11111111100  


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  497 (549)
                           .+........+..+.+++..|+..++.+  ||++.|++++
T Consensus       265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                 0000001122466788999999865544  8899999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.9e-40  Score=330.29  Aligned_cols=243  Identities=23%  Similarity=0.250  Sum_probs=197.5

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      +.||+|+||.||++... +|+.||+|+++....  ......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 689999999975421  122345778999999999999999999999999999999999999


Q ss_pred             chhhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          310 SVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       310 ~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      +|..++.....+++..+..++.||+.||.|||+ .   +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~  156 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTF  156 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccc
Confidence            999999877789999999999999999999997 6   99999999999999999999999999987543221 122334


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||++.+..++.++|||||||++|||+||+.||......       .........       .    ..++..
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~~-------~----~~~p~~  218 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILME-------E----IRFPRT  218 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhcC-------C----CCCCCC
Confidence            6999999999999999999999999999999999999999643211       111111100       0    011222


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          469 ELEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                      ...++.+++.+|++.||++|+     ++.+++++
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            346788999999999999997     89998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.4e-39  Score=327.99  Aligned_cols=242  Identities=24%  Similarity=0.298  Sum_probs=195.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCC-CccceEEEEecCCceeeEe
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHR-NLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  303 (549)
                      +|++.+.||+|+||.||+|... +++.||+|+++....  ......+..|..++..+.|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999976 578999999875421  22344677888899888765 5888999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-  156 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence            9999999999998777899999999999999999999999   999999999999999999999999999875322221 


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||......       .........           ..
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~-----------~~  218 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQSIMEH-----------NV  218 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC-----------CC
Confidence            223456999999999999999999999999999999999999999643211       111111110           01


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKM  491 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~  491 (549)
                      .++......+.+++.+|++.||.+||+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            1122234678899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.1e-39  Score=313.58  Aligned_cols=246  Identities=27%  Similarity=0.364  Sum_probs=197.8

Q ss_pred             eeeeeCCeEEEEEEEC---CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCC
Q 008893          234 LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       234 ~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      .||+|+||.||+|.++   ++..+|+|+++..... .....+..|+.+++.+.||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   5789999998754322 22446889999999999999999999875 45678999999999


Q ss_pred             chhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee--ec
Q 008893          310 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TA  387 (549)
Q Consensus       310 ~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~  387 (549)
                      +|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++..........  ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9999998777899999999999999999999998   999999999999999999999999999987654332211  12


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCC
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD  466 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  466 (549)
                      ..++..|+|||.+....++.++||||||+++|||+| |+.||.....       ..+........          ....+
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~i~~~~----------~~~~~  220 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------NEVTQMIESGE----------RMECP  220 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCC----------CCCCC
Confidence            234578999999988889999999999999999998 9999864221       11112111111          11112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          467 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       467 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...+.++.+++.+||+.||++||++.+|.+.|++
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            2334678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.5e-39  Score=322.89  Aligned_cols=257  Identities=28%  Similarity=0.417  Sum_probs=205.0

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEECC------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT  296 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  296 (549)
                      ...++|+..+.||+|+||.||++...+      ...+|+|.+...........+.+|+.++.++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            345678889999999999999998642      3689999987654333345688999999999 799999999999999


Q ss_pred             CceeeEeeccCCCchhhhhcc----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee
Q 008893          297 TERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL  360 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  360 (549)
                      +..+++|||+++|+|.++++.                ...+++..+..++.|++.||.|||+.   +|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence            999999999999999999853                34689999999999999999999998   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG  438 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  438 (549)
                      ++++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......    
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----  241 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----  241 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH----
Confidence            99999999999999876543221 1122235678999999988899999999999999999998 88887532211    


Q ss_pred             cHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         +........          .....+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus       242 ---~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         242 ---ELFKLLKEG----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             ---HHHHHHHcC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence               111111110          0111122334678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.8e-39  Score=314.03  Aligned_cols=252  Identities=27%  Similarity=0.389  Sum_probs=203.3

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .++|++.+.||+|+||.||+|...++..||+|.++...  .....+.+|+++++.++||||+++++++. ....++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            35688999999999999999998777789999997533  23457899999999999999999999874 4568999999


Q ss_pred             cCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++|+|.+++..  ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||.++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999999974  34589999999999999999999998   9999999999999999999999999999876543322


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......++..|+|||+..+..++.++||||||+++|||+| |..||......    ..   .......          ..
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~---~~~~~~~----------~~  221 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EV---LDQVERG----------YR  221 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HH---HHHHhcC----------CC
Confidence            2223346778999999988899999999999999999999 77777532211    00   1111100          00


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .......+..+.+++.+|++.+|++||++.++++.|++
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            11123345778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.3e-39  Score=318.20  Aligned_cols=253  Identities=24%  Similarity=0.387  Sum_probs=198.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCC----EEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      .+|+..+.||+|+||+||+|.+. +++    .+++|.+...........+..|+..++.+.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46778899999999999999964 344    4778887543322233467788888999999999999998764 45788


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ++||+++|+|.+++.. ...+++..+..++.||+.||.|||+.   +++||||||+||++++++.+||+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            9999999999999974 45789999999999999999999998   9999999999999999999999999999866433


Q ss_pred             CCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          381 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       381 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ... ......++..|+|||.+.++.++.++||||||+++|||+| |+.||......    ...+++    .....  ...
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~----~~~~~--~~~  232 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLL----EKGER--LAQ  232 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH----HCCCc--CCC
Confidence            221 2233457788999999998999999999999999999998 99888643211    111111    11110  001


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                             +......+.+++.+|+..+|++|||+.|+++.|..
T Consensus       233 -------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         233 -------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             -------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence                   11123567889999999999999999999998876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.3e-39  Score=314.48  Aligned_cols=257  Identities=20%  Similarity=0.311  Sum_probs=207.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||+|... +++.||||.++....  ......+.+|+.+++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999965 689999998864322  222346889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          304 PYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       304 e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998875    234589999999999999999999998   999999999999999999999999999887643


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....     ....+........      .+
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~~~~~~------~~  226 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKIEQCD------YP  226 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHHHhcCC------CC
Confidence            221 11233588899999999888899999999999999999999999863221     1122222211111      00


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                         ..........+.+++.+||+.+|++||++.+|++.+++.
T Consensus       227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence               111123346789999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.6e-39  Score=319.79  Aligned_cols=253  Identities=28%  Similarity=0.393  Sum_probs=201.8

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      +|.+.+.||+|+||.||+|...      ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4678899999999999999853      2357999988765433334578899999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhccC------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCe
Q 008893          302 VYPYMSNGSVASRLKAK------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN  357 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  357 (549)
                      ++||+.+++|.+++...                        ..+++..+..++.|++.||.|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            99999999999987531                        2478999999999999999999998   99999999999


Q ss_pred             eeecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCcccc
Q 008893          358 ILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTAN  435 (549)
Q Consensus       358 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~  435 (549)
                      |++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            99999999999999999765332221 1122345678999999988889999999999999999999 98888532211 


Q ss_pred             ccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         .+..+.   .          .......+...+.++.+++.+|++.+|++||++.|+++.|++
T Consensus       237 ---~~~~~~---~----------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         237 ---RLFNLL---K----------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             ---HHHHHH---h----------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence               111111   1          101111122234678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.5e-39  Score=313.80  Aligned_cols=252  Identities=28%  Similarity=0.434  Sum_probs=204.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .++|++.+.||+|+||.||+|..++++.||+|.+....  .....+.+|+.+++.++|+|++++++++. .+..+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            45788899999999999999998889999999987543  23457899999999999999999999864 4678999999


Q ss_pred             cCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++++|.+++..  ...+++.++..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            999999998864  34689999999999999999999998   9999999999999999999999999999876533222


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......++..|+|||++....++.++||||||+++||+++ |+.||......       +.........          .
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~----------~  221 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNLERGY----------R  221 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHHHHcCC----------C
Confidence            2223346678999999998899999999999999999999 99998643211       1111111110          0


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11112234679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.4e-39  Score=332.46  Aligned_cols=265  Identities=21%  Similarity=0.268  Sum_probs=201.1

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecCC-----cee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----ERL  300 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  300 (549)
                      +|++.+.||+|+||.||++... +|+.||+|.+.... .......+.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999964 68999999986432 1223456889999999999999999999998766     789


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +|+||+. ++|.+.+.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            9999996 57888887777899999999999999999999999   9999999999999999999999999999866543


Q ss_pred             CCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHH--------HHhhcc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK--------KIHQEK  451 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~  451 (549)
                      .........++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+.+...        .... .
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~  235 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-G  235 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-H
Confidence            33333334578999999998774 478999999999999999999999975432211111111000        0000 0


Q ss_pred             chhhhccccccC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          452 KLEMLVDKDLKN-------NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       452 ~~~~~~d~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ....+.......       .......+++.+++.+|++.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            000000000000       0111124678899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-39  Score=319.21  Aligned_cols=251  Identities=25%  Similarity=0.348  Sum_probs=200.7

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      +|+..+.||+|+||+||++... +++.||+|.+......  .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999965 6899999998653221  223457789999999999999999999999999999999


Q ss_pred             ccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |+++|+|.+++..  ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            9999999988753  34689999999999999999999999   99999999999999999999999999998754322 


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........   .........          . ..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~----------~-~~  221 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVK----------E-DQ  221 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhh----------h-cc
Confidence             12234589999999999988999999999999999999999999974322111   001000000          0 01


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                      ..++...+..+.+++.+|++.||++||     ++++++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            112233456789999999999999999     77787654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-40  Score=336.49  Aligned_cols=253  Identities=19%  Similarity=0.237  Sum_probs=198.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||++... +++.||||++.....  ......+.+|++++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999865 689999999864321  222346888999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+......
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            9999999999998777899999999999999999999999   9999999999999999999999999998643211000


Q ss_pred             ----------------------------------------------eeeccccccCccCchhhccCCCCCcccchhHhHH
Q 008893          384 ----------------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL  417 (549)
Q Consensus       384 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~i  417 (549)
                                                                    ......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                          0012459999999999999899999999999999


Q ss_pred             HHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHH
Q 008893          418 LLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR---PKMSEV  494 (549)
Q Consensus       418 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~ev  494 (549)
                      +|||+||+.||........       .........  .+.   +..  .......+.+++.+|+. +|.+|   +++.|+
T Consensus       238 l~elltG~~Pf~~~~~~~~-------~~~i~~~~~--~~~---~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         238 MFECLIGWPPFCSENSHET-------YRKIINWRE--TLY---FPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHH-------HHHHHccCC--ccC---CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence            9999999999964332111       111110000  000   000  01123568899999997 66665   588888


Q ss_pred             HHH
Q 008893          495 VRM  497 (549)
Q Consensus       495 l~~  497 (549)
                      +++
T Consensus       303 l~h  305 (377)
T cd05629         303 KSH  305 (377)
T ss_pred             hcC
Confidence            864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-39  Score=334.94  Aligned_cols=253  Identities=20%  Similarity=0.227  Sum_probs=198.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....  ......+.+|++++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999965 589999999864321  122446889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  382 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            9999999999998877899999999999999999999999   999999999999999999999999999753310000 


Q ss_pred             -----------------------------------------ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHH
Q 008893          383 -----------------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL  421 (549)
Q Consensus       383 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el  421 (549)
                                                               .......||+.|+|||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                     001124699999999999999999999999999999999


Q ss_pred             HhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 008893          422 ISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRP---KMSEVVRM  497 (549)
Q Consensus       422 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~evl~~  497 (549)
                      +||+.||........       .........       .............+.+++.+|+ .+|.+|+   ++.|++++
T Consensus       238 l~G~~Pf~~~~~~~~-------~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         238 LVGQPPFLADTPAET-------QLKVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhCCCCCCCCCHHHH-------HHHHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999975432111       111110000       0000001112355677888766 4999999   88888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.4e-39  Score=326.08  Aligned_cols=242  Identities=24%  Similarity=0.301  Sum_probs=195.4

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEe
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      +|.+.+.||+|+||.||+|... +++.||+|+++....  ......+..|..++... +|++|+++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999976 578999999875432  12233466677777766 5899999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+.+.....+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++...... .
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V  156 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence            9999999999998777899999999999999999999999   99999999999999999999999999997543221 1


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||......    .+   .......         .  .
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~---~~~i~~~---------~--~  218 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----EL---FQSIMEH---------N--V  218 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----HH---HHHHHhC---------C--C
Confidence            223456899999999999999999999999999999999999999743211    11   1111110         0  1


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKM  491 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~  491 (549)
                      .++...+.++.+++.+|++.+|++|++.
T Consensus       219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            1222334678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.5e-39  Score=324.21  Aligned_cols=245  Identities=25%  Similarity=0.350  Sum_probs=194.1

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHH---hhccCCCccceEEEEecCCceeeE
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMI---SLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      |++.+.||+|+||.||+|... +|+.||||+++....  ......+..|+.++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999965 689999999975421  12233566666654   466799999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||+++|+|...++.. .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~E~~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD-VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence            9999999999888654 699999999999999999999999   99999999999999999999999999987543221 


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......       ..........           
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~-----------  217 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------EVFDSIVNDE-----------  217 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC-----------
Confidence            2233456999999999999999999999999999999999999999643211       1111111110           


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  496 (549)
                      ..++...+..+.+++.+|++.||.+||+     +.++++
T Consensus       218 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            0112223467889999999999999994     555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.1e-39  Score=320.56  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC-CC--EEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD-GT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|++.+.||+|+||.||+|..++ +.  .+++|.++..........+..|+.++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999998753 33  47888887543333345688999999999 799999999999999999999


Q ss_pred             eeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCce
Q 008893          303 YPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA  366 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  366 (549)
                      +||+++++|.+++...                ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            9999999999998642                2488999999999999999999998   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHH
Q 008893          367 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       367 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      ||+|||++.......  .......+..|+|||.+.+..++.++|||||||++|||+| |..||.....       .+...
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~~~~  229 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AELYE  229 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence            999999986432111  1111223557999999998889999999999999999998 9999864221       11111


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....          ......+...+..+.+++.+|++.+|.+||++.++++.|++
T Consensus       230 ~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  274 (297)
T cd05089         230 KLPQ----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR  274 (297)
T ss_pred             HHhc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1111          11111122234678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-39  Score=313.13  Aligned_cols=252  Identities=25%  Similarity=0.337  Sum_probs=204.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC----cHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++|...+.||+|++|.||++... +++.||+|.+.......    ....+.+|+++++.++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999964 68999999986443211    22468889999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ++||+++++|.+.+.....+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||+++......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            999999999999998777899999999999999999999999   99999999999999999999999999997654322


Q ss_pred             Ccee--eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          382 SHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       382 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ....  ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......      . ......         .
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~-~~~~~~---------~  222 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA------A-IFKIAT---------Q  222 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH------H-HHHHhc---------c
Confidence            1111  23457889999999999889999999999999999999999986322110      0 011100         0


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ......+......+.+++.+|+..+|++|||+.|++++
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            01112223344678999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.2e-39  Score=311.48  Aligned_cols=246  Identities=27%  Similarity=0.362  Sum_probs=196.7

Q ss_pred             eeeeeCCeEEEEEEEC---CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCc
Q 008893          234 LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS  310 (549)
Q Consensus       234 ~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  310 (549)
                      .||+|+||.||+|.+.   ++..||+|++...........+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999864   355799999976544334456899999999999999999999875 457899999999999


Q ss_pred             hhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee--ec
Q 008893          311 VASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TA  387 (549)
Q Consensus       311 L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~  387 (549)
                      |.+++.. ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...........  ..
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999874 45789999999999999999999998   999999999999999999999999999986543332211  11


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCC
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD  466 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  466 (549)
                      ..++..|+|||.+.+..++.++||||||+++||+++ |..||.....       .++........          ....+
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~----------~~~~~  220 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-------PEVMSFIEQGK----------RLDCP  220 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCCC----------CCCCC
Confidence            223578999999988889999999999999999996 9999864321       11111111111          11122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          467 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       467 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...+.++.+++.+||+.+|++||++.+|.+.|+.
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            2335788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.9e-39  Score=317.81  Aligned_cols=256  Identities=26%  Similarity=0.381  Sum_probs=206.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECC-----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec-CCc
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTE  298 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  298 (549)
                      ..++|.+.+.||+|+||.||+|.+.+     +..|++|++...........+.+|+.+++.++|+|++++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45678899999999999999999765     788999998765444445568899999999999999999998876 467


Q ss_pred             eeeEeeccCCCchhhhhccC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEee
Q 008893          299 RLLVYPYMSNGSVASRLKAK--------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD  370 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  370 (549)
                      .+++++|+++++|.+++...        ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998632        4589999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHh
Q 008893          371 FGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       371 fg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      ||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||.....       .++.....
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-------FEMAAYLK  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-------HHHHHHHH
Confidence            99998654333221 122346678999999998889999999999999999999 9999864221       11111111


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .....          ......+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       234 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  275 (280)
T cd05043         234 DGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD  275 (280)
T ss_pred             cCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            11110          0111234678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.7e-39  Score=322.63  Aligned_cols=242  Identities=26%  Similarity=0.333  Sum_probs=193.6

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhh-ccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||+||+|... +++.||+|+++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 578999999975421  1223446667777765 4899999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTF  156 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeee
Confidence            99999998777899999999999999999999999   99999999999999999999999999987532221 122345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......       .........       .+    .++..
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~-------~~----~~~~~  218 (316)
T cd05619         157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMD-------NP----CYPRW  218 (316)
T ss_pred             cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC-------CC----CCCcc
Confidence            6899999999999989999999999999999999999999643211       111111100       01    11222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKMS-EVVR  496 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~~-evl~  496 (549)
                      ....+.+++.+|++.+|++||++. ++.+
T Consensus       219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         219 LTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            346788999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.5e-39  Score=319.76  Aligned_cols=256  Identities=25%  Similarity=0.352  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  298 (549)
                      .++|...+.||+|+||.||+|...      .+..||+|.++..........+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            457889999999999999999742      35589999987654333445689999999999 79999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          299 RLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      .+++|||+++|+|.++++...  .+++.++..++.|++.||.|||+.   +|+|+||||+||++++++.++++|||+++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999987433  389999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchh
Q 008893          377 LDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       377 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      ....... ......++..|+|||.+.+..++.++|||||||++|||+| |..||.......   .....   .. ..   
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~---~~-~~---  260 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKL---IK-EG---  260 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHH---HH-cC---
Confidence            5433221 1122345678999999999999999999999999999998 888886432111   11111   10 00   


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                            .....+...+..+.+++.+|++.+|++||++.|+++.|+.
T Consensus       261 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         261 ------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             ------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                  0001111223678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2e-39  Score=334.37  Aligned_cols=252  Identities=20%  Similarity=0.218  Sum_probs=195.9

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .|+..+.||+|+||+||+|... +++.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788999999999999999965 588999999865321  1223468899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC--
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS--  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  382 (549)
                      |+++|+|.+++.....+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..+.....  
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            999999999998777899999999999999999999999   999999999999999999999999999753211000  


Q ss_pred             --------------------------------------------ceeeccccccCccCchhhccCCCCCcccchhHhHHH
Q 008893          383 --------------------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL  418 (549)
Q Consensus       383 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il  418 (549)
                                                                  .......||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                        001124689999999999999999999999999999


Q ss_pred             HHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 008893          419 LELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK---MSEVV  495 (549)
Q Consensus       419 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl  495 (549)
                      |||+||+.||........       .......       ...+..........++.+++.+++ .+|++|++   +.|++
T Consensus       239 ~elltG~~Pf~~~~~~~~-------~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         239 YEMLVGQPPFLAQTPLET-------QMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             HHHHhCCCCCCCCCHHHH-------HHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence            999999999974322111       0111100       000000001112355677777765 49999998   77766


Q ss_pred             HH
Q 008893          496 RM  497 (549)
Q Consensus       496 ~~  497 (549)
                      ++
T Consensus       304 ~h  305 (382)
T cd05625         304 AH  305 (382)
T ss_pred             cC
Confidence            53

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.6e-39  Score=323.59  Aligned_cols=242  Identities=25%  Similarity=0.314  Sum_probs=193.6

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhh-ccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||.||+|..+ +|+.||+|.++....  ......+..|..++.. .+||||+++++++...+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 588999999975421  1223456667777765 4899999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF  156 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceecc
Confidence            99999998777899999999999999999999999   99999999999999999999999999987432211 223345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......       .........       .    ..++..
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~-------~----~~~~~~  218 (316)
T cd05620         157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVD-------T----PHYPRW  218 (316)
T ss_pred             CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC-------C----CCCCCC
Confidence            6999999999999999999999999999999999999999643211       111111100       0    111222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKMS-EVVR  496 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~~-evl~  496 (549)
                      ...++.+++.+|++.||++||++. ++++
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         219 ITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            346788999999999999999985 5553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.9e-39  Score=318.44  Aligned_cols=253  Identities=26%  Similarity=0.440  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+.... ......+.+|+..++.++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            45778899999999999999742      35578999886543 223356889999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC
Q 008893          301 LVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY  364 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  364 (549)
                      +||||+++++|.+++...                ..+++..++.++.||+.||+|||++   +|+||||||+||++++++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            999999999999998643                2489999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHH
Q 008893          365 EAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLD  442 (549)
Q Consensus       365 ~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~  442 (549)
                      .++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||......       .
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~  233 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------E  233 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H
Confidence            9999999999765432211 1223346788999999999999999999999999999999 99988643211       1


Q ss_pred             HHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          443 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       443 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...... ....         ...+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus       234 ~~~~~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~  281 (291)
T cd05094         234 VIECIT-QGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA  281 (291)
T ss_pred             HHHHHh-CCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence            111111 1111         01112234678999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.3e-39  Score=317.56  Aligned_cols=244  Identities=24%  Similarity=0.300  Sum_probs=193.9

Q ss_pred             eeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCch
Q 008893          235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV  311 (549)
Q Consensus       235 iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  311 (549)
                      ||+|+||+||++... +|+.||+|.+......  .....+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 6889999998653221  1234577899999999999999999999999999999999999999


Q ss_pred             hhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeec
Q 008893          312 ASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA  387 (549)
Q Consensus       312 ~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  387 (549)
                      .+.+.    ....+++..+..++.||+.||.|||+.   +|+||||||+||++++++.++|+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            88763    344689999999999999999999999   999999999999999999999999999976653322 2233


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCH
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR  467 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  467 (549)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||.........   .......         ....  ..++.
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~---------~~~~--~~~~~  222 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRI---------LNDS--VTYPD  222 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhh---------cccC--CCCcc
Confidence            46899999999999999999999999999999999999999743221110   0001110         1110  11222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 008893          468 IELEEMVQVALLCTQYLPSLRP-----KMSEVVR  496 (549)
Q Consensus       468 ~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  496 (549)
                      ..+..+.+++.+|++.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            3446789999999999999999     5566664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.9e-39  Score=332.74  Aligned_cols=258  Identities=23%  Similarity=0.344  Sum_probs=203.9

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecC
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTT  296 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  296 (549)
                      ...++|.+.+.||+|+||.||+|.+.      .++.||+|+++..........+..|+.++.++. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34456788899999999999999864      246899999986543333456889999999997 99999999999999


Q ss_pred             CceeeEeeccCCCchhhhhccC----------------------------------------------------------
Q 008893          297 TERLLVYPYMSNGSVASRLKAK----------------------------------------------------------  318 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------------  318 (549)
                      ...++|+||+++|+|.++++..                                                          
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            9999999999999999988532                                                          


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCee
Q 008893          319 ----------------------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI  358 (549)
Q Consensus       319 ----------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  358 (549)
                                                              ..+++..+..++.||+.||.|||+.   +++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence                                                    2367788899999999999999998   999999999999


Q ss_pred             eecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccc
Q 008893          359 LLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQ  436 (549)
Q Consensus       359 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~  436 (549)
                      |+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            9999999999999999865322211 1122346788999999998889999999999999999998 8888753221110


Q ss_pred             cccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          437 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         .   .......          .....+......+.+++.+||+.+|++||+++|+++.|+.
T Consensus       351 ---~---~~~~~~~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         351 ---F---YNAIKRG----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             ---H---HHHHHcC----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               0   0111111          0111122234679999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.8e-39  Score=317.99  Aligned_cols=253  Identities=26%  Similarity=0.434  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.+.... ......+.+|+.++++++|||++++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            46888999999999999999842      34578999886543 223446899999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhccCC-------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceE
Q 008893          301 LVYPYMSNGSVASRLKAKP-------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV  367 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~-------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  367 (549)
                      ++|||+++++|.+++....             .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            9999999999999886332             489999999999999999999998   999999999999999999999


Q ss_pred             EeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHH
Q 008893          368 VGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       368 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      |+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |..||......       +...
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~~~~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIE  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence            9999999865432211 1122335778999999998899999999999999999999 88887533211       1111


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...... ..     .    .+...+..+.+++.+|++.+|.+|||+.|+...|++
T Consensus       234 ~i~~~~-~~-----~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~  278 (288)
T cd05093         234 CITQGR-VL-----Q----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN  278 (288)
T ss_pred             HHHcCC-cC-----C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            111111 00     0    111223578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.7e-39  Score=323.86  Aligned_cols=243  Identities=27%  Similarity=0.324  Sum_probs=196.6

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||+||+|... +++.||+|+++...  .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 57899999997542  122334567788888777 699999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|...+.....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++...... ......
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTF  156 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccce
Confidence            99999998777899999999999999999999999   99999999999999999999999999987532221 122334


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||++.+..++.++|||||||++|+|+||+.||.....       ..........         .  ..++..
T Consensus       157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~---------~--~~~~~~  218 (318)
T cd05570         157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILED---------E--VRYPRW  218 (318)
T ss_pred             ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcC---------C--CCCCCc
Confidence            689999999999999999999999999999999999999964321       1111111110         0  011222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKM-----SEVVRM  497 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~  497 (549)
                      .+..+.+++.+||+.||++||++     .+++++
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            34678999999999999999999     777653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-39  Score=326.46  Aligned_cols=239  Identities=23%  Similarity=0.303  Sum_probs=195.4

Q ss_pred             CeeeeeCCeEEEEEEE----CCCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccC
Q 008893          233 NLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      +.||+|+||.||++..    .+|+.||+|+++.... ......+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    3588999999975432 1223457789999999999999999999999999999999999


Q ss_pred             CCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeec
Q 008893          308 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA  387 (549)
Q Consensus       308 ~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  387 (549)
                      +|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||++++++.+||+|||+++...... .....
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~  157 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS  157 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence            999999998777899999999999999999999999   99999999999999999999999999997654322 22334


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCH
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR  467 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  467 (549)
                      ..||+.|+|||.+.+..++.++|||||||++|||+||+.||......       ..........           ...+.
T Consensus       158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~~~i~~~~-----------~~~p~  219 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETMTMILKAK-----------LGMPQ  219 (318)
T ss_pred             ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-------HHHHHHHcCC-----------CCCCC
Confidence            56899999999999888999999999999999999999999643211       1111111100           01122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHH
Q 008893          468 IELEEMVQVALLCTQYLPSLRPKMSE  493 (549)
Q Consensus       468 ~~~~~l~~l~~~cl~~dP~~RPs~~e  493 (549)
                      .....+.+++.+||+.||++||++.+
T Consensus       220 ~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            23467889999999999999999666

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.2e-38  Score=326.49  Aligned_cols=262  Identities=21%  Similarity=0.237  Sum_probs=204.2

Q ss_pred             HHHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecC
Q 008893          220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT  296 (549)
Q Consensus       220 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  296 (549)
                      .++....++|++.+.||+|+||.||++..+ +++.||+|++.....  ......+.+|+.+++.++||||+++++++...
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344556689999999999999999999976 588999999864221  12234578899999999999999999999999


Q ss_pred             CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          297 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      ...++||||+++|+|.+++... .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            9999999999999999998754 488999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhccC----CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK  452 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (549)
                      .............||+.|+|||++...    .++.++|||||||++|||++|+.||.....       ......+.....
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~  264 (371)
T cd05622         192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMNHKN  264 (371)
T ss_pred             cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC
Confidence            654332233445699999999998654    378899999999999999999999974321       111111111111


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHh
Q 008893          453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRMLE  499 (549)
Q Consensus       453 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L~  499 (549)
                      .....+       ....+..+.+++..|+..++.+  ||+++|++++..
T Consensus       265 ~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~  306 (371)
T cd05622         265 SLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  306 (371)
T ss_pred             cccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence            000000       1123466889999999844443  779999987654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-38  Score=310.07  Aligned_cols=251  Identities=27%  Similarity=0.390  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      ++|.+.+.||+|++|.||+|...++..+|+|.+....  .....+.+|+++++.++|+|++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4678889999999999999998877789999886543  23456889999999999999999999875 45688999999


Q ss_pred             CCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          307 SNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       307 ~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      ++++|.++++..  ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            999999998643  3589999999999999999999998   99999999999999999999999999998764332222


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      .....++..|+|||...+..++.++||||||+++|||+| |+.||......    ....+   .....          ..
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~---~~~~~----------~~  222 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQ---VERGY----------RM  222 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH---HHcCC----------CC
Confidence            223346678999999998899999999999999999999 88888642211    11111   11100          01


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..+...+..+.+++.+|++.+|++||+++++++.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1122334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=323.48  Aligned_cols=269  Identities=26%  Similarity=0.400  Sum_probs=222.4

Q ss_pred             HHHhcCCCCCCeeeeeCCeEEEEEEECC---C--CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC
Q 008893          223 QSATSNFSSKNLVGKGGFGNVYKGYLQD---G--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT  297 (549)
Q Consensus       223 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---g--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  297 (549)
                      +...+..+..+.||.|-||.||+|...+   |  -.||||.-+.+...+..+.|..|..+++.++||||++++|+|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            3344556677899999999999998532   3  36899999887777778889999999999999999999999986 4


Q ss_pred             ceeeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          298 ERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      ..|+|||.++-|.|.++++. +..++......++.||+.||+|||+.   .+|||||..+|||+...-.+|++|||+++.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence            67999999999999999985 44789999999999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      +........+...-...|||||.++-.+++.++|||.|||.+||++. |.+||.+-...+--+                 
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-----------------  603 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-----------------  603 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-----------------
Confidence            88665554444445678999999999999999999999999999887 999998543322211                 


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCcchhhhhhH
Q 008893          456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQK  512 (549)
Q Consensus       456 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~  512 (549)
                      .+...-+-..++.+++.+..|+.+||..||.+||++.|+...|.+....++-.+.+.
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq  660 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQ  660 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHH
Confidence            111122234566778899999999999999999999999998887655555444433

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.4e-39  Score=318.72  Aligned_cols=253  Identities=24%  Similarity=0.343  Sum_probs=200.9

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      +|.+.+.||+|+||.||+|...      +++.||+|+++..........+..|+.++..++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4566788999999999999863      2578999999755432233568899999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhcc----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc
Q 008893          302 VYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE  365 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  365 (549)
                      ++||+++++|.+++..                ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            9999999999998742                23478899999999999999999998   9999999999999999999


Q ss_pred             eEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHH
Q 008893          366 AVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDW  443 (549)
Q Consensus       366 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  443 (549)
                      +||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||+| |..||.....       .++
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~  235 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDV  235 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence            999999998865432221 1223346779999999988899999999999999999998 7777753211       112


Q ss_pred             HHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          444 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       444 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ........ .         ...+...+..+.+++..|++.+|++||++++|+..|+.
T Consensus       236 ~~~i~~~~-~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRNRQ-V---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHcCC-c---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            22211111 0         11122334678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.3e-39  Score=318.29  Aligned_cols=258  Identities=25%  Similarity=0.404  Sum_probs=204.0

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT  297 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  297 (549)
                      ...++|++.+.||+|+||.||+|..+      .+..||+|.+...........+.+|+..++.++||||+++++++....
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34678999999999999999999754      245899999875543333456888999999999999999999999999


Q ss_pred             ceeeEeeccCCCchhhhhccC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceE
Q 008893          298 ERLLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV  367 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  367 (549)
                      ..++||||+++|+|.+++...          ...++..+..++.|++.||.|||++   +|+||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            999999999999999998631          2456778899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHH
Q 008893          368 VGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       368 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      |+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||.....       .++..
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~~~~  232 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLK  232 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH
Confidence            99999998654322211 112235678999999998899999999999999999999 6778753211       11111


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      .......          ...+...+..+.+++.+|++.+|++|||+.++++.|++.
T Consensus       233 ~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 FVMDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            1111110          011122246799999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.2e-38  Score=316.81  Aligned_cols=262  Identities=23%  Similarity=0.350  Sum_probs=205.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC-----------------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD-----------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR  288 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  288 (549)
                      .++|++.+.||+|+||.||+|...+                 +..||+|.+...........+.+|+++++.++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578899999999999999988542                 24689999876554444567899999999999999999


Q ss_pred             eEEEEecCCceeeEeeccCCCchhhhhccCC-----------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCe
Q 008893          289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKP-----------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN  357 (549)
Q Consensus       289 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  357 (549)
                      +++++...+..++++||+++++|.+++....           .+++..++.++.|++.||.|||+.   +++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            9999999999999999999999999987544           689999999999999999999998   99999999999


Q ss_pred             eeecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh--CCcccccCccc
Q 008893          358 ILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEFGKTA  434 (549)
Q Consensus       358 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~  434 (549)
                      |++++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++  |..||..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            99999999999999999765432221 2223446778999999998899999999999999999998  5566643211 


Q ss_pred             cccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          435 NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         .................      .....+...+.++.+++.+|++.+|++|||+.|+++.|+.
T Consensus       240 ---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 ---QQVIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ---HHHHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence               11111111111110000      0011122234679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-38  Score=312.37  Aligned_cols=255  Identities=22%  Similarity=0.284  Sum_probs=202.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            357889999999999999999964 688999999875432 234467889999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++........ .
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~  162 (267)
T cd06646          87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K  162 (267)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence            999999999998777899999999999999999999998   999999999999999999999999999986643221 1


Q ss_pred             eeccccccCccCchhhc---cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          385 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      .....|+..|+|||.+.   ...++.++|||||||++|||++|+.|+..........   .    ...    .....+..
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~----~~~----~~~~~~~~  231 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---L----MSK----SNFQPPKL  231 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---e----eec----CCCCCCCC
Confidence            22345888999999874   3457889999999999999999999985322111100   0    000    00000111


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                      .  .....+..+.+++.+||+.+|++||+++++++++
T Consensus       232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0  0112246789999999999999999999999765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.6e-39  Score=323.95  Aligned_cols=240  Identities=26%  Similarity=0.272  Sum_probs=191.3

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHH-HHhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||+||+|... +|+.||+|++.....  ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 689999999864321  112234445544 46778999999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTF  156 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccccc
Confidence            99999998877899999999999999999999999   99999999999999999999999999987532221 223345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .......... .      ..+    ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~-~------~~~----~~~  218 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNK-P------LRL----KPN  218 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcC-C------CCC----CCC
Confidence            699999999999999999999999999999999999999964321       1111111110 0      011    112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHH
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKMSEV  494 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~~ev  494 (549)
                      .+..+.+++.+|++.||++||++.+.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~  244 (323)
T cd05575         219 ISVSARHLLEGLLQKDRTKRLGAKDD  244 (323)
T ss_pred             CCHHHHHHHHHHhhcCHHhCCCCCCC
Confidence            24678999999999999999998633

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.5e-39  Score=339.49  Aligned_cols=248  Identities=21%  Similarity=0.260  Sum_probs=200.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-C-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-D-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+.... ......+..|+.+++.++||||+++++++...+..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3788899999999999999854 3 6788888775432 22334578899999999999999999999999999999999


Q ss_pred             cCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          306 MSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       306 ~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      +++|+|.+.+.    ...++++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            99999998775    344689999999999999999999998   99999999999999999999999999998765332


Q ss_pred             C-ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          382 S-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       382 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      . .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....       ........... .       
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~-~-------  288 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLYGK-Y-------  288 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-C-------
Confidence            2 123345699999999999999999999999999999999999999964221       11111111100 0       


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                        ...+...+..+.+++.+|++.+|++||++.+++.
T Consensus       289 --~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 --DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              0112223467899999999999999999999975

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.9e-39  Score=319.77  Aligned_cols=253  Identities=27%  Similarity=0.405  Sum_probs=199.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCC--EEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  301 (549)
                      .++|++.+.||+|+||.||+|.++ ++.  .+++|.++..........+.+|+.++.++ +|+||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888899999999999999975 344  46788776544333445788999999999 89999999999999999999


Q ss_pred             EeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc
Q 008893          302 VYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE  365 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  365 (549)
                      +|||+++++|.++++..                ..+++..+..++.|++.||+|||+.   +++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            99999999999998632                2578999999999999999999998   9999999999999999999


Q ss_pred             eEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHH
Q 008893          366 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWV  444 (549)
Q Consensus       366 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  444 (549)
                      +||+|||+++......  ......++..|+|||++.+..++.++|||||||++|||+| |..||......       +..
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~  233 (303)
T cd05088         163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELY  233 (303)
T ss_pred             EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-------HHH
Confidence            9999999986432111  1111224668999999988889999999999999999998 99998632211       111


Q ss_pred             HHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       445 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ......          .....+...+..+.+++.+|++.+|++||++.+++++|+.
T Consensus       234 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         234 EKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             HHHhcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111110          0001111223568899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-39  Score=315.52  Aligned_cols=255  Identities=25%  Similarity=0.422  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  299 (549)
                      .++|.+.+.||+|+||.||+|...+      +..||+|.+...........+.+|+.++..++|||++++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578889999999999999998642      4689999987554334445788999999999999999999999999999


Q ss_pred             eeEeeccCCCchhhhhccC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEe
Q 008893          300 LLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG  369 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  369 (549)
                      ++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            9999999999999998532          2478899999999999999999998   99999999999999999999999


Q ss_pred             ecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHH
Q 008893          370 DFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKI  447 (549)
Q Consensus       370 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  447 (549)
                      |||+++........ ......++..|+|||.+.+..++.++|||||||++||++| |..||......    ....+.   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~~---  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE----EVLKFV---  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH----HHHHHH---
Confidence            99999765433221 1223346789999999988889999999999999999998 88888532211    111111   


Q ss_pred             hhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       448 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      . ....         ...+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus       235 ~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 I-DGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             h-cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            1 1110         01112224678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.8e-39  Score=314.84  Aligned_cols=253  Identities=24%  Similarity=0.404  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCC----EEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++|+..+.||+|+||+||+|.+. +|+    .||+|.++..........+..|+.++..+.|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            56888899999999999999854 444    4899998765544445678899999999999999999999875 45789


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ++||+++|+|.+.+.. ...+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            9999999999999975 44689999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          381 DSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       381 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      .... .....++..|+|||...+..++.++|||||||++|||+| |..||.....    ..+..++..   ..       
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~---~~-------  228 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLEK---GE-------  228 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHC---CC-------
Confidence            2221 112235678999999998899999999999999999999 8888853221    111111111   00       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         ....+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus       229 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~  267 (279)
T cd05109         229 ---RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR  267 (279)
T ss_pred             ---cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               001112234678899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-39  Score=318.18  Aligned_cols=260  Identities=22%  Similarity=0.354  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC---------------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD---------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG  291 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  291 (549)
                      ++|++.+.||+|+||.||++...+               ...||+|.++..........+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578889999999999999987542               23589999976543334456899999999999999999999


Q ss_pred             EEecCCceeeEeeccCCCchhhhhccC------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeee
Q 008893          292 FCMTTTERLLVYPYMSNGSVASRLKAK------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL  359 (549)
Q Consensus       292 ~~~~~~~~~lv~e~~~~g~L~~~l~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  359 (549)
                      ++...+..++||||+++++|.+++...            ..+++..+..++.|++.||.|||+.   +++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            999999999999999999999988532            2478899999999999999999999   9999999999999


Q ss_pred             ecCCCceEEeecccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh--CCcccccCccccc
Q 008893          360 LDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEFGKTANQ  436 (549)
Q Consensus       360 l~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~~~  436 (549)
                      +++++.+||+|||++.......... .....++..|+|||.+.++.++.++||||||+++|+|++  |..||......  
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence            9999999999999997654322211 122335678999999998899999999999999999998  44555432211  


Q ss_pred             cccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          437 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                        ................      .....+...+..+.+++.+|++.+|++||++++|++.|+
T Consensus       240 --~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 --QVIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HHHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              1111111111100000      000111123467999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-38  Score=321.19  Aligned_cols=245  Identities=23%  Similarity=0.262  Sum_probs=194.4

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||+||+|... +++.||+|+++.....  .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 5789999999754322  2234578888888887 699999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|..++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF  156 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence            99999988777899999999999999999999999   99999999999999999999999999987532211 223345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||++.+..++.++|||||||++|||+||+.||......... ....+.........          ...+..
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~----------~~~p~~  225 (327)
T cd05617         157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILEKP----------IRIPRF  225 (327)
T ss_pred             cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHHhCC----------CCCCCC
Confidence            6999999999999999999999999999999999999999643221111 11112211111110          011222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKMS  492 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~~  492 (549)
                      .+..+.+++.+|++.||++||++.
T Consensus       226 ~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         226 LSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCC
Confidence            336688999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-38  Score=310.42  Aligned_cols=254  Identities=29%  Similarity=0.425  Sum_probs=206.5

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ..++|.+.+.||+|+||.||+|..++++.||||.+....  .....+.+|+.+++.++|+|++++++++......+++||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            346788999999999999999998888899999987543  234578999999999999999999999998899999999


Q ss_pred             ccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |+++++|.+++...  ..+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.+|++|||++........
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999999753  3689999999999999999999999   999999999999999999999999999986653221


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      .......++..|+|||.+.+..++.++||||||+++|||+| |+.||.....    ....   .......          
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~---~~~~~~~----------  221 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVL---EQVERGY----------  221 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHH---HHHHcCC----------
Confidence            11222235568999999998889999999999999999999 9988853221    1111   1111100          


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            001111224678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.9e-39  Score=336.81  Aligned_cols=262  Identities=21%  Similarity=0.282  Sum_probs=193.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC-------
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-------  296 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  296 (549)
                      ...+|.+.+.||+|+||.||+|... +++.||||++....     ....+|+.+++.++||||+++++++...       
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            3467999999999999999999975 58899999885432     1345799999999999999999886432       


Q ss_pred             -CceeeEeeccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC-ceEEee
Q 008893          297 -TERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGD  370 (549)
Q Consensus       297 -~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~D  370 (549)
                       ...++||||+++ ++.+++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence             235689999985 6666553    456799999999999999999999999   999999999999999654 799999


Q ss_pred             cccccccCCCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          371 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       371 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      ||+++.+....  ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...........+.........
T Consensus       215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99998664322  22334689999999998664 6899999999999999999999999754322111111110000000


Q ss_pred             -----------ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 -----------EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 -----------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                                 ......+....+...++...+.++.+++.+||+.||.+|||+.|++++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                       000000011111111222334678999999999999999999999854

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3e-38  Score=308.96  Aligned_cols=255  Identities=23%  Similarity=0.335  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++....  ......+.+|++++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999976 799999998864322  222457889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          304 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       304 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ||+++++|.+++..    ...+++..+..++.+++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998852    34689999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....     ...+........         
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~---------  223 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEKC---------  223 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHhhhhcC---------
Confidence            3222 2234588899999999988899999999999999999999999864321     111222111110         


Q ss_pred             cccCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDR-IELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       .....+. .....+.+++.+|+..+|++||++.+|++.|+.
T Consensus       224 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         224 -DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             -CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence             0111111 344678999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-38  Score=312.02  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CC---CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      .++|+..+.||+|+||.||+|... ++   ..+|+|.++..........+..|+++++.++|+|++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346788899999999999999975 23   37999998755433334578899999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ||||+++++|.+++.. ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            9999999999999875 35789999999999999999999999   9999999999999999999999999999866533


Q ss_pred             CCceee--ccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          381 DSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       381 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ......  ....+..|+|||++....++.++||||||+++|||+| |+.||.....       .++...+....      
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~~~i~~~~------  227 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDGF------  227 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhcCC------
Confidence            222111  1223457999999998889999999999999999998 9999864321       11222221111      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                          ........+..+.+++.+|++.+|++||++.+|++.|++
T Consensus       228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                011111234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.5e-39  Score=320.19  Aligned_cols=255  Identities=29%  Similarity=0.406  Sum_probs=202.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC--------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT  296 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  296 (549)
                      .++|.+.+.||+|+||.||+|...        ++..+|+|.++..........+..|+.++..+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            457889999999999999999753        23579999997654333345688899999999 799999999999999


Q ss_pred             CceeeEeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee
Q 008893          297 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL  360 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  360 (549)
                      +..++||||+++|+|.+++...                ..+++.++..++.|++.||+|||+.   +++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            9999999999999999998643                2488999999999999999999998   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG  438 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  438 (549)
                      ++++.+||+|||.++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....      
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------  247 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------  247 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence            999999999999987654322111 112224568999999998889999999999999999998 778875321      


Q ss_pred             cHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       ..+.........          ....+.....++.+++.+|++.+|++||++.++++.|+.
T Consensus       248 -~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~  298 (307)
T cd05098         248 -VEELFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  298 (307)
T ss_pred             -HHHHHHHHHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence             111111111110          011122234678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=309.33  Aligned_cols=248  Identities=29%  Similarity=0.437  Sum_probs=199.4

Q ss_pred             CeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||.||+|....    +..+|+|.+...........+..|+++++.+.|+|++++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998532    36899999986654444567899999999999999999999876 4568999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceee--
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT--  386 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~--  386 (549)
                      |+|.+++.....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++...........  
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence            99999998777899999999999999999999998   9999999999999999999999999999866443322111  


Q ss_pred             ccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.....    ..+..++   .....          ...
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~---~~~~~----------~~~  219 (257)
T cd05060         157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAML---ESGER----------LPR  219 (257)
T ss_pred             CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHH---HcCCc----------CCC
Confidence            1223567999999999999999999999999999998 9999864321    1122221   11111          011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      +...+..+.+++.+|++.+|++||++.++++.|++.
T Consensus       220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            122346789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.6e-39  Score=319.86  Aligned_cols=261  Identities=22%  Similarity=0.302  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||.||++... ++..+|+|.++.........++.+|++++..++||||+++++++...+..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999965 58889999987543333344688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++.....+++..+..++.|++.||.|||+.+  +++||||||+||++++++.+||+|||++......   ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~  155 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA  155 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---cc
Confidence            999999999987778999999999999999999999732  8999999999999999999999999998765322   12


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc--------------
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK--------------  451 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------  451 (549)
                      ....|+..|+|||.+.+..++.++||||||+++|+|+||+.||.......    ...+........              
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCccccccccCCcccccCCCC
Confidence            23458899999999988889999999999999999999999986432111    111110000000              


Q ss_pred             ----------chhhhccccccCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          452 ----------KLEMLVDKDLKNNY-DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       452 ----------~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                                ....+.... .... ......++.+++.+|++.+|++||++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      000000000 0000 01134568999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.5e-38  Score=311.50  Aligned_cols=254  Identities=26%  Similarity=0.393  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-C---CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-D---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .+|++.+.||+|+||.||+|.+. +   +..+|+|.++..........+..|+.++..++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999864 2   3479999987544333345789999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++++|.+++... ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++++|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999998753 4689999999999999999999999   99999999999999999999999999998765433


Q ss_pred             Cceee--ccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          382 SHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       382 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      .....  ...++..|+|||.+.+..++.++||||||+++||+++ |..||......    ....   .......      
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----~~~~---~~~~~~~------  227 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----DVIK---AIEEGYR------  227 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----HHHH---HHhCCCc------
Confidence            22221  1223568999999998899999999999999999887 99998643211    1111   1111100      


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                          ...+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence                01111234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-38  Score=318.49  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=203.8

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC--------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEec
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMT  295 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  295 (549)
                      ...+|.+.+.||+|+||.||+|...        ++..||+|.+...........+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3457888999999999999999741        24579999987544333445788999999999 89999999999999


Q ss_pred             CCceeeEeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeee
Q 008893          296 TTERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL  359 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  359 (549)
                      ....+++|||+++|+|.+++...                ..+++..+..++.||+.||.|||+.   +++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence            99999999999999999998642                2478889999999999999999999   9999999999999


Q ss_pred             ecCCCceEEeecccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCcccccc
Q 008893          360 LDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQK  437 (549)
Q Consensus       360 l~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~  437 (549)
                      +++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |..||....     
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----  244 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----  244 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----
Confidence            9999999999999998764332221 222345678999999998889999999999999999998 777775321     


Q ss_pred             ccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          438 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        ..++.........          ...+...+..+.+++.+||+.+|++||++.|+++.|+.
T Consensus       245 --~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         245 --VEELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             --HHHHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence              1122222211110          01112234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-38  Score=311.32  Aligned_cols=252  Identities=24%  Similarity=0.331  Sum_probs=200.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|++++.+++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577889999999999999986 468999999987554333445688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|..+    ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++......   ..
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~  150 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA  150 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence            999998654    2478889999999999999999999   9999999999999999999999999999765432   12


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....|+..|+|||++.+..++.++||||||+++|+|++|+.||..............+........      .+.+   .
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~---~  221 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL---P  221 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC---C
Confidence            234689999999999998999999999999999999999999964322211111111111111000      0011   0


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ......++.+++.+|++.+|++||+++|++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11123568999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5e-39  Score=339.99  Aligned_cols=254  Identities=23%  Similarity=0.278  Sum_probs=203.0

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCC----
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----  297 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  297 (549)
                      ...++|.+.+.||+|+||+||+|... +|+.||||++..... ......+.+|+..+..++|+|++++.+.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34578999999999999999999854 689999999875432 222346888999999999999999988765432    


Q ss_pred             ----ceeeEeeccCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEe
Q 008893          298 ----ERLLVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG  369 (549)
Q Consensus       298 ----~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  369 (549)
                          ..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence                35799999999999998863    34689999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCC-ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          370 DFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       370 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      |||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....       ....+....
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-------~~~~~~~~~  258 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEVMHKTL  258 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHh
Confidence            9999987643221 22334569999999999999999999999999999999999999996422       112222211


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...     .     ...+...+..+.+++.+||+.+|++||++.+++++
T Consensus       259 ~~~-----~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 AGR-----Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             cCC-----C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            110     0     11122334678999999999999999999999864

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=308.44  Aligned_cols=248  Identities=31%  Similarity=0.435  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .++|+..+.||+|+||.||+|... |+.||+|.++....  ...++..|+.+++.++|+|++++++++...+..++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            357888999999999999999875 78999999976543  456789999999999999999999999998999999999


Q ss_pred             cCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++++|.+++....  .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||.++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999997554  699999999999999999999999   999999999999999999999999999986632211 


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                         ....+..|+|||.+.++.++.++||||||+++||+++ |+.||.....       .+........          ..
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~----------~~  217 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPHVEKG----------YR  217 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhcC----------CC
Confidence               2235668999999998899999999999999999998 9888853211       1111111110          01


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...+...+..+.+++.+|+..+|++||++.|++.+|+.
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            11122234778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.9e-38  Score=308.45  Aligned_cols=249  Identities=26%  Similarity=0.377  Sum_probs=203.9

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|+..+.||+|++|.||+|..+ +++.|++|.+.... .......+.+|+.+++.++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777889999999999999975 68999999986432 223345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++++|.+++..  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            999999999875  35789999999999999999999998   9999999999999999999999999999876543222


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                       .....|++.|+|||+..+..++.++||||||+++|+|+||+.||.....    .   ........ .         ...
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~---~~~~~~~~-~---------~~~  219 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----G---ALILKIIR-G---------VFP  219 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----H---HHHHHHHc-C---------CCC
Confidence             2334588999999999999999999999999999999999999864321    0   11111111 0         011


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..+......+.+++.+|++.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1222344679999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=336.74  Aligned_cols=252  Identities=22%  Similarity=0.256  Sum_probs=204.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECCC-CEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEE-EEec------CCc
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQDG-TVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIG-FCMT------TTE  298 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------~~~  298 (549)
                      ++++.+.|.+|||+.||.|....+ ..||+|++... .......+.+|++++++++ |+|||.+++ ....      .-+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            456778999999999999997765 99999999765 3455667999999999997 999999999 3322      246


Q ss_pred             eeeEeeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          299 RLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      .+|.||||.+|.|.++++.  ...|++.++++|+.|+++|+++||.. .|+|||||||-+||||+.++..||||||.+..
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            7899999999999999973  34599999999999999999999985 77899999999999999999999999999875


Q ss_pred             cCCCC-Cc-------eeeccccccCccCchhh---ccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHH
Q 008893          377 LDHCD-SH-------VTTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       377 ~~~~~-~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      .-... ..       .......|+.|+|||++   .+...++|+|||+|||+||-|+....||+.....           
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----------  264 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----------  264 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----------
Confidence            43322 11       01123378999999986   4667899999999999999999999999854211           


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                               .+++....-.-.+.+...+.+||..||+++|++||++-+|+..+...
T Consensus       265 ---------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  265 ---------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             ---------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                     12222222222346778999999999999999999999999887764

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.7e-39  Score=320.84  Aligned_cols=265  Identities=21%  Similarity=0.299  Sum_probs=199.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|...+.||+|+||.||+|..+ +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46888999999999999999975 58899999997654444445678899999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++ +|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....... .
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  160 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T  160 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence            985 78777754 34589999999999999999999998   999999999999999999999999999976543222 1


Q ss_pred             eeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHH--------HHHhhccchhh
Q 008893          385 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV--------KKIHQEKKLEM  455 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  455 (549)
                      .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+....+....        ...........
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            223457899999998865 458899999999999999999999997543221111010000        00000000000


Q ss_pred             hccccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          456 LVDKDLKN----NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       456 ~~d~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .-.+....    ........++.+++.+|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000000    000112456889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=309.96  Aligned_cols=252  Identities=27%  Similarity=0.411  Sum_probs=198.9

Q ss_pred             CCCCCeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCc-----
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE-----  298 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  298 (549)
                      |.+.+.||+|+||.||+|....    +..||+|+++..... .....+..|+..++.++|||++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    368999998754322 223468899999999999999999999876554     


Q ss_pred             -eeeEeeccCCCchhhhhcc------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeec
Q 008893          299 -RLLVYPYMSNGSVASRLKA------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF  371 (549)
Q Consensus       299 -~~lv~e~~~~g~L~~~l~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  371 (549)
                       .++++||+++|+|..++..      ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             7899999999999988742      23689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhh
Q 008893          372 GLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       372 g~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      |+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....    ..+.++.   ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~~---~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDYL---RH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH---Hc
Confidence            9998664332211 112235678999999988889999999999999999999 8888753221    1111111   11


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..          ....+...+..+.+++.+|++.||++||++.|+++.|++
T Consensus       231 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         231 GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            11          011122334679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.7e-39  Score=328.23  Aligned_cols=250  Identities=20%  Similarity=0.267  Sum_probs=196.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|+..+.||+|+||.||++... +++.||+|+++...  .......+..|+.++..++|+||+++++.+...+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999975 58999999997432  1223446888999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  382 (549)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            9999999999998878899999999999999999999999   999999999999999999999999999875432110 


Q ss_pred             ---------------------------------ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccc
Q 008893          383 ---------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE  429 (549)
Q Consensus       383 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  429 (549)
                                                       .......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             00123469999999999999999999999999999999999999997


Q ss_pred             cCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 008893          430 FGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV  494 (549)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev  494 (549)
                      ......       ....+....... .+.+    .  .....++.+++.+++. +|++|++...+
T Consensus       238 ~~~~~~-------~~~~i~~~~~~~-~~p~----~--~~~s~~~~~li~~l~~-~p~~R~~~~~~  287 (360)
T cd05627         238 SETPQE-------TYRKVMNWKETL-VFPP----E--VPISEKAKDLILRFCT-DSENRIGSNGV  287 (360)
T ss_pred             CCCHHH-------HHHHHHcCCCce-ecCC----C--CCCCHHHHHHHHHhcc-ChhhcCCCCCH
Confidence            433211       111111100000 0000    0  0123567788888764 99999964333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2e-38  Score=315.42  Aligned_cols=261  Identities=21%  Similarity=0.350  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-----------------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-----------------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL  289 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  289 (549)
                      ++|++.+.||+|+||.||++...                 ++..||+|.++..........+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46889999999999999998532                 2347999999765433344578999999999999999999


Q ss_pred             EEEEecCCceeeEeeccCCCchhhhhccC-----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCee
Q 008893          290 IGFCMTTTERLLVYPYMSNGSVASRLKAK-----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI  358 (549)
Q Consensus       290 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  358 (549)
                      ++++...+..+++|||+++++|.+++...           ..+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999988642           2477889999999999999999999   999999999999


Q ss_pred             eecCCCceEEeecccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh--CCcccccCcccc
Q 008893          359 LLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEFGKTAN  435 (549)
Q Consensus       359 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~~  435 (549)
                      ++++++.++|+|||+++.+....... .....++..|+|||...++.++.++|||||||++|||+|  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999998654322211 122234678999999888899999999999999999998  566765322111


Q ss_pred             ccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                          .................      ...+..++..+.+++.+||+.||++||++.||++.|+.
T Consensus       242 ----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 ----VIENTGEFFRDQGRQVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ----HHHHHHHHHhhcccccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                11111111111000000      01112234678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2e-38  Score=308.42  Aligned_cols=251  Identities=27%  Similarity=0.452  Sum_probs=203.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      .+|+..+.||+|+||.||+|.+.+++.+|+|.+....  .....+.+|+++++++.|||++++++++......++++||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            4677889999999999999998778899999987543  23457889999999999999999999999999999999999


Q ss_pred             CCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      ++++|.+++.. ...++++.+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++...........
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            99999999875 34689999999999999999999998   999999999999999999999999999876543222222


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      ....++.+|+|||.+.++.++.++||||||+++|||++ |+.||.....       ...........   ...       
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~---~~~-------  221 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETINAGF---RLY-------  221 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHhCCC---CCC-------
Confidence            22335678999999998899999999999999999998 8888863221       11111111110   001       


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      .+...+..+.+++.+||+.+|++||++.|++++|.
T Consensus       222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            11122467999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-38  Score=321.30  Aligned_cols=255  Identities=18%  Similarity=0.207  Sum_probs=198.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||++... +++.||+|++....  .......+.+|..++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47888999999999999999976 58899999986432  1122345788999999999999999999999999999999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999976 45789999999999999999999999   999999999999999999999999999987654333


Q ss_pred             ceeeccccccCccCchhhcc-----CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          383 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      .......||+.|+|||++.+     +.++.++|||||||++|||++|+.||......       .............   
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~---  227 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHEERF---  227 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHHHHHcCCCcc---
Confidence            22334569999999999875     46788999999999999999999999643211       1111111110000   


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  497 (549)
                        .+ .......+..+.+++.+|+..++++  |+++++++++
T Consensus       228 --~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 --QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             --cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence              00 0001122467889999998866544  4577777754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=8.4e-39  Score=322.37  Aligned_cols=247  Identities=24%  Similarity=0.267  Sum_probs=194.3

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHH-HHhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||+||+|... +++.||+|++.....  ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 578899999864321  112233444443 56778999999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|.+++.....+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~~  156 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccccc
Confidence            99999998877889999999999999999999999   999999999999999999999999999975432221 23345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......       .........         ..  .....
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~---------~~--~~~~~  218 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNK---------PL--QLKPN  218 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-------HHHHHHHhC---------Cc--CCCCC
Confidence            6999999999999999999999999999999999999999643211       111111110         00  01112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      ....+.+++.+|++.+|.+||++.+.+..+.+.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~  251 (325)
T cd05602         219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNH  251 (325)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcC
Confidence            236788999999999999999988655544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.7e-38  Score=310.34  Aligned_cols=252  Identities=27%  Similarity=0.392  Sum_probs=195.7

Q ss_pred             CCCCCeeeeeCCeEEEEEEECC-CC--EEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecC------Cc
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQD-GT--VVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TE  298 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  298 (549)
                      |.+.+.||+|+||.||+|...+ +.  .||+|.++.... ......+..|+..++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467899999999999999764 33  689998875432 22244688899999999999999999987532      24


Q ss_pred             eeeEeeccCCCchhhhhc------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecc
Q 008893          299 RLLVYPYMSNGSVASRLK------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG  372 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  372 (549)
                      .++++||+++|+|.+++.      ....+++.....++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999988763      223589999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhc
Q 008893          373 LAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQE  450 (549)
Q Consensus       373 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (549)
                      +++......... .....+++.|+|||...+..++.++||||||+++|||++ |+.||......    .+.   ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~---~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS----EIY---DYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHH---HHHHcC
Confidence            998764332211 122235678999999999999999999999999999999 78888642211    111   111111


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       451 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...          ..+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            110          0111234668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-38  Score=316.98  Aligned_cols=255  Identities=20%  Similarity=0.212  Sum_probs=197.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||++... +++.||+|++....  .......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999975 58999999986422  1223345888999999999999999999999999999999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+++|+|.+++.. ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            99999999999975 45789999999999999999999999   999999999999999999999999999876543332


Q ss_pred             ceeeccccccCccCchhhcc-----CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          383 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      .......||+.|+|||++..     ..++.++|||||||++|||++|+.||.....       .+.............+.
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~  230 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKEHFQFP  230 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCcccCC
Confidence            22233469999999999863     4578899999999999999999999964321       11111111111000000


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCC--CCCCCHHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLP--SLRPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP--~~RPs~~evl~~  497 (549)
                           . .....+..+.+++.+|+..++  ..||++++++++
T Consensus       231 -----~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         231 -----P-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -----C-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                 0 011134567888888775433  347898888875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.4e-39  Score=322.36  Aligned_cols=246  Identities=25%  Similarity=0.256  Sum_probs=194.0

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHH-HHhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||+||+|... +|+.||+|++.....  ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999965 689999999865321  122234555554 46778999999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|...+.....+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~  156 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTF  156 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccc
Confidence            99999998877899999999999999999999999   99999999999999999999999999987532211 122345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......       ......... .      ..+    ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~~~~~-~------~~~----~~~  218 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDNILHK-P------LVL----RPG  218 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHHHHcC-C------ccC----CCC
Confidence            6999999999999999999999999999999999999999643211       111111110 0      001    111


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....+.+++.+|++.+|++||++.+.++.+..
T Consensus       219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~  250 (325)
T cd05604         219 ASLTAWSILEELLEKDRQRRLGAKEDFLEIQE  250 (325)
T ss_pred             CCHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence            23568899999999999999998755544433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.8e-38  Score=318.45  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC--------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT  296 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  296 (549)
                      .++|.+.+.||+|+||.||+|...        .+..+|+|.++..........+..|+.++..+ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            457888999999999999999742        24579999987654333445688999999999 699999999999998


Q ss_pred             CceeeEeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee
Q 008893          297 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL  360 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  360 (549)
                      ...+++|||+++|+|.+++...                ..+++..+..++.|++.||.|||+.   +++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence            8999999999999999998642                3488999999999999999999998   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG  438 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  438 (549)
                      ++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....     
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----  242 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-----  242 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            999999999999998664322211 112224567999999998899999999999999999999 8888753211     


Q ss_pred             cHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        ............          ...+...+.++.+++.+|++.+|++||++.|+++.|+.
T Consensus       243 --~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~  292 (314)
T cd05099         243 --EELFKLLREGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK  292 (314)
T ss_pred             --HHHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence              111111111100          01122234678899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-38  Score=320.57  Aligned_cols=243  Identities=23%  Similarity=0.294  Sum_probs=195.2

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeEe
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  303 (549)
                      +|+..+.||+|+||+||+|... +|+.||+|++.....  ......+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999965 689999999875321  223345777888888775 577888999999989999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-V  156 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-c
Confidence            9999999999998877899999999999999999999999   99999999999999999999999999987543221 1


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||......       .........         .  .
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~---------~--~  218 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------ELFQSIMEH---------N--V  218 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC---------C--C
Confidence            223446899999999999989999999999999999999999999743211       111111110         0  1


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMS  492 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  492 (549)
                      .++...+..+.+++.+|++.+|.+|++..
T Consensus       219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         219 SYPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence            12222346788999999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.5e-38  Score=311.53  Aligned_cols=248  Identities=25%  Similarity=0.287  Sum_probs=195.4

Q ss_pred             eeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCch
Q 008893          235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV  311 (549)
Q Consensus       235 iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  311 (549)
                      ||+|+||.||++..+ +|+.||+|.+.....  ......+..|+++++.++||||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999965 589999999864321  12233456799999999999999999999999999999999999999


Q ss_pred             hhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccc
Q 008893          312 ASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR  389 (549)
Q Consensus       312 ~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  389 (549)
                      .+.+..  ...+++..+..++.||+.||.|||+.   +|+||||||+||++++++.++|+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            988753  33589999999999999999999998   99999999999999999999999999998664322  223346


Q ss_pred             cccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHH
Q 008893          390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE  469 (549)
Q Consensus       390 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  469 (549)
                      |+..|+|||++.+..++.++|||||||++|||++|+.||........   .........         ...... .....
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---~~~~~~~~~---------~~~~~~-~~~~~  222 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---KEELKRRTL---------EDEVKF-EHQNF  222 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---HHHHHHHhh---------cccccc-ccccC
Confidence            89999999999998999999999999999999999999864221111   111111111         000000 01123


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          470 LEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       470 ~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..++.+++.+||+.||++||+++|+++.+..
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~  253 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDPRK  253 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence            4678999999999999999999888765554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-38  Score=322.50  Aligned_cols=256  Identities=27%  Similarity=0.399  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE------CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC-C
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT-T  297 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  297 (549)
                      .++|.+.+.||+|+||.||+|..      .+++.||||+++..........+.+|+.++..+ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35788999999999999999973      347899999997654333445688999999999 689999999988654 4


Q ss_pred             ceeeEeeccCCCchhhhhccC-----------------------------------------------------------
Q 008893          298 ERLLVYPYMSNGSVASRLKAK-----------------------------------------------------------  318 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~-----------------------------------------------------------  318 (549)
                      ..+++|||+++|+|.++++..                                                           
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            578999999999999887532                                                           


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc-eeeccc
Q 008893          319 --------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVR  389 (549)
Q Consensus       319 --------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~  389 (549)
                              ..+++..+..++.||+.||.|||+.   +|+||||||+||++++++.+||+|||++......... ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    2368888999999999999999999   9999999999999999999999999999765322211 112233


Q ss_pred             cccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       390 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||.......      ...........          ...+..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~----------~~~~~~  306 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTR----------MRAPDY  306 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCC----------CCCCCC
Confidence            5678999999988899999999999999999997 888886422110      01111111100          001111


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...++.+++..||+.+|++||++.|++++|+.
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            23568999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.5e-39  Score=292.76  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=203.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC---CcH----HHHHHHHHHHhhc-cCCCccceEEEEec
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI---GGE----IQFQTEVEMISLA-VHRNLLRLIGFCMT  295 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~----~~~~~e~~~l~~l-~h~niv~l~~~~~~  295 (549)
                      -...|...+.+|.|..++|-+..++ +|+.+|+|++......   ...    +.-..|+.+|+++ .||+|+++.++|..
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3456788899999999999998865 5889999998543211   111    2345689999988 59999999999999


Q ss_pred             CCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          296 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      +...++|+|.|+.|.|.+++.+.-.+++....+|+.|+..|+.|||..   .||||||||+|||+|++.++||+|||+++
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceee
Confidence            999999999999999999999998999999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCceeeccccccCccCchhhcc------CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          376 LLDHCDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      .+..+  ......+||++|+|||.+.-      ..|+..+|+||.||++|.|+.|.+||.-.              ... 
T Consensus       172 ~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--------------kQm-  234 (411)
T KOG0599|consen  172 QLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--------------KQM-  234 (411)
T ss_pred             ccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--------------HHH-
Confidence            87743  44566789999999998753      35788999999999999999999998521              100 


Q ss_pred             ccchhhhccccc--cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 EKKLEMLVDKDL--KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 ~~~~~~~~d~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       -.+..+.....  ...--...+....+|+.+|++.||++|.|++|++.+
T Consensus       235 -lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  235 -LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             -HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence             01111111111  111112345678999999999999999999999864

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.9e-38  Score=309.25  Aligned_cols=256  Identities=22%  Similarity=0.340  Sum_probs=205.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||+|.. .+++.+|||.+......  .....+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677889999999999999996 47899999988653322  22346889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          304 PYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       304 e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ||+++++|.+++.    ....+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999875    244689999999999999999999999   999999999999999999999999999876643


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ... ......++..|+|||.+.+..++.++||||||+++|+|++|..||......     ...+......      ...+
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~------~~~~  226 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIEQ------CDYP  226 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-----HHHHhhhhhc------CCCC
Confidence            222 122345889999999999888999999999999999999999998642211     1111111111      0111


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..   ........+.+++.+|++.+|++|||+.+|++.++.
T Consensus       227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            11   112244679999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.9e-38  Score=307.16  Aligned_cols=249  Identities=19%  Similarity=0.270  Sum_probs=203.3

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      +|++.+.||+|+||.||++... +++.+|+|.++..........+..|+.+++.++|+|++++++++...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999965 688999999865443444567889999999999999999999999999999999999


Q ss_pred             CCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          307 SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       307 ~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      ++++|.+++..  ...+++.....++.|++.||.|||+.   +|+|+||||+||++++++.++++|||.+........ .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            99999998863  34589999999999999999999999   999999999999999999999999999976643222 2


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.....       ......... ...         ..
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~---------~~  219 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLILKVCQ-GSY---------KP  219 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHHHHhc-CCC---------CC
Confidence            2334588999999999988899999999999999999999999964221       111111111 100         11


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+......+.+++.+||+.||++||++.|++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            122234668899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.2e-38  Score=313.85  Aligned_cols=255  Identities=25%  Similarity=0.416  Sum_probs=203.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  299 (549)
                      .++|+..+.||+|+||.||+|...      ++..||+|.+...........+.+|+.+++.+.|||++++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467889999999999999999863      46789999987654333345689999999999999999999999999999


Q ss_pred             eeEeeccCCCchhhhhccC----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCe
Q 008893          300 LLVYPYMSNGSVASRLKAK----------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN  357 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  357 (549)
                      +++|||+++|+|.+++...                      ..+++..++.++.|++.||.|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            9999999999999998632                      2478889999999999999999998   99999999999


Q ss_pred             eeecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCcccc
Q 008893          358 ILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTAN  435 (549)
Q Consensus       358 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~  435 (549)
                      |++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....  
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--  238 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--  238 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            99999999999999998765332211 1122234667999999998899999999999999999998 8778753221  


Q ss_pred             ccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                           ..+........ ..         ..+...+..+.+++.+|++.+|++|||+.|+++.|+.
T Consensus       239 -----~~~~~~~~~~~-~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 -----EEVIYYVRDGN-VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -----HHHHHHHhcCC-CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                 11222211111 10         0111234678999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-38  Score=313.98  Aligned_cols=260  Identities=24%  Similarity=0.367  Sum_probs=203.1

Q ss_pred             CCCCCCeeeeeCCeEEEEEEE-----CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC--Ccee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERL  300 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  300 (549)
                      -|.+.+.||+|+||.||.+..     .++..||+|.++..........+.+|+.+++.++|||++++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467889999999999999974     247899999987554344455799999999999999999999998775  5688


Q ss_pred             eEeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          301 LVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      +||||+++++|.+++... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999998653 4689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCc--eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccc--------cccccHHHHHHHHhh
Q 008893          380 CDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTA--------NQKGAMLDWVKKIHQ  449 (549)
Q Consensus       380 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~  449 (549)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||+|++.|.......        ........++.....
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            3221  112344677899999998888999999999999999999987664321110        000011111111111


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..          ....+...+..+.+++.+|++.+|++||+++++++.++.
T Consensus       242 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         242 GK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             Cc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            10          011122234779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3e-38  Score=308.08  Aligned_cols=252  Identities=23%  Similarity=0.391  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .++|.+.+.||+|+||.||+|...++..+|+|.++...  .....+.+|+.+++.++|+|++++.+++.. ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            46788999999999999999998778889999887532  234568899999999999999999999887 778999999


Q ss_pred             cCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++++|.+++..  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999999864  34678999999999999999999998   9999999999999999999999999999766433222


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......++..|+|||++....++.++||||||+++|+++| |+.||......    ....+.   ....          .
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~---~~~~----------~  221 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRAL---ERGY----------R  221 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHHHH---hCCC----------C
Confidence            2223345678999999998889999999999999999999 88888632211    111111   1110          0


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .......+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus       222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            01112234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-38  Score=306.55  Aligned_cols=247  Identities=31%  Similarity=0.472  Sum_probs=203.7

Q ss_pred             CeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||.||+|....    +..|++|.++..........+.+|++.+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999999753    7899999998665433456799999999999999999999999999999999999999


Q ss_pred             CchhhhhccC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          309 GSVASRLKAK---------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       309 g~L~~~l~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++|.+++...         ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999864         7799999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCC-ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          380 CDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       380 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ... .......++..|+|||.+....++.++||||||+++|||++ |..||.....       ..........       
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~-------  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLRKG-------  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcC-------
Confidence            331 12233457889999999988889999999999999999999 5888864311       1111111110       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                         .....+...+.++.+++.+|++.+|++||++.|++++|+
T Consensus       224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               011112233577999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.3e-38  Score=310.47  Aligned_cols=253  Identities=26%  Similarity=0.410  Sum_probs=202.1

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECC-C---CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQD-G---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      +|++.+.||+|+||.||+|.... +   ..||||.++..........|..|+.+++.++||||+++.+++......++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            47788999999999999999653 3   3699999876543334457999999999999999999999999999999999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            99999999999874 45689999999999999999999998   999999999999999999999999999876643322


Q ss_pred             cee--eccc--cccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          383 HVT--TAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       383 ~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ...  ....  .+..|+|||.+.+..++.++||||||+++||+++ |..||......    ....++   ....      
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~i---~~~~------  228 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINAI---EQDY------  228 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHHH---HcCC------
Confidence            111  1111  2457999999999999999999999999999987 99998642211    111111   1110      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                          ....+...+..+.+++.+|++.+|++||++.+++..|+.
T Consensus       229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         229 ----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                001112234678899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.2e-38  Score=312.58  Aligned_cols=253  Identities=25%  Similarity=0.408  Sum_probs=200.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      .+|...+.||+|+||.||++...      ++..+|+|.+.... ......+.+|+++++.++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            46777899999999999999632      35689999887543 233457999999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc
Q 008893          301 LVYPYMSNGSVASRLKAK---------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE  365 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  365 (549)
                      ++|||+++++|.+++...               ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            999999999999998643               2489999999999999999999998   9999999999999999999


Q ss_pred             eEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHH
Q 008893          366 AVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDW  443 (549)
Q Consensus       366 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  443 (549)
                      +||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......       +.
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~  233 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------EA  233 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------HH
Confidence            999999999765432211 1122235678999999999999999999999999999999 88888532211       11


Q ss_pred             HHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          444 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       444 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .........          ...+...+..+.+++.+||+.||++||++.||++.|+.
T Consensus       234 ~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 IECITQGRE----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHcCcc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            111111000          01112234678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-38  Score=310.32  Aligned_cols=254  Identities=28%  Similarity=0.415  Sum_probs=200.7

Q ss_pred             CCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHH-HHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      |+..+.||+|+||+||++.... ++.||+|++.......... ....|+..+..++||||+++++++......+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999999764 6789999998764322221 2355899999999999999999999999999999999


Q ss_pred             CCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceee
Q 008893          307 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT  386 (549)
Q Consensus       307 ~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  386 (549)
                      ++++|.+++.....+++..+..++.|++.||.+||+.   +++|+||||+||++++++.++|+|||.+..... ......
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~  156 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENFN  156 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEBS
T ss_pred             ccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cccccc
Confidence            9999999998667799999999999999999999999   999999999999999999999999999976421 222334


Q ss_pred             ccccccCccCchhhc-cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          387 AVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ...++..|+|||.+. +..++.++||||+|+++|+|++|..||.........    .......... ...   . ..  .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~----~~~~~~~~~~-~~~---~-~~--~  225 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL----EIIEKILKRP-LPS---S-SQ--Q  225 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH----HHHHHHHHTH-HHH---H-TT--S
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhh----hhhhhccccc-ccc---c-cc--c
Confidence            556899999999998 788999999999999999999999999754111111    1111110000 000   0 00  0


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .......+.+++.+|++.||++||++.+++++
T Consensus       226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00012679999999999999999999999863

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-38  Score=309.32  Aligned_cols=246  Identities=27%  Similarity=0.402  Sum_probs=194.1

Q ss_pred             CeeeeeCCeEEEEEEECC-CC--EEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQD-GT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||.||+|..++ +.  .+++|.++..........+..|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999754 43  57888887544334445788999999999 799999999999999999999999999


Q ss_pred             CchhhhhccCC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecc
Q 008893          309 GSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG  372 (549)
Q Consensus       309 g~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  372 (549)
                      |+|.+++....                .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            99999986432                478999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhcc
Q 008893          373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEK  451 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (549)
                      ++.......  .......+..|+|||++....++.++||||||+++|||+| |..||.....       .+.........
T Consensus       158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~  228 (270)
T cd05047         158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYEKLPQGY  228 (270)
T ss_pred             Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HHHHHHHhCCC
Confidence            986322111  1111224567999999988889999999999999999997 9999853221       11111111110


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       452 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .          ...+......+.+++.+|++.+|.+||++.+++..|+.
T Consensus       229 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         229 R----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             C----------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            0          01111233578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-41  Score=298.83  Aligned_cols=253  Identities=22%  Similarity=0.291  Sum_probs=207.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++.|++.+.||+|.|+.||+..+. +|+.+|+|++.... .....+.+.+|+.+.+.++||||+++.+.+.+....++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            356777889999999999998865 68999999886432 2335667999999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec---CCCceEEeecccccccCCC
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  380 (549)
                      |+|.|++|..-+-.+..+++..+-.++.||+.+|.|+|.+   +|||||+||+|+++.   ...-+|++|||+|..+.  
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--  164 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence            9999999988776666788899999999999999999999   999999999999995   44568999999999887  


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      ++.......|||+|||||++...+|+..+|||+-||+||-|+.|+.||......    .+.+   .+...     .+  +
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~----rlye---~I~~g-----~y--d  230 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYE---QIKAG-----AY--D  230 (355)
T ss_pred             CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH----HHHH---HHhcc-----cc--C
Confidence            455666778999999999999999999999999999999999999999753221    1111   11110     01  1


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..+..-....++..+|+.+|+..||.+|.|+.|++.+
T Consensus       231 ~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  231 YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            1111222334778999999999999999999998753

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.8e-38  Score=319.41  Aligned_cols=238  Identities=25%  Similarity=0.276  Sum_probs=189.9

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHH-HHhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||.||+|... +|+.||+|++.....  ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 588999999864321  122234555554 57888999999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|...+.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTF  156 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccccc
Confidence            99999888777899999999999999999999998   99999999999999999999999999987532222 122345


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||.....       .........         ...  ..+..
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~---------~~~--~~~~~  218 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILH---------KPL--QLPGG  218 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhc---------CCC--CCCCC
Confidence            689999999999998999999999999999999999999964321       111111111         000  11222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHH
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKMS  492 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~~  492 (549)
                      ....+.+++.+|++.+|.+||+..
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         219 KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCHHHHHHHHHHccCCHhhcCCCC
Confidence            346788999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-38  Score=312.42  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=207.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||+||++... +|+.||+|++...........+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46778899999999999999965 58899999987654444456789999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++...+.+++..+..++.+++.||.|||+..  +++||||||+||++++++.++|+|||++.......   .
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~  159 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---A  159 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---c
Confidence            999999999987778999999999999999999999731  89999999999999999999999999986543221   1


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccc----ccccHHHHHHHHhhccchhhhccccc
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN----QKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      ....|+..|+|||++.+..++.++|||||||++|+|+||+.||.......    ....+..+........      .+.+
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  233 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPRL  233 (284)
T ss_pred             CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCCC
Confidence            23468999999999988899999999999999999999999997543221    1111222222221111      0001


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                      .   ....+..+.+++.+|++.||++||++.|++++.
T Consensus       234 ~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         234 P---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             C---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0   112346789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-38  Score=321.26  Aligned_cols=193  Identities=25%  Similarity=0.349  Sum_probs=166.2

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ...+|.+.+.||+|+||.||+|... +++.||+|......       ...|+.+++.++||||+++++++......++|+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            4467999999999999999999976 47889999754322       346899999999999999999999999999999


Q ss_pred             eccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+. ++|.+++. ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....  
T Consensus       137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            9995 57888775 355799999999999999999999999   9999999999999999999999999999754322  


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF  430 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  430 (549)
                      .......||..|+|||++.+..++.++|||||||++|||+++..++..
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~  258 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE  258 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence            122345689999999999999999999999999999999997666543

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.9e-38  Score=310.65  Aligned_cols=262  Identities=26%  Similarity=0.389  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-----CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec--CCce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  299 (549)
                      .+|.+.+.||+|+||.||++..+     ++..||+|.++... ......+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            46788899999999999999742     57899999987543 2334578899999999999999999998754  3467


Q ss_pred             eeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          300 LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      ++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++...
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            899999999999999865 34689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcee--eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc-----
Q 008893          379 HCDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK-----  451 (549)
Q Consensus       379 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  451 (549)
                      .......  ....++..|+|||++.+..++.++||||||+++|||++|..++......        +........     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  231 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRMMGNDKQGQMI  231 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------hhhhcccccccccc
Confidence            4322111  1122345699999999889999999999999999999987765422110        000000000     


Q ss_pred             --chhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          452 --KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       452 --~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        .+.+..........+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence              0001111111111122234679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.2e-38  Score=313.76  Aligned_cols=264  Identities=24%  Similarity=0.294  Sum_probs=193.9

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhc---cCCCccceEEEEecC-----C
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLIGFCMTT-----T  297 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~  297 (549)
                      +|++.+.||+|+||+||+|... +|+.||+|.++...... ....+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999976 58999999987543222 223456677776655   699999999988642     3


Q ss_pred             ceeeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      ..+++|||+++ +|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999985 888887643  3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          376 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      ......  ......||..|+|||.+.+..++.++|||||||++|||++|+.||...........+..+............
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            664322  223345889999999999889999999999999999999999998643322111111111100000000000


Q ss_pred             ------hcccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 ------LVDKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ------~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                            ...+...   ....+.....+.+++.+|++.||++|||+.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  0000000   00111234568899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=309.87  Aligned_cols=249  Identities=29%  Similarity=0.373  Sum_probs=204.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+++++.++|+|++++.+++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36778899999999999999975 58899999987654444455788999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++... .+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++|+|||+++....... ..
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~  155 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KR  155 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-cc
Confidence            9999999999865 789999999999999999999998   999999999999999999999999999987754322 22


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....++..|+|||++.+..++.++||||||+++|+|+||+.||......       ........ ..     .+.+... 
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~-~~-----~~~~~~~-  221 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIPK-NN-----PPSLEGN-  221 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhhh-cC-----CCCCccc-
Confidence            3345888999999999988999999999999999999999998643211       11111111 10     0111111 


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                        ..+..+.+++.+|+..+|++||+++++++
T Consensus       222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 --KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              03467889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.5e-38  Score=310.16  Aligned_cols=254  Identities=24%  Similarity=0.359  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|.....||+|+||.||+|..+      +.+.|++|.+...........+.+|++++++++|+|++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888899999999999999964      246799998865443223457899999999999999999999999989999


Q ss_pred             eEeeccCCCchhhhhccCC---------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeec
Q 008893          301 LVYPYMSNGSVASRLKAKP---------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF  371 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~---------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  371 (549)
                      +||||+++|+|.+++....         .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987544         689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhc
Q 008893          372 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQE  450 (549)
Q Consensus       372 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (549)
                      |++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.....       ...+.... .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~-~  233 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQ-A  233 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHH-c
Confidence            9987543322222233346778999999988889999999999999999999 7778753211       11111111 0


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       451 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      ....        ...+...+..+.+++.+|++.+|++||++.|++..|.
T Consensus       234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1100        0111123367899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.1e-38  Score=311.32  Aligned_cols=249  Identities=25%  Similarity=0.329  Sum_probs=198.3

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC--cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      |+..+.||+|+||.||++... +++.||+|.+.......  ....+..|+.+++.++|+|++++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999965 68999999986543222  223577899999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++++|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++........ 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            999999998853  23589999999999999999999998   999999999999999999999999999876543221 


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                       .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||..................              ...
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~--------------~~~  222 (285)
T cd05630         158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--------------VQE  222 (285)
T ss_pred             -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh--------------hhh
Confidence             12346899999999999999999999999999999999999999753221110000000000              001


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVR  496 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  496 (549)
                      .++......+.+++.+||+.||++|||     ++|+++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            112223366889999999999999999     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.8e-38  Score=310.23  Aligned_cols=252  Identities=27%  Similarity=0.364  Sum_probs=198.7

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC-----
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT-----  296 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----  296 (549)
                      .+++.|+..+.||+|+||.||+|... +++.||+|.+....  .....+..|+.++.++ +|+|++++++++...     
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            35677888999999999999999975 58899999986543  3345688899999988 699999999998753     


Q ss_pred             -CceeeEeeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccc
Q 008893          297 -TERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL  373 (549)
Q Consensus       297 -~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  373 (549)
                       ...+++|||+++++|.+++..  ...+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence             457899999999999999875  34689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCceeeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          374 AKLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       374 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      +........ ......|+..|+|||++.     ...++.++|||||||++|||++|+.||......      ..... ..
T Consensus       158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~-~~  229 (272)
T cd06637         158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFL-IP  229 (272)
T ss_pred             ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHH-Hh
Confidence            986543222 223346899999999986     335788999999999999999999998632211      01100 00


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      . ..     ....   .....+..+.+++.+||+.+|.+|||+.|++++
T Consensus       230 ~-~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         230 R-NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             c-CC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            0 00     0101   111223578999999999999999999999863

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-38  Score=303.18  Aligned_cols=247  Identities=30%  Similarity=0.444  Sum_probs=199.2

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCchh
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVA  312 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  312 (549)
                      +.||+|+||.||++...+++.||+|.+...........+..|+++++++.|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999987799999999876543334557899999999999999999999999999999999999999999


Q ss_pred             hhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee-ecccc
Q 008893          313 SRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRG  390 (549)
Q Consensus       313 ~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~g  390 (549)
                      +++.. ...+++..+..++.+++.||.|||++   +++||||||+||+++.++.+||+|||++........... ....+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99864 44689999999999999999999999   999999999999999999999999999976542211111 11224


Q ss_pred             ccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHH
Q 008893          391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE  469 (549)
Q Consensus       391 t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  469 (549)
                      +..|+|||.+.++.++.++||||||+++|||+| |..||......       ........          ......+...
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~----------~~~~~~~~~~  220 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIES----------GYRMPAPQLC  220 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhc----------CCCCCCCccC
Confidence            567999999988899999999999999999999 77777532211       11111110          0011112233


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          470 LEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       470 ~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      +..+.+++.+|++.+|++||++.|+++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            467999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.5e-38  Score=308.55  Aligned_cols=253  Identities=24%  Similarity=0.391  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|.+.+.||+|+||.||+|...+    ...|++|...........+.+.+|+.+++.+.|||++++++++.. ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999998643    247899988755433344578999999999999999999998875 557899


Q ss_pred             eeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++|+|.+++... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999753 3689999999999999999999998   99999999999999999999999999998765432


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      ........++..|+|||.+....++.++||||||+++||+++ |..||......    ....   ........       
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~---~~~~~~~~-------  227 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIG---RIENGERL-------  227 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHH---HHHcCCcC-------
Confidence            222222334568999999988889999999999999999996 99998643221    1111   11111100       


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         ..+...+..+.+++.+|+..+|++|||+.++++.|++
T Consensus       228 ---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~  264 (270)
T cd05056         228 ---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD  264 (270)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               1122234679999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-38  Score=316.61  Aligned_cols=252  Identities=22%  Similarity=0.277  Sum_probs=211.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCc--HHHHHHHHHHHhhcc-CCCccceEEEEecCCceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  301 (549)
                      ...|++.+.||+|.||.||+++.+. |+.+|+|.+.+......  ...+.+|+.+|+++. |||||.+.+++......++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            3568888999999999999999775 99999999976654332  357999999999998 9999999999999999999


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC----CCceEEeeccccccc
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE----YYEAVVGDFGLAKLL  377 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Dfg~~~~~  377 (549)
                      |||++.+|.|.+.+... .+++..+..++.|++.++.|||+.   ||+||||||+|+|+..    ++.+|++|||++...
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            99999999999998766 499999999999999999999998   9999999999999963    357999999999988


Q ss_pred             CCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          378 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ..  .......+||+.|+|||++....|+..+||||+||++|.|++|..||..........       .+....      
T Consensus       190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~------  254 (382)
T KOG0032|consen  190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGD------  254 (382)
T ss_pred             cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCC------
Confidence            75  445567789999999999999999999999999999999999999997543221110       111110      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       ..+...........+.+++..|+..||.+|+|+.++++|
T Consensus       255 -~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  255 -FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence             112222333446789999999999999999999999985

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.7e-38  Score=311.58  Aligned_cols=250  Identities=19%  Similarity=0.287  Sum_probs=202.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .+|+..+.||+|+||.||+|+.. +++.|++|.+..... .....+.+|+.+++.+.|+|++++++++......++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            47888899999999999999964 688999999875443 3345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++... .+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......... .
T Consensus        99 ~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~  173 (296)
T cd06654          99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R  173 (296)
T ss_pred             cCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-c
Confidence            9999999998654 589999999999999999999999   9999999999999999999999999998765432221 2


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......      .+.. ......      +  ....
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~-~~~~~~------~--~~~~  238 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYL-IATNGT------P--ELQN  238 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHH-HhcCCC------C--CCCC
Confidence            23458899999999998889999999999999999999999996432111      1111 110000      0  0011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +......+.+++.+|+..+|++||++.|++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            22334668899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.4e-38  Score=304.12  Aligned_cols=246  Identities=28%  Similarity=0.397  Sum_probs=199.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEe-cCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM-TTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~  305 (549)
                      .+|.+.+.||+|+||.||++... |..||+|.++...   ....+.+|+.+++.++|+|++++++++. ..+..++++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            46888899999999999999875 7889999986432   2456889999999999999999999765 44578999999


Q ss_pred             cCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++++|.+++....  .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999999987533  489999999999999999999998   99999999999999999999999999987543221  


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                        ....++..|+|||++.+..++.++||||||+++|||++ |+.||....       ...........          ..
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-------~~~~~~~~~~~----------~~  217 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKG----------YK  217 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhcC----------CC
Confidence              22335668999999998889999999999999999998 888875321       11111111111          01


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            11122334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=313.32  Aligned_cols=267  Identities=21%  Similarity=0.275  Sum_probs=205.7

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|+..+.||+|+||.||+|... +++.||+|.++.... ......+.+|+++++.++|+||+++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6888899999999999999976 588999999875432 22345789999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      ++++.+..+......+++..+..++.||+.||.|||+.   +++|+||+|+||++++++.+||+|||++...........
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            99888777776666799999999999999999999999   999999999999999999999999999987665433233


Q ss_pred             eccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh--------hccch---
Q 008893          386 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH--------QEKKL---  453 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~---  453 (549)
                      ....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+........        .....   
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            345678899999999888 789999999999999999999999864322111000000000000        00000   


Q ss_pred             --hhhccc-cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          454 --EMLVDK-DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       454 --~~~~d~-~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        ....+. .....++...+.++.+++.+||+.+|++||++++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence              000000 00011222335789999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-38  Score=323.85  Aligned_cols=262  Identities=22%  Similarity=0.285  Sum_probs=201.5

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC---CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+....      ...+|+++++.++||||+++++++......+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            357899999999999999999753   35789999886432      346899999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||++. ++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||+++.......
T Consensus       165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            99996 68888887777899999999999999999999999   999999999999999999999999999976554322


Q ss_pred             c-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc-ch-------
Q 008893          383 H-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK-KL-------  453 (549)
Q Consensus       383 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~-------  453 (549)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+....... ..       
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            2 22345699999999999999999999999999999999999999975443322111111111110000 00       


Q ss_pred             --hh--hccccccCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          454 --EM--LVDKDLKNNYD-------RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       454 --~~--~~d~~l~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        ..  -........+.       .....++.+++.+|++.||++||++.|++.+
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence              00  00000000000       0123567889999999999999999999975

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.1e-38  Score=319.16  Aligned_cols=255  Identities=19%  Similarity=0.208  Sum_probs=197.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||++..+ +++.+|+|++....  .......+..|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999976 47889999986422  1122335888999999999999999999999999999999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            99999999999975 45789999999999999999999999   999999999999999999999999999876543332


Q ss_pred             ceeeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          383 HVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.....       ...............  
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~--  228 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKERFQ--  228 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCcccc--
Confidence            2333456999999999986     34578999999999999999999999964321       111111111110000  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  497 (549)
                         . .......+..+.+++.+|+..++.+  ||+++|++++
T Consensus       229 ---~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 ---F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ---C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence               0 0001123467888899888654444  6888888865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.3e-38  Score=305.57  Aligned_cols=247  Identities=30%  Similarity=0.408  Sum_probs=198.9

Q ss_pred             CeeeeeCCeEEEEEEECC--C--CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQD--G--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|++|.||+|.+.+  +  ..||+|.+...........+..|+..+++++||||+++++++.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999643  3  36999999766543445579999999999999999999999988 889999999999


Q ss_pred             CchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce--
Q 008893          309 GSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--  384 (549)
Q Consensus       309 g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--  384 (549)
                      ++|.+.+...  ..+++.....++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.........  
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            9999998754  3689999999999999999999999   99999999999999999999999999998765432221  


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      .....++..|+|||++.+..++.++||||||+++|||+| |+.||.....       .+..........         ..
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~---------~~  220 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-------SQILKKIDKEGE---------RL  220 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCC---------cC
Confidence            122347789999999999899999999999999999999 9999853221       111111111000         00


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      ..+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            111223467999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.6e-38  Score=307.55  Aligned_cols=251  Identities=21%  Similarity=0.334  Sum_probs=202.3

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC-----CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      +|...+.||+|+||.||+|...+|+.+|+|.+......     .....+.+|+.+++.++|+||+++.+++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47788999999999999999888999999988643211     1123588999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      +||+++++|.+++.....+++..+..++.|++.||+|||+.   +|+|+||+|+||++++++.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence            99999999999998777899999999999999999999998   999999999999999999999999999876532111


Q ss_pred             -----ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          383 -----HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       383 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                           .......|+..|+|||++.+..++.++||||||+++|+|+||+.||.......      ...........     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~-----  226 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYIGAHRGL-----  226 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHhhhccCC-----
Confidence                 11223458899999999998889999999999999999999999996422111      00000000000     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .+    ..+......+.+++.+|++.+|++||++.|+++
T Consensus       227 ~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 MP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            01    112223467899999999999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.5e-38  Score=310.46  Aligned_cols=267  Identities=21%  Similarity=0.244  Sum_probs=203.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|+..+.||+|+||.||+|..+ +|+.||+|++..... ......+.+|+.+++.++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888899999999999999976 589999999865432 2233467899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+++++|..++.....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++........ .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~  156 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D  156 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence            999999988887666799999999999999999999998   999999999999999999999999999987654322 1


Q ss_pred             eeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh--------ccchhh
Q 008893          385 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ--------EKKLEM  455 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~  455 (549)
                      .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+....+.........        ......
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            223457889999999876 45789999999999999999999999754322111111100000000        000000


Q ss_pred             hccccccCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 LVDKDLKNNY-----DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+......     .......+.+++.+|++.+|++||++.|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0000000000     01124678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.3e-38  Score=306.16  Aligned_cols=251  Identities=27%  Similarity=0.395  Sum_probs=191.7

Q ss_pred             CeeeeeCCeEEEEEEECC---CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCC
Q 008893          233 NLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      +.||+|+||.||+|...+   +..+|+|.++..........+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   45799999876554344457889999999999999999999999999999999999999


Q ss_pred             chhhhhccC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          310 SVASRLKAK-----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       310 ~L~~~l~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +|.+++...     ...++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            999998632     2467788889999999999999999   99999999999999999999999999997543322211


Q ss_pred             -eeccccccCccCchhhccC-------CCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          385 -TTAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       385 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.||.......    ....  .. . .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----~~~~--~~-~-~~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ----VLTY--TV-R-EQQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH----HHHH--Hh-h-cccCC
Confidence             1233467889999998642       35789999999999999997 999986432111    1110  00 0 11111


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       456 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      ..++.+..    .....+.+++..|+ .+|++|||++||++.|+
T Consensus       230 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11121111    12356788999999 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.8e-38  Score=307.37  Aligned_cols=249  Identities=27%  Similarity=0.358  Sum_probs=205.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ..|+..+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.+.|+|++++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35677789999999999999975 58899999987554334455788999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++... .+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++........ ..
T Consensus        84 ~~~~~L~~~i~~~-~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~  158 (277)
T cd06640          84 LGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR  158 (277)
T ss_pred             CCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence            9999999998754 589999999999999999999998   999999999999999999999999999976643322 22


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....++..|+|||++.+..++.++||||||+++|||+||..||........       ...          .........
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~----------~~~~~~~~~  221 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------LFL----------IPKNNPPTL  221 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------hhh----------hhcCCCCCC
Confidence            234578899999999988899999999999999999999999864321110       000          011111223


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ....+..+.+++.+||+.+|++||++.+++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            34556789999999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-37  Score=305.02  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=202.0

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc--------HHHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--------EIQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      +|.+...||+|+||.||+|... +++.||+|.+........        ...+..|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999864 588999998865432211        1357889999999999999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++++||+++++|.+++.....+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||.++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            999999999999999998877899999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCc-----eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccch
Q 008893          379 HCDSH-----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       379 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      .....     ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......       -+.....    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~----  226 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-------AIFKIGE----  226 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-------HHHHHhc----
Confidence            32111     1122347889999999998889999999999999999999999997422110       0011000    


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       454 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                        ...    ...+...+..+.+++.+||+.+|++||++.|+++
T Consensus       227 --~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 --NAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --cCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              011    1122233467899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-37  Score=324.23  Aligned_cols=261  Identities=20%  Similarity=0.269  Sum_probs=197.5

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ..+|.+.+.||+|+||.||+|... .++.||||....       ..+.+|++++++++|+||+++++++......++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            457899999999999999999976 478999996432       235689999999999999999999999999999999


Q ss_pred             ccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ++. ++|.+++.. ...++|..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            995 688888764 34699999999999999999999999   9999999999999999999999999999876433221


Q ss_pred             -eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccc----cHHHHHHHHhhc-cchhh--
Q 008893          384 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG----AMLDWVKKIHQE-KKLEM--  455 (549)
Q Consensus       384 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~--  455 (549)
                       ......||..|+|||++.+..++.++|||||||++|||++|..++..........    .+...+...... .....  
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence             2234569999999999999999999999999999999999987765332221111    111111111000 00000  


Q ss_pred             -------hcc---ccccCCCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 -------LVD---KDLKNNYDR-------IELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 -------~~d---~~l~~~~~~-------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                             ...   ......+..       .....+.+++.+||+.||++|||+.|++++
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                   000   000000000       112468899999999999999999999974

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.4e-38  Score=303.83  Aligned_cols=248  Identities=26%  Similarity=0.362  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|+..+.||+|+||.||+|...+ ++.+++|.+.....   ...+.+|+++++.++|+|++++++++......++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            578889999999999999999875 78999999865432   56799999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++........ .
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K  155 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence            999999999864 45789999999999999999999999   999999999999999999999999999987654322 2


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      .....++..|+|||++.+..++.++||||||+++|+|+||+.||........   ..    ... ..     ..+.  ..
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~----~~~-~~-----~~~~--~~  220 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IF----MIP-NK-----PPPT--LS  220 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hh----hhc-cC-----CCCC--CC
Confidence            2234478899999999998999999999999999999999999874322110   00    000 00     0000  01


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .+......+.+++.+|++.+|++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            12223467899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5e-38  Score=318.04  Aligned_cols=255  Identities=29%  Similarity=0.406  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC--------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCC
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT  297 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  297 (549)
                      .+|.+.+.||+|+||.||+|...        .+..||+|.++..........+..|++++.++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999742        12368999887554333455788999999999 7999999999999999


Q ss_pred             ceeeEeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec
Q 008893          298 ERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD  361 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  361 (549)
                      ..++++||+++|+|.+++...                ..+++..+..++.|++.||.|||+.   +++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence            999999999999999998632                2478899999999999999999998   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCcccccccc
Q 008893          362 EYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGA  439 (549)
Q Consensus       362 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~  439 (549)
                      +++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....       
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------  241 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-------  241 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-------
Confidence            99999999999998654322111 122234567999999999999999999999999999999 778875322       


Q ss_pred             HHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          440 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      ..++.........          ...+...+..+.+++.+|++.+|++||++.|+++.|+..
T Consensus       242 ~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         242 VEELFKLLKEGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             HHHHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            1122222211110          011122346788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.6e-38  Score=313.59  Aligned_cols=267  Identities=21%  Similarity=0.281  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|...+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888999999999999999875 58899999987554444445678899999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      ++ ++|.+++.. ...+++..+..++.||+.||.|||+.   +|+|+||||+||++++++.+||+|||++........ .
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~  160 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T  160 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence            97 588888764 45689999999999999999999998   999999999999999999999999999976443221 1


Q ss_pred             eeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc-----
Q 008893          385 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD-----  458 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----  458 (549)
                      .....+++.|+|||.+.+. .++.++||||||+++|||+||+.||...........+........ ......+..     
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  239 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILSNEEFK  239 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhhhcccccc
Confidence            2233478899999998654 578899999999999999999999975432111100000000000 000000000     


Q ss_pred             ----ccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          459 ----KDLKN----NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       459 ----~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                          +....    .........+.+++.+|++.||.+|||++|++++--
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~  288 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY  288 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence                00000    001122456889999999999999999999987443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.8e-38  Score=310.33  Aligned_cols=247  Identities=28%  Similarity=0.377  Sum_probs=200.7

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccC
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      |+..+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            455678999999999999865 5789999998755433444578999999999999999999999999999999999999


Q ss_pred             CCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeec
Q 008893          308 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA  387 (549)
Q Consensus       308 ~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  387 (549)
                      +++|.+++.. ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||++........ ....
T Consensus        86 ~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~  160 (277)
T cd06642          86 GGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNT  160 (277)
T ss_pred             CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhc
Confidence            9999998865 4589999999999999999999998   999999999999999999999999999976643221 1223


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCH
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR  467 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  467 (549)
                      ..++..|+|||++.+..++.++||||||+++|||+||+.|+.......    .   .....          .........
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~---~~~~~----------~~~~~~~~~  223 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----V---LFLIP----------KNSPPTLEG  223 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----H---Hhhhh----------cCCCCCCCc
Confidence            357889999999999899999999999999999999999986322110    0   00010          000111122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          468 IELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       468 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..+..+.+++.+|++.+|++||++.+++++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            334678999999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.1e-38  Score=309.72  Aligned_cols=261  Identities=23%  Similarity=0.345  Sum_probs=204.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-----CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec--CCce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  299 (549)
                      +.|...+.||+|+||.||+|.+.     ++..||||.++..........+.+|++.++.+.|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35677789999999999999864     3689999999765432235579999999999999999999999877  5578


Q ss_pred             eeEeeccCCCchhhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          300 LLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      +++|||+++++|.+++.... .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            99999999999999997543 699999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCcee--eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccccc--------ccHHHHHHHHh
Q 008893          379 HCDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK--------GAMLDWVKKIH  448 (549)
Q Consensus       379 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~  448 (549)
                      .......  ....++..|+|||.+.+..++.++||||||+++|||+||+.|+.........        .....+.... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL-  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH-
Confidence            3222111  1223556799999999889999999999999999999999987643221100        0011111111 


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                               ........+...+.++.+++.+|++.+|++||++.||+++|+.
T Consensus       240 ---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         240 ---------KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             ---------HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence                     1111111122334679999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.4e-38  Score=306.74  Aligned_cols=248  Identities=29%  Similarity=0.470  Sum_probs=197.5

Q ss_pred             CeeeeeCCeEEEEEEECC-------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          233 NLVGKGGFGNVYKGYLQD-------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +.||+|+||.||+|...+       ++.+|+|.+...........+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999998643       2579999887654334456788999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC-----ceEEeeccc
Q 008893          306 MSNGSVASRLKA-------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-----EAVVGDFGL  373 (549)
Q Consensus       306 ~~~g~L~~~l~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~Dfg~  373 (549)
                      +++++|.+++..       ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999863       23478999999999999999999998   999999999999999877     899999999


Q ss_pred             ccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhcc
Q 008893          374 AKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEK  451 (549)
Q Consensus       374 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (549)
                      ++........ ......++..|+|||.+.++.++.++||||||+++|||+| |+.||......    ...   .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~----~~~---~~~~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ----EVL---QHVTAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH----HHH---HHHhcCC
Confidence            9765432211 1122235678999999999999999999999999999998 99988632211    111   1111100


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       452 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                                ....+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       231 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 ----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                      011122345778999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1e-37  Score=304.48  Aligned_cols=248  Identities=30%  Similarity=0.439  Sum_probs=191.7

Q ss_pred             CeeeeeCCeEEEEEEEC----CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec-CCceeeEeeccC
Q 008893          233 NLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTERLLVYPYMS  307 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  307 (549)
                      +.||+|+||.||+|.+.    ++..||+|.+...........+.+|+.+++.++|||++++++++.. +...++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999998644333334578889999999999999999998764 556889999999


Q ss_pred             CCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc---
Q 008893          308 NGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH---  383 (549)
Q Consensus       308 ~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---  383 (549)
                      +|+|.+++... ...++..+..++.|++.||.|||+.   +++||||||+|||+++++.+||+|||+++........   
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999998753 4567888899999999999999998   9999999999999999999999999999765432111   


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCc-ccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR-ALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+. ||....       .............          
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~~----------  220 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-------SFDITVYLLQGRR----------  220 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHhcCCC----------
Confidence            1122346778999999988899999999999999999999654 443211       1111111111100          


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...+...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus       221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            00111223678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.6e-37  Score=302.12  Aligned_cols=250  Identities=29%  Similarity=0.444  Sum_probs=202.4

Q ss_pred             CCCCCeeeeeCCeEEEEEEECC-----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      |++.+.||+|+||.||++...+     +..||+|.++..........+..|+..+..++|+|++++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999999764     38899999976554335667999999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCC--CCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          304 PYMSNGSVASRLKAKPS--LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~--l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||+++++|.+++.....  +++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999975443  89999999999999999999999   99999999999999999999999999998765442


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      ........+++.|+|||.+.+..++.++||||+|+++++|++ |+.||....       .............        
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~--------  222 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-------NEEVLEYLKKGYR--------  222 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhcCCC--------
Confidence            222222337789999999988889999999999999999999 777775311       1111111111110        


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                        ...+...+..+.+++.+|+..+|++|||+.|+++.|
T Consensus       223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              111122346799999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-37  Score=305.38  Aligned_cols=255  Identities=21%  Similarity=0.314  Sum_probs=201.0

Q ss_pred             HHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          223 QSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       223 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      +.+++++.....||+|+||.||+|... ++..|++|.+..... .....+.+|+.+++.++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            345667777789999999999999965 578899998875432 234578899999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhccC-CCC--CHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-CCceEEeeccccccc
Q 008893          302 VYPYMSNGSVASRLKAK-PSL--DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLL  377 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~-~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~  377 (549)
                      ++||+++++|.+++... ..+  ++..+..++.||+.||.|||+.   +|+||||||+||+++. ++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999999998753 445  8888999999999999999998   9999999999999986 679999999998765


Q ss_pred             CCCCCceeeccccccCccCchhhccCC--CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          378 DHCDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      ..... ......|+..|+|||++....  ++.++||||||+++|+|++|+.||........    ..+.....       
T Consensus       160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----~~~~~~~~-------  227 (268)
T cd06624         160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----AMFKVGMF-------  227 (268)
T ss_pred             ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----hHhhhhhh-------
Confidence            43222 122335889999999986644  78899999999999999999999864221110    00000000       


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                          ......+.....++.+++.+|++.+|++|||+.|++++
T Consensus       228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                00111223344678999999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2e-37  Score=303.30  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=197.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC----CcHHHHHHHHHHHhhccCCCccceEEEEecC--Cce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  299 (549)
                      .+|+..+.||+|+||.||+|... ++..|++|.+......    .....+.+|+.+++.++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999975 5899999988643211    1223588899999999999999999988753  567


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++++||+++++|.+.+.....+++.....++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            89999999999999998777799999999999999999999998   999999999999999999999999999976542


Q ss_pred             CCC--ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          380 CDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       380 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ...  .......++..|+|||.+.+..++.++|||||||++|||++|+.||......       ..+.....        
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~--------  223 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIAT--------  223 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhc--------
Confidence            211  1112345888999999999888999999999999999999999998632110       00111100        


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       .......+......+.+++ .||..+|++||+++||+++
T Consensus       224 -~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         224 -QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             -CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence             0011122233335566676 6888999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.7e-38  Score=308.70  Aligned_cols=245  Identities=26%  Similarity=0.342  Sum_probs=195.0

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      |+..+.||+|+||+||+|... +++.||+|.+......  .....+.+|+++++.++|+|++++.+++...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999975 6899999998654321  2233577899999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++++|.+.+..  ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            999999988753  34699999999999999999999998   99999999999999999999999999997654322  


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......|+..|+|||.+.+..++.++|+||||+++|||+||+.||........   ...+.......   .        .
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~---~--------~  222 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLET---E--------E  222 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcc---c--------c
Confidence            12334689999999999988999999999999999999999999974321111   01111111000   0        0


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMS  492 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  492 (549)
                      .+.......+.+++..|++.+|++||++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence            11222345688999999999999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-37  Score=318.31  Aligned_cols=265  Identities=21%  Similarity=0.262  Sum_probs=197.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCC-----
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----  297 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  297 (549)
                      ..++|...+.||+|+||.||++... +|+.||+|.+..... ......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999965 589999999975432 223446789999999999999999999986443     


Q ss_pred             -ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          298 -ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       298 -~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                       ..++||||+++ ++.+.+..  .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence             46899999975 56665543  478899999999999999999999   999999999999999999999999999975


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccH--------HHH-----
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM--------LDW-----  443 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~--------~~~-----  443 (549)
                      ....  .......||..|+|||.+.+..++.++|||||||++|+|+||+.||...........+        ..+     
T Consensus       173 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         173 ACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             cccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            4322  1223346899999999999999999999999999999999999999754321110000        000     


Q ss_pred             --HHHHhhcc------chhhhcccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          444 --VKKIHQEK------KLEMLVDKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       444 --~~~~~~~~------~~~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        +.......      ...+.......   ..........+.+++.+|++.||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence              00000000      00000000000   00111224568899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.1e-38  Score=312.31  Aligned_cols=267  Identities=22%  Similarity=0.301  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++...... .....+.+|+++++.++||||+++++++......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888899999999999999986 5899999998654322 234568899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+++++|..+......+++..+..++.||+.||.|||+.   +++|+||+|+||++++++.++|+|||++....... ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~  156 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV  156 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence            999999988877666799999999999999999999998   99999999999999999999999999998664332 22


Q ss_pred             eeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc--------cchhh
Q 008893          385 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE--------KKLEM  455 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~  455 (549)
                      .....++..|+|||++.+ ..++.++||||||+++|||++|+.||...........+..+.......        .....
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            233457889999999875 347889999999999999999998886433211111111111000000        00000


Q ss_pred             hccccccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 LVDKDLKNN-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+.....     .....+..+.+++.+||+.+|++||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            000000000     011234678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-37  Score=337.90  Aligned_cols=256  Identities=23%  Similarity=0.312  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||+|... +|+.||+|++......  ....++.+|+++++.++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999975 5899999999754322  22346899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhcc-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecc
Q 008893          304 PYMSNGSVASRLKA-----------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG  372 (549)
Q Consensus       304 e~~~~g~L~~~l~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  372 (549)
                      ||+++|+|.+++..           ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998852           12456778899999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC-----------------ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccc
Q 008893          373 LAKLLDHCDS-----------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN  435 (549)
Q Consensus       373 ~~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~  435 (549)
                      +++.......                 .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                 01112459999999999999999999999999999999999999996422110


Q ss_pred             ccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhc
Q 008893          436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRP-KMSEVVRMLEG  500 (549)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~  500 (549)
                          +..   .    ..   +.++.-.. .....+..+.+++.+|++.||++|| +++++.+.|+.
T Consensus       239 ----i~~---~----~~---i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 ----ISY---R----DV---ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             ----hhh---h----hh---ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                000   0    00   00000000 0112336688999999999999996 56666666654

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.1e-38  Score=330.81  Aligned_cols=265  Identities=17%  Similarity=0.249  Sum_probs=193.4

Q ss_pred             HHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC------CCccceEEEE
Q 008893          221 ELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH------RNLLRLIGFC  293 (549)
Q Consensus       221 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~  293 (549)
                      ++...+++|.+.+.||+|+||+||+|... .++.||||+++...  .....+..|+.++..++|      .+++++++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            34445688999999999999999999965 58899999996432  122345567777766654      4588888888


Q ss_pred             ecC-CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCC-------
Q 008893          294 MTT-TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYY-------  364 (549)
Q Consensus       294 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~-------  364 (549)
                      ... ...++|||++ +++|.+++.....+++..+..|+.||+.||.|||+ .   +|+||||||+|||++.++       
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccc
Confidence            754 4678999988 67888888777789999999999999999999997 5   899999999999998765       


Q ss_pred             ---------ceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccc
Q 008893          365 ---------EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN  435 (549)
Q Consensus       365 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~  435 (549)
                               .+||+|||.+.....    ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                     499999998764322    2234569999999999999999999999999999999999999997543211


Q ss_pred             ccccHH--------HHHHHHhhccchhhhcccc--ccCCC---------------CHHHHHHHHHHHHHhcccCCCCCCC
Q 008893          436 QKGAML--------DWVKKIHQEKKLEMLVDKD--LKNNY---------------DRIELEEMVQVALLCTQYLPSLRPK  490 (549)
Q Consensus       436 ~~~~~~--------~~~~~~~~~~~~~~~~d~~--l~~~~---------------~~~~~~~l~~l~~~cl~~dP~~RPs  490 (549)
                      ....+.        .|...... .....+++..  +....               .......+.+|+.+||+.||++|||
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGT-EEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccc-hhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            110000        11100000 0000000000  00000               0011356789999999999999999


Q ss_pred             HHHHHH
Q 008893          491 MSEVVR  496 (549)
Q Consensus       491 ~~evl~  496 (549)
                      ++|+++
T Consensus       432 a~e~L~  437 (467)
T PTZ00284        432 ARQMTT  437 (467)
T ss_pred             HHHHhc
Confidence            999986

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.2e-37  Score=310.85  Aligned_cols=253  Identities=24%  Similarity=0.436  Sum_probs=199.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCC----EEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++|+..+.||+|+||.||+|.+. +|+    .||+|.+...........+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46778899999999999999864 444    57889887554333344688999999999999999999998754 4679


Q ss_pred             EeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ++||+++|+|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999999998754 3689999999999999999999998   9999999999999999999999999999876533


Q ss_pred             CCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          381 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       381 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....    ....+++.   .....     
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~~~---~~~~~-----  230 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDLLE---KGERL-----  230 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH---CCCCC-----
Confidence            221 1122335678999999998899999999999999999998 8888853211    11112111   11000     


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                           ..+......+.+++..||..+|++||+++++++.|+.
T Consensus       231 -----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         231 -----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                 0111233678899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=302.23  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=204.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|+..+.||+|+||.||+|... +++.+++|.+..... .....+.+|+.+++.++|||++++++++......+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            57888999999999999999975 578999999976543 2456789999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++++|.+++... ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||.+....... ..
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  157 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK  157 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence            9999999998765 6799999999999999999999998   99999999999999999999999999987654321 12


Q ss_pred             eeccccccCccCchhhccC---CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          385 TTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      .....++..|+|||.+.+.   .++.++||||||+++|||+||+.||........   ..    .....    ...... 
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---~~----~~~~~----~~~~~~-  225 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---LF----LISKS----NFPPPK-  225 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHhc----cCCCcc-
Confidence            2334588899999999776   789999999999999999999999864321110   00    00000    000000 


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       .......+.++.+++.+|++.+|.+||++.+++.
T Consensus       226 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 -LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             1112334567999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=319.22  Aligned_cols=244  Identities=24%  Similarity=0.360  Sum_probs=201.5

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCch
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV  311 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  311 (549)
                      -+||+|.||+||.|+.. +...+|||-+...... ...-+++|+.+-+.++|.|||+++|.+.+++..-+.||.++||+|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            37899999999999965 4567899988755432 233588999999999999999999999999999999999999999


Q ss_pred             hhhhcc-CCCC--CHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec-CCCceEEeecccccccCCCCCceeec
Q 008893          312 ASRLKA-KPSL--DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA  387 (549)
Q Consensus       312 ~~~l~~-~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~  387 (549)
                      .++++. -+++  .+.++-.+.+||++||.|||++   .|||||||-+|||++ -.|.+||+|||-++.+..- ...+.+
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TET  735 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTET  735 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccc
Confidence            999974 4666  7888889999999999999999   999999999999997 6789999999999877532 334566


Q ss_pred             cccccCccCchhhccCC--CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          388 VRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      +.||..|||||++..++  |..++|||||||++.||.||++||..-..+...  .       .+-+    +  -...+..
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--M-------FkVG----m--yKvHP~i  800 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--M-------FKVG----M--YKVHPPI  800 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--h-------hhhc----c--eecCCCC
Confidence            77999999999997764  889999999999999999999999743322111  0       0000    0  1123456


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      +.+.+.+...+|.+|+.+||.+||+++++++
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            7778889999999999999999999999985

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-38  Score=301.09  Aligned_cols=251  Identities=24%  Similarity=0.255  Sum_probs=204.6

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .|+..+.||+|.-|+||.+.+++ +..+|+|++.+....  ....+.+.|.++|+.++||.+..+++.+..++..+++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            45667899999999999999874 689999999765432  223467889999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC---
Q 008893          305 YMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH---  379 (549)
Q Consensus       305 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~---  379 (549)
                      ||+||+|..+++.+  +.+++..++.++.+++.||+|||..   |||+|||||+||||-++|++.|+||.++.....   
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            99999999998754  4799999999999999999999999   999999999999999999999999998743311   


Q ss_pred             ------------------------------CCC----------------------ceeeccccccCccCchhhccCCCCC
Q 008893          380 ------------------------------CDS----------------------HVTTAVRGTVGHIAPEYLSTGQSSE  407 (549)
Q Consensus       380 ------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~  407 (549)
                                                    ...                      ..+...+||-.|+|||++.+...+.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          000                      0112345899999999999999999


Q ss_pred             cccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCC
Q 008893          408 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSL  487 (549)
Q Consensus       408 ~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~  487 (549)
                      ++|.|+|||++|||+.|..||.+......                +..++.+.+.-...+..+..+.+||.+.|.+||++
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence            99999999999999999999986543322                22233333322222245678999999999999999


Q ss_pred             CCC----HHHHHHH
Q 008893          488 RPK----MSEVVRM  497 (549)
Q Consensus       488 RPs----~~evl~~  497 (549)
                      |..    +.||-+|
T Consensus       379 Rlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRH  392 (459)
T ss_pred             hhccccchHHhhcC
Confidence            998    7777654

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2e-37  Score=308.28  Aligned_cols=249  Identities=19%  Similarity=0.284  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+|++++++++...+..++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            6788999999999999999996 4699999999875432 3345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++... .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......... .
T Consensus        98 ~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~  172 (297)
T cd06656          98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R  172 (297)
T ss_pred             cCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-c
Confidence            9999999998654 589999999999999999999998   9999999999999999999999999998765433221 2


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....+++.|+|||.+.+..++.++||||||+++|+|+||+.||..........       ....        ........
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------~~~~--------~~~~~~~~  237 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIAT--------NGTPELQN  237 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-------eecc--------CCCCCCCC
Confidence            23458889999999999889999999999999999999999996432211100       0000        00000011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      +......+.+++.+|++.+|++||+++++++
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2223466889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.7e-38  Score=320.33  Aligned_cols=265  Identities=19%  Similarity=0.241  Sum_probs=197.7

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecC------
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------  296 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  296 (549)
                      ..++|...+.||+|+||.||++... .++.||||.+...... .....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999865 5889999998754322 2234678899999999999999999988643      


Q ss_pred             CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          297 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      ...++||||+++ ++.+.+..  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence            346899999975 66666643  488999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH--------HHH----
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWV----  444 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~----  444 (549)
                      ....  .......||..|+|||.+.+..++.++|||||||++|||++|+.||.............        .+.    
T Consensus       169 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             CCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            5422  22233468999999999999899999999999999999999999997533211100000        000    


Q ss_pred             ---HHHhh-ccchhhhc-----ccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          445 ---KKIHQ-EKKLEMLV-----DKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       445 ---~~~~~-~~~~~~~~-----d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                         ..... ......+.     .....   ..........+.+++.+|++.||++|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               00000 00000000     00000   00111224568899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-37  Score=308.23  Aligned_cols=252  Identities=23%  Similarity=0.375  Sum_probs=200.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||.||++... +|+.||+|.++..........+.+|+.++++++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999976 68999999987543333345788999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          306 MSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       306 ~~~g~L~~~l~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+  +|+||||||+||+++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999999888753   36899999999999999999999632  8999999999999999999999999998765322  


Q ss_pred             ceeeccccccCccCchhhccCC------CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                       ......++..|+|||.+.+..      ++.++|||||||++|+|+||+.||.......    ........         
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~---------  222 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQLSAI---------  222 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHHHHHH---------
Confidence             122345788999999986543      4889999999999999999999986422111    11111111         


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+.. ....+.....++.+++.+|++.+|++||++.+++.+
T Consensus       223 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         223 VDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             hhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            1100 111233355778999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-38  Score=312.43  Aligned_cols=254  Identities=22%  Similarity=0.283  Sum_probs=203.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeE
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  302 (549)
                      ....|++.+.||+||.+.||++...+.+.+|+|++...... ....-|.+|+.+|.+++ |.+||++++|-..++..|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            44668899999999999999999988889999887654322 22345999999999995 89999999999999999999


Q ss_pred             eeccCCCchhhhhccCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||-+ .+|..+|+++.. .+.-.++.++.||+.|+.++|++   ||||.||||.|+|+-+ |.+||+|||+|..+....
T Consensus       439 mE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence            99975 499999986543 22237888999999999999999   9999999999999976 799999999999887655


Q ss_pred             Cc-eeeccccccCccCchhhccC-----------CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          382 SH-VTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       382 ~~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      .. .....+||+.||+||.+...           ..+.++||||+|||||+|+.|+.||..         +...      
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~---------~~n~------  578 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ---------IINQ------  578 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH---------HHHH------
Confidence            44 33456799999999998533           246789999999999999999999962         2211      


Q ss_pred             ccchhhhccccccCCCCHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          450 EKKLEMLVDKDLKNNYDRIEL-EEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~-~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                      -.++..+.|+....+|+..-. .++.++++.||+.||++||++.|++++-
T Consensus       579 ~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp  628 (677)
T KOG0596|consen  579 IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP  628 (677)
T ss_pred             HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence            123444556644434432221 2399999999999999999999999753

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.7e-37  Score=304.30  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=188.2

Q ss_pred             eeeeeCCeEEEEEEECC---CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCc
Q 008893          234 LVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS  310 (549)
Q Consensus       234 ~iG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  310 (549)
                      .||+|+||.||+|...+   ...+++|.+...........+.+|+..++.++|+||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   457888887654433334568899999999999999999999999999999999999999


Q ss_pred             hhhhhccCC-----CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc-e
Q 008893          311 VASRLKAKP-----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-V  384 (549)
Q Consensus       311 L~~~l~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~  384 (549)
                      |.+++....     ..++.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++......... .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999986432     346788899999999999999999   9999999999999999999999999998754322211 1


Q ss_pred             eeccccccCccCchhhcc-------CCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          385 TTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......       +......... ...+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~-~~~~  230 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQ-DIKL  230 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhcc-CccC
Confidence            122345678999998743       356889999999999999999 77777532211       1111111111 1111


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      .++.    .+...+..+.+++..|+ .||++||+++||++.|.
T Consensus       231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111    12223456778888898 59999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-37  Score=305.13  Aligned_cols=253  Identities=23%  Similarity=0.401  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC-CC----EEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD-GT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      .+|...+.||+|+||.||+|.+.+ |+    .+|+|.+...........+.+|+..++.++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            467788999999999999998643 33    5899988765543344578899999999999999999999987 78899


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ++||+++|+|.+++.. ...+++..+..++.||+.||+|||+.   +++||||||+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            9999999999999875 34689999999999999999999998   9999999999999999999999999999876533


Q ss_pred             CCcee-eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          381 DSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       381 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ..... ....++..|+|||.+....++.++||||||+++||++| |+.||.....       .++.........      
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~------  229 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------VEIPDLLEKGER------  229 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhCCCC------
Confidence            22211 12224568999999988889999999999999999999 9999864321       111111111100      


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                          ...+......+.+++.+||..+|++||++.++++.|+.
T Consensus       230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~  267 (279)
T cd05057         230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK  267 (279)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                11112233568899999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-37  Score=304.75  Aligned_cols=252  Identities=25%  Similarity=0.343  Sum_probs=205.7

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      +|+..+.||+|+||.||++..+ +++.||+|.+..........++.+|+++++.++||||+++++++......++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999976 589999999876654444567899999999999999999999999999999999999


Q ss_pred             CCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          307 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       307 ~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      ++++|.+++... ..+++.....++.|++.||.|||+ .   +++|+||||+||++++++.++|+|||.+......... 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-  157 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-  157 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence            999999999765 678999999999999999999999 7   9999999999999999999999999998765322111 


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                        ...++..|+|||.+.+..++.++||||||+++|+|++|+.||.......  ....+..........          ..
T Consensus       158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~----------~~  223 (265)
T cd06605         158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP--DGIFELLQYIVNEPP----------PR  223 (265)
T ss_pred             --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc--ccHHHHHHHHhcCCC----------CC
Confidence              1558889999999999999999999999999999999999986432211  112222222211110          01


Q ss_pred             CCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          465 YDRI-ELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       465 ~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+.. ....+.+++.+|+..+|++|||+.+++.+
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            1111 44678999999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.7e-38  Score=319.70  Aligned_cols=265  Identities=20%  Similarity=0.265  Sum_probs=197.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecC------
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------  296 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  296 (549)
                      ..++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3468999999999999999999965 588999999975432 22344678899999999999999999987543      


Q ss_pred             CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          297 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      ...++||||+++ +|.+.+..  .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            346999999975 67666643  488999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH--------HHHHHH-
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKI-  447 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~-  447 (549)
                      ....  .......||..|+|||++.+..++.++|||||||++|||++|+.||...........+.        .+.... 
T Consensus       176 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         176 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             cCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            5432  12233468999999999999999999999999999999999999997543211110000        000000 


Q ss_pred             ------hhcc-c-----hhhhccccc---cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          448 ------HQEK-K-----LEMLVDKDL---KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       448 ------~~~~-~-----~~~~~d~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                            .... .     .........   ...........+.+++.+|++.||.+|||+.|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                  0000 0     000000000   000111123568899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.7e-37  Score=306.85  Aligned_cols=265  Identities=21%  Similarity=0.280  Sum_probs=197.1

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|++.+.||+|++|.||+|... +++.||+|.++..... .....+.+|+.+++.++|||++++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999975 6899999998654322 2235688899999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          306 MSNGSVASRLKA---KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       306 ~~~g~L~~~l~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ++ ++|.+++..   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 588887753   24689999999999999999999998   99999999999999999999999999997654322 


Q ss_pred             ceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHH--------Hhhccch
Q 008893          383 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK--------IHQEKKL  453 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~  453 (549)
                      .......+++.|+|||.+.+. .++.++||||||+++|+|+||+.||..................        .......
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            122233478899999988654 4788999999999999999999998743221110000000000        0000000


Q ss_pred             hhhcccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          454 EMLVDKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       454 ~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ....+....   .........++.+++.+|++.||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000000000   00011124667899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.1e-37  Score=309.08  Aligned_cols=193  Identities=24%  Similarity=0.353  Sum_probs=159.4

Q ss_pred             CCeeeeeCCeEEEEEEEC---CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec--CCceeeEeecc
Q 008893          232 KNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLVYPYM  306 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  306 (549)
                      .+.||+|+||+||+|...   +++.||+|.+....   ....+.+|+.+++.++||||+++++++..  ....+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999864   46789999986543   23457789999999999999999998864  34678999998


Q ss_pred             CCCchhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee----cCCCceEEeeccc
Q 008893          307 SNGSVASRLKA---------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGL  373 (549)
Q Consensus       307 ~~g~L~~~l~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~  373 (549)
                      .+ +|.+++..         ...+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            65 77776641         12589999999999999999999999   99999999999999    4567999999999


Q ss_pred             ccccCCCCCc--eeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccC
Q 008893          374 AKLLDHCDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFG  431 (549)
Q Consensus       374 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~  431 (549)
                      ++........  ......||+.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9876533221  22345689999999998774 5899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-37  Score=301.08  Aligned_cols=249  Identities=27%  Similarity=0.399  Sum_probs=202.9

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC----CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA----IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      +|...+.||+|+||.||+|... +++.|++|.+.....    ......+..|+.+++.++|+|++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999976 789999999864331    12335688999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      +||+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++....... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-  156 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence            99999999999998777799999999999999999999998   99999999999999999999999999987654322 


Q ss_pred             ceeeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                       ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.....       .............        
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~--------  220 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKEL--------  220 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccC--------
Confidence             223345889999999987776 89999999999999999999999864321       1111111110111        


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       ...+......+.+++.+|++.+|++||++.+++++
T Consensus       221 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         221 -PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence             11122234678899999999999999999999863

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3e-37  Score=301.85  Aligned_cols=255  Identities=27%  Similarity=0.379  Sum_probs=205.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||+||+|... ++..+++|++...........+.+|++.++.++|+|++++++.+...+..++++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999965 58899999997654444556799999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          306 MSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       306 ~~~g~L~~~l~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      +++++|.+++...   ..+++.....++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999999753   4589999999999999999999998   999999999999999999999999999987654322


Q ss_pred             c---eeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          383 H---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       383 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      .   ......|+..|+|||.+... .++.++||||||+++|+|++|+.||.......   ......    ...      .
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~----~~~------~  224 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTL----QND------P  224 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHh----cCC------C
Confidence            2   12334588999999998877 78999999999999999999999986432211   111111    000      0


Q ss_pred             ccccCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          459 KDLKNNY-DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       459 ~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +.+.... ....+..+.+++.+|++.+|++||++.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0111100 11334678999999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-37  Score=302.28  Aligned_cols=239  Identities=22%  Similarity=0.322  Sum_probs=187.0

Q ss_pred             CeeeeeCCeEEEEEEECC-------------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCce
Q 008893          233 NLVGKGGFGNVYKGYLQD-------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  299 (549)
                      +.||+|+||.||+|.+..             ...|++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            468999999999998532             2258889876533 22344688899999999999999999999999999


Q ss_pred             eeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc-------eEEeec
Q 008893          300 LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-------AVVGDF  371 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------~kl~Df  371 (549)
                      +++|||+++|+|..++.. ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.       ++++||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999988864 45689999999999999999999999   9999999999999987664       899999


Q ss_pred             ccccccCCCCCceeeccccccCccCchhhc-cCCCCCcccchhHhHHHHHHH-hCCcccccCccccccccHHHHHHHHhh
Q 008893          372 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI-SGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       372 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      |++......     ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......       ... ....
T Consensus       157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~-~~~~  223 (262)
T cd05077         157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EKE-RFYE  223 (262)
T ss_pred             CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HHH-HHHh
Confidence            998754321     2234788999999886 466899999999999999998 577776532111       000 0000


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                       ...      ..    ......++.+++.+||+.||++||++.++++.++
T Consensus       224 -~~~------~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 -GQC------ML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -cCc------cC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence             000      00    0112356889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.6e-37  Score=300.63  Aligned_cols=249  Identities=24%  Similarity=0.315  Sum_probs=200.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecC-CceeeEee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-TERLLVYP  304 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  304 (549)
                      +|++.+.||+|++|.||++..+ +++.||+|.+..... ......+.+|+++++.++|+|++++.+.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999965 578999999865432 22344688899999999999999999987644 45789999


Q ss_pred             ccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |+++++|.+++..  ...+++.++..++.+++.|+.|||+.   +++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            9999999998874  34689999999999999999999999   999999999999999999999999999987643222


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......+++.|+|||.+.+..++.++||||||+++++|++|+.||.....       ......... ...         
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~-~~~---------  219 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRIIE-GKL---------  219 (257)
T ss_pred             -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHh-cCC---------
Confidence             22334588999999999999999999999999999999999999863221       111111111 111         


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+......+.+++.+|++.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11223344678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.7e-37  Score=300.40  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=204.2

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|+..+.||+|+||.||.+... +++.+++|.+.... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4778899999999999999854 58899999886443 233345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999754  4689999999999999999999998   999999999999999999999999999987654332 


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||.....       ........... .         .
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~-~---------~  219 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKIVQGN-Y---------T  219 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCC-C---------C
Confidence            22334589999999999888899999999999999999999999864221       11111111110 0         0


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                      ......+..+.+++.+|++.+|++||+++++++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11122346788999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.4e-37  Score=303.72  Aligned_cols=255  Identities=24%  Similarity=0.376  Sum_probs=200.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC---------cHHHHHHHHHHHhhccCCCccceEEEEecCC
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG---------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT  297 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  297 (549)
                      +|...+.||+|+||.||+|... +|+.||+|.++......         ..+.+..|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999864 68999999886421110         1235788999999999999999999999999


Q ss_pred             ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      ..++||||+++++|.+++.....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++++|||+++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            9999999999999999998877899999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCCc-eeeccccccCccCchhhccCC--CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          378 DHCDSH-VTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       378 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      ...... ......|+..|+|||.+....  ++.++||||||+++||+++|..||......      .... ...... ..
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~-~~~~~~-~~  230 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMF-KLGNKR-SA  230 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHH-Hhhccc-cC
Confidence            432211 123345889999999987654  789999999999999999999998532111      1111 111000 01


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..+..    ......+..+.+++.+|++.+|++||++++|+++
T Consensus       231 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         231 PPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11111    1112234678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.5e-37  Score=304.21  Aligned_cols=253  Identities=21%  Similarity=0.305  Sum_probs=200.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..++++||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            46777789999999999999865 688999999875432 2334578899999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++.....+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........ ..
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~  163 (267)
T cd06645          88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KR  163 (267)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-cc
Confidence            99999999998777899999999999999999999999   999999999999999999999999999876543221 22


Q ss_pred             eccccccCccCchhhc---cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          386 TAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ....|+..|+|||.+.   ...++.++|||||||++|+|++|+.||........   .    .......    ...+...
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~----~~~~~~~----~~~~~~~  232 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---L----FLMTKSN----FQPPKLK  232 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---H----HhhhccC----CCCCccc
Confidence            3345899999999974   45688999999999999999999999853221110   0    0000000    0000000


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .  ....+..+.+++.+|++.+|++||++++++++
T Consensus       233 ~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         233 D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            0  00123568899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.5e-38  Score=317.87  Aligned_cols=260  Identities=23%  Similarity=0.340  Sum_probs=201.3

Q ss_pred             CCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-C-----CCccceEEEEecCCcee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-H-----RNLLRLIGFCMTTTERL  300 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~  300 (549)
                      +|++.++||+|+||.|-++.. ++++.||||+++....  -..+-..|+.+|..++ |     -|+|++++++.-.++.+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            789999999999999999995 4699999999986542  2345678999999887 3     48999999999999999


Q ss_pred             eEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC--CceEEeecccccc
Q 008893          301 LVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY--YEAVVGDFGLAKL  376 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfg~~~~  376 (549)
                      ||+|.+.. +|+++++..  .+++...+..++.||+.||.+||+.   +|||+||||+||||.+-  ..+||+|||.+.+
T Consensus       265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999965 999999743  4799999999999999999999999   99999999999999743  4799999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHH-----Hhhcc
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK-----IHQEK  451 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~  451 (549)
                      ....   .. ...-+..|+|||++.+.+|+.+.||||||||++||+||.+.|.+....++-..+.+....     +....
T Consensus       341 ~~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  341 ESQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             cCCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            5432   22 445678999999999999999999999999999999998777765544443333322210     00000


Q ss_pred             chhhhccc-----------c------------------cc---C--------CCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 008893          452 KLEMLVDK-----------D------------------LK---N--------NYDRIELEEMVQVALLCTQYLPSLRPKM  491 (549)
Q Consensus       452 ~~~~~~d~-----------~------------------l~---~--------~~~~~~~~~l~~l~~~cl~~dP~~RPs~  491 (549)
                      +....++.           .                  ..   .        ......-..+.+++.+|+..||.+|+|.
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence            00001111           0                  00   0        0011223568999999999999999999


Q ss_pred             HHHHHH
Q 008893          492 SEVVRM  497 (549)
Q Consensus       492 ~evl~~  497 (549)
                      .|+++|
T Consensus       497 ~qal~H  502 (586)
T KOG0667|consen  497 AQALNH  502 (586)
T ss_pred             HHHhcC
Confidence            999975

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.1e-37  Score=300.84  Aligned_cols=251  Identities=24%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC----CcHHHHHHHHHHHhhccCCCccceEEEEecC--Cce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  299 (549)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+......    .....+.+|+.+++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999999975 5899999988643211    1234688899999999999999999988764  457


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      +++|||+++++|.+++.....+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            79999999999999998767789999999999999999999999   999999999999999999999999999976542


Q ss_pred             CCC--ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          380 CDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       380 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ...  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....      .... ....         
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~-~~~~---------  222 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAI-FKIA---------  222 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHH-HHHh---------
Confidence            211  112234588899999999888899999999999999999999999863211      0000 0000         


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ........+......+.+++.+|+. +|++||+++|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         223 TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            0001122344455678889999985 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.9e-37  Score=301.68  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=199.7

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECC--CCEEEEEEcccCC---------CCCcHHHHHHHHHHHhh-ccCCCccceEEEEec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQD--GTVVAVKRLKDGN---------AIGGEIQFQTEVEMISL-AVHRNLLRLIGFCMT  295 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~--g~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  295 (549)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+....         ......++..|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999765  7889999885322         11122346778887764 799999999999999


Q ss_pred             CCceeeEeeccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCCceEEee
Q 008893          296 TTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGD  370 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~D  370 (549)
                      .+..+++|||+++++|.+.+.    ....+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999998874    34468999999999999999999996 5   899999999999999999999999


Q ss_pred             cccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc
Q 008893          371 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE  450 (549)
Q Consensus       371 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (549)
                      ||.+.......  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....       ..........
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~~  228 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLATKIVEA  228 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHHHHhhc
Confidence            99998765432  22344588999999999988899999999999999999999999863221       1111111110


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       451 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      . .    .+.    ........+.+++.+|++.||++||++.|+..++++
T Consensus       229 ~-~----~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         229 V-Y----EPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             c-C----CcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            0 0    000    011223678999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-38  Score=317.60  Aligned_cols=237  Identities=24%  Similarity=0.260  Sum_probs=185.1

Q ss_pred             eeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhc---cCCCccceEEEEecCCceeeEeeccCC
Q 008893          235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA---VHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       235 iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      ||+|+||+||+|... +++.||+|++......  .....+..|..++...   .||||+++++++......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999975 5899999998643211  1122345566666554   699999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |+|.+.+.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~  156 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTF  156 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccCc
Confidence            99999998888899999999999999999999999   999999999999999999999999999875432221 22345


Q ss_pred             ccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCH
Q 008893          389 RGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR  467 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  467 (549)
                      .||..|+|||.+.+. .++.++|||||||++|||+||+.||.....       .......... .      ..+..   .
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~~-~------~~~~~---~  219 (330)
T cd05586         157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFG-K------VRFPK---N  219 (330)
T ss_pred             cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHcC-C------CCCCC---c
Confidence            699999999998765 479999999999999999999999964321       1111111110 0      00000   1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH
Q 008893          468 IELEEMVQVALLCTQYLPSLRPKMS  492 (549)
Q Consensus       468 ~~~~~l~~l~~~cl~~dP~~RPs~~  492 (549)
                      .....+.+++.+||+.||++||++.
T Consensus       220 ~~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         220 VLSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence            1236688999999999999999543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3e-37  Score=299.87  Aligned_cols=245  Identities=27%  Similarity=0.401  Sum_probs=197.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      ++|++.+.||+|+||.||++.. +++.||+|.++...   ....+.+|+.+++.++|||++++++++... ..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4578899999999999999975 57889999986532   245688999999999999999999998654 579999999


Q ss_pred             CCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          307 SNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       307 ~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......    
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            999999998743  3589999999999999999999998   9999999999999999999999999998754321    


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......+..|+|||.+.+..++.++||||||+++|||++ |+.||.....       ..+.......          ...
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~----------~~~  216 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KEVKECVEKG----------YRM  216 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HHHHHHHhCC----------CCC
Confidence            112234568999999998899999999999999999998 8888864321       1111111111          011


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..+...+..+.+++.+|++.+|++||+++++++.|++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1122234678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.8e-37  Score=306.95  Aligned_cols=261  Identities=25%  Similarity=0.316  Sum_probs=202.5

Q ss_pred             cCHHHHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEe
Q 008893          217 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM  294 (549)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  294 (549)
                      +.++.+..++++|++.+.||+|+||.||++... +++.+|+|.+....  .....+..|+.+++.+ +|||++++++++.
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            344556667889999999999999999999875 58899999876432  2234678899999998 6999999999884


Q ss_pred             -----cCCceeeEeeccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc
Q 008893          295 -----TTTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE  365 (549)
Q Consensus       295 -----~~~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  365 (549)
                           ..+..++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence                 3456899999999999998764    334689999999999999999999998   9999999999999999999


Q ss_pred             eEEeecccccccCCCCCceeeccccccCccCchhhcc-----CCCCCcccchhHhHHHHHHHhCCcccccCccccccccH
Q 008893          366 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM  440 (549)
Q Consensus       366 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~  440 (549)
                      +||+|||+++....... ......|+..|+|||++..     ..++.++|||||||++|||++|+.|+.......     
T Consensus       163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----  236 (286)
T cd06638         163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----  236 (286)
T ss_pred             EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----
Confidence            99999999986643221 2223458999999999853     447889999999999999999999986432111     


Q ss_pred             HHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       441 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                       ... ..... ......+       +......+.+++.+||+.+|++||++.|++++.
T Consensus       237 -~~~-~~~~~-~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         237 -ALF-KIPRN-PPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -HHh-hcccc-CCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence             000 00000 0000001       111235688999999999999999999999764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.2e-37  Score=299.69  Aligned_cols=252  Identities=25%  Similarity=0.393  Sum_probs=203.2

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|...+.||+|+||.||+|... +++.|++|.++..... .....+..|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999965 6899999998765432 2345789999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            99999999998877789999999999999999999999   999999999999999999999999999987654332221


Q ss_pred             ---eccccccCccCchhhccCC---CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          386 ---TAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       386 ---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                         ....++..|+|||++.+..   .+.++||||||+++||+++|+.||.......   ..   ...... ..     .+
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~---~~~~~~-~~-----~~  225 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QI---MFHVGA-GH-----KP  225 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HH---HHHHhc-CC-----CC
Confidence               1345788999999998766   8899999999999999999999996432110   01   100100 00     00


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .+..  .......+.+++.+|++.+|++||++.|++.
T Consensus       226 ~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 PIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0100  1112466889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3e-37  Score=300.54  Aligned_cols=237  Identities=25%  Similarity=0.401  Sum_probs=189.4

Q ss_pred             CeeeeeCCeEEEEEEECCCC-----------EEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          233 NLVGKGGFGNVYKGYLQDGT-----------VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      +.||+|+||.||+|...+..           .+++|.+......  ...+.+|+.+++.++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            46899999999999976432           5788877654322  5678999999999999999999999988 78899


Q ss_pred             EeeccCCCchhhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC-------ceEEeeccc
Q 008893          302 VYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-------EAVVGDFGL  373 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~~kl~Dfg~  373 (549)
                      ||||+++|+|.+++.... .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++       .+||+|||+
T Consensus        78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999997655 789999999999999999999998   999999999999999887       799999999


Q ss_pred             ccccCCCCCceeeccccccCccCchhhccC--CCCCcccchhHhHHHHHHHhC-CcccccCccccccccHHHHHHHHhhc
Q 008893          374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISG-LRALEFGKTANQKGAMLDWVKKIHQE  450 (549)
Q Consensus       374 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (549)
                      +.....     .....++..|+|||++...  .++.++||||||+++|||++| ..|+......       .+.......
T Consensus       155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-------~~~~~~~~~  222 (259)
T cd05037         155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-------EKERFYQDQ  222 (259)
T ss_pred             cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-------hHHHHHhcC
Confidence            986543     1223467789999999876  789999999999999999994 6666532211       111111100


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       451 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      .   .     .    +......+.+++.+|+..+|++||++.++++.|+
T Consensus       223 ~---~-----~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 H---R-----L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C---C-----C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0   0     0    0001167899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-37  Score=307.24  Aligned_cols=262  Identities=21%  Similarity=0.271  Sum_probs=197.0

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|+..+.||+|+||.||+|... +|+.||+|.++..... .....+.+|+.+++.++|||++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999975 6899999998754322 2234577899999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++ +|.+++.. ...+++..+..++.||+.||.|||+.   +++||||||+||+++.++.+||+|||+++....... .
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~  155 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C  155 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence            975 77777653 55799999999999999999999999   999999999999999999999999999986543222 1


Q ss_pred             eeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc------chhhhc
Q 008893          385 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK------KLEMLV  457 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  457 (549)
                      .....++..|+|||.+.+.. ++.++|||||||++|||+||+.|+........   ............      ......
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH---HHHHHHHHhCCCChHHhHHhhhcc
Confidence            22335788999999987654 68999999999999999999998754322111   000000000000      000000


Q ss_pred             ccccc---------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          458 DKDLK---------NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~---------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +....         .......+.++.+++.+|++.||.+|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            00000         01111234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.9e-37  Score=299.76  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=208.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|++|.||+|... +++.|++|++...........+..|+..+..++|+|++++++++......++++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888899999999999999976 49999999987654334456799999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++++|.+++.....+++..+..++.|++.|+.|||+ .   +++||||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-  156 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-  156 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence            9999999999877789999999999999999999999 8   9999999999999999999999999999876543322 


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      .....++..|+|||.+.+..++.++||||||+++|+|+||+.||......    ...+........         .. ..
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~---------~~-~~  222 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFELMQAICDG---------PP-PS  222 (264)
T ss_pred             ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHHHHHHHhcC---------CC-CC
Confidence            22345788999999999999999999999999999999999998654321    111111111111         00 11


Q ss_pred             CCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          465 YDRI-ELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       465 ~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+.. .+..+.+++.+|++.+|++||++.|++++
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1222 44789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-38  Score=302.56  Aligned_cols=268  Identities=26%  Similarity=0.366  Sum_probs=198.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHh--hccCCCccceEEEEecCC----c
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS--LAVHRNLLRLIGFCMTTT----E  298 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~  298 (549)
                      ......+.+.||+|.||.||+|.|+ |+.||||++....    +..+.+|.++.+  .++|+||+.+++.-..+.    .
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc-CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            3456778899999999999999997 8999999997533    445667777765  569999999999876543    5


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCceEecccCcCeeeecCCCceEEeeccc
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ-----CDPKIIHRDVKAANILLDEYYEAVVGDFGL  373 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  373 (549)
                      ++||++|.+.|+|+|+|.. ..++.+..++++..+|.||+|||..     ..|.|.|||||+.|||+.+++...|+|+|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            7899999999999999987 4699999999999999999999964     468999999999999999999999999999


Q ss_pred             ccccCCCCCce---eeccccccCccCchhhccCC------CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHH
Q 008893          374 AKLLDHCDSHV---TTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV  444 (549)
Q Consensus       374 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~  444 (549)
                      |-.........   ....+||.+|||||++...-      .-..+||||||.|+||++-...-  .+..++..-...+|+
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~--ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES--GGIVEEYQLPYYDVV  440 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc--CCEehhhcCCcccCC
Confidence            97665443322   23346999999999986542      12468999999999999864211  000011111111222


Q ss_pred             HHHhhccch-hhhccccccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          445 KKIHQEKKL-EMLVDKDLKNN-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       445 ~~~~~~~~~-~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..-...+.. .-+..+.++..     .....+..+.++++.||..+|..|-|+--+-+.|..
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence            111111111 11222333322     234567889999999999999999999888877765

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3e-37  Score=306.83  Aligned_cols=249  Identities=19%  Similarity=0.290  Sum_probs=202.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .+|+..+.||.|+||.||+|.. .+|+.|++|.+.... ......+.+|+.+++.++|||++++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4588889999999999999986 468999999986543 23355788999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++... .+++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ ..
T Consensus        98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~  172 (296)
T cd06655          98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR  172 (296)
T ss_pred             cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence            9999999988754 589999999999999999999999   999999999999999999999999999876543322 12


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....++..|+|||.+.+..++.++|||||||++|+|++|+.||.......       ......... ...     +  ..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------~~~~~~~~~-~~~-----~--~~  237 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNG-TPE-----L--QN  237 (296)
T ss_pred             CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcC-Ccc-----c--CC
Confidence            23458889999999998889999999999999999999999996432211       111111000 000     0  01


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      +......+.+++.+||..+|++||++.+++.
T Consensus       238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            1223356889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-36  Score=304.28  Aligned_cols=258  Identities=20%  Similarity=0.240  Sum_probs=204.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|+..+.||+|+||.||++... .++.|++|.+.....  ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999976 578999999875432  122346788999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  382 (549)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+|++|||+++....... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            9999999999998777899999999999999999999998   999999999999999999999999999864211000 


Q ss_pred             -------------ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          383 -------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       383 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                                   .......++..|+|||.+....++.++||||||+++|||++|+.||.....       ..+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~~~~~~  230 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQVIS  230 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh
Confidence                         011123578899999999888899999999999999999999999863221       111111111


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 008893          450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG  502 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  502 (549)
                      ..    ...+..    ....+..+.+++.+|++.+|++||++.++.+.|+...
T Consensus       231 ~~----~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~  275 (305)
T cd05609         231 DD----IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF  275 (305)
T ss_pred             cc----cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence            10    000110    1123466899999999999999999887777777643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.6e-37  Score=300.25  Aligned_cols=253  Identities=26%  Similarity=0.386  Sum_probs=203.4

Q ss_pred             CCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCC-----cHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+.......     ....+..|+++++.++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 468999999986433111     23468899999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC-ceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  380 (549)
                      |+||+++++|.+++....++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++ .+||+|||.+......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            999999999999998777899999999999999999999999   999999999999998775 6999999999776533


Q ss_pred             CCc---eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          381 DSH---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       381 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ...   ......++..|+|||.+.+..++.++||||+|+++|+|++|..||........    ........         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~---------  224 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIA---------  224 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHh---------
Confidence            111   11234578899999999888899999999999999999999999864322111    11111110         


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ........+......+.+++.+|++.+|++||++.|++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            001112233344577899999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.1e-37  Score=312.58  Aligned_cols=261  Identities=19%  Similarity=0.241  Sum_probs=193.4

Q ss_pred             CCCeeeee--CCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          231 SKNLVGKG--GFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       231 ~~~~iG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      +.++||+|  +|++||++..+ +|+.||+|++....... ....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78999999865 68999999997654322 2345788999999999999999999999999999999999


Q ss_pred             CCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc-
Q 008893          307 SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-  383 (549)
Q Consensus       307 ~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  383 (549)
                      ++|+|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++++||+........... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999999863  34689999999999999999999998   9999999999999999999999999865433211110 


Q ss_pred             -----eeeccccccCccCchhhcc--CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh--------
Q 008893          384 -----VTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH--------  448 (549)
Q Consensus       384 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  448 (549)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||........   .........        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~  235 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDTTT  235 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCccccccccc
Confidence                 0112246778999999976  4588999999999999999999999964221100   000000000        


Q ss_pred             --hcc----chhhhcc-----------------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          449 --QEK----KLEMLVD-----------------KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       449 --~~~----~~~~~~d-----------------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        .+.    ......+                 ......+.......+.+++.+|++.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence              000    0000000                 000011122334678999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.6e-37  Score=299.31  Aligned_cols=249  Identities=27%  Similarity=0.366  Sum_probs=201.3

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEec--CCceeeEe
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLVY  303 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  303 (549)
                      +|++.+.||+|+||.||++... +++.||+|.+...... .....+..|+++++.++|+|++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999864 6889999998754322 223468889999999999999999998764  34578999


Q ss_pred             eccCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhh-----hcCCCceEecccCcCeeeecCCCceEEeecccc
Q 008893          304 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLH-----EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA  374 (549)
Q Consensus       304 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  374 (549)
                      ||+++++|.+++..    ...+++..++.++.||+.||.|||     +.   +++|+||||+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            99999999998864    457999999999999999999999     66   9999999999999999999999999999


Q ss_pred             cccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      ......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....    ..+.   .... ..   
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~---~~~~-~~---  225 (265)
T cd08217         158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLA---SKIK-EG---  225 (265)
T ss_pred             ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HHHH---HHHh-cC---
Confidence            876543321 2334589999999999998899999999999999999999999874321    1111   1111 01   


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                            .....+...+..+.+++.+|++.+|++||++++|+++
T Consensus       226 ------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 ------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  1112233445789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.2e-36  Score=302.01  Aligned_cols=251  Identities=22%  Similarity=0.288  Sum_probs=198.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +.|++.+.||+|+||.||+|... +++.|++|.+.... ......+..|+.+++.++|+|++++++++..+...++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            56888999999999999999976 48899999987543 23345688899999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++++|..++.. ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~  166 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR  166 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence            999999887753 45689999999999999999999998   99999999999999999999999999987543221 11


Q ss_pred             eeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          385 TTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .....++..|+|||++.     ...++.++|||||||++|||++|+.||.....       ............      +
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~------~  233 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEP------P  233 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhcCCC------c
Confidence            22345888999999984     34568899999999999999999999864221       011111111000      0


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..  ..+...+.++.+++.+||+.+|++||++.|++++
T Consensus       234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00  0112233568899999999999999999999863

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1e-36  Score=298.62  Aligned_cols=250  Identities=22%  Similarity=0.348  Sum_probs=187.9

Q ss_pred             eeeeeCCeEEEEEEECCC---CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCc
Q 008893          234 LVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS  310 (549)
Q Consensus       234 ~iG~G~~g~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  310 (549)
                      .||+|+||.||+|...++   ..+++|.+...........+.+|+..++.++||||+++++++......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999985433   35667776654433345679999999999999999999999999999999999999999


Q ss_pred             hhhhhccC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-cee
Q 008893          311 VASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVT  385 (549)
Q Consensus       311 L~~~l~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~  385 (549)
                      |.++++..    ...++.....++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++........ ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99998743    3467778889999999999999998   999999999999999999999999999864321111 112


Q ss_pred             eccccccCccCchhhcc-------CCCCCcccchhHhHHHHHHHhC-CcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          386 TAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELISG-LRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ ..||.....       .......... ....+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~-~~~~~~  230 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKD-QQVKLF  230 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhh-cccccC
Confidence            23457889999998743       2457899999999999999975 556643211       1111211111 112223


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      ++.+...    ....+.+++..|| .+|++||++++|++.|.
T Consensus       231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3333222    2356788999999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.9e-37  Score=300.94  Aligned_cols=248  Identities=27%  Similarity=0.378  Sum_probs=201.9

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      -|...+.||+|+||.||+|... +++.||+|.+...........+.+|+..++.++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667789999999999999864 688999999865443344457889999999999999999999999999999999999


Q ss_pred             CCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceee
Q 008893          307 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT  386 (549)
Q Consensus       307 ~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  386 (549)
                      ++++|.+++... .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        85 ~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~  159 (277)
T cd06641          85 GGGSALDLLEPG-PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN  159 (277)
T ss_pred             CCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhc
Confidence            999999988754 589999999999999999999998   999999999999999999999999999876543221 122


Q ss_pred             ccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCC
Q 008893          387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD  466 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  466 (549)
                      ...++..|+|||.+.+..++.++|||||||++|+|++|..|+......       .+....... .         .....
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~-~---------~~~~~  222 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-------KVLFLIPKN-N---------PPTLE  222 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-------HHHHHHhcC-C---------CCCCC
Confidence            345788999999998888999999999999999999999998632210       111111110 0         01112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          467 RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       467 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+..+.+++.+|++.+|.+||++.+++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            2234678899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-37  Score=301.40  Aligned_cols=248  Identities=26%  Similarity=0.362  Sum_probs=201.1

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc---CCCccceEEEEecCCceeeEe
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .|+..+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++   |||++++++++......+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4677889999999999999964 689999999876544445567889999999886   999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++++|.+++... .+++.....++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-  156 (277)
T ss_pred             ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence            999999999998764 689999999999999999999999   999999999999999999999999999987654332 


Q ss_pred             eeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||......       .+......      ...+.+.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~~~~~------~~~~~~~  223 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAMMLIPK------SKPPRLE  223 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hhhhcccc------CCCCCCC
Confidence            22334588999999998754 4689999999999999999999999643211       11111000      0011111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ..   ..+.++.+++.+|++.||++||++.|+++
T Consensus       224 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         224 DN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11   13467899999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=308.25  Aligned_cols=251  Identities=26%  Similarity=0.290  Sum_probs=200.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC--cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|+..+.||+|+||+||+|... +++.||+|.+.......  ....+..|++++..++|+||+++++++......+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999976 48999999997654322  3446889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          304 PYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       304 e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||+.+++|.+++...  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998743  4689999999999999999999998   99999999999999999999999999987553221


Q ss_pred             Cc----------------------------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcc
Q 008893          382 SH----------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT  433 (549)
Q Consensus       382 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~  433 (549)
                      ..                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            11                            01123578899999999998899999999999999999999999864322


Q ss_pred             ccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 008893          434 ANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK----MSEVVR  496 (549)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~  496 (549)
                      ..      .+..          +.+...........+..+.+++.+|++.+|++||+    ++|++.
T Consensus       238 ~~------~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DE------TFSN----------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HH------HHHH----------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            11      0110          11111111111114578999999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.2e-37  Score=299.11  Aligned_cols=249  Identities=20%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|+..+.||+|+||.+|++... +|+.||+|.+..... ......+.+|+.+++.++||||+++.+++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999865 688999999865422 22344788999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++++|.+.+...  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            9999999988643  3578999999999999999999998   999999999999999999999999999976643221 


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......|+..|+|||++.+..++.++||||||+++++|+||+.||.....       .+.+....... .         .
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~-~---------~  219 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKIIRGS-Y---------P  219 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHhcCC-C---------C
Confidence            11233478899999999988999999999999999999999999864221       11111111110 0         1


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..+.....++.+++.+|++.+|++||++.||+++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1122334678999999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-37  Score=303.71  Aligned_cols=238  Identities=24%  Similarity=0.352  Sum_probs=185.7

Q ss_pred             eeeeeCCeEEEEEEECC-------------------------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccc
Q 008893          234 LVGKGGFGNVYKGYLQD-------------------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR  288 (549)
Q Consensus       234 ~iG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  288 (549)
                      .||+|+||.||+|.+..                         ...|++|++..... .....+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            69999999999998521                         13588898864332 22346888899999999999999


Q ss_pred             eEEEEecCCceeeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC---
Q 008893          289 LIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---  364 (549)
Q Consensus       289 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---  364 (549)
                      +++++......++||||+++|+|..++.. ...+++..+..++.||+.||+|||++   +|+||||||+||++++++   
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999998864 55789999999999999999999998   999999999999997643   


Q ss_pred             ----ceEEeecccccccCCCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHH-hCCcccccCccccccc
Q 008893          365 ----EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELI-SGLRALEFGKTANQKG  438 (549)
Q Consensus       365 ----~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~ell-tg~~p~~~~~~~~~~~  438 (549)
                          .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......   
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---  229 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---  229 (274)
T ss_pred             CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence                4799999988643221     12247788999998865 56899999999999999995 6888886432211   


Q ss_pred             cHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                       ...+..   ..        .....    .....+.+++.+||+.+|++||++.++++.|.
T Consensus       230 -~~~~~~---~~--------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 -KERFYE---KK--------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -HHHHHH---hc--------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             111100   00        00111    11246889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.1e-37  Score=335.48  Aligned_cols=254  Identities=20%  Similarity=0.302  Sum_probs=197.9

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecC--Cce
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER  299 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  299 (549)
                      ...++|.+.+.||+|+||+||+|... ++..||+|.+..... ......+..|+.++..++||||+++++++...  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568999999999999999999975 578899999875432 22345688999999999999999999988543  568


Q ss_pred             eeEeeccCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCC----CceEecccCcCeeeecC---------
Q 008893          300 LLVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCD----PKIIHRDVKAANILLDE---------  362 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlkp~Nill~~---------  362 (549)
                      ++||||+++|+|.+++..    ...+++..++.|+.||+.||.|||+...    .+|+||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            999999999999998864    3569999999999999999999998521    25999999999999964         


Q ss_pred             --------CCceEEeecccccccCCCCCceeeccccccCccCchhhcc--CCCCCcccchhHhHHHHHHHhCCcccccCc
Q 008893          363 --------YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGK  432 (549)
Q Consensus       363 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~  432 (549)
                              ...+||+|||++..+....  ......||+.|+|||++.+  ..++.++|||||||++|||+||+.||....
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                    3458999999998664322  2234469999999999854  458899999999999999999999996422


Q ss_pred             cccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          433 TANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .      ....+..+....        .+.   ....+..+.+|+..||+.+|.+||++.|++.
T Consensus       248 ~------~~qli~~lk~~p--------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 N------FSQLISELKRGP--------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             c------HHHHHHHHhcCC--------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            1      112222111110        000   0112367899999999999999999999984

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.7e-37  Score=305.55  Aligned_cols=260  Identities=27%  Similarity=0.341  Sum_probs=202.7

Q ss_pred             cCHHHHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEe
Q 008893          217 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM  294 (549)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  294 (549)
                      +++.++..++++|.+.+.||+|+||.||++... +++.+|+|.+....  .....+..|+.++..+ +|||++++++++.
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            344555667889999999999999999999974 68899999986532  2244678899999888 7999999999987


Q ss_pred             cC-----CceeeEeeccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc
Q 008893          295 TT-----TERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE  365 (549)
Q Consensus       295 ~~-----~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  365 (549)
                      ..     ...++||||+++++|.++++    ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence            53     35799999999999999875    345789999999999999999999998   9999999999999999999


Q ss_pred             eEEeecccccccCCCCCceeeccccccCccCchhhccCC-----CCCcccchhHhHHHHHHHhCCcccccCccccccccH
Q 008893          366 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ-----SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM  440 (549)
Q Consensus       366 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~  440 (549)
                      +||+|||++........ ......|+..|+|||.+....     ++.++|||||||++|||++|+.||.......   .+
T Consensus       167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~---~~  242 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK---TL  242 (291)
T ss_pred             EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH---HH
Confidence            99999999886543221 122345888999999986543     6889999999999999999999986432111   01


Q ss_pred             HHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       441 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..    ... .....+.       .+......+.+++.+|++.+|++||++.|++++
T Consensus       243 ~~----~~~-~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         243 FK----IPR-NPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HH----Hhc-CCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11    110 0000111       111223568999999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-37  Score=304.51  Aligned_cols=262  Identities=23%  Similarity=0.346  Sum_probs=196.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999976 68999999987544333334577899999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +.+ +|.+++.. ...+++.....++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....... .
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~  159 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T  159 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence            985 89888764 34689999999999999999999999   999999999999999999999999999875432211 1


Q ss_pred             eeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh---ccchhhh----
Q 008893          385 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ---EKKLEML----  456 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----  456 (549)
                      .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........   ..........   .......    
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED---QLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH---HHHHHHHhcCCCChhhhhhhhhcc
Confidence            122346789999999875 4578999999999999999999999864331110   0000000000   0000000    


Q ss_pred             --c--------cccccCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          457 --V--------DKDLKNNYDR-IELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       457 --~--------d~~l~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                        .        ...+....+. .....+.+++.+|++.+|++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              0        0000000000 01256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.2e-37  Score=303.75  Aligned_cols=245  Identities=23%  Similarity=0.290  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|+..+.||+|+||.||++... +++.||+|.+.....  ......+.+|+++++.+.||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999975 589999999865332  223456889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||++......   
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence            9999999999998878899999999999999999999998   9999999999999999999999999999876533   


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                       .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||......       ....... ...          .
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~-~~~----------~  215 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKIL-EGK----------V  215 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHh-cCC----------c
Confidence             23345889999999998888999999999999999999999998643210       0001111 000          0


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVR  496 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  496 (549)
                      ..+......+.+++.+||+.+|++||     +++|+++
T Consensus       216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            11222246788999999999999999     6667664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.1e-37  Score=302.06  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=192.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHH-HhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEM-ISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++..........+..|+.. ++..+|||++++++++......+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888999999999999999976 6999999998765433334455566665 566789999999999999999999999


Q ss_pred             ccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          305 YMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       305 ~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      |++ |+|.+++.    ....+++..+..++.||+.||.|||+++  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 57777664    2346899999999999999999999743  7999999999999999999999999999865422


Q ss_pred             CCceeeccccccCccCchhhcc----CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          381 DSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      .  ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||......     . ..........     
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~-~~~~~~~~~~-----  224 (283)
T cd06617         158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----F-QQLKQVVEEP-----  224 (283)
T ss_pred             c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----H-HHHHHHHhcC-----
Confidence            1  1222458889999998865    44688999999999999999999998532111     0 1111111100     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       .+.+.   ....+..+.+++.+|++.+|++||++.++++
T Consensus       225 -~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 -SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00000   1123467899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=296.38  Aligned_cols=247  Identities=23%  Similarity=0.326  Sum_probs=207.0

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccC
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      |.+.+.||+|+||.||+|.++ .|+.+|||.+..+.   ...++..|+.++++++.|++|+++|.|.....+|+|||||.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            556788999999999999976 59999999987654   35578899999999999999999999999999999999999


Q ss_pred             CCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceee
Q 008893          308 NGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT  386 (549)
Q Consensus       308 ~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  386 (549)
                      .|++.+.++ .++++++..+..++...+.||+|||..   .-+|||||+.|||++-+|.+|++|||.+..+... -....
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRN  187 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRN  187 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhC
Confidence            999999997 566899999999999999999999998   8899999999999999999999999999766532 22345


Q ss_pred             ccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc-cccCCC
Q 008893          387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK-DLKNNY  465 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~l~~~~  465 (549)
                      .+.||+.|||||++..-.|+.++||||+|++..||..|++|+..-.+.                ..+..+... ...-.-
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPPTF~K  251 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPPTFKK  251 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCCCCCC
Confidence            677999999999999999999999999999999999999998742221                111111111 111112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                      +..-+.++.++++.|+-+.|++|-|+.+++++-
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            334457889999999999999999999988764

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1e-36  Score=302.28  Aligned_cols=266  Identities=20%  Similarity=0.251  Sum_probs=198.0

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++++|...+.||+|+||.||+|... +|+.||+|++...........+.+|+.+++.++|+||+++.+++...+..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999865 688999999976544444456788999999999999999999999999999999


Q ss_pred             eccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+. +++.+.+. ....+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9996 56766654 345688899999999999999999999   999999999999999999999999999875432221


Q ss_pred             ceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHH-----------HHhhc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK-----------KIHQE  450 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~  450 (549)
                       ......++..|+|||.+.+. .++.++||||||+++|||+||+.||........  .+.....           .....
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhhhc
Confidence             12233478899999998764 478899999999999999999999974332110  0000000           00000


Q ss_pred             c-chhhhccccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          451 K-KLEMLVDKDLKNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       451 ~-~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      . ...............     ......+.+++.+|++.||++|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0 000000000000000     0113568899999999999999999999853

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-36  Score=299.87  Aligned_cols=258  Identities=24%  Similarity=0.280  Sum_probs=201.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC--CceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  303 (549)
                      ++|+..+.||.|++|.||++... +++.+|+|.+...........+.+|+++++.++||||+++++++...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36778899999999999999975 58899999987654434456789999999999999999999998654  4689999


Q ss_pred             eccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          304 PYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       304 e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ||+++++|.+++.    ....+++.....++.||+.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999988764    244689999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ..   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........  ...+........ ....+.+.
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~  231 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL--GPIELLSYIVNM-PNPELKDE  231 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC--ChHHHHHHHhcC-CchhhccC
Confidence            21   1234578899999999999999999999999999999999999975432111  111111111110 11111111


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       ..  .....+..+.+++.+|++.+|++|||+.|+++
T Consensus       232 -~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 -PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             00  00123467899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.6e-37  Score=304.60  Aligned_cols=263  Identities=22%  Similarity=0.277  Sum_probs=201.1

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++|||++++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999975 689999999876542 22345789999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      + +++|.+++.. ...+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9 9999998863 45799999999999999999999999   99999999999999999999999999998765433222


Q ss_pred             eeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc-----------cc
Q 008893          385 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE-----------KK  452 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~  452 (549)
                      .....++..|+|||.+.+. .++.++||||+|+++|||+||..+|........   +..........           ..
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcch
Confidence            3344688999999998654 468999999999999999999777753322111   00000000000           00


Q ss_pred             hhhhcccccc----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          453 LEMLVDKDLK----NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       453 ~~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+..+...    ..........+.+++.+|++.+|++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000000    00001223778999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.8e-37  Score=303.25  Aligned_cols=258  Identities=25%  Similarity=0.353  Sum_probs=201.4

Q ss_pred             cCHHHHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEe
Q 008893          217 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM  294 (549)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  294 (549)
                      .++.++..+.+.|++.+.||+|+||.||+|... +++.+|+|.+....  .....+..|+.++.++ +|+|++++++++.
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            355566667789999999999999999999974 58899999986532  2334678889988888 6999999999985


Q ss_pred             c------CCceeeEeeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCce
Q 008893          295 T------TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA  366 (549)
Q Consensus       295 ~------~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  366 (549)
                      .      ....+++|||+++|+|.+++..  ...+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.+
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence            3      4567999999999999998864  34588889999999999999999998   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH
Q 008893          367 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML  441 (549)
Q Consensus       367 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~  441 (549)
                      +|+|||++........ ......|+..|+|||.+.     ...++.++|||||||++|||+||+.||........   + 
T Consensus       161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---~-  235 (282)
T cd06636         161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---L-  235 (282)
T ss_pred             EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh---h-
Confidence            9999999876542221 122345889999999875     34578899999999999999999999864221110   0 


Q ss_pred             HHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          442 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       442 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                         ....      .......   .....+..+.+++.+||+.||.+||++.|+++
T Consensus       236 ---~~~~------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 ---FLIP------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---hhHh------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence               0000      0000100   11123467999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-38  Score=315.87  Aligned_cols=247  Identities=25%  Similarity=0.364  Sum_probs=204.8

Q ss_pred             CCCCCeeeeeCCeEEEEEEECC--CC--EEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQD--GT--VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~~--g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ....++||+|+||+|++|.|..  |+  .||||.++.+........|.+|+.++.+++|+|+++++|+..+ ....+|||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            3456789999999999999863  44  6899999877654456689999999999999999999999987 77889999


Q ss_pred             ccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      .++.|+|.+.|+.  ...|-......++.|||.||.||.++   ++|||||..+|+|+-....+||+|||+.+.+...+.
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999999985  44688888999999999999999999   999999999999999999999999999998876655


Q ss_pred             ceee--ccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          383 HVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       383 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ....  ...-.+.|+|||.+....++.++|||+|||+||||+| |..||.+-..       .+          +.+.+|.
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------~q----------IL~~iD~  330 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------IQ----------ILKNIDA  330 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------HH----------HHHhccc
Confidence            4322  2234568999999999999999999999999999999 5677754221       11          1122232


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .-+-.-+..++++++++++.||..+|++|||+..+.+
T Consensus       331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            2223345667899999999999999999999999974

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.4e-36  Score=299.95  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=196.5

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccC
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      |++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++|||++++++++...+..++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            456788999999999999976 47788999886433 2234568889999999999999999999999999999999999


Q ss_pred             CCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceee
Q 008893          308 NGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT  386 (549)
Q Consensus       308 ~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  386 (549)
                      +++|...+.. ..++++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... ....
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~  161 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD  161 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence            9999988754 45799999999999999999999999   99999999999999999999999999987653221 1223


Q ss_pred             ccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          387 AVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      ...++..|+|||++.     ...++.++|||||||++|||++|+.||......       ............ ..     
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~-~~-----  228 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEPP-TL-----  228 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------HHHHHHhhcCCC-CC-----
Confidence            345889999999984     345788999999999999999999998632210       111111111000 00     


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        ..+...+..+.+++.+||+.+|++||++.+++++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0111234678999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-37  Score=301.35  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+..|+++++.++|||++++++++......++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            356888899999999999999975 68999999986543 2234568899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            9999999999875 45799999999999999999999999   999999999999999999999999999876543222 


Q ss_pred             eeeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          384 VTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ......++..|+|||.+.     ...++.++||||||+++|||++|+.||......       ...........      
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------  225 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVLLKILKSEP------  225 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHHHHHhcCCC------
Confidence            223345889999999975     344678999999999999999999998643211       11111111000      


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +.+  ..+...+..+.+++.+||+.+|.+||++.+++++
T Consensus       226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            000  0112234578899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.3e-37  Score=304.90  Aligned_cols=265  Identities=23%  Similarity=0.278  Sum_probs=199.7

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC----CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      +|+..+.||+|+||.||+|... +|+.||+|.++.....    .....+..|+++++.++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999975 6899999999755422    1234577899999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+ +++|.+++.... .+++..+..++.||+.||.|||++   +++|+||||+||+++.++.++|+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 899999998665 799999999999999999999999   99999999999999999999999999998765432


Q ss_pred             CceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHH-----hhccchhh
Q 008893          382 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI-----HQEKKLEM  455 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  455 (549)
                      . ......++..|+|||.+.+ ..++.++|||||||++|||++|..+|...........+.......     ........
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            2 1222346788999999865 457899999999999999999977775432211100000000000     00000000


Q ss_pred             hccccccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 LVDKDLKNN-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .........     ........+.+++.+||+.+|++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000000     112234678999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-37  Score=313.65  Aligned_cols=264  Identities=24%  Similarity=0.291  Sum_probs=195.6

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecC-----
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----  296 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  296 (549)
                      ...++|...+.||+|+||.||+|... +++.||||.+...... .....+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999864 6889999998754321 2234577899999999999999999887533     


Q ss_pred             -CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          297 -TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       297 -~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                       ...+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.   +|+||||||+||++++++.+||+|||+++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence             3468999988 6788887764 4599999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHH--------HHH
Q 008893          376 LLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW--------VKK  446 (549)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~  446 (549)
                      .....    .....||..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+...        ...
T Consensus       167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            65432    223458999999999876 56899999999999999999999999643321110000000        000


Q ss_pred             Hhhcc------chhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          447 IHQEK------KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       447 ~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .....      .+.......+.. ........+.+++.+|++.||++|||+.|++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             cchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000      000000000000 000112457899999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-37  Score=301.91  Aligned_cols=239  Identities=23%  Similarity=0.374  Sum_probs=187.1

Q ss_pred             CeeeeeCCeEEEEEEECC--------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          233 NLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      +.||+|+||.||+|....        ...|++|.+.... ......+.+|+.+++.+.|||++++++++......++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            468999999999998642        2348888875432 2233468889999999999999999999999899999999


Q ss_pred             ccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc--------eEEeeccccc
Q 008893          305 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--------AVVGDFGLAK  375 (549)
Q Consensus       305 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl~Dfg~~~  375 (549)
                      |+++|+|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.        ++++|||++.
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99999999999753 4689999999999999999999999   9999999999999987765        5899999886


Q ss_pred             ccCCCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCC-cccccCccccccccHHHHHHHHhhccch
Q 008893          376 LLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGL-RALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      ....     .....++..|+|||++.+. .++.++||||||+++|||++|. .|+......       .... ....   
T Consensus       157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-------~~~~-~~~~---  220 (258)
T cd05078         157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-------KKLQ-FYED---  220 (258)
T ss_pred             ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------HHHH-HHHc---
Confidence            5432     1224578899999999764 5789999999999999999995 444321110       0000 0000   


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       454 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                              ....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    01112222367899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=302.15  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=210.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .-|...+.||+|.|++|-.|++- +|+.||||++.+.... -....+.+|+.-++.++|||||++|++.......|||.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45778889999999999999854 7999999999765422 223468899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee-cCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL-DEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      .-++|+|++++- ....+.++...+++.||+.|+.|+|+.   .+|||||||+||.+ .+-|-+|+.|||++..+..  +
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--G  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--G  172 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC--c
Confidence            999999999985 445799999999999999999999999   99999999999877 5678999999999987654  3


Q ss_pred             ceeeccccccCccCchhhccCCCC-CcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      ......+|+..|-|||++.+..|+ +++||||+|||||.|++|+.||......+                -+..++|-. 
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------------TLTmImDCK-  235 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------------TLTMIMDCK-  235 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----------------hhhhhhccc-
Confidence            445667899999999999999885 67899999999999999999998544322                233444443 


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       -..+...+.+..+||..|+..||++|.+.+||..
T Consensus       236 -YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 -YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             3456777889999999999999999999999974

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1e-36  Score=296.17  Aligned_cols=248  Identities=26%  Similarity=0.375  Sum_probs=200.6

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|+..+.||+|+||.||++... +++.+|+|.+..... ......+.+|+.+++.++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 688999999865432 23345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC-CceEEeecccccccCCCCC
Q 008893          306 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       306 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~  382 (549)
                      +++++|.+++...  ..+++..+..++.+++.||.|||++   +++|+||+|+||+++++ +.+|++|||++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            9999999999753  4589999999999999999999999   99999999999999854 568999999998765332 


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.....       ........... .         
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~~~~~~-~---------  218 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLKIMSGT-F---------  218 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHHHHhcC-C---------
Confidence             22234588899999999988899999999999999999999999864321       11111111110 0         


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+......+.+++.+||+.+|++|||+.|++++
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            01112234678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.2e-36  Score=303.76  Aligned_cols=193  Identities=24%  Similarity=0.353  Sum_probs=158.7

Q ss_pred             CCeeeeeCCeEEEEEEEC---CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec--CCceeeEeecc
Q 008893          232 KNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLVYPYM  306 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  306 (549)
                      ...||+|+||+||+|...   ++..||+|.+....   ....+.+|+.+++.++||||+++++++..  ....++++||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999965   35789999986543   23457889999999999999999998854  45678999998


Q ss_pred             CCCchhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee----cCCCceEEeeccc
Q 008893          307 SNGSVASRLKA---------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGL  373 (549)
Q Consensus       307 ~~g~L~~~l~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~  373 (549)
                      .+ +|.+++..         ...+++..+..++.||+.||.|||+.   +|+||||||+||++    ++++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            75 67666531         22588999999999999999999999   99999999999999    5667999999999


Q ss_pred             ccccCCCCCc--eeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccC
Q 008893          374 AKLLDHCDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFG  431 (549)
Q Consensus       374 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~  431 (549)
                      ++........  ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9876533221  12334689999999998764 5789999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=311.15  Aligned_cols=244  Identities=30%  Similarity=0.395  Sum_probs=198.6

Q ss_pred             CCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          229 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      |...+.||.|+||.||.|+. .+.+.||||.+........  ..++..|+..|.+++|||++.+.|+|......||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            44567799999999999995 4688999999975543333  34689999999999999999999999999999999999


Q ss_pred             cCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |- |+-.+++. ..+++.+..+..|+.+.+.||+|||+.   +.||||||+.|||+++.|.+|++|||.|.......   
T Consensus       108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn---  180 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN---  180 (948)
T ss_pred             Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh---
Confidence            95 57777775 455799999999999999999999999   99999999999999999999999999998776443   


Q ss_pred             eeccccccCccCchhhc---cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          385 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                        .++|||.|||||++.   .+.|+-|+||||+|++..||.-.++|.......       .-+..+..++.      +.+
T Consensus       181 --sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SALYHIAQNes------PtL  245 (948)
T KOG0577|consen  181 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNES------PTL  245 (948)
T ss_pred             --cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHHHHHHhcCC------CCC
Confidence              356999999999985   468999999999999999999999997632211       11222222211      111


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .   ..+-+..+.+++..|+++-|.+|||.++++++
T Consensus       246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            1   22334678999999999999999999998754

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.4e-37  Score=301.73  Aligned_cols=264  Identities=22%  Similarity=0.321  Sum_probs=200.2

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      +|+..+.||+|++|.||+|... +|+.||+|.++..........+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788899999999999999976 588999999976554444556788999999999999999999999999999999999


Q ss_pred             CCCchhhhhccC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          307 SNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       307 ~~g~L~~~l~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ++ +|.+++...   ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.++++|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 888877532   4689999999999999999999998   999999999999999999999999999976543221 


Q ss_pred             eeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc-ccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD-KDL  461 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~l  461 (549)
                      ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+....... .......+.+ +..
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP-TESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC-ChhhHHHHhcCchh
Confidence            12233478899999998664 46889999999999999999999987543322111111100000 0000000000 000


Q ss_pred             c-----------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 K-----------NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~-----------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .           ..........+.+++.+|++.||.+||++.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0           00111234678899999999999999999999853

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.4e-37  Score=304.11  Aligned_cols=266  Identities=21%  Similarity=0.299  Sum_probs=200.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecC--CceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  302 (549)
                      ++|+..+.||+|+||.||+|... +++.+++|.++..... .....+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999976 5889999999754322 2233577899999999999999999998877  889999


Q ss_pred             eeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      +||+.+ +|.+.+... ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999974 888888643 3589999999999999999999999   99999999999999999999999999998765432


Q ss_pred             CceeeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccccHHH---------HHHH--Hh-
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD---------WVKK--IH-  448 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~--~~-  448 (549)
                      . ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...........+..         |...  .. 
T Consensus       161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence            1 122334788999999987644 68999999999999999999999875432211111111         0000  00 


Q ss_pred             -hccchhhhccccccCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          449 -QEKKLEMLVDKDLKNNYDRI-ELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       449 -~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       ............+...++.. ....+.+++.+|++.+|++|||+.|++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence             00000011111111222222 35678899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.7e-37  Score=304.32  Aligned_cols=261  Identities=20%  Similarity=0.304  Sum_probs=197.6

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|+..+.||+|++|.||+|... +|+.||||.++..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999975 6899999998754322 2234688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +. ++|.+++..  ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 588888754  35689999999999999999999998   999999999999999999999999999876543222 


Q ss_pred             eeeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc-----------
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK-----------  451 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------  451 (549)
                      ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||........   ............           
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCChhhhhhhhHHH
Confidence            122334688999999887654 58899999999999999999999864332111   111111000000           


Q ss_pred             ----chhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          452 ----KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       452 ----~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                          .........+. .........+.+++.+|++.||++|||+++++.+
T Consensus       233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                00000000000 0001123567899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=318.41  Aligned_cols=251  Identities=26%  Similarity=0.420  Sum_probs=209.6

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CC----CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ....++||+|+||+||+|.|- +|    -+||+|++..........++.+|+..+..++|||+++++|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            345689999999999999863 33    3789999988776667778999999999999999999999998766 88999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      +||+.|+|.++++. +..+-....+.|..|||+||.|||++   ++|||||..+|||+..-..+||.|||+++.......
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            99999999999984 45788999999999999999999999   999999999999999999999999999998876554


Q ss_pred             ceee-ccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          383 HVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       383 ~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      .... ...-.+.|||=|.+....++.++|||||||++||++| |..|++.....                 .+.+++...
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~dlle~g  916 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPDLLEKG  916 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhHHHhcc
Confidence            4332 2234568999999999999999999999999999999 88887643221                 122222222


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .+-.-++.+..++..++.+||..|++.||+++++...+..
T Consensus       917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            2233466777899999999999999999999999876665

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-37  Score=302.79  Aligned_cols=260  Identities=22%  Similarity=0.318  Sum_probs=197.7

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      |+..+.||+|++|.||+|... +|+.||+|++...... .....+.+|+++++.++|||++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999965 6999999998754322 22346888999999999999999999999999999999999


Q ss_pred             CCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          307 SNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       307 ~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      + ++|.+++....  .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence            5 68999887654  789999999999999999999998   9999999999999999999999999999765432221 


Q ss_pred             eeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc--------chhh
Q 008893          385 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK--------KLEM  455 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~  455 (549)
                      .....++..|+|||++.+. .++.++||||||+++|+|+||+.||........   ............        ...+
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ---LFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhhhhhchh
Confidence            1223468899999987664 578899999999999999999999864332111   111111000000        0000


Q ss_pred             h---c----cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 L---V----DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ~---~----d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .   .    .... .......+..+.+++.+|++.+|++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0   0    0000 00111223678899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.8e-37  Score=304.79  Aligned_cols=248  Identities=22%  Similarity=0.292  Sum_probs=198.0

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccC
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      |.....||+|+||.||++... ++..||||.+.... ......+.+|+..++.++|+|++++++.+...+..++||||++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            334467999999999999865 58899999986433 2334568899999999999999999999999999999999999


Q ss_pred             CCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeec
Q 008893          308 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA  387 (549)
Q Consensus       308 ~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  387 (549)
                      +++|.+++... .+++..+..++.||+.||.|||+.   +|+||||||+||++++++.++|+|||++........ ....
T Consensus       103 ~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~  177 (292)
T cd06658         103 GGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS  177 (292)
T ss_pred             CCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence            99999988654 589999999999999999999999   999999999999999999999999999876543222 1223


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCH
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR  467 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  467 (549)
                      ..|+..|+|||.+.+..++.++||||||+++|||++|+.||......       .......      ......+..  ..
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~------~~~~~~~~~--~~  242 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------QAMRRIR------DNLPPRVKD--SH  242 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH------hcCCCcccc--cc
Confidence            45889999999998888999999999999999999999998642211       0011110      011111111  11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          468 IELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       468 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .....+.+++.+|+..+|++|||++|++++
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            223568899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-36  Score=299.93  Aligned_cols=261  Identities=22%  Similarity=0.246  Sum_probs=193.8

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecC--CceeeEee
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTT--TERLLVYP  304 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  304 (549)
                      |++.+.||+|+||.||+|... +++.||+|.++.............|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566788999999999999965 689999999876433333334557888888885 99999999999887  88999999


Q ss_pred             ccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      |++ +++.+.+.. ...+++..+..++.|++.||.|||+.   +++||||+|+||+++. +.+||+|||+++....... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            997 477777764 45789999999999999999999999   9999999999999999 9999999999986643222 


Q ss_pred             eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH--------HHHHHHhhccchh
Q 008893          384 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKIHQEKKLE  454 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~  454 (549)
                       .....++..|+|||.+.+ ..++.++|||||||++|||++|..||......+....+.        .|......... .
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  232 (282)
T cd07831         155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH-M  232 (282)
T ss_pred             -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc-c
Confidence             122357889999997654 557889999999999999999999996543211100000        11000000000 0


Q ss_pred             hhccccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 MLVDKDLKN----NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ....+....    ......+..+.+++.+|++++|++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000000000    0011235789999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.5e-37  Score=298.16  Aligned_cols=248  Identities=24%  Similarity=0.276  Sum_probs=203.6

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      +|++.+.||+|+||.||+|... +++.||+|.+......  .....+.+|++++++++||||+++++++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999976 5899999999754322  234578999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+.+++|.+++....++++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.......  .
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~  155 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L  155 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence            999999999998777899999999999999999999998   99999999999999999999999999987654322  2


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......     ...+.......          ....
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~----------~~~~  220 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET----------ADVL  220 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc----------cccc
Confidence            23345888999999998888999999999999999999999998754321     11111111110          0111


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKM--SEVV  495 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl  495 (549)
                      .+...+..+.+++.+||+.||.+||++  +|++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            222334788999999999999999999  6655

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2e-36  Score=295.44  Aligned_cols=243  Identities=23%  Similarity=0.282  Sum_probs=198.2

Q ss_pred             eeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCch
Q 008893          235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV  311 (549)
Q Consensus       235 iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  311 (549)
                      ||+|+||.||++... +++.||+|.+......  .....+.+|+.+++.++||||+++++++.+....++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999976 4899999998754322  3345689999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccc
Q 008893          312 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT  391 (549)
Q Consensus       312 ~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt  391 (549)
                      .+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......  ......++
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~  155 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT  155 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence            99998777799999999999999999999998   99999999999999999999999999998765432  22234588


Q ss_pred             cCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHH
Q 008893          392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE  471 (549)
Q Consensus       392 ~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  471 (549)
                      ..|+|||.+.+..++.++|+||||+++|+|++|..||......     .........         +......++.....
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~---------~~~~~~~~~~~~~~  221 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-----PMEIYNDIL---------KGNGKLEFPNYIDK  221 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-----HHHHHHHHh---------ccCCCCCCCcccCH
Confidence            8999999998888999999999999999999999999753320     111111111         11111122223357


Q ss_pred             HHHHHHHHhcccCCCCCCC-----HHHHHH
Q 008893          472 EMVQVALLCTQYLPSLRPK-----MSEVVR  496 (549)
Q Consensus       472 ~l~~l~~~cl~~dP~~RPs-----~~evl~  496 (549)
                      .+.+++.+||+.+|++||+     ++|+++
T Consensus       222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            8999999999999999999     666664

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.9e-36  Score=297.47  Aligned_cols=252  Identities=27%  Similarity=0.396  Sum_probs=195.5

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC----CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCC------
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------  297 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  297 (549)
                      |.+.+.||+|+||.||+|.+.    +++.||||++..... .....++.+|+++++.++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999854    368899999975432 223446889999999999999999999886532      


Q ss_pred             ceeeEeeccCCCchhhhhcc------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeec
Q 008893          298 ERLLVYPYMSNGSVASRLKA------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF  371 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  371 (549)
                      ..+++++|+.+|+|.+++..      ...+++.....++.|++.||+|||+.   +|+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            23688999999999887642      12578999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhh
Q 008893          372 GLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       372 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      |+++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.||......    .+..+.   ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~----~~~~~~---~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS----EIYNYL---IK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH----HHHHHH---Hc
Confidence            999865432211 1122335678999999998889999999999999999999 78887532211    111111   11


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....          ..+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus       231 ~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1100          0111233679999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=296.87  Aligned_cols=251  Identities=28%  Similarity=0.371  Sum_probs=199.1

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCC-----
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT-----  297 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----  297 (549)
                      ++++|++.+.||+|++|.||+|..+ +++.+++|++.....  ....+.+|+.+++++ .|+||+++++++....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            5678999999999999999999975 578999999875432  345789999999998 6999999999997644     


Q ss_pred             -ceeeEeeccCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecc
Q 008893          298 -ERLLVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG  372 (549)
Q Consensus       298 -~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  372 (549)
                       ..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             48999999999999998863    35789999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeeccccccCccCchhhcc-----CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHH
Q 008893          373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI  447 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  447 (549)
                      ++........ ......|+..|+|||.+..     ..++.++||||||+++|+|+||+.||.......   .+.    ..
T Consensus       159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~----~~  230 (275)
T cd06608         159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---ALF----KI  230 (275)
T ss_pred             cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---HHH----Hh
Confidence            9876543222 2233458899999998754     346789999999999999999999996321110   011    11


Q ss_pred             hhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       448 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ... .     .+.+  ..+......+.+++.+|+..||++|||+.|+++
T Consensus       231 ~~~-~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRN-P-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hcc-C-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            000 0     0011  111223467899999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.8e-36  Score=300.62  Aligned_cols=246  Identities=29%  Similarity=0.360  Sum_probs=196.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC--cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ..|...+.||+|+||+||+|... +|+.||+|.+.......  ....+.+|+.+++.++|||++++.+++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999975 68999999986443222  2346889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+. |++.+.+. ....+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9997 46666654 345699999999999999999999998   9999999999999999999999999998765432  


Q ss_pred             ceeeccccccCccCchhhc---cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          383 HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                         ....++..|+|||.+.   ...++.++||||||+++|||+||+.||......       ..........        
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-------~~~~~~~~~~--------  230 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQND--------  230 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-------HHHHHHhcCC--------
Confidence               2235788999999874   456889999999999999999999998632211       1111111100        


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       ............+.+++.+||+.+|++||++.+++.+
T Consensus       231 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 -SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             0011122244678999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-37  Score=312.74  Aligned_cols=245  Identities=27%  Similarity=0.423  Sum_probs=195.7

Q ss_pred             CCCeeeeeCCeEEEEEEEC-CCCEEEEEEcc---cCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCc--eeeEee
Q 008893          231 SKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK---DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE--RLLVYP  304 (549)
Q Consensus       231 ~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~---~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  304 (549)
                      ....||+|+|-+||+|... +|..||---++   .........+|..|+.+|+.++||||++++.++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3468999999999999965 47777743332   22333344689999999999999999999999987655  778999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-CCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      .|..|+|..++++.+.++......|+.||++||.|||++ .|+|+|||||-+||+|+. .|.+||+|+|+|+......  
T Consensus       124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--  200 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--  200 (632)
T ss_pred             cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence            999999999999988999999999999999999999997 789999999999999984 5899999999999876432  


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                       ...+.|||.|||||++. ..|++.+||||||+.++||+|+..|+..-....+   +.   +......+... +.     
T Consensus       201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ---IY---KKV~SGiKP~s-l~-----  266 (632)
T KOG0584|consen  201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ---IY---KKVTSGIKPAA-LS-----  266 (632)
T ss_pred             -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH---HH---HHHHcCCCHHH-hh-----
Confidence             22367999999999987 7899999999999999999999999874322111   11   22222111111 10     


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                         ...-+++.++|.+|+.. .++|||+.|++.
T Consensus       267 ---kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  267 ---KVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ---ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence               11125688999999999 999999999986

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=301.37  Aligned_cols=265  Identities=22%  Similarity=0.309  Sum_probs=199.7

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecC--CceeeEee
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVYP  304 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  304 (549)
                      |++.+.||+|+||.||+|... +++.+|+|++.... .......+.+|+.+++.++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999976 48899999998653 222344688899999999999999999999888  78999999


Q ss_pred             ccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      |+++ +|.+++... ..+++..+..++.||+.||.|||+.   +++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9975 888888654 5799999999999999999999998   9999999999999999999999999999876544322


Q ss_pred             eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc--chhh-----
Q 008893          384 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK--KLEM-----  455 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----  455 (549)
                      ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...........+...........  ....     
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            2333457888999998765 4578999999999999999999999874332211111111000000000  0000     


Q ss_pred             ------hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 ------LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ------~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                            .....+...+...++..+.+++.+|++.+|++||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                  000000001111125678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.3e-36  Score=299.51  Aligned_cols=246  Identities=20%  Similarity=0.273  Sum_probs=197.3

Q ss_pred             CCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCC
Q 008893          231 SKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       231 ~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      ....||+|+||.||+|... +++.||+|.+..... .....+.+|+..+..+.|||++++++++...+..++++||++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            3457999999999999865 689999999865432 33456889999999999999999999999999999999999999


Q ss_pred             chhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccc
Q 008893          310 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR  389 (549)
Q Consensus       310 ~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  389 (549)
                      +|.+++.. ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ ......
T Consensus       104 ~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~  178 (297)
T cd06659         104 ALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLV  178 (297)
T ss_pred             CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccccee
Confidence            99987765 4589999999999999999999999   999999999999999999999999999875543221 223345


Q ss_pred             cccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHH
Q 008893          390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE  469 (549)
Q Consensus       390 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  469 (549)
                      |+..|+|||++.+..++.++||||||+++|||++|+.||......       ..........      .....  .....
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~------~~~~~--~~~~~  243 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMKRLRDSP------PPKLK--NAHKI  243 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhccC------CCCcc--ccCCC
Confidence            889999999999889999999999999999999999998642211       1111111100      00000  01112


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          470 LEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       470 ~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+.+++.+|++.+|++||++++++++
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            3568899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.2e-36  Score=297.99  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=204.9

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++.|+..+.||+|++|.||+|..+ +++.|++|.+.....  ....+..|+++++.++|+|++++++++......++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4567888899999999999999976 688999999975443  4557889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            9999999999998765 799999999999999999999998   999999999999999999999999999876543221


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+......       ........ .....     . 
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~-----~-  236 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFLITT-KGIPP-----L-  236 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh-cCCCC-----C-
Confidence             122334788999999998888999999999999999999999998632211       00111110 00000     0 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       ......+..+.+++.+|++.+|.+||++.++++
T Consensus       237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             011123467899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5e-36  Score=290.02  Aligned_cols=249  Identities=29%  Similarity=0.393  Sum_probs=204.3

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      +|+..+.||+|++|.||++... +++.+++|++..... .....+.+|+..++.++|+|++++++++......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            4777899999999999999976 688999999976543 34567899999999999999999999999999999999999


Q ss_pred             CCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      ++++|.+++... ..+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||.+........  .
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence            999999998765 5799999999999999999999998   999999999999999999999999999987654332  2


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......       ........ ........       
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~~~~-------  219 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-------KALFKIAT-NGPPGLRN-------  219 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHHh-cCCCCcCc-------
Confidence            3445889999999998888999999999999999999999998643211       11111110 00011100       


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .......+.+++.+|++.||++|||+.|++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11114678999999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-37  Score=309.67  Aligned_cols=263  Identities=19%  Similarity=0.285  Sum_probs=197.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC-----Cce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  299 (549)
                      +++|++.+.||+|+||.||+|... +|+.||+|.+...........+.+|+.+++.++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999864 68999999986543333345688899999999999999999987654     347


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++++||+.+ ++.+.+.. ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            899999975 78777754 3699999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCc--eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc---cch
Q 008893          380 CDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE---KKL  453 (549)
Q Consensus       380 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~  453 (549)
                      ....  ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........    ...+......   +..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~----~~~~~~~~~~~~~~~~  234 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ----LNLILGVLGTPSQEDL  234 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCCHHHH
Confidence            2211  1123458899999998754 5688999999999999999999999964322111    0000000000   000


Q ss_pred             hhhccccc---------cCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          454 EMLVDKDL---------KNN-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       454 ~~~~d~~l---------~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..+.+...         ...     ..+.....+.+++.+||+.+|++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000         000     001124668899999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.5e-36  Score=298.02  Aligned_cols=250  Identities=20%  Similarity=0.282  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .+|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|||++++++++...+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            57888999999999999999864 68899999986433 23345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++... .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........ ..
T Consensus        98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~  172 (293)
T cd06647          98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  172 (293)
T ss_pred             CCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence            9999999998754 488999999999999999999999   999999999999999999999999999876543322 22


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....+++.|+|||.+....++.++||||||+++|++++|+.||.........       .......        ......
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-------~~~~~~~--------~~~~~~  237 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIATNG--------TPELQN  237 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-------eehhcCC--------CCCCCC
Confidence            2345888999999998888999999999999999999999999643221110       0000000        000011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +......+.+++.+||+.+|++||++.+++.+
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            12234568899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.3e-36  Score=295.93  Aligned_cols=244  Identities=25%  Similarity=0.291  Sum_probs=190.0

Q ss_pred             eeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhh---ccCCCccceEEEEecCCceeeEeeccC
Q 008893          234 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISL---AVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       234 ~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      .||+|+||.||++... +++.+|+|.+......  .....+.+|..++..   ..|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 5899999998654322  112234455444433   479999999999999999999999999


Q ss_pred             CCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeec
Q 008893          308 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA  387 (549)
Q Consensus       308 ~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  387 (549)
                      +++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++.......   ...
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~  154 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA  154 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccC
Confidence            999999998777899999999999999999999999   99999999999999999999999999987554221   123


Q ss_pred             cccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCC
Q 008893          388 VRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD  466 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  466 (549)
                      ..|+..|+|||.+.+ ..++.++|||||||++|||++|..||.........     .......      ...    ...+
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~~~------~~~----~~~~  219 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMTL------TVN----VELP  219 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-----HHHHHhh------cCC----cCCc
Confidence            458999999999864 55889999999999999999999999743221110     0111000      001    1122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 008893          467 RIELEEMVQVALLCTQYLPSLRP-----KMSEVVRML  498 (549)
Q Consensus       467 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L  498 (549)
                      ...+.++.+++.+|++.||++||     +++|++++-
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence            33446789999999999999999     598887753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.3e-35  Score=293.62  Aligned_cols=247  Identities=21%  Similarity=0.283  Sum_probs=199.2

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccC
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      |...+.||+|++|.||++... +++.+++|.+.... ......+.+|+.+++.+.|||++++++++...+..++++||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            445579999999999999964 68899999886433 2334568899999999999999999999999999999999999


Q ss_pred             CCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeec
Q 008893          308 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA  387 (549)
Q Consensus       308 ~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  387 (549)
                      +++|.+++.. ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||.+........ ....
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~  174 (285)
T cd06648         100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS  174 (285)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence            9999999877 5689999999999999999999999   999999999999999999999999998875543221 2233


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCH
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR  467 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  467 (549)
                      ..|+..|+|||.+.+..++.++||||||+++|||++|+.||.....       ...........      .+...  ...
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~~~~~------~~~~~--~~~  239 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDNL------PPKLK--NLH  239 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHhcC------CCCCc--ccc
Confidence            4588999999999888899999999999999999999999864221       11111111110      00110  011


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          468 IELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       468 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .....+.+++.+|++.+|++||++.++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            13367999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-36  Score=299.49  Aligned_cols=253  Identities=25%  Similarity=0.347  Sum_probs=194.4

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|...+.||+|+||.||++... +++.||+|.+...........+..|+.++.++. |+||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555678999999999999965 589999999875543344557889999999986 99999999999998999999999


Q ss_pred             cCCCchhhh---hc--cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          306 MSNGSVASR---LK--AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       306 ~~~g~L~~~---l~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +.. ++.++   +.  ....+++..+..++.|++.||+|||+..  +++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 44443   22  3357999999999999999999999732  8999999999999999999999999999765432


Q ss_pred             CCceeeccccccCccCchhhccC---CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      .  ......|+..|+|||.+.+.   .++.++||||||+++|||++|+.||....      .....+.......      
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~------  227 (288)
T cd06616         162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGD------  227 (288)
T ss_pred             C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCC------
Confidence            2  12233588899999998776   68899999999999999999999986422      1111111111000      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+.+........+..+.+++.+|++.+|++|||+++|+++
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111111122345679999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.1e-36  Score=307.26  Aligned_cols=264  Identities=20%  Similarity=0.274  Sum_probs=198.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecC------
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------  296 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  296 (549)
                      ..++|+..+.||+|+||.||+|... +|+.||+|.+.... .......+.+|+.+++.++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4568999999999999999999965 68999999986432 222334677899999999999999999988643      


Q ss_pred             CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          297 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      ...++||||+. ++|.+.+...  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence            34699999996 4888877644  89999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccH--------HHHHHHH-
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM--------LDWVKKI-  447 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~~-  447 (549)
                      .....  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+        ..+.... 
T Consensus       168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         168 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             CCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            54322  122345788999999999999999999999999999999999999754321110000        0000000 


Q ss_pred             ------hhc------cchhhhcccccc----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          448 ------HQE------KKLEMLVDKDLK----NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       448 ------~~~------~~~~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                            ...      .....+......    ..........+.+++.+|++.||++|||+.|++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  000      000011111000    0011233567889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-36  Score=292.20  Aligned_cols=251  Identities=24%  Similarity=0.314  Sum_probs=199.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC----CCCcHHHHHHHHHHHhhccCCCccceEEEEecC--Cce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  299 (549)
                      .+|.+.+.||+|+||.||+|... +++.||+|.+....    .......+.+|+++++.++|+||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47889999999999999999965 58999999875321    122234688999999999999999999998764  457


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++++||+++++|.+.+.....+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            89999999999999998777799999999999999999999999   999999999999999999999999999986542


Q ss_pred             CCC--ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          380 CDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       380 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ...  .......++..|+|||.+.+..++.++||||||+++|+|++|+.||......      .. +...         .
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~~---------~  222 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AA-IFKI---------A  222 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HH-HHHH---------H
Confidence            111  1112345889999999999888999999999999999999999998632110      00 0111         1


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ........+....+.+.+++.+|++ +|.+||+..+++.+
T Consensus       223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            1111122334445779999999999 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.7e-36  Score=296.16  Aligned_cols=240  Identities=26%  Similarity=0.302  Sum_probs=190.8

Q ss_pred             eeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCch
Q 008893          235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV  311 (549)
Q Consensus       235 iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  311 (549)
                      ||+|+||+||++... +|+.||+|.+....  .......+..|+++++.++|||++++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 68999999986432  122234567899999999999999999999999999999999999999


Q ss_pred             hhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccc
Q 008893          312 ASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR  389 (549)
Q Consensus       312 ~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  389 (549)
                      .+++....  .+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||.+......  .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence            99987544  789999999999999999999999   9999999999999999999999999998765432  1222345


Q ss_pred             cccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHH
Q 008893          390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE  469 (549)
Q Consensus       390 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  469 (549)
                      ++..|+|||.+.+..++.++||||||+++|+|++|+.||...........    +....        ..  ....++...
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~--------~~--~~~~~~~~~  221 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE----LKRRT--------LE--MAVEYPDKF  221 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH----HHhcc--------cc--ccccCCccC
Confidence            78899999999888899999999999999999999999964332111100    00000        00  001122223


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHH
Q 008893          470 LEEMVQVALLCTQYLPSLRPKMSE  493 (549)
Q Consensus       470 ~~~l~~l~~~cl~~dP~~RPs~~e  493 (549)
                      ...+.+++.+||+.+|++||+.++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCc
Confidence            467899999999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.9e-36  Score=289.19  Aligned_cols=252  Identities=27%  Similarity=0.367  Sum_probs=206.7

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecC--CceeeEe
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVY  303 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  303 (549)
                      +|...+.||+|++|.||+|... +++.|++|.+..... ......+.+|+..+++++|+|++++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999976 689999999875432 23345789999999999999999999999988  8899999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            9999999999998777899999999999999999999998   9999999999999999999999999999876544321


Q ss_pred             -eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......++..|+|||.+.....+.++||||||+++++|++|+.||.....      ..........         ....
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~---------~~~~  222 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYKIGS---------SGEP  222 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHhccc---------cCCC
Confidence             12334588899999999888899999999999999999999999975431      1111111110         1111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+......+.+++.+|++.+|++||++.|++.+
T Consensus       223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            12233335789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.2e-36  Score=298.49  Aligned_cols=265  Identities=19%  Similarity=0.226  Sum_probs=194.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhcc-CCCccceEEEEecCCc-----
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTE-----  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  298 (549)
                      ++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999975 6899999998654322 22346788999999995 6999999999877665     


Q ss_pred             eeeEeeccCCCchhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-CCceEEeecc
Q 008893          299 RLLVYPYMSNGSVASRLKA-----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFG  372 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg  372 (549)
                      .+++|||+++ +|.+++..     ...+++..+..++.||+.||.|||+.   +|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 78887752     23589999999999999999999999   9999999999999998 8999999999


Q ss_pred             cccccCCCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc
Q 008893          373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK  451 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (549)
                      +++.+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|+||..||...........+...... ....
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~  234 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTEQ  234 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CChh
Confidence            99765432221 122346888999998865 45789999999999999999999998753322111111000000 0000


Q ss_pred             chhhh---cc----cccc----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          452 KLEML---VD----KDLK----NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       452 ~~~~~---~d----~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .....   .+    +...    ....+.....+.+++.+|++++|++||++.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000   00    0000    00001234678999999999999999999999863

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6e-36  Score=296.69  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=198.6

Q ss_pred             CCCCCCeeeeeCCeEEEEEEE----CCCCEEEEEEcccCCC---CCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCce
Q 008893          228 NFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  299 (549)
                      +|++.+.||+|+||.||++..    .+|+.||+|+++....   ......+..|++++..+ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999986    3689999999875321   22234678899999999 589999999999988899


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            99999999999999998777899999999999999999999998   999999999999999999999999999987644


Q ss_pred             CCCceeeccccccCccCchhhccC--CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ..........|+..|+|||.+...  .++.++||||||+++|+|+||+.||.......   ....+.......       
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~-------  227 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRILKS-------  227 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHHHHHhhcc-------
Confidence            332222344588999999998753  46789999999999999999999986422211   111211111110       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVR  496 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  496 (549)
                      .    ..++......+.+++.+|++.+|++||     ++++++.
T Consensus       228 ~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            0    111222346788999999999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.7e-36  Score=291.44  Aligned_cols=247  Identities=26%  Similarity=0.353  Sum_probs=203.2

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|++.+.||+|+||.||++... +++.+++|.+..... ......+.+|+.+++.++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999865 688999999875432 22344678899999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          306 MSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       306 ~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999998864    35689999999999999999999999   9999999999999999999999999999876543 


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                        ......++..|+|||.+.+..++.++|+||||+++|||++|+.||......    .+.   ....          ...
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~---~~~~----------~~~  217 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DLR---YKVQ----------RGK  217 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHH---HHHh----------cCC
Confidence              222345788999999999989999999999999999999999998643211    011   1110          111


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ....+.....++.+++.+|++.+|++||++.|++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            112233455779999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.6e-36  Score=299.20  Aligned_cols=268  Identities=23%  Similarity=0.301  Sum_probs=199.3

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCC----
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----  297 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  297 (549)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|.++.... ......+.+|+.+++.++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999976 588999999975432 223346788999999999999999999987654    


Q ss_pred             ------ceeeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEee
Q 008893          298 ------ERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD  370 (549)
Q Consensus       298 ------~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  370 (549)
                            ..++++||+++ ++...+.. ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999986 66666654 34689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          371 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       371 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      ||++...............++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+........ 
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-  238 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC-  238 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-
Confidence            999987654332222333467889999988654 578999999999999999999999864332111101111000000 


Q ss_pred             ccchhhhc--------cc------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 EKKLEMLV--------DK------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 ~~~~~~~~--------d~------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ......+.        +.      ...... ...+..+.+++..||+.+|++||++.+++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00000000        00      000000 1124678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.5e-36  Score=292.58  Aligned_cols=249  Identities=21%  Similarity=0.330  Sum_probs=200.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|+..+.||+|+||.||+|..+ +|..+|+|.+..... ......+.+|+.+++.++|+|++++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999976 588999999865422 22345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC-ceEEeecccccccCCCCC
Q 008893          306 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       306 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~  382 (549)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++ .+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            9999999998643  3579999999999999999999998   999999999999999875 569999999986653222


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......|++.|+|||.+.+..++.++||||||+++|||++|..||....       ...+........ .         
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~-~---------  219 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKICQGY-F---------  219 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhccc-C---------
Confidence             2223458899999999988889999999999999999999999986322       112222211111 0         


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..........+.+++.+|++.+|++|||+.|++++
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            01112233678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.6e-36  Score=296.07  Aligned_cols=259  Identities=22%  Similarity=0.277  Sum_probs=204.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEE----CCCCEEEEEEcccCCC---CCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCce
Q 008893          228 NFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  299 (549)
                      +|++.+.||+|+||.||++..    .+++.||||.++....   ......+..|++++..+ +|||++++.+.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            467788999999999999984    2578899999874321   12234688899999999 599999999999988999


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+++|+|.+.+.....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            99999999999999998777799999999999999999999998   999999999999999999999999999876544


Q ss_pred             CCCceeeccccccCccCchhhccCC--CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ..........|+..|+|||.+.+..  .+.++||||||+++|||+||..||........   ...........       
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~-------  227 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---QSEISRRILKS-------  227 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch---HHHHHHHHHcc-------
Confidence            3322223345889999999987665  78899999999999999999999863221111   11111111100       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL  503 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  503 (549)
                      .    ...+......+.+++.+|++.+|++|||+.++.+.|+...+
T Consensus       228 ~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~  269 (288)
T cd05583         228 K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF  269 (288)
T ss_pred             C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence            0    11122234668899999999999999999999888877544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-35  Score=297.30  Aligned_cols=247  Identities=28%  Similarity=0.356  Sum_probs=195.8

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      |+..+.||+|+||.||+|... ++..||+|.+......  .....+..|+++++.++|||++++++++...+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            666788999999999999965 6889999998654322  2234688899999999999999999999999999999999


Q ss_pred             cCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +.+ ++.+.+. ....+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++......    
T Consensus       107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----  178 (317)
T cd06635         107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----  178 (317)
T ss_pred             CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence            975 7777664 355699999999999999999999999   9999999999999999999999999998754422    


Q ss_pred             eeccccccCccCchhhc---cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          385 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                       ....|+..|+|||++.   .+.++.++|||||||++|||++|+.||......       ...........         
T Consensus       179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~---------  241 (317)
T cd06635         179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNES---------  241 (317)
T ss_pred             -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhccC---------
Confidence             2335888999999974   456889999999999999999999998632110       11111111100         


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...........+.+++.+|++.+|.+||++.++++++.-
T Consensus       242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            001112234668999999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=334.33  Aligned_cols=258  Identities=27%  Similarity=0.344  Sum_probs=209.0

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEE-ECCCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ..+-++.....||.|.||.||.|. ..+|+..|+|-++.... ......+.+|+.++..++|||+|+++|+-...+..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            345567788999999999999999 45799999998864432 2223458899999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      .||||++|+|.+.+..+...++.....+..|++.|++|||+.   |||||||||.||+++.+|.+|++|||.|..+....
T Consensus      1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            999999999999999888788888888999999999999999   99999999999999999999999999998775442


Q ss_pred             Cc---eeeccccccCccCchhhccCC---CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          382 SH---VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       382 ~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      ..   .-....||+.|||||.+.+..   ..-++||||+|||+.||+||+.||..-+...   .+...+           
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V----------- 1454 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHV----------- 1454 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHH-----------
Confidence            11   112456999999999997643   4568899999999999999999997422211   111111           


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       456 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        ...-.+.+|...+.+-.+++..|++.||++|+++.|++++--+
T Consensus      1455 --~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1455 --AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred             --hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence              1111234455566778999999999999999999998876554

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.4e-35  Score=288.76  Aligned_cols=246  Identities=21%  Similarity=0.265  Sum_probs=192.8

Q ss_pred             HHHhcCCCCCCee--eeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhh-ccCCCccceEEEEecCCc
Q 008893          223 QSATSNFSSKNLV--GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       223 ~~~~~~~~~~~~i--G~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~  298 (549)
                      ....++|++.+.+  |+|+||.||++..+ ++..+|+|.+.......      .|+..... .+|||++++++++...+.
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            3344567777776  99999999999965 68899999986543211      12222222 269999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC-ceEEeeccccccc
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLL  377 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~  377 (549)
                      .++||||+++++|.+++.....+++..+..++.|++.||.|||+.   +++||||||+||+++.++ .++|+|||+++..
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            999999999999999998777899999999999999999999999   999999999999999988 9999999998765


Q ss_pred             CCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          378 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ...     ....++..|+|||++.+..++.++||||||+++|||++|+.||.......  .....+.....         
T Consensus       161 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~---------  224 (267)
T PHA03390        161 GTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQQ---------  224 (267)
T ss_pred             CCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhhc---------
Confidence            432     12358899999999999899999999999999999999999997332211  11122221110         


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK-MSEVVR  496 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~  496 (549)
                       ..  ..........+.+++.+|++.+|.+||+ ++|+++
T Consensus       225 -~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 -KK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -cc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence             00  0112234477899999999999999996 688874

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.4e-36  Score=297.09  Aligned_cols=265  Identities=19%  Similarity=0.260  Sum_probs=194.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|+..+.||+|++|+||+|... +|+.||+|.+...... .....+.+|+++++.++|||++++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999975 6899999998654322 223468889999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-CCceEEeecccccccCCCC
Q 008893          305 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |++ ++|.+.+....  .+++.....++.||+.||.|||+.   +++||||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 47777775433  357888889999999999999998   9999999999999985 5679999999997654321


Q ss_pred             CceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc-----chhh
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK-----KLEM  455 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~  455 (549)
                      . ......++..|+|||++.+. .++.++||||||+++|+|+||+.||..............+........     .+..
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            1 12233578899999988664 578999999999999999999999964332111100000000000000     0000


Q ss_pred             hcc--ccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          456 LVD--KDLKN----NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       456 ~~d--~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ...  +....    .........+.+++.+|++.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000  00000    001112356889999999999999999999986

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7e-36  Score=291.57  Aligned_cols=248  Identities=25%  Similarity=0.309  Sum_probs=199.8

Q ss_pred             eeeeCCeEEEEEEECC-CCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCch
Q 008893          235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV  311 (549)
Q Consensus       235 iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  311 (549)
                      ||+|+||.||++...+ |+.+++|.+......  .....+.+|+++++.++|||++++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999874 999999998654321  3345688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-------ce
Q 008893          312 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-------HV  384 (549)
Q Consensus       312 ~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-------~~  384 (549)
                      .+++.....+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++........       ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            99998766899999999999999999999998   999999999999999999999999999876543211       12


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      .....++..|+|||.......+.++||||||+++|+|++|+.||.....       ......... ...          .
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~----------~  219 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNILN-GKI----------E  219 (265)
T ss_pred             ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhc-CCc----------C
Confidence            2334578899999999888899999999999999999999999864321       111111111 000          0


Q ss_pred             CCHH--HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 008893          465 YDRI--ELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL  503 (549)
Q Consensus       465 ~~~~--~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  503 (549)
                      .+..  .+..+.+++.+|++.+|++|||+.++.+.|+...+
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~  260 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF  260 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence            1111  24678999999999999999999777776665433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-37  Score=277.46  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=198.5

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeEeecc
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      .+....||.|+-|+|++.+.+ .|..+|||.+.........+++...++++.+.+ .|.||+.+|||..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            345578999999999999976 589999999987766666667888888776664 899999999999999999999998


Q ss_pred             CCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      .. .+..++. -.+++++.-.-++...++.||.||.+++  +|+|||+||+|||+|+.|++|+||||++..+-..  ...
T Consensus       174 s~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAh  248 (391)
T KOG0983|consen  174 ST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAH  248 (391)
T ss_pred             HH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--ccc
Confidence            54 3344443 4557899888999999999999999875  9999999999999999999999999999876533  334


Q ss_pred             eccccccCccCchhhcc---CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          386 TAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      +..+|-+.|||||.+.-   ..|+.++||||||++++||+||+.||.....+..      .+..+..++.      +.+.
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln~eP------P~L~  316 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLNEEP------PLLP  316 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHhcCC------CCCC
Confidence            45568999999999854   4688999999999999999999999985433211      1122222111      2222


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                      +.  ...+..+.+++..|+++|+.+||...+++++-
T Consensus       317 ~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  317 GH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             cc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence            11  11457799999999999999999999998753

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.6e-36  Score=302.94  Aligned_cols=268  Identities=22%  Similarity=0.321  Sum_probs=198.7

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC--Cce
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT--TER  299 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~  299 (549)
                      ..++|++.+.||+|+||.||+|... +|+.+|+|++.... .......+..|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467888899999999999999976 58899999886432 122334577899999999 999999999998654  367


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||++ ++|.+++... .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            99999997 5998888766 789999999999999999999998   999999999999999999999999999986643


Q ss_pred             CCCc----eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHH-------
Q 008893          380 CDSH----VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI-------  447 (549)
Q Consensus       380 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-------  447 (549)
                      ....    ......|+..|+|||.+.+ ..++.++||||||+++|+|+||+.||...........+.......       
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            3221    2233458899999998765 457889999999999999999999986433221111111100000       


Q ss_pred             hhccchhhhcc----cccc--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          448 HQEKKLEMLVD----KDLK--NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       448 ~~~~~~~~~~d----~~l~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ........+.+    ....  .......+..+.+++.+|++.+|++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00000000110    0000  00011134678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.7e-35  Score=294.32  Aligned_cols=252  Identities=25%  Similarity=0.376  Sum_probs=194.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|++.+.||+|+||.||+|..++ ++.||||.++..........+..|+.++.+.. |+||+++++++......+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3567889999999999999999875 89999999976543334455677777666664 999999999999999999999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||+.+ ++.+.+.. ...+++..+..++.|++.||.|||+ .   +|+||||+|+||++++++.+||+|||++.......
T Consensus        94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            99854 66666543 4478999999999999999999997 5   89999999999999999999999999997654322


Q ss_pred             CceeeccccccCccCchhhccCC----CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      .  .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......      .+......... ...  
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-~~~--  238 (296)
T cd06618         170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEE-PPS--  238 (296)
T ss_pred             c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCC-CCC--
Confidence            1  12234788999999987654    788999999999999999999998632111      11111111111 000  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                         ..  .......++.+++.+|++.||++||++.+++++
T Consensus       239 ---~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 ---LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ---CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               00  001124678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-36  Score=294.03  Aligned_cols=263  Identities=22%  Similarity=0.296  Sum_probs=197.7

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeEeecc
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      |.+.+.||+|++|+||+|... +++.|++|++.............+|+..+..++ |+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999976 478999999875543233334567889999998 999999999999999999999999


Q ss_pred             CCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          307 SNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       307 ~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                       +|+|.+.+....  .+++..+..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|||++........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             789999887543  789999999999999999999998   999999999999999999999999999986543221  


Q ss_pred             eeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH---------HHHHHHhhccchh
Q 008893          385 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML---------DWVKKIHQEKKLE  454 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~  454 (549)
                      .....++..|+|||.+.+ ..++.++||||||++++||++|+.||.............         .|...........
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            223457889999998754 457899999999999999999999986543221111010         1111110000000


Q ss_pred             hhcccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 MLVDKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..+.....   ..........+.+++.+|++.+|++||+++|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000   00001114678999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.4e-36  Score=303.81  Aligned_cols=267  Identities=19%  Similarity=0.286  Sum_probs=200.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEec----CCce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  299 (549)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368899999999999999999965 589999999875432 2334567789999999999999999988753    3467


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+. ++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||++++++.+||+|||++.....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            99999996 68999998777799999999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCc---eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH--------HHHHHH
Q 008893          380 CDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKI  447 (549)
Q Consensus       380 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~  447 (549)
                      ....   ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.        ......
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            2211   1123468889999999865 458899999999999999999999996433211100000        000000


Q ss_pred             hhccchhhhccc-cccCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          448 HQEKKLEMLVDK-DLKNNY-----DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       448 ~~~~~~~~~~d~-~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      . ...+....+. ......     .+..+..+.+++.+|++.+|++||++.+++.+
T Consensus       240 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         240 G-SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             c-hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0 0000000000 000001     12235779999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-35  Score=287.80  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=204.6

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|...+.||+|+||.||++... +++.|++|++...... .....+..|++.++.++|+|++++.+.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999975 5889999999754322 3345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          306 MSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       306 ~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      +++++|.+.+..    ...+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999875    36799999999999999999999999   99999999999999999999999999998765432


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                       .......|++.|+|||...+..++.++||||+|+++++|++|+.||.....       ...........          
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~----------  219 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKILKGQ----------  219 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHHhcCC----------
Confidence             222334588899999999888899999999999999999999999864321       11111111110          


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ....+......+.+++.+|+..+|++||++.|++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            011122334678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-36  Score=302.93  Aligned_cols=248  Identities=21%  Similarity=0.309  Sum_probs=210.8

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .+..|.+...||+|.|+.|..|++. ++..||+|.+.+..-. .....+.+|++++..++|||||+++.+.......|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3567889999999999999999965 5999999999765422 2234588999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||+.+|.+.+++...+.+.+..+..++.|+.+|++|||++   .|+|||||++|||++.+.++||+|||++.++.  ..
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~  208 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--YG  208 (596)
T ss_pred             EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--cc
Confidence            99999999999999888888899999999999999999999   99999999999999999999999999999887  34


Q ss_pred             ceeeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      ......+|++.|.|||++.+..| .+++|+||+|+++|.|+.|..||++.....-.                    ++.+
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr--------------------~rvl  268 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR--------------------PRVL  268 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc--------------------chhe
Confidence            45566789999999999999876 68999999999999999999999864432211                    1111


Q ss_pred             cCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNN--YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+.  .+.-...+..+++++++-.+|.+|++++++.++
T Consensus       269 ~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  269 RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             eeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            111  122234668899999999999999999999864

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=295.66  Aligned_cols=266  Identities=21%  Similarity=0.306  Sum_probs=196.2

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC---CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecC--Ccee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERL  300 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  300 (549)
                      +|.+.+.||+|+||.||+|...   +++.||+|.+....  .......+.+|+.++..++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4777889999999999999975   47899999997632  112234578899999999999999999999988  7899


Q ss_pred             eEeeccCCCchhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC----CCceEEeec
Q 008893          301 LVYPYMSNGSVASRLK-----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE----YYEAVVGDF  371 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Df  371 (549)
                      +||||+++ ++.+.+.     ....+++..+..++.||+.||.|||+.   +|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6666553     123689999999999999999999999   9999999999999999    999999999


Q ss_pred             ccccccCCCCCc--eeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCcccccc------ccHHH
Q 008893          372 GLAKLLDHCDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQK------GAMLD  442 (549)
Q Consensus       372 g~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~------~~~~~  442 (549)
                      |++.........  ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.........      ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            999876433221  12234578899999988664 5789999999999999999999999754432210      01111


Q ss_pred             HHHHHhh-----------ccchhhhccccccCCCC---------H--HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          443 WVKKIHQ-----------EKKLEMLVDKDLKNNYD---------R--IELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       443 ~~~~~~~-----------~~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+.....           ........+......++         .  .....+.+++.+|++.||++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1110000           00000000000000011         0  223568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.6e-35  Score=291.64  Aligned_cols=258  Identities=17%  Similarity=0.177  Sum_probs=185.3

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCCCcHH----------HHHHHHHHHhhccCCCccceEE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEI----------QFQTEVEMISLAVHRNLLRLIG  291 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~----------~~~~e~~~l~~l~h~niv~l~~  291 (549)
                      .++|.+.+.||+|+||+||+|...+    +..+|+|+..........+          ....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3578999999999999999999754    4566777543322111000          1122333455678999999999


Q ss_pred             EEecCC----ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceE
Q 008893          292 FCMTTT----ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV  367 (549)
Q Consensus       292 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  367 (549)
                      ++....    ..+++++++.. ++.+.+......++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence            765443    34677777643 5666665555578889999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCCc------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccc--c
Q 008893          368 VGDFGLAKLLDHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG--A  439 (549)
Q Consensus       368 l~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--~  439 (549)
                      |+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........  .
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999999866432211      1123459999999999999999999999999999999999999997432111100  0


Q ss_pred             HHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          440 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      ..++......         ....   ....+..+.+++..|++.+|++||++.++.+.++
T Consensus       247 ~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        247 KCDFIKRLHE---------GKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHHHhhh---------hhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1111111111         1110   0112367899999999999999999999998763

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1e-35  Score=297.90  Aligned_cols=266  Identities=26%  Similarity=0.305  Sum_probs=196.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecC--Cceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  301 (549)
                      .++|++.+.||+|+||.||+|... +|+.||+|.++...... ....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467899999999999999999975 58999999987543222 233466899999999999999999998765  46899


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.   +++||||||+||++++++.+||+|||++......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999975 78777764 45789999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh---
Q 008893          381 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML---  456 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  456 (549)
                      ... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..+..... .......   
T Consensus       162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  239 (309)
T cd07845         162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDL  239 (309)
T ss_pred             cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC-hhhchhhhcc
Confidence            221 222335788999999865 4578999999999999999999999974332211111111000000 0000000   


Q ss_pred             -----c--cccccCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          457 -----V--DKDLKNNY---DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       457 -----~--d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                           .  ........   .......+.+++.+|++.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                 0  00000000   01124667899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=293.54  Aligned_cols=248  Identities=25%  Similarity=0.299  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .+.|..-++||+||||.||....+ +|+.+|.|.+.+..  ...++.-..+|-.+|.+++.+.||.+--.|...+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356788899999999999999865 59999999885432  223344577899999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          303 YPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +..|.||+|.-++.+-  +.+++..+..++.+|+.||++||+.   +||+|||||+|||+|+.|+++|+|.|+|..+...
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            9999999999988643  4899999999999999999999999   9999999999999999999999999999887644


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      .  .....+||.+|||||++.+..|+...|.||+||+||||+.|+.||...........+.             ..+.. 
T Consensus       341 ~--~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd-------------rr~~~-  404 (591)
T KOG0986|consen  341 K--PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD-------------RRTLE-  404 (591)
T ss_pred             C--ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH-------------HHHhc-
Confidence            3  3333479999999999999999999999999999999999999997432211111110             00000 


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMS  492 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  492 (549)
                      -...++...+++..++....+++||++|..-.
T Consensus       405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            01334555567888999999999999998443

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.2e-36  Score=304.28  Aligned_cols=266  Identities=18%  Similarity=0.260  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecC-----Cc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  298 (549)
                      .++|.+.+.||+|+||+||+|... +++.||||.+.... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357888999999999999999964 68999999987532 222234677899999999999999999987644     34


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++++||+. ++|.+++.....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            799999996 68988888777899999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHH-------Hhhc
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK-------IHQE  450 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~  450 (549)
                      ... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...........+......       ....
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            332 12233457889999998865 46889999999999999999999999643211110000000000       0000


Q ss_pred             cchhhhc-------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          451 KKLEMLV-------DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       451 ~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .......       +..... .....+..+.+++.+|++.+|++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            0000000       000000 011234678999999999999999999999975

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=285.78  Aligned_cols=248  Identities=27%  Similarity=0.422  Sum_probs=203.9

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|+..+.||+|++|.||+|... +++.|++|.+...... .....+.+|+++++.++|+|++++++++......+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 5789999999765422 2345689999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++......... .
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~  156 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D  156 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence            99999999998777899999999999999999999999   9999999999999999999999999999876543332 2


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....++..|+|||...+..++.++||||+|+++|+|++|+.||.....      ........ . ..         ....
T Consensus       157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~~-~-~~---------~~~~  219 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIV-Q-DD---------HPPL  219 (254)
T ss_pred             cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-c-cC---------CCCC
Confidence            334588899999999888889999999999999999999999863221      01111100 0 00         0111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      +......+.+++.+|+..+|++||++.+++.
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            2223467889999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-36  Score=303.83  Aligned_cols=265  Identities=20%  Similarity=0.272  Sum_probs=202.1

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCC-----cee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----ERL  300 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  300 (549)
                      +|.+.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++|+||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999975 489999999875432 233457889999999999999999999988765     789


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ++|||++ ++|.+.+.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            9999998 48999888777899999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC--ceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh-------hc
Q 008893          381 DS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH-------QE  450 (549)
Q Consensus       381 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~  450 (549)
                      ..  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+........       ..
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            21  112234578899999999887 789999999999999999999999975432211111111000000       00


Q ss_pred             cchhhhcc---ccc---cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          451 KKLEMLVD---KDL---KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       451 ~~~~~~~d---~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ......+.   ...   .....+..+..+.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            00000000   000   00011123467899999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=293.43  Aligned_cols=263  Identities=21%  Similarity=0.245  Sum_probs=200.3

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      |+..+.||+|++|.||+|... +++.+++|.+...... .....+..|+.+++.++|+|++++++++...+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999975 6899999998754422 23456888999999999999999999999999999999999


Q ss_pred             CCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      ++ ++.+.+.. ...+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.++|+|||.+....... ...
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~  155 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY  155 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence            75 88877765 45799999999999999999999999   99999999999999999999999999998765433 122


Q ss_pred             eccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc-------
Q 008893          386 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV-------  457 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  457 (549)
                      ....++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+....+........ ........       
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD-PEVWPKFTSLARNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCc-hHhcccchhhhhhhh
Confidence            234578899999998876 789999999999999999999999865432211100000000000 00000000       


Q ss_pred             ----cccc--cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          458 ----DKDL--KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       458 ----d~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                          +...  .....+....++.+++.+|++.||.+||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                0000  001112345789999999999999999999999863

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-36  Score=280.85  Aligned_cols=268  Identities=22%  Similarity=0.317  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC---C--CCEEEEEEcccCCCCCc-HHHHHHHHHHHhhccCCCccceEEEEec-CCce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ---D--GTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMT-TTER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~---~--g~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  299 (549)
                      ..|+....||+|.||.||+|+-+   +  .+.+|+|.++......+ .....+|+.+++.++|||++.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46888999999999999999743   2  33799999987644333 3457899999999999999999998877 7788


Q ss_pred             eeEeeccCCCchhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC----CceEEee
Q 008893          300 LLVYPYMSNGSVASRLK-----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY----YEAVVGD  370 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~D  370 (549)
                      ++++||.+. +|.+.++     ....++...+..|+.||+.|+.|||++   =|+||||||.|||+..+    |++||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 8888885     234688999999999999999999999   79999999999999877    9999999


Q ss_pred             cccccccCCCCCc--eeeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCcccccc--ccHHHHHH
Q 008893          371 FGLAKLLDHCDSH--VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQK--GAMLDWVK  445 (549)
Q Consensus       371 fg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~--~~~~~~~~  445 (549)
                      ||+++.+...-..  ....++.|..|+|||++.+.. ||.+.||||.|||..||+|-.+.|.+.+..-..  ....+.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999988654332  234567899999999998864 899999999999999999998887754332111  11222222


Q ss_pred             HHhhc-------cc--hhhhccc-----ccc-CCCCHH-----------HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          446 KIHQE-------KK--LEMLVDK-----DLK-NNYDRI-----------ELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       446 ~~~~~-------~~--~~~~~d~-----~l~-~~~~~~-----------~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                      .+..-       .+  +..+.+-     .+. ..+...           ..+...+|+.++++.||.+|.|+++++++.
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            22110       00  0000000     000 000000           012368899999999999999999998753

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=289.43  Aligned_cols=246  Identities=22%  Similarity=0.275  Sum_probs=191.5

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHH-HhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEM-ISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||.||+|... +|+.||+|.++.....  .....+..|..+ .....|+|++++++++...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999975 5899999998654321  112234444444 3455899999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      ++|.+++.....+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||+++....     ....
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~  153 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF  153 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence            99999998777899999999999999999999998   999999999999999999999999999875432     1233


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      .++..|+|||.+.+..++.++||||||+++|||+||..||......       ........ ...      .........
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~------~~~~~~~~~  219 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILS-RRI------NWPEEVKEF  219 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHh-ccc------CCCCccccc
Confidence            5788999999998888899999999999999999999999643211       11111110 000      001111122


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .+..+.+++.+|++.+|++||++.++.+.|..
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            34778999999999999999988766665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.8e-35  Score=294.61  Aligned_cols=264  Identities=23%  Similarity=0.332  Sum_probs=194.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCc-----
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE-----  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  298 (549)
                      .++|+..+.||+|+||.||+|... +++.||||.+...... .....+.+|+.+++.++||||+++++++.....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357889999999999999999975 6899999998654322 223356789999999999999999999876543     


Q ss_pred             ---eeeEeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccc
Q 008893          299 ---RLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA  374 (549)
Q Consensus       299 ---~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  374 (549)
                         .++||||+.+ +|.+.+... ..+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence               4999999975 777777643 3689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCc---eeeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh-
Q 008893          375 KLLDHCDSH---VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ-  449 (549)
Q Consensus       375 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  449 (549)
                      .........   ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||.........    ..+..... 
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~----~~~~~~~~~  242 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL----TLISQLCGS  242 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHhCC
Confidence            866432221   112334778899999886654 688999999999999999999998653321111    11111000 


Q ss_pred             --ccchh-----hhccc-cccCCC---------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 --EKKLE-----MLVDK-DLKNNY---------DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 --~~~~~-----~~~d~-~l~~~~---------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        .....     ...+. ......         .......+.+++.+|++.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence              00000     00000 000000         00112457799999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.2e-36  Score=316.44  Aligned_cols=269  Identities=20%  Similarity=0.253  Sum_probs=188.4

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECC--CCEEEEEEc--------------ccC--CCCCcHHHHHHHHHHHhhccCCCc
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQD--GTVVAVKRL--------------KDG--NAIGGEIQFQTEVEMISLAVHRNL  286 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--g~~vavK~~--------------~~~--~~~~~~~~~~~e~~~l~~l~h~ni  286 (549)
                      ..++|.+.+.||+|+||+||++..+.  +..++.|.+              ...  ........+.+|+.+++.++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            35689999999999999999987542  222222211              000  111123458899999999999999


Q ss_pred             cceEEEEecCCceeeEeeccCCCchhhhhccC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec
Q 008893          287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD  361 (549)
Q Consensus       287 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  361 (549)
                      +++++++...+..+++++++. ++|.+++...     ..........++.||+.||.|||++   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            999999999999999999985 4676665422     2234566778999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH
Q 008893          362 EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML  441 (549)
Q Consensus       362 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~  441 (549)
                      .++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++...........+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999999998765433333334569999999999999999999999999999999999875543222211111111


Q ss_pred             HHHHHHhh--cc------chhhhcccc-c---cCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          442 DWVKKIHQ--EK------KLEMLVDKD-L---KNNYDR-----IELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       442 ~~~~~~~~--~~------~~~~~~d~~-l---~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..+.....  ..      .+...++.. +   ....+.     .....+.+++.+|++.||++|||+.|++.+
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11111000  00      000000000 0   000000     012456788999999999999999999874

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=290.77  Aligned_cols=260  Identities=23%  Similarity=0.303  Sum_probs=194.5

Q ss_pred             CCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCC-cHHHHHHHHHHHhhc---cCCCccceEEEEecCCc-----
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLIGFCMTTTE-----  298 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  298 (549)
                      |++.+.||+|+||.||+|..+. ++.||+|+++...... ....+.+|+.++.++   .|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5677899999999999999874 8999999997543222 223466777776655   59999999999988776     


Q ss_pred             eeeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          299 RLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      .+++|||+.+ +|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 788887643  3589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc---h
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK---L  453 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  453 (549)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||+||+.||......+.   +..+.........   .
T Consensus       157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhcC
Confidence            643321  1223478899999999999999999999999999999999988864332211   1111111000000   0


Q ss_pred             ------hhhcccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          454 ------EMLVDKDLK---NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       454 ------~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                            .........   ..........+.+++.+||+.||++||++.|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                  000000000   01112234677899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=282.04  Aligned_cols=249  Identities=24%  Similarity=0.294  Sum_probs=208.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcH--HHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .++|+..++||+|.||.|-.++-+ .|+.+|+|+++++..+...  ..-..|-++|...+||.+..+.-.+...+..++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467888999999999999999865 6999999999887544332  2456788899999999999998888999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||+.||.|.-++.....++++....+-..|+.||.|||+.   +||.||||.+|.|+|.||++||+|||+++.-- ..+
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g  322 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYG  322 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-ccc
Confidence            99999999999999888899999999999999999999999   99999999999999999999999999998532 234


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......+||+.|+|||++....|...+|.|.+||++|||++|+.||...+..    .+..            -+.-..  
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~----kLFe------------LIl~ed--  384 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE----KLFE------------LILMED--  384 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh----HHHH------------HHHhhh--
Confidence            4567789999999999999999999999999999999999999999732211    1111            111111  


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  496 (549)
                      -.+++...++...|+...+.+||++|.     .++||.+
T Consensus       385 ~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  385 LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            124555667888999999999999998     4555554

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-35  Score=297.84  Aligned_cols=258  Identities=23%  Similarity=0.299  Sum_probs=191.7

Q ss_pred             Ceeeee--CCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKG--GFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      ..||+|  +||+||++... +|+.||+|++....... ..+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999975 69999999987543222 235688999999999999999999999999999999999999


Q ss_pred             CchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce--
Q 008893          309 GSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--  384 (549)
Q Consensus       309 g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--  384 (549)
                      +++.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999988753  3589999999999999999999998   99999999999999999999999998654332111110  


Q ss_pred             ----eeccccccCccCchhhccC--CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHH------------
Q 008893          385 ----TTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK------------  446 (549)
Q Consensus       385 ----~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~------------  446 (549)
                          .....++..|+|||++.+.  .++.++|||||||++|||++|+.||........   .......            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccccccc
Confidence                0111245679999999764  478999999999999999999999864321110   0000000            


Q ss_pred             --------------------HhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          447 --------------------IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       447 --------------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                                          .........+.+..+...........+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                00000000111111222223345678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.6e-35  Score=288.52  Aligned_cols=242  Identities=25%  Similarity=0.300  Sum_probs=188.6

Q ss_pred             eeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHH---HhhccCCCccceEEEEecCCceeeEeeccC
Q 008893          234 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEM---ISLAVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       234 ~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      .||+|+||.||+|... +++.||+|.+......  .....+..|..+   ++...|||++++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 5889999998654321  112223444433   344579999999999999999999999999


Q ss_pred             CCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeec
Q 008893          308 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA  387 (549)
Q Consensus       308 ~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  387 (549)
                      +|+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.......   ...
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~  154 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA  154 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcC
Confidence            999999998777899999999999999999999998   99999999999999999999999999987554321   123


Q ss_pred             cccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCC
Q 008893          388 VRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD  466 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  466 (549)
                      ..|+..|+|||.+.++ .++.++||||||+++|||++|+.||.........    . ......      ....    ..+
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----~-~~~~~~------~~~~----~~~  219 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----E-IDRMTL------TMAV----ELP  219 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----H-HHHHhh------ccCC----CCC
Confidence            4589999999998754 6899999999999999999999999753221110    0 000000      0011    112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 008893          467 RIELEEMVQVALLCTQYLPSLRP-----KMSEVVR  496 (549)
Q Consensus       467 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  496 (549)
                      ...+..+.+++.+|+..+|.+||     ++.++++
T Consensus       220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            22346799999999999999999     8889875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=319.58  Aligned_cols=270  Identities=21%  Similarity=0.252  Sum_probs=217.8

Q ss_pred             HHHHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEec
Q 008893          219 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT  295 (549)
Q Consensus       219 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  295 (549)
                      ..+++-..++|.+.++||+|+||.|..++++ +++.||+|++.+...  ......|..|-.++...+.+.|+.+.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3455666789999999999999999999976 589999999986432  2334579999999999999999999999999


Q ss_pred             CCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          296 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      ..++|+|||||+||+|..++.....++++.+..++..|+.||.-||+.   |+|||||||+|||+|.+|++||+|||.+-
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence            999999999999999999998877899999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCceeeccccccCccCchhhcc-----CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc
Q 008893          376 LLDHCDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE  450 (549)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (549)
                      .+.....-.+...+|||.|++||++..     +.|+..+|.||+||++|||+.|..||.....       +.-...+...
T Consensus       224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-------veTY~KIm~h  296 (1317)
T KOG0612|consen  224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-------VETYGKIMNH  296 (1317)
T ss_pred             hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-------HHHHHHHhch
Confidence            777554445556679999999999853     5789999999999999999999999974332       2222233322


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHHhcCCCcchhh
Q 008893          451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK---MSEVVRMLEGDGLAEKWA  508 (549)
Q Consensus       451 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~L~~~~~~~~~~  508 (549)
                      +....+.+.       ...++...+||.+.+. +|+.|..   ++++..|..-.  ...|.
T Consensus       297 k~~l~FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~--g~~W~  347 (1317)
T KOG0612|consen  297 KESLSFPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE--GIDWD  347 (1317)
T ss_pred             hhhcCCCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcccc--CCChh
Confidence            221111111       1245678888887766 7888888   88887765432  33563

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=319.63  Aligned_cols=261  Identities=26%  Similarity=0.363  Sum_probs=211.1

Q ss_pred             HHHHHhcCCCCCCeeeeeCCeEEEEEEEC----C----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEE
Q 008893          221 ELQSATSNFSSKNLVGKGGFGNVYKGYLQ----D----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIG  291 (549)
Q Consensus       221 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~  291 (549)
                      .++...++..+.+.+|+|.||.|++|...    .    ...||||.++..........+..|+++++.+ +|+|++.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34455566677789999999999999843    1    4579999999877666677899999999988 6999999999


Q ss_pred             EEecCCceeeEeeccCCCchhhhhccCC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCc
Q 008893          292 FCMTTTERLLVYPYMSNGSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKA  355 (549)
Q Consensus       292 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  355 (549)
                      +|..+...++|+||+..|+|.++++..+                .++..+.+.++.|||.|++||++.   +++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999997544                488899999999999999999999   999999999


Q ss_pred             CeeeecCCCceEEeecccccccCCCCCceeecccc--ccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCc
Q 008893          356 ANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK  432 (549)
Q Consensus       356 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~  432 (549)
                      +|||++++..+||+|||+++...+..........|  ...|||||.+....|+.|+|||||||+||||+| |..|+..-.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999999765544433232223  346999999999999999999999999999999 666765310


Q ss_pred             cccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          433 TANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         .   ..+....+...          .+-..|..+..++.++++.||+.+|++||++.|+.+.++.
T Consensus       527 ---~---~~~l~~~l~~G----------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  527 ---P---TEELLEFLKEG----------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             ---c---HHHHHHHHhcC----------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence               0   11111111111          1122344456889999999999999999999999999987

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-37  Score=304.32  Aligned_cols=251  Identities=21%  Similarity=0.277  Sum_probs=197.8

Q ss_pred             CCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccC
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      |++...||.|+||.||+|..++ +-..|.|++.... ......|.-|+++|+.+.||+||++++.|.-.+.++++.|||.
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            4566789999999999999875 4445666664432 3445579999999999999999999999999999999999999


Q ss_pred             CCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceee
Q 008893          308 NGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT  386 (549)
Q Consensus       308 ~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  386 (549)
                      ||-+...+- -...+++.++.-+++|++.||.|||++   .|||||||+.|||++-+|.++++|||.+..... ......
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRD  188 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRD  188 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhhhc
Confidence            999988775 355799999999999999999999999   999999999999999999999999999864321 223445


Q ss_pred             ccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          387 AVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      .+.||+.|||||+..     ..+|+.++||||||++|.||..+.+|...-..       ...+-.+.... ...+..+  
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKiaKSe-PPTLlqP--  258 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSE-PPTLLQP--  258 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHHhhcC-CCcccCc--
Confidence            677999999999864     45799999999999999999999888653221       11111111111 1112222  


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                           ..-...+.+++.+|+.++|..||++.+++++-.
T Consensus       259 -----S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf  291 (1187)
T KOG0579|consen  259 -----SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF  291 (1187)
T ss_pred             -----chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence                 222367889999999999999999999987543

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-35  Score=292.62  Aligned_cols=249  Identities=23%  Similarity=0.301  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|...+.||+|+||.||+|... +|+.||+|++.....  ......+..|.+++..+. |+||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999975 689999999875322  122346888999999998 99999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            99999999999998887899999999999999999999998   999999999999999999999999999986543221


Q ss_pred             -------------------ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHH
Q 008893          383 -------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW  443 (549)
Q Consensus       383 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~  443 (549)
                                         .......++..|+|||......++.++||||||++++++++|+.||......       ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~  230 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-------LT  230 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-------HH
Confidence                               1122335788999999998888999999999999999999999998743210       00


Q ss_pred             HHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 008893          444 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKM----SEVVR  496 (549)
Q Consensus       444 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~  496 (549)
                      .....         +  ....++....+.+.+++.+|++.+|++||++    +++++
T Consensus       231 ~~~~~---------~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 FQKIL---------K--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHH---------h--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            01110         0  0111222234678999999999999999999    77765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-35  Score=298.25  Aligned_cols=265  Identities=22%  Similarity=0.266  Sum_probs=196.6

Q ss_pred             cCCC-CCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-------------cHHHHHHHHHHHhhccCCCccceEE
Q 008893          227 SNFS-SKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-------------GEIQFQTEVEMISLAVHRNLLRLIG  291 (549)
Q Consensus       227 ~~~~-~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~niv~l~~  291 (549)
                      ++|. +.+.||+|+||+||+|... +++.||||.++......             ....+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 4578999999999999965 68999999986543221             1124678999999999999999999


Q ss_pred             EEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeec
Q 008893          292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF  371 (549)
Q Consensus       292 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  371 (549)
                      ++...+..+++|||+. |+|.+++.....+++.....++.|++.||.|||+.   +++||||+|+||+++.++.++|+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence            9999999999999997 68999988777899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCC-------------CceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCcccccc
Q 008893          372 GLAKLLDHCD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQK  437 (549)
Q Consensus       372 g~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~  437 (549)
                      |++.......             ........++..|+|||.+.+. .++.++||||||+++|||+||+.||.........
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  243 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL  243 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9997654110             0111223467889999998764 4689999999999999999999999754322111


Q ss_pred             ccHHHHHHHHhhccchhh-----------hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          438 GAMLDWVKKIHQEKKLEM-----------LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~-----------~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ..+...............           ....... .........+.+++.+|++.+|++||+++|++.
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            111111000000000000           0000000 001112466889999999999999999999986

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-35  Score=296.89  Aligned_cols=268  Identities=25%  Similarity=0.301  Sum_probs=194.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCC------
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------  297 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  297 (549)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+....... ....+.+|+++++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999975 58999999986543222 2335778999999999999999999875433      


Q ss_pred             --ceeeEeeccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccc
Q 008893          298 --ERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA  374 (549)
Q Consensus       298 --~~~lv~e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  374 (549)
                        ..++|+||+.+ ++...+. ....+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence              46899999975 5666655 345799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCc----------eeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHH
Q 008893          375 KLLDHCDSH----------VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW  443 (549)
Q Consensus       375 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~  443 (549)
                      +........          ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            765432211          11233568889999987654 5789999999999999999999998643322111111110


Q ss_pred             HHHHhh-----ccchhhhccccccCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          444 VKKIHQ-----EKKLEMLVDKDLKNNYD-------RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       444 ~~~~~~-----~~~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ......     ...+....+.......+       ......+.+++.+|++.+|++|||+.|++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            000000     00000000000000000       1112568899999999999999999998853

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.5e-35  Score=292.32  Aligned_cols=248  Identities=29%  Similarity=0.351  Sum_probs=195.0

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .|+..+.||+|+||.||+|... +++.+|+|.+.....  .....++.+|+++++.++|+|++++.+++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4666788999999999999975 588999998864321  1223467889999999999999999999999999999999


Q ss_pred             ccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      |+. |++.+.+. ....+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++......   
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            997 57777664 345689999999999999999999998   9999999999999999999999999998765432   


Q ss_pred             eeeccccccCccCchhhc---cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          384 VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                        ....++..|+|||.+.   ...++.++|||||||++|+|++|+.|+......       ...........      + 
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~------~-  232 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNES------P-  232 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHHHHhhcCC------C-
Confidence              2235788999999974   356788999999999999999999998532110       11111111000      0 


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        ..........+.+++.+||+.+|++||++.+++++...
T Consensus       233 --~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         233 --ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             --CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence              00112234668899999999999999999999976443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9.4e-35  Score=288.29  Aligned_cols=243  Identities=21%  Similarity=0.293  Sum_probs=195.3

Q ss_pred             CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCch
Q 008893          233 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV  311 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  311 (549)
                      ..||+|+||.||++..+ +|+.||+|.+.... ......+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            57899999999999875 68999999885433 23345688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccc
Q 008893          312 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT  391 (549)
Q Consensus       312 ~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt  391 (549)
                      .+++... .+++.....++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++........ ......|+
T Consensus       105 ~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~  179 (292)
T cd06657         105 TDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGT  179 (292)
T ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccC
Confidence            9987544 589999999999999999999999   999999999999999999999999999876543221 22334588


Q ss_pred             cCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHH
Q 008893          392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE  471 (549)
Q Consensus       392 ~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  471 (549)
                      ..|+|||.+.+..++.++||||||+++|+|++|..||......       .........      ....+..  ......
T Consensus       180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~~~~~~~~------~~~~~~~--~~~~~~  244 (292)
T cd06657         180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDN------LPPKLKN--LHKVSP  244 (292)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhh------CCcccCC--cccCCH
Confidence            9999999998888999999999999999999999998642211       111111100      0011100  111235


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          472 EMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       472 ~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .+.+++.+|++.+|.+||++.++++
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhc
Confidence            6889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.4e-34  Score=289.96  Aligned_cols=244  Identities=30%  Similarity=0.380  Sum_probs=192.4

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      |...+.||+|+||+||+|+.. +|+.|++|.+......  .....+..|+.+++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556678999999999999965 5889999998654322  2234688899999999999999999999999999999999


Q ss_pred             cCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +. |++.+.+. ....+++..+..++.||+.||.|||+.   +++||||+|+||++++++.+||+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            96 57777664 345789999999999999999999999   999999999999999999999999999864322     


Q ss_pred             eeccccccCccCchhhc---cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          385 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      .....|+..|+|||++.   ...++.++||||||+++|||++|..|+.....       ........... ...      
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~-~~~------  239 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQND-SPT------  239 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcC-CCC------
Confidence            12345888999999984   45688899999999999999999999864321       11111111111 000      


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        .........+.+++.+|++.+|++||++.+++++
T Consensus       240 --~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 --LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0111223568899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.4e-35  Score=294.83  Aligned_cols=267  Identities=21%  Similarity=0.288  Sum_probs=199.4

Q ss_pred             HHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEec-CCc
Q 008893          222 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTE  298 (549)
Q Consensus       222 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  298 (549)
                      +...+++|+..+.||+|+||.||+|... +++.||+|++..... ......+..|+.++..++|||++++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3446788999999999999999999865 689999998864322 2234567889999999999999999998865 457


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++++||+ +++|.++++.. .+++.....++.|++.||.|||+.   +|+||||+|+||++++++.++|+|||.+....
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            88999998 46888887654 588899999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH--------HHHHHHhh
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKIHQ  449 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~  449 (549)
                      ..    .....++..|+|||.+.+ ..++.++||||||+++|+|+||+.||...........+.        ++......
T Consensus       160 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         160 PQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             CC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            22    122347889999998766 568999999999999999999999997543211111111        11111111


Q ss_pred             ccchhhhccccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 EKKLEMLVDKDLKNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .........-......+     ......+.+++.+|++.+|++||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            10000000000001111     1123678999999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=301.77  Aligned_cols=255  Identities=24%  Similarity=0.337  Sum_probs=197.5

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC------Cceee
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TERLL  301 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  301 (549)
                      +...+.||+|+||.||+|+++ .|+.||||.++........+...+|++++++++|+|||+++++-...      ...++
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            345678999999999999965 69999999998876666677899999999999999999999986543      45789


Q ss_pred             EeeccCCCchhhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec--CCC--ceEEeecccc
Q 008893          302 VYPYMSNGSVASRLKA---KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYY--EAVVGDFGLA  374 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~kl~Dfg~~  374 (549)
                      +||||.+|+|...++.   ...+++...+.+..+++.||.|||++   +|+||||||.||++-  .+|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999973   44799999999999999999999999   999999999999984  334  4699999999


Q ss_pred             cccCCCCCceeeccccccCccCchhhc-cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccch
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      +.++..  .......||..|++||++. .+.|+..+|.|||||++|+.+||..||........... ..|.....+....
T Consensus       172 rel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~-~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  172 RELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE-IMWHIITKKPSGV  248 (732)
T ss_pred             ccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch-hhhhhhccCCCce
Confidence            988754  3566778999999999998 48899999999999999999999999975443322111 1122111111111


Q ss_pred             hhhccccccC------------CCCHHHHHHHHHHHHHhcccCCCCCC
Q 008893          454 EMLVDKDLKN------------NYDRIELEEMVQVALLCTQYLPSLRP  489 (549)
Q Consensus       454 ~~~~d~~l~~------------~~~~~~~~~l~~l~~~cl~~dP~~RP  489 (549)
                      ....++..++            ...+.....+...+..++..+|++|.
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            1111111111            11233445567778888888999998

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.5e-36  Score=318.85  Aligned_cols=254  Identities=25%  Similarity=0.349  Sum_probs=190.5

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC------
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------  296 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  296 (549)
                      +-..+|+..++||+||||.||+++.+ ||+.||||++...........+.+|+..+++++|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45568888999999999999999987 89999999998665444455688999999999999999987631100      


Q ss_pred             --------------------------------------------------------------------------------
Q 008893          297 --------------------------------------------------------------------------------  296 (549)
Q Consensus       297 --------------------------------------------------------------------------------  296 (549)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CceeeEeeccCCCchhhhhccCCCC-CHHHHHHHHHHHHHHHHHhhh
Q 008893          297 ---------------------------------TERLLVYPYMSNGSVASRLKAKPSL-DWATRKRIALGAARGLLYLHE  342 (549)
Q Consensus       297 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~l-~~~~~~~i~~~i~~~L~~LH~  342 (549)
                                                       ...||=||||+..++.++++.+... .....++++.+|+.||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                             0135678888888888877765543 577889999999999999999


Q ss_pred             cCCCceEecccCcCeeeecCCCceEEeecccccccC-----------------CCCCceeeccccccCccCchhhccC--
Q 008893          343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-----------------HCDSHVTTAVRGTVGHIAPEYLSTG--  403 (549)
Q Consensus       343 ~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~--  403 (549)
                      +   |||||||||.||++|+++.+||+|||+|+...                 .......+...||.-|+|||++.+.  
T Consensus       716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            9   99999999999999999999999999998721                 0011123455699999999999765  


Q ss_pred             -CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcc
Q 008893          404 -QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQ  482 (549)
Q Consensus       404 -~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~  482 (549)
                       .|+.|+||||+|||++||+.   ||..+  .+.    ...+..+. .+.+..-      ..+.......=..+|.++++
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MER----a~iL~~LR-~g~iP~~------~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTS--MER----ASILTNLR-KGSIPEP------ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCch--HHH----HHHHHhcc-cCCCCCC------cccccccchHHHHHHHHHhc
Confidence             49999999999999999995   55421  111    11111111 1111111      11222333556789999999


Q ss_pred             cCCCCCCCHHHHHH
Q 008893          483 YLPSLRPKMSEVVR  496 (549)
Q Consensus       483 ~dP~~RPs~~evl~  496 (549)
                      .||.+|||+.|++.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999875

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=289.50  Aligned_cols=263  Identities=24%  Similarity=0.317  Sum_probs=199.3

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      |+..+.||+|++|.||+|... +++.||+|.+..... ......+..|+.+++.++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456688999999999999976 489999999976532 223456788999999999999999999999999999999999


Q ss_pred             CCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      + ++|.+++... ..+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.++|+|||.++....... ..
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~  155 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY  155 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence            8 5899999765 5799999999999999999999999   999999999999999999999999999987654322 12


Q ss_pred             eccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh------------ccc
Q 008893          386 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ------------EKK  452 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~  452 (549)
                      ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.........            ...
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            233467789999998776 7899999999999999999999988643321111111100000000            000


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       453 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ............. ......+.+++.+|++.+|++||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         236 FPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0000000000001 1124679999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-34  Score=294.34  Aligned_cols=261  Identities=22%  Similarity=0.307  Sum_probs=192.5

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCC------
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------  297 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  297 (549)
                      ..+|...+.||+|+||.||+|... +|+.||+|+++..... .....+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368999999999999999999965 6899999998754322 22345789999999999999999999986542      


Q ss_pred             ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      ..++|+||+.. +|.....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            45899999964 6666553  3589999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH--------HHHHHHh
Q 008893          378 DHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKKIH  448 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~  448 (549)
                      ...    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.        .+.....
T Consensus       168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         168 DAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            321    123457889999999876 458899999999999999999999997533211100000        0000000


Q ss_pred             hccchhhhcc---ccccCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          449 QEKKLEMLVD---KDLKNNY---DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       449 ~~~~~~~~~d---~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      . .......+   .......   .+.....+.+++.+|++.||++||++.|++.+
T Consensus       244 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         244 D-KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             c-cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0 00000000   0000000   01123568899999999999999999999864

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-34  Score=290.15  Aligned_cols=259  Identities=22%  Similarity=0.254  Sum_probs=190.6

Q ss_pred             CCeeeeeCCeEEEEEEECCCCEEEEEEcccC-CCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCc
Q 008893          232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS  310 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  310 (549)
                      .+.+|.|+++.||++.. +++.||||++... ........+..|+..++.++|+||+++++++...+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34445555555555544 6899999999765 223344579999999999999999999999999999999999999999


Q ss_pred             hhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC------
Q 008893          311 VASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS------  382 (549)
Q Consensus       311 L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------  382 (549)
                      |.+++..  ...+++.....++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||.+........      
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            9999874  34688999999999999999999999   999999999999999999999999998865432111      


Q ss_pred             ceeeccccccCccCchhhccC--CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh----hc------
Q 008893          383 HVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH----QE------  450 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~------  450 (549)
                      .......++..|+|||++...  .++.++|||||||++|||++|+.||........   .........    ..      
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM---LLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCccccccCchhhh
Confidence            011233477789999998763  578999999999999999999999974321110   000000000    00      


Q ss_pred             -cchhh----hccc----cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          451 -KKLEM----LVDK----DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       451 -~~~~~----~~d~----~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       .....    ..+.    ............++.+++.+||+.+|++|||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             00000    0000    00111233345678999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-35  Score=297.31  Aligned_cols=270  Identities=23%  Similarity=0.273  Sum_probs=199.6

Q ss_pred             CHHHHHHHhcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEec
Q 008893          218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT  295 (549)
Q Consensus       218 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  295 (549)
                      ...++...+++|.+.+.||+|+||.||+|.. .+|+.||+|++..... ......+.+|+.++..++||||+++.+++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3456677889999999999999999999985 4689999999875421 2223467889999999999999999998864


Q ss_pred             C------CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEe
Q 008893          296 T------TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG  369 (549)
Q Consensus       296 ~------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  369 (549)
                      .      ...+++++++ +++|.+++... .+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEe
Confidence            3      3467788876 77898877654 589999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHH-----
Q 008893          370 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW-----  443 (549)
Q Consensus       370 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-----  443 (549)
                      |||+++.....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+...     
T Consensus       163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99998754321    223457889999999866 46888999999999999999999998643221110000000     


Q ss_pred             ---HHHHhhccchhhh---ccccccCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          444 ---VKKIHQEKKLEML---VDKDLKNNY---DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       444 ---~~~~~~~~~~~~~---~d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                         ...... ......   ........+   .......+.+++.+|++.||.+||++.+++++
T Consensus       239 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         239 AELLKKISS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHhhccc-HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence               000000 000000   000000000   00123568899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=9.3e-35  Score=283.31  Aligned_cols=248  Identities=23%  Similarity=0.335  Sum_probs=195.0

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCC----CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      +|.+.+.||+|+||.||++.... +..+++|.++...    ......++..|+.+++.++|||++++++++......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998653 4556666654321    122334577889999999999999999999998999999


Q ss_pred             eeccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          303 YPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       303 ~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      +||+++++|.+.+.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999998875    345799999999999999999999998   9999999999999986 569999999987664


Q ss_pred             CCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      .... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....       ...........        
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~--------  220 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVEG--------  220 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcC--------
Confidence            3221 2223457889999999988888999999999999999999999985321       11111111110        


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        .....+...+.++.+++.+|++.+|++||++.|++++
T Consensus       221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         221 --PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             --CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence              0111233445788999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-35  Score=250.65  Aligned_cols=265  Identities=20%  Similarity=0.271  Sum_probs=200.8

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +|...+.||+|.||+||+|+.. +++.||+|+++.+... .......+|+-+++.++|.|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3455678999999999999955 5899999999855433 3345678999999999999999999999999999999999


Q ss_pred             cCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |.. +|..+.. -.+.++.+....++.|+++||.|+|++   ++.|||+||+|.||+.+|+.|++|||+++.++-. ...
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-vrc  157 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VRC  157 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-eEe
Confidence            976 7777665 356789999999999999999999999   9999999999999999999999999999977642 223


Q ss_pred             eeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccc--hhhhcccc
Q 008893          385 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKK--LEMLVDKD  460 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~  460 (549)
                      ......|..|.+|.++.+.. |+...|+||-||++.|+.. |++.|.+.+..++-..+...+....++.+  +..+.|-.
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            44556899999999988765 8899999999999999997 44445544433333233322222222222  22233332


Q ss_pred             ccCCCCHH---------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          461 LKNNYDRI---------ELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       461 l~~~~~~~---------~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ....|+..         ....=.+++...+.-+|.+|.++++++++
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            22223211         11223678888888899999999998864

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-34  Score=293.95  Aligned_cols=261  Identities=21%  Similarity=0.257  Sum_probs=192.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC---------
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT---------  296 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------  296 (549)
                      .+|...+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+++++.++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            57889999999999999999965 589999999865543 3445688999999999999999999876543         


Q ss_pred             -----CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec-CCCceEEee
Q 008893          297 -----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGD  370 (549)
Q Consensus       297 -----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~D  370 (549)
                           ...++||||++ ++|.+.+... .+++.....++.||+.||.|||+.   +|+||||||+||+++ +++.+|++|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence                 35789999997 5888887644 589999999999999999999998   999999999999997 556789999


Q ss_pred             cccccccCCCCCc--eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHH
Q 008893          371 FGLAKLLDHCDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI  447 (549)
Q Consensus       371 fg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  447 (549)
                      ||+++........  ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.........   .......
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~~~~~~  235 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM---QLILESV  235 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhc
Confidence            9999765432111  1122347889999998754 45788999999999999999999999644321110   0000000


Q ss_pred             hh--c----c---chhhhcc-ccccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          448 HQ--E----K---KLEMLVD-KDLKNN-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       448 ~~--~----~---~~~~~~d-~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ..  .    .   ....... ......     .......++.+++.+|++.||++|||+.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00  0    0   0000000 000000     00112356889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=277.81  Aligned_cols=237  Identities=27%  Similarity=0.290  Sum_probs=194.8

Q ss_pred             eeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC--cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCch
Q 008893          235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV  311 (549)
Q Consensus       235 iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  311 (549)
                      ||+|+||.||++... +++.+|+|.+.......  ....+..|+.+++.++|+|++++++.+......+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999976 58999999987654322  344688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccc
Q 008893          312 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT  391 (549)
Q Consensus       312 ~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt  391 (549)
                      .+++.....+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT  156 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence            99998777899999999999999999999998   99999999999999999999999999998664332 122344588


Q ss_pred             cCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHH
Q 008893          392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE  471 (549)
Q Consensus       392 ~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  471 (549)
                      ..|+|||...+...+.++|+||||+++|++++|+.||.....       .........         .  ....+...+.
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~---------~--~~~~~~~~~~  218 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILK---------D--PLRFPEFLSP  218 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhc---------C--CCCCCCCCCH
Confidence            899999999888899999999999999999999999964322       111111111         0  0112222246


Q ss_pred             HHHHHHHHhcccCCCCCCCHHH
Q 008893          472 EMVQVALLCTQYLPSLRPKMSE  493 (549)
Q Consensus       472 ~l~~l~~~cl~~dP~~RPs~~e  493 (549)
                      .+.+++.+|+..||++||++.+
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCccc
Confidence            7899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.6e-34  Score=287.64  Aligned_cols=264  Identities=20%  Similarity=0.245  Sum_probs=192.8

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-C--CCEEEEEEcccCCCC-CcHHHHHHHHHHHhhc-cCCCccceEEEEecC----Cc
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-D--GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT----TE  298 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~--g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  298 (549)
                      +|++.+.||+|+||.||++... .  +..||+|.+...... .....+..|+.++..+ .||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999965 3  779999998653222 2244678899999988 599999999875432    45


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .+++++|+. ++|.+.+.....+++..+..++.||+.||.|||+.   +|+||||||+||++++++.+||+|||+++...
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            678888886 68999888777899999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCc---eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH--------HHHHH
Q 008893          379 HCDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWVKK  446 (549)
Q Consensus       379 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~  446 (549)
                      .....   ......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.        .+...
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32211   1123458899999998765 468999999999999999999999986533211100000        00000


Q ss_pred             Hhhccc------hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          447 IHQEKK------LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       447 ~~~~~~------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ......      ........+. .........+.+++.+|++.+|++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000      0000000000 000112367899999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.3e-35  Score=295.11  Aligned_cols=263  Identities=22%  Similarity=0.297  Sum_probs=197.0

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCc----
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE----  298 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  298 (549)
                      ..++|+..+.||+|++|.||+|... +++.||+|++..... ......+.+|+.+++.++|+|++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999976 588999999865321 2223457789999999999999999988765554    


Q ss_pred             --eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          299 --RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       299 --~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                        .++|+||+ +++|.+++... .+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++..
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence              89999998 56998888754 699999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHH--------HHHHH
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--------WVKKI  447 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~  447 (549)
                      ....    .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||...........+..        +....
T Consensus       168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            5432    223357889999999865 3678999999999999999999999974332111100000        00000


Q ss_pred             hhccchhhhcc---ccccCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          448 HQEKKLEMLVD---KDLKNNY---DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       448 ~~~~~~~~~~d---~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ... .......   ......+   ....+..+.+++.+|++.+|++|||+.|++++
T Consensus       244 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         244 SSE-SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             cch-hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000 0000000   0000000   01124678999999999999999999999853

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-34  Score=289.00  Aligned_cols=262  Identities=23%  Similarity=0.290  Sum_probs=195.4

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCC-----
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----  297 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  297 (549)
                      ..++|+..+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4568999999999999999999854 6899999998643221 22345789999999999999999999987543     


Q ss_pred             -ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          298 -ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       298 -~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                       ..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++..
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence             358999998 6788887764 4689999999999999999999998   999999999999999999999999999976


Q ss_pred             cCCCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccH--------HHHHHHH
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM--------LDWVKKI  447 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~~  447 (549)
                      ....    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+        ..+....
T Consensus       168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         168 TDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            5432    123357889999999876 45889999999999999999999998743221110000        0111111


Q ss_pred             hhccc------hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          448 HQEKK------LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       448 ~~~~~------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .....      +.......+ ..........+.+++.+|++.||++|||+.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             cchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000      000000000 0001122356889999999999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=273.10  Aligned_cols=250  Identities=26%  Similarity=0.322  Sum_probs=193.9

Q ss_pred             CCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEeeccCCC
Q 008893          232 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      ...||.|+||+|+|-.++ .|+..|||+++......+.+++..|.+...+- +.||||+++|.+..+...|+.||.|+- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            467999999999999876 59999999999877655666788888876554 689999999999999999999999964 


Q ss_pred             chhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          310 SVASRLK-----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       310 ~L~~~l~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      ++..+-.     ++..+++.-.-+|....+.||.||-+..  .|+|||+||+|||+|..|.+|+||||.+..+..  +..
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiA  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIA  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--HHH
Confidence            5544332     4456888888899999999999998764  899999999999999999999999999876542  222


Q ss_pred             eeccccccCccCchhhcc--CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          385 TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      .+.-+|-..|||||.+..  ..|+.++||||||++|||+.||+.|+..-.      ++.+.+..........-..+.   
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svfeql~~Vv~gdpp~l~~~~---  294 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVFEQLCQVVIGDPPILLFDK---  294 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHHHHHHHHHcCCCCeecCcc---
Confidence            233458889999999854  348999999999999999999999986311      233333333322211111111   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        -.......+..++..|+.+|-.+||...++.++
T Consensus       295 --~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  295 --ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             --cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence              112345678999999999999999999998753

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-35  Score=267.97  Aligned_cols=252  Identities=21%  Similarity=0.241  Sum_probs=195.0

Q ss_pred             HhcCCCCC-CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEec----CC
Q 008893          225 ATSNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMT----TT  297 (549)
Q Consensus       225 ~~~~~~~~-~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~  297 (549)
                      .+++|.+. ++||-|-.|.|-....+ +|+.+|+|++.+..      ...+|+++--.. .|||||.++++|.+    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            34566543 68999999999998876 68999999997543      345777765444 69999999999864    34


Q ss_pred             ceeeEeeccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec---CCCceEEeecc
Q 008893          298 ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFG  372 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg  372 (549)
                      .+++|||.|+||.|.+.+++++  .+++.++..|+.||+.|+.|||+.   +|.||||||+|+|..   .|..+||+|||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence            5789999999999999998655  599999999999999999999999   999999999999996   45689999999


Q ss_pred             cccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc
Q 008893          373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK  452 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (549)
                      +|+.-...  ......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||............    +.-...+.
T Consensus       210 FAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM----k~rI~~gq  283 (400)
T KOG0604|consen  210 FAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KRRIRTGQ  283 (400)
T ss_pred             cccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH----HhHhhccC
Confidence            99865432  2334557899999999999999999999999999999999999999754432211111    11111000


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       453 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       -++.     ..--...++...++|+.++..+|++|.|+.|++.+
T Consensus       284 -y~FP-----~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  284 -YEFP-----EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             -ccCC-----ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence             0000     01112345778899999999999999999999853

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.1e-33  Score=307.17  Aligned_cols=146  Identities=29%  Similarity=0.398  Sum_probs=132.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC--cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||+||+|... +++.||||+++......  ....+..|+.++..++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999976 68999999997543222  2346888999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      ||+.+++|.+++.....+++..++.|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999998777899999999999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7e-34  Score=273.26  Aligned_cols=220  Identities=20%  Similarity=0.186  Sum_probs=177.7

Q ss_pred             eCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCchhhhhc
Q 008893          238 GGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK  316 (549)
Q Consensus       238 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~  316 (549)
                      |.+|.||++... +++.||+|.++...      .+..|...+....|||++++++++...+..+++|||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999965 68999999987543      22344455555679999999999999999999999999999999998


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccccCccC
Q 008893          317 AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA  396 (549)
Q Consensus       317 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a  396 (549)
                      ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++++|||.+......    .....++..|+|
T Consensus        78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a  150 (237)
T cd05576          78 KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA  150 (237)
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence            777799999999999999999999998   9999999999999999999999999988655432    122345778999


Q ss_pred             chhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHH
Q 008893          397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQV  476 (549)
Q Consensus       397 PE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  476 (549)
                      ||...+..++.++||||+|+++|||++|+.|+........                  ....    ...+......+.++
T Consensus       151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------------~~~~----~~~~~~~~~~~~~l  208 (237)
T cd05576         151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------------THTT----LNIPEWVSEEARSL  208 (237)
T ss_pred             CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------------cccc----cCCcccCCHHHHHH
Confidence            9999888899999999999999999999987653211000                  0000    01122234678899


Q ss_pred             HHHhcccCCCCCCCHH
Q 008893          477 ALLCTQYLPSLRPKMS  492 (549)
Q Consensus       477 ~~~cl~~dP~~RPs~~  492 (549)
                      +.+|++.||++||++.
T Consensus       209 i~~~l~~dp~~R~~~~  224 (237)
T cd05576         209 LQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHccCCHHHhcCCC
Confidence            9999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=268.23  Aligned_cols=263  Identities=24%  Similarity=0.313  Sum_probs=201.7

Q ss_pred             CHHHHHHHhcCCCCCCeeeeeCCeEEEEEE-ECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEec
Q 008893          218 HFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMT  295 (549)
Q Consensus       218 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  295 (549)
                      ++.++.+.|     .++||+|+|+.|-.++ ..+|..+|||++.+. ......++.+|++++...+ |+||+.+++|+.+
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            345555554     3579999999999888 678999999999765 3344567889999999885 9999999999999


Q ss_pred             CCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC---ceEEeecc
Q 008893          296 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGDFG  372 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg  372 (549)
                      +...|||||.|.||.|...+++...+++.++..+..+|+.||.|||.+   ||.||||||+|||-.+..   -+|||||.
T Consensus       148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence            999999999999999999999999999999999999999999999999   999999999999987544   47999999


Q ss_pred             cccccCCCC------CceeeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCcccccc---c
Q 008893          373 LAKLLDHCD------SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK---G  438 (549)
Q Consensus       373 ~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~---~  438 (549)
                      +..-+....      .......+|+..|||||+..     ...|+.+.|.||||||+|-|++|..||.+.-..+-+   +
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            875432111      11223456888999999863     345889999999999999999999999865433221   1


Q ss_pred             cHH-----HHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          439 AML-----DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       439 ~~~-----~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ...     .....+. ++. -++.|++     ....+.+..+++...+..|+.+|.++.+++.
T Consensus       305 e~Cr~CQ~~LFesIQ-EGk-YeFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQ-EGK-YEFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHHHHHHHh-ccC-CcCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            111     1111111 111 0111111     1223466788999999999999999999886

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=290.41  Aligned_cols=239  Identities=23%  Similarity=0.309  Sum_probs=195.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++.|+....+|.|+|+.|-.+... +++..+||++.+...     +-.+|+.++... .|||++++.+.+.+..+.++||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            567888888999999999998864 688999999976522     123566555444 7999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee-cCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL-DEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |.+.++-+.+.+...+... ..+..|+.+|+.|+.|||++   |+|||||||+|||+ ++.++++|+|||.++..+..  
T Consensus       396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999999988887666555 77788999999999999999   99999999999999 58899999999999877643  


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                        ....+-|..|.|||++....|++++|+||||++||+|++|+.||......      .             ++......
T Consensus       470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~-------------ei~~~i~~  528 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------I-------------EIHTRIQM  528 (612)
T ss_pred             --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------H-------------HHHHhhcC
Confidence              23345688999999999999999999999999999999999999754322      0             01111112


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      +.+....+....+|+..||+.||.+||+|.++..
T Consensus       529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            2233445678999999999999999999999975

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=281.93  Aligned_cols=253  Identities=21%  Similarity=0.244  Sum_probs=211.3

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCC-CEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDG-TVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      -++++....||-|+||.|-.+..+.. ..+|+|++++...  ..+.+.+..|-.++...+.|.||+++--|.+....|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            34566677899999999999986643 3589999976543  23344688899999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||-|-||.+...++.++.++..+...++..+++|++|||++   +||+|||||+|.++|.+|-+||.|||+|+.+..+  
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--  573 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--  573 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence            99999999999999999999999999999999999999999   9999999999999999999999999999988744  


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ..+-+++||+.|.|||++.+...+..+|.||+|+++|||+||.+||...++......+..-+..                
T Consensus       574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----------------  637 (732)
T KOG0614|consen  574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----------------  637 (732)
T ss_pred             CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------------
Confidence            4456678999999999999999999999999999999999999999876654443222211111                


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHh
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRMLE  499 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L~  499 (549)
                      -.+|+.......+++++.+..+|.+|..     +.+|-+|--
T Consensus       638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence            1234455567889999999999999985     566655443

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=279.88  Aligned_cols=244  Identities=22%  Similarity=0.304  Sum_probs=199.4

Q ss_pred             CCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCC
Q 008893          232 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      .+.||+|.||+||-|+++ +|+.||||++.+.. ....+.++.+|+++|..++||.||.+--.|...+..++|||.+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            578999999999999975 69999999997654 344456899999999999999999999999999999999999965 


Q ss_pred             chhhhh-c-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC---CCceEEeecccccccCCCCCce
Q 008893          310 SVASRL-K-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       310 ~L~~~l-~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +..+.+ . +.+.+++..-..++.||+.||.|||.+   +|+|+||||+|||+..   .-.+||||||+|++++.  ...
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ksF  722 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KSF  722 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch--hhh
Confidence            555554 3 456799999999999999999999999   9999999999999963   45799999999999874  344


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      ...+.||+.|+|||++.++.|...-|+||.|||+|--++|..||...+.      +-+.+...      .-++.+..+  
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd------IndQIQNA------aFMyPp~PW--  788 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED------INDQIQNA------AFMYPPNPW--  788 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc------hhHHhhcc------ccccCCCch--
Confidence            5667899999999999999999999999999999999999999974332      22222111      111222222  


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        .+.....+++|...++..=.+|-+.+..+.+
T Consensus       789 --~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  789 --SEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             --hhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence              3344678899999999999999999887754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-34  Score=274.30  Aligned_cols=257  Identities=25%  Similarity=0.365  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEE-ECCCCEEEEEEcccCCCCCcH------HHHHHHHHHHhhccCCCccceEEEEe-cCC
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE------IQFQTEVEMISLAVHRNLLRLIGFCM-TTT  297 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~------~~~~~e~~~l~~l~h~niv~l~~~~~-~~~  297 (549)
                      .++|-..++||+|||+.||+|. +...+.||||+-.....+..+      +...+|..+-+.+.||.||++++++. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            3456677899999999999998 456889999987654433332      23678999999999999999999986 556


Q ss_pred             ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec---CCCceEEeecccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLA  374 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~  374 (549)
                      .++-|.|||+|.+|.-+|+....+++..+..|+.||+.||.||.+. .++|||-||||.|||+.   ..|.+||.|||++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            7899999999999999999999999999999999999999999987 67899999999999995   4588999999999


Q ss_pred             cccCCCCCc------eeeccccccCccCchhhccC----CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHH
Q 008893          375 KLLDHCDSH------VTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV  444 (549)
Q Consensus       375 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~  444 (549)
                      +.++.....      .+.-..||.+|++||.+.-+    ..+.|+||||.|||+|..+.|++||.-...  +    .+.+
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--Q----QdIL  694 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--Q----QDIL  694 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--H----HHHH
Confidence            988654322      23445799999999988543    468899999999999999999999963221  1    1111


Q ss_pred             HHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 008893          445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV  495 (549)
Q Consensus       445 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  495 (549)
                          .+.-+.....  +.-...+....+...+|.+|+++.-++|..+.++.
T Consensus       695 ----qeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  695 ----QENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ----hhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                1111100000  00011122346788999999999999998877765

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=272.77  Aligned_cols=244  Identities=24%  Similarity=0.323  Sum_probs=200.9

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhc-cCCCccceEEEEecCCcee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  300 (549)
                      ...+|....+||+|+||.|..|.-+ +.+.+|||+++++..+..  .+.-+.|-++|... +-|.++.+..++..-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3457889999999999999999865 467899999987653322  22334566667665 4678999999999899999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +||||+.+|+|-..+++-+.+.+..+..+|..||-||-+||++   +|++||||.+||++|.+|++||+|||+++.--. 
T Consensus       427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-  502 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-  502 (683)
T ss_pred             eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc-
Confidence            9999999999999999888899999999999999999999999   999999999999999999999999999975322 


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      +...+...+||+.|+|||++...+|+..+|.|||||+||||+.|+.||++.+..+.                ...+.+..
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el----------------F~aI~ehn  566 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----------------FQAIMEHN  566 (683)
T ss_pred             CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------HHHHHHcc
Confidence            23345678899999999999999999999999999999999999999986443211                11122222


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPK  490 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs  490 (549)
                        -.|+...+.+...+....+.+.|.+|..
T Consensus       567 --vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  567 --VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --CcCcccccHHHHHHHHHHhhcCCccccC
Confidence              2356666678889999999999999974

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.3e-33  Score=295.59  Aligned_cols=259  Identities=18%  Similarity=0.204  Sum_probs=170.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-C----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEE------E
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-D----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF------C  293 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~  293 (549)
                      ..++|...+.||+|+||.||+|.+. +    +..||+|++.....   .+.+..+  .+....+.++..+...      +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4578999999999999999999975 4    68999998764321   1111111  1112222222222211      2


Q ss_pred             ecCCceeeEeeccCCCchhhhhccCC-C-------------------CCHHHHHHHHHHHHHHHHHhhhcCCCceEeccc
Q 008893          294 MTTTERLLVYPYMSNGSVASRLKAKP-S-------------------LDWATRKRIALGAARGLLYLHEQCDPKIIHRDV  353 (549)
Q Consensus       294 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~-------------------l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  353 (549)
                      ......++|+||+.+++|.+++.... .                   .....+..++.||+.||.|||+.   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            35567899999999999999886432 1                   12334567999999999999998   9999999


Q ss_pred             CcCeeeecC-CCceEEeecccccccCCCCCceeeccccccCccCchhhccC----------------------CCCCccc
Q 008893          354 KAANILLDE-YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG----------------------QSSEKTD  410 (549)
Q Consensus       354 kp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  410 (549)
                      ||+|||+++ ++.+||+|||+++.+............+|+.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999985 68999999999987654433344456789999999966432                      2345679


Q ss_pred             chhHhHHHHHHHhCCcccccCcc------ccccccHHHHHHHHhhccchhhhccccccCCC--CHHHHHHHHHHHHHhcc
Q 008893          411 VFGFGILLLELISGLRALEFGKT------ANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY--DRIELEEMVQVALLCTQ  482 (549)
Q Consensus       411 v~s~G~il~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~cl~  482 (549)
                      ||||||++|||+++..++.....      .........|.......      ..+.+...+  .........+|+.+|++
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999997655431100      00001112222111100      000000000  00011245689999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 008893          483 YLPSLRPKMSEVVRM  497 (549)
Q Consensus       483 ~dP~~RPs~~evl~~  497 (549)
                      .||++|||++|+++|
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999975

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-35  Score=262.69  Aligned_cols=267  Identities=24%  Similarity=0.335  Sum_probs=197.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecC--------
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--------  296 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  296 (549)
                      +.|+...+||+|.||.||+|+.+ +|+.||+|++--++ ...-...-.+|+++|..++|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34556678999999999999965 47888988764322 222234567899999999999999999988532        


Q ss_pred             CceeeEeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          297 TERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      ...++||.+|+. +|.-++.+. ..++..++.+++.++..||.|+|..   .|+|||+||.|+||+.++.+||+|||+++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence            347899999987 888888755 5789999999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCC---ceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc
Q 008893          376 LLDHCDS---HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK  451 (549)
Q Consensus       376 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (549)
                      .+.....   ...+..+.|..|++||.+.+. .|+++.|||..|||+.||.||.+.+.+.....+-..+.........+-
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            6643322   233455579999999998875 589999999999999999999888776544333222222222222211


Q ss_pred             ch-------hhhc-ccccc-CCCC--HHH------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          452 KL-------EMLV-DKDLK-NNYD--RIE------LEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       452 ~~-------~~~~-d~~l~-~~~~--~~~------~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +.       -.-+ -+.+. +.+.  ...      -.+..+|+..++..||.+|+++++++.+
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            11       0000 00010 0000  000      1367889999999999999999999864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=267.26  Aligned_cols=262  Identities=24%  Similarity=0.312  Sum_probs=211.6

Q ss_pred             HHHHHHHhcCCCCCCeeeeeCCeEEEEEEECC------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEE
Q 008893          219 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF  292 (549)
Q Consensus       219 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  292 (549)
                      ..++.....++....++-+|.||.||.|.|.+      .+.|-+|.++.....-+...+..|.-++....|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            35566667788889999999999999997653      346778888877665555678889989999999999999999


Q ss_pred             EecC-CceeeEeeccCCCchhhhhc--------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC
Q 008893          293 CMTT-TERLLVYPYMSNGSVASRLK--------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY  363 (549)
Q Consensus       293 ~~~~-~~~~lv~e~~~~g~L~~~l~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  363 (549)
                      +.+. ...+.++.++.-|+|..++.        ....++..+...++.|++.|++|||..   ++||.||..+|.+||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            8764 56789999999999999997        123577788899999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCCcee-eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHH
Q 008893          364 YEAVVGDFGLAKLLDHCDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAML  441 (549)
Q Consensus       364 ~~~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~  441 (549)
                      .++||+|=.+++.+...+.+.- ........||+||.+....|+.++|||||||++|||+| |+.|+..-++.+.     
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-----  507 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-----  507 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----
Confidence            9999999999998766655533 23346678999999999999999999999999999998 8888764322111     


Q ss_pred             HHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          442 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       442 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        ...+....+          -.-+-.++++++.++..||...|++||+++|++.-|.+
T Consensus       508 --~~ylkdGyR----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  508 --EHYLKDGYR----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             --HHHHhccce----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence              111111111          12244567899999999999999999999999987764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.4e-32  Score=262.46  Aligned_cols=239  Identities=27%  Similarity=0.329  Sum_probs=194.4

Q ss_pred             CCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCchhhhhcc
Q 008893          239 GFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA  317 (549)
Q Consensus       239 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  317 (549)
                      +||.||+|... +|+.+++|++...........+.+|++.++.++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48999999997655433256899999999999999999999999999999999999999999999987


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccccCccCc
Q 008893          318 KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP  397 (549)
Q Consensus       318 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP  397 (549)
                      ...+++..+..++.+++.++.|||+.   +++|+||+|+||++++++.++|+|||.+.......  ......++..|++|
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p  155 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP  155 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence            66689999999999999999999998   99999999999999999999999999998765432  22344588899999


Q ss_pred             hhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHH
Q 008893          398 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVA  477 (549)
Q Consensus       398 E~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  477 (549)
                      |.+....++.++||||||+++++|++|..||.....   ...+.++.   ..... .    .   .........++.+++
T Consensus       156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~---~~~~~~~~---~~~~~-~----~---~~~~~~~~~~~~~~i  221 (244)
T smart00220      156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ---LLELFKKI---GKPKP-P----F---PPPEWKISPEAKDLI  221 (244)
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHH---hccCC-C----C---ccccccCCHHHHHHH
Confidence            999988899999999999999999999999864211   11111111   11000 0    0   000000336789999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 008893          478 LLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       478 ~~cl~~dP~~RPs~~evl~  496 (549)
                      .+|+..+|++||++.++++
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHccCCchhccCHHHHhh
Confidence            9999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-33  Score=259.23  Aligned_cols=251  Identities=22%  Similarity=0.260  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  301 (549)
                      -.+|...++||+|+|+.|-.+.++ +.+.+|+|+++++-.  .....-.+.|-.+..+. +||.+|-+..++......++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467899999999999999999965 588999999986532  12223456666666554 79999999999999999999


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |.||+++|+|--.++.+..++++.+..+...|..||.|||+.   ||+.||||.+|||+|..|++|+.|+|+++.-- .+
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-GP  404 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-CC
Confidence            999999999999999888999999999999999999999999   99999999999999999999999999998532 23


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      +..+.+.+||+.|+|||.+.+..|...+|.|++||+++||+.|+.||+.-...+....-.+++.++..++.+        
T Consensus       405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--------  476 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--------  476 (593)
T ss_pred             CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--------
Confidence            445677899999999999999999999999999999999999999998544333333334444443333221        


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPK  490 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs  490 (549)
                        ..++..+.....+++.-+.+||++|..
T Consensus       477 --riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  477 --RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --cccceeehhhHHHHHHhhcCCcHHhcC
Confidence              123334456678889999999999873

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=7e-32  Score=280.94  Aligned_cols=260  Identities=20%  Similarity=0.193  Sum_probs=180.5

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEE-----------------CCCCEEEEEEcccCCCCC-------------cHHHHHHH
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYL-----------------QDGTVVAVKRLKDGNAIG-------------GEIQFQTE  274 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~-------------~~~~~~~e  274 (549)
                      ..++|++.++||+|+||+||+|..                 .+++.||||+++......             .......|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 235689999986432110             11123446


Q ss_pred             HHHHhhccCCCc-----cceEEEEec--------CCceeeEeeccCCCchhhhhccC-----------------------
Q 008893          275 VEMISLAVHRNL-----LRLIGFCMT--------TTERLLVYPYMSNGSVASRLKAK-----------------------  318 (549)
Q Consensus       275 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~-----------------------  318 (549)
                      +.++.+++|.++     ++++++|..        ....++||||+++++|.++++..                       
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766554     677887753        35689999999999999887531                       


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccccCccCc
Q 008893          319 -PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP  397 (549)
Q Consensus       319 -~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP  397 (549)
                       ..++|..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             1246788899999999999999998   999999999999999999999999999976543222111222357899999


Q ss_pred             hhhccCCC----------------------CCcccchhHhHHHHHHHhCCc-ccccCcccc-----ccccHHHHHHHHhh
Q 008893          398 EYLSTGQS----------------------SEKTDVFGFGILLLELISGLR-ALEFGKTAN-----QKGAMLDWVKKIHQ  449 (549)
Q Consensus       398 E~~~~~~~----------------------~~~~Dv~s~G~il~elltg~~-p~~~~~~~~-----~~~~~~~~~~~~~~  449 (549)
                      |.+.....                      ..+.||||+||++++|++|.. |+......+     .......|......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98754321                      235799999999999999875 554211100     01111122111000


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 008893          450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLP---SLRPKMSEVVRM  497 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~~  497 (549)
                      .      .+-.    ..........+++.+++..+|   .+|+|++|+++|
T Consensus       460 ~------~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        460 K------YDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             C------CCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0      0111    111224678899999999766   689999999864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.4e-32  Score=282.60  Aligned_cols=258  Identities=25%  Similarity=0.337  Sum_probs=204.6

Q ss_pred             HHHHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEe--
Q 008893          219 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM--  294 (549)
Q Consensus       219 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--  294 (549)
                      ++.+-..++-|++.+.||+|.+|.||+++.. +++.+|+|++.....  ..++++.|.++++.. .|||++.++|++.  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3344445677899999999999999999954 689999999876553  344567788888776 6999999999986  


Q ss_pred             ---cCCceeeEeeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEe
Q 008893          295 ---TTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG  369 (549)
Q Consensus       295 ---~~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  369 (549)
                         .++.+|||||||.+|+..++++.  +..+.|+.+..|+..++.|+.+||..   .++|||+|-.|||++.++.+|+.
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence               35789999999999999999874  45799999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCCceeeccccccCccCchhhccC-----CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHH
Q 008893          370 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV  444 (549)
Q Consensus       370 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~  444 (549)
                      |||++..++.... .+....||+.|||||++...     .|+..+|+||+|++..||.-|.+|+....+...       +
T Consensus       166 DFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------L  237 (953)
T KOG0587|consen  166 DFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------L  237 (953)
T ss_pred             eeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-------h
Confidence            9999987764322 34455699999999998543     467889999999999999999999864322111       0


Q ss_pred             HHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       445 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      -.+.+        .+...-.-+..-.+++.++|..|+.+|-++||++.+++++
T Consensus       238 F~IpR--------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  238 FLIPR--------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ccCCC--------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            00000        1111111233345788999999999999999999998864

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=4.9e-33  Score=264.67  Aligned_cols=262  Identities=20%  Similarity=0.265  Sum_probs=196.3

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc--CCC----ccceEEEEecCCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRN----LLRLIGFCMTTTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~n----iv~l~~~~~~~~~  298 (549)
                      +.+|.+...+|+|.||.|-..... .+..||||+++.-...  .+.-.-|++++.++.  .|+    +|.+.+|+.-.++
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY--reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY--REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH--hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            678999999999999999999854 4789999999754322  223566888999884  233    7788888999999


Q ss_pred             eeeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC--------------
Q 008893          299 RLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--------------  362 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--------------  362 (549)
                      .++|+|.+ |-++.+++..+  .+++...+..|+.|++++++|||+.   +++|-||||+|||+.+              
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999998 45899999754  4789999999999999999999999   9999999999999931              


Q ss_pred             ------CCceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccc
Q 008893          363 ------YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ  436 (549)
Q Consensus       363 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~  436 (549)
                            +..+|++|||-|++-....    ..++.|..|+|||++.+-.++..+||||+||||.|+.||...|...+..+.
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                  3458999999998754322    455689999999999999999999999999999999999998886552221


Q ss_pred             c-------ccHHHHHHH------Hhhccch-----------hhhccccc--c--CCCCHHHHHHHHHHHHHhcccCCCCC
Q 008893          437 K-------GAMLDWVKK------IHQEKKL-----------EMLVDKDL--K--NNYDRIELEEMVQVALLCTQYLPSLR  488 (549)
Q Consensus       437 ~-------~~~~~~~~~------~~~~~~~-----------~~~~d~~l--~--~~~~~~~~~~l~~l~~~cl~~dP~~R  488 (549)
                      -       +.++..+-.      ....+.+           ..+.+...  .  -.....+...|++|+.+++..||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence            0       011110000      0000000           00000000  0  00123345679999999999999999


Q ss_pred             CCHHHHHHH
Q 008893          489 PKMSEVVRM  497 (549)
Q Consensus       489 Ps~~evl~~  497 (549)
                      +|+.|++.+
T Consensus       398 iTl~EAL~H  406 (415)
T KOG0671|consen  398 ITLREALSH  406 (415)
T ss_pred             ccHHHHhcC
Confidence            999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=7.1e-33  Score=242.31  Aligned_cols=201  Identities=24%  Similarity=0.321  Sum_probs=167.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++......||+|++|.|-+-++. +|+..|+|+++........++...|+++..+. ..|.+|.++|.+.+....++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            344555678999999999988864 79999999998766555566788888876554 6899999999999999999999


Q ss_pred             eccCCCchhhh----hccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          304 PYMSNGSVASR----LKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       304 e~~~~g~L~~~----l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      |.|.. +|..+    +..+..+++...-+|+..+.+||.|||++.  .++|||+||+|||++.+|++||||||.+..+..
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99964 66554    346778999999999999999999999985  899999999999999999999999999976653


Q ss_pred             CCCceeeccccccCccCchhhcc----CCCCCcccchhHhHHHHHHHhCCcccccC
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELISGLRALEFG  431 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~il~elltg~~p~~~~  431 (549)
                      .  -..+.-.|-..|||||.+..    ..|+.|+||||||+++.||.+++.|++..
T Consensus       202 S--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  202 S--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             h--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            2  11122347889999998753    46899999999999999999999998743

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.5e-32  Score=272.12  Aligned_cols=216  Identities=22%  Similarity=0.330  Sum_probs=181.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .-|..++.||-|+||+|..+.- ++...+|+|.+++....  .....+..|.++|.....+.||+++-.|.+++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            4477788999999999999984 45778999998764322  22345788999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC-----
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-----  378 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~-----  378 (549)
                      +|++||++-.+|-.-+-+.+..+..++.++..|+++.|..   |+|||||||+|||||.+|++||.|||++.-+.     
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccc
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999985321     


Q ss_pred             ----CCCCce--------------------------------eeccccccCccCchhhccCCCCCcccchhHhHHHHHHH
Q 008893          379 ----HCDSHV--------------------------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI  422 (549)
Q Consensus       379 ----~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ell  422 (549)
                          .++...                                .-..+||+.|+|||++....++.-+|.||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                110000                                01234999999999999999999999999999999999


Q ss_pred             hCCcccccCccccccccHHHHHH
Q 008893          423 SGLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       423 tg~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      .|+.||-..........+..|-.
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~  888 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRN  888 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhh
Confidence            99999987666655555555544

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-33  Score=252.99  Aligned_cols=268  Identities=22%  Similarity=0.286  Sum_probs=200.4

Q ss_pred             CCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccC-CCCCcHHHHHHHHHHHhhccCCCccceEEEEecC-----Cceee
Q 008893          229 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TERLL  301 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~l  301 (549)
                      .+..+.||-|+||.||.+.. ++|+.||+|++..- ......+.+-+|+++|..++|.|++..++...-.     .+.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            44568899999999999985 47999999988532 1223345678999999999999999998876543     35678


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ++|.|. .+|...+-....++.+.+.-+.+||++||.|||+.   +|.||||||.|.|++.+..+||||||+++..+..+
T Consensus       135 ~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence            899885 48888888888899999999999999999999999   99999999999999999999999999999876555


Q ss_pred             CceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh-------ccch
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ-------EKKL  453 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~  453 (549)
                      ....+....|..|+|||.+++. .|+.++||||.|||..||+..+..|....+..+-.-+.+.+..-..       ++.-
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            4444555678999999999886 4899999999999999999988888754443333222222211000       0100


Q ss_pred             hhhcccccc-CCC--------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          454 EMLVDKDLK-NNY--------DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       454 ~~~~d~~l~-~~~--------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..++....+ ...        +.....+...+...++.+||++|.+..+.+.++-.
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            111111111 011        11122345678888999999999999999876653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=5.3e-32  Score=240.25  Aligned_cols=260  Identities=18%  Similarity=0.303  Sum_probs=196.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEE-ECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecC--Ccee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTT--TERL  300 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~  300 (549)
                      ..++|++.+.+|+|.|+.||.|. ..+++.++||+++.-.    .+.+.+|+.+|..+. ||||+++++...+.  ....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            34678899999999999999998 4568899999997432    457899999999997 99999999998765  4568


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-CCceEEeecccccccCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~  379 (549)
                      +|+||+.+.+...+.   +.++...+..++.+++.||.|+|+.   ||+|||+||.|++||. ...++|+|||+|.++..
T Consensus       112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999999987766554   3577888999999999999999999   9999999999999994 56799999999999875


Q ss_pred             CCCceeeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCcccc-cccc---------HHHHHHHHh
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTAN-QKGA---------MLDWVKKIH  448 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-~~~~---------~~~~~~~~~  448 (549)
                      ...  ..-...+..|.-||++...+ |+..-|+|||||++..|+..+.||.-+.... +-..         +..++....
T Consensus       186 ~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  186 GKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             Cce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            432  22223566788999987754 6788899999999999999999998654321 1111         111221111


Q ss_pred             --hccchhhhccccccCC---C-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          449 --QEKKLEMLVDKDLKNN---Y-----DRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       449 --~~~~~~~~~d~~l~~~---~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                        .......++....+..   +     .....++..+++.+.+..|..+|||++|++.
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence              1112222222211111   0     1112367899999999999999999999875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=276.56  Aligned_cols=243  Identities=26%  Similarity=0.333  Sum_probs=185.6

Q ss_pred             CCCCCeeeeeCCeE-EEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEeecc
Q 008893          229 FSSKNLVGKGGFGN-VYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       229 ~~~~~~iG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      |...+++|.|+.|+ ||+|..+ |+.||||++-.+.    .....+|+..|+.- .|||||++++.-.+....|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            34456789998865 6999986 7899999986432    33567899999887 5999999999988899999999999


Q ss_pred             CCCchhhhhccC-CC---CCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-----CCceEEeeccccccc
Q 008893          307 SNGSVASRLKAK-PS---LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----YYEAVVGDFGLAKLL  377 (549)
Q Consensus       307 ~~g~L~~~l~~~-~~---l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfg~~~~~  377 (549)
                      . .+|.+++... ..   ......+.+..|++.||++||+.   +||||||||+||||+.     ..+++|+|||+++.+
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            6 4999998753 11   11134567889999999999998   9999999999999975     257899999999988


Q ss_pred             CCCCCce--eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhC-CcccccCccccccccHHHHHHHHhhccchh
Q 008893          378 DHCDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG-LRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       378 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      .......  .....||-+|+|||++....-+.++||||+||++|+.++| .+||......+        ..-+.....+.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~  733 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLV  733 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCcccee
Confidence            7655432  3456699999999999999888899999999999999997 89986321110        00001111111


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+     . ... .  ....+||.+|++++|..||++.+|+.|
T Consensus       734 ~L-----~-~~~-d--~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  734 HL-----E-PLP-D--CEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ee-----c-cCc-h--HHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            11     0 001 1  167899999999999999999999853

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=4.2e-29  Score=234.03  Aligned_cols=211  Identities=35%  Similarity=0.507  Sum_probs=184.9

Q ss_pred             eeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCchhh
Q 008893          235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS  313 (549)
Q Consensus       235 iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  313 (549)
                      ||+|.+|.||++...+ ++.+++|++...........+.+|++.++.+.|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999764 899999999865432234578999999999999999999999999999999999999999999


Q ss_pred             hhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-CCceEEeecccccccCCCCCceeeccccc
Q 008893          314 RLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHCDSHVTTAVRGT  391 (549)
Q Consensus       314 ~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt  391 (549)
                      ++... ..+++..+..++.+++.++.+||+.   +++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence            98765 5689999999999999999999999   9999999999999999 89999999999987654321 12234478


Q ss_pred             cCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHH
Q 008893          392 VGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL  470 (549)
Q Consensus       392 ~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  470 (549)
                      ..|++||..... ..+.++|+|++|+++++|                                                 
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------  187 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------  187 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence            899999999887 788999999999999998                                                 


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          471 EEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       471 ~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                      ..+.+++..|++.+|++||++.++++++
T Consensus       188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            3478999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=7.8e-30  Score=253.41  Aligned_cols=197  Identities=23%  Similarity=0.333  Sum_probs=170.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-----Cc--HHHHHHHHHHHhhcc---CCCccceEEEEec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-----GG--EIQFQTEVEMISLAV---HRNLLRLIGFCMT  295 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~--~~~~~~e~~~l~~l~---h~niv~l~~~~~~  295 (549)
                      .+|+..+.+|+|+||.|+.+.++ +...|+||.+.++...     ..  .-.+-.|+++|+.++   |+||++++++|.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46888999999999999999986 4678999998764311     10  113567999999997   9999999999999


Q ss_pred             CCceeeEeecc-CCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccc
Q 008893          296 TTERLLVYPYM-SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA  374 (549)
Q Consensus       296 ~~~~~lv~e~~-~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  374 (549)
                      ++.+||+||-. ++-+|.+++.-++.+++.....|+.||+.|+++||+.   +|||||||-+||.++.+|.+||+|||.+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccch
Confidence            99999999976 5679999999889999999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccc
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALE  429 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~  429 (549)
                      .....+   .....+||..|.|||++.+..| ...-|||++|++||.++....||.
T Consensus       718 a~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            766543   3345679999999999999887 566799999999999998877763

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=2.8e-28  Score=231.57  Aligned_cols=199  Identities=29%  Similarity=0.425  Sum_probs=173.6

Q ss_pred             CCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccC
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      |...+.||+|++|.||++...+ ++.+++|.+...........+.+|++.+..++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999875 899999999765432245578899999999999999999999999999999999999


Q ss_pred             CCchhhhhccCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceee
Q 008893          308 NGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT  386 (549)
Q Consensus       308 ~g~L~~~l~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  386 (549)
                      +++|.+++..... +++.....++.+++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            9999999987665 89999999999999999999999   9999999999999999999999999999877644311223


Q ss_pred             ccccccCccCchhh-ccCCCCCcccchhHhHHHHHHHhCCccccc
Q 008893          387 AVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELISGLRALEF  430 (549)
Q Consensus       387 ~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg~~p~~~  430 (549)
                      ...++..|++||.. ....++.++|||+||+++++|++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            34578899999998 666788899999999999999999999953

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=236.19  Aligned_cols=256  Identities=23%  Similarity=0.266  Sum_probs=193.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecC------Cc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TE  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  298 (549)
                      .+|.-...+|.|.- .|..+... .++.||+|.+.... .....++..+|...+..+.|+|+++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            35666677888877 55555533 58899999875432 233345678899999999999999999998643      35


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .|+|||+|.. +|...+.  ..++-.+...|..|++.|+.|||+.   +|+||||||+||++..+..+||.|||+|+.-.
T Consensus        96 ~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccC
Confidence            7899999964 8888877  3478889999999999999999999   99999999999999999999999999998544


Q ss_pred             CCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc------
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK------  452 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  452 (549)
                      ..  ...+....|..|.|||++.+..+.+.+||||.||++.||++|+..|.+...      +.+|.+....-+.      
T Consensus       170 ~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~------idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  170 TD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH------IDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             cc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH------HHHHHHHHHHhcCCCHHHH
Confidence            22  345666789999999999998899999999999999999999988875433      3333332211100      


Q ss_pred             ---------------------h-hhhccccccC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          453 ---------------------L-EMLVDKDLKN--NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       453 ---------------------~-~~~~d~~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                                           . ..+.|..+..  +.++.....+.+++.+||-.+|++|-+++++++|
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                                 0 0011111111  1112233557899999999999999999999974

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-29  Score=254.28  Aligned_cols=253  Identities=23%  Similarity=0.273  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|+....+|.|.||.|||++.. .++..|+|+++.... +...-+++|+-+++..+||||+.++|.+...+..++.||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            357889999999999999999964 689999999986542 334457889999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+.+|+|.+.-+-.+++++.++..++...++|+.|||+.   +-+|||||-.|||+++.|.+|++|||.+..+.. ....
T Consensus        93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti~K  168 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TIAK  168 (829)
T ss_pred             ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-hhhh
Confidence            999999999999888999999999999999999999999   999999999999999999999999999876643 2234


Q ss_pred             eeccccccCccCchhh---ccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          385 TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      +..+.||+.|||||+.   ..+.|..++|||+.|+...|+---..|...-....        +-.+.    ....+++.-
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--------~l~Lm----TkS~~qpp~  236 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--------ALFLM----TKSGFQPPT  236 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--------HHHHh----hccCCCCCc
Confidence            4556799999999986   45679999999999999999977665643211100        00000    011111111


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ..+ ...-.+.+.++++.|+.++|++||+++..++
T Consensus       237 lkD-k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 LKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            110 1111356889999999999999999998775

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=224.41  Aligned_cols=254  Identities=18%  Similarity=0.292  Sum_probs=190.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEE-ecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFC-MTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~-~~~~~~~lv  302 (549)
                      .+.|++.+.+|+|.||.+-.+.++ ..+.+++|.+....  ....+|.+|...--.+ .|.||+.-+++. ...+.++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            356889999999999999999987 47789999987654  3356788888764444 589999887754 455678899


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec--CCCceEEeecccccccCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +||++.|+|.+.+... .+-+....+++.|+++|+.|+|++   .+||||||.+||||-  +..++|+||||+++..+. 
T Consensus       101 qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-  175 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-  175 (378)
T ss_pred             eccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence            9999999999988764 478888999999999999999999   999999999999994  556899999999875431 


Q ss_pred             CCceeeccccccCccCchhhccC-----CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc-chh
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK-KLE  454 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~  454 (549)
                         ......-+..|.|||.....     ...+.+|||.||++++.++||+.||......+  .....|.....+.. .+.
T Consensus       176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d--~~Y~~~~~w~~rk~~~~P  250 (378)
T KOG1345|consen  176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD--KPYWEWEQWLKRKNPALP  250 (378)
T ss_pred             ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC--chHHHHHHHhcccCccCc
Confidence               11223356689999987432     24678899999999999999999998433222  23444444332211 111


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..+         ....+.+.++.++-+.++|++|--..++.++-..
T Consensus       251 ~~F---------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~  287 (378)
T KOG1345|consen  251 KKF---------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC  287 (378)
T ss_pred             hhh---------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence            111         1223678899999999999999666666655544

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-27  Score=233.41  Aligned_cols=131  Identities=23%  Similarity=0.363  Sum_probs=109.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-----C---CCccceEEEEec-
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----H---RNLLRLIGFCMT-  295 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~-  295 (549)
                      ..+|.+.++||=|-|++||.+.. .+.+.||+|+.+...  .-.+....||++|++++     |   ..||+++++|.. 
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            36788999999999999999995 468899999997543  22335678999999884     3   359999999864 


Q ss_pred             ---CCceeeEeeccCCCchhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec
Q 008893          296 ---TTERLLVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD  361 (549)
Q Consensus       296 ---~~~~~lv~e~~~~g~L~~~l~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  361 (549)
                         ..+.++|+|++ |.+|..++.  ..+.++...+.+|+.||+.||.|||.+|  +|||-||||+|||+.
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence               45789999999 557888776  4457999999999999999999999998  999999999999983

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=1.1e-28  Score=242.23  Aligned_cols=261  Identities=20%  Similarity=0.207  Sum_probs=198.5

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc------CCCccceEEEEecC
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV------HRNLLRLIGFCMTT  296 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~  296 (549)
                      ....+|.+....|+|-|++|..|... .|..||||++......  .+.=+.|+++|.+++      .-|+++++-.|...
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            34578999999999999999999965 4889999999865422  223457899999885      35799999999999


Q ss_pred             CceeeEeeccCCCchhhhhccC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC-CceEEeecc
Q 008893          297 TERLLVYPYMSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFG  372 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg  372 (549)
                      +++|||||-+. .+|.++|+..   -.|....+..++.|+.-||..|-..   +|+|.||||.|||+++. ..+||||||
T Consensus       507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence            99999999885 4899999743   3688899999999999999999988   99999999999999865 568999999


Q ss_pred             cccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHH-----
Q 008893          373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI-----  447 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----  447 (549)
                      .|.......   .+....+..|.|||++.+.+|+...|+||.||.||||.||+..|.+...-    .+..+...+     
T Consensus       583 SA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN----~MLrl~me~KGk~p  655 (752)
T KOG0670|consen  583 SASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN----QMLRLFMELKGKFP  655 (752)
T ss_pred             ccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH----HHHHHHHHhcCCCc
Confidence            998765433   23334566899999999999999999999999999999999998764331    111111110     


Q ss_pred             ----hhccchhhhccccc--------------------------------c--CCCC---HHHHHHHHHHHHHhcccCCC
Q 008893          448 ----HQEKKLEMLVDKDL--------------------------------K--NNYD---RIELEEMVQVALLCTQYLPS  486 (549)
Q Consensus       448 ----~~~~~~~~~~d~~l--------------------------------~--~~~~---~~~~~~l~~l~~~cl~~dP~  486 (549)
                          ........-+|..+                                .  ..++   ......+.+|+..|+..||+
T Consensus       656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence                00000011111110                                0  0122   23356788999999999999


Q ss_pred             CCCCHHHHHHH
Q 008893          487 LRPKMSEVVRM  497 (549)
Q Consensus       487 ~RPs~~evl~~  497 (549)
                      +|.|..+++.|
T Consensus       736 KRit~nqAL~H  746 (752)
T KOG0670|consen  736 KRITVNQALKH  746 (752)
T ss_pred             hcCCHHHHhcC
Confidence            99999999875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=8.8e-28  Score=232.05  Aligned_cols=267  Identities=22%  Similarity=0.303  Sum_probs=196.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC----CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCce
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  299 (549)
                      ..+.|...++||+|.|++||++...    .++.||+|.+.....   ...+..|+++|..+ .+.||+++.+++...+..
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            4567889999999999999999853    367999999976543   34688999999988 489999999999999999


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec-CCCceEEeecccccccC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~  378 (549)
                      .+|+||++.....++...   ++...+..++..+..||.++|.+   |||||||||+|+|.+ ..+.-.|.|||+|...+
T Consensus       111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHH
Confidence            999999999888888764   66889999999999999999999   999999999999998 55778899999996211


Q ss_pred             CC---------------------------------CC----------ceeeccccccCccCchhhcc-CCCCCcccchhH
Q 008893          379 HC---------------------------------DS----------HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGF  414 (549)
Q Consensus       379 ~~---------------------------------~~----------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~  414 (549)
                      ..                                 .+          .......||++|.|||++.. ...++++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            00                                 00          01122359999999999865 457999999999


Q ss_pred             hHHHHHHHhCCcccccCcccccc-ccHHHHHHH------Hhhccc--h----------------hhh----ccc-c---c
Q 008893          415 GILLLELISGLRALEFGKTANQK-GAMLDWVKK------IHQEKK--L----------------EML----VDK-D---L  461 (549)
Q Consensus       415 G~il~elltg~~p~~~~~~~~~~-~~~~~~~~~------~~~~~~--~----------------~~~----~d~-~---l  461 (549)
                      |||++-+++++.||......-.. ..+......      ....+.  +                +.+    +.+ +   .
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            99999999999999754322111 111111000      000000  0                000    000 0   0


Q ss_pred             c-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          462 K-NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       462 ~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      . .......+..+.+++.+|+..||.+|-|++|++++---
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF  384 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF  384 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence            0 00111123468899999999999999999999976443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.6e-27  Score=267.16  Aligned_cols=194  Identities=16%  Similarity=0.164  Sum_probs=138.5

Q ss_pred             ccC-CCccceEEEE-------ecCCceeeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEec
Q 008893          281 AVH-RNLLRLIGFC-------MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR  351 (549)
Q Consensus       281 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  351 (549)
                      +.| +||+++++++       ......+.++||+ +++|.+++.. ...+++.++..++.||+.||.|||++   +|+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            345 5788888877       2234567788887 5599999964 45699999999999999999999999   99999


Q ss_pred             ccCcCeeeecC-------------------CCceEEeecccccccCCCCC---------------ceeeccccccCccCc
Q 008893          352 DVKAANILLDE-------------------YYEAVVGDFGLAKLLDHCDS---------------HVTTAVRGTVGHIAP  397 (549)
Q Consensus       352 Dlkp~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~~---------------~~~~~~~gt~~y~aP  397 (549)
                      ||||+||||+.                   ++.+|++|||+++.......               .......||+.|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999954                   44566667776653211000               001123478899999


Q ss_pred             hhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHH
Q 008893          398 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVA  477 (549)
Q Consensus       398 E~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  477 (549)
                      |++.+..++.++|||||||+||||++|..|+....         ........     ....+..     ........+++
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~  245 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRH-----RVLPPQI-----LLNWPKEASFC  245 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHH-----hhcChhh-----hhcCHHHHHHH
Confidence            99999999999999999999999999887764211         01111100     0011110     11123456888


Q ss_pred             HHhcccCCCCCCCHHHHHHH
Q 008893          478 LLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       478 ~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+||+++|.+||++.|++++
T Consensus       246 ~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHhCCCChhhCcChHHHhhc
Confidence            99999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=3.5e-26  Score=209.13  Aligned_cols=165  Identities=19%  Similarity=0.177  Sum_probs=125.6

Q ss_pred             Cchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeec
Q 008893          309 GSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA  387 (549)
Q Consensus       309 g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  387 (549)
                      |+|.+++.. +..+++..++.++.||+.||.|||+.   +      ||+|||++.++.+|+  ||+++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence            688899875 45699999999999999999999998   5      999999999999999  99998765322      


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCH
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR  467 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  467 (549)
                      ..||+.|+|||++.+..++.++|||||||++|||+||+.||.......  ..+..+.......       ++. ......
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~-------~~~-~~~~~~  133 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD-------DPR-DRSNLE  133 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC-------Ccc-ccccHH
Confidence            258999999999999999999999999999999999999986422111  1111111111100       000 001112


Q ss_pred             HHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          468 IELE--EMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       468 ~~~~--~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....  .+.+++.+|++.+|++||++.|+++++..
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            2222  68999999999999999999999998865

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.8e-26  Score=208.79  Aligned_cols=247  Identities=21%  Similarity=0.298  Sum_probs=193.1

Q ss_pred             CCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          230 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       230 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      ....+|.+...|..|+|+|+. ..+++|+++..... .....|.+|.-.|+.+.||||..++|.|.......++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            344567888999999999984 45666877644322 2234699999999999999999999999999999999999999


Q ss_pred             CchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceee
Q 008893          309 GSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT  386 (549)
Q Consensus       309 g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  386 (549)
                      |+|+..++++.  ..+-.++.+++.+||+|++|||+. .|-|.---|.+..|++|++.+++|+ .+-+++..     ...
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsf-----qe~  344 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF-----QEV  344 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeee-----ecc
Confidence            99999999765  467889999999999999999997 4445555789999999999998874 22222111     112


Q ss_pred             ccccccCccCchhhccCCC---CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          387 AVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ...-.+.||+||.++..+.   -..+|+|||++++|||.|...||..-...+..                ..+.-+.++.
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------mkialeglrv  408 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------MKIALEGLRV  408 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------hhhhhccccc
Confidence            2235678999999987764   35789999999999999999999754433322                1122344556


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..++..+..+.+++.-|+..||.+||.++.|+-.|+.
T Consensus       409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            6677777889999999999999999999999988876

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=2.1e-24  Score=215.86  Aligned_cols=178  Identities=20%  Similarity=0.215  Sum_probs=135.2

Q ss_pred             HHHHhcCCCCCCeeeeeCCeEEEEEEEC--CCCEEEEEEcccCCC----CCcHHHHHHHHHHHhhccCCCccceEEEEec
Q 008893          222 LQSATSNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGNA----IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT  295 (549)
Q Consensus       222 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  295 (549)
                      ......+|...+.||+|+||+||+|.+.  +++.||||++.....    ......+.+|++++..++|+|++..+..   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            3445678999999999999999999865  578889998753311    1124468999999999999999853322   


Q ss_pred             CCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccc-CcCeeeecCCCceEEeecccc
Q 008893          296 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV-KAANILLDEYYEAVVGDFGLA  374 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Dfg~~  374 (549)
                      ....++||||+++++|... ...   .   ...++.+++.+|.|||+.   +|+|||| ||+|||++.++.+||+|||++
T Consensus        90 ~~~~~LVmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             cCCcEEEEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            2467999999999999732 111   1   146788999999999999   9999999 999999999999999999999


Q ss_pred             cccCCCCCce-------eeccccccCccCchhhccCC------CCCcccch
Q 008893          375 KLLDHCDSHV-------TTAVRGTVGHIAPEYLSTGQ------SSEKTDVF  412 (549)
Q Consensus       375 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~  412 (549)
                      +.+.......       -....+++.|+|||++...+      .+..+|-|
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            8765432111       13456888999999986543      23446666

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-22  Score=203.72  Aligned_cols=255  Identities=20%  Similarity=0.256  Sum_probs=190.2

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECCC--CEEEEEEcccCCCCCcHHHHHHHHHHHhhccC----CCccceEEEE-ecCCcee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQDG--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH----RNLLRLIGFC-MTTTERL  300 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~  300 (549)
                      +|.+.+.||+|+||.||.+.....  ..+|+|........... .+..|..++..+..    +++..+++.. ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            789999999999999999997653  57899988765433333 57778888887763    5888888888 4777889


Q ss_pred             eEeeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC-----CceEEeeccc
Q 008893          301 LVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-----YEAVVGDFGL  373 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~Dfg~  373 (549)
                      +||+.+ +.+|.++...  ...++..+...|+.|++.+|.+||+.   |++||||||.|+++...     ..+.+.|||+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            999988 6799987743  35799999999999999999999999   99999999999999854     4689999999


Q ss_pred             ccccC--CCCCc----e---eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHH
Q 008893          374 AKLLD--HCDSH----V---TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV  444 (549)
Q Consensus       374 ~~~~~--~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~  444 (549)
                      ++...  .....    .   .....||..|.++....+.+.+.+.|+||++.++.|++.|..||............    
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~----  249 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF----  249 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH----
Confidence            98322  11111    1   22355999999999999999999999999999999999999999643322111111    


Q ss_pred             HHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       445 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .......    ....     .....+..+.++...+-..+...+|....+...++.
T Consensus       250 ~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~  296 (322)
T KOG1164|consen  250 EKDPRKL----LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD  296 (322)
T ss_pred             HHHhhhh----cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence            1111000    0000     111122456666666667899999999999888665

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=5.5e-22  Score=199.00  Aligned_cols=259  Identities=28%  Similarity=0.358  Sum_probs=198.9

Q ss_pred             CCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhccCC-CccceEEEEecCCceeeEeec
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHR-NLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  305 (549)
                      |...+.||.|+||.||++...  ..+++|.+........  ...+.+|+..++.+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999987  7899999986654443  56799999999999988 799999999777778999999


Q ss_pred             cCCCchhhhhccCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC-ceEEeecccccccCCCC
Q 008893          306 MSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       306 ~~~g~L~~~l~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  381 (549)
                      +.++++.+.+....   .++......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997777554   689999999999999999999999   999999999999999988 79999999998655433


Q ss_pred             Cc-----eeeccccccCccCchhhcc---CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccch
Q 008893          382 SH-----VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       382 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      ..     ......|+..|+|||.+.+   ..++...|+||+|++++++++|..|+...............+......   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            22     2355679999999999987   578899999999999999999999965433210001111111111100   


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       454 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        .................+.+++..|+..+|..|.+..+....
T Consensus       234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              000000000001223568899999999999999999987764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=1.1e-23  Score=224.27  Aligned_cols=254  Identities=20%  Similarity=0.220  Sum_probs=187.1

Q ss_pred             CCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHH----HHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          230 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEI----QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       230 ~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~----~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ...+++|.|.+|.|+..... ..+..+.|.+.... ......    .+..|+.+-..+.|+|++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35678999999988777643 33434444332100 111111    2555666677889999988877777666666669


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  382 (549)
                      ||+++ +|...+.....+....+..++.|++.|+.|+|+.   ||.|||+|++|++++.++.+||+|||.+........ 
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            99999 9999998776788999999999999999999999   999999999999999999999999999987654433 


Q ss_pred             --ceeeccccccCccCchhhccCCCCCc-ccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          383 --HVTTAVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       383 --~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                        ......+|+..|+|||.+....|.+. .||||.|+++..|++|+.||......+...      .......+   .-..
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~---~~~~  547 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQ---RNIF  547 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccc---cccc
Confidence              34566789999999999999998765 699999999999999999998655443321      00000000   0000


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .-........+.....++.++++.+|.+|-|+++|++
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0001112333466788999999999999999999985

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=2.1e-22  Score=180.71  Aligned_cols=252  Identities=19%  Similarity=0.226  Sum_probs=193.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEE-ECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC-CCccceEEEEecCCceeeE
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv  302 (549)
                      ....|...+.||+|+||.+|.|. ..+|+.||||+-.....   ..++..|..+...+++ ..|..+..|..+.....+|
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            34689999999999999999998 56799999998765443   3356788889888875 6677788888889999999


Q ss_pred             eeccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC---CCceEEeecccccccC
Q 008893          303 YPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLD  378 (549)
Q Consensus       303 ~e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~~  378 (549)
                      |+.. +.+|.++.+ ....++..+++..+-|++.-++|+|.+   +++||||||+|+|..-   ...+-++|||+++.+.
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9998 669988886 455689999999999999999999999   9999999999999973   3567899999998775


Q ss_pred             CCCCc------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc
Q 008893          379 HCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK  452 (549)
Q Consensus       379 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (549)
                      .....      ......||.+|.+-....+.+.+.+.|+=|+|.+|.++.-|..||.+-.......             +
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-------------K  232 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-------------K  232 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-------------H
Confidence            43322      2234569999999998888888999999999999999999999998643322110             1


Q ss_pred             hhhhccccccC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          453 LEMLVDKDLKN---NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       453 ~~~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .+.+....+..   ......+.++.-.+..|-..--++-|...-+-+
T Consensus       233 yEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrq  279 (341)
T KOG1163|consen  233 YEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQ  279 (341)
T ss_pred             HHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHH
Confidence            11111111110   111122466778888898888888897665544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=3.4e-23  Score=220.16  Aligned_cols=253  Identities=23%  Similarity=0.277  Sum_probs=189.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHH---HHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++...+-+|++.|=+|.+|++++|. |+||++-+....-....|.   .|++ ....+|||++++.-+.......|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5666788999999999999998887 8899986655333333343   3444 556689999999887777777889999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc--cCCCCC
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL--LDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~--~~~~~~  382 (549)
                      |+.+ +|+|.+..++-+...+.+.|+.|++.||..+|..   ||+|||||.+||||+.-.-+.|+||.--+.  +++.+.
T Consensus       102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            9976 9999999998899999999999999999999999   999999999999999999999999976542  222222


Q ss_pred             ce----eeccccccCccCchhhccC-----------CCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHH
Q 008893          383 HV----TTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKK  446 (549)
Q Consensus       383 ~~----~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  446 (549)
                      ..    ..+...-.+|+|||.+...           ..+++.||||+||+++||++ |+++|....       +..+-..
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------L~aYr~~  250 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------LLAYRSG  250 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-------HHhHhcc
Confidence            11    1222344579999988652           14678899999999999998 577775321       1111100


Q ss_pred             --HhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCcc
Q 008893          447 --IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAE  505 (549)
Q Consensus       447 --~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  505 (549)
                        ...+..++.+-|            ..+.+++..|++.||.+|.++++.++.-.+..+++
T Consensus       251 ~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~  299 (1431)
T KOG1240|consen  251 NADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPE  299 (1431)
T ss_pred             CccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHH
Confidence              000111122222            35789999999999999999999999888876665

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=7.2e-22  Score=185.14  Aligned_cols=201  Identities=20%  Similarity=0.262  Sum_probs=170.7

Q ss_pred             CCCCCCeeeeeCCeEEEEEE-ECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .|.+.+.||+|+||+.+.|+ +-+++.||||.-....   ...++..|....+.+. .++|...+-|-.+..+..||+|.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            68899999999999999998 4579999999875443   2336788888888775 68898888888888889999999


Q ss_pred             cCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-----CCceEEeecccccccCC
Q 008893          306 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----YYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       306 ~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~  379 (549)
                      + |-+|.++.. .+..++..++..+|.|++.-++|+|++   .+|.|||||+|+||..     ...+.|+|||+|+.+..
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            8 668888875 566799999999999999999999999   9999999999999974     34678999999998876


Q ss_pred             CCCce------eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccc
Q 008893          380 CDSHV------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN  435 (549)
Q Consensus       380 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~  435 (549)
                      .....      .....||.+||+-....+.+.+.+.|+=|+|-+.++++-|..||.+-....
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t  243 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT  243 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence            54432      234559999999999999999999999999999999999999998655443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=6.3e-22  Score=182.22  Aligned_cols=141  Identities=16%  Similarity=0.184  Sum_probs=111.3

Q ss_pred             CCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCC-c-------HH-----------------HHHHHHHHHhhccCCCc
Q 008893          232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-G-------EI-----------------QFQTEVEMISLAVHRNL  286 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~-------~~-----------------~~~~e~~~l~~l~h~ni  286 (549)
                      ...||+|+||.||+|...+|+.||||+++...... .       ..                 ....|++.+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46899999999999998889999999997542111 0       01                 22348999999988877


Q ss_pred             cceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCceEecccCcCeeeecCCCc
Q 008893          287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL-HEQCDPKIIHRDVKAANILLDEYYE  365 (549)
Q Consensus       287 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~Nill~~~~~  365 (549)
                      .....+..  ...++||||++++++.........+++.....++.|++.+|.|+ |+.   +|+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCc
Confidence            54433322  23489999999887765544445789999999999999999999 687   999999999999998 478


Q ss_pred             eEEeecccccccC
Q 008893          366 AVVGDFGLAKLLD  378 (549)
Q Consensus       366 ~kl~Dfg~~~~~~  378 (549)
                      ++|+|||++....
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=9.9e-21  Score=174.94  Aligned_cols=142  Identities=18%  Similarity=0.163  Sum_probs=113.5

Q ss_pred             CCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCC--------------------c-----HHHHHHHHHHHhhccCCCc
Q 008893          232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG--------------------G-----EIQFQTEVEMISLAVHRNL  286 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--------------------~-----~~~~~~e~~~l~~l~h~ni  286 (549)
                      ...||+|+||.||+|...+|+.||||+++......                    .     ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            56899999999999998789999999987642110                    0     1124678899999999987


Q ss_pred             cceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCCc
Q 008893          287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYE  365 (549)
Q Consensus       287 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~  365 (549)
                      .....+...  ..++||||++++++.........++......++.|++.++.++|+ .   ||+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCC
Confidence            655544433  358999999988654433234467888999999999999999999 8   999999999999999 799


Q ss_pred             eEEeecccccccCC
Q 008893          366 AVVGDFGLAKLLDH  379 (549)
Q Consensus       366 ~kl~Dfg~~~~~~~  379 (549)
                      ++|+|||++....+
T Consensus       156 ~~liDFG~a~~~~~  169 (190)
T cd05145         156 PYIIDVSQAVELDH  169 (190)
T ss_pred             EEEEEcccceecCC
Confidence            99999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=4.2e-21  Score=195.41  Aligned_cols=214  Identities=23%  Similarity=0.370  Sum_probs=164.5

Q ss_pred             HhhccCCCccceEEEEecCCceeeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCce-EecccCc
Q 008893          278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKI-IHRDVKA  355 (549)
Q Consensus       278 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~Dlkp  355 (549)
                      |+.+.|.|+.+++|.+.+....+.|.+|+..|+|.+.+.. ...++|.....++.+|+.||.|||+.   +| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence            3567899999999999999999999999999999999975 55799999999999999999999987   44 9999999


Q ss_pred             CeeeecCCCceEEeecccccccCCC-CCceeeccccccCccCchhhccCC-------CCCcccchhHhHHHHHHHhCCcc
Q 008893          356 ANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLSTGQ-------SSEKTDVFGFGILLLELISGLRA  427 (549)
Q Consensus       356 ~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~s~G~il~elltg~~p  427 (549)
                      +|.++|..+.+|++|||+....... .........-..-|.|||.+....       .+.++||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999999876421 111112222445799999987641       46789999999999999999999


Q ss_pred             cccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          428 LEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      |...........+..+++.     .-...+.+.+....  +..+.+..++..||..+|++||++++|-..++..
T Consensus       158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9865443333334444333     11111222221110  2334789999999999999999999998877753

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=2.5e-21  Score=180.17  Aligned_cols=173  Identities=10%  Similarity=0.056  Sum_probs=134.4

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcH--HH------HHHHHHHHhhccCCCccceEEEEecC
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE--IQ------FQTEVEMISLAVHRNLLRLIGFCMTT  296 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~--~~------~~~e~~~l~~l~h~niv~l~~~~~~~  296 (549)
                      ..++|...+++|.|+||.||.+.. ++..+|||.++........  ..      +.+|+..+.++.|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            568899999999999999999766 5778999999765432221  11      67899999999999999998886533


Q ss_pred             --------CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEE
Q 008893          297 --------TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV  368 (549)
Q Consensus       297 --------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  368 (549)
                              ...+++|||++|.+|.+...    ++.    ....+++.++..+|+.   |++|||+||+||+++.++ +++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEE
Confidence                    35789999999999987632    232    2456899999999999   999999999999999988 999


Q ss_pred             eecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh
Q 008893          369 GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS  423 (549)
Q Consensus       369 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt  423 (549)
                      +|||...........             ..+.....+..++|+||||+++..+..
T Consensus       176 iDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        176 IDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999988654321110             113444556779999999999876654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.6e-21  Score=198.18  Aligned_cols=234  Identities=23%  Similarity=0.228  Sum_probs=188.2

Q ss_pred             eeeeCCeEEEEEE----ECCCCEEEEEEcccCCCCCcH-HHHHHHHHHHhhcc-CCCccceEEEEecCCceeeEeeccCC
Q 008893          235 VGKGGFGNVYKGY----LQDGTVVAVKRLKDGNAIGGE-IQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       235 iG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +|+|+||.|+.+.    .+.|..+|+|++++....... .....|..++...+ ||.+|++...+..+...+++.+|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6899999999765    345788999988754322111 14556777888886 99999999999999999999999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeecc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV  388 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  388 (549)
                      |++...+.....+++.....+...++-+++++|+.   +|+|||+|++||+++.+|.+++.|||+++..-.....     
T Consensus        82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-----  153 (612)
T KOG0603|consen   82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-----  153 (612)
T ss_pred             chhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence            99999999888889999999999999999999999   9999999999999999999999999999865432221     


Q ss_pred             ccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHH
Q 008893          389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI  468 (549)
Q Consensus       389 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  468 (549)
                      +||..|||||++.  .....+|.||||++++||+||..||..           +.+..+..           ..-..++.
T Consensus       154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~-----------~~~~~p~~  209 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILK-----------AELEMPRE  209 (612)
T ss_pred             ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhh-----------hccCCchh
Confidence            7999999999998  567789999999999999999999864           11122211           11234666


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH--HHHHHHHhc
Q 008893          469 ELEEMVQVALLCTQYLPSLRPKM--SEVVRMLEG  500 (549)
Q Consensus       469 ~~~~l~~l~~~cl~~dP~~RPs~--~evl~~L~~  500 (549)
                      ....+.+++..++..+|..|--.  ..+.+..+.
T Consensus       210 l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h  243 (612)
T KOG0603|consen  210 LSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH  243 (612)
T ss_pred             hhHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence            67788899999999999999866  344444444

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.2e-20  Score=177.92  Aligned_cols=197  Identities=20%  Similarity=0.203  Sum_probs=139.6

Q ss_pred             cCCCccceEEEEecC---------------------------CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHH
Q 008893          282 VHRNLLRLIGFCMTT---------------------------TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA  334 (549)
Q Consensus       282 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~  334 (549)
                      +|||||++.++|.+.                           ...|+||.-.+. +|.+++..+. .+.....-|+.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence            599999999876531                           345788887765 8888887654 45566777889999


Q ss_pred             HHHHHhhhcCCCceEecccCcCeeeec--CCC--ceEEeecccccccCCCC-----CceeeccccccCccCchhhccCC-
Q 008893          335 RGLLYLHEQCDPKIIHRDVKAANILLD--EYY--EAVVGDFGLAKLLDHCD-----SHVTTAVRGTVGHIAPEYLSTGQ-  404 (549)
Q Consensus       335 ~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~kl~Dfg~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-  404 (549)
                      +|+.|||.+   ||.|||+|++|||+.  +|+  ...|+|||++-.-+...     ........|...-||||+....+ 
T Consensus       352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            999999999   999999999999994  443  46799999875332210     11112234777899999986543 


Q ss_pred             -----CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHH
Q 008893          405 -----SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALL  479 (549)
Q Consensus       405 -----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~  479 (549)
                           --.|+|.|+.|.+.||+++...||.......-.  ..    .          +.+.-....+..++..+.+++..
T Consensus       429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--~r----~----------Yqe~qLPalp~~vpp~~rqlV~~  492 (598)
T KOG4158|consen  429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--TR----T----------YQESQLPALPSRVPPVARQLVFD  492 (598)
T ss_pred             CceeeccchhhhhhhhhhHHHHhccCCcccccchheec--hh----h----------hhhhhCCCCcccCChHHHHHHHH
Confidence                 136899999999999999999999752211110  00    0          11111122334445778999999


Q ss_pred             hcccCCCCCCCHHHHHHHHh
Q 008893          480 CTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       480 cl~~dP~~RPs~~evl~~L~  499 (549)
                      .++.||.+|++..-....|+
T Consensus       493 lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HhcCCccccCCccHHHhHHH
Confidence            99999999999887766554

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.7e-19  Score=164.29  Aligned_cols=186  Identities=17%  Similarity=0.052  Sum_probs=139.8

Q ss_pred             CCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCc---HHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeEeec
Q 008893          230 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG---EIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       230 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .....|++|+||+||.+.- .+..++.+.+........   ...+.+|+++|+++. |+++.+++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999996665 577788777765433211   124789999999995 5889999886    457999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccc-CcCeeeecCCCceEEeecccccccCCCCCc-
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV-KAANILLDEYYEAVVGDFGLAKLLDHCDSH-  383 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  383 (549)
                      +.+.+|.......       ...++.|++.+|.++|+.   ||+|||| ||+|||++.++.++|+|||++......... 
T Consensus        80 I~G~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         80 LAGAAMYQRPPRG-------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             ecCccHHhhhhhh-------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            9998887543211       235778999999999999   9999999 799999999999999999999865433211 


Q ss_pred             ---e--------eeccccccCccCchhhccC-CCC-CcccchhHhHHHHHHHhCCccccc
Q 008893          384 ---V--------TTAVRGTVGHIAPEYLSTG-QSS-EKTDVFGFGILLLELISGLRALEF  430 (549)
Q Consensus       384 ---~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~s~G~il~elltg~~p~~~  430 (549)
                         .        ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+...
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence               0        1112367788888865332 223 567889999999999999887653

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=8.8e-20  Score=198.18  Aligned_cols=200  Identities=21%  Similarity=0.218  Sum_probs=162.8

Q ss_pred             HHHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc---CCCccceEEEEecCC
Q 008893          221 ELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTTT  297 (549)
Q Consensus       221 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~  297 (549)
                      +.+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+....++-..    =.+++.+++   -+-|..+...+.-.+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI----~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI----CLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee----hHHHHHhhchhhhcchHHHHHHHccCC
Confidence            4455667888999999999999999998889999999987665443321    112233333   234455555555667


Q ss_pred             ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec-------CCCceEEee
Q 008893          298 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-------EYYEAVVGD  370 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-------~~~~~kl~D  370 (549)
                      .-++|+||.+.|+|.++++..+.++|...+.++.|++..+++||..   +||||||||+|+||.       ++..++|+|
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence            7899999999999999999888999999999999999999999999   999999999999994       345689999


Q ss_pred             cccccccCC-CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcc
Q 008893          371 FGLAKLLDH-CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA  427 (549)
Q Consensus       371 fg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p  427 (549)
                      ||.+-.+.- .++......++|-.+-.+|+..+..++..+|-|.++.+++-||.|+..
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999865432 233456677899999999999999999999999999999999999543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=3.7e-19  Score=170.66  Aligned_cols=230  Identities=23%  Similarity=0.256  Sum_probs=147.1

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhcc----------CCCccceEEEEe-
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAV----------HRNLLRLIGFCM-  294 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~----------h~niv~l~~~~~-  294 (549)
                      +...+.||.|+++.||.++.. +|+.+|||++....  .....+++.+|......+.          |-.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999986 48999999986443  2233456777765555432          222222222221 


Q ss_pred             --------cC---C-----ceeeEeeccCCCchhhhhc---c-CC---CCCHHHHHHHHHHHHHHHHHhhhcCCCceEec
Q 008893          295 --------TT---T-----ERLLVYPYMSNGSVASRLK---A-KP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHR  351 (549)
Q Consensus       295 --------~~---~-----~~~lv~e~~~~g~L~~~l~---~-~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  351 (549)
                              ..   .     ..+++|+-+ .++|.+++.   . ..   .+....+..+..|+++.+++||+.   |++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                    11   1     235677777 458877754   1 11   234455667779999999999999   99999


Q ss_pred             ccCcCeeeecCCCceEEeecccccccCCCCCceeeccccccCccCchhhccC--------CCCCcccchhHhHHHHHHHh
Q 008893          352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG--------QSSEKTDVFGFGILLLELIS  423 (549)
Q Consensus       352 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~s~G~il~ellt  423 (549)
                      ||+|+|++++.+|.+.|+||+.....+.    .......+..|.+||.....        .++.+.|.|++|+++|.|.+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999987765432    12213456789999987442        46889999999999999999


Q ss_pred             CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCC
Q 008893          424 GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR  488 (549)
Q Consensus       424 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R  488 (549)
                      |+.||...........                    .+ .... ..++.+..||..+++++|.+|
T Consensus       246 ~~lPf~~~~~~~~~~~--------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW--------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG--------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc--------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999975432221100                    11 1222 556889999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.3e-18  Score=161.69  Aligned_cols=136  Identities=17%  Similarity=0.177  Sum_probs=106.1

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-----cCCCccceEEEEecCC---c-
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-----VHRNLLRLIGFCMTTT---E-  298 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-  298 (549)
                      ++..+.||+|+||.||.  +. ++.. +||++..... .....+.+|+.++..+     .||||++++|++..+.   . 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            34567999999999996  43 3444 6898865432 3455789999999999     5799999999998764   3 


Q ss_pred             eeeEeec--cCCCchhhhhccCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCceEecccCcCeeeecC----CCceEEeec
Q 008893          299 RLLVYPY--MSNGSVASRLKAKPSLDWATRKRIALGAARGL-LYLHEQCDPKIIHRDVKAANILLDE----YYEAVVGDF  371 (549)
Q Consensus       299 ~~lv~e~--~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Df  371 (549)
                      ..+|+||  +.+++|.+++.+. .+++.  ..++.+++.++ +|||++   +|+||||||+|||++.    ++.++|+||
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            3378999  5579999999764 46655  35677888777 999999   9999999999999974    348999994


Q ss_pred             ccc
Q 008893          372 GLA  374 (549)
Q Consensus       372 g~~  374 (549)
                      +-+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            433

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=2.7e-18  Score=163.53  Aligned_cols=144  Identities=16%  Similarity=0.144  Sum_probs=113.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEE--ECCCCEEEEEEcccCCCCC-----------------------cHHHHHHHHHHHhhc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIG-----------------------GEIQFQTEVEMISLA  281 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l  281 (549)
                      ..|.+.+.||+|+||.||+|.  ..+|+.||+|+++......                       ....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347788999999999999998  5679999999987542100                       012357899999999


Q ss_pred             cCCC--ccceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc-eEecccCcCee
Q 008893          282 VHRN--LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK-IIHRDVKAANI  358 (549)
Q Consensus       282 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~Ni  358 (549)
                      .+..  +.+++++    ...++||||++++++.........+.......++.||+.++.+||+.   + ++||||||+||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI  180 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI  180 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence            7633  3344433    24589999999988877654444566677789999999999999999   9 99999999999


Q ss_pred             eecCCCceEEeecccccccC
Q 008893          359 LLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       359 ll~~~~~~kl~Dfg~~~~~~  378 (549)
                      +++ ++.++|+|||.+....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 8899999999987554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=9.2e-19  Score=186.66  Aligned_cols=217  Identities=23%  Similarity=0.265  Sum_probs=151.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|+.+++|..|+||.||..+++. .+.+|+|+-+ .+.      +.+-  ++.....|.+|                 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l------ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL------ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch------hhhc--cccccCCccee-----------------
Confidence            3578899999999999999999774 6778884332 221      1110  22222333332                 


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC---
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD---  381 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---  381 (549)
                          |+-...++.-++++.+.        +.+++|||+.   +|+|||+||+|.+|+.=|++|+.|||+++..-...   
T Consensus       136 ----gDc~tllk~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ----chhhhhcccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence                56666666655555443        7789999999   99999999999999999999999999987532110   


Q ss_pred             -----------CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc
Q 008893          382 -----------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE  450 (549)
Q Consensus       382 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (549)
                                 ......++||+.|+|||++....|...+|.|++|+|+||.+.|+.||.+...++-.+..+       .+
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi-------sd  273 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-------SD  273 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh-------hh
Confidence                       012244679999999999999999999999999999999999999998654433221111       10


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       451 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                      .        ..+.+-......+..+++.+.++.+|..|--....++.-
T Consensus       274 ~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk  313 (1205)
T KOG0606|consen  274 D--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVK  313 (1205)
T ss_pred             h--------ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhh
Confidence            0        000011112236788999999999999998655554433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.2e-17  Score=157.23  Aligned_cols=135  Identities=19%  Similarity=0.246  Sum_probs=114.3

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCc-------HHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +.||+|++|.||+|.+ +|..+++|+.........       ...+.+|+.++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999988 577899998654322111       13477899999999999998888887777889999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      +++++|.+.+.....    .+..++.+++.+|.++|+.   +++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998865432    7889999999999999999   999999999999999 78999999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.3e-17  Score=155.25  Aligned_cols=144  Identities=19%  Similarity=0.169  Sum_probs=111.8

Q ss_pred             HHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC---------------------CcHHHHHHHHHHHhh
Q 008893          222 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI---------------------GGEIQFQTEVEMISL  280 (549)
Q Consensus       222 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~  280 (549)
                      +.....-|...+.||+|+||.||++...+|+.||||++......                     .....+..|+..+..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33333347788999999999999999888999999987643200                     001135678888888


Q ss_pred             ccCCC--ccceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCee
Q 008893          281 AVHRN--LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI  358 (549)
Q Consensus       281 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  358 (549)
                      +.|++  +...++    ....+++|||+++++|......      .....++.+++.++.++|+.   +|+||||||+||
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Ni  156 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNI  156 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccE
Confidence            88774  444443    2456899999999998765431      34567889999999999998   999999999999


Q ss_pred             eecCCCceEEeecccccccC
Q 008893          359 LLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       359 ll~~~~~~kl~Dfg~~~~~~  378 (549)
                      ++++++.++|+|||++....
T Consensus       157 ll~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         157 LVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EEcCCCcEEEEECCccccCC
Confidence            99999999999999996554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=2.5e-17  Score=153.71  Aligned_cols=131  Identities=19%  Similarity=0.264  Sum_probs=108.0

Q ss_pred             eeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCc-------HHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          234 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       234 ~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      +||+|+||.||+|.+ +|..|++|..........       ..++.+|++++..+.|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 477899998654321111       235778999999999988766666666777789999999


Q ss_pred             CCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          307 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       307 ~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      ++++|.+.+.....       .++.+++.+|.+||+.   +++|||++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988754321       7899999999999999   999999999999999 78999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.72  E-value=2.8e-17  Score=176.09  Aligned_cols=141  Identities=19%  Similarity=0.267  Sum_probs=113.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC------CcHHHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI------GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      ....|...+.||+|+||+||+|.+.+...++.++.......      .....+.+|++++..++|++++....++.....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34455678999999999999998765443332222221111      112358899999999999999988888887778


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccccc
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      .++||||+++++|.+++.        ....++.+++.+|.|||+.   +++||||||+|||+ +++.++|+|||+++..
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            899999999999998875        4577999999999999999   99999999999999 6789999999999753

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.72  E-value=3.6e-18  Score=170.75  Aligned_cols=172  Identities=23%  Similarity=0.330  Sum_probs=129.2

Q ss_pred             ceeeEeeccCCCchhhhhccC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA  374 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  374 (549)
                      ..++.|+++...+|.+++...   ...++.....++.|++.|+.|   +   +.+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            478999999999999999643   356888899999999999999   5   8999999999999999999999999999


Q ss_pred             cccCCCC-----CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhC-CcccccCccccccccHHHHHHHHh
Q 008893          375 KLLDHCD-----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG-LRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       375 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      .......     ....+...||..||+||.+.+..|+.|+||||||++|+|+++- ..+++.             .+.. 
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-------------~~t~-  469 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-------------IATL-  469 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-------------HHhh-
Confidence            8776544     2233455699999999999999999999999999999999971 111110             0000 


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV  495 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  495 (549)
                       ...-...+++.....++     .=..++.+++.+.|.+||++.++.
T Consensus       470 -~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  470 -TDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             -hhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHh
Confidence             00011122222222232     234788999999999999555443

>PLN03150 hypothetical protein; Provisional

Probab=99.70  E-value=2.8e-17  Score=177.98  Aligned_cols=125  Identities=35%  Similarity=0.590  Sum_probs=109.5

Q ss_pred             eeeeeeecC----CceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCC
Q 008893           12 VLIQVICSD----GVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAI   87 (549)
Q Consensus        12 ~~~~~~c~~----~~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~   87 (549)
                      .+.|+.|+.    +...+..++|++|.++|.+|..|++|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+
T Consensus       403 ~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~i  482 (623)
T PLN03150        403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI  482 (623)
T ss_pred             ccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCC
Confidence            477899952    2234667899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCCceEeccCCCCCCCCCcccc------ccccccCCccccCCCCCCcc
Q 008893           88 PPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLICATGAEEDC  136 (549)
Q Consensus        88 p~~~~~l~~L~~l~l~~N~l~~~~p~~~~------~~~~l~~N~~~~~~~~~~~c  136 (549)
                      |..++++++|+.|+|++|.++|.+|..+.      ..+++.+|+..|+.+....|
T Consensus       483 P~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C  537 (623)
T PLN03150        483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC  537 (623)
T ss_pred             chHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence            99999999999999999999999997543      35788999998875443444

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=6.5e-16  Score=142.56  Aligned_cols=137  Identities=20%  Similarity=0.228  Sum_probs=98.7

Q ss_pred             CCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCc-HHH----------------------HHHHHHHHhhccCCC--c
Q 008893          232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-EIQ----------------------FQTEVEMISLAVHRN--L  286 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~----------------------~~~e~~~l~~l~h~n--i  286 (549)
                      .+.||+|+||+||+|...+|+.||||+++....... ...                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999988899999999875321111 001                      134555555554432  3


Q ss_pred             cceEEEEecCCceeeEeeccCCCchhhh-hccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCC
Q 008893          287 LRLIGFCMTTTERLLVYPYMSNGSVASR-LKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYY  364 (549)
Q Consensus       287 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~  364 (549)
                      .+.+++    ...+++|||++++.+... +... ... .....++.+++.++.++|. .   +|+||||||+||+++ ++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CC
Confidence            444433    346899999998554321 1111 111 6678899999999999998 7   999999999999999 89


Q ss_pred             ceEEeecccccccC
Q 008893          365 EAVVGDFGLAKLLD  378 (549)
Q Consensus       365 ~~kl~Dfg~~~~~~  378 (549)
                      .++++|||.+....
T Consensus       152 ~~~liDfg~a~~~~  165 (187)
T cd05119         152 KVYIIDVPQAVEID  165 (187)
T ss_pred             cEEEEECccccccc
Confidence            99999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=2.3e-15  Score=133.35  Aligned_cols=135  Identities=19%  Similarity=0.136  Sum_probs=115.3

Q ss_pred             CCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC--CCccceEEEEecCCceeeEeeccCC
Q 008893          231 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       231 ~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.+.||+|.++.||++...+ ..+++|.......   ...+..|+..+..++|  .++.+++++....+..++++||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35789999999999999864 7899999865432   4568899999999976  5899999988887889999999998


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      +.+...       +......++.+++.++.++|.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus        78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777654       6677788999999999999986445799999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=1.3e-16  Score=170.50  Aligned_cols=254  Identities=23%  Similarity=0.278  Sum_probs=190.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC--CCEEEEEEcccCC-CCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD--GTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~--g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  302 (549)
                      ..|...+.||+|+|+.|-......  ...+|+|.+.... ..........|..+-..+. |+|++.+++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456777889999999998887543  4456666665432 2222334445666666665 99999999999999999999


Q ss_pred             eeccCCCchhhhh-ccCC-CCCHHHHHHHHHHHHHHHHHhh-hcCCCceEecccCcCeeeecCCC-ceEEeecccccccC
Q 008893          303 YPYMSNGSVASRL-KAKP-SLDWATRKRIALGAARGLLYLH-EQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLD  378 (549)
Q Consensus       303 ~e~~~~g~L~~~l-~~~~-~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~  378 (549)
                      .+|..++++.+.+ .... ..+......+..|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999998 5444 6778888899999999999999 77   999999999999999999 99999999998876


Q ss_pred             C--CCCceeecccc-ccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          379 H--CDSHVTTAVRG-TVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       379 ~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      .  +........+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+.........  ...|...-       
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~~~~~-------  247 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSWKSNK-------  247 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--ceeecccc-------
Confidence            6  22223345568 9999999999885 4567889999999999999999999865543321  11221110       


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .........    .......++..+++..+|..|.+.+++..
T Consensus       248 ~~~~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 GRFTQLPWN----SISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccccCccc----cCChhhhhcccccccCCchhccccccccc
Confidence            000011111    12245678888888899999999888754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=1.1e-14  Score=139.17  Aligned_cols=137  Identities=18%  Similarity=0.178  Sum_probs=106.2

Q ss_pred             CCeee-eeCCeEEEEEEECCCCEEEEEEcccCCC------------CCcHHHHHHHHHHHhhccCCCc--cceEEEEecC
Q 008893          232 KNLVG-KGGFGNVYKGYLQDGTVVAVKRLKDGNA------------IGGEIQFQTEVEMISLAVHRNL--LRLIGFCMTT  296 (549)
Q Consensus       232 ~~~iG-~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  296 (549)
                      ...|| .|+.|+||.+... +..++||++.....            ......+.+|+.++..+.|+++  .+.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45788 8999999999886 67889998854210            1122457889999999998875  6677765432


Q ss_pred             C----ceeeEeeccCC-CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeec
Q 008893          297 T----ERLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF  371 (549)
Q Consensus       297 ~----~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  371 (549)
                      .    ..++||||+++ .+|.+++... .++..    .+.+|+.++.+||+.   ||+||||||.|||++.++.++|+||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence            2    23599999997 6888887653 35543    357899999999999   9999999999999999899999999


Q ss_pred             cccccc
Q 008893          372 GLAKLL  377 (549)
Q Consensus       372 g~~~~~  377 (549)
                      |.+...
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            988753

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=2.6e-14  Score=134.67  Aligned_cols=201  Identities=21%  Similarity=0.288  Sum_probs=138.7

Q ss_pred             HHHHhhccCCCccceEEEEecC-----CceeeEeeccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 008893          275 VEMISLAVHRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCD  345 (549)
Q Consensus       275 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  345 (549)
                      +.-|-++.|.|||++..|+.+.     ....+++|||..|++..+|+    .+..+....-.+++.||..||.|||+ |+
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            3445566799999999988654     34689999999999999997    34467777888999999999999998 58


Q ss_pred             CceEecccCcCeeeecCCCceEEeecccccccCCC----CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHH
Q 008893          346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC----DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL  421 (549)
Q Consensus       346 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el  421 (549)
                      |+|+|+++..+-|++..++-+||+--- .......    .........+-++|.|||+-.....+..+|||+||+...||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            899999999999999999999884311 1111100    00111223367899999998888888899999999999999


Q ss_pred             HhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          422 ISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       422 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..+..--..+.....            .+......+-. +..       ..=..++..|++..|..||+|++.+.|
T Consensus       276 ailEiq~tnseS~~~------------~ee~ia~~i~~-len-------~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  276 AILEIQSTNSESKVE------------VEENIANVIIG-LEN-------GLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHheeccCCCcceee------------hhhhhhhheee-ccC-------ccccCcCcccccCCCCCCcchhhhhcC
Confidence            887433111110000            00000000000 000       011246778999999999999998754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=1.7e-13  Score=142.13  Aligned_cols=141  Identities=23%  Similarity=0.247  Sum_probs=99.6

Q ss_pred             CCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCc---------------------------------------HHHHH
Q 008893          232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG---------------------------------------EIQFQ  272 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---------------------------------------~~~~~  272 (549)
                      .+.||.|++|.||+|++++|+.||||+.+......-                                       +.+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            468999999999999999999999999864321000                                       01244


Q ss_pred             HHHHHHhhcc----CCCccceEEEEe-cCCceeeEeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHH-HHHHhhhcCC
Q 008893          273 TEVEMISLAV----HRNLLRLIGFCM-TTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAAR-GLLYLHEQCD  345 (549)
Q Consensus       273 ~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~-~L~~LH~~~~  345 (549)
                      .|...+.+++    |.+-+.+-.++. .....++||||++|++|.+..... ...   .+..++..++. .+..+|..  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~--  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD--  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC--
Confidence            4554444442    323233333332 345679999999999998876421 122   24456666666 46788888  


Q ss_pred             CceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       346 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                       |++|+|+||.||++++++.++++|||++..+.
T Consensus       277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             99999999999999999999999999997665

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.37  E-value=1.1e-12  Score=151.68  Aligned_cols=126  Identities=33%  Similarity=0.509  Sum_probs=106.2

Q ss_pred             ccceeeeeeeeeecCCce-------eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeec
Q 008893            6 EKVLIIVLIQVICSDGVF-------FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL   78 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~~~~-------~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l   78 (549)
                      .+|+.|++.++..+....       ....++|++|++.+.+|..+.++++|++|+|++|.++|.+|..|..+++|+.|+|
T Consensus       475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  554 (968)
T PLN00113        475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL  554 (968)
T ss_pred             ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence            456777776655542111       2234789999999999999999999999999999999999999999999999999


Q ss_pred             cCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc----ccccccCCccccCCC
Q 008893           79 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATG  131 (549)
Q Consensus        79 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~~~~~  131 (549)
                      ++|+++|.+|..+..++.|+.|++++|+++|.+|....    ....+.||+..|+..
T Consensus       555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~  611 (968)
T PLN00113        555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD  611 (968)
T ss_pred             CCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCc
Confidence            99999999999999999999999999999999996422    344678999888743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=9.1e-13  Score=134.82  Aligned_cols=247  Identities=21%  Similarity=0.163  Sum_probs=180.8

Q ss_pred             CCCCCCeeee--eCCeEEEEEEE---CCCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhc-cCCCccceEEEEecCCcee
Q 008893          228 NFSSKNLVGK--GGFGNVYKGYL---QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       228 ~~~~~~~iG~--G~~g~Vy~~~~---~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  300 (549)
                      .|.....+|.  |.+|.||.+..   .++..+|+|.-+..... .....=.+|+.....+ .|+|.++....+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4566788999  99999999986   35888999985433221 1111223566666666 4999999888888888999


Q ss_pred             eEeeccCCCchhhhhccCCC-CCHHHHHHHHHHHHH----HHHHhhhcCCCceEecccCcCeeeecCC-CceEEeecccc
Q 008893          301 LVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAAR----GLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLA  374 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~  374 (549)
                      +-+|++. .+|.++.+.... ++....+.+..+..+    |+.++|+.   .++|-|+||.||+...+ ...+++|||+.
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCccee
Confidence            9999986 577777765443 788888888888888    99999999   99999999999999998 88999999999


Q ss_pred             cccCCCCCc----eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc
Q 008893          375 KLLDHCDSH----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE  450 (549)
Q Consensus       375 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (549)
                      ..+....-.    ......|...|++||..+ +.++...|+|++|.++.+-.+|.++...+......       .     
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-------~-----  337 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-------Q-----  337 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-------c-----
Confidence            887654422    122335788899999874 45788999999999999999998777654221110       0     


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       451 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                        ++...   +..++......++...+..+++.+|..|++.+.+..
T Consensus       338 --~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 --LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence              00000   111122222345666889999999999999888763

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=4.8e-12  Score=114.68  Aligned_cols=130  Identities=19%  Similarity=0.137  Sum_probs=96.8

Q ss_pred             CCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCcc-ceEEEEecCCceeeEeeccCCCc
Q 008893          232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-RLIGFCMTTTERLLVYPYMSNGS  310 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~  310 (549)
                      .+.++.|.++.||++... ++.|++|.......  ....+..|+..+..+.+.+++ +++.+.  ....++||||+++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence            356889999999999876 77899999865432  123467889999888765554 444443  334689999999988


Q ss_pred             hhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          311 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQC--DPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       311 L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      +.+..        .....++.+++.+|..||+..  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            76430        112345678999999999872  22369999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.34  E-value=3.1e-12  Score=134.30  Aligned_cols=146  Identities=19%  Similarity=0.201  Sum_probs=94.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCC--------------------------C-------cH---
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--------------------------G-------GE---  268 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--------------------------~-------~~---  268 (549)
                      -..|+. +.||+|++|.||+|++++ |+.||||+.+.+...                          .       -.   
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999987 999999999743100                          0       00   


Q ss_pred             ---HHHHHHHHHHhhcc----CCCccceEEEEec-CCceeeEeeccCCCchhhhh--ccCCCCCHHHHHHHHHHHHHH-H
Q 008893          269 ---IQFQTEVEMISLAV----HRNLLRLIGFCMT-TTERLLVYPYMSNGSVASRL--KAKPSLDWATRKRIALGAARG-L  337 (549)
Q Consensus       269 ---~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~l~~~~~~~i~~~i~~~-L  337 (549)
                         .+|..|..-+.+++    +.+.+.+-.++.+ ....++||||++|+.+.+.-  ...+ .+..   .++...+.. +
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~---~la~~~v~~~~  273 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMK---LLAERGVEVFF  273 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHH---HHHHHHHHHHH
Confidence               12344444444442    3344444444433 45678999999999997742  2222 2211   122221111 2


Q ss_pred             HHhhhcCCCceEecccCcCeeeecCCC----ceEEeecccccccCC
Q 008893          338 LYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAKLLDH  379 (549)
Q Consensus       338 ~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~~~~~~~  379 (549)
                      ..++..   |++|+|+||.||+++.++    .+++.|||++..++.
T Consensus       274 ~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            223345   999999999999999888    999999999987653

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.32  E-value=3.4e-11  Score=109.94  Aligned_cols=139  Identities=16%  Similarity=0.162  Sum_probs=100.8

Q ss_pred             CCeeeeeCCeEEEEEEECC-------CCEEEEEEcccCC------------C---------CCcHHHH----HHHHHHHh
Q 008893          232 KNLVGKGGFGNVYKGYLQD-------GTVVAVKRLKDGN------------A---------IGGEIQF----QTEVEMIS  279 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~------------~---------~~~~~~~----~~e~~~l~  279 (549)
                      ...||.|.-+.||.|...+       +..+|||+.+...            .         ......+    ..|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998543       4799999875211            0         0112223    37999998


Q ss_pred             hccC--CCccceEEEEecCCceeeEeeccCCCchhh-hhccCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCceEecccCc
Q 008893          280 LAVH--RNLLRLIGFCMTTTERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYL-HEQCDPKIIHRDVKA  355 (549)
Q Consensus       280 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp  355 (549)
                      ++..  -++.+++++    ...++||||+.++.+.. .++. ..++......+..+++.+|..+ |+.   +++||||++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            8864  455566654    56789999997654422 2322 2355566677889999999998 777   999999999


Q ss_pred             CeeeecCCCceEEeecccccccCC
Q 008893          356 ANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       356 ~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      .||++++ +.+.|+|||.+....+
T Consensus       154 ~NIL~~~-~~v~iIDF~qav~~~h  176 (197)
T cd05146         154 YNMLWHD-GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHEEEEC-CcEEEEECCCceeCCC
Confidence            9999974 6899999998876554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.27  E-value=1.1e-10  Score=120.86  Aligned_cols=165  Identities=19%  Similarity=0.232  Sum_probs=124.6

Q ss_pred             CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHH
Q 008893          249 QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR  328 (549)
Q Consensus       249 ~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~  328 (549)
                      .++.+|.|...+.... .......+.++.++.++||||++++.........|+|+|-+.  -|..++.+.   .......
T Consensus        35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~~  108 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVCL  108 (690)
T ss_pred             ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHHH
Confidence            3678888888876553 334457788889999999999999999999999999999875  345555432   2556667


Q ss_pred             HHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCc
Q 008893          329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK  408 (549)
Q Consensus       329 i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  408 (549)
                      .+.||+.||.|||+.|  +++|++|.-+-|+++..|+-||++|-++........ ......--..|..|+.+....  -.
T Consensus       109 Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s  183 (690)
T KOG1243|consen  109 GLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WS  183 (690)
T ss_pred             HHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cc
Confidence            7899999999999776  899999999999999999999999988764432221 011111223466677653332  34


Q ss_pred             ccchhHhHHHHHHHhC
Q 008893          409 TDVFGFGILLLELISG  424 (549)
Q Consensus       409 ~Dv~s~G~il~elltg  424 (549)
                      .|.|-||++++|++.|
T Consensus       184 ~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhhHHHHHHHHhCc
Confidence            6999999999999998

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=8.6e-11  Score=111.32  Aligned_cols=143  Identities=20%  Similarity=0.276  Sum_probs=112.5

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC--CCccceEEEEecCC---ceeeEeeccC
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLIGFCMTTT---ERLLVYPYMS  307 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~  307 (549)
                      +.|+.|.++.||++...+|+.+++|.............+..|.+++..+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999999877789999998654332234468899999999876  34567777766542   5689999999


Q ss_pred             CCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------------
Q 008893          308 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ--------------------------------------------  343 (549)
Q Consensus       308 ~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------  343 (549)
                      +.++.+.+.. ..++...+..++.+++.+|.+||+.                                            
T Consensus        84 G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          84 GRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence            9988876643 3578888888999999999999852                                            


Q ss_pred             ---------CCCceEecccCcCeeeecC--CCceEEeecccccc
Q 008893          344 ---------CDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKL  376 (549)
Q Consensus       344 ---------~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~~~~  376 (549)
                               ....++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                     1246899999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.21  E-value=1.3e-11  Score=126.48  Aligned_cols=250  Identities=20%  Similarity=0.179  Sum_probs=176.5

Q ss_pred             HHHhcCCCCCCeeeeeCCeEEEEEEEC--CCCEEEEEEcccCCCCCcHH-HHHHHHHHHhhc-cCCCccceEEEEecCCc
Q 008893          223 QSATSNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLA-VHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       223 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  298 (549)
                      .....+|.....||.|.|+.|++...+  ++..|++|.+.........+ .-..|+.+...+ .|.++++....+...+.
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            345667888999999999999998744  57889999887554322221 223455554444 58888887777777777


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC-CceEEeeccccccc
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLL  377 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~  377 (549)
                      .++--||++++++.........++...++++..|++.++.++|+.   .++|+|+||+||++..+ +.-+++|||.+..+
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccc
Confidence            789999999999888776556688899999999999999999998   99999999999999886 78899999998642


Q ss_pred             CCCCCceeeccccccCc-cCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          378 DHCDSHVTTAVRGTVGH-IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      ...   ......++..| .+|+......+..+.|+||||..+.|.++|..--.....         |..  ...+.+   
T Consensus       418 ~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------~~~--i~~~~~---  480 (524)
T KOG0601|consen  418 AFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------SLT--IRSGDT---  480 (524)
T ss_pred             cee---cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---------cee--eecccc---
Confidence            211   11111133344 366666777889999999999999999998533221110         000  000000   


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                            ...+. ....+..+...+..+++..||.+.+...+..
T Consensus       481 ------p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  481 ------PNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ------cCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                  01111 1255677888889999999999888765443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=2.4e-10  Score=100.68  Aligned_cols=132  Identities=20%  Similarity=0.253  Sum_probs=101.0

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEE-cccCCCCCc------HHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIGG------EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~-~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ..+++|+-+.+|.+.+.+. .+++|. +++.-....      ..+-.+|..++.+++--.|.-.+=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            3578999999999987643 355553 332221111      12356789999988776766666677788889999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      +++..|.+.+...       ...++..+-.-+.-||..   +|+|+||.++||++..+. +.++|||++.+
T Consensus        81 I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888765       255666777778889999   999999999999998765 99999999974

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.15  E-value=7.5e-12  Score=107.56  Aligned_cols=98  Identities=30%  Similarity=0.526  Sum_probs=86.8

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .+.|++|+++ .+|+.+..|.+|+.|++++|+|+ .+|.+++.|+.|+.|+++-|++. .+|..|+.++.|+.|||++|+
T Consensus        37 rLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynn  113 (264)
T KOG0617|consen   37 RLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNN  113 (264)
T ss_pred             hhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccc
Confidence            4569999999 78889999999999999999999 89999999999999999999999 999999999999999999999


Q ss_pred             CCC-CCCcccc-----ccccccCCccc
Q 008893          107 LSG-PVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus       107 l~~-~~p~~~~-----~~~~l~~N~~~  127 (549)
                      ++. ..|.-|.     ..+.++.|.+.
T Consensus       114 l~e~~lpgnff~m~tlralyl~dndfe  140 (264)
T KOG0617|consen  114 LNENSLPGNFFYMTTLRALYLGDNDFE  140 (264)
T ss_pred             cccccCCcchhHHHHHHHHHhcCCCcc
Confidence            974 4565332     45678888775

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.11  E-value=1.3e-09  Score=109.53  Aligned_cols=216  Identities=16%  Similarity=0.177  Sum_probs=151.2

Q ss_pred             CCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEe----cCCceeeEeeccCC-Cchh
Q 008893          239 GFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM----TTTERLLVYPYMSN-GSVA  312 (549)
Q Consensus       239 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~  312 (549)
                      -..+.||+... ||..|++|+++........ .-..-+++++++.|+|+|++.+++.    .+...++||+|.++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            34688999854 8999999999644322221 1234467889999999999999876    34568999999985 5676


Q ss_pred             hhhc---------------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccccc
Q 008893          313 SRLK---------------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       313 ~~l~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      +.--               ++...++...|.++.|+..||.++|+.   |+..+-|.+.+|+++.+.+++|+..|....+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            6532               233578899999999999999999999   9999999999999999999999999988766


Q ss_pred             CCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          378 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ...+..               -+.   .-.+-|.=.||.+++.|.||..--.....              .....+    
T Consensus       444 ~~d~~~---------------~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~--------------~~~s~~----  487 (655)
T KOG3741|consen  444 QEDPTE---------------PLE---SQQQNDLRDLGLLLLALATGTENSNRTDS--------------TQSSHL----  487 (655)
T ss_pred             cCCCCc---------------chh---HHhhhhHHHHHHHHHHHhhcccccccccc--------------hHHHHH----
Confidence            543311               011   12356889999999999998432110000              000000    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                           ....+..+.++.+++.......+++ -++.+++.+.-+
T Consensus       488 -----~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~  524 (655)
T KOG3741|consen  488 -----TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS  524 (655)
T ss_pred             -----HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence                 1112334566777777777777776 677777765544

>PLN03150 hypothetical protein; Provisional

Probab=99.08  E-value=2.7e-10  Score=123.76  Aligned_cols=105  Identities=30%  Similarity=0.404  Sum_probs=87.8

Q ss_pred             ceeeeeeeeeecCCc-------eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccC
Q 008893            8 VLIIVLIQVICSDGV-------FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN   80 (549)
Q Consensus         8 ~~~~~~~~~~c~~~~-------~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~   80 (549)
                      ++.|+|.+...+...       .....++|++|+|+|.+|..+++|++|+.|||++|+|+|.+|..+++|++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            566777666554211       1233477999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccccC-CCCceEeccCCCCCCCCC
Q 008893           81 NSLTGAIPPSLSNM-SQLAFLDLSYNNLSGPVP  112 (549)
Q Consensus        81 N~l~g~~p~~~~~l-~~L~~l~l~~N~l~~~~p  112 (549)
                      |+++|.+|..+..+ .++..+++++|...+..|
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCC
Confidence            99999999998874 467899999998655444

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.07  E-value=2.6e-11  Score=130.50  Aligned_cols=252  Identities=17%  Similarity=0.179  Sum_probs=173.0

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ...+.+.+.+-+-+|.++.++.+.-. .|...+.|.......+..  ......+-.++-..+||-+++..--+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34466777778888999998877633 344444444332211110  111222222222334566665544444566789


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ++++|..+++|...++..+..+.+........+..+++|||..   .+.|+|++|.|.++..++..++.|||........
T Consensus       881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence            9999999999999999888888888888888899999999997   7999999999999999999999999843221100


Q ss_pred             ---------------------C---C------ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCccccc
Q 008893          381 ---------------------D---S------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF  430 (549)
Q Consensus       381 ---------------------~---~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  430 (549)
                                           .   .      .......||+.|.+||...+......+|.|++|++++|.++|..||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                 0   0      011234589999999999999999999999999999999999999975


Q ss_pred             CccccccccHHHHHHHHhhccchhhhccccc-cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 008893          431 GKTANQKGAMLDWVKKIHQEKKLEMLVDKDL-KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV  494 (549)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev  494 (549)
                      .......                +.+..... +...+........+++...+..+|.+|-.+.-.
T Consensus      1038 ~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~ 1086 (1205)
T KOG0606|consen 1038 ETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGA 1086 (1205)
T ss_pred             cchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccc
Confidence            4332211                11111111 122334445667888899999999999988743

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.04  E-value=3.5e-09  Score=92.94  Aligned_cols=142  Identities=18%  Similarity=0.225  Sum_probs=104.3

Q ss_pred             CCCeeeeeCCeEEEEEEECCCCEEEEEE-cccCCCCCc------HHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          231 SKNLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIGG------EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       231 ~~~~iG~G~~g~Vy~~~~~~g~~vavK~-~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ...+|-+|+-+.|+++.+. |+...||. +.+.-....      ..+..+|.+.+.+++--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678999999999999986 66666664 322211111      224678999998887666655555677777889999


Q ss_pred             eccCC-CchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC---ceEEeecccccc
Q 008893          304 PYMSN-GSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGDFGLAKL  376 (549)
Q Consensus       304 e~~~~-g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~~~~  376 (549)
                      ||+++ .++.+++...  ...........+..|-+.+.-||..   +|+||||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 4677777532  2233333367888999999999999   999999999999997544   457999999864

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.96  E-value=3.8e-10  Score=83.13  Aligned_cols=61  Identities=48%  Similarity=0.637  Sum_probs=53.4

Q ss_pred             CCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           47 SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        47 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+|++|+|+...+..|..+++|+.|+|++|+|+...|..|..+++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5789999999999965557889999999999999999977778899999999999999975

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.95  E-value=1.1e-08  Score=98.92  Aligned_cols=140  Identities=14%  Similarity=0.044  Sum_probs=100.6

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC----------CcHHHHHHHHHHHhhccCCC--ccceEEEEec-----
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI----------GGEIQFQTEVEMISLAVHRN--LLRLIGFCMT-----  295 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----  295 (549)
                      +.+-+.....|++..+ +|+.|.||+.......          .....+.+|...+.++...+  ...++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444455667666 4778999977432211          11124778999888885443  3444555543     


Q ss_pred             CCceeeEeeccCCC-chhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-------CCc
Q 008893          296 TTERLLVYPYMSNG-SVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-------YYE  365 (549)
Q Consensus       296 ~~~~~lv~e~~~~g-~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~  365 (549)
                      ...-++|+|++++. +|.+++..  ..+.+...+..++.+++..+.-||+.   ||+|+|++++|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence            23468999999986 78888753  33456677889999999999999999   9999999999999975       578


Q ss_pred             eEEeecccccc
Q 008893          366 AVVGDFGLAKL  376 (549)
Q Consensus       366 ~kl~Dfg~~~~  376 (549)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            89999998863

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=1.1e-08  Score=93.23  Aligned_cols=127  Identities=23%  Similarity=0.287  Sum_probs=83.2

Q ss_pred             EEEEEEECCCCEEEEEEcccCC--------------C-------CCc----HHHHHHHHHHHhhccCC--CccceEEEEe
Q 008893          242 NVYKGYLQDGTVVAVKRLKDGN--------------A-------IGG----EIQFQTEVEMISLAVHR--NLLRLIGFCM  294 (549)
Q Consensus       242 ~Vy~~~~~~g~~vavK~~~~~~--------------~-------~~~----~~~~~~e~~~l~~l~h~--niv~l~~~~~  294 (549)
                      .||.|...+|..+|||+.+...              .       ...    .....+|.+.|.++...  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899999889999999875321              0       001    12367899999999765  45566654  


Q ss_pred             cCCceeeEeeccC--CCchhhhhccCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCceEecccCcCeeeecCCCceEEeec
Q 008893          295 TTTERLLVYPYMS--NGSVASRLKAKPSLDWATRKRIALGAARGLLY-LHEQCDPKIIHRDVKAANILLDEYYEAVVGDF  371 (549)
Q Consensus       295 ~~~~~~lv~e~~~--~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  371 (549)
                        ...++||||++  +..+.. +.... ++.+....++.+++..+.. +|..   ||+||||.+.||+++++ .+.|+||
T Consensus        79 --~~~~ivME~I~~~G~~~~~-l~~~~-~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPR-LKDVD-LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGC-HHHCG-GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred             --eCCEEEEEecCCCccchhh-HHhcc-ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence              25689999998  544433 33221 2244566777788886655 5677   99999999999999987 9999999


Q ss_pred             ccccccC
Q 008893          372 GLAKLLD  378 (549)
Q Consensus       372 g~~~~~~  378 (549)
                      |.+....
T Consensus       151 ~qav~~~  157 (188)
T PF01163_consen  151 GQAVDSS  157 (188)
T ss_dssp             TTEEETT
T ss_pred             CcceecC
Confidence            9886544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.90  E-value=1.5e-10  Score=117.72  Aligned_cols=103  Identities=36%  Similarity=0.391  Sum_probs=69.8

Q ss_pred             cccceeeeeeeeeecC------CceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeec
Q 008893            5 LEKVLIIVLIQVICSD------GVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL   78 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~------~~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l   78 (549)
                      ++.|.+|||+++....      -....+.++|++|+|..+..+-|.+|+.|-+||||+|+|. .+|+.+..|..|++|+|
T Consensus       102 l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L  180 (1255)
T KOG0444|consen  102 LKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL  180 (1255)
T ss_pred             cccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence            6788888888776532      1234555778888888333345678888888888888887 67777777777777777


Q ss_pred             cCcccc-------------------------cCCCcccccCCCCceEeccCCCCC
Q 008893           79 NNNSLT-------------------------GAIPPSLSNMSQLAFLDLSYNNLS  108 (549)
Q Consensus        79 ~~N~l~-------------------------g~~p~~~~~l~~L~~l~l~~N~l~  108 (549)
                      |+|.+.                         ..+|..+..+.+|..+|||.|+|.
T Consensus       181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp  235 (1255)
T KOG0444|consen  181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP  235 (1255)
T ss_pred             CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC
Confidence            777332                         245566666666666666666665

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.83  E-value=3.1e-10  Score=97.67  Aligned_cols=120  Identities=23%  Similarity=0.282  Sum_probs=94.2

Q ss_pred             ccceeeeeeeeeecCC------ceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            6 EKVLIIVLIQVICSDG------VFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~~------~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +.+..|+|+++....-      ......+++.+|+|+ .+|.++++|++|+.|+++-|++. .+|..|+.++.|+.|||.
T Consensus        33 s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt  110 (264)
T KOG0617|consen   33 SNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT  110 (264)
T ss_pred             hhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence            4555666666555321      112234679999998 88999999999999999999999 899999999999999999


Q ss_pred             Ccccc-cCCCcccccCCCCceEeccCCCCCCCCCccc----cccccccCCccc
Q 008893           80 NNSLT-GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLI  127 (549)
Q Consensus        80 ~N~l~-g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~----~~~~~l~~N~~~  127 (549)
                      .|+++ ..+|..|.-+..|+.|+|++|.+.-.+|+.-    ...+.+..|.+.
T Consensus       111 ynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll  163 (264)
T KOG0617|consen  111 YNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL  163 (264)
T ss_pred             ccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh
Confidence            99997 3589999999999999999999997777642    244555566554

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.82  E-value=3e-08  Score=92.81  Aligned_cols=138  Identities=21%  Similarity=0.201  Sum_probs=97.5

Q ss_pred             CCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCC-----------------CC----cHHHHHHHHHHHhhccCC--C
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-----------------IG----GEIQFQTEVEMISLAVHR--N  285 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------------~~----~~~~~~~e~~~l~~l~h~--n  285 (549)
                      ..+.+.||-|.-+.||.|...+|..+|||.-+.+..                 .+    .....++|.+.|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            346789999999999999999999999996432110                 00    112367788888888644  5


Q ss_pred             ccceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc
Q 008893          286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE  365 (549)
Q Consensus       286 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  365 (549)
                      +.+.+++    +...+||||+++--|...-     ++......++..|+.-+.-+-..   ||||+|+++-||++++||.
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCC
Confidence            6665554    5678999999986655432     12333344445555544444455   9999999999999999999


Q ss_pred             eEEeecccccccC
Q 008893          366 AVVGDFGLAKLLD  378 (549)
Q Consensus       366 ~kl~Dfg~~~~~~  378 (549)
                      +.++||--+....
T Consensus       241 ~~vIDwPQ~v~~~  253 (304)
T COG0478         241 IVVIDWPQAVPIS  253 (304)
T ss_pred             EEEEeCcccccCC
Confidence            9999998765433

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.79  E-value=6.1e-10  Score=112.78  Aligned_cols=123  Identities=28%  Similarity=0.206  Sum_probs=91.6

Q ss_pred             cccceeeeeeeeeec---CCce----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICS---DGVF----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~---~~~~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      ++++..|+|..+.-.   .|.+    ....++|+.|.|....++.+.-+++|++|+||+|+|+...+.+|..|.+|+.|+
T Consensus       268 l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln  347 (873)
T KOG4194|consen  268 LEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN  347 (873)
T ss_pred             ecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence            566777777666653   2222    222367999999988888898899999999999999977777888888888888


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCcc--------ccccccccCCccc
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF--------HAKTFNITGNSLI  127 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--------~~~~~~l~~N~~~  127 (549)
                      |++|+|+..-..+|..+++|+.|||++|.|++.+.+.        ....+.|.||.+.
T Consensus       348 Ls~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk  405 (873)
T KOG4194|consen  348 LSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK  405 (873)
T ss_pred             ccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee
Confidence            8888888666667888888888888888887666542        1145666677664

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.75  E-value=1e-09  Score=106.51  Aligned_cols=96  Identities=32%  Similarity=0.450  Sum_probs=84.8

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCccccc-CCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS-HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      ++|..|+|. .+| +|.+|..|.+|+++.|+|. .+|.... +|++|..|||.+|+++ .+|+.+.-+.+|..||+|+|.
T Consensus       211 LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~  286 (565)
T KOG0472|consen  211 LYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNND  286 (565)
T ss_pred             HHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCc
Confidence            678999998 777 8999999999999999998 8888876 8999999999999999 999999999999999999999


Q ss_pred             CCCCCCcc---ccccccccCCccc
Q 008893          107 LSGPVPSF---HAKTFNITGNSLI  127 (549)
Q Consensus       107 l~~~~p~~---~~~~~~l~~N~~~  127 (549)
                      |++.++..   ....+.+.|||+.
T Consensus       287 is~Lp~sLgnlhL~~L~leGNPlr  310 (565)
T KOG0472|consen  287 ISSLPYSLGNLHLKFLALEGNPLR  310 (565)
T ss_pred             cccCCcccccceeeehhhcCCchH
Confidence            99988864   2356788899874

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.73  E-value=4.3e-09  Score=109.65  Aligned_cols=152  Identities=16%  Similarity=0.241  Sum_probs=103.8

Q ss_pred             HHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc--------eeeccccccCccCchhhc
Q 008893          330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--------VTTAVRGTVGHIAPEYLS  401 (549)
Q Consensus       330 ~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~  401 (549)
                      +.+++.|+.|+|..  +++||++|.|++|.++..+..||+.|+.+.........        ......-...|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34455899999986  48999999999999999999999999988654431111        011112345799999999


Q ss_pred             cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhc
Q 008893          402 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCT  481 (549)
Q Consensus       402 ~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl  481 (549)
                      ....+.++|+||+|+++|.+..|..+.............             ....+..-...+....+.++.+-+.+.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------------~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------------SRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------------hhcccccccccccccCcHHHHHHHHHHh
Confidence            988899999999999999999554443322111110000             0001111111233445578889999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 008893          482 QYLPSLRPKMSEVVR  496 (549)
Q Consensus       482 ~~dP~~RPs~~evl~  496 (549)
                      ..++.-||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998887754

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.70  E-value=2.2e-09  Score=108.87  Aligned_cols=126  Identities=25%  Similarity=0.314  Sum_probs=85.2

Q ss_pred             ccceeeeeeeeeec---CCceeehh----hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcc---cccCCcccCe
Q 008893            6 EKVLIIVLIQVICS---DGVFFSFG----RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS---TVSHLETLQY   75 (549)
Q Consensus         6 ~~~~~~~~~~~~c~---~~~~~~~~----l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~---~~~~l~~L~~   75 (549)
                      ++|..|+|+.+...   .+.+.++.    ++|++|+|+-..-..|..+++|+.|||++|.|++.+.+   .|..|++|+.
T Consensus       317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk  396 (873)
T KOG4194|consen  317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK  396 (873)
T ss_pred             ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence            56666666666553   24444333    45777777755566777778888888888877766544   3667888888


Q ss_pred             eeccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc----ccccccCCccccCCC
Q 008893           76 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATG  131 (549)
Q Consensus        76 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~~~~~  131 (549)
                      |+|.+|+|....-.+|..++.|++|||.+|.|...-|..|.    +.+-+..-.++|.|.
T Consensus       397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq  456 (873)
T KOG4194|consen  397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ  456 (873)
T ss_pred             eeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence            88888888744445788888888888888888777776554    334455556777753

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.70  E-value=1.3e-08  Score=91.14  Aligned_cols=97  Identities=34%  Similarity=0.424  Sum_probs=37.5

Q ss_pred             hhhhcccCcccccCCcccC-CCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCccc-ccCCCCceEecc
Q 008893           26 FGRLLQNNNISGHIPTEIG-KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLS  103 (549)
Q Consensus        26 ~~l~l~~n~l~~~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~l~l~  103 (549)
                      ..++|++|.|+ .+. .++ .+++|+.||||+|+|+ .++ .+..|++|+.|+|++|+|+ .++..+ ..+++|+.|+|+
T Consensus        22 ~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~   96 (175)
T PF14580_consen   22 RELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLS   96 (175)
T ss_dssp             ----------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-T
T ss_pred             ccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECc
Confidence            46889999998 443 566 6899999999999999 554 5888999999999999999 566555 468999999999


Q ss_pred             CCCCCCCCCc-c-----ccccccccCCccc
Q 008893          104 YNNLSGPVPS-F-----HAKTFNITGNSLI  127 (549)
Q Consensus       104 ~N~l~~~~p~-~-----~~~~~~l~~N~~~  127 (549)
                      +|+|...--- .     ....+++.|||+.
T Consensus        97 ~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   97 NNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             TS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            9999753221 1     1245788899883

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.66  E-value=1.7e-07  Score=87.55  Aligned_cols=107  Identities=17%  Similarity=0.179  Sum_probs=85.7

Q ss_pred             HHHHHHHHHHHhhccCC--CccceEEEEecCC----ceeeEeeccCCC-chhhhhccCCCCCHHHHHHHHHHHHHHHHHh
Q 008893          268 EIQFQTEVEMISLAVHR--NLLRLIGFCMTTT----ERLLVYPYMSNG-SVASRLKAKPSLDWATRKRIALGAARGLLYL  340 (549)
Q Consensus       268 ~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~L  340 (549)
                      .....+|...+..+...  .+.+.+++.....    ..++|+|++++. +|.+++......+......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            33577888888777543  3556667665432    347999999874 7898887644577788899999999999999


Q ss_pred             hhcCCCceEecccCcCeeeecCCC---ceEEeeccccccc
Q 008893          341 HEQCDPKIIHRDVKAANILLDEYY---EAVVGDFGLAKLL  377 (549)
Q Consensus       341 H~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~~~~~  377 (549)
                      |+.   ||+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999   999999999999999877   8999999987754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.66  E-value=3.4e-09  Score=108.20  Aligned_cols=101  Identities=32%  Similarity=0.479  Sum_probs=87.1

Q ss_pred             hhhcccCccc-ccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCc-ccccCCCCceEeccC
Q 008893           27 GRLLQNNNIS-GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSY  104 (549)
Q Consensus        27 ~l~l~~n~l~-~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l~~  104 (549)
                      .+++.+|++. ..+|+.+..|..|+.||||+|+|. ..|..+..-+++..|+||+|+|. .+|. -|.++..|-+||||+
T Consensus        82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~  159 (1255)
T KOG0444|consen   82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSN  159 (1255)
T ss_pred             HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcccc
Confidence            3568888875 458899999999999999999999 88999999999999999999999 6665 466889999999999


Q ss_pred             CCCCCCCCcc----ccccccccCCccccC
Q 008893          105 NNLSGPVPSF----HAKTFNITGNSLICA  129 (549)
Q Consensus       105 N~l~~~~p~~----~~~~~~l~~N~~~~~  129 (549)
                      |.|...+|..    ..+.+.|++|++...
T Consensus       160 NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hf  188 (1255)
T KOG0444|consen  160 NRLEMLPPQIRRLSMLQTLKLSNNPLNHF  188 (1255)
T ss_pred             chhhhcCHHHHHHhhhhhhhcCCChhhHH
Confidence            9999888864    347789999998754

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.65  E-value=1.2e-08  Score=75.09  Aligned_cols=57  Identities=42%  Similarity=0.551  Sum_probs=52.4

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCccc
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL   83 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l   83 (549)
                      .++|++|+|+...+..|.++++|++|+|++|.|+...|..|.++++|++|+|++|+|
T Consensus         5 ~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    5 SLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             EEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             EEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            567999999977778999999999999999999977778999999999999999986

...

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.64  E-value=4e-07  Score=89.67  Aligned_cols=259  Identities=14%  Similarity=0.138  Sum_probs=156.3

Q ss_pred             CCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEe------cCCc-eee
Q 008893          230 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM------TTTE-RLL  301 (549)
Q Consensus       230 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~------~~~~-~~l  301 (549)
                      ...+.||+|+-+.+|..--- +.. +-|+++...... .   .+.+..|... .||-+..=+.|-.      +... .-+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~-~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAA-Q---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchh-hch-hheeecCCCchH-H---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            45678999999999964321 222 347776543211 1   1223333333 4554433122211      1122 456


Q ss_pred             EeeccCCCc-hhhhh------ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccc
Q 008893          302 VYPYMSNGS-VASRL------KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA  374 (549)
Q Consensus       302 v~e~~~~g~-L~~~l------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  374 (549)
                      +|..+++.. ...+.      +..+..+|+..++.+..+|.+.+.||+.   |.+-||+.++|+|+.+++.+.+.|=..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence            677666531 11111      1334689999999999999999999999   9999999999999999999999885443


Q ss_pred             cccCCCCCceeeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhC-CcccccCcccc-ccccHHHHHHH-
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISG-LRALEFGKTAN-QKGAMLDWVKK-  446 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~-~~~~~~~~~~~-  446 (549)
                      ...  ..+.......|...|.+||.-.     +...+...|-|.+|+++++++.| ++||.+-.... ..+....-+.. 
T Consensus       165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            322  2333445567899999999865     33457789999999999999987 99998532211 11111100000 


Q ss_pred             -HhhccchhhhccccccCCCC-HHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHhc
Q 008893          447 -IHQEKKLEMLVDKDLKNNYD-RIELEEMVQVALLCTQYL--PSLRPKMSEVVRMLEG  500 (549)
Q Consensus       447 -~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~cl~~d--P~~RPs~~evl~~L~~  500 (549)
                       +....+...-..+. ....+ ...+.++..+..+|+...  +.-|||++-.+..|..
T Consensus       243 ~f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         243 RFAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             eeeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence             00000000000000 01111 233467888889998764  5689999988776654

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.60  E-value=1.5e-08  Score=98.61  Aligned_cols=96  Identities=38%  Similarity=0.604  Sum_probs=72.4

Q ss_pred             hcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCC--------------------
Q 008893           29 LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP--------------------   88 (549)
Q Consensus        29 ~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--------------------   88 (549)
                      ++++|.+ +.+|..++.+++|+.|+|++|-+. .+|..++.+..|+.||+|+|+|. .+|                    
T Consensus       418 ~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~  494 (565)
T KOG0472|consen  418 VLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG  494 (565)
T ss_pred             HhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccc
Confidence            3555554 488989999999999999999988 88999999999999999998776 333                    


Q ss_pred             ---c-ccccCCCCceEeccCCCCCCCCCccc----cccccccCCccc
Q 008893           89 ---P-SLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLI  127 (549)
Q Consensus        89 ---~-~~~~l~~L~~l~l~~N~l~~~~p~~~----~~~~~l~~N~~~  127 (549)
                         + .+.+|.+|+.|||.+|.+...+|...    ...+.+.||+|.
T Consensus       495 ~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  495 SVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence               3 36667777777777777776666432    245677777773

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.58  E-value=1.3e-08  Score=98.96  Aligned_cols=97  Identities=27%  Similarity=0.270  Sum_probs=84.9

Q ss_pred             ccccCCc-ccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCCCCCCc
Q 008893           35 ISGHIPT-EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS  113 (549)
Q Consensus        35 l~~~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~  113 (549)
                      ..+.-|. .|..|++|+.|+|++|+|++.-+.+|..+..|+.|.|..|+|.-.-...|.++..|++|+|.+|+|+...|.
T Consensus       261 ~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~  340 (498)
T KOG4237|consen  261 PDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG  340 (498)
T ss_pred             cCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecc
Confidence            3444553 689999999999999999999999999999999999999999866667899999999999999999988887


Q ss_pred             ccc-----ccccccCCccccCCC
Q 008893          114 FHA-----KTFNITGNSLICATG  131 (549)
Q Consensus       114 ~~~-----~~~~l~~N~~~~~~~  131 (549)
                      .|.     ..+++-+|++.|.+.
T Consensus       341 aF~~~~~l~~l~l~~Np~~CnC~  363 (498)
T KOG4237|consen  341 AFQTLFSLSTLNLLSNPFNCNCR  363 (498)
T ss_pred             cccccceeeeeehccCcccCccc
Confidence            665     567888999999863

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.57  E-value=4.3e-09  Score=112.22  Aligned_cols=96  Identities=38%  Similarity=0.544  Sum_probs=65.9

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+|.......+.++..|++|+||+|+|+ .+|.++.++..|++|..-+|+|. .+| .+.++++|+++|+|.|+|
T Consensus       388 LhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L  464 (1081)
T KOG0618|consen  388 LHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNL  464 (1081)
T ss_pred             eeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchh
Confidence            346666666333345666666666666666666 66666666666666666666766 677 788888899999999998


Q ss_pred             CCC-C----CccccccccccCCcc
Q 008893          108 SGP-V----PSFHAKTFNITGNSL  126 (549)
Q Consensus       108 ~~~-~----p~~~~~~~~l~~N~~  126 (549)
                      +-. +    |....+.+||+||..
T Consensus       465 ~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  465 SEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             hhhhhhhhCCCcccceeeccCCcc
Confidence            732 2    333457889999985

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.52  E-value=4.5e-07  Score=95.02  Aligned_cols=141  Identities=23%  Similarity=0.269  Sum_probs=92.4

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEEcccCCC---------------------CC----c--------------HHHHHH
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA---------------------IG----G--------------EIQFQT  273 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------------------~~----~--------------~~~~~~  273 (549)
                      +-|+.++-|.||+|++++|+.||||+.+.+-.                     ..    .              +-++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68899999999999999999999998753210                     00    0              001334


Q ss_pred             HHHHHhhcc----CCCccceEEEEe-cCCceeeEeeccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHH-HHHhhhcCCC
Q 008893          274 EVEMISLAV----HRNLLRLIGFCM-TTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARG-LLYLHEQCDP  346 (549)
Q Consensus       274 e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~-L~~LH~~~~~  346 (549)
                      |..-+.+++    +..-+++=.+|. -....+++|||++|-.+.+... +...++.   ..++..++++ +..+-..   
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~~~d---  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQLLRD---  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHHHhc---
Confidence            444444432    222223333333 3567899999999988888742 2234553   3333333333 2222223   


Q ss_pred             ceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       347 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      |++|.|.+|.||+++.++++.+.|||+...+..
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            899999999999999999999999999976653

>PRK09902 hypothetical protein; Provisional

Probab=98.51  E-value=1.7e-06  Score=79.42  Aligned_cols=135  Identities=18%  Similarity=0.127  Sum_probs=100.0

Q ss_pred             eeeCCeEEEEEEECCCCEEEEEEcccC-----CCCCcHHHHHHHHHHHhhccCCC--ccceEEEEe-cC----CceeeEe
Q 008893          236 GKGGFGNVYKGYLQDGTVVAVKRLKDG-----NAIGGEIQFQTEVEMISLAVHRN--LLRLIGFCM-TT----TERLLVY  303 (549)
Q Consensus       236 G~G~~g~Vy~~~~~~g~~vavK~~~~~-----~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~-~~----~~~~lv~  303 (549)
                      |+||-+-|+....+ |+.+-+|+-...     .-+-+...|.+|+..+..+...+  +.++. ++. ..    -.-+||+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            66888888887775 446888876411     11335668999999999886433  44444 332 11    2357999


Q ss_pred             eccCC-CchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc--eEEeeccccc
Q 008893          304 PYMSN-GSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--AVVGDFGLAK  375 (549)
Q Consensus       304 e~~~~-g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~  375 (549)
                      |-+.+ -+|.+++.+.  .+.+...+..++.+++..+.-||+.   |+.|+|+.+.||+++.++.  ++++||--++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97764 5788877553  3457788889999999999999999   9999999999999986666  9999998665

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.50  E-value=7.9e-09  Score=100.33  Aligned_cols=113  Identities=24%  Similarity=0.221  Sum_probs=90.6

Q ss_pred             eeeeecCCceeehhh---------hcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccC-ccc
Q 008893           14 IQVICSDGVFFSFGR---------LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN-NSL   83 (549)
Q Consensus        14 ~~~~c~~~~~~~~~l---------~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~-N~l   83 (549)
                      -.|.|++..+..+|.         .|..|.|+...|.+|+.+++|+.||||+|+|+-.-|..|..|++|..|-+-+ |+|
T Consensus        49 ~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI  128 (498)
T KOG4237|consen   49 GIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI  128 (498)
T ss_pred             ceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence            358888877777774         4889999977778999999999999999999988899999999988776655 999


Q ss_pred             ccCCCcccccCCCCceEeccCCCCCCCCCccccc-----cccccCCcc
Q 008893           84 TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAK-----TFNITGNSL  126 (549)
Q Consensus        84 ~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~-----~~~l~~N~~  126 (549)
                      +......|.+|..|+-|.+.-|++.....+.+..     .+.+-.|.+
T Consensus       129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~  176 (498)
T KOG4237|consen  129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKI  176 (498)
T ss_pred             hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhh
Confidence            9555567999999999999999998877765542     334455554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.45  E-value=4.5e-06  Score=77.66  Aligned_cols=156  Identities=24%  Similarity=0.268  Sum_probs=101.0

Q ss_pred             ccCHHHHHHHhcCCCCCCeee---eeCCeEEEEEEECCCCEEEEEEcccCCCC------------------CcHH-----
Q 008893          216 RFHFKELQSATSNFSSKNLVG---KGGFGNVYKGYLQDGTVVAVKRLKDGNAI------------------GGEI-----  269 (549)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~iG---~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------------~~~~-----  269 (549)
                      ..+++.+....++..+..+.|   .|.-+.||+|...++..+|||+++.....                  ....     
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            345555666666666666555   56667899999888999999998643210                  0000     


Q ss_pred             HHHHHHHHHhhcc--CCCccceEEEEecCCceeeEeeccCCC-chhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 008893          270 QFQTEVEMISLAV--HRNLLRLIGFCMTTTERLLVYPYMSNG-SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP  346 (549)
Q Consensus       270 ~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  346 (549)
                      -...|+.-|.++.  +=.+.+.+++    ....|||||+... .-.-.|..- ++.......+..++++.+.-|-..+  
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a--  186 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEA--  186 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhc--
Confidence            1344555555553  2233333443    3457999998653 222223322 2333356777788888887776632  


Q ss_pred             ceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       347 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||+||+.-|||+. ++.+.|+|||-+....+
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence            999999999999999 78999999998876554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.43  E-value=4.1e-06  Score=79.32  Aligned_cols=132  Identities=14%  Similarity=0.110  Sum_probs=84.7

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCC--ccceEEEEecCCceeeEeeccCCCc
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGFCMTTTERLLVYPYMSNGS  310 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~  310 (549)
                      ..||+|..+.||+.   .|..+++|......   ......+|.+.+..+..-.  +.+.+++....+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999984   24567788876432   2345788999998886443  4667777777777889999999863


Q ss_pred             -hhhhhccCCCCCHHHHHHHHHHHHHHH---------------------------------------HHhhhc-CCCceE
Q 008893          311 -VASRLKAKPSLDWATRKRIALGAARGL---------------------------------------LYLHEQ-CDPKII  349 (549)
Q Consensus       311 -L~~~l~~~~~l~~~~~~~i~~~i~~~L---------------------------------------~~LH~~-~~~~iv  349 (549)
                       +...+.    .+......++..++..+                                       .+|... ..+.++
T Consensus        81 ~~~~~~~----~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        81 SFSRIIS----DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             chhhhhc----CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence             211110    00011111111111111                                       222111 234678


Q ss_pred             ecccCcCeeeecCCCceEEeeccccc
Q 008893          350 HRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       350 H~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      |+|+.|.||++++++ +.|+||+.+.
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcC
Confidence            999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.41  E-value=1.6e-07  Score=84.18  Aligned_cols=100  Identities=31%  Similarity=0.332  Sum_probs=41.0

Q ss_pred             cceeeeeeeeeecC----C-ce-eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccc-cCCcccCeeecc
Q 008893            7 KVLIIVLIQVICSD----G-VF-FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLN   79 (549)
Q Consensus         7 ~~~~~~~~~~~c~~----~-~~-~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l~~L~~L~l~   79 (549)
                      +++.|+|.++..+.    + .+ ....++|++|.|+. ++ .+..|++|+.|+|++|+|+ .++..+ ..+++|+.|+|+
T Consensus        20 ~~~~L~L~~n~I~~Ie~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~   96 (175)
T PF14580_consen   20 KLRELNLRGNQISTIENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLS   96 (175)
T ss_dssp             ----------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-T
T ss_pred             ccccccccccccccccchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECc
Confidence            46778888877753    1 12 22357899999994 43 5888999999999999999 565555 468999999999


Q ss_pred             CcccccCCC--cccccCCCCceEeccCCCCCCC
Q 008893           80 NNSLTGAIP--PSLSNMSQLAFLDLSYNNLSGP  110 (549)
Q Consensus        80 ~N~l~g~~p--~~~~~l~~L~~l~l~~N~l~~~  110 (549)
                      +|+|.. +-  ..+..+++|+.|+|.+|+++..
T Consensus        97 ~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv~~~  128 (175)
T PF14580_consen   97 NNKISD-LNELEPLSSLPKLRVLSLEGNPVCEK  128 (175)
T ss_dssp             TS---S-CCCCGGGGG-TT--EEE-TT-GGGGS
T ss_pred             CCcCCC-hHHhHHHHcCCCcceeeccCCcccch
Confidence            999973 32  4678899999999999999844

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.29  E-value=1.6e-07  Score=88.11  Aligned_cols=97  Identities=22%  Similarity=0.239  Sum_probs=65.3

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|.|+ .+.++..-+++++.|+||+|+|. .+. ++..|++|+.||||+|.++ .+-..-..+.+.+.|+|+.|.
T Consensus       288 elDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~  363 (490)
T KOG1259|consen  288 ELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNK  363 (490)
T ss_pred             hccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhh
Confidence            4677888777 55566666777888888888877 443 3777788888888888777 666666667777777777777


Q ss_pred             CCCCCC---ccccccccccCCccc
Q 008893          107 LSGPVP---SFHAKTFNITGNSLI  127 (549)
Q Consensus       107 l~~~~p---~~~~~~~~l~~N~~~  127 (549)
                      |....-   -.....+++.+|++.
T Consensus       364 iE~LSGL~KLYSLvnLDl~~N~Ie  387 (490)
T KOG1259|consen  364 IETLSGLRKLYSLVNLDLSSNQIE  387 (490)
T ss_pred             HhhhhhhHhhhhheeccccccchh
Confidence            753221   111245677777764

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.27  E-value=5.4e-07  Score=60.89  Aligned_cols=37  Identities=43%  Similarity=0.630  Sum_probs=26.9

Q ss_pred             CCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccc
Q 008893           47 SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT   84 (549)
Q Consensus        47 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~   84 (549)
                      ++|++|+|++|+|+ .+|+.+++|++|+.|+|++|+|+
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            46778888888887 66767778888888888888777

...

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.26  E-value=8.8e-06  Score=77.46  Aligned_cols=139  Identities=17%  Similarity=0.160  Sum_probs=83.2

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCC--ccceEEEEecC---CceeeEeeccC
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGFCMTT---TERLLVYPYMS  307 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~---~~~~lv~e~~~  307 (549)
                      +.++.|..+.||+....+ ..+++|.....   .....+..|..++..+....  +.+++.+....   ...+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            578999999999999887 68999987543   23456788888888885433  45666654332   34689999999


Q ss_pred             CCchhh----------------hh---ccC----CCCCHHHHH---------HH------------HHHHHH-HHHHhhh
Q 008893          308 NGSVAS----------------RL---KAK----PSLDWATRK---------RI------------ALGAAR-GLLYLHE  342 (549)
Q Consensus       308 ~g~L~~----------------~l---~~~----~~l~~~~~~---------~i------------~~~i~~-~L~~LH~  342 (549)
                      +..+..                .+   +..    ....+....         ..            ...+.. .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            887776                11   111    111111100         00            111222 2333332


Q ss_pred             c----CCCceEecccCcCeeeec-CCCceEEeeccccc
Q 008893          343 Q----CDPKIIHRDVKAANILLD-EYYEAVVGDFGLAK  375 (549)
Q Consensus       343 ~----~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~  375 (549)
                      .    ....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            1    245799999999999999 66667899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.25  E-value=3.9e-06  Score=87.72  Aligned_cols=143  Identities=22%  Similarity=0.249  Sum_probs=91.2

Q ss_pred             CCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC------------------------------------CcHHHHHHHH
Q 008893          232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI------------------------------------GGEIQFQTEV  275 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------------------------------~~~~~~~~e~  275 (549)
                      .+.||.-+.|.||+|++++|+.||||+-+.+-..                                    ..+-+|..|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            4679999999999999999999999986532110                                    0011244444


Q ss_pred             HHHhh----ccCCCc---cceEEEEe-cCCceeeEeeccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 008893          276 EMISL----AVHRNL---LRLIGFCM-TTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDP  346 (549)
Q Consensus       276 ~~l~~----l~h~ni---v~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  346 (549)
                      +-..+    +.|-+.   |.+=.++. -....+|+||||+|..+.+.-. ....++......-+.+.     |++.....
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~-----~~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEA-----YLEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHH-----HHHHHHhc
Confidence            43332    334441   12222222 2357899999999988777542 22235555443333332     22222223


Q ss_pred             ceEecccCcCeeeec----CCCceEEeecccccccCC
Q 008893          347 KIIHRDVKAANILLD----EYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       347 ~ivH~Dlkp~Nill~----~~~~~kl~Dfg~~~~~~~  379 (549)
                      |++|+|-+|.||++.    .++.+.+-|||+.....+
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            899999999999998    367899999999976653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.24  E-value=1.2e-05  Score=74.11  Aligned_cols=137  Identities=15%  Similarity=0.107  Sum_probs=88.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHH---------HHHHHHHhhccCC---CccceEEE
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF---------QTEVEMISLAVHR---NLLRLIGF  292 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~---------~~e~~~l~~l~h~---niv~l~~~  292 (549)
                      ...+|...+++-......|.+-.. +|+.+++|..+..... .+..|         .+.+..+..++..   ..+.++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            456777777777766666666555 4788999988754422 12221         2233333333222   22232332


Q ss_pred             Ee-----cCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceE
Q 008893          293 CM-----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV  367 (549)
Q Consensus       293 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  367 (549)
                      ..     -....+++|||++|..|.+...    ++.    .++..++.++.-+|+.   |++|+|..|.|++++++ .++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~  174 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIR  174 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEE
Confidence            22     2245578999999987766532    222    2455677889999999   99999999999999965 489


Q ss_pred             Eeeccccc
Q 008893          368 VGDFGLAK  375 (549)
Q Consensus       368 l~Dfg~~~  375 (549)
                      +.||+..+
T Consensus       175 iID~~~k~  182 (229)
T PF06176_consen  175 IIDTQGKR  182 (229)
T ss_pred             EEECcccc
Confidence            99998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.23  E-value=1e-06  Score=96.87  Aligned_cols=92  Identities=25%  Similarity=0.435  Sum_probs=59.6

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+++ .+|..+.  ++|+.|++++|.|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|.|
T Consensus       309 L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~L  379 (754)
T PRK15370        309 LNVQSNSLT-ALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNAL  379 (754)
T ss_pred             HHhcCCccc-cCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcC
Confidence            445566665 3443332  56777777777777 4666553  67888888888887 5666553  5788888888888


Q ss_pred             CCCCCccc--cccccccCCcccc
Q 008893          108 SGPVPSFH--AKTFNITGNSLIC  128 (549)
Q Consensus       108 ~~~~p~~~--~~~~~l~~N~~~~  128 (549)
                      +..++...  ...+++++|.+..
T Consensus       380 t~LP~~l~~sL~~LdLs~N~L~~  402 (754)
T PRK15370        380 TNLPENLPAALQIMQASRNNLVR  402 (754)
T ss_pred             CCCCHhHHHHHHHHhhccCCccc
Confidence            76544322  2456777777753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.18  E-value=5e-07  Score=93.50  Aligned_cols=181  Identities=19%  Similarity=0.168  Sum_probs=131.0

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCC-ccceEEEEecCCceeeEeeccCCC-c
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTTERLLVYPYMSNG-S  310 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-~  310 (549)
                      +-.++|+++.+||.+-...+....+.+...      ....-++++|.+++||| .+..++-+..++..+++++++..+ +
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            456889999999987443334445555432      34456888999999999 777777777788889999999887 2


Q ss_pred             hhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccc
Q 008893          311 VASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR  389 (549)
Q Consensus       311 L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  389 (549)
                      -..... ....+...+...+...-.++++++|+.   .=+|+|    ||+..+ +..+..||+....+....  ......
T Consensus       322 ~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~  391 (829)
T KOG0576|consen  322 SALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAI  391 (829)
T ss_pred             ccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccccCC
Confidence            222221 111233334445555667889999986   458888    777665 688999999988766443  334456


Q ss_pred             cccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccc
Q 008893          390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE  429 (549)
Q Consensus       390 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  429 (549)
                      +|+.++|||......+..+.|+|+.|+-..++.-|-+|-.
T Consensus       392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            8999999999999999999999999987777777766643

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.18  E-value=3e-06  Score=93.30  Aligned_cols=112  Identities=25%  Similarity=0.289  Sum_probs=64.9

Q ss_pred             cceeeeeeeeeecCCc----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcc
Q 008893            7 KVLIIVLIQVICSDGV----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS   82 (549)
Q Consensus         7 ~~~~~~~~~~~c~~~~----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~   82 (549)
                      +...+++.+..+..-.    .....++|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  .+|+.|+|++|+
T Consensus       179 ~~~~L~L~~~~LtsLP~~Ip~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~  252 (754)
T PRK15370        179 NKTELRLKILGLTTIPACIPEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINR  252 (754)
T ss_pred             CceEEEeCCCCcCcCCcccccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCc
Confidence            3556666554443211    12334668888888 5665553  47888888888877 5666543  356677777777


Q ss_pred             cccCCCcccccCCCCceEeccCCCCCCCCCccc--cccccccCCccc
Q 008893           83 LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH--AKTFNITGNSLI  127 (549)
Q Consensus        83 l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~--~~~~~l~~N~~~  127 (549)
                      |. .+|..+.  ++|+.|++++|+|+..+....  ...+++++|.+.
T Consensus       253 L~-~LP~~l~--s~L~~L~Ls~N~L~~LP~~l~~sL~~L~Ls~N~Lt  296 (754)
T PRK15370        253 IT-ELPERLP--SALQSLDLFHNKISCLPENLPEELRYLSVYDNSIR  296 (754)
T ss_pred             cC-cCChhHh--CCCCEEECcCCccCccccccCCCCcEEECCCCccc
Confidence            66 5565543  356666666666664322111  244556666554

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.16  E-value=2e-07  Score=77.68  Aligned_cols=59  Identities=32%  Similarity=0.502  Sum_probs=28.2

Q ss_pred             CCCEEEccCCcCCCCCcccccCC-cccCeeeccCcccccCCCcccccCCCCceEeccCCCCC
Q 008893           48 KLLTLDLSNNFFTGPIPSTVSHL-ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS  108 (549)
Q Consensus        48 ~L~~L~ls~N~l~g~~p~~~~~l-~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  108 (549)
                      .|+.++|++|.|. .+|..|... +.++.|+|++|+|+ .+|..+..++.|+.||++.|+|.
T Consensus        54 el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~  113 (177)
T KOG4579|consen   54 ELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN  113 (177)
T ss_pred             eEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc
Confidence            3344455555554 344444332 24455555555555 44544555555555555555554

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.15  E-value=2.6e-05  Score=75.05  Aligned_cols=136  Identities=19%  Similarity=0.150  Sum_probs=83.0

Q ss_pred             eeeeCC-eEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeEeeccCCCchh
Q 008893          235 VGKGGF-GNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMSNGSVA  312 (549)
Q Consensus       235 iG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  312 (549)
                      |-.|.+ ..||+.... +..+.||+.....    ...+..|++++..+. +--+.+++++....+..++|||+++|.++.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444545 788998765 4678888876442    224667888887774 334556777776666789999999987765


Q ss_pred             hhh-------------------ccCC----CCCH--HHHHHHHHH--------------------HHHHHHHhhh----c
Q 008893          313 SRL-------------------KAKP----SLDW--ATRKRIALG--------------------AARGLLYLHE----Q  343 (549)
Q Consensus       313 ~~l-------------------~~~~----~l~~--~~~~~i~~~--------------------i~~~L~~LH~----~  343 (549)
                      ...                   +.-.    ++..  .........                    +...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            431                   1100    1110  000000000                    1111112211    1


Q ss_pred             CCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       344 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      ..+.++|+|+.|.||+++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23569999999999999998778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.14  E-value=3.4e-05  Score=87.19  Aligned_cols=80  Identities=10%  Similarity=0.243  Sum_probs=58.4

Q ss_pred             CCeeeeeCCeEEEEEEECCC---CEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCc--cceEEEEecC---CceeeE
Q 008893          232 KNLVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNL--LRLIGFCMTT---TERLLV  302 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  302 (549)
                      .+.++.|.+..+|+....++   ..+++|+............+.+|+++++.+. |.++  .+++++|.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45678999999999887654   3677887654433333446889999999885 6664  7778887664   457899


Q ss_pred             eeccCCCch
Q 008893          303 YPYMSNGSV  311 (549)
Q Consensus       303 ~e~~~~g~L  311 (549)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987643

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.13  E-value=3.3e-07  Score=98.15  Aligned_cols=100  Identities=26%  Similarity=0.358  Sum_probs=85.9

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcc-cccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .++|.+|.++...=+.|.++.+|+.|+|++|+|. .+|+ .+.+|..|+.|+||+|+|+ .+|..+.+++.|++|...+|
T Consensus       363 ~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN  440 (1081)
T KOG0618|consen  363 ELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSN  440 (1081)
T ss_pred             HHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCC
Confidence            3679999999887778999999999999999999 6665 5788999999999999999 99999999999999999999


Q ss_pred             CCCCCCCccc----cccccccCCccccC
Q 008893          106 NLSGPVPSFH----AKTFNITGNSLICA  129 (549)
Q Consensus       106 ~l~~~~p~~~----~~~~~l~~N~~~~~  129 (549)
                      ++...+ ...    .+-+|++.|.+.-.
T Consensus       441 ~l~~fP-e~~~l~qL~~lDlS~N~L~~~  467 (1081)
T KOG0618|consen  441 QLLSFP-ELAQLPQLKVLDLSCNNLSEV  467 (1081)
T ss_pred             ceeech-hhhhcCcceEEecccchhhhh
Confidence            998554 432    25678999988644

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.12  E-value=1.3e-06  Score=58.98  Aligned_cols=39  Identities=44%  Similarity=0.653  Sum_probs=33.9

Q ss_pred             cccCeeeccCcccccCCCcccccCCCCceEeccCCCCCCC
Q 008893           71 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP  110 (549)
Q Consensus        71 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~  110 (549)
                      ++|++|+|++|+|+ .+|+.|.+|++|+.|++++|+|+..
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~i   39 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISDI   39 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSBE
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCCC
Confidence            57999999999999 7888899999999999999999843

...

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.10  E-value=1.5e-05  Score=72.88  Aligned_cols=103  Identities=22%  Similarity=0.213  Sum_probs=83.6

Q ss_pred             HHHHHHHhhccC-CCccceEEEEecCCceeeEeeccCCCchhh---hhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 008893          272 QTEVEMISLAVH-RNLLRLIGFCMTTTERLLVYPYMSNGSVAS---RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK  347 (549)
Q Consensus       272 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~---~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  347 (549)
                      ..|.-++..+.+ +++.+++|+|-    .+++.||...+++..   .+.+...-+|..|.+||.+++..+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457778888876 69999999984    478999998776643   2223335799999999999999999999865446


Q ss_pred             eEecccCcCeeeecCCCceEEeecccccccC
Q 008893          348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       348 ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      +.-.|++++|+-+++++++|+.|...+....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            8899999999999999999999998775443

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.05  E-value=6.7e-06  Score=90.20  Aligned_cols=90  Identities=27%  Similarity=0.397  Sum_probs=44.3

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcc---cccC-------------C-cccCeeeccCcccccCCCcc
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS---TVSH-------------L-ETLQYLRLNNNSLTGAIPPS   90 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~---~~~~-------------l-~~L~~L~l~~N~l~g~~p~~   90 (549)
                      ++|++|+|+ .+|..   +++|+.|+|++|+|++ +|.   .+..             + .+|+.|+|++|+|+ .+|..
T Consensus       287 L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls-~LP~l  360 (788)
T PRK15387        287 LWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA-SLPTL  360 (788)
T ss_pred             EECcCCccc-ccccc---ccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccC-CCCCC
Confidence            345666665 34432   3456666666666663 222   1111             1 35777777777777 45542


Q ss_pred             cccCCCCceEeccCCCCCCCCCccc--cccccccCCccc
Q 008893           91 LSNMSQLAFLDLSYNNLSGPVPSFH--AKTFNITGNSLI  127 (549)
Q Consensus        91 ~~~l~~L~~l~l~~N~l~~~~p~~~--~~~~~l~~N~~~  127 (549)
                      .   ++|+.|++++|.|++. |...  ...+++++|.+.
T Consensus       361 p---~~L~~L~Ls~N~L~~L-P~l~~~L~~LdLs~N~Lt  395 (788)
T PRK15387        361 P---SELYKLWAYNNRLTSL-PALPSGLKELIVSGNRLT  395 (788)
T ss_pred             C---cccceehhhccccccC-cccccccceEEecCCccc
Confidence            2   3455555555555542 2211  234455555543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.02  E-value=6e-07  Score=84.40  Aligned_cols=115  Identities=25%  Similarity=0.339  Sum_probs=81.1

Q ss_pred             ccceeeeeeeeeec--CCcee----ehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            6 EKVLIIVLIQVICS--DGVFF----SFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         6 ~~~~~~~~~~~~c~--~~~~~----~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +.|.-+||+++..+  |.+..    +..++|+.|.|...-  .+..|.+|+.||||+|.|+ .+-..-..|-+.+.|.|+
T Consensus       284 q~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  284 QELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhhccccccchhhhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            44666788776553  43332    334779999998333  3888999999999999998 566666778888888888


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCC--------CCCccccccccccCCccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSG--------PVPSFHAKTFNITGNSLI  127 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~--------~~p~~~~~~~~l~~N~~~  127 (549)
                      .|.|. .+. .+..+-+|..||+++|+|..        .+|  ....+.+.+|++.
T Consensus       361 ~N~iE-~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LP--CLE~l~L~~NPl~  412 (490)
T KOG1259|consen  361 QNKIE-TLS-GLRKLYSLVNLDLSSNQIEELDEVNHIGNLP--CLETLRLTGNPLA  412 (490)
T ss_pred             hhhHh-hhh-hhHhhhhheeccccccchhhHHHhccccccc--HHHHHhhcCCCcc
Confidence            88876 333 36667778888888888862        222  1245667777774

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=97.98  E-value=4.6e-06  Score=91.49  Aligned_cols=73  Identities=33%  Similarity=0.363  Sum_probs=54.2

Q ss_pred             CCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCCCCCCccc-----cccccc
Q 008893           47 SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH-----AKTFNI  121 (549)
Q Consensus        47 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-----~~~~~l  121 (549)
                      ++|+.|+|++|+|+ .+|...   ++|+.|+|++|+|+ .+|..   ..+|+.|++++|+|+. +|..+     ...+++
T Consensus       382 ~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt~-LP~sl~~L~~L~~LdL  452 (788)
T PRK15387        382 SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLTR-LPESLIHLSSETTVNL  452 (788)
T ss_pred             cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCcccc-cChHHhhccCCCeEEC
Confidence            46888999999988 466543   57888999999998 57753   2467889999999984 45432     256788


Q ss_pred             cCCcccc
Q 008893          122 TGNSLIC  128 (549)
Q Consensus       122 ~~N~~~~  128 (549)
                      ++|++.+
T Consensus       453 s~N~Ls~  459 (788)
T PRK15387        453 EGNPLSE  459 (788)
T ss_pred             CCCCCCc
Confidence            9998863

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.94  E-value=0.0001  Score=65.10  Aligned_cols=128  Identities=17%  Similarity=0.248  Sum_probs=86.5

Q ss_pred             CCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccc-eEEEEecCCceeeEeeccCCC
Q 008893          231 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR-LIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       231 ~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      ..+.|++|++|.||++.+. |..+|+|+-+.+.   ....+..|.++|..+.-.++.+ ++.|    ++-++.|||+.|-
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~   97 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCc
Confidence            4568999999999999997 5588888876544   3456889999999888766654 3333    2234459999987


Q ss_pred             chhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCc--CeeeecCCCceEEeeccccccc
Q 008893          310 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKA--ANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       310 ~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp--~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      .|.+.....   +..+    ...++..-.-|-..   ||-|+.|.-  .||++.+ +.+.|+||.-|++-
T Consensus        98 ~L~~~~~~~---~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k  156 (201)
T COG2112          98 PLGKLEIGG---DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATFK  156 (201)
T ss_pred             chhhhhhcc---cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence            776654322   2222    23344443334444   888888863  4555554 59999999988743

>PRK10593 hypothetical protein; Provisional

Probab=97.91  E-value=0.00023  Score=70.42  Aligned_cols=78  Identities=13%  Similarity=0.093  Sum_probs=57.2

Q ss_pred             CCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC---CCccceEEEEec---CCceeeEe
Q 008893          230 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH---RNLLRLIGFCMT---TTERLLVY  303 (549)
Q Consensus       230 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~  303 (549)
                      ...+.||.|..+.||.....+++ +++|..+...   ....+..|...++.+..   -.+.++++++..   .+..++||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            34568999999999999876664 6677754311   22468899999988853   357788888754   35689999


Q ss_pred             eccCCCch
Q 008893          304 PYMSNGSV  311 (549)
Q Consensus       304 e~~~~g~L  311 (549)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.91  E-value=1.2e-06  Score=89.34  Aligned_cols=75  Identities=36%  Similarity=0.592  Sum_probs=40.1

Q ss_pred             cccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCC
Q 008893           30 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS  108 (549)
Q Consensus        30 l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  108 (549)
                      +++|+++ .+|..++.+..|..||.+.|.+. .+|+.++.|.+|+.|++..|++. .+|..+..| .|..||+|+|+++
T Consensus       150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis  224 (722)
T KOG0532|consen  150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS  224 (722)
T ss_pred             EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence            5555555 55555665556666666666655 45555555555555555555544 444444422 3445555555554

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=97.89  E-value=1.3e-06  Score=91.26  Aligned_cols=96  Identities=35%  Similarity=0.475  Sum_probs=71.0

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcc-cccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      ++|++|++....  .+..|++|++|||+.|+|+ .+|. ....+. |+.|.|++|-++ .+- .+.+|.+|+.|||++|-
T Consensus       192 LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~-tL~-gie~LksL~~LDlsyNl  265 (1096)
T KOG1859|consen  192 LNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT-TLR-GIENLKSLYGLDLSYNL  265 (1096)
T ss_pred             hccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHH-hhh-hHHhhhhhhccchhHhh
Confidence            678888887544  6788888888888888888 5553 223344 888888888887 333 47789999999999999


Q ss_pred             CCCCCCc---c---ccccccccCCccccC
Q 008893          107 LSGPVPS---F---HAKTFNITGNSLICA  129 (549)
Q Consensus       107 l~~~~p~---~---~~~~~~l~~N~~~~~  129 (549)
                      |++--.-   .   ....+.|.|||+-|.
T Consensus       266 l~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  266 LSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             hhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            9864321   1   125678999999887

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.86  E-value=9.2e-07  Score=73.82  Aligned_cols=104  Identities=20%  Similarity=0.196  Sum_probs=80.8

Q ss_pred             ceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEe
Q 008893           22 VFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLD  101 (549)
Q Consensus        22 ~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  101 (549)
                      ......++|++|.+....+..-..++.++.|+|++|.|+ .+|..+..++.|+.|+++.|.|. ..|..+..|.+|-.|+
T Consensus        52 ~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld  129 (177)
T KOG4579|consen   52 GYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD  129 (177)
T ss_pred             CceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence            344555779999999444444445678999999999999 89999999999999999999999 8888888899999999


Q ss_pred             ccCCCCCCCCCcccc----ccccccCCccc
Q 008893          102 LSYNNLSGPVPSFHA----KTFNITGNSLI  127 (549)
Q Consensus       102 l~~N~l~~~~p~~~~----~~~~l~~N~~~  127 (549)
                      ..+|.+.-..-+.+.    ....+..|++.
T Consensus       130 s~~na~~eid~dl~~s~~~al~~lgnepl~  159 (177)
T KOG4579|consen  130 SPENARAEIDVDLFYSSLPALIKLGNEPLG  159 (177)
T ss_pred             CCCCccccCcHHHhccccHHHHHhcCCccc
Confidence            999998744433222    23455555553

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.85  E-value=0.00032  Score=64.53  Aligned_cols=134  Identities=21%  Similarity=0.258  Sum_probs=92.1

Q ss_pred             CCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCC---------------CCCcHHHHHHHHHHHhhcc------CCCccc
Q 008893          230 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGN---------------AIGGEIQFQTEVEMISLAV------HRNLLR  288 (549)
Q Consensus       230 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~l~------h~niv~  288 (549)
                      +....||+|+.-.||.  +.+.....||+.+...               ......+..+|+.....+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3456899999999986  4445667888886544               1122456677777766665      788999


Q ss_pred             eEEEEecCCceeeEeeccCC------CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC
Q 008893          289 LIGFCMTTTERLLVYPYMSN------GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE  362 (549)
Q Consensus       289 l~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  362 (549)
                      ++|+...+....+|+|.+.+      -+|.+++.... ++. ...+.+.   .-..||-+.   .|+.+|++|+||++..
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVVQR  153 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEEEe
Confidence            99999999889999998643      24666665443 554 3333333   334666666   8999999999999963


Q ss_pred             C--C--ceEEee-ccc
Q 008893          363 Y--Y--EAVVGD-FGL  373 (549)
Q Consensus       363 ~--~--~~kl~D-fg~  373 (549)
                      .  +  .+.|+| ||.
T Consensus       154 ~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  154 RDSGEFRLVLIDGLGE  169 (199)
T ss_pred             cCCCceEEEEEeCCCC
Confidence            2  2  466776 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.85  E-value=0.00015  Score=69.27  Aligned_cols=73  Identities=14%  Similarity=0.144  Sum_probs=44.7

Q ss_pred             CeeeeeCCe-EEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCC---CccceEEEEecC---CceeeEeec
Q 008893          233 NLVGKGGFG-NVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLIGFCMTT---TERLLVYPY  305 (549)
Q Consensus       233 ~~iG~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~  305 (549)
                      +.|+.|+.. .||+.    +..+++|..+...   ....+..|.+.+..+...   -+.++++.....   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            456766665 58875    2357778755422   244688899998877532   233344433222   134789999


Q ss_pred             cCCCchh
Q 008893          306 MSNGSVA  312 (549)
Q Consensus       306 ~~~g~L~  312 (549)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.83  E-value=3.7e-06  Score=85.81  Aligned_cols=103  Identities=19%  Similarity=0.319  Sum_probs=85.6

Q ss_pred             cceeeeeeeeeecC------CceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccC
Q 008893            7 KVLIIVLIQVICSD------GVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN   80 (549)
Q Consensus         7 ~~~~~~~~~~~c~~------~~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~   80 (549)
                      -|.++.++++.-..      ...+..-++.+.|.|. .+|+.+++|++|+.|++..|++. .+|..+. .-.|..||+|.
T Consensus       144 pLkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfSc  220 (722)
T KOG0532|consen  144 PLKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSC  220 (722)
T ss_pred             cceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeeccc
Confidence            45666666655421      2223444789999998 88999999999999999999999 7899998 56699999999


Q ss_pred             cccccCCCcccccCCCCceEeccCCCCCCCCCc
Q 008893           81 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS  113 (549)
Q Consensus        81 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~  113 (549)
                      |+++ .+|..|.+|..|++|-|.+|.|..++..
T Consensus       221 Nkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAq  252 (722)
T KOG0532|consen  221 NKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQ  252 (722)
T ss_pred             Ccee-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence            9999 9999999999999999999999966543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	549
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-130
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-127
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-45
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-44
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-41
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-38
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-19
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		9e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-12
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-12
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-04
3soa_A	444	Full-Length Human Camkii Length = 444		2e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  460 bits (1184), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 228/337 (67%), Positives = 267/337 (79%), Gaps = 5/337 (1%)
Query: 190 RQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ 249
           R++  Q  FFDV  +   EV LG LKRF  +ELQ A+ NFS+KN++G+GGFG VYKG L 
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 250 DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 309
           DGT+VAVKRLK+    GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NG
Sbjct: 61  DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 310 SVAS----RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 365
           SVAS    R +++P LDW  R+RIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE +E
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 180
Query: 366 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 425
           AVVGDFGLAKL+D+ D HV  AVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELI+G 
Sbjct: 181 AVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 240
Query: 426 RALEFGKTANQKGAM-LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYL 484
           RA +  + AN    M LDWVK + +EKKLE LVD DL+ NY   E+E+++QVALLCTQ  
Sbjct: 241 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 300
Query: 485 PSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRAN 521
           P  RPKMSEVVRMLEGDGLAE+W   QK E  R   N
Sbjct: 301 PMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFN 337

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  451 bits (1159), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 222/326 (68%), Positives = 259/326 (79%), Gaps = 5/326 (1%)
Query: 198 FFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVK 257
           FFDV  +   EV LG LKRF  +ELQ A+ NF +KN++G+GGFG VYKG L DG +VAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 258 RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS---- 313
           RLK+    GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS    
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 314 RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 373
           R +++P LDW  R+RIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 433
           AKL+D+ D HV  AVRG +GHIAPEYLSTG+SSEKTDVFG+G++LLELI+G RA +  + 
Sbjct: 181 AKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 434 ANQKGAM-LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMS 492
           AN    M LDWVK + +EKKLE LVD DL+ NY   E+E+++QVALLCTQ  P  RPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 493 EVVRMLEGDGLAEKWAASQKAEATRS 518
           EVVRMLEGDGLAE+W   QK E  R 
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  179 bits (453), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 110/289 (38%), Positives = 162/289 (56%), Gaps = 10/289 (3%)
Query: 216 RFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEV 275
           R    +L+ AT+NF  K L+G G FG VYKG L+DG  VA+KR +   +  G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEI 86
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP----SLDWATRKRIAL 331
           E +S   H +L+ LIGFC    E +L+Y YM NG++   L        S+ W  R  I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRG 390
           GAARGL YLH +    IIHRDVK+ NILLDE +   + DFG++K     D +H+   V+G
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
           T+G+I PEY   G+ +EK+DV+ FG++L E++    A+       +   + +W  + H  
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVESHNN 262
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +LE +VD +L +      L +    A+ C       RP M +V+  LE
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/289 (37%), Positives = 162/289 (56%), Gaps = 10/289 (3%)
Query: 216 RFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEV 275
           R    +L+ AT+NF  K L+G G FG VYKG L+DG  VA+KR +   +  G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEI 86
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP----SLDWATRKRIAL 331
           E +S   H +L+ LIGFC    E +L+Y YM NG++   L        S+ W  R  I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRG 390
           GAARGL YLH +    IIHRDVK+ NILLDE +   + DFG++K   +   +H+   V+G
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
           T+G+I PEY   G+ +EK+DV+ FG++L E++    A+       +   + +W  + H  
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVESHNN 262
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +LE +VD +L +      L +    A+ C       RP M +V+  LE
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  165 bits (417), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 114/310 (36%), Positives = 173/310 (55%), Gaps = 21/310 (6%)
Query: 203 EQRREEVCLGNLKRFHFKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAV 256
           E +  EV       F F EL++ T+NF  +      N +G+GGFG VYKGY+ + T VAV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAV 59
Query: 257 KRLKDGNAIGGE---IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS 313
           K+L     I  E    QF  E+++++   H NL+ L+GF     +  LVY YM NGS+  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 314 RLKA---KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 370
           RL      P L W  R +IA GAA G+ +LHE      IHRD+K+ANILLDE + A + D
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 371 FGLAKLLDHCDSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 429
           FGLA+  +     V  + + GT  ++APE L  G+ + K+D++ FG++LLE+I+GL A++
Sbjct: 177 FGLARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 430 FGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRP 489
             +    +  +    +   +EK +E  +DK + N+ D   +E M  VA  C     + RP
Sbjct: 236 --EHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 490 KMSEVVRMLE 499
            + +V ++L+
Sbjct: 293 DIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 114/310 (36%), Positives = 172/310 (55%), Gaps = 21/310 (6%)
Query: 203 EQRREEVCLGNLKRFHFKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAV 256
           E +  EV       F F EL++ T+NF  +      N +G+GGFG VYKGY+ + T VAV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAV 59
Query: 257 KRLKDGNAIGGE---IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS 313
           K+L     I  E    QF  E+++++   H NL+ L+GF     +  LVY YM NGS+  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 314 RLKA---KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 370
           RL      P L W  R +IA GAA G+ +LHE      IHRD+K+ANILLDE + A + D
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 371 FGLAKLLDHCDSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 429
           FGLA+  +     V    + GT  ++APE L  G+ + K+D++ FG++LLE+I+GL A++
Sbjct: 177 FGLARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 430 FGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRP 489
             +    +  +    +   +EK +E  +DK + N+ D   +E M  VA  C     + RP
Sbjct: 236 --EHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 490 KMSEVVRMLE 499
            + +V ++L+
Sbjct: 293 DIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 170/300 (56%), Gaps = 24/300 (8%)
Query: 216 RFH---FKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG 266
           RFH   F EL++ T+NF  +      N +G+GGFG VYKGY+ + T VAVK+L     I 
Sbjct: 5   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 63
Query: 267 GE---IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA---KPS 320
            E    QF  E+++++   H NL+ L+GF     +  LVY YM NGS+  RL      P 
Sbjct: 64  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 123
Query: 321 LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 380
           L W  R +IA GAA G+ +LHE      IHRD+K+ANILLDE + A + DFGLA+  +  
Sbjct: 124 LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 381 DSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA 439
              V    + GT  ++APE L  G+ + K+D++ FG++LLE+I+GL A++  +    +  
Sbjct: 181 AQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLL 237
Query: 440 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +    +   +EK +E  +DK + N+ D   +E M  VA  C     + RP + +V ++L+
Sbjct: 238 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  155 bits (393), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 111/300 (37%), Positives = 165/300 (55%), Gaps = 24/300 (8%)
Query: 216 RFH---FKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG 266
           RFH   F EL++ T+NF  +      N  G+GGFG VYKGY+ + T VAVK+L     I 
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 60
Query: 267 GE---IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA---KPS 320
            E    QF  E+++ +   H NL+ L+GF     +  LVY Y  NGS+  RL      P 
Sbjct: 61  TEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP 120
Query: 321 LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 380
           L W  R +IA GAA G+ +LHE      IHRD+K+ANILLDE + A + DFGLA+  +  
Sbjct: 121 LSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 381 DSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA 439
              V  + + GT  + APE L  G+ + K+D++ FG++LLE+I+GL A++  +    +  
Sbjct: 178 AQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLL 234
Query: 440 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +    +   +EK +E  +DK   N+ D   +E    VA  C     + RP + +V ++L+
Sbjct: 235 LDIKEEIEDEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 82
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 83  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 139
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 200 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 239
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 240 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 85
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 86  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 142
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 203 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 242
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 243 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 274

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 84
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 85  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 141
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 202 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 241
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 242 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 233
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 78
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 79  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 135
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 195
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 196 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 235
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 236 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 267

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 77
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 78  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 134
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 195 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 234
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 235 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 266

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 86
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 87  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 143
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 204 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 243
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 244 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 275

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 233
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 82
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 83  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 139
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 200 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 239
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 240 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 81
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 82  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 138
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 199 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 238
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 239 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 233
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 71
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 72  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 128
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 189 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 228
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 229 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 127/272 (46%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G  G V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 233
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L+RL  + +
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 72
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            T E + ++  YM NGS+   LK    +     K + + A  A G+ ++ E+     IHR
Sbjct: 73  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 129
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           +++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+DV
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-- 469
           + FGILL E+++  R    G T  +                    V ++L+  Y  +   
Sbjct: 190 WSFGILLTEIVTHGRIPYPGMTNPE--------------------VIQNLERGYRMVRPD 229
Query: 470 --LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 230 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 261

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 106/200 (53%), Gaps = 7/200 (3%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNL 286
           + + K  +G G FG V++     G+ VAVK L + +     + +F  EV ++    H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLK---AKPSLDWATRKRIALGAARGLLYLHEQ 343
           +  +G         +V  Y+S GS+   L    A+  LD   R  +A   A+G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
            +P I+HRD+K+ N+L+D+ Y   V DFGL++ L       +    GT   +APE L   
Sbjct: 157 -NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 404 QSSEKTDVFGFGILLLELIS 423
            S+EK+DV+ FG++L EL +
Sbjct: 215 PSNEKSDVYSFGVILWELAT 234

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 7/200 (3%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNL 286
           + + K  +G G FG V++     G+ VAVK L + +     + +F  EV ++    H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLK---AKPSLDWATRKRIALGAARGLLYLHEQ 343
           +  +G         +V  Y+S GS+   L    A+  LD   R  +A   A+G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
            +P I+HR++K+ N+L+D+ Y   V DFGL++L         +A  GT   +APE L   
Sbjct: 157 -NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDE 214
Query: 404 QSSEKTDVFGFGILLLELIS 423
            S+EK+DV+ FG++L EL +
Sbjct: 215 PSNEKSDVYSFGVILWELAT 234

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 30/269 (11%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY  +   VA+K +K+G+    E  F  E E++    H  L++L G C+
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSM--SEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWA-TRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 LV+ +M +G ++  L+ +  L  A T   + L    G+ YL E C   +IHRD+
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 149
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
            A N L+ E     V DFG+ + +       +T  +  V   +PE  S  + S K+DV+ 
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 414 FGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY----DRIE 469
           FG+L+ E+ S                      KI  E +    V +D+   +     R+ 
Sbjct: 210 FGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKPRLA 249
Query: 470 LEEMVQVALLCTQYLPSLRPKMSEVVRML 498
              + Q+   C +  P  RP  S ++R L
Sbjct: 250 STHVYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ YL  +   
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK--- 171
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +   ++   H  T  +  V  +A E L T 
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 232 KFTTKSDVWSFGVLLWELMT 251

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ YL  +   
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK--- 170
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +   ++   H  T  +  V  +A E L T 
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 231 KFTTKSDVWSFGVLLWELMT 250

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ YL  +   
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK--- 144
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +   ++   H  T  +  V  +A E L T 
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 205 KFTTKSDVWSFGVLLWELMT 224

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY  +   VA+K +++G     E  F  E E++    H  L++L G C+
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWA-TRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 LV+ +M +G ++  L+ +  L  A T   + L    G+ YL E C   +IHRD+
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 132
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
            A N L+ E     V DFG+ + +       +T  +  V   +PE  S  + S K+DV+ 
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 414 FGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY----DRIE 469
           FG+L+ E+ S                      KI  E +    V +D+   +     R+ 
Sbjct: 193 FGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKPRLA 232
Query: 470 LEEMVQVALLCTQYLPSLRPKMSEVVRML 498
              + Q+   C +  P  RP  S ++R L
Sbjct: 233 STHVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ YL  +   
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK--- 152
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +   ++   H  T  +  V  +A E L T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ YL  +   
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK--- 152
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +   ++   H  T  +  V  +A E L T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ YL  +   
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK--- 151
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +   ++   H  T  +  V  +A E L T 
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 212 KFTTKSDVWSFGVLLWELMT 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ YL  +   
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK--- 149
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +   ++   H  T  +  V  +A E L T 
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 210 KFTTKSDVWSFGVLLWELMT 229

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY  +   VA+K +++G     E  F  E E++    H  L++L G C+
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWA-TRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 LV+ +M +G ++  L+ +  L  A T   + L    G+ YL E C   +IHRD+
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 129
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
            A N L+ E     V DFG+ + +       +T  +  V   +PE  S  + S K+DV+ 
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 414 FGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY----DRIE 469
           FG+L+ E+ S                      KI  E +    V +D+   +     R+ 
Sbjct: 190 FGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKPRLA 229
Query: 470 LEEMVQVALLCTQYLPSLRPKMSEVVRML 498
              + Q+   C +  P  RP  S ++R L
Sbjct: 230 STHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY  +   VA+K +++G     E  F  E E++    H  L++L G C+
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWA-TRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 LV+ +M +G ++  L+ +  L  A T   + L    G+ YL E C   +IHRD+
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 127
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
            A N L+ E     V DFG+ + +       +T  +  V   +PE  S  + S K+DV+ 
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 414 FGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY----DRIE 469
           FG+L+ E+ S                      KI  E +    V +D+   +     R+ 
Sbjct: 188 FGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKPRLA 227
Query: 470 LEEMVQVALLCTQYLPSLRPKMSEVVRML 498
              + Q+   C +  P  RP  S ++R L
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ YL  +   
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK--- 147
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +   ++   H  T  +  V  +A E L T 
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 208 KFTTKSDVWSFGVLLWELMT 227

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ YL  +   
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK--- 150
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +   ++   H  T  +  V  +A E L T 
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 211 KFTTKSDVWSFGVLLWELMT 230

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 108/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ YL  +   
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK--- 151
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +   +    H  T  +  V  +A E L T 
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 212 KFTTKSDVWSFGVLLWELMT 231

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 137/293 (46%), Gaps = 44/293 (15%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGE------IQFQTEVEM 277
           A +    +  +GKGGFG V+KG L +D +VVA+K L  G++ G         +FQ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL--KAKPSLDWATRKRIALGAAR 335
           +S   H N+++L G  M    R +V  ++  G +  RL  KA P + W+ + R+ L  A 
Sbjct: 77  MSNLNHPNIVKLYGL-MHNPPR-MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLLDHCDSHVTTAVRG 390
           G+ Y+  Q +P I+HRD+++ NI L    E     A V DFGL++       H  + + G
Sbjct: 134 GIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLG 188
Query: 391 TVGHIAPEYLSTGQSS--EKTDVFGFGILLLELISG---LRALEFGKTANQKGAMLDWVK 445
               +APE +   + S  EK D + F ++L  +++G        +GK             
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI------------ 236
Query: 446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
                K + M+ ++ L+          +  V  LC    P  RP  S +V+ L
Sbjct: 237 -----KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 111/200 (55%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ +L  +   
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK--- 153
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAK-LLD-HCDS-HVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +LD   DS H  T  +  V  +A E L T 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 214 KFTTKSDVWSFGVLLWELMT 233

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 119/269 (44%), Gaps = 30/269 (11%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY  +   VA+K +++G     E  F  E E++    H  L++L G C+
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWA-TRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 LV  +M +G ++  L+ +  L  A T   + L    G+ YL E C   +IHRD+
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
            A N L+ E     V DFG+ + +       +T  +  V   +PE  S  + S K+DV+ 
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 414 FGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY----DRIE 469
           FG+L+ E+ S                      KI  E +    V +D+   +     R+ 
Sbjct: 191 FGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKPRLA 230
Query: 470 LEEMVQVALLCTQYLPSLRPKMSEVVRML 498
              + Q+   C +  P  RP  S ++R L
Sbjct: 231 STHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ +L  +   
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK--- 150
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDS-HVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +     DS H  T  +  V  +A E L T 
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 211 KFTTKSDVWSFGVLLWELMT 230

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ +L  +   
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK--- 211
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDS-HVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +     DS H  T  +  V  +A E L T 
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 272 KFTTKSDVWSFGVLLWELMT 291

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ +L  +   
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK--- 152
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDS-HVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +     DS H  T  +  V  +A E L T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ +L  +   
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK--- 157
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDS-HVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +     DS H  T  +  V  +A E L T 
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 218 KFTTKSDVWSFGVLLWELMT 237

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 100/230 (43%), Gaps = 9/230 (3%)
Query: 203 EQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKD 261
           E   EE      K    K+ Q A  +F     +GKG FGNVY     Q   ++A+K L  
Sbjct: 10  ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 69
Query: 262 GN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP 319
                 G E Q + EVE+ S   H N+LRL G+    T   L+  Y   G+V   L+   
Sbjct: 70  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 129
Query: 320 SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 379
             D           A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H
Sbjct: 130 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---H 183
Query: 380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 429
             S   T + GT+ ++ PE +      EK D++  G+L  E + G    E
Sbjct: 184 APSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG V+ GY  + T VAVK LK G      +Q F  E  ++    H  L+RL    
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
                  ++  YM+ GS+   LK+         K I   A  A G+ Y+  +     IHR
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 134
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AAN+L+ E     + DFGLA++++  +       +  +   APE ++ G  + K+DV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 412 FGFGILLLELIS 423
           + FGILL E+++
Sbjct: 195 WSFGILLYEIVT 206

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ +L  +   
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK--- 152
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDS-HVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +     DS H  T  +  V  +A E L T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 234 LVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY G L   DG  +  AVK L     IG   QF TE  ++    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 290 IGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCDP 346
           +G C+ +    L+V PYM +G + + ++ + + +   +  I  G   A+G+ +L  +   
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK--- 153
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDS-HVTTAVRGTVGHIAPEYLSTG 403
           K +HRD+ A N +LDE +   V DFGLA+ +     DS H  T  +  V  +A E L T 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 404 QSSEKTDVFGFGILLLELIS 423
           + + K+DV+ FG+LL EL++
Sbjct: 214 KFTTKSDVWSFGVLLWELMT 233

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 94/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G V   L+     D           A  
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLP 179
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 44/293 (15%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGE------IQFQTEVEM 277
           A +    +  +GKGGFG V+KG L +D +VVA+K L  G++ G         +FQ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL--KAKPSLDWATRKRIALGAAR 335
           +S   H N+++L G  M    R +V  ++  G +  RL  KA P + W+ + R+ L  A 
Sbjct: 77  MSNLNHPNIVKLYGL-MHNPPR-MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLLDHCDSHVTTAVRG 390
           G+ Y+  Q +P I+HRD+++ NI L    E     A V DFG ++       H  + + G
Sbjct: 134 GIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ----SVHSVSGLLG 188
Query: 391 TVGHIAPEYLSTGQSS--EKTDVFGFGILLLELISG---LRALEFGKTANQKGAMLDWVK 445
               +APE +   + S  EK D + F ++L  +++G        +GK             
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI------------ 236
Query: 446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
                K + M+ ++ L+          +  V  LC    P  RP  S +V+ L
Sbjct: 237 -----KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 44/293 (15%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGE------IQFQTEVEM 277
           A +    +  +GKGGFG V+KG L +D +VVA+K L  G++ G         +FQ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL--KAKPSLDWATRKRIALGAAR 335
           +S   H N+++L G  M    R +V  ++  G +  RL  KA P + W+ + R+ L  A 
Sbjct: 77  MSNLNHPNIVKLYGL-MHNPPR-MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLLDHCDSHVTTAVRG 390
           G+ Y+  Q +P I+HRD+++ NI L    E     A V DF L++       H  + + G
Sbjct: 134 GIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ----SVHSVSGLLG 188
Query: 391 TVGHIAPEYLSTGQSS--EKTDVFGFGILLLELISG---LRALEFGKTANQKGAMLDWVK 445
               +APE +   + S  EK D + F ++L  +++G        +GK             
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI------------ 236
Query: 446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
                K + M+ ++ L+          +  V  LC    P  RP  S +V+ L
Sbjct: 237 -----KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ 
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLP 175
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 119/269 (44%), Gaps = 30/269 (11%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ GY  +   VA+K +++G     E  F  E E++    H  L++L G C+
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWA-TRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 LV+ +M +G ++  L+ +  L  A T   + L    G+ YL E     +IHRD+
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIHRDL 129
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
            A N L+ E     V DFG+ + +       +T  +  V   +PE  S  + S K+DV+ 
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 414 FGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY----DRIE 469
           FG+L+ E+ S                      KI  E +    V +D+   +     R+ 
Sbjct: 190 FGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKPRLA 229
Query: 470 LEEMVQVALLCTQYLPSLRPKMSEVVRML 498
              + Q+   C +  P  RP  S ++R L
Sbjct: 230 STHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 18  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 77
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 78  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 137
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ 
Sbjct: 138 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLP 191
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 192 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 219

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLP 177
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLP 179
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G V   L+     D           A  
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+ ++ 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLXGTLDYLP 179
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 95/205 (46%), Gaps = 9/205 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGYLQDGT-VVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY    ++   ++A+K L        G E Q + EVE+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+   +T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   K+IHRD+K  N+LL    E  + DFG +    H  S    A+ GT+ ++ PE 
Sbjct: 124 CHSK---KVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEM 177
Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +      EK D++  G+L  E + G
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLP 179
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 180 PEXIEGRXHDEKVDLWSLGVLCYEFLVG 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ 
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLP 175
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLP 174
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLP 177
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLP 179
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 94/210 (44%), Gaps = 9/210 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ PE 
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEM 177
Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRALE 429
           +      EK D++  G+L  E + G    E
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ PE 
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTELCGTLDYLPPEM 177
Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +      EK D++  G+L  E + G
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 138/282 (48%), Gaps = 29/282 (10%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGT-----VVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           S  + + ++G G FG VYKG L+  +      VA+K LK G      + F  E  ++   
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLY 339
            H N++RL G        +++  YM NG++   L+ K   +++  + + +  G A G+ Y
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKY 162
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAP 397
           L    +   +HRD+ A NIL++      V DFGL+++L  D   ++ T+  +  +   AP
Sbjct: 163 L---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 398 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
           E +S  + +  +DV+ FGI++ E+++      +G+    + +  + +K I+   +L   +
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMT------YGERPYWELSNHEVMKAINDGFRLPTPM 273
Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           D              + Q+ + C Q   + RPK +++V +L+
Sbjct: 274 DCP----------SAIYQLMMQCWQQERARRPKFADIVSILD 305

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 122
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ PE 
Sbjct: 123 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEM 176
Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +      EK D++  G+L  E + G
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVG 201

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S    A+ GT+ ++ PE 
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEM 177
Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +      EK D++  G+L  E + G
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ PE 
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEM 177
Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +      EK D++  G+L  E + G
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S    A+ GT+ ++ PE 
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEM 180
Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +      EK D++  G+L  E + G
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 99/230 (43%), Gaps = 9/230 (3%)
Query: 203 EQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKD 261
           E   EE      K    K+ Q A  +F     +GKG FGNVY     Q   ++A+K L  
Sbjct: 10  ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 69
Query: 262 GN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP 319
                 G E Q + EVE+ S   H N+LRL G+    T   L+  Y   G+V   L+   
Sbjct: 70  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 129
Query: 320 SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 379
             D           A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H
Sbjct: 130 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---H 183
Query: 380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 429
             S     + GT+ ++ PE +      EK D++  G+L  E + G    E
Sbjct: 184 APSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ PE 
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTXLCGTLDYLPPEM 177
Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +      EK D++  G+L  E + G
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 127
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ PE 
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEM 181
Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +      EK D++  G+L  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 120
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ PE 
Sbjct: 121 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEM 174
Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +      EK D++  G+L  E + G
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVG 199

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + +FG +    H  S   T + GT+ ++ 
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTTLCGTLDYLP 176
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 204

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + +FG +    H  S   T + GT+ ++ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTTLCGTLDYLP 177
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG V+ GY  + T VAVK LK G      +Q F  E  ++    H  L+RL    
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
                  ++  +M+ GS+   LK+         K I   A  A G+ Y+  +     IHR
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 133
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AAN+L+ E     + DFGLA++++  +       +  +   APE ++ G  + K++V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 412 FGFGILLLELIS 423
           + FGILL E+++
Sbjct: 194 WSFGILLYEIVT 205

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+ ++ 
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDTLCGTLDYLP 175
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+ ++ 
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDYLP 176
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 204

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 222 LQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 279
           L+   +  + + ++G GGFG VY+  ++ D   V   R      I   I+  + E ++ +
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK---PSL--DWATRKRIALGAA 334
           +  H N++ L G C+      LV  +   G +   L  K   P +  +WA +       A
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IA 115
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYE--------AVVGDFGLAKLLDHCDSHVTT 386
           RG+ YLH++    IIHRD+K++NIL+ +  E          + DFGLA+     + H TT
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTT 170
Query: 387 --AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
             +  G    +APE +     S+ +DV+ +G+LL EL++G
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 9/208 (4%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 276
           K+ Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S   H N+LRL G+    T   L+  Y   G+V   L+     D           A  
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+ ++ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDYLP 177
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE +      EK D++  G+L  E + G
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L+        VA+K LK G        F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V  YM NGS+ S L+ K    +   + + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 156
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGLA++L+  D       RG   
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED-DPEAAYTTRGGKI 212
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 266
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 267 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 9/210 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMIS 279
           Q    +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSY 127
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ PE 
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEM 181
Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRALE 429
           +      EK D++  G+L  E + G+   E
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L+        VA+K LK G        F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V  YM NGS+ S L+ K    +   + + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 156
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 157 ASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 212
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 266
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 267 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 9/205 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+ ++ PE 
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDYLPPEM 177
Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +      EK D++  G+L  E + G
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L+        VA+K LK G        F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V  YM NGS+ S L+ K    +   + + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 156
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 212
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 266
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 267 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L+        VA+K LK G        F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V  YM NGS+ S L+ K    +   + + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 156
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 212
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 266
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 267 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L+        VA+K LK G        F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V  YM NGS+ S L+ K    +   + + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 156
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 212
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 266
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 267 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L+        VA+K LK G        F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V  YM NGS+ S L+ K    +   + + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 156
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 212
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 266
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 267 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L+        VA+K LK G        F  E 
Sbjct: 38  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 95
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V  YM NGS+ S L+ K    +   + + +  G 
Sbjct: 96  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 154
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 155 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 210
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 211 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 264
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 265 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 303

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L A  +  +      IA   ARG+ YLH +    IIHRD
Sbjct: 78  -TKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRD 133
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA +      SH    + G++  +APE +    S   S +
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 194 SDVYAFGIVLYELMTG 209

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L    +    VA+K LK G        F  E 
Sbjct: 28  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 85
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V  YM NGS+ S L+ K    +   + + +  G 
Sbjct: 86  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 144
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 145 ASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 200
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 201 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 254
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 255 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 293

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 9/205 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 279
           Q A  +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+ ++ PE 
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDYLPPEM 180
Query: 400 LSTGQSSEKTDVFGFGILLLELISG 424
           +      EK D++  G+L  E + G
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L+        VA+K LK G        F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V  YM NGS+ S L+ K    +   + + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 156
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL ++L+  D       RG   
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED-DPEAAYTTRGGKI 212
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 266
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 267 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L    +    VA+K LK G        F  E 
Sbjct: 11  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V  YM NGS+ S L+ K    +   + + +  G 
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 127
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 128 ASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 183
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 237
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 238 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 276

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 13/209 (6%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G FG V+ G L+ D T+VAVK  ++      + +F  E  ++    H N++RLIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
                  +V   +  G   + L+ + + L   T  ++   AA G+ YL  +C    IHRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG----TVGHIAPEYLSTGQSSEK 408
           + A N L+ E     + DFG+++  +  D  V  A  G     V   APE L+ G+ S +
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR--EEADG-VXAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 409 TDVFGFGILLLELISGLRALEFGKTANQK 437
           +DV+ FGILL E  S L A  +   +NQ+
Sbjct: 296 SDVWSFGILLWETFS-LGASPYPNLSNQQ 323

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 134/294 (45%), Gaps = 42/294 (14%)
Query: 212 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF 271
           G+L    +KE++        + +VG+G FG V K   +    VA+K+++  +       F
Sbjct: 1   GSLHMIDYKEIEV-------EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE---RKAF 49
Query: 272 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI-- 329
             E+  +S   H N+++L G C+      LV  Y   GS+ + L     L + T      
Sbjct: 50  IVELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 107
Query: 330 -ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCD--SHVT 385
             L  ++G+ YLH      +IHRD+K  N+LL      + + DFG A     CD  +H+T
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMT 162
Query: 386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRAL-EFGKTANQKGAMLDWV 444
              +G+   +APE       SEK DVF +GI+L E+I+  +   E G  A +    + W 
Sbjct: 163 NN-KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWA 217
Query: 445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
             +H   +  +     +KN    IE      +   C    PS RP M E+V+++
Sbjct: 218 --VHNGTRPPL-----IKNLPKPIE-----SLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 135/302 (44%), Gaps = 39/302 (12%)
Query: 217 FHFKELQSATSNFSSK---------NLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGN 263
           F F++   A   F+ +          ++G G FG V  G+L+        VA+K LK G 
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 264 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW 323
                  F +E  ++    H N++ L G    +T  +++  +M NGS+ S L+      +
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QF 132
Query: 324 ATRKRIAL--GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DH 379
              + + +  G A G+ YL    D   +HRD+ A NIL++      V DFGL++ L  D 
Sbjct: 133 TVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 189
Query: 380 CDSHVTTAVRGTVG--HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK 437
            D   T+A+ G +     APE +   + +  +DV+ +GI++ E++S      +G+     
Sbjct: 190 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------YGERPYWD 243
Query: 438 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 497
               D +  I Q+ +L   +D              + Q+ L C Q   + RPK  ++V  
Sbjct: 244 MTNQDVINAIEQDYRLPPPMDCP----------SALHQLMLDCWQKDRNHRPKFGQIVNT 293
Query: 498 LE 499
           L+
Sbjct: 294 LD 295

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 13/209 (6%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G FG V+ G L+ D T+VAVK  ++      + +F  E  ++    H N++RLIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
                  +V   +  G   + L+ + + L   T  ++   AA G+ YL  +C    IHRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG----TVGHIAPEYLSTGQSSEK 408
           + A N L+ E     + DFG+++  +  D  V  A  G     V   APE L+ G+ S +
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR--EEADG-VYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 409 TDVFGFGILLLELISGLRALEFGKTANQK 437
           +DV+ FGILL E  S L A  +   +NQ+
Sbjct: 296 SDVWSFGILLWETFS-LGASPYPNLSNQQ 323

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 132/285 (46%), Gaps = 38/285 (13%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VY+G  +D       T VAVK + +  ++   I+F  E  ++      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA----------KPSLDWATRKRIALGAARGLL 338
           L+G        L+V   M++G + S L++          +P        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIA 396
           YL+ +   K +HRD+ A N ++   +   +GDFG+ + +   D       +G   V  +A
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG-KGLLPVRWMA 200
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 456
           PE L  G  +  +D++ FG++L E+ S          A Q        + +  E+ L+ +
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP------YQGLSNEQVLKFV 245
Query: 457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           +D    +  D    E +  +  +C Q+ P++RP   E+V +L+ D
Sbjct: 246 MDGGYLDQPDNCP-ERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 9/210 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMIS 279
           Q    +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSY 127
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+ ++ PE 
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRDTLCGTLDYLPPEM 181
Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRALE 429
           +      EK D++  G+L  E + G+   E
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 132/285 (46%), Gaps = 38/285 (13%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VY+G  +D       T VAVK + +  ++   I+F  E  ++      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA----------KPSLDWATRKRIALGAARGLL 338
           L+G        L+V   M++G + S L++          +P        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIA 396
           YL+ +   K +HRD+ A N ++   +   +GDFG+ + +   D +     +G   V  +A
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMA 200
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 456
           PE L  G  +  +D++ FG++L E+ S          A Q        + +  E+ L+ +
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP------YQGLSNEQVLKFV 245
Query: 457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           +D    +  D    E +  +  +C Q+ P +RP   E+V +L+ D
Sbjct: 246 MDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 38/285 (13%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VY+G  +D       T VAVK + +  ++   I+F  E  ++      +++R
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA----------KPSLDWATRKRIALGAARGLL 338
           L+G        L+V   M++G + S L++          +P        ++A   A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIA 396
           YL+ +   K +HRD+ A N ++   +   +GDFG+ + +   D       +G   V  +A
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG-KGLLPVRWMA 197
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 456
           PE L  G  +  +D++ FG++L E+ S          A Q        + +  E+ L+ +
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP------YQGLSNEQVLKFV 242
Query: 457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           +D    +  D    E +  +  +C Q+ P +RP   E+V +L+ D
Sbjct: 243 MDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 286

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 38/285 (13%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VY+G  +D       T VAVK + +  ++   I+F  E  ++      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA----------KPSLDWATRKRIALGAARGLL 338
           L+G        L+V   M++G + S L++          +P        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIA 396
           YL+ +   K +HRD+ A N ++   +   +GDFG+ + +   D       +G   V  +A
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG-KGLLPVRWMA 200
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 456
           PE L  G  +  +D++ FG++L E+ S          A Q        + +  E+ L+ +
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP------YQGLSNEQVLKFV 245
Query: 457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           +D    +  D    E +  +  +C Q+ P +RP   E+V +L+ D
Sbjct: 246 MDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L A  +  +      IA   ARG+ YLH +    IIHRD
Sbjct: 90  -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRD 145
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA        SH    + G++  +APE +    S   S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 206 SDVYAFGIVLYELMTG 221

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L A  +  +      IA   ARG+ YLH +    IIHRD
Sbjct: 90  -TKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRD 145
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA        SH    + G++  +APE +    S   S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 206 SDVYAFGIVLYELMTG 221

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 229 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           F+    +GKG FG V+KG   +   VVA+K +    A       Q E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           +  G  +  T+  ++  Y+  GS    L+  P LD      I     +GL YLH +   K
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE---K 124
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
            IHRD+KAAN+LL E+ E  + DFG+A  L        T V GT   +APE +       
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 183
Query: 408 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE---KKLEMLVDKD---- 460
           K D++  GI  +EL  G                    +  H E    K+  L+ K+    
Sbjct: 184 KADIWSLGITAIELARG--------------------EPPHSELHPMKVLFLIPKNNPPT 223
Query: 461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
           L+ NY +  L+E V+    C    PS RP   E+++
Sbjct: 224 LEGNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 255

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 229 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           F+    +GKG FG V+KG   +   VVA+K +    A       Q E+ ++S      + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           +  G  +  T+  ++  Y+  GS    L+  P LD      I     +GL YLH +   K
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE---K 144
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
            IHRD+KAAN+LL E+ E  + DFG+A  L        T V GT   +APE +       
Sbjct: 145 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 203
Query: 408 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE---KKLEMLVDKD---- 460
           K D++  GI  +EL  G                    +  H E    K+  L+ K+    
Sbjct: 204 KADIWSLGITAIELARG--------------------EPPHSELHPMKVLFLIPKNNPPT 243
Query: 461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
           L+ NY +  L+E V+    C    PS RP   E+++
Sbjct: 244 LEGNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 275

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 132/285 (46%), Gaps = 38/285 (13%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VY+G  +D       T VAVK + +  ++   I+F  E  ++      +++R
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA----------KPSLDWATRKRIALGAARGLL 338
           L+G        L+V   M++G + S L++          +P        ++A   A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIA 396
           YL+ +   K +HRD+ A N ++   +   +GDFG+ + +   D +     +G   V  +A
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMA 199
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 456
           PE L  G  +  +D++ FG++L E+ S          A Q        + +  E+ L+ +
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP------YQGLSNEQVLKFV 244
Query: 457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           +D    +  D    E +  +  +C Q+ P +RP   E+V +L+ D
Sbjct: 245 MDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 288

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 227 SNFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVH 283
           S+     ++GKG FG   K  + + G V+ +K L   +    E Q  F  EV+++    H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEH 66
Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHE 342
            N+L+ IG          +  Y+  G++   +K+  S   W+ R   A   A G+ YLH 
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-------------LDHCDSHVTTAVR 389
                IIHRD+ + N L+ E    VV DFGLA+L             L   D      V 
Sbjct: 127 M---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA 427
           G    +APE ++     EK DVF FGI+L E+I  + A
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 131/289 (45%), Gaps = 46/289 (15%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VY+G  +D       T VAVK + +  ++   I+F  E  ++      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA----------KPSLDWATRKRIALGAARGLL 338
           L+G        L+V   M++G + S L++          +P        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           YL+ +   K +HRD+ A N ++   +   +GDFG+ +     D + T   R        V
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETAYYRKGGKGLLPV 196
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             +APE L  G  +  +D++ FG++L E+ S          A Q        + +  E+ 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP------YQGLSNEQV 241
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           L+ ++D    +  D    E +  +  +C Q+ P +RP   E+V +L+ D
Sbjct: 242 LKFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 71
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 128
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 189 WSFGILLTELTTKGRV 204

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 133/285 (46%), Gaps = 38/285 (13%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VY+G  +D       T VAVK + +  ++   I+F  E  ++      +++R
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA----------KPSLDWATRKRIALGAARGLL 338
           L+G        L+V   M++G + S L++          +P        ++A   A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIA 396
           YL+ +   K +HR++ A N ++   +   +GDFG+ + +   D +     +G   V  +A
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMA 201
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 456
           PE L  G  +  +D++ FG++L E+ S          A Q        + +  E+ L+ +
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP------YQGLSNEQVLKFV 246
Query: 457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           +D    +  D    E +  +  +C Q+ P++RP   E+V +L+ D
Sbjct: 247 MDGGYLDQPDNCP-ERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 290

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 229 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           F+    +GKG FG V+KG   +   VVA+K +    A       Q E+ ++S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           +  G  +  T+  ++  Y+  GS    L+  P LD      I     +GL YLH +   K
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE---K 139
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRGTVGHIAPEYLSTGQSS 406
            IHRD+KAAN+LL E+ E  + DFG+A  L   D+ +      GT   +APE +      
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQSAYD 197
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD----LK 462
            K D++  GI  +EL  G                     ++H  K L  L+ K+    L+
Sbjct: 198 SKADIWSLGITAIELARGEPPHS----------------ELHPMKVL-FLIPKNNPPTLE 240
Query: 463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
            NY +  L+E V+    C    PS RP   E+++
Sbjct: 241 GNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 270

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 62
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 63  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 123 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 179
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 224
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 225 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 126/274 (45%), Gaps = 35/274 (12%)
Query: 232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           + +VG+G FG V K   +    VA+K+++  +       F  E+  +S   H N+++L G
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLYG 68
Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI---ALGAARGLLYLHEQCDPKI 348
            C+      LV  Y   GS+ + L     L + T        L  ++G+ YLH      +
Sbjct: 69  ACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 349 IHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCD--SHVTTAVRGTVGHIAPEYLSTGQS 405
           IHRD+K  N+LL      + + DFG A     CD  +H+T   +G+   +APE       
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNN-KGSAAWMAPEVFEGSNY 180
Query: 406 SEKTDVFGFGILLLELISGLRAL-EFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 464
           SEK DVF +GI+L E+I+  +   E G  A +    + W   +H   +  +     +KN 
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWA--VHNGTRPPL-----IKNL 229
Query: 465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
              IE      +   C    PS RP M E+V+++
Sbjct: 230 PKPIE-----SLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 133/285 (46%), Gaps = 38/285 (13%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG VY+G  +D       T VAVK + +  ++   I+F  E  ++      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA----------KPSLDWATRKRIALGAARGLL 338
           L+G        L+V   M++G + S L++          +P        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIA 396
           YL+ +   K +HR++ A N ++   +   +GDFG+ + +   D +     +G   V  +A
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMA 200
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 456
           PE L  G  +  +D++ FG++L E+ S          A Q        + +  E+ L+ +
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP------YQGLSNEQVLKFV 245
Query: 457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           +D    +  D    E +  +  +C Q+ P++RP   E+V +L+ D
Sbjct: 246 MDGGYLDQPDNCP-ERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L+        VA+K LK G        F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V   M NGS+ S L+ K    +   + + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 156
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 157 ASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 212
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 266
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 267 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L+        VA+K LK G        F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V   M NGS+ S L+ K    +   + + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 156
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 212
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 266
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 267 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 66
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 127 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 228
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 229 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 131/282 (46%), Gaps = 36/282 (12%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++ + K+ +G G FG VY+G  +  ++ VAVK LK+      E  F  E  ++    H N
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L++L+G C       ++  +M+ G++   L+         R+ ++   A  LLY+  Q  
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE------CNRQEVS---AVVLLYMATQIS 119
Query: 346 PKI--------IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
             +        IHRD+ A N L+ E +   V DFGL++L+           +  +   AP
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 179
Query: 398 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
           E L+  + S K+DV+ FG+LL E+ +   +   G   +Q          +++      L+
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ----------VYE------LL 223
Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 224 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 66
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 127 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 183
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 228
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 229 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 63
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 124 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW 180
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 225
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 226 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 330
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 412 FGFGILLLELISGLR 426
           + FGILL EL +  R
Sbjct: 448 WSFGILLTELTTKGR 462

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 365 WSFGILLTELTTKGRV 380

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 62
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 63  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 123 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW 179
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 224
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 225 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 365 WSFGILLTELTTKGRV 380

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK GN       F  E +++    H  L++L  + +
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 248
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 305
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGL +L++  +       +  +   APE    G+ + K+DV
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 366 WSFGILLTELTTKGRV 381

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 229 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           F+    +GKG FG V+KG   +   VVA+K +    A       Q E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           +  G  +  T+  ++  Y+  GS    L+  P LD      I     +GL YLH +   K
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE---K 124
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRGTVGHIAPEYLSTGQSS 406
            IHRD+KAAN+LL E+ E  + DFG+A  L   D+ +      GT   +APE +      
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQSAYD 182
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD----LK 462
            K D++  GI  +EL  G                     ++H  K L  L+ K+    L+
Sbjct: 183 SKADIWSLGITAIELARGEPPHS----------------ELHPMKVL-FLIPKNNPPTLE 225
Query: 463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
            NY +  L+E V+    C    PS RP   E+++
Sbjct: 226 GNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 255

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 65
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 66  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 125
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 126 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 227
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 228 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  +N S   +VG G FG V  G L    +    VA+K LK G        F  E 
Sbjct: 11  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++RL G    +   ++V   M NGS+ S L+ K    +   + + +  G 
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-KHDAQFTVIQLVGMLRGI 127
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 128 ASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 183
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   +PE ++  + +  +DV+ +GI+L E++S      +G+    + +  D +K + + 
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQDVIKAVDEG 237
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 238 YRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 276

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 66
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 127 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 228
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 229 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 231 SKNLVGKGGFGNVYKG-YL---QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           S  ++GKG FG VY G Y+   Q+    A+K L     +     F  E  ++    H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 287 LRLIGFCMTTTERL--LVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHE 342
           L LIG  M   E L  ++ PYM +G +   +++ P  +   +  I+ G   ARG+ YL E
Sbjct: 85  LALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLD--HCDSHVTTAVRGTVGHIAPEY 399
           Q   K +HRD+ A N +LDE +   V DFGLA+ +LD  +         R  V   A E 
Sbjct: 143 Q---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 400 LSTGQSSEKTDVFGFGILLLELIS 423
           L T + + K+DV+ FG+LL EL++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 74
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 131
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 192 WSFGILLTELTTKGRV 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 66
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 127 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 228
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 229 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 138
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 199 WSFGILLTELTTKGRV 214

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 74
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 75  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 134
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 135 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 191
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 192 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 236
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 237 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 280

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 72
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 129
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 190 WSFGILLTELTTKGRV 205

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 63
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 124 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 225
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 226 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 129/282 (45%), Gaps = 36/282 (12%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  ++    H N
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L++L+G C       ++  +M+ G++   L+         R+ ++   A  LLY+  Q  
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE------CNRQEVS---AVVLLYMATQIS 119
Query: 346 PKI--------IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
             +        IHRD+ A N L+ E +   V DFGL++L+           +  +   AP
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 179
Query: 398 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
           E L+  + S K+DV+ FG+LL E+ +   +   G   +Q                +  L+
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ----------------VYELL 223
Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 224 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 135/291 (46%), Gaps = 36/291 (12%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 61
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           ++    H NL++L+G C       ++  +M+ G++   L+         R+ ++   A  
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE------CNRQEVS---AVV 112
Query: 337 LLYLHEQCDPKI--------IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           LLY+  Q    +        IHRD+ A N L+ E +   V DFGL++L+           
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           +  +   APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +  
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-- 223
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                  L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 224 -------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 61
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 122 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 223
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 224 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 70
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 127
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 188 WSFGILLTELTTKGRV 203

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 365 WSFGILLTELTTKGRV 380

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 63
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 124 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 225
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 226 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 135/291 (46%), Gaps = 36/291 (12%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 66
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           ++    H NL++L+G C       ++  +M+ G++   L+         R+ ++   A  
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE------CNRQEVS---AVV 117
Query: 337 LLYLHEQCDPKI--------IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           LLY+  Q    +        IHRD+ A N L+ E +   V DFGL++L+           
Sbjct: 118 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 177
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           +  +   APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +  
Sbjct: 178 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-- 228
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                  L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 229 -------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 61
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHRD+ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 122 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 223
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 224 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKIRHEKLVQL--YAV 81
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 138
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 199 WSFGILLTELTTKGRV 214

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KE+++  S  + + ++G G FG V  G L+        VA+K LK G        F  E 
Sbjct: 17  KEIEA--SCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEA 74
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++ L G    +   ++V  YM NGS+ + LK K    +   + + +  G 
Sbjct: 75  SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLK-KNDGQFTVIQLVGMLRGI 133
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--- 390
           + G+ YL    D   +HRD+ A NIL++      V DFGL+++L+  D       RG   
Sbjct: 134 SAGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKI 189
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +   APE ++  + +  +DV+ +GI++ E++S      +G+    +    D +K + + 
Sbjct: 190 PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS------YGERPYWEMTNQDVIKAVEEG 243
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +L   +D              + Q+ L C Q   + RPK  E+V ML+
Sbjct: 244 YRLPSPMDCPAA----------LYQLMLDCWQKERNSRPKFDEIVNMLD 282

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 135/291 (46%), Gaps = 36/291 (12%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 61
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           ++    H NL++L+G C       ++  +M+ G++   L+         R+ ++   A  
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE------CNRQEVS---AVV 112
Query: 337 LLYLHEQCDPKI--------IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           LLY+  Q    +        IHRD+ A N L+ E +   V DFGL++L+           
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           +  +   APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +  
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-- 223
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                  L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 224 -------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 138
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 199 WSFGILLTELTTKGRV 214

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 135/291 (46%), Gaps = 36/291 (12%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 61
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           ++    H NL++L+G C       ++  +M+ G++   L+         R+ ++   A  
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE------CNRQEVS---AVV 112
Query: 337 LLYLHEQCDPKI--------IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           LLY+  Q    +        IHRD+ A N L+ E +   V DFGL++L+           
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           +  +   APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +  
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-- 223
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                  L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 224 -------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 135/291 (46%), Gaps = 36/291 (12%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 276
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 61
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           ++    H NL++L+G C       ++  +M+ G++   L+         R+ ++   A  
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE------CNRQEVS---AVV 112
Query: 337 LLYLHEQCDPKI--------IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           LLY+  Q    +        IHRD+ A N L+ E +   V DFGL++L+           
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           +  +   APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +  
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-- 223
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                  L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 224 -------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 138
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 199 WSFGILLTELTTKGRV 214

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 82  VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 138
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 199 WSFGILLTELTTKGRV 214

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 136/285 (47%), Gaps = 26/285 (9%)
Query: 219 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQ-FQTEVE 276
           + + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E++ F  E  
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAA 307
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAA 334
           ++    H NL++L+G C       ++  +M+ G++   L+   +  ++      +A   +
Sbjct: 308 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 367
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             + YL ++     IHR++ A N L+ E +   V DFGL++L+           +  +  
Sbjct: 368 SAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 424
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V +        
Sbjct: 425 TAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE-------- 469
Query: 455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 470 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 130/278 (46%), Gaps = 30/278 (10%)
Query: 232 KNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           + ++G G FG V +G L+      + VA+K LK G       +F +E  ++    H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCD 345
           RL G    +   +++  +M NG++ S L+      +   + + +  G A G+ YL E   
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDG-QFTVIQLVGMLRGIASGMRYLAEM-- 135
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH--CDSHVTTAVRGTVG--HIAPEYLS 401
              +HRD+ A NIL++      V DFGL++ L+    D   T+++ G +     APE ++
Sbjct: 136 -SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 461
             + +  +D + +GI++ E++S      FG+      +  D +  I Q+ +L    D   
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMS------FGERPYWDMSNQDVINAIEQDYRLPPPPDCPT 248
Query: 462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                      + Q+ L C Q   + RP+  +VV  L+
Sbjct: 249 S----------LHQLMLDCWQKDRNARPRFPQVVSALD 276

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 130/278 (46%), Gaps = 30/278 (10%)
Query: 232 KNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           + ++G G FG V +G L+      + VA+K LK G       +F +E  ++    H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCD 345
           RL G    +   +++  +M NG++ S L+      +   + + +  G A G+ YL E   
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDG-QFTVIQLVGMLRGIASGMRYLAEM-- 137
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH--CDSHVTTAVRGTVG--HIAPEYLS 401
              +HRD+ A NIL++      V DFGL++ L+    D   T+++ G +     APE ++
Sbjct: 138 -SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 461
             + +  +D + +GI++ E++S      FG+      +  D +  I Q+ +L    D   
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMS------FGERPYWDMSNQDVINAIEQDYRLPPPPDCPT 250
Query: 462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                      + Q+ L C Q   + RP+  +VV  L+
Sbjct: 251 S----------LHQLMLDCWQKDRNARPRFPQVVSALD 278

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           F+  + +GKG FG VYKG + + T  VVA+K +    A       Q E+ ++S      +
Sbjct: 21  FTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            R  G  + +T+  ++  Y+  GS    LK  P L+      I     +GL YLH +   
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSE--- 135
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRGTVGHIAPEYLSTGQS 405
           + IHRD+KAAN+LL E  +  + DFG+A  L   D+ +      GT   +APE +     
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 406 SEKTDVFGFGILLLELISG 424
             K D++  GI  +EL  G
Sbjct: 194 DFKADIWSLGITAIELAKG 212

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 137/292 (46%), Gaps = 38/292 (13%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQ-FQTEV 275
           ++ + +   ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E++ F  E 
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEA 267
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 335
            ++    H NL++L+G C       ++  +M+ G++   L+         R+ ++   A 
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE------CNRQEVS---AV 318
Query: 336 GLLYLHEQCDPKI--------IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
            LLY+  Q    +        IHR++ A N L+ E +   V DFGL++L+          
Sbjct: 319 VLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
            +  +   APE L+  + S K+DV+ FG+LL E+ +      +G +    G  L  V + 
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSP-YPGIDLSQVYE- 430
Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                   L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 431 --------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 14/213 (6%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVE 276
           ++ E++++    S++  +G G FG VYKG       VAVK LK  +    + Q F+ EV 
Sbjct: 29  YYWEIEASEVMLSTR--IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVA 84
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAAR 335
           ++    H N+L  +G+ MT     +V  +    S+   L  + +         IA   A+
Sbjct: 85  VLRKTRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ 143
Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGH 394
           G+ YLH +    IIHRD+K+ NI L E     +GDFGLA +      S       G+V  
Sbjct: 144 GMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 395 IAPEYLSTGQS---SEKTDVFGFGILLLELISG 424
           +APE +    +   S ++DV+ +GI+L EL++G
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 232 KNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           + ++G G FG V  G+L+        VA+K LK G        F +E  ++    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCD 345
            L G    +T  +++  +M NGS+ S L+      +   + + +  G A G+ YL    D
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYL---AD 127
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVG--HIAPEYLS 401
              +HR + A NIL++      V DFGL++ L  D  D   T+A+ G +     APE + 
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 461
             + +  +DV+ +GI++ E++S      +G+         D +  I Q+ +L   +D   
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMS------YGERPYWDMTNQDVINAIEQDYRLPPPMDCP- 240
Query: 462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                      + Q+ L C Q   + RPK  ++V  L+
Sbjct: 241 ---------SALHQLMLDCWQKDRNHRPKFGQIVNTLD 269

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 134/301 (44%), Gaps = 39/301 (12%)
Query: 217 FHFKELQSATSNFSSK---------NLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGN 263
           F F++   A   F+ +          ++G G FG V  G L+        VA+K LK G 
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 264 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW 323
                  F +E  ++    H N++ L G        +++  YM NGS+ + L+ K    +
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR-KNDGRF 128
Query: 324 ATRKRIAL--GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 381
              + + +  G   G+ YL    D   +HRD+ A NIL++      V DFG++++L+  D
Sbjct: 129 TVIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED-D 184
Query: 382 SHVTTAVRG---TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG 438
                  RG    +   APE ++  + +  +DV+ +GI++ E++S      +G+      
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------YGERPYWDM 238
Query: 439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
           +  D +K I +  +L   +D  +           + Q+ L C Q   S RPK  ++V ML
Sbjct: 239 SNQDVIKAIEEGYRLPPPMDCPIA----------LHQLMLDCWQKERSDRPKFGQIVNML 288
Query: 499 E 499
           +
Sbjct: 289 D 289

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D    TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YM+ GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NYVHR 135
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 196 WSFGILLTELTTKGRV 211

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YM+ GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NYVHR 135
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 196 WSFGILLTELTTKGRV 211

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 36/282 (12%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++ + K+ +G G +G VY+G  +  ++ VAVK LK+      E  F  E  ++    H N
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L++L+G C       ++  +M+ G++   L+         R+ ++   A  LLY+  Q  
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE------CNRQEVS---AVVLLYMATQIS 119
Query: 346 PKI--------IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
             +        IHRD+ A N L+ E +   V DFGL++L+           +  +   AP
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAP 179
Query: 398 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
           E L+  + S K+DV+ FG+LL E+ +   +   G   +Q          +++      L+
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ----------VYE------LL 223
Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 224 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS GS+   LK +        + + + A  A G+ Y+        +HR
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 138
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D+ AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 199 WSFGILLTELTTKGRV 214

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L   +   +      IA   A+G+ YLH +    IIHRD
Sbjct: 74  -TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA +      SH    + G++  +APE +        S +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 190 SDVYAFGIVLYELMTG 205

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 294 MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L   +   +      IA   A+G+ YLH +    IIHRD
Sbjct: 76  -TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 131
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA +      SH    + G++  +APE +        S +
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 192 SDVYAFGIVLYELMTG 207

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 294 MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L   +   +      IA   A+G+ YLH +    IIHRD
Sbjct: 101 -TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 156
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA +      SH    + G++  +APE +        S +
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 217 SDVYAFGIVLYELMTG 232

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L   +   +      IA   A+G+ YLH +    IIHRD
Sbjct: 74  -TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA +      SH    + G++  +APE +        S +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 190 SDVYAFGIVLYELMTG 205

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS G +   LK +        + + + A  A G+ Y+        +HR
Sbjct: 82  VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 138
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 199 WSFGILLTELTTKGRV 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 294 MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L   +   +      IA   A+G+ YLH +    IIHRD
Sbjct: 79  -TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA +      SH    + G++  +APE +        S +
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 195 SDVYAFGIVLYELMTG 210

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++++           T K +   
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  TT  
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 294 MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L   +   +      IA   A+G+ YLH +    IIHRD
Sbjct: 79  -TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA +      SH    + G++  +APE +        S +
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 195 SDVYAFGIVLYELMTG 210

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 294 MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L   +   +      IA   A+G+ YLH +    IIHRD
Sbjct: 102 -TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 157
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA +      SH    + G++  +APE +        S +
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 218 SDVYAFGIVLYELMTG 233

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 351
            + E + +V  YMS G +   LK +        + + + A  A G+ Y+        +HR
Sbjct: 82  VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 138
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL +  R 
Sbjct: 199 WSFGILLTELTTKGRV 214

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 8/191 (4%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+       T VAVK +K G ++  E  F  E  ++    H  L++L    +
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVE-AFLAEANVMKTLQHDKLVKLHA-VV 79
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHRD 352
           T     ++  +M+ GS+   LK+         K I   A  A G+ ++ ++     IHRD
Sbjct: 80  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD 136
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 412
           ++AANIL+       + DFGLA++++  +       +  +   APE ++ G  + K+DV+
Sbjct: 137 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 413 GFGILLLELIS 423
            FGILL+E+++
Sbjct: 197 SFGILLMEIVT 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 127/277 (45%), Gaps = 30/277 (10%)
Query: 232 KNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           + ++G G FG V  G L+        VA+K LK G        F +E  ++    H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCD 345
            L G        +++  YM NGS+ + L+ K    +   + + +  G   G+ YL    D
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLR-KNDGRFTVIQLVGMLRGIGSGMKYLS---D 134
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG---TVGHIAPEYLST 402
              +HRD+ A NIL++      V DFG++++L+  D       RG    +   APE ++ 
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 462
            + +  +DV+ +GI++ E++S      +G+      +  D +K I +  +L   +D  + 
Sbjct: 194 RKFTSASDVWSYGIVMWEVMS------YGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIA 247
Query: 463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                     + Q+ L C Q   S RPK  ++V ML+
Sbjct: 248 ----------LHQLMLDCWQKERSDRPKFGQIVNMLD 274

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 127/277 (45%), Gaps = 30/277 (10%)
Query: 232 KNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           + ++G G FG V  G L+        VA+K LK G        F +E  ++    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCD 345
            L G        +++  YM NGS+ + L+ K    +   + + +  G   G+ YL    D
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLR-KNDGRFTVIQLVGMLRGIGSGMKYLS---D 128
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG---TVGHIAPEYLST 402
              +HRD+ A NIL++      V DFG++++L+  D       RG    +   APE ++ 
Sbjct: 129 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 462
            + +  +DV+ +GI++ E++S      +G+      +  D +K I +  +L   +D  + 
Sbjct: 188 RKFTSASDVWSYGIVMWEVMS------YGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIA 241
Query: 463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                     + Q+ L C Q   S RPK  ++V ML+
Sbjct: 242 ----------LHQLMLDCWQKERSDRPKFGQIVNMLD 268

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K      T VAVK LK            +E+EM+ +   H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKR--------------I 329
           ++ L+G C       ++  Y S G++   L+A+  P L+++                   
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
           A   ARG+ YL  +   K IHRD+ A N+L+ E     + DFGLA+ + H D +  TT  
Sbjct: 145 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+LL E+ +
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K   ++   VAVK LKD           +E+EM+ +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRIA-- 330
           ++ L+G C       ++  Y S G++   L+A+  P ++ +           T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 331 -LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAV 388
               ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D    TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+L+ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 116/249 (46%), Gaps = 27/249 (10%)
Query: 224 SATSNFSSKNL-----VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQT 273
           S  + F  ++L     +GKG FG+V       LQD  G VVAVK+L+          F+ 
Sbjct: 2   SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFER 60
Query: 274 EVEMISLAVHRNLLRLIGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIA 330
           E+E++    H N+++  G C +   R   L+  Y+  GS+   L K K  +D     +  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAV 388
               +G+ YL  +   + IHRD+   NIL++      +GDFGL K+L  D     V    
Sbjct: 121 SQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
              +   APE L+  + S  +DV+ FG++L EL        F      K    ++++ I 
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIG 229
Query: 449 QEKKLEMLV 457
            +K+ +M+V
Sbjct: 230 NDKQGQMIV 238

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 294 MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L   +   +      IA   A+G+ YLH +    IIHRD
Sbjct: 94  -TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 149
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA        SH    + G++  +APE +        S +
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 210 SDVYAFGIVLYELMTG 225

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K      T VAVK LK            +E+EM+ +   H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKR--------------I 329
           ++ L+G C       ++  Y S G++   L+A+  P L++                    
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
           A   ARG+ YL  +   K IHRD+ A N+L+ E     + DFGLA+ + H D +  TT  
Sbjct: 141 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+LL E+ +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 8/191 (4%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+       T VAVK +K G+       F  E  ++    H  L++L    +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHA-VV 252
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHRD 352
           T     ++  +M+ GS+   LK+         K I   A  A G+ ++ ++     IHRD
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD 309
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 412
           ++AANIL+       + DFGLA++++  +       +  +   APE ++ G  + K+DV+
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 413 GFGILLLELIS 423
            FGILL+E+++
Sbjct: 370 SFGILLMEIVT 380

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K      T VAVK LK            +E+EM+ +   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKR--------------I 329
           ++ L+G C       ++  Y S G++   L+A+  P L+++                   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
           A   ARG+ YL  +   K IHRD+ A N+L+ E     + DFGLA+ + H D +  TT  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+LL E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K      T VAVK LK            +E+EM+ +   H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKR--------------I 329
           ++ L+G C       ++  Y S G++   L+A+  P L+++                   
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
           A   ARG+ YL  +   K IHRD+ A N+L+ E     + DFGLA+ + H D +  TT  
Sbjct: 149 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+LL E+ +
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K      T VAVK LK            +E+EM+ +   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKR--------------I 329
           ++ L+G C       ++  Y S G++   L+A+  P L+++                   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
           A   ARG+ YL  +   K IHRD+ A N+L+ E     + DFGLA+ + H D +  TT  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+LL E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           F+    +GKG FG V+KG   +   VVA+K +    A       Q E+ ++S      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCD 345
           +  G  +  ++  ++  Y+  GS    L+A P      AT  +  L   +GL YLH +  
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE-- 139
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
            K IHRD+KAAN+LL E  +  + DFG+A  L        T V GT   +APE +     
Sbjct: 140 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 197
Query: 406 SEKTDVFGFGILLLELISG 424
             K D++  GI  +EL  G
Sbjct: 198 DSKADIWSLGITAIELAKG 216

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L   +   +      IA   A+G+ YLH +    IIHRD
Sbjct: 74  -TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA        SH    + G++  +APE +        S +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 190 SDVYAFGIVLYELMTG 205

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 107
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 224
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 225 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 269

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+ G     T VA+K LK G        F  E +++    H  L++L  + +
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTM--SPESFLEEAQIMKKLKHDKLVQL--YAV 72
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
            + E + +V  YM+ GS+   LK     +L       +A   A G+ Y+        IHR
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHR 129
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           D+++ANIL+       + DFGLA+L++  +       +  +   APE    G+ + K+DV
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 412 FGFGILLLELISGLRA 427
           + FGILL EL++  R 
Sbjct: 190 WSFGILLTELVTKGRV 205

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K      T VAVK LK            +E+EM+ +   H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKR--------------I 329
           ++ L+G C       ++  Y S G++   L+A+  P L+++                   
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
           A   ARG+ YL  +   K IHRD+ A N+L+ E     + DFGLA+ + H D +  TT  
Sbjct: 148 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+LL E+ +
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K      T VAVK LK            +E+EM+ +   H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKR--------------I 329
           ++ L+G C       ++  Y S G++   L+A+  P L+++                   
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
           A   ARG+ YL  +   K IHRD+ A N+L+ E     + DFGLA+ + H D +  TT  
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+LL E+ +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 79
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 136
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 197 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 241

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 81
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 138
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 198
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 199 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 243

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 75
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 132
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 192
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 193 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 237

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 8/209 (3%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI-GGEIQF-QTEVEMISLA 281
              NF    ++GKG FG V    +++ G + AVK LK    +   +++   TE  ++SLA
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 282 VHRNLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
            +   L  +  C  T +RL  V  +++ G +   ++     D A  +  A      L++L
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
           H   D  II+RD+K  N+LLD      + DFG+ K    C+   T    GT  +IAPE L
Sbjct: 141 H---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEIL 196
Query: 401 STGQSSEKTDVFGFGILLLELISGLRALE 429
                    D +  G+LL E++ G    E
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 82
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 139
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 199
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 200 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 244

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 80
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 137
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 197
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 198 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 242

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 294 MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
            T  +  +V  +    S+   L   +   +      IA   A+G+ YLH +    IIHRD
Sbjct: 102 -TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 157
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           +K+ NI L E     +GDFGLA        SH    + G++  +APE +        S +
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 409 TDVFGFGILLLELISG 424
           +DV+ FGI+L EL++G
Sbjct: 218 SDVYAFGIVLYELMTG 233

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 11/212 (5%)
Query: 222 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 279
           + S   ++     +G G +G   K   + DG ++  K L  G+    E Q   +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 280 LAVHRNLLRLIGFCM--TTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGA 333
              H N++R     +  T T   +V  Y   G +AS +    K +  LD     R+    
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 334 ARGLLYLHEQCD--PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
              L   H + D    ++HRD+K AN+ LD      +GDFGLA++L+H D+    A  GT
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGT 179
Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +++PE ++    +EK+D++  G LL EL +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 115/256 (44%), Gaps = 16/256 (6%)
Query: 223 QSATSNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVE--MIS 279
           + +  +F     +G G FG V+      +G   A+K LK    +  +    T  E  M+S
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
           +  H  ++R+ G      +  ++  Y+  G + S L+          K  A      L Y
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           LH +    II+RD+K  NILLD+     + DFG AK +      VT  + GT  +IAPE 
Sbjct: 122 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDYIAPEV 174
Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 459
           +ST   ++  D + FGIL+ E+++G        T      M  + K ++ E +     ++
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELRFPPFFNE 228
Query: 460 DLKNNYDRIELEEMVQ 475
           D+K+   R+   ++ Q
Sbjct: 229 DVKDLLSRLITRDLSQ 244

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 76
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 194 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 83
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 140
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 200
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 201 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 245

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K      T VAVK LK            +E+EM+ +   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKR--------------I 329
           ++ L+G C       ++  Y S G++   L+A+  P L++                    
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 388
           A   ARG+ YL  +   K IHRD+ A N+L+ E     + DFGLA+ + H D +  TT  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+LL E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL- 122
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D 
Sbjct: 123 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 178
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
                 +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 179 XRKGG-KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 225
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + ++++  +C QY P +RP   E++
Sbjct: 226 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 74
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 131
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 191
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 192 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 236

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 94
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 151
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 212 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 256

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 94
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 151
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 212 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 256

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 11/212 (5%)
Query: 222 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 279
           + S   ++     +G G +G   K   + DG ++  K L  G+    E Q   +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 280 LAVHRNLLRLIGFCM--TTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGA 333
              H N++R     +  T T   +V  Y   G +AS +    K +  LD     R+    
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 334 ARGLLYLHEQCD--PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
              L   H + D    ++HRD+K AN+ LD      +GDFGLA++L+H  S   T V GT
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GT 179
Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +++PE ++    +EK+D++  G LL EL +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL- 128
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D 
Sbjct: 129 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD- 183
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           +     +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 184 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 231
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + + ++  +C QY P +RP   E++
Sbjct: 232 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL- 124
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D 
Sbjct: 125 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD- 179
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           +     +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 227
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + + ++  +C QY P +RP   E++
Sbjct: 228 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 134/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL- 131
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D 
Sbjct: 132 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 187
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
                 +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 188 XRKGG-KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 234
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + + ++  +C QY P +RP   E++
Sbjct: 235 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL- 137
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D 
Sbjct: 138 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD- 192
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           +     +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 240
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + + ++  +C QY P +RP   E++
Sbjct: 241 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL- 137
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D 
Sbjct: 138 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD- 192
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           +     +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 240
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + + ++  +C QY P +RP   E++
Sbjct: 241 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL- 131
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D 
Sbjct: 132 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD- 186
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           +     +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 187 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 234
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + + ++  +C QY P +RP   E++
Sbjct: 235 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL- 130
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D 
Sbjct: 131 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD- 185
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           +     +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 233
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + + ++  +C QY P +RP   E++
Sbjct: 234 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 235 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 285
           +G+G FG V         K      T VAVK LK            +E+EM+ +   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKR--------------I 329
           ++ L+G C       ++  Y S G++   L+A+  P L+++                   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAV 388
           A   ARG+ YL  +   K IHRD+ A N+L+ E     + DFGLA+ + H D    TT  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE L     + ++DV+ FG+LL E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL- 127
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D 
Sbjct: 128 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD- 182
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           +     +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 183 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 230
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + + ++  +C QY P +RP   E++
Sbjct: 231 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL- 130
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D 
Sbjct: 131 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD- 185
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           +     +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 233
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + + ++  +C QY P +RP   E++
Sbjct: 234 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 116/249 (46%), Gaps = 27/249 (10%)
Query: 224 SATSNFSSKNL-----VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQT 273
           S  + F  ++L     +GKG FG+V       LQD  G VVAVK+L+          F+ 
Sbjct: 2   SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFER 60
Query: 274 EVEMISLAVHRNLLRLIGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIA 330
           E+E++    H N+++  G C +   R   L+  Y+  GS+   L K K  +D     +  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAV 388
               +G+ YL  +   + IHRD+   NIL++      +GDFGL K+L  D     V    
Sbjct: 121 SQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
              +   APE L+  + S  +DV+ FG++L EL        F      K    ++++ I 
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIG 229
Query: 449 QEKKLEMLV 457
            +K+ +M+V
Sbjct: 230 NDKQGQMIV 238

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 79
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L+A    +D     +      +G+ YL  +   
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTK--- 136
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 197 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 241

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL- 159
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D 
Sbjct: 160 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD- 214
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           +     +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 215 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 262
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + + ++  +C QY P +RP   E++
Sbjct: 263 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 79
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  ++  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 136
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + IHRD+   NIL++      +GDFGL K+L  D     V       +   APE L+  +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 197 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 241

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 106/207 (51%), Gaps = 29/207 (14%)
Query: 233 NLVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
            ++G G FG VYKG ++ +G  V    A+K L +       ++F  E  +++   H +L+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 288 RLIGFCMTTTERL----------LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
           RL+G C++ T +L          L Y +    ++ S+L     L+W  +       A+G+
Sbjct: 81  RLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQL----LLNWCVQ------IAKGM 130
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-AVRGTVGHIA 396
           +YL E+   +++HRD+ A N+L+       + DFGLA+LL+  +        +  +  +A
Sbjct: 131 MYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 187
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELIS 423
            E +   + + ++DV+ +G+ + EL++
Sbjct: 188 LECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 130/300 (43%), Gaps = 51/300 (17%)
Query: 232 KNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           K  +G+G FG V+          +D  +VAVK LKD   +     FQ E E+++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEH 78
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLK----------------AKPSLDWATRKRI 329
           +++  G C      ++V+ YM +G +   L+                AK  L  +    I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-----SHV 384
           A   A G++YL  Q     +HRD+   N L+       +GDFG+++ +   D      H 
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
              +R     + PE +   + + ++DV+ FG++L E+ +      +GK    + +  + +
Sbjct: 196 MLPIRW----MPPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNTEVI 245
Query: 445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLA 504
           + I Q + LE            R+  +E+  V L C Q  P  R  + E+ ++L   G A
Sbjct: 246 ECITQGRVLER----------PRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 274
           E + A    +    +G+G FG VY    KG ++D   T VA+K + +  ++   I+F  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK------------AKPSLD 322
             ++      +++RL+G        L++   M+ G + S L+            A PSL 
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL- 124
Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
            +   ++A   A G+ YL+     K +HRD+ A N  + E +   +GDFG+ + +   D 
Sbjct: 125 -SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETD- 179
Query: 383 HVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           +     +G   V  ++PE L  G  +  +DV+ FG++L E+ +          A Q    
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP--- 227
Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
               + +  E+ L  +++  L +  D    + ++++  +C QY P +RP   E++
Sbjct: 228 ---YQGLSNEQVLRFVMEGGLLDKPDNCP-DMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 130/297 (43%), Gaps = 52/297 (17%)
Query: 235 VGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG V++         +  T+VAVK LK+  +   +  FQ E  +++   + N+++
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA------------------------KPSLDWA 324
           L+G C       L++ YM+ G +   L++                         P L  A
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 325 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 384
            +  IA   A G+ YL E+   K +HRD+   N L+ E     + DFGL++ +   D + 
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 385 TTAVRGT-VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLD 442
                   +  + PE +   + + ++DV+ +G++L E+ S GL+   +G           
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY-YG----------- 279
Query: 443 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
               +  E+ +  + D ++    +   L E+  +  LC   LP+ RP    + R+L+
Sbjct: 280 ----MAHEEVIYYVRDGNILACPENCPL-ELYNLMRLCWSKLPADRPSFCSIHRILQ 331

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 106/207 (51%), Gaps = 29/207 (14%)
Query: 233 NLVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
            ++G G FG VYKG ++ +G  V    A+K L +       ++F  E  +++   H +L+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 288 RLIGFCMTTTERL----------LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
           RL+G C++ T +L          L Y +    ++ S+L     L+W  +       A+G+
Sbjct: 104 RLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQL----LLNWCVQ------IAKGM 153
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-AVRGTVGHIA 396
           +YL E+   +++HRD+ A N+L+       + DFGLA+LL+  +        +  +  +A
Sbjct: 154 MYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 210
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELIS 423
            E +   + + ++DV+ +G+ + EL++
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 11/212 (5%)
Query: 222 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 279
           + S   ++     +G G +G   K   + DG ++  K L  G+    E Q   +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 280 LAVHRNLLRLIGFCM--TTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGA 333
              H N++R     +  T T   +V  Y   G +AS +    K +  LD     R+    
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 334 ARGLLYLHEQCD--PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
              L   H + D    ++HRD+K AN+ LD      +GDFGLA++L+H D        GT
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DEDFAKEFVGT 179
Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +++PE ++    +EK+D++  G LL EL +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 110/233 (47%), Gaps = 22/233 (9%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +GKG FG+V       LQD  G VVAVK+L+          F+ E+E++    H N+++ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 77
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C +   R   L+  Y+  GS+   L K K  +D     +      +G+ YL  +   
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--- 134
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQ 404
           + IHR++   NIL++      +GDFGL K+L     +      G   +   APE L+  +
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 194
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            S  +DV+ FG++L EL        F      K    ++++ I  +K+ +M+V
Sbjct: 195 FSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 239

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 36/284 (12%)
Query: 233 NLVGKGGFGNVYKGYL--QDGTV--VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 287
            ++G+G FG+V +G L  +DGT   VAVK +K  N+   EI+ F +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 288 RLIGFCMTTTER-----LLVYPYMSNGSV-----ASRLKAKPS-LDWATRKRIALGAARG 336
           RL+G C+  + +     +++ P+M  G +      SRL+  P  +   T  +  +  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV-RGTVGHI 395
           + YL  +     +HRD+ A N +L +     V DFGL+K +   D +    + +  V  I
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 396 APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 455
           A E L+    + K+DV+ FG+ + E+ +  R +       Q   M D++   H+ K+ E 
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIAT--RGMT-PYPGVQNHEMYDYLLHGHRLKQPED 273
Query: 456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +D             E+ ++   C +  P  RP  S +   LE
Sbjct: 274 CLD-------------ELYEIMYSCWRTDPLDRPTFSVLRLQLE 304

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 119/268 (44%), Gaps = 26/268 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V  G  +    VAVK +K+G+    E  FQ    M+ L+ H  L++  G C 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEF-FQEAQTMMKLS-HPKLVKFYGVCS 73
Query: 295 TTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 +V  Y+SNG + + L++    L+ +    +      G+ +L      + IHRD+
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDL 130
Query: 354 KAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDV 411
            A N L+D      V DFG+ + +LD  D +V++   +  V   APE     + S K+DV
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELE 471
           + FGIL+ E+ S       GK         + V K+ Q  +L              +  +
Sbjct: 189 WAFGILMWEVFS------LGKMPYDLYTNSEVVLKVSQGHRLYR----------PHLASD 232
Query: 472 EMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            + Q+   C   LP  RP   +++  +E
Sbjct: 233 TIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 9/202 (4%)
Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVH 283
            +F     +GKG FGNVY     Q+  ++A+K L        G E Q + E+E+ S   H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            N+LR+  +        L+  +   G +   L+     D           A  L Y HE+
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 134
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              K+IHRD+K  N+L+    E  + DFG +    H  S     + GT+ ++ PE +   
Sbjct: 135 ---KVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 404 QSSEKTDVFGFGILLLELISGL 425
              EK D++  G+L  E + G+
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGM 210

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK------AKP-SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+      ++P SL       +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 224
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 278
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 279 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 315

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 9/202 (4%)
Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVH 283
            +F     +GKG FGNVY     Q+  ++A+K L        G E Q + E+E+ S   H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            N+LR+  +        L+  +   G +   L+     D           A  L Y HE+
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              K+IHRD+K  N+L+    E  + DFG +    H  S     + GT+ ++ PE +   
Sbjct: 134 ---KVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 404 QSSEKTDVFGFGILLLELISGL 425
              EK D++  G+L  E + G+
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGM 209

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK-AKP------SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+  +P      SL       +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 210
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 264
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 265 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 301

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGT-VVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHR 284
           +F     +GKG FGNVY    +    +VA+K L        G E Q + E+E+ +   H 
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           N+LRL  +        L+  Y   G +   L+   + D      I    A  L+Y H + 
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGK- 142
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
             K+IHRD+K  N+LL    E  + DFG +    H  S     + GT+ ++ PE +    
Sbjct: 143 --KVIHRDIKPENLLLGLKGELKIADFGWSV---HAPSLRRKTMCGTLDYLPPEMIEGRM 197
Query: 405 SSEKTDVFGFGILLLELISG 424
            +EK D++  G+L  EL+ G
Sbjct: 198 HNEKVDLWCIGVLCYELLVG 217

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK------AKP-SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+      ++P SL       +A   A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 201
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 202 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 255
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 256 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 292

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK------AKP-SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+      ++P SL       +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 224
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 278
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 279 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 315

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK------AKP-SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+      ++P SL       +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 209
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 263
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 264 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 300

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK------AKP-SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+      ++P SL       +A   A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 216
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 217 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 270
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 271 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 307

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK------AKP-SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+      ++P SL       +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 209
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 263
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 264 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 300

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK-AKP------SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+  +P      SL       +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 210
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 264
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 265 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 301

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK------AKP-SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+      ++P SL       +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 224
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 278
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 279 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 315

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK------AKP-SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+      ++P SL       +A   A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 226
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 227 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 280
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 281 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 317

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK------AKP-SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+      ++P SL       +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ-----DIYRASYYRKGGCAMLPV 210
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 264
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 265 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 301

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 46/287 (16%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK-AKP------SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+  +P      SL       +A   A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TV 392
           E      IHRD+ A N LL        A +GDFG+A+     D +  +  R        V
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 236
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
             + PE    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +   
Sbjct: 237 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR--- 290
Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             M   K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 291 --MDPPKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 327

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 125/282 (44%), Gaps = 36/282 (12%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK------AKP-SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+      ++P SL       +A   A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG-TVGHIAP 397
           E      IHRD+ A N LL        A +GDFG+A+ +     +         V  + P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 398 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
           E    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +     M  
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR-----MDP 307
Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 308 PKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 341

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 125/282 (44%), Gaps = 36/282 (12%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLK------AKP-SLDWATRKRIALGAARGLLYLH 341
            IG  + +  R ++   M+ G + S L+      ++P SL       +A   A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 342 EQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCDSHVTTAVRG-TVGHIAP 397
           E      IHRD+ A N LL        A +GDFG+A+ +     +         V  + P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 398 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
           E    G  + KTD + FG+LL E+ S L  + +   +NQ+  +L++V    +     M  
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTSGGR-----MDP 284
Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            K+      RI    M Q    C Q+ P  RP  + ++  +E
Sbjct: 285 PKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 318

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHR 284
           ++ + K+ +G G +G VY G  +  ++ VAVK LK+      E++ F  E  ++    H 
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHP 88
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           NL++L+G C       +V  YM  G++   L+         R+ +    A  LLY+  Q 
Sbjct: 89  NLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRE------CNREEVT---AVVLLYMATQI 139
Query: 345 DPKI--------IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
              +        IHRD+ A N L+ E +   V DFGL++L+           +  +   A
Sbjct: 140 SSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 199
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELIS 423
           PE L+    S K+DV+ FG+LL E+ +
Sbjct: 200 PESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 137/297 (46%), Gaps = 55/297 (18%)
Query: 232 KNLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLL 287
           ++++G+G FG V K  ++ DG  +  A+KR+K+  +      F  E+E++  L  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 288 RLIGFCMTTTERLLVYPYMSNGSV-----ASR-LKAKPSLDWATRK----------RIAL 331
            L+G C       L   Y  +G++      SR L+  P+   A               A 
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
             ARG+ YL ++   + IHRD+ A NIL+ E Y A + DFGL++  +         V+ T
Sbjct: 140 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 189
Query: 392 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +G +     A E L+    +  +DV+ +G+LL E++S       G T        +  +K
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYEK 243
Query: 447 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV----RMLE 499
           + Q  +LE  ++ D          +E+  +   C +  P  RP  ++++    RMLE
Sbjct: 244 LPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 290

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 14/220 (6%)
Query: 212 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAIGG 267
           G   R   +E+++  S    + ++G G  G V  G L    Q    VA+K LK G     
Sbjct: 36  GRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
              F +E  ++    H N++RL G        ++V  YM NGS+ + L+      +   +
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQ 152
Query: 328 RIAL--GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSH 383
            + +  G   G+ YL    D   +HRD+ A N+L+D      V DFGL+++L  D   ++
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
            TT  +  +   APE ++    S  +DV+ FG+++ E+++
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 137/297 (46%), Gaps = 55/297 (18%)
Query: 232 KNLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLL 287
           ++++G+G FG V K  ++ DG  +  A+KR+K+  +      F  E+E++  L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 288 RLIGFCMTTTERLLVYPYMSNGSV-----ASR-LKAKPSLDWATRK----------RIAL 331
            L+G C       L   Y  +G++      SR L+  P+   A               A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
             ARG+ YL ++   + IHRD+ A NIL+ E Y A + DFGL++  +         V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 199
Query: 392 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +G +     A E L+    +  +DV+ +G+LL E++S       G T        +  +K
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYEK 253
Query: 447 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV----RMLE 499
           + Q  +LE  ++ D          +E+  +   C +  P  RP  ++++    RMLE
Sbjct: 254 LPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 130/288 (45%), Gaps = 30/288 (10%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           KEL +  S    + ++G G FG V  G L+        VA+K LK G        F  E 
Sbjct: 38  KELDA--SCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEA 95
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GA 333
            ++    H N++ L G        ++V  +M NG++ + L+ K    +   + + +  G 
Sbjct: 96  SIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLR-KHDGQFTVIQLVGMLRGI 154
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-- 391
           A G+ YL    D   +HRD+ A NIL++      V DFGL+++++     V T   G   
Sbjct: 155 AAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIP 211
Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 451
           V   APE +   + +  +DV+ +GI++ E++S      +G+      +  D +K I +  
Sbjct: 212 VRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------YGERPYWDMSNQDVIKAIEEGY 265
Query: 452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +L   +D              + Q+ L C Q   + RPK  ++V +L+
Sbjct: 266 RLPAPMDCPAG----------LHQLMLDCWQKERAERPKFEQIVGILD 303

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +GKG FG+V  G  + G  VAVK +K+         F  E  +++   H NL++L+G  +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP------- 346
                L +V  YM+ GS+   L+        +R R  LG    L +  + C+        
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
             +HRD+ A N+L+ E   A V DFGL K            V+ T    APE L   + S
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 177
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            K+DV+ FGILL E+ S      FG+    +  + D V ++ +  K++
Sbjct: 178 TKSDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMD 219

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +GKG FG+V  G  + G  VAVK +K+         F  E  +++   H NL++L+G  +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 256
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP------- 346
                L +V  YM+ GS+   L+        +R R  LG    L +  + C+        
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
             +HRD+ A N+L+ E   A V DFGL K            V+ T    APE L   + S
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            K+DV+ FGILL E+ S      FG+    +  + D V ++ +  K++
Sbjct: 365 TKSDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMD 406

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 106/229 (46%), Gaps = 32/229 (13%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +GKG FG+V  G  + G  VAVK +K D  A      F  E  +++   H NL++L+G  
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVI 74
Query: 294 MTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP------ 346
           +     L +V  YM+ GS+   L+        +R R  LG    L +  + C+       
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 347 -KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
              +HRD+ A N+L+ E   A V DFGL K            V+ T    APE L     
Sbjct: 127 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREAAF 182
Query: 406 SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
           S K+DV+ FGILL E+ S      FG+    +  + D V ++ +  K++
Sbjct: 183 STKSDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMD 225

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +GKG FG+V  G  + G  VAVK +K+         F  E  +++   H NL++L+G  +
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 295 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP------- 346
                L +V  YM+ GS+   L+        +R R  LG    L +  + C+        
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
             +HRD+ A N+L+ E   A V DFGL K            V+ T    APE L   + S
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 192
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            K+DV+ FGILL E+ S      FG+    +  + D V ++ +  K++
Sbjct: 193 TKSDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMD 234

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           N     L+G+G +G VYKG L D   VAVK     N        +  +  + L  H N+ 
Sbjct: 14  NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIA 70
Query: 288 RLIGFCMTTT-----ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH- 341
           R I      T     E LLV  Y  NGS+   L    S DW +  R+A    RGL YLH 
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-DWVSSCRLAHSVTRGLAYLHT 129
Query: 342 -----EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD--------HCDSHVTTAV 388
                +   P I HRD+ + N+L+      V+ DFGL+  L           D+   + V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 389 RGTVGHIAPEYLSTG-------QSSEKTDVFGFGILLLELI 422
            GT+ ++APE L           + ++ D++  G++  E+ 
Sbjct: 190 -GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-- 287
           +GKG FG+V       L D  G +VAVK+L+       +  FQ E++++  A+H + +  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILK-ALHSDFIVK 72
Query: 288 -RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-- 344
            R + +     E  LV  Y+ +G +          D+  R R  L A+R LLY  + C  
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLR---------DFLQRHRARLDASRLLLYSSQICKG 123
Query: 345 -----DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL--LDHCDSHVTTAVRGTVGHIAP 397
                  + +HRD+ A NIL++      + DFGLAKL  LD     V    +  +   AP
Sbjct: 124 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAP 183
Query: 398 EYLSTGQSSEKTDVFGFGILLLELIS 423
           E LS    S ++DV+ FG++L EL +
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 14/220 (6%)
Query: 212 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAIGG 267
           G   R   +E+++  S    + ++G G  G V  G L    Q    VA+K LK G     
Sbjct: 36  GRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 268 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 327
              F +E  ++    H N++RL G        ++V  YM NGS+ + L+      +   +
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQ 152
Query: 328 RIAL--GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSH 383
            + +  G   G+ YL    D   +HRD+ A N+L+D      V DFGL+++L  D   + 
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
            TT  +  +   APE ++    S  +DV+ FG+++ E+++
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 94/216 (43%), Gaps = 18/216 (8%)
Query: 222 LQSATSNFSSKNL-----VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--Q 270
           LQS T     K+L     +G G FG V +G           VAVK LK       E    
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 271 FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRI 329
           F  EV  +    HRNL+RL G  +T   ++ V      GS+  RL K +      T  R 
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 389
           A+  A G+ YL  +   + IHRD+ A N+LL       +GDFGL + L   D H      
Sbjct: 127 AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 183
Query: 390 GTV--GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             V     APE L T   S  +D + FG+ L E+ +
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG V   Y  D      G +VAVK LK+G        +Q E+E++    H ++++
Sbjct: 17  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 289 LIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
             G C    E+   LV  Y+  GS+   L  +  +  A     A     G+ YLH Q   
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQ--- 131
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLST 402
             IHR + A N+LLD      +GDFGLAK +   + H    VR      V   APE L  
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 403 GQSSEKTDVFGFGILLLELIS 423
            +    +DV+ FG+ L EL++
Sbjct: 190 CKFYYASDVWSFGVTLYELLT 210

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           VGKG +G V++G L  G  VAVK    +D  +   E    TE+    L  H N+L  I  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRE----TEIYNTVLLRHDNILGFIAS 70
Query: 293 CMTT----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH-----EQ 343
            MT+    T+  L+  Y  +GS+   L+ + +L+     R+A+ AA GL +LH      Q
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQ-RQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYL 400
             P I HRD K+ N+L+    +  + D GLA +      ++       VG   ++APE L
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 401 STG------QSSEKTDVFGFGILLLEL 421
                    +S + TD++ FG++L E+
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGF 292
           VGKG +G V++G  Q G  VAVK     +    E  +  E E+ +  +  H N+L  I  
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIAS 99
Query: 293 CMTT----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH-----EQ 343
            MT+    T+  L+  Y   GS+   L+   +LD  +  RI L  A GL +LH      Q
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYL 400
             P I HRD+K+ NIL+ +  +  + D GLA +     + +       VG   ++APE L
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 401 STG------QSSEKTDVFGFGILLLEL 421
                     S ++ D++ FG++L E+
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 94/216 (43%), Gaps = 18/216 (8%)
Query: 222 LQSATSNFSSKNL-----VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--Q 270
           LQS T     K+L     +G G FG V +G           VAVK LK       E    
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 271 FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRI 329
           F  EV  +    HRNL+RL G  +T   ++ V      GS+  RL K +      T  R 
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 389
           A+  A G+ YL  +   + IHRD+ A N+LL       +GDFGL + L   D H      
Sbjct: 127 AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 390 GTV--GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             V     APE L T   S  +D + FG+ L E+ +
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGF 292
           VGKG +G V++G  Q G  VAVK     +    E  +  E E+ +  +  H N+L  I  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIAS 70
Query: 293 CMTT----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH-----EQ 343
            MT+    T+  L+  Y   GS+   L+   +LD  +  RI L  A GL +LH      Q
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYL 400
             P I HRD+K+ NIL+ +  +  + D GLA +     + +       VG   ++APE L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 401 STG------QSSEKTDVFGFGILLLEL 421
                     S ++ D++ FG++L E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGF 292
           VGKG +G V++G  Q G  VAVK     +    E  +  E E+ +  +  H N+L  I  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIAS 70
Query: 293 CMTT----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH-----EQ 343
            MT+    T+  L+  Y   GS+   L+   +LD  +  RI L  A GL +LH      Q
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYL 400
             P I HRD+K+ NIL+ +  +  + D GLA +     + +       VG   ++APE L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 401 STG------QSSEKTDVFGFGILLLEL 421
                     S ++ D++ FG++L E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG V   Y  D      G +VAVK LK+G        +Q E+E++    H ++++
Sbjct: 16  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 289 LIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
             G C    E+   LV  Y+  GS+   L  +  +  A     A     G+ YLH Q   
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQ--- 130
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLST 402
             IHR + A N+LLD      +GDFGLAK +   + H    VR      V   APE L  
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 403 GQSSEKTDVFGFGILLLELIS 423
            +    +DV+ FG+ L EL++
Sbjct: 189 CKFYYASDVWSFGVTLYELLT 209

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 138/322 (42%), Gaps = 65/322 (20%)
Query: 219 FKELQSATSNFSSKNLV-----GKGGFGNVYK----------GYLQDGTVVAVKRLKDGN 263
           FK L+     F  KNLV     G+G FG V K          GY    T VAVK LK+ N
Sbjct: 10  FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKE-N 64
Query: 264 AIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAK 318
           A   E++   +E  ++    H ++++L G C      LL+  Y   GS+   L    K  
Sbjct: 65  ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124
Query: 319 PS------------LDWATRKRIALG--------AARGLLYLHEQCDPKIIHRDVKAANI 358
           P             LD    + + +G         ++G+ YL E    K++HRD+ A NI
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI 181
Query: 359 LLDEYYEAVVGDFGLAKLLDHCDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGIL 417
           L+ E  +  + DFGL++ +   DS+V  +  R  V  +A E L     + ++DV+ FG+L
Sbjct: 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 418 LLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVA 477
           L E+++       G               I  E+   +L         D    EEM ++ 
Sbjct: 242 LWEIVT------LGGNP---------YPGIPPERLFNLLKTGHRMERPDNCS-EEMYRLM 285
Query: 478 LLCTQYLPSLRPKMSEVVRMLE 499
           L C +  P  RP  +++ + LE
Sbjct: 286 LQCWKQEPDKRPVFADISKDLE 307

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 137/297 (46%), Gaps = 55/297 (18%)
Query: 232 KNLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLL 287
           ++++G+G FG V K  ++ DG  +  A+KR+K+  +      F  E+E++  L  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 288 RLIGFCMTTTERLLVYPYMSNGSV-----ASR-LKAKPSLDWATRK----------RIAL 331
            L+G C       L   Y  +G++      SR L+  P+   A               A 
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
             ARG+ YL ++   + IHR++ A NIL+ E Y A + DFGL++  +         V+ T
Sbjct: 147 DVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 196
Query: 392 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +G +     A E L+    +  +DV+ +G+LL E++S       G T        +  +K
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYEK 250
Query: 447 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV----RMLE 499
           + Q  +LE  ++ D          +E+  +   C +  P  RP  ++++    RMLE
Sbjct: 251 LPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 297

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 92/191 (48%), Gaps = 18/191 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V+       T VAVK +K G+       F  E  ++    H  L++L    +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHA-VV 246
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHRD 352
           T     ++  +M+ GS+   LK+         K I   A  A G+ ++ ++     IHRD
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD 303
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 412
           ++AANIL+       + DFGLA++            +  +   APE ++ G  + K+DV+
Sbjct: 304 LRAANILVSASLVCKIADFGLARV----------GAKFPIKWTAPEAINFGSFTIKSDVW 353
Query: 413 GFGILLLELIS 423
            FGILL+E+++
Sbjct: 354 SFGILLMEIVT 364

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 128/296 (43%), Gaps = 48/296 (16%)
Query: 228 NFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           N   K  +G+G FG V+          QD  +VAVK LKD +       F  E E+++  
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNL 72
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-------------PSLDWATRKR 328
            H ++++  G C+     ++V+ YM +G +   L+A                L  +    
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-----SH 383
           IA   A G++YL  Q     +HRD+   N L+ E     +GDFG+++ +   D      H
Sbjct: 133 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 443
               +R     + PE +   + + ++DV+  G++L E+ +      +GK    + +  + 
Sbjct: 190 TMLPIRW----MPPESIMYRKFTTESDVWSLGVVLWEIFT------YGKQPWYQLSNNEV 239
Query: 444 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           ++ I Q + L+            R   +E+ ++ L C Q  P +R  +  +  +L+
Sbjct: 240 IECITQGRVLQR----------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 112/251 (44%), Gaps = 34/251 (13%)
Query: 236 GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA--VHRNLLRLIGF- 292
            +G FG V+K  L +   VAVK       I  +  +Q E E+ SL    H N+L+ IG  
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIF----PIQDKQSWQNEYEVYSLPGMKHENILQFIGAE 87
Query: 293 ---CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC----- 344
                   +  L+  +   GS++  LKA   + W     IA   ARGL YLHE       
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 345 --DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLS 401
              P I HRD+K+ N+LL     A + DFGLA   +   S   T  + GT  ++APE L 
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 402 TGQSSE-----KTDVFGFGILLLELISGLRA---------LEFGKTANQKGAMLDWVKKI 447
              + +     + D++  G++L EL S   A         L F +   Q  ++ D  + +
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVV 266
Query: 448 HQEKKLEMLVD 458
             +KK  +L D
Sbjct: 267 VHKKKRPVLRD 277

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 227 SNFSSKNLVGKGGFGNVYK----GYLQDGTV--VAVKRLKDGNAIGGEIQFQTEVEMIS- 279
           +N      +G G FG V +    G  ++  V  VAVK LK       +    +E++++S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGL 337
           L  H N++ L+G C      L++  Y   G + +  R KA+  LD    + + L   R L
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL---RDL 154
Query: 338 LYLHEQ--------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAV 388
           L+   Q             IHRDV A N+LL   + A +GDFGLA+ +++  +  V    
Sbjct: 155 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE +     + ++DV+ +GILL E+ S
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 93/215 (43%), Gaps = 18/215 (8%)
Query: 223 QSATSNFSSKNL-----VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--QF 271
           QS T     K+L     +G G FG V +G           VAVK LK       E    F
Sbjct: 3   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 272 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIA 330
             EV  +    HRNL+RL G  +T   ++ V      GS+  RL K +      T  R A
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 390
           +  A G+ YL  +   + IHRD+ A N+LL       +GDFGL + L   D H       
Sbjct: 122 VQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 391 TV--GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
            V     APE L T   S  +D + FG+ L E+ +
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 93/215 (43%), Gaps = 18/215 (8%)
Query: 223 QSATSNFSSKNL-----VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--QF 271
           QS T     K+L     +G G FG V +G           VAVK LK       E    F
Sbjct: 3   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 272 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIA 330
             EV  +    HRNL+RL G  +T   ++ V      GS+  RL K +      T  R A
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 390
           +  A G+ YL  +   + IHRD+ A N+LL       +GDFGL + L   D H       
Sbjct: 122 VQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 391 TV--GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
            V     APE L T   S  +D + FG+ L E+ +
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 137/322 (42%), Gaps = 65/322 (20%)
Query: 219 FKELQSATSNFSSKNLV-----GKGGFGNVYK----------GYLQDGTVVAVKRLKDGN 263
           FK L+     F  KNLV     G+G FG V K          GY    T VAVK LK+ N
Sbjct: 10  FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKE-N 64
Query: 264 AIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAK 318
           A   E++   +E  ++    H ++++L G C      LL+  Y   GS+   L    K  
Sbjct: 65  ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124
Query: 319 PS------------LDWATRKRIALG--------AARGLLYLHEQCDPKIIHRDVKAANI 358
           P             LD    + + +G         ++G+ YL E    K++HRD+ A NI
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI 181
Query: 359 LLDEYYEAVVGDFGLAKLLDHCDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGIL 417
           L+ E  +  + DFGL++ +   DS V  +  R  V  +A E L     + ++DV+ FG+L
Sbjct: 182 LVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 418 LLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVA 477
           L E+++       G               I  E+   +L         D    EEM ++ 
Sbjct: 242 LWEIVT------LGGNP---------YPGIPPERLFNLLKTGHRMERPDNCS-EEMYRLM 285
Query: 478 LLCTQYLPSLRPKMSEVVRMLE 499
           L C +  P  RP  +++ + LE
Sbjct: 286 LQCWKQEPDKRPVFADISKDLE 307

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 227 SNFSSKNLVGKGGFGNVYK----GYLQDGTV--VAVKRLKDGNAIGGEIQFQTEVEMIS- 279
           +N      +G G FG V +    G  ++  V  VAVK LK       +    +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGL 337
           L  H N++ L+G C      L++  Y   G + +  R KA+  LD    + + L   R L
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL---RDL 162
Query: 338 LYLHEQ--------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAV 388
           L+   Q             IHRDV A N+LL   + A +GDFGLA+ +++  +  V    
Sbjct: 163 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           R  V  +APE +     + ++DV+ +GILL E+ S
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 122/284 (42%), Gaps = 27/284 (9%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           ++  + ++G G    V   Y       VA+KR+          +   E++ +S   H N+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLK---AKPS-----LDWATRKRIALGAARGLL 338
           +      +   E  LV   +S GSV   +K   AK       LD +T   I      GL 
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL----DHCDSHVTTAVRGTVGH 394
           YLH+      IHRDVKA NILL E     + DFG++  L    D   + V     GT   
Sbjct: 136 YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 395 IAPEYLSTGQSSE-KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 453
           +APE +   +  + K D++ FGI  +EL +G  A  + K    K  ML      +    L
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTLQ---NDPPSL 247
Query: 454 EMLV-DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
           E  V DK++   Y +    +M+    LC Q  P  RP  +E++R
Sbjct: 248 ETGVQDKEMLKKYGK-SFRKMIS---LCLQKDPEKRPTAAELLR 287

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 122/284 (42%), Gaps = 27/284 (9%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           ++  + ++G G    V   Y       VA+KR+          +   E++ +S   H N+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLK---AKPS-----LDWATRKRIALGAARGLL 338
           +      +   E  LV   +S GSV   +K   AK       LD +T   I      GL 
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL----DHCDSHVTTAVRGTVGH 394
           YLH+      IHRDVKA NILL E     + DFG++  L    D   + V     GT   
Sbjct: 131 YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 395 IAPEYLSTGQSSE-KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 453
           +APE +   +  + K D++ FGI  +EL +G  A  + K    K  ML      +    L
Sbjct: 188 MAPEVMEQVRGYDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTLQ---NDPPSL 242
Query: 454 EMLV-DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
           E  V DK++   Y +    +M+    LC Q  P  RP  +E++R
Sbjct: 243 ETGVQDKEMLKKYGK-SFRKMIS---LCLQKDPEKRPTAAELLR 282

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 27/234 (11%)
Query: 213 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ- 270
           +L       L+     F    LVG G +G VYKG +++ G + A+K +   +  G E + 
Sbjct: 10  SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEE 66
Query: 271 FQTEVEMIS-LAVHRNLLRLIGFCMTTT------ERLLVYPYMSNGSVASRLKAKP---- 319
            + E+ M+   + HRN+    G  +         +  LV  +   GSV   +K       
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 320 SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 379
             +W     I     RGL +LH+    K+IHRD+K  N+LL E  E  + DFG++  LD 
Sbjct: 127 KEEWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 380 CDSHVTTAVRGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELISGLRAL 428
                 T + GT   +APE ++  ++ +     K+D++  GI  +E+  G   L
Sbjct: 182 TVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 8/208 (3%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVE--M 277
           +++    +F    ++GKG FG V+   + +     A+K LK    +  +    T VE  +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 278 ISLAVHRNLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           +SLA     L  +     T E L  V  Y++ G +   +++    D +     A     G
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 131
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L +LH +    I++RD+K  NILLD+     + DFG+ K     D+  T    GT  +IA
Sbjct: 132 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNEFCGTPDYIA 187
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE L   + +   D + FG+LL E++ G
Sbjct: 188 PEILLGQKYNHSVDWWSFGVLLYEMLIG 215

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 122/275 (44%), Gaps = 42/275 (15%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVA 255
           N Q   + C+ ++KR           +   K  +G+G FG V+          QD  +VA
Sbjct: 26  NPQYFSDACVHHIKR----------RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVA 75
Query: 256 VKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL 315
           VK LK+ +    +  FQ E E++++  H++++R  G C      L+V+ YM +G +   L
Sbjct: 76  VKALKEASESARQ-DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134
Query: 316 K---------------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 360
           +               A   L       +A   A G++YL        +HRD+   N L+
Sbjct: 135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLV 191
Query: 361 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL 419
            +     +GDFG+++ +   D + V       +  + PE +   + + ++DV+ FG++L 
Sbjct: 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 251
Query: 420 ELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
           E+ +      +GK    + +  + +  I Q ++LE
Sbjct: 252 EIFT------YGKQPWYQLSNTEAIDCITQGRELE 280

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/87 (52%), Positives = 57/87 (65%), Gaps = 3/87 (3%)
Query: 30  LQNNNISGHIPTEIGKLS-KLLTLDLSNNFFTGPI-PSTVSHLE-TLQYLRLNNNSLTGA 86
           L  N  SG +P  +  LS  LLTLDLS+N F+GPI P+   + + TLQ L L NN  TG 
Sbjct: 347 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 406
Query: 87  IPPSLSNMSQLAFLDLSYNNLSGPVPS 113
           IPP+LSN S+L  L LS+N LSG +PS
Sbjct: 407 IPPTLSNCSELVSLHLSFNYLSGTIPS 433

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 13/217 (5%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVH 283
           ++FS   ++G+GGFG VY     D G + A+K L  K      GE     E  M+SL   
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 284 RN--LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
            +   +  + +   T ++L  +   M+ G +   L        A  +  A     GL ++
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
           H +    +++RD+K ANILLDE+    + D GLA        H +    GT G++APE L
Sbjct: 309 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 362
Query: 401 STGQSSEKT-DVFGFGILLLELISGLRALEFGKTANQ 436
             G + + + D F  G +L +L+ G       KT ++
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIG---GEIQFQTEVEMISLAV 282
           ++FS   ++G+GGFG VY     D G + A+K L D   I    GE     E  M+SL  
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVS 246
Query: 283 HRN--LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
             +   +  + +   T ++L  +   M+ G +   L        A  +  A     GL +
Sbjct: 247 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 306
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           +H +    +++RD+K ANILLDE+    + D GLA        H +    GT G++APE 
Sbjct: 307 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 360
Query: 400 LSTGQSSEKT-DVFGFGILLLELISGLRALEFGKTANQ 436
           L  G + + + D F  G +L +L+ G       KT ++
Sbjct: 361 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 398

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/87 (52%), Positives = 57/87 (65%), Gaps = 3/87 (3%)
Query: 30  LQNNNISGHIPTEIGKLS-KLLTLDLSNNFFTGPI-PSTVSHLE-TLQYLRLNNNSLTGA 86
           L  N  SG +P  +  LS  LLTLDLS+N F+GPI P+   + + TLQ L L NN  TG 
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 87  IPPSLSNMSQLAFLDLSYNNLSGPVPS 113
           IPP+LSN S+L  L LS+N LSG +PS
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPS 436

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 87/198 (43%), Gaps = 13/198 (6%)
Query: 235 VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLR 288
           +G G FG V +G           VAVK LK       E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           L G  +T   ++ V      GS+  RL K +      T  R A+  A G+ YL  +   +
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---R 131
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV--GHIAPEYLSTGQS 405
            IHRD+ A N+LL       +GDFGL + L   D H        V     APE L T   
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 406 SEKTDVFGFGILLLELIS 423
           S  +D + FG+ L E+ +
Sbjct: 192 SHASDTWMFGVTLWEMFT 209

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 87/198 (43%), Gaps = 13/198 (6%)
Query: 235 VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLR 288
           +G G FG V +G           VAVK LK       E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           L G  +T   ++ V      GS+  RL K +      T  R A+  A G+ YL  +   +
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---R 131
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV--GHIAPEYLSTGQS 405
            IHRD+ A N+LL       +GDFGL + L   D H        V     APE L T   
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTF 191
Query: 406 SEKTDVFGFGILLLELIS 423
           S  +D + FG+ L E+ +
Sbjct: 192 SHASDTWMFGVTLWEMFT 209

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIG---GEIQFQTEVEMISLAV 282
           ++FS   ++G+GGFG VY     D G + A+K L D   I    GE     E  M+SL  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVS 247
Query: 283 HRN--LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
             +   +  + +   T ++L  +   M+ G +   L        A  +  A     GL +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           +H +    +++RD+K ANILLDE+    + D GLA        H +    GT G++APE 
Sbjct: 308 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 361
Query: 400 LSTGQSSEKT-DVFGFGILLLELISGLRALEFGKTANQ 436
           L  G + + + D F  G +L +L+ G       KT ++
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIG---GEIQFQTEVEMISLAV 282
           ++FS   ++G+GGFG VY     D G + A+K L D   I    GE     E  M+SL  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVS 247
Query: 283 HRN--LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
             +   +  + +   T ++L  +   M+ G +   L        A  +  A     GL +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           +H +    +++RD+K ANILLDE+    + D GLA        H +    GT G++APE 
Sbjct: 308 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 361
Query: 400 LSTGQSSEKT-DVFGFGILLLELISGLRALEFGKTANQ 436
           L  G + + + D F  G +L +L+ G       KT ++
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-- 287
           +GKG FG+V       L D  G +VAVK+L+       +  FQ E++++  A+H + +  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILK-ALHSDFIVK 75
Query: 288 -RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-- 344
            R + +        LV  Y+ +G +          D+  R R  L A+R LLY  + C  
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLR---------DFLQRHRARLDASRLLLYSSQICKG 126
Query: 345 -----DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL--LDHCDSHVTTAVRGTVGHIAP 397
                  + +HRD+ A NIL++      + DFGLAKL  LD     V    +  +   AP
Sbjct: 127 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 186
Query: 398 EYLSTGQSSEKTDVFGFGILLLELIS 423
           E LS    S ++DV+ FG++L EL +
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 8/208 (3%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVE--M 277
           +++    +F    ++GKG FG V+   + +     A+K LK    +  +    T VE  +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 278 ISLAVHRNLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           +SLA     L  +     T E L  V  Y++ G +   +++    D +     A     G
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 130
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L +LH +    I++RD+K  NILLD+     + DFG+ K     D+  T    GT  +IA
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGTPDYIA 186
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE L   + +   D + FG+LL E++ G
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 229 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHR 284
           FS    +G G FG VY    +++  VVA+K++        E ++Q    EV  +    H 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 114
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQ 343
           N ++  G  +      LV  Y   GS +  L+  K  L       +  GA +GL YLH  
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---L 400
               +IHRDVKA NILL E     +GDFG A ++   +  V     GT   +APE    +
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 225
Query: 401 STGQSSEKTDVFGFGILLLEL 421
             GQ   K DV+  GI  +EL
Sbjct: 226 DEGQYDGKVDVWSLGITCIEL 246

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 88/322 (27%), Positives = 136/322 (42%), Gaps = 65/322 (20%)
Query: 219 FKELQSATSNFSSKNLV-----GKGGFGNVYK----------GYLQDGTVVAVKRLKDGN 263
           FK L+     F  KNLV     G+G FG V K          GY    T VAVK LK+ N
Sbjct: 10  FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKE-N 64
Query: 264 AIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAK 318
           A   E++   +E  ++    H ++++L G C      LL+  Y   GS+   L    K  
Sbjct: 65  ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124
Query: 319 PS------------LDWATRKRIALG--------AARGLLYLHEQCDPKIIHRDVKAANI 358
           P             LD    + + +G         ++G+ YL E     ++HRD+ A NI
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNI 181
Query: 359 LLDEYYEAVVGDFGLAKLLDHCDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGIL 417
           L+ E  +  + DFGL++ +   DS V  +  R  V  +A E L     + ++DV+ FG+L
Sbjct: 182 LVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 418 LLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVA 477
           L E+++       G               I  E+   +L         D    EEM ++ 
Sbjct: 242 LWEIVT------LGGNP---------YPGIPPERLFNLLKTGHRMERPDNCS-EEMYRLM 285
Query: 478 LLCTQYLPSLRPKMSEVVRMLE 499
           L C +  P  RP  +++ + LE
Sbjct: 286 LQCWKQEPDKRPVFADISKDLE 307

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 87/198 (43%), Gaps = 13/198 (6%)
Query: 235 VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLR 288
           +G G FG V +G           VAVK LK       E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           L G  +T   ++ V      GS+  RL K +      T  R A+  A G+ YL  +   +
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---R 131
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV--GHIAPEYLSTGQS 405
            IHRD+ A N+LL       +GDFGL + L   D H        V     APE L T   
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 406 SEKTDVFGFGILLLELIS 423
           S  +D + FG+ L E+ +
Sbjct: 192 SHASDTWMFGVTLWEMFT 209

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG V   Y  D      G +VAVK LK          ++ E++++    H ++++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 289 LIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
             G C    E+   LV  Y+  GS+   L  + S+  A     A     G+ YLH Q   
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHSQ--- 136
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLST 402
             IHR++ A N+LLD      +GDFGLAK +   + H    VR      V   APE L  
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 403 GQSSEKTDVFGFGILLLELIS 423
            +    +DV+ FG+ L EL++
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-- 287
           +GKG FG+V       L D  G +VAVK+L+       +  FQ E++++  A+H + +  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILK-ALHSDFIVK 88
Query: 288 -RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-- 344
            R + +        LV  Y+ +G +          D+  R R  L A+R LLY  + C  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLR---------DFLQRHRARLDASRLLLYSSQICKG 139
Query: 345 -----DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL--LDHCDSHVTTAVRGTVGHIAP 397
                  + +HRD+ A NIL++      + DFGLAKL  LD     V    +  +   AP
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 398 EYLSTGQSSEKTDVFGFGILLLELIS 423
           E LS    S ++DV+ FG++L EL +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V  G  +    VA+K +K+G+    E +F  E +++    H  L++L G C 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCDPKIIHRD 352
                 ++  YM+NG + + L+      + T++ + +       + YL  +   + +HRD
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRD 129
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV--RGTVGHIAPEYLSTGQSSEKTD 410
           + A N L+++     V DFGL++ +   D   T++V  +  V    PE L   + S K+D
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 187
Query: 411 VFGFGILLLELISGLRALEFGKTANQKGA 439
           ++ FG+L+ E+ S L  + + +  N + A
Sbjct: 188 IWAFGVLMWEIYS-LGKMPYERFTNSETA 215

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 11/208 (5%)
Query: 224 SATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
           S++S F     +G G +  VYKG  +  G  VA+K +K  +  G       E+ ++    
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG---SVASRL--KAKPSLDWATRKRIALGAARGL 337
           H N++RL     T  +  LV+ +M N     + SR        L+    K       +GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
            + HE    KI+HRD+K  N+L+++  +  +GDFGLA+      +  ++ V  T+ + AP
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAP 177
Query: 398 EYLSTGQS-SEKTDVFGFGILLLELISG 424
           + L   ++ S   D++  G +L E+I+G
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITG 205

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 227 SNFSSKNLVGKGGFGNVYK----GYLQDGTV--VAVKRLKDGNAIGGEIQFQTEVEMIS- 279
           +N      +G G FG V +    G  ++  V  VAVK LK       +    +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARG 336
           L  H N++ L+G C      L++  Y   G + + L+ K  +   D A     +  + R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 337 LLYLHEQ--------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTA 387
           LL+   Q             IHRDV A N+LL   + A +GDFGLA+ +++  +  V   
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
            R  V  +APE +     + ++DV+ +GILL E+ S
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 235 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-- 287
           +GKG FG+V       L D  G +VAVK+L+       +  FQ E++++  A+H + +  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILK-ALHSDFIVK 76
Query: 288 -RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-- 344
            R + +        LV  Y+ +G +          D+  R R  L A+R LLY  + C  
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLR---------DFLQRHRARLDASRLLLYSSQICKG 127
Query: 345 -----DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL--LDHCDSHVTTAVRGTVGHIAP 397
                  + +HRD+ A NIL++      + DFGLAKL  LD     V    +  +   AP
Sbjct: 128 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 187
Query: 398 EYLSTGQSSEKTDVFGFGILLLELIS 423
           E LS    S ++DV+ FG++L EL +
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 229 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHR 284
           FS    +G G FG VY    +++  VVA+K++        E ++Q    EV  +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQ 343
           N ++  G  +      LV  Y   GS +  L+  K  L       +  GA +GL YLH  
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---L 400
               +IHRDVKA NILL E     +GDFG A ++   +  V     GT   +APE    +
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 186
Query: 401 STGQSSEKTDVFGFGILLLEL 421
             GQ   K DV+  GI  +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V  G  +    VA+K +K+G+    E +F  E +++    H  L++L G C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCDPKIIHRD 352
                 ++  YM+NG + + L+      + T++ + +       + YL  +   + +HRD
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRD 125
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV--RGTVGHIAPEYLSTGQSSEKTD 410
           + A N L+++     V DFGL++ +   D   T++V  +  V    PE L   + S K+D
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 411 VFGFGILLLELISGLRALEFGKTANQKGA 439
           ++ FG+L+ E+ S L  + + +  N + A
Sbjct: 184 IWAFGVLMWEIYS-LGKMPYERFTNSETA 211

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V  G  +    VA+K +K+G+    E +F  E +++    H  L++L G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCDPKIIHRD 352
                 ++  YM+NG + + L+      + T++ + +       + YL  +   + +HRD
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRD 130
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV--RGTVGHIAPEYLSTGQSSEKTD 410
           + A N L+++     V DFGL++ +   D   T++V  +  V    PE L   + S K+D
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 411 VFGFGILLLELISGLRALEFGKTANQKGA 439
           ++ FG+L+ E+ S L  + + +  N + A
Sbjct: 189 IWAFGVLMWEIYS-LGKMPYERFTNSETA 216

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 123/273 (45%), Gaps = 37/273 (13%)
Query: 234 LVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY+G       +   VAVK  K    +  + +F +E  ++    H ++++L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 290 IGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           IG        ++  +YPY   G    R   K SL   T    +L   + + YL       
Sbjct: 91  IGIIEEEPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESI---N 145
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
            +HRD+   NIL+       +GDFGL++ ++  D +  +  R  +  ++PE ++  + + 
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 205
Query: 408 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 467
            +DV+ F + + E++S      FGK          W+    + K +  +++K      DR
Sbjct: 206 ASDVWMFAVCMWEILS------FGKQP------FFWL----ENKDVIGVLEKG-----DR 244
Query: 468 IELEEMVQVALL-----CTQYLPSLRPKMSEVV 495
           +   ++    L      C  Y PS RP+ +E+V
Sbjct: 245 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 277

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V  G  +    VA+K +K+G+    E +F  E +++    H  L++L G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 295 TTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 ++  YM+NG + + L+  +          +       + YL  +   + +HRD+
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 146
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV--RGTVGHIAPEYLSTGQSSEKTDV 411
            A N L+++     V DFGL++ +   D   T++V  +  V    PE L   + S K+D+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 412 FGFGILLLELISGLRALEFGKTANQKGA 439
           + FG+L+ E+ S L  + + +  N + A
Sbjct: 205 WAFGVLMWEIYS-LGKMPYERFTNSETA 231

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG V   Y  D      G +VAVK LK          ++ E++++    H ++++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 289 LIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
             G C    E+   LV  Y+  GS+   L  + S+  A     A     G+ YLH Q   
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ--- 136
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLST 402
             IHR++ A N+LLD      +GDFGLAK +   + H    VR      V   APE L  
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 403 GQSSEKTDVFGFGILLLELIS 423
            +    +DV+ FG+ L EL++
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 123/273 (45%), Gaps = 37/273 (13%)
Query: 234 LVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY+G       +   VAVK  K    +  + +F +E  ++    H ++++L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 290 IGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           IG        ++  +YPY   G    R   K SL   T    +L   + + YL       
Sbjct: 79  IGIIEEEPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESI---N 133
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
            +HRD+   NIL+       +GDFGL++ ++  D +  +  R  +  ++PE ++  + + 
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 408 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 467
            +DV+ F + + E++S      FGK          W+    + K +  +++K      DR
Sbjct: 194 ASDVWMFAVCMWEILS------FGKQP------FFWL----ENKDVIGVLEKG-----DR 232
Query: 468 IELEEMVQVALL-----CTQYLPSLRPKMSEVV 495
           +   ++    L      C  Y PS RP+ +E+V
Sbjct: 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 265

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 123/273 (45%), Gaps = 37/273 (13%)
Query: 234 LVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           ++G+G FG VY+G       +   VAVK  K    +  + +F +E  ++    H ++++L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 290 IGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           IG        ++  +YPY   G    R   K SL   T    +L   + + YL       
Sbjct: 75  IGIIEEEPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESI---N 129
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
            +HRD+   NIL+       +GDFGL++ ++  D +  +  R  +  ++PE ++  + + 
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 189
Query: 408 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 467
            +DV+ F + + E++S      FGK          W+    + K +  +++K      DR
Sbjct: 190 ASDVWMFAVCMWEILS------FGKQP------FFWL----ENKDVIGVLEKG-----DR 228
Query: 468 IELEEMVQVALL-----CTQYLPSLRPKMSEVV 495
           +   ++    L      C  Y PS RP+ +E+V
Sbjct: 229 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 261

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 233 NLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
            ++G G FG VYKG ++ DG      VA+K L++  +     +   E  +++      + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVAS-------RLKAKPSLDWATRKRIALGAARGLLYL 340
           RL+G C+T+T +L V   M  G +         RL ++  L+W       +  A+G+ YL
Sbjct: 83  RLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWC------MQIAKGMSYL 135
Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 398
               D +++HRD+ A N+L+       + DFGLA+LL  D  + H     +  +  +A E
Sbjct: 136 E---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG-KVPIKWMALE 191
Query: 399 YLSTGQSSEKTDVFGFGILLLELIS 423
            +   + + ++DV+ +G+ + EL++
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 227 SNFSSKNLVGKGGFGNVYK----GYLQDGTV--VAVKRLKDGNAIGGEIQFQTEVEMIS- 279
           +N      +G G FG V +    G  ++  V  VAVK LK       +    +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA---TRKRIALGAA 334
           L  H N++ L+G C      L++  Y   G + + L+ K  P L+++   +       ++
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 335 RGLLYLHEQ--------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVT 385
           R LL+   Q             IHRDV A N+LL   + A +GDFGLA+ +++  +  V 
Sbjct: 166 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
              R  V  +APE +     + ++DV+ +GILL E+ S
Sbjct: 226 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 7/206 (3%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V  G  +    VA+K +K+G+    E +F  E +++    H  L++L G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 295 TTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 ++  YM+NG + + L+  +          +       + YL  +   + +HRD+
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 146
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
            A N L+++     V DFGL++ +   +   +   +  V    PE L   + S K+D++ 
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 414 FGILLLELISGLRALEFGKTANQKGA 439
           FG+L+ E+ S L  + + +  N + A
Sbjct: 207 FGVLMWEIYS-LGKMPYERFTNSETA 231

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V  G  +    VA+K +K+G+    E +F  E +++    H  L++L G C 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCDPKIIHRD 352
                 ++  YM+NG + + L+      + T++ + +       + YL  +   + +HRD
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRD 136
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV--RGTVGHIAPEYLSTGQSSEKTD 410
           + A N L+++     V DFGL++ +   D   T++V  +  V    PE L   + S K+D
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 194
Query: 411 VFGFGILLLELISGLRALEFGKTANQKGA 439
           ++ FG+L+ E+ S L  + + +  N + A
Sbjct: 195 IWAFGVLMWEIYS-LGKMPYERFTNSETA 222

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 102/231 (44%), Gaps = 16/231 (6%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMI---S 279
           ATS +     +G G +G VYK      G  VA+K ++  N   G  I    EV ++    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 280 LAVHRNLLRLIGFCMTT-TER----LLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGA 333
              H N++RL+  C T+ T+R     LV+ ++         KA P  L   T K +    
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 393
            RGL +LH  C   I+HRD+K  NIL+       + DFGLA++  +  +     V  T+ 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV--TLW 176
Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
           + APE L     +   D++  G +  E+            A+Q G + D +
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 120/269 (44%), Gaps = 42/269 (15%)
Query: 208 EVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKD 261
           + C+ ++KR           +   K  +G+G FG V+          QD  +VAVK LK+
Sbjct: 3   DACVHHIKR----------RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE 52
Query: 262 GNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----- 316
            +    +  FQ E E++++  H++++R  G C      L+V+ YM +G +   L+     
Sbjct: 53  ASESARQ-DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPD 111
Query: 317 ----------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 366
                     A   L       +A   A G++YL        +HRD+   N L+ +    
Sbjct: 112 AKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVV 168
Query: 367 VVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 425
            +GDFG+++ +   D + V       +  + PE +   + + ++DV+ FG++L E+ +  
Sbjct: 169 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT-- 226
Query: 426 RALEFGKTANQKGAMLDWVKKIHQEKKLE 454
               +GK    + +  + +  I Q ++LE
Sbjct: 227 ----YGKQPWYQLSNTEAIDCITQGRELE 251

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 120/269 (44%), Gaps = 42/269 (15%)
Query: 208 EVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKD 261
           + C+ ++KR           +   K  +G+G FG V+          QD  +VAVK LK+
Sbjct: 9   DACVHHIKR----------RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE 58
Query: 262 GNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----- 316
            +    +  FQ E E++++  H++++R  G C      L+V+ YM +G +   L+     
Sbjct: 59  ASESARQ-DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPD 117
Query: 317 ----------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 366
                     A   L       +A   A G++YL        +HRD+   N L+ +    
Sbjct: 118 AKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVV 174
Query: 367 VVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 425
            +GDFG+++ +   D + V       +  + PE +   + + ++DV+ FG++L E+ +  
Sbjct: 175 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT-- 232
Query: 426 RALEFGKTANQKGAMLDWVKKIHQEKKLE 454
               +GK    + +  + +  I Q ++LE
Sbjct: 233 ----YGKQPWYQLSNTEAIDCITQGRELE 257

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 236 GKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA--VHRNLLRLIGF 292
            +G FG V+K  L  D   V +  L+D  +      +Q+E E+ S     H NLL+ I  
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFPLQDKQS------WQSEREIFSTPGMKHENLLQFIAA 77
Query: 293 ----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC---- 344
                    E  L+  +   GS+   LK    + W     +A   +RGL YLHE      
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKGN-IITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 345 ----DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD----HCDSHVTTAVRGTVGHIA 396
                P I HRD K+ N+LL     AV+ DFGLA   +      D+H      GT  ++A
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GTRRYMA 193
Query: 397 PEYLSTGQSSE-----KTDVFGFGILLLELISGLRA 427
           PE L    + +     + D++  G++L EL+S  +A
Sbjct: 194 PEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKA 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 102/231 (44%), Gaps = 16/231 (6%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMI---S 279
           ATS +     +G G +G VYK      G  VA+K ++  N   G  I    EV ++    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 280 LAVHRNLLRLIGFCMTT-TER----LLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGA 333
              H N++RL+  C T+ T+R     LV+ ++         KA P  L   T K +    
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 393
            RGL +LH  C   I+HRD+K  NIL+       + DFGLA++  +  +     V  T+ 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV--TLW 176
Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
           + APE L     +   D++  G +  E+            A+Q G + D +
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDV 191
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 192 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 224

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDV 190
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 191 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 223

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V  G  +    VA+K +K+G+    E +F  E +++    H  L++L G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 295 TTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 ++  YM+NG + + L+  +          +       + YL  +   + +HRD+
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 131
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT---VGHIAPEYLSTGQSSEKTD 410
            A N L+++     V DFGL++ +   D   T++ RG+   V    PE L   + S K+D
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-RGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 411 VFGFGILLLELISGLRALEFGKTANQKGA 439
           ++ FG+L+ E+ S L  + + +  N + A
Sbjct: 189 IWAFGVLMWEIYS-LGKMPYERFTNSETA 216

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 234 LVGKGGFGNVYKGYLQDGTV----VAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLL 287
           +V K G G +   YL + T+    VA+K +        E   +F+ EV   S   H+N++
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
            +I          LV  Y+   +++  +++   L   T          G+ + H   D +
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
           I+HRD+K  NIL+D      + DFG+AK L       T  V GTV + +PE      + E
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 408 KTDVFGFGILLLELISG 424
            TD++  GI+L E++ G
Sbjct: 192 CTDIYSIGIVLYEMLVG 208

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYK----GYLQDGTV--VAVKRLKDGNAIGGEIQFQTEVEMIS- 279
           +N      +G G FG V +    G  ++  V  VAVK LK       +    +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-------PSLDWA-----TRK 327
           L  H N++ L+G C      L++  Y   G + + L+ K       P+   A     TR 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 328 RIALGA--ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHV 384
            +   +  A+G+ +L  +     IHRDV A N+LL   + A +GDFGLA+ +++  +  V
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
               R  V  +APE +     + ++DV+ +GILL E+ S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDV 190
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 191 WSCGIVLTAMLAG--ELPWDQPSDSXQEYSDWKEK 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L++   M  G +   ++           L+W  +       A
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 129 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 184
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L++   M  G +   ++           L+W  +       A
Sbjct: 75  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 183
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 34/227 (14%)
Query: 228 NFSSKNLVGKGGFGNVYK----GYLQDGTV--VAVKRLKDGNAIGGEIQFQTEVEMIS-L 280
           N     ++G G FG V      G  + G    VAVK LK+           +E++M++ L
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK------PSLDWATRKRI----- 329
             H N++ L+G C  +    L++ Y   G + + L++K        +++  +KR+     
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 330 ------------ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-L 376
                       A   A+G+ +L  +     +HRD+ A N+L+       + DFGLA+ +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           +   +  V    R  V  +APE L  G  + K+DV+ +GILL E+ S
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 85  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 137
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 138 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 193
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L++   M  G +   ++           L+W  +       A
Sbjct: 78  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 186
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L++   M  G +   ++           L+W  +       A
Sbjct: 79  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 132 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 187
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 235 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G+G FG V   Y  D      G +VAVK LK          ++ E++++    H ++++
Sbjct: 39  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 289 LIGFC--MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
             G C         LV  Y+  GS+   L  + S+  A     A     G+ YLH Q   
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ--- 153
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLST 402
             IHRD+ A N+LLD      +GDFGLAK +   + H    VR      V   APE L  
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP--EGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 403 GQSSEKTDVFGFGILLLELIS 423
            +    +DV+ FG+ L EL++
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L++   M  G +   ++           L+W  +       A
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 185
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 16/231 (6%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMI---S 279
           ATS +     +G G +G VYK      G  VA+K ++  N   G  I    EV ++    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 280 LAVHRNLLRLIGFCMTT-TER----LLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGA 333
              H N++RL+  C T+ T+R     LV+ ++         KA P  L   T K +    
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 393
            RGL +LH  C   I+HRD+K  NIL+       + DFGLA++  +        V  T+ 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALDPVVVTLW 176
Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
           + APE L     +   D++  G +  E+            A+Q G + D +
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L++   M  G +   ++           L+W  +       A
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQ-LMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 129 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 184
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 233 NLVGKGGFGNVYKGYLQ-DGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           + +G G FG V  G  +  G  VAVK     +++  + +G   + + E++ + L  H ++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG---KIRREIQNLKLFRHPHI 78
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           ++L     T ++  +V  Y+S G +   +     LD    +R+      G+ Y H     
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QS 405
            ++HRD+K  N+LLD +  A + DFGL+ ++   D        G+  + APE +S    +
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRXSCGSPNYAAPEVISGRLYA 193
Query: 406 SEKTDVFGFGILLLELISG 424
             + D++  G++L  L+ G
Sbjct: 194 GPEVDIWSSGVILYALLCG 212

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 186
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDV 190
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 191 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 223

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 183
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 100 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 152
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 153 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 208
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 186
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 191 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 223

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 185
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 18/227 (7%)
Query: 235 VGKGGFGNVYKGYL---QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +G G FG+V +G     +    VA+K LK G       +   E +++    +  ++RLIG
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 292 FCMTTTERLLVYPYMSNGSVASR--LKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
            C    E L++   M+ G    +  +  +  +  +    +    + G+ YL E+     +
Sbjct: 78  VC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFV 132
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPEYLSTGQSSE 407
           HRD+ A N+LL   + A + DFGL+K L   DS+ T  +A +  +   APE ++  + S 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 408 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
           ++DV+ +G+ + E      AL +G+   +K    + +  I Q K++E
Sbjct: 193 RSDVWSYGVTMWE------ALSYGQKPYKKMKGPEVMAFIEQGKRME 233

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 186
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 183
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQ-LMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 183
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDV 190
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 191 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 223

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 31/268 (11%)
Query: 235 VGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G  +T     ++    + G + S L+ +  SLD A+    A   +  L YL  +   + +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFV 133
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSSE 407
           HRD+ A N+L+       +GDFGL++ ++  DS    A +G   +  +APE ++  + + 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 408 KTDVFGFGILLLE-LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 466
            +DV+ FG+ + E L+ G++  + G   N      D + +I   ++L M  +        
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQ-GVKNN------DVIGRIENGERLPMPPNCP------ 238
Query: 467 RIELEEMVQVALLCTQYLPSLRPKMSEV 494
                 +  +   C  Y PS RP+ +E+
Sbjct: 239 ----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 81  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 133
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 134 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 189
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 44/228 (19%)
Query: 228 NFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +F    L+G GGFG V+K  +  DG    ++R+K  N      + + EV+ ++   H N+
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNE-----KAEREVKALAKLDHVNI 67
Query: 287 LRLIGFCM--------TTTERLLVYPYM-SNGSVASRLKAKPSL------------DWAT 325
           +   G C         T+ + L    Y   N   +SR K K                W  
Sbjct: 68  VHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 126
Query: 326 RKR-------IAL----GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 374
           ++R       +AL       +G+ Y+H +   K+IHRD+K +NI L +  +  +GDFGL 
Sbjct: 127 KRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 422
             L +      T  +GT+ +++PE +S+    ++ D++  G++L EL+
Sbjct: 184 TSLKN--DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 121
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 122 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 177
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 190
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ + ++  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 192 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 224

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 123/266 (46%), Gaps = 27/266 (10%)
Query: 235 VGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LI
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G  +T     ++    + G + S L+  K SLD A+    A   +  L YL  +   + +
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFV 161
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           HRD+ A N+L+       +GDFGL++ ++    +  +  +  +  +APE ++  + +  +
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 221
Query: 410 DVFGFGILLLE-LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           DV+ FG+ + E L+ G++  + G   N      D + +I   ++L M  +          
Sbjct: 222 DVWMFGVCMWEILMHGVKPFQ-GVKNN------DVIGRIENGERLPMPPNCP-------- 266
Query: 469 ELEEMVQVALLCTQYLPSLRPKMSEV 494
               +  +   C  Y PS RP+ +E+
Sbjct: 267 --PTLYSLMTKCWAYDPSRRPRFTEL 290

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 192 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 224

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 19/234 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----EIQFQTEVEMI- 278
           ATS +     +G G +G VYK      G  VA+K ++  N  GG     I    EV ++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 279 --SLAVHRNLLRLIGFCMTT-TER----LLVYPYMSNGSVASRLKAKPS-LDWATRKRIA 330
                 H N++RL+  C T+ T+R     LV+ ++         KA P  L   T K + 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 390
               RGL +LH  C   I+HRD+K  NIL+       + DFGLA++  +      T V  
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALTPVVV 181
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
           T+ + APE L     +   D++  G +  E+            A+Q G + D +
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 191 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 223

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 191 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 223

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDI 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 191 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 223

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 123/266 (46%), Gaps = 27/266 (10%)
Query: 235 VGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G  +T     ++    + G + S L+  K SLD A+    A   +  L YL  +   + +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFV 133
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           HRD+ A N+L+       +GDFGL++ ++    +  +  +  +  +APE ++  + +  +
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 193
Query: 410 DVFGFGILLLE-LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           DV+ FG+ + E L+ G++  + G   N      D + +I   ++L M  +          
Sbjct: 194 DVWMFGVCMWEILMHGVKPFQ-GVKNN------DVIGRIENGERLPMPPNCP-------- 238
Query: 469 ELEEMVQVALLCTQYLPSLRPKMSEV 494
               +  +   C  Y PS RP+ +E+
Sbjct: 239 --PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 192 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 224

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 18/227 (7%)
Query: 235 VGKGGFGNVYKGYL---QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +G G FG+V +G     +    VA+K LK G       +   E +++    +  ++RLIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 292 FCMTTTERLLVYPYMSNGSVASR--LKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
            C    E L++   M+ G    +  +  +  +  +    +    + G+ YL E+     +
Sbjct: 404 VCQA--EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFV 458
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPEYLSTGQSSE 407
           HR++ A N+LL   + A + DFGL+K L   DS+ T  +A +  +   APE ++  + S 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 408 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
           ++DV+ +G+ + E      AL +G+   +K    + +  I Q K++E
Sbjct: 519 RSDVWSYGVTMWE------ALSYGQKPYKKMKGPEVMAFIEQGKRME 559

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 191 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 223

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 123/266 (46%), Gaps = 27/266 (10%)
Query: 235 VGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LI
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G  +T     ++    + G + S L+  K SLD A+    A   +  L YL  +   + +
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFV 138
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           HRD+ A N+L+       +GDFGL++ ++    +  +  +  +  +APE ++  + +  +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 198
Query: 410 DVFGFGILLLE-LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           DV+ FG+ + E L+ G++  + G   N      D + +I   ++L M  +          
Sbjct: 199 DVWMFGVCMWEILMHGVKPFQ-GVKNN------DVIGRIENGERLPMPPNCP-------- 243
Query: 469 ELEEMVQVALLCTQYLPSLRPKMSEV 494
               +  +   C  Y PS RP+ +E+
Sbjct: 244 --PTLYSLMTKCWAYDPSRRPRFTEL 267

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 129
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 130 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 189
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 190 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 222

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 228 NFSSKNLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQ-FQTEVEMISLAV 282
            F+   ++GKG FG+V +  L  +DG+ V  AVK LK       +I+ F  E   +    
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 283 HRNLLRLIGFCMTTTER------LLVYPYMSNGSV-----ASRLKAKP-SLDWATRKRIA 330
           H ++ +L+G  + +  +      +++ P+M +G +     ASR+   P +L   T  R  
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVR 389
           +  A G+ YL  +     IHRD+ A N +L E     V DFGL++ +   D +    A +
Sbjct: 144 VDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             V  +A E L+    +  +DV+ FG+ + E+++
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 191 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 223

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/266 (23%), Positives = 123/266 (46%), Gaps = 27/266 (10%)
Query: 235 VGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G  +T     ++    + G + S L+ +  SLD A+    A   +  L YL  +   + +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFV 133
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           HRD+ A N+L+       +GDFGL++ ++    +  +  +  +  +APE ++  + +  +
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 193
Query: 410 DVFGFGILLLE-LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           DV+ FG+ + E L+ G++  + G   N      D + +I   ++L M  +          
Sbjct: 194 DVWMFGVCMWEILMHGVKPFQ-GVKNN------DVIGRIENGERLPMPPNCP-------- 238
Query: 469 ELEEMVQVALLCTQYLPSLRPKMSEV 494
               +  +   C  Y PS RP+ +E+
Sbjct: 239 --PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 192 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 224

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 192 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 224

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 192 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 224

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 192 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 224

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 9/218 (4%)
Query: 211 LGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 269
           LG ++   +K+ +     +  ++++G G F  V      +   +VA+K +      G E 
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG 61
Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
             + E+ ++    H N++ L     +     L+   +S G +  R+  K         R+
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANIL---LDEYYEAVVGDFGLAKLLDHCDSHVTT 386
                  + YLH   D  I+HRD+K  N+L   LDE  + ++ DFGL+K+ D     V +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLS 176
Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
              GT G++APE L+    S+  D +  G++   L+ G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 9/218 (4%)
Query: 211 LGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 269
           LG ++   +K+ +     +  ++++G G F  V      +   +VA+K +      G E 
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG 61
Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
             + E+ ++    H N++ L     +     L+   +S G +  R+  K         R+
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANIL---LDEYYEAVVGDFGLAKLLDHCDSHVTT 386
                  + YLH   D  I+HRD+K  N+L   LDE  + ++ DFGL+K+ D     V +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLS 176
Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
              GT G++APE L+    S+  D +  G++   L+ G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 125/268 (46%), Gaps = 31/268 (11%)
Query: 235 VGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LI
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G  +T     ++    + G + S L+  K SLD A+    A   +  L YL  +   + +
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFV 136
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSSE 407
           HRD+ A N+L+       +GDFGL++ ++  DS    A +G   +  +APE ++  + + 
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 408 KTDVFGFGILLLE-LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 466
            +DV+ FG+ + E L+ G++  + G   N      D + +I   ++L M  +        
Sbjct: 195 ASDVWMFGVCMWEILMHGVKPFQ-GVKNN------DVIGRIENGERLPMPPNCP------ 241
Query: 467 RIELEEMVQVALLCTQYLPSLRPKMSEV 494
                 +  +   C  Y PS RP+ +E+
Sbjct: 242 ----PTLYSLMTKCWAYDPSRRPRFTEL 265

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 125/268 (46%), Gaps = 31/268 (11%)
Query: 235 VGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LI
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G  +T     ++    + G + S L+  K SLD A+    A   +  L YL  +   + +
Sbjct: 75  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFV 130
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSSE 407
           HRD+ A N+L+       +GDFGL++ ++  DS    A +G   +  +APE ++  + + 
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 408 KTDVFGFGILLLE-LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 466
            +DV+ FG+ + E L+ G++  + G   N      D + +I   ++L M  +        
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQ-GVKNN------DVIGRIENGERLPMPPNCP------ 235
Query: 467 RIELEEMVQVALLCTQYLPSLRPKMSEV 494
                 +  +   C  Y PS RP+ +E+
Sbjct: 236 ----PTLYSLMTKCWAYDPSRRPRFTEL 259

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 123/266 (46%), Gaps = 27/266 (10%)
Query: 235 VGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G  +T     ++    + G + S L+  K SLD A+    A   +  L YL  +   + +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFV 133
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           HRD+ A N+L+       +GDFGL++ ++    +  +  +  +  +APE ++  + +  +
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 193
Query: 410 DVFGFGILLLE-LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           DV+ FG+ + E L+ G++  + G   N      D + +I   ++L M  +          
Sbjct: 194 DVWMFGVCMWEILMHGVKPFQ-GVKNN------DVIGRIENGERLPMPPNCP-------- 238
Query: 469 ELEEMVQVALLCTQYLPSLRPKMSEV 494
               +  +   C  Y PS RP+ +E+
Sbjct: 239 --PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 8/215 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G V     +     VAVK +    A+      + E+ +  +  H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                + L   Y S G +  R++    +     +R       G++YLH      I HRD+
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
           +  GI+L  +++G   L + + ++      DW +K
Sbjct: 191 WSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEK 223

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 9/218 (4%)
Query: 211 LGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 269
           LG ++   +K+ +     +  ++++G G F  V      +   +VA+K +      G E 
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG 61
Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
             + E+ ++    H N++ L     +     L+   +S G +  R+  K         R+
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANIL---LDEYYEAVVGDFGLAKLLDHCDSHVTT 386
                  + YLH   D  I+HRD+K  N+L   LDE  + ++ DFGL+K+ D     V +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLS 176
Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
              GT G++APE L+    S+  D +  G++   L+ G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/266 (23%), Positives = 122/266 (45%), Gaps = 27/266 (10%)
Query: 235 VGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LI
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G  +T     ++    + G + S L+  K SLD A+    A   +  L YL  +   + +
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFV 135
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           HRD+ A N+L+       +GDFGL++ ++    +  +  +  +  +APE ++  + +  +
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 195
Query: 410 DVFGFGILLLE-LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           DV+ FG+ + E L+ G++  +  K         D + +I   ++L M  +          
Sbjct: 196 DVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERLPMPPNCP-------- 240
Query: 469 ELEEMVQVALLCTQYLPSLRPKMSEV 494
               +  +   C  Y PS RP+ +E+
Sbjct: 241 --PTLYSLMTKCWAYDPSRRPRFTEL 264

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 228 NFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRL-KDGNAIGGEIQ-FQTEVEMISLAVHR 284
           +F   NL+GKG F  VY+   +  G  VA+K + K      G +Q  Q EV++     H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHE 342
           ++L L  +   +    LV     NG +   LK   KP  +   R  +      G+LYLH 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHS 130
Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-CDSHVTTAVRGTVGHIAPEYLS 401
                I+HRD+  +N+LL       + DFGLA  L    + H T    GT  +I+PE  +
Sbjct: 131 H---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEIAT 185
Query: 402 TGQSSEKTDVFGFGILLLELISG 424
                 ++DV+  G +   L+ G
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIG 208

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 72  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 124
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
            G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 125 EGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 180
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 37/211 (17%)
Query: 233 NLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAV----H 283
            ++G G FG V+KG ++ +G      V +K ++D +   G   FQ   + + LA+    H
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHM-LAIGSLDH 92
Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA---------- 333
            +++RL+G C  ++ +L V  Y+  GS+         LD   + R ALG           
Sbjct: 93  AHIVRLLGLCPGSSLQL-VTQYLPLGSL---------LDHVRQHRGALGPQLLLNWGVQI 142
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRGTV 392
           A+G+ YL E     ++HR++ A N+LL    +  V DFG+A LL   D  +  +  +  +
Sbjct: 143 AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 199
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +  G+ + ++DV+ +G+ + EL++
Sbjct: 200 KWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 223 QSATSNFSSKNLVGKGGFGNVY---KGYLQD-GTVVAVKRLKDGN-AIGGEIQFQTEVEM 277
           ++  S+F    ++G+G FG V+   K    D G + A+K LK     +   ++ + E ++
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
           ++   H  +++L     T  +  L+  ++  G + +RL  +        K      A GL
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIA 396
            +LH      II+RD+K  NILLDE     + DFGL+K  +DH     +    GTV ++A
Sbjct: 144 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC--GTVEYMA 198
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE ++    S   D + +G+L+ E+++G
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 122/266 (45%), Gaps = 27/266 (10%)
Query: 235 VGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G  +T     ++    + G + S L+ +  SLD A+    A   +  L YL  +   + +
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFV 513
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           HRD+ A N+L+       +GDFGL++ ++    +  +  +  +  +APE ++  + +  +
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 410 DVFGFGILLLE-LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           DV+ FG+ + E L+ G++  +  K         D + +I   ++L M  +          
Sbjct: 574 DVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERLPMPPNCP-------- 618
Query: 469 ELEEMVQVALLCTQYLPSLRPKMSEV 494
               +  +   C  Y PS RP+ +E+
Sbjct: 619 --PTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 122/266 (45%), Gaps = 27/266 (10%)
Query: 235 VGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           +G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G  +T     ++    + G + S L+ +  SLD A+    A   +  L YL  +   + +
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFV 513
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           HRD+ A N+L+       +GDFGL++ ++    +  +  +  +  +APE ++  + +  +
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 410 DVFGFGILLLE-LISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           DV+ FG+ + E L+ G++  +  K         D + +I   ++L M  +          
Sbjct: 574 DVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERLPMPPNCP-------- 618
Query: 469 ELEEMVQVALLCTQYLPSLRPKMSEV 494
               +  +   C  Y PS RP+ +E+
Sbjct: 619 --PTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 43/287 (14%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 288 RLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPS---------LDWATRKRI---ALGAA 334
            L+G C      L+V   +   G++++ L++K +          D+ T + +   +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTVG 393
           +G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R  + 
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKIHQEK 451
            +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++ +  
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRLKEGT 264
Query: 452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
           ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 265 RMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+  L++  +     +   E  +++  
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 109 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 161
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 162 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 217
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L++   M  G +   ++           L+W  +       A
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  +  + H     +  +
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 185
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L++   M  G +   ++           L+W  +       A
Sbjct: 79  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  +  + H     +  +
Sbjct: 132 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 187
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 15/212 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMI 278
           K+ +     F  K  +G G F  V     +  G + AVK +      G E   + E+ ++
Sbjct: 15  KQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 279 SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK---PSLDWATRKRIALGAAR 335
               H N++ L     +     LV   +S G +  R+  K      D +T  R  L A  
Sbjct: 75  RKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA-- 132
Query: 336 GLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
            + YLH      I+HRD+K  N+L    DE  + ++ DFGL+K+    D  V +   GT 
Sbjct: 133 -VYYLHRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD--VMSTACGTP 186
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           G++APE L+    S+  D +  G++   L+ G
Sbjct: 187 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++  G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L++   M  G +   ++           L+W  +       A
Sbjct: 82  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 190
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD--GT--VVAVKRLKDGNAIGGEIQFQTEVE--MISL 280
           ++F+   ++GKG FG V    L D  GT  + A+K LK    I  +    T VE  +++L
Sbjct: 19  TDFNFLMVLGKGSFGKVM---LADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLAL 75
Query: 281 AVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
                 L  +  C  T +RL  V  Y++ G +   ++             A   + GL +
Sbjct: 76  LDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFF 135
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-AVRGTVGHIAPE 398
           LH++    II+RD+K  N++LD      + DFG+ K  +H    VTT    GT  +IAPE
Sbjct: 136 LHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPE 190
Query: 399 YLSTGQSSEKTDVFGFGILLLELISG 424
            ++     +  D + +G+LL E+++G
Sbjct: 191 IIAYQPYGKSVDWWAYGVLLYEMLAG 216

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L++   M  G +   ++           L+W  +       A
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  +  + H     +  +
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 185
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 39/285 (13%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 288 RLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPS---------LDWATRKRI---ALGAA 334
            L+G C      L+V   +   G++++ L++K +          D+ T + +   +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTVG 393
           +G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R  + 
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 453
            +APE +     + ++DV+ FG+LL E+ S       G +    G  +D        ++ 
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKID--------EEF 256
Query: 454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
              + +  +         EM Q  L C    PS RP  SE+V  L
Sbjct: 257 XRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 18/197 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG VYK   ++ +V+A  ++ D  +      +  E+++++   H N+++L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 295 TTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 ++  + + G+V A  L+ +  L  +  + +       L YLH   D KIIHRD+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 354 KAANILLDEYYEAVVGDFGLA----KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 407
           KA NIL     +  + DFG++    + +   DS +     GT   +APE +    S +  
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-----GTPYWMAPEVVMCETSKDRP 216
Query: 408 ---KTDVFGFGILLLEL 421
              K DV+  GI L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++  G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 183
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 37/211 (17%)
Query: 233 NLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAV----H 283
            ++G G FG V+KG ++ +G      V +K ++D +   G   FQ   + + LA+    H
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHM-LAIGSLDH 74
Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA---------- 333
            +++RL+G C  ++ +L V  Y+  GS+         LD   + R ALG           
Sbjct: 75  AHIVRLLGLCPGSSLQL-VTQYLPLGSL---------LDHVRQHRGALGPQLLLNWGVQI 124
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRGTV 392
           A+G+ YL E     ++HR++ A N+LL    +  V DFG+A LL   D  +  +  +  +
Sbjct: 125 AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +  G+ + ++DV+ +G+ + EL++
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 9/210 (4%)
Query: 219 FKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 277
           +K+ +     +  ++++G G F  V      +   +VA+K +      G E   + E+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 69
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
           +    H N++ L     +     L+   +S G +  R+  K         R+       +
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 129
Query: 338 LYLHEQCDPKIIHRDVKAANIL---LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
            YLH   D  I+HRD+K  N+L   LDE  + ++ DFGL+K+ D     V +   GT G+
Sbjct: 130 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGY 184
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           +APE L+    S+  D +  G++   L+ G
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 18/197 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG VYK   ++ +V+A  ++ D  +      +  E+++++   H N+++L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 295 TTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 ++  + + G+V A  L+ +  L  +  + +       L YLH   D KIIHRD+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 354 KAANILLDEYYEAVVGDFGLA----KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 407
           KA NIL     +  + DFG++    + +   DS +     GT   +APE +    S +  
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKDRP 216
Query: 408 ---KTDVFGFGILLLEL 421
              K DV+  GI L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  +  + H     +  +
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 185
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  +  + H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 183
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 7/195 (3%)
Query: 254 VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS 313
           VAVK +    A+      + E+ +  +  H N+++  G       + L   Y S G +  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 314 RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 373
           R++    +     +R       G++YLH      I HRD+K  N+LLDE     + DFGL
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGL 150
Query: 374 AKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFG 431
           A +  + +   +   + GT+ ++APE L   +  +E  DV+  GI+L  +++G   L + 
Sbjct: 151 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG--ELPWD 208
Query: 432 KTANQKGAMLDWVKK 446
           + ++      DW +K
Sbjct: 209 QPSDSCQEYSDWKEK 223

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 53/290 (18%)
Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ---FQTEVEMISLAVHRNLLRL 289
            L+GKG FG VY G       + +  ++  N    E Q   F+ EV       H N++  
Sbjct: 39  ELIGKGRFGQVYHGRWHGEVAIRLIDIERDN----EDQLKAFKREVMAYRQTRHENVVLF 94
Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +G CM+     ++       ++ S ++ AK  LD    ++IA    +G+ YLH +    I
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR---------GTVGHIAPEY 399
           +H+D+K+ N+  D   + V+ DFGL  +     S V  A R         G + H+APE 
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSI-----SGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 400 ---LSTGQSSEK------TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
              LS     +K      +DVF  G +  EL +                  +W  K    
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR-----------------EWPFKTQPA 248
Query: 451 KKLEMLVDKDLKNNYDRIEL-EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           + +   +   +K N  +I + +E+  + L C  +    RP  ++++ MLE
Sbjct: 249 EAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++  G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  +  + H     +  +
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 190
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  FC    E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 157 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 214 KSACKSSDLWALGCIIYQLVAGLPPFRAG 242

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-------LDWATRKRIALGAA 334
            + ++ RL+G C+T+T +L+    M  G +   ++           L+W  +       A
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  +  + H     +  +
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 190
Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
             +A E +     + ++DV+ +G+ + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 227 SNFSSKNLVGKGGFGNVYK----GYLQDGTV--VAVKRLKDGNAIGGEIQFQTEVEMIS- 279
           +N      +G G FG V +    G  ++  V  VAVK LK       +    +E++++S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK------PSL---------DWA 324
           L  H N++ L+G C      L++  Y   G + + L+ K      PSL         D  
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 325 TRKRIALGAARGLLYLHEQ--------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK- 375
             + + L   R LL+   Q             IHRDV A N+LL   + A +GDFGLA+ 
Sbjct: 151 DGRPLEL---RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 376 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           +++  +  V    R  V  +APE +     + ++DV+ +GILL E+ S
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 39/219 (17%)
Query: 228 NFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +F    L+G GGFG V+K  +  DG    +KR+K  N      + + EV+ ++   H N+
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----KAEREVKALAKLDHVNI 66
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL------------DWATRKR------ 328
           +   G C    +    Y   ++   +SR K K                W  ++R      
Sbjct: 67  VHYNG-CWDGFD----YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 329 -IAL----GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 383
            +AL       +G+ Y+H +   K+I+RD+K +NI L +  +  +GDFGL   L +    
Sbjct: 122 VLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 422
             +  +GT+ +++PE +S+    ++ D++  G++L EL+
Sbjct: 179 XRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +GKG +G V+ G  + G  VAVK              +TE+    L  H N+L  I   +
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 295 ----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-----QCD 345
               + T+  L+  Y  NGS+   LK+  +LD  +  ++A  +  GL +LH      Q  
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAK--LLDHCDSHVTTAVR-GTVGHIAPEYLST 402
           P I HRD+K+ NIL+ +     + D GLA   + D  +  +    R GT  ++ PE L  
Sbjct: 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220
Query: 403 G------QSSEKTDVFGFGILLLEL 421
                  QS    D++ FG++L E+
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-----LKDGNAIGGEIQFQTEVEMISL 280
           +NF  +  +G+G F  VY+   L DG  VA+K+     L D  A    I+   E++++  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQ 88
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARG 336
             H N+++     +   E  +V      G ++  +K     K  +   T  +  +     
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG--- 393
           L ++H +   +++HRD+K AN+ +       +GD GL +      S  TTA    VG   
Sbjct: 149 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPY 201
Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 453
           +++PE +     + K+D++  G LL E+ + L++  +G   N    +    KKI Q    
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMN----LYSLCKKIEQCDYP 256
Query: 454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV 494
            +  D     +Y     EE+ Q+  +C    P  RP ++ V
Sbjct: 257 PLPSD-----HYS----EELRQLVNMCINPDPEKRPDVTYV 288

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 131/290 (45%), Gaps = 46/290 (15%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 288 RLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPS------------LDWATRKRI---AL 331
            L+G C      L+V   +   G++++ L++K +             D+ T + +   + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRG 390
             A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +      V     R 
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKIH 448
            +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRLK 265
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
           +  ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 266 EGTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 235 VGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +G+G FG V            G  VAVK LK  +        + E+E++    H N+++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C         L+  ++ +GS+   L K K  ++   + + A+   +G+ YL  +   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR--- 145
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + +HRD+ A N+L++  ++  +GDFGL K +  D     V       V   APE L   +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 405 SSEKTDVFGFGILLLELIS 423
               +DV+ FG+ L EL++
Sbjct: 206 FYIASDVWSFGVTLHELLT 224

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 132/291 (45%), Gaps = 47/291 (16%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 288 RLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPS-------------LDWATRKRI---A 330
            L+G C      L+V   +   G++++ L++K +              D+ T + +   +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VR 389
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R
Sbjct: 157 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKI 447
             +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRL 266
Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
            +  ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 267 KEGTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 131/289 (45%), Gaps = 45/289 (15%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 288 RLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPS-----------LDWATRKRI---ALG 332
            L+G C      L+V   +   G++++ L++K +            D+ T + +   +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGT 391
            A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +      V     R  
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKIHQ 449
           +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++ +
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRLKE 266
Query: 450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
             ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 267 GTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 132/291 (45%), Gaps = 47/291 (16%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 288 RLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPS-------------LDWATRKRI---A 330
            L+G C      L+V   +   G++++ L++K +              D+ T + +   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VR 389
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKI 447
             +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRL 264
Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
            +  ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 265 KEGTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 235 VGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +G+G FG V            G  VAVK LK  +        + E+E++    H N+++ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 290 IGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
            G C         L+  ++ +GS+   L K K  ++   + + A+   +G+ YL  +   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR--- 133
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           + +HRD+ A N+L++  ++  +GDFGL K +  D     V       V   APE L   +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 405 SSEKTDVFGFGILLLELIS 423
               +DV+ FG+ L EL++
Sbjct: 194 FYIASDVWSFGVTLHELLT 212

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/316 (22%), Positives = 139/316 (43%), Gaps = 28/316 (8%)
Query: 224 SATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISL 280
            +   + +  LVG+G +G V K   +D G +VA+K+    D + +  +I  + E++++  
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQ 80
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLY 339
             H NL+ L+  C       LV+ ++ + ++   L+  P+ LD+   ++       G+ +
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            H      IIHRD+K  NIL+ +     + DFG A+ L      V      T  + APE 
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPEL 195
Query: 400 L-STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI---HQE----- 450
           L    +  +  DV+  G L+ E+  G          +Q   ++  +  +   HQE     
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 451 ------KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR--MLEGDG 502
                 +  E+   + L+  Y ++  E ++ +A  C    P  RP  +E++     + DG
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLS-EVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314
Query: 503 LAEKWAASQKAEATRS 518
            AE+++   + +  + 
Sbjct: 315 FAERFSQELQLKVQKD 330

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 207 EEVCLGNLKRFHFKEL------QSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRL 259
           E V L N  R   K+L      +     F     +G+G +G+VYK  + + G +VA+K++
Sbjct: 3   ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62
Query: 260 KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS--RLKA 317
              + +   I+   E+ ++      ++++  G     T+  +V  Y   GSV+   RL+ 
Sbjct: 63  PVESDLQEIIK---EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN 119
Query: 318 KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA-KL 376
           K +L       I     +GL YLH     + IHRD+KA NILL+    A + DFG+A +L
Sbjct: 120 K-TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            D         V GT   +APE +     +   D++  GI  +E+  G
Sbjct: 176 TDXMAKR--NXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQTEVE--MISLAV 282
           ++F+   ++GKG FG V     + GT  + AVK LK    I  +    T VE  +++L  
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSE-RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 283 HRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
               L  +  C  T +RL  V  Y++ G +   ++             A   A GL +L 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
            +    II+RD+K  N++LD      + DFG+ K  +  D   T    GT  +IAPE ++
Sbjct: 460 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKXFCGTPDYIAPEIIA 515
Query: 402 TGQSSEKTDVFGFGILLLELISGLRALE 429
                +  D + FG+LL E+++G    E
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 47/291 (16%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 288 RLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPS-------------LDWATRKRI---A 330
            L+G C      L+V   +   G++++ L++K +              D+ T + +   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VR 389
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +      V     R
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKI 447
             +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRL 264
Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
            +  ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 265 KEGTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 88/193 (45%), Gaps = 12/193 (6%)
Query: 235 VGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGF 292
           +G+G F  VYKG   + TV VA   L+D      E Q F+ E E +    H N++R    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 293 CMTTTER----LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
             +T +     +LV    ++G++ + LK          +       +GL +LH +  P I
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRT-PPI 152
Query: 349 IHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
           IHRD+K  NI +     +V +GD GLA L     +    AV GT    APE     +  E
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFXAPEXYEE-KYDE 208
Query: 408 KTDVFGFGILLLE 420
             DV+ FG   LE
Sbjct: 209 SVDVYAFGXCXLE 221

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 132/291 (45%), Gaps = 47/291 (16%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 288 RLIGFCMTTTERLLVYP-YMSNGSVASRLKAKPS-------------LDWATRKRI---A 330
            L+G C      L+V   +   G++++ L++K +              D+ T + +   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VR 389
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKI 447
             +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRL 255
Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
            +  ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 256 KEGTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQTEVE--MISLAV 282
           ++F+   ++GKG FG V     + GT  + AVK LK    I  +    T VE  +++L  
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSE-RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 283 HRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
               L  +  C  T +RL  V  Y++ G +   ++             A   A GL +L 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
            +    II+RD+K  N++LD      + DFG+ K  +  D   T    GT  +IAPE ++
Sbjct: 139 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKXFCGTPDYIAPEIIA 194
Query: 402 TGQSSEKTDVFGFGILLLELISGLRALE 429
                +  D + FG+LL E+++G    E
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 132/291 (45%), Gaps = 47/291 (16%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 288 RLIGFCMTTTERLLVYP-YMSNGSVASRLKAKPS-------------LDWATRKRI---A 330
            L+G C      L+V   +   G++++ L++K +              D+ T + +   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VR 389
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKI 447
             +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRL 255
Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
            +  ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 256 KEGTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 132/291 (45%), Gaps = 47/291 (16%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 288 RLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPS-------------LDWATRKRI---A 330
            L+G C      L+V   +   G++++ L++K +              D+ T + +   +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VR 389
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R
Sbjct: 192 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKI 447
             +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRL 301
Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
            +  ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 302 KEGTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 47/291 (16%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 288 RLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPS-------------LDWATRKRI---A 330
            L+G C      L+V   +   G++++ L++K +              D+ T + +   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVR 389
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +    D       R
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKI 447
             +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRL 264
Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
            +  ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 265 KEGTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 18/197 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG VYK   ++ +V+A  ++ D  +      +  E+++++   H N+++L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 295 TTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 ++  + + G+V A  L+ +  L  +  + +       L YLH   D KIIHRD+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 354 KAANILLDEYYEAVVGDFGLA----KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 407
           KA NIL     +  + DFG++    + +   D  +     GT   +APE +    S +  
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-----GTPYWMAPEVVMCETSKDRP 216
Query: 408 ---KTDVFGFGILLLEL 421
              K DV+  GI L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 47/291 (16%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 288 RLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPS-------------LDWATRKRI---A 330
            L+G C      L+V   +   G++++ L++K +              D+ T + +   +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VR 389
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +      V     R
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKI 447
             +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRL 255
Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
            +  ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 256 KEGTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 47/291 (16%)
Query: 235 VGKGGFGNVYKG--YLQDGT----VVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           +G+G FG V +   +  D T     VAVK LK+G          +E++ +I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 288 RLIGFCMTTTERLLVYP-YMSNGSVASRLKAKPS-------------LDWATRKRI---A 330
            L+G C      L+V   +   G++++ L++K +              D+ T + +   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VR 389
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +      V     R
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKI 447
             +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRL 255
Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
            +  ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 256 KEGTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGYLQDGT----VVAVKRLKDGN-AIGGEIQFQTEVEM 277
           ++  S F    ++G+G FG V+      G+    + A+K LK     +   ++ + E ++
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
           +    H  +++L     T  +  L+  ++  G + +RL  +        K      A  L
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIA 396
            +LH      II+RD+K  NILLDE     + DFGL+K  +DH     +    GTV ++A
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTVEYMA 194
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE ++    ++  D + FG+L+ E+++G
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 235 VGKGGFGNV--YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           +G+GGF  V   +G L DG   A+KR+        E + Q E +M  L  H N+LRL+ +
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNILRLVAY 94
Query: 293 CM----TTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRI---ALGAARGLLYLHEQC 344
           C+       E  L+ P+   G++ + + + K   ++ T  +I    LG  RGL  +H + 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK- 153
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFG-LAKLLDHCDS-------HVTTAVRGTVGHIA 396
                HRD+K  NILL +  + V+ D G + +   H +            A R T+ + A
Sbjct: 154 --GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 397 PEYLSTGQS---SEKTDVFGFGILLLELISG 424
           PE  S        E+TDV+  G +L  ++ G
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 233 NLVGKGGFGNVYKGYLQ-DGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           + +G G FG V  G  Q  G  VAVK     +++  + +G   + + E++ + L  H ++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG---KIKREIQNLKLFRHPHI 73
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           ++L     T T+  +V  Y+S G +   +     ++    +R+       + Y H     
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-- 131
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QS 405
            ++HRD+K  N+LLD +  A + DFGL+ ++   D        G+  + APE +S    +
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 406 SEKTDVFGFGILLLELISG 424
             + D++  G++L  L+ G
Sbjct: 189 GPEVDIWSCGVILYALLCG 207

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L          +  GT  +++PE L+ 
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             +S+ +D++  G ++ +L++GL     G
Sbjct: 209 KSASKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 10/225 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGG--EIQFQTEVEMIS 279
            +  S+F    ++GKG FG V    +  +    AVK L+    +    E    +E  ++ 
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 280 LAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 338
             V    L  + F   T ++L  V  Y++ G +   L+ +        +  A   A  L 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRGTVGHIAP 397
           YLH      I++RD+K  NILLD     V+ DFGL K  ++H  +  T+   GT  ++AP
Sbjct: 154 YLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAP 208
Query: 398 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
           E L         D +  G +L E++ GL       TA     +L+
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 235 VGKGGFGN-VYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGF 292
           +G+G FG  +     +DG    +K +        E +  + EV +++   H N+++    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPS--------LDWATRKRIALGAARGLLYLHEQC 344
                   +V  Y   G +  R+ A+          LDW  +  +AL       ++H   
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK------HVH--- 142
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           D KI+HRD+K+ NI L +     +GDFG+A++L+     +  A  GT  +++PE      
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELARACIGTPYYLSPEICENKP 201
Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTAN 435
            + K+D++  G +L EL +   A E G   N
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L          A  GT  +++PE L+ 
Sbjct: 150 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAG 235

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 17/227 (7%)
Query: 210 CLGNLKRF----HFKE--LQSATSNFSSKNLVGKGGFGNVYKGYLQDGT----VVAVKRL 259
            +G++K      H KE   ++  S F    ++G+G FG V+      G+    + A+K L
Sbjct: 2   AMGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 61
Query: 260 KDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK 318
           K     +   ++ + E +++    H  +++L     T  +  L+  ++  G + +RL  +
Sbjct: 62  KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE 121
Query: 319 PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LL 377
                   K      A  L +LH      II+RD+K  NILLDE     + DFGL+K  +
Sbjct: 122 VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 178
Query: 378 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           DH     +    GTV ++APE ++    ++  D + FG+L+ E+++G
Sbjct: 179 DHEKKAYSFC--GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYKGYLQDGT----VVAVKRLKDGN-AIGGEIQFQTEVEM 277
           ++  S F    ++G+G FG V+      G+    + A+K LK     +   ++ + E ++
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
           +    H  +++L     T  +  L+  ++  G + +RL  +        K      A  L
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIA 396
            +LH      II+RD+K  NILLDE     + DFGL+K  +DH     +    GTV ++A
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTVEYMA 194
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE ++    ++  D + FG+L+ E+++G
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 233 NLVGKGGFGNVYKGYLQ-DGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           + +G G FG V  G  Q  G  VAVK     +++  + +G   + + E++ + L  H ++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG---KIKREIQNLKLFRHPHI 73
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           ++L     T T+  +V  Y+S G +   +     ++    +R+       + Y H     
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-- 131
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QS 405
            ++HRD+K  N+LLD +  A + DFGL+ ++   D        G+  + APE +S    +
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRDSCGSPNYAAPEVISGRLYA 188
Query: 406 SEKTDVFGFGILLLELISG 424
             + D++  G++L  L+ G
Sbjct: 189 GPEVDIWSCGVILYALLCG 207

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG V KGY Q         V  +K   +  A+  E+    E  ++    +  ++R
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL--AEANVMQQLDNPYIVR 92
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +IG C   +  +LV      G +   L+    +       +    + G+ YL E      
Sbjct: 93  MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 148
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L   +++      G   V   APE ++  + S
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
            K+DV+ FG+L+ E  S  +    G   ++  AML+
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG V KGY Q         V  +K   +  A+  E+    E  ++    +  ++R
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL--AEANVMQQLDNPYIVR 92
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +IG C   +  +LV      G +   L+    +       +    + G+ YL E      
Sbjct: 93  MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 148
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L   +++      G   V   APE ++  + S
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
            K+DV+ FG+L+ E  S  +    G   ++  AML+
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++F     +G+GGFG V++   + D    A+KR++  N      +   EV+ ++   H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 286 LLRLIGFCM--TTTERLL-----VYPYMSNGSVASRLKAKPSL-DWAT-------RKR-- 328
           ++R     +   TTE+L      VY Y     +  +L  K +L DW         R+R  
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLY-----IQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 329 ---IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 385
              I L  A  + +LH +    ++HRD+K +NI         VGDFGL   +D  +   T
Sbjct: 120 CLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 386 -----------TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 422
                      T   GT  +++PE +     S K D+F  G++L EL+
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG V KGY Q         V  +K   +  A+  E+    E  ++    +  ++R
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL--AEANVMQQLDNPYIVR 90
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +IG C   +  +LV      G +   L+    +       +    + G+ YL E      
Sbjct: 91  MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 146
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L   +++      G   V   APE ++  + S
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 206
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
            K+DV+ FG+L+ E  S  +    G   ++  AML+
Sbjct: 207 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 242

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 222 LQSATSNFSSKNLVGKGGFGNVYKG--YLQDGTVVAVKRLKDGNAIGG-------EIQFQ 272
           L  A   +     +G+G +G V+K       G  VA+KR++      G       E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 273 TEVEMISLAVHRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLKA-KPSLDWATR 326
             +E      H N++RL   C  +     T+  LV+ ++         K  +P +   T 
Sbjct: 66  RHLETFE---HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 327 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
           K +     RGL +LH     +++HRD+K  NIL+    +  + DFGLA++  +      T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALT 177
Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
           +V  T+ + APE L     +   D++  G +  E+             +Q G +LD +
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 6/205 (2%)
Query: 222 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISL 280
            Q     +     VG+G +G VYK     G +VA+KR++ D    G       E+ ++  
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
             H N++ LI    +     LV+ +M         + K  L  +  K       RG+ + 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
           H+    +I+HRD+K  N+L++      + DFGLA+         T  V  T+ + AP+ L
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 401 -STGQSSEKTDVFGFGILLLELISG 424
             + + S   D++  G +  E+I+G
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +  K  +G GGFG V +   QD G  VA+K+ +   +     ++  E++++    H N++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 288 R---------------LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
                           L    M   E   +  Y++       LK  P       + +   
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI------RTLLSD 130
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG---DFGLAKLLDHCDSHVTTAVR 389
            +  L YLHE    +IIHRD+K  NI+L    + ++    D G AK LD     + T   
Sbjct: 131 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFV 185
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 426
           GT+ ++APE L   + +   D + FG L  E I+G R
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG V KGY Q         V  +K   +  A+  E+    E  ++    +  ++R
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL--AEANVMQQLDNPYIVR 434
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +IG C   +  +LV      G +   L+    +       +    + G+ YL E      
Sbjct: 435 MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 490
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L   +++      G   V   APE ++  + S
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 550
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
            K+DV+ FG+L+ E  S  +    G   ++  AML+
Sbjct: 551 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +  K  +G GGFG V +   QD G  VA+K+ +   +     ++  E++++    H N++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 288 R---------------LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
                           L    M   E   +  Y++       LK  P       + +   
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI------RTLLSD 129
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG---DFGLAKLLDHCDSHVTTAVR 389
            +  L YLHE    +IIHRD+K  NI+L    + ++    D G AK LD     + T   
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFV 184
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 426
           GT+ ++APE L   + +   D + FG L  E I+G R
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG V KGY Q         V  +K   +  A+  E+    E  ++    +  ++R
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL--AEANVMQQLDNPYIVR 435
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +IG C   +  +LV      G +   L+    +       +    + G+ YL E      
Sbjct: 436 MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 491
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L   +++      G   V   APE ++  + S
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 551
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
            K+DV+ FG+L+ E  S  +    G   ++  AML+
Sbjct: 552 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 587

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG V KGY Q         V  +K   +  A+  E+    E  ++    +  ++R
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL--AEANVMQQLDNPYIVR 70
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +IG C   +  +LV      G +   L+    +       +    + G+ YL E      
Sbjct: 71  MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 126
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L   +++      G   V   APE ++  + S
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 186
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
            K+DV+ FG+L+ E  S  +    G   ++  AML+
Sbjct: 187 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG V KGY Q         V  +K   +  A+  E+    E  ++    +  ++R
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL--AEANVMQQLDNPYIVR 82
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +IG C   +  +LV      G +   L+    +       +    + G+ YL E      
Sbjct: 83  MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 138
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L   +++      G   V   APE ++  + S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
            K+DV+ FG+L+ E  S  +    G   ++  AML+
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 6/205 (2%)
Query: 222 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISL 280
            Q     +     VG+G +G VYK     G +VA+KR++ D    G       E+ ++  
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
             H N++ LI    +     LV+ +M         + K  L  +  K       RG+ + 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
           H+    +I+HRD+K  N+L++      + DFGLA+         T  V  T+ + AP+ L
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 401 -STGQSSEKTDVFGFGILLLELISG 424
             + + S   D++  G +  E+I+G
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG V KGY Q         V  +K   +  A+  E+    E  ++    +  ++R
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL--AEANVMQQLDNPYIVR 72
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +IG C   +  +LV      G +   L+    +       +    + G+ YL E      
Sbjct: 73  MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 128
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L   +++      G   V   APE ++  + S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
            K+DV+ FG+L+ E  S  +    G   ++  AML+
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG V KGY Q         V  +K   +  A+  E+    E  ++    +  ++R
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL--AEANVMQQLDNPYIVR 76
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +IG C   +  +LV      G +   L+    +       +    + G+ YL E      
Sbjct: 77  MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 132
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L   +++      G   V   APE ++  + S
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
            K+DV+ FG+L+ E  S  +    G   ++  AML+
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 9/210 (4%)
Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVH 283
            +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 284 RNLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 342
              ++L  F     E+L     Y  NG +   ++   S D    +         L YLH 
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 127
Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLS 401
           +    IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+
Sbjct: 128 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFG 431
              + + +D++  G ++ +L++GL     G
Sbjct: 185 EKSACKSSDLWALGCIIYQLVAGLPPFRAG 214

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 9/210 (4%)
Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVH 283
            +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 284 RNLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 342
              ++L  F     E+L     Y  NG +   ++   S D    +         L YLH 
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLS 401
           +    IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+
Sbjct: 127 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFG 431
              + + +D++  G ++ +L++GL     G
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAG 213

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 71  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 130 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 187 KSACKSSDLWALGCIIYQLVAGLPPFRAG 215

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 234 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR--LIG 291
            +GKGGF   ++    D   V   ++   + +      Q E   + +++HR+L    ++G
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 105
Query: 292 FCMTTTERLLVYPYM------SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQ 343
           F     +   V+  +      S   +  R KA  +P   +  R+ I LG      YLH  
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ-IVLGCQ----YLHRN 160
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              ++IHRD+K  N+ L+E  E  +GDFGLA  +++ D      + GT  +IAPE LS  
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTPNYIAPEVLSKK 216
Query: 404 QSSEKTDVFGFGILLLELISGLRALE 429
             S + DV+  G ++  L+ G    E
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 234 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR--LIG 291
            +GKGGF   ++    D   V   ++   + +      Q E   + +++HR+L    ++G
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 81
Query: 292 FCMTTTERLLVYPYM------SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQ 343
           F     +   V+  +      S   +  R KA  +P   +  R+ I LG      YLH  
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ-IVLGCQ----YLHRN 136
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              ++IHRD+K  N+ L+E  E  +GDFGLA  +++ D      + GT  +IAPE LS  
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCGTPNYIAPEVLSKK 192
Query: 404 QSSEKTDVFGFGILLLELISGLRALE 429
             S + DV+  G ++  L+ G    E
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L          +  GT  +++PE L+ 
Sbjct: 153 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPFRAG 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 234 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR--LIG 291
            +GKGGF   ++    D   V   ++   + +      Q E   + +++HR+L    ++G
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 81
Query: 292 FCMTTTERLLVYPYM------SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQ 343
           F     +   V+  +      S   +  R KA  +P   +  R+ I LG      YLH  
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ-IVLGCQ----YLHRN 136
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              ++IHRD+K  N+ L+E  E  +GDFGLA  +++ D      + GT  +IAPE LS  
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCGTPNYIAPEVLSKK 192
Query: 404 QSSEKTDVFGFGILLLELISGLRALE 429
             S + DV+  G ++  L+ G    E
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 222 LQSATSNFSSKNLVGKGGFGNVYKG--YLQDGTVVAVKRLKDGNAIGG-------EIQFQ 272
           L  A   +     +G+G +G V+K       G  VA+KR++      G       E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 273 TEVEMISLAVHRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLKA-KPSLDWATR 326
             +E      H N++RL   C  +     T+  LV+ ++         K  +P +   T 
Sbjct: 66  RHLETFE---HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 327 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
           K +     RGL +LH     +++HRD+K  NIL+    +  + DFGLA++  +      T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALT 177
Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
           +V  T+ + APE L     +   D++  G +  E+             +Q G +LD +
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 234 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR--LIG 291
            +GKGGF   ++    D   V   ++   + +      Q E   + +++HR+L    ++G
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 103
Query: 292 FCMTTTERLLVYPYM------SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQ 343
           F     +   V+  +      S   +  R KA  +P   +  R+ I LG      YLH  
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ-IVLGCQ----YLHRN 158
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              ++IHRD+K  N+ L+E  E  +GDFGLA  +++ D      + GT  +IAPE LS  
Sbjct: 159 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTPNYIAPEVLSKK 214
Query: 404 QSSEKTDVFGFGILLLELISGLRALE 429
             S + DV+  G ++  L+ G    E
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 44/231 (19%)
Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
            S+F    ++G+G FG V K     D    A+K+++        I   +EV +++   H+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL--SEVMLLASLNHQ 62
Query: 285 NLLRLIGFC---------MTTTER----LLVYPYMSNGSV-----ASRLKAKPSLDWATR 326
            ++R              MT  ++     +   Y  NG++     +  L  +    W   
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 327 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC------ 380
           ++I       L Y+H Q    IIHRD+K  NI +DE     +GDFGLAK +         
Sbjct: 123 RQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 381 DSH--------VTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI 422
           DS         +T+A+ GT  ++A E L  TG  +EK D++  GI+  E+I
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 222 LQSATSNFSSKNLVGKGGFGNVYKG--YLQDGTVVAVKRLKDGNAIGG-------EIQFQ 272
           L  A   +     +G+G +G V+K       G  VA+KR++      G       E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 273 TEVEMISLAVHRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLKA-KPSLDWATR 326
             +E      H N++RL   C  +     T+  LV+ ++         K  +P +   T 
Sbjct: 66  RHLETFE---HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 327 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
           K +     RGL +LH     +++HRD+K  NIL+    +  + DFGLA++  +      T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALT 177
Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
           +V  T+ + APE L     +   D++  G +  E+             +Q G +LD +
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 234 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR--LIG 291
            +GKGGF   ++    D   V   ++   + +      Q E   + +++HR+L    ++G
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 85
Query: 292 FCMTTTERLLVYPYM------SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQ 343
           F     +   V+  +      S   +  R KA  +P   +  R+ I LG      YLH  
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ-IVLGCQ----YLHRN 140
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              ++IHRD+K  N+ L+E  E  +GDFGLA  +++ D      + GT  +IAPE LS  
Sbjct: 141 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCGTPNYIAPEVLSKK 196
Query: 404 QSSEKTDVFGFGILLLELISGLRALE 429
             S + DV+  G ++  L+ G    E
Sbjct: 197 GHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 68  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 127 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 184 KSACKSSDLWALGCIIYQLVAGLPPFRAG 212

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGF 292
           +GKG FG V++G  + G  VAVK          E  +  E E+    +  H N+L  I  
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 293 ----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH-----EQ 343
                 T T+  LV  Y  +GS+   L  + ++      ++AL  A GL +LH      Q
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYL 400
             P I HRD+K+ NIL+ +     + D GLA   D     +  A    VG   ++APE L
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 401 STG------QSSEKTDVFGFGILLLEL 421
                    +S ++ D++  G++  E+
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 223 QSATSNFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           Q+  ++  +   +G G  G V+K  + + G V+AVK+++         +   +++++ L 
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV-LK 79
Query: 282 VHR--NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR--KRIALGAARGL 337
            H    +++  G  +T T+  +    M  G+ A +LK +       R   ++ +   + L
Sbjct: 80  SHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
            YL E+    +IHRDVK +NILLDE  +  + DFG++  L   D        G   ++AP
Sbjct: 138 YYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAP 193
Query: 398 EYLSTGQSSE-----KTDVFGFGILLLELISG 424
           E +     ++     + DV+  GI L+EL +G
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 14/216 (6%)
Query: 235 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G FG V KGY Q         V  +K   +  A+  E+    E  ++    +  ++R
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL--AEANVMQQLDNPYIVR 76
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +IG C   +  +LV      G +   L+    +       +    + G+ YL E      
Sbjct: 77  MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 132
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L  D       T  +  V   APE ++  + S
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
            K+DV+ FG+L+ E  S  +    G   ++  AML+
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L          +  GT  +++PE L+ 
Sbjct: 149 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLPPFRAG 234

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGF 292
           +GKG FG V++G  + G  VAVK          E  +  E E+    +  H N+L  I  
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 66
Query: 293 ----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH-----EQ 343
                 T T+  LV  Y  +GS+   L  + ++      ++AL  A GL +LH      Q
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYL 400
             P I HRD+K+ NIL+ +     + D GLA   D     +  A    VG   ++APE L
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 401 STG------QSSEKTDVFGFGILLLEL 421
                    +S ++ D++  G++  E+
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGF 292
           +GKG FG V++G  + G  VAVK          E  +  E E+    +  H N+L  I  
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 91
Query: 293 ----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH-----EQ 343
                 T T+  LV  Y  +GS+   L  + ++      ++AL  A GL +LH      Q
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYL 400
             P I HRD+K+ NIL+ +     + D GLA   D     +  A    VG   ++APE L
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 401 STG------QSSEKTDVFGFGILLLEL 421
                    +S ++ D++  G++  E+
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGF 292
           +GKG FG V++G  + G  VAVK          E  +  E E+    +  H N+L  I  
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 71
Query: 293 ----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH-----EQ 343
                 T T+  LV  Y  +GS+   L  + ++      ++AL  A GL +LH      Q
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYL 400
             P I HRD+K+ NIL+ +     + D GLA   D     +  A    VG   ++APE L
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 401 STG------QSSEKTDVFGFGILLLEL 421
                    +S ++ D++  G++  E+
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGF 292
           +GKG FG V++G  + G  VAVK          E  +  E E+    +  H N+L  I  
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 293 ----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH-----EQ 343
                 T T+  LV  Y  +GS+   L  + ++      ++AL  A GL +LH      Q
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYL 400
             P I HRD+K+ NIL+ +     + D GLA   D     +  A    VG   ++APE L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 401 STG------QSSEKTDVFGFGILLLEL 421
                    +S ++ D++  G++  E+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 234 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR--LIG 291
            +GKGGF   ++    D   V   ++   + +      Q E   + +++HR+L    ++G
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 79
Query: 292 FCMTTTERLLVYPYM------SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQ 343
           F     +   V+  +      S   +  R KA  +P   +  R+ I LG      YLH  
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ-IVLGCQ----YLHRN 134
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              ++IHRD+K  N+ L+E  E  +GDFGLA  +++ D      + GT  +IAPE LS  
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTPNYIAPEVLSKK 190
Query: 404 QSSEKTDVFGFGILLLELISGLRALE 429
             S + DV+  G ++  L+ G    E
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGF 292
           +GKG FG V++G  + G  VAVK          E  +  E E+    +  H N+L  I  
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 68
Query: 293 ----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH-----EQ 343
                 T T+  LV  Y  +GS+   L  + ++      ++AL  A GL +LH      Q
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYL 400
             P I HRD+K+ NIL+ +     + D GLA   D     +  A    VG   ++APE L
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 401 STG------QSSEKTDVFGFGILLLEL 421
                    +S ++ D++  G++  E+
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 150 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAG 235

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 153 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPFRAG 238

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 150 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAG 235

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 66/120 (55%), Gaps = 5/120 (4%)
Query: 305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 364
           +M  GS+   LK    +      ++++   RGL YL E+   +I+HRDVK +NIL++   
Sbjct: 95  HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRG 152
Query: 365 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           E  + DFG++  L   DS   + V GT  ++APE L     S ++D++  G+ L+EL  G
Sbjct: 153 EIKLCDFGVSGQL--IDSMANSFV-GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 103/218 (47%), Gaps = 6/218 (2%)
Query: 228 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +F   + +G G  G V+K  +   G V+A K +          Q   E++++       +
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +   G   +  E  +   +M  GS+   LK    +      ++++   +GL YL E+   
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--H 143
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           KI+HRDVK +NIL++   E  + DFG++  L   DS   + V GT  +++PE L     S
Sbjct: 144 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYS 200
Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
            ++D++  G+ L+E+  G   +  G  +     +LD++
Sbjct: 201 VQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYI 238

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 109/227 (48%), Gaps = 8/227 (3%)
Query: 199 FDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYK-GYLQDGTVVAVK 257
            +++EQ+R+ +     ++    EL+    +F   + +G G  G V+K  +   G V+A K
Sbjct: 7   LELDEQQRKRLEAFLTQKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 258 RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA 317
            +          Q   E++++       ++   G   +  E  +   +M  GS+   LK 
Sbjct: 65  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124
Query: 318 KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 377
              +      ++++   +GL YL E+   KI+HRDVK +NIL++   E  + DFG++  L
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182
Query: 378 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
              DS   + V GT  +++PE L     S ++D++  G+ L+E+  G
Sbjct: 183 --IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 13/242 (5%)
Query: 216 RFHFKELQSATSN-FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQF 271
           ++ + E Q  T N F    ++GKGGFG V    ++  G + A K+L+        GE   
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 272 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL 331
             E +++     R ++ L     T     LV   M+ G +   +       +   + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 332 GA--ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 389
            A    GL  LH +   +I++RD+K  NILLD++    + D GLA    H     T   R
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGR 345
Query: 390 -GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
            GTVG++APE +   + +   D +  G LL E+I+G    +  K   ++  +   VK++ 
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405
Query: 449 QE 450
           +E
Sbjct: 406 EE 407

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 96  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 155 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 212 KSACKSSDLWALGCIIYQLVAGLPPFRAG 240

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 13/242 (5%)
Query: 216 RFHFKELQSATSN-FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQF 271
           ++ + E Q  T N F    ++GKGGFG V    ++  G + A K+L+        GE   
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 272 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL 331
             E +++     R ++ L     T     LV   M+ G +   +       +   + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 332 GA--ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 389
            A    GL  LH +   +I++RD+K  NILLD++    + D GLA    H     T   R
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGR 345
Query: 390 -GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
            GTVG++APE +   + +   D +  G LL E+I+G    +  K   ++  +   VK++ 
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405
Query: 449 QE 450
           +E
Sbjct: 406 EE 407

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 75  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 134 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 191 KSACKSSDLWALGCIIYQLVAGLPPFRAG 219

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 149 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLPPFRAG 234

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGN-VYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F   V    L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 150 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAG 235

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 107/224 (47%), Gaps = 8/224 (3%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLK 260
           +EQ+R+ +     ++    EL+    +F   + +G G  G V+K  +   G V+A K + 
Sbjct: 45  DEQQRKRLEAFLTQKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH 102
Query: 261 DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS 320
                    Q   E++++       ++   G   +  E  +   +M  GS+   LK    
Sbjct: 103 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR 162
Query: 321 LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 380
           +      ++++   +GL YL E+   KI+HRDVK +NIL++   E  + DFG++  L   
Sbjct: 163 IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--I 218
Query: 381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           DS   + V GT  +++PE L     S ++D++  G+ L+E+  G
Sbjct: 219 DSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-GEIQFQT-EVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I   ++ + T E +++S   H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 285 NLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++L  F     E+L     Y  NG +   ++   S D    +         L YLH +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 402
               IIHRD+K  NILL+E     + DFG AK+L             GT  +++PE L+ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFG 431
             + + +D++  G ++ +L++GL     G
Sbjct: 209 KSAXKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 228 NFSSKNLVGKGGFGNVY--KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
            F    ++G G F  V+  K  L  G + A+K +K   A       + E+ ++    H N
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDS-SLENEIAVLKKIKHEN 67
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           ++ L     +TT   LV   +S G +  R+  +          +       + YLHE   
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN-- 125
Query: 346 PKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
             I+HRD+K  N+L    +E  + ++ DFGL+K+     + + +   GT G++APE L+ 
Sbjct: 126 -GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTACGTPGYVAPEVLAQ 181
Query: 403 GQSSEKTDVFGFGILLLELISG 424
              S+  D +  G++   L+ G
Sbjct: 182 KPYSKAVDCWSIGVITYILLCG 203

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISL 280
           Q    N+     +GKG F  V    ++  G  VAVK +         +Q    EV ++ +
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
             H N+++L     T     LV  Y S G V   L A   +    +++ A    R ++  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRM----KEKEARAKFRQIVSA 125
Query: 341 HEQCDPK-IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            + C  K I+HRD+KA N+LLD      + DFG +      +   T    G+  + APE 
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPE- 182
Query: 400 LSTGQSSE--KTDVFGFGILLLELISG 424
           L  G+  +  + DV+  G++L  L+SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 44/291 (15%)
Query: 235 VGKGGFGNVYK----GYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLL 287
           +G G FG V +    G ++      VAVK LK    +       +E++++S L  H N++
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---------------- 331
            L+G C      L++  Y   G + + L+ K      ++   A+                
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 332 --GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-V 388
               A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     
Sbjct: 167 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           R  V  +APE +     + ++DV+ +GI L EL S       G ++   G  +D      
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LG-SSPYPGMPVD------ 270
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              K   ++ +  +         EM  +   C    P  RP   ++V+++E
Sbjct: 271 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 234 LVGKGGFGNVYKGYLQDGTV---VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRL 289
           ++GKG FG V K   +D       AVK +   +A   +      EVE++    H N+++L
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
                 ++   +V    + G +   +  +         RI      G+ Y+H+     I+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIV 143
Query: 350 HRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           HRD+K  NILL+   +     + DFGL+      ++ +   + GT  +IAPE L  G   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYIAPEVLR-GTYD 200
Query: 407 EKTDVFGFGILLLELISG 424
           EK DV+  G++L  L+SG
Sbjct: 201 EKCDVWSAGVILYILLSG 218

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNL--L 287
             +GKGGF   Y     + T +  K +  G  +   +     Q E     +A+H++L   
Sbjct: 48  RFLGKGGFAKCY-----EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 288 RLIGFCMTTTERLLVYPYM------SNGSVASRLKA--KPSLDWATRKRIALGAARGLLY 339
            ++GF     +   VY  +      S   +  R KA  +P   +  R+ I     +G+ Y
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQY 157
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           LH     ++IHRD+K  N+ L++  +  +GDFGLA  ++  D      + GT  +IAPE 
Sbjct: 158 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKTLCGTPNYIAPEV 213
Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRALE 429
           L     S + D++  G +L  L+ G    E
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 44/291 (15%)
Query: 235 VGKGGFGNVYK----GYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLL 287
           +G G FG V +    G ++      VAVK LK    +       +E++++S L  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---------------- 331
            L+G C      L++  Y   G + + L+ K      ++   A+                
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 332 --GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-V 388
               A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           R  V  +APE +     + ++DV+ +GI L EL S       G ++   G  +D      
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LG-SSPYPGMPVD------ 254
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              K   ++ +  +         EM  +   C    P  RP   ++V+++E
Sbjct: 255 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNL--L 287
             +GKGGF   Y     + T +  K +  G  +   +     Q E     +A+H++L   
Sbjct: 48  RFLGKGGFAKCY-----EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 288 RLIGFCMTTTERLLVYPYM------SNGSVASRLKA--KPSLDWATRKRIALGAARGLLY 339
            ++GF     +   VY  +      S   +  R KA  +P   +  R+ I     +G+ Y
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQY 157
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           LH     ++IHRD+K  N+ L++  +  +GDFGLA  ++  D      + GT  +IAPE 
Sbjct: 158 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKXLCGTPNYIAPEV 213
Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRALE 429
           L     S + D++  G +L  L+ G    E
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISL 280
           Q    N+     +GKG F  V    ++  G  VAVK +         +Q    EV ++ +
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
             H N+++L     T     LV  Y S G V   L A   +    +++ A    R ++  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRM----KEKEARAKFRQIVSA 125
Query: 341 HEQCDPK-IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            + C  K I+HRD+KA N+LLD      + DFG +      +   T    G+  + APE 
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPE- 182
Query: 400 LSTGQSSE--KTDVFGFGILLLELISG 424
           L  G+  +  + DV+  G++L  L+SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISL 280
           Q    N+     +GKG F  V    ++  G  VAVK +         +Q    EV ++ +
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
             H N+++L     T     LV  Y S G V   L A   +    +++ A    R ++  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRM----KEKEARAKFRQIVSA 125
Query: 341 HEQCDPK-IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            + C  K I+HRD+KA N+LLD      + DFG +   +    +   A  G   + APE 
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPE- 182
Query: 400 LSTGQSSE--KTDVFGFGILLLELISG 424
           L  G+  +  + DV+  G++L  L+SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 44/291 (15%)
Query: 235 VGKGGFGNVYK----GYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLL 287
           +G G FG V +    G ++      VAVK LK    +       +E++++S L  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---------------- 331
            L+G C      L++  Y   G + + L+ K      ++   A+                
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 332 --GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-V 388
               A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     
Sbjct: 174 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           R  V  +APE +     + ++DV+ +GI L EL S       G ++   G  +D      
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LG-SSPYPGMPVD------ 277
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              K   ++ +  +         EM  +   C    P  RP   ++V+++E
Sbjct: 278 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 44/291 (15%)
Query: 235 VGKGGFGNVYK----GYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLL 287
           +G G FG V +    G ++      VAVK LK    +       +E++++S L  H N++
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---------------- 331
            L+G C      L++  Y   G + + L+ K      ++   A+                
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 332 --GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-V 388
               A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     
Sbjct: 169 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           R  V  +APE +     + ++DV+ +GI L EL S       G ++   G  +D      
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LG-SSPYPGMPVD------ 272
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              K   ++ +  +         EM  +   C    P  RP   ++V+++E
Sbjct: 273 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           ++GKG +G VY G  L +   +A+K + + ++   +     E+ +     H+N+++ +G 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLG- 86
Query: 293 CMTTTERLLVYPYMSN---GSVASRLKAKPSLDWATRKRIALGAAR---GLLYLHEQCDP 346
             + +E   +  +M     GS+++ L++K        + I     +   GL YLH   D 
Sbjct: 87  --SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DN 141
Query: 347 KIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
           +I+HRD+K  N+L++ Y   + + DFG +K L   +   T    GT+ ++APE +  G  
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPR 200
Query: 406 --SEKTDVFGFGILLLELISG 424
              +  D++  G  ++E+ +G
Sbjct: 201 GYGKAADIWSLGCTIIEMATG 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 222 LQSATSNFSSK----NLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQT 273
           +Q +T+ FS +     ++GKG FG V     K   Q+  V  + + +       E     
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLR 75
Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 333
           EV+++    H N+++L  F        LV    + G +   + ++         RI    
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVR- 389
             G+ Y+H+    KI+HRD+K  N+LL+   +     + DFGL+    H ++      + 
Sbjct: 136 LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKI 189
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           GT  +IAPE L  G   EK DV+  G++L  L+SG
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 44/291 (15%)
Query: 235 VGKGGFGNVYK----GYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLL 287
           +G G FG V +    G ++      VAVK LK    +       +E++++S L  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---------------- 331
            L+G C      L++  Y   G + + L+ K      ++   A+                
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 332 --GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-V 388
               A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     
Sbjct: 174 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           R  V  +APE +     + ++DV+ +GI L EL S       G ++   G  +D      
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LG-SSPYPGMPVD------ 277
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              K   ++ +  +         EM  +   C    P  RP   ++V+++E
Sbjct: 278 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 12/202 (5%)
Query: 228 NFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRN 285
           N+     +GKG F  V    ++  G  VAVK +         +Q    EV ++ +  H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           +++L     T     LV  Y S G V   L A     W   K  A    R ++   + C 
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GWMKEKE-ARAKFRQIVSAVQYCH 123
Query: 346 PK-IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
            K I+HRD+KA N+LLD      + DFG +      +   T    G+  + APE L  G+
Sbjct: 124 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPE-LFQGK 180
Query: 405 SSE--KTDVFGFGILLLELISG 424
             +  + DV+  G++L  L+SG
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSG 202

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNL--L 287
             +GKGGF   Y     + T +  K +  G  +   +     Q E     +A+H++L   
Sbjct: 48  RFLGKGGFAKCY-----EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 288 RLIGFCMTTTERLLVYPYM------SNGSVASRLKA--KPSLDWATRKRIALGAARGLLY 339
            ++GF     +   VY  +      S   +  R KA  +P   +  R+ I     +G+ Y
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQY 157
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           LH     ++IHRD+K  N+ L++  +  +GDFGLA  ++  D      + GT  +IAPE 
Sbjct: 158 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTPNYIAPEV 213
Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRALE 429
           L     S + D++  G +L  L+ G    E
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 6/198 (3%)
Query: 228 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +F   + +G G  G V+K  +   G V+A K +          Q   E++++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +   G   +  E  +   +M  GS+   LK    +      ++++   +GL YL E+   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-- 124
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           KI+HRDVK +NIL++   E  + DFG++  L   DS   + V GT  +++PE L     S
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYS 181
Query: 407 EKTDVFGFGILLLELISG 424
            ++D++  G+ L+E+  G
Sbjct: 182 VQSDIWSMGLSLVEMAVG 199

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHR 284
           N+     +G+G FG V   Y    G  VA+K +        ++Q   + E+  + L  H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           ++++L     +  E ++V  Y  N  +   +  +  +     +R        + Y H   
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH- 132
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG- 403
             KI+HRD+K  N+LLDE+    + DFGL+ ++   D +      G+  + APE +S   
Sbjct: 133 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKL 188
Query: 404 QSSEKTDVFGFGILLLELISGLRALEF 430
            +  + DV+  G++L  ++   R L F
Sbjct: 189 YAGPEVDVWSCGVILYVMLC--RRLPF 213

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 234 LVGKGGFGNVYKGYLQDGTV---VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRL 289
           ++GKG FG V K   +D       AVK +   +A   +      EVE++    H N+++L
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
                 ++   +V    + G +   +  +         RI      G+ Y+H+     I+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIV 143
Query: 350 HRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           HRD+K  NILL+   +     + DFGL+      ++ +   + GT  +IAPE L  G   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYIAPEVLR-GTYD 200
Query: 407 EKTDVFGFGILLLELISG 424
           EK DV+  G++L  L+SG
Sbjct: 201 EKCDVWSAGVILYILLSG 218

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 103/234 (44%), Gaps = 11/234 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF---QTEVEMISLAVHR 284
           +F    ++G+G +  V    L+    +   R+     +  +      QTE  +   A + 
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 285 NLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  +  C  T  RL  V  Y++ G +   ++ +  L     +  +   +  L YLHE+
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRGTVGHIAPEYLST 402
               II+RD+K  N+LLD      + D+G+ K  L   D+  T+   GT  +IAPE L  
Sbjct: 173 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRG 227
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEF-GKTANQKGAMLDWVKKIHQEKKLEM 455
                  D +  G+L+ E+++G    +  G + N      D++ ++  EK++ +
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 89/192 (46%), Gaps = 6/192 (3%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G VYK     G   A+K+++ +    G       E+ ++    H N+++L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
            T    +LV+ ++           +  L+  T K   L    G+ Y H   D +++HRD+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDL 126
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL-STGQSSEKTDVF 412
           K  N+L++   E  + DFGLA+         T  V  T+ + AP+ L  + + S   D++
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIW 185
Query: 413 GFGILLLELISG 424
             G +  E+++G
Sbjct: 186 SVGCIFAEMVNG 197

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISL 280
           Q    N+     +GKG F  V    ++  G  VAV+ +         +Q    EV ++ +
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
             H N+++L     T     LV  Y S G V   L A   +    +++ A    R ++  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRM----KEKEARAKFRQIVSA 125
Query: 341 HEQCDPK-IIHRDVKAANILLDEYYEAVVGDFGLA-------KLLDHCDSHVTTAVRGTV 392
            + C  K I+HRD+KA N+LLD      + DFG +       KL + C         G+ 
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC---------GSP 176
Query: 393 GHIAPEYLSTGQSSE--KTDVFGFGILLLELISG 424
            + APE L  G+  +  + DV+  G++L  L+SG
Sbjct: 177 PYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHR 284
           N+     +G+G FG V   Y    G  VA+K +        ++Q   + E+  + L  H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           ++++L     +  E ++V  Y  N  +   +  +  +     +R        + Y H   
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH- 122
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG- 403
             KI+HRD+K  N+LLDE+    + DFGL+ ++   D +      G+  + APE +S   
Sbjct: 123 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKL 178
Query: 404 QSSEKTDVFGFGILLLELISGLRALEF 430
            +  + DV+  G++L  ++   R L F
Sbjct: 179 YAGPEVDVWSCGVILYVMLC--RRLPF 203

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 234 LVGKGGFGNVYKGYLQDGTV---VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRL 289
           ++GKG FG V K   +D       AVK +   +A   +      EVE++    H N+++L
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
                 ++   +V    + G +   +  +         RI      G+ Y+H+     I+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIV 143
Query: 350 HRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           HRD+K  NILL+   +     + DFGL+      ++ +   + GT  +IAPE L  G   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYIAPEVLR-GTYD 200
Query: 407 EKTDVFGFGILLLELISG 424
           EK DV+  G++L  L+SG
Sbjct: 201 EKCDVWSAGVILYILLSG 218

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 89/192 (46%), Gaps = 6/192 (3%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G VYK     G   A+K+++ +    G       E+ ++    H N+++L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
            T    +LV+ ++           +  L+  T K   L    G+ Y H   D +++HRD+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDL 126
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL-STGQSSEKTDVF 412
           K  N+L++   E  + DFGLA+         T  V  T+ + AP+ L  + + S   D++
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIW 185
Query: 413 GFGILLLELISG 424
             G +  E+++G
Sbjct: 186 SVGCIFAEMVNG 197

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 6/198 (3%)
Query: 228 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +F   + +G G  G V+K  +   G V+A K +          Q   E++++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +   G   +  E  +   +M  GS+   LK    +      ++++   +GL YL E+   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--H 124
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           KI+HRDVK +NIL++   E  + DFG++  L   DS   + V GT  +++PE L     S
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYS 181
Query: 407 EKTDVFGFGILLLELISG 424
            ++D++  G+ L+E+  G
Sbjct: 182 VQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 6/198 (3%)
Query: 228 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +F   + +G G  G V+K  +   G V+A K +          Q   E++++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +   G   +  E  +   +M  GS+   LK    +      ++++   +GL YL E+   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--H 124
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           KI+HRDVK +NIL++   E  + DFG++  L   DS   + V GT  +++PE L     S
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYS 181
Query: 407 EKTDVFGFGILLLELISG 424
            ++D++  G+ L+E+  G
Sbjct: 182 VQSDIWSMGLSLVEMAVG 199

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 6/198 (3%)
Query: 228 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +F   + +G G  G V+K  +   G V+A K +          Q   E++++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +   G   +  E  +   +M  GS+   LK    +      ++++   +GL YL E+   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-- 124
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           KI+HRDVK +NIL++   E  + DFG++  L   DS   + V GT  +++PE L     S
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYS 181
Query: 407 EKTDVFGFGILLLELISG 424
            ++D++  G+ L+E+  G
Sbjct: 182 VQSDIWSMGLSLVEMAVG 199

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHR 284
           N+     +G+G FG V   Y    G  VA+K +        ++Q   + E+  + L  H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           ++++L     +  E ++V  Y  N  +   +  +  +     +R        + Y H   
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH- 131
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG- 403
             KI+HRD+K  N+LLDE+    + DFGL+ ++   D +      G+  + APE +S   
Sbjct: 132 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKL 187
Query: 404 QSSEKTDVFGFGILLLELISGLRALEF 430
            +  + DV+  G++L  ++   R L F
Sbjct: 188 YAGPEVDVWSCGVILYVMLC--RRLPF 212

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 6/198 (3%)
Query: 228 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +F   + +G G  G V+K  +   G V+A K +          Q   E++++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +   G   +  E  +   +M  GS+   LK    +      ++++   +GL YL E+   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-- 124
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           KI+HRDVK +NIL++   E  + DFG++  L   DS   + V GT  +++PE L     S
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYS 181
Query: 407 EKTDVFGFGILLLELISG 424
            ++D++  G+ L+E+  G
Sbjct: 182 VQSDIWSMGLSLVEMAVG 199

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +G+G +G V+K   +D G +VA+K+    + + +  +I  + E+ M+    H NL+ L+ 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69
Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
                    LV+ Y  +  +    + +  +     K I     + + + H+      IHR
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHR 126
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLL----DHCDSHVTTAVRGTVGHIAPEYL-STGQSS 406
           DVK  NIL+ ++    + DFG A+LL    D+ D  V T       + +PE L    Q  
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPELLVGDTQYG 181
Query: 407 EKTDVFGFGILLLELISGL 425
              DV+  G +  EL+SG+
Sbjct: 182 PPVDVWAIGCVFAELLSGV 200

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNL--L 287
             +GKGGF   Y     + T +  K +  G  +   +     Q E     +A+H++L   
Sbjct: 32  RFLGKGGFAKCY-----EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 86
Query: 288 RLIGFCMTTTERLLVYPYM------SNGSVASRLKA--KPSLDWATRKRIALGAARGLLY 339
            ++GF     +   VY  +      S   +  R KA  +P   +  R+ I     +G+ Y
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQY 141
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           LH     ++IHRD+K  N+ L++  +  +GDFGLA  ++  D      + GT  +IAPE 
Sbjct: 142 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTPNYIAPEV 197
Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRALE 429
           L     S + D++  G +L  L+ G    E
Sbjct: 198 LCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 222 LQSATSNFSSK----NLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQT 273
           +Q +T+ FS +     ++GKG FG V     K   Q+  V  + + +       E     
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLR 81
Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 333
           EV+++    H N+++L  F        LV    + G +   + ++         RI    
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 141
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRG 390
             G+ Y+H+    KI+HRD+K  N+LL+   +     + DFGL+   +   S       G
Sbjct: 142 LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIG 196
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           T  +IAPE L  G   EK DV+  G++L  L+SG
Sbjct: 197 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHR 284
           N+     +G+G FG V   Y    G  VA+K +        ++Q   + E+  + L  H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           ++++L     +  E ++V  Y  N  +   +  +  +     +R        + Y H   
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH- 126
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG- 403
             KI+HRD+K  N+LLDE+    + DFGL+ ++   D +      G+  + APE +S   
Sbjct: 127 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKL 182
Query: 404 QSSEKTDVFGFGILLLELISGLRALEF 430
            +  + DV+  G++L  ++   R L F
Sbjct: 183 YAGPEVDVWSCGVILYVMLC--RRLPF 207

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI------------------GG 267
           + ++ K+ +GKG +G V   Y + D T  A+K L     I                  GG
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 268 EIQFQTEVEMISLAV-------HRNLLRLIGFCMTTTER--LLVYPYMSNGSVASRLKAK 318
            IQ +  +E +   +       H N+++L+       E    +V+  ++ G V      K
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 319 PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 378
           P  +   R        +G+ YLH Q   KIIHRD+K +N+L+ E     + DFG++    
Sbjct: 133 PLSEDQARFYFQ-DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 379 HCDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISG 424
             D+ ++  V GT   +APE LS  +   S +  DV+  G+ L   + G
Sbjct: 189 GSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISL 280
           Q    N+     +GKG F  V    ++  G  VAV+ +         +Q    EV ++ +
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
             H N+++L     T     LV  Y S G V   L A   +    +++ A    R ++  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRM----KEKEARAKFRQIVSA 125
Query: 341 HEQCDPK-IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            + C  K I+HRD+KA N+LLD      + DFG +      +   T    G+  + APE 
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPE- 182
Query: 400 LSTGQSSE--KTDVFGFGILLLELISG 424
           L  G+  +  + DV+  G++L  L+SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           ++GKG +G VY G  L +   +A+K + + ++   +     E+ +     H+N+++ +G 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLG- 72
Query: 293 CMTTTERLLVYPYMSN---GSVASRLKAKPSLDWATRKRIALGAAR---GLLYLHEQCDP 346
             + +E   +  +M     GS+++ L++K        + I     +   GL YLH   D 
Sbjct: 73  --SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DN 127
Query: 347 KIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
           +I+HRD+K  N+L++ Y   + + DFG +K L   +   T    GT+ ++APE +  G  
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPR 186
Query: 406 --SEKTDVFGFGILLLELISG 424
              +  D++  G  ++E+ +G
Sbjct: 187 GYGKAADIWSLGCTIIEMATG 207

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISL 280
           Q    N+  +  +GKG F  V    ++  G  VAVK +         +Q    EV ++ +
Sbjct: 11  QPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKI 70
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
             H N+++L     T     LV  Y S G V   L A   +    +++ A    R ++  
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRM----KEKEARAKFRQIVSA 126
Query: 341 HEQCDPK-IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            + C  K I+HRD+KA N+LLD      + DFG +      +   T    G+  + APE 
Sbjct: 127 VQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC--GSPPYAAPE- 183
Query: 400 LSTGQSSE--KTDVFGFGILLLELISG 424
           L  G+  +  + DV+  G++L  L+SG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 89/192 (46%), Gaps = 6/192 (3%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G +G VYK     G   A+K+++ +    G       E+ ++    H N+++L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
            T    +LV+ ++           +  L+  T K   L    G+ Y H   D +++HRD+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDL 126
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL-STGQSSEKTDVF 412
           K  N+L++   E  + DFGLA+         T  +  T+ + AP+ L  + + S   D++
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIW 185
Query: 413 GFGILLLELISG 424
             G +  E+++G
Sbjct: 186 SVGCIFAEMVNG 197

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 222 LQSATSNFSSK----NLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQT 273
           +Q +T+ FS +     ++GKG FG V     K   Q+  V  + + +       E   + 
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR- 98
Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 333
           EV+++    H N+++L  F        LV    + G +   + ++         RI    
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 158
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRG 390
             G+ Y+H+    KI+HRD+K  N+LL+   +     + DFGL+   +   S       G
Sbjct: 159 LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIG 213
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           T  +IAPE L  G   EK DV+  G++L  L+SG
Sbjct: 214 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 222 LQSATSNFSSK----NLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQT 273
           +Q +T+ FS +     ++GKG FG V     K   Q+  V  + + +       E   + 
Sbjct: 41  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR- 99
Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 333
           EV+++    H N+++L  F        LV    + G +   + ++         RI    
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 159
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRG 390
             G+ Y+H+    KI+HRD+K  N+LL+   +     + DFGL+   +   S       G
Sbjct: 160 LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIG 214
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           T  +IAPE L  G   EK DV+  G++L  L+SG
Sbjct: 215 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 229 FSSKNLVGKGGFGNVYKGY----LQDGTVVAVKRLKDGNAI---GGEIQFQTEVEMISLA 281
           F    ++GKGG+G V++         G + A+K LK    +         + E  ++   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
            H  ++ LI    T  +  L+  Y+S G +  +L+ +      T        +  L +LH
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
           ++    II+RD+K  NI+L+      + DFGL K   H D  VT    GT+ ++APE L 
Sbjct: 139 QK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH-DGTVTHTFCGTIEYMAPEILM 194
Query: 402 TGQSSEKTDVFGFGILLLELISG 424
               +   D +  G L+ ++++G
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTG 217

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 44/231 (19%)
Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
            S+F    ++G+G FG V K     D    A+K+++        I   +EV +++   H+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL--SEVMLLASLNHQ 62
Query: 285 NLLRLIGFC---------MTTTER----LLVYPYMSNGSV-----ASRLKAKPSLDWATR 326
            ++R              MT  ++     +   Y  N ++     +  L  +    W   
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 327 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC------ 380
           ++I       L Y+H Q    IIHRD+K  NI +DE     +GDFGLAK +         
Sbjct: 123 RQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 381 DSH--------VTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI 422
           DS         +T+A+ GT  ++A E L  TG  +EK D++  GI+  E+I
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 9/206 (4%)
Query: 235 VGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           +G+G +  VYKG   L D  +VA+K ++  +  G       EV ++    H N++ L   
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
             T     LV+ Y+              ++    K       RGL Y H Q   K++HRD
Sbjct: 69  IHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRD 125
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-LSTGQSSEKTDV 411
           +K  N+L++E  E  + DFGLA+            V  T+ +  P+  L +   S + D+
Sbjct: 126 LKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQIDM 184
Query: 412 FGFGILLLELISGLRALEFGKTANQK 437
           +G G +  E+ +G R L  G T  ++
Sbjct: 185 WGVGCIFYEMATG-RPLFPGSTVEEQ 209

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 229 FSSKNLVGKGGFGNVYKGY----LQDGTVVAVKRLKDGNAI---GGEIQFQTEVEMISLA 281
           F    ++GKGG+G V++         G + A+K LK    +         + E  ++   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
            H  ++ LI    T  +  L+  Y+S G +  +L+ +      T        +  L +LH
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
           ++    II+RD+K  NI+L+      + DFGL K   H D  VT    GT+ ++APE L 
Sbjct: 139 QK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH-DGTVTHXFCGTIEYMAPEILM 194
Query: 402 TGQSSEKTDVFGFGILLLELISG 424
               +   D +  G L+ ++++G
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 11/234 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF---QTEVEMISLAVHR 284
           +F    ++G+G +  V    L+    +   ++     +  +      QTE  +   A + 
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 285 NLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  +  C  T  RL  V  Y++ G +   ++ +  L     +  +   +  L YLHE+
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRGTVGHIAPEYLST 402
               II+RD+K  N+LLD      + D+G+ K  L   D+  T+   GT  +IAPE L  
Sbjct: 130 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEILRG 184
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEF-GKTANQKGAMLDWVKKIHQEKKLEM 455
                  D +  G+L+ E+++G    +  G + N      D++ ++  EK++ +
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 228 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +F   + +G G  G V+K  +   G V+A K +          Q   E++++       +
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +   G   +  E  +   +M  GS+   LK    +      ++++   +GL YL E+   
Sbjct: 70  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-- 127
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
           KI+HRDVK +NIL++   E  + DFG++ +L+D     +     GT  +++PE L     
Sbjct: 128 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----EMANEFVGTRSYMSPERLQGTHY 183
Query: 406 SEKTDVFGFGILLLELISG 424
           S ++D++  G+ L+E+  G
Sbjct: 184 SVQSDIWSMGLSLVEMAVG 202

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 11/234 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF---QTEVEMISLAVHR 284
           +F    ++G+G +  V    L+    +   ++     +  +      QTE  +   A + 
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 285 NLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  +  C  T  RL  V  Y++ G +   ++ +  L     +  +   +  L YLHE+
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 125
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRGTVGHIAPEYLST 402
               II+RD+K  N+LLD      + D+G+ K  L   D+  T+   GT  +IAPE L  
Sbjct: 126 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEILRG 180
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEF-GKTANQKGAMLDWVKKIHQEKKLEM 455
                  D +  G+L+ E+++G    +  G + N      D++ ++  EK++ +
Sbjct: 181 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 234

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 11/234 (4%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF---QTEVEMISLAVHR 284
           +F    ++G+G +  V    L+    +   ++     +  +      QTE  +   A + 
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 285 NLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  +  C  T  RL  V  Y++ G +   ++ +  L     +  +   +  L YLHE+
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 140
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRGTVGHIAPEYLST 402
               II+RD+K  N+LLD      + D+G+ K  L   D+  T+   GT  +IAPE L  
Sbjct: 141 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEILRG 195
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEF-GKTANQKGAMLDWVKKIHQEKKLEM 455
                  D +  G+L+ E+++G    +  G + N      D++ ++  EK++ +
Sbjct: 196 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 249

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 12/207 (5%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISL 280
           Q    N+     +GKG F  V    ++  G  VAVK +         +Q    EV +  +
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKV 69
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
             H N+++L     T     LV  Y S G V   L A        +++ A    R ++  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGR----XKEKEARAKFRQIVSA 125
Query: 341 HEQCDPK-IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
            + C  K I+HRD+KA N+LLD      + DFG +   +    +   A  G   + APE 
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPE- 182
Query: 400 LSTGQSSE--KTDVFGFGILLLELISG 424
           L  G+  +  + DV+  G++L  L+SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 31/228 (13%)
Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDG--NAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +GKG +G V+K    + G VVAVK++ D   N+   +  F+  + +  L+ H N++ L+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 292 FCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
                 +R   LV+ YM    + + ++A   L+   ++ +     + + YLH      ++
Sbjct: 77  VLRADNDRDVYLVFDYMET-DLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSG---GLL 131
Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHC--------------------DSHVTTAVR 389
           HRD+K +NILL+      V DFGL++   +                     D  + T   
Sbjct: 132 HRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYV 191
Query: 390 GTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 436
            T  + APE  L + + ++  D++  G +L E++ G        T NQ
Sbjct: 192 ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 286
           +G+G  G VY    +  G  VA++++         +Q Q + E+I   + V R     N+
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMRENKNPNI 79
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +  +   +   E  +V  Y++ GS+ + +  +  +D      +     + L +LH     
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           ++IHRD+K+ NILL       + DFG    +    S  +T V GT   +APE ++     
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 407 EKTDVFGFGILLLELISG 424
            K D++  GI+ +E+I G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISL 280
           Q    N+     +GKG F  V    ++  G  VA+K +         +Q    EV ++ +
Sbjct: 11  QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI 70
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
             H N+++L     T     L+  Y S G V   L A   +     +         + Y 
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
           H++   +I+HRD+KA N+LLD      + DFG +   +        A  G   + APE L
Sbjct: 131 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDAFCGAPPYAAPE-L 184
Query: 401 STGQSSE--KTDVFGFGILLLELISG 424
             G+  +  + DV+  G++L  L+SG
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 283
            S +     +G+G FG V+K  + + G  VA+K+ L +    G  I    E++++ L  H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 284 RNLLRLIGFCMTTTERL--------LVYPYMSN--GSVASRLKAKPSLDWATRKRIALGA 333
            N++ LI  C T             LV+ +  +    + S +  K +L  +  KR+    
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVMQML 134
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
             GL Y+H     KI+HRD+KAAN+L+       + DFGLA+
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISL 280
           Q    N+     +GKG F  V    ++  G  VA+K +         +Q    EV ++ +
Sbjct: 8   QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI 67
Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
             H N+++L     T     L+  Y S G V   L A   +     +         + Y 
Sbjct: 68  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 127
Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA-------KLLDHCDSHVTTAVRGTVG 393
           H++   +I+HRD+KA N+LLD      + DFG +       KL   C         G+  
Sbjct: 128 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC---------GSPP 175
Query: 394 HIAPEYLSTGQSSE--KTDVFGFGILLLELISG 424
           + APE L  G+  +  + DV+  G++L  L+SG
Sbjct: 176 YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 283
            S +     +G+G FG V+K  + + G  VA+K+ L +    G  I    E++++ L  H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 284 RNLLRLIGFCMTTTERL--------LVYPYMSN--GSVASRLKAKPSLDWATRKRIALGA 333
            N++ LI  C T             LV+ +  +    + S +  K +L  +  KR+    
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVMQML 133
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
             GL Y+H     KI+HRD+KAAN+L+       + DFGLA+
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 283
            S +     +G+G FG V+K  + + G  VA+K+ L +    G  I    E++++ L  H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 284 RNLLRLIGFCMTTTERL--------LVYPYMSN--GSVASRLKAKPSLDWATRKRIALGA 333
            N++ LI  C T             LV+ +  +    + S +  K +L  +  KR+    
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVMQML 134
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
             GL Y+H     KI+HRD+KAAN+L+       + DFGLA+
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 227 SNFSSKNLVGKGGFGNVY-----KGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMI 278
            NF    ++G G +G V+      G+   G + A+K LK    +         +TE +++
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 279 SLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
                   L  + +   T  +L L+  Y++ G + + L  +      T   + +     +
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF---TEHEVQIYVGEIV 169
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
           L L       II+RD+K  NILLD     V+ DFGL+K     ++       GT+ ++AP
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 398 EYLSTGQS--SEKTDVFGFGILLLELISG 424
           + +  G S   +  D +  G+L+ EL++G
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 283
            S +     +G+G FG V+K  + + G  VA+K+ L +    G  I    E++++ L  H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 284 RNLLRLIGFCMTTTERL--------LVYPYMSN--GSVASRLKAKPSLDWATRKRIALGA 333
            N++ LI  C T             LV+ +  +    + S +  K +L  +  KR+    
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVMQML 134
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
             GL Y+H     KI+HRD+KAAN+L+       + DFGLA+
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           F  ++ +G+G    VY+   Q GT    A+K LK    +  +I  +TE+ ++    H N+
Sbjct: 55  FEVESELGRGATSIVYRCK-QKGTQKPYALKVLK--KTVDKKI-VRTEIGVLLRLSHPNI 110
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL----YLHE 342
           ++L     T TE  LV   ++ G +  R+  K        +R A  A + +L    YLHE
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYS----ERDAADAVKQILEAVAYLHE 166
Query: 343 QCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
                I+HRD+K  N+L           + DFGL+K+++H    +   V GT G+ APE 
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPEI 221
Query: 400 LSTGQSSEKTDVFGFGILLLELISGL 425
           L       + D++  GI+   L+ G 
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGF 247

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 41/223 (18%)
Query: 228 NFSSKNL-----VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           +F++++L     +G+G +G+V K  +   G ++AVKR++  + +  + Q Q  +++  + 
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVM 75
Query: 282 VHRNLLRLIGF------------CM----TTTERLLVYPYMSNGSVASRLKAKPSLDWAT 325
              +   ++ F            CM    T+ ++   Y Y    SV   +  +  L    
Sbjct: 76  RSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVY----SVLDDVIPEEILG--- 128
Query: 326 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 385
             +I L   + L +L E    KIIHRD+K +NILLD      + DFG++  L   DS   
Sbjct: 129 --KITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAK 182
Query: 386 TAVRGTVGHIAPEYLSTGQSSE----KTDVFGFGILLLELISG 424
           T   G   ++APE +    S +    ++DV+  GI L EL +G
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 222 LQSATSNFSSK----NLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQT 273
           +Q +T+ FS +     ++GKG FG V     K   Q+  V  + + +       E   + 
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR- 75
Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 333
           EV+++    H N+ +L  F        LV    + G +   + ++         RI    
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRG 390
             G+ Y H+    KI+HRD+K  N+LL+   +     + DFGL+   +   S       G
Sbjct: 136 LSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKXKDKIG 190
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           T  +IAPE L  G   EK DV+  G++L  L+SG
Sbjct: 191 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 11/209 (5%)
Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIG-GEIQ-FQTEVEMISLAVHRNLLRLIG 291
           +GKG FG V      D   + A+K +     +   E++    E++++    H  L+ L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
                 +  +V   +  G +   L+        T K         L YL  Q   +IIHR
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHR 139
Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS---SEK 408
           D+K  NILLDE+    + DF +A +L   ++ +TT   GT  ++APE  S+ +    S  
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITTMA-GTKPYMAPEMFSSRKGAGYSFA 197
Query: 409 TDVFGFGILLLELISGLRALEFGKTANQK 437
            D +  G+   EL+ G R      + + K
Sbjct: 198 VDWWSLGVTAYELLRGRRPYHIRSSTSSK 226

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +++   ++G G FG VY+  L D G +VA+K++  G A         E++++    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-----ELQIMRKLDHCNI 75
Query: 287 LRLIGFCMTTTER--------LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGL 337
           +RL  F  ++ E+        +L Y   +   VA    +AK +L     K       R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
            Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + A
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRA 190
Query: 397 PEYL-STGQSSEKTDVFGFGILLLELISG 424
           PE +      +   DV+  G +L EL+ G
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 222 LQSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMI 278
           LQ    ++    ++G+G FG V    +     V A+K L     I       F  E +++
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 279 SLAVHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + A    +++L  FC    ++ L  V  YM  G + + +           K      A  
Sbjct: 130 AFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEV 183
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAVRGT 391
           +L L       +IHRDVK  N+LLD++    + DFG    +D     HCD+ V     GT
Sbjct: 184 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-----GT 238
Query: 392 VGHIAPEYLST----GQSSEKTDVFGFGILLLELISG 424
             +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 21/198 (10%)
Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 286
           +G+G  G VY    +  G  VA++++         +Q Q + E+I   + V R     N+
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMRENKNPNI 79
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +  +   +   E  +V  Y++ GS+ + +  +  +D      +     + L +LH     
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           ++IHRD+K+ NILL       + DFG    +    S  +  V GT   +APE ++     
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYG 194
Query: 407 EKTDVFGFGILLLELISG 424
            K D++  GI+ +E+I G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 286
           +G+G  G VY    +  G  VA++++         +Q Q + E+I   + V R     N+
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMRENKNPNI 80
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +  +   +   E  +V  Y++ GS+ + +  +  +D      +     + L +LH     
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 136
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           ++IHR++K+ NILL       + DFG    +    S  +T V GT   +APE ++     
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 195
Query: 407 EKTDVFGFGILLLELISG 424
            K D++  GI+ +E+I G
Sbjct: 196 PKVDIWSLGIMAIEMIEG 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 21/198 (10%)
Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 286
           +G+G  G VY    +  G  VA++++         +Q Q + E+I   + V R     N+
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMRENKNPNI 80
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +  +   +   E  +V  Y++ GS+ + +  +  +D      +     + L +LH     
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 136
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           ++IHRD+K+ NILL       + DFG    +    S  +  V GT   +APE ++     
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYG 195
Query: 407 EKTDVFGFGILLLELISG 424
            K D++  GI+ +E+I G
Sbjct: 196 PKVDIWSLGIMAIEMIEG 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 21/198 (10%)
Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 286
           +G+G  G VY    +  G  VA++++         +Q Q + E+I   + V R     N+
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMRENKNPNI 79
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +  +   +   E  +V  Y++ GS+ + +  +  +D      +     + L +LH     
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           ++IHRD+K+ NILL       + DFG    +    S  +  V GT   +APE ++     
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRKAYG 194
Query: 407 EKTDVFGFGILLLELISG 424
            K D++  GI+ +E+I G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 48/233 (20%)
Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
            S+F    ++G+G FG V K     D    A+K+++        I   +EV +++   H+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL--SEVXLLASLNHQ 62
Query: 285 NLLRLIGFCMTTTERLLVYP---------------YMSNGSV-----ASRLKAKPSLDWA 324
            ++R   +      R  V P               Y  N ++     +  L  +    W 
Sbjct: 63  YVVRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 325 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC---- 380
             ++I       L Y+H Q    IIHR++K  NI +DE     +GDFGLAK +       
Sbjct: 121 LFRQIL----EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 381 --DSH--------VTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI 422
             DS         +T+A+ GT  ++A E L  TG  +EK D +  GI+  E I
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   Y ++ G  +AVK+L +   +I    +   E+ +
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 278 ISLAVHRNLLRLIGFCMTTTE-----RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+      T       + +  ++    + + +K +   D   +  I   
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 162
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 163 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 215
Query: 393 GHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
            + APE +        T D++  G ++ EL++G
Sbjct: 216 WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +++   ++G G FG VY+  L D G +VA+K++  G A         E++++    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-----ELQIMRKLDHCNI 75
Query: 287 LRLIGFCMTTTER--------LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGL 337
           +RL  F  ++ E+        +L Y   +   VA    +AK +L     K       R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
            Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + A
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRA 190
Query: 397 PEYL-STGQSSEKTDVFGFGILLLELISG 424
           PE +      +   DV+  G +L EL+ G
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 100/232 (43%), Gaps = 28/232 (12%)
Query: 215 KRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGE 268
           K+   KE+  +   F  +  +G+  FG VYKG+L      +    VA+K LKD       
Sbjct: 16  KQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR 73
Query: 269 IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL------------- 315
            +F+ E  + +   H N++ L+G         +++ Y S+G +   L             
Sbjct: 74  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133
Query: 316 ---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
                K +L+      +    A G+ YL       ++H+D+   N+L+ +     + D G
Sbjct: 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLG 190
Query: 373 LAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           L + +   D + +       +  +APE +  G+ S  +D++ +G++L E+ S
Sbjct: 191 LFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +++   ++G G FG VY+  L D G +VA+K++  G A         E++++    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-----ELQIMRKLDHCNI 75
Query: 287 LRLIGFCMTTTER--------LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGL 337
           +RL  F  ++ E+        +L Y   +   VA    +AK +L     K       R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
            Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + A
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRA 190
Query: 397 PEYL-STGQSSEKTDVFGFGILLLELISG 424
           PE +      +   DV+  G +L EL+ G
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 130/307 (42%), Gaps = 28/307 (9%)
Query: 232 KNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEM--ISLAVHRNLLR 288
           +  +G+G FG V    + +    VA+K +        ++  + E E+  + L  H ++++
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           L     T T+ ++V  Y + G +   +  K  +     +R        + Y H     KI
Sbjct: 74  LYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KI 129
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSE 407
           +HRD+K  N+LLD+     + DFGL+ ++   D +      G+  + APE ++    +  
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 408 KTDVFGFGILLLELISGLRALE-------FGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 460
           + DV+  GI+L  ++ G    +       F K  +    M D++    Q     M+V   
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADP 247
Query: 461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV------VRMLEGDGLAEKWAASQKAE 514
           ++    RI ++E+ +           LRP M EV       R++   G A  ++     E
Sbjct: 248 MQ----RITIQEIRRDPWFNVNLPDYLRP-MEEVQGSYADSRIVSKLGEAMGFSEDYIVE 302
Query: 515 ATRSRAN 521
           A RS  N
Sbjct: 303 ALRSDEN 309

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 231 SKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           +  L+G+G +  V     LQ+G   AVK ++          F+    +     ++N+L L
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           I F    T   LV+  +  GS+ + ++ +   +     R+    A  L +LH +    I 
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTK---GIA 133
Query: 350 HRDVKAANILLDEYYEAV----VGDFGLA---KLLDHCDSHVT---TAVRGTVGHIAPEY 399
           HRD+K  NIL  E  E V    + DF L    KL + C    T   T   G+  ++APE 
Sbjct: 134 HRDLKPENILC-ESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 400 LS--TGQSS---EKTDVFGFGILLLELISG 424
           +   T Q++   ++ D++  G++L  ++SG
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
           +A H +++ LI    +++   LV+  M  G +   L  K +L     + I       + +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           LH      I+HRD+K  NILLD+  +  + DFG +  L+  +      + GT G++APE 
Sbjct: 216 LHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEI 270
Query: 400 LSTGQSS------EKTDVFGFGILLLELISG 424
           L            ++ D++  G++L  L++G
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEV 275
           H KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V
Sbjct: 22  HMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 81
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRK 327
            M  +     LL+ +    +   RLL +    +  V    + +P  D         A ++
Sbjct: 82  PMEVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 136
Query: 328 RIALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVT 385
            +A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V 
Sbjct: 137 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VY 193
Query: 386 TAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
           T   GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 194 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 228 NFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV- 282
           N+  K ++G+G    V    +K   ++  V  +     G+    E+Q   E  +  + + 
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 283 -----HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
                H N+++L     T T   LV+  M  G +   L  K +L     ++I       +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
             LH+     I+HRD+K  NILLD+     + DFG +  LD  +     +V GT  ++AP
Sbjct: 138 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LRSVCGTPSYLAP 192
Query: 398 EYLSTGQSS------EKTDVFGFGILLLELISG 424
           E +    +       ++ D++  G+++  L++G
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 111/251 (44%), Gaps = 29/251 (11%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVH 283
           S +     +G GG G V+     D    VA+K+  L D  ++   ++   E+++I    H
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR---EIKIIRRLDH 67
Query: 284 RNLLRL--------------IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
            N++++              +G         +V  YM    +A+ L+  P L+   R   
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHAR-LF 125
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAV 388
                RGL Y+H      ++HRD+K AN+ ++ E     +GDFGLA+++D   SH     
Sbjct: 126 MYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 389 RGTVG--HIAPEYL-STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK 445
            G V   + +P  L S    ++  D++  G +  E+++G           Q   +L+ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 446 KIHQEKKLEML 456
            +H+E + E+L
Sbjct: 243 VVHEEDRQELL 253

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 89/197 (45%), Gaps = 18/197 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG VYK   ++   +A  ++ +  +      +  E+E+++   H  +++L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 295 TTTERLLVYPYMSNGSVAS------RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
              +  ++  +   G+V +      R   +P +    R+ +       L +LH +   +I
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLHSK---RI 138
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLA----KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           IHRD+KA N+L+    +  + DFG++    K L   DS + T        +  E +    
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 405 SSEKTDVFGFGILLLEL 421
              K D++  GI L+E+
Sbjct: 199 YDYKADIWSLGITLIEM 215

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 228 NFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV- 282
           N+  K ++G+G    V    +K   ++  V  +     G+    E+Q   E  +  + + 
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 64
Query: 283 -----HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
                H N+++L     T T   LV+  M  G +   L  K +L     ++I       +
Sbjct: 65  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 124
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
             LH+     I+HRD+K  NILLD+     + DFG +  LD  +      V GT  ++AP
Sbjct: 125 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAP 179
Query: 398 EYLSTGQSS------EKTDVFGFGILLLELISG 424
           E +    +       ++ D++  G+++  L++G
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 98/228 (42%), Gaps = 28/228 (12%)
Query: 219 FKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQ 272
            KE+  +   F  +  +G+  FG VYKG+L      +    VA+K LKD        +F+
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 273 TEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----------------K 316
            E  + +   H N++ L+G         +++ Y S+G +   L                 
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 317 AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 376
            K +L+      +    A G+ YL       ++H+D+   N+L+ +     + D GL + 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 377 LDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 423
           +   D + +       +  +APE +  G+ S  +D++ +G++L E+ S
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 75
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 136 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYR 190
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLG 220

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 89/197 (45%), Gaps = 18/197 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG VYK   ++   +A  ++ +  +      +  E+E+++   H  +++L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 295 TTTERLLVYPYMSNGSVAS------RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
              +  ++  +   G+V +      R   +P +    R+ +       L +LH +   +I
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLHSK---RI 130
Query: 349 IHRDVKAANILLDEYYEAVVGDFGLA----KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           IHRD+KA N+L+    +  + DFG++    K L   DS + T        +  E +    
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 190
Query: 405 SSEKTDVFGFGILLLEL 421
              K D++  GI L+E+
Sbjct: 191 YDYKADIWSLGITLIEM 207

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 228 NFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV- 282
           N+  K ++G+G    V    +K   ++  V  +     G+    E+Q   E  +  + + 
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 283 -----HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
                H N+++L     T T   LV+  M  G +   L  K +L     ++I       +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
             LH+     I+HRD+K  NILLD+     + DFG +  LD  +      V GT  ++AP
Sbjct: 138 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAP 192
Query: 398 EYLSTGQSS------EKTDVFGFGILLLELISG 424
           E +    +       ++ D++  G+++  L++G
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 1/89 (1%)
Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + + N+SG IP  + ++  L+TLD S N  +G +P ++S L  L  +  + N ++GAIP 
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 90  SLSNMSQL-AFLDLSYNNLSGPVPSFHAK 117
           S  + S+L   + +S N L+G +P   A 
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFAN 196

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 16/185 (8%)
Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
           +   E+ ++    H N+++L           LV  +   G +  ++  +   D      I
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTT 386
                 G+ YLH+     I+HRD+K  NILL+     +   + DFGL+      D  +  
Sbjct: 152 MKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKLRD 207
Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
            + GT  +IAPE L   + +EK DV+  G+++  L+ G     FG   +Q     D +KK
Sbjct: 208 RL-GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP--FGGQNDQ-----DIIKK 258
Query: 447 IHQEK 451
           + + K
Sbjct: 259 VEKGK 263

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 20/175 (11%)
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-V 388
           +   ARG+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     
Sbjct: 205 SFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH 448
           R  +  +APE +     S K+DV+ +G+LL E+ S   +   G   ++     D+  ++ 
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDE-----DFCSRLR 316
Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL 503
           +           ++         E+ Q+ L C    P  RP+ +E+V  L GD L
Sbjct: 317 E----------GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL-GDLL 360

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--TTAVRGTVGHIAPEYLSTGQS 405
           IIHRDVK ANIL+       V DFG+A+ +    + V  T AV GT  +++PE       
Sbjct: 137 IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSV 196
Query: 406 SEKTDVFGFGILLLELISG 424
             ++DV+  G +L E+++G
Sbjct: 197 DARSDVYSLGCVLYEVLTG 215

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYR 189
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 93
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 154 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYR 208
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAELLLG 238

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYR 189
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYR 189
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 147 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYR 201
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 108
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 169 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYR 223
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 82
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 143 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYR 197
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAELLLG 227

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 147 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYR 201
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 78
Query: 286 LLRLIGFCMTTTER--------LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+        +L Y   +   VA    +AK +L     K       R 
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 139 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYR 193
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELLLG 223

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 9/154 (5%)
Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 333
           EV ++ L  H N+++L  F        LV      G +   +  +   +      I    
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRG 390
             G+ YLH+     I+HRD+K  N+LL+   +     + DFGL+ + +  +        G
Sbjct: 146 LSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLG 200
Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           T  +IAPE L   +  EK DV+  G++L  L++G
Sbjct: 201 TAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAG 233

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 7/201 (3%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++F    L+GKG FG V     +  G   A+K L+    I  +    T  E   L   R+
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 129
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 130 ---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDN 185
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCG 206

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 189
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--TTAVRGTVGHIAPEYLSTGQS 405
           IIHRDVK ANI++       V DFG+A+ +    + V  T AV GT  +++PE       
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 406 SEKTDVFGFGILLLELISG 424
             ++DV+  G +L E+++G
Sbjct: 197 DARSDVYSLGCVLYEVLTG 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--TTAVRGTVGHIAPEYLSTGQS 405
           IIHRDVK ANI++       V DFG+A+ +    + V  T AV GT  +++PE       
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 406 SEKTDVFGFGILLLELISG 424
             ++DV+  G +L E+++G
Sbjct: 197 DARSDVYSLGCVLYEVLTG 215

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 7/201 (3%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++F    L+GKG FG V     +  G   A+K L+    I  +    T  E   L   R+
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCG 201

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--TTAVRGTVGHIAPEYLSTGQS 405
           IIHRDVK ANI++       V DFG+A+ +    + V  T AV GT  +++PE       
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 406 SEKTDVFGFGILLLELISG 424
             ++DV+  G +L E+++G
Sbjct: 197 DARSDVYSLGCVLYEVLTG 215

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 87
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 148 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 202
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 203 APELIFGATDYTSSIDVWSAGCVLAELLLG 232

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--TTAVRGTVGHIAPEYLSTGQS 405
           IIHRDVK ANI++       V DFG+A+ +    + V  T AV GT  +++PE       
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 406 SEKTDVFGFGILLLELISG 424
             ++DV+  G +L E+++G
Sbjct: 197 DARSDVYSLGCVLYEVLTG 215

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 7/201 (3%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++F    L+GKG FG V     +  G   A+K L+    I  +    T  E   L   R+
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 127
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 128 ---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDN 183
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCG 204

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 102
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 163 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 217
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLG 247

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 7/201 (3%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++F    L+GKG FG V     +  G   A+K L+    I  +    T  E   L   R+
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCG 201

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 108
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 169 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 223
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
            F+ E+++I+   +   L   G      E  ++Y YM N S+    +    LD      I
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 330 ALGAARGLL--------YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 381
            +   + ++        Y+H +    I HRDVK +NIL+D+     + DFG ++ +   D
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VD 204
Query: 382 SHVTTAVRGTVGHIAPEYLSTGQSSE--KTDVFGFGILL 418
             +  + RGT   + PE+ S   S    K D++  GI L
Sbjct: 205 KKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 7/201 (3%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++F    L+GKG FG V     +  G   A+K L+    I  +    T  E   L   R+
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCG 201

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 7/201 (3%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++F    L+GKG FG V     +  G   A+K L+    I  +    T  E   L   R+
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCG 201

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 110
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 171 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 225
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLG 255

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 10/204 (4%)
Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVH 283
           + N+  K  +GKG F  V +  +   G   A K +        + Q  + E  +     H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            N++RL       +   LV+  ++ G +   + A+     A            + Y H  
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 344 CDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
               I+HR++K  N+LL    +     + DFGLA  ++  DS       GT G+++PE L
Sbjct: 148 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVL 202
Query: 401 STGQSSEKTDVFGFGILLLELISG 424
                S+  D++  G++L  L+ G
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVG 226

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 7/201 (3%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++F    L+GKG FG V     +  G   A+K L+    I  +    T  E   L   R+
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCG 201

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 79
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 140 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 194
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLG 224

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L K   +I    +   E+ +
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 145
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 146 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 198
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMS----NGSVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++S    +   AS L   P       K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIP---LPLIKSYLFQLLQGLA 120
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 10/204 (4%)
Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVH 283
           + N+  K  +GKG F  V +  +   G   A K +        + Q  + E  +     H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            N++RL       +   LV+  ++ G +   + A+     A            + Y H  
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 344 CDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
               I+HR++K  N+LL    +     + DFGLA  ++  DS       GT G+++PE L
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 401 STGQSSEKTDVFGFGILLLELISG 424
                S+  D++  G++L  L+ G
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVG 203

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 124
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 180
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTR-RAL 207

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 153
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 214 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 268
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLG 298

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 10/204 (4%)
Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVH 283
           + N+  K  +GKG F  V +  +   G   A K +        + Q  + E  +     H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            N++RL       +   LV+  ++ G +   + A+     A            + Y H  
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 344 CDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
               I+HR++K  N+LL    +     + DFGLA  ++  DS       GT G+++PE L
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 401 STGQSSEKTDVFGFGILLLELISG 424
                S+  D++  G++L  L+ G
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVG 203

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 253 VVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 310
           +++ ++   G+A   +  +  +TE+E++    H  ++++  F     +  +V   M  G 
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGE 225
Query: 311 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV--- 367
           +  ++     L  AT K         + YLHE     IIHRD+K  N+LL    E     
Sbjct: 226 LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 282
Query: 368 VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELISG 424
           + DFG +K+L   ++ +   + GT  ++APE L    T   +   D +  G++L   +SG
Sbjct: 283 ITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--TTAVRGTVGHIAPEYLSTGQS 405
           IIHRDVK ANI++       V DFG+A+ +    + V  T AV GT  +++PE       
Sbjct: 154 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 213
Query: 406 SEKTDVFGFGILLLELISG 424
             ++DV+  G +L E+++G
Sbjct: 214 DARSDVYSLGCVLYEVLTG 232

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H N
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 112
Query: 286 LLRLIGFCMTTTERL------LVYPYMSNG--SVASRL-KAKPSLDWATRKRIALGAARG 336
           ++RL  F  ++ E+       LV  Y+      VA    +AK +L     K       R 
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           L Y+H      I HRD+K  N+LLD     + + DFG AK L   + +V+     +  + 
Sbjct: 173 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 227
Query: 396 APEYL-STGQSSEKTDVFGFGILLLELISG 424
           APE +      +   DV+  G +L EL+ G
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLG 257

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 138
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 139 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYV-ATR 191
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 118
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
           + H     +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 174
Query: 399 Y-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
             L     S   D++  G +  E+++  RAL
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMS----NGSVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++S    +   AS L   P       K       +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIP---LPLIKSYLFQLLQGLA 119
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 205

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 127
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTR-RAL 210

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 10/208 (4%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGN----AIGGEIQFQTEV 275
           +++S    +   + +G+G F  VYK   ++   +VA+K++K G+      G       E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 335
           +++    H N++ L+      +   LV+ +M              L  +  K   L   +
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           GL YLH+     I+HRD+K  N+LLDE     + DFGLAK     +      V  T  + 
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYR 179
Query: 396 APEYLSTGQ-SSEKTDVFGFGILLLELI 422
           APE L   +      D++  G +L EL+
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 10/204 (4%)
Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVH 283
           + N+  K  +GKG F  V +  +   G   A K +        + Q  + E  +     H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            N++RL       +   LV+  ++ G +   + A+     A            + Y H  
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 123
Query: 344 CDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
               I+HR++K  N+LL    +     + DFGLA  ++  DS       GT G+++PE L
Sbjct: 124 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVL 178
Query: 401 STGQSSEKTDVFGFGILLLELISG 424
                S+  D++  G++L  L+ G
Sbjct: 179 KKDPYSKPVDIWACGVILYILLVG 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 127
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTR-RAL 210

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 253 VVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 310
           +++ ++   G+A   +  +  +TE+E++    H  ++++  F     +  +V   M  G 
Sbjct: 181 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGE 239
Query: 311 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV--- 367
           +  ++     L  AT K         + YLHE     IIHRD+K  N+LL    E     
Sbjct: 240 LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 296
Query: 368 VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELISG 424
           + DFG +K+L   ++ +   + GT  ++APE L    T   +   D +  G++L   +SG
Sbjct: 297 ITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 119
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTR-RAL 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 120
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTR-RAL 203

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGXV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
           +S+F  K+L+G+G +G V    +   G +VA+K+++  +     ++   E++++    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           N++ +       +       Y+    + + L    S    +   I     + L  +    
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC---DSHVTTAVRGTVGHI------ 395
              +IHRD+K +N+L++   +  V DFGLA+++D     +S  T    G V  +      
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 396 APEY-LSTGQSSEKTDVFGFGILLLEL 421
           APE  L++ + S   DV+  G +L EL
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 11/203 (5%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNL 286
           F    ++G+GGFG V+   ++  G + A K+L        +      VE   LA VH   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 287 LRLIGFCM-TTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARGLLYLH 341
           +  + +   T T+  LV   M+ G +   +    +  P                GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
           ++    II+RD+K  N+LLD+     + D GLA  L    +  T    GT G +APE L 
Sbjct: 307 QR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 402 TGQSSEKTDVFGFGILLLELISG 424
             +     D F  G+ L E+I+ 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAA 385

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 135
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 136 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 188
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 11/203 (5%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNL 286
           F    ++G+GGFG V+   ++  G + A K+L        +      VE   LA VH   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 287 LRLIGFCM-TTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARGLLYLH 341
           +  + +   T T+  LV   M+ G +   +    +  P                GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
           ++    II+RD+K  N+LLD+     + D GLA  L    +  T    GT G +APE L 
Sbjct: 307 QR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 402 TGQSSEKTDVFGFGILLLELISG 424
             +     D F  G+ L E+I+ 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAA 385

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 120
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTR-RAL 203

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 119
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTR-RAL 202

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 11/203 (5%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNL 286
           F    ++G+GGFG V+   ++  G + A K+L        +      VE   LA VH   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 287 LRLIGFCM-TTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARGLLYLH 341
           +  + +   T T+  LV   M+ G +   +    +  P                GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
           ++    II+RD+K  N+LLD+     + D GLA  L    +  T    GT G +APE L 
Sbjct: 307 QR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 402 TGQSSEKTDVFGFGILLLELISG 424
             +     D F  G+ L E+I+ 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAA 385

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 106/238 (44%), Gaps = 45/238 (18%)
Query: 228 NFSSKNLVGKGGFGN-VYKGYLQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHR 284
           +F  K+++G G  G  VY+G   D   VAVKR+  +  +    E+Q   E +      H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADREVQLLRESDE-----HP 78
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIA-LG---------AA 334
           N++R   FC T  +R   Y       +A  L A    ++  +K  A LG           
Sbjct: 79  NVIRY--FC-TEKDRQFQY-------IAIELCAATLQEYVEQKDFAHLGLEPITLLQQTT 128
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDE-----YYEAVVGDFGLAKLL---DHCDSHVTT 386
            GL +LH      I+HRD+K  NIL+         +A++ DFGL K L    H  S   +
Sbjct: 129 SGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR-RS 184
Query: 387 AVRGTVGHIAPEYLSTGQSSEKT---DVFGFGILLLELISGLRALEFGKTANQKGAML 441
            V GT G IAPE LS       T   D+F  G +   +IS   +  FGK+  ++  +L
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE-GSHPFGKSLQRQANIL 241

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 11/203 (5%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNL 286
           F    ++G+GGFG V+   ++  G + A K+L        +      VE   LA VH   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 287 LRLIGFCM-TTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARGLLYLH 341
           +  + +   T T+  LV   M+ G +   +    +  P                GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
           ++    II+RD+K  N+LLD+     + D GLA  L    +  T    GT G +APE L 
Sbjct: 307 QR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 402 TGQSSEKTDVFGFGILLLELISG 424
             +     D F  G+ L E+I+ 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAA 385

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 138
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 139 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 191
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 132
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 133 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 185
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 186 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 76  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 187
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 188 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 120
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTR-RAL 203

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 76  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 187
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 188 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 77  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 188
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 189 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 135
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 136 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 188
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 144
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 145 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYV-ATR 197
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 198 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 140
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 141 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 193
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 61  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 115
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 116 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 172
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 173 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + +G G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 138
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 139 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYV-ATR 191
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 138
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 139 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 191
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 62  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 116
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 173
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 174 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG-----GEIQFQT 273
           K+ ++  + +    L+GKGGFG V+ G+ L D   VA+K +     +G       +    
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 274 EVEMI----SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK-R 328
           EV ++    +   H  ++RL+ +  T    +LV        +   L A+   D+ T K  
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV--------LERPLPAQDLFDYITEKGP 135
Query: 329 IALGAARG----LLYLHEQCDPK-IIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDS 382
           +  G +R     ++   + C  + ++HRD+K  NIL+D     A + DFG   LL H + 
Sbjct: 136 LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEP 194
Query: 383 HVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISG 424
           +  T   GT  +  PE++S  Q  +    V+  GILL +++ G
Sbjct: 195 Y--TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMS----NGSVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++S        AS L   P       K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 120
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 206

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 62  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 116
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 173
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 174 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 77  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 188
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 189 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 104 EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 158
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 215
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 216 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 89  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 200
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 201 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLSFCH 120
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTR-RAL 203

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 139
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 140 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 192
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 77  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD 188
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 189 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 144
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 145 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 197
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 198 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 129
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 130 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 182
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 89  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 200
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 201 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 89  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 200
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 201 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 90  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 201
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 202 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 135
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 136 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 188
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMS----NGSVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++S        AS L   P       K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 118
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 204

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 130
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 131 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 183
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 184 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 153
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 154 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 206
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 139
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 140 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGYV-ATR 192
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 90  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 201
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 202 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 90  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 201
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 202 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 89  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 200
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 201 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 135
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 136 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGYV-ATR 188
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 139
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 140 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 192
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 130
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 131 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 183
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 184 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 156
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 157 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 209
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 210 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 90  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 201
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 202 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 96  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 150
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 207
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 152
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 153 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 205
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 206 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 104 EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 158
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 215
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 216 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 131
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 132 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 184
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 185 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 145
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 146 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 198
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 145
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 146 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 198
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
           +S+F  K+L+G+G +G V    +   G +VA+K+++  +     ++   E++++    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           N++ +       +       Y+    + + L    S    +   I     + L  +    
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC---DSHVTTAVRGTVGHI------ 395
              +IHRD+K +N+L++   +  V DFGLA+++D     +S  T    G   ++      
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYR 189
Query: 396 APEY-LSTGQSSEKTDVFGFGILLLEL 421
           APE  L++ + S   DV+  G +L EL
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 139
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 140 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 192
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 49  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 108
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 109 EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 163
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 164 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 220
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 221 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 129
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 130 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 182
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 131/308 (42%), Gaps = 57/308 (18%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKR-LKDGNAIG-GEIQFQTEVEMIS 279
           QS  +   S+ ++G G  G V ++G  Q G  VAVKR L D   I   EI+  TE +   
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESD--- 66
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPY-MSNGSVASRLKAKPSLDWATRKR-----IAL-- 331
              H N++R   +C  TT+R L     + N ++   +++K   D   + +     I+L  
Sbjct: 67  --DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLD-------------EYYEAVVGDFGLAKLLD 378
             A G+ +LH     KIIHRD+K  NIL+              E    ++ DFGL K LD
Sbjct: 123 QIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 379 HCDSHVTTAVR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGILLLELISGLRAL 428
              S   T +    GT G  APE L    +       +   D+F  G +   ++S  +  
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH- 238
Query: 429 EFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR 488
            FG   +++  ++  +  + + K L           +DR  + E   +      + P  R
Sbjct: 239 PFGDKYSRESNIIRGIFSLDEMKCL-----------HDRSLIAEATDLISQMIDHDPLKR 287
Query: 489 PKMSEVVR 496
           P   +V+R
Sbjct: 288 PTAMKVLR 295

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 153
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 154 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 206
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 61  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEEL 115
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 116 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 172
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 173 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           KE +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRI 329
             +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +
Sbjct: 62  EVV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 116
Query: 330 ALGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTA 387
           A      +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T 
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTD 173
Query: 388 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 174 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 152
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 153 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 205
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 206 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 235 VGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           VG G +G+V   +  + G  VAVK+L +   +I    +   E+ ++    H N++ L+  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 293 -----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
                 +     + +  ++    + + +K +   D   +  I     RGL Y+H      
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---D 155
Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTGQSS 406
           IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T  + APE  L+    +
Sbjct: 156 IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWYRAPEIMLNWMHYN 211
Query: 407 EKTDVFGFGILLLELISG 424
           +  D++  G ++ EL++G
Sbjct: 212 QTVDIWSVGCIMAELLTG 229

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTV-VAVKRL-KDGNAIGGE------IQFQTEVEMISLAVHRNL 286
           +G G  G V   + +     VA+K + K   AIG        +  +TE+E++    H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +++  F     +  +V   M  G +  ++     L  AT K         + YLHE    
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN--- 133
Query: 347 KIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--- 400
            IIHRD+K  N+LL    E     + DFG +K+L   ++ +   + GT  ++APE L   
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSV 191
Query: 401 STGQSSEKTDVFGFGILLLELISG 424
            T   +   D +  G++L   +SG
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  YM  G + S L+          +  A        YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  YM  G + S L+          +  A        YLH    
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 160
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + +   
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTV-VAVKRL-KDGNAIGGE------IQFQTEVEMISLAVHRNL 286
           +G G  G V   + +     VA+K + K   AIG        +  +TE+E++    H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +++  F     +  +V   M  G +  ++     L  AT K         + YLHE    
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN--- 133
Query: 347 KIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--- 400
            IIHRD+K  N+LL    E     + DFG +K+L   ++ +   + GT  ++APE L   
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSV 191
Query: 401 STGQSSEKTDVFGFGILLLELISG 424
            T   +   D +  G++L   +SG
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTV-VAVKRL-KDGNAIGGE------IQFQTEVEMISLAVHRNL 286
           +G G  G V   + +     VA+K + K   AIG        +  +TE+E++    H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +++  F     +  +V   M  G +  ++     L  AT K         + YLHE    
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN--- 133
Query: 347 KIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--- 400
            IIHRD+K  N+LL    E     + DFG +K+L   ++ +   + GT  ++APE L   
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSV 191
Query: 401 STGQSSEKTDVFGFGILLLELISG 424
            T   +   D +  G++L   +SG
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTV-VAVKRL-KDGNAIGGE------IQFQTEVEMISLAVHRNL 286
           +G G  G V   + +     VA+K + K   AIG        +  +TE+E++    H  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +++  F     +  +V   M  G +  ++     L  AT K         + YLHE    
Sbjct: 77  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN--- 132
Query: 347 KIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--- 400
            IIHRD+K  N+LL    E     + DFG +K+L   ++ +   + GT  ++APE L   
Sbjct: 133 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSV 190
Query: 401 STGQSSEKTDVFGFGILLLELISG 424
            T   +   D +  G++L   +SG
Sbjct: 191 GTAGYNRAVDCWSLGVILFICLSG 214

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 7/191 (3%)
Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G  G V    ++  G +VAVK++        E+ F  EV ++    H N++ +    
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 217
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +   E  +V  ++  G++   +     ++      + L   + L  LH Q    +IHRD+
Sbjct: 218 LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDI 273
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
           K+ +ILL       + DFG    +          V GT   +APE +S      + D++ 
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWS 332
Query: 414 FGILLLELISG 424
            GI+++E++ G
Sbjct: 333 LGIMVIEMVDG 343

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTV-VAVKRL-KDGNAIGGE------IQFQTEVEMISLAVHRNL 286
           +G G  G V   + +     VA+K + K   AIG        +  +TE+E++    H  +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +++  F     +  +V   M  G +  ++     L  AT K         + YLHE    
Sbjct: 84  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN--- 139
Query: 347 KIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--- 400
            IIHRD+K  N+LL    E     + DFG +K+L   ++ +   + GT  ++APE L   
Sbjct: 140 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSV 197
Query: 401 STGQSSEKTDVFGFGILLLELISG 424
            T   +   D +  G++L   +SG
Sbjct: 198 GTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
           +S+F  K+L+G+G +G V    +   G +VA+K+++  +     ++   E++++    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           N++ +       +       Y+    + + L    S    +   I     + L  +    
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC---DSHVT------TAVRGTVGHI 395
              +IHRD+K +N+L++   +  V DFGLA+++D     +S  T      T    T  + 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYR 189
Query: 396 APEY-LSTGQSSEKTDVFGFGILLLEL 421
           APE  L++ + S   DV+  G +L EL
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 91/206 (44%), Gaps = 7/206 (3%)
Query: 235 VGKGGFGNVYKGYLQDG-TVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           +G+G +G V+K   ++   +VA+KR++ D +  G       E+ ++    H+N++RL   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
             +  +  LV+ +               LD    K       +GL + H +    ++HRD
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRD 126
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           +K  N+L++   E  + DFGLA+          +A   T+ +  P+ L   +  S   D+
Sbjct: 127 LKPQNLLINRNGELKLADFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 412 FGFGILLLELISGLRALEFGKTANQK 437
           +  G +  EL +  R L  G   + +
Sbjct: 186 WSAGCIFAELANAARPLFPGNDVDDQ 211

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 6/201 (2%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           + F    L+GKG FG V        G   A+K LK    +  +    T  E   L   R+
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 270
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
            +  +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 271 KN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCG 348

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 119
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTR-RAL 202

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 6/201 (2%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           + F    L+GKG FG V        G   A+K LK    +  +    T  E   L   R+
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
            +  +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCG 345

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 117
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 203

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 283 HRNLLRLIGFCMTTTERLLVYPYM----SNGSVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++     +   AS L   P       K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIP---LPLIKSYLFQLLQGLA 117
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 118 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 203

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 17/197 (8%)
Query: 235 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLI 290
           +G+G F    K  + +     AVK       I   ++  T+ E+ +L +   H N+++L 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVK------IISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
                     LV   ++ G +  R+K K          I       + ++H   D  ++H
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVH 129
Query: 351 RDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
           RD+K  N+L    ++  E  + DFG A+L    +  + T    T+ + APE L+     E
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYDE 188
Query: 408 KTDVFGFGILLLELISG 424
             D++  G++L  ++SG
Sbjct: 189 SCDLWSLGVILYTMLSG 205

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + D+GLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 120
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 119
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 205

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 117
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 119
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 205

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K     D   +  I   
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLI-YQ 129
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +T  V  T 
Sbjct: 130 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATR 182
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 117
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 119
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 205

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 117
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 118
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 120
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 206

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 7/191 (3%)
Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G  G V    ++  G +VAVK++        E+ F  EV ++    H N++ +    
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 95
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +   E  +V  ++  G++   +     ++      + L   + L  LH Q    +IHRD+
Sbjct: 96  LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDI 151
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
           K+ +ILL       + DFG    +          V GT   +APE +S      + D++ 
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWS 210
Query: 414 FGILLLELISG 424
            GI+++E++ G
Sbjct: 211 LGIMVIEMVDG 221

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 119
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAPEY- 399
                +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEIL 174
Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           L     S   D++  G +  E+++  RAL
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTR-RAL 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIP---LPLIKSYLFQLLQGLA 120
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 206

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 6/201 (2%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           + F    L+GKG FG V     +  G   A+K LK    +  +    T  E   L   R+
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 127
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
            +  +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 128 KN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCG 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 118
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 204

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 6/201 (2%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           + F    L+GKG FG V        G   A+K LK    +  +    T  E   L   R+
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 129
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
            +  +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 130 KN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCG 207

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K++   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGL +   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 14/203 (6%)
Query: 233 NLVGKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
            ++GKG F  V +   ++        +V V +      +  E   + E  +  +  H ++
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHMLKHPHI 88
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-D 345
           + L+    +     +V+ +M    +   +  +    +   + +A    R +L     C D
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 346 PKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLS 401
             IIHRDVK  N+LL   +      +GDFG+A  L   +S +    R GT   +APE + 
Sbjct: 149 NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--ESGLVAGGRVGTPHFMAPEVVK 206
Query: 402 TGQSSEKTDVFGFGILLLELISG 424
                +  DV+G G++L  L+SG
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 121
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 176
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 207

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 7/191 (3%)
Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G  G V    ++  G +VAVK++        E+ F  EV ++    H N++ +    
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 140
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +   E  +V  ++  G++   +     ++      + L   + L  LH Q    +IHRD+
Sbjct: 141 LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDI 196
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
           K+ +ILL       + DFG    +          V GT   +APE +S      + D++ 
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWS 255
Query: 414 FGILLLELISG 424
            GI+++E++ G
Sbjct: 256 LGIMVIEMVDG 266

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 119
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAPEY- 399
                +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEIL 174
Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           L     S   D++  G +  E+++  RAL
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTR-RAL 202

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVH 283
            + S   VG G +G+V      + G  VA+K+L        EI   +   E+ ++    H
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQH 100
Query: 284 RNLLRLIG-FCMTTTER-----LLVYPYMSNGSVASRLKAKPSLDWATRK--RIALGAAR 335
            N++ L+  F   ++ R      LV P+M      + L+    ++++  K   +     +
Sbjct: 101 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGMEFSEEKIQYLVYQMLK 155
Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           GL Y+H      ++HRD+K  N+ ++E  E  + DFGLA+   H D+ +T  V  T  + 
Sbjct: 156 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWYR 208
Query: 396 APEY-LSTGQSSEKTDVFGFGILLLELISG 424
           APE  LS    ++  D++  G ++ E+++G
Sbjct: 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 35/277 (12%)
Query: 235 VGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +G+G F  ++KG  ++         T V +K L   +    E  F+    M+S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 345
           +   G C+   E +LV  ++  GS+ + LK  K  ++   +  +A   A  + +L E   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN-- 132
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA---VRGTVGHIAPEYLST 402
             +IH +V A NILL    +   G+    KL D   S        ++  +  + PE +  
Sbjct: 133 -TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191
Query: 403 GQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 461
            ++ +  TD + FG  L E+ SG          ++  + LD       ++KL+   D+  
Sbjct: 192 PKNLNLATDKWSFGTTLWEICSG---------GDKPLSALD------SQRKLQFYEDRHQ 236
Query: 462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
                  EL  ++     C  Y P  RP    ++R L
Sbjct: 237 LPAPKAAELANLINN---CMDYEPDHRPSFRAIIRDL 270

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 35/277 (12%)
Query: 235 VGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +G+G F  ++KG  ++         T V +K L   +    E  F+    M+S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 345
           +   G C    E +LV  ++  GS+ + LK  K  ++   +  +A   A  + +L E   
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEEN-- 132
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA---VRGTVGHIAPEYLST 402
             +IH +V A NILL    +   G+    KL D   S        ++  +  + PE +  
Sbjct: 133 -TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191
Query: 403 GQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 461
            ++ +  TD + FG  L E+ SG          ++  + LD       ++KL+   D+  
Sbjct: 192 PKNLNLATDKWSFGTTLWEICSG---------GDKPLSALD------SQRKLQFYEDRHQ 236
Query: 462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
                  EL  ++     C  Y P  RP    ++R L
Sbjct: 237 LPAPKAAELANLINN---CMDYEPDHRPSFRAIIRDL 270

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVH 283
            + S   VG G +G+V      + G  VA+K+L        EI   +   E+ ++    H
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 284 RNLLRLIG-FCMTTTER-----LLVYPYMSNGSVASRLKAKPSLDWATRK--RIALGAAR 335
            N++ L+  F   ++ R      LV P+M      + L+    L ++  K   +     +
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGLKFSEEKIQYLVYQMLK 137
Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
           GL Y+H      ++HRD+K  N+ ++E  E  + DFGLA+   H D+ +T  V  T  + 
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYV-VTRWYR 190
Query: 396 APEY-LSTGQSSEKTDVFGFGILLLELISG 424
           APE  LS    ++  D++  G ++ E+++G
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 6/201 (2%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           + F    L+GKG FG V     +  G   A+K LK    +  +    T  E   L   R+
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 286 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +   T +RL  V  Y + G +   L  +        +         L YLH +
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 128
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
            +  +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L   
Sbjct: 129 KN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 404 QSSEKTDVFGFGILLLELISG 424
                 D +G G+++ E++ G
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCG 206

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 121
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAPEY- 399
                +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + APE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEIL 176
Query: 400 LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           L     S   D++  G +  E+++  RAL
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTR-RAL 204

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 7/191 (3%)
Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G  G V    ++  G +VAVK++        E+ F  EV ++    H N++ +    
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 97
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +   E  +V  ++  G++   +     ++      + L   + L  LH Q    +IHRD+
Sbjct: 98  LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDI 153
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
           K+ +ILL       + DFG    +          V GT   +APE +S      + D++ 
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWS 212
Query: 414 FGILLLELISG 424
            GI+++E++ G
Sbjct: 213 LGIMVIEMVDG 223

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 23/169 (13%)
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGT 391
            A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R  
Sbjct: 207 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKIHQ 449
           +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++ +
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRLKE 316
Query: 450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
             ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 317 GTRMRA-------PDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 7/191 (3%)
Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G  G V    ++  G +VAVK++        E+ F  EV ++    H N++ +    
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 86
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +   E  +V  ++  G++   +     ++      + L   + L  LH Q    +IHRD+
Sbjct: 87  LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDI 142
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
           K+ +ILL       + DFG    +          V GT   +APE +S      + D++ 
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWS 201
Query: 414 FGILLLELISG 424
            GI+++E++ G
Sbjct: 202 LGIMVIEMVDG 212

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+ +++ D    G       E+ ++    H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 120
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTR-RAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK   +  G VVA+ +++ D    G       E+ ++    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 286 LLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
           +++L+    T  +  LV+ ++         AS L   P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLAFCH 119
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-L 400
                +++HRD+K  N+L++      + DFGLA+         T  V  T+ + APE  L
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 401 STGQSSEKTDVFGFGILLLELISGLRAL 428
                S   D++  G +  E+++  RAL
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTR-RAL 202

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 6/174 (3%)
Query: 251 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 310
           G  VAVK++        E+ F  EV ++    H N++ +    +   E  +V  ++  G+
Sbjct: 70  GKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGA 128
Query: 311 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 370
           +   +     ++      + L   R L YLH Q    +IHRD+K+ +ILL       + D
Sbjct: 129 LTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSD 184
Query: 371 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           FG    +   +      + GT   +APE +S      + D++  GI+++E+I G
Sbjct: 185 FGFCAQVSK-EVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 8/194 (4%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G G FG V++   +    V V +  +      +   + E+ +++   H  L+ L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 295 TTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
              E +L+  ++S G +  R+ A+   +  A        A  GL ++HE     I+H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDI 175
Query: 354 KAANILLDEYYEAVVG--DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           K  NI+ +    + V   DFGLA  L+     +      T    APE +        TD+
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTDM 233
Query: 412 FGFGILLLELISGL 425
           +  G+L   L+SGL
Sbjct: 234 WAIGVLGYVLLSGL 247

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 23/169 (13%)
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGT 391
            A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R  
Sbjct: 209 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKIHQ 449
           +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++ +
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRLKE 318
Query: 450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
             ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 319 GTRMRA-------PDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 23/169 (13%)
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGT 391
            A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R  
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKIHQ 449
           +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++ +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRLKE 311
Query: 450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
             ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 312 GTRMRA-------PDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
           +IA+   + L +LH +    +IHRDVK +N+L++   +  + DFG++  L   DS   T 
Sbjct: 157 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTI 212
Query: 388 VRGTVGHIAPEY----LSTGQSSEKTDVFGFGILLLEL 421
             G   ++APE     L+    S K+D++  GI ++EL
Sbjct: 213 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 7/191 (3%)
Query: 235 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G  G V    ++  G +VAVK++        E+ F  EV ++    H N++ +    
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 90
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +   E  +V  ++  G++   +     ++      + L   + L  LH Q    +IHRD+
Sbjct: 91  LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDI 146
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
           K+ +ILL       + DFG    +          V GT   +APE +S      + D++ 
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWS 205
Query: 414 FGILLLELISG 424
            GI+++E++ G
Sbjct: 206 LGIMVIEMVDG 216

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 23/169 (13%)
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGT 391
            A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R  
Sbjct: 200 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--WVKKIHQ 449
           +  +APE +     + ++DV+ FG+LL E+ S       G +    G  +D  + +++ +
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP-YPGVKIDEEFCRRLKE 309
Query: 450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
             ++          +Y      EM Q  L C    PS RP  SE+V  L
Sbjct: 310 GTRMRA-------PDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 153
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +   V  T 
Sbjct: 154 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGXV-ATR 206
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +   V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 282
           +  NF     +G+G +G VYK   +  G VVA+K+++ D    G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNG----SVASRLKAKPSLDWATRKRIALGAARGLL 338
           H N+++L+    T  +  LV+ ++         AS L   P       K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIP---LPLIKSYLFQLLQGLA 120
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAP 397
           + H     +++HRD+K  N+L++      + DFGLA+       ++    V  T+ + AP
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 398 EY-LSTGQSSEKTDVFGFGILLLELISGLRAL 428
           E  L     S   D++  G +  E+++  RAL
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTR-RAL 206

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 229 FSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
            +SK L G+G F  V     K   Q+     +K+ + G     EI  +  V  ++ +  R
Sbjct: 32  LTSKEL-GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK----RIALGAARGLLYL 340
            ++ L      T+E +L+  Y + G + S     P L     +    R+      G+ YL
Sbjct: 91  -VINLHEVYENTSEIILILEYAAGGEIFSL--CLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 341 HEQCDPKIIHRDVKAANILLDEYY---EAVVGDFGLAKLLDH-CDSHVTTAVRGTVGHIA 396
           H+     I+H D+K  NILL   Y   +  + DFG+++ + H C+      + GT  ++A
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLA 201
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELIS 423
           PE L+    +  TD++  GI+   L++
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 156
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +   V  T 
Sbjct: 157 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGYV-ATR 209
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 210 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRL-----KDGNAIGGEIQFQTEVEMISLAVH 283
           F  K  +G G FG+V+   L +     ++R+     KD + +  E Q + E+E++    H
Sbjct: 24  FIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPME-QIEAEIEVLKSLDH 79
Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK----PSLDWATRKRIALGAARGLLY 339
            N++++           +V      G +  R+ +      +L       +       L Y
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 340 LHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
            H Q    ++H+D+K  NIL  +   +    + DFGLA+L    D H T A  GT  ++A
Sbjct: 140 FHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAA-GTALYMA 194
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE      +  K D++  G+++  L++G
Sbjct: 195 PEVFKRDVTF-KCDIWSAGVVMYFLLTG 221

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +   V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEMI 278
           E +   S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M 
Sbjct: 1   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 60
Query: 279 SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRIA 330
            +     LL+ +    +   RLL +    +  V    + +P  D         A ++ +A
Sbjct: 61  VV-----LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 115
Query: 331 LGAARGLLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAV 388
                 +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T  
Sbjct: 116 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDF 172
Query: 389 RGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
            GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 173 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 129
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H D  +   V  T 
Sbjct: 130 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFV-ATR 182
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  Y+  G + S L+          +  A        YLH    
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 160
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + +   
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/268 (20%), Positives = 99/268 (36%), Gaps = 75/268 (27%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++F     +G+GGFG V++   + D    A+KR++  N      +   EV+ ++   H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 286 LLRLIGFCMTT------------------TERLL---------------VYPYMSNGSVA 312
           ++R     + T                  T+  L               + P+ +  +V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 313 SRLKAKPSL---------------DWATRK------------RIALGAARGLLYLHEQCD 345
               + P +               DW  R+             I +  A  + +LH +  
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV--------RGTVG---H 394
             ++HRD+K +NI         VGDFGL   +D  +   T            G VG   +
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLY 242
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELI 422
           ++PE +     S K D+F  G++L EL+
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    +++ G   A+K L     +   EI+     + I  AV+   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  Y   G + S L+          +  A        YLH    
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 160
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+++D+     V DFGLAK +       T  + GT  ++APE + +   
Sbjct: 161 -DLIYRDLKPENLMIDQQGYIQVTDFGLAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    +++ G   A+K L     +   EI+     + I  AV+   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  Y   G + S L+          +  A        YLH    
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 160
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+++D+     V DFGLAK +       T  + GT  ++APE + +   
Sbjct: 161 -DLIYRDLKPENLMIDQQGYIKVTDFGLAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEMISLAVHR 284
           S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M  +    
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV---- 59
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRIALGAARG 336
            LL+ +    +   RLL +    +  V    + +P  D         A ++ +A      
Sbjct: 60  -LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 337 LLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
           +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T   GT  +
Sbjct: 119 VLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVY 175
Query: 395 IAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             PE++   +   ++  V+  GILL +++ G
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 17/210 (8%)
Query: 224 SATSNFSSKNLVGKGGFGNVYK------GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 277
           S T  +     +GKG F  V +      G+     ++  K+L   +      + + E  +
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARD----HQKLEREARI 56
Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
             L  H N++RL           LV+  ++ G +   + A+     A            +
Sbjct: 57  CRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV 116
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGH 394
           L+ H+     ++HRD+K  N+LL    +     + DFGLA +    D        GT G+
Sbjct: 117 LHCHQM---GVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGY 172
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           ++PE L      +  D++  G++L  L+ G
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEMISLAVHR 284
           S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M  +    
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV---- 59
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRIALGAARG 336
            LL+ +    +   RLL +    +  V    + +P  D         A ++ +A      
Sbjct: 60  -LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 337 LLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
           +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T   GT  +
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVY 175
Query: 395 IAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             PE++   +   ++  V+  GILL +++ G
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 31  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 90
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 91  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 150
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 151 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 208 FAKRVKGA----TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DF LA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 140
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H    +T  V  T 
Sbjct: 141 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV-ATR 193
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEMISLAVHR 284
           S +    L+G GGFG+VY G  + D   VA+K + KD  +  GE+   T V M  +    
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV---- 59
Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW--------ATRKRIALGAARG 336
            LL+ +    +   RLL +    +  V    + +P  D         A ++ +A      
Sbjct: 60  -LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 337 LLYLHEQC-DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
           +L     C +  ++HRD+K  NIL+D    E  + DFG   LL      V T   GT  +
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVY 175
Query: 395 IAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
             PE++   +   ++  V+  GILL +++ G
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 123/289 (42%), Gaps = 39/289 (13%)
Query: 219 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEM 277
           FK+L     NF +K  + +   G ++KG  Q +  VV V +++D +       F  E   
Sbjct: 9   FKQL-----NFLTK--LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSR-DFNEECPR 60
Query: 278 ISLAVHRNLLRLIGFCMT--TTERLLVYPYMSNGSVASRLKAKPS--LDWATRKRIALGA 333
           + +  H N+L ++G C +       L+  +M  GS+ + L    +  +D +   + AL  
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 393
           ARG+ +LH   +P I    + + ++++DE   A +       + D   S  +        
Sbjct: 121 ARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARIS------MADVKFSFQSPGRMYAPA 173
Query: 394 HIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE 450
            +APE L       +    D++ F +LL EL++  R + F   +N +  M     K+  E
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVT--REVPFADLSNMEIGM-----KVALE 226
Query: 451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             L   +   +  +  ++          +C    P+ RPK   +V +LE
Sbjct: 227 -GLRPTIPPGISPHVSKL--------MKICMNEDPAKRPKFDMIVPILE 266

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 187 FAKRV----KGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  +  FGLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 140
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H    +T  V  T 
Sbjct: 141 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV-ATR 193
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 140
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H    +T  V  T 
Sbjct: 141 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV-ATR 193
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 128/304 (42%), Gaps = 53/304 (17%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKR-LKDGNAIG-GEIQFQTEVEMIS 279
           QS  +   S+ ++G G  G V ++G  Q G  VAVKR L D   I   EI+  TE +   
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESD--- 84
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPY-MSNGSVASRLKAKPSLDWATRKR-----IAL-- 331
              H N++R   +C  TT+R L     + N ++   +++K   D   + +     I+L  
Sbjct: 85  --DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 140
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLD-------------EYYEAVVGDFGLAKLLD 378
             A G+ +LH     KIIHRD+K  NIL+              E    ++ DFGL K LD
Sbjct: 141 QIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 379 HCDSHVTTAVR---GTVGHIAPEYLSTGQSSEKT---DVFGFGILLLELISGLRALEFGK 432
                    +    GT G  APE L        T   D+F  G +   ++S  +   FG 
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH-PFGD 256
Query: 433 TANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMS 492
             +++  ++  +  + + K L           +DR  + E   +      + P  RP   
Sbjct: 257 KYSRESNIIRGIFSLDEMKCL-----------HDRSLIAEATDLISQMIDHDPLKRPTAM 305
Query: 493 EVVR 496
           +V+R
Sbjct: 306 KVLR 309

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + D GLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 17/128 (13%)
Query: 308 NGSVASRLKAKPSLDWATRKRIALGAAR----GLLYLHEQCDPKIIHRDVKAANILL--D 361
           NGS+      + SLD+  R+++     R     L YLH Q    I HRD+K  N L   +
Sbjct: 151 NGSIHG---FRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTN 204
Query: 362 EYYEAVVGDFGLAK---LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS--EKTDVFGFGI 416
           + +E  + DFGL+K    L++ + +  T   GT   +APE L+T   S   K D +  G+
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 417 LLLELISG 424
           LL  L+ G
Sbjct: 265 LLHLLLMG 272

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 148 --NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSN 228

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  Y++ G + S L+          +  A        YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 187 FAKRV----KGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 129/304 (42%), Gaps = 53/304 (17%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKR-LKDGNAIG-GEIQFQTEVEMIS 279
           QS  +   S+ ++G G  G V ++G  Q G  VAVKR L D   I   EI+  TE +   
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESD--- 84
Query: 280 LAVHRNLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKR-----IAL-- 331
              H N++R   +C  TT+R L +   + N ++   +++K   D   + +     I+L  
Sbjct: 85  --DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 140
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLD-------------EYYEAVVGDFGLAKLLD 378
             A G+ +LH     KIIHRD+K  NIL+              E    ++ DFGL K LD
Sbjct: 141 QIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 379 HCDSHVTTAVR---GTVGHIAPEYLSTGQSSEKT---DVFGFGILLLELISGLRALEFGK 432
                    +    GT G  APE L        T   D+F  G +   ++S  +   FG 
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH-PFGD 256
Query: 433 TANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMS 492
             +++  ++  +  + + K L           +DR  + E   +      + P  RP   
Sbjct: 257 KYSRESNIIRGIFSLDEMKCL-----------HDRSLIAEATDLISQMIDHDPLKRPTAM 305
Query: 493 EVVR 496
           +V+R
Sbjct: 306 KVLR 309

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + D GLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+ 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  Y+  G + S L+          +  A        YLH  
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 146
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 147 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEYLAPEIILSK 199
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 200 GYNKAVDWWALGVLIYEMAAG 220

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    + + G   A+K L     +   +I+     + I  AV+ 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  Y++ G + S L+          +  A        YLH  
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 147
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+DE     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 148 ---DLIYRDLKPENLLIDEQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 200
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 201 GYNKAVDWWALGVLIYEMAAG 221

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 11/95 (11%)
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-----HVTTAVR 389
           RGL Y+H     ++IHRD+K +N+L++E  E  +GDFG+A+ L  C S     +  T   
Sbjct: 170 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL--CTSPAEHQYFMTEYV 224
Query: 390 GTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELIS 423
            T  + APE  LS  + ++  D++  G +  E+++
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 91/206 (44%), Gaps = 7/206 (3%)
Query: 235 VGKGGFGNVYKGYLQDG-TVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           +G+G +G V+K   ++   +VA+KR++ D +  G       E+ ++    H+N++RL   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
             +  +  LV+ +               LD    K       +GL + H +    ++HRD
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRD 126
Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 411
           +K  N+L++   E  + +FGLA+          +A   T+ +  P+ L   +  S   D+
Sbjct: 127 LKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 412 FGFGILLLELISGLRALEFGKTANQK 437
           +  G +  EL +  R L  G   + +
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQ 211

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  Y+  G + S L+          +  A        YLH    
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 161
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + +   
Sbjct: 162 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEYLAPEIILSKGY 216
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 217 NKAVDWWALGVLIYEMAAG 235

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 93/231 (40%), Gaps = 16/231 (6%)
Query: 203 EQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVVA 255
           EQ   +  L   K    K+ +S   N      F     +G G FG V    + + G   A
Sbjct: 12  EQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYA 71
Query: 256 VKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVAS 313
           +K L     +   +I+     + I  AV+   L  + F       L +V  Y   G + S
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFS 131
Query: 314 RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 373
            L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG 
Sbjct: 132 HLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGF 188
Query: 374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 189 AKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 87/191 (45%), Gaps = 7/191 (3%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G+G  G V     +  G  VAVK +        E+ F  EV ++    H N++ +    
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHFNVVEMYKSY 111
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +   E  ++  ++  G++   + ++  L+      +     + L YLH Q    +IHRD+
Sbjct: 112 LVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDI 167
Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
           K+ +ILL       + DFG    +   D      + GT   +APE +S    + + D++ 
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKXLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 414 FGILLLELISG 424
            GI+++E++ G
Sbjct: 227 LGIMVIEMVDG 237

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 235 VGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNLLRLI 290
           VG G +G V      + G  VA+K+L        E+   +   E+ ++    H N++ L+
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 291 GFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
               T  E L       LV P+M  G+   +L     L     + +     +GL Y+H  
Sbjct: 91  D-VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY-LST 402
               IIHRD+K  N+ ++E  E  + DFGLA+     DS +   V  T  + APE  L+ 
Sbjct: 148 G---IIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXV-VTRWYRAPEVILNW 200
Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
            + ++  D++  G ++ E+I+       GKT  +    LD +K+I
Sbjct: 201 MRYTQTVDIWSVGCIMAEMIT-------GKTLFKGSDHLDQLKEI 238

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 143
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 144 --NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSN 224

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  Y+  G + S L+          +  A        YLH  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 162 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  Y+  G + S L+          +  A        YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  Y+  G + S L+          +  A        YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 223 QSATSNF---SSKNLVGKGGFGNVYK------GYLQDGTVVAVKRLKDGNAIGGEIQFQT 273
           Q A ++F   S   ++G G FG V+K      G      ++  + +KD   +  EI    
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL-- 331
           +++      H NL++L     +  + +LV  Y+  G +  R+    S +      I    
Sbjct: 142 QLD------HANLIQLYDAFESKNDIVLVMEYVDGGELFDRI-IDESYNLTELDTILFMK 194
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILL--DEYYEAVVGDFGLAKLLDHCDSHVTTAVR 389
               G+ ++H+     I+H D+K  NIL    +  +  + DFGLA+   +          
Sbjct: 195 QICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNF 249
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 425
           GT   +APE ++    S  TD++  G++   L+SGL
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 277
           K +      + + + VG G +G+V   +  + G  VAVK+L +   +I    +   E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 278 ISLAVHRNLLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           +    H N++ L+        +     + +  ++    + + +K +   D   +  I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQ 133
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
             RGL Y+H      IIHRD+K +N+ ++E  E  + D GLA+   H D  +T  V  T 
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLAR---HTDDEMTGYV-ATR 186
Query: 393 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 424
            + APE  L+    ++  D++  G ++ EL++G
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  Y+  G + S L+          +  A        YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 143
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 144 --NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 145
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 146 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSN 226

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 393 GHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
            + APE +   +   K+ D++  G +L E++S 
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 148 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSN 228

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 143
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 144 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 129/308 (41%), Gaps = 57/308 (18%)
Query: 223 QSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKR-LKDGNAIG-GEIQFQTEVEMIS 279
           QS  +   S+ ++G G  G V ++G  Q G  VAVKR L D   I   EI+  TE +   
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESD--- 66
Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPY-MSNGSVASRLKAKPSLDWATRKR-----IAL-- 331
              H N++R   +C  TT+R L     + N ++   +++K   D   + +     I+L  
Sbjct: 67  --DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLD-------------EYYEAVVGDFGLAKLLD 378
             A G+ +LH     KIIHRD+K  NIL+              E    ++ DFGL K LD
Sbjct: 123 QIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 379 HCDSHVTTAVR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGILLLELISGLRAL 428
                    +    GT G  APE L    +       +   D+F  G +   ++S  +  
Sbjct: 180 SGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH- 238
Query: 429 EFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR 488
            FG   +++  ++  +  + + K L           +DR  + E   +      + P  R
Sbjct: 239 PFGDKYSRESNIIRGIFSLDEMKCL-----------HDRSLIAEATDLISQMIDHDPLKR 287
Query: 489 PKMSEVVR 496
           P   +V+R
Sbjct: 288 PTAMKVLR 295

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 145
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 146 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSN 226

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 187 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 130 SHLRRIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 187 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  Y+  G + S L+          +  A        YLH  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 161
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 162 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/298 (22%), Positives = 128/298 (42%), Gaps = 39/298 (13%)
Query: 215 KRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQT 273
           +  +F+ +      +S    +G GG   V++   +   + A+K +    A    +  ++ 
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 274 EVEMIS-LAVHRN-LLRLIGFCMTTTERLLVYPYMSNGSVA--SRLKAKPSLDWATRKRI 329
           E+  ++ L  H + ++RL  + +T      +Y  M  G++   S LK K S+D   RK  
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSY 132
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA-KLLDHCDSHVTTAV 388
                  +  +H+     I+H D+K AN L+ +    ++ DFG+A ++     S V  + 
Sbjct: 133 WKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQ 188
Query: 389 RGTVGHIAPEYLSTGQSSEKT-----------DVFGFGILLLELISGLRALEFGKTANQK 437
            GTV ++ PE +    SS +            DV+  G +L         + +GKT  Q 
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY-------YMTYGKTPFQ- 240
Query: 438 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
                  + I+Q  KL  ++D + +  +  I  +++  V   C +  P  R  + E++
Sbjct: 241 -------QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  Y+  G + S L+          +  A        YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 11/95 (11%)
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-----HVTTAVR 389
           RGL Y+H     ++IHRD+K +N+L++E  E  +GDFG+A+ L  C S     +  T   
Sbjct: 169 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL--CTSPAEHQYFMTEYV 223
Query: 390 GTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELIS 423
            T  + APE  LS  + ++  D++  G +  E+++
Sbjct: 224 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 11  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 70
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 130
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 131 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 188 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 187 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  Y+  G + S L+          +  A        YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 393 GHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
            + APE +   +   K+ D++  G +L E++S 
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 16/231 (6%)
Query: 203 EQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVVA 255
           EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   A
Sbjct: 11  EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 256 VKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVAS 313
           +K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + S
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 314 RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 373
            L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG 
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 188 AKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 90/202 (44%), Gaps = 10/202 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 163
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 164 --NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 403 GQSSEKT-DVFGFGILLLELIS 423
            +   K+ D++  G +L E++S
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLS 243

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 187 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 16/231 (6%)
Query: 203 EQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVVA 255
           EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   A
Sbjct: 11  EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 256 VKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVAS 313
           +K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + S
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 314 RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 373
            L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG 
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 188 AKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 145
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 146 --NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSN 226

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 151
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 152 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSN 232

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 143
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 144 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ +S   N      F     +G G FG V    + + G   
Sbjct: 11  SEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHY 70
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y+  G + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF 130
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 131 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 188 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ +S   N      F     +G G FG V    + + G   
Sbjct: 11  SEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHY 70
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y+  G + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF 130
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 131 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 188 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 16/231 (6%)
Query: 203 EQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVVA 255
           EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   A
Sbjct: 6   EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 65
Query: 256 VKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVAS 313
           +K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + S
Sbjct: 66  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 125
Query: 314 RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 373
            L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG 
Sbjct: 126 HLRRIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 182
Query: 374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 183 AKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 130 SHLRRIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 187 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 31  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 90
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 91  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 150
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 151 SHLRRIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 208 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 141
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 142 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSN 222

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 141
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 142 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSN 222

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 90/202 (44%), Gaps = 10/202 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 163
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 164 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 403 GQSSEKT-DVFGFGILLLELIS 423
            +   K+ D++  G +L E++S
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLS 243

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 235 VGKGGFGNVYKGYLQDGTV---VAVKRL-KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           VG G +G+V   Y  D  +   VAVK+L +   ++    +   E+ ++    H N++ L+
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 291 GFCMTTT------ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
                 T      E  LV   M  G+  + +    +L     + +     RGL Y+H   
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTG 403
              IIHRD+K +N+ ++E  E  + DFGLA+     D  +T  V  T  + APE  L+  
Sbjct: 152 ---IIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYV-ATRWYRAPEIMLNWM 204
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D++  G ++ EL+ G
Sbjct: 205 HYNQTVDIWSVGCIMAELLQG 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTV 392
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 393 GHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 424
            + APE +   +   K+ D++  G +L E++S 
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 148
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 149 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSN 229

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 149
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 150 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSN 230

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 140
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 141 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSN 221

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE +  
Sbjct: 148 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 16/231 (6%)
Query: 203 EQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVVA 255
           EQ   +  L   K    K+ +S   N      F     +G G FG V    + + G   A
Sbjct: 12  EQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYA 71
Query: 256 VKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVAS 313
           +K L     +   +I+     + I  AV+   L  + F       L +V  Y+  G + S
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS 131
Query: 314 RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 373
            L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG 
Sbjct: 132 HLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 188
Query: 374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 189 AKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ +S   N      F     +G G FG V    + + G   
Sbjct: 31  SEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHY 90
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y+  G + 
Sbjct: 91  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF 150
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 151 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 208 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 16/231 (6%)
Query: 203 EQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVVA 255
           EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   A
Sbjct: 11  EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 256 VKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVAS 313
           +K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + S
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 314 RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 373
            L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG 
Sbjct: 131 HLRRIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 188 AKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/231 (20%), Positives = 102/231 (44%), Gaps = 36/231 (15%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +  ++L+G G +G+V + Y + +  VVA+K+ L+    +    +   E+ +++   H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 287 LRLIGFCMTTT----ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 342
           ++++   +       + L V   +++       +    L     K +      G+ Y+H 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS 174
Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-------------------- 382
                I+HRD+K AN L+++     V DFGLA+ +D+ ++                    
Sbjct: 175 A---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 383 HVTTAVRGTVGHI------APEYLSTGQS-SEKTDVFGFGILLLELISGLR 426
           H     R   GH+      APE +   ++ +E  DV+  G +  EL++ ++
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 121/278 (43%), Gaps = 39/278 (14%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS-LAVHRN-LLRLIG 291
           +G GG   V++   +   + A+K +    A    +  ++ E+  ++ L  H + ++RL  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 292 FCMTTTERLLVYPYMSNGSVA--SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           + +T      +Y  M  G++   S LK K S+D   RK         +  +H+     I+
Sbjct: 124 YEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIV 177
Query: 350 HRDVKAANILLDEYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
           H D+K AN L+ +    ++ DFG+A ++     S V  +  GTV ++ PE +    SS +
Sbjct: 178 HSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 236
Query: 409 T-----------DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
                       DV+  G +L         + +GKT  Q        + I+Q  KL  ++
Sbjct: 237 NGKSKSKISPKSDVWSLGCILY-------YMTYGKTPFQ--------QIINQISKLHAII 281
Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
           D + +  +  I  +++  V   C +  P  R  + E++
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  Y   G + S L+          +  A        YLH    
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 161
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+++D+     V DFG AK +       T  + GT  ++APE + +   
Sbjct: 162 -DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 216
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 217 NKAVDWWALGVLIYEMAAG 235

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 85/202 (42%), Gaps = 17/202 (8%)
Query: 235 VGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +G G FG      ++D     +VAVK ++ G AI   +Q +  +   SL  H N++R   
Sbjct: 28  IGSGNFG--VARLMRDKLTKELVAVKYIERGAAIDENVQREI-INHRSLR-HPNIVRFKE 83
Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
             +T T   ++  Y S G +  R+           +        G+ Y H     +I HR
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHR 140
Query: 352 DVKAANILLD--EYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
           D+K  N LLD        + DFG +K  + H     T    GT  +IAPE L   +   K
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLRQEYDGK 197
Query: 409 -TDVFGFGILLLELISGLRALE 429
             DV+  G+ L  ++ G    E
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFE 219

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 16/231 (6%)
Query: 203 EQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVVA 255
           EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   A
Sbjct: 11  EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 256 VKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVAS 313
           +K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + S
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 314 RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 373
            L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG 
Sbjct: 131 HLRRIGRFAEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 188 AKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+++D+     V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLIIDQQGYIQVTDFG 186
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 187 FAKRV----KGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  Y   G + S L+          +  A        YLH    
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 161
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+++D+     V DFG AK +       T  + GT  ++APE + +   
Sbjct: 162 -DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 216
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 217 NKAVDWWALGVLIYEMAAG 235

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD--HCDSHVTTAVRGTV 392
           RGL Y+H      ++HRD+K +N+L++   +  + DFGLA++ D  H  +   T    T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 393 GHIAPEYLSTGQSSEKT-DVFGFGILLLELIS 423
            + APE +   +   K+ D++  G +L E++S
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 121/278 (43%), Gaps = 39/278 (14%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS-LAVHRN-LLRLIG 291
           +G GG   V++   +   + A+K +    A    +  ++ E+  ++ L  H + ++RL  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 292 FCMTTTERLLVYPYMSNGSVA--SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           + +T      +Y  M  G++   S LK K S+D   RK         +  +H+     I+
Sbjct: 124 YEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IV 177
Query: 350 HRDVKAANILLDEYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
           H D+K AN L+ +    ++ DFG+A ++     S V  +  GTV ++ PE +    SS +
Sbjct: 178 HSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 236
Query: 409 T-----------DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
                       DV+  G +L         + +GKT  Q        + I+Q  KL  ++
Sbjct: 237 NGKSKSKISPKSDVWSLGCILY-------YMTYGKTPFQ--------QIINQISKLHAII 281
Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
           D + +  +  I  +++  V   C +  P  R  + E++
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 53/258 (20%)
Query: 206 REEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKR------ 258
           RE +    +K  H         N+  K+L+G+G +G VY  Y ++    VA+K+      
Sbjct: 11  RENLYFQGIKNVH------VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE 64
Query: 259 -LKDGNAIGGEIQFQTE------VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 311
            L D   I  EI           + +  L +  +LL+         + L +   +++  +
Sbjct: 65  DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF--------DELYIVLEIADSDL 116
Query: 312 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 371
               K    L     K I      G  ++HE     IIHRD+K AN LL++     V DF
Sbjct: 117 KKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDF 173
Query: 372 GLAKLLD-HCDSHVTTAV--------------RGTVGHI------APEYLSTGQSSEKT- 409
           GLA+ ++   D+++   +              +    H+      APE +   ++  K+ 
Sbjct: 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI 233
Query: 410 DVFGFGILLLELISGLRA 427
           D++  G +  EL++ L++
Sbjct: 234 DIWSTGCIFAELLNMLQS 251

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 235 VGKGGFGNVYKGYLQDGTV---VAVKRL-KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           VG G +G+V   Y  D  +   VAVK+L +   ++    +   E+ ++    H N++ L+
Sbjct: 28  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 291 GFCMTTT------ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
                 T      E  LV   M  G+  + +    +L     + +     RGL Y+H   
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH--- 140
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTG 403
              IIHRD+K +N+ ++E  E  + DFGLA+     D  +T  V  T  + APE  L+  
Sbjct: 141 SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMTGYV-ATRWYRAPEIMLNWM 196
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D++  G ++ EL+ G
Sbjct: 197 HYNQTVDIWSVGCIMAELLQG 217

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++  ++G G FG V++  L +   VA+K+ L+D      E+Q      ++ +  H N++
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ------IMRIVKHPNVV 95
Query: 288 RLIGFCMTTTERL------LVYPYMSNGSV-ASR--LKAKPSLDWATRKRIALGAARGLL 338
            L  F  +  ++       LV  Y+      ASR   K K ++     K       R L 
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
           Y+H      I HRD+K  N+LLD     + + DFG AK+L   + +V+     +  + AP
Sbjct: 156 YIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC--SRYYRAP 210
Query: 398 EYL-STGQSSEKTDVFGFGILLLELISG 424
           E +      +   D++  G ++ EL+ G
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 84/215 (39%), Gaps = 32/215 (14%)
Query: 232 KNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           + ++ +GGF  VY+   +  G   A+KRL            Q    M  L+ H N+++  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ-- 90
Query: 291 GFCM----------TTTERLLVYPYMSNGSVASRLKAKPS---LDWATRKRIALGAARGL 337
            FC           T     L+   +  G +   LK   S   L   T  +I     R +
Sbjct: 91  -FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-------- 389
            ++H Q  P IIHRD+K  N+LL       + DFG A  + H   +  +A R        
Sbjct: 150 QHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 390 ---GTVGHIAPEYL---STGQSSEKTDVFGFGILL 418
               T  +  PE +   S     EK D++  G +L
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  Y   G + S L+          +  A        YLH    
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-- 161
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+++D+     V DFG AK +       T  + GT  ++APE + +   
Sbjct: 162 -DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 216
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 217 NKAVDWWALGVLIYEMAAG 235

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 121/278 (43%), Gaps = 39/278 (14%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS-LAVHRN-LLRLIG 291
           +G GG   V++   +   + A+K +    A    +  ++ E+  ++ L  H + ++RL  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 292 FCMTTTERLLVYPYMSNGSVA--SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           + +T      +Y  M  G++   S LK K S+D   RK         +  +H+     I+
Sbjct: 80  YEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIV 133
Query: 350 HRDVKAANILLDEYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
           H D+K AN L+ +    ++ DFG+A ++     S V  +  GTV ++ PE +    SS +
Sbjct: 134 HSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 192
Query: 409 T-----------DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
                       DV+  G +L         + +GKT  Q        + I+Q  KL  ++
Sbjct: 193 NGKSKSKISPKSDVWSLGCILY-------YMTYGKTPFQ--------QIINQISKLHAII 237
Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
           D + +  +  I  +++  V   C +  P  R  + E++
Sbjct: 238 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  Y   G + S L+          +  A        YLH    
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 160
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+++D+     V DFG AK +       T  + GT  ++APE + +   
Sbjct: 161 -DLIYRDLKPENLMIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 121/278 (43%), Gaps = 39/278 (14%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS-LAVHRN-LLRLIG 291
           +G GG   V++   +   + A+K +    A    +  ++ E+  ++ L  H + ++RL  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 292 FCMTTTERLLVYPYMSNGSVA--SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           + +T      +Y  M  G++   S LK K S+D   RK         +  +H+     I+
Sbjct: 77  YEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IV 130
Query: 350 HRDVKAANILLDEYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
           H D+K AN L+ +    ++ DFG+A ++     S V  +  GTV ++ PE +    SS +
Sbjct: 131 HSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 409 T-----------DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
                       DV+  G +L         + +GKT  Q        + I+Q  KL  ++
Sbjct: 190 NGKSKSKISPKSDVWSLGCILY-------YMTYGKTPFQ--------QIINQISKLHAII 234
Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
           D + +  +  I  +++  V   C +  P  R  + E++
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  Y   G + S L+          +  A        YLH    
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 160
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+++D+     V DFG AK +       T  + GT  ++APE + +   
Sbjct: 161 -DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 86/198 (43%), Gaps = 16/198 (8%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG V++   +  G   A K +   +    E   + E++ +S+  H  L+ L    
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAF 117
Query: 294 MTTTERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
               E +++Y +MS G +  ++     K S D A          +GL ++HE      +H
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV--EYMRQVCKGLCHMHEN---NYVH 172
Query: 351 RDVKAANILL--DEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSE 407
            D+K  NI+       E  + DFGL   LD   S  VTT   GT    APE         
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGY 229
Query: 408 KTDVFGFGILLLELISGL 425
            TD++  G+L   L+SGL
Sbjct: 230 YTDMWSVGVLSYILLSGL 247

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 235 VGKGGFGNVYKGYLQDGTV---VAVKRL-KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           VG G +G+V   Y  D  +   VAVK+L +   ++    +   E+ ++    H N++ L+
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 291 GFCMTTT------ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
                 T      E  LV   M  G+  + +    +L     + +     RGL Y+H   
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH--- 148
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTG 403
              IIHRD+K +N+ ++E  E  + DFGLA+     D  +T  V  T  + APE  L+  
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYV-ATRWYRAPEIMLNWM 204
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D++  G ++ EL+ G
Sbjct: 205 HYNQTVDIWSVGCIMAELLQG 225

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    + + G   A+K L     +   +I+     + I  AV+   
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  Y+  G + S L+          +  A        YLH    
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 153
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + +   
Sbjct: 154 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 208
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 209 NKAVDWWALGVLIYEMAAG 227

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ ++ +G
Sbjct: 187 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 123/284 (43%), Gaps = 39/284 (13%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS-LAVHRN- 285
           +S    +G GG   V++   +   + A+K +    A    +  ++ E+  ++ L  H + 
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVA--SRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
           ++RL  + +T      +Y  M  G++   S LK K S+D   RK         +  +H+ 
Sbjct: 70  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLST 402
               I+H D+K AN L+ +    ++ DFG+A ++     S V  +  GTV ++ PE +  
Sbjct: 127 ---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 182
Query: 403 GQSSEKT-----------DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 451
             SS +            DV+  G +L         + +GKT  Q        + I+Q  
Sbjct: 183 MSSSRENGKSKSKISPKSDVWSLGCILY-------YMTYGKTPFQ--------QIINQIS 227
Query: 452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
           KL  ++D + +  +  I  +++  V   C +  P  R  + E++
Sbjct: 228 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 92/226 (40%), Gaps = 24/226 (10%)
Query: 235 VGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG        Q   +VAVK ++ G  I   ++ +  +   SL  H N++R     
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREI-INHRSLR-HPNIVRFKEVI 84
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +T T   +V  Y S G +  R+           +        G+ Y H     ++ HRD+
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---QVCHRDL 141
Query: 354 KAANILLD--EYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT- 409
           K  N LLD        + DFG +K  + H     T    GT  +IAPE L   +   K  
Sbjct: 142 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLKKEYDGKVA 198
Query: 410 DVFGFGILLLELISGLRALE-------FGKTA----NQKGAMLDWV 444
           DV+  G+ L  ++ G    E       F KT     N + A+ D+V
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV 244

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 25/166 (15%)
Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKR-------LKDGNAIGGEIQFQTE---- 274
            N+  K+L+G+G +G VY  Y ++    VA+K+       L D   I  EI         
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 275 --VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
             + +  L +  +LL+         + L +   +++  +    K    L     K I   
Sbjct: 88  YIIRLHDLIIPEDLLKF--------DELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYN 139
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 378
              G  ++HE     IIHRD+K AN LL++     + DFGLA+ ++
Sbjct: 140 LLLGEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTIN 182

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    +++ G   A+K L     +   +I+     + I  AV+   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + F       L +V  Y   G + S L+          +  A        YLH    
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-- 160
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+++D+     V DFG AK +       T  + GT  ++APE + +   
Sbjct: 161 -DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    + + G   A+K L     +   +I+     + I  AV+ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + F       L +V  Y+  G + S L+          +  A        YLH  
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 153
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 154 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 206
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 207 GYNKAVDWWALGVLIYEMAAG 227

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/298 (21%), Positives = 126/298 (42%), Gaps = 39/298 (13%)
Query: 215 KRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQT 273
           +  +F+ +      +S    +G GG   V++   +   + A+K +    A    +  ++ 
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 274 EVEMIS-LAVHRN-LLRLIGFCMTTTERLLVYPYMSNGSVA--SRLKAKPSLDWATRKRI 329
           E+  ++ L  H + ++RL  + +T      +Y  M  G++   S LK K S+D   RK  
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSY 132
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 389
                  +  +H+     I+H D+K AN L+ +    ++ DFG+A  +      V    +
Sbjct: 133 WKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQ 188
Query: 390 -GTVGHIAPEYLSTGQSSEKT-----------DVFGFGILLLELISGLRALEFGKTANQK 437
            GTV ++ PE +    SS +            DV+  G +L         + +GKT  Q 
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY-------YMTYGKTPFQ- 240
Query: 438 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
                  + I+Q  KL  ++D + +  +  I  +++  V   C +  P  R  + E++
Sbjct: 241 -------QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 43/210 (20%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           VG+G FG V+             R+KD      +  FQ  V+ + L V R +  L+    
Sbjct: 66  VGRGSFGEVH-------------RMKDK-----QTGFQCAVKKVRLEVFR-VEELVACAG 106
Query: 295 TTTERLL-VY------PY-------MSNGSVASRLKAKPSLDWATRKRIALGAA-RGLLY 339
            ++ R++ +Y      P+       +  GS+   +K    L    R    LG A  GL Y
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLGQALEGLEY 165
Query: 340 LHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLL--DHCDSHVTTA--VRGTVGH 394
           LH +   +I+H DVKA N+LL  +   A + DFG A  L  D     + T   + GT  H
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           +APE +       K D++    ++L +++G
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ +S   N      F     +G G FG V    + + G   
Sbjct: 11  SEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHY 70
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y   G + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF 130
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+++D+     V DFG
Sbjct: 131 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++APE + +   ++  D +  G+L+ E+ +G
Sbjct: 188 FAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT   +APE + +   ++  D +  G+L+ E+ +G
Sbjct: 187 FAKRV----KGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 86/198 (43%), Gaps = 16/198 (8%)
Query: 235 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG V++   +  G   A K +   +    E   + E++ +S+  H  L+ L    
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAF 223
Query: 294 MTTTERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
               E +++Y +MS G +  ++     K S D A          +GL ++HE      +H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV--EYMRQVCKGLCHMHEN---NYVH 278
Query: 351 RDVKAANILL--DEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSE 407
            D+K  NI+       E  + DFGL   LD   S  VTT   GT    APE         
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGY 335
Query: 408 KTDVFGFGILLLELISGL 425
            TD++  G+L   L+SGL
Sbjct: 336 YTDMWSVGVLSYILLSGL 353

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 15/202 (7%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLL 287
           ++ +N +G+G +G V K  +Q GT +     K       ++ +F+ E+E++    H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           RL       T+  LV    + G +  R+  K     +   RI       + Y H+     
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---N 126
Query: 348 IIHRDVKAANILL-----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
           + HRD+K  N L      D   + +  DFGLA          T    GT  +++P+ L  
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLI--DFGLAARFKPGKMMRTKV--GTPYYVSPQVLE- 181
Query: 403 GQSSEKTDVFGFGILLLELISG 424
           G    + D +  G+++  L+ G
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCG 203

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 15/202 (7%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLL 287
           ++ +N +G+G +G V K  +Q GT +     K       ++ +F+ E+E++    H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           RL       T+  LV    + G +  R+  K     +   RI       + Y H+     
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---N 143
Query: 348 IIHRDVKAANILL-----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
           + HRD+K  N L      D   + +  DFGLA          T    GT  +++P+ L  
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLI--DFGLAARFKPGKMMRTKV--GTPYYVSPQVLE- 198
Query: 403 GQSSEKTDVFGFGILLLELISG 424
           G    + D +  G+++  L+ G
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCG 220

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 43/210 (20%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           VG+G FG V+             R+KD      +  FQ  V+ + L V R +  L+    
Sbjct: 82  VGRGSFGEVH-------------RMKDK-----QTGFQCAVKKVRLEVFR-VEELVACAG 122
Query: 295 TTTERLL-VY------PY-------MSNGSVASRLKAKPSLDWATRKRIALGAA-RGLLY 339
            ++ R++ +Y      P+       +  GS+   +K    L    R    LG A  GL Y
Sbjct: 123 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLGQALEGLEY 181
Query: 340 LHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLL--DHCDSHVTTA--VRGTVGH 394
           LH +   +I+H DVKA N+LL  +   A + DFG A  L  D     + T   + GT  H
Sbjct: 182 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 238
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           +APE +       K D++    ++L +++G
Sbjct: 239 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 41/209 (19%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+             R++D      +  FQ  V+ + L V R    +    +
Sbjct: 101 LGRGSFGEVH-------------RMEDK-----QTGFQCAVKKVRLEVFRAEELMACAGL 142
Query: 295 TTTERLLVY------PY-------MSNGSVASRLKAKPSLDWATRKRIALGAA-RGLLYL 340
           T+   + +Y      P+       +  GS+   +K +  L    R    LG A  GL YL
Sbjct: 143 TSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP-EDRALYYLGQALEGLEYL 201
Query: 341 HEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLL--DHCDSHVTTA--VRGTVGHI 395
           H +   +I+H DVKA N+LL  +   A + DFG A  L  D     + T   + GT  H+
Sbjct: 202 HSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHM 258
Query: 396 APEYLSTGQSSEKTDVFGFGILLLELISG 424
           APE +       K DV+    ++L +++G
Sbjct: 259 APEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 21/217 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVE 276
           ++L+    ++    ++G+G FG V    +     V A+K L     I       F  E +
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           +++ A    +++L           +V  YM  G + + +           K      A  
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEV 182
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAVRGT 391
           +L L        IHRDVK  N+LLD+     + DFG    ++      CD+ V     GT
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GT 237
Query: 392 VGHIAPEYLST----GQSSEKTDVFGFGILLLELISG 424
             +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 89/203 (43%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +        T  + APE +  
Sbjct: 148 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 89/203 (43%), Gaps = 10/203 (4%)
Query: 229 FSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +++ + +G+G +G V   Y     V VA+K++          +   E++++    H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQC 344
            +       T   +   Y+    + + L         +   I        RGL Y+H   
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 148
Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLST 402
              ++HRD+K +N+LL+   +  + DFGLA++   DH  +        T  + APE +  
Sbjct: 149 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 403 GQSSEKT-DVFGFGILLLELISG 424
            +   K+ D++  G +L E++S 
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSN 229

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
           +IA+   + L +LH +    +IHRDVK +N+L++   +  + DFG++  L   D      
Sbjct: 113 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDI 168
Query: 388 VRGTVGHIAPEY----LSTGQSSEKTDVFGFGILLLEL 421
             G   ++APE     L+    S K+D++  GI ++EL
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 41/209 (19%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+             R++D      +  FQ  V+ + L V R    +    +
Sbjct: 82  LGRGSFGEVH-------------RMEDK-----QTGFQCAVKKVRLEVFRAEELMACAGL 123
Query: 295 TTTERLLVY------PY-------MSNGSVASRLKAKPSLDWATRKRIALGAA-RGLLYL 340
           T+   + +Y      P+       +  GS+   +K +  L    R    LG A  GL YL
Sbjct: 124 TSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP-EDRALYYLGQALEGLEYL 182
Query: 341 HEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLL--DHCDSHVTTA--VRGTVGHI 395
           H +   +I+H DVKA N+LL  +   A + DFG A  L  D     + T   + GT  H+
Sbjct: 183 HSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHM 239
Query: 396 APEYLSTGQSSEKTDVFGFGILLLELISG 424
           APE +       K DV+    ++L +++G
Sbjct: 240 APEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 333
           EV ++    H N+++L  F        LV      G +   +  +          I    
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 113
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVG--DFGLAKLLDHCDSHVTTAVR- 389
             G  YLH+     I+HRD+K  N+LL+ +  +A++   DFGL+    H +       R 
Sbjct: 114 LSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERL 167
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           GT  +IAPE L   +  EK DV+  G++L  L+ G
Sbjct: 168 GTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 201

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 21/217 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVE 276
           ++L+    ++    ++G+G FG V    +     V A+K L     I       F  E +
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           +++ A    +++L           +V  YM  G + + +           K      A  
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEV 177
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAVRGT 391
           +L L        IHRDVK  N+LLD+     + DFG    ++      CD+ V     GT
Sbjct: 178 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GT 232
Query: 392 VGHIAPEYLST----GQSSEKTDVFGFGILLLELISG 424
             +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 16/232 (6%)
Query: 202 NEQRREEVCLGNLKRFHFKELQSATSN------FSSKNLVGKGGFGNVY-KGYLQDGTVV 254
           +EQ   +  L   K    K+ ++ + N      F     +G G FG V    + + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 255 AVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVA 312
           A+K L     +   +I+     + I  AV+   L  + F       L +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK +       T  + GT  ++AP  + +   ++  D +  G+L+ E+ +G
Sbjct: 187 FAKRV----KGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 22/225 (9%)
Query: 235 VGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG        Q   +VAVK ++ G  I   ++ +  +   SL  H N++R     
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREI-INHRSLR-HPNIVRFKEVI 84
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +T T   +V  Y S G +  R+           +        G+ Y H     ++ HRD+
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAM---QVAHRDL 141
Query: 354 KAANILLD--EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-D 410
           K  N LLD        + DFG +K      S   +AV GT  +IAPE L   +   K  D
Sbjct: 142 KLENTLLDGSPAPRLKIADFGYSK-ASVLHSQPKSAV-GTPAYIAPEVLLKKEYDGKVAD 199
Query: 411 VFGFGILLLELISGLRALE-------FGKTA----NQKGAMLDWV 444
           V+  G+ L  ++ G    E       F KT     N + A+ D+V
Sbjct: 200 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV 244

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 66/144 (45%), Gaps = 14/144 (9%)
Query: 226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEV-EMISLAV- 282
           T+ F     +G G FG+V+K   + DG + A+KR K    + G +  Q  + E+ + AV 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 65
Query: 283 --HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARG 336
             H +++R           L+   Y + GS+A  +    +       A  K + L   RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 337 LLYLHEQCDPKIIHRDVKAANILL 360
           L Y+H      ++H D+K +NI +
Sbjct: 126 LRYIHSM---SLVHMDIKPSNIFI 146

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 66/144 (45%), Gaps = 14/144 (9%)
Query: 226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEV-EMISLAV- 282
           T+ F     +G G FG+V+K   + DG + A+KR K    + G +  Q  + E+ + AV 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 65
Query: 283 --HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARG 336
             H +++R           L+   Y + GS+A  +    +       A  K + L   RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 337 LLYLHEQCDPKIIHRDVKAANILL 360
           L Y+H      ++H D+K +NI +
Sbjct: 126 LRYIHSM---SLVHMDIKPSNIFI 146

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 66/144 (45%), Gaps = 14/144 (9%)
Query: 226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEV-EMISLAV- 282
           T+ F     +G G FG+V+K   + DG + A+KR K    + G +  Q  + E+ + AV 
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 63
Query: 283 --HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARG 336
             H +++R           L+   Y + GS+A  +    +       A  K + L   RG
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 337 LLYLHEQCDPKIIHRDVKAANILL 360
           L Y+H      ++H D+K +NI +
Sbjct: 124 LRYIHSMS---LVHMDIKPSNIFI 144

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 21/217 (9%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVE 276
           ++L+    ++    ++G+G FG V    +     V A+K L     I       F  E +
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           +++ A    +++L           +V  YM  G + + +           K      A  
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEV 182
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAVRGT 391
           +L L        IHRDVK  N+LLD+     + DFG    ++      CD+ V     GT
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GT 237
Query: 392 VGHIAPEYLST----GQSSEKTDVFGFGILLLELISG 424
             +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 66/144 (45%), Gaps = 14/144 (9%)
Query: 226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEV-EMISLAV- 282
           T+ F     +G G FG+V+K   + DG + A+KR K    + G +  Q  + E+ + AV 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 67
Query: 283 --HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARG 336
             H +++R           L+   Y + GS+A  +    +       A  K + L   RG
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 337 LLYLHEQCDPKIIHRDVKAANILL 360
           L Y+H      ++H D+K +NI +
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFI 148

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 10/199 (5%)
Query: 229 FSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNL 286
           F     +G G FG V    + + G   A+K L     +   +I+     + I  AV+   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           L  + +       L +V  Y+  G + S L+          +  A        YLH    
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 160
Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + +   
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 406 SEKTDVFGFGILLLELISG 424
           ++  D +  G+L+ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 120/278 (43%), Gaps = 39/278 (14%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS-LAVHRN-LLRLIG 291
           +G GG   V++   +   + A+K +    A    +  ++ E+  ++ L  H + ++RL  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 292 FCMTTTERLLVYPYMSNGSVA--SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           + +T      +Y  M  G++   S LK K S+D   RK         +  +H+     I+
Sbjct: 124 YEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IV 177
Query: 350 HRDVKAANILLDEYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
           H D+K AN L+ +    ++ DFG+A ++     S V  +  G V ++ PE +    SS +
Sbjct: 178 HSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 409 T-----------DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
                       DV+  G +L         + +GKT  Q        + I+Q  KL  ++
Sbjct: 237 NGKSKSKISPKSDVWSLGCILY-------YMTYGKTPFQ--------QIINQISKLHAII 281
Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
           D + +  +  I  +++  V   C +  P  R  + E++
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 13/168 (7%)
Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 333
           EV ++    H N+++L  F        LV      G +   +  +          I    
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVG--DFGLAKLLDHCDSHVTTAVR- 389
             G  YLH+     I+HRD+K  N+LL+ +  +A++   DFGL+    H +       R 
Sbjct: 131 LSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERL 184
Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK 437
           GT  +IAPE L   +  EK DV+  G++L  L+ G     FG   +Q+
Sbjct: 185 GTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP--FGGQTDQE 229

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 43/210 (20%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           +G+G FG V+             R+KD      +  FQ  V+ + L V R +  L+    
Sbjct: 80  LGRGSFGEVH-------------RMKDK-----QTGFQCAVKKVRLEVFR-VEELVACAG 120
Query: 295 TTTERLL-VY------PY-------MSNGSVASRLKAKPSLDWATRKRIALGAA-RGLLY 339
            ++ R++ +Y      P+       +  GS+   +K    L    R    LG A  GL Y
Sbjct: 121 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLGQALEGLEY 179
Query: 340 LHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLL--DHCDSHVTTA--VRGTVGH 394
           LH +   +I+H DVKA N+LL  +   A + DFG A  L  D     + T   + GT  H
Sbjct: 180 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 236
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           +APE +       K D++    ++L +++G
Sbjct: 237 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    + + G   A+K L     +   +I+     + I  AV+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +       L +V  Y+  G + S L+          +  A        YLH  
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 227 SNFSSKNLVGKGGFGNVY-KGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHR 284
             F     +G G FG V    + + G   A+K L     +   +I+     + I  AV+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 285 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  + +       L +V  Y+  G + S L+          +  A        YLH  
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               +I+RD+K  N+L+D+     V DFG AK +       T  + GT  ++APE + + 
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D +  G+L+ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 92/226 (40%), Gaps = 24/226 (10%)
Query: 235 VGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG        Q   +VAVK ++ G  I   ++ +  +   SL  H N++R     
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-INHRSLR-HPNIVRFKEVI 83
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +T T   +V  Y S G +  R+           +        G+ Y H     ++ HRD+
Sbjct: 84  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---QVCHRDL 140
Query: 354 KAANILLD--EYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT- 409
           K  N LLD        + DFG +K  + H     T    GT  +IAPE L   +   K  
Sbjct: 141 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLKKEYDGKVA 197
Query: 410 DVFGFGILLLELISGLRALE-------FGKTA----NQKGAMLDWV 444
           DV+  G+ L  ++ G    E       F KT     N + A+ D+V
Sbjct: 198 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV 243

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 81/199 (40%), Gaps = 17/199 (8%)
Query: 235 VGKGGFG------NVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +GKG F        V  G      ++  K+L   +      + + E  +  L  H N++R
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARD----HQKLEREARICRLLKHPNIVR 85
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           L           L++  ++ G +   + A+     A            +L+ H+     +
Sbjct: 86  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GV 142
Query: 349 IHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
           +HRD+K  N+LL    +     + DFGLA  ++  +        GT G+++PE L     
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 406 SEKTDVFGFGILLLELISG 424
            +  D++  G++L  L+ G
Sbjct: 202 GKPVDLWACGVILYILLVG 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/204 (21%), Positives = 83/204 (40%), Gaps = 9/204 (4%)
Query: 226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVH 283
           T ++     +GKG F  V +   +  T     ++ +   +      + + E  +  L  H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            N++RL           LV+  ++ G +   + A+     A            + ++H+ 
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 344 CDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
               I+HRD+K  N+LL    +     + DFGLA +    +        GT G+++PE L
Sbjct: 150 ---DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSPEVL 205
Query: 401 STGQSSEKTDVFGFGILLLELISG 424
                 +  D++  G++L  L+ G
Sbjct: 206 RKDPYGKPVDIWACGVILYILLVG 229

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           VG+G +G+VYK   +DG       LK     G  +    E+ ++    H N++ L    +
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 295 TTTER--LLVYPYMSNG-------SVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQC 344
           +  +R   L++ Y  +          AS+   KP  L     K +      G+ YLH   
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148
Query: 345 DPKIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPE 398
              ++HRD+K ANIL+     E     + D G A+L +     +     V  T  + APE
Sbjct: 149 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205
Query: 399 YLSTGQSSEKT-DVFGFGILLLELIS 423
            L   +   K  D++  G +  EL++
Sbjct: 206 LLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 14/203 (6%)
Query: 233 NLVGKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
            ++GKG F  V +   ++        +V V +      +  E   + E  +  +  H ++
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHMLKHPHI 90
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-D 345
           + L+    +     +V+ +M    +   +  +    +   + +A    R +L     C D
Sbjct: 91  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 150
Query: 346 PKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLS 401
             IIHRDVK   +LL   +      +G FG+A  L   +S +    R GT   +APE + 
Sbjct: 151 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPHFMAPEVVK 208
Query: 402 TGQSSEKTDVFGFGILLLELISG 424
                +  DV+G G++L  L+SG
Sbjct: 209 REPYGKPVDVWGCGVILFILLSG 231

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 21/212 (9%)
Query: 224 SATS--NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK----DGNAIGGEIQFQTEVE 276
           SATS   +     +G+G +G VYK         VA+KR++    +    G  I+   EV 
Sbjct: 29  SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---EVS 85
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           ++    HRN++ L           L++ Y  N  +   +   P +     K        G
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 337 LLYLHEQCDPKIIHRDVKAANILL-----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
           + + H +   + +HRD+K  N+LL      E     +GDFGLA+         T  +  T
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-T 200
Query: 392 VGHIAPEY-LSTGQSSEKTDVFGFGILLLELI 422
           + +  PE  L +   S   D++    +  E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 14/203 (6%)
Query: 233 NLVGKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
            ++GKG F  V +   ++        +V V +      +  E   + E  +  +  H ++
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHMLKHPHI 88
Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-D 345
           + L+    +     +V+ +M    +   +  +    +   + +A    R +L     C D
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 346 PKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLS 401
             IIHRDVK   +LL   +      +G FG+A  L   +S +    R GT   +APE + 
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPHFMAPEVVK 206
Query: 402 TGQSSEKTDVFGFGILLLELISG 424
                +  DV+G G++L  L+SG
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 9/159 (5%)
Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
           + + EV ++   +H N++ L       T+ +L+   +S G +   L  K SL        
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVT 385
                 G+ YLH +   KI H D+K  NI+L +    +    + DFGLA  ++  D    
Sbjct: 121 IKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF 175
Query: 386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
             + GT   +APE ++      + D++  G++   L+SG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 9/159 (5%)
Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
           + + EV ++   +H N++ L       T+ +L+   +S G +   L  K SL        
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVT 385
                 G+ YLH +   KI H D+K  NI+L +    +    + DFGLA  ++  D    
Sbjct: 121 IKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF 175
Query: 386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
             + GT   +APE ++      + D++  G++   L+SG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 9/159 (5%)
Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
           + + EV ++   +H N++ L       T+ +L+   +S G +   L  K SL        
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVT 385
                 G+ YLH +   KI H D+K  NI+L +    +    + DFGLA  ++  D    
Sbjct: 121 IKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF 175
Query: 386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
             + GT   +APE ++      + D++  G++   L+SG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 9/159 (5%)
Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
           + + EV ++   +H N++ L       T+ +L+   +S G +   L  K SL        
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVT 385
                 G+ YLH +   KI H D+K  NI+L +    +    + DFGLA  ++  D    
Sbjct: 121 IKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF 175
Query: 386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
             + GT   +APE ++      + D++  G++   L+SG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 9/159 (5%)
Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
           + + EV ++   +H N++ L       T+ +L+   +S G +   L  K SL        
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVT 385
                 G+ YLH +   KI H D+K  NI+L +    +    + DFGLA  ++  D    
Sbjct: 121 IKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF 175
Query: 386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
             + GT   +APE ++      + D++  G++   L+SG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 339 YLHEQCDPKIIHRDVKAANIL-LDEYYEA---VVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
           YLH Q    ++HRD+K +NIL +DE        + DFG AK L   +  + T    T   
Sbjct: 136 YLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANF 191
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           +APE L      E  D++  GILL  +++G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/199 (21%), Positives = 82/199 (41%), Gaps = 17/199 (8%)
Query: 235 VGKGGFGNVYK------GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +GKG F  V +      G      ++  K+L   +      + + E  +  L  H N++R
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVR 74
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           L           L++  ++ G +   + A+     A            +L+ H+     +
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GV 131
Query: 349 IHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
           +HR++K  N+LL    +     + DFGLA  ++  +        GT G+++PE L     
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 406 SEKTDVFGFGILLLELISG 424
            +  D++  G++L  L+ G
Sbjct: 191 GKPVDLWACGVILYILLVG 209

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 339 YLHEQCDPKIIHRDVKAANIL-LDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGH 394
           YLH Q    ++HRD+K +NIL +DE        + DFG AK L   +  + T    T   
Sbjct: 136 YLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANF 191
Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           +APE L      E  D++  GILL  +++G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 9/159 (5%)
Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
           + + EV ++   +H N++ L       T+ +L+   +S G +   L  K SL        
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVT 385
                 G+ YLH +   KI H D+K  NI+L +    +    + DFGLA  ++  D    
Sbjct: 121 IKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF 175
Query: 386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
             + GT   +APE ++      + D++  G++   L+SG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 46/100 (46%), Gaps = 6/100 (6%)
Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L +LH Q    ++H DVK ANI L       +GDFGL  L++   +       G   ++A
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMA 224
Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 436
           PE L  G      DVF  G+ +LE+   +     G+   Q
Sbjct: 225 PELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
           +IA+   + L +LH +    +IHRDVK +N+L++   +    DFG++  L   D      
Sbjct: 140 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYL--VDDVAKDI 195
Query: 388 VRGTVGHIAPEY----LSTGQSSEKTDVFGFGILLLEL 421
             G   + APE     L+    S K+D++  GI  +EL
Sbjct: 196 DAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 18/166 (10%)
Query: 274 EVEMI-SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           EVEM+     HRN+L LI F        LV+  M  GS+ S +  +   +      +   
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD 119
Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLA---KLLDHCDSHVTT 386
            A  L +LH +    I HRD+K  NIL +   +     + DFGL    KL   C    T 
Sbjct: 120 VASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 387 AVR---GTVGHIAPEYLSTGQS-----SEKTDVFGFGILLLELISG 424
            +    G+  ++APE +           ++ D++  G++L  L+SG
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 9/206 (4%)
Query: 224 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLA 281
           S T  +     +GKG F  V +   +  G   A K +        + Q  + E  +  L 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
            H N++RL           LV+  ++ G +   + A+     A            + + H
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
                 I+HRD+K  N+LL    +     + DFGLA +    D        GT G+++PE
Sbjct: 121 LN---GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE 176
Query: 399 YLSTGQSSEKTDVFGFGILLLELISG 424
            L      +  D++  G++L  L+ G
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 9/206 (4%)
Query: 224 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLA 281
           S T  +     +GKG F  V +   +  G   A K +        + Q  + E  +  L 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
            H N++RL           LV+  ++ G +   + A+     A            + + H
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 342 EQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
                 I+HRD+K  N+LL    +     + DFGLA +    D        GT G+++PE
Sbjct: 121 LN---GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE 176
Query: 399 YLSTGQSSEKTDVFGFGILLLELISG 424
            L      +  D++  G++L  L+ G
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 91/226 (40%), Gaps = 24/226 (10%)
Query: 235 VGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG        Q   +VAVK ++ G  I   ++ +  +   SL  H N++R     
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-INHRSLR-HPNIVRFKEVI 84
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +T T   +V  Y S G +  R+           +        G+ Y H     ++ HRD+
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---QVCHRDL 141
Query: 354 KAANILLD--EYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT- 409
           K  N LLD        +  FG +K  + H     T    GT  +IAPE L   +   K  
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLKKEYDGKVA 198
Query: 410 DVFGFGILLLELISGLRALE-------FGKTA----NQKGAMLDWV 444
           DV+  G+ L  ++ G    E       F KT     N + A+ D+V
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV 244

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 33/241 (13%)
Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQDG-TVVAVKRLKDGNAI--GGEIQFQTEVE 276
           K+++    +F    ++G+G FG V    L++   V A+K L     +       F+ E +
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS-------RLKAKPSLDWATRKRI 329
           ++     + +  L           LV  Y   G + +       RL  + +  +     I
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG-LAKLLDHCDSHVTTAV 388
           A+ +   L Y         +HRD+K  NIL+D      + DFG   KL++      + AV
Sbjct: 187 AIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 389 RGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRAL-------EFGKTANQ 436
            GT  +I+PE L       G+   + D +  G+ + E++ G            +GK  N 
Sbjct: 238 -GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296
Query: 437 K 437
           K
Sbjct: 297 K 297

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 15/200 (7%)
Query: 235 VGKGGFGNVYK------GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G F  V K      G       +  +R K           + EV ++    H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           L       T+ +L+   ++ G +   L  K SL              G+ YLH     +I
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QI 135
Query: 349 IHRDVKAANI-LLDEYY---EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
            H D+K  NI LLD         + DFGLA  +D  +      + GT   +APE ++   
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPAFVAPEIVNYEP 193
Query: 405 SSEKTDVFGFGILLLELISG 424
              + D++  G++   L+SG
Sbjct: 194 LGLEADMWSIGVITYILLSG 213

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 25/213 (11%)
Query: 233 NLVGKGGFGNVYKGYLQDGT-----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           +L+G+G +G V K  L   T     V  +K+ K      GE   + E++++    H+N++
Sbjct: 11  DLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG--------LLY 339
           +L+   +   E+  +Y  M           +  LD    KR  +  A G        L Y
Sbjct: 70  QLVDV-LYNEEKQKMYMVMEYCVCG----MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           LH Q    I+H+D+K  N+LL       +   G+A+ L    +  T           P  
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 400 LSTGQ---SSEKTDVFGFGILLLELISGLRALE 429
           ++ G    S  K D++  G+ L  + +GL   E
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 106/240 (44%), Gaps = 21/240 (8%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQT------- 273
           EL +  S ++ +  +  G +G V  G   +G  VA+KR+ +  + G  +   +       
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 274 ---EVEMISLAVHRNLLRL----IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR 326
              E+ +++   H N+L L    + F      +L +   +    +A  +  +  +   + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV--ISP 133
Query: 327 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
           + I       LL LH   +  ++HRD+   NILL +  +  + DF LA+  D  D++ T 
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTH 192
Query: 387 AVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELISGLRALEFGKT-ANQKGAMLDWV 444
            V     + APE +   +   K  D++  G ++ E+ +  +AL  G T  NQ   +++ V
Sbjct: 193 YVTHR-WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQLNKIVEVV 250

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 106/240 (44%), Gaps = 21/240 (8%)
Query: 221 ELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQT------- 273
           EL +  S ++ +  +  G +G V  G   +G  VA+KR+ +  + G  +   +       
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 274 ---EVEMISLAVHRNLLRL----IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR 326
              E+ +++   H N+L L    + F      +L +   +    +A  +  +  +   + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV--ISP 133
Query: 327 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
           + I       LL LH   +  ++HRD+   NILL +  +  + DF LA+  D  D++ T 
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTH 192
Query: 387 AVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELISGLRALEFGKT-ANQKGAMLDWV 444
            V     + APE +   +   K  D++  G ++ E+ +  +AL  G T  NQ   +++ V
Sbjct: 193 YVTHR-WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQLNKIVEVV 250

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 91/226 (40%), Gaps = 24/226 (10%)
Query: 235 VGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG        Q   +VAVK ++ G  I   ++ +  +   SL  H N++R     
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-INHRSLR-HPNIVRFKEVI 84
Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
           +T T   +V  Y S G +  R+           +        G+ Y H     ++ HRD+
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---QVCHRDL 141
Query: 354 KAANILLD--EYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT- 409
           K  N LLD        +  FG +K  + H     T    GT  +IAPE L   +   K  
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV---GTPAYIAPEVLLKKEYDGKVA 198
Query: 410 DVFGFGILLLELISGLRALE-------FGKTA----NQKGAMLDWV 444
           DV+  G+ L  ++ G    E       F KT     N + A+ D+V
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV 244

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 33/216 (15%)
Query: 226 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIG---------GEIQFQTEV 275
           +  +S+ + +G G FG V+    ++    V VK +K    +          G++    E+
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL--EI 80
Query: 276 EMISLAVHRNLLRLI------GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
            ++S   H N+++++      GF     E+     + S   + + +   P LD      I
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEK-----HGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 330 --ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
              L +A G L L +     IIHRD+K  NI++ E +   + DFG A  L+      T  
Sbjct: 136 FRQLVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190
Query: 388 VRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELI 422
             GT+ + APE L        + +++  G+ L  L+
Sbjct: 191 --GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 39/228 (17%)
Query: 229 FSSKNLVGKGGFGNVY--KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           F  ++ +G+G F +VY     LQ G    +  LK        I+   E++ +++A  ++ 
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIA-LKHLIPTSHPIRIAAELQCLTVAGGQDN 81
Query: 287 LRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 345
           +  + +C    + +++  PY+ + S    L    SL +   +   L   + L  +H+   
Sbjct: 82  VMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF-- 136
Query: 346 PKIIHRDVKAANILLDEYYEA-VVGDFGLAK--------LLDHCDSHV------------ 384
             I+HRDVK +N L +   +   + DFGLA+        LL    S              
Sbjct: 137 -GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSI 195
Query: 385 ------TTAVR-GTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISG 424
                   A R GT G  APE L+     +   D++  G++ L L+SG
Sbjct: 196 CLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 9/157 (5%)
Query: 272 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL 331
           + EV ++    H N++ L       T+ +L+   ++ G +   L  K SL          
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANI-LLDEYY---EAVVGDFGLAKLLDHCDSHVTTA 387
               G+ YLH     +I H D+K  NI LLD         + DFGLA  +D  +      
Sbjct: 122 QILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           + GT   +APE ++      + D++  G++   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 15/200 (7%)
Query: 235 VGKGGFGNVYK------GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G F  V K      G       +  +R K           + EV ++    H N++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           L       T+ +L+   ++ G +   L  K SL              G+ YLH     +I
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QI 135
Query: 349 IHRDVKAANI-LLDEYY---EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
            H D+K  NI LLD         + DFGLA  +D  +      + GT   +APE ++   
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEP 193
Query: 405 SSEKTDVFGFGILLLELISG 424
              + D++  G++   L+SG
Sbjct: 194 LGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 15/200 (7%)
Query: 235 VGKGGFGNVYK------GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G F  V K      G       +  +R K           + EV ++    H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           L       T+ +L+   ++ G +   L  K SL              G+ YLH     +I
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QI 134
Query: 349 IHRDVKAANI-LLDEYY---EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
            H D+K  NI LLD         + DFGLA  +D  +      + GT   +APE ++   
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEP 192
Query: 405 SSEKTDVFGFGILLLELISG 424
              + D++  G++   L+SG
Sbjct: 193 LGLEADMWSIGVITYILLSG 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 15/200 (7%)
Query: 235 VGKGGFGNVYK------GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G F  V K      G       +  +R K           + EV ++    H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           L       T+ +L+   ++ G +   L  K SL              G+ YLH     +I
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QI 135
Query: 349 IHRDVKAANI-LLDEYY---EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
            H D+K  NI LLD         + DFGLA  +D  +      + GT   +APE ++   
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEP 193
Query: 405 SSEKTDVFGFGILLLELISG 424
              + D++  G++   L+SG
Sbjct: 194 LGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 15/200 (7%)
Query: 235 VGKGGFGNVYK------GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
           +G G F  V K      G       +  +R K           + EV ++    H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           L       T+ +L+   ++ G +   L  K SL              G+ YLH     +I
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QI 134
Query: 349 IHRDVKAANI-LLDEYY---EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
            H D+K  NI LLD         + DFGLA  +D  +      + GT   +APE ++   
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEP 192
Query: 405 SSEKTDVFGFGILLLELISG 424
              + D++  G++   L+SG
Sbjct: 193 LGLEADMWSIGVITYILLSG 212

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	549
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	0.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-147
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-133
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-78
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-65
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-52
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-51
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-51
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-51
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-50
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-37
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-33
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-33
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-33
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-31
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-29
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-21
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-12
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-32
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-32
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-24
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-24
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-07
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-28
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-28
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-27
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-23
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-07
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-20
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-19
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-19
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-08
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-10
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-08
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-04
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-08
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-09
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-16
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-16
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-16
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-15
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-15
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-09
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-14
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-09
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-12
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-12
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-10
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-13
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-04
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-13
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-04
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-13
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-08
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-13
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-12
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-08
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-12
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-06
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-07
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-10
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-12
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-05
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-12
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-06
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-05
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-05
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-07
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-07
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-09
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-05
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-06
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-05
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-07
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-07
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-05
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-04
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-06
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-05
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-05
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-05
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  570 bits (1471), Expect = 0.0
 Identities = 227/325 (69%), Positives = 265/325 (81%), Gaps = 5/325 (1%)

Query: 198 FFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVK 257
           FFDV  +   EV LG LKRF  +ELQ A+ NFS+KN++G+GGFG VYKG L DGT+VAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60

Query: 258 RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL-- 315
           RLK+    GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L  
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120

Query: 316 --KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 373
             +++P LDW  R+RIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180

Query: 374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 433
           AKL+D+ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELI+G RA +  + 
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240

Query: 434 ANQKGAML-DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMS 492
           AN    ML DWVK + +EKKLE LVD DL+ NY   E+E+++QVALLCTQ  P  RPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300

Query: 493 EVVRMLEGDGLAEKWAASQKAEATR 517
           EVVRMLEGDGLAE+W   QK E  R
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFR 325

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  425 bits (1096), Expect = e-147
 Identities = 116/313 (37%), Positives = 179/313 (57%), Gaps = 23/313 (7%)

Query: 203 EQRREEVCLGNLKRFHFKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAV 256
           E +  EV       F F EL++ T+NF  +      N +G+GGFG VYKGY+ + T VAV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59

Query: 257 KRLKDGNAIG---GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS 313
           K+L     I     + QF  E+++++   H NL+ L+GF     +  LVY YM NGS+  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 314 RL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 370
           RL      P L W  R +IA GAA G+ +LHE      IHRD+K+ANILLDE + A + D
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176

Query: 371 FGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 429
           FGLA+  +    + +T+ + GT  ++APE L  G+ + K+D++ FG++LLE+I+GL A++
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235

Query: 430 FGKTANQKGAMLDWVKKIHQEKK-LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR 488
             +   +   +LD  ++I  E+K +E  +DK + N+ D   +E M  VA  C     + R
Sbjct: 236 EHR---EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKR 291

Query: 489 PKMSEVVRMLEGD 501
           P + +V ++L+  
Sbjct: 292 PDIKKVQQLLQEM 304

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  388 bits (1000), Expect = e-133
 Identities = 112/294 (38%), Positives = 164/294 (55%), Gaps = 10/294 (3%)

Query: 213 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQ 272
              R    +L+ AT+NF  K L+G G FG VYKG L+DG  VA+KR    ++ G E +F+
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE-EFE 83

Query: 273 TEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKR 328
           TE+E +S   H +L+ LIGFC    E +L+Y YM NG++   L        S+ W  R  
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTA 387
           I +GAARGL YLH +    IIHRDVK+ NILLDE +   + DFG++K     D +H++T 
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
           V+GT+G+I PEY   G+ +EK+DV+ FG++L E++    A+           + +W  + 
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAVES 259

Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           H   +LE +VD +L +      L +    A+ C       RP M +V+  LE  
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  247 bits (633), Expect = 5e-78
 Identities = 71/302 (23%), Positives = 116/302 (38%), Gaps = 28/302 (9%)

Query: 221 ELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 280
            L   +       +  +G FG V+K  L     VAVK     +      Q + EV  +  
Sbjct: 18  NLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPG 74

Query: 281 AVHRNLLRLIGFCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
             H N+L+ IG          +  L+  +   GS++  LK    + W     IA   ARG
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARG 133

Query: 337 LLYLHE-------QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAV 388
           L YLHE          P I HRD+K+ N+LL     A + DFGLA   +   S   T   
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193

Query: 389 RGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 443
            GT  ++APE L         +  + D++  G++L EL S   A + G          + 
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD-GPVDEYMLPFEEE 252

Query: 444 VKKIHQEKKLEMLVDKD-----LKNNYDRIE-LEEMVQVALLCTQYLPSLRPKMSEVVRM 497
           + +    + ++ +V        L++ + +   +  + +    C  +    R     V   
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312

Query: 498 LE 499
           + 
Sbjct: 313 IT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  214 bits (547), Expect = 3e-65
 Identities = 72/318 (22%), Positives = 120/318 (37%), Gaps = 41/318 (12%)

Query: 217 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVE 276
               E      N     L+G+G +G VYKG L D   VAVK     N       F  E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKN 57

Query: 277 MISLAV--HRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
           +  + +  H N+ R I            E LLV  Y  NGS+   L    + DW +  R+
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRL 116

Query: 330 ALGAARGLLYLHE------QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--- 380
           A    RGL YLH          P I HRD+ + N+L+      V+ DFGL+  L      
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 381 ----DSHVTTAVRGTVGHIAPEYL-------STGQSSEKTDVFGFGILLLELISGLRALE 429
               + +   +  GT+ ++APE L           + ++ D++  G++  E+      L 
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 430 FGKTANQ-KGAMLDWVKKIHQEKKLEMLVDKD-----LKNNY--DRIELEEMVQVALLCT 481
            G++  + + A    V      + +++LV ++         +  + + +  + +    C 
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

Query: 482 QYLPSLRPKMSEVVRMLE 499
                 R         + 
Sbjct: 297 DQDAEARLTAQXAEERMA 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  193 bits (493), Expect = 2e-57
 Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 33/274 (12%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG V++     G+ VAVK L + +     +  F  EV ++    H N++  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 294 MTTTERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
                  +V  Y+S GS+   L    A+  LD   R  +A   A+G+ YLH   +P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 410
           R++K+ N+L+D+ Y   V DFGL++L        + +  GT   +APE L    S+EK+D
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSD 221

Query: 411 VFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 470
           V+ FG++L EL +                   W   ++  + +  +  K       R+E+
Sbjct: 222 VYSFGVILWELATL---------------QQPW-GNLNPAQVVAAVGFKCK-----RLEI 260

Query: 471 -----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                 ++  +   C    P  RP  + ++ +L 
Sbjct: 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  190 bits (484), Expect = 3e-56
 Identities = 69/283 (24%), Positives = 108/283 (38%), Gaps = 34/283 (12%)

Query: 232 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
             ++GKG FG   K  + + G V+ +K L   +    +  F  EV+++    H N+L+ I
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-ETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 291 GFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G          +  Y+  G++   +        W+ R   A   A G+ YLH      II
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-------------TAVRGTVGHIA 396
           HRD+ + N L+ E    VV DFGLA+L+    +                  V G    +A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 456
           PE ++     EK DVF FGI+L E+I  + A             L+          L+  
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-DYLPRTMDFGLN------VRGFLDRY 243

Query: 457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              +               + + C    P  RP   ++   LE
Sbjct: 244 CPPNC--------PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  189 bits (481), Expect = 5e-56
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 46/288 (15%)

Query: 232 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEI------QFQTEVEMISLAVHR 284
           +  +GKGGFG V+KG  ++D +VVA+K L  G++ G         +FQ EV ++S   H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQ 343
           N+++L G         +V  ++  G +  RL      + W+ + R+ L  A G+ Y+   
Sbjct: 84  NIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-N 140

Query: 344 CDPKIIHRDVKAANILLDEYYEAV-----VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
            +P I+HRD+++ NI L    E       V DFGL++       H  + + G    +APE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPE 196

Query: 399 YLSTGQS--SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML 456
            +   +   +EK D + F ++L  +++G    +   +  +   +              M+
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFI-------------NMI 242

Query: 457 VDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            ++ L     R  +       +  V  LC    P  RP  S +V+ L 
Sbjct: 243 REEGL-----RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  186 bits (474), Expect = 7e-55
 Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 37/273 (13%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           VG+G FG V K   +    VA+K+++  +       F  E+  +S   H N+++L G C+
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERK---AFIVELRQLSRVNHPNIVKLYGACL 71

Query: 295 TT----TERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
                  E      Y   GS+ + L   +  P    A      L  ++G+ YLH      
Sbjct: 72  NPVCLVME------YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 348 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           +IHRD+K  N+LL      + + DFG A  +        T  +G+   +APE       S
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNYS 181

Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 466
           EK DVF +GI+L E+I+  R   F       G     +  +H   +  ++ +        
Sbjct: 182 EKCDVFSWGIILWEVIT--RRKPF---DEIGGPAFRIMWAVHNGTRPPLIKNLP------ 230

Query: 467 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
               + +  +   C    PS RP M E+V+++ 
Sbjct: 231 ----KPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  182 bits (464), Expect = 7e-54
 Identities = 68/279 (24%), Positives = 113/279 (40%), Gaps = 38/279 (13%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNLLRLIG 291
           +G GGFG VY+ +   G  VAVK  +              + E ++ ++  H N++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
            C+      LV  +   G +   L  K  +        A+  ARG+ YLH++    IIHR
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132

Query: 352 DVKAANILLDEYYEAV--------VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
           D+K++NIL+ +  E          + DFGLA+           +  G    +APE +   
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRAS 189

Query: 404 QSSEKTDVFGFGILLLELISGL---RALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 460
             S+ +DV+ +G+LL EL++G    R ++    A                 KL + +   
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA-----------MNKLALPIPST 238

Query: 461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                     E   ++   C    P  RP  + ++  L 
Sbjct: 239 C--------PEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  182 bits (463), Expect = 3e-53
 Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 34/293 (11%)

Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLI 290
             VGKG +G V++G  Q G  VAVK     +    E  +  E E+ +  +  H N+L  I
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFI 68

Query: 291 GFCMTT----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE---- 342
              MT+    T+  L+  Y   GS+   L+   +LD  +  RI L  A GL +LH     
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 343 -QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV---TTAVRGTVGHIAPE 398
            Q  P I HRD+K+ NIL+ +  +  + D GLA +     + +        GT  ++APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 399 ------YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV-KKIHQEK 451
                  +    S ++ D++ FG++L E+    R +  G   + K    D V      E 
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVAR--RMVSNGIVEDYKPPFYDVVPNDPSFED 245

Query: 452 KLEMLVDKDL-----KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             +++             +    L  + ++   C    PS R     + + L 
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  180 bits (458), Expect = 4e-52
 Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 40/296 (13%)

Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLI 290
             +GKG +G V+ G  + G  VAVK          E  +  E E+    +  H N+L  I
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97

Query: 291 GFCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE---- 342
              +    + T+  L+  Y  NGS+   LK   +LD  +  ++A  +  GL +LH     
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLK-STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 343 -QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV---TTAVRGTVGHIAPE 398
            Q  P I HRD+K+ NIL+ +     + D GLA       + V        GT  ++ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 399 ------YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
                   +  QS    D++ FG++L E+     +         +   L +   +  +  
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS-----GGIVEEYQLPYHDLVPSDPS 271

Query: 453 LEMLVDKDLKNNY---------DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            E + +                    L +M ++   C  + P+ R     V + L 
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  177 bits (451), Expect = 1e-51
 Identities = 77/275 (28%), Positives = 126/275 (45%), Gaps = 32/275 (11%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           +G G FG VYKG    G V AVK L        ++Q F+ EV ++    H N+L  +G+ 
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 294 MTTTERL-LVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
             T  +L +V  +    S+   L  ++   +      IA   ARG+ YLH +    IIHR
Sbjct: 90  --TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHR 144

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLSTGQS---SE 407
           D+K+ NI L E     +GDFGLA        SH    + G++  +APE +    S   S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 408 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 467
           ++DV+ FGI+L EL++G                L +    ++++ +EM+    L  +  +
Sbjct: 205 QSDVYAFGIVLYELMTG---------------QLPYSNINNRDQIIEMVGRGSLSPDLSK 249

Query: 468 IEL---EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +     + M ++   C +     RP    ++  +E
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  176 bits (448), Expect = 2e-51
 Identities = 57/279 (20%), Positives = 105/279 (37%), Gaps = 44/279 (15%)

Query: 235 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 293
           + +   G ++KG  Q G  + VK LK  +    + + F  E   + +  H N+L ++G C
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 294 MTTTERLL--VYPYMSNGSVASRL--KAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
            +        +  +M  GS+ + L       +D +   + AL  ARG+ +LH   +P I 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS---S 406
              + + ++++DE   A +    +        S  +         +APE L         
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDTNR 189

Query: 407 EKTDVFGFGILLLELI------SGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 460
              D++ F +LL EL+      + L  +E G     +G        I             
Sbjct: 190 RSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS------------ 237

Query: 461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                       + ++  +C    P+ RPK   +V +LE
Sbjct: 238 ----------PHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  176 bits (448), Expect = 5e-51
 Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 41/285 (14%)

Query: 232 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRL 289
             L+GKG FG VY G +  +   VA++ +        +++ F+ EV       H N++  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +G CM+     ++       ++ S +  AK  LD    ++IA    +G+ YLH +    I
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD----SHVTTAVRGTVGHIAPEYLSTGQ 404
           +H+D+K+ N+  D   + V+ DFGL  +                 G + H+APE +    
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 405 S---------SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 455
                     S+ +DVF  G +  EL +     +      Q    + W            
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-----TQPAEAIIWQ----------- 254

Query: 456 LVDKDLKNNYDRIEL-EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +   +K N  +I + +E+  + L C  +    RP  ++++ MLE
Sbjct: 255 -MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (447), Expect = 1e-50
 Identities = 66/294 (22%), Positives = 117/294 (39%), Gaps = 36/294 (12%)

Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLI 290
             +GKG FG V++G  + G  VAVK          E  +  E E+    +  H N+L  I
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102

Query: 291 GFCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE---- 342
                   T T+  LV  Y  +GS+   L  + ++      ++AL  A GL +LH     
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 343 -QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT---TAVRGTVGHIAPE 398
            Q  P I HRD+K+ NIL+ +     + D GLA   D     +        GT  ++APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 399 YL------STGQSSEKTDVFGFGILLLELISGLRALEFGKT-------ANQKGAMLDWVK 445
            L         +S ++ D++  G++  E+          +               ++ ++
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281

Query: 446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           K+  E+KL   +    ++      + ++++    C     + R     + + L 
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (377), Expect = 3e-40
 Identities = 67/276 (24%), Positives = 112/276 (40%), Gaps = 40/276 (14%)

Query: 236 GKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           G+G FG V+ G L+     VAVK  ++      + +F  E  ++    H N++RLIG C 
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182

Query: 295 TTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                 +V   +  G   + L+     L   T  ++   AA G+ YL  +     IHRD+
Sbjct: 183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDL 239

Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYLSTGQSSEK 408
            A N L+ E     + DFG+++     D        G +  +     APE L+ G+ S +
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEA--DGVYAA--SGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 409 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRI 468
           +DV+ FGILL E  S   +     +  Q                      + ++    R+
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQ--------------------TREFVEKGG-RL 334

Query: 469 EL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                  + + ++   C  Y P  RP  S + + L+
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  142 bits (361), Expect = 1e-38
 Identities = 76/288 (26%), Positives = 120/288 (41%), Gaps = 52/288 (18%)

Query: 233 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
            ++G+G FG VY G L D        AVK L     IG   QF TE  ++    H N+L 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 289 LIGFCMTTTE-RLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 346
           L+G C+ +    L+V PYM +G + + ++    +          L  A+G+ YL  +   
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK--- 147

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYLS 401
           K +HRD+ A N +LDE +   V DFGLA+ +   + +  +    T   +     A E L 
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALESLQ 205

Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEML 456
           T + + K+DV+ FG+LL EL++       G                              
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFD------------------- 240

Query: 457 VDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +   L     R+       + + +V L C      +RP  SE+V  + 
Sbjct: 241 ITVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  142 bits (360), Expect = 2e-38
 Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 27/280 (9%)

Query: 236 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           G+G FG V            G  VAVK LK  +        + E+E++    H N+++  
Sbjct: 30  GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYK 89

Query: 291 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           G C         L+  ++ +GS+   L   K  ++   + + A+   +G+ YL  +   +
Sbjct: 90  GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---Q 146

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQ 404
            +HRD+ A N+L++  ++  +GDFGL K +   D    T        +   APE L   +
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPECLMQSK 205

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 464
               +DV+ FG+ L EL++      +  + +   A+   +      +     +   LK  
Sbjct: 206 FYIASDVWSFGVTLHELLT------YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259

Query: 465 YDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             R+       +E+ Q+   C ++ PS R     ++   E
Sbjct: 260 K-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  141 bits (358), Expect = 2e-38
 Identities = 64/266 (24%), Positives = 109/266 (40%), Gaps = 33/266 (12%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLIG 291
            +G+G F  VYKG   +    VA   L+D      E  +F+ E EM+    H N++R   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 292 FCMTTTE---RLLVYP-YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
              +T +    +++    M++G++ + LK    +     +       +GL +LH    P 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPP 151

Query: 348 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           IIHRD+K  NI +     +V +GD GLA L     +    AV GT   +APE        
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEEK-YD 207

Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK---LEMLVDKDLKN 463
           E  DV+ FG+ +LE+ +           ++        +++    K    + +   ++K 
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDKVAIPEVK- 260

Query: 464 NYDRIELEEMVQVALLCTQYLPSLRP 489
             + IE          C +     R 
Sbjct: 261 --EIIE---------GCIRQNKDERY 275

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  139 bits (353), Expect = 2e-37
 Identities = 68/282 (24%), Positives = 112/282 (39%), Gaps = 33/282 (11%)

Query: 236 GKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           G+G FG V            G +VAVK LK          ++ E++++    H ++++  
Sbjct: 40  GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYK 99

Query: 291 GFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           G C         LV  Y+  GS+   L  + S+  A     A     G+ YLH Q     
Sbjct: 100 GCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQ---HY 155

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLST 402
           IHRD+ A N+LLD      +GDFGLAK +     +      G           APE L  
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----APECLKE 211

Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 462
            +    +DV+ FG+ L EL++         ++         +  I Q +   + + + L+
Sbjct: 212 YKFYYASDVWSFGVTLYELLT------HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265

Query: 463 NNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
               R+        E+  +   C +   S RP    ++ +L+
Sbjct: 266 RGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  139 bits (352), Expect = 2e-37
 Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 52/289 (17%)

Query: 232 KNLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
             ++GKG FG VY G   D        A+K L     +     F  E  ++    H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 288 RLIGFCMTTTERLL-VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 345
            LIG  +        + PYM +G +   +++ + +          L  ARG+ YL EQ  
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ-- 143

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYL 400
            K +HRD+ A N +LDE +   V DFGLA+ +   +    +  +     +     A E L
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKWTALESL 200

Query: 401 STGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEM 455
            T + + K+DV+ FG+LL EL++       G                             
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT------RGAPPYRHIDPFD------------------ 236

Query: 456 LVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +   L     R+       + + QV   C +  P++RP    +V  +E
Sbjct: 237 -LTHFLAQGR-RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  140 bits (355), Expect = 3e-37
 Identities = 75/288 (26%), Positives = 118/288 (40%), Gaps = 52/288 (18%)

Query: 233 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
            ++G+G FG VY G L D        AVK L     IG   QF TE  ++    H N+L 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 289 LIGFCMTTTE-RLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 346
           L+G C+ +    L+V PYM +G + + ++    +          L  A+G+ +L  +   
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK--- 211

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYLS 401
           K +HRD+ A N +LDE +   V DFGLA+ +   +         T   +     A E L 
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALESLQ 269

Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEML 456
           T + + K+DV+ FG+LL EL++       G                              
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFD------------------- 304

Query: 457 VDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +   L     R+       + + +V L C      +RP  SE+V  + 
Sbjct: 305 ITVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  138 bits (350), Expect = 5e-37
 Identities = 71/299 (23%), Positives = 123/299 (41%), Gaps = 64/299 (21%)

Query: 232 KNLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 286
             ++G+G FG+V +G L+        VAVK +K  N+   EI+ F +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 287 LRLIGFC-----MTTTERLLVYPYMSNGSVASRLKA------KPSLDWATRKRIALGAAR 335
           +RL+G C         + +++ P+M  G + + L           +   T  +  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRG 390
           G+ YL  +     +HRD+ A N +L +     V DFGL+K +   D +         V+ 
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVK 445
                A E L+    + K+DV+ FG+ + E+ +       G T      N          
Sbjct: 216 I----AIESLADRVYTSKSDVWAFGVTMWEIAT------RGMTPYPGVQNH--------- 256

Query: 446 KIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                   EM     L + + R++     L+E+ ++   C +  P  RP  S +   LE
Sbjct: 257 --------EMY--DYLLHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  137 bits (346), Expect = 1e-36
 Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 29/281 (10%)

Query: 236 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           GKG FG+V            G VVAVK+L+          F+ E+E++    H N+++  
Sbjct: 19  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 291 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           G C +   R   L+  Y+  GS+   L+  K  +D     +      +G+ YL  +   +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---R 134

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQ 404
            IHRD+   NIL++      +GDFGL K+L   D             I   APE L+  +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPESLTESK 193

Query: 405 SSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 463
            S  +DV+ FG++L EL +   ++        +        + I         + + LKN
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------LIELLKN 247

Query: 464 NYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           N  R+       +E+  +   C     + RP   ++   ++
Sbjct: 248 NG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  137 bits (347), Expect = 2e-36
 Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 29/281 (10%)

Query: 236 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           GKG FG+V            G VVAVK+L+          F+ E+E++    H N+++  
Sbjct: 50  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYK 108

Query: 291 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           G C +   R   L+  Y+  GS+   L+  K  +D     +      +G+ YL  +   +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---R 165

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQ 404
            IHRD+   NIL++      +GDFGL K+L   D             I   APE L+  +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPESLTESK 224

Query: 405 SSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 463
            S  +DV+ FG++L EL +   ++        +        + I         + + LKN
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------LIELLKN 278

Query: 464 NYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           N  R+       +E+  +   C     + RP   ++   ++
Sbjct: 279 NG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  137 bits (347), Expect = 2e-36
 Identities = 56/285 (19%), Positives = 109/285 (38%), Gaps = 55/285 (19%)

Query: 236 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           G G FG VYKG            VA+K L++  +     +   E  +++   + ++ RL+
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G C  T+   L+   M  G +   ++  K ++         +  A+G+ YL ++   +++
Sbjct: 84  GIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLV 139

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 404
           HRD+ A N+L+       + DFGLAKLL   +           ++      A E +    
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRI 195

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 459
            + ++DV+ +G+ + EL++      FG          +                   +  
Sbjct: 196 YTHQSDVWSYGVTVWELMT------FGSKPYDGIPASE-------------------ISS 230

Query: 460 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L+    R+        ++  +   C       RPK  E++    
Sbjct: 231 ILEKGE-RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  137 bits (346), Expect = 2e-36
 Identities = 69/326 (21%), Positives = 118/326 (36%), Gaps = 66/326 (20%)

Query: 236 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLI 290
           GKG FG+V +  L+        VAVK LK       +I+ F  E   +    H ++ +L+
Sbjct: 32  GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91

Query: 291 GFC------MTTTERLLVYPYMSNGSVASRLKA------KPSLDWATRKRIALGAARGLL 338
           G              +++ P+M +G + + L A        +L   T  R  +  A G+ 
Sbjct: 92  GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVG 393
           YL  +     IHRD+ A N +L E     V DFGL++ +   D +         V+    
Sbjct: 152 YLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL-- 206

Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIH 448
             A E L+    +  +DV+ FG+ + E+++       G+T      N +           
Sbjct: 207 --ALESLADNLYTVHSDVWAFGVTMWEIMT------RGQTPYAGIENAE----------- 247

Query: 449 QEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL 503
                   +   L     R++      EE+  +   C    P  RP  + +   LE + L
Sbjct: 248 --------IYNYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE-NIL 297

Query: 504 AEKWAASQKAEATRSRANEFSSSERY 529
                 S   +              +
Sbjct: 298 GHLSVLSTSQDPLYINIERAHHHHHH 323

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  135 bits (342), Expect = 9e-36
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 34/283 (12%)

Query: 236 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           GKG FG+V            G +VAVK+L+       +  FQ E++++       +++  
Sbjct: 32  GKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 291 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           G       +   LV  Y+ +G +   L+  +  LD +     +    +G+ YL  +   +
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---R 147

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLS 401
            +HRD+ A NIL++      + DFGLAKLL     +      G           APE LS
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----APESLS 203

Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 461
               S ++DV+ FG++L EL +      +   +    A    +    ++      + + L
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257

Query: 462 KNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +    R+        E+ ++  LC    P  RP  S +   L+
Sbjct: 258 EEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  134 bits (339), Expect = 2e-35
 Identities = 61/325 (18%), Positives = 119/325 (36%), Gaps = 56/325 (17%)

Query: 236 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           G G FG VYKG            VA+K L++  +     +   E  +++   + ++ RL+
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G C  T+   L+   M  G +   ++  K ++         +  A+G+ YL ++   +++
Sbjct: 84  GIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLV 139

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 404
           HRD+ A N+L+       + DFGLAKLL   +           ++      A E +    
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRI 195

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 459
            + ++DV+ +G+ + EL++      FG          +                   +  
Sbjct: 196 YTHQSDVWSYGVTVWELMT------FGSKPYDGIPASE-------------------ISS 230

Query: 460 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAE 514
            L+    R+        ++  + + C       RPK  E++         +         
Sbjct: 231 ILEKGE-RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS-KMARDPQRYLVIQG 288

Query: 515 ATRSRANEFSSSERYSDLTDDSSLL 539
             R      + S  Y  L D+  + 
Sbjct: 289 DERMHLPSPTDSNFYRALMDEEDMD 313

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  136 bits (344), Expect = 4e-35
 Identities = 73/280 (26%), Positives = 114/280 (40%), Gaps = 34/280 (12%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
            +   +  +G+G FG V+ G     T VA+K LK G        F  E +++    H  L
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 241

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQC 344
           ++L     +     +V  YMS GS+   LK +    L       +A   A G+ Y+    
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 299

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
               +HRD++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+
Sbjct: 300 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 464
            + K+DV+ FGILL EL +  R    G    +                    V   ++  
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------------------VLDQVERG 397

Query: 465 YDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           Y R+       E +  +   C +  P  RP    +   LE
Sbjct: 398 Y-RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  136 bits (343), Expect = 1e-34
 Identities = 73/271 (26%), Positives = 111/271 (40%), Gaps = 34/271 (12%)

Query: 236 GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 295
           G+G FG V+ G     T VA+K LK G        F  E +++    H  L++L     +
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV-S 332

Query: 296 TTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                +V  YMS GS+   LK +    L       +A   A G+ Y+        +HRD+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 389

Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
           +AANIL+ E     V DFGLA+L++  +       +  +   APE    G+ + K+DV+ 
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449

Query: 414 FGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL--- 470
           FGILL EL +  R    G    +                    V   ++  Y R+     
Sbjct: 450 FGILLTELTTKGRVPYPGMVNRE--------------------VLDQVERGY-RMPCPPE 488

Query: 471 --EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             E +  +   C +  P  RP    +   LE
Sbjct: 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  128 bits (325), Expect = 8e-34
 Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 57/285 (20%)

Query: 236 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           G+G FG VY+G   +       VAVK  K    +  + +F +E  ++    H ++++LIG
Sbjct: 21  GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
                    ++      G +   L+  K SL   T    +L   + + YL        +H
Sbjct: 81  II-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVH 136

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLSTGQ 404
           RD+   NIL+       +GDFGL++ ++  D     A              +PE ++  +
Sbjct: 137 RDIAVRNILVASPECVKLGDFGLSRYIE--DEDYYKASVTRLPIKWM----SPESINFRR 190

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 459
            +  +DV+ F + + E++S      FGK       N+                    V  
Sbjct: 191 FTTASDVWMFAVCMWEILS------FGKQPFFWLENKD-------------------VIG 225

Query: 460 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            L+    R+         +  +   C  Y PS RP+ +E+V  L 
Sbjct: 226 VLEKGD-RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  128 bits (325), Expect = 9e-34
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 232 KNLVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 288
              +G G FG+V +G  +       VA+K LK G       +   E +++    +  ++R
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           LIG C      +LV      G +   L   +  +  +    +    + G+ YL E+    
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLS 401
            +HRD+ A N+LL   + A + DFGL+K L   DS+ T    G           APE ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECIN 186

Query: 402 TGQSSEKTDVFGFGILLLELIS 423
             + S ++DV+ +G+ + E +S
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALS 208

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  129 bits (327), Expect = 1e-33
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 19/199 (9%)

Query: 236 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           G G FG V+KG            V +K ++D +           +  I    H +++RL+
Sbjct: 22  GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLL 81

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G C   +   LV  Y+  GS+   ++  + +L         +  A+G+ YL E     ++
Sbjct: 82  GLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMV 137

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 404
           HR++ A N+LL    +  V DFG+A LL   D  +  +     ++      A E +  G+
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----ALESIHFGK 193

Query: 405 SSEKTDVFGFGILLLELIS 423
            + ++DV+ +G+ + EL++
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  127 bits (322), Expect = 2e-33
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 57/285 (20%)

Query: 236 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LIG
Sbjct: 24  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
              T     ++    + G + S L+  K SLD A+    A   +  L YL  +   + +H
Sbjct: 84  VI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVH 139

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLSTGQ 404
           RD+ A N+L+       +GDFGL++ ++  DS    A +G           APE ++  +
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWM----APESINFRR 193

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 459
            +  +DV+ FG+ + E++        G        N                     V  
Sbjct: 194 FTSASDVWMFGVCMWEILM------HGVKPFQGVKNND-------------------VIG 228

Query: 460 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            ++N   R+ +       +  +   C  Y PS RP+ +E+   L 
Sbjct: 229 RIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  132 bits (333), Expect = 2e-33
 Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 36/273 (13%)

Query: 236 GKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIGFC 293
           G G +G VY+G  +  ++ VAVK LK+        +F  E   M  +  H NL++L+G C
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIK-HPNLVQLLGVC 285

Query: 294 MTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
                  ++  +M+ G++   L+   +  +       +A   +  + YL ++     IHR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHR 342

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 411
           ++ A N L+ E +   V DFGL++L+           +  +   APE L+  + S K+DV
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402

Query: 412 FGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL- 470
           + FG+LL E+ +   +   G   +Q                    V + L+ +Y R+E  
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQ--------------------VYELLEKDY-RMERP 441

Query: 471 ----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
               E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  128 bits (324), Expect = 2e-33
 Identities = 62/290 (21%), Positives = 124/290 (42%), Gaps = 54/290 (18%)

Query: 236 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G+G FG VY+G  +        T VA+K + +  ++   I+F  E  ++      +++RL
Sbjct: 34  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAK-------PSLDWATRKR---IALGAARGLLY 339
           +G        L++   M+ G + S L++        P L   +  +   +A   A G+ Y
Sbjct: 94  LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 153

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---- 395
           L+     K +HRD+ A N ++ E +   +GDFG+ + +   D       +G  G +    
Sbjct: 154 LNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRW 206

Query: 396 -APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE 454
            +PE L  G  +  +DV+ FG++L E+ +        +               +Q    E
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQP-------------YQGLSNE 247

Query: 455 MLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            ++   +      ++      + + ++  +C QY P +RP   E++  ++
Sbjct: 248 QVLRF-VMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  129 bits (326), Expect = 3e-33
 Identities = 72/304 (23%), Positives = 116/304 (38%), Gaps = 73/304 (24%)

Query: 236 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNL 286
           G+G FG V                  VAVK LKD           +E+E M  +  H+N+
Sbjct: 90  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRK-----------RIA 330
           + L+G C       ++  Y S G++     A R           R               
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 387
              ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  T    
Sbjct: 210 YQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266

Query: 388 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAM 440
             V+      APE L     + ++DV+ FG+L+ E+ +       G +       ++   
Sbjct: 267 LPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEE--- 313

Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVV 495
                           + K LK  + R++       E+  +   C   +PS RP   ++V
Sbjct: 314 ----------------LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356

Query: 496 RMLE 499
             L+
Sbjct: 357 EDLD 360

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  130 bits (330), Expect = 4e-33
 Identities = 72/288 (25%), Positives = 112/288 (38%), Gaps = 54/288 (18%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
                   +GKG FG+V  G  + G  VAVK +K+         F  E  +++   H NL
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNL 248

Query: 287 LRLIGFCMTTTERLLVY---PYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYLH 341
           ++L+G      E+  +Y    YM+ GS+    R + +  L      + +L     + YL 
Sbjct: 249 VQLLGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
                  +HRD+ A N+L+ E   A V DFGL K            V+ T    APE L 
Sbjct: 307 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALR 359

Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEML 456
             + S K+DV+ FGILL E+ S      FG+        +                    
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS------FGRVPYPRIPLKD------------------- 394

Query: 457 VDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           V   ++  Y +++        +  V   C     + RP   ++   LE
Sbjct: 395 VVPRVEKGY-KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (335), Expect = 4e-33
 Identities = 64/285 (22%), Positives = 116/285 (40%), Gaps = 57/285 (20%)

Query: 236 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           G+G FG+V++G           VA+K  K+  +     +F  E   +    H ++++LIG
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 458

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
              T     ++    + G + S L+  K SLD A+    A   +  L YL  +   + +H
Sbjct: 459 VI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVH 514

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA------VRGTVGHIAPEYLSTGQ 404
           RD+ A N+L+       +GDFGL++ ++  DS    A      ++      APE ++  +
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWM----APESINFRR 568

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 459
            +  +DV+ FG+ + E++        G        N                     V  
Sbjct: 569 FTSASDVWMFGVCMWEILM------HGVKPFQGVKNND-------------------VIG 603

Query: 460 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            ++N   R+ +       +  +   C  Y PS RP+ +E+   L 
Sbjct: 604 RIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  126 bits (318), Expect = 4e-33
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 48/287 (16%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           S  +    +G G FG V+ GY  +   VA+K +++G     E  F  E E++    H  L
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKL 65

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 345
           ++L G C+      LV  +M +G ++  L+  +      T   + L    G+ YL E   
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-- 123

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLST 402
             +IHRD+ A N L+ E     V DFG+ + +        T+  GT   +   +PE  S 
Sbjct: 124 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSF 179

Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLV 457
            + S K+DV+ FG+L+ E+ S       GK      +N +                   V
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFS------EGKIPYENRSNSE-------------------V 214

Query: 458 DKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +D+   + R+         + Q+   C +  P  RP  S ++R L 
Sbjct: 215 VEDISTGF-RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  132 bits (333), Expect = 5e-33
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 10/194 (5%)

Query: 236 GKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           G G FG+V +G  +       VA+K LK G       +   E +++    +  ++RLIG 
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404

Query: 293 CMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
           C      +LV      G +   L   +  +  +    +    + G+ YL E+     +HR
Sbjct: 405 C-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHR 460

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSSEKT 409
           ++ A N+LL   + A + DFGL+K L   DS+ T    G   +   APE ++  + S ++
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 520

Query: 410 DVFGFGILLLELIS 423
           DV+ +G+ + E +S
Sbjct: 521 DVWSYGVTMWEALS 534

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  127 bits (321), Expect = 6e-33
 Identities = 29/85 (34%), Positives = 50/85 (58%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           +   NN+ G IP  I KL++L  L +++   +G IP  +S ++TL  L  + N+L+G +P
Sbjct: 83  IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPS 113
           PS+S++  L  +    N +SG +P 
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPD 167

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  127 bits (321), Expect = 6e-33
 Identities = 27/114 (23%), Positives = 42/114 (36%), Gaps = 11/114 (9%)

Query: 25  SFGRL------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 78
           +F  L      L  N + G      G       + L+ N     +   V   + L  L L
Sbjct: 193 TFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDL 251

Query: 79  NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNSLIC 128
            NN + G +P  L+ +  L  L++S+NNL G +P               N  +C
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  122 bits (309), Expect = 2e-31
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 8/97 (8%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 77
           +  +L       + + N+SG IP  + ++  L+TLD S N  +G +P ++S L  L  + 
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155

Query: 78  LNNNSLTGAIPPSLSNMSQLA-FLDLSYNNLSGPVPS 113
            + N ++GAIP S  + S+L   + +S N L+G +P 
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  116 bits (294), Expect = 2e-29
 Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 9/97 (9%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL-QYL 76
              ++          N +SG +P  I  L  L+ +    N  +G IP +      L   +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179

Query: 77  RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 113
            ++ N LTG IPP+ +N++ LAF+DLS N L G    
Sbjct: 180 TISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV 215

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 27/86 (31%), Positives = 49/86 (56%), Gaps = 3/86 (3%)

Query: 32  NNNISGHIPTEIGKLSKLLTLDLSNNFFTG--PIPSTVSHLETLQYLRL-NNNSLTGAIP 88
           N    G +     +  ++  LDLS        PIPS++++L  L +L +   N+L G IP
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSF 114
           P+++ ++QL +L +++ N+SG +P F
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIPDF 120

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 66.8 bits (164), Expect = 3e-12
 Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 12/100 (12%)

Query: 39  IPTEIGKLSKL----LTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG--AIPPSLS 92
           I  ++G  + L     T D  N  + G +  T +    +  L L+  +L     IP SL+
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 93  NMSQLAFLDLS-YNNLSGPVPSFHAK-----TFNITGNSL 126
           N+  L FL +   NNL GP+P   AK        IT  ++
Sbjct: 74  NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  126 bits (318), Expect = 7e-33
 Identities = 70/279 (25%), Positives = 109/279 (39%), Gaps = 44/279 (15%)

Query: 236 GKGGFGNVYKGYLQDG---TVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           G G FG V KGY Q       VAVK LK+  N    + +   E  ++    +  ++R+IG
Sbjct: 26  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
            C      +LV      G +   L+    +       +    + G+ YL E      +HR
Sbjct: 86  IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHR 141

Query: 352 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLSTGQS 405
           D+ A N+LL   + A + DFGL+K L   +++      G           APE ++  + 
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINYYKF 197

Query: 406 SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 465
           S K+DV+ FG+L+ E  S      +G+          +      E      V   L+   
Sbjct: 198 SSKSDVWSFGVLMWEAFS------YGQKP--------YRGMKGSE------VTAMLEKGE 237

Query: 466 DRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            R+        EM  +  LC  Y    RP  + V   L 
Sbjct: 238 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  127 bits (320), Expect = 8e-33
 Identities = 73/295 (24%), Positives = 115/295 (38%), Gaps = 64/295 (21%)

Query: 236 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R 
Sbjct: 39  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKA-------KPSLDWATRKRIALGAARGLLYLHE 342
           IG  + +  R ++   M+ G + S L+          SL       +A   A G  YL E
Sbjct: 99  IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 158

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVV---GDFGLAKLLDHCDSHVTTAVRGTVGHI---- 395
                 IHRD+ A N LL       V   GDFG+A+ +           +G    +    
Sbjct: 159 N---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAMLPVKW 211

Query: 396 -APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQ 449
             PE    G  + KTD + FG+LL E+ S       G       +NQ+            
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS------LGYMPYPSKSNQE------------ 253

Query: 450 EKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                  V + + +   R++        + ++   C Q+ P  RP  + ++  +E
Sbjct: 254 -------VLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  125 bits (316), Expect = 8e-33
 Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 52/289 (17%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
              +    +G G FG V  G  +    VAVK +K+G+    E +F  E + +    H  L
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKL 65

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 345
           ++  G C       +V  Y+SNG + + L++    L+ +    +      G+ +L     
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH-- 123

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYL 400
            + IHRD+ A N L+D      V DFG+ + +   D +V++      V+ +    APE  
Sbjct: 124 -QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWS----APEVF 177

Query: 401 STGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEM 455
              + S K+DV+ FGIL+ E+ S       GK       N +                  
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS------LGKMPYDLYTNSE------------------ 213

Query: 456 LVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            V   +   + R+       + + Q+   C   LP  RP   +++  +E
Sbjct: 214 -VVLKVSQGH-RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  125 bits (317), Expect = 1e-32
 Identities = 66/203 (32%), Positives = 86/203 (42%), Gaps = 25/203 (12%)

Query: 236 GKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQ--FQTEVE-MISLAVHRNLLR 288
           G G FG V +G           VAVK LK       E    F  EV  M SL  HRNL+R
Sbjct: 27  GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIR 85

Query: 289 LIGFCMTTTERL-LVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 346
           L G     T  + +V      GS+  RL+  +      T  R A+  A G+ YL  +   
Sbjct: 86  LYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--- 140

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYL 400
           + IHRD+ A N+LL       +GDFGL + L   D H                  APE L
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----APESL 196

Query: 401 STGQSSEKTDVFGFGILLLELIS 423
            T   S  +D + FG+ L E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  127 bits (320), Expect = 1e-32
 Identities = 71/304 (23%), Positives = 119/304 (39%), Gaps = 73/304 (24%)

Query: 236 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNL 286
           G+G FG V                  VAVK LKD           +E+E M  +  H+N+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIA 330
           + L+G C       ++  Y S G++   L+A+                  + +       
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 387
              ARG+ YL  Q   K IHRD+ A N+L+ E     + DFGLA+ +++ D +  T    
Sbjct: 164 YQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220

Query: 388 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAM 440
             V+      APE L     + ++DV+ FG+L+ E+ +       G +       ++   
Sbjct: 221 LPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEE--- 267

Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVV 495
                           + K LK  + R++       E+  +   C   +PS RP   ++V
Sbjct: 268 ----------------LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

Query: 496 RMLE 499
             L+
Sbjct: 311 EDLD 314

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  125 bits (315), Expect = 2e-32
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 12/201 (5%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
            + +    +G G FG V  G  +    VA+K +K+G+    E +F  E +++    H  L
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKL 81

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 345
           ++L G C       ++  YM+NG + + L+  +          +       + YL  +  
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLST 402
            + +HRD+ A N L+++     V DFGL++ +        T+  G+   +    PE L  
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMY 195

Query: 403 GQSSEKTDVFGFGILLLELIS 423
            + S K+D++ FG+L+ E+ S
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYS 216

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  128 bits (323), Expect = 3e-32
 Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 50/279 (17%)

Query: 236 GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 295
           G G FG V+       T VAVK +K G+       F  E  ++    H  L++L     T
Sbjct: 197 GAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVV-T 253

Query: 296 TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
                ++  +M+ GS+   LK+              +   A G+ ++ ++     IHRD+
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDL 310

Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQSSEKTD 410
           +AANIL+       + DFGLA+++   + +  TA  G    I   APE ++ G  + K+D
Sbjct: 311 RAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 411 VFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 465
           V+ FGILL+E+++      +G+      +N +                   V + L+  Y
Sbjct: 368 VWSFGILLMEIVT------YGRIPYPGMSNPE-------------------VIRALERGY 402

Query: 466 DRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            R+       EE+  + + C +  P  RP    +  +L+
Sbjct: 403 -RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  124 bits (313), Expect = 3e-32
 Identities = 81/291 (27%), Positives = 126/291 (43%), Gaps = 56/291 (19%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
                   +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQC 344
           +RL     T     ++  YM NGS+   LK      L       +A   A G+ ++ E+ 
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA------VRGTVGHIAPE 398
               IHRD++AANIL+ +     + DFGLA+L++  D+  T        ++ T    APE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWT----APE 180

Query: 399 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKL 453
            ++ G  + K+DV+ FGILL E+++       G+       N +                
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT------HGRIPYPGMTNPE---------------- 218

Query: 454 EMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              V ++L+  Y R+       EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 219 ---VIQNLERGY-RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  125 bits (316), Expect = 3e-32
 Identities = 71/285 (24%), Positives = 119/285 (41%), Gaps = 54/285 (18%)

Query: 236 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           G G  G V  G L+        VA+K LK G        F +E  ++    H N++RL G
Sbjct: 58  GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
                   ++V  YM NGS+ + L+             +  G   G+ YL +      +H
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVH 174

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 404
           RD+ A N+L+D      V DFGL+++L D  D+  TT      +R T    APE ++   
Sbjct: 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAFRT 230

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDK 459
            S  +DV+ FG+++ E+++      +G+       N+                    V  
Sbjct: 231 FSSASDVWSFGVVMWEVLA------YGERPYWNMTNRD-------------------VIS 265

Query: 460 DLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            ++  Y R+         + Q+ L C     + RP+ S++V +L+
Sbjct: 266 SVEEGY-RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  125 bits (316), Expect = 3e-32
 Identities = 70/303 (23%), Positives = 124/303 (40%), Gaps = 71/303 (23%)

Query: 232 KNLVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
           ++++G+G FG V K  ++        A+KR+K+  +      F  E+E +  L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK----------------RIAL 331
            L+G C       L   Y  +G++   L+    L+                       A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
             ARG+ YL ++   + IHRD+ A NIL+ E Y A + DFGL++  +         V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 199

Query: 392 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAML 441
           +G +     A E L+    +  +DV+ +G+LL E++S       G T        +    
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAE---- 249

Query: 442 DWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVR 496
                          + + L   Y R+E      +E+  +   C +  P  RP  ++++ 
Sbjct: 250 ---------------LYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293

Query: 497 MLE 499
            L 
Sbjct: 294 SLN 296

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  124 bits (313), Expect = 7e-32
 Identities = 70/304 (23%), Positives = 115/304 (37%), Gaps = 73/304 (24%)

Query: 236 GKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 288
           G+G FG V +              VAVK LK+G          +E++ +I +  H N++ 
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95

Query: 289 LIGFCMTTTE-RLLVYPYMSNGSV-----ASRLKAKPSLDWATRKR-----------IAL 331
           L+G C       +++  +   G++     + R +  P                     + 
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155

Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA---- 387
             A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V       
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212

Query: 388 -VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT------ANQKGAM 440
            ++      APE +     + ++DV+ FG+LL E+ S       G +       +++   
Sbjct: 213 PLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEE--- 259

Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVV 495
                             + LK    R+        EM Q  L C    PS RP  SE+V
Sbjct: 260 ----------------FCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302

Query: 496 RMLE 499
             L 
Sbjct: 303 EHLG 306

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  124 bits (314), Expect = 2e-31
 Identities = 73/304 (24%), Positives = 116/304 (38%), Gaps = 73/304 (24%)

Query: 236 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNL 286
           G+G FG V                T VAVK LK            +E+E M  +  H+N+
Sbjct: 78  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRK-----------RIA 330
           + L+G C       ++  Y S G++     A R          +               A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 387
              ARG+ YL  +   K IHRD+ A N+L+ E     + DFGLA+ + H D +  T    
Sbjct: 198 YQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254

Query: 388 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAM 440
             V+      APE L     + ++DV+ FG+LL E+ +       G +       ++   
Sbjct: 255 LPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEE--- 301

Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVV 495
                           + K LK  + R++       E+  +   C   +PS RP   ++V
Sbjct: 302 ----------------LFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344

Query: 496 RMLE 499
             L+
Sbjct: 345 EDLD 348

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  122 bits (308), Expect = 2e-31
 Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 64/293 (21%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
                   +GKG FG+V  G  + G  VAVK +K+         F  E  +++   H NL
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNL 76

Query: 287 LRLIGFCMTTTERLLVY---PYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYLH 341
           ++L+G      E+  +Y    YM+ GS+    R + +  L      + +L     + YL 
Sbjct: 77  VQLLGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIA 396
                  +HRD+ A N+L+ E   A V DFGL K     ++  T       V+ T    A
Sbjct: 135 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWT----A 182

Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEK 451
           PE L   + S K+DV+ FGILL E+ S      FG+        +               
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS------FGRVPYPRIPLKD-------------- 222

Query: 452 KLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                V   ++  Y +++        + +V   C     ++RP   ++   LE
Sbjct: 223 -----VVPRVEKGY-KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  123 bits (311), Expect = 2e-31
 Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 55/286 (19%)

Query: 236 GKGGFGNVYKGYLQDGTV-----VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           G G FG VYKG L+  +      VA+K LK G      + F  E  ++    H N++RL 
Sbjct: 53  GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
           G        +++  YM NG++   L+             +  G A G+ YL        +
Sbjct: 113 GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYV 169

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTA-----VRGTVGHIAPEYLSTG 403
           HRD+ A NIL++      V DFGL+++L D  ++  TT+     +R T    APE +S  
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISYR 225

Query: 404 QSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVD 458
           + +  +DV+ FGI++ E+++      +G+      +N +                   V 
Sbjct: 226 KFTSASDVWSFGIVMWEVMT------YGERPYWELSNHE-------------------VM 260

Query: 459 KDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           K + + + R+         + Q+ + C Q   + RPK +++V +L+
Sbjct: 261 KAINDGF-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  124 bits (312), Expect = 2e-31
 Identities = 73/295 (24%), Positives = 115/295 (38%), Gaps = 64/295 (21%)

Query: 236 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G G FG VY+G +           VAVK L +  +   E+ F  E  +IS   H+N++R 
Sbjct: 80  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKA-------KPSLDWATRKRIALGAARGLLYLHE 342
           IG  + +  R ++   M+ G + S L+          SL       +A   A G  YL E
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 199

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVV---GDFGLAKLLDHCDSHVTTAVRGTVGHI---- 395
                 IHRD+ A N LL       V   GDFG+A+ +           +G    +    
Sbjct: 200 N---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAMLPVKW 252

Query: 396 -APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQ 449
             PE    G  + KTD + FG+LL E+ S       G       +NQ+            
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS------LGYMPYPSKSNQE------------ 294

Query: 450 EKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                  V + + +   R++        + ++   C Q+ P  RP  + ++  +E
Sbjct: 295 -------VLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  124 bits (312), Expect = 2e-31
 Identities = 84/333 (25%), Positives = 139/333 (41%), Gaps = 56/333 (16%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
           +N S   +VG G FG V  G L+        VA+K LK G        F  E  ++    
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLH 341
           H N++RL G    +   ++V  YM NGS+ S L+             +  G A G+ YL 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTA-----VRGTVGHI 395
           +      +HRD+ A NIL++      V DFGL ++L D  ++  TT      +R T    
Sbjct: 165 DM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT---- 217

Query: 396 APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQE 450
           +PE ++  + +  +DV+ +GI+L E++S      +G+      +NQ              
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSNQD------------- 258

Query: 451 KKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAE 505
                 V K +   Y R+         + Q+ L C Q   + RPK  ++V +L  D L  
Sbjct: 259 ------VIKAVDEGY-RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL--DKLIR 309

Query: 506 KWAASQKAEATRSRANEFSSSERYSDLTDDSSL 538
              + +   +  +R +     +   D+T   + 
Sbjct: 310 NPGSLKIITSAAARPSNLLLDQSNVDITTFRTT 342

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  122 bits (309), Expect = 3e-31
 Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 58/295 (19%)

Query: 236 GKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 288
           G G FG V +              VAVK LK       +    +E++ M  L  H N++ 
Sbjct: 55  GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAK--------------PSLDWATRKRIALGAA 334
           L+G C      L++  Y   G + + L+ K               +         +   A
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VR 389
           +G+ +L  +     IHRDV A N+LL   + A +GDFGLA+ + +  +++        V+
Sbjct: 175 QGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231

Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 449
                 APE +     + ++DV+ +GILL E+ S       G      G +      ++ 
Sbjct: 232 WM----APESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYP-GIL------VNS 274

Query: 450 EKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +        K +K+ Y ++       + +  +   C    P+ RP   ++   L+
Sbjct: 275 K------FYKLVKDGY-QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  121 bits (305), Expect = 4e-31
 Identities = 71/282 (25%), Positives = 129/282 (45%), Gaps = 54/282 (19%)

Query: 236 GKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           G G +G VY+G  +  ++ VAVK LK+        +F  E  ++    H NL++L+G C 
Sbjct: 22  GGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 295 TTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 352
                 ++  +M+ G++   L+   +  +       +A   +  + YL ++     IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136

Query: 353 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQSSE 407
           + A N L+ E +   V DFGL++L+   D++   A     ++ T    APE L+  + S 
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWT----APESLAYNKFSI 191

Query: 408 KTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKKLEMLVDKDLK 462
           K+DV+ FG+LL E+ +      +G +        +                   V + L+
Sbjct: 192 KSDVWAFGVLLWEIAT------YGMSPYPGIDLSQ-------------------VYELLE 226

Query: 463 NNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +Y R+E      E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 227 KDY-RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  120 bits (304), Expect = 6e-31
 Identities = 60/301 (19%), Positives = 112/301 (37%), Gaps = 70/301 (23%)

Query: 236 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G+  FG VYKG+L           VA+K LKD        +F+ E  + +   H N++ L
Sbjct: 18  GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 77

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGA 333
           +G         +++ Y S+G +   L                  K +L+      +    
Sbjct: 78  LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----V 388
           A G+ YL       ++H+D+   N+L+ +     + D GL + +   D +         +
Sbjct: 138 AAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDW 443
           R      APE +  G+ S  +D++ +G++L E+ S      +G       +NQ       
Sbjct: 195 RWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS------YGLQPYCGYSNQD------ 238

Query: 444 VKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRML 498
                        V + ++N    +         +  + + C    PS RP+  ++   L
Sbjct: 239 -------------VVEMIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

Query: 499 E 499
            
Sbjct: 285 R 285

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  121 bits (306), Expect = 7e-31
 Identities = 66/305 (21%), Positives = 108/305 (35%), Gaps = 74/305 (24%)

Query: 236 GKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 288
           G G FG V +              VAVK LK    +       +E++ +  L  H N++ 
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91

Query: 289 LIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRKR-------------IA 330
           L+G C      L++  Y   G +       R     S                      +
Sbjct: 92  LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 387
              A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V      
Sbjct: 152 YQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208

Query: 388 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT------ANQKGA 439
             V+      APE +     + ++DV+ +GI L EL S       G +       + K  
Sbjct: 209 LPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS------LGSSPYPGMPVDSK-- 256

Query: 440 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEV 494
                              K +K  + R+        EM  +   C    P  RP   ++
Sbjct: 257 -----------------FYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

Query: 495 VRMLE 499
           V+++E
Sbjct: 299 VQLIE 303

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  121 bits (306), Expect = 9e-31
 Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 15/211 (7%)

Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 278
            E +      + +  VG+G FG V++    Q G   AVK+      +  E+    E+   
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVAC 104

Query: 279 SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 338
           +      ++ L G         +    +  GS+   +K    L           A  GL 
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTA----VRGTVG 393
           YLH +   +I+H DVKA N+LL        + DFG A  L       +      + GT  
Sbjct: 165 YLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221

Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           H+APE +       K D++    ++L +++G
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  126 bits (318), Expect = 9e-31
 Identities = 42/105 (40%), Positives = 58/105 (55%), Gaps = 8/105 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +  N +SG+IP EIG +  L  L+L +N  +G IP  V  L  L  L L++N L G IP 
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPS---FHAKTFNIT---GNSLIC 128
           ++S ++ L  +DLS NNLSGP+P    F   TF       N  +C
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFE--TFPPAKFLNNPGLC 741

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  122 bits (308), Expect = 2e-29
 Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 4/133 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N+++G IP+ +   + L  + LSNN  TG IP  +  LE L  L+L+NNS +G IP 
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPS-FHAKTFNITGNSLICATGAEEDCFGTAPMPLSFAL 148
            L +   L +LDL+ N  +G +P+    ++  I  N +    G          M      
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI---AGKRYVYIKNDGMKKECHG 589

Query: 149 NNSPNSKPSGMPK 161
             +         +
Sbjct: 590 AGNLLEFQGIRSE 602

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  121 bits (307), Expect = 2e-29
 Identities = 37/85 (43%), Positives = 52/85 (61%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N +SG IP+ +G LSKL  L L  N   G IP  + +++TL+ L L+ N LTG IP 
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSF 114
            LSN + L ++ LS N L+G +P +
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKW 509

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  121 bits (305), Expect = 4e-29
 Identities = 27/102 (26%), Positives = 48/102 (47%), Gaps = 5/102 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + +    GH          ++ LD+S N  +G IP  +  +  L  L L +N ++G+IP 
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAK-----TFNITGNSL 126
            + ++  L  LDLS N L G +P   +        +++ N+L
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  121 bits (305), Expect = 5e-29
 Identities = 35/84 (41%), Positives = 51/84 (60%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           LQNN  +G IP  +   S+L++L LS N+ +G IPS++  L  L+ L+L  N L G IP 
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPS 113
            L  +  L  L L +N+L+G +PS
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPS 484

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  120 bits (302), Expect = 1e-28
 Identities = 35/84 (41%), Positives = 48/84 (57%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N + G IP E+  +  L TL L  N  TG IPS +S+   L ++ L+NN LTG IP 
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPS 113
            +  +  LA L LS N+ SG +P+
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPA 532

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  113 bits (286), Expect = 1e-26
 Identities = 39/104 (37%), Positives = 52/104 (50%), Gaps = 7/104 (6%)

Query: 30  LQNNNISGHIPTEIGK--LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAI 87
           L +NN SG I   + +   + L  L L NN FTG IP T+S+   L  L L+ N L+G I
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434

Query: 88  PPSLSNMSQLAFLDLSYNNLSGPVPSFHAK-----TFNITGNSL 126
           P SL ++S+L  L L  N L G +P          T  +  N L
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  111 bits (281), Expect = 5e-26
 Identities = 35/86 (40%), Positives = 50/86 (58%), Gaps = 2/86 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP-STVSHLETLQYLRLNNNSLTGAIP 88
           L  N+  G +P   G  S L +L LS+N F+G +P  T+  +  L+ L L+ N  +G +P
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360

Query: 89  PSLSNMS-QLAFLDLSYNNLSGPVPS 113
            SL+N+S  L  LDLS NN SGP+  
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILP 386

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  111 bits (280), Expect = 7e-26
 Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 9/103 (8%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + +NN S  IP  +G  S L  LD+S N  +G     +S    L+ L +++N   G IPP
Sbjct: 207 VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSL 126
               +  L +L L+ N  +G +P F +         +++GN  
Sbjct: 266 --LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHF 306

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  107 bits (269), Expect = 1e-24
 Identities = 34/84 (40%), Positives = 43/84 (51%), Gaps = 3/84 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH-LETLQYLRLNNNSLTGAIP 88
           + +N   G IP     L  L  L L+ N FTG IP  +S   +TL  L L+ N   GA+P
Sbjct: 254 ISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVP 112
           P   + S L  L LS NN SG +P
Sbjct: 312 PFFGSCSLLESLALSSNNFSGELP 335

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  104 bits (263), Expect = 7e-24
 Identities = 19/82 (23%), Positives = 41/82 (50%)

Query: 32  NNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL 91
                G    ++ +LS     ++++  + G    T  +  ++ +L ++ N L+G IP  +
Sbjct: 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652

Query: 92  SNMSQLAFLDLSYNNLSGPVPS 113
            +M  L  L+L +N++SG +P 
Sbjct: 653 GSMPYLFILNLGHNDISGSIPD 674

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  101 bits (255), Expect = 8e-23
 Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 4/96 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS--HLETLQYLRLNNNSLTGAI 87
           L N++I+G +       + L +LDLS N  +GP+ +  S      L++L +++N+L    
Sbjct: 84  LSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG 142

Query: 88  P-PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT 122
                  ++ L  LDLS N++SG        +    
Sbjct: 143 KVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  101 bits (254), Expect = 1e-22
 Identities = 31/122 (25%), Positives = 50/122 (40%), Gaps = 16/122 (13%)

Query: 21  GVFFSFGRL-------LQNNNISGHIPT--EIGKLSKLLTLDLSNNFFTGPIP-STVSHL 70
           G    F          L  N++SG + T   +G  S L  L++S+N    P   S    L
Sbjct: 91  GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKL 150

Query: 71  ETLQYLRLNNNSLTGAIPPSL---SNMSQLAFLDLSYNNLSGPVPSFHAK---TFNITGN 124
            +L+ L L+ NS++GA            +L  L +S N +SG V           +++ N
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSN 210

Query: 125 SL 126
           + 
Sbjct: 211 NF 212

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 94.2 bits (235), Expect = 2e-20
 Identities = 23/93 (24%), Positives = 34/93 (36%), Gaps = 2/93 (2%)

Query: 23  FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNF--FTGPIPSTVSHLETLQYLRLNN 80
            F     +  N I+G     I           + N   F G     ++ L T     + +
Sbjct: 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS 617

Query: 81  NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 113
               G   P+  N   + FLD+SYN LSG +P 
Sbjct: 618 RVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 94.2 bits (235), Expect = 2e-20
 Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 11/106 (10%)

Query: 18  CS-DGVFFSFGRL----LQNNNIS---GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 69
           C+ DGV     ++    L +  ++     + + +  L+ L +L LSN+   G +      
Sbjct: 40  CTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKC 98

Query: 70  LETLQYLRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPS 113
             +L  L L+ NSL+G +    SL + S L FL++S N L  P   
Sbjct: 99  SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKV 144

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 85.7 bits (213), Expect = 1e-17
 Identities = 15/87 (17%), Positives = 27/87 (31%), Gaps = 6/87 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL--NNNSLTGAI 87
           L  N  +G IP  + K S      ++ NF  G     + +    +      N     G  
Sbjct: 545 LNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600

Query: 88  PPSLSNMSQLAFLDLSYNNLSGPVPSF 114
              L+ +S     +++     G     
Sbjct: 601 SEQLNRLSTRNPCNITSRVYGGHTSPT 627

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 51.4 bits (124), Expect = 5e-07
 Identities = 14/63 (22%), Positives = 29/63 (46%), Gaps = 4/63 (6%)

Query: 68  SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITG 123
             + ++       N    A+  SL +++ L  L LS ++++G V  F       + +++ 
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109

Query: 124 NSL 126
           NSL
Sbjct: 110 NSL 112

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  120 bits (303), Expect = 1e-30
 Identities = 68/301 (22%), Positives = 120/301 (39%), Gaps = 71/301 (23%)

Query: 236 GKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G+G FG V+          +D  +VAVK LKD   +     FQ E E+++   H ++++ 
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKF 82

Query: 290 IGFCMTTTERLLVYPYMSNGS-----VASRLKAKPSLDWATRKR-----------IALGA 333
            G C      ++V+ YM +G       A    A   +D   R+            IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----V 388
           A G++YL  Q     +HRD+   N L+       +GDFG+++ +   D +         +
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDW 443
           R       PE +   + + ++DV+ FG++L E+ +      +GK      +N +      
Sbjct: 200 RWM----PPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNTE------ 243

Query: 444 VKKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRML 498
                        V + +      +E      +E+  V L C Q  P  R  + E+ ++L
Sbjct: 244 -------------VIECITQGR-VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

Query: 499 E 499
            
Sbjct: 290 H 290

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  119 bits (301), Expect = 2e-30
 Identities = 57/289 (19%), Positives = 105/289 (36%), Gaps = 59/289 (20%)

Query: 236 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           G+G F  ++KG  ++         T V +K L           F     M+S   H++L+
Sbjct: 17  GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLV 75

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 346
              G C+   E +LV  ++  GS+ + LK  K  ++   +  +A   A  + +L E    
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN--- 132

Query: 347 KIIHRDVKAANILLDEYYEAV--------VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
            +IH +V A NILL    +          + D G++  +      +   +        PE
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-KDILQERIPWV----PPE 187

Query: 399 YLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWVKKIHQEKK 452
            +   ++ +  TD + FG  L E+ S       G        +Q+               
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICS------GGDKPLSALDSQR--------------- 226

Query: 453 LEMLVDKDLKNNY--DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                 +  ++ +     +  E+  +   C  Y P  RP    ++R L 
Sbjct: 227 ----KLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  120 bits (302), Expect = 3e-30
 Identities = 61/300 (20%), Positives = 114/300 (38%), Gaps = 70/300 (23%)

Query: 236 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G+G FG V+     +        +VAVK LK+ +       FQ E E++++  H++++R 
Sbjct: 50  GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTMLQHQHIVRF 108

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKR--------------IALGAA 334
            G C      L+V+ YM +G +   L++  P                       +A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
            G++YL        +HRD+   N L+ +     +GDFG+++ +   D        G    
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVGGRTM 221

Query: 395 I-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----ANQKGAMLDWV 444
           +      PE +   + + ++DV+ FG++L E+ +      +GK      +N +       
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT------YGKQPWYQLSNTE------- 268

Query: 445 KKIHQEKKLEMLVDKDLKNNYDRIEL-----EEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                           +      +E       E+  +   C Q  P  R  + +V   L+
Sbjct: 269 ------------AIDCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  120 bits (302), Expect = 4e-30
 Identities = 64/310 (20%), Positives = 108/310 (34%), Gaps = 79/310 (25%)

Query: 236 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 288
           G G FG V                VAVK LK+           +E++ M  L  H N++ 
Sbjct: 54  GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113

Query: 289 LIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRKR--------------- 328
           L+G C  +    L++ Y   G +     + R K          ++               
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173

Query: 329 ---IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 385
               A   A+G+ +L  +     +HRD+ A N+L+       + DFGLA+ +    ++V 
Sbjct: 174 LLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230

Query: 386 TA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT------A 434
                  V+      APE L  G  + K+DV+ +GILL E+ S       G         
Sbjct: 231 RGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS------LGVNPYPGIPV 280

Query: 435 NQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRP 489
           +                       K ++N + +++      EE+  +   C  +    RP
Sbjct: 281 DAN-------------------FYKLIQNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRP 320

Query: 490 KMSEVVRMLE 499
               +   L 
Sbjct: 321 SFPNLTSFLG 330

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  118 bits (297), Expect = 9e-30
 Identities = 73/309 (23%), Positives = 120/309 (38%), Gaps = 78/309 (25%)

Query: 236 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G+G FG V K            T VAVK LK+  +        +E  ++    H ++++L
Sbjct: 32  GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91

Query: 290 IGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRK----------------- 327
            G C      LL+  Y   GS+      SR      L     +                 
Sbjct: 92  YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151

Query: 328 --RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 385
               A   ++G+ YL E    K++HRD+ A NIL+ E  +  + DFGL++ +   DS+V 
Sbjct: 152 LISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208

Query: 386 TA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----AN 435
            +     V+      A E L     + ++DV+ FG+LL E+++       G         
Sbjct: 209 RSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGNPYPGIPP 258

Query: 436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPK 490
           +                  +     LK  + R+E      EEM ++ L C +  P  RP 
Sbjct: 259 E-----------------RLF--NLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPV 298

Query: 491 MSEVVRMLE 499
            +++ + LE
Sbjct: 299 FADISKDLE 307

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (295), Expect = 1e-29
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 16/200 (8%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
           ++GKG +G VY G  L +   +A+K    +D            E+ +     H+N+++ +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLKHKNIVQYL 85

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA---RGLLYLHEQCDPK 347
           G         +    +  GS+++ L++K        + I         GL YLH+    +
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142

Query: 348 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS- 405
           I+HRD+K  N+L++ Y   + + DFG +K L   +    T   GT+ ++APE +  G   
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRG 201

Query: 406 -SEKTDVFGFGILLLELISG 424
             +  D++  G  ++E+ +G
Sbjct: 202 YGKAADIWSLGCTIIEMATG 221

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  116 bits (292), Expect = 4e-29
 Identities = 53/206 (25%), Positives = 78/206 (37%), Gaps = 17/206 (8%)

Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--- 282
            +F   + +G G +G V+K    +DG + AVKR         +   +   E+ S      
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQ 115

Query: 283 HRNLLRLIGFCMTTTERLLVYPYM--SNGSVASRLKAKP-SLDWATRKRIALGAARGLLY 339
           H   +RL            +Y        S+    +A   SL  A            L +
Sbjct: 116 HPCCVRLEQAWEEGGI---LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           LH Q    ++H DVK ANI L       +GDFGL   L    +       G   ++APE 
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPEL 227

Query: 400 LSTGQSSEKTDVFGFGILLLELISGL 425
           L  G      DVF  G+ +LE+   +
Sbjct: 228 LQ-GSYGTAADVFSLGLTILEVACNM 252

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  116 bits (293), Expect = 5e-29
 Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 78/309 (25%)

Query: 236 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G+G FG V++            T+VAVK LK+  +   +  FQ E  +++   + N+++L
Sbjct: 56  GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 115

Query: 290 IGFCMTTTERLLVYPYMSNGS-----VASRLKAKPSLDWATRK----------------- 327
           +G C       L++ YM+ G       +       SL  +                    
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175

Query: 328 --RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 385
              IA   A G+ YL E+   K +HRD+   N L+ E     + DFGL++ +   D    
Sbjct: 176 QLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---- 228

Query: 386 TAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-----AN 435
                    I      PE +   + + ++DV+ +G++L E+ S      +G       A+
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------YGLQPYYGMAH 282

Query: 436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPK 490
           ++                   V   +++    +        E+  +  LC   LP+ RP 
Sbjct: 283 EE-------------------VIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPS 322

Query: 491 MSEVVRMLE 499
              + R+L+
Sbjct: 323 FCSIHRILQ 331

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  114 bits (288), Expect = 1e-28
 Identities = 65/291 (22%), Positives = 124/291 (42%), Gaps = 51/291 (17%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
            +F    L+G GGFG V+K     DG    +KR+K  N      + + EV+ ++   H N
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----KAEREVKALAKLDHVN 65

Query: 286 LLRLIGFCMTTTERLLVYP----------------YMSNGSVASRLKAKPS--LDWATRK 327
           ++   G                             +   G++   ++ +    LD     
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
            +     +G+ Y+H +   K+I+RD+K +NI L +  +  +GDFGL   L + D   T +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRTRS 181

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
             GT+ +++PE +S+    ++ D++  G++L EL+          TA +       ++  
Sbjct: 182 K-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------CDTAFETSKFFTDLRDG 234

Query: 448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
                        + + +D+ + + ++Q  LL  +  P  RP  SE++R L
Sbjct: 235 I------------ISDIFDK-KEKTLLQ-KLLSKK--PEDRPNTSEILRTL 269

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  115 bits (291), Expect = 1e-28
 Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 15/198 (7%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
            +GKGGF   ++        V A K      L   +      +   E+ +     H++++
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVV 104

Query: 288 RLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
              G      + + +V       S+    K + +L     +        G  YLH     
Sbjct: 105 GFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 160

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           ++IHRD+K  N+ L+E  E  +GDFGLA  +++          GT  +IAPE LS    S
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHS 219

Query: 407 EKTDVFGFGILLLELISG 424
            + DV+  G ++  L+ G
Sbjct: 220 FEVDVWSIGCIMYTLLVG 237

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  114 bits (288), Expect = 1e-28
 Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 15/198 (7%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
            +GKGGF   ++        V A K      L   +      +   E+ +     H++++
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVV 78

Query: 288 RLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
              G      + + +V       S+    K + +L     +        G  YLH     
Sbjct: 79  GFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 134

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           ++IHRD+K  N+ L+E  E  +GDFGLA  +++          GT  +IAPE LS    S
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHS 193

Query: 407 EKTDVFGFGILLLELISG 424
            + DV+  G ++  L+ G
Sbjct: 194 FEVDVWSIGCIMYTLLVG 211

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  114 bits (288), Expect = 1e-28
 Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 6/200 (3%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
              F+    +GKG FG V+KG   +   VVA+K +    A       Q E+ ++S     
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
            + +  G  +  T+  ++  Y+  GS    L+  P LD      I     +GL YLH + 
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE- 138

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
             K IHRD+KAAN+LL E+ E  + DFG+A  L        T V GT   +APE +    
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 195

Query: 405 SSEKTDVFGFGILLLELISG 424
              K D++  GI  +EL  G
Sbjct: 196 YDSKADIWSLGITAIELARG 215

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  115 bits (290), Expect = 1e-28
 Identities = 63/295 (21%), Positives = 120/295 (40%), Gaps = 41/295 (13%)

Query: 213 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF 271
             +  +F+ ++     +     +G+G FG        +DG    +K +        E + 
Sbjct: 14  GTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE 69

Query: 272 -QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--------LD 322
            + EV +++   H N+++            +V  Y   G +  R+ A+          LD
Sbjct: 70  SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129

Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
           W  +  I L     L ++H++   KI+HRD+K+ NI L +     +GDFG+A++L+    
Sbjct: 130 WFVQ--ICLA----LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180

Query: 383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 442
                + GT  +++PE       + K+D++  G +L EL +   A  F +  + K     
Sbjct: 181 LARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA--F-EAGSMKNL--- 233

Query: 443 WVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 497
            V KI             +  +Y   +L  +V   L      P  RP ++ ++  
Sbjct: 234 -VLKIISGSF------PPVSLHYSY-DLRSLVS-QLFKRN--PRDRPSVNSILEK 277

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  114 bits (287), Expect = 2e-28
 Identities = 58/297 (19%), Positives = 104/297 (35%), Gaps = 49/297 (16%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++F     +G+GGFG V++     D    A+KR++  N      +   EV+ ++   H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 286 LLRLIGFCMTTTERLLVYP------------YMSNGSVASRLKAK---PSLDWATRKRIA 330
           ++R     +       + P                 ++   +  +      + +    I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR- 389
           L  A  + +LH +    ++HRD+K +NI         VGDFGL   +D  +   T     
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 390 ----------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA 439
                     GT  +++PE +     S K D+F  G++L EL+          T  ++  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFS------TQMERVR 235

Query: 440 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
            L     +   K             Y       MVQ         P  RP+   ++ 
Sbjct: 236 TL---TDVRNLK-----FPPLFTQKYP--CEYVMVQ---DMLSPSPMERPEAINIIE 279

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  113 bits (285), Expect = 3e-28
 Identities = 59/305 (19%), Positives = 118/305 (38%), Gaps = 40/305 (13%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVH 283
           +NF  +  +G+G F  VY+   L DG  VA+K+++  + +  +       E++++    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS----------LDWATRKRIALGA 333
            N+++     +   E  +V      G ++  +K                +  +  +    
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ--LCSA- 148

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 393
              L ++H +   +++HRD+K AN+ +       +GD GL +      +   + V GT  
Sbjct: 149 ---LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201

Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 453
           +++PE +     + K+D++  G LL E+ +             K  +    KKI Q    
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLYSLCKKIEQCD-- 254

Query: 454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKA 513
                    ++Y   EL ++V    +C    P  RP ++ V    +         AS   
Sbjct: 255 ---YPPLPSDHYSE-ELRQLVN---MCINPDPEKRPDVTYV---YDVAKRMHACTASSLE 304

Query: 514 EATRS 518
                
Sbjct: 305 HHHHH 309

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  113 bits (285), Expect = 4e-28
 Identities = 63/314 (20%), Positives = 121/314 (38%), Gaps = 47/314 (14%)

Query: 202 NEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKD 261
           +            +  +F+ +      +S    +G GG   V++   +   + A+K +  
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL 62

Query: 262 GNAIGGEIQ-FQTEVEMISLAVHRNL--LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK 318
             A    +  ++ E+  ++     +   +RL  + +T     +V     N  + S LK K
Sbjct: 63  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK 121

Query: 319 PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAKL 376
            S+D   RK         +  +H+     I+H D+K AN L+    + ++   DFG+A  
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQ 175

Query: 377 L-DHCDSHVTTAVRGTVGHIAPEYL-----------STGQSSEKTDVFGFGILLLELISG 424
           +     S V  +  GTV ++ PE +           S  + S K+DV+  G +L  +  G
Sbjct: 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235

Query: 425 LRALEFGKTANQKGAMLDWVKKIHQEKKLEM--LVDKDLKNNYDRIELEEMVQVALL--C 480
                F +  NQ   +      I    ++E   + +KDL++              +L  C
Sbjct: 236 --KTPFQQIINQISKLH---AIIDPNHEIEFPDIPEKDLQD--------------VLKCC 276

Query: 481 TQYLPSLRPKMSEV 494
            +  P  R  + E+
Sbjct: 277 LKRDPKQRISIPEL 290

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  112 bits (281), Expect = 1e-27
 Identities = 61/214 (28%), Positives = 89/214 (41%), Gaps = 21/214 (9%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVH 283
            ++  + ++G G    V   Y       VA+KR  L+       E+    E++ +S   H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL--KEIQAMSQCHH 72

Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR-----IAL---GAAR 335
            N++      +   E  LV   +S GSV   +K   +             IA        
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-VGH 394
           GL YLH+      IHRDVKA NILL E     + DFG++  L          VR T VG 
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 395 ---IAPEYLSTGQS-SEKTDVFGFGILLLELISG 424
              +APE +   +    K D++ FGI  +EL +G
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  110 bits (277), Expect = 3e-27
 Identities = 60/201 (29%), Positives = 87/201 (43%), Gaps = 9/201 (4%)

Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVH 283
            +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S   H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y H +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              ++IHRD+K  N+LL    E  + DFG +               GT+ ++ PE +   
Sbjct: 129 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLC--GTLDYLPPEMIEGR 182

Query: 404 QSSEKTDVFGFGILLLELISG 424
              EK D++  G+L  E + G
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVG 203

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  110 bits (278), Expect = 5e-27
 Identities = 61/281 (21%), Positives = 113/281 (40%), Gaps = 43/281 (15%)

Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL--LRL 289
             +G GG   V++   +   + A+K +    A    +  ++ E+  ++     +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 290 IGFCMTTTERLLVYPYM--SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
             + +T      +Y  M   N  + S LK K S+D   RK         +  +H+     
Sbjct: 75  YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---G 128

Query: 348 IIHRDVKAANILLDEYYEAVV--GDFGLAKLL-DHCDSHVTTAVRGTVGHIAPEYL---- 400
           I+H D+K AN L+    + ++   DFG+A  +     S V  +  GTV ++ PE +    
Sbjct: 129 IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 401 -------STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 453
                  S  + S K+DV+  G +L  +  G     F +  NQ               KL
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYG--KTPFQQIINQI-------------SKL 230

Query: 454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV 494
             ++D + +  +  I  +++  V   C +  P  R  + E+
Sbjct: 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  108 bits (273), Expect = 8e-27
 Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 52/296 (17%)

Query: 224 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLA 281
           S   ++     +G G +G   K     DG ++  K L  G+    E Q   +EV ++   
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62

Query: 282 VHRNLLRLIG-FCMTTTERL-LVYPYMSNGSVASRLKAKPS----------LDWATRKRI 329
            H N++R        T   L +V  Y   G +AS +               L   T+  +
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ--L 120

Query: 330 ALGAARGLLYLHEQCDP--KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
            L     L   H + D    ++HRD+K AN+ LD      +GDFGLA++L+H  S   T 
Sbjct: 121 TLA----LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF 176

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI 447
           V GT  +++PE ++    +EK+D++  G LL EL + +    F                 
Sbjct: 177 V-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--F----------------- 216

Query: 448 HQEKKLEMLVDKDLKNNYDRI------ELEEMVQVALLCTQYLPSLRPKMSEVVRM 497
                 + L  K  +  + RI      EL E++   +L  +     RP + E++  
Sbjct: 217 -TAFSQKELAGKIREGKFRRIPYRYSDELNEIIT-RMLNLK--DYHRPSVEEILEN 268

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  111 bits (278), Expect = 1e-26
 Identities = 65/331 (19%), Positives = 125/331 (37%), Gaps = 42/331 (12%)

Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL--LRL 289
             +G GG   V++   +   + A+K +    A    +  ++ E+  ++     +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
             + +T     +V     N  + S LK K S+D   RK         +  +H+     I+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIV 177

Query: 350 HRDVKAANILLDEYYEAVV--GDFGLAKLL-DHCDSHVTTAVRGTVGHIAPEYLS----- 401
           H D+K AN L+    + ++   DFG+A  +     S V  +  G V ++ PE +      
Sbjct: 178 HSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 402 ------TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM 455
                   + S K+DV+  G +L  +  G     F +  NQ   +      I    ++E 
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYG--KTPFQQIINQISKLH---AIIDPNHEIEF 289

Query: 456 --LVDKDLKN------NYD---RIELEEMVQVALLCTQYLP--SLRPKMSEVVRMLEGDG 502
             + +KDL++        D   RI + E++    +  Q  P   +    +E ++ + G  
Sbjct: 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQL 349

Query: 503 LAEKWAASQKAEATRSRANEFSSSERYSDLT 533
           +      S    A     +        S  +
Sbjct: 350 VGLNSPNSILKAAKTLYEHYSGGESHNSSSS 380

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  108 bits (271), Expect = 3e-26
 Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 36/230 (15%)

Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
            S+F    ++G+G FG V K     D    A+K+++  +         +EV +++   H+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62

Query: 285 NLLRLIGFCMTTTERLLVYP-------------YMSNGSVASRLKAKPS-LDWATRKRIA 330
            ++R     +     +                 Y  NG++   + ++          R+ 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC---------- 380
                 L Y+H Q    IIHRD+K  NI +DE     +GDFGLAK +             
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 381 ----DSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGL 425
                 ++T+A+ GT  ++A E L  TG  +EK D++  GI+  E+I   
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF 228

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  107 bits (269), Expect = 3e-26
 Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 30/204 (14%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           GKG F  VY+   +  G  VA+K      +          + Q EV++     H ++L L
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM---VQRVQNEVKIHCQLKHPSILEL 76

Query: 290 IGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYL 340
                  +  + LV     NG +   LK +        K  +   AR        G+LYL
Sbjct: 77  YN-YFEDSNYVYLVLEMCHNGEMNRYLKNR-------VKPFSENEARHFMHQIITGMLYL 128

Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
           H      I+HRD+  +N+LL       + DFGLA  L        T   GT  +I+PE  
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIA 184

Query: 401 STGQSSEKTDVFGFGILLLELISG 424
           +      ++DV+  G +   L+ G
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIG 208

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (273), Expect = 4e-26
 Identities = 43/214 (20%), Positives = 73/214 (34%), Gaps = 19/214 (8%)

Query: 226 TSNFSSKNLVGKG--GFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLA 281
              +    ++GKG      V        G  V V+R+         + F Q E+ +  L 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLL 338
            H N++      +   E  +V  +M+ GS    +      D      IA    G  + L 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALD 142

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI--- 395
           Y+H       +HR VKA++IL+    +  +        +                 +   
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 396 ---APEYLSTGQS--SEKTDVFGFGILLLELISG 424
              +PE L         K+D++  GI   EL +G
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (268), Expect = 5e-26
 Identities = 48/234 (20%), Positives = 83/234 (35%), Gaps = 41/234 (17%)

Query: 223 QSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 277
               S ++++      +G G FG+V+K     DG + A+KR K   A   + Q     E+
Sbjct: 3   MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREV 61

Query: 278 ISLAV---HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA----KPSLDWATRKRIA 330
            + AV   H +++R           L+   Y + GS+A  +            A  K + 
Sbjct: 62  YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----------------YYEAVV--GDF 371
           L   RGL Y+H      ++H D+K +NI +                     + +   GD 
Sbjct: 122 LQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 372 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 424
           G    +            G    +A E L    +   K D+F   + ++     
Sbjct: 179 GHVTRISS-----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  107 bits (268), Expect = 8e-26
 Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 24/225 (10%)

Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 278
             +     ++     +G+GGF  V     L DG   A+KR+        E + Q E +M 
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMH 80

Query: 279 SLAVHRNLLRLIGFCMTTTER----LLVYPYMSNGSVA----SRLKAKPSLDWATRKRIA 330
            L  H N+LRL+ +C+          L+ P+   G++             L       + 
Sbjct: 81  RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR- 389
           LG  RGL  +H        HRD+K  NILL +  + V+ D G              A+  
Sbjct: 141 LGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 390 -------GTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISG 424
                   T+ + APE  S        E+TDV+  G +L  ++ G
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  107 bits (268), Expect = 1e-25
 Identities = 45/215 (20%), Positives = 82/215 (38%), Gaps = 32/215 (14%)

Query: 236 GKGGFGNVYKGYLQDGTVVAVKRLK----------------DGNAIGGEIQFQTEVEMIS 279
            +G F  +     +D    A+K+ +                  +       F+ E+++I+
Sbjct: 40  NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98

Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR---- 335
              +   L   G      E  ++Y YM N S+    +    LD      I +   +    
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158

Query: 336 ----GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
                  Y+H + +  I HRDVK +NIL+D+     + DFG ++ +   D  +  +  GT
Sbjct: 159 SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSR-GT 213

Query: 392 VGHIAPEYLST--GQSSEKTDVFGFGILLLELISG 424
              + PE+ S     +  K D++  GI L  +   
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  107 bits (268), Expect = 1e-25
 Identities = 45/306 (14%), Positives = 99/306 (32%), Gaps = 33/306 (10%)

Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQT 273
            E Q  +      +L+G+G F  VY+         ++     +K  K  N     I  Q 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ- 116

Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW-----ATRKR 328
            +E +  ++    ++     +     +LV    S G++ + +    +             
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG-----------DFGLAKLL 377
            A+     +  +H+    +IIH D+K  N +L   +                D G +  +
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 378 DHC-DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 436
                  + TA   T G    E LS    + + D FG    +  ++ G   ++       
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMKVKNE-GG 291

Query: 437 KGAMLDWVKKIHQEKKLEMLVDKDLK-NNYDRIELEEMVQVAL---LCTQYLPSLRPKMS 492
           +       +++             L   +   +   ++++  L       Y   +R   +
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRN 351

Query: 493 EVVRML 498
            ++ +L
Sbjct: 352 RLIVLL 357

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (262), Expect = 3e-25
 Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 9/194 (4%)

Query: 234 LVGKGGFGNVYKG-YLQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
            +GKG FGNVY     Q+  ++A+K L        G E Q + E+E+ S   H N+LR+ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
            +        L+  +   G +   L+     D           A  L Y HE+   K+IH
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIH 137

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 410
           RD+K  N+L+    E  + DFG +    H  S     + GT+ ++ PE +      EK D
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVD 194

Query: 411 VFGFGILLLELISG 424
           ++  G+L  E + G
Sbjct: 195 LWCAGVLCYEFLVG 208

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  107 bits (268), Expect = 4e-25
 Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 22/210 (10%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIGGEIQFQTEVE-MISLAVHRN 285
           +F  K+++G G  G +    + D   VAVKR L +  +         EV+ +     H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPN 79

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQC 344
           ++R          + +     +  ++   ++ K  +        +      GL +LH   
Sbjct: 80  VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL- 137

Query: 345 DPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLLDHCDS--HVTTAVRGTVGHIAP 397
              I+HRD+K  NIL+          A++ DFGL K L          + V GT G IAP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 398 EYLSTGQS---SEKTDVFGFGILLLELISG 424
           E LS       +   D+F  G +   +IS 
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  104 bits (261), Expect = 6e-25
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 20/215 (9%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVH 283
              F     +G+G +G+VYK    + G +VA+K++     +  ++Q    E+ ++     
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDS 83

Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHE 342
            ++++  G     T+  +V  Y   GSV+  ++ +   L       I     +GL YLH 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
               + IHRD+KA NILL+    A + DFG+A  L    +   T + GT   +APE +  
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199

Query: 403 GQSSEKTDVFGFGILLLELISG---------LRAL 428
              +   D++  GI  +E+  G         +RA+
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  104 bits (261), Expect = 7e-25
 Identities = 68/243 (27%), Positives = 110/243 (45%), Gaps = 34/243 (13%)

Query: 212 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ 270
            +L       L+     F    LVG G +G VYKG  ++ G + A+K +   +  G E +
Sbjct: 9   RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEE 65

Query: 271 -FQTEVEMIS-LAVHRNLLRLIG-----FCMTTTERL-LVYPYMSNGSVASRLKAKPSLD 322
             + E+ M+   + HRN+    G           ++L LV  +   GSV   +K     +
Sbjct: 66  EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-N 124

Query: 323 WATRKRIAL---GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 379
               + IA       RGL +LH+    K+IHRD+K  N+LL E  E  + DFG++  LD 
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181

Query: 380 CDSHVTTAVRGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELISG---------L 425
                 T + GT   +APE ++  ++ +     K+D++  GI  +E+  G         +
Sbjct: 182 TVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240

Query: 426 RAL 428
           RAL
Sbjct: 241 RAL 243

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (258), Expect = 1e-24
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 16/213 (7%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
              ++    +G+G  G VY    +  G  VA++++        E+    E+ ++    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           N++  +   +   E  +V  Y++ GS+   +     +D      +     + L +LH   
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN- 135

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
             ++IHRD+K+ NILL       + DFG    +    S  +T V GT   +APE ++   
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192

Query: 405 SSEKTDVFGFGILLLELISG---------LRAL 428
              K D++  GI+ +E+I G         LRAL
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  103 bits (259), Expect = 2e-24
 Identities = 52/191 (27%), Positives = 92/191 (48%), Gaps = 6/191 (3%)

Query: 235 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 293
           +G G  G V+K  +   G V+A K +          Q   E++++       ++   G  
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 294 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 353
            +  E  +   +M  GS+   LK    +      ++++   +GL YL E+   KI+HRDV
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDV 158

Query: 354 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 413
           K +NIL++   E  + DFG++  L   DS   + V GT  +++PE L     S ++D++ 
Sbjct: 159 KPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSDIWS 215

Query: 414 FGILLLELISG 424
            G+ L+E+  G
Sbjct: 216 MGLSLVEMAVG 226

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  102 bits (256), Expect = 3e-24
 Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 16/213 (7%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
                S   +G+G  G V        G  VAVK +        E+    EV ++    H 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHF 102

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           N++ +    +   E  ++  ++  G++   +     L+      +     + L YLH Q 
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQ- 160

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
              +IHRD+K+ +ILL       + DFG    +        + V GT   +APE +S   
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSL 217

Query: 405 SSEKTDVFGFGILLLELISG---------LRAL 428
            + + D++  GI+++E++ G         ++A+
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  103 bits (258), Expect = 5e-24
 Identities = 29/232 (12%), Positives = 63/232 (27%), Gaps = 44/232 (18%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVK---------------------------RLKDGNAI 265
           ++G+       +    + G    V                             +K+    
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 266 GGEIQFQTEVEMISLAVHRNLLRLIGF--CMTTTERLLVYPYMSN------GSVASRLKA 317
              ++F    +++     + ++R+      M    R  +YP M +        + S    
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 318 KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 377
             SL    R ++ L   R L  LH      ++H  ++  +I+LD+     +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 378 DHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISG 424
                             A   L          +   D +  G+ +  +   
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  101 bits (253), Expect = 6e-24
 Identities = 47/218 (21%), Positives = 90/218 (41%), Gaps = 25/218 (11%)

Query: 229 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRN 285
           +     +G G FG VYK    + G + A K    K    +     +  E+E+++   H  
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPY 77

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQC 344
           +++L+G      +  ++  +   G+V + +      L     + +       L +LH + 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK- 136

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
             +IIHRD+KA N+L+    +  + DFG++           + + GT   +APE +    
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCET 193

Query: 405 SSE-----KTDVFGFGILLLELISG---------LRAL 428
             +     K D++  GI L+E+            +R L
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (254), Expect = 1e-23
 Identities = 29/238 (12%), Positives = 67/238 (28%), Gaps = 55/238 (23%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVK---------------------------RLKDGNAI 265
           ++G+       +    + G    V                             +K+    
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 266 GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVYPYMSN------GSVASRLKA 317
              ++F    +++     + ++R+           R  +YP M +        + S    
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 318 KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 377
             SL    R ++ L   R L  LH      ++H  ++  +I+LD+     +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 378 DHCDSHVTTAVRGTVGHIAPEYLSTGQS-----------SEKTDVFGFGILLLELISG 424
                        + G   PE  +   +           +   D +  G+++  +   
Sbjct: 257 GA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  103 bits (258), Expect = 2e-23
 Identities = 43/201 (21%), Positives = 73/201 (36%), Gaps = 21/201 (10%)

Query: 234 LVGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
            +  GG G +Y       +G  V +K L        +     E + ++  VH +++++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 292 FCMTTTERLLVYPYM-----SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           F   T        Y+        S+      K  +  A      L     L YLH     
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLHSI--- 201

Query: 347 KIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
            +++ D+K  NI+L E  E + + D G    ++         + GT G  APE +     
Sbjct: 202 GLVYNDLKPENIMLTE--EQLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IVRTGP 253

Query: 406 SEKTDVFGFGILLLELISGLR 426
           +  TD++  G  L  L   L 
Sbjct: 254 TVATDIYTVGRTLAALTLDLP 274

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 41/220 (18%), Positives = 87/220 (39%), Gaps = 23/220 (10%)

Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
            ++   +   +++G+G   NV++G   + G + A+K   + + +        E E++   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 282 VHRNLLRLIGFCMTTTERL--LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA---ARG 336
            H+N+++L      TT R   L+  +   GS+ + L+   +          +       G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVTTAVRGTV 392
           + +L E     I+HR++K  NI+     +      + DFG A+ L+  D    +   GT 
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GTE 179

Query: 393 GHIAPEYLSTGQS--------SEKTDVFGFGILLLELISG 424
            ++ P+                   D++  G+      +G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  101 bits (252), Expect = 4e-23
 Identities = 67/304 (22%), Positives = 111/304 (36%), Gaps = 53/304 (17%)

Query: 223 QSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLA 281
           QS  +   S+ ++G G  G V       G  VAVKR+              E++ +    
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESD 66

Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR------ 335
            H N++R      T     +      N ++   +++K   D   + +             
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125

Query: 336 -GLLYLHEQCDPKIIHRDVKAANILLD-------------EYYEAVVGDFGLAKLLDHCD 381
            G+ +LH     KIIHRD+K  NIL+              E    ++ DFGL K LD   
Sbjct: 126 SGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 382 SHVTTAVR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGILLLELISGLRALEFG 431
           S   T +    GT G  APE L    +       +   D+F  G +   ++S  +   FG
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-HPFG 241

Query: 432 KTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPSLRPK 490
              +++  ++   + I    +++ L D+ L     D I              + P  RP 
Sbjct: 242 DKYSRESNII---RGIFSLDEMKCLHDRSLIAEATDLIS---------QMIDHDPLKRPT 289

Query: 491 MSEV 494
             +V
Sbjct: 290 AMKV 293

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  100 bits (249), Expect = 4e-23
 Identities = 23/241 (9%), Positives = 54/241 (22%), Gaps = 44/241 (18%)

Query: 221 ELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEM 277
            L            +  G    V+    ++     A+K   +   N+     +       
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 278 ISLAVHRNLLRLIGFC--------------------------MTTTERLLVYPYMS---- 307
            +  +  +                                        LL+ P  S    
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 308 --NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 365
               ++      +          +     R    L  +    ++H      N+ +     
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGR 232

Query: 366 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELIS 423
            ++GD                A    V +   E+L  ST   +   + +  G+ +  +  
Sbjct: 233 LMLGDVSAL----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288

Query: 424 G 424
            
Sbjct: 289 L 289

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 99.1 bits (247), Expect = 6e-23
 Identities = 51/217 (23%), Positives = 85/217 (39%), Gaps = 28/217 (12%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIG 291
           ++ +GGF  VY+   +  G   A+KRL   N          EV  M  L+ H N+++   
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 292 FCMTTTER-------LLVYPYMSNGSVAS---RLKAKPSLDWATRKRIALGAARGLLYLH 341
                 E         L+   +  G +     +++++  L   T  +I     R + ++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----------VRG 390
            Q  P IIHRD+K  N+LL       + DFG A  + H   +  +A              
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 391 TVGHIAPEYLSTGQS---SEKTDVFGFGILLLELISG 424
           T  +  PE +    +    EK D++  G +L  L   
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 98.8 bits (246), Expect = 2e-22
 Identities = 41/220 (18%), Positives = 87/220 (39%), Gaps = 23/220 (10%)

Query: 223 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
            ++   +   +++G+G   NV++G   + G + A+K   + + +        E E++   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 282 VHRNLLRLIGFCMTTTERL--LVYPYMSNGSVASRLKAKPSLDWATRK---RIALGAARG 336
            H+N+++L      TT R   L+  +   GS+ + L+   +           +      G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVTTAVRGTV 392
           + +L E     I+HR++K  NI+     +      + DFG A+ L+  D    +   GT 
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GTE 179

Query: 393 GHIAPEYLSTGQS--------SEKTDVFGFGILLLELISG 424
            ++ P+                   D++  G+      +G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 64/219 (29%), Positives = 90/219 (41%), Gaps = 25/219 (11%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAV 282
              FS    +G G FG VY    +++  VVA+K+       +         EV  +    
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLH 341
           H N ++  G  +      LV  Y   GS +  L+     L       +  GA +GL YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
                 +IHRDVKA NILL E     +GDFG A ++   +S V     GT   +APE + 
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 223

Query: 402 TGQSSE---KTDVFGFGILLLELISG---------LRAL 428
                +   K DV+  GI  +EL            + AL
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 99.3 bits (248), Expect = 4e-22
 Identities = 23/106 (21%), Positives = 40/106 (37%), Gaps = 7/106 (6%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           +  N+   +   +I  +L  L  LDLS        P+  + L +LQ L +++N+      
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLIC 128
                ++ L  LD S N++                  N+T N   C
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 93.2 bits (232), Expect = 3e-20
 Identities = 23/115 (20%), Positives = 42/115 (36%), Gaps = 13/115 (11%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 77
           SF          L    I          LS L TL L+ N          S L +LQ L 
Sbjct: 47  SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106

Query: 78  LNNNSLTGAIPPSLSNMSQLAFLDLSYNNL-SGPVPSF-----HAKTFNITGNSL 126
               +L       + ++  L  L++++N + S  +P +     + +  +++ N +
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 91.6 bits (228), Expect = 9e-20
 Identities = 18/85 (21%), Positives = 24/85 (28%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N +            +L  LDLS              L  L  L L  N +      
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSF 114
           + S +S L  L     NL+      
Sbjct: 95  AFSGLSSLQKLVAVETNLASLENFP 119

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 83.9 bits (208), Expect = 3e-17
 Identities = 16/85 (18%), Positives = 30/85 (35%), Gaps = 2/85 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP-STVSHLETLQYLRLNNNSLTGAIP 88
           L  N +   + +    L +L  LD  ++        S    L  L YL +++     A  
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPS 113
              + +S L  L ++ N+       
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLP 463

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 81.6 bits (202), Expect = 2e-16
 Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 5/89 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLNNNSLTGAIP 88
               N++      IG L  L  L++++N      +P   S+L  L++L L++N +     
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166

Query: 89  PSLSNMSQLAF----LDLSYNNLSGPVPS 113
             L  + Q+      LDLS N ++   P 
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 3/93 (3%)

Query: 23  FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNF--FTGPIPSTVSHLETLQYLRLNN 80
                + L   +  G        L  L  LDLS N   F G    +     +L+YL L+ 
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382

Query: 81  NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 113
           N +   +  +   + QL  LD  ++NL      
Sbjct: 383 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 76.6 bits (189), Expect = 6e-15
 Identities = 17/85 (20%), Positives = 27/85 (31%), Gaps = 3/85 (3%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
                N    IP  +        LDLS N        +      LQ L L+   +     
Sbjct: 13  QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPS 113
            +  ++S L+ L L+ N +      
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALG 94

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 76.6 bits (189), Expect = 6e-15
 Identities = 22/89 (24%), Positives = 34/89 (38%), Gaps = 6/89 (6%)

Query: 30  LQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY----LRLNNNSLT 84
           + +N I S  +P     L+ L  LDLS+N       + +  L  +      L L+ N + 
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 85  GAIPPSLSNMSQLAFLDLSYNNLSGPVPS 113
              P +   +  L  L L  N  S  V  
Sbjct: 191 FIQPGAFKEIR-LHKLTLRNNFDSLNVMK 218

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 63.9 bits (156), Expect = 7e-11
 Identities = 23/122 (18%), Positives = 40/122 (32%), Gaps = 27/122 (22%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFT-------------------GPIPSTVSHL 70
           L +  I                L+L N  F                    G    +   L
Sbjct: 289 LVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346

Query: 71  ETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGN 124
            +L++L L+ N L+  G    S    + L +LDLS+N +     +F      +  +   +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406

Query: 125 SL 126
           +L
Sbjct: 407 NL 408

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 17/101 (16%), Positives = 27/101 (26%), Gaps = 28/101 (27%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET-LQYLRLNNNSLTG--- 85
           + +NN           L+ L  LD S N         + H  + L +L L  N       
Sbjct: 501 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

Query: 86  -----------------------AIPPSLSNMSQLAFLDLS 103
                                  A P     M  +  L+++
Sbjct: 561 HQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 21/100 (21%), Positives = 30/100 (30%), Gaps = 21/100 (21%)

Query: 28  RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT--- 84
           RL   +     I      L+ + +  L +           S+    Q+L L N       
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNFGWQHLELVNCKFGQFP 320

Query: 85  ----------------GAIPPSLSNMSQLAFLDLSYNNLS 108
                           G    S  ++  L FLDLS N LS
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 57.7 bits (140), Expect = 6e-09
 Identities = 22/112 (19%), Positives = 39/112 (34%), Gaps = 16/112 (14%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH-LETLQYLRL------NNNS 82
           L  N ++  I     K  +L  L L NNF +  +  T    L  L+  RL      N  +
Sbjct: 184 LSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242

Query: 83  LTGAIPPSLSNMSQLAFLDLSYNNLSG----PVPSFHA----KTFNITGNSL 126
           L      +L  +  L   +     L       +  F+      +F++   ++
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 13/108 (12%), Positives = 24/108 (22%), Gaps = 11/108 (10%)

Query: 25  SFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNN------FFTGPIPSTVSHLETLQYLRL 78
             G      N+          L  L  L +         ++   I    + L  +    L
Sbjct: 233 VLGEFRNEGNLEKFDK---SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL 289

Query: 79  NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSL 126
            + ++        S       L+L                  +T  S 
Sbjct: 290 VSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN 335

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 6/194 (3%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLI 290
            +G GG   VY          VA+K +        E    F+ EV   S   H+N++ +I
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
                     LV  Y+   +++  +++   L   T          G+ + H+    +I+H
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVH 134

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 410
           RD+K  NIL+D      + DFG+AK L       T  V GTV + +PE      + E TD
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194

Query: 411 VFGFGILLLELISG 424
           ++  GI+L E++ G
Sbjct: 195 IYSIGIVLYEMLVG 208

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 98.6 bits (245), Expect = 7e-22
 Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 18/210 (8%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
            +  K  +G GGFG V +      G  VA+K+ +   +     ++  E++++    H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 287 LRLI------GFCMTTTERLLVYPYMSNGSVASRLKAK---PSLDWATRKRIALGAARGL 337
           +                  LL   Y   G +   L        L     + +    +  L
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGH 394
            YLHE    +IIHRD+K  NI+L    + +   + D G AK LD      T  V GT+ +
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTEFV-GTLQY 189

Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           +APE L   + +   D + FG L  E I+G
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 18/203 (8%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISLAVHRNLL 287
           ++G GG   V+    L+D   VAVK L+     D +      +F+ E +  +   H  ++
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYL---RFRREAQNAAALNHPAIV 75

Query: 288 RL--IGFCMTTTERL--LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            +   G   T    L  +V  Y+   ++   +  +  +       +   A + L + H+ 
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT--AVRGTVGHIAPEYLS 401
               IIHRDVK ANI++       V DFG+A+ +    + VT   AV GT  +++PE   
Sbjct: 136 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 402 TGQSSEKTDVFGFGILLLELISG 424
                 ++DV+  G +L E+++G
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTG 215

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 92.4 bits (230), Expect = 9e-21
 Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 18/202 (8%)

Query: 235 VGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +G+G +G+V K      G ++AVK  R         ++    +V M   +    +++  G
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM-RSSDCPYIVQFYG 88

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK-----RIALGAARGLLYLHEQCDP 346
                 +  +    M + S     K   S+           +I L   + L +L E    
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-- 145

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS- 405
           KIIHRD+K +NILLD      + DFG++  L   DS   T   G   ++APE +    S 
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPSASR 203

Query: 406 ---SEKTDVFGFGILLLELISG 424
                ++DV+  GI L EL +G
Sbjct: 204 QGYDVRSDVWSLGITLYELATG 225

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 46/199 (23%), Positives = 82/199 (41%), Gaps = 16/199 (8%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRL- 289
           LVG+GG G+VY+        +VA+K + +  +     +   Q E          +++ + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 290 -IGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
             G       +L +    ++   +A+ L+ +  L       I       L   H      
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---G 154

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT--AVRGTVGHIAPEYLSTGQS 405
             HRDVK  NIL+     A + DFG+A      D  +T      GT+ ++APE  S   +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 406 SEKTDVFGFGILLLELISG 424
           + + D++    +L E ++G
Sbjct: 213 TYRADIYALTCVLYECLTG 231

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 13/213 (6%)

Query: 220 KELQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVK--RLKDGNAIGGEIQFQTEVE 276
           +  Q+  ++  +   +G G  G V+K  + + G V+AVK  R          I    +V 
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           + S      +++  G  +T T+  +    M   +   + + +  +      ++ +   + 
Sbjct: 78  LKSHD-CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           L YL E+    +IHRDVK +NILLDE  +  + DFG++  L   D        G   ++A
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAAYMA 192

Query: 397 PEYLSTGQSSE-----KTDVFGFGILLLELISG 424
           PE +     ++     + DV+  GI L+EL +G
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 94.3 bits (235), Expect = 2e-20
 Identities = 23/110 (20%), Positives = 46/110 (41%), Gaps = 13/110 (11%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--------GPIPSTVSHLETLQYLRLNNN 81
           + N      +PT +  L ++  ++++ N               +     E +Q + +  N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315

Query: 82  SL-TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 126
           +L T  +  SL  M +L  L+  YN L G +P+F +     + N+  N +
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQI 365

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 89.3 bits (222), Expect = 6e-19
 Identities = 22/94 (23%), Positives = 39/94 (41%), Gaps = 11/94 (11%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 77
           S  ++          N + G +P   G   KL +L+L+ N  T    +     E ++ L 
Sbjct: 325 SLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLS 383

Query: 78  LNNNSLTGAIPPSLS--NMSQLAFLDLSYNNLSG 109
             +N L   IP      ++S ++ +D SYN +  
Sbjct: 384 FAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGS 416

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 88.9 bits (221), Expect = 8e-19
 Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 15/111 (13%)

Query: 30  LQNNNI--------SGHIPTEIGKLSKLLTLDLS-NNFFTGPIPSTVSHLETLQYLRLNN 80
           +  N                +     K+  + +  NN  T P+ +++  ++ L  L    
Sbjct: 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY 339

Query: 81  NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKT-----FNITGNSL 126
           N L G   P+  +  +LA L+L+YN ++    +F   T      +   N L
Sbjct: 340 NQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL 389

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 86.6 bits (215), Expect = 5e-18
 Identities = 23/117 (19%), Positives = 37/117 (31%), Gaps = 20/117 (17%)

Query: 30  LQNNNISG-------HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 82
              N I          +     K   + +++LSNN  +       S    L  + L  N 
Sbjct: 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM 468

Query: 83  LTG-------AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSL 126
           LT            +  N   L  +DL +N L+     F A         +++ NS 
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF 525

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 86.2 bits (214), Expect = 6e-18
 Identities = 13/94 (13%), Positives = 30/94 (31%), Gaps = 9/94 (9%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA-- 86
             +          +   L  L  +++ N      +P+ +  L  +Q + +  N       
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290

Query: 87  ------IPPSLSNMSQLAFLDLSYNNL-SGPVPS 113
                          ++  + + YNNL + PV +
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 85.5 bits (212), Expect = 1e-17
 Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 10/91 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSN------NFFTGPIPSTVSHLETLQYLRLNNNSL 83
           L  N+ S   PT+    S L    + N      N      P  ++   +L  L++ +N +
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578

Query: 84  TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 114
              +   +     ++ LD+  N       S+
Sbjct: 579 RK-VNEKI--TPNISVLDIKDNPNISIDLSY 606

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 83.6 bits (207), Expect = 4e-17
 Identities = 18/89 (20%), Positives = 34/89 (38%), Gaps = 10/89 (11%)

Query: 30  LQNNNISGHIP--TEIGKLSKLLTLDLSNNFFTG-------PIPSTVSHLETLQYLRLNN 80
             +N +   IP   +   +S +  +D S N           P+  T      +  + L+N
Sbjct: 384 FAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSN 442

Query: 81  NSLTGAIPPSLSNMSQLAFLDLSYNNLSG 109
           N ++       S  S L+ ++L  N L+ 
Sbjct: 443 NQISKFPKELFSTGSPLSSINLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 82.4 bits (204), Expect = 1e-16
 Identities = 12/81 (14%), Positives = 22/81 (27%), Gaps = 3/81 (3%)

Query: 28  RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAI 87
           R  Q N      P  I     L  L + +N     +   +     +  L + +N      
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISID 603

Query: 88  PPSLSNMSQLAFLDLSYNNLS 108
              +    +     L Y+   
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 17/103 (16%), Positives = 34/103 (33%), Gaps = 11/103 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             +NNI+  +   + +L+KL    + N+ F           E  +Y +            
Sbjct: 190 QLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDL 243

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAK-----TFNITGNSLI 127
              N+  L  +++        +P+F          N+  N  I
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 79.7 bits (197), Expect = 7e-16
 Identities = 14/90 (15%), Positives = 30/90 (33%), Gaps = 6/90 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQYLRLNNNSLTG 85
           L+    SG +P  IG+L++L  L L ++          P  +S   + +  +        
Sbjct: 88  LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQK 147

Query: 86  AIPPSLS--NMSQLAFLDLSYNNLSGPVPS 113
                    + S L    ++ +     +  
Sbjct: 148 TFVDYDPREDFSDLIKDCINSDPQQKSIKK 177

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 79.3 bits (196), Expect = 1e-15
 Identities = 19/98 (19%), Positives = 27/98 (27%), Gaps = 15/98 (15%)

Query: 30  LQNNNISG-------HIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLNNN 81
           L  N ++                   L ++DL  N  T        + L  L  + L+ N
Sbjct: 464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYN 523

Query: 82  SLTGAIPPSLSNMSQLAFL------DLSYNNLSGPVPS 113
           S +   P    N S L         D   N      P 
Sbjct: 524 SFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 10/85 (11%), Positives = 22/85 (25%), Gaps = 4/85 (4%)

Query: 33  NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG----AIP 88
           +         +    ++  L L     +G +P  +  L  L+ L L ++          P
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPS 113
             +S             +       
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVD 151

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 11/98 (11%), Positives = 25/98 (25%), Gaps = 13/98 (13%)

Query: 25  SFGRL-------LQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET- 72
           + G+L       L ++          P  I               +           +  
Sbjct: 100 AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFS 159

Query: 73  -LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 109
            L    +N++    +I  S     +   +    NN++ 
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 8/64 (12%), Positives = 23/64 (35%)

Query: 51  TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 110
             +   + +      +++    +  L L     +G +P ++  +++L  L L  +     
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 111 VPSF 114
              F
Sbjct: 121 ERLF 124

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.9 bits (228), Expect = 1e-19
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQFQTE---VEMISL 280
           ++FS   ++G+GGFG VY     D G + A+K L         GE     E   + ++S 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 281 AVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
                ++ +  +   T ++L  +   M+ G +   L        A  +  A     GL +
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 399
           +H +    +++RD+K ANILLDE+    + D GLA        H   +V GT G++APE 
Sbjct: 308 MHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEV 361

Query: 400 LSTGQSSEKT-DVFGFGILLLELISGL 425
           L  G + + + D F  G +L +L+ G 
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGH 388

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 91.6 bits (228), Expect = 1e-19
 Identities = 27/114 (23%), Positives = 42/114 (36%), Gaps = 12/114 (10%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 77
           +F R        +  N IS   P    KL  L  L+L +N  +     T +    L  L 
Sbjct: 44  NFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103

Query: 78  LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 126
           L +NS+             L  LDLS+N LS   + +       +   ++ N +
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 26/128 (20%), Positives = 44/128 (34%), Gaps = 18/128 (14%)

Query: 19  SDGVFFSFGRL----LQNNNIS--------GHIPTEIGKLSKLLTLDLSNNFFTGPIPST 66
           +D +     +L    LQ+NN++        G     +  LS L  L+L +N F       
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555

Query: 67  VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFN 120
              L  L+ + L  N+L        +N   L  L+L  N ++                 +
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD 615

Query: 121 ITGNSLIC 128
           +  N   C
Sbjct: 616 MRFNPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 87.4 bits (217), Expect = 3e-18
 Identities = 18/84 (21%), Positives = 34/84 (40%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L +N +         + S+L +LD+  N  +   P     L  L+ L L +N L+     
Sbjct: 32  LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDK 91

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPS 113
           + +  + L  L L  N++     +
Sbjct: 92  TFAFCTNLTELHLMSNSIQKIKNN 115

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 84.7 bits (210), Expect = 2e-17
 Identities = 21/105 (20%), Positives = 32/105 (30%), Gaps = 8/105 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           L  N IS         L  L  LDL  N     +       LE +  + L+ N       
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHA-------KTFNITGNSL 126
            S + +  L  L L    L     S             +++ N++
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 79.7 bits (197), Expect = 7e-16
 Identities = 26/103 (25%), Positives = 36/103 (34%), Gaps = 9/103 (8%)

Query: 20  DGVFFSFGRL----LQNNNISGHIPTEIG--KLSKLLTLDLSNNFFTGPIPSTVSHLETL 73
            G       L    L NN I      E+     S L  L+LS+N      P     +  L
Sbjct: 138 LGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRL 197

Query: 74  QYLRLNNNSLTGAIPPSLS---NMSQLAFLDLSYNNLSGPVPS 113
             L LNN  L  ++   L      + +  L LS + LS    +
Sbjct: 198 FGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 78.5 bits (194), Expect = 2e-15
 Identities = 23/130 (17%), Positives = 44/130 (33%), Gaps = 22/130 (16%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNF---------FTGPIPS 65
            +  F    +L    L+ NNI       +  L  +  L+L  +F                
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323

Query: 66  TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--------- 116
           +   L+ L++L + +N + G      + +  L +L LS +  S    +            
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383

Query: 117 KTFNITGNSL 126
              N+T N +
Sbjct: 384 HILNLTKNKI 393

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 77.7 bits (192), Expect = 3e-15
 Identities = 24/90 (26%), Positives = 33/90 (36%), Gaps = 10/90 (11%)

Query: 30  LQNNNISG--HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT--- 84
           L+   +      P+    L  L  LDLSNN         +  LE L+ L L +N+L    
Sbjct: 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLW 520

Query: 85  -----GAIPPSLSNMSQLAFLDLSYNNLSG 109
                G     L  +S L  L+L  N    
Sbjct: 521 KHANPGGPIYFLKGLSHLHILNLESNGFDE 550

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 77.0 bits (190), Expect = 5e-15
 Identities = 18/114 (15%), Positives = 44/114 (38%), Gaps = 11/114 (9%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             +  ++  +P ++   + +  L+L++N       +  +    L  L +  N+++   P 
Sbjct: 11  CSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE 67

Query: 90  SLSNMSQLAFLDLSYNNLSGPVP-SFHA----KTFNITGNSLICATGAEEDCFG 138
               +  L  L+L +N LS     +F         ++  NS+      + + F 
Sbjct: 68  LCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSI---QKIKNNPFV 118

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 76.6 bits (189), Expect = 8e-15
 Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 2/82 (2%)

Query: 30  LQNNNISGHIPTEIG--KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAI 87
           L N+ +S    T     K + L  LDLS N        + + L  L+Y  L  N++    
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288

Query: 88  PPSLSNMSQLAFLDLSYNNLSG 109
             SL  +  + +L+L  +    
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQ 310

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 21/100 (21%), Positives = 32/100 (32%), Gaps = 9/100 (9%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIG----KLSKLLTLDLSNNFFTGPIPSTVSHL 70
              +F     L    L N+  S    T         S L  L+L+ N  +       S L
Sbjct: 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL 404

Query: 71  ETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLSG 109
             L+ L L  N +   +       +  +  + LSYN    
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 20/83 (24%), Positives = 31/83 (37%), Gaps = 8/83 (9%)

Query: 49  LLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
               D S+   T  +P  +     +  L L +N L      + +  SQL  LD+ +N +S
Sbjct: 6   HEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 109 GPVP-SFHA----KTFNITGNSL 126
              P         K  N+  N L
Sbjct: 63  KLEPELCQKLPMLKVLNLQHNEL 85

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 55/239 (23%), Positives = 97/239 (40%), Gaps = 29/239 (12%)

Query: 209 VCLGNLKRFHFKELQSATSNFSSKNL---------VGKGGFGNVYKGY-LQDGTVVAVK- 257
           + L   K F F +L     +   K L         +G G  G V   +  +    VA++ 
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167

Query: 258 ------RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 311
                  +         +  +TE+E++    H  ++++  F     +  +V   M  G +
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL 226

Query: 312 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV---V 368
             ++     L  AT K         + YLHE     IIHRD+K  N+LL    E     +
Sbjct: 227 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283

Query: 369 GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELISG 424
            DFG +K+L   ++ +   + GT  ++APE L +  +   +   D +  G++L   +SG
Sbjct: 284 TDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 43/200 (21%), Positives = 87/200 (43%), Gaps = 15/200 (7%)

Query: 235 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLRLIGF 292
           +G+G +G V K  ++  G ++AVKR++       + +   ++++          +   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR----KRIALGAARGLLYLHEQCDPKI 348
                +  +    M + S+    K               +IA+   + L +LH +    +
Sbjct: 75  LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 131

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS--- 405
           IHRDVK +N+L++   +  + DFG++  L   D        G   ++APE ++   +   
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELNQKG 189

Query: 406 -SEKTDVFGFGILLLELISG 424
            S K+D++  GI ++EL   
Sbjct: 190 YSVKSDIWSLGITMIELAIL 209

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 88.6 bits (220), Expect = 7e-19
 Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 15/214 (7%)

Query: 222 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEV 275
           + S   + S        +G G +G V            A+K ++  +           EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 335
            ++ L  H N+++L  F        LV      G +   +  +   +      I      
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147

Query: 336 GLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
           G+ YLH+     I+HRD+K  N+LL   ++     + DFGL+ + +  +        GT 
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTA 202

Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 426
            +IAPE L   +  EK DV+  G++L  L++G  
Sbjct: 203 YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 88.3 bits (219), Expect = 1e-18
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 16/220 (7%)

Query: 216 RFHFKELQSAT-SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQF 271
           ++ + E Q      F    ++G+GGFG V+   ++  G + A K+L         G    
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232

Query: 272 QTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWA-TRKRI 329
             E ++++    R ++ L  +   T   L LV   M+ G +   +      +      R 
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291

Query: 330 ALGAAR---GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
               A+   GL +LH++    II+RD+K  N+LLD+     + D GLA  L    +    
Sbjct: 292 IFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348

Query: 387 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 425
              GT G +APE L  G+  + + D F  G+ L E+I+  
Sbjct: 349 YA-GTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAAR 386

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 16/213 (7%)

Query: 222 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE--IQFQTE 274
           +Q +T+ FS +     ++GKG FG V        G   AVK +                E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 275 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA 334
           V+++    H N+++L  F        LV    + G +   + ++         RI     
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
            G+ Y+H+    KI+HRD+K  N+LL    +     + DFGL+   +   S       GT
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGT 191

Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
             +IAPE L  G   EK DV+  G++L  L+SG
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 27/120 (22%), Positives = 45/120 (37%), Gaps = 10/120 (8%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETL 73
            DG+F     L    +  N+   +  + +    + L  LDLS              L  L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499

Query: 74  QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC 128
           Q L +++N+L        + +  L+ LD S+N +                FN+T NS+ C
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC 559

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 20/115 (17%), Positives = 39/115 (33%), Gaps = 13/115 (11%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 77
           SF          L    I          L  L  L L+ N      P + S L +L+ L 
Sbjct: 51  SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110

Query: 78  LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSF-----HAKTFNITGNSL 126
                L       +  +  L  L++++N +    +P++     +    +++ N +
Sbjct: 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI 165

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 78.5 bits (194), Expect = 2e-15
 Identities = 25/104 (24%), Positives = 39/104 (37%), Gaps = 7/104 (6%)

Query: 30  LQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
            Q++ +           L KLL LD+S              L +L  L++  NS      
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465

Query: 89  PS-LSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 126
            +  +N + L FLDLS   L       F      +  N++ N+L
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 76.6 bits (189), Expect = 6e-15
 Identities = 22/102 (21%), Positives = 30/102 (29%), Gaps = 5/102 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N +           S+L  LDLS              L  L  L L  N +    P 
Sbjct: 39  LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG 98

Query: 90  SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 126
           S S ++ L  L      L+             K  N+  N +
Sbjct: 99  SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 16/85 (18%), Positives = 28/85 (32%), Gaps = 2/85 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP-STVSHLETLQYLRLNNNSLTGAIP 88
           L  N     +      L +L  LD  ++        S    LE L YL ++  +      
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPS 113
                ++ L  L ++ N+      S
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLS 466

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 71.2 bits (175), Expect = 4e-13
 Identities = 17/80 (21%), Positives = 32/80 (40%), Gaps = 3/80 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             +  +S  +P +I   S    +DLS N        + S+   LQ+L L+   +      
Sbjct: 18  CMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74

Query: 90  SLSNMSQLAFLDLSYNNLSG 109
           +   +  L+ L L+ N +  
Sbjct: 75  AWHGLHHLSNLILTGNPIQS 94

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 70.1 bits (172), Expect = 7e-13
 Identities = 18/84 (21%), Positives = 36/84 (42%), Gaps = 5/84 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLNNNSLTGAIP 88
                ++      IG+L  L  L++++NF     +P+  S+L  L ++ L+ N +     
Sbjct: 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170

Query: 89  PSLSNMSQLAF----LDLSYNNLS 108
             L  + +       LD+S N + 
Sbjct: 171 NDLQFLRENPQVNLSLDMSLNPID 194

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 23/93 (24%), Positives = 35/93 (37%), Gaps = 9/93 (9%)

Query: 23  FFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET--LQYL 76
                 L    L  N  S  I  +   L  L  LDLS N  +     + S L T  L++L
Sbjct: 324 TLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381

Query: 77  RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 109
            L+ N     +  +   + +L  LD  ++ L  
Sbjct: 382 DLSFNGAII-MSANFMGLEELQHLDFQHSTLKR 413

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 57.7 bits (140), Expect = 6e-09
 Identities = 24/118 (20%), Positives = 43/118 (36%), Gaps = 18/118 (15%)

Query: 21  GVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 76
             F     +    L   +I  ++  ++ K  K  +L +         P+    L  L+ L
Sbjct: 279 VKFHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQLKQ-FPT--LDLPFLKSL 333

Query: 77  RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA------KTFNITGNSLI 127
            L  N  +  I      +  L++LDLS N LS     S+        +  +++ N  I
Sbjct: 334 TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 57.7 bits (140), Expect = 6e-09
 Identities = 14/109 (12%), Positives = 33/109 (30%), Gaps = 12/109 (11%)

Query: 30  LQNNNISGHIP-TEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ--------YLRLNN 80
           L+ N  S +I  T +  L+ L    L    F       +     ++          RL  
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270

Query: 81  NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSL 126
            +           ++ ++ + L+  ++            ++ +I    L
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL 319

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 24/111 (21%), Positives = 38/111 (34%), Gaps = 15/111 (13%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL------NNNS 82
           +  N I   I  +  +  KL  L L  NF +  I  T   +L  L   RL      +  +
Sbjct: 188 MSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN 246

Query: 83  LTGAIPPSLSNMSQLAF--LDLSYNNLSGPVP-SFHA----KTFNITGNSL 126
           L    P  +  +  +      L+Y N        FH        ++ G S+
Sbjct: 247 LEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 17/214 (7%)

Query: 221 ELQSAT-SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQFQTEVE 276
           E Q  T + F    ++GKGGFG V    ++  G + A K+L+        GE     E +
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236

Query: 277 MISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 335
           ++     R ++ L  +   T + L LV   M+ G +   +            R    AA 
Sbjct: 237 ILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFYAAE 294

Query: 336 ---GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
              GL  LH +   +I++RD+K  NILLD++    + D GLA  +   +        GTV
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRVGTV 349

Query: 393 GHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 425
           G++APE +   +    + D +  G LL E+I+G 
Sbjct: 350 GYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQ 382

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 84.9 bits (210), Expect = 3e-18
 Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 33/173 (19%)

Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------ 389
            + +LH +    ++HRD+K +NI         VGDFGL   +D  +   T          
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232

Query: 390 -----GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
                GT  +++PE +     S K D+F  G++L EL+          T  ++  ++  V
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF------STQMERVRIITDV 286

Query: 445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM 497
           + +                 Y   +   MVQ  +L     P+ RP+ ++++  
Sbjct: 287 RNLK--------FPLLFTQKYP--QEHMMVQ-DMLSPS--PTERPEATDIIEN 326

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 17/71 (23%), Positives = 33/71 (46%), Gaps = 1/71 (1%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           ++F     +G+GGFG V++     D    A+KR++  N      +   EV+ ++   H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 286 LLRLIGFCMTT 296
           ++R     + T
Sbjct: 66  IVRYFNAWLET 76

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 25/222 (11%)

Query: 223 QSATSNFSSK----NLVGKGGFGNVYKG-YLQDGTVVAVK--------RLKDGNAIGGEI 269
             +T  F        ++G+G    V +  +       AVK                    
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 270 QFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR 328
               EV+ +  ++ H N+++L     T T   LV+  M  G +   L  K +L     ++
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           I       +  LH+     I+HRD+K  NILLD+     + DFG +  LD     +    
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVC 184

Query: 389 RGTVGHIAPEYLSTGQSSEKT------DVFGFGILLLELISG 424
            GT  ++APE +    +          D++  G+++  L++G
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISL----AVH 283
           L+GKGGFG V+ G+ L D   VA+K     R+   + +   +    EV ++        H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGS-VASRLKAKPSLDWATRKRIALGAARGLLYLHE 342
             ++RL+ +  T    +LV         +   +  K  L     +         + + H 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157

Query: 343 QCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
           +    ++HRD+K  NIL+D       + DFG   LL   D   T    GT  +  PE++S
Sbjct: 158 R---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFD-GTRVYSPPEWIS 211

Query: 402 TGQ-SSEKTDVFGFGILLLELISG 424
             Q  +    V+  GILL +++ G
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCG 235

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 85.7 bits (212), Expect = 1e-17
 Identities = 22/124 (17%), Positives = 41/124 (33%), Gaps = 24/124 (19%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP---------IPSTVS 68
           S+  L       L N      +P  +  L +L +L+++ N              +     
Sbjct: 486 SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545

Query: 69  HLETLQYLRLNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNIT 122
               +Q   +  N+L    P S  L  M +L  LD  +N +   + +F          + 
Sbjct: 546 TGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLD 603

Query: 123 GNSL 126
            N +
Sbjct: 604 YNQI 607

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 81.8 bits (202), Expect = 2e-16
 Identities = 14/90 (15%), Positives = 24/90 (26%), Gaps = 9/90 (10%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG--- 85
                    +       L  L  ++L N      +P  +  L  LQ L +  N       
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532

Query: 86  ------AIPPSLSNMSQLAFLDLSYNNLSG 109
                  +        ++    + YNNL  
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEE 562

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 80.7 bits (199), Expect = 4e-16
 Identities = 22/118 (18%), Positives = 37/118 (31%), Gaps = 17/118 (14%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDL------SNNFFTGPIPSTVSHLETLQYLRLNNNSL 83
           +  N  S   PT+    S+L    +        N      P+ ++   +L  L++ +N +
Sbjct: 760 VSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818

Query: 84  TGAIPPSLSNMSQLAFLDLSYNNL-SGPVPSF------HAKTFNITGNSLICATGAEE 134
              +   L    QL  LD++ N   S  V S                   I    A  
Sbjct: 819 RK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 78.4 bits (193), Expect = 2e-15
 Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 19/110 (17%)

Query: 28  RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP-------------------IPSTVS 68
           ++    N    I   I +L+KL  +  +N+ FT                        + S
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488

Query: 69  HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKT 118
           +L+ L  + L N      +P  L ++ +L  L+++ N            T
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 73.8 bits (181), Expect = 6e-14
 Identities = 18/99 (18%), Positives = 36/99 (36%), Gaps = 5/99 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             +N +  H+    G   KL  L L  N          +  + ++ L  ++N L   IP 
Sbjct: 580 CVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPN 636

Query: 90  --SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSL 126
             +  ++  +  +D SYN +     +      +  G + 
Sbjct: 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 73.8 bits (181), Expect = 6e-14
 Identities = 12/86 (13%), Positives = 30/86 (34%), Gaps = 8/86 (9%)

Query: 30  LQNNNISGHIP--TEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET-----LQYLRLNNNS 82
             +N +   IP       +  + ++D S N       +    ++         + L+ N 
Sbjct: 626 FSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684

Query: 83  LTGAIPPSLSNMSQLAFLDLSYNNLS 108
           +        +  S ++ + LS N ++
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMT 710

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 69.9 bits (171), Expect = 9e-13
 Identities = 19/98 (19%), Positives = 31/98 (31%), Gaps = 15/98 (15%)

Query: 30  LQNNNIS-------GHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLNNN 81
           L NN ++                   L T+DL  N  T        + L  L  + ++ N
Sbjct: 704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYN 763

Query: 82  SLTGAIPPSLSNMSQLAFLDLSY------NNLSGPVPS 113
             +   P    N SQL    + +      N +    P+
Sbjct: 764 CFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 15/84 (17%), Positives = 26/84 (30%), Gaps = 3/84 (3%)

Query: 25  SFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT 84
              R  + N I    PT I     L+ L + +N     +   +     L  L + +N   
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNI 840

Query: 85  GAIPPSLSNMSQLAFLDLSYNNLS 108
                S+    +     L Y+   
Sbjct: 841 SIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 14/81 (17%), Positives = 25/81 (30%), Gaps = 1/81 (1%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L      G +P  IG+L++L  L    +  T           T        + +      
Sbjct: 330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389

Query: 90  -SLSNMSQLAFLDLSYNNLSG 109
             L    +L   DL  + ++ 
Sbjct: 390 MFLDYDQRLNLSDLLQDAINR 410

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 64.5 bits (157), Expect = 6e-11
 Identities = 9/81 (11%), Positives = 23/81 (28%)

Query: 33  NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLS 92
           +        ++    ++  L L+     G +P  +  L  L+ L    +S T +      
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 93  NMSQLAFLDLSYNNLSGPVPS 113
                   +   + +      
Sbjct: 369 EELTPDMSEERKHRIRMHYKK 389

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 57.6 bits (139), Expect = 6e-09
 Identities = 12/105 (11%), Positives = 29/105 (27%), Gaps = 7/105 (6%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLT-LDLSNNFFT-----GPIPSTVSHLETLQYLRLNNNS 82
             + + I  H         + L   DL  +         PI            +    N 
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR 436

Query: 83  LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLI 127
           +T  I  ++  +++L  +  + +  +    +   +  N       
Sbjct: 437 ITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 54.5 bits (131), Expect = 7e-08
 Identities = 7/76 (9%), Positives = 24/76 (31%)

Query: 51  TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 110
             +   + +       + +   +  L L      G +P ++  +++L  L    ++ +  
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 111 VPSFHAKTFNITGNSL 126
              F  +      +  
Sbjct: 363 GRLFGDEELTPDMSEE 378

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 17/202 (8%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHR--N 285
           L+G GGFG+VY G  + D   VA+K     R+ D   +    +   EV ++         
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 286 LLRLIGFCMTTTERLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           ++RL+ +       +L+         +   +  + +L     +         + + H   
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 168

Query: 345 DPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              ++HRD+K  NIL+D     + + DFG   LL   D+  T    GT  +  PE++   
Sbjct: 169 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFD-GTRVYSPPEWIRYH 223

Query: 404 Q-SSEKTDVFGFGILLLELISG 424
           +       V+  GILL +++ G
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCG 245

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 45/216 (20%), Positives = 81/216 (37%), Gaps = 19/216 (8%)

Query: 219 FKELQSATSNFSS----KNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT 273
            ++L   +  F+     K  +G G +    +          AVK +        E     
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----- 64

Query: 274 EVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
           E+E ++    H N++ L           +V   M  G +  ++  +          +   
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT 124

Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVTTAV 388
             + + YLH Q    ++HRD+K +NIL  +         + DFG AK L   +  + T  
Sbjct: 125 ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181

Query: 389 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
             T   +APE L         D++  G+LL  +++G
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 11/217 (5%)

Query: 213 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ- 270
           +  R +     +    ++   ++GKG FG V K          AVK +   +A   +   
Sbjct: 8   SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67

Query: 271 FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIA 330
              EVE++    H N+++L      ++   +V    + G +   +  +         RI 
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTA 387
                G+ Y+H+     I+HRD+K  NILL   ++  +  + DFGL+      ++ +   
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDR 183

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           + GT  +IAPE L  G   EK DV+  G++L  L+SG
Sbjct: 184 I-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 49/223 (21%), Positives = 86/223 (38%), Gaps = 26/223 (11%)

Query: 222 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLK------------DGNA 264
           ++               +G G +G V         +  A+K +K            + N 
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 265 IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWA 324
                +   E+ ++    H N+++L           LV  +   G +  ++  +   D  
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146

Query: 325 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCD 381
               I      G+ YLH+     I+HRD+K  NILL   +      + DFGL+      D
Sbjct: 147 DAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-D 202

Query: 382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
             +   + GT  +IAPE L   + +EK DV+  G+++  L+ G
Sbjct: 203 YKLRDRL-GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 13/218 (5%)

Query: 212 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ 270
              +  +F+   +    ++   ++GKG FG V K          AVK +   +A   +  
Sbjct: 9   SGRENLYFQG--TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66

Query: 271 -FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 329
               EVE++    H N+++L      ++   +V    + G +   +  +         RI
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI 126

Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTT 386
                 G+ Y+H+     I+HRD+K  NILL   ++  +  + DFGL+      ++ +  
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKD 182

Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            + GT  +IAPE L  G   EK DV+  G++L  L+SG
Sbjct: 183 RI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 81.4 bits (201), Expect = 6e-17
 Identities = 56/247 (22%), Positives = 87/247 (35%), Gaps = 59/247 (23%)

Query: 232 KNLVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           K  +G+G +G V      Q   + A+K     +++  N    E + +TEV ++    H N
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE-RIKTEVRLMKKLHHPN 89

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG------------- 332
           + RL           LV      G +  +L               +              
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 333 --------------------AAR-------GLLYLHEQCDPKIIHRDVKAANILL--DEY 363
                                +         L YLH Q    I HRD+K  N L   ++ 
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKS 206

Query: 364 YEAVVGDFGLAKLLDHCDSH----VTTAVRGTVGHIAPEYLSTGQSS--EKTDVFGFGIL 417
           +E  + DFGL+K     ++     +TT   GT   +APE L+T   S   K D +  G+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 418 LLELISG 424
           L  L+ G
Sbjct: 266 LHLLLMG 272

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)

Query: 226 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVK-------RLKDGNAIGGEIQFQTEVE- 276
              +  K+++G+G    V +  +   G   AVK       RL            + E   
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           +  +A H +++ LI    +++   LV+  M  G +   L  K +L     + I       
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
           + +LH      I+HRD+K  NILLD+  +  + DFG +  L+     +     GT G++A
Sbjct: 213 VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELC-GTPGYLA 267

Query: 397 PEYLSTGQS------SEKTDVFGFGILLLELISG 424
           PE L            ++ D++  G++L  L++G
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 28/121 (23%), Positives = 50/121 (41%), Gaps = 13/121 (10%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 74
           S   F  F  L    L   ++S  +P+ +  LS L  L LS N F      + S+  +L 
Sbjct: 270 SSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT 328

Query: 75  YLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHA-------KTFNITGNSL 126
           +L +  N+    +    L N+  L  LDLS++++                ++ N++ N  
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388

Query: 127 I 127
           +
Sbjct: 389 L 389

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.4 bits (199), Expect = 4e-16
 Identities = 29/122 (23%), Positives = 55/122 (45%), Gaps = 13/122 (10%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIG---KLSKLLTLDLSNNFFTGPIPSTVSHLE 71
           S+ +F     L    LQ N+       +      L +L  L LS    +       + L+
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500

Query: 72  TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS-FHA----KTFNITGNSL 126
            + ++ L++N LT +   +LS++  + +L+L+ N++S  +PS        +T N+  N L
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559

Query: 127 IC 128
            C
Sbjct: 560 DC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.4 bits (199), Expect = 4e-16
 Identities = 18/85 (21%), Positives = 23/85 (27%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
              N +     T   +L  L  LDL+          T      L  L L  N L      
Sbjct: 40  FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET 99

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSF 114
           +LS    L  L      +S      
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIP 124

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.1 bits (198), Expect = 6e-16
 Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 1/84 (1%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           LQ +             S L  LDL+    +  +PS +  L TL+ L L+ N        
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQI 319

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPS 113
           S SN   L  L +  N     + +
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGT 343

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 74.7 bits (184), Expect = 3e-14
 Identities = 18/102 (17%), Positives = 33/102 (32%), Gaps = 5/102 (4%)

Query: 13  LIQVICSDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTV 67
           +    C +    +   L    L  N           +  +L  LDL+          S  
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421

Query: 68  SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 109
            +L  L+ L L+++ L  +       +  L  L+L  N+   
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 18/117 (15%), Positives = 35/117 (29%), Gaps = 11/117 (9%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
            +N  ++  IP  +   +    L+ S N       +T S L  L +L L    +      
Sbjct: 19  CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75

Query: 90  SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICATGAEEDCFGTAP 141
           +  +  +L  L L+ N L      +       K        +   +  +        
Sbjct: 76  TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI---SSIDFIPLHNQK 129

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 20/94 (21%), Positives = 32/94 (34%), Gaps = 7/94 (7%)

Query: 23  FFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQYLR 77
                 L    L  N               L  L +  N     + +  + +LE L+ L 
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356

Query: 78  LNNNSLT--GAIPPSLSNMSQLAFLDLSYNNLSG 109
           L+++ +         L N+S L  L+LSYN    
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 14/105 (13%), Positives = 28/105 (26%), Gaps = 8/105 (7%)

Query: 30  LQNNNISGHIPTEIG--KLSKLLTLDLSNNFFTGPIPSTVSHLE--TLQYLRLNNNSLTG 85
                    I   +    +  L      +       P+    L   +++ + L  +    
Sbjct: 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268

Query: 86  AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 126
               +    S L  LDL+  +LS            K   ++ N  
Sbjct: 269 ISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKF 313

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 18/107 (16%), Positives = 39/107 (36%), Gaps = 12/107 (11%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP-----STVSHLETLQYLRLNNNSLT 84
           L  N+I+  I       +   +L+         I      ST+  L    +  +++  ++
Sbjct: 186 LNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244

Query: 85  GAIPPSLSNMSQLAFLDLSYNNLSGPVP-SFHA----KTFNITGNSL 126
            A+   L  MS +  ++L  +        +FH     +  ++T   L
Sbjct: 245 PAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 39/251 (15%)

Query: 200 DVNEQRREEVCLGNLKRF-----HFKELQSATSNFSSKNLVGKGGFGNVY----KGYLQD 250
           + +  RRE+  L  L+         K+++    +F    ++G+G FG V     K     
Sbjct: 42  NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---A 98

Query: 251 GTVVAVKRLKDGNAIG-GEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMS 307
             V A+K L     +   E   F+ E +++     + +  L  +       L LV  Y  
Sbjct: 99  DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYV 157

Query: 308 NG---SVASRLKAKPSLDWATRKR-----IALGAARGLLYLHEQCDPKIIHRDVKAANIL 359
            G   ++ S+ + +   + A   R     + +     +  +H+      +HRD+K  NIL
Sbjct: 158 GGDLLTLLSKFEDRLPEEMA---RFYLAEMVIA----IDSVHQL---HYVHRDIKPDNIL 207

Query: 360 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-----DVFGF 414
           +D      + DFG    L    +  ++   GT  +I+PE L   +  +       D +  
Sbjct: 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267

Query: 415 GILLLELISGL 425
           G+ + E++ G 
Sbjct: 268 GVCMYEMLYGE 278

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 71/289 (24%), Positives = 108/289 (37%), Gaps = 67/289 (23%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-------------------------RLKDGNAIGGEI 269
           GKG +G V   Y   D T  A+K                                 G   
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRK 327
           Q   E+ ++    H N+++L+       E  L  V+  ++ G V         ++  T K
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---------MEVPTLK 132

Query: 328 RIALGAAR--------GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 379
            ++   AR        G+ YLH Q   KIIHRD+K +N+L+ E     + DFG++     
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 380 CDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISG--------LRAL 428
            D+ ++  V GT   +APE LS  +   S +  DV+  G+ L   + G        +  L
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248

Query: 429 EFGKTANQKGAMLDWVKKIHQEKKL--EMLVDKDLKNNYDRIELEEMVQ 475
              K  +Q     D        K L   ML     KN   RI + E+  
Sbjct: 249 -HSKIKSQALEFPDQPDIAEDLKDLITRMLD----KNPESRIVVPEIKL 292

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 45/200 (22%), Positives = 81/200 (40%), Gaps = 13/200 (6%)

Query: 230 SSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 287
                +G+G F    K    +     AVK +        E   Q E+  +     H N++
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIV 69

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           +L           LV   ++ G +  R+K K          I       + ++H+     
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---G 126

Query: 348 IIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           ++HRD+K  N+L    ++  E  + DFG A+L    +  + T    T+ + APE L+   
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNG 185

Query: 405 SSEKTDVFGFGILLLELISG 424
             E  D++  G++L  ++SG
Sbjct: 186 YDESCDLWSLGVILYTMLSG 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
              F    ++G G F  V+       G + A+K +K  +    +   + E+ ++    H 
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHE 66

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLH 341
           N++ L     +TT   LV   +S G +  R+  +      D +   +  L A   + YLH
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA---VKYLH 123

Query: 342 EQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
           E     I+HRD+K  N+L    +E  + ++ DFGL+K+    +  ++TA  GT G++APE
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTAC-GTPGYVAPE 177

Query: 399 YLSTGQSSEKTDVFGFGILLLELISG 424
            L+    S+  D +  G++   L+ G
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCG 203

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 80.7 bits (199), Expect = 3e-16
 Identities = 50/230 (21%), Positives = 89/230 (38%), Gaps = 20/230 (8%)

Query: 207 EEVCLGNLKRFHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKD 261
           +       K+++ + ++    +          +G G FG V++      G   A K +  
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192

Query: 262 GNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS- 320
            +    E   + E++ +S+  H  L+ L        E +++Y +MS G +  ++  + + 
Sbjct: 193 PHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251

Query: 321 ---LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 375
               +     R       GL ++HE      +H D+K  NI+        +   DFGL  
Sbjct: 252 MSEDEAVEYMRQVCK---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305

Query: 376 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 425
            LD     V     GT    APE          TD++  G+L   L+SGL
Sbjct: 306 HLDP-KQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 14/218 (6%)

Query: 215 KRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT 273
            R +     +    F  K  +G G FG+V+       G    +K +    +     Q + 
Sbjct: 10  GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69

Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 333
           E+E++    H N++++           +V      G +  R+ +  +   A  +      
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129

Query: 334 AR----GLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTT 386
            +     L Y H Q    ++H+D+K  NIL      +    + DFGLA+L    D H T 
Sbjct: 130 MKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTN 185

Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           A  GT  ++APE       + K D++  G+++  L++G
Sbjct: 186 AA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 29/209 (13%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVK---RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           L+G+G +G V +    +     AVK   + K      GE   + E++++    H+N+++L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 290 --IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLY 339
             + +     +  +V  Y   G     +     LD    KR  +  A         GL Y
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGM--QEM-----LDSVPEKRFPVCQAHGYFCQLIDGLEY 124

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAP 397
           LH Q    I+H+D+K  N+LL       +   G+A+ L     D    T+ +G+     P
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPP 180

Query: 398 EYLSTGQ--SSEKTDVFGFGILLLELISG 424
           E  +     S  K D++  G+ L  + +G
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 47/224 (20%), Positives = 89/224 (39%), Gaps = 26/224 (11%)

Query: 216 RFHFKELQSATSNFS-----SKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 269
              F+  +      +     SK ++G G  G V + +  + G   A+K L D      E+
Sbjct: 13  EVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV 72

Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTER----LLVYPYMSNGSVASRLKAKPSLDWAT 325
                      +   +++ ++             L++   M  G + SR++ +    +  
Sbjct: 73  DH-----HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE 127

Query: 326 RK--RIALGAARGLLYLHEQCDPKIIHRDVKAANILL-DEYYEAVV--GDFGLAKLLDHC 380
           R+   I       + +LH      I HRDVK  N+L   +  +AV+   DFG AK     
Sbjct: 128 REAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-- 182

Query: 381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            + + T    T  ++APE L   +  +  D++  G+++  L+ G
Sbjct: 183 QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 20/203 (9%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-------RLKDGNAIGGEIQFQTEVEMISLAVHRNLL 287
           G G  G V   +  +    VA+K        +         +  +TE+E++    H  ++
Sbjct: 19  GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           ++  F     +  +V   M  G +  ++     L  AT K         + YLHE     
Sbjct: 79  KIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---G 134

Query: 348 IIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
           IIHRD+K  N+LL    E     + DFG +K+L   ++ +   + GT  ++APE L +  
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVG 192

Query: 405 S---SEKTDVFGFGILLLELISG 424
           +   +   D +  G++L   +SG
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSG 215

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 21/203 (10%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G G F  V K      G   A K     + +         + + EV ++   +H N++ L
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 346
                  T+ +L+   +S G +   L  K SL   +  +  +  L    G+ YLH +   
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYLHTK--- 134

Query: 347 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
           KI H D+K  NI+L           + DFGLA  ++           GT   +APE ++ 
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKNIF-GTPEFVAPEIVNY 192

Query: 403 GQSSEKTDVFGFGILLLELISGL 425
                + D++  G++   L+SG 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGA 215

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 79.3 bits (196), Expect = 6e-16
 Identities = 45/211 (21%), Positives = 87/211 (41%), Gaps = 19/211 (9%)

Query: 226 TSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 279
            + F+ +      +GKG F  V +   +  G   A   +        + Q  + E  +  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARG 336
           L  H N++RL           L++  ++ G +   + A+      D +   +  L A   
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA--- 122

Query: 337 LLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 393
           +L+ H+     ++HR++K  N+LL    +     + DFGLA  ++           GT G
Sbjct: 123 VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178

Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           +++PE L      +  D++  G++L  L+ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 78.6 bits (194), Expect = 8e-16
 Identities = 55/253 (21%), Positives = 93/253 (36%), Gaps = 41/253 (16%)

Query: 200 DVNEQRREEVCLGNLKRF-----HFKELQSATSNFSSKNLVGKGGFGNVY----KGYLQD 250
             +E  +++     L+         KE++    +F    ++G+G F  V     K     
Sbjct: 29  GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---T 85

Query: 251 GTVVAVKRLKDGNAIG-GEI-QFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMS 307
           G V A+K +   + +  GE+  F+ E +++     R + +L  F       L LV  Y  
Sbjct: 86  GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYV 144

Query: 308 NGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDPKIIHRDVKAANIL 359
            G + + L           +RI    AR         +  +H       +HRD+K  NIL
Sbjct: 145 GGDLLTLLSKF-------GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNIL 194

Query: 360 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG------ 413
           LD      + DFG    L    +  +    GT  +++PE L        T  +G      
Sbjct: 195 LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254

Query: 414 -FGILLLELISGL 425
             G+   E+  G 
Sbjct: 255 ALGVFAYEMFYGQ 267

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 76.4 bits (189), Expect = 1e-15
 Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 14/208 (6%)

Query: 226 TSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 279
           ++ FS        +GKG F  V +      G   A K +        + Q  + E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
              H N++RL       +   LV+  ++ G +   + A+     A            + Y
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
            H      I+HR++K  N+LL    +     + DFGLA  ++  DS       GT G+++
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLS 175

Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISG 424
           PE L     S+  D++  G++L  L+ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 25/214 (11%)

Query: 224 SATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQT 273
           S   + +      N +G+G +G V            A K      ++D +        + 
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF------KQ 55

Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 333
           E+E++    H N++RL       T+  LV    + G +  R+  K     +   RI    
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 390
              + Y H+     + HRD+K  N L           + DFGLA         +     G
Sbjct: 116 LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVG 170

Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           T  +++P+ L  G    + D +  G+++  L+ G
Sbjct: 171 TPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 24/203 (11%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
            +G+G +G V           VAVK +    A+      + E+ +  +  H N+++  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQC 344
                 + L   Y S G +  R++            +    A+        G++YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD--------IGMPEPDAQRFFHQLMAGVVYLHGI- 124

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAPEYLS- 401
              I HRD+K  N+LLDE     + DFGLA +  +   +  +     GT+ ++APE L  
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181

Query: 402 TGQSSEKTDVFGFGILLLELISG 424
               +E  DV+  GI+L  +++G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 20/222 (9%)

Query: 215 KRFHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 269
           K++  + ++    +          +G G FG V++      G V   K +     +    
Sbjct: 35  KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY- 93

Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL----DWAT 325
             + E+ +++   H  L+ L        E +L+  ++S G +  R+ A+       +   
Sbjct: 94  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153

Query: 326 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--DEYYEAVVGDFGLAKLLDHCDSH 383
             R A     GL ++HE     I+H D+K  NI+    +     + DFGLA  L+  D  
Sbjct: 154 YMRQACE---GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEI 206

Query: 384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 425
           V      T    APE +        TD++  G+L   L+SGL
Sbjct: 207 VKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 20/215 (9%)

Query: 222 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEV 275
           + +A++ FS        +GKG F  V +      G   A K +        + Q  + E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALG 332
            +     H N++RL       +   LV+  ++ G +   + A+      D +   +  L 
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139

Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA---VVGDFGLAKLLDHCDSHVTTAVR 389
           +   + Y H      I+HR++K  N+LL    +     + DFGLA  ++  DS       
Sbjct: 140 S---IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFA 191

Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           GT G+++PE L     S+  D++  G++L  L+ G
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 18/202 (8%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           GKG F  V +    + G   AVK     +      +  E   + E  +  +  H +++ L
Sbjct: 33  GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHMLKHPHIVEL 91

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL----YLHEQCD 345
           +    +     +V+ +M    +   +  +    +   + +A    R +L    Y H+   
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-- 149

Query: 346 PKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
             IIHRDVK   +LL   +      +G FG+A  L          V GT   +APE +  
Sbjct: 150 -NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKR 207

Query: 403 GQSSEKTDVFGFGILLLELISG 424
               +  DV+G G++L  L+SG
Sbjct: 208 EPYGKPVDVWGCGVILFILLSG 229

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 21/203 (10%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G G F  V K      G   A K     + +         + + EV ++   +H N++ L
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 346
                  T+ +L+   +S G +   L  K SL   +  +  +  L    G+ YLH +   
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYLHTK--- 134

Query: 347 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
           KI H D+K  NI+L           + DFGLA  ++           GT   +APE ++ 
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKNIF-GTPEFVAPEIVNY 192

Query: 403 GQSSEKTDVFGFGILLLELISGL 425
                + D++  G++   L+SG 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGA 215

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 51/223 (22%), Positives = 84/223 (37%), Gaps = 27/223 (12%)

Query: 224 SATSNFS-----SKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE- 276
           S +  F       ++++G+G    V     L      AVK ++         +   EVE 
Sbjct: 5   SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEM 63

Query: 277 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           +     HRN+L LI F        LV+  M  GS+ S +  +   +      +    A  
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123

Query: 337 LLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHV-------TT 386
           L +LH +    I HRD+K  NIL    ++     + DF L   +               T
Sbjct: 124 LDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 387 AVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELISG 424
              G+  ++APE +              D++  G++L  L+SG
Sbjct: 181 PC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 21/203 (10%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G G F  V K      G   A K     RL          + + EV ++    H N++ L
Sbjct: 14  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 346
                  T+ +L+   +S G +   L  K SL   +     +  L    G+ YLH +   
Sbjct: 74  HDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSK--- 127

Query: 347 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
           +I H D+K  NI+L           + DFG+A  ++   +       GT   +APE ++ 
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIF-GTPEFVAPEIVNY 185

Query: 403 GQSSEKTDVFGFGILLLELISGL 425
                + D++  G++   L+SG 
Sbjct: 186 EPLGLEADMWSIGVITYILLSGA 208

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 21/211 (9%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIG-GEIQF-QTEVEMISLAVH 283
            +F     +GKG FG V      D   + A+K +     +   E++    E++++    H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 284 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRK----RIALGAARGLL 338
             L+ L  +     E + +V   +  G +   L+        T K     + +     L 
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA----LD 129

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
           YL  Q   +IIHRD+K  NILLDE+    + DF +A +L        T + GT  ++APE
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITTMAGTKPYMAPE 184

Query: 399 YLSTGQSSEKT---DVFGFGILLLELISGLR 426
             S+ + +  +   D +  G+   EL+ G R
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 53/250 (21%), Positives = 92/250 (36%), Gaps = 40/250 (16%)

Query: 200 DVNEQRREEVCLGNLKRF-----HFKELQSATSNFSSKNLVGKGGFGNVY----KGYLQD 250
           D    R+ +     L R+       ++L+    ++    ++G+G FG V     K     
Sbjct: 37  DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---T 93

Query: 251 GTVVAVKRLKDGNAIG-GEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMS 307
             V A+K L     I   +   F  E ++++ A    +++L  +       L +V  YM 
Sbjct: 94  RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMP 152

Query: 308 NGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDPKIIHRDVKAANIL 359
            G + + +             +    AR         L  +H       IHRDVK  N+L
Sbjct: 153 GGDLVNLMS---------NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNML 200

Query: 360 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK----TDVFGFG 415
           LD+     + DFG    ++           GT  +I+PE L +           D +  G
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260

Query: 416 ILLLELISGL 425
           + L E++ G 
Sbjct: 261 VFLYEMLVGD 270

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 17/200 (8%)

Query: 236 GKGGFGNVYKG-YLQDGTVVAVK-----RLKDGNAIGGEI--QFQTEVEMISLAVHRNLL 287
           G G FG V+     +    V VK     ++ +   I      +   E+ ++S   H N++
Sbjct: 33  GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92

Query: 288 RLIGFCMTTTERLLVYPYMSNGS-VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           +++          LV     +G  + + +   P LD      I       + YL  +   
Sbjct: 93  KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK--- 149

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
            IIHRD+K  NI++ E +   + DFG A  L+       T   GT+ + APE L  G   
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYTFC-GTIEYCAPEVLM-GNPY 206

Query: 407 E--KTDVFGFGILLLELISG 424
              + +++  G+ L  L+  
Sbjct: 207 RGPELEMWSLGVTLYTLVFE 226

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 25/212 (11%)

Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAI-GGEIQF-QTEVEMISLAVH 283
            +F    ++G+G F  V     L      A+K L+  + I   ++ +   E +++S   H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 284 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR------- 335
              ++L  F     E+L     Y  NG +   ++                  R       
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKI--------GSFDETCTRFYTAEIV 140

Query: 336 -GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTVG 393
             L YLH +    IIHRD+K  NILL+E     + DFG AK+L             GT  
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGL 425
           +++PE L+   + + +D++  G ++ +L++GL
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 40/175 (22%), Positives = 67/175 (38%), Gaps = 25/175 (14%)

Query: 216 RFHFKELQSATS--NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----- 267
                   SATS   +     +G+G +G VYK         VA+KR++  +   G     
Sbjct: 21  SMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA 80

Query: 268 --EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWAT 325
             E+    E++      HRN++ L           L++ Y  N  +   +   P +    
Sbjct: 81  IREVSLLKELQ------HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRV 133

Query: 326 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG-----DFGLAK 375
            K        G+ + H +   + +HRD+K  N+LL     +        DFGLA+
Sbjct: 134 IKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 16/205 (7%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
             S   ++G G FG V+K      G  +A K +K       E + + E+ +++   H NL
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANL 148

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS----LDWATRKRIALGAARGLLYLHE 342
           ++L     +  + +LV  Y+  G +  R+  +      LD     +       G+ ++H+
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQ 205

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
                I+H D+K  NIL        +   DFGLA+        +     GT   +APE +
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVNF-GTPEFLAPEVV 260

Query: 401 STGQSSEKTDVFGFGILLLELISGL 425
           +    S  TD++  G++   L+SGL
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGL 285

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 74.6 bits (184), Expect = 8e-15
 Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 18/197 (9%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           GKG F  V     +  G  VA+K     +L   +      +   EV ++ +  H N+++L
Sbjct: 24  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS----LQKLFREVRIMKILNHPNIVKL 79

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 349
                T     L+  Y S G V   L A   +     +         + Y H++    I+
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IV 136

Query: 350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 407
           HRD+KA N+LLD      + DFG +         +     G   + APE    G+  +  
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC-GAPPYAAPELFQ-GKKYDGP 193

Query: 408 KTDVFGFGILLLELISG 424
           + DV+  G++L  L+SG
Sbjct: 194 EVDVWSLGVILYTLVSG 210

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 24/203 (11%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
            +G+G +G V           VAVK +    A+      + E+ +  +  H N+++  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQC 344
                 + L   Y S G +  R+             +    A+        G++YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI--------EPDIGMPEPDAQRFFHQLMAGVVYLHGI- 124

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAPEYLS- 401
              I HRD+K  N+LLDE     + DFGLA +  +   +  +     GT+ ++APE L  
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181

Query: 402 TGQSSEKTDVFGFGILLLELISG 424
               +E  DV+  GI+L  +++G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 19/167 (11%)

Query: 224 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISL- 280
            ATS +     +G G +G VYK      G  VA+K ++  N  GG      + V  ++L 
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 281 -----AVHRNLLRLIGFCMTTTERL-----LVYPYMSN--GSVASRLKAKPSLDWATRKR 328
                  H N++RL+  C T+         LV+ ++     +   +    P L   T K 
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP-PPGLPAETIKD 124

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
           +     RGL +LH      I+HRD+K  NIL+       + DFGLA+
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 49/203 (24%), Positives = 78/203 (38%), Gaps = 21/203 (10%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G G F  V K      G   A K     R K           + EV ++    H N++ L
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 346
                  T+ +L+   ++ G +   L  K SL   +     +  L     + YLH     
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---VYYLHSL--- 133

Query: 347 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
           +I H D+K  NI+L           + DFGLA  +D   +       GT   +APE ++ 
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIF-GTPEFVAPEIVNY 191

Query: 403 GQSSEKTDVFGFGILLLELISGL 425
                + D++  G++   L+SG 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGA 214

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 20/199 (10%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           G G  G V + +  +     A+K L+D      E++          +   +++R++    
Sbjct: 71  GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVYE 125

Query: 295 TTTER----LLVYPYMSNGSVASRLKAKPSLDWATRK--RIALGAARGLLYLHEQCDPKI 348
                    L+V   +  G + SR++ +    +  R+   I       + YLH      I
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NI 182

Query: 349 IHRDVKAANILL-DEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
            HRDVK  N+L   +   A++   DFG AK     +S +TT    T  ++APE L   + 
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKY 240

Query: 406 SEKTDVFGFGILLLELISG 424
            +  D++  G+++  L+ G
Sbjct: 241 DKSCDMWSLGVIMYILLCG 259

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 74.9 bits (183), Expect = 4e-14
 Identities = 61/365 (16%), Positives = 105/365 (28%), Gaps = 99/365 (27%)

Query: 190 RQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLV--GKGGFGNVYKGY 247
           R  ++ Q+F   N  R +      L++    EL+ A      KN++  G  G G   K  
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYL--KLRQ-ALLELRPA------KNVLIDGVLGSG---K-- 163

Query: 248 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-----LV 302
               T VA+           + +   ++  ++L            C +    L     L+
Sbjct: 164 ----TWVALDVCLS---YKVQCKMDFKIFWLNL----------KNCNSPETVLEMLQKLL 206

Query: 303 YPYMSNGSVASRLKAKPSL---DWATRKRIALGA---ARGLLYLHEQCDPKIIHRDVKAA 356
           Y    N +  S   +   L         R  L +      LL L    + K       A 
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW----NA- 261

Query: 357 NILLDEYYEAVVGDFGLAKLLDHC-------DSHVTTAVRG-TVGHIAPEYLSTGQSSEK 408
                         F L      C          VT  +   T  HI+ ++ S   + ++
Sbjct: 262 --------------FNL-----SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302

Query: 409 T-DVFG--FGI--------------LLLELISGLRALEFGKTANQ-KGAMLDWVKKIHQE 450
              +                       L +I      +   T +  K    D +  I  E
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNPRRLSII-AESIRDGLATWDNWKHVNCDKLTTI-IE 360

Query: 451 KKLEMLVDKDLKNNYDRIE-LEEMVQV--ALLCTQYLPSLRPKMSEVVRMLEGDGLAEKW 507
             L +L   + +  +DR+        +   LL   +   ++  +  VV  L    L EK 
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420

Query: 508 AASQK 512
                
Sbjct: 421 PKEST 425

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.2 bits (119), Expect = 1e-06
 Identities = 68/546 (12%), Positives = 154/546 (28%), Gaps = 170/546 (31%)

Query: 12  VLIQVICSD---------GVF-FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG 61
            +   +C            +F  +            + P  + ++ + L   +  N+ + 
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNC--------NSPETVLEMLQKLLYQIDPNWTSR 216

Query: 62  P---------IPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 112
                     I S  + L  L   +   N L   +   L N+      + ++N       
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLL--V---LLNVQNAKAWN-AFN------- 263

Query: 113 SFHAKTFNITGNSLIC----ATGAEEDCFGTAPMPLS-------FA--LNNSPNSKPSGM 159
               K    T    +     A            M L+           L+  P   P  +
Sbjct: 264 -LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV 322

Query: 160 PKGQKIALALGSSLGCISLLILGFGFLLW--WRQRHNQQIFFDVNEQRREEVCLGNLK-- 215
                  L++      I+  I       W  W+  +  ++          E  L  L+  
Sbjct: 323 LTTNPRRLSI------IAESIRDG-LATWDNWKHVNCDKL------TTIIESSLNVLEPA 369

Query: 216 --RFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQT 273
             R  F  L                                         ++     F  
Sbjct: 370 EYRKMFDRL-----------------------------------------SV-----FPP 383

Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 333
               I   +    L LI F +  ++ ++V   +   S+  +                   
Sbjct: 384 SAH-IPTIL----LSLIWFDVIKSDVMVVVNKLHKYSLVEK-------QP---------- 421

Query: 334 ARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
               + +     + K+   +  A +  + ++Y           +  + D +  +      
Sbjct: 422 KESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYS------ 475

Query: 393 GHIAPEY-LSTGQSSEKTDVFGFGILLLEL--ISG-LRALEFGKTANQKGAMLDWVKKIH 448
            HI   + L   +  E+  +  F ++ L+   +   +R        N  G++L+ ++++ 
Sbjct: 476 -HIG--HHLKNIEHPERMTL--FRMVFLDFRFLEQKIRHD--STAWNASGSILNTLQQLK 528

Query: 449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR---MLEGDGLAE 505
             K    + D D    Y+R+ +  ++       + L  +  K ++++R   M E + + E
Sbjct: 529 FYKP--YICDND--PKYERL-VNAILDFLPKIEENL--ICSKYTDLLRIALMAEDEAIFE 581

Query: 506 KWAASQ 511
           + A  Q
Sbjct: 582 E-AHKQ 586

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 72.2 bits (178), Expect = 4e-14
 Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)

Query: 223 QSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-------EIQFQTEV 275
           Q     +     VG+G +G VYK     G +VA+KR++      G       EI    E+
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76

Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAA 334
                  H N++ LI    +     LV+ +M    +   L    + L  +  K       
Sbjct: 77  H------HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
           RG+ + H+    +I+HRD+K  N+L++      + DFGLA+
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 71.8 bits (177), Expect = 7e-14
 Identities = 20/79 (25%), Positives = 37/79 (46%), Gaps = 4/79 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + +N IS    + +  LS+L +L L+NN         +  L  L  L L+ N +T   P 
Sbjct: 272 VGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP- 328

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L+++S++   D +   + 
Sbjct: 329 -LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 71.0 bits (175), Expect = 1e-13
 Identities = 22/80 (27%), Positives = 38/80 (47%), Gaps = 4/80 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +  N IS      +  L+KL  L++ +N  +    S +++L  L  L LNNN L      
Sbjct: 250 IGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME 305

Query: 90  SLSNMSQLAFLDLSYNNLSG 109
            +  ++ L  L LS N+++ 
Sbjct: 306 VIGGLTNLTTLFLSQNHITD 325

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 66.4 bits (163), Expect = 4e-12
 Identities = 21/85 (24%), Positives = 39/85 (45%), Gaps = 6/85 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N I+   P  +  L KL  L +  N  T    S + +L  L+ L LN ++++     
Sbjct: 73  LNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--IS 126

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSF 114
            L+N++++  L+L  N+    +   
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSPL 151

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 64.1 bits (157), Expect = 3e-11
 Identities = 17/101 (16%), Positives = 39/101 (38%), Gaps = 10/101 (9%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N+    +   +  ++ L  L ++ +      P  +++L  L  L LN N +    P 
Sbjct: 139 LGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP- 194

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 126
            L++++ L +     N ++  +          +  I  N +
Sbjct: 195 -LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKI 233

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 63.7 bits (156), Expect = 4e-11
 Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 11/101 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N I    P  +  L+ L       N  T   P  V+++  L  L++ NN +T   P 
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP- 238

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 126
            L+N+SQL +L++  N +S  + +       K  N+  N +
Sbjct: 239 -LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQI 277

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 57.9 bits (141), Expect = 2e-09
 Identities = 13/83 (15%), Positives = 30/83 (36%), Gaps = 6/83 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
                I+   P     L++ +   L     T  +      LE++  L +    +      
Sbjct: 7   TLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQ 60

Query: 90  SLSNMSQLAFLDLSYNNLSGPVP 112
            +  ++ L +L+L+ N ++   P
Sbjct: 61  GIEYLTNLEYLNLNGNQITDISP 83

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 71.5 bits (176), Expect = 8e-14
 Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 23/203 (11%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVE-MISLAVHRNLLRLIGF 292
           G+G F  V +      G   A K LK              E+  +        ++ L   
Sbjct: 38  GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97

Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR-------GLLYLHEQCD 345
              T+E +L+  Y + G + S    + +   +          R       G+ YLH+   
Sbjct: 98  YENTSEIILILEYAAGGEIFSLCLPELAEMVSEND-----VIRLIKQILEGVYYLHQN-- 150

Query: 346 PKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
             I+H D+K  NILL       +  + DFG+++ + H    +   + GT  ++APE L+ 
Sbjct: 151 -NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-ACELREIM-GTPEYLAPEILNY 207

Query: 403 GQSSEKTDVFGFGILLLELISGL 425
              +  TD++  GI+   L++  
Sbjct: 208 DPITTATDMWNIGIIAYMLLTHT 230

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 28/217 (12%)

Query: 222 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRL---KDGNAIGGEIQFQT 273
             S     S      + +G+G    VY+          A+K L    D   +      +T
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV------RT 97

Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIA 330
           E+ ++    H N+++L     T TE  LV   ++ G +  R+  K      D A   +  
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTA 387
           L A   + YLHE     I+HRD+K  N+L           + DFGL+K+++H    + T 
Sbjct: 158 LEA---VAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVLMKTV 210

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
             GT G+ APE L       + D++  GI+   L+ G
Sbjct: 211 C-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 49/183 (26%), Positives = 75/183 (40%), Gaps = 41/183 (22%)

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTA 387
            +   A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V    
Sbjct: 198 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254

Query: 388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT------ANQKGAML 441
            R  +  +APE +     + ++DV+ FG+LL E+ S       G +       +++    
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEE---- 304

Query: 442 DWVKKIHQEKKLEMLVDKDLKNNYDRIE-----LEEMVQVALLCTQYLPSLRPKMSEVVR 496
                            + LK    R+        EM Q  L C    PS RP  SE+V 
Sbjct: 305 ---------------FCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348

Query: 497 MLE 499
            L 
Sbjct: 349 HLG 351

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 32/156 (20%), Positives = 58/156 (37%), Gaps = 15/156 (9%)

Query: 236 GKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 288
           G+G FG V +              VAVK LK+G          +E++ +I +  H N++ 
Sbjct: 31  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90

Query: 289 LIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
           L+G C      L+V   +   G++++ L++K       R        +G  +   +    
Sbjct: 91  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-------RNEFVPYKTKGARFRQGKDYVG 143

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 383
            I  D+K     +     +    F   K L   +  
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.7 bits (178), Expect = 1e-13
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)

Query: 227 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
           ++F+   ++GKG FG V     KG      + AVK LK    I  +     +VE     V
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDD-----DVE--CTMV 390

Query: 283 HRNLLRLIG---------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
            + +L L G          C  T +RL  V  Y++ G +   ++             A  
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 450

Query: 333 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 392
            A GL +L  +    II+RD+K  N++LD      + DFG+ K  +  D   T    GT 
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTP 506

Query: 393 GHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 425
            +IAPE +   Q   K+ D + FG+LL E+++G 
Sbjct: 507 DYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.0 bits (175), Expect = 1e-13
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 37/218 (16%)

Query: 227 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
           S F    ++G+G FG V+            + A+K LK        ++ +  V       
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT-----LKVRDRVRTKM--- 75

Query: 283 HRNLLRLIG--------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR----- 328
            R++L  +         +   T  +L L+  ++  G + +RL  +         +     
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLAE 134

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           +AL     L +LH      II+RD+K  NILLDE     + DFGL+K           + 
Sbjct: 135 LALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSF 186

Query: 389 RGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 425
            GTV ++APE +   +   ++ D + FG+L+ E+++G 
Sbjct: 187 CGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGT 223

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 10/204 (4%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 285
           + F    L+GKG FG V     +  G   A+K LK    +  +    T  E   L   R+
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 286 --LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 342
             L  L  +   T +RL  V  Y + G +   L  +        +         L YLH 
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
           + +  +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L  
Sbjct: 267 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVL-E 322

Query: 403 GQSSEKT-DVFGFGILLLELISGL 425
                +  D +G G+++ E++ G 
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 26/102 (25%), Positives = 43/102 (42%), Gaps = 7/102 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLNNNSLTGAIP 88
           L NN I+     + G  S++  LDL  N           +  +TL++L L  N +   + 
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 126
             +   ++L  LDLS N L+   P F +       ++  N L
Sbjct: 186 GQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 17/79 (21%), Positives = 36/79 (45%), Gaps = 2/79 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + ++++   + +       +  LDLS N  +    + ++    L+ L L++N L      
Sbjct: 17  VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L ++S L  LDL+ N + 
Sbjct: 75  DLESLSTLRTLDLNNNYVQ 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 15/92 (16%), Positives = 35/92 (38%), Gaps = 5/92 (5%)

Query: 39  IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 98
           I       ++     ++++     + S       ++ L L+ N L+      L+  ++L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 99  FLDLSYNNLSGPVPSFHA----KTFNITGNSL 126
            L+LS N L        +    +T ++  N +
Sbjct: 62  LLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 18/79 (22%), Positives = 32/79 (40%), Gaps = 8/79 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L NN +      E+     + TL  +NN  +  +    S  +  + + L NN +T     
Sbjct: 87  LNNNYV-----QELLVGPSIETLHAANNNISR-VSC--SRGQGKKNIYLANNKITMLRDL 138

Query: 90  SLSNMSQLAFLDLSYNNLS 108
                S++ +LDL  N + 
Sbjct: 139 DEGCRSRVQYLDLKLNEID 157

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 14/102 (13%), Positives = 30/102 (29%), Gaps = 4/102 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L +N ++  +  E    + +  + L NN     I   +   + L++  L  N        
Sbjct: 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLR 255

Query: 90  SL-SNMSQLAFLDLSYN-NLSGPVPSFHAKTFNITGNSLICA 129
              S   ++  +       L+G               +  C 
Sbjct: 256 DFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 18/84 (21%), Positives = 37/84 (44%), Gaps = 3/84 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L++  +    P +  +LS L  + +        +P T+     L+ L L  N L  A+P 
Sbjct: 88  LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPA 144

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPS 113
           S++++++L  L +        +P 
Sbjct: 145 SIASLNRLRELSIRACPELTELPE 168

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 23/123 (18%), Positives = 45/123 (36%), Gaps = 22/123 (17%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSNN---------FFTGPIPSTVS 68
           +  +        L  N +   +P  I  L++L  L +              +        
Sbjct: 122 TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180

Query: 69  HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGN 124
            L  LQ LRL    +  ++P S++N+  L  L +  + LS   P+ H     +  ++ G 
Sbjct: 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGC 239

Query: 125 SLI 127
           + +
Sbjct: 240 TAL 242

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 13/92 (14%), Positives = 30/92 (32%), Gaps = 9/92 (9%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYL 76
           +   L       L+      + P   G  + L  L L + +     +P  +  L  L+ L
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKL 282

Query: 77  RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
            L        +P  ++ +     + +  +  +
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 13/82 (15%), Positives = 28/82 (34%), Gaps = 5/82 (6%)

Query: 29  LLQNNNISGHIPTEIGKLS--KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA 86
                 +       +   +    + L+L +       P     L  LQ++ ++   L   
Sbjct: 62  TRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-E 118

Query: 87  IPPSLSNMSQLAFLDLSYNNLS 108
           +P ++   + L  L L+ N L 
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR 140

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 24/97 (24%), Positives = 38/97 (39%), Gaps = 10/97 (10%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 77
           S   L       ++N+ +S  +   I  L KL  LDL         P        L+ L 
Sbjct: 201 SIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259

Query: 78  L-NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 113
           L + ++L   +P  +  ++QL  LDL        +PS
Sbjct: 260 LKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPS 295

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 21/122 (17%), Positives = 43/122 (35%), Gaps = 22/122 (18%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 77
              RL       +    +   +P  + + + L TL L+ N     +P++++ L  L+ L 
Sbjct: 99  QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELS 156

Query: 78  LNNNSLTGAIPPSLSN---------MSQLAFLDLSYNNLSGPVPSFHA----KTFNITGN 124
           +        +P  L++         +  L  L L +  +     S       K+  I  +
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNS 216

Query: 125 SL 126
            L
Sbjct: 217 PL 218

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 22/167 (13%)

Query: 221 ELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----------EI 269
           +++S    +   + +G+G F  VYK        +VA+K++K G+              EI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKR 328
           +   E+       H N++ L+      +   LV+ +M    +   +K     L  +  K 
Sbjct: 64  KLLQELS------HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKA 116

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
             L   +GL YLH+     I+HRD+K  N+LLDE     + DFGLAK
Sbjct: 117 YMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 18/208 (8%)

Query: 227 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
            +F    ++GKG FG V    +K         A+K LK    +  +    T VE   L++
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73

Query: 283 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 338
                 L  +      T E L  V  Y++ G +   +++    D +     A     GL 
Sbjct: 74  AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
           +LH +    I++RD+K  NILLD+     + DFG+ K  +      T    GT  +IAPE
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPE 188

Query: 399 YLSTGQSSEKT-DVFGFGILLLELISGL 425
            L  GQ    + D + FG+LL E++ G 
Sbjct: 189 IL-LGQKYNHSVDWWSFGVLLYEMLIGQ 215

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 41/212 (19%), Positives = 82/212 (38%), Gaps = 25/212 (11%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVK----RLKDGNAIGGEIQFQTEVEMISL 280
              +     +G+G FG V++            K    +  D   +      + E+ ++++
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV------KKEISILNI 57

Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR----G 336
           A HRN+L L     +  E ++++ ++S   +  R+       +   +R  +         
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEA 114

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGH 394
           L +LH      I H D++  NI+      + +   +FG A+ L     +          +
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLF-TAPEY 169

Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLR 426
            APE       S  TD++  G L+  L+SG+ 
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 22/93 (23%), Positives = 36/93 (38%), Gaps = 6/93 (6%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
            Q++N+       +   L  L+ LD+S+           + L +L+ L++  NS      
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

Query: 89  P-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 120
           P   + +  L FLDLS   L           FN
Sbjct: 463 PDIFTELRNLTFLDLSQCQLE----QLSPTAFN 491

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 18/79 (22%), Positives = 24/79 (30%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N +            +L  LDLS              L  L  L L  N +      
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94

Query: 90  SLSNMSQLAFLDLSYNNLS 108
           + S +S L  L     NL+
Sbjct: 95  AFSGLSSLQKLVAVETNLA 113

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 16/85 (18%), Positives = 31/85 (36%), Gaps = 2/85 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           L  N +   + +    L +L  LD  ++        +V   L  L YL +++     A  
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPS 113
              + +S L  L ++ N+       
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLP 463

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 23/115 (20%), Positives = 42/115 (36%), Gaps = 13/115 (11%)

Query: 25  SFGRL-------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 77
           SF          L    I          LS L TL L+ N          S L +LQ L 
Sbjct: 47  SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106

Query: 78  LNNNSLTGAIPPSLSNMSQLAFLDLSYNNL-SGPVPSF-----HAKTFNITGNSL 126
               +L       + ++  L  L++++N + S  +P +     + +  +++ N +
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 21/94 (22%), Positives = 36/94 (38%), Gaps = 5/94 (5%)

Query: 20  DGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 74
           +G+F     L    +  N+   +   +I  +L  L  LDLS        P+  + L +LQ
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497

Query: 75  YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
            L + +N L          ++ L  + L  N   
Sbjct: 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 9/99 (9%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFT-GPIPSTVSHLETL 73
           + G F     L        N++      IG L  L  L++++N      +P   S+L  L
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151

Query: 74  QYLRLNNNSLTGAIPPSLSNMSQLAF----LDLSYNNLS 108
           ++L L++N +       L  + Q+      LDLS N ++
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 19/91 (20%), Positives = 30/91 (32%), Gaps = 7/91 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
               N    IP  +        LDLS N        +      LQ L L+   +      
Sbjct: 14  CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 120
           +  ++S L+ L L+ N +     S     F+
Sbjct: 71  AYQSLSHLSTLILTGNPIQ----SLALGAFS 97

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 24/114 (21%), Positives = 44/114 (38%), Gaps = 9/114 (7%)

Query: 19  SDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 78
            D  +    + L+  N        + KL  L  L  ++N            L +L++L L
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTL-KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDL 354

Query: 79  NNNSLT--GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 126
           + N L+  G    S    + L +LDLS+N +     +F      +  +   ++L
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 23/110 (20%), Positives = 35/110 (31%), Gaps = 17/110 (15%)

Query: 14  IQVICSDGVFFSFGRL--------LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 65
           IQ I          ++        L  N ++  I     K  +L  L L NNF +  +  
Sbjct: 161 IQSIYC-TDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMK 218

Query: 66  TV-SHLETLQYLRL------NNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
           T    L  L+  RL      N  +L      +L  +  L   +     L 
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 31/222 (13%)

Query: 219 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEM 277
            K  +     +++  ++G G FG V++  L +   VA+K+ L+D      E+Q    V+ 
Sbjct: 32  GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK- 90

Query: 278 ISLAVHRNLLRLIGFCMTTTERL------LVYPYMS---NGSVASRLKAKPSLDWATRKR 328
                H N++ L  F  +  ++       LV  Y+      +     K K ++     K 
Sbjct: 91  -----HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTA 387
                 R L Y+H      I HRD+K  N+LLD     + + DFG AK+L   + +V+  
Sbjct: 146 YMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202

Query: 388 V----RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 424
                R      APE +    + +   D++  G ++ EL+ G
Sbjct: 203 CSRYYR------APELIFGATNYTTNIDIWSTGCVMAELMQG 238

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.7 bits (166), Expect = 3e-13
 Identities = 14/79 (17%), Positives = 36/79 (45%), Gaps = 1/79 (1%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +   +++      +  L+ L  LD+S++     I + ++ L  +  + L+ N     I P
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L  + +L  L++ ++ + 
Sbjct: 155 -LKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.5 bits (163), Expect = 7e-13
 Identities = 17/78 (21%), Positives = 35/78 (44%), Gaps = 2/78 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + N + +      I  LS L  L +     T      +S L +L  L +++++   +I  
Sbjct: 73  INNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 90  SLSNMSQLAFLDLSYNNL 107
            ++ + ++  +DLSYN  
Sbjct: 131 KINTLPKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.7 bits (148), Expect = 7e-11
 Identities = 23/103 (22%), Positives = 46/103 (44%), Gaps = 9/103 (8%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L N N++  + T I     +  L ++N   T    + +S L  L+ LR+    +T    P
Sbjct: 51  LANINVT-DL-TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIP 106

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 127
           +LS ++ L  LD+S++     + +         + +++ N  I
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 16/80 (20%), Positives = 32/80 (40%), Gaps = 3/80 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + ++     I T+I  L K+ ++DLS N     I   +  L  L+ L +  + +      
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG- 176

Query: 90  SLSNMSQLAFLDLSYNNLSG 109
            + +  +L  L      + G
Sbjct: 177 -IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 14/80 (17%), Positives = 31/80 (38%), Gaps = 7/80 (8%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
            L+ +  + +IP         L   L  +  T  I  T + + +L Y+ L N ++T    
Sbjct: 7   GLKASQDNVNIPDS--TFKAYLNGLLGQSS-TANI--TEAQMNSLTYITLANINVTDLTG 61

Query: 89  PSLSNMSQLAFLDLSYNNLS 108
             +     +  L ++  + +
Sbjct: 62  --IEYAHNIKDLTINNIHAT 79

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 9/151 (5%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVHR 284
            + +  LVG+G +G V K      G +VA+K+  + +     ++     E++++    H 
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRHE 84

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQ 343
           NL+ L+  C       LV+ ++ + ++   L+  P+ LD+   ++       G+ + H  
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLA 374
               IIHRD+K  NIL+ +     + DFG A
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFA 171

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 18/208 (8%)

Query: 227 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
            NF    ++GKG FG V     K     G + AVK LK    +  +    T  E   L++
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79

Query: 283 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 338
            RN   L +L   C  T +RL  V  +++ G +   ++     D A  +  A      L+
Sbjct: 80  ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
           +LH++    II+RD+K  N+LLD      + DFG+ K    C+   T    GT  +IAPE
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPE 194

Query: 399 YLSTGQSSEKT-DVFGFGILLLELISGL 425
            L          D +  G+LL E++ G 
Sbjct: 195 IL-QEMLYGPAVDWWAMGVLLYEMLCGH 221

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 21/166 (12%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 283
             +++   ++G G FG VY+  L D G +VA+K+ L+D      E+Q   +++      H
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------H 106

Query: 284 RNLLRLIGFCMTTTERL------LVYPYMS---NGSVASRLKAKPSLDWATRKRIALGAA 334
            N++RL  F  ++ E+       LV  Y+            +AK +L     K       
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDH 379
           R L Y+H      I HRD+K  N+LLD     + + DFG AK L  
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 69.1 bits (170), Expect = 4e-13
 Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 33/217 (15%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMIS 279
            +     +G+G +G V+K    +   +VA+KR++  +   G       EI    E++   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59

Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLL 338
              H+N++RL     +  +  LV+ +     +     +    LD    K       +GL 
Sbjct: 60  ---HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSH--VTTAVRGTVG 393
           + H +    ++HRD+K  N+L++   E  + +FGLA+       C S   VT   R    
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR---- 168

Query: 394 HIAPEYL--STGQSSEKTDVFGFGILLLELISGLRAL 428
              P+ L  +   S+   D++  G +  EL +  R L
Sbjct: 169 --PPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPL 202

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 17/79 (21%), Positives = 36/79 (45%), Gaps = 2/79 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + ++++   + +       +  LDLS N  +    + ++    L+ L L++N L      
Sbjct: 17  VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L ++S L  LDL+ N + 
Sbjct: 75  DLESLSTLRTLDLNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 37/207 (17%), Positives = 65/207 (31%), Gaps = 14/207 (6%)

Query: 19  SDGVFFSFGRL----LQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 73
            D       R+    L+ N I   +          L  L+L  NF    +   V     L
Sbjct: 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKL 193

Query: 74  QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICA 129
           + L L++N L   + P   + + + ++ L  N L     +       + F++ GN   C 
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252

Query: 130 TGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWW 189
           T    D F       + A             +     L    +  C  L       L+  
Sbjct: 253 T--LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIAL 310

Query: 190 RQRHNQQIFFDVNEQRREEVCLGNLKR 216
           +++ +  +    +E  R E    N  R
Sbjct: 311 KRKEHALLSGQGSETERLECERENQAR 337

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 15/92 (16%), Positives = 35/92 (38%), Gaps = 5/92 (5%)

Query: 39  IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 98
           I       ++     ++++     + S       ++ L L+ N L+      L+  ++L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 99  FLDLSYNNLSGPVPSFHA----KTFNITGNSL 126
            L+LS N L        +    +T ++  N +
Sbjct: 62  LLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 18/79 (22%), Positives = 32/79 (40%), Gaps = 8/79 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L NN +      E+     + TL  +NN  +  +    S  +  + + L NN +T     
Sbjct: 87  LNNNYV-----QELLVGPSIETLHAANNNISR-VSC--SRGQGKKNIYLANNKITMLRDL 138

Query: 90  SLSNMSQLAFLDLSYNNLS 108
                S++ +LDL  N + 
Sbjct: 139 DEGCRSRVQYLDLKLNEID 157

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 7/99 (7%), Positives = 19/99 (19%), Gaps = 3/99 (3%)

Query: 30  LQNNNISGHIPTEIGKL--SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAI 87
               ++       +  L   +   L    +     +     +    + +          I
Sbjct: 294 YCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVI 352

Query: 88  PPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSL 126
                       L+     L   V +       + G   
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQ 391

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 8/89 (8%), Positives = 21/89 (23%), Gaps = 3/89 (3%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           L    + +  +  E    ++   +D     +   I       +    L     +L   + 
Sbjct: 318 LSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377

Query: 89  PSLSNMSQL---AFLDLSYNNLSGPVPSF 114
                 ++L       +    L       
Sbjct: 378 NGRRAHAELDGTLQQAVGQIELQHATEEQ 406

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 69.5 bits (171), Expect = 4e-13
 Identities = 40/168 (23%), Positives = 72/168 (42%), Gaps = 23/168 (13%)

Query: 224 SATSNFSSKNLVGKGGFGNVYKG--YLQDGTVVAVKRLKDGNAIGG-------EIQFQTE 274
            A   +     +G+G +G V+K       G  VA+KR++      G       E+     
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--- 64

Query: 275 VEMISLAVHRNLLRLIGFCMTTTERL-----LVYPYMSN--GSVASRLKAKPSLDWATRK 327
           +  +    H N++RL   C  +         LV+ ++     +   ++  +P +   T K
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIK 123

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
            +     RGL +LH     +++HRD+K  NIL+    +  + DFGLA+
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 43/224 (19%)

Query: 227 SNFSSKNLVGKGGFGNVY---KGYLQD-GTVVAVKRL-KDGNAIGGEIQFQTEVEMISLA 281
            NF    ++G G +G V+   K    D G + A+K L K       +    T  E     
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE----- 108

Query: 282 VHRNLLRLIG---------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIAL 331
             R +L  I          +   T  +L L+  Y++ G + + L          R+R   
Sbjct: 109 --RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--------QRERFTE 158

Query: 332 GAAR--------GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 383
              +         L +LH+     II+RD+K  NILLD     V+ DFGL+K     ++ 
Sbjct: 159 HEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215

Query: 384 VTTAVRGTVGHIAPEYLSTGQSSEKTDV--FGFGILLLELISGL 425
                 GT+ ++AP+ +  G S     V  +  G+L+ EL++G 
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 31/204 (15%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G G FG V  G     G  VAVK     +++  + +G   + + E++ + L  H ++++L
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG---KIKREIQNLKLFRHPHIIKL 76

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 341
                T T+  +V  Y+S G +   +            R+    AR         + Y H
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEEMEARRLFQQILSAVDYCH 128

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
                 ++HRD+K  N+LLD +  A + DFGL+ ++      + T+  G+  + APE +S
Sbjct: 129 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVIS 183

Query: 402 -TGQSSEKTDVFGFGILLLELISG 424
               +  + D++  G++L  L+ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCG 207

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 46/166 (27%), Positives = 72/166 (43%), Gaps = 29/166 (17%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMI 278
           S +     +G+G FG V+K    + G  VA+K++   N   G       EI+    ++  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-- 74

Query: 279 SLAVHRNLLRLIGFCMTTTERL--------LVYPYMSN--GSVASRLKAKPSLDWATRKR 328
               H N++ LI  C T             LV+ +  +    + S +  K     +  KR
Sbjct: 75  ----HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKR 128

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 374
           +      GL Y+H     KI+HRD+KAAN+L+       + DFGLA
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 70.0 bits (172), Expect = 6e-13
 Identities = 24/100 (24%), Positives = 39/100 (39%), Gaps = 9/100 (9%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N +     + I  L  L  L L  N  +   P  VS L  LQ L   NN ++     
Sbjct: 294 LNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VS 347

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAK---TFNITGNSL 126
           SL+N++ + +L   +N +S   P  +        +   + 
Sbjct: 348 SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAW 387

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 25/83 (30%), Positives = 41/83 (49%), Gaps = 6/83 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             NN ++   P  +  L+KL+ + ++NN      P  +++L  L  L L NN +T   P 
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP- 129

Query: 90  SLSNMSQLAFLDLSYNNLSGPVP 112
            L N++ L  L+LS N +S    
Sbjct: 130 -LKNLTNLNRLELSSNTISDISA 151

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.5 bits (163), Expect = 7e-12
 Identities = 23/80 (28%), Positives = 40/80 (50%), Gaps = 6/80 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + +N +S    + + KL+ L +L  +NN  +   P  +  L  L  L LN N L      
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IG 237

Query: 90  SLSNMSQLAFLDLSYNNLSG 109
           +L++++ L  LDL+ N +S 
Sbjct: 238 TLASLTNLTDLDLANNQISN 257

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 6/83 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N IS    + +  L+ L  L+L+ N      P  +S+L+ L YL L  N+++   P 
Sbjct: 272 LGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP- 326

Query: 90  SLSNMSQLAFLDLSYNNLSGPVP 112
            +S++++L  L    N +S    
Sbjct: 327 -VSSLTKLQRLFFYNNKVSDVSS 348

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 21/83 (25%), Positives = 35/83 (42%), Gaps = 6/83 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
                I       +  L+ L  ++ SNN  T   P  + +L  L  + +NNN +    P 
Sbjct: 53  ADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP- 107

Query: 90  SLSNMSQLAFLDLSYNNLSGPVP 112
            L+N++ L  L L  N ++   P
Sbjct: 108 -LANLTNLTGLTLFNNQITDIDP 129

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 26/80 (32%), Positives = 38/80 (47%), Gaps = 6/80 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             NN IS   P  +G L+ L  L L+ N        T++ L  L  L L NN ++  + P
Sbjct: 206 ATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN-LAP 260

Query: 90  SLSNMSQLAFLDLSYNNLSG 109
            LS +++L  L L  N +S 
Sbjct: 261 -LSGLTKLTELKLGANQISN 279

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 63.4 bits (155), Expect = 6e-11
 Identities = 12/84 (14%), Positives = 31/84 (36%), Gaps = 6/84 (7%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           + Q+  I+         L++ +   L     T  +    + L+ +  L+ +   +     
Sbjct: 8   ITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SI 61

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVP 112
             +  ++ L  ++ S N L+   P
Sbjct: 62  DGVEYLNNLTQINFSNNQLTDITP 85

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 61.1 bits (149), Expect = 4e-10
 Identities = 25/83 (30%), Positives = 38/83 (45%), Gaps = 7/83 (8%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L NN I+   P  +  L+ L  L+LS+N  +      +S L +LQ L   N         
Sbjct: 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTD---LK 171

Query: 90  SLSNMSQLAFLDLSYNNLSGPVP 112
            L+N++ L  LD+S N +S    
Sbjct: 172 PLANLTTLERLDISSNKVSDISV 194

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 14/81 (17%), Positives = 35/81 (43%), Gaps = 4/81 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             +N IS   P  +  L+++  L L++  +T    +  +++     ++    +L    P 
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APA 415

Query: 90  SLSNMSQLAFLDLSYNNLSGP 110
           ++S+       D+++N  S  
Sbjct: 416 TISDGGSYTEPDITWNLPSYT 436

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 68.3 bits (168), Expect = 6e-13
 Identities = 39/156 (25%), Positives = 70/156 (44%), Gaps = 18/156 (11%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISL 280
            +     +G+G +G VYK     G   A+K+++      G       EI    E++    
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK---- 58

Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLY 339
             H N+++L     T    +LV+ ++    +   L      L+  T K   L    G+ Y
Sbjct: 59  --HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
            H++   +++HRD+K  N+L++   E  + DFGLA+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 227 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
           S+F    ++GKG FG V     K    +    AVK L+    +  + +     E   L  
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94

Query: 283 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR-----IALGA 333
           +     L+ L  F   T ++L  V  Y++ G +   L+ +       R R     IA   
Sbjct: 95  NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFL-EPRARFYAAEIASA- 151

Query: 334 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 393
              L YLH      I++RD+K  NILLD     V+ DFGL K  +   +  T+   GT  
Sbjct: 152 ---LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPE 204

Query: 394 HIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 425
           ++APE L   Q  ++T D +  G +L E++ GL
Sbjct: 205 YLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGL 236

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 68.3 bits (168), Expect = 7e-13
 Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 20/158 (12%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMIS 279
           NF     +G+G +G VYK      G VVA+K+++      G       EI    E+    
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--- 60

Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--LDWATRKRIALGAARGL 337
              H N+++L+    T  +  LV+ ++    +   + A     +     K       +GL
Sbjct: 61  ---HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
            + H     +++HRD+K  N+L++      + DFGLA+
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 68.7 bits (169), Expect = 7e-13
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 35/218 (16%)

Query: 227 SNFSSKNLVGKGGFGNVY---KGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
             F    ++GKGG+G V+   K    + G + A+K LK    +    +   +        
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV----RNAKDTA--HTKA 70

Query: 283 HRNLLRLIG--------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR----- 328
            RN+L  +         +   T  +L L+  Y+S G +  +L+ +               
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM-EDTACFYLAE 129

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           I++     L +LH++    II+RD+K  NI+L+      + DFGL K     D  VT   
Sbjct: 130 ISMA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTF 181

Query: 389 RGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 425
            GT+ ++APE L       +  D +  G L+ ++++G 
Sbjct: 182 CGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGA 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.8 bits (169), Expect = 8e-13
 Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 46/222 (20%)

Query: 227 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
            +F    ++G+G +  V     K       + A+K +K       E     + E      
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTE------ 59

Query: 283 HRNLLRLIG---------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALG 332
            +++               C  T  RL  V  Y++ G +   ++         ++++   
Sbjct: 60  -KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ--------RQRKLPEE 110

Query: 333 AAR--------GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 384
            AR         L YLHE+    II+RD+K  N+LLD      + D+G+ K         
Sbjct: 111 HARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDT 166

Query: 385 TTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 425
           T+   GT  +IAPE L  G+    + D +  G+L+ E+++G 
Sbjct: 167 TSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGR 207

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 34/133 (25%), Positives = 56/133 (42%), Gaps = 20/133 (15%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 69
           ++ I S+G F     L    L   NI   +P  +  L  L  L++S N F    P +   
Sbjct: 184 LEYI-SEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHG 240

Query: 70  LETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITG 123
           L +L+ L + N+ ++  I   +   ++ L  L+L++NNLS  P   F         ++  
Sbjct: 241 LSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH 299

Query: 124 NSLICATGAEEDC 136
           N   C      DC
Sbjct: 300 NPWNC------DC 306

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 23/80 (28%), Positives = 30/80 (37%), Gaps = 2/80 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  NNI          L  L  L L  N          + L +L  L L +N LT  IP 
Sbjct: 82  LMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPS 140

Query: 90  -SLSNMSQLAFLDLSYNNLS 108
            +   +S+L  L L  N + 
Sbjct: 141 GAFEYLSKLRELWLRNNPIE 160

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 31/100 (31%), Positives = 44/100 (44%), Gaps = 11/100 (11%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV- 67
           IQ+I     F     L    L  N+I   I       L+ L TL+L +N+ T  IPS   
Sbjct: 87  IQMI-QADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTV-IPSGAF 143

Query: 68  SHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNN 106
            +L  L+ L L NN +  +IP  + + +  L  LDL    
Sbjct: 144 EYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 30/109 (27%), Positives = 45/109 (41%), Gaps = 13/109 (11%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV- 67
           I+ I   G F     L    L +N ++  IP+     LSKL  L L NN     IPS   
Sbjct: 111 IRQI-EVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAF 167

Query: 68  SHLETLQYLRL-NNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSF 114
           + + +L  L L     L   I   +   +  L +L+L   N+   +P+ 
Sbjct: 168 NRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIKD-MPNL 214

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 22/92 (23%), Positives = 36/92 (39%), Gaps = 9/92 (9%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           +     +S  +P  I   S    L+L  N        T  HL  L+ L+L  NS+   I 
Sbjct: 60  VCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIE 115

Query: 89  P-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 119
             + + ++ L  L+L  N L+       +  F
Sbjct: 116 VGAFNGLASLNTLELFDNWLT----VIPSGAF 143

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 68.4 bits (168), Expect = 8e-13
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 25/165 (15%)

Query: 224 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK----DG---NAIGGEIQFQTEV 275
           S++S F     +G G +  VYKG     G  VA+K +K    +G    AI  EI    E+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKEL 60

Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN------GSVASRLKAKPSLDWATRKRI 329
           +      H N++RL     T  +  LV+ +M N       S       +  L+    K  
Sbjct: 61  K------HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG-LELNLVKYF 113

Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 374
                +GL + HE    KI+HRD+K  N+L+++  +  +GDFGLA
Sbjct: 114 QWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 37/144 (25%), Positives = 62/144 (43%), Gaps = 9/144 (6%)

Query: 235 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVHRNLLRLIG 291
           +G+G +G V+K      G +VA+K+  +       I+     E+ M+    H NL+ L+ 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV-IKKIALREIRMLKQLKHPNLVNLLE 69

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIH 350
                    LV+ Y  + +V   L      +     K I     + + + H+      IH
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIH 125

Query: 351 RDVKAANILLDEYYEAVVGDFGLA 374
           RDVK  NIL+ ++    + DFG A
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFA 149

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 53/256 (20%), Positives = 94/256 (36%), Gaps = 46/256 (17%)

Query: 193 HNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY----KGYL 248
            N      +     EE    N +            +F    ++G+G +  V     K   
Sbjct: 18  ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKK-- 75

Query: 249 QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG---------FCMTTTER 299
               + A++ +K       E     + E       +++               C  T  R
Sbjct: 76  -TDRIYAMRVVKKELVNDDEDIDWVQTE-------KHVFEQASNHPFLVGLHSCFQTESR 127

Query: 300 L-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDPKIIH 350
           L  V  Y++ G +   ++         ++++    AR         L YLHE+    II+
Sbjct: 128 LFFVIEYVNGGDLMFHMQ--------RQRKLPEEHARFYSAEISLALNYLHER---GIIY 176

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT- 409
           RD+K  N+LLD      + D+G+ K         T+   GT  +IAPE L  G+    + 
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEIL-RGEDYGFSV 234

Query: 410 DVFGFGILLLELISGL 425
           D +  G+L+ E+++G 
Sbjct: 235 DWWALGVLMFEMMAGR 250

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 20/157 (12%)

Query: 228 NFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLK----DG---NAIGGEIQFQTEVEMIS 279
            +   + +G+G +  VYKG       +VA+K ++    +G    AI  E+    +++   
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLK--- 58

Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLL 338
              H N++ L     T     LV+ Y+    +   L    + ++    K       RGL 
Sbjct: 59  ---HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 375
           Y H Q   K++HRD+K  N+L++E  E  + DFGLA+
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR 148

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 34/133 (25%), Positives = 54/133 (40%), Gaps = 20/133 (15%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 69
           +  I S+G F     L    L   N+   IP  +  L KL  LDLS N  +   P +   
Sbjct: 173 LSYI-SEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQG 229

Query: 70  LETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITG 123
           L  LQ L +  + +   I   +  N+  L  ++L++NNL+  P   F      +  ++  
Sbjct: 230 LMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHH 288

Query: 124 NSLICATGAEEDC 136
           N   C      +C
Sbjct: 289 NPWNC------NC 295

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 23/80 (28%), Positives = 29/80 (36%), Gaps = 2/80 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N I          L  L  L LS N          + L  L  L L +N LT  IP 
Sbjct: 71  LHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPN 129

Query: 90  -SLSNMSQLAFLDLSYNNLS 108
            +   +S+L  L L  N + 
Sbjct: 130 GAFVYLSKLKELWLRNNPIE 149

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 30/119 (25%), Positives = 48/119 (40%), Gaps = 14/119 (11%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETL 73
             G F     L    L +N ++  IP      LSKL  L L NN          + + +L
Sbjct: 104 EIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSL 162

Query: 74  QYLRL-NNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 126
           + L L     L+  I   +   +S L +L+L+  NL   +P+          +++GN L
Sbjct: 163 RRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHL 219

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 28/99 (28%), Positives = 39/99 (39%), Gaps = 9/99 (9%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 68
           IQ+I     F     L    L  N+I   I       L+ L TL+L +N  T        
Sbjct: 76  IQII-KVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFV 133

Query: 69  HLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNN 106
           +L  L+ L L NN +  +IP    + +  L  LDL    
Sbjct: 134 YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 19/92 (20%), Positives = 37/92 (40%), Gaps = 9/92 (9%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           +    N+   +P  I   +    L+L  N       ++  HL  L+ L+L+ N +   I 
Sbjct: 49  ICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIE 104

Query: 89  P-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 119
             + + ++ L  L+L  N L+    +     F
Sbjct: 105 IGAFNGLANLNTLELFDNRLT----TIPNGAF 132

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 55/201 (27%), Positives = 80/201 (39%), Gaps = 27/201 (13%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           G G FG            +VAVK ++ G AI   +Q   E+       H N++R     +
Sbjct: 29  GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIVRFKEVIL 86

Query: 295 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDP 346
           T T   ++  Y S G +  R+            R +   AR        G+ Y H     
Sbjct: 87  TPTHLAIIMEYASGGELYERI--------CNAGRFSEDEARFFFQQLLSGVSYCHSM--- 135

Query: 347 KIIHRDVKAANILLDEYYEAV--VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-TG 403
           +I HRD+K  N LLD        + DFG +K      S   + V GT  +IAPE L    
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV-GTPAYIAPEVLLRQE 193

Query: 404 QSSEKTDVFGFGILLLELISG 424
              +  DV+  G+ L  ++ G
Sbjct: 194 YDGKIADVWSCGVTLYVMLVG 214

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 28/220 (12%)

Query: 223 QSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISL 280
           +     F  + + G+G FG V  G  +  G  VA+K+ ++D      E+Q    ++ +++
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAV 75

Query: 281 AVHRNLLRLIGFCMTTTER-------LLVYPYMS---NGSVASRLKAKPSLDWATRKRIA 330
             H N+++L  +  T  ER        +V  Y+    +    +  + + +      K   
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDHCDSHVTTAV- 388
               R +  LH      + HRD+K  N+L++E      + DFG AK L   + +V     
Sbjct: 136 FQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194

Query: 389 ---RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 424
              R      APE +   Q  +   D++  G +  E++ G
Sbjct: 195 RYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 12/203 (5%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI-GGEIQ-FQTEVEMISLAVH 283
             F     +G G FG V     ++ G   A+K L     +   +I+    E  ++     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 284 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 342
             L++L  F       L +V  Y++ G + S L+          +  A        YLH 
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
                +I+RD+K  N+L+D+     V DFG AK +       T  + GT   +APE + +
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILS 212

Query: 403 GQSSEKTDVFGFGILLLELISGL 425
              ++  D +  G+L+ E+ +G 
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGY 235

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 18/208 (8%)

Query: 227 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
           ++F+   ++GKG FG V     KG      + AVK LK    I  +    T VE   LA+
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76

Query: 283 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 338
                 L +L   C  T +RL  V  Y++ G +   ++             A   A GL 
Sbjct: 77  PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135

Query: 339 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 398
           +L  +    II+RD+K  N++LD      + DFG+ K  +  D   T    GT  +IAPE
Sbjct: 136 FLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPE 191

Query: 399 YLSTGQSSEKT-DVFGFGILLLELISGL 425
            +   Q   K+ D + FG+LL E+++G 
Sbjct: 192 II-AYQPYGKSVDWWAFGVLLYEMLAGQ 218

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 23/91 (25%), Positives = 35/91 (38%), Gaps = 7/91 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS----HLETLQYLRLNNN---S 82
           +   +       ++     L TLDLS+N   G      +       TLQ L L N    +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215

Query: 83  LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 113
            +G      +   QL  LDLS+N+L     +
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 18/93 (19%), Positives = 30/93 (32%), Gaps = 6/93 (6%)

Query: 30  LQNNNISGHIPTEIGKLS--KLLTLDLSNNFFTGPIPSTVS----HLETLQYLRLNNNSL 83
           L+N  ++G  P  + + +   L  L+L N  +                 L+ L +     
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161

Query: 84  TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA 116
                  +     L+ LDLS N   G      A
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 18/82 (21%), Positives = 28/82 (34%), Gaps = 6/82 (7%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           L +N++            S+L +L+LS            + L     L L+ N L     
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSV---LDLSYNRLDRN-- 289

Query: 89  PSLSNMSQLAFLDLSYNNLSGP 110
           PS   + Q+  L L  N     
Sbjct: 290 PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 21/102 (20%), Positives = 32/102 (31%), Gaps = 4/102 (3%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET---LQYLRLNNNSLTG 85
              +        T+I K   L  L +        I      +     LQ L L N  +TG
Sbjct: 50  KRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTG 109

Query: 86  AIPPSLSNMSQLAFLDLSYNNLS-GPVPSFHAKTFNITGNSL 126
             PP L   +      L+  N+S     ++ A+        L
Sbjct: 110 TAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGL 151

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 28/114 (24%), Positives = 49/114 (42%), Gaps = 15/114 (13%)

Query: 30  LQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           + + N++  +P   +  L  L  L+LS N  +    S +  L  LQ ++L    L   + 
Sbjct: 231 ITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVE 288

Query: 89  P-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICATGAEEDC 136
           P +   ++ L  L++S N L+      FH+    +T  +  N L C      DC
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC------DC 336

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 26/96 (27%), Positives = 40/96 (41%), Gaps = 8/96 (8%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETL 73
             G F +   L    L++N +   IP  +   LS L  LD+S N     +      L  L
Sbjct: 72  EPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130

Query: 74  QYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 108
           + L + +N L   I   + S ++ L  L L   NL+
Sbjct: 131 KSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT 165

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 6/95 (6%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETL 73
           S   F     L    L+  N++  IPTE    L  L+ L L +         +   L  L
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRL 202

Query: 74  QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
           + L +++      + P+      L  L +++ NL+
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 63.2 bits (154), Expect = 8e-11
 Identities = 20/106 (18%), Positives = 36/106 (33%), Gaps = 10/106 (9%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 74
            D  F    RL    + +      +         L +L +++   T      V HL  L+
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR 251

Query: 75  YLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 119
           +L L+ N ++  I    L  + +L  + L    L+          F
Sbjct: 252 FLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA----VVEPYAF 292

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 27/119 (22%), Positives = 48/119 (40%), Gaps = 9/119 (7%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV- 67
           I ++  D +F     L    + +N++  +I       L+ L  L L     T  IP+   
Sbjct: 116 IVIL-LDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS-IPTEAL 172

Query: 68  SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSL 126
           SHL  L  LRL + ++      S   + +L  L++S+      +        N+T  S+
Sbjct: 173 SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 25/96 (26%), Positives = 42/96 (43%), Gaps = 8/96 (8%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETL 73
             GVF     L    +  N I   +   +   L  L +L++ +N          S L +L
Sbjct: 96  PLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSL 154

Query: 74  QYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 108
           + L L   +LT +IP  +LS++  L  L L + N++
Sbjct: 155 EQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 20/91 (21%), Positives = 31/91 (34%), Gaps = 9/91 (9%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
                    +P  I   ++   LDL  N          +    L+ L LN N ++ A+ P
Sbjct: 18  CHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEP 73

Query: 90  -SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 119
            + +N+  L  L L  N L           F
Sbjct: 74  GAFNNLFNLRTLGLRSNRLK----LIPLGVF 100

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 27/212 (12%)

Query: 227 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
           ++F    L+GKG FG V     K     G   A+K L+    I  +    T  E   L  
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 283 HRN--LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR-----IALGAA 334
            R+  L  L  +   T +RL  V  Y + G +   L  +       R R     I     
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARFYGAEIVSA-- 117

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
             L YLH +    +++RD+K  N++LD+     + DFGL K     D        GT  +
Sbjct: 118 --LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEY 171

Query: 395 IAPEYLSTGQSSEKT-DVFGFGILLLELISGL 425
           +APE L       +  D +G G+++ E++ G 
Sbjct: 172 LAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 202

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 41/176 (23%), Positives = 68/176 (38%), Gaps = 30/176 (17%)

Query: 235 VGKGGFGNVYKG---YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           VG+G +G+VYK      +D    A+K+++     G  +    E+ ++    H N++ L  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVISLQK 85

Query: 292 FCMTTTERL--LVYPYMS--------NGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
             ++  +R   L++ Y              +   K    L     K +      G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLA-------KLLDHCDSHVTT 386
                 ++HRD+K ANIL+           + D G A       K L   D  V T
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 31/134 (23%), Positives = 51/134 (38%), Gaps = 20/134 (14%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 68
           +Q +   G+F     L    LQ+N +   +P +    L  L  L L  N  +        
Sbjct: 117 LQEL-GPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174

Query: 69  HLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNIT 122
            L +L  L L+ N +   + P +  ++ +L  L L  NNLS  P  +       +   + 
Sbjct: 175 GLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233

Query: 123 GNSLICATGAEEDC 136
            N  +C      DC
Sbjct: 234 DNPWVC------DC 241

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 18/80 (22%), Positives = 30/80 (37%), Gaps = 1/80 (1%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N IS            L  L L +N       +  + L  L+ L L++N+   ++ P
Sbjct: 39  LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDP 98

Query: 90  S-LSNMSQLAFLDLSYNNLS 108
           +    + +L  L L    L 
Sbjct: 99  ATFHGLGRLHTLHLDRCGLQ 118

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 16/77 (20%), Positives = 29/77 (37%), Gaps = 5/77 (6%)

Query: 31  QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP- 89
               +   +P  I   +    + L  N  +    ++      L  L L++N L   I   
Sbjct: 19  PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA 74

Query: 90  SLSNMSQLAFLDLSYNN 106
           + + ++ L  LDLS N 
Sbjct: 75  AFTGLALLEQLDLSDNA 91

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 11/59 (18%), Positives = 19/59 (32%), Gaps = 3/59 (5%)

Query: 50  LTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
           +T           +P  +      Q + L+ N ++     S      L  L L  N L+
Sbjct: 14  VTTSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 28/135 (20%), Positives = 50/135 (37%), Gaps = 20/135 (14%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 68
            +V   +G+F     L    +  N+   +   +I  +L  L  LDLS        P+  +
Sbjct: 138 TRVA-FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196

Query: 69  HLETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLSG-PVPSFHA-----KTFNI 121
            L +LQ L +++N+   ++       ++ L  LD S N++                  N+
Sbjct: 197 SLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255

Query: 122 TGNSLICATGAEEDC 136
           T N   C       C
Sbjct: 256 TQNDFAC------TC 264

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 18/102 (17%), Positives = 32/102 (31%), Gaps = 8/102 (7%)

Query: 18  CSDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLET 72
           C     F    L    L  N +   + +    L +L  LD  ++        S    L  
Sbjct: 69  CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127

Query: 73  LQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPS 113
           L YL +++            + +S L  L ++ N+       
Sbjct: 128 LIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLP 168

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 21/81 (25%), Positives = 34/81 (41%), Gaps = 5/81 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT--GAI 87
             +  ++  +PT I   S    L+L +N            L  L  L L++N L+  G  
Sbjct: 14  CNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70

Query: 88  PPSLSNMSQLAFLDLSYNNLS 108
             S    + L +LDLS+N + 
Sbjct: 71  SQSDFGTTSLKYLDLSFNGVI 91

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 14/58 (24%), Positives = 24/58 (41%), Gaps = 3/58 (5%)

Query: 51  TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
            +  ++   T  +P+ +    +   L L +N L          ++QL  L LS N LS
Sbjct: 11  EIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 23/196 (11%), Positives = 51/196 (26%), Gaps = 40/196 (20%)

Query: 234 LVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLR 288
             G       ++    D      VA+  +     +  ++     +    +S      + R
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           ++    T    L+V  ++  GS+       PS   A R       A      H      +
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHRA---GV 150

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 408
                  + + +    + V+                               +    ++ +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD--ANPQ 182

Query: 409 TDVFGFGILLLELISG 424
            D+ G G  L  L+  
Sbjct: 183 DDIRGIGASLYALLVN 198

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 31/204 (15%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G G FG V  G     G  VAVK     +++  + +G   + + E++ + L  H ++++L
Sbjct: 25  GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG---KIRREIQNLKLFRHPHIIKL 81

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 341
                T ++  +V  Y+S G +   +            R+    +R        G+ Y H
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI--------CKNGRLDEKESRRLFQQILSGVDYCH 133

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
                 ++HRD+K  N+LLD +  A + DFGL+ ++      + T+  G+  + APE +S
Sbjct: 134 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVIS 188

Query: 402 -TGQSSEKTDVFGFGILLLELISG 424
               +  + D++  G++L  L+ G
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCG 212

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 24/95 (25%), Positives = 41/95 (43%), Gaps = 7/95 (7%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           L  N I+  +       L+ L  L LS N  +     ++++   L+ L LNNN L   +P
Sbjct: 199 LDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITG 123
             L++   +  + L  NN+S    +  +  F   G
Sbjct: 257 GGLADHKYIQVVYLHNNNIS----AIGSNDFCPPG 287

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 28/95 (29%), Positives = 42/95 (44%), Gaps = 9/95 (9%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 74
            +G F    +L    + + NI+  IP   G    L  L L  N  T    +++  L  L 
Sbjct: 163 ENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 219

Query: 75  YLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 108
            L L+ NS++ A+   SL+N   L  L L+ N L 
Sbjct: 220 KLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV 253

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 19/105 (18%), Positives = 38/105 (36%), Gaps = 12/105 (11%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 69
           I  +           L    L  N+IS      +     L  L L+NN     +P  ++ 
Sbjct: 204 ITKV-DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLAD 261

Query: 70  LETLQYLRLNNNSLTG------AIPPSLSNMSQLAFLDLSYNNLS 108
            + +Q + L+NN+++         P   +  +  + + L  N + 
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 9/96 (9%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 74
           S G F    +L    L  N +   +P ++     L  L +  N  T    S  + L  + 
Sbjct: 92  SPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMI 148

Query: 75  YLRLNNNSLT-GAIPP-SLSNMSQLAFLDLSYNNLS 108
            + L  N L    I   +   M +L+++ ++  N++
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 23/79 (29%), Positives = 34/79 (43%), Gaps = 3/79 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           LQNN I+     +   L  L TL L NN  +   P   + L  L+ L L+ N L   +P 
Sbjct: 59  LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE 117

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            +     L  L +  N ++
Sbjct: 118 KMP--KTLQELRVHENEIT 134

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 17/99 (17%), Positives = 32/99 (32%), Gaps = 13/99 (13%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG------PIPSTVS 68
            +G   +   L    L NN +   +P  +     +  + L NN  +         P   +
Sbjct: 232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 290

Query: 69  HLETLQYLRLNNNSLT-GAIPPSL-SNMSQLAFLDLSYN 105
              +   + L +N +    I PS    +   A + L   
Sbjct: 291 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 20/79 (25%), Positives = 33/79 (41%), Gaps = 3/79 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             +  +   +P ++        LDL NN  T        +L+ L  L L NN ++   P 
Sbjct: 38  CSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 94

Query: 90  SLSNMSQLAFLDLSYNNLS 108
           + + + +L  L LS N L 
Sbjct: 95  AFAPLVKLERLYLSKNQLK 113

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 29/99 (29%), Positives = 44/99 (44%), Gaps = 4/99 (4%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           L +N I   I  E   + SKL  L L +N        ++S L TL+ L L+NN L+  +P
Sbjct: 200 LDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257

Query: 89  PSLSNMSQLAFLDLSYNNLSG-PVPSFHAKTFNITGNSL 126
             L ++  L  + L  NN++   V  F    F +     
Sbjct: 258 AGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYY 296

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 21/81 (25%), Positives = 30/81 (37%), Gaps = 7/81 (8%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           +    ++  IP ++     L  L L +N     I          L  L L +N +   I 
Sbjct: 179 ISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIR-MIE 233

Query: 89  P-SLSNMSQLAFLDLSYNNLS 108
             SLS +  L  L L  N LS
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS 254

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 23/107 (21%), Positives = 40/107 (37%), Gaps = 16/107 (14%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 68
           IQ I        + +L    L +N I   I       L  L  L L NN  +  +P+ + 
Sbjct: 205 IQAI-ELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VPAGLP 261

Query: 69  HLETLQYLRLNNNSLTGAIPPS-------LSNMSQLAFLDLSYNNLS 108
            L+ LQ + L+ N++T  +  +           +    + L  N + 
Sbjct: 262 DLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 27/79 (34%), Positives = 35/79 (44%), Gaps = 3/79 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           LQNN+IS     +   L  L  L L NN  +       S L  LQ L ++ N L   IPP
Sbjct: 61  LQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP 119

Query: 90  SLSNMSQLAFLDLSYNNLS 108
           +L   S L  L +  N + 
Sbjct: 120 NLP--SSLVELRIHDNRIR 136

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 19/115 (16%), Positives = 34/115 (29%), Gaps = 30/115 (26%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFT-GPIPSTVSHLETLQYLRLNNNSLTGAI 87
           + +N I   +P  +   L  +  +++  N                L YLR++   LT  I
Sbjct: 130 IHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GI 187

Query: 88  PP----------------------SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 120
           P                        L   S+L  L L +N +          + +
Sbjct: 188 PKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR----MIENGSLS 238

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 21/80 (26%), Positives = 33/80 (41%), Gaps = 5/80 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             +  +   +P EI        LDL NN  +         L+ L  L L NN ++  I  
Sbjct: 40  CSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHE 95

Query: 90  -SLSNMSQLAFLDLSYNNLS 108
            + S + +L  L +S N+L 
Sbjct: 96  KAFSPLRKLQKLYISKNHLV 115

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 16/99 (16%), Positives = 30/99 (30%), Gaps = 13/99 (13%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET-- 72
            +G       L    L NN +S  +P  +  L  L  + L  N  T    +    +    
Sbjct: 233 ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV 291

Query: 73  ----LQYLRLNNNSLT-GAIPPSL-SNMSQLAFLDLSYN 105
                  + L NN +    + P+    ++    +     
Sbjct: 292 KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 36/215 (16%)

Query: 227 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVE------ 276
            +F     +G G FG V+    +    +G   A+K LK        +    +VE      
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKE-----IVVRLKQVEHTNDER 57

Query: 277 -MISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRK----RIA 330
            M+S+  H  ++R+        +++ ++  Y+  G + S L+          K     + 
Sbjct: 58  LMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 390
           L     L YLH +    II+RD+K  NILLD+     + DFG AK +      VT  + G
Sbjct: 117 LA----LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCG 165

Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 425
           T  +IAPE +ST   ++  D + FGIL+ E+++G 
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 17/79 (21%), Positives = 32/79 (40%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N I+     ++   + L  L L ++            L +L++L L++N L+     
Sbjct: 33  LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSS 92

Query: 90  SLSNMSQLAFLDLSYNNLS 108
               +S L +L+L  N   
Sbjct: 93  WFGPLSSLKYLNLMGNPYQ 111

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 24/122 (19%), Positives = 42/122 (34%), Gaps = 15/122 (12%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGK-LSKLLTLDLSNNFFT---GPIPSTVSHL 70
              V+    ++    ++N+ +   +P    + L  L  LDLS N          +     
Sbjct: 302 LSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360

Query: 71  ETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGN 124
            +LQ L L+ N L         L  +  L  LD+S N       S       +  N++  
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSST 420

Query: 125 SL 126
            +
Sbjct: 421 GI 422

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 20/104 (19%), Positives = 34/104 (32%), Gaps = 11/104 (10%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNIS---GHIPTEIGKLSKLLTLDLSNNFFT--GPIP 64
           + ++           L    L  N +           G    L TL LS N         
Sbjct: 322 VFLV-PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380

Query: 65  STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
             +  L+ L  L ++ N+    +P S     ++ FL+LS   + 
Sbjct: 381 EILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 23/121 (19%), Positives = 37/121 (30%), Gaps = 25/121 (20%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFT---GPIPSTV--------------SHLET 72
           +  N     +P       K+  L+LS+         IP T+                L  
Sbjct: 394 ISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPR 452

Query: 73  LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 127
           LQ L ++ N L   +P + S    L  + +S N L              +   +  N   
Sbjct: 453 LQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

Query: 128 C 128
           C
Sbjct: 511 C 511

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 16/120 (13%), Positives = 38/120 (31%), Gaps = 5/120 (4%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVS 68
            Q +    +F +   L    + N      I       L+ L  L++           ++ 
Sbjct: 110 YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLK 169

Query: 69  HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC 128
            +  + +L L+ +     +      +S + +L+L   NL+    S        +    + 
Sbjct: 170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 26/106 (24%), Positives = 40/106 (37%), Gaps = 8/106 (7%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 68
           I  I   G   +   L    L+++ I+  I  +    L  L  LDLS+N  +    S   
Sbjct: 38  ITYI-GHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG 95

Query: 69  HLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPS 113
            L +L+YL L  N        SL  N++ L  L +        +  
Sbjct: 96  PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 20/79 (25%), Positives = 37/79 (46%), Gaps = 3/79 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
            ++ + +  IP+ +   + + +LDLS N  T      +     LQ L L ++ +      
Sbjct: 12  GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68

Query: 90  SLSNMSQLAFLDLSYNNLS 108
           +  ++  L  LDLS N+LS
Sbjct: 69  AFYSLGSLEHLDLSDNHLS 87

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 17/87 (19%), Positives = 36/87 (41%), Gaps = 2/87 (2%)

Query: 24  FSFGRLLQNNNISGHIPTEIGKLS--KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 81
            +   L   N     + +E+GK+    +  L +   +    + +  S LE ++ + + N+
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320

Query: 82  SLTGAIPPSLSNMSQLAFLDLSYNNLS 108
            +         ++  L FLDLS N + 
Sbjct: 321 KVFLVPCSFSQHLKSLEFLDLSENLMV 347

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.4 bits (113), Expect = 8e-06
 Identities = 15/123 (12%), Positives = 37/123 (30%), Gaps = 6/123 (4%)

Query: 25  SFGRLLQNNNISGHIPT-EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 83
           SF  LL+       +   E    +     D + +              T++ L +    L
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298

Query: 84  TGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICATGAEEDCFG 138
              +    S + ++  + +  + +   P          +  +++ N ++        C G
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358

Query: 139 TAP 141
             P
Sbjct: 359 AWP 361

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 22/94 (23%), Positives = 36/94 (38%), Gaps = 9/94 (9%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 74
               F    RL    + NN +   +      +  L  LDLS+N     +       + L+
Sbjct: 264 MYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLE 321

Query: 75  YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
            L L++NS+   +    S    L  L LS+N+  
Sbjct: 322 NLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 24/105 (22%), Positives = 40/105 (38%), Gaps = 8/105 (7%)

Query: 19  SDGVFFSFGRL-LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 77
              V      L LQ+NN++      +     L+ +DLS N     +      ++ L+ L 
Sbjct: 221 RGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 278

Query: 78  LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT 122
           ++NN L  A+      +  L  LDLS+N+L               
Sbjct: 279 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL----HVERNQPQFD 318

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 17/81 (20%), Positives = 36/81 (44%), Gaps = 4/81 (4%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
            +N+ +   +P  +     ++  L+L++           ++  T+Q L +  N++   +P
Sbjct: 52  FKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP 109

Query: 89  PS-LSNMSQLAFLDLSYNNLS 108
           P    N+  L  L L  N+LS
Sbjct: 110 PHVFQNVPLLTVLVLERNDLS 130

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 19/81 (23%), Positives = 31/81 (38%), Gaps = 4/81 (4%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           +  N I  ++P  +   +  L  L L  N  +        +   L  L ++NN+L   I 
Sbjct: 100 MGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIE 157

Query: 89  PS-LSNMSQLAFLDLSYNNLS 108
                  + L  L LS N L+
Sbjct: 158 DDTFQATTSLQNLQLSSNRLT 178

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 17/79 (21%), Positives = 32/79 (40%), Gaps = 5/79 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             +N+I+  +   +    +L  L L +N  T    + + +   L  + L+ N L   +  
Sbjct: 212 ASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH 266

Query: 90  SLSNMSQLAFLDLSYNNLS 108
               M +L  L +S N L 
Sbjct: 267 PFVKMQRLERLYISNNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 9/80 (11%), Positives = 26/80 (32%), Gaps = 2/80 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +       +   E   L+    +   N+       + +     ++ L LN+  +   I  
Sbjct: 28  IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDT 86

Query: 90  -SLSNMSQLAFLDLSYNNLS 108
            + +    +  L + +N + 
Sbjct: 87  YAFAYAHTIQKLYMGFNAIR 106

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 7/87 (8%)

Query: 24  FSFGRL--LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 81
                +  L + N+S ++ + +     +  LD S+N     +   V     L  L+L +N
Sbjct: 180 VDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHN 236

Query: 82  SLTGAIPPSLSNMSQLAFLDLSYNNLS 108
           +LT      L N   L  +DLSYN L 
Sbjct: 237 NLTD--TAWLLNYPGLVEVDLSYNELE 261

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 8/71 (11%), Positives = 24/71 (33%), Gaps = 2/71 (2%)

Query: 39  IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS-LSNMSQL 97
           I + +        + +               L   + +   N+++   +P + L +  Q+
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 98  AFLDLSYNNLS 108
             L+L+   + 
Sbjct: 72  ELLNLNDLQIE 82

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 31/140 (22%), Positives = 49/140 (35%), Gaps = 27/140 (19%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV- 67
           +  I S   F     L    L +N++   +   +   L  L  L L NN     +     
Sbjct: 76  LNFI-SSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAF 132

Query: 68  SHLETLQYLRLNNNSLTGAIPP----SLSNMSQLAFLDLSYNNLS-------GPVPSFHA 116
             +  LQ L L+ N ++   P       + + +L  LDLS N L          +P++  
Sbjct: 133 EDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191

Query: 117 KTFNITGNSLICATGAEEDC 136
               +  N L C      DC
Sbjct: 192 NGLYLHNNPLEC------DC 205

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 11/95 (11%)

Query: 30  LQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGA 86
           L +NN+S  +  E    +L+ L +L LS+N     I S     +  L+YL L++N L   
Sbjct: 46  LSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH-T 102

Query: 87  IPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 120
           +     S++  L  L L  N++           F 
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIV----VVDRNAFE 133

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 20/71 (28%), Positives = 30/71 (42%), Gaps = 7/71 (9%)

Query: 51  TLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 108
            LDLS+N  +        + L  L  L L++N L   I   +   +  L +LDLS N+L 
Sbjct: 43  LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101

Query: 109 GPVPSFHAKTF 119
               +     F
Sbjct: 102 ----TLDEFLF 108

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 22/94 (23%), Positives = 36/94 (38%), Gaps = 9/94 (9%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 74
               F    RL    + NN +   +      +  L  LDLS+N     +       + L+
Sbjct: 270 MYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLE 327

Query: 75  YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
            L L++NS+   +    S    L  L LS+N+  
Sbjct: 328 NLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 17/81 (20%), Positives = 36/81 (44%), Gaps = 4/81 (4%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
            +N+ +   +P  +     ++  L+L++           ++  T+Q L +  N++   +P
Sbjct: 58  FKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP 115

Query: 89  PS-LSNMSQLAFLDLSYNNLS 108
           P    N+  L  L L  N+LS
Sbjct: 116 PHVFQNVPLLTVLVLERNDLS 136

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 60.7 bits (147), Expect = 6e-10
 Identities = 24/106 (22%), Positives = 38/106 (35%), Gaps = 12/106 (11%)

Query: 20  DGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 74
             +  SF ++    L +  I   I T        +  L +  N      P    ++  L 
Sbjct: 68  AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 126

Query: 75  YLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPSFHAKTF 119
            L L  N L+ ++P  +  N  +L  L +S NNL          TF
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE----RIEDDTF 167

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 19/81 (23%), Positives = 31/81 (38%), Gaps = 4/81 (4%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           +  N I  ++P  +   +  L  L L  N  +        +   L  L ++NN+L   I 
Sbjct: 106 MGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIE 163

Query: 89  PS-LSNMSQLAFLDLSYNNLS 108
                  + L  L LS N L+
Sbjct: 164 DDTFQATTSLQNLQLSSNRLT 184

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 17/79 (21%), Positives = 32/79 (40%), Gaps = 5/79 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             +N+I+  +   +    +L  L L +N  T    + + +   L  + L+ N L   +  
Sbjct: 218 ASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH 272

Query: 90  SLSNMSQLAFLDLSYNNLS 108
               M +L  L +S N L 
Sbjct: 273 PFVKMQRLERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 21/79 (26%), Positives = 32/79 (40%), Gaps = 10/79 (12%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +  N +     + +     +  LD S+N     +   V     L  L+L +N+LT     
Sbjct: 199 VSYNLL-----STLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD--TA 248

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L N   L  +DLSYN L 
Sbjct: 249 WLLNYPGLVEVDLSYNELE 267

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 9/82 (10%), Positives = 28/82 (34%), Gaps = 4/82 (4%)

Query: 30  LQNNNISGHIPT--EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAI 87
           +  +  +  +    E   L+    +   N+       + +     ++ L LN+  +   I
Sbjct: 32  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 90

Query: 88  PP-SLSNMSQLAFLDLSYNNLS 108
              + +    +  L + +N + 
Sbjct: 91  DTYAFAYAHTIQKLYMGFNAIR 112

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 8/71 (11%), Positives = 24/71 (33%), Gaps = 2/71 (2%)

Query: 39  IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS-LSNMSQL 97
           I + +        + +               L   + +   N+++   +P + L +  Q+
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77

Query: 98  AFLDLSYNNLS 108
             L+L+   + 
Sbjct: 78  ELLNLNDLQIE 88

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 62.4 bits (151), Expect = 9e-11
 Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 13/104 (12%)

Query: 39  IPTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQ 96
               +     L  L + N      +    +  L  L+ L +  + L   + P +     +
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 97  LAFLDLSYNNLS----GPVPSFHAKTFNITGNSLICATGAEEDC 136
           L+ L+LS+N L       V     +   ++GN L C       C
Sbjct: 82  LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC------SC 119

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 20/79 (25%), Positives = 34/79 (43%), Gaps = 8/79 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + NN +   +P E+   S L  +D+ NN     +P       +L+++   NN L     P
Sbjct: 138 VSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELP 189

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L N+  L  +    N+L 
Sbjct: 190 ELQNLPFLTAIYADNNSLK 208

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 23/98 (23%), Positives = 35/98 (35%), Gaps = 9/98 (9%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             NN +   +P E+  L  L  +   NN     +P       +L+ +   NN L     P
Sbjct: 180 AGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-LPD---LPLSLESIVAGNNILE--ELP 231

Query: 90  SLSNMSQLAFLDLSYNNLSG-PVPSFHAKTFNITGNSL 126
            L N+  L  +    N L   P      +  N+  N L
Sbjct: 232 ELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYL 269

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 20/79 (25%), Positives = 33/79 (41%), Gaps = 10/79 (12%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
              N+++  +P     L  LL  + +    +   P        L+YL ++NN L     P
Sbjct: 98  ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEKL--P 147

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L N S L  +D+  N+L 
Sbjct: 148 ELQNSSFLKIIDVDNNSLK 166

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 57.3 bits (139), Expect = 7e-09
 Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 20/111 (18%)

Query: 29  LLQNNNISGHIPTEIGKLS-------------KLLTLDLSNNFFTGPIPSTVSHLETLQY 75
               +    + P   G+               +   L+L+N   +  +P    HLE+L  
Sbjct: 40  YNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL-- 96

Query: 76  LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSL 126
              + NSLT  +P    ++  L   + +   LS   P    +   ++ N L
Sbjct: 97  -VASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLL--EYLGVSNNQL 143

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 18/93 (19%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL-------------ETLQY 75
           L  ++N++  +P E   +        + + +    P                        
Sbjct: 17  LRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHE 75

Query: 76  LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
           L LNN  L+ ++P    +   L  L  S N+L+
Sbjct: 76  LELNNLGLS-SLPELPPH---LESLVASCNSLT 104

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 19/79 (24%), Positives = 29/79 (36%), Gaps = 12/79 (15%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             +N I   +         L  L++SNN     +P+       L+ L  + N L   +P 
Sbjct: 304 ASSNEIR-SLCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE 354

Query: 90  SLSNMSQLAFLDLSYNNLS 108
              N   L  L + YN L 
Sbjct: 355 LPQN---LKQLHVEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 19/93 (20%), Positives = 32/93 (34%), Gaps = 20/93 (21%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             NN +   +P     L     L++ +N+ T  +P     L  L       + L+  +PP
Sbjct: 244 ADNNLLK-TLPDLPPSLE---ALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLS-ELPP 297

Query: 90  SL--------------SNMSQLAFLDLSYNNLS 108
           +L                   L  L++S N L 
Sbjct: 298 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 12/79 (15%), Positives = 28/79 (35%), Gaps = 7/79 (8%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L+ N+    +P     L +L    +  N      P      E+++ LR+N+  +      
Sbjct: 382 LRMNSHLAEVPELPQNLKQL---HVETNPLRE-FPDI---PESVEDLRMNSERVVDPYEF 434

Query: 90  SLSNMSQLAFLDLSYNNLS 108
           +     +L      +++  
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 16/105 (15%), Positives = 30/105 (28%), Gaps = 25/105 (23%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET----------------L 73
              N+++  +P     L +L    +  N      P     +E                 L
Sbjct: 344 ASFNHLA-EVPELPQNLKQL---HVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNL 398

Query: 74  QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKT 118
           + L +  N L    P    +   +  L ++   +  P    H  T
Sbjct: 399 KQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETT 439

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 19/95 (20%), Positives = 35/95 (36%), Gaps = 4/95 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L +  +          L  L  L+L+ N            L+ LQ L L+ N L      
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 124
           +   + ++A++DL  N+++        +TF     
Sbjct: 333 NFYGLPKVAYIDLQKNHIA----IIQDQTFKFLEK 363

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 23/107 (21%), Positives = 36/107 (33%), Gaps = 18/107 (16%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
            +  N++  +P     L+    L LS N+      S+   LE LQ L L +      I  
Sbjct: 11  YRFCNLT-QVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66

Query: 90  -SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF---------NITGNSL 126
            +  N+  L  LDL  + +       H   F          +    L
Sbjct: 67  EAFRNLPNLRILDLGSSKIY----FLHPDAFQGLFHLFELRLYFCGL 109

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 18/81 (22%), Positives = 31/81 (38%), Gaps = 3/81 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           L  N I     +    L +L  L+L + +    I      +L  L+ L L ++ +   + 
Sbjct: 31  LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLH 89

Query: 89  PS-LSNMSQLAFLDLSYNNLS 108
           P     +  L  L L +  LS
Sbjct: 90  PDAFQGLFHLFELRLYFCGLS 110

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 61.0 bits (148), Expect = 7e-10
 Identities = 25/106 (23%), Positives = 39/106 (36%), Gaps = 9/106 (8%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-----SHLETLQYLRLNNNSL 83
           L  N  S     +   +   L  L L  N       + +       L  LQ L LN+N L
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492

Query: 84  TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSL 126
               P   S+++ L  L L+ N L+    +      +  +I+ N L
Sbjct: 493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQL 538

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 27/109 (24%), Positives = 42/109 (38%), Gaps = 12/109 (11%)

Query: 30  LQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLNNNSLTGAI 87
           L  N +    I   + ++  L  L L+ N F+      T S   +L+ L L  N L  A 
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467

Query: 88  PPSL-----SNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 126
              L       +S L  L L++N L+  P   F      +  ++  N L
Sbjct: 468 ETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 28/113 (24%), Positives = 45/113 (39%), Gaps = 10/113 (8%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 74
           +D  F+    L    L  N +     +    L K+  +DL  N        T   LE LQ
Sbjct: 306 ADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ 365

Query: 75  YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHAKTFNITGNSL 126
            L L +N+LT     ++  +  +  + LS N L   P  +  A   +++ N L
Sbjct: 366 TLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRL 413

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 22/105 (20%), Positives = 36/105 (34%), Gaps = 9/105 (8%)

Query: 30  LQNNNISGHIPTEI---GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA 86
              +NI              S +  LDLS+ F           L+ L+ L L  N +   
Sbjct: 247 FGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKI 305

Query: 87  IPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 126
              +   +  L  L+LSYN L      +F+        ++  N +
Sbjct: 306 ADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 24/116 (20%), Positives = 38/116 (32%), Gaps = 10/116 (8%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHI--PTEIGKLSKLLTLDLSNNFFTG-PIPST 66
           I  +     F     L    L    +S  +        L  L  LDLS N      +  +
Sbjct: 85  IYFL-HPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS 143

Query: 67  VSHLETLQYLRLNNNSLTGAIPPSLSN--MSQLAFLDLSYNNLSGPVPSFHAKTFN 120
              L +L+ +  ++N +       L       L+F  L+ N+L   V     K  N
Sbjct: 144 FGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 17/104 (16%), Positives = 41/104 (39%), Gaps = 7/104 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--TLQYLRLNNNSLTGAI 87
             +N IS      +     ++      +    P  +T + L   ++++L L++  +    
Sbjct: 223 NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN 282

Query: 88  PPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 126
                 +  L  L+L+YN ++     +F+     +  N++ N L
Sbjct: 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 22/102 (21%), Positives = 38/102 (37%), Gaps = 9/102 (8%)

Query: 30  LQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--TLQYLRLNNNSLTGA 86
           L  N I   ++    GKL+ L ++D S+N         +  L+  TL +  L  NSL   
Sbjct: 130 LSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSR 189

Query: 87  IPPSLSNMSQ------LAFLDLSYNNLSGPVPSFHAKTFNIT 122
           +               L  LD+S N  +  +    +   + +
Sbjct: 190 VSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 24/129 (18%), Positives = 34/129 (26%), Gaps = 32/129 (24%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG------------- 61
            D  F    +L    L++N +     T I  +  +  + LS N                 
Sbjct: 354 QDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHL 408

Query: 62  --------PIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSG-PV 111
                    I   +  +  LQ L LN N  +        S    L  L L  N L     
Sbjct: 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468

Query: 112 PSFHAKTFN 120
                  F 
Sbjct: 469 TELCWDVFE 477

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 34/205 (16%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 289
           G+G FG V      +    VA+K      LK  +      + + E+  + L  H ++++L
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM---RVEREISYLKLLRHPHIIKL 74

Query: 290 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 341
                T T+ ++V  Y + G +   +          +KR+     R         + Y H
Sbjct: 75  YDVITTPTDIVMVIEY-AGGELFDYI--------VEKKRMTEDEGRRFFQQIICAIEYCH 125

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
                KI+HRD+K  N+LLD+     + DFGL+ ++    + + T+  G+  + APE ++
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTSC-GSPNYAAPEVIN 180

Query: 402 TGQSSE--KTDVFGFGILLLELISG 424
            G+     + DV+  GI+L  ++ G
Sbjct: 181 -GKLYAGPEVDVWSCGIVLYVMLVG 204

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 33/153 (21%), Positives = 58/153 (37%), Gaps = 24/153 (15%)

Query: 236 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 294
           G G  G V + +  +     A+K L+D      E++          +   +++R++    
Sbjct: 27  GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVYE 81

Query: 295 TTTER----LLVYPYMSNGSVASRLKAKPSLDWATRK-----RIALGAARGLLYLHEQCD 345
                    L+V   +  G + SR++ +    +  R+     +    A   + YLH    
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLHSI-- 136

Query: 346 PKIIHRDVKAANILL---DEYYEAVVGDFGLAK 375
             I HRDVK  N+L           + DFG AK
Sbjct: 137 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 39/236 (16%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQT---------EV 275
            S ++ +  +  G +G V  G   +G  VA+KR+ +  + G  +              E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 276 EMISLAVHRNLLRLIG-FCMTTTERL----LVYPYMS---NGSVASRLKAKPSLDWATRK 327
            +++   H N+L L   F       +    LV   M       +  +   +  +     +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ---RIVISPQHIQ 137

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 387
                   GL  LHE     ++HRD+   NILL +  +  + DF LA+     D++ T  
Sbjct: 138 YFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTA-DANKTHY 193

Query: 388 V-----RGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 436
           V     R      APE  +     ++  D++  G ++ E+ +  +AL  G    NQ
Sbjct: 194 VTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQ 242

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 26/95 (27%), Positives = 39/95 (41%), Gaps = 9/95 (9%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 74
           S      + RL    L    ++  +  + G L  L TLDLS+N     +P     L  L 
Sbjct: 47  SLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQS-LPLLGQTLPALT 103

Query: 75  YLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 108
            L ++ N LT ++P      + +L  L L  N L 
Sbjct: 104 VLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 27/81 (33%), Positives = 37/81 (45%), Gaps = 5/81 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           L +N +   +P     L  L  LD+S N  T  +P      L  LQ L L  N L   +P
Sbjct: 84  LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLP 140

Query: 89  PSL-SNMSQLAFLDLSYNNLS 108
           P L +   +L  L L+ NNL+
Sbjct: 141 PGLLTPTPKLEKLSLANNNLT 161

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 19/79 (24%), Positives = 33/79 (41%), Gaps = 3/79 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N +       +   ++L  L+L     T  +      L  L  L L++N L  ++P 
Sbjct: 38  LSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPL 94

Query: 90  SLSNMSQLAFLDLSYNNLS 108
               +  L  LD+S+N L+
Sbjct: 95  LGQTLPALTVLDVSFNRLT 113

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 22/82 (26%), Positives = 36/82 (43%), Gaps = 6/82 (7%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAI 87
           +  N ++  +P      L +L  L L  N     +P  + +    L+ L L NN+LT  +
Sbjct: 107 VSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-EL 163

Query: 88  PPSL-SNMSQLAFLDLSYNNLS 108
           P  L + +  L  L L  N+L 
Sbjct: 164 PAGLLNGLENLDTLLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 28/98 (28%), Positives = 39/98 (39%), Gaps = 10/98 (10%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV- 67
           +  +   G     G L    L+ N +   +P  +     KL  L L+NN  T  +P+ + 
Sbjct: 112 LTSL-PLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLL 168

Query: 68  SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 105
           + LE L  L L  NSL   IP        L F  L  N
Sbjct: 169 NGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 59.9 bits (145), Expect = 9e-10
 Identities = 52/243 (21%), Positives = 93/243 (38%), Gaps = 38/243 (15%)

Query: 215 KRFHFKELQSAT----SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 269
            +F+  E+  +T      + +   +G G  G V   Y       VA+K+L          
Sbjct: 46  NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------- 97

Query: 270 QFQT---------EVEMISLAVHRNLLRLI------GFCMTTTERLLVYPYMSNGSVASR 314
            FQ          E+ ++    H+N++ L+             +  LV   M   +   +
Sbjct: 98  PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQ 155

Query: 315 LKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 374
           +     LD      +      G+ +LH      IIHRD+K +NI++       + DFGLA
Sbjct: 156 VIQME-LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211

Query: 375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-T 433
           +      S + T    T  + APE +      E  D++  G ++ E++   + L  G+  
Sbjct: 212 RTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDY 268

Query: 434 ANQ 436
            +Q
Sbjct: 269 IDQ 271

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 35/123 (28%), Positives = 49/123 (39%), Gaps = 15/123 (12%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLET 72
              VF  F  L    L  N I+  I       L+ LL L+LS NF    I S +  +L+ 
Sbjct: 291 LKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDK 348

Query: 73  LQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNL-SGPVPSFHA----KTFNITGNSL 126
           L+ L L+ N +  A+   S   +  L  L L  N L S P   F      +   +  N  
Sbjct: 349 LEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

Query: 127 ICA 129
            C+
Sbjct: 408 DCS 410

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 20/84 (23%), Positives = 33/84 (39%), Gaps = 3/84 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           L  N+I+    T   +L  L  L +        I +     L +L  L+L+ N     + 
Sbjct: 37  LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLE 95

Query: 89  PS-LSNMSQLAFLDLSYNNLSGPV 111
               + ++ L  L L+  NL G V
Sbjct: 96  TGAFNGLANLEVLTLTQCNLDGAV 119

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 33/177 (18%), Positives = 55/177 (31%), Gaps = 19/177 (10%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLET 72
           ++  F     L    ++       I       LS L+ L L  N F   + +   + L  
Sbjct: 46  NETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLAN 104

Query: 73  LQYLRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLS--GPVPSFHA----KTFNITGN 124
           L+ L L   +L GA+        ++ L  L L  NN+    P   F         ++T N
Sbjct: 105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164

Query: 125 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLIL 181
            +       E+            L  S  +    M +        G+     S+  L
Sbjct: 165 KVKS---ICEEDLLNFQGKHFTLLRLSSITLQD-MNEYWLGWEKCGNPFKNTSITTL 217

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 23/93 (24%), Positives = 37/93 (39%), Gaps = 10/93 (10%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAI 87
           L  + I   +   +    + L  L L+ N     I       L  L  L L+ N L  +I
Sbjct: 282 LSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SI 338

Query: 88  PP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 119
                 N+ +L  LDLSYN++     +   ++F
Sbjct: 339 DSRMFENLDKLEVLDLSYNHIR----ALGDQSF 367

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 26/101 (25%), Positives = 38/101 (37%), Gaps = 11/101 (10%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV- 67
           I  I  D  F+    L    L  N +   I + +   L KL  LDLS N     +     
Sbjct: 311 INKI-DDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSF 367

Query: 68  SHLETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNL 107
             L  L+ L L+ N L  ++P      ++ L  + L  N  
Sbjct: 368 LGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 16/59 (27%), Positives = 26/59 (44%), Gaps = 1/59 (1%)

Query: 51  TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 108
            +DLS N       ++ S L+ LQ+L++   +    I   +   +S L  L L YN   
Sbjct: 34  YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL 92

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 22/109 (20%), Positives = 41/109 (37%), Gaps = 21/109 (19%)

Query: 20  DGVFFSFGRL----LQNNNISGHIPTEIGKL---SKLLTLDLSNNF----------FTGP 62
            G  F    +    L  N     +          +K+ +L LSN++          F  P
Sbjct: 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP 264

Query: 63  IPSTVSHLET--LQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 108
              T   LE   ++   L+ + +  A+  S+ S+ + L  L L+ N ++
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN 312

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.7 bits (141), Expect = 1e-09
 Identities = 33/210 (15%), Positives = 55/210 (26%), Gaps = 48/210 (22%)

Query: 225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRL-------------KDGNAIGGEIQF 271
            T        +G+G FG V++    D T VA+K +             K    I  EI  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 272 QTEVEMISLAV---HRNLLRLIGFCM-----------------------------TTTER 299
             E+ ++S  V       + L                                     ++
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 359
           L +      G +            AT K I       L         +  HRD+   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVL 194

Query: 360 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 389
           L +     +      K        +  ++ 
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 53/231 (22%), Positives = 87/231 (37%), Gaps = 40/231 (17%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 275
              + +   +G G  G V   Y       VA+K+L           FQ          E+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75

Query: 276 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKA--KPSLDWATR 326
            ++    H+N++ L+    T  + L       +V   M      + L    +  LD    
Sbjct: 76  VLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQMELDHERM 129

Query: 327 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
             +      G+ +LH      IIHRD+K +NI++       + DFGLA+      S + T
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT 184

Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 436
               T  + APE +      E  D++  G ++ E+I G   L  G    +Q
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQ 234

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 21/79 (26%), Positives = 35/79 (44%), Gaps = 9/79 (11%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +  N ++  +P    +L +L    +S N  T  +P        L  L +  N LT  +P 
Sbjct: 228 VSGNRLT-SLPVLPSELKEL---MVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPE 278

Query: 90  SLSNMSQLAFLDLSYNNLS 108
           SL ++S    ++L  N LS
Sbjct: 279 SLIHLSSETTVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 14/79 (17%), Positives = 34/79 (43%), Gaps = 8/79 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +  + ++  +P  +     + TL + +N  T  +P+       L+ L ++ N LT ++P 
Sbjct: 47  VGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV 98

Query: 90  SLSNMSQLAFLDLSYNNLS 108
               + +L+       +L 
Sbjct: 99  LPPGLLELSIFSNPLTHLP 117

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 15/79 (18%), Positives = 25/79 (31%), Gaps = 12/79 (15%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +  N ++  +P     L +L                       L  L +  N LT ++P 
Sbjct: 88  VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPV 138

Query: 90  SLSNMSQLAFLDLSYNNLS 108
                  L  L +S N L+
Sbjct: 139 LPPG---LQELSVSDNQLA 154

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 50.7 bits (121), Expect = 9e-07
 Identities = 22/79 (27%), Positives = 37/79 (46%), Gaps = 12/79 (15%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + +N ++  +PT   +L KL      NN  T  +P+       L+ L ++ N LT ++P 
Sbjct: 188 VSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPA---LPSGLKELIVSGNRLT-SLPV 238

Query: 90  SLSNMSQLAFLDLSYNNLS 108
             S    L  L +S N L+
Sbjct: 239 LPSE---LKELMVSGNRLT 254

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 13/78 (16%), Positives = 29/78 (37%), Gaps = 8/78 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +  N ++  +P     L  L    +  N  T  +P ++ HL +   + L  N L+     
Sbjct: 248 VSGNRLT-SLPMLPSGLLSL---SVYRNQLTR-LPESLIHLSSETTVNLEGNPLS---ER 299

Query: 90  SLSNMSQLAFLDLSYNNL 107
           +L  + ++         +
Sbjct: 300 TLQALREITSAPGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 20/79 (25%), Positives = 33/79 (41%), Gaps = 12/79 (15%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + +N ++  +P    +L KL      NN  T  +P        LQ L +++N L  ++P 
Sbjct: 148 VSDNQLA-SLPALPSELCKL---WAYNNQLTS-LPML---PSGLQELSVSDNQLA-SLPT 198

Query: 90  SLSNMSQLAFLDLSYNNLS 108
             S    L  L    N L+
Sbjct: 199 LPSE---LYKLWAYNNRLT 214

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 9/75 (12%), Positives = 22/75 (29%), Gaps = 1/75 (1%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +  N ++  +P  +  LS   T++L  N  +      +  + +             A   
Sbjct: 268 VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326

Query: 90  SLSNMSQLAFLDLSY 104
           +      L      +
Sbjct: 327 APRETRALHLAAADW 341

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 36/214 (16%), Positives = 63/214 (29%), Gaps = 11/214 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +  N IS    ++I  LSKL  L +S+N       S     + L+YL L++N L      
Sbjct: 28  ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH 87

Query: 90  SLSNMSQLAFLDLSYNNLS--GPVPSFHA----KTFNITGNSLICATGAEEDCFGTAPMP 143
              N   L  LDLS+N          F      K   ++   L  ++         + + 
Sbjct: 88  PTVN---LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVL 144

Query: 144 LSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGF--LLWWRQRHNQQIFFDV 201
           L           P G+      +L +          IL      +      + + +  D 
Sbjct: 145 LVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204

Query: 202 NEQRREEVCLGNLKRFHFKELQSATSNFSSKNLV 235
                  +            L       +  + +
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 25/118 (21%), Positives = 41/118 (34%), Gaps = 15/118 (12%)

Query: 21  GVFFSFGRL----LQNNNISGHIPTEIG---KLSKLLTLDLSNNFFTGPIPSTV-SHLET 72
                   L    LQ N +   +        ++  L  LD+S N  +        S  ++
Sbjct: 342 ENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400

Query: 73  LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA---KTFNITGNSL 126
           L  L +++N LT  I   L    ++  LDL  N +   P         +  N+  N L
Sbjct: 401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQL 456

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 57.2 bits (138), Expect = 9e-09
 Identities = 24/111 (21%), Positives = 39/111 (35%), Gaps = 8/111 (7%)

Query: 10  IIVLIQVICSDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 65
           ++  +       ++  F  +       +           K+S  L LD SNN  T  +  
Sbjct: 283 VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFE 342

Query: 66  TVSHLETLQYLRLNNNSLTGAIPPS---LSNMSQLAFLDLSYNNLSGPVPS 113
              HL  L+ L L  N L   +       + M  L  LD+S N++S     
Sbjct: 343 NCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 22/106 (20%), Positives = 43/106 (40%), Gaps = 9/106 (8%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           +  N++S             LL+L++S+N  T  I         ++ L L++N +  +IP
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR--CLPPRIKVLDLHSNKIK-SIP 437

Query: 89  PSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICA 129
             +  +  L  L+++ N L   P   F      +   +  N   C+
Sbjct: 438 KQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 483

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 19/79 (24%), Positives = 36/79 (45%), Gaps = 3/79 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
              N +  H+P ++    K   L++S N+ +    S +  L  L+ L +++N +      
Sbjct: 7   RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63

Query: 90  SLSNMSQLAFLDLSYNNLS 108
                 +L +LDLS+N L 
Sbjct: 64  VFKFNQELEYLDLSHNKLV 82

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 22/99 (22%), Positives = 38/99 (38%), Gaps = 9/99 (9%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 69
           +      G       L    + +N ++  I   +    ++  LDL +N     IP  V  
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVK 442

Query: 70  LETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNL 107
           LE LQ L + +N L  ++P      ++ L  + L  N  
Sbjct: 443 LEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 16/102 (15%), Positives = 25/102 (24%), Gaps = 5/102 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           LQ              L  L    + ++ F  P          +       +        
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318

Query: 90  SLSNMSQLAFLDLSYNNL-SGPVPSFHA----KTFNITGNSL 126
             S +S    LD S N L      +       +T  +  N L
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 49/235 (20%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 275
              + S   VG G +G+V      + G  VA+K+L           FQ+         E+
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74

Query: 276 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKR 328
            ++    H N++ L+    T    L       LV P+M    +   +  K S +    + 
Sbjct: 75  LLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEE--KIQY 130

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           +     +GL Y+H      ++HRD+K  N+ ++E  E  + DFGLA+   H D+ +T  V
Sbjct: 131 LVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYV 184

Query: 389 -----RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 436
                R      APE  LS    ++  D++  G ++ E+++G + L  GK   +Q
Sbjct: 185 VTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQ 232

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 58.2 bits (140), Expect = 4e-09
 Identities = 24/80 (30%), Positives = 36/80 (45%), Gaps = 4/80 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG-AIP 88
           L +N +   +P  +  L  L  L  S+N     +   V++L  LQ L L NN L   A  
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNRLQQSAAI 526

Query: 89  PSLSNMSQLAFLDLSYNNLS 108
             L +  +L  L+L  N+L 
Sbjct: 527 QPLVSCPRLVLLNLQGNSLC 546

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.8 bits (135), Expect = 4e-09
 Identities = 24/81 (29%), Positives = 35/81 (43%), Gaps = 4/81 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           L+ N I    P       KL  +DLSNN  +  +       L +L  L L  N +T  +P
Sbjct: 39  LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-ELP 96

Query: 89  PSL-SNMSQLAFLDLSYNNLS 108
            SL   +  L  L L+ N ++
Sbjct: 97  KSLFEGLFSLQLLLLNANKIN 117

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.7 bits (127), Expect = 5e-08
 Identities = 32/123 (26%), Positives = 51/123 (41%), Gaps = 15/123 (12%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLET 72
             G F  + +L    L NN IS  +  +    L  L +L L  N  T  +P ++   L +
Sbjct: 48  PPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFS 105

Query: 73  LQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNL-SGPVPSFHA----KTFNITGNSL 126
           LQ L LN N +   +   +  ++  L  L L  N L +    +F      +T ++  N  
Sbjct: 106 LQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

Query: 127 ICA 129
           IC 
Sbjct: 165 ICD 167

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 14/60 (23%), Positives = 26/60 (43%), Gaps = 4/60 (6%)

Query: 51  TLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 108
            + L  N     IP    S  + L+ + L+NN ++  + P +   +  L  L L  N ++
Sbjct: 36  EIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 45/254 (17%), Positives = 87/254 (34%), Gaps = 68/254 (26%)

Query: 222 LQSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT---EVEM 277
           L++++  +S    +G G FG V + +  + G   A+K++            +    E+++
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL--------QDPRYKNRELDI 53

Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA---- 333
           + +  H N+++L+ +  TT +     P   +       K     +      +        
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 334 -------------------------------------ARGLLYLHEQCDPKIIHRDVKAA 356
                                                 R + ++H      I HRD+K  
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQ 170

Query: 357 NILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAV----RGTVGHIAPE-YLSTGQSSEKTD 410
           N+L++ +     + DFG AK L   +  V        R      APE  L   + +   D
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSID 224

Query: 411 VFGFGILLLELISG 424
           ++  G +  ELI G
Sbjct: 225 LWSIGCVFGELILG 238

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 56.1 bits (136), Expect = 7e-09
 Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 10/97 (10%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLET 72
               F    +L    L +N +   +P  I  +L  L TL +++N     +P  V   L  
Sbjct: 53  PSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVN 110

Query: 73  LQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 108
           L  LRL+ N L  ++PP +  ++++L +L L YN L 
Sbjct: 111 LAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 4/81 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           LQ+N +S        +L+KL  L L++N     +P+ +   L+ L+ L + +N L  A+P
Sbjct: 44  LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ-ALP 101

Query: 89  PSL-SNMSQLAFLDLSYNNLS 108
             +   +  LA L L  N L 
Sbjct: 102 IGVFDQLVNLAELRLDRNQLK 122

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 26/93 (27%), Positives = 39/93 (41%), Gaps = 8/93 (8%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLET 72
              VF S  +L    L  N +   +P  +  KL+ L  L L NN     +P      L  
Sbjct: 125 PPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTE 182

Query: 73  LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 105
           L+ L+L+NN L      +  ++ +L  L L  N
Sbjct: 183 LKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 56.1 bits (136), Expect = 7e-09
 Identities = 27/109 (24%), Positives = 43/109 (39%), Gaps = 15/109 (13%)

Query: 21  GVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQY 75
           G F     L        N++      IG L  L  L++++N      +P   S+L  L++
Sbjct: 94  GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153

Query: 76  LRLNNNSLTGAIPP----SLSNMSQLAF-LDLSYNNLSGPVPSFHAKTF 119
           L L++N +  +I       L  M  L   LDLS N ++          F
Sbjct: 154 LDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN----FIQPGAF 197

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 25/102 (24%), Positives = 37/102 (36%), Gaps = 13/102 (12%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKL----LTLDLSNNFFTGPIP 64
           IQ       F +   L    L +N I   I       L ++    L+LDLS N     I 
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQ 193

Query: 65  STVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYN 105
                   L+ L L+ N L  ++P      ++ L  + L  N
Sbjct: 194 PGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 18/72 (25%), Positives = 27/72 (37%), Gaps = 6/72 (8%)

Query: 39  IPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIPPSL-SNMSQ 96
           IP  +        LDLS N     + S        LQ L L+   +   I      ++S 
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 97  LAFLDLSYNNLS 108
           L+ L L+ N + 
Sbjct: 78  LSTLILTGNPIQ 89

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 46/222 (20%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 275
            + +     VG G +G V      + G  VA+K+L           FQ+         E+
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75

Query: 276 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKR 328
            ++    H N++ L+    T  E L       LV P+M  G+   +L     L     + 
Sbjct: 76  RLLKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQF 132

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           +     +GL Y+H      IIHRD+K  N+ ++E  E  + DFGLA+     DS +T  V
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYV 186

Query: 389 -----RGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELISG 424
                R      APE  L+  + ++  D++  G ++ E+I+G
Sbjct: 187 VTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 20/93 (21%), Positives = 33/93 (35%), Gaps = 7/93 (7%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           L NN  +    T I  KL +L  ++ SNN  T            +  + L +N L   + 
Sbjct: 39  LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQ 97

Query: 89  PSL-SNMSQLAFLDLSYNNLSGPVPSFHAKTFN 120
             +   +  L  L L  N ++         +F 
Sbjct: 98  HKMFKGLESLKTLMLRSNRIT----CVGNDSFI 126

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 13/84 (15%)

Query: 38  HIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNMS 95
           HIP           L L+NN FT          L  L+ +  +NN +T  I   +    S
Sbjct: 29  HIPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81

Query: 96  QLAFLDLSYNNLSGPVPSFHAKTF 119
            +  + L+ N L     +   K F
Sbjct: 82  GVNEILLTSNRLE----NVQHKMF 101

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 23/100 (23%), Positives = 43/100 (43%), Gaps = 12/100 (12%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV- 67
           I  I  +G F     +    L +N +   +  ++   L  L TL L +N  T  + +   
Sbjct: 69  ITDI-EEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITC-VGNDSF 125

Query: 68  SHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNN 106
             L +++ L L +N +T  + P +   +  L+ L+L   N
Sbjct: 126 IGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNL-LAN 163

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 21/79 (26%), Positives = 40/79 (50%), Gaps = 8/79 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             N++I+    T I KL+ L  L  ++N  T  +   +S    L YL  ++N LT  +  
Sbjct: 49  CHNSSITD--MTGIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLT-NLD- 101

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            ++ +++L +L+   N L+
Sbjct: 102 -VTPLTKLTYLNCDTNKLT 119

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 23/79 (29%), Positives = 34/79 (43%), Gaps = 8/79 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
              N        ++   ++L TLD S N  T      VS  + L  L  + N++T  +  
Sbjct: 155 CHLNKKIT--KLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD- 207

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L+   QL FLD S N L+
Sbjct: 208 -LNQNIQLTFLDCSSNKLT 225

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 21/100 (21%), Positives = 36/100 (36%), Gaps = 7/100 (7%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           +     +         +L+ L +LD  N+  T    + +  L  L  L   +N++T  + 
Sbjct: 24  VAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLD 80

Query: 89  PSLSNMSQLAFLDLSYNNLSG-PVPSFHA-KTFNITGNSL 126
             LS  + L +L    N L+   V         N   N L
Sbjct: 81  --LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKL 118

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 17/79 (21%), Positives = 30/79 (37%), Gaps = 6/79 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
            Q          ++   ++L  LD      T  +   +S    L YL LNN  LT  +  
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD- 334

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            +S+ ++L  L     ++ 
Sbjct: 335 -VSHNTKLKSLSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 18/79 (22%), Positives = 32/79 (40%), Gaps = 8/79 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
              N ++  +   + +   L  L+ + N  T  I   VSH   L  L  + N        
Sbjct: 113 CDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KL 164

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            ++  +QL  LD S+N ++
Sbjct: 165 DVTPQTQLTTLDCSFNKIT 183

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 15/79 (18%), Positives = 29/79 (36%), Gaps = 8/79 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
              N ++  +   +  LSKL TL          I   ++H   L Y +         +  
Sbjct: 240 CSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE-ID--LTHNTQLIYFQAEGCRKIKELD- 292

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            +++ +QL  LD     ++
Sbjct: 293 -VTHNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 18/78 (23%), Positives = 29/78 (37%), Gaps = 9/78 (11%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
             +N ++  I   +  L++L   D S N  T  +   VS L  L  L      L   I  
Sbjct: 219 CSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID- 270

Query: 90  SLSNMSQLAFLDLSYNNL 107
            L++ +QL +        
Sbjct: 271 -LTHNTQLIYFQAEGCRK 287

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 13/78 (16%), Positives = 28/78 (35%), Gaps = 7/78 (8%)

Query: 31  QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 90
           Q  + +   P +    +  +               +   L TL  L  +N+S+T      
Sbjct: 7   QTQSFNDWFPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITDM--TG 59

Query: 91  LSNMSQLAFLDLSYNNLS 108
           +  ++ L  L  + NN++
Sbjct: 60  IEKLTGLTKLICTSNNIT 77

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 23/79 (29%), Positives = 38/79 (48%), Gaps = 6/79 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N +     + I  L  + TLDL++   T   P  ++ L  LQ L L+ N +T  I P
Sbjct: 92  LSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN-ISP 146

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L+ ++ L +L +    +S
Sbjct: 147 -LAGLTNLQYLSIGNAQVS 164

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 6/88 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + N  +S   P  +  LSKL TL   +N  +  I   ++ L  L  + L NN ++   P 
Sbjct: 158 IGNAQVSDLTP--LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP- 212

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAK 117
            L+N S L  + L+   ++     ++  
Sbjct: 213 -LANTSNLFIVTLTNQTITNQPVFYNNN 239

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 25/79 (31%), Positives = 38/79 (48%), Gaps = 6/79 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L +  I+    T +  LS L  L L  N  T   P  ++ L  LQYL + N  ++  + P
Sbjct: 114 LTSTQITD--VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP 168

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L+N+S+L  L    N +S
Sbjct: 169 -LANLSKLTTLKADDNKIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 21/79 (26%), Positives = 34/79 (43%), Gaps = 6/79 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
              +N++         L  + TL       T  I   V +L  L  L L +N +T  + P
Sbjct: 26  AGKSNVTD--TVTQADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKDNQITD-LAP 80

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L N++++  L+LS N L 
Sbjct: 81  -LKNLTKITELELSGNPLK 98

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 15/82 (18%), Positives = 31/82 (37%), Gaps = 6/82 (7%)

Query: 27  GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA 86
           G + Q   I+   P     L+  + +    +  T     T + L+ +  L      +T  
Sbjct: 1   GSITQPTAINVIFP--DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-T 55

Query: 87  IPPSLSNMSQLAFLDLSYNNLS 108
           I   +  ++ L  L+L  N ++
Sbjct: 56  IEG-VQYLNNLIGLELKDNQIT 76

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 18/81 (22%), Positives = 34/81 (41%), Gaps = 4/81 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L+NN IS   P  +   S L  + L+N   T       ++L     ++  + +     P 
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APA 257

Query: 90  SLSNMSQLAFLDLSYNNLSGP 110
           ++S+    A  +L++N  S  
Sbjct: 258 TISDNGTYASPNLTWNLTSFI 278

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 37/202 (18%), Positives = 76/202 (37%), Gaps = 35/202 (17%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---EVEMISLA 281
              +  ++L+G G +G+V + Y   +  VVA+K++         I  +    E+ +++  
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRL 109

Query: 282 VHRNLLRLIGFCMTTTERL-----LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA-- 334
            H ++++++   +           +V          S  K         R  + L     
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-----SDFKK------LFRTPVYLTELHI 158

Query: 335 --------RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
                    G+ Y+H      I+HRD+K AN L+++     V DFGLA+ +D+ ++  + 
Sbjct: 159 KTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 387 AVRGTVGHIAPEYLSTGQSSEK 408
                              + K
Sbjct: 216 LPISPREDDMNLVTFPHTKNLK 237

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 51/244 (20%), Positives = 91/244 (37%), Gaps = 26/244 (10%)

Query: 197 IFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVA 255
           ++ DVN  R  E          +        ++     +G+G +  V++   + +   V 
Sbjct: 10  VYTDVNTHRPREYWDYESHVVEW----GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV 65

Query: 256 VKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER--LLVYPYMSNGSV 311
           VK LK      I  EI+      + +L    N++ L         R   LV+ +++N   
Sbjct: 66  VKILKPVKKKKIKREIKI-----LENLRGGPNIITLADIVKDPVSRTPALVFEHVNN--- 117

Query: 312 ASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVG 369
            +  K    +L     +       + L Y H      I+HRDVK  N+++D E+ +  + 
Sbjct: 118 -TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI 173

Query: 370 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRAL 428
           D+GLA+       +    V  +     PE L   Q      D++  G +L  +I      
Sbjct: 174 DWGLAEFYHPGQEY-NVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

Query: 429 EFGK 432
             G 
Sbjct: 232 FHGH 235

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 19/128 (14%), Positives = 38/128 (29%), Gaps = 20/128 (15%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGP----IPSTVS- 68
                 S   +    L        +        S +  L+L +          + +  + 
Sbjct: 190 EPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248

Query: 69  ---HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFN 120
                 T + +++ + SL   +   L+ +S L  L+ S N L   P   F      +   
Sbjct: 249 SLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIW 307

Query: 121 ITGNSLIC 128
           +  N   C
Sbjct: 308 LHTNPWDC 315

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 13/104 (12%), Positives = 36/104 (34%), Gaps = 9/104 (8%)

Query: 14  IQVICSDGVFFSFGRL-----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV 67
            + +    +F    +L        +  +  I  +    L+ L  L++  +      P ++
Sbjct: 136 YKTLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDLQSYEPKSL 194

Query: 68  SHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGP 110
             ++ + +L L+       +    +   S +  L+L   +L   
Sbjct: 195 KSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF 237

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 22/103 (21%), Positives = 41/103 (39%), Gaps = 11/103 (10%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLET 72
           S+        L    L +N I+  I  +    L  L  LDLS N+ +  + S+    L +
Sbjct: 68  SNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSS 125

Query: 73  LQYLRLNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLSGPVPS 113
           L +L L  N     +  +   S++++L  L +   +    +  
Sbjct: 126 LTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 16/141 (11%), Positives = 39/141 (27%), Gaps = 19/141 (13%)

Query: 3   LLLEKVLIIVLIQVICSDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNN 57
           L + +V  +     I     F     L    +  +++      +    +  +  L L   
Sbjct: 151 LQILRVGNMDTFTKI-QRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMK 208

Query: 58  FFTGPIPSTVSHLETLQYLRLNNNSLTG----AIPP----SLSNMSQLAFLDLSYNNLSG 109
                +   V    +++ L L +  L       +      SL        + ++  +L  
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ 268

Query: 110 PVPSFHA----KTFNITGNSL 126
            +   +          + N L
Sbjct: 269 VMKLLNQISGLLELEFSRNQL 289

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 27/71 (38%), Positives = 36/71 (50%), Gaps = 4/71 (5%)

Query: 39  IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQL 97
           IP+ +     + +LDLSNN  T    S +     LQ L L +N +   I   S S++  L
Sbjct: 46  IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102

Query: 98  AFLDLSYNNLS 108
             LDLSYN LS
Sbjct: 103 EHLDLSYNYLS 113

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 17/82 (20%), Positives = 30/82 (36%), Gaps = 4/82 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL-NNNSLTGAI 87
                +             L  +++S N     I + V S+L  L  +R+   N+L   I
Sbjct: 37  FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YI 95

Query: 88  PPS-LSNMSQLAFLDLSYNNLS 108
            P    N+  L +L +S   + 
Sbjct: 96  NPEAFQNLPNLQYLLISNTGIK 117

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 19/80 (23%), Positives = 32/80 (40%), Gaps = 8/80 (10%)

Query: 28  RLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTG 85
            L  NNN+   +P ++    S  + LD+S       +PS    +L+ L+     N     
Sbjct: 183 NLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKL- 239

Query: 86  AIPPSLSNMSQLAFLDLSYN 105
              P+L  +  L    L+Y 
Sbjct: 240 ---PTLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 23/100 (23%), Positives = 34/100 (34%), Gaps = 8/100 (8%)

Query: 28  RLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA 86
           R+ + NN+  +I  E    L  L  L +SN            H      L + +N     
Sbjct: 85  RIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143

Query: 87  IPP-SLSNMS-QLAFLDLSYNNLSGPVPSFHAKTFNITGN 124
           I   S   +S +   L L+ N +       H   FN T  
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQ----EIHNSAFNGTQL 179

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 18/102 (17%), Positives = 34/102 (33%), Gaps = 9/102 (8%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPSTV 67
           I+ +  D       +     +Q+N     I      G   + + L L+ N       S  
Sbjct: 116 IKHL-PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAF 174

Query: 68  SHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 108
           +  +  +    +NN+L   +P       S    LD+S   + 
Sbjct: 175 NGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH 215

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 13/79 (16%), Positives = 29/79 (36%), Gaps = 6/79 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
            Q + ++  IP+++      + L          I     S    L+ + ++ N +   I 
Sbjct: 16  CQESKVT-EIPSDL--PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIE 71

Query: 89  PS-LSNMSQLAFLDLSYNN 106
               SN+ +L  + +   N
Sbjct: 72  ADVFSNLPKLHEIRIEKAN 90

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 38/230 (16%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 275
              + + + VG G +G+V   +  + G  VAVK+L           FQ+         E+
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79

Query: 276 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKR 328
            ++    H N++ L+    T    L       LV   M    + + +K +  L     + 
Sbjct: 80  RLLKHMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQF 136

Query: 329 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 388
           +     RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA+   H    +T  V
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV 190

Query: 389 RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 436
             T  + APE  L+    ++  D++  G ++ EL++G R L  G    +Q
Sbjct: 191 -ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQ 238

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 54.0 bits (129), Expect = 9e-08
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 6/79 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L++N IS  I   +  L +L +L L NN  T    + +S L  L  L L +N ++  I P
Sbjct: 116 LEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP 170

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L+ +++L  L LS N++S
Sbjct: 171 -LAGLTKLQNLYLSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 11/80 (13%), Positives = 31/80 (38%), Gaps = 6/80 (7%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           +  +  I    P      ++ +  +L     T  +    + L ++  +  NN+ +  ++ 
Sbjct: 5   ITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ 59

Query: 89  PSLSNMSQLAFLDLSYNNLS 108
             +  +  +  L L+ N L+
Sbjct: 60  G-IQYLPNVTKLFLNGNKLT 78

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 51.3 bits (122), Expect = 5e-07
 Identities = 23/86 (26%), Positives = 39/86 (45%), Gaps = 6/86 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L NN I+    T + +L+KL TL L +N  +  I   ++ L  LQ L L+ N ++  +  
Sbjct: 138 LGNNKIT--DITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLRA 192

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFH 115
            L+ +  L  L+L          +  
Sbjct: 193 -LAGLKNLDVLELFSQECLNKPINHQ 217

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 51.3 bits (122), Expect = 5e-07
 Identities = 24/79 (30%), Positives = 38/79 (48%), Gaps = 6/79 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N I   + + +  L KL +L L +N  +    + + HL  L+ L L NN +T     
Sbjct: 94  LDENKIK-DLSS-LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT--DIT 147

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            LS +++L  L L  N +S
Sbjct: 148 VLSRLTKLDTLSLEDNQIS 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 47.4 bits (112), Expect = 8e-06
 Identities = 19/81 (23%), Positives = 36/81 (44%), Gaps = 10/81 (12%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--GPIPSTVSHLETLQYLRLNNNSLTGAI 87
           L+  +++  +     +L+ +  +  +N+       I     +L  +  L LN N LT  I
Sbjct: 28  LKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGI----QYLPNVTKLFLNGNKLTD-I 80

Query: 88  PPSLSNMSQLAFLDLSYNNLS 108
            P L+N+  L +L L  N + 
Sbjct: 81  KP-LTNLKNLGWLFLDENKIK 100

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.6 bits (102), Expect = 1e-04
 Identities = 14/79 (17%), Positives = 29/79 (36%), Gaps = 4/79 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N+IS      +  L  L  L+L +        +  S+L     ++  + SL    P 
Sbjct: 182 LSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPE 237

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            +S+       ++ ++   
Sbjct: 238 IISDDGDYEKPNVKWHLPE 256

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 48/223 (21%), Positives = 92/223 (41%), Gaps = 44/223 (19%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 275
              +++ + +G+G +G V   Y   +   VA+K++           F+          E+
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---------FEHQTYCQRTLREI 76

Query: 276 EMISLAVHRNLLRLIG-FCMTTTERL----LVYPYMSNGSVASRLKAKPSLDWATRKRIA 330
           +++    H N++ +       T E++    +V   M   +   +L     L         
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFL 134

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH------- 383
               RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++ D    H       
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191

Query: 384 -VTTAVRGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELISG 424
             T   R      APE  L++   ++  D++  G +L E++S 
Sbjct: 192 VATRWYR------APEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 14/89 (15%), Positives = 32/89 (35%), Gaps = 6/89 (6%)

Query: 29  LLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGA 86
           +  +  +   + +     LSK+  +++ N      I       L  L++L + N  L   
Sbjct: 62  VSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-M 119

Query: 87  IPP--SLSNMSQLAFLDLSYNNLSGPVPS 113
            P    + +      L+++ N     +P 
Sbjct: 120 FPDLTKVYSTDIFFILEITDNPYMTSIPV 148

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 9/103 (8%)

Query: 14  IQVICSDGVFFSFGRL----LQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPSTV 67
           +++       +S        + +N     IP     G  ++ LTL L NN FT  +    
Sbjct: 117 LKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYA 175

Query: 68  SHLETLQYLRLNNNSLTGAIPP-SLSNM-SQLAFLDLSYNNLS 108
            +   L  + LN N     I   +   + S  + LD+S  +++
Sbjct: 176 FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 53/246 (21%), Positives = 94/246 (38%), Gaps = 57/246 (23%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 275
            S +     +G GG G V+          VA+K+          I             E+
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK----------IVLTDPQSVKHALREI 59

Query: 276 EMISLAVHRNLLRLI----------GFCMTTTERL----LVYPYMSNGSVASRLKAKPSL 321
           ++I    H N++++              + +   L    +V  YM   +  + +  +  L
Sbjct: 60  KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPL 117

Query: 322 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHC 380
                +       RGL Y+H      ++HRD+K AN+ ++ E     +GDFGLA+++D  
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174

Query: 381 DSH--------VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFG 431
            SH        VT   R      +P   LS    ++  D++  G +  E+++G + L  G
Sbjct: 175 YSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAG 227

Query: 432 K-TANQ 436
                Q
Sbjct: 228 AHELEQ 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 14/80 (17%), Positives = 32/80 (40%), Gaps = 6/80 (7%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           + +   I+   P     L+  +  +L     T     +   L  +Q    +N+++  ++ 
Sbjct: 3   IQRPTPINQVFP--DPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SLA 57

Query: 89  PSLSNMSQLAFLDLSYNNLS 108
             +   + L  L LS+N +S
Sbjct: 58  G-MQFFTNLKELHLSHNQIS 76

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 21/79 (26%), Positives = 34/79 (43%), Gaps = 7/79 (8%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +  N +           + L  L L NN        ++ HL+ L+ L + NN L  +I  
Sbjct: 92  VNRNRLKN---LNGIPSACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLK-SIVM 145

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L  +S+L  LDL  N ++
Sbjct: 146 -LGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 21/81 (25%), Positives = 36/81 (44%), Gaps = 11/81 (13%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--TLQYLRLNNNSLTGAI 87
           L +N IS  + + +  L+KL  L ++ N     +   ++ +    L  L L+NN L    
Sbjct: 70  LSHNQIS-DL-SPLKDLTKLEELSVNRN----RL-KNLNGIPSACLSRLFLDNNELRD-- 120

Query: 88  PPSLSNMSQLAFLDLSYNNLS 108
             SL ++  L  L +  N L 
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK 141

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 49/249 (19%), Positives = 87/249 (34%), Gaps = 69/249 (27%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 275
             N+  K+L+G+G +G VY  Y       VA+K++           F+          E+
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------MFEDLIDCKRILREI 76

Query: 276 EMISLAVHRNLLRLIGFCMTTTERL-----LVYPYMSNGSVASRLKAKPSLDWATRKRIA 330
            +++      ++RL    +           +V          S LK         +  I 
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK------LFKTPIF 125

Query: 331 LGAA----------RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 380
           L              G  ++HE     IIHRD+K AN LL++     V DFGLA+ ++  
Sbjct: 126 LTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182

Query: 381 DSHVTTAVRGTVGHI---------------------APEYLSTGQS-SEKTDVFGFGILL 418
                                               APE +   ++ ++  D++  G + 
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242

Query: 419 LELISGLRA 427
            EL++ L++
Sbjct: 243 AELLNMLQS 251

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 23/80 (28%), Positives = 36/80 (45%), Gaps = 4/80 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           LQ+  ++         L+KL  L+L  N     + + V   L  L  L L NN L  ++P
Sbjct: 42  LQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA-SLP 99

Query: 89  PSL-SNMSQLAFLDLSYNNL 107
             +  +++QL  L L  N L
Sbjct: 100 LGVFDHLTQLDKLYLGGNQL 119

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 10/97 (10%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLET 72
           SD  F    +L    L  N +   +   +   L++L TL L+NN     +P  V  HL  
Sbjct: 51  SDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQ 108

Query: 73  LQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 108
           L  L L  N L  ++P  +   +++L  L L+ N L 
Sbjct: 109 LDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 11/96 (11%)

Query: 21  GVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFT----GPIPSTVSHLET 72
               +  RL    LQ N +  +          + +L+  +             T +  E+
Sbjct: 371 QGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429

Query: 73  LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
           +  L L++N LTG++   L    ++  LDL  N + 
Sbjct: 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM 463

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 49.1 bits (117), Expect = 3e-06
 Identities = 19/72 (26%), Positives = 35/72 (48%), Gaps = 4/72 (5%)

Query: 38  HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQ 96
           H+P ++    +   L LS N  +      +S L  L+ LRL++N +  ++   +      
Sbjct: 45  HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101

Query: 97  LAFLDLSYNNLS 108
           L +LD+S+N L 
Sbjct: 102 LEYLDVSHNRLQ 113

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 23/79 (29%), Positives = 38/79 (48%), Gaps = 7/79 (8%)

Query: 30  LQNNNISGHIPTEIGKLSKLLT-LDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           L +N ++G +      L   +  LDL NN     IP  V+HL+ LQ L + +N L  ++P
Sbjct: 435 LSSNMLTGSVFR---CLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVP 489

Query: 89  P-SLSNMSQLAFLDLSYNN 106
                 ++ L ++ L  N 
Sbjct: 490 DGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 24/139 (17%), Positives = 40/139 (28%), Gaps = 13/139 (9%)

Query: 30  LQNNNISGHIPTEIG-----KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT 84
           + N  I+  I  E        L  L+   + N  F     +  S    +    L+ +   
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP 342

Query: 85  GAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICATGAEEDCFGT 139
                   + S   FL+ + N  +             +T  +  N L       +    T
Sbjct: 343 FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL---KNFFKVALMT 399

Query: 140 APMPLSFALNNSPNSKPSG 158
             M     L+ S NS  S 
Sbjct: 400 KNMSSLETLDVSLNSLNSH 418

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.1 bits (104), Expect = 9e-05
 Identities = 20/96 (20%), Positives = 41/96 (42%), Gaps = 11/96 (11%)

Query: 20  DGVFFSFGRL-------LQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE 71
             V      +       +  N++ S            +L L+LS+N  TG +   +    
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--P 450

Query: 72  TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 107
            ++ L L+NN +  +IP  ++++  L  L+++ N L
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 50.3 bits (121), Expect = 7e-07
 Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 17/114 (14%)

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 394
           R +  LH      +IHRD+K +N+L++   +  V DFGLA+++D   +   +   G    
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE-SAADNSEPTGQQSG 178

Query: 395 I----------APEY-LSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 436
           +          APE  L++ + S   DV+  G +L EL    R +  G+   +Q
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRHQ 231

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.8 bits (117), Expect = 7e-07
 Identities = 24/80 (30%), Positives = 36/80 (45%), Gaps = 3/80 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N  +  +P E+     L  +DLSNN  +     + S++  L  L L+ N L   IPP
Sbjct: 38  LDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPP 95

Query: 90  SL-SNMSQLAFLDLSYNNLS 108
                +  L  L L  N++S
Sbjct: 96  RTFDGLKSLRLLSLHGNDIS 115

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 9/71 (12%)

Query: 39  IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQL 97
           IP ++ +L       L  N FT  +P  +S+ + L  + L+NN ++  +     SNM+QL
Sbjct: 29  IPRDVTEL------YLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 98  AFLDLSYNNLS 108
             L LSYN L 
Sbjct: 81  LTLILSYNRLR 91

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 45/226 (19%), Positives = 85/226 (37%), Gaps = 55/226 (24%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-----------A 281
            +G G F  V+    + + T VA+K ++           + E++++              
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 282 VHRNLLRLIGF-----------CMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRI 329
              ++L+L+              M   E L      +  ++  + + +   L +   K+I
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVF-EVL----GENLLALIKKYEHRGIPLIYV--KQI 136

Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDE------YYEAVVGDFGLAKLLDHCDSH 383
           +     GL Y+H +C   IIH D+K  N+L++         +  + D G A   D    H
Sbjct: 137 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---H 191

Query: 384 VTTAV-----RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            T ++     R      +PE L         D++    L+ ELI+G
Sbjct: 192 YTNSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITG 231

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 22/79 (27%), Positives = 34/79 (43%), Gaps = 12/79 (15%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + NN ++  +P     L  +   +  NN  T  +P   + LE L    + NN LT  +P 
Sbjct: 127 VDNNQLT-MLPELPALLEYI---NADNNQLTM-LPELPTSLEVL---SVRNNQLT-FLPE 177

Query: 90  SLSNMSQLAFLDLSYNNLS 108
              +   L  LD+S N L 
Sbjct: 178 LPES---LEALDVSTNLLE 193

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 17/79 (21%), Positives = 34/79 (43%), Gaps = 12/79 (15%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           +  N +   +P     L  L   D  +N  +  +P       +L++L ++NN LT  +P 
Sbjct: 87  ITQNALI-SLPELPASLEYL---DACDNRLST-LPEL---PASLKHLDVDNNQLT-MLPE 137

Query: 90  SLSNMSQLAFLDLSYNNLS 108
             +    L +++   N L+
Sbjct: 138 LPAL---LEYINADNNQLT 153

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 16/111 (14%), Positives = 33/111 (29%), Gaps = 9/111 (8%)

Query: 30  LQNNNISGHIPTEIGKLSKLLT----LDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG 85
           +  N +   +P    +               N  T  IP  +  L+    + L +N L+ 
Sbjct: 187 VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSS 244

Query: 86  AIPPSLSNMSQLAFL---DLSYNNLSGPVPSFHAKTFNITGNSLICATGAE 133
            I  SLS  +         + ++   G   + H    +           ++
Sbjct: 245 RIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSD 295

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 19/98 (19%), Positives = 37/98 (37%), Gaps = 8/98 (8%)

Query: 14  IQVICSDGVFFSFGRLLQNNNISG---HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 70
           + ++      FS  +    N ISG      +   K  K      + N     +      +
Sbjct: 1   MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLI 58

Query: 71  ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
                L+LN  +L+ ++P +L    Q+  L+++ N L 
Sbjct: 59  NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI 93

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 15/91 (16%), Positives = 28/91 (30%), Gaps = 3/91 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
            + N I+ HIP  I  L    T+ L +N  +  I  ++S               +  +  
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS--MSD 270

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 120
              N       D           S  ++ ++
Sbjct: 271 GQQNTLHRPLADAVTAWFPENKQSDVSQIWH 301

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 11/80 (13%), Positives = 29/80 (36%), Gaps = 6/80 (7%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           +     I           ++ +  +L     T     T + L ++  +  NN+ +  ++ 
Sbjct: 8   ITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ 62

Query: 89  PSLSNMSQLAFLDLSYNNLS 108
             +  +  +  L L+ N L+
Sbjct: 63  G-IQYLPNVTKLFLNGNKLT 81

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 6/79 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N +   + + +  L KL +L L +N  +    + + HL  L+ L L NN +T  I  
Sbjct: 97  LDENKVK-DL-SSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITD-ITV 151

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            LS +++L  L L  N +S
Sbjct: 152 -LSRLTKLDTLSLEDNQIS 169

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 18/79 (22%), Positives = 37/79 (46%), Gaps = 6/79 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L+  +++  +     +L+ +  +  +N+     +   + +L  +  L LN N LT  I P
Sbjct: 31  LKKKSVTDAVT--QNELNSIDQIIANNSDIKS-V-QGIQYLPNVTKLFLNGNKLT-DIKP 85

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            L+N+  L +L L  N + 
Sbjct: 86  -LANLKNLGWLFLDENKVK 103

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 20/91 (21%), Positives = 34/91 (37%), Gaps = 4/91 (4%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L++N IS  I   +  L+KL  L LS N  +      ++ L+ L  L L +         
Sbjct: 163 LEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPIN 218

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 120
             SN+     +  +  +L  P        + 
Sbjct: 219 HQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 249

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 14/79 (17%), Positives = 30/79 (37%), Gaps = 4/79 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N+IS  +   +  L  L  L+L +        +  S+L     ++  + SL    P 
Sbjct: 185 LSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PE 240

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            +S+       ++ ++   
Sbjct: 241 IISDDGDYEKPNVKWHLPE 259

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 39/167 (23%), Positives = 59/167 (35%), Gaps = 34/167 (20%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----EIQFQTEV---EMISLAVHRN 285
            +G GGFG +Y  +        A   +K      G    E++F   V   + I   + R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 286 LLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDW---ATRK-------RIA 330
            L  +G         T  +   Y +M    V  RL     L                ++ 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFM----VMERLG--IDLQKISGQNGTFKKSTVLQLG 157

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 375
           +     L Y+HE      +H D+KAAN+LL       V   D+GL+ 
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 42/192 (21%), Positives = 76/192 (39%), Gaps = 20/192 (10%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKD--GNAIGG-----EIQFQTEVEM 277
              +     +GKG +G V+K    + G VVAVK++ D   N+        EI       +
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI-----L 62

Query: 278 ISLAVHRNLLRLIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 335
             L+ H N++ L+       +R   LV+ YM   +    +     L+   ++ +     +
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQLIK 120

Query: 336 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 395
            + YLH      ++HRD+K +NILL+      V DFGL++   +              + 
Sbjct: 121 VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 396 APEYLSTGQSSE 407
                     ++
Sbjct: 178 ENFDDDQPILTD 189

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 36/170 (21%), Positives = 62/170 (36%), Gaps = 37/170 (21%)

Query: 234 LVGKGGFGNVYKGYLQDGT------VVAVKRLKDGNA-IGGEIQFQTEV---EMISLAVH 283
            +G+GGFG +Y   +             VK     N  +  E++F       E I   + 
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 284 RNLLRLIGFCM-----TTTERLLVYPYMSNGSVASRLKAKPSL----DWATRK------- 327
              L+ +G           +    Y +M    +  R      L    +   ++       
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFG--SDLQKIYEANAKRFSRKTVL 155

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 375
           +++L     L Y+HE      +H D+KA+N+LL+      V   D+GLA 
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 51/215 (23%), Positives = 85/215 (39%), Gaps = 45/215 (20%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVH-----RNL 286
           ++GKG FG V K Y  +    VA+K +++        Q   E+ ++  L         N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 287 LRLIGF-------CMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
           + ++         CMT  E L   +Y  +         K +        ++ A    + L
Sbjct: 162 IHMLENFTFRNHICMTF-ELLSMNLYELIKKN------KFQG-FSLPLVRKFAHSILQCL 213

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAV--VGDFGLAKLLDHCDSHVTTAV-----RG 390
             LH+    +IIH D+K  NILL +   +   V DFG +         V T +     R 
Sbjct: 214 DALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYR- 266

Query: 391 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 425
                APE +   +     D++  G +L EL++G 
Sbjct: 267 -----APEVILGARYGMPIDMWSLGCILAELLTGY 296

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.3 bits (105), Expect = 1e-05
 Identities = 20/77 (25%), Positives = 33/77 (42%), Gaps = 3/77 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG-AIP 88
             N  ++  I   + KL+KL  L+LS+N  +G +         L +L L+ N +   +  
Sbjct: 49  TINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI 106

Query: 89  PSLSNMSQLAFLDLSYN 105
             L  +  L  LDL   
Sbjct: 107 EPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 4e-05
 Identities = 18/80 (22%), Positives = 33/80 (41%), Gaps = 2/80 (2%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           L  + +  G +     +  +L  L   N   T  I + +  L  L+ L L++N ++G + 
Sbjct: 24  LDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-I-ANLPKLNKLKKLELSDNRVSGGLE 81

Query: 89  PSLSNMSQLAFLDLSYNNLS 108
                   L  L+LS N + 
Sbjct: 82  VLAEKCPNLTHLNLSGNKIK 101

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.5 bits (109), Expect = 1e-05
 Identities = 12/72 (16%), Positives = 26/72 (36%), Gaps = 7/72 (9%)

Query: 44  GKLSKLLTLDLSNNFFTGPIPSTVSH---LETLQYLRLNNNSLTG----AIPPSLSNMSQ 96
            +   L  L + +      +         L  L+ + ++   LT      +   +  +  
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308

Query: 97  LAFLDLSYNNLS 108
           L F+++ YN LS
Sbjct: 309 LKFINMKYNYLS 320

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 20/80 (25%), Positives = 29/80 (36%), Gaps = 2/80 (2%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           L    +  G I     +   L  L L N        S +  L  L+ L L+ N + G + 
Sbjct: 31  LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGLD 88

Query: 89  PSLSNMSQLAFLDLSYNNLS 108
                +  L  L+LS N L 
Sbjct: 89  MLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 23/78 (29%), Positives = 32/78 (41%), Gaps = 5/78 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT--GAI 87
           L N  +   +   + KL KL  L+LS N   G +      L  L +L L+ N L     +
Sbjct: 56  LINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL 113

Query: 88  PPSLSNMSQLAFLDLSYN 105
            P L  +  L  LDL   
Sbjct: 114 EP-LKKLECLKSLDLFNC 130

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 23/80 (28%), Positives = 32/80 (40%), Gaps = 4/80 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           L +N I+   P     L  L  L L +N     +P  V   L  L  L L  N LT  +P
Sbjct: 47  LHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT-VLP 104

Query: 89  PSL-SNMSQLAFLDLSYNNL 107
            ++   +  L  L +  N L
Sbjct: 105 SAVFDRLVHLKELFMCCNKL 124

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 20/95 (21%), Positives = 36/95 (37%), Gaps = 19/95 (20%)

Query: 30  LQNNNIS----GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--------TLQYLR 77
           LQN  ++    G + + +  L  L  L LS+N       + +  L          L+ L+
Sbjct: 92  LQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG---DAGLQLLCEGLLDPQCRLEKLQ 148

Query: 78  LNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLS 108
           L   SL+      +   L        L +S N+++
Sbjct: 149 LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 5/67 (7%)

Query: 47  SKLLTLDLSNNFFTGP-IPSTVSHLETLQYLRLNNNSLT----GAIPPSLSNMSQLAFLD 101
             + +LD+     +       +  L+  Q +RL++  LT      I  +L     LA L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 102 LSYNNLS 108
           L  N L 
Sbjct: 63  LRSNELG 69

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 17/95 (17%), Positives = 34/95 (35%), Gaps = 19/95 (20%)

Query: 30  LQNNNIS----GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL--------ETLQYLR 77
           L+  ++S      + + +        L +SNN       + V  L          L+ L+
Sbjct: 149 LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN---EAGVRVLCQGLKDSPCQLEALK 205

Query: 78  LNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLS 108
           L +  +T      +   +++ + L  L L  N L 
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 18/82 (21%), Positives = 28/82 (34%), Gaps = 10/82 (12%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR---LNNNSLTGA 86
                I   +   +  L     L LS N         +S L  ++ LR   L  N +   
Sbjct: 32  GMIPPIE-KMDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIK-K 84

Query: 87  IPPSLSNMSQLAFLDLSYNNLS 108
           I    +    L  L +SYN ++
Sbjct: 85  IENLDAVADTLEELWISYNQIA 106

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 18/79 (22%), Positives = 35/79 (44%), Gaps = 5/79 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  NNI   I + +  +  L  L L  N     I +  +  +TL+ L ++ N +  ++  
Sbjct: 55  LSTNNIE-KI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLSG 110

Query: 90  SLSNMSQLAFLDLSYNNLS 108
            +  +  L  L +S N ++
Sbjct: 111 -IEKLVNLRVLYMSNNKIT 128

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 18/79 (22%), Positives = 29/79 (36%), Gaps = 3/79 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L+   I   I      L +   +D S+N     +      L  L+ L +NNN +      
Sbjct: 26  LRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEG 82

Query: 90  SLSNMSQLAFLDLSYNNLS 108
               +  L  L L+ N+L 
Sbjct: 83  LDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 7e-05
 Identities = 22/78 (28%), Positives = 33/78 (42%), Gaps = 5/78 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT--GAI 87
             +N I   +      L +L TL ++NN            L  L  L L NNSL   G +
Sbjct: 49  FSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL 106

Query: 88  PPSLSNMSQLAFLDLSYN 105
            P L+++  L +L +  N
Sbjct: 107 DP-LASLKSLTYLCILRN 123

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 24/83 (28%), Positives = 38/83 (45%), Gaps = 10/83 (12%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           L+ N++         +L+ L  L L  N     +P+ V + L +L YL L+ N L  ++P
Sbjct: 35  LETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQ-SLP 92

Query: 89  P----SLSNMSQLAFLDLSYNNL 107
                 L   +QL  L L+ N L
Sbjct: 93  NGVFDKL---TQLKELALNTNQL 112

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 27/170 (15%), Positives = 51/170 (30%), Gaps = 39/170 (22%)

Query: 235 VGKGGFGNVYKGY---------LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHR 284
             +   G +Y+                  ++K       +  E  F Q   + + +   +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGS-----VASRLKAKPSL----DWATRK-------- 327
            L       + T        +  +       V   L    SL    D + +         
Sbjct: 110 KLYSTPLLAIPT-----CMGFGVHQDKYRFLVLPSLG--RSLQSALDVSPKHVLSERSVL 162

Query: 328 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 375
           ++A      L +LHE      +H +V A NI +D   ++ V    +G A 
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 22/83 (26%), Positives = 40/83 (48%), Gaps = 12/83 (14%)

Query: 30  LQNNNISGHIPTEIG---KLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTG 85
           L  N +      +I    +L+ L  L L+ N     +P+ V   L  L+ L L  N L  
Sbjct: 70  LGGNKL-----HDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ- 122

Query: 86  AIPPSLSN-MSQLAFLDLSYNNL 107
           ++P  + + ++ L +L+L++N L
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQL 145

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 28/94 (29%), Positives = 39/94 (41%), Gaps = 10/94 (10%)

Query: 21  GVFFSFGRL----LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQ 74
                   L    L  N +   +P  +  KL+ L  L L  N     +P  V   L  L 
Sbjct: 79  SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLT 136

Query: 75  YLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNL 107
           YL L +N L  ++P  +   ++ L  LDLSYN L
Sbjct: 137 YLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL 169

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 24/80 (30%), Positives = 36/80 (45%), Gaps = 4/80 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
           L++N +         KL++L  L LS N     +P  V   L  L  L L+ N L  ++P
Sbjct: 35  LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ-SLP 92

Query: 89  PSL-SNMSQLAFLDLSYNNL 107
             +   ++QL  L L  N L
Sbjct: 93  NGVFDKLTQLKELALDTNQL 112

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 20/85 (23%), Positives = 27/85 (31%), Gaps = 13/85 (15%)

Query: 38  HIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIPPSL-SNMS 95
            IP    +L       L++N         +   L  L  L L  N LT  I P+     S
Sbjct: 26  DIPLHTTEL------LLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78

Query: 96  QLAFLDLSYNNLSGPVPSFHAKTFN 120
            +  L L  N +         K F 
Sbjct: 79  HIQELQLGENKIK----EISNKMFL 99

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	549
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.56
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.56
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.55
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.54
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.52
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.49
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.47
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.47
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.46
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.45
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.42
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.42
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.42
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.42
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.41
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.41
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.41
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.4
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.39
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.38
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.37
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.37
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.36
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.35
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.35
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.34
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.34
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.33
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.33
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.32
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.32
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.31
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.3
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.3
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.27
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.25
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.25
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.25
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.25
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.24
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.24
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.23
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.22
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.22
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.21
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.21
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.2
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.2
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.2
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.2
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.19
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.19
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.19
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.18
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.18
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.16
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.13
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.1
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.1
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.07
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.05
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.04
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.04
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.03
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.03
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.02
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.02
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.02
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.02
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.01
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.01
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.01
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.01
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.0
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.99
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.98
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.98
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.98
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.97
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.96
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.9
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.9
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.88
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.88
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.87
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.86
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.86
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.85
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.83
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.82
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.79
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.79
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.74
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.74
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.72
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.69
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.67
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.65
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.62
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.62
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.61
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.58
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.57
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.57
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.56
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.56
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.55
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.51
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.5
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.42
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.41
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.39
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.36
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.33
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.31
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.31
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.21
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.15
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.1
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.09
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.03
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.02
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.98
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.89
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.8
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.77
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.76
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.6
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.57
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.47
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.44
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.39
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.35
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.24
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.24
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.22
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.21
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.19
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.14
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.03
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.97
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.93
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.91
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.87
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.62
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.61
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.21
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	96.12
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	95.95
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.67
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	95.14
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.45
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	94.42
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	93.84
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.82
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	93.42
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	93.39
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	92.93
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	92.93
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	92.82
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.06
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	90.29
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	89.45
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	88.73
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.14
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.14
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	87.15

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.4e-56  Score=439.80  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=209.9

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      +++..+.||+|+||+||+|.+.      +++.||||+++........++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3556788999999999999863      4678999999876555556789999999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc
Q 008893          302 VYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE  365 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  365 (549)
                      |||||++|+|.+++...                ..++|..+..|+.|||.||.|||++   +||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            99999999999999532                3589999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCC-ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHH
Q 008893          366 AVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDW  443 (549)
Q Consensus       366 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  443 (549)
                      +||+|||+++.....+. .......||+.|||||++.++.++.++|||||||++|||+| |+.||.....       .+.
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------~~~  256 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDV  256 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------HHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence            99999999987643322 22344579999999999999999999999999999999999 8999864321       112


Q ss_pred             HHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          444 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       444 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +..+....          ....+..++..+.+++.+||+.||++||||+||+++|+.
T Consensus       257 ~~~i~~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          257 VEMIRNRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHcCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            22221111          111233445779999999999999999999999999985

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.6e-56  Score=436.25  Aligned_cols=253  Identities=25%  Similarity=0.419  Sum_probs=208.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||+++... ....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            46778899999999999999864      47789999997543 233557999999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhccC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceE
Q 008893          301 LVYPYMSNGSVASRLKAK-------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV  367 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  367 (549)
                      +|||||++|+|.++++..             ..++|.++..|+.|||.||.|||++   +|+||||||+|||+++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence            999999999999999642             3699999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHH
Q 008893          368 VGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       368 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      |+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.....       .+.+.
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~~  241 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIE  241 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence            99999998765433322 233569999999999999999999999999999999999 8999974321       11122


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .+.....          ...+..++.++.+++.+||+.||++|||++||.+.|++
T Consensus       242 ~i~~~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          242 CITQGRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             HHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2221111          11233345779999999999999999999999998875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.3e-55  Score=437.60  Aligned_cols=253  Identities=25%  Similarity=0.409  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++... ....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45667789999999999999864      47899999997543 233457999999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc
Q 008893          301 LVYPYMSNGSVASRLKAK---------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE  365 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  365 (549)
                      +|||||++|+|.++++..               .+++|.++..|+.|||.||.|||++   +|+||||||+|||+++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence            999999999999998642               3599999999999999999999998   9999999999999999999


Q ss_pred             eEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHH
Q 008893          366 AVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDW  443 (549)
Q Consensus       366 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  443 (549)
                      +||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.....       .+.
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~  269 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------TEA  269 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------HHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence            999999999876543322 3345679999999999999999999999999999999999 8999974321       111


Q ss_pred             HHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          444 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       444 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +..+.....          ...+..+++++.+++.+||+.||++|||++||+++|+.
T Consensus       270 ~~~i~~g~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~  316 (329)
T 4aoj_A          270 IDCITQGRE----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA  316 (329)
T ss_dssp             HHHHHHTCC----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHHcCCC----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            222221111          11233345779999999999999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-54  Score=427.90  Aligned_cols=257  Identities=27%  Similarity=0.400  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .+++.+.+.||+|+||+||+|++++  .||||+++..... ...+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3567788999999999999998753  5999999754322 234579999999999999999999999865 56899999


Q ss_pred             ccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-
Q 008893          305 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  382 (549)
                      ||++|+|.++++. ...++|.++..|+.|||.||+|||++   +||||||||+|||+++++.+||+|||+|+....... 
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999999999974 45799999999999999999999999   999999999999999999999999999987654332 


Q ss_pred             ceeeccccccCccCchhhcc---CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          383 HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .......||+.|||||++.+   +.|+.++|||||||++|||+||+.||.......       .+.......    ...+
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-------~~~~~~~~~----~~~p  257 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-------QIIFMVGRG----YASP  257 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------HHHHHHHTT----CCCC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-------HHHHHHhcC----CCCC
Confidence            23345679999999999964   468999999999999999999999997432211       111111111    1111


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .+ ...+..++..+.+++.+||+.||++|||+.||+++|+.
T Consensus       258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11 11223345779999999999999999999999998874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.9e-53  Score=423.28  Aligned_cols=250  Identities=22%  Similarity=0.200  Sum_probs=205.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +.|+..+.||+|+||+||+|++. +|+.||||+++....      ..+|+.+++.++|||||++++++.+.+..++||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45777889999999999999975 599999999976432      24699999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC-ceEEeecccccccCCCCCc-
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDSH-  383 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~-  383 (549)
                      +++|+|.++++..+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|+.+...... 
T Consensus       132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            99999999998878899999999999999999999999   999999999999999887 6999999999977543221 


Q ss_pred             ---eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          384 ---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       384 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                         .....+||+.|||||++.+..|+.++|||||||++|||+||+.||........    ..   .+......       
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~---~i~~~~~~-------  274 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----CL---KIASEPPP-------  274 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----HH---HHHHSCCG-------
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----HH---HHHcCCCC-------
Confidence               12335799999999999999999999999999999999999999975332221    11   11111100       


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       ....+...+..+.+++.+||+.||++|||+.|++++|..
T Consensus       275 -~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          275 -IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             -GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence             011222334678999999999999999999999998765

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.7e-53  Score=421.59  Aligned_cols=249  Identities=20%  Similarity=0.276  Sum_probs=207.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +.|+..+.||+|+||+||+|... +|+.||||++..... .....+.+|+.+++.++|||||++++++.+.+..|+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            46888899999999999999976 699999999975432 3345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++|+|.+++... .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+.... ...
T Consensus       153 ~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~  227 (346)
T 4fih_A          153 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR  227 (346)
T ss_dssp             CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred             CCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence            9999999999764 599999999999999999999999   99999999999999999999999999998775432 234


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ...+||+.|||||++.+..|+.++|||||||++|||+||+.||.....       .+....+....      .+.+  ..
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~------~~~~--~~  292 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNL------PPRL--KN  292 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSS------CCCC--SC
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCC------CCCC--Cc
Confidence            456799999999999999999999999999999999999999974321       11111111110      0111  11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ....+.++.+++.+||+.||++|||++|+++
T Consensus       293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1223467899999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.4e-54  Score=428.50  Aligned_cols=250  Identities=21%  Similarity=0.294  Sum_probs=202.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++...... .....+.+|+++++.++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57899999999999999999975 6999999999765422 224569999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |+++|+|.+++..  ...+++..+..|+.||+.||.|||++   +|+||||||+|||+++++.+||+|||+|+..... .
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence            9999999999964  34579999999999999999999999   9999999999999999999999999999876421 1


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.....       .+.+..+.... .     +.  
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~-~-----~~--  244 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLVLKIISGS-F-----PP--  244 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTC-C-----CC--
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCC-C-----CC--
Confidence            123456799999999999999999999999999999999999999974321       12222222111 0     01  


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        .+...+.++.+++.+||+.||++|||++|++++
T Consensus       245 --~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          245 --VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              122234678999999999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.2e-54  Score=431.84  Aligned_cols=264  Identities=26%  Similarity=0.369  Sum_probs=215.8

Q ss_pred             CHHHHHHHhcCCCCCCeeeeeCCeEEEEEEECC------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC-CCccceE
Q 008893          218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLI  290 (549)
Q Consensus       218 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~  290 (549)
                      ..++++...++|++.+.||+|+||+||+|.+..      ++.||||+++..........|.+|++++.++.| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            345566667889999999999999999998642      368999999876544445679999999999965 8999999


Q ss_pred             EEEecC-CceeeEeeccCCCchhhhhcc----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccc
Q 008893          291 GFCMTT-TERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV  353 (549)
Q Consensus       291 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  353 (549)
                      |+|... +..++|||||++|+|.++++.                ...++|..+..++.|||.||.|||++   +||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence            999765 568999999999999999963                23589999999999999999999999   9999999


Q ss_pred             CcCeeeecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccC
Q 008893          354 KAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG  431 (549)
Q Consensus       354 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~  431 (549)
                      ||+|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999977544333 3445679999999999999999999999999999999998 89999743


Q ss_pred             ccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          432 KTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....   .+.   ..+....          ....+...+.++.+++.+||+.||++|||+.||+++|+.
T Consensus       292 ~~~~---~~~---~~i~~g~----------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          292 KIDE---EFC---RRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             CCSH---HHH---HHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHH---HHH---HHHHcCC----------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            2211   111   1111111          111223334679999999999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.7e-54  Score=421.41  Aligned_cols=248  Identities=21%  Similarity=0.282  Sum_probs=210.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....  .......+.+|+++++.++|||||++++++.+.+..++||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46889999999999999999975 69999999996432  2234567999999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  382 (549)
                      ||+++|+|.+++...+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..... 
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            9999999999998878899999999999999999999999   999999999999999999999999999998754332 


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....       ......+....       .   
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~-------~---  251 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------GLIFAKIIKLE-------Y---  251 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC-------C---
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCC-------C---
Confidence            234566899999999999999999999999999999999999999974321       11112221111       0   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV  495 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  495 (549)
                       .++...+.++.+++.+||+.||++|||++|++
T Consensus       252 -~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence             11222346789999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-52  Score=410.30  Aligned_cols=247  Identities=25%  Similarity=0.371  Sum_probs=198.1

Q ss_pred             CCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEec----CCceeeEe
Q 008893          230 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTERLLVY  303 (549)
Q Consensus       230 ~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  303 (549)
                      ...+.||+|+||+||+|.+. ++..||+|++...... .....|.+|+.+++.++|||||++++++..    ....++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45567999999999999976 5899999999754322 234569999999999999999999999864    34579999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec-CCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||++|+|.+++.....+++..+..++.||+.||+|||++ .++|+||||||+|||++ .++.+||+|||+|+....   
T Consensus       109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~---  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence            9999999999998888899999999999999999999998 12399999999999998 479999999999986542   


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.....      .......+..... .    ....
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~-~----~~~~  252 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVK-P----ASFD  252 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCC-C----GGGG
T ss_pred             CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCC-C----CCCC
Confidence            23345679999999998864 699999999999999999999999964321      1111122211111 0    0111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ..    .++++.+++.+||+.||++|||++|+++
T Consensus       253 ~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          253 KV----AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11    2356889999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.6e-52  Score=406.02  Aligned_cols=246  Identities=20%  Similarity=0.320  Sum_probs=193.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||++.....  ......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            58999999999999999999965 699999999975432  233457999999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+ +|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+......  
T Consensus        93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence            999 689999998888899999999999999999999999   99999999999999999999999999998765322  


Q ss_pred             eeeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||....       .......+....       .   
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-------~~~~~~~i~~~~-------~---  229 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-------IPVLFKNISNGV-------Y---  229 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTC-------C---
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCC-------C---
Confidence            2344679999999999998876 579999999999999999999996422       112222221111       0   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       .++...++++.+++.+||+.||++|||++|+++
T Consensus       230 -~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 -TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             112223467899999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-52  Score=414.94  Aligned_cols=265  Identities=23%  Similarity=0.321  Sum_probs=200.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC----ceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----ERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv  302 (549)
                      ++|.+.+.||+|+||+||+|++. |+.||||+++...  .....++.|+..+..++|||||+++|+|...+    ..++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            35677889999999999999984 8999999996532  11223445666677889999999999998654    57999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCceEecccCcCeeeecCCCceEEeeccccccc
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ-----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      |||+++|+|.++++.. .++|+.+.+++.|++.||+|||++     ..++|+||||||+|||+++++++||+|||+++..
T Consensus        80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999999999865 599999999999999999999976     2468999999999999999999999999999877


Q ss_pred             CCCCCce---eeccccccCccCchhhccC------CCCCcccchhHhHHHHHHHhCCcccccCccccc--------cccH
Q 008893          378 DHCDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELISGLRALEFGKTANQ--------KGAM  440 (549)
Q Consensus       378 ~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------~~~~  440 (549)
                      .......   .....||+.|||||++.+.      .++.++|||||||++|||+||+.|+........        ....
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            5443322   2345799999999999764      367899999999999999999888754322111        0011


Q ss_pred             HHHHHHHhhccchhhhccccccCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          441 LDWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       441 ~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ......... .    ..++.+... .....+..+.+++.+||+.||++||||.||++.|+.
T Consensus       239 ~~~~~~~~~-~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          239 EEMRKVVCE-Q----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             HHHHHHHTT-S----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHhc-c----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            111111111 1    111111111 123456788999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-51  Score=421.91  Aligned_cols=249  Identities=20%  Similarity=0.276  Sum_probs=208.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +.|+..+.||+|+||+||+|... +|+.||||++..... .....+.+|+.+++.++|||||++++++...+..|+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            56899999999999999999976 699999999975542 3345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      |++|+|.+++... .+++..+..|+.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.+.... ...
T Consensus       230 ~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~  304 (423)
T 4fie_A          230 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR  304 (423)
T ss_dssp             CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred             CCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence            9999999999765 599999999999999999999999   99999999999999999999999999998775432 234


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|+.||.....       ......+....      .+.+  ..
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~------~~~~--~~  369 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNL------PPRL--KN  369 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSC------CCCC--SC
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCC------CCCC--cc
Confidence            456799999999999999999999999999999999999999964321       11112221111      1111  11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ....+.++.+++.+||+.||++|||+.|+++
T Consensus       370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1123467899999999999999999999975

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.1e-51  Score=413.00  Aligned_cols=313  Identities=70%  Similarity=1.114  Sum_probs=263.0

Q ss_pred             hhhhhhhhcCCccccCHHHHHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc
Q 008893          203 EQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV  282 (549)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~  282 (549)
                      .+.......+....|++.++..++++|+..+.||+|+||.||+|...+|+.||||++...........+.+|+.+++.++
T Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~   85 (326)
T 3uim_A            6 AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV   85 (326)
T ss_dssp             ---------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCC
T ss_pred             cccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhcc
Confidence            33444556677889999999999999999999999999999999988899999999986654444447899999999999


Q ss_pred             CCCccceEEEEecCCceeeEeeccCCCchhhhhccC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCee
Q 008893          283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI  358 (549)
Q Consensus       283 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  358 (549)
                      ||||+++++++......++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.+.++|+||||||+||
T Consensus        86 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni  165 (326)
T 3uim_A           86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI  165 (326)
T ss_dssp             CTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred             CCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence            999999999999999999999999999999999743    3499999999999999999999998778999999999999


Q ss_pred             eecCCCceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcc-cccc
Q 008893          359 LLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT-ANQK  437 (549)
Q Consensus       359 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~-~~~~  437 (549)
                      |+++++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||+||+.||..... ....
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  245 (326)
T 3uim_A          166 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD  245 (326)
T ss_dssp             EECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred             EECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence            999999999999999998765555555566799999999999998999999999999999999999999974322 2233


Q ss_pred             ccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCcchhhhhhHHHh
Q 008893          438 GAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEA  515 (549)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~  515 (549)
                      ....+|+...........+.+..+...+....+..+.+++.+||+.||++|||+.||+++|++..+.++|..++..+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~  323 (326)
T 3uim_A          246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEM  323 (326)
T ss_dssp             SBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-------
T ss_pred             hhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHHh
Confidence            356777777777777888888888888899999999999999999999999999999999999999998887655443

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.1e-53  Score=413.74  Aligned_cols=243  Identities=23%  Similarity=0.293  Sum_probs=195.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC----CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++|++.+.||+|+||+||+|+..    +++.||||+++.... ......+.+|+++++.++|||||++++++.+.+..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56899999999999999999862    478999999975421 1223367889999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||||+++|+|.+++...+.+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+......
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            999999999999999888899999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                       ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.....       .+....+....          
T Consensus       181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~----------  242 (304)
T 3ubd_A          181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KETMTMILKAK----------  242 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC----------
T ss_pred             -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HHHHHHHHcCC----------
Confidence             223456799999999999999999999999999999999999999974321       11122221110          


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKM  491 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  491 (549)
                       ..++...+.++.+++.+||+.||++|||+
T Consensus       243 -~~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          243 -LGMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence             11222334678999999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.8e-51  Score=402.64  Aligned_cols=249  Identities=20%  Similarity=0.307  Sum_probs=188.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC--------
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--------  297 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  297 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++..........+.+|+.+++.++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46889999999999999999975 699999999976554334457899999999999999999999987543        


Q ss_pred             ----ceeeEeeccCCCchhhhhccCCC---CCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEee
Q 008893          298 ----ERLLVYPYMSNGSVASRLKAKPS---LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD  370 (549)
Q Consensus       298 ----~~~lv~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  370 (549)
                          ..++||||+++|+|.+++.....   .++..++.|+.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999986543   45667889999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCc-----------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccccccc
Q 008893          371 FGLAKLLDHCDSH-----------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA  439 (549)
Q Consensus       371 fg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~  439 (549)
                      ||+|+.+......           .....+||+.|||||++.+..|+.++|||||||++|||++   ||....      .
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------~  232 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------E  232 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------H
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------H
Confidence            9999877543221           1234579999999999999999999999999999999996   664210      0


Q ss_pred             HHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          440 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ....+..... ....         .......+.+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~-~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          233 RVRTLTDVRN-LKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHHHHT-TCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHhc-CCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0111111111 0000         0011223557789999999999999999999863

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-49  Score=401.16  Aligned_cols=267  Identities=18%  Similarity=0.266  Sum_probs=202.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEec------CCc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT------TTE  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  298 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||+++..... .....+.+|+++|+.++|||||++++++..      ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57899999999999999999975 6999999999755432 223468899999999999999999999764      356


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .|+||||++ |+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            899999996 68999998888999999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCC---CceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc----
Q 008893          379 HCD---SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE----  450 (549)
Q Consensus       379 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  450 (549)
                      ...   .......+||+.|+|||++.+. .++.++||||+||++|||+||+.||...........+..........    
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            322   1233456799999999998875 46999999999999999999999997543222111111100000000    


Q ss_pred             ---cchhhhcccc-ccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          451 ---KKLEMLVDKD-LKNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       451 ---~~~~~~~d~~-l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                         .......... .....+     .....++.+|+.+||+.||++|||++|+++|
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               0000000000 000000     1123568899999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-47  Score=388.53  Aligned_cols=199  Identities=25%  Similarity=0.386  Sum_probs=171.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC----CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCce
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  299 (549)
                      ..++|++.+.||+|+||+||+|+.+    .++.||+|.+....   ...++.+|++++..+ +||||+++++++.+.+..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            4578999999999999999999853    46789999986543   345688999999988 699999999999999999


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC-CceEEeecccccccC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLD  378 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~  378 (549)
                      ++||||+++|+|.++++   .+++..+..++.||+.||+|||++   +|+||||||+|||++.+ +.+||+|||+|+...
T Consensus        96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            99999999999999984   489999999999999999999999   99999999999999876 799999999998654


Q ss_pred             CCCC---------------------------ceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCccccc
Q 008893          379 HCDS---------------------------HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEF  430 (549)
Q Consensus       379 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~  430 (549)
                      ....                           ......+||+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            3211                           112334699999999999876 489999999999999999999999975


Q ss_pred             Cc
Q 008893          431 GK  432 (549)
Q Consensus       431 ~~  432 (549)
                      +.
T Consensus       250 ~~  251 (361)
T 4f9c_A          250 AS  251 (361)
T ss_dssp             CS
T ss_pred             CC
Confidence            43

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.7e-47  Score=378.24  Aligned_cols=278  Identities=40%  Similarity=0.680  Sum_probs=238.4

Q ss_pred             CHHHHHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC
Q 008893          218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT  297 (549)
Q Consensus       218 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  297 (549)
                      .+.++..++++|+..+.||+|+||.||+|.+++|+.||||++.... ......+.+|+.+++.++||||+++++++...+
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            3344455778999999999999999999998889999999987653 334567999999999999999999999999999


Q ss_pred             ceeeEeeccCCCchhhhhccCC----CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAKP----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL  373 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  373 (549)
                      ..++||||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999996432    589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC-ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc
Q 008893          374 AKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK  452 (549)
Q Consensus       374 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (549)
                      ++....... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||....... ......|.........
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTHHHHTTTC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhhhcccccc
Confidence            986543222 22334568999999999999999999999999999999999999997544332 2345566655555666


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       453 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +...+++.+........+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  312 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY  312 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            677777777777888889999999999999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.7e-47  Score=402.08  Aligned_cols=249  Identities=24%  Similarity=0.277  Sum_probs=201.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHH---HHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTE---VEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.+..  .......+.+|   +.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999976 59999999996432  11223334444   55666778999999999999999999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +||||++||+|.+++...+.+++..+..++.||+.||.|||++   +||||||||+||||+.+|.+||+|||+|+.+...
T Consensus       269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .   ....+||+.|||||++.. ..|+.++|||||||++|||+||+.||........    ..........       . 
T Consensus       346 ~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~----~~i~~~i~~~-------~-  410 (689)
T 3v5w_A          346 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLTM-------A-  410 (689)
T ss_dssp             C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH----HHHHHHHHHC-------C-
T ss_pred             C---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhhcCC-------C-
Confidence            2   334679999999999975 5799999999999999999999999975332211    1111111110       0 


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVR  496 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  496 (549)
                         ..++...+.++.+++.+||+.||++|++     ++||++
T Consensus       411 ---~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 ---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ---CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence               1122233467899999999999999998     567664

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.1e-46  Score=401.92  Aligned_cols=251  Identities=20%  Similarity=0.273  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||+||+|..+ +|+.||+|++..... .....+.+|+.+|+.++|||||++++++.+....++||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            57999999999999999999976 699999999976442 2345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC--CceEEeecccccccCCCCC
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY--YEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |++|+|.+++.. ...+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+++.+...  
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--  310 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  310 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence            999999999864 45799999999999999999999999   99999999999999854  89999999999987643  


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||......       .....+.....   -+.....
T Consensus       311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~~~~~i~~~~~---~~~~~~~  380 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDW---NMDDSAF  380 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCC---CCCSGGG
T ss_pred             CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHhCCC---CCCcccc
Confidence            2334557999999999999999999999999999999999999999743321       11112111110   0111111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .    ..+.++.+|+.+||+.||++|||+.|+++|
T Consensus       381 ~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          381 S----GISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             c----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1    223678899999999999999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.1e-43  Score=351.54  Aligned_cols=279  Identities=40%  Similarity=0.681  Sum_probs=230.1

Q ss_pred             CccccCHHHHHHHhcCCCCC------CeeeeeCCeEEEEEEECCCCEEEEEEcccCCC---CCcHHHHHHHHHHHhhccC
Q 008893          213 NLKRFHFKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVH  283 (549)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~------~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h  283 (549)
                      ....|++.++..++++|...      +.||+|+||.||+|.. +++.||||++.....   ......+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45778999999999999887      9999999999999987 588999999875432   2234579999999999999


Q ss_pred             CCccceEEEEecCCceeeEeeccCCCchhhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee
Q 008893          284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK---AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL  360 (549)
Q Consensus       284 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  360 (549)
                      |||+++++++...+..++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.   +|+||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence            999999999999999999999999999999886   345699999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccccccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA  439 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~  439 (549)
                      ++++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|+|+||+.||........   
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---  242 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL---  242 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB---
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH---
Confidence            99999999999999876543322 2334569999999998864 588999999999999999999999976443322   


Q ss_pred             HHHHHHHHhh-ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          440 MLDWVKKIHQ-EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       440 ~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +..+...... ...+...+++.+ ...+...+..+.+++.+||+.||++|||+++++++|+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~  303 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE  303 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            2222222222 222344444443 34567778899999999999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-44  Score=369.62  Aligned_cols=255  Identities=27%  Similarity=0.414  Sum_probs=209.3

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC--------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT  296 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  296 (549)
                      .++|.+.+.||+|+||.||+|.+.        ++..||||+++..........+.+|+.+++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            357888999999999999999852        35679999998664434455799999999999 899999999999999


Q ss_pred             CceeeEeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee
Q 008893          297 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL  360 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  360 (549)
                      +..++||||+++|+|.+++...                ..+++..+..++.||+.||.|||++   +|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            9999999999999999998743                2489999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG  438 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  438 (549)
                      +.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......    
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----  312 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  312 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence            99999999999999876543322 2233457889999999999999999999999999999999 99998743221    


Q ss_pred             cHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .+...   ....          .....+...+..+.+++.+||+.||++||++.|+++.|+.
T Consensus       313 ~~~~~---~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          313 ELFKL---LKEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             GHHHH---HHTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHH---HhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11111   1111          1111222334679999999999999999999999999986

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-43  Score=351.46  Aligned_cols=251  Identities=19%  Similarity=0.276  Sum_probs=207.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|+..+.||+|+||+||+|.. .+|+.||||++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            35799999999999999999996 4689999999875442 345678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+++|+|.+++... .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  172 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (297)
T ss_dssp             CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence            99999999999765 589999999999999999999999   999999999999999999999999999987654332 2


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      .....||+.|+|||.+.+..++.++||||||+++|||+||+.||......       ............ .       ..
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~-~-------~~  237 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTP-E-------LQ  237 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSC-C-------CS
T ss_pred             cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC-C-------CC
Confidence            34456999999999999999999999999999999999999999643211       111111111100 0       01


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+...+..+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            112234678999999999999999999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=354.54  Aligned_cols=272  Identities=16%  Similarity=0.193  Sum_probs=216.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC--ceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  303 (549)
                      ++|.+.+.||+|+||+||+|... +|+.||||+++..........+.+|+++++.++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999976 489999999986554455667889999999999999999999998765  679999


Q ss_pred             eccCCCchhhhhccCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee----cCCCceEEeecccccc
Q 008893          304 PYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGLAKL  376 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~~~~  376 (549)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999997533   399999999999999999999999   99999999999999    7888899999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhc--------cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLS--------TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      ......  .....||+.|+|||++.        +..++.++|||||||++|||+||+.||..............-+....
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            654332  23456999999999986        56789999999999999999999999975433322221111111111


Q ss_pred             hccchhhhc-----------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 008893          449 QEKKLEMLV-----------DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL  503 (549)
Q Consensus       449 ~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  503 (549)
                      .......+.           +..............+.+++.+||+.||++|||++|++++..++..
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            100000000           0011124557778889999999999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-44  Score=362.90  Aligned_cols=249  Identities=21%  Similarity=0.300  Sum_probs=207.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35788999999999999999997 47999999999754322 23446889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence            9999999999998777899999999999999999999999   99999999999999999999999999998765332  


Q ss_pred             eeeccccccCccCchhhccCCCC-CcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......||+.|+|||.+.+..++ .++|||||||++|||+||+.||.....       ...........           
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~-----------  230 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KELRERVLRGK-----------  230 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-----------
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-----------
Confidence            23455799999999999888875 789999999999999999999974321       11111111110           


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+...+..+.+++.+||+.||++|||++|++++
T Consensus       231 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            01112234678899999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7e-44  Score=355.59  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|...+.||+|+||+||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            56788899999999999999975 58999999886532 23345799999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++|+|.+++.. ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            999999999975 56799999999999999999999999   99999999999999999999999999998764332211


Q ss_pred             -------------eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccc--cHHHHHHHHhh
Q 008893          385 -------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG--AMLDWVKKIHQ  449 (549)
Q Consensus       385 -------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~  449 (549)
                                   .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..........  .....      
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~------  239 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF------  239 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH------
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc------
Confidence                         114569999999999999999999999999999999999999987533222111  11111      


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                             .+...    +...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       240 -------~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~  279 (310)
T 3s95_A          240 -------LDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET  279 (310)
T ss_dssp             -------HHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------ccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                   11111    11223568899999999999999999999998886

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.4e-44  Score=357.58  Aligned_cols=256  Identities=28%  Similarity=0.398  Sum_probs=201.9

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ...++|++.+.||+|+||+||+|.. +|+.||||++...... .....+.+|+.++++++||||+++++++......++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3456788999999999999999987 4889999999765422 2234688999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCC---CCHHHHHHHHHHHHHHHHHhhhcCCCc--eEecccCcCeeeecCCCceEEeeccccccc
Q 008893          303 YPYMSNGSVASRLKAKPS---LDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      |||+++|+|.+++.....   +++..+..++.||+.||.|||+.   +  |+||||||+||+++.++.+||+|||+++..
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999986553   99999999999999999999998   8  999999999999999999999999999865


Q ss_pred             CCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          378 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      .... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||......       ..........      
T Consensus       190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~------  255 (309)
T 3p86_A          190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-------QVVAAVGFKC------  255 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHHSC------
T ss_pred             cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcC------
Confidence            4322 2233456999999999999999999999999999999999999999643211       1111111000      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         .....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       256 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~  295 (309)
T 3p86_A          256 ---KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP  295 (309)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               0111222334678999999999999999999999999886

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=362.02  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=207.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC----CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|.+.+.||+|+||.||+|.+.    .+..||||+++..........+.+|+.+++.++||||+++++++...+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56788899999999999999974    34569999998655444456799999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++|+|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            9999999999999643 5799999999999999999999999   99999999999999999999999999998775433


Q ss_pred             Cc--eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          382 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       382 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ..  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......       +........        
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~~~~~~~~--------  270 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------DVISSVEEG--------  270 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTT--------
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcC--------
Confidence            22  2223346788999999999999999999999999999999 99998643211       111111111        


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        .....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       271 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~  310 (325)
T 3kul_A          271 --YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA  310 (325)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence              1111222334679999999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.9e-44  Score=349.67  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=211.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .++|++.+.||+|+||.||+|..+++..||+|+++...  .....+.+|+.++..++||||+++++++......++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            35788899999999999999999988899999997654  2346789999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++++|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..........
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence            9999999999754 3599999999999999999999999   99999999999999999999999999998776544333


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......       ..........          ..
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~----------~~  224 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------EVVLKVSQGH----------RL  224 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTC----------CC
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-------HHHHHHHcCC----------CC
Confidence            444557788999999999899999999999999999999 99998643221       1111111111          00


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      ..+...+..+.+++.+||+.||++|||+.|++++|+..
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            11112236789999999999999999999999999874

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-44  Score=351.18  Aligned_cols=252  Identities=28%  Similarity=0.449  Sum_probs=210.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      ++|+..+.||+|+||.||+|...+++.||+|++....  .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            5688889999999999999999889999999997654  23467999999999999999999999999999999999999


Q ss_pred             CCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      ++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            99999999964 44689999999999999999999999   999999999999999999999999999987654322233


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      ....+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||......       .........          ....
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-------~~~~~~~~~----------~~~~  227 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTG----------FRLY  227 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTT----------CCCC
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhcC----------ccCC
Confidence            34457788999999999999999999999999999999 99998643211       111111111          0111


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .+...+..+.+++.+|++.||++||++.|++++|+.
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence            122234678999999999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.4e-43  Score=350.92  Aligned_cols=262  Identities=19%  Similarity=0.257  Sum_probs=213.3

Q ss_pred             cccCHHHHHHHhcC----------CCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC
Q 008893          215 KRFHFKELQSATSN----------FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH  283 (549)
Q Consensus       215 ~~~~~~~~~~~~~~----------~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h  283 (549)
                      ..++++++..+++.          |+..+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence            34677777777654          666779999999999999986 69999999997544 3445678899999999999


Q ss_pred             CCccceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC
Q 008893          284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY  363 (549)
Q Consensus       284 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  363 (549)
                      |||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||.|||+.   +|+||||||+||+++.+
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence            99999999999999999999999999999998754 599999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHH
Q 008893          364 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW  443 (549)
Q Consensus       364 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~  443 (549)
                      +.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.....       ...
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-------~~~  249 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQA  249 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHH
T ss_pred             CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHH
Confidence            9999999999987654322 23345699999999999999999999999999999999999999964321       111


Q ss_pred             HHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          444 VKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       444 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ........      .+.+.  .....+..+.+++.+||+.||++|||+.|++++
T Consensus       250 ~~~~~~~~------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          250 MKRLRDSP------PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHHHHSS------CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhcCC------CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111110      01110  011223678899999999999999999999874

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.6e-44  Score=359.67  Aligned_cols=253  Identities=23%  Similarity=0.347  Sum_probs=204.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||+||+|... +++.||||++...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57889999999999999999976 68999999997654444445688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-ce
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  384 (549)
                      +++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            99999999999888899999999999999999999999   999999999999999999999999999986643222 12


Q ss_pred             eeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||........  ....|..    ....   .      
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~----~~~~---~------  228 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKE----KKTY---L------  228 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHHT----TCTT---S------
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHhc----cccc---C------
Confidence            234569999999999988775 7789999999999999999999975332211  1111110    0000   0      


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .........+.+++.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0011223668899999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1e-44  Score=369.25  Aligned_cols=265  Identities=26%  Similarity=0.381  Sum_probs=213.6

Q ss_pred             cCHHHHHHHhcCCCCCCeeeeeCCeEEEEEEE------CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccce
Q 008893          217 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRL  289 (549)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l  289 (549)
                      +...+++...++|.+.+.||+|+||.||+|.+      .+++.||||+++..........+.+|++++..+ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34455566778999999999999999999984      246799999998655444455799999999999 79999999


Q ss_pred             EEEEecCCc-eeeEeeccCCCchhhhhccCCC------------------------------------------------
Q 008893          290 IGFCMTTTE-RLLVYPYMSNGSVASRLKAKPS------------------------------------------------  320 (549)
Q Consensus       290 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------  320 (549)
                      ++++...+. .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 8999999999999999975432                                                


Q ss_pred             ------------------CCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          321 ------------------LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       321 ------------------l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                                        +++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                              89999999999999999999999   999999999999999999999999999987644332


Q ss_pred             -ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          383 -HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       383 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                       .......||+.|+|||++.+..++.++||||||+++|||+| |+.||........   ...   ......         
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~---~~~~~~---------  313 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR---RLKEGT---------  313 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---HHH---HHHHTC---------
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---HHH---HHHcCC---------
Confidence             23344568999999999999999999999999999999999 9999975332111   111   111100         


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       ....+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       314 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          314 -RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence             111122233678999999999999999999999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.2e-44  Score=353.78  Aligned_cols=259  Identities=24%  Similarity=0.287  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC--cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.......  ....+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            57889999999999999999965 68999999986543322  2346899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence            9999999999998877899999999999999999999999   9999999999999999999999999999876544333


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......       .......... .... ....  
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~-~~~~-~~~~--  236 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDS-VPNV-TTDV--  236 (294)
T ss_dssp             -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSC-CCCH-HHHS--
T ss_pred             ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhcc-CCCc-chhc--
Confidence            344556999999999999999999999999999999999999999743221       1111111110 0000 0011  


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcC
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRP-KMSEVVRMLEGD  501 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~  501 (549)
                        ....+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus       237 --~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          237 --RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             --CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             --ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence              112236789999999999999999 899999988863

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3e-44  Score=367.28  Aligned_cols=254  Identities=28%  Similarity=0.413  Sum_probs=198.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC----CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|++.+.||+|+||.||+|...    ++..||||+++..........|.+|+.++++++||||+++++++......++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57899999999999999999865    57789999997654334455799999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++|+|.++++.. ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            9999999999999754 4699999999999999999999999   99999999999999999999999999998765432


Q ss_pred             Cce--eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          382 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       382 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ...  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+........        
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------~~~~~~i~~~--------  266 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------QDVIKAVDEG--------  266 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------HHHHHHHHTT--------
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC--------
Confidence            221  122235778999999999999999999999999999998 9999864321       1111111111        


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        .....+...+..+.+++.+||+.||++||++.||++.|+.
T Consensus       267 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~  306 (373)
T 2qol_A          267 --YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK  306 (373)
T ss_dssp             --EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence              1111122334679999999999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-44  Score=374.10  Aligned_cols=264  Identities=19%  Similarity=0.215  Sum_probs=212.0

Q ss_pred             CHHHHHHHhcCCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEe
Q 008893          218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCM  294 (549)
Q Consensus       218 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  294 (549)
                      .+.++....++|++.+.||+|+||+||+|..+. ++.||+|+++....  ......+.+|+.++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            345556677899999999999999999999874 78999999964211  112224789999999999999999999999


Q ss_pred             cCCceeeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccc
Q 008893          295 TTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL  373 (549)
Q Consensus       295 ~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  373 (549)
                      +.+..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence            99999999999999999999986 56799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCceeeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          374 AKLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       374 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      ++.............+||+.|+|||++.     ...++.++|||||||++|||+||+.||........       ...+.
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-------~~~i~  294 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIM  294 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHH
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-------HHhhh
Confidence            9876654444445567999999999987     45689999999999999999999999975332111       11111


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRM  497 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  497 (549)
                      ....  ...-+....    ..+..+.+++.+|+..+|++  ||+++|++++
T Consensus       295 ~~~~--~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          295 NHKE--RFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             THHH--HCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hccc--cccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            1000  000010001    12367889999999988888  9999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.4e-44  Score=370.54  Aligned_cols=255  Identities=26%  Similarity=0.395  Sum_probs=207.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|.+.+.||+|+||.||+|.+. +++.||||+++..........|.+|+++++.++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            457888899999999999999986 6899999999765432333468899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      |+++|+|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999753 4699999999999999999999999   9999999999999999999999999999865432111


Q ss_pred             ee-eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          384 VT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       384 ~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      .. ....++..|+|||.+.+..++.++|||||||++|||+| |..||......    ....   .....          .
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----~~~~---~~~~~----------~  332 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----QTRE---FVEKG----------G  332 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----HHHH---HHHTT----------C
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH---HHHcC----------C
Confidence            11 12235778999999999999999999999999999999 99998643211    1111   11111          1


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            111222334678999999999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.9e-43  Score=354.57  Aligned_cols=253  Identities=22%  Similarity=0.254  Sum_probs=208.3

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-----cHHHHHHHHHHHhhccCCCccceEEEEecCCce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  299 (549)
                      .+.|++.+.||+|+||.||+|... +|+.||+|+++......     ....+.+|+.++..++||||+++++++......
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            457889999999999999999976 58999999997654321     246789999999999999999999999999999


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC----ceEEeeccccc
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAK  375 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~~~  375 (549)
                      ++||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||+++++    .+||+|||+++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            99999999999999998888899999999999999999999999   999999999999998777    79999999998


Q ss_pred             ccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          376 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......       .....+.....   
T Consensus       168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~---  235 (361)
T 2yab_A          168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANITAVSY---  235 (361)
T ss_dssp             ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCC---
T ss_pred             EcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCC---
Confidence            765432  233456999999999999999999999999999999999999999643211       11111111100   


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      -+++.....    .+..+.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          236 DFDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             CCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            001111111    23668899999999999999999999863

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.9e-44  Score=360.34  Aligned_cols=266  Identities=27%  Similarity=0.336  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC----ceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----ERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l  301 (549)
                      .++|++.+.||+|+||+||+|... ++.||||++....  .....+..|+.+++.++||||+++++++....    ..++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            357889999999999999999886 7899999996542  22335667888899999999999999998754    3699


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcC-------CCceEecccCcCeeeecCCCceEEeecccc
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-------DPKIIHRDVKAANILLDEYYEAVVGDFGLA  374 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  374 (549)
                      ||||+++|+|.+++... .+++..+..++.|++.||.|||+.+       .++|+||||||+|||++.++.+||+|||++
T Consensus       100 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            99999999999999765 4999999999999999999999752       348999999999999999999999999999


Q ss_pred             cccCCCCCc-eeeccccccCccCchhhccC-----CCCCcccchhHhHHHHHHHhCCcccccCccccccc---------c
Q 008893          375 KLLDHCDSH-VTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGKTANQKG---------A  439 (549)
Q Consensus       375 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~---------~  439 (549)
                      +........ ......||+.|+|||.+.+.     .++.++|||||||++|||+||+.||..........         .
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            876543322 22335699999999999863     45668899999999999999999997543322111         1


Q ss_pred             HHHHHHHHhhccchhhhccccccCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          440 MLDWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...+........     ..+.+... .....+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       259 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          259 LEDMQEVVVHKK-----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             HHHHHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhhhhhhhhccc-----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            111111111111     01111110 112345779999999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.8e-44  Score=351.32  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=207.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .++|++.+.||+|+||+||+|.+.++..||+|+++...  .....+.+|++++..++||||+++++++......++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            45788889999999999999999988899999997654  2346789999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence            999999999975 45799999999999999999999999   99999999999999999999999999998765432222


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......       .........          ...
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~----------~~~  240 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQG----------LRL  240 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTT----------CCC
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-------HHHHHHhcc----------cCC
Confidence            333457788999999999999999999999999999999 99998643221       111111111          011


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..+...+..+.+++.+||+.||++|||++|++++|++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            1112223678999999999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-43  Score=357.12  Aligned_cols=249  Identities=23%  Similarity=0.254  Sum_probs=208.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||+||+|..+ +|+.||+|+++...  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57888999999999999999976 68999999997532  2234557889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus        85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~  160 (337)
T 1o6l_A           85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA  160 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CC
Confidence            9999999999998777899999999999999999999999   9999999999999999999999999999864322 22


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+....           .
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~-----------~  222 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEE-----------I  222 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-----------C
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC-----------C
Confidence            33456799999999999999999999999999999999999999964321       11111111110           0


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                      .++...+..+.+++.+||+.||++||     +++|++++
T Consensus       223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            12223346789999999999999999     89998865

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-43  Score=354.09  Aligned_cols=264  Identities=21%  Similarity=0.245  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||+||+|...+|+.||+|++....... ....+.+|+.+++.++||||+++++++......++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            46788999999999999999999889999999997543322 23568899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      |+++ +|.+.+.. ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  174 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-  174 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence            9985 77777754 44699999999999999999999999   999999999999999999999999999987653322 


Q ss_pred             eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc--chhh-----
Q 008893          384 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK--KLEM-----  455 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----  455 (549)
                      ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||.........   ...........  ....     
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGGTTSH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhhhccc
Confidence            2334468999999999876 56899999999999999999999999754433221   11111110000  0000     


Q ss_pred             -h-------ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 -L-------VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 -~-------~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       .       .+.............++.+++.+||+.||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             0       00000000011123578899999999999999999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1e-43  Score=357.11  Aligned_cols=254  Identities=23%  Similarity=0.394  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCC----EEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++|+..+.||+|+||+||+|.+. +++    .||+|.++..........+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            46888899999999999999964 344    468888876555555678999999999999999999999998754 789


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ++||+.+|+|.+++.. ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            9999999999999875 45799999999999999999999999   9999999999999999999999999999877543


Q ss_pred             CCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          381 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       381 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.......    +...+.             
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~-------------  233 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILE-------------  233 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHH-------------
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHHHHH-------------
Confidence            332 2233457889999999999999999999999999999999 999997432211    111111             


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      .......+...+..+.+++.+||+.||++||++.|++++|+..
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1111112223346799999999999999999999999999863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-44  Score=360.53  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=208.7

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEE------CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT  296 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  296 (549)
                      ...++|.+.+.||+|+||.||+|..      .++..||||+++..........+.+|+.++.++ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3457889999999999999999996      245689999998654444456799999999999 899999999999999


Q ss_pred             CceeeEeeccCCCchhhhhccCC-----------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccc
Q 008893          297 TERLLVYPYMSNGSVASRLKAKP-----------------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV  353 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  353 (549)
                      +..++||||+++|+|.+++....                       .+++..+..++.||+.||.|||+.   +|+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence            99999999999999999997542                       379999999999999999999999   9999999


Q ss_pred             CcCeeeecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccC
Q 008893          354 KAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG  431 (549)
Q Consensus       354 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~  431 (549)
                      ||+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999999999999999999876543322 2334557889999999999999999999999999999998 99999753


Q ss_pred             ccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          432 KTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....   .....+    ...         .....+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       279 ~~~~---~~~~~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  331 (344)
T 1rjb_A          279 PVDA---NFYKLI----QNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  331 (344)
T ss_dssp             CCSH---HHHHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcHH---HHHHHH----hcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            3211   111111    111         1111122234679999999999999999999999999987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-43  Score=353.77  Aligned_cols=256  Identities=27%  Similarity=0.379  Sum_probs=210.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEE------CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      ..++|.+.+.||+|+||.||+|..      .+++.||||+++..........+.+|+.+++.++||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            346788899999999999999986      23579999999865544445678999999999999999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCC------------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKP------------------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVK  354 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~------------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  354 (549)
                      .++||||+++|+|.+++....                        .+++..+..++.||+.||.|||++   +|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence            999999999999999997543                        389999999999999999999999   99999999


Q ss_pred             cCeeeecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCc
Q 008893          355 AANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK  432 (549)
Q Consensus       355 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~  432 (549)
                      |+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876543332 1223457889999999999899999999999999999999 999986433


Q ss_pred             cccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          433 TANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..    .+...+.   . .         .....+...+..+.+++.+||+.||++||++.|++++|+.
T Consensus       258 ~~----~~~~~~~---~-~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          258 PE----RLFNLLK---T-G---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             GG----GHHHHHH---T-T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH----HHHHHhh---c-C---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            21    1111111   1 0         0111122234679999999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=363.55  Aligned_cols=255  Identities=29%  Similarity=0.399  Sum_probs=209.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC--------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT  296 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  296 (549)
                      .++|.+.+.||+|+||+||+|...        .+..||||+++..........+.+|+++++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            357888899999999999999852        24579999998665444456789999999999 899999999999999


Q ss_pred             CceeeEeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee
Q 008893          297 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL  360 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  360 (549)
                      +..++||||+++|+|.+++...                ..+++..+..++.||+.||.|||+.   +|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            9999999999999999999743                3599999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCC-ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG  438 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  438 (549)
                      ++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.....     
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-----  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999987654332 22333457889999999999999999999999999999999 9999864321     


Q ss_pred             cHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        ...........          ....+...+..+.+++.+||+.||++|||++|++++|+.
T Consensus       300 --~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  349 (382)
T 3tt0_A          300 --EELFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  349 (382)
T ss_dssp             --HHHHHHHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHHHHHHHcCC----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              11112111111          111122234679999999999999999999999999986

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=354.54  Aligned_cols=252  Identities=20%  Similarity=0.248  Sum_probs=207.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-----CcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++......     .....+.+|+.+++.++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46888999999999999999976 5899999999754322     13567999999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC----ceEEeecccccc
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAKL  376 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~~~~  376 (549)
                      +||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|||+++.
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            9999999999999998888899999999999999999999999   999999999999999887    899999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      .....  ......||+.|+|||.+.+..++.++|||||||++|+|+||+.||......       ...........   .
T Consensus       168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~---~  235 (326)
T 2y0a_A          168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNY---E  235 (326)
T ss_dssp             CCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHTCC---C
T ss_pred             CCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHHhcCC---C
Confidence            65332  223456999999999999999999999999999999999999999643211       11111111000   0


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .......    ..+..+.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          236 FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000001    123568899999999999999999999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.5e-43  Score=348.13  Aligned_cols=254  Identities=22%  Similarity=0.364  Sum_probs=196.3

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      .++|++.+.||+|+||.||+|....    +..||+|+++..........+.+|+.+++.++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4578889999999999999998743    45799999876544344557899999999999999999999984 467899


Q ss_pred             EeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999999754 3699999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......    ....   .......       
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----~~~~---~i~~~~~-------  235 (281)
T 1mp8_A          170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIG---RIENGER-------  235 (281)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHH---HHHTTCC-------
T ss_pred             cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----HHHH---HHHcCCC-------
Confidence            3333334457889999999999999999999999999999997 99998743321    1111   1111110       


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         ...+...+..+.+++.+|++.||++|||+.|++++|+.
T Consensus       236 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          236 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               11122334678999999999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.6e-43  Score=346.62  Aligned_cols=265  Identities=19%  Similarity=0.226  Sum_probs=203.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||+++...... ....+.+|+.+++.++||||+++++++......++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888999999999999999976 58999999997654333 23578899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |++++.+..+......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  157 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C  157 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-C
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-c
Confidence            998644444444567899999999999999999999999   999999999999999999999999999987653322 2


Q ss_pred             eeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc--cch---hhhcc
Q 008893          385 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE--KKL---EMLVD  458 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~~d  458 (549)
                      .....||+.|+|||.+.+.. ++.++|||||||++|||+||+.|+........  .+..........  ...   ....+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhccccc
Confidence            33456899999999998766 79999999999999999999988754322111  111111111000  000   00000


Q ss_pred             c---------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          459 K---------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       459 ~---------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .         .............+.+++.+|++.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0         00011112234678899999999999999999999863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.8e-43  Score=347.80  Aligned_cols=260  Identities=27%  Similarity=0.379  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhh--ccCCCccceEEEEecC----Cce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCMTT----TER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~  299 (549)
                      .++|++.+.||+|+||+||+|.. +|+.||||++...    ....+..|.+++..  ++||||+++++++...    ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46789999999999999999998 5899999998643    23456667776665  7999999999987543    457


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCceEecccCcCeeeecCCCceEEeec
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH--------EQCDPKIIHRDVKAANILLDEYYEAVVGDF  371 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  371 (549)
                      ++||||+++|+|.++++.. .+++..+..++.||+.||.|||        +.   +|+||||||+|||++.++.+||+||
T Consensus        82 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEehhhccCCCHHHHHhhc-ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence            8999999999999999654 6999999999999999999999        77   9999999999999999999999999


Q ss_pred             ccccccCCCCCce---eeccccccCccCchhhccC------CCCCcccchhHhHHHHHHHhC----------CcccccCc
Q 008893          372 GLAKLLDHCDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELISG----------LRALEFGK  432 (549)
Q Consensus       372 g~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~il~elltg----------~~p~~~~~  432 (549)
                      |+++.........   .....||+.|+|||.+.+.      .++.++||||||+++|||+||          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9998765443322   2234699999999999876      445799999999999999999          77775432


Q ss_pred             cccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          433 TANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .....  ................+.    ........+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       238 ~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          238 PNDPS--FEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CSSCC--HHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcc--hhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            22211  111111111111111100    011233466889999999999999999999999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.1e-43  Score=372.96  Aligned_cols=257  Identities=23%  Similarity=0.384  Sum_probs=211.4

Q ss_pred             HHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          222 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       222 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++...++|.+.+.||+|+||+||+|.++++..||||+++...  .....|.+|+.+++.++||||+++++++. .+..++
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            344567788999999999999999999888999999997643  34668999999999999999999999986 567899


Q ss_pred             EeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          302 VYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ||||+++|+|.++++..  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999999999999753  3689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ..........+|..|+|||.+....++.++|||||||++|||+| |+.||.....       .+....+....       
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~-------  402 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALERGY-------  402 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHHTC-------
T ss_pred             CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC-------
Confidence            22122233346788999999999999999999999999999999 9999964321       11111111111       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                         ....+...+..+.+++.+||+.||++|||+++|++.|+..
T Consensus       403 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          403 ---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence               1111223346799999999999999999999999999873

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=358.46  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=210.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      ..++|++.+.||+|+||.||+|...      +++.||||+++..........+.+|+.+++.++||||+++++++...+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            4578999999999999999999974      3489999999865543445579999999999999999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccC------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccC
Q 008893          299 RLLVYPYMSNGSVASRLKAK------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVK  354 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  354 (549)
                      .++||||+++|+|.+++...                        ..+++..++.++.||+.||.|||+.   +|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            99999999999999998642                        5699999999999999999999999   99999999


Q ss_pred             cCeeeecCCCceEEeecccccccCCCCC-ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCc
Q 008893          355 AANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK  432 (549)
Q Consensus       355 p~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~  432 (549)
                      |+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999986543221 12234458899999999999999999999999999999999 999986432


Q ss_pred             cccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          433 TANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      .       .......... ..         ...+...+..+.+++.+||+.||++||++.+++++|+..
T Consensus       282 ~-------~~~~~~~~~~-~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~  333 (343)
T 1luf_A          282 H-------EEVIYYVRDG-NI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  333 (343)
T ss_dssp             H-------HHHHHHHHTT-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             h-------HHHHHHHhCC-Cc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence            1       1111111111 11         111222346799999999999999999999999999973

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.1e-43  Score=352.10  Aligned_cols=262  Identities=23%  Similarity=0.344  Sum_probs=190.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467899999999999999999965 5899999999765544445678899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          305 YMSNGSVASRLKAK------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       305 ~~~~g~L~~~l~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      |++ |+|.+++...      ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5998887532      3589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc------
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK------  451 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  451 (549)
                      .... ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||...........+...........      
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence            3222 22344689999999999764 689999999999999999999999975432211111111000000000      


Q ss_pred             --------------chhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          452 --------------KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       452 --------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                                    .+.....+....    .....+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                          000000111111    12357899999999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.6e-43  Score=359.03  Aligned_cols=252  Identities=22%  Similarity=0.269  Sum_probs=202.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  301 (549)
                      .++|++.+.||+|+||+||+|+.+ +++.||+|+++.....  .....+..|..++.++ +||||+++++++...+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357889999999999999999976 5889999999754322  2223578899998877 89999999999999999999


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..... 
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence            999999999999998877899999999999999999999999   9999999999999999999999999999863322 


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccccc-ccHHHHHHHHhhccchhhhcccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK-GAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+.+.......        .
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------~  278 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------Q  278 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--------C
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--------c
Confidence            22344567999999999999999999999999999999999999999743221111 11111111111111        1


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKM  491 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  491 (549)
                        ..++...+..+.+++.+||+.||++||++
T Consensus       279 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 --IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             --cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence              11222334678999999999999999996

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.6e-43  Score=347.68  Aligned_cols=262  Identities=21%  Similarity=0.310  Sum_probs=200.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||+||+|...+|+.||+|++..... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999998899999999975432 22235788999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++ +|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  156 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K  156 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence            985 88888864 46799999999999999999999999   999999999999999999999999999987653222 2


Q ss_pred             eeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc--cc---hhh--h
Q 008893          385 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE--KK---LEM--L  456 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~--~  456 (549)
                      .....||+.|+|||.+.+. .++.++|||||||++|||+||+.||........   +..........  ..   ...  .
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhcccc
Confidence            2334689999999999764 589999999999999999999999975332111   11111111000  00   000  0


Q ss_pred             cccccc-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          457 VDKDLK-------NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       457 ~d~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .++...       .......+..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            010000       0111123467889999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=360.19  Aligned_cols=250  Identities=26%  Similarity=0.341  Sum_probs=202.0

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCcee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  300 (549)
                      ..++|++.+.||+|+||+||+|..+ +|+.||||+++...  .......+..|..++..+ +||||+++++++...+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3468999999999999999999976 58999999997532  122345678899999887 6999999999999999999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            9999999999999998877899999999999999999999999   9999999999999999999999999999854322


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                       .......+||+.|+|||++.+..++.++|||||||++|||+||+.||......       +....+....         
T Consensus       178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~---------  240 (353)
T 3txo_A          178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDE---------  240 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC---------
T ss_pred             -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC---------
Confidence             22334567999999999999989999999999999999999999999743221       1111111110         


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKM------SEVVR  496 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~  496 (549)
                        ..++......+.+++.+|++.||++||++      .|+++
T Consensus       241 --~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 --VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              11222234678999999999999999998      66665

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4e-43  Score=362.05  Aligned_cols=264  Identities=20%  Similarity=0.219  Sum_probs=211.4

Q ss_pred             HHHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecC
Q 008893          220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT  296 (549)
Q Consensus       220 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  296 (549)
                      .++....++|++.+.||+|+||+||+|... +++.||+|+++...  .......+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344556789999999999999999999976 58999999986421  112223478999999999999999999999999


Q ss_pred             CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          297 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      ...++||||+++|+|.++++.. .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            9999999999999999999765 589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhccCC----CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK  452 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (549)
                      ............+||+.|+|||++.+..    ++.++|||||||++|||+||+.||......       .....+.....
T Consensus       218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~  290 (410)
T 3v8s_A          218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHKN  290 (410)
T ss_dssp             CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHH
T ss_pred             eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------hHHHHHHhccc
Confidence            7644333344567999999999998765    789999999999999999999999743221       11111111100


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHhcC
Q 008893          453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSL--RPKMSEVVRMLEGD  501 (549)
Q Consensus       453 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L~~~  501 (549)
                      ....  + ...    ..+..+.+++.+|++.+|++  ||+++||++|---.
T Consensus       291 ~~~~--p-~~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          291 SLTF--P-DDN----DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             HCCC--C-TTC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             cccC--C-Ccc----cccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence            0000  0 001    12367899999999999998  99999999865443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.4e-43  Score=372.78  Aligned_cols=256  Identities=25%  Similarity=0.404  Sum_probs=213.0

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++...  .....|.+|+.++++++||||++++++|......++||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            44678888999999999999999875 8899999997643  24567999999999999999999999999999999999


Q ss_pred             eccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          304 PYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       304 e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||+++|+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            99999999999974  34689999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      ........++..|+|||.+....++.++|||||||++|||+| |+.||......    .+...+   .          ..
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~~~~~~---~----------~~  435 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELL---E----------KD  435 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHH---H----------TT
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHH---H----------cC
Confidence            222333446789999999999999999999999999999999 99998743321    111111   1          11


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG  502 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  502 (549)
                      .....+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            111222334477999999999999999999999999999753

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.9e-43  Score=351.34  Aligned_cols=256  Identities=27%  Similarity=0.393  Sum_probs=210.5

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE------CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  298 (549)
                      .++|.+.+.||+|+||.||+|..      .+++.||||+++..........+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            45788899999999999999985      246799999998655434456799999999999 99999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCC------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee
Q 008893          299 RLLVYPYMSNGSVASRLKAKP------------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL  360 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  360 (549)
                      .++||||+++|+|.+++....                  .+++..+..++.||+.||.|||+.   +|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            999999999999999987433                  489999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG  438 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  438 (549)
                      +.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence            99999999999999876544332 2234457889999999999999999999999999999999 9999864332111  


Q ss_pred             cHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       ....+.    ..         .....+...+..+.+++.+|++.||++|||+.|++++|+.
T Consensus       257 -~~~~~~----~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          257 -FYKMIK----EG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             -HHHHHH----HT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHHHhc----cC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence             111111    00         1111112234678999999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-44  Score=363.47  Aligned_cols=254  Identities=28%  Similarity=0.386  Sum_probs=206.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|.+.+.||+|+||+||+|.+.      +++.||||+++..........+.+|+.+++.++||||+++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56888899999999999999953      467899999976544444557899999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhccC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC---ceEEee
Q 008893          301 LVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGD  370 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~D  370 (549)
                      +||||+++|+|.+++...       ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            999999999999999642       3589999999999999999999999   999999999999999544   599999


Q ss_pred             cccccccCCCC-CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHh
Q 008893          371 FGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       371 fg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      ||+++...... ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....       ........
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------~~~~~~i~  300 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEFVT  300 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHH
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence            99997543211 122234558899999999999999999999999999999998 9999864321       11111111


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...          ....+...+..+.+++.+||+.||++||++.||+++|+.
T Consensus       301 ~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          301 SGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            111          011122234678999999999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-43  Score=349.92  Aligned_cols=246  Identities=27%  Similarity=0.346  Sum_probs=206.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++...  .......+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888999999999999999976 69999999997532  1234556889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus        86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence            9999999999998888899999999999999999999999   9999999999999999999999999999875432   


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                       .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+...         ..  
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~---------~~--  220 (318)
T 1fot_A          160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNA---------EL--  220 (318)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHC---------CC--
T ss_pred             -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC---------CC--
Confidence             23456999999999999999999999999999999999999999643211       111111111         00  


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                      .++.....++.+++.+|++.||++||     +++|++++
T Consensus       221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            11222346789999999999999999     88888754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.8e-43  Score=349.18  Aligned_cols=253  Identities=21%  Similarity=0.290  Sum_probs=196.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhccCCCccceEEEEecCCce----
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTER----  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----  299 (549)
                      ++|++.+.||+|+||.||+|.. .+++.||||+++.......  ...+.+|+.++..++||||+++++++......    
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            5788999999999999999997 4689999999976543222  34688999999999999999999998765443    


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            99999999999999998777899999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCc--eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          380 CDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       380 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ....  ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......       ..............  
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~--  239 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIPP--  239 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCCH--
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCCCc--
Confidence            3222  223456899999999999999999999999999999999999999643221       11111111111000  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       ......    .+..+.+++.+||+.||++||+..+++.
T Consensus       240 -~~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          240 -SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             -HHHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             -ccccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence             000111    2367899999999999999998887765

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.2e-43  Score=352.31  Aligned_cols=250  Identities=20%  Similarity=0.319  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC-------
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-------  297 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------  297 (549)
                      .++|++.+.||+|+||.||+|... +|+.||||+++..........+.+|+.+++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            356889999999999999999986 799999999986655555667999999999999999999999986543       


Q ss_pred             --------------------------------------------------ceeeEeeccCCCchhhhhccCC---CCCHH
Q 008893          298 --------------------------------------------------ERLLVYPYMSNGSVASRLKAKP---SLDWA  324 (549)
Q Consensus       298 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~---~l~~~  324 (549)
                                                                        ..++||||+++++|.+++....   ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              2789999999999999997643   35667


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-----------ceeeccccccC
Q 008893          325 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-----------HVTTAVRGTVG  393 (549)
Q Consensus       325 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~gt~~  393 (549)
                      .++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            7899999999999999999   999999999999999999999999999987764321           11233469999


Q ss_pred             ccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHH
Q 008893          394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEM  473 (549)
Q Consensus       394 y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  473 (549)
                      |+|||.+.+..++.++||||||+++|||++|..|+...         ......... ...         ..........+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------~~~~~~~~~-~~~---------~~~~~~~~~~~  302 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------VRIITDVRN-LKF---------PLLFTQKYPQE  302 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------HHHHHHHHT-TCC---------CHHHHHHCHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------HHHHHHhhc-cCC---------CcccccCChhH
Confidence            99999999999999999999999999999987665310         011111100 000         00112234667


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHH
Q 008893          474 VQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       474 ~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+++.+||+.||++|||+.|++++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHccCCCCcCCCHHHHhhc
Confidence            899999999999999999999874

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-43  Score=354.81  Aligned_cols=246  Identities=20%  Similarity=0.291  Sum_probs=204.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||+|.. .+|+.||||++....  .......+.+|+.+++.++||||+++++++......++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788999999999999999997 468999999986431  1223457889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+ +|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||++.......  
T Consensus        89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--  162 (336)
T ss_dssp             CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred             ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence            999 689999988777899999999999999999999999   99999999999999999999999999998765332  


Q ss_pred             eeeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||..........                .+...  .
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i~~~--~  224 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KVNSC--V  224 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CCCSS--C
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HHHcC--C
Confidence            2334569999999999988776 789999999999999999999997543221110                00000  0


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ...+...+..+.+++.+|++.||.+|||++|+++
T Consensus       225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1122223467899999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.5e-43  Score=356.90  Aligned_cols=250  Identities=24%  Similarity=0.297  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....  .......+.+|+.+++.++||||+++++++......++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888999999999999999976 58899999986432  2234557889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+.+|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....  .
T Consensus        95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T  169 (384)
T ss_dssp             CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence            9999999999999888899999999999999999999999   9999999999999999999999999999876533  2


Q ss_pred             eeeccccccCccCchhhcc---CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          384 VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      ......||+.|+|||++..   ..++.++|||||||++|||+||+.||........    ..........          
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~----~~~~~~~~~~----------  235 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS----KEIVHTFETT----------  235 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH----HHHHHHHHHC----------
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH----HHHHHHHhhc----------
Confidence            3345679999999999964   4589999999999999999999999974332211    1111111110          


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPK-MSEVVR  496 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~  496 (549)
                       ...++...+..+.+++.+||+.||++||+ ++++.+
T Consensus       236 -~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 -VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence             01122223467899999999999999998 676664

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.4e-43  Score=348.05  Aligned_cols=262  Identities=24%  Similarity=0.387  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-----CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC--Cce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  299 (549)
                      ++|++.+.||+|+||+||+|.+     .+++.||||++.... ......+.+|+.+++.++||||+++++++...  ...
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            5788899999999999999984     258899999997543 23345789999999999999999999998653  458


Q ss_pred             eeEeeccCCCchhhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          300 LLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      ++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            99999999999999997543 599999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCc--eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc------
Q 008893          379 HCDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE------  450 (549)
Q Consensus       379 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  450 (549)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||+||..|+......        +.......      
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~  237 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQMI  237 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------HHHHHCTTCCTHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------HHhhhcCccccchh
Confidence            43221  222344778899999999999999999999999999999999887632110        00000000      


Q ss_pred             -cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          451 -KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       451 -~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       ...............+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  288 (295)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence             00001111111112233345789999999999999999999999999976

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=346.71  Aligned_cols=251  Identities=19%  Similarity=0.241  Sum_probs=206.3

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|.+.+.||+|+||+||+|... +++.||+|.+....  .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            357889999999999999999976 58899999987432  234568899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC--CCceEEeecccccccCCCC
Q 008893          305 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       305 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |+++|+|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.  ++.+||+|||+++......
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            99999999999764 4799999999999999999999999   9999999999999987  7899999999998775432


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                        ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......       ............   .+...
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~---~~~~~  226 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEYT---FDEEA  226 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCC---CCHHH
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHcCCCC---CChhh
Confidence              334456999999999999888999999999999999999999999743211       111111111100   00000


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...    .+.++.+++.+|++.||++|||+.|++++
T Consensus       227 ~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          227 FKE----ISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hcc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111    23678999999999999999999999973

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.3e-43  Score=345.21  Aligned_cols=253  Identities=28%  Similarity=0.442  Sum_probs=208.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ..++|++.+.||+|+||.||+|...++..||+|.++...  .....+.+|+++++.++||||+++++++. .+..++|||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   87 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE   87 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence            346788899999999999999999888899999997543  23567999999999999999999999986 456899999


Q ss_pred             ccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999999997543  699999999999999999999999   999999999999999999999999999987764433


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      .......++..|+|||.+.+..++.++||||||+++|||+| |+.||.....       ...........          
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~----------  227 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGY----------  227 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTC----------
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HHHHHHHhccc----------
Confidence            33334457889999999998889999999999999999999 8989864321       11111111110          


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....+...+..+.+++.+|++.||++|||+.++++.|+.
T Consensus       228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  266 (279)
T 1qpc_A          228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (279)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            011112234678999999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.9e-43  Score=341.49  Aligned_cols=252  Identities=28%  Similarity=0.430  Sum_probs=209.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      ++|+..+.||+|+||.||+|...+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            56888899999999999999998889999999976542  3467899999999999999999999999999999999999


Q ss_pred             CCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      ++++|.+++... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...........
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            999999999754 5689999999999999999999999   999999999999999999999999999987643222222


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      ....++..|+|||.+.+..++.++||||||+++|||+| |+.||.....       ...........          ...
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~i~~~~----------~~~  225 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGF----------RLY  225 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTC----------CCC
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHHHHHHhcCC----------cCC
Confidence            33457788999999999999999999999999999999 8999864321       11111111110          011


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .+...+..+.+++.+|++.||++||++.|++++|+.
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  261 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            112234678999999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.8e-43  Score=367.62  Aligned_cols=255  Identities=27%  Similarity=0.375  Sum_probs=205.0

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ...++|.+.+.||+|+||.||+|.++++..||||+++...  .....|.+|+.+++.++||||+++++++.. +..++||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence            3456788899999999999999999888889999998654  235679999999999999999999999876 6789999


Q ss_pred             eccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          304 PYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       304 e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||+++|+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+++......
T Consensus       258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            99999999999974  34699999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      ........++..|+|||.+....++.++||||||+++|||+| |+.||.....       .+........          
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~----------  397 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERG----------  397 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTT----------
T ss_pred             eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC----------
Confidence            223334457889999999999999999999999999999999 8999864321       1111111111          


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      .....+...+..+.+++.+||+.||++|||++++++.|+..
T Consensus       398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~  438 (452)
T 1fmk_A          398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  438 (452)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11112233447799999999999999999999999999873

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1e-42  Score=340.02  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=195.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC---CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI---GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|+..+.||+|+||.||+|.+. |+.||||+++.....   .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57888999999999999999986 889999998754322   22457899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC--------CCceEEeeccccc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--------YYEAVVGDFGLAK  375 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--------~~~~kl~Dfg~~~  375 (549)
                      ||+++++|.+++... .+++..+..++.|++.||.|||+....+|+||||||+||+++.        ++.+||+|||+++
T Consensus        86 e~~~~~~L~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~  164 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR  164 (271)
T ss_dssp             ECCTTEEHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred             EcCCCCCHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence            999999999998644 6999999999999999999999981112999999999999986        7789999999998


Q ss_pred             ccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          376 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      ......   .....||+.|+|||.+.+..++.++||||||+++|+|+||+.||......       ........      
T Consensus       165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~------  228 (271)
T 3dtc_A          165 EWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAYGVAM------  228 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHT------
T ss_pred             cccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHhhhc------
Confidence            654322   22346899999999999999999999999999999999999999743211       11111111      


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       456 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         .......+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       229 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          229 ---NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ---SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence               111111222334679999999999999999999999999975

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=363.28  Aligned_cols=255  Identities=19%  Similarity=0.231  Sum_probs=206.7

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ..++|++.+.||+|+||+||+|... +|+.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3567899999999999999999975 6899999999765422 2234689999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec---CCCceEEeecccccccCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~~~  379 (549)
                      |||+++|+|.+.+.....+++..+..++.||+.||.|||+.   +|+||||||+|||++   +++.+||+|||+++....
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            99999999999998888899999999999999999999999   999999999999998   568899999999987654


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.....       ......+.... . .. ..
T Consensus       166 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~-~-~~-~~  234 (444)
T 3soa_A          166 EQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------HRLYQQIKAGA-Y-DF-PS  234 (444)
T ss_dssp             TCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTC-C-CC-CT
T ss_pred             CCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhCC-C-CC-Cc
Confidence            322 23345699999999999999999999999999999999999999964321       11111111110 0 00 00


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..    ....+..+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          235 PE----WDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TT----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cc----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00    11223678999999999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=345.47  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=196.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-------------------------cHHHHHHHHHHHhh
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-------------------------GEIQFQTEVEMISL  280 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-------------------------~~~~~~~e~~~l~~  280 (549)
                      ++|++.+.||+|+||.||+|... +++.||||++.......                         ....+.+|+.+++.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57889999999999999999975 58899999996543111                         12358899999999


Q ss_pred             ccCCCccceEEEEec--CCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCee
Q 008893          281 AVHRNLLRLIGFCMT--TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI  358 (549)
Q Consensus       281 l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  358 (549)
                      ++||||+++++++..  ....++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.   +|+||||||+||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL  168 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence            999999999999986  5678999999999999987654 4699999999999999999999999   999999999999


Q ss_pred             eecCCCceEEeecccccccCCCCCceeeccccccCccCchhhccCC---CCCcccchhHhHHHHHHHhCCcccccCcccc
Q 008893          359 LLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGKTAN  435 (549)
Q Consensus       359 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~  435 (549)
                      |++.++.+||+|||+++....... ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||.....  
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--  245 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI--  245 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred             EECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH--
Confidence            999999999999999987654322 233456999999999997765   37789999999999999999999964321  


Q ss_pred             ccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                           ..+....... ..    .......    .+..+.+++.+||+.||++|||+.|+++
T Consensus       246 -----~~~~~~~~~~-~~----~~~~~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          246 -----MCLHSKIKSQ-AL----EFPDQPD----IAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             -----HHHHHHHHHC-CC----CCCSSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----HHHHHHHhcc-cC----CCCCccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence                 1111111111 00    0000111    2367899999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.7e-42  Score=350.34  Aligned_cols=253  Identities=20%  Similarity=0.267  Sum_probs=206.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|++.+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999976 5899999999765422 22346889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC---CceEEeecccccccCCC
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY---YEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~  380 (549)
                      ||+++|+|.+.+.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.+   +.+||+|||++......
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            9999999999998888899999999999999999999999   99999999999999864   45999999999876533


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....       ......+.... ..  ....
T Consensus       185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~-~~--~~~~  252 (362)
T 2bdw_A          185 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGA-YD--YPSP  252 (362)
T ss_dssp             C--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC-CC--CCTT
T ss_pred             c--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCC-CC--CCcc
Confidence            2  23345699999999999999999999999999999999999999964321       11111111110 00  0000


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..    ...+..+.+++.+||+.||++||++.|++++
T Consensus       253 ~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          253 EW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             GG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            01    1123678999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.9e-43  Score=353.62  Aligned_cols=254  Identities=23%  Similarity=0.390  Sum_probs=203.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCE----EEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTV----VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++|.+.+.||+|+||+||+|.+. +++.    ||+|.+...........+.+|+.+++.++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            46888899999999999999965 3443    88888865543344446778999999999999999999986 466899


Q ss_pred             EeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ||||+++|+|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999764 5799999999999999999999999   9999999999999999999999999999987544


Q ss_pred             CCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          381 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       381 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ... ......||..|+|||.+.+..++.++||||||+++|||+| |+.||......    .+...+.   ...       
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~---~~~-------  234 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPDLLE---KGE-------  234 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----HHHHHHH---TTC-------
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----HHHHHHH---cCC-------
Confidence            332 2344568889999999999999999999999999999999 99999753321    1111111   110       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                         ....+...+..+.+++.+||+.||++||++.|++++|+..
T Consensus       235 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          235 ---RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             ---BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               0111112234578999999999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.2e-43  Score=351.27  Aligned_cols=266  Identities=25%  Similarity=0.351  Sum_probs=208.4

Q ss_pred             CCCCCeeeeeCCeEEEEEEEC-----CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC--Cceee
Q 008893          229 FSSKNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL  301 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  301 (549)
                      |++.+.||+|+||+||++.+.     +++.||||+++..........+.+|+++++.++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            478899999999999998753     58899999998665434455799999999999999999999999874  56799


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||||+++|+|.+++.... +++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus       113 v~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred             EEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence            999999999999997654 99999999999999999999999   99999999999999999999999999998876543


Q ss_pred             Cc--eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          382 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       382 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ..  ......+|..|+|||.+.+..++.++||||||+++|||+||+.||........  ....+..............+.
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL--ELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHHCSCCHHHHHHHHHHHHHT
T ss_pred             cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh--hhhcccccchhHHHHHHHHhc
Confidence            32  22334578889999999999999999999999999999999999864221100  000000000000111112222


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ......+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT  307 (318)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            22222333445789999999999999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.7e-43  Score=353.07  Aligned_cols=246  Identities=21%  Similarity=0.252  Sum_probs=206.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....  .......+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999999999976 68999999986432  2234557889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus       121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence            9999999999998777899999999999999999999999   9999999999999999999999999999876432   


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+....           .
T Consensus       195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~-----------~  255 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGK-----------V  255 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-----------C
T ss_pred             -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHHHHHcCC-----------C
Confidence             2345699999999999999999999999999999999999999974321       11111111110           0


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  497 (549)
                      .++...+..+.+++.+||+.||++||+     ++|++++
T Consensus       256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            112223467899999999999999998     7888754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.3e-43  Score=347.83  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=213.3

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ..++|++.+.||+|+||.||+|.+.. +..||+|++....  .....+.+|+.+++.++||||+++++++......++||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            45678889999999999999999864 8899999997543  34567899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          304 PYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       304 e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            99999999999974  34599999999999999999999999   99999999999999999999999999998776554


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......    ....+   .          ..
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----~~~~~---~----------~~  228 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELL---E----------KD  228 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHHH---H----------TT
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH---h----------cc
Confidence            444455567889999999999999999999999999999999 989986433211    11111   1          11


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .....+...+..+.+++.+|++.||++|||+.|+++.|+.
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence            1111222334679999999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.1e-43  Score=349.38  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=206.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-----CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC--Cce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  299 (549)
                      ..|++.+.||+|+||.||+|.+     .+++.||+|+++..........+.+|+.+++.++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3577889999999999999984     358899999998665555567899999999999999999999999876  668


Q ss_pred             eeEeeccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          300 LLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      ++||||+++|+|.+++. ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence            99999999999999995 455799999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCc--eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcc--------ccccccHHHHHHHHh
Q 008893          379 HCDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT--------ANQKGAMLDWVKKIH  448 (549)
Q Consensus       379 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~--------~~~~~~~~~~~~~~~  448 (549)
                      .....  ......||..|+|||.+.+..++.++||||||+++|||+||+.|+.....        .............  
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--  255 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT--  255 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH--
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH--
Confidence            54332  22345588889999999999999999999999999999999988653210        0000011111111  


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                              .........+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       256 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          256 --------LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             --------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence                    11111112233344779999999999999999999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.1e-43  Score=351.33  Aligned_cols=255  Identities=27%  Similarity=0.415  Sum_probs=208.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC--------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT  296 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  296 (549)
                      .++|.+.+.||+|+||.||+|...        ++..||||+++..........+.+|+.+++.+ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467889999999999999999863        46789999998655434455789999999999 899999999999999


Q ss_pred             CceeeEeeccCCCchhhhhccCC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee
Q 008893          297 TERLLVYPYMSNGSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL  360 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  360 (549)
                      +..++||||+++|+|.+++....                .+++..++.++.||+.||.|||+.   +|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            99999999999999999997543                389999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG  438 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  438 (549)
                      +.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....     
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----  265 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  265 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence            99999999999999876543322 2233457889999999998889999999999999999999 9999864321     


Q ss_pred             cHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        ...........          ....+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       266 --~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  315 (334)
T 2pvf_A          266 --EELFKLLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  315 (334)
T ss_dssp             --HHHHHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHHHHHHhcCC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence              11111111111          011122234678999999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-42  Score=363.96  Aligned_cols=248  Identities=27%  Similarity=0.389  Sum_probs=204.7

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC-ceeeEe
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-ERLLVY  303 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  303 (549)
                      ..++|++.+.||+|+||.||+|.+. |+.||||+++...   ....|.+|+.++++++||||+++++++.... ..++||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            3467888999999999999999986 7899999997643   3457999999999999999999999987765 789999


Q ss_pred             eccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          304 PYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||+++|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..... 
T Consensus       267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            9999999999997533  479999999999999999999999   9999999999999999999999999999854322 


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                         .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.......    ...   .....          
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~---~i~~~----------  402 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVP---RVEKG----------  402 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----HHH---HHHTT----------
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH---HHHcC----------
Confidence               122357889999999999999999999999999999999 999997433211    111   11111          


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .....+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1111223344789999999999999999999999999876

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.9e-43  Score=355.51  Aligned_cols=251  Identities=25%  Similarity=0.329  Sum_probs=206.1

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCce
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  299 (549)
                      ...++|.+.+.||+|+||.||+|..+ +|+.||+|+++...  .......+..|..++..+ +||||+++++++...+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            45678999999999999999999986 58999999997532  123345678889888876 899999999999999999


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+++|+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            99999999999999998777899999999999999999999999   999999999999999999999999999986432


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .. ......+||+.|+|||.+.+..++.++|||||||++|||++|+.||......       .....+....       .
T Consensus       171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~-------~  235 (345)
T 1xjd_A          171 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDN-------P  235 (345)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC-------C
T ss_pred             CC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHhCC-------C
Confidence            22 2234567999999999999999999999999999999999999999743211       1111111110       1


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMS-EVVR  496 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~  496 (549)
                          .++...+..+.+++.+||+.||++||++. |+++
T Consensus       236 ----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          236 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                11222346789999999999999999997 6654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.7e-43  Score=342.99  Aligned_cols=254  Identities=22%  Similarity=0.377  Sum_probs=203.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      .++|.+.+.||+|+||+||+|...+    +..||+|.++..........+.+|+.+++.++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4678889999999999999998643    346999999866444445679999999999999999999999765 45789


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            9999999999999974 44699999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......    ....+   .....       
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~~~~~---~~~~~-------  232 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVL---EKGDR-------  232 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----HHHHH---HHTCC-------
T ss_pred             cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----HHHHH---hcCCC-------
Confidence            3333344557889999999999999999999999999999998 999996433211    11111   11110       


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         ...+...+..+.+++.+||+.||++||++.|++++|+.
T Consensus       233 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          233 ---LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence               01112233678999999999999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.8e-42  Score=348.81  Aligned_cols=251  Identities=23%  Similarity=0.273  Sum_probs=201.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC--cHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|++.+.||+|+||.||+|..+ +++.||+|+++......  ....+..|..++..+ +||||+++++++......++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46888999999999999999976 58899999997654222  234578899999887 899999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||+++|+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence            99999999999998777899999999999999999999999   99999999999999999999999999998643222 


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccccc-ccHHHHHHHHhhccchhhhccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK-GAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+.......        . 
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--------~-  235 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------Q-  235 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--------C-
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--------C-
Confidence            2334557999999999999999999999999999999999999999743221110 00111111111111        0 


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKM  491 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  491 (549)
                       ..++...+..+.+++.+||+.||++||++
T Consensus       236 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 -IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence             11222334678999999999999999996

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.9e-43  Score=355.30  Aligned_cols=253  Identities=23%  Similarity=0.246  Sum_probs=196.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|.+.+.||+|+||+||++... +++.||||++.....  ....+.+|+.+++.++||||+++++++......++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            357889999999999999999976 689999999976442  23568899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc--eEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--AVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~  382 (549)
                      |+++|+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.  +||+|||+++.....  
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--  171 (361)
T 3uc3_A           97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--  171 (361)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence            999999999998777899999999999999999999999   9999999999999987765  999999999743322  


Q ss_pred             ceeeccccccCccCchhhccCCCCCc-ccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      .......||+.|+|||.+.+..++.+ +|||||||++|+|++|+.||........   ............         .
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~---------~  239 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVK---------Y  239 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTTC---------C
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCC---------C
Confidence            12234469999999999988887665 8999999999999999999975433222   112122111110         0


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ........+..+.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            000001123678899999999999999999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.5e-42  Score=348.28  Aligned_cols=251  Identities=22%  Similarity=0.273  Sum_probs=184.2

Q ss_pred             CCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeEeeccCCC
Q 008893          232 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      .+.||+|+||+||+|... +|+.||||++...    ....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            478999999999999976 5899999999643    3456889999999997 999999999999999999999999999


Q ss_pred             chhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC---ceEEeecccccccCCCCCceee
Q 008893          310 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGDFGLAKLLDHCDSHVTT  386 (549)
Q Consensus       310 ~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~  386 (549)
                      +|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++   .+||+|||+++....... ...
T Consensus        92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~  167 (325)
T 3kn6_A           92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK  167 (325)
T ss_dssp             BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence            9999999888899999999999999999999999   999999999999997665   899999999987654322 233


Q ss_pred             ccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCC
Q 008893          387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD  466 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  466 (549)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||........................       .......
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-------~~~~~~~  240 (325)
T 3kn6_A          168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-------SFEGEAW  240 (325)
T ss_dssp             ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-------CCCSHHH
T ss_pred             ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-------CCCcccc
Confidence            456899999999999999999999999999999999999999754433222222222222221110       0000000


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          467 RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       467 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+..+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            1234678999999999999999999999753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.3e-42  Score=345.81  Aligned_cols=257  Identities=18%  Similarity=0.181  Sum_probs=206.5

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|.+.+.||+|+||+||+|.. .+|+.||||++......   ..+..|+.+++.+ +||||+++++++...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            35788999999999999999996 46899999998754322   2578999999999 9999999999999999999999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc-----eEEeeccccccc
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLL  377 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfg~~~~~  377 (549)
                      ||+ +++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.     +||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 9999999975 46799999999999999999999999   9999999999999998887     999999999876


Q ss_pred             CCCCCc------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc
Q 008893          378 DHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK  451 (549)
Q Consensus       378 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (549)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........    ...........
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~----~~~~~~i~~~~  236 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL----KERYQKIGDTK  236 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH----HHHHHHHHHHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH----HHHHHHHHhhh
Confidence            543321      12345699999999999999999999999999999999999999975432221    11111111100


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       452 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      . .. ....+...    .+ .+.+++..|++.||.+||+++++.+.|++
T Consensus       237 ~-~~-~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          237 R-AT-PIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             H-HS-CHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             c-cC-CHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence            0 00 00000011    12 79999999999999999999999998875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=365.20  Aligned_cols=264  Identities=22%  Similarity=0.236  Sum_probs=209.4

Q ss_pred             cCHHHHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEE
Q 008893          217 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFC  293 (549)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~  293 (549)
                      +.+++.....++|++.+.||+|+||+||+|..+ +|+.||||+++....  ......+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            344555566789999999999999999999986 699999999964221  11223478899999999999999999999


Q ss_pred             ecCCceeeEeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecc
Q 008893          294 MTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG  372 (549)
Q Consensus       294 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  372 (549)
                      .+.+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence            9999999999999999999999753 4799999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeeccccccCccCchhhc-------cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHH
Q 008893          373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLS-------TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      +++.............+||+.|+|||++.       ...++.++|||||||++|||+||+.||........       ..
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~  280 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-------YG  280 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HH
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-------HH
Confidence            99877654433344567999999999987       35689999999999999999999999975332111       11


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR---PKMSEVVRM  497 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~~  497 (549)
                      .+.....  ...-+..    ....+.++.+++.+||. +|++|   |+++|+++|
T Consensus       281 ~i~~~~~--~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          281 KIVHYKE--HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHhccc--CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            1111000  0000111    11223678999999999 99998   589998764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.4e-43  Score=349.88  Aligned_cols=264  Identities=26%  Similarity=0.378  Sum_probs=212.8

Q ss_pred             CHHHHHHHhcCCCCCCeeeeeCCeEEEEEEE------CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceE
Q 008893          218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLI  290 (549)
Q Consensus       218 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~  290 (549)
                      ...++....++|.+.+.||+|+||+||+|.+      .+++.||||+++..........+.+|+.++..+ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3444455667899999999999999999984      246899999998655444455789999999999 799999999


Q ss_pred             EEEecCC-ceeeEeeccCCCchhhhhccCCC----------------CCHHHHHHHHHHHHHHHHHhhhcCCCceEeccc
Q 008893          291 GFCMTTT-ERLLVYPYMSNGSVASRLKAKPS----------------LDWATRKRIALGAARGLLYLHEQCDPKIIHRDV  353 (549)
Q Consensus       291 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  353 (549)
                      +++...+ ..++||||+++|+|.+++.....                +++..+..++.|++.||.|||+.   +|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence            9988755 48999999999999999975443                89999999999999999999999   9999999


Q ss_pred             CcCeeeecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccC
Q 008893          354 KAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG  431 (549)
Q Consensus       354 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~  431 (549)
                      ||+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999999999999999999876543332 2334568899999999999999999999999999999998 99998643


Q ss_pred             ccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          432 KTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....   ...   ........          ...+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       255 ~~~~---~~~---~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  307 (316)
T 2xir_A          255 KIDE---EFC---RRLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  307 (316)
T ss_dssp             CCSH---HHH---HHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             chhH---HHH---HHhccCcc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            3211   111   11111100          11112223678999999999999999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-42  Score=349.44  Aligned_cols=250  Identities=24%  Similarity=0.283  Sum_probs=196.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE----CCCCEEEEEEcccCCC---CCcHHHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      .++|++.+.||+|+||.||++..    .+|+.||+|+++....   ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35788999999999999999997    4689999999976432   1223457889999999999999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            999999999999999998777899999999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......       .....+....       
T Consensus       173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~-------  237 (327)
T 3a62_A          173 HDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-------KTIDKILKCK-------  237 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTC-------
T ss_pred             cCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCC-------
Confidence            222 2234456999999999999999999999999999999999999999743211       1111111110       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                          ...+......+.+++.+||+.||++||     ++.|++++
T Consensus       238 ----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 ----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                011222346789999999999999999     67777764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.9e-42  Score=339.86  Aligned_cols=252  Identities=29%  Similarity=0.501  Sum_probs=202.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcH------HHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGE------IQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~------~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      .++|++.+.||+|+||+||+|... +++.||+|++.........      ..+.+|+.+++.++||||+++++++.... 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            357888999999999999999975 6899999999755433222      56899999999999999999999986554 


Q ss_pred             eeeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEecccCcCeeeecCCCc-----eEEee
Q 008893          299 RLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYE-----AVVGD  370 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~-----~kl~D  370 (549)
                       ++||||+++|+|.+.+.. ...+++..+..++.|++.||.|||+.   +  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999888754 44799999999999999999999998   8  999999999999988776     99999


Q ss_pred             cccccccCCCCCceeeccccccCccCchhhc--cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          371 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       371 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      ||+++....    ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||.......     ..+.....
T Consensus       173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~  243 (287)
T 4f0f_A          173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIR  243 (287)
T ss_dssp             CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----HHHHHHHH
T ss_pred             CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----HHHHHHHh
Confidence            999975432    234456999999999984  4557899999999999999999999997432211     11111111


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .         .......+...+..+.+++.+||+.||++|||++|+++.|++
T Consensus       244 ~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          244 E---------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             H---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             c---------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            1         111112223334779999999999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8e-43  Score=353.06  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=199.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccC--CCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVH--RNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv  302 (549)
                      .++|++.+.||+|+||.||++...+++.||||++....... ....+.+|+.++..++|  |||+++++++......++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            35688899999999999999999889999999997554222 23568999999999976  9999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      || +.+++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||+++.......
T Consensus        88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            99 56789999999888899999999999999999999999   999999999999997 57899999999987654332


Q ss_pred             c-eeeccccccCccCchhhcc-----------CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc
Q 008893          383 H-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE  450 (549)
Q Consensus       383 ~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (549)
                      . ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     . ...      
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~-~~~------  230 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I-SKL------  230 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H-HHH------
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----H-HHH------
Confidence            2 2334569999999999865           67889999999999999999999999632210     1 111      


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       451 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                         ..+.++.....++......+.+++.+||+.||++|||+.|++++
T Consensus       231 ---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          231 ---HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ---HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence               11122222222222234678999999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-41  Score=337.50  Aligned_cols=258  Identities=17%  Similarity=0.199  Sum_probs=207.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++......   ..+.+|+..+..+ +|+|++++++++......++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            35788999999999999999996 46899999998754322   2477899999998 7999999999999999999999


Q ss_pred             eccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc-----eEEeeccccccc
Q 008893          304 PYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLL  377 (549)
Q Consensus       304 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfg~~~~~  377 (549)
                      ||+ +++|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.     +||+|||+++..
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999 99999999753 4699999999999999999999999   9999999999999987766     999999999876


Q ss_pred             CCCCCc------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc
Q 008893          378 DHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK  451 (549)
Q Consensus       378 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (549)
                      ......      ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...........+ ..+.......
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~  240 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQST  240 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHHS
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH-HHHHhhccCc
Confidence            543321      223456999999999999999999999999999999999999999754322221111 1111111011


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       452 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....     +...    .+..+.+++.+||+.||++||++++|++.|+.
T Consensus       241 ~~~~-----~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~  280 (298)
T 1csn_A          241 PLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  280 (298)
T ss_dssp             CHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             cHHH-----HHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence            1111     1111    23678999999999999999999999999886

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=352.45  Aligned_cols=251  Identities=22%  Similarity=0.274  Sum_probs=192.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||+|... +++.||||+++...   ....+.+|+.++..++||||+++++++......++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            457889999999999999999986 58899999997543   23467889999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC---CCceEEeecccccccCCCC
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++..... 
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-  204 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence            999999999998888899999999999999999999999   9999999999999975   899999999999866432 


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                       .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......      .......... .      ..
T Consensus       205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~-~------~~  270 (349)
T 2w4o_A          205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCE-Y------YF  270 (349)
T ss_dssp             ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTC-C------CC
T ss_pred             -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCC-C------cc
Confidence             12234569999999999999999999999999999999999999996432211      0111111110 0      00


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ........+..+.+++.+||+.||++|||+.|++++
T Consensus       271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            011112234678999999999999999999999874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=346.81  Aligned_cols=244  Identities=25%  Similarity=0.283  Sum_probs=192.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|+..+.||+|+||+||+|... +|+.||||++...... .....+..|+..+..+ +||||+++++++.+....++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57889999999999999999986 6999999998654322 2223455556555555 8999999999999999999999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+ +++|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 6688888764 45699999999999999999999999   99999999999999999999999999998764322 


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....         | ...... .    ..+...
T Consensus       212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~-~~~~~~-~----~~~~~~  274 (311)
T 3p1a_A          212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------W-QQLRQG-Y----LPPEFT  274 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------H-HHHTTT-C----CCHHHH
T ss_pred             -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------H-HHHhcc-C----CCcccc
Confidence             2334569999999999875 799999999999999999999777643110         1 111110 0    011111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .    ..+..+.+++.+||+.||++|||++|+++
T Consensus       275 ~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 A----GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             c----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            1    12367899999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5e-43  Score=353.01  Aligned_cols=259  Identities=25%  Similarity=0.366  Sum_probs=210.2

Q ss_pred             HHHhcCCCCCCeeeeeCCeEEEEEEECC------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEec
Q 008893          223 QSATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMT  295 (549)
Q Consensus       223 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  295 (549)
                      +...++|.+.+.||+|+||.||+|....      +..||+|.++..........+.+|+.+++.+ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3445789999999999999999999642      2489999998655444456799999999999 89999999999999


Q ss_pred             CCceeeEeeccCCCchhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec
Q 008893          296 TTERLLVYPYMSNGSVASRLKA--------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD  361 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  361 (549)
                      .+..++||||+++|+|.+++..              ...+++..+..++.||+.||.|||+.   +|+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence            9999999999999999999863              34589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCcccccccc
Q 008893          362 EYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGA  439 (549)
Q Consensus       362 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~  439 (549)
                      .++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......   .
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~  275 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---K  275 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---H
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---H
Confidence            9999999999999866433322 2234457889999999999999999999999999999999 888986432211   1


Q ss_pred             HHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          440 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....+..    .         .....+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       276 ~~~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          276 FYKLVKD----G---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             HHHHHHH----T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHhc----C---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence            1111111    0         0011112224678999999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=355.92  Aligned_cols=266  Identities=18%  Similarity=0.223  Sum_probs=212.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC--ceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  303 (549)
                      ++|.+.+.||+|+||+||+|... +|+.||||+++..........+.+|+++++.++||||+++++++....  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56888999999999999999976 489999999986554455667889999999999999999999998765  679999


Q ss_pred             eccCCCchhhhhccCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee----cCCCceEEeecccccc
Q 008893          304 PYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGLAKL  376 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~~~~  376 (549)
                      ||+++|+|.+++....   .+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999997533   399999999999999999999999   99999999999999    7888899999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhcc--------CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      .....  ......||+.|+|||++.+        ..++.++|||||||++|||+||+.||..........   ..+....
T Consensus       166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~---~~~~~~~  240 (396)
T 4eut_A          166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK---EVMYKII  240 (396)
T ss_dssp             CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH---HHHHHHH
T ss_pred             ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH---HHHHHHh
Confidence            65322  2234569999999999865        457789999999999999999999997543322221   1122221


Q ss_pred             hccc---hhhhc-----------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          449 QEKK---LEMLV-----------DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       449 ~~~~---~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....   ...+.           +..............+.+++.+||+.||++||+++|+++.++.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence            1110   00000           0011123457778889999999999999999999999988876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-42  Score=338.44  Aligned_cols=248  Identities=22%  Similarity=0.319  Sum_probs=203.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecC--CceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||+|.++ ++.||||+++..... .....+.+|+.+++.++||||+++++++...  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57888999999999999999986 889999999765422 2234689999999999999999999999877  7789999


Q ss_pred             eccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          304 PYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ||+++|+|.+++....  .+++..+..++.|++.||.|||+.   +  |+||||||+||+++.++.++|+|||++.....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999999999998654  589999999999999999999998   7  99999999999999999999999998764332


Q ss_pred             CCCceeeccccccCccCchhhccCCCCC---cccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSE---KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                            ....||+.|+|||.+.+..++.   ++||||||+++|||+||+.||......       .........      
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~------  226 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVALE------  226 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHHS------
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHhc------
Confidence                  2235899999999998765544   799999999999999999999643211       111111111      


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         ......+...+..+.+++.+||+.||++|||++|+++.|+.
T Consensus       227 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          227 ---GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             ---CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               11111222334679999999999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-42  Score=353.66  Aligned_cols=252  Identities=22%  Similarity=0.282  Sum_probs=206.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++..++||||+++++++.+....++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            357899999999999999999976 689999999975432 234468899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec--CCCceEEeecccccccCCCC
Q 008893          305 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       305 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |+++|+|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++  .++.+||+|||+++......
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            99999999999754 3799999999999999999999999   999999999999997  45789999999998765432


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                        ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....       ............   ..+...
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~---~~~~~~  273 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDW---EFDEDA  273 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCC---CCCSST
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC---CCCccc
Confidence              23344699999999999999999999999999999999999999974321       111111111110   011111


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                          ....+..+.+++.+||+.||++|||+.|++++
T Consensus       274 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          274 ----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                11234678999999999999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.1e-43  Score=351.24  Aligned_cols=244  Identities=21%  Similarity=0.287  Sum_probs=204.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-------cHHHHHHHHHHHhhccCCCccceEEEEecC
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLIGFCMTT  296 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  296 (549)
                      ..++|++.+.||+|+||.||+|... +++.||||+++......       ....+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3467999999999999999999965 68999999997653211       222477899999999999999999999999


Q ss_pred             CceeeEeeccCCC-chhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          297 TERLLVYPYMSNG-SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       297 ~~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      +..++||||+.+| +|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            9999999999777 9999999888899999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCceeeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          376 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      .......  .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......                    
T Consensus       179 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------------  236 (335)
T 3dls_A          179 YLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------------  236 (335)
T ss_dssp             ECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------
T ss_pred             ECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------
Confidence            7654332  234569999999999988876 78999999999999999999999631110                    


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        ......  .+...+..+.+++.+||+.||++|||+.|++++
T Consensus       237 --~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 --VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             --TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             --HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000000  011123678999999999999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-41  Score=344.66  Aligned_cols=252  Identities=21%  Similarity=0.258  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccC----CCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDG----NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||++...    ........+.+|+.+++.++||||+++++++...+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46889999999999999999975 6899999998632    112235679999999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc---eEEeecccc
Q 008893          302 VYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLA  374 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~~  374 (549)
                      ||||+++++|.+.+..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            9999999999887752    34589999999999999999999999   9999999999999986554   999999999


Q ss_pred             cccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      +...... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.....        ...........  
T Consensus       181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~~--  249 (351)
T 3c0i_A          181 IQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGKY--  249 (351)
T ss_dssp             EECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTCC--
T ss_pred             eEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCCC--
Confidence            8765432 223345699999999999999999999999999999999999999974211        11111111100  


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       ...+.....    .+..+.+++.+||+.||++|||+.|++++
T Consensus       250 -~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          250 -KMNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             -CCCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -CCCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             000000111    23678999999999999999999999863

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.4e-42  Score=348.29  Aligned_cols=256  Identities=25%  Similarity=0.375  Sum_probs=192.2

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECC-C---CEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCce
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQD-G---TVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  299 (549)
                      ..++|++.+.||+|+||.||+|.... +   ..||||+++.... ......+.+|+.+++.++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45689999999999999999999653 3   2799999976532 23345799999999999999999999999877655


Q ss_pred             ------eeEeeccCCCchhhhhccC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceE
Q 008893          300 ------LLVYPYMSNGSVASRLKAK------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV  367 (549)
Q Consensus       300 ------~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  367 (549)
                            ++||||+++|+|.+++...      ..+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence                  9999999999999998532      2599999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHH
Q 008893          368 VGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       368 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      |+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......    +..   
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~---  250 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----IYN---  250 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHH---
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----HHH---
Confidence            9999999876443322 2223457789999999999999999999999999999999 899987433211    111   


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ......          ....+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus       251 ~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  295 (323)
T 3qup_A          251 YLIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN  295 (323)
T ss_dssp             HHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            111111          011122234679999999999999999999999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=344.45  Aligned_cols=267  Identities=20%  Similarity=0.235  Sum_probs=201.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|++.+.||+|+||+||+|... +|+.||+|++....... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888999999999999999986 58999999986554322 23458899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........ .
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  158 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y  158 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence            999999999998878899999999999999999999999   999999999999999999999999999987653322 2


Q ss_pred             eeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHH--------HHHhhccchhh
Q 008893          385 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV--------KKIHQEKKLEM  455 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  455 (549)
                      .....||+.|+|||.+.+ ..++.++||||||+++|+|+||+.||...........+....        ...........
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            234468999999999976 568999999999999999999999997543322111111000        00000000000


Q ss_pred             hccccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 LVDKDLKNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+......+     ...+..+.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000000000     1223568899999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=347.44  Aligned_cols=254  Identities=23%  Similarity=0.388  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCC----EEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++|++.+.||+|+||.||+|.+. +++    .||+|.+...........+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            57889999999999999999964 344    368888876655566778999999999999999999999998754 789


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ++||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            9999999999999875 45799999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          381 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       381 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......    +...+   .          
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~---~----------  233 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSIL---E----------  233 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHH---H----------
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHH---H----------
Confidence            222 2233447889999999999999999999999999999999 999997432211    11111   1          


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      .......+...+..+.+++.+||+.||++||++.|+++.|+..
T Consensus       234 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1111112222346789999999999999999999999999873

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-42  Score=351.21  Aligned_cols=251  Identities=23%  Similarity=0.276  Sum_probs=205.7

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECC-CCEEEEEEcccCC--CCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCcee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  300 (549)
                      ..++|++.+.||+|+||.||+|.... |+.||+|+++...  .......+..|..++..+ +||||+++++++...+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34689999999999999999999864 8899999997532  123345688899999887 7999999999999999999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            9999999999999998777899999999999999999999999   9999999999999999999999999999864322


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+....         
T Consensus       175 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~---------  237 (353)
T 2i0e_A          175 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHN---------  237 (353)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC---------
T ss_pred             -CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhCC---------
Confidence             2233456799999999999999999999999999999999999999974321       11111111110         


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM  497 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  497 (549)
                        ..++...+..+.+++.+||+.||++||+     ++|++++
T Consensus       238 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          238 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              1122233467899999999999999996     4666643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.7e-43  Score=365.06  Aligned_cols=251  Identities=23%  Similarity=0.240  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .++|++.+.||+|+||.||+|... +|+.||||+++...  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            367889999999999999999975 68999999997532  222334678899999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++|+|.+++.....+++..+..++.||+.||.|||+ .   +|+||||||+|||++.++.+||+|||+++......
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            9999999999999877789999999999999999999998 7   99999999999999999999999999998643322


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                       .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....       ...........          
T Consensus       304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~----------  365 (446)
T 4ejn_A          304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEE----------  365 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC----------
T ss_pred             -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHHhCC----------
Confidence             223446799999999999999999999999999999999999999964321       11111111110          


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRML  498 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L  498 (549)
                       ..++...+..+.+++.+||+.||++||     +++|++++-
T Consensus       366 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          366 -IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             -CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence             011222346789999999999999999     999998643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.7e-43  Score=351.42  Aligned_cols=264  Identities=23%  Similarity=0.384  Sum_probs=213.3

Q ss_pred             CHHHHHHHhcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEE
Q 008893          218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG  291 (549)
Q Consensus       218 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  291 (549)
                      ..++++...++|++.+.||+|+||.||+|...      +++.||+|.+...........+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            33445556778999999999999999999864      367899999986554444556899999999999999999999


Q ss_pred             EEecCCceeeEeeccCCCchhhhhccC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec
Q 008893          292 FCMTTTERLLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD  361 (549)
Q Consensus       292 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  361 (549)
                      ++...+..++||||+++|+|.+++...          ..+++..+..++.||+.||.|||++   +|+||||||+||+++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence            999999999999999999999998631          4579999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCcccccccc
Q 008893          362 EYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGA  439 (549)
Q Consensus       362 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~  439 (549)
                      .++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....      
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------  246 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------  246 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------
Confidence            9999999999999865432221 1123346889999999999999999999999999999999 8888864321      


Q ss_pred             HHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          440 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                       ........... .         ...+...+..+.+++.+||+.||++|||+.|++++|+..
T Consensus       247 -~~~~~~~~~~~-~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          247 -EQVLRFVMEGG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             -HHHHHHHHTTC-C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             -HHHHHHHHcCC-c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence             11111111111 0         011222346789999999999999999999999999974

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-42  Score=340.07  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=206.0

Q ss_pred             cCCCCCC-eeeeeCCeEEEEEEEC---CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKN-LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~-~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|.+.+ .||+|+||.||+|...   ++..||||+++..........+.+|+.+++.++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            3455555 8999999999999854   57889999998754444456799999999999999999999999 45678999


Q ss_pred             eeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            999999999999864 45699999999999999999999999   99999999999999999999999999998775433


Q ss_pred             Cce--eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          382 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       382 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ...  .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......       +.........       
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~i~~~~-------  230 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGK-------  230 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTC-------
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHhcCC-------
Confidence            322  223346889999999998889999999999999999999 99999643221       1111111111       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         ....+...+..+.+++.+||+.||++||++.|++++|+.
T Consensus       231 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  269 (287)
T 1u59_A          231 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  269 (287)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               111222334779999999999999999999999999987

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.2e-42  Score=337.37  Aligned_cols=253  Identities=23%  Similarity=0.350  Sum_probs=207.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            357889999999999999999976 6899999999765544555679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-c
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-H  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  383 (549)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........ .
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            999999999998877899999999999999999999999   999999999999999999999999999986543221 1


Q ss_pred             eeeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......||+.|+|||.+.+..+ +.++||||||+++|||+||+.||........  ....|.    .....   ..    
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~----~~~~~---~~----  229 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWK----EKKTY---LN----  229 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHH----TTCTT---ST----
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhh----hcccc---cC----
Confidence            2234568999999999987765 7789999999999999999999975332211  111111    10000   00    


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                        .....+..+.+++.+|++.||++|||+.|+++
T Consensus       230 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 --PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence              01112367889999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.3e-42  Score=343.14  Aligned_cols=254  Identities=26%  Similarity=0.349  Sum_probs=204.4

Q ss_pred             hcCCCCCC-eeeeeCCeEEEEEEEC---CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          226 TSNFSSKN-LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       226 ~~~~~~~~-~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      .++|.+.+ .||+|+||+||+|.+.   +++.||||+++...... ....+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 9999999999999643   46889999997654322 245799999999999999999999999 567789


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999999877544


Q ss_pred             CCcee--eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          381 DSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       381 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      .....  ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......       ..........      
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~------  237 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGE------  237 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTC------
T ss_pred             CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC------
Confidence            33222  22346788999999998889999999999999999999 99998643211       1111111110      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                          ....+...+..+.+++.+||+.||++||++.++++.|++
T Consensus       238 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          238 ----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                111222334679999999999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-41  Score=339.64  Aligned_cols=253  Identities=22%  Similarity=0.262  Sum_probs=208.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-----cHHHHHHHHHHHhhccCCCccceEEEEecCCce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  299 (549)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++......     ....+.+|+.+++.++||||+++++++......
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356889999999999999999976 58999999997543222     356799999999999999999999999999999


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC----ceEEeeccccc
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAK  375 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~~~  375 (549)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++    .+||+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999999998888899999999999999999999999   999999999999999887    79999999998


Q ss_pred             ccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          376 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      ......  ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||......       ..........   .
T Consensus       168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~---~  235 (321)
T 2a2a_A          168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANITSVS---Y  235 (321)
T ss_dssp             ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTC---C
T ss_pred             ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcc---c
Confidence            765432  223446999999999999999999999999999999999999999643211       1111111100   0


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..++.....    .+..+.+++.+|++.||++|||+.|++++
T Consensus       236 ~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            001111111    23568999999999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2e-42  Score=355.87  Aligned_cols=251  Identities=21%  Similarity=0.291  Sum_probs=199.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhcc--CCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV--HRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .+|.+.+.||+|+||.||+|...+++.||||++...... .....+.+|+.++..++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458899999999999999999888999999999754422 22356899999999996  599999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      | +.+++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus       136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            9 56889999998878899999999999999999999999   999999999999996 589999999999876543222


Q ss_pred             -eeeccccccCccCchhhcc-----------CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc
Q 008893          384 -VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK  451 (549)
Q Consensus       384 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (549)
                       ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....      ....+.      
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~------  278 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLH------  278 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHH------
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------HHHHHH------
Confidence             2334569999999999865           3688999999999999999999999964221      111111      


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       452 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                         .+.+......++......+.+++.+||+.||++|||+.|++++
T Consensus       279 ---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          279 ---AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ---HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence               1112211112222224678999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-41  Score=335.54  Aligned_cols=249  Identities=20%  Similarity=0.268  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|.+.+.||+|+||+||++... ++..||+|++...........+.+|+++++.++||||+++++++......++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46888999999999999999975 58999999998766555667899999999999999999999999999999999999


Q ss_pred             cCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee---cCCCceEEeecccccccC
Q 008893          306 MSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       306 ~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~  378 (549)
                      +++|+|.+.+.    ....+++..+..++.|++.||.|||+.   +|+||||||+||++   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999999885    346799999999999999999999999   99999999999999   456889999999998665


Q ss_pred             CCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ...  ......||+.|+|||.+. ..++.++||||||+++|||++|+.||......       .............    
T Consensus       179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~----  244 (285)
T 3is5_A          179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-------EVQQKATYKEPNY----  244 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCC----
T ss_pred             Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-------HHHhhhccCCccc----
Confidence            322  233456999999999985 56899999999999999999999999743211       1111111100000    


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ......    .+..+.+++.+|++.||++|||+.|+++
T Consensus       245 ~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          245 AVECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000011    2367889999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=353.41  Aligned_cols=257  Identities=23%  Similarity=0.283  Sum_probs=206.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE----CCCCEEEEEEcccCCC---CCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  298 (549)
                      ++|++.+.||+|+||.||+|..    .+|+.||||+++....   ......+.+|+.++..+ .||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5788999999999999999997    3689999999864321   12234567899999999 69999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            999999999999999998777899999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceeeccccccCccCchhhccC--CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      ...........||+.|+|||++.+.  .++.++|||||||++|||+||+.||........   ...........      
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~------  281 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKS------  281 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHC------
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---HHHHHHHHhcc------
Confidence            4333334456799999999999863  478999999999999999999999975433222   11222111111      


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHhc
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRMLEG  500 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~~  500 (549)
                       .    ..++...+..+.+++.+||+.||++||     +++|++++.--
T Consensus       282 -~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f  325 (355)
T 1vzo_A          282 -E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  325 (355)
T ss_dssp             -C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             -C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence             0    112223346788999999999999999     99999876544

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.4e-42  Score=353.13  Aligned_cols=266  Identities=19%  Similarity=0.235  Sum_probs=203.5

Q ss_pred             hcCCCCCCeeeee--CCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          226 TSNFSSKNLVGKG--GFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      .++|++.+.||+|  +||+||+|... +|+.||||+++...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4578899999999  99999999986 69999999997654322 23468889999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          302 VYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999754  6799999999999999999999999   999999999999999999999999999865422


Q ss_pred             CCC------ceeeccccccCccCchhhcc--CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh--
Q 008893          380 CDS------HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ--  449 (549)
Q Consensus       380 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  449 (549)
                      ...      .......||+.|+|||.+.+  ..++.++|||||||++|||+||+.||.........   .........  
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~  257 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML---LEKLNGTVPCL  257 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH---HHC--------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHhcCCCCcc
Confidence            111      11122368999999999987  57899999999999999999999999753322211   000000000  


Q ss_pred             -------cc-------------chhhhcc---------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 -------EK-------------KLEMLVD---------KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 -------~~-------------~~~~~~d---------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                             ..             .......         ......+.......+.+++.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                   00             0000000         000001222334678999999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3e-42  Score=361.84  Aligned_cols=248  Identities=23%  Similarity=0.359  Sum_probs=207.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||+|... +|+.||||++....  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888999999999999999976 69999999996432  1233457899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--  170 (476)
T 2y94_A           96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  170 (476)
T ss_dssp             ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999998765432  


Q ss_pred             eeeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      .....+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......       .....+....         . 
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~---------~-  233 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------TLFKKICDGI---------F-  233 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------HHHHHHHTTC---------C-
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcCC---------c-
Confidence            2334569999999999988775 68999999999999999999999743221       1111111110         0 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       ..+......+.+++.+||+.||++|||+.|++++
T Consensus       234 -~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          234 -YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence             0111223678999999999999999999999963

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.5e-43  Score=350.47  Aligned_cols=269  Identities=24%  Similarity=0.323  Sum_probs=209.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-----CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEe--cCCce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM--TTTER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  299 (549)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++.... ......+.+|+++++.++||||+++++++.  +....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            5688899999999999999984     358899999997543 233456899999999999999999999987  44568


Q ss_pred             eeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          300 LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      ++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            899999999999999975 44699999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCCc--eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          379 HCDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       379 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      .....  ......||..|+|||.+.+..++.++||||||+++|+|+||+.||..........  ..+.............
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM--MGCERDVPALSRLLEL  256 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--CC----CCHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh--cccccccccHHHHHHH
Confidence            44332  2233458888999999999999999999999999999999999986422110000  0000000000011111


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      .........+...+..+.+++.+||+.||++|||+.|++++|+..
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            112222223334457899999999999999999999999999974

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.2e-42  Score=351.52  Aligned_cols=264  Identities=17%  Similarity=0.170  Sum_probs=202.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC------CCEEEEEEcccCCCCCc----------HHHHHHHHHHHhhccCCCccce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGG----------EIQFQTEVEMISLAVHRNLLRL  289 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~l~h~niv~l  289 (549)
                      .++|.+.+.||+|+||.||+|.+..      ++.||||++........          ...+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578899999999999999999764      47899999875431100          0123345556667789999999


Q ss_pred             EEEEecC----CceeeEeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec--C
Q 008893          290 IGFCMTT----TERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--E  362 (549)
Q Consensus       290 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~  362 (549)
                      ++++...    ...++||||+ +++|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCC
Confidence            9998764    4579999999 99999999754 6799999999999999999999999   999999999999999  8


Q ss_pred             CCceEEeecccccccCCCCCc------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccc
Q 008893          363 YYEAVVGDFGLAKLLDHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ  436 (549)
Q Consensus       363 ~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~  436 (549)
                      ++.+||+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....... 
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~-  268 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP-  268 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH-
Confidence            899999999999876432211      1133459999999999999999999999999999999999999997432211 


Q ss_pred             cccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          437 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        ....+.... ....+..+.++.+...   ..+..+.+++..||+.+|++||++.++++.|+.
T Consensus       269 --~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~  326 (364)
T 3op5_A          269 --KYVRDSKIR-YRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ  326 (364)
T ss_dssp             --HHHHHHHHH-HHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             --HHHHHHHHH-hhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence              111111111 1122334444433211   123678999999999999999999999998875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.8e-42  Score=366.04  Aligned_cols=253  Identities=25%  Similarity=0.302  Sum_probs=207.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .++|...+.||+|+||.||+|... +|+.||+|++....  .......+.+|+.++..++||||+++++++...+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467889999999999999999976 69999999996432  223455688999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          303 YPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      |||+++|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999987543  499999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+..   .          
T Consensus       340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~---~----------  404 (576)
T 2acx_A          340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---V----------  404 (576)
T ss_dssp             C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH---C----------
T ss_pred             c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc---c----------
Confidence            2  233457999999999999989999999999999999999999999754332221111111110   0          


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                       ...++...+..+.+++.+||+.||++||     +++|+++|
T Consensus       405 -~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 -PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence             0112222346789999999999999999     67787754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-42  Score=346.68  Aligned_cols=254  Identities=28%  Similarity=0.431  Sum_probs=200.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC-----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++|...+.||+|+||.||+|....     +..||||+++..........+.+|+.+++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456678999999999999998653     236999999865443344578999999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ||||+++|+|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999753 5799999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCc--eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          381 DSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       381 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ...  ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....       ............     
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~~-----  268 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFR-----  268 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC-----
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHCCCc-----
Confidence            221  1222346788999999999999999999999999999999 9999864221       111111111110     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                           ...+...+..+.+++.+||+.||++||++.|++++|+.
T Consensus       269 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  306 (333)
T 1mqb_A          269 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  306 (333)
T ss_dssp             -----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                 11122234678999999999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.5e-42  Score=337.29  Aligned_cols=252  Identities=20%  Similarity=0.270  Sum_probs=205.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|++.+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.+++.++||||+++++++......++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467899999999999999999976 5899999999754422 22346889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc---eEEeecccccccCCC
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHC  380 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~  380 (549)
                      ||+++++|.+.+.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.   +||+|||++......
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            9999999999988777899999999999999999999999   9999999999999986655   999999999876533


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      .  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......       .......... .. .    
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~-~~-~----  226 (284)
T 3kk8_A          162 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGA-YD-Y----  226 (284)
T ss_dssp             C--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTC-CC-C----
T ss_pred             c--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-------HHHHHHHhcc-cc-C----
Confidence            2  223456999999999999999999999999999999999999999643211       1111111110 00 0    


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       ........+..+.+++.+|++.||++|||+.|+++
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 -PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             00001122367899999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-41  Score=338.75  Aligned_cols=258  Identities=18%  Similarity=0.183  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .++|.+.+.||+|+||.||+|... +++.||+|++........  ...+.+|+.++..++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999976 688999999975532222  35688999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence            99999999999998777899999999999999999999999   999999999999999999999999999987654333


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      .......||+.|+|||.+.+..++.++||||||+++|||+||+.||......        ..........    ...   
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~----~~~---  254 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAI----PRP---  254 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCC----CCG---
T ss_pred             ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCC----CCc---
Confidence            3334456999999999999999999999999999999999999999742211        1111111100    000   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcC
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRP-KMSEVVRMLEGD  501 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~  501 (549)
                      .......+..+.+++.+||+.||++|| +++++++.|+..
T Consensus       255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~  294 (309)
T 2h34_A          255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA  294 (309)
T ss_dssp             GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred             cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence            011122235788999999999999999 999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.9e-42  Score=338.53  Aligned_cols=248  Identities=28%  Similarity=0.407  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .++|++.+.||+|+||+||+|... +++.||+|++....  .......+.+|+.+++.++||||+++++++......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467889999999999999999976 57899999986432  112345688999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||+++++|.+.+.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......  
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence            99999999999998777899999999999999999999998   9999999999999999999999999998654322  


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......       .........       .    
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~-------~----  223 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRV-------E----  223 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHT-------C----
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-------HHHHHHHhC-------C----
Confidence             223456899999999999999999999999999999999999999743211       111111110       0    


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+...+..+.+++.+||+.||++|||++|++++
T Consensus       224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11122233678899999999999999999999974

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=343.25  Aligned_cols=263  Identities=26%  Similarity=0.300  Sum_probs=199.0

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCC----CCcHHHHHHHHHHHhhcc---CCCccceEEEEecC
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA----IGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTT  296 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  296 (549)
                      ..++|++.+.||+|+||+||+|.. .+|+.||||+++....    ......+.+|+.+++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999996 4689999999864321    122345777888877665   99999999999875


Q ss_pred             C-----ceeeEeeccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEe
Q 008893          297 T-----ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG  369 (549)
Q Consensus       297 ~-----~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  369 (549)
                      .     ..++||||+. ++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence            5     4789999997 59999987654  399999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          370 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       370 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      |||+++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........   +.........
T Consensus       163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~  237 (308)
T 3g33_A          163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGL  237 (308)
T ss_dssp             SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred             eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCC
Confidence            999998765322  23445699999999999999999999999999999999999999975332211   1111111100


Q ss_pred             ---ccchhh--hccccccC--C-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          450 ---EKKLEM--LVDKDLKN--N-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       450 ---~~~~~~--~~d~~l~~--~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                         ......  ........  .     ........+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence               000000  00000000  0     00112367899999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=371.99  Aligned_cols=246  Identities=26%  Similarity=0.371  Sum_probs=199.8

Q ss_pred             eeeeeCCeEEEEEEEC---CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCc
Q 008893          234 LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS  310 (549)
Q Consensus       234 ~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  310 (549)
                      .||+|+||.||+|.+.   ++..||||+++..........+.+|+++++.++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   4668999999876555566789999999999999999999999976 56899999999999


Q ss_pred             hhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee--ec
Q 008893          311 VASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TA  387 (549)
Q Consensus       311 L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~  387 (549)
                      |.+++.. ...+++..+..++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+++..........  ..
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            9999864 44699999999999999999999999   999999999999999999999999999987654332211  22


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCC
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD  466 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  466 (549)
                      ..+++.|+|||++.+..++.++|||||||++|||+| |+.||......    .+.   ..+....          ....+
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~---~~i~~~~----------~~~~p  561 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVM---AFIEQGK----------RMECP  561 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----HHH---HHHHTTC----------CCCCC
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHH---HHHHcCC----------CCCCC
Confidence            335689999999999999999999999999999998 99999753321    111   1111111          11122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          467 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       467 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..++..+.+++..||+.||++||++.++++.|+.
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            3344789999999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-42  Score=338.25  Aligned_cols=254  Identities=28%  Similarity=0.382  Sum_probs=202.9

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECC-C---CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCce-eeE
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQD-G---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER-LLV  302 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv  302 (549)
                      .|...+.||+|+||+||+|.+.+ +   ..||+|.+...........+.+|+.+++.++||||+++++++...+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            35566899999999999998542 2   379999997655444456789999999999999999999999876655 999


Q ss_pred             eeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999975 45789999999999999999999999   99999999999999999999999999998654321


Q ss_pred             ---CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          382 ---SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       382 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                         ........+|+.|+|||.+.+..++.++||||||+++|+|+||..|+.......   .....+.   ...       
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~---~~~-------  245 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTHFLA---QGR-------  245 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHHHHH---TTC-------
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHHHhh---cCC-------
Confidence               112233458899999999999999999999999999999999766654322211   1111111   110       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         ....+...+..+.+++.+|++.||++|||++++++.|+.
T Consensus       246 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  284 (298)
T 3pls_A          246 ---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ  284 (298)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               011122233678999999999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-41  Score=349.83  Aligned_cols=250  Identities=20%  Similarity=0.267  Sum_probs=192.4

Q ss_pred             cCCCCC-CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHh-hccCCCccceEEEEec----CCce
Q 008893          227 SNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLLRLIGFCMT----TTER  299 (549)
Q Consensus       227 ~~~~~~-~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~  299 (549)
                      ++|.+. +.||+|+||+||+|... +|+.||||++...      ..+.+|+.++. ..+||||+++++++..    ....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            355555 68999999999999976 5899999998632      35678888874 4589999999998865    5578


Q ss_pred             eeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC---CCceEEeecccc
Q 008893          300 LLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA  374 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~  374 (549)
                      ++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence            9999999999999999764  3599999999999999999999999   9999999999999997   789999999999


Q ss_pred             cccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      +......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||...............+..    ... 
T Consensus       212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----~~~-  284 (400)
T 1nxk_A          212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQY-  284 (400)
T ss_dssp             EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----TCC-
T ss_pred             cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----Ccc-
Confidence            8654322  233456899999999999999999999999999999999999999754433222112211111    000 


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                           ..........+.++.+++.+||+.||++|||+.|++++
T Consensus       285 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 00000011223678999999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=347.20  Aligned_cols=266  Identities=18%  Similarity=0.184  Sum_probs=200.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC----CCCEEEEEEcccCCCCC----------cHHHHHHHHHHHhhccCCCccceEEE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIG----------GEIQFQTEVEMISLAVHRNLLRLIGF  292 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~~  292 (549)
                      ++|.+.+.||+|+||.||+|...    ++..||+|++.......          ....+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            56888999999999999999975    57889999987543210          11236677888889999999999999


Q ss_pred             Eec----CCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC--ce
Q 008893          293 CMT----TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY--EA  366 (549)
Q Consensus       293 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~--~~  366 (549)
                      +..    ....++||||+ +++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++  .+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSE
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcE
Confidence            987    67889999999 999999998777899999999999999999999999   999999999999999877  99


Q ss_pred             EEeecccccccCCCCC------ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccH
Q 008893          367 VVGDFGLAKLLDHCDS------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM  440 (549)
Q Consensus       367 kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~  440 (549)
                      ||+|||+++.+.....      .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........  ..
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~  270 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--AV  270 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--HH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--HH
Confidence            9999999987643211      111344699999999999999999999999999999999999999964221111  11


Q ss_pred             HHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 008893          441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL  503 (549)
Q Consensus       441 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  503 (549)
                      ........ . ...........   ....+..+.+++.+||+.||++||+++++++.|+....
T Consensus       271 ~~~~~~~~-~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          271 QTAKTNLL-D-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHH-H-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHhhc-c-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            11111111 0 01111000000   00123679999999999999999999999999998543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=370.50  Aligned_cols=256  Identities=27%  Similarity=0.373  Sum_probs=210.2

Q ss_pred             HHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          223 QSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       223 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      +...++|.+.+.||+|+||.||+|.+.++..||||+++...  .....|.+|+.+++.++||||+++++++.+ +..++|
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            34456788899999999999999999888889999998654  235679999999999999999999999876 678999


Q ss_pred             eeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          303 YPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      |||+++|+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            999999999999974  34699999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .........++..|+|||.+....++.++|||||||++|||+| |+.||.....       .+....+....        
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~--------  481 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGY--------  481 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHHHHHTTC--------
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC--------
Confidence            1112223446789999999999999999999999999999999 8999864321       11111111111        


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                        ....+...+..+.+++.+||+.||++|||+++|++.|+..
T Consensus       482 --~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          482 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              1111223346789999999999999999999999999873

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.9e-42  Score=350.81  Aligned_cols=253  Identities=25%  Similarity=0.273  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHH-HhhccCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEM-ISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|+++.....  .....+..|..+ ++.++||||+++++++...+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            46888999999999999999976 5889999999764322  223346666666 5678999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||+++|+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-  193 (373)
T 2r5t_A          118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-  193 (373)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence            99999999999998777899999999999999999999999   99999999999999999999999999998643222 


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......       .....+...         .+ 
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~---------~~-  256 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNK---------PL-  256 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-------HHHHHHHHS---------CC-
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhc---------cc-
Confidence            2334567999999999999999999999999999999999999999643211       111111111         00 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                       .++...+..+.+++.+||+.||++||++.+.++.+...
T Consensus       257 -~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          257 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             -CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence             11122236789999999999999999987655555543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.3e-41  Score=330.46  Aligned_cols=258  Identities=20%  Similarity=0.257  Sum_probs=206.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEE-ecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC-MTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  303 (549)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++.....   ...+.+|+.++..++|++++..++++ ......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            46789999999999999999997 4789999999875442   23588999999999998877776666 5566789999


Q ss_pred             eccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee---cCCCceEEeecccccccCC
Q 008893          304 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       304 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ||+ +++|.+++. ....+++..+..++.|++.||.|||++   +|+||||||+|||+   ++++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999 899999997 455799999999999999999999999   99999999999999   4889999999999987654


Q ss_pred             CCCc------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccch
Q 008893          380 CDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       380 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      ....      ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...........+......... ...
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~  239 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI  239 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SCH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-Cch
Confidence            4321      123456999999999999999999999999999999999999999864433322222221111110 000


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       454 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .     .+...+    +..+.+++.+||+.||++|||+.++++.|+.
T Consensus       240 ~-----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  277 (296)
T 3uzp_A          240 E-----VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             H-----HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             H-----HHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence            0     011112    3678999999999999999999999999886

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.5e-41  Score=330.66  Aligned_cols=259  Identities=20%  Similarity=0.255  Sum_probs=203.1

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEE-ecCCceeeE
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC-MTTTERLLV  302 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv  302 (549)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++......   ..+..|+.++..++|++++..++++ ...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            457899999999999999999997 46899999987654322   2478899999999988877777766 566778999


Q ss_pred             eeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee---cCCCceEEeecccccccC
Q 008893          303 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~  378 (549)
                      |||+ +++|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+|||+   ++++.+||+|||+++...
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 9999999873 55799999999999999999999999   99999999999999   789999999999998765


Q ss_pred             CCCCc------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc
Q 008893          379 HCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK  452 (549)
Q Consensus       379 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (549)
                      .....      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...........+......... ..
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~  238 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-ch
Confidence            44321      123456999999999999999999999999999999999999999864433332222221111110 00


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       453 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...     ....+    +..+.+++.+|++.||++|||+.++++.|++
T Consensus       239 ~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (296)
T 4hgt_A          239 IEV-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             HHH-----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             hhh-----hhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence            000     11112    3678999999999999999999999999886

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.4e-42  Score=345.28  Aligned_cols=252  Identities=27%  Similarity=0.407  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCE--EEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTV--VAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~--vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|++.+.||+|+||.||+|... ++..  ||+|.++..........+.+|+.++.++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999965 4654  4999987654444455789999999999 899999999999999999999


Q ss_pred             eeccCCCchhhhhccCC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCce
Q 008893          303 YPYMSNGSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA  366 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  366 (549)
                      |||+++|+|.+++....                .+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999997543                699999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHH
Q 008893          367 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       367 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      ||+|||+++.....  .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....       .....
T Consensus       182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYE  252 (327)
T ss_dssp             EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHH
T ss_pred             EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HHHHH
Confidence            99999999743321  11223347889999999998889999999999999999998 9999964321       11111


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .....          .....+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       253 ~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          253 KLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             HGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhhcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            11111          0111122234678999999999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.4e-42  Score=346.91  Aligned_cols=252  Identities=20%  Similarity=0.289  Sum_probs=202.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|++.+.||+|+||.||++..+ +|+.||||++.....     ...+|++++.++ +||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467899999999999999999976 588999999976542     234678888777 7999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC----CceEEeecccccccCC
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY----YEAVVGDFGLAKLLDH  379 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~~~~~~~  379 (549)
                      ||+++|+|.+.+.....+++..+..++.||+.||.|||+.   +|+||||||+|||+.++    +.+||+|||+++....
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            9999999999998888899999999999999999999999   99999999999998533    3599999999987654


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    .......+.... .      
T Consensus       173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~~~-~------  240 (342)
T 2qr7_A          173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT----PEEILARIGSGK-F------  240 (342)
T ss_dssp             TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC----HHHHHHHHHHCC-C------
T ss_pred             CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC----HHHHHHHHccCC-c------
Confidence            332 2334568999999999988888999999999999999999999997432211    112222221111 0      


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+...+....+..+.+++.+||+.||++||++.|++++
T Consensus       241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            01111122234678999999999999999999999863

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-42  Score=351.65  Aligned_cols=253  Identities=30%  Similarity=0.450  Sum_probs=193.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC--C--CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec-CCceeeE
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ--D--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTERLLV  302 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv  302 (549)
                      .|...+.||+|+||+||+|.+.  +  +..||||.++..........+.+|+.+++.++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3566789999999999999864  2  246899999765544555679999999999999999999999765 4578999


Q ss_pred             eeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++|+|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999754 4689999999999999999999999   99999999999999999999999999998664322


Q ss_pred             Cc---eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          382 SH---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       382 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ..   ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......    ....+   .....     
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~~~~~---~~~~~-----  314 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYL---LQGRR-----  314 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----HHHHH---HTTCC-----
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----HHHHH---HcCCC-----
Confidence            11   1233457889999999999999999999999999999999 566665332211    11111   11110     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                           ...+...+..+.+++.+||+.||++||++.|++++|+.
T Consensus       315 -----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~  352 (373)
T 3c1x_A          315 -----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  352 (373)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                 01112234678999999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-41  Score=339.27  Aligned_cols=266  Identities=26%  Similarity=0.356  Sum_probs=201.2

Q ss_pred             HHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhh--ccCCCccceEEEEecC---
Q 008893          222 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCMTT---  296 (549)
Q Consensus       222 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~---  296 (549)
                      -....++|++.+.||+|+||.||+|... |+.||||++....    ...+..|.+++..  ++||||+++++++...   
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            3445678999999999999999999986 8999999986432    3344555555554  4899999999999877   


Q ss_pred             -CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCceEecccCcCeeeecCCCceEEee
Q 008893          297 -TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-----DPKIIHRDVKAANILLDEYYEAVVGD  370 (549)
Q Consensus       297 -~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~D  370 (549)
                       ...++||||+++|+|.++++.. .+++..+..++.|++.||.|||+.+     .++|+||||||+|||++.++.+||+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence             6789999999999999999765 5999999999999999999999752     34899999999999999999999999


Q ss_pred             cccccccCCCCCce---eeccccccCccCchhhccCCCCCc------ccchhHhHHHHHHHhC----------CcccccC
Q 008893          371 FGLAKLLDHCDSHV---TTAVRGTVGHIAPEYLSTGQSSEK------TDVFGFGILLLELISG----------LRALEFG  431 (549)
Q Consensus       371 fg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~G~il~elltg----------~~p~~~~  431 (549)
                      ||+++.........   .....||+.|+|||.+.+...+.+      +|||||||++|||+||          +.||...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            99997665433221   124469999999999988776665      9999999999999999          4454432


Q ss_pred             ccccccccHHHHHHHHhhccchhhhccccccC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          432 KTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN-NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .....  ..... .........    .+.... ......+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       266 ~~~~~--~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          266 VPSDP--SYEDM-REIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             SCSSC--CHHHH-HHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCC--chhhh-HHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence            21111  11111 111111110    111110 0122567889999999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.9e-42  Score=346.89  Aligned_cols=263  Identities=19%  Similarity=0.252  Sum_probs=195.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|.+.+.||+|+||+||+|... +++.||||+++...... ....+.+|+.+++.++||||+++++++......++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            457889999999999999999965 68999999997554322 2345789999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee-----cCCCceEEeecccccccC
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL-----DEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-----~~~~~~kl~Dfg~~~~~~  378 (549)
                      ||++ |+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||+     ++++.+||+|||+++...
T Consensus       113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9998 49999998888899999999999999999999999   99999999999999     455669999999998765


Q ss_pred             CCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc--chhh
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK--KLEM  455 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  455 (549)
                      .... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........   +...........  ....
T Consensus       189 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          189 IPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---LFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSTT
T ss_pred             Cccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---HHHHHHHhCCCchhhhhh
Confidence            3322 22344589999999999875 489999999999999999999999975332111   111111110000  0000


Q ss_pred             hc-cccc-------cCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          456 LV-DKDL-------KNN-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       456 ~~-d~~l-------~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .. .+..       ...     ........+.+++.+||+.||++|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00 0000       000     00112367889999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.3e-42  Score=336.69  Aligned_cols=251  Identities=21%  Similarity=0.266  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-----CcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++.....     .....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999986 6899999998754322     13567999999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC----ceEEeecccccc
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAKL  376 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~~~~  376 (549)
                      +||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++    .+||+|||++..
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            9999999999999998777899999999999999999999999   999999999999998877    899999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      .....  ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||......       ...........   .
T Consensus       162 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~---~  229 (283)
T 3bhy_A          162 IEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-------ETLTNISAVNY---D  229 (283)
T ss_dssp             CC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTCC---C
T ss_pred             ccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------HHHHHhHhccc---C
Confidence            65322  223445899999999999999999999999999999999999999743211       11111111000   0


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ........    .+..+.+++.+|++.||++||++.|+++
T Consensus       230 ~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          230 FDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Ccchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00001111    2366899999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.5e-42  Score=337.43  Aligned_cols=259  Identities=29%  Similarity=0.438  Sum_probs=194.7

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ..++|++.+.||+|+||+||+|...  ..||+|+++..... .....+.+|+.+++.++||||+++++++ .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3467899999999999999999864  35999999765432 2235689999999999999999999965 456789999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC-
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-  381 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  381 (549)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999963 45799999999999999999999999   99999999999999999999999999998654322 


Q ss_pred             CceeeccccccCccCchhhc---cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          382 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ........||+.|+|||.+.   +..++.++||||||+++|||++|+.||.......   .+...+.   . ...    .
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~---~-~~~----~  244 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVG---R-GSL----S  244 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH---HHHHHHH---H-TSC----C
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH---HHHHHhc---c-ccc----C
Confidence            22233456999999999986   5678889999999999999999999997432211   1111111   1 111    0


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      +.+ .......+..+.+++.+||+.+|++|||+.|+++.|+..
T Consensus       245 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          245 PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            100 111222346799999999999999999999999999873

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.3e-41  Score=329.10  Aligned_cols=250  Identities=19%  Similarity=0.233  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|.+.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            456889999999999999999976 477999999876442 345679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee---cCCCceEEeecccccccCCCC
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||++   +.++.+||+|||++.......
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            999999999998777899999999999999999999999   99999999999999   788999999999998765332


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                        ......||+.|+|||.+.+. ++.++||||||+++|||+||+.||......       ........... .  .....
T Consensus       164 --~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-~--~~~~~  230 (277)
T 3f3z_A          164 --MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------EVMLKIREGTF-T--FPEKD  230 (277)
T ss_dssp             --CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC-C--CCHHH
T ss_pred             --chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCC-C--CCchh
Confidence              23344699999999998654 899999999999999999999999743211       11111111100 0  00000


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ..    ..+..+.+++.+|++.||++|||+.|+++
T Consensus       231 ~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          231 WL----NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00    12367899999999999999999999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-41  Score=337.44  Aligned_cols=249  Identities=29%  Similarity=0.399  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +.|+..+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++......++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            46888999999999999999965 68999999998665555567899999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++++|.+++.. ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........ ..
T Consensus       102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  176 (303)
T 3a7i_A          102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR  176 (303)
T ss_dssp             CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CB
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-cc
Confidence            999999999875 4699999999999999999999999   999999999999999999999999999987654321 22


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......       .........      ..+.+...+
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~------~~~~~~~~~  243 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPKN------NPPTLEGNY  243 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS------CCCCCCSSC
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------HHHHHhhcC------CCCCCcccc
Confidence            3456899999999999999999999999999999999999998643211       111111111      011122222


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                          +..+.+++.+||+.||++|||+.|++++
T Consensus       244 ----~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          244 ----SKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                3668999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-41  Score=342.91  Aligned_cols=258  Identities=22%  Similarity=0.227  Sum_probs=200.6

Q ss_pred             HHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC----CCCcHHHHHHHHHHHhhccCCCccceEEEEecCC
Q 008893          223 QSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT  297 (549)
Q Consensus       223 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  297 (549)
                      ....++|.+.+.||+|+||+||+|... +++.||+|++....    .......+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            445678999999999999999999975 68899999986432    2334567999999999999999999999999999


Q ss_pred             ceeeEeeccCCCchhhhhcc----------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 008893          298 ERLLVYPYMSNGSVASRLKA----------------------------------------KPSLDWATRKRIALGAARGL  337 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~----------------------------------------~~~l~~~~~~~i~~~i~~~L  337 (549)
                      ..++||||+++|+|.+++..                                        ...+++..+..++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            99999999999999998851                                        11235777889999999999


Q ss_pred             HHhhhcCCCceEecccCcCeeeecCCC--ceEEeecccccccCCCCC---ceeeccccccCccCchhhcc--CCCCCccc
Q 008893          338 LYLHEQCDPKIIHRDVKAANILLDEYY--EAVVGDFGLAKLLDHCDS---HVTTAVRGTVGHIAPEYLST--GQSSEKTD  410 (549)
Q Consensus       338 ~~LH~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~D  410 (549)
                      .|||+.   +|+||||||+||+++.++  .+||+|||+++.+.....   .......||+.|+|||.+.+  ..++.++|
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999   999999999999998766  899999999986543221   12344569999999999975  67899999


Q ss_pred             chhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 008893          411 VFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK  490 (549)
Q Consensus       411 v~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs  490 (549)
                      |||||+++|||++|+.||......       +...........  ...+.     ....+..+.+++.+||+.||++||+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLC--FENPN-----YNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC--TTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcccc--cCCcc-----cccCCHHHHHHHHHHcCCChhHCCC
Confidence            999999999999999999643321       111111111100  00000     0112367899999999999999999


Q ss_pred             HHHHHHH
Q 008893          491 MSEVVRM  497 (549)
Q Consensus       491 ~~evl~~  497 (549)
                      +.|++++
T Consensus       325 ~~~~l~h  331 (345)
T 3hko_A          325 AMRALQH  331 (345)
T ss_dssp             HHHHHHS
T ss_pred             HHHHhcC
Confidence            9999873

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.5e-42  Score=340.58  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=201.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC-C-------CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD-G-------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      ++|.+.+.||+|+||+||+|.... +       ..||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            568888999999999999998653 3       479999986543 2345679999999999999999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc--------eEEe
Q 008893          299 RLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--------AVVG  369 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl~  369 (549)
                      .++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence            999999999999999997654 399999999999999999999999   9999999999999998887        9999


Q ss_pred             ecccccccCCCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          370 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       370 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      |||++.....     .....||+.|+|||.+.+ ..++.++||||||+++|||+||..|+.......      .......
T Consensus       164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~~~~~~~  232 (289)
T 4fvq_A          164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------RKLQFYE  232 (289)
T ss_dssp             CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHH
T ss_pred             cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------HHHHHhh
Confidence            9999875432     223458899999999987 678999999999999999999765554322111      1111111


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGL  503 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  503 (549)
                      ....        +    +...+..+.+++.+||+.||++|||+.|++++|+....
T Consensus       233 ~~~~--------~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          233 DRHQ--------L----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             TTCC--------C----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             ccCC--------C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1000        1    11112458899999999999999999999999998533

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.3e-42  Score=339.78  Aligned_cols=249  Identities=27%  Similarity=0.411  Sum_probs=195.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      ++|++.+.||+|+||+||+|.+. ++.||||++...   .....+.+|+.+++.++||||+++++++.  +..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            46788899999999999999986 788999998643   23557899999999999999999999876  4589999999


Q ss_pred             CCCchhhhhccCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc-eEEeecccccccCCCCC
Q 008893          307 SNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-AVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       307 ~~g~L~~~l~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~  382 (549)
                      ++|+|.+++....   .+++..+..++.|++.||.|||+....+|+||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            9999999997654   4789999999999999999999932239999999999999998886 799999999765422  


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                        .....||+.|+|||.+.+..++.++||||||+++|||+||+.||.......     ...........      .+...
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~------~~~~~  226 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FRIMWAVHNGT------RPPLI  226 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-----HHHHHHHHTTC------CCCCB
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-----HHHHHHHhcCC------CCCcc
Confidence              223458999999999999999999999999999999999999996432211     11111111110      11111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .    ..+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       227 ~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  260 (307)
T 2eva_A          227 K----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH  260 (307)
T ss_dssp             T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             c----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            1    223678899999999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-42  Score=353.87  Aligned_cols=267  Identities=22%  Similarity=0.341  Sum_probs=191.9

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhcc-CCCccceEEEEecCC--ce
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT--ER  299 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~  299 (549)
                      ..++|++.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++..+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999975 689999999865422 222346788999999997 999999999997544  68


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||++ ++|.+++... .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             EEEecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence            99999998 5898888764 689999999999999999999999   999999999999999999999999999986532


Q ss_pred             CC--------------------CceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccc
Q 008893          380 CD--------------------SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG  438 (549)
Q Consensus       380 ~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  438 (549)
                      ..                    ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  241 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE  241 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            11                    112234569999999999976 678999999999999999999999997543222111


Q ss_pred             cHHHHHHHHhhccchhhh--------c----------cccccCCC------------CHHHHHHHHHHHHHhcccCCCCC
Q 008893          439 AMLDWVKKIHQEKKLEML--------V----------DKDLKNNY------------DRIELEEMVQVALLCTQYLPSLR  488 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~--------~----------d~~l~~~~------------~~~~~~~l~~l~~~cl~~dP~~R  488 (549)
                      .+...+.. .....+..+        .          .......+            .......+.+++.+||+.||++|
T Consensus       242 ~i~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          242 RIIGVIDF-PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHCC-CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHhcCC-CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            11100000 000000000        0          00000000            00123578999999999999999


Q ss_pred             CCHHHHHHH
Q 008893          489 PKMSEVVRM  497 (549)
Q Consensus       489 Ps~~evl~~  497 (549)
                      ||++|++++
T Consensus       321 ~t~~e~l~H  329 (388)
T 3oz6_A          321 ISANDALKH  329 (388)
T ss_dssp             CCHHHHTTS
T ss_pred             CCHHHHhCC
Confidence            999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.5e-42  Score=348.72  Aligned_cols=208  Identities=21%  Similarity=0.266  Sum_probs=180.3

Q ss_pred             ccccCHHHHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-----CCCcc
Q 008893          214 LKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----HRNLL  287 (549)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv  287 (549)
                      ...+++++.+...++|.+.+.||+|+||+||+|... +++.||||+++...  .....+..|+.++..+.     ||||+
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            345555555566789999999999999999999974 68999999997432  22345778999999886     99999


Q ss_pred             ceEEEEecCCceeeEeeccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC---
Q 008893          288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---  362 (549)
Q Consensus       288 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---  362 (549)
                      ++++++...+..++||||+ +++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.   
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence            9999999999999999999 899999997543  599999999999999999999999   9999999999999975   


Q ss_pred             ----------------------CCceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHH
Q 008893          363 ----------------------YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE  420 (549)
Q Consensus       363 ----------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~e  420 (549)
                                            ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++||
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                  789999999999865432    234568999999999999999999999999999999


Q ss_pred             HHhCCcccccC
Q 008893          421 LISGLRALEFG  431 (549)
Q Consensus       421 lltg~~p~~~~  431 (549)
                      |+||+.||...
T Consensus       252 ll~g~~pf~~~  262 (360)
T 3llt_A          252 LYTGSLLFRTH  262 (360)
T ss_dssp             HHHSSCSCCCS
T ss_pred             HHHCCCCCCCC
Confidence            99999999753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=332.16  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=184.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||+|... +|+.||||++....  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            56888999999999999999974 68999999986432  1223457899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            999999999999764 5799999999999999999999999   999999999999999999999999999987653222


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.........       .         .+..... 
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~---------~~~~~~~-  229 (278)
T 3cok_A          168 -KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------N---------KVVLADY-  229 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSSCC-
T ss_pred             -cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------H---------HHhhccc-
Confidence             223356899999999999989999999999999999999999999753322110       0         0000000 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       ..+...+..+.+++.+||+.||++|||++++++
T Consensus       230 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 -EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence             112223467899999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-41  Score=337.61  Aligned_cols=254  Identities=30%  Similarity=0.436  Sum_probs=200.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec-CCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l  301 (549)
                      .+|.+.+.||+|+||+||+|...+    +..||+|.+...........+.+|+.++++++||||+++++++.. ....++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457788999999999999998643    236899998765544445679999999999999999999999754 557899


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence            9999999999999975 45689999999999999999999999   9999999999999999999999999999866432


Q ss_pred             CC---ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCc-ccccCccccccccHHHHHHHHhhccchhhh
Q 008893          381 DS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR-ALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       381 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      ..   .......+|+.|+|||.+.+..++.++||||||+++|||++|.. ||.......    ...   ......     
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----~~~---~~~~~~-----  249 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITV---YLLQGR-----  249 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----HHH---HHHTTC-----
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----HHH---HHhcCC-----
Confidence            21   12233457889999999999999999999999999999999554 443222111    111   111110     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                           ....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       250 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  288 (298)
T 3f66_A          250 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  288 (298)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                 001111223678999999999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=342.48  Aligned_cols=247  Identities=16%  Similarity=0.186  Sum_probs=201.8

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEE------ECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc---CCCccceEEEEec
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCMT  295 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  295 (549)
                      ..++|.+.+.||+|+||+||+|.      ..+++.||||+++..    ....+..|+.++..++   |+|++++++++..
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            34678889999999999999994      446889999999753    2456778888887776   9999999999999


Q ss_pred             CCceeeEeeccCCCchhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC--------
Q 008893          296 TTERLLVYPYMSNGSVASRLK-----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--------  362 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--------  362 (549)
                      .+..++||||+++|+|.+++.     ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence            999999999999999999996     355799999999999999999999998   9999999999999998        


Q ss_pred             ---CCceEEeecccccccCCC-CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccc
Q 008893          363 ---YYEAVVGDFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG  438 (549)
Q Consensus       363 ---~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  438 (549)
                         ++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.||........  
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--  293 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--  293 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence               899999999999765422 23344556799999999999999999999999999999999999999864322111  


Q ss_pred             cHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhc
Q 008893          439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLR-PKMSEVVRMLEG  500 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~evl~~L~~  500 (549)
                                   ..    ...+... +  ..+.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus       294 -------------~~----~~~~~~~-~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          294 -------------KP----EGLFRRL-P--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             -------------EE----CSCCTTC-S--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             -------------ee----chhcccc-C--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                         01    1111111 1  13567889999999999999 567777777765

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.5e-42  Score=351.85  Aligned_cols=266  Identities=21%  Similarity=0.275  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||+|... +++.||+|+++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357889999999999999999976 6899999999866443445578999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+++++|.+++.....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||++......   .
T Consensus       112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~  186 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M  186 (360)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---c
Confidence            9999999999987778999999999999999999999831  7999999999999999999999999999755321   2


Q ss_pred             eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccH----------------------HH
Q 008893          385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM----------------------LD  442 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~----------------------~~  442 (549)
                      .....||+.|+|||.+.+..++.++||||||+++|||+||+.||............                      ..
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            23346899999999999999999999999999999999999999753321100000                      00


Q ss_pred             HHHHHhhccch----hhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          443 WVKKIHQEKKL----EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       443 ~~~~~~~~~~~----~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      +..........    ..+.............+..+.+++.+||+.||++|||++|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            00000000000    0000000000011112467899999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.9e-41  Score=339.61  Aligned_cols=266  Identities=24%  Similarity=0.322  Sum_probs=208.6

Q ss_pred             HHHHHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhh--ccCCCccceEEEEecC
Q 008893          219 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCMTT  296 (549)
Q Consensus       219 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~  296 (549)
                      +.--....++|.+.+.||+|+||.||+|... |+.||||++...    ....+..|.+++..  ++||||+++++++...
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3333455678999999999999999999984 899999998643    24567788888877  7899999999999877


Q ss_pred             C----ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCceEecccCcCeeeecCCC
Q 008893          297 T----ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH--------EQCDPKIIHRDVKAANILLDEYY  364 (549)
Q Consensus       297 ~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~Nill~~~~  364 (549)
                      .    ..++||||+++|+|.+++... .+++..++.++.|++.||.|||        +.   +|+||||||+||+++.++
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence            6    789999999999999999764 5899999999999999999999        66   999999999999999999


Q ss_pred             ceEEeecccccccCCCCCc---eeeccccccCccCchhhccCC------CCCcccchhHhHHHHHHHhC----------C
Q 008893          365 EAVVGDFGLAKLLDHCDSH---VTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELISG----------L  425 (549)
Q Consensus       365 ~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~il~elltg----------~  425 (549)
                      .+||+|||++.........   ......||+.|+|||.+.+..      ++.++||||||+++|||+||          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            9999999999876544332   123446999999999997763      33689999999999999999          5


Q ss_pred             cccccCccccccccHHHHHHHHhhccchhhhccccccCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          426 RALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN-YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       426 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .||........  ....+........     ..+.+... ........+.+++.+||+.||++|||+.||+++|+.
T Consensus       265 ~p~~~~~~~~~--~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          265 LPYYDLVPSDP--SVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             CTTTTTSCSSC--CHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cCccccCcCcc--cHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            66654322111  1222222221111     11111111 123566789999999999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.7e-41  Score=341.04  Aligned_cols=257  Identities=21%  Similarity=0.261  Sum_probs=203.0

Q ss_pred             HHHHhcCCCCC-CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhcc-CCCccceEEEEecCC
Q 008893          222 LQSATSNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT  297 (549)
Q Consensus       222 ~~~~~~~~~~~-~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  297 (549)
                      .+...+.|.+. +.||+|+||.||+|... +|+.||+|+++.... ......+.+|+.++..+. ||||+++++++....
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            34445567776 89999999999999976 589999999975432 233567899999999884 699999999999999


Q ss_pred             ceeeEeeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC---CCceEEeecc
Q 008893          298 ERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFG  372 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg  372 (549)
                      ..++||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.   ++.+||+|||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            99999999999999999864  36799999999999999999999999   9999999999999997   7899999999


Q ss_pred             cccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc
Q 008893          373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK  452 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (549)
                      +++......  ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.......       ......... 
T Consensus       180 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~-  249 (327)
T 3lm5_A          180 MSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-------TYLNISQVN-  249 (327)
T ss_dssp             GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTC-
T ss_pred             cccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------HHHHHHhcc-
Confidence            998765332  2234569999999999999999999999999999999999999996432211       111111100 


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       453 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                            ...........+..+.+++.+||+.||++|||++|++++
T Consensus       250 ------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          250 ------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                  001111112234678999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.6e-42  Score=349.38  Aligned_cols=245  Identities=23%  Similarity=0.274  Sum_probs=195.1

Q ss_pred             CCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCCCc
Q 008893          232 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS  310 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  310 (549)
                      .+.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            568999999999999975 689999999976432 334578999999999999999999999999999999999999999


Q ss_pred             hhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee--cCCCceEEeecccccccCCCCCceeec
Q 008893          311 VASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--DEYYEAVVGDFGLAKLLDHCDSHVTTA  387 (549)
Q Consensus       311 L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~  387 (549)
                      |.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+|||+  ++++.+||+|||+++......  ....
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~  247 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKV  247 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cccc
Confidence            9998864 34699999999999999999999999   99999999999999  567899999999998765432  2233


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCH
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR  467 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  467 (549)
                      ..||+.|+|||++.+..++.++|||||||++|||+||+.||......       .....+......   ........   
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~---~~~~~~~~---  314 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACRWD---LEDEEFQD---  314 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCC---SCSGGGTT---
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCC---CChhhhcc---
Confidence            46999999999999889999999999999999999999999753321       111111111100   00011111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          468 IELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       468 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       .+..+.+++.+||+.||++|||+.|+++
T Consensus       315 -~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          315 -ISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             2367899999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=348.35  Aligned_cols=261  Identities=21%  Similarity=0.300  Sum_probs=194.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|.+.+.||+|+||+||+|... +++.||+|++...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888999999999999999976 68999999997544322222455799999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      ++ |+|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~  156 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T  156 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence            97 588888764 44699999999999999999999999   999999999999999999999999999986543222 2


Q ss_pred             eeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc---chhhhcc--
Q 008893          385 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK---KLEMLVD--  458 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d--  458 (549)
                      .....||+.|+|||.+.+ ..++.++|||||||++|||+||+.||........    ...+.......   .......  
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ----LHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHhchhhhcch
Confidence            234468999999999876 5689999999999999999999999975432211    11111111000   0000000  


Q ss_pred             -------ccccCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          459 -------KDLKNN----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       459 -------~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                             +.....    ........+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                   000000    00112367889999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-41  Score=345.29  Aligned_cols=246  Identities=30%  Similarity=0.394  Sum_probs=200.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCC--cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      +.|...+.||+|+||+||+|.. .+|+.||||++.......  ....+.+|+.+++.++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4578889999999999999996 468999999997543222  2246889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+. |+|.+.+. ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 57877775 456799999999999999999999999   9999999999999999999999999999865432  


Q ss_pred             ceeeccccccCccCchhhc---cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          383 HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                         ....||+.|+|||.+.   ...++.++|||||||++|||+||+.||.....       ............      +
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~~------~  271 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNES------P  271 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCC------C
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCC------C
Confidence               2346999999999985   56789999999999999999999999864321       111111111110      1


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...   ....+..+.+++.+||+.||++|||+++++++
T Consensus       272 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          272 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            110   11223668899999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3e-41  Score=350.51  Aligned_cols=255  Identities=22%  Similarity=0.322  Sum_probs=195.0

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-------CCcHHHHHHHHHHHhhccCCCccceEEEEec
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT  295 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  295 (549)
                      ...++|.+.+.||+|+||+||+|... +++.||||++.....       ......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999975 589999999865321       1112248899999999999999999999754


Q ss_pred             CCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC---CceEEeecc
Q 008893          296 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY---YEAVVGDFG  372 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg  372 (549)
                       +..++||||+++|+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.+   +.+||+|||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence             55799999999999999998888899999999999999999999999   99999999999999754   459999999


Q ss_pred             cccccCCCCCceeeccccccCccCchhhcc---CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      +++.....  .......||+.|+|||++.+   ..++.++|||||||++|+|+||+.||........   +...+..   
T Consensus       288 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~~i~~---  359 (419)
T 3i6u_A          288 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKDQITS---  359 (419)
T ss_dssp             TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC---HHHHHHT---
T ss_pred             cceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH---HHHHHhc---
Confidence            99876532  22344569999999999864   5678899999999999999999999975332211   1111110   


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       ....  ..+.....    .+..+.+++.+||+.||++|||+.|++++
T Consensus       360 -~~~~--~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          360 -GKYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             -TCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -CCCC--CCchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             0000  00000011    23678999999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-41  Score=341.28  Aligned_cols=266  Identities=22%  Similarity=0.319  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|++.+.||+|+||.||+|... +|+.||||++....... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            56888899999999999999976 48999999987554322 23457899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....... .
T Consensus       105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  180 (331)
T 4aaa_A          105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V  180 (331)
T ss_dssp             CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-c
Confidence            999999999887777899999999999999999999999   999999999999999999999999999986653222 2


Q ss_pred             eeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHH--------HHHHHhhccchhh
Q 008893          385 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--------WVKKIHQEKKLEM  455 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~  455 (549)
                      .....||+.|+|||.+.+. .++.++||||||+++|+|+||+.||...........+..        +............
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            3344689999999999875 689999999999999999999999975432211111100        0000011111111


Q ss_pred             hccccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          456 LVDKDLKNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       456 ~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ...+......+     ...+..+.+++.+||+.||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11111111111     122467999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.3e-42  Score=343.65  Aligned_cols=255  Identities=27%  Similarity=0.389  Sum_probs=203.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE------CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  299 (549)
                      .++|.+.+.||+|+||.||+|.+      .+++.||||++...........+.+|+.+++.++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46788999999999999999984      247799999997554444455789999999999999999999999999999


Q ss_pred             eeEeeccCCCchhhhhccC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec---CCCceEEe
Q 008893          300 LLVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVG  369 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~  369 (549)
                      ++||||+++++|.+++...       ..+++..++.++.||+.||.|||+.   +|+||||||+|||++   ++..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999743       3489999999999999999999999   999999999999998   44569999


Q ss_pred             ecccccccCCCCC-ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHH
Q 008893          370 DFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKI  447 (549)
Q Consensus       370 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  447 (549)
                      |||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.....       .......
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------HHHHHHH
Confidence            9999976543222 12234458899999999999999999999999999999998 8889864321       1111111


Q ss_pred             hhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          448 HQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       448 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .....          ...+...+..+.+++.+||+.||++||++.|++++|+.
T Consensus       259 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          259 TSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hcCCC----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            11110          11122234678999999999999999999999999886

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.2e-41  Score=355.61  Aligned_cols=264  Identities=18%  Similarity=0.225  Sum_probs=195.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecC------C
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------T  297 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  297 (549)
                      .++|++.+.||+|+||+||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            367889999999999999999965 589999999975422 22345688999999999999999999999654      3


Q ss_pred             ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      ..++||||+++ ++.+.+..  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            56999999986 46666643  489999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHH------------
Q 008893          378 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK------------  445 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~------------  445 (549)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....            
T Consensus       215 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          215 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             --C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             CCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            532  223445799999999999999999999999999999999999999975432221111111000            


Q ss_pred             ---HHhhc------cchhhhccccccCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          446 ---KIHQE------KKLEMLVDKDLKNN---YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       446 ---~~~~~------~~~~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                         .....      ......+...+...   ........+.+++.+||+.||++|||++|++++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00000      00000000000000   011225678999999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-41  Score=334.39  Aligned_cols=244  Identities=25%  Similarity=0.397  Sum_probs=202.8

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec--------
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--------  295 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  295 (549)
                      ...+|+..+.||+|+||.||+|... +|+.||+|+++...     ..+.+|+.+++.++||||+++++++..        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            3457889999999999999999986 79999999997543     246789999999999999999998854        


Q ss_pred             --------CCceeeEeeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc
Q 008893          296 --------TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE  365 (549)
Q Consensus       296 --------~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  365 (549)
                              ....++||||+++++|.+++..  ...+++..+..++.||+.||.|||+.   +|+||||||+||++++++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence                    3457899999999999999964  35799999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHH
Q 008893          366 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       366 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      +||+|||++.......  ......||+.|+|||.+.+..++.++||||||+++|||+||..|+...         ..+..
T Consensus       161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~  229 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFT  229 (284)
T ss_dssp             EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHH
T ss_pred             EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHH
Confidence            9999999998765432  223345999999999999999999999999999999999998887521         11111


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...         +..+...+    +..+.+++.+||+.||++|||+.|++++|+.
T Consensus       230 ~~~---------~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          230 DLR---------DGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             HHH---------TTCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             Hhh---------cccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            111         11111222    3568899999999999999999999999976

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.4e-41  Score=369.82  Aligned_cols=247  Identities=27%  Similarity=0.354  Sum_probs=199.6

Q ss_pred             CeeeeeCCeEEEEEEEC---CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||+||+|.+.   .++.||||+++..... .....+.+|++++..++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   4678999999765332 234679999999999999999999999964 568899999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc--eee
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--VTT  386 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~  386 (549)
                      |+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.+......  ...
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            99999998888899999999999999999999999   9999999999999999999999999999877543322  223


Q ss_pred             ccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||......       .....+...          .....
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~----------~~~~~  593 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKG----------ERMGC  593 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTT----------CCCCC
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC----------CCCCC
Confidence            3347789999999999999999999999999999999 99999643221       111111111          11112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +...+..+.+++..||+.||++||++.+|++.|++
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            23344789999999999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.1e-41  Score=336.43  Aligned_cols=256  Identities=22%  Similarity=0.344  Sum_probs=196.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||+|... +|+.||+|+++.....  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            46888999999999999999974 6899999999754322  22346889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          304 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       304 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999998863    55799999999999999999999999   999999999999999999999999999986653


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....     ............. ..     
T Consensus       189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-~~-----  256 (310)
T 2wqm_A          189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCD-YP-----  256 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHHHHTTC-SC-----
T ss_pred             CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHHhhccc-CC-----
Confidence            222 22334689999999999999999999999999999999999999864321     1112222221111 00     


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..   .....+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       257 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~  294 (310)
T 2wqm_A          257 PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR  294 (310)
T ss_dssp             CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            00   011223678999999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-41  Score=338.74  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=195.7

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC----CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      ...++|.+.+.||+|+||.||+|...    .+..||+|+++..... .....+.+|+.+++.++||||+++++++.....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34567889999999999999999864    2458999999755422 223468999999999999999999999987553


Q ss_pred             -----eeeEeeccCCCchhhhhc------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceE
Q 008893          299 -----RLLVYPYMSNGSVASRLK------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV  367 (549)
Q Consensus       299 -----~~lv~e~~~~g~L~~~l~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  367 (549)
                           .++||||+++|+|.+++.      ....+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence                 499999999999999983      345799999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHH
Q 008893          368 VGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       368 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      |+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |..||.......    ....  
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~--  261 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----MYDY--  261 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHH--
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HHHH--
Confidence            9999999876433221 2233457889999999999999999999999999999999 888886432211    1111  


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       .....          ....+...+..+.+++.+||+.||++|||+.+++++|+.
T Consensus       262 -~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          262 -LLHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK  305 (313)
T ss_dssp             -HHTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             11110          011122233679999999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-41  Score=333.99  Aligned_cols=247  Identities=28%  Similarity=0.396  Sum_probs=197.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC-CceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-TERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||+|... |+.||||+++...   ....+.+|+.+++.++||||+++++++... +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            357888999999999999999885 8899999997543   345789999999999999999999997655 47899999


Q ss_pred             ccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......  
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            999999999997543  389999999999999999999999   9999999999999999999999999999755432  


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                        .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......    ..   ......          .
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~---~~~~~~----------~  231 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VV---PRVEKG----------Y  231 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HH---HHHTTT----------C
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----HH---HHHhcC----------C
Confidence              122357889999999999999999999999999999998 999986432211    11   111111          1


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....+...+..+.+++.+||+.||++||++.|+++.|+.
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence            111222334679999999999999999999999999886

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.5e-41  Score=334.29  Aligned_cols=246  Identities=24%  Similarity=0.375  Sum_probs=205.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888999999999999999976 57899999986432  1233457899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......   
T Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred             EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence            9999999999998777899999999999999999999999   9999999999999999999999999999765432   


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......       .........       +.    
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~-------~~----  229 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------ETHRRIVNV-------DL----  229 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTT-------CC----
T ss_pred             ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------HHHHHHhcc-------cc----
Confidence            223456899999999999999999999999999999999999999643211       111111110       11    


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .++...+..+.+++.+|++.||++||+++|+++
T Consensus       230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            112223467899999999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.9e-41  Score=358.38  Aligned_cols=249  Identities=23%  Similarity=0.305  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .++|...+.||+|+||.||+|... +|+.||+|++....  .......+..|+.+++.++||||+++++++......++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888899999999999999986 69999999996432  123345788999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          303 YPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      |||+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999998864    34699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      .... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||.........   ..........        
T Consensus       341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~---~~~~~~i~~~--------  408 (543)
T 3c4z_A          341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRVLEQ--------  408 (543)
T ss_dssp             TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH---HHHHHHHHHC--------
T ss_pred             CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH---HHHHHHHhhc--------
Confidence            4322 233457999999999999999999999999999999999999999754322111   1111111111        


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMS  492 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  492 (549)
                       .  ..++...+..+.+++.+||+.||++||++.
T Consensus       409 -~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          409 -A--VTYPDKFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             -C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             -c--cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence             0  112223346789999999999999999763

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-41  Score=333.74  Aligned_cols=244  Identities=24%  Similarity=0.372  Sum_probs=198.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .++|++.+.||+|+||+||+|... +++.||+|+++.... ......+.+|+..+..+ +||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467889999999999999999986 699999999976432 22345688899999988 999999999999999999999


Q ss_pred             eeccCCCchhhhhccC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC----------------
Q 008893          303 YPYMSNGSVASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE----------------  362 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----------------  362 (549)
                      |||+++++|.+++...    ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999743    5799999999999999999999999   9999999999999984                


Q ss_pred             ---CCceEEeecccccccCCCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccc
Q 008893          363 ---YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKG  438 (549)
Q Consensus       363 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  438 (549)
                         ...+||+|||.+.......     ...||+.|+|||.+.+. .++.++||||||+++|+|++|..++....      
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------  235 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------  235 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence               4479999999998765432     23489999999999776 56789999999999999999987764211      


Q ss_pred             cHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       .  + ..... ...     +.+    +...+..+.+++.+||+.||++|||+.|++++
T Consensus       236 -~--~-~~~~~-~~~-----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          236 -Q--W-HEIRQ-GRL-----PRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -H--H-HHHHT-TCC-----CCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -H--H-HHHHc-CCC-----CCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence             0  1 11111 111     111    12223678999999999999999999999863

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.2e-41  Score=334.83  Aligned_cols=249  Identities=22%  Similarity=0.311  Sum_probs=206.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||+|... +++.||+|++......  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            56888999999999999999976 5889999998754322  23446889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........ 
T Consensus        95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  170 (294)
T 2rku_A           95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-  170 (294)
T ss_dssp             ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence            9999999999998777899999999999999999999999   999999999999999999999999999987653222 


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||......       +.........       .    
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~-------~----  232 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKNE-------Y----  232 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTC-------C----
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhhcc-------C----
Confidence            233456899999999999989999999999999999999999999643211       1111111110       0    


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..+......+.+++.+|++.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1111223678899999999999999999999863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.3e-41  Score=335.56  Aligned_cols=256  Identities=20%  Similarity=0.236  Sum_probs=198.6

Q ss_pred             cCCCCC-CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~-~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      +.|.+. +.||+|+||+||+|... +++.||||++.... ......+.+|+.++.++ +||||+++++++...+..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            457764 78999999999999964 68999999997653 34456789999999884 7999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc---eEEeecccccccCCC
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHC  380 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~  380 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.   +||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            9999999999998777899999999999999999999999   9999999999999998766   999999999765422


Q ss_pred             CC------ceeeccccccCccCchhhcc-----CCCCCcccchhHhHHHHHHHhCCcccccCcccccccc--------HH
Q 008893          381 DS------HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA--------ML  441 (549)
Q Consensus       381 ~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~--------~~  441 (549)
                      ..      .......||+.|+|||.+..     ..++.++|||||||++|||+||+.||...........        ..
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            11      11223459999999999875     4578999999999999999999999976443221100        00


Q ss_pred             HHHHHHhhccchhhhccccccCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          442 DWVKKIHQEKKLEMLVDKDLKNNYDR----IELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       442 ~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ........ ..          ..++.    ..+..+.+++.+||+.||++|||+.|++++
T Consensus       248 ~~~~~i~~-~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          248 MLFESIQE-GK----------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHH-CC----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHhc-cC----------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            01111111 00          01111    123678999999999999999999999873

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.6e-40  Score=338.90  Aligned_cols=257  Identities=20%  Similarity=0.309  Sum_probs=206.6

Q ss_pred             HHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc-------HHHHHHHHHHHhhc-cCCCccceEEE
Q 008893          222 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISLA-VHRNLLRLIGF  292 (549)
Q Consensus       222 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l-~h~niv~l~~~  292 (549)
                      .....++|.+.+.||+|+||.||+|... +|+.||||++........       ...+.+|+.++..+ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445678999999999999999999986 699999999875432111       23578899999999 79999999999


Q ss_pred             EecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecc
Q 008893          293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG  372 (549)
Q Consensus       293 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  372 (549)
                      +......++||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence            999999999999999999999998777899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeeccccccCccCchhhcc------CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHH
Q 008893          373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK  446 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  446 (549)
                      ++.......  ......||+.|+|||++.+      ..++.++|||||||++|||+||+.||.....       ......
T Consensus       246 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~~  316 (365)
T 2y7j_A          246 FSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------ILMLRM  316 (365)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH
T ss_pred             cccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------HHHHHH
Confidence            998765432  2334569999999999864      3578899999999999999999999964221       111111


Q ss_pred             HhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          447 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       447 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..... ..  ........    .+..+.+++.+||+.||++|||+.|++++
T Consensus       317 i~~~~-~~--~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          317 IMEGQ-YQ--FSSPEWDD----RSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHTC-CC--CCHHHHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhCC-CC--CCCccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11110 00  00000011    13568999999999999999999999873

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=339.28  Aligned_cols=258  Identities=25%  Similarity=0.310  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEe----cCCcee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM----TTTERL  300 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~  300 (549)
                      .++|++.+.||+|+||.||++.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++.    .....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            35788999999999999999997 468999999986543 233456899999999999999999999987    334788


Q ss_pred             eEeeccCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          301 LVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      +||||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999998864    56799999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCc--------eeeccccccCccCchhhccCC---CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHH
Q 008893          377 LDHCDSH--------VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       377 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      .......        ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||........  ...... 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~-  260 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALAV-  260 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHHH-
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHHh-
Confidence            5321110        012234799999999987654   68999999999999999999999863211111  111100 


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDG  502 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  502 (549)
                        .          ...........+..+.+++.+||+.||++|||+.|++++|+...
T Consensus       261 --~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          261 --Q----------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             --H----------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             --h----------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence              0          00001111222367999999999999999999999999998743

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.3e-42  Score=337.17  Aligned_cols=253  Identities=24%  Similarity=0.346  Sum_probs=203.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEec--CCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  302 (549)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+...... .....+.+|+.+++.++||||+++++++..  ....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            57888999999999999999976 6899999999765422 234468999999999999999999998753  5678999


Q ss_pred             eeccCCCchhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCc-----eEecccCcCeeeecCCCceEEeeccc
Q 008893          303 YPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPK-----IIHRDVKAANILLDEYYEAVVGDFGL  373 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~Dfg~  373 (549)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +     |+||||||+||+++.++.+||+|||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            999999999999863    34599999999999999999999998   7     99999999999999999999999999


Q ss_pred             ccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccch
Q 008893          374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       374 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      ++....... ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||.....       ......... ...
T Consensus       163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~-~~~  233 (279)
T 2w5a_A          163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIRE-GKF  233 (279)
T ss_dssp             HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-TCC
T ss_pred             heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHhh-ccc
Confidence            987653321 22334689999999999999999999999999999999999999874321       111111111 111


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       454 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                               ...+...+..+.+++.+||+.||++||++.|+++++..
T Consensus       234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          234 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                     01122234678999999999999999999999987765

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.6e-41  Score=340.76  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=205.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||++... +++.||+|++......  .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            46778899999999999999976 4889999998754322  23446889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++++|.+++.....+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+||+|||+++....... 
T Consensus       121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-  196 (335)
T 2owb_A          121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-  196 (335)
T ss_dssp             CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence            9999999999998777899999999999999999999999   999999999999999999999999999987653222 


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......||..|+|||.+.+..++.++||||||+++|||++|+.||......       ..........       ..   
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-------~~---  259 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKNE-------YS---  259 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTC-------CC---
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHhcCC-------CC---
Confidence            233456999999999999999999999999999999999999999643211       1111111110       01   


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       .+......+.+++.+||+.||++||++.|+++
T Consensus       260 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          260 -IPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             11122356889999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=344.66  Aligned_cols=256  Identities=17%  Similarity=0.203  Sum_probs=203.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC---------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccc---------
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD---------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR---------  288 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  288 (549)
                      ++|.+.+.||+|+||.||+|....         ++.||+|++...      ..+.+|+.++..++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            578899999999999999999763         789999998754      25789999999999999988         


Q ss_pred             ------eEEEEec-CCceeeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeee
Q 008893          289 ------LIGFCMT-TTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL  359 (549)
Q Consensus       289 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  359 (549)
                            +++++.. ....++||||+ +++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence                  6777765 67889999999 99999999865  6799999999999999999999999   9999999999999


Q ss_pred             ecCCC--ceEEeecccccccCCCCCc------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccC
Q 008893          360 LDEYY--EAVVGDFGLAKLLDHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG  431 (549)
Q Consensus       360 l~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~  431 (549)
                      ++.++  .+||+|||+++........      ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999876432211      123346999999999999999999999999999999999999999754


Q ss_pred             ccccccccHHHHHHHHhhccchhhhcccccc-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          432 KTANQKGAMLDWVKKIHQEKKLEMLVDKDLK-NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ....  ..+.........  ....+.+.... ..+    +..+.+++.+||+.||++||+++++++.|+.
T Consensus       272 ~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  333 (352)
T 2jii_A          272 LPNT--EDIMKQKQKFVD--KPGPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLEA  333 (352)
T ss_dssp             TTCH--HHHHHHHHHHHH--SCCCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             CcCH--HHHHHHHHhccC--ChhhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence            3111  112222111111  11111111100 112    3679999999999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-40  Score=347.65  Aligned_cols=200  Identities=25%  Similarity=0.332  Sum_probs=168.5

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecC-----Cc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  298 (549)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++..... .....+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            357899999999999999999975 5889999999754322 2235688999999999999999999999765     56


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++||||+. |+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            899999987 59999999888899999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCc---------------------eeeccccccCccCchhh-ccCCCCCcccchhHhHHHHHHHhCCcccc
Q 008893          379 HCDSH---------------------VTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELISGLRALE  429 (549)
Q Consensus       379 ~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg~~p~~  429 (549)
                      .....                     ......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            33211                     12455799999999986 55679999999999999999998655543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=341.46  Aligned_cols=265  Identities=26%  Similarity=0.401  Sum_probs=197.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHH--HhhccCCCccceEEEEec-----CCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEM--ISLAVHRNLLRLIGFCMT-----TTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~  298 (549)
                      .++|++.+.||+|+||.||+|.. +++.||||++....    ...+..|.++  +..++||||+++++++..     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            35788899999999999999987 58999999996432    2334444444  456899999999986542     235


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCceEecccCcCeeeecCCCceEEeecc
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC------DPKIIHRDVKAANILLDEYYEAVVGDFG  372 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  372 (549)
                      .++||||+++|+|.+++.... .++..+..++.||+.||.|||+.+      .++|+||||||+|||++.++.+||+|||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            689999999999999997654 599999999999999999999863      3389999999999999999999999999


Q ss_pred             cccccCCCCC-------ceeeccccccCccCchhhcc-------CCCCCcccchhHhHHHHHHHhCCcccccCccccccc
Q 008893          373 LAKLLDHCDS-------HVTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG  438 (549)
Q Consensus       373 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  438 (549)
                      +++.+.....       .......||+.|+|||.+.+       ..++.++|||||||++|||+||+.|+..........
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9987653221       12234469999999999976       345678999999999999999988876543322211


Q ss_pred             -cHH---------HHHHHHhhccchhhhccccccCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          439 -AML---------DWVKKIHQEKKLEMLVDKDLKNN--YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       439 -~~~---------~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       .+.         ............    .+.+...  .....+..+.+++.+||+.||++|||++|+++.|+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence             100         000111100000    0111111  123456789999999999999999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.8e-42  Score=338.91  Aligned_cols=260  Identities=28%  Similarity=0.390  Sum_probs=186.8

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ...++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999854 68999999987654444455788999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccc
Q 008893          303 YPYMSNGSVASRLKA--------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA  374 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  374 (549)
                      |||+++++|.+++..        ...+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999862        45699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC----ceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          375 KLLDHCDS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       375 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      ........    .......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||........    .  ......
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~--~~~~~~  242 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----L--MLTLQN  242 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----H--HHHHTS
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH----H--HHHhcc
Confidence            87643221    11234468999999999876 5689999999999999999999999975332111    0  111111


Q ss_pred             cc-ch-hhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          450 EK-KL-EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       450 ~~-~~-~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .. .. ....+......+    +..+.+++.+||+.||++||++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00 00 011111112222    357889999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.5e-41  Score=331.15  Aligned_cols=248  Identities=22%  Similarity=0.339  Sum_probs=197.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||+|... +|+.||||++....  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888999999999999999986 69999999986432  2234557899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++.......  
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  165 (276)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence            9999999999998777899999999999999999999999   99999999999999999999999999998765322  


Q ss_pred             eeeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.....       ...........           
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~-----------  227 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKKIRGGV-----------  227 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-----------
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcCc-----------
Confidence            2234468999999999988765 6899999999999999999999964221       11111111110           


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...+......+.+++.+|++.||++|||+.|++++
T Consensus       228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00111223678899999999999999999999974

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-40  Score=350.77  Aligned_cols=194  Identities=23%  Similarity=0.354  Sum_probs=155.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecC-----Cce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  299 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||++...... .....+.+|+.+++.++||||+++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            57899999999999999999965 6899999998654322 2235688999999999999999999998543     568


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+. ++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             EEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            99999984 69999998888899999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCC--------------------------ceeeccccccCccCchhh-ccCCCCCcccchhHhHHHHHHHhC
Q 008893          380 CDS--------------------------HVTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELISG  424 (549)
Q Consensus       380 ~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg  424 (549)
                      ...                          .......||+.|+|||++ ....++.++|||||||++|||+||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            211                          122345689999999986 456799999999999999999994

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5e-41  Score=331.60  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=198.9

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEec----CCceee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTERLL  301 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l  301 (549)
                      .|.+.+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3667788999999999999975 5889999998754322 234468999999999999999999999865    345899


Q ss_pred             EeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEecccCcCeeeec-CCCceEEeecccccccC
Q 008893          302 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLD-EYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~  378 (549)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+.   +  |+||||||+||+++ +++.+||+|||++....
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            999999999999998777899999999999999999999998   7  99999999999998 78999999999997654


Q ss_pred             CCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ..   ......||+.|+|||.+. +.++.++||||||+++|+|+||+.||......      .............     
T Consensus       184 ~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~-----  248 (290)
T 1t4h_A          184 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKP-----  248 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCC-----
T ss_pred             cc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCc-----
Confidence            32   223456999999999886 45899999999999999999999999643221      1111111111110     


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .....    ..+..+.+++.+||+.||++|||+.|++++
T Consensus       249 ~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          249 ASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccCC----CCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            01111    112568999999999999999999999863

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1e-40  Score=353.52  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=206.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.....  ......+.+|+.+++.++||||+++++++......++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356888999999999999999976 689999999965432  33456799999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee---cCCCceEEeecccccccCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~  379 (549)
                      |||+.+|+|.+.+.....+++..+..++.||+.||.|||++   +|+||||||+|||+   +.++.+||+|||+++....
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            99999999999998888899999999999999999999999   99999999999999   5678999999999987654


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ..  ......||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.....       ......+.......   ..
T Consensus       182 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~---~~  248 (484)
T 3nyv_A          182 SK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDILKKVEKGKYTF---EL  248 (484)
T ss_dssp             CC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCC---CS
T ss_pred             cc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCC---CC
Confidence            32  2334569999999999866 699999999999999999999999974321       11111211111000   00


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ..    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          249 PQ----WKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             GG----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            00    0122367899999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-41  Score=340.95  Aligned_cols=266  Identities=23%  Similarity=0.294  Sum_probs=198.0

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC----cHHHHHHHHHHHhhccCCCccceEEEEecCCce
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  299 (549)
                      ..++|.+.+.||+|+||.||+|... +|+.||||+++......    ....+.+|+.+++.++||||+++++++......
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4568999999999999999999975 58999999997543211    123578999999999999999999999999999


Q ss_pred             eeEeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          300 LLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      ++||||+++ +|.+.+... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            999999986 888887654 4689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc--cchh-
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE--KKLE-  454 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~-  454 (549)
                      .... ......||+.|+|||.+.+. .++.++|||||||++|||++|..||........   +..........  .... 
T Consensus       164 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          164 SPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             SCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSS
T ss_pred             CCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChhhhhh
Confidence            3322 23345689999999999764 488999999999999999999999865332111   11111111000  0000 


Q ss_pred             --hhccc---cccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 008893          455 --MLVDK---DLKNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRML  498 (549)
Q Consensus       455 --~~~d~---~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  498 (549)
                        ...+.   ......+     ...+..+.+++.+|++.||++|||+.|++++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence              00000   0000001     12236799999999999999999999999753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-41  Score=347.06  Aligned_cols=274  Identities=19%  Similarity=0.232  Sum_probs=200.1

Q ss_pred             CHHHHHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCc----------HHHHHHHHHHHhhccCCCcc
Q 008893          218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG----------EIQFQTEVEMISLAVHRNLL  287 (549)
Q Consensus       218 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~l~h~niv  287 (549)
                      ...++....++|.+.+.||+|+||.||+|...+|+.||||++........          ...+.+|+.+++.++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            35677888899999999999999999999988899999999865332211          25789999999999999999


Q ss_pred             ceEEEEec-----CCceeeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec
Q 008893          288 RLIGFCMT-----TTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD  361 (549)
Q Consensus       288 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  361 (549)
                      ++++++..     ....++||||+. |+|.+.+.. ...+++..+..++.||+.||.|||+.   +|+||||||+||+++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence            99999854     335799999998 578777764 44799999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccH
Q 008893          362 EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM  440 (549)
Q Consensus       362 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~  440 (549)
                      .++.+||+|||+++......  ......||+.|+|||.+.+ ..++.++|||||||++|+|+||+.||...........+
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  246 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI  246 (362)
T ss_dssp             TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999997544322  2334568999999999877 67899999999999999999999999754322111111


Q ss_pred             HHHHHHH-------hhccchhhhccccccC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          441 LDWVKKI-------HQEKKLEMLVDKDLKN-------NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       441 ~~~~~~~-------~~~~~~~~~~d~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .......       ................       .........+.+++.+||+.||++|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            1100000       0000000000000000       0011123668999999999999999999999863

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.9e-40  Score=333.61  Aligned_cols=257  Identities=17%  Similarity=0.240  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEec--CCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMT--TTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  302 (549)
                      ++|++.+.||+|+||+||+|... +++.||||+++..    ....+.+|+.++..++ ||||+++++++..  ....++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            57888999999999999999864 6899999998743    3467899999999997 9999999999987  5678999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC-ceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++++|.+++..   +++..+..++.||+.||.|||+.   +|+||||||+|||++.++ .+||+|||+++......
T Consensus       112 ~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             EeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            999999999998853   88999999999999999999999   999999999999999776 89999999998765432


Q ss_pred             CceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc---------
Q 008893          382 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK---------  451 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  451 (549)
                      .  .....||..|+|||.+.+ ..++.++|||||||++|||+||+.||........  .+...........         
T Consensus       186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHTT
T ss_pred             c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcCCchhhhHHHHhc
Confidence            2  234468999999999977 6789999999999999999999999964332111  1111111000000         


Q ss_pred             -----chhhhcc--------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          452 -----KLEMLVD--------KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       452 -----~~~~~~d--------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                           .......        ...........+..+.+++.+||+.||++|||++|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 0000000        000011111234779999999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-41  Score=337.11  Aligned_cols=262  Identities=24%  Similarity=0.381  Sum_probs=205.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-----CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC--ce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~  299 (549)
                      ++|++.+.||+|+||.||+|.+     .+|+.||||++.... ......+.+|+.+++.++||||+++++++...+  ..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            5678889999999999999984     358899999997643 233457999999999999999999999987654  68


Q ss_pred             eeEeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          300 LLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999754 4699999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCCce--eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc------
Q 008893          379 HCDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE------  450 (549)
Q Consensus       379 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  450 (549)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||+||..|+.....        .+.......      
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--------~~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------EFMRMIGNDKQGQMI  268 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--------HHHHHHCTTCCTHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--------HHHHhhccccchhhh
Confidence            443321  1233477789999999988899999999999999999999988763210        000000000      


Q ss_pred             -cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          451 -KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       451 -~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       ..+...+........+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             00011111111111223344779999999999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-41  Score=347.85  Aligned_cols=260  Identities=20%  Similarity=0.286  Sum_probs=195.7

Q ss_pred             HHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC-----
Q 008893          223 QSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----  296 (549)
Q Consensus       223 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  296 (549)
                      +...++|.+.+.||+|+||+||+|... +|+.||||++......     ..+|+++++.++||||+++++++...     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            345678999999999999999999974 6999999998754322     23799999999999999999998442     


Q ss_pred             ---------------------------------CceeeEeeccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHH
Q 008893          297 ---------------------------------TERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLY  339 (549)
Q Consensus       297 ---------------------------------~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~  339 (549)
                                                       ...++||||+++ +|.+.+.    ....+++..+..++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             337899999984 7766654    46679999999999999999999


Q ss_pred             hhhcCCCceEecccCcCeeeec-CCCceEEeecccccccCCCCCceeeccccccCccCchhhccC-CCCCcccchhHhHH
Q 008893          340 LHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGIL  417 (549)
Q Consensus       340 LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~i  417 (549)
                      ||+.   +|+||||||+|||++ +++.+||+|||+++......  ......||+.|+|||.+.+. .++.++|||||||+
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999   999999999999998 68999999999998765332  22344689999999998775 48999999999999


Q ss_pred             HHHHHhCCcccccCccccccccHHHHHHHHhhc---------cc-----hhhhccccccCCCCHHHHHHHHHHHHHhccc
Q 008893          418 LLELISGLRALEFGKTANQKGAMLDWVKKIHQE---------KK-----LEMLVDKDLKNNYDRIELEEMVQVALLCTQY  483 (549)
Q Consensus       418 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~-----~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~  483 (549)
                      +|||++|+.||......+.   +...+......         ..     ............++...+..+.+++.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            9999999999975432221   11111110000         00     0000001111111222346789999999999


Q ss_pred             CCCCCCCHHHHHH
Q 008893          484 LPSLRPKMSEVVR  496 (549)
Q Consensus       484 dP~~RPs~~evl~  496 (549)
                      ||++|||+.|+++
T Consensus       309 dP~~R~t~~e~l~  321 (383)
T 3eb0_A          309 EPDLRINPYEAMA  321 (383)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.7e-41  Score=334.90  Aligned_cols=251  Identities=22%  Similarity=0.329  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|.+.+.||+|+||.||++... +|+.||+|+++.... .....+.+|+.+++.++||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            357889999999999999999976 689999999975432 233468899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee---cCCCceEEeecccccccCCCC
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||++   ++++.+||+|||++...... 
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            999999999998777899999999999999999999999   99999999999999   78899999999999754322 


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                        ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....       ........... .      ..
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~-~------~~  226 (304)
T 2jam_A          163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------SKLFEKIKEGY-Y------EF  226 (304)
T ss_dssp             --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHCC-C------CC
T ss_pred             --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCC-C------CC
Confidence              22334689999999999999999999999999999999999999964321       11111111110 0      00


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ........+..+.+++.+|++.||++|||+.|++++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            011112234678999999999999999999999863

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.1e-42  Score=351.73  Aligned_cols=240  Identities=13%  Similarity=0.119  Sum_probs=190.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCC--CCCcHHHHHHHH---HHHhhccCCCccceE-------EE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN--AIGGEIQFQTEV---EMISLAVHRNLLRLI-------GF  292 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~  292 (549)
                      .++|.+.+.||+|+||+||+|.. .+|+.||||++....  .......+.+|+   +.++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999996 469999999997542  223345789999   455566899999998       66


Q ss_pred             EecCCc-----------------eeeEeeccCCCchhhhhccCCCCC-------HHHHHHHHHHHHHHHHHhhhcCCCce
Q 008893          293 CMTTTE-----------------RLLVYPYMSNGSVASRLKAKPSLD-------WATRKRIALGAARGLLYLHEQCDPKI  348 (549)
Q Consensus       293 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~l~-------~~~~~~i~~~i~~~L~~LH~~~~~~i  348 (549)
                      +...+.                 .++||||+ +|+|.+++.....++       +..+..|+.||+.||.|||+.   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            665532                 78999999 689999997543344       488889999999999999999   99


Q ss_pred             EecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccccCccCchhhccC-----------CCCCcccchhHhHH
Q 008893          349 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGIL  417 (549)
Q Consensus       349 vH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~i  417 (549)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999985432    3344567 999999999887           89999999999999


Q ss_pred             HHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          418 LLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       418 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      +|||+||+.||.........                ..+...  ...+    +..+.+++.+||+.||++|||+.|+++
T Consensus       303 l~elltg~~Pf~~~~~~~~~----------------~~~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGS----------------EWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CCS----------------GGGGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccch----------------hhhhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999643321111                111110  0122    367899999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.5e-40  Score=352.07  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=202.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC------------CcHHHHHHHHHHHhhccCCCccceEEE
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI------------GGEIQFQTEVEMISLAVHRNLLRLIGF  292 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~l~~~  292 (549)
                      .++|.+.+.||+|+||+||+|... +++.||+|++......            .....+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467889999999999999999976 5889999999754321            234578999999999999999999999


Q ss_pred             EecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC---ceEEe
Q 008893          293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVG  369 (549)
Q Consensus       293 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~  369 (549)
                      +......++||||+++|+|.+.+.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++   .+||+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence            999999999999999999999998777899999999999999999999999   999999999999998775   69999


Q ss_pred             ecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          370 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       370 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      |||+++......  ......||+.|+|||.+. +.++.++|||||||++|+|++|+.||.....       ......+..
T Consensus       192 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~  261 (504)
T 3q5i_A          192 DFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-------QDIIKKVEK  261 (504)
T ss_dssp             CCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH
T ss_pred             ECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHc
Confidence            999998765432  233456999999999986 4689999999999999999999999974322       111222211


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ....   .+......    .+..+.+++.+|++.||++|||+.|++++
T Consensus       262 ~~~~---~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          262 GKYY---FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCCC---CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCC---CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1100   00000011    23678999999999999999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-41  Score=344.17  Aligned_cols=261  Identities=22%  Similarity=0.282  Sum_probs=195.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCC------c
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------E  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  298 (549)
                      ++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            57888999999999999999975 6999999999654322 22346889999999999999999999997653      4


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            59999999 7899999876 4699999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHH--------HHHhh
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV--------KKIHQ  449 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~  449 (549)
                      ..    .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....        .....
T Consensus       180 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          180 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            32    234568999999999887 679999999999999999999999997543221111111000        00000


Q ss_pred             c------cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 E------KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 ~------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .      ..+.......+. .........+.+++.+|++.||++|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0      000000000110 1112234678999999999999999999999974

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=342.64  Aligned_cols=250  Identities=24%  Similarity=0.285  Sum_probs=184.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEe--------c
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCM--------T  295 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~  295 (549)
                      ..+|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++..+. ||||+++++++.        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            347888999999999999999975 68999999986543 233456889999999996 999999999994        2


Q ss_pred             CCceeeEeeccCCCchhhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEecccCcCeeeecCCCceEEee
Q 008893          296 TTERLLVYPYMSNGSVASRLKA---KPSLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYEAVVGD  370 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~D  370 (549)
                      ....+++|||+. |+|.+++..   ...+++..++.++.||+.||.|||+.   +  |+||||||+|||++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            334789999996 689888753   55799999999999999999999998   7  99999999999999999999999


Q ss_pred             cccccccCCCCCce-----------eeccccccCccCchhh---ccCCCCCcccchhHhHHHHHHHhCCcccccCccccc
Q 008893          371 FGLAKLLDHCDSHV-----------TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ  436 (549)
Q Consensus       371 fg~~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~  436 (549)
                      ||+++.........           .....||+.|+|||.+   .+..++.++||||||+++|||+||+.||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            99998765432211           1134589999999998   566788999999999999999999999964321110


Q ss_pred             cccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          437 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                             ..             ..............+.+++.+||+.||++|||+.|++++|+.
T Consensus       262 -------~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  305 (337)
T 3ll6_A          262 -------VN-------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE  305 (337)
T ss_dssp             ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             -------hc-------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                   00             000000011112457899999999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.4e-41  Score=340.75  Aligned_cols=263  Identities=23%  Similarity=0.323  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecC--------
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--------  296 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  296 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||++...... .....+.+|+.+++.++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57888999999999999999974 6899999998654432 2345688999999999999999999998763        


Q ss_pred             CceeeEeeccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          297 TERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      +..++||||+++ +|.+.+. ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            468999999986 6666665 345799999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC---ceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc
Q 008893          376 LLDHCDS---HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK  451 (549)
Q Consensus       376 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (549)
                      .......   .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||........    ...+.......
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~  248 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ----LALISQLCGSI  248 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCC
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCC
Confidence            7653222   22234568999999999876 4589999999999999999999999975332211    11111111000


Q ss_pred             c---hhhhcccccc--------CCCC-HH------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          452 K---LEMLVDKDLK--------NNYD-RI------ELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       452 ~---~~~~~d~~l~--------~~~~-~~------~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .   ..........        .... ..      ....+.+++.+||+.||++|||++|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            0   0000000000        0000 00      12458899999999999999999999873

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.5e-40  Score=329.88  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=198.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-------CCcHHHHHHHHHHHhhccCCCccceEEEEecCC
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT  297 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  297 (549)
                      .++|.+.+.||+|+||.||+|... +++.||||++.....       ......+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            457899999999999999999975 588999999865321       112234889999999999999999999987654


Q ss_pred             ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc---eEEeecccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLA  374 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~~  374 (549)
                       .++||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.   +||+|||++
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence             899999999999999998888899999999999999999999999   9999999999999987654   999999999


Q ss_pred             cccCCCCCceeeccccccCccCchhhc---cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK  451 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (549)
                      +.....  .......||+.|+|||.+.   ...++.++||||||+++|+|++|+.||.......   .+...+..    .
T Consensus       165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~----~  235 (322)
T 2ycf_A          165 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQITS----G  235 (322)
T ss_dssp             EECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHHHHHH----T
T ss_pred             eecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHHHHHh----C
Confidence            876432  2223456999999999974   4678999999999999999999999997533221   12111111    0


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       452 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...  ..+.....    .+..+.+++.+||+.||++||++.|++++
T Consensus       236 ~~~--~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          236 KYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             CCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccc--cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            000  00001111    23678999999999999999999999863

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.7e-40  Score=350.98  Aligned_cols=250  Identities=22%  Similarity=0.324  Sum_probs=199.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|.+.+.||+|+||+||+|... ++..||+|++..... ......+.+|+.+++.++||||+++++++......++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46888999999999999999976 688999999975432 2335578999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC---CCceEEeecccccccCCCC
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |+++|+|.+.+.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++......
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            999999999998777899999999999999999999999   9999999999999975   4569999999998765432


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                        ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.....       ............   ..+...
T Consensus       194 --~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~---~~~~~~  260 (494)
T 3lij_A          194 --KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QEILRKVEKGKY---TFDSPE  260 (494)
T ss_dssp             --CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC---CCCSGG
T ss_pred             --cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC---CCCchh
Confidence              233456999999999986 5699999999999999999999999974322       111122111110   001111


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ...    .+..+.+++.+||+.||++|||+.|+++
T Consensus       261 ~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          261 WKN----VSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             GTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccc----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            111    2367889999999999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=327.60  Aligned_cols=249  Identities=21%  Similarity=0.308  Sum_probs=197.4

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      +|.....||+|+||.||+|... +++.||||.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            4555679999999999999964 68899999997654 233457899999999999999999999999999999999999


Q ss_pred             CCCchhhhhccC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-CCceEEeecccccccCCCCC
Q 008893          307 SNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       307 ~~g~L~~~l~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ++++|.+++...   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++. ++.+||+|||++........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            999999998743   3567899999999999999999999   9999999999999987 89999999999987653221


Q ss_pred             ceeeccccccCccCchhhccCC--CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                       ......||+.|+|||.+.+..  ++.++||||||+++|+|+||+.||........     ....... .     ...  
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~-~-----~~~--  244 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AMFKVGM-F-----KVH--  244 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HHHHHHH-H-----CCC--
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HHHhhcc-c-----ccc--
Confidence             223446899999999997654  78999999999999999999999964221110     0000000 0     001  


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                        ...+...+..+.+++.+||+.||++||++.|+++
T Consensus       245 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          245 --PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             --CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             --ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              1122223467899999999999999999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.9e-40  Score=351.53  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC-CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|.+.+.||+|+||+||+|... +++.||||++.... .......+.+|+.+++.++||||+++++++......++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            357889999999999999999976 68999999986432 2234567899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec---CCCceEEeecccccccCCC
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ||+.+|+|.+.+.....+++..+..++.||+.||.|||+.   +|+||||||+|||++   .++.+||+|||+++.....
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9999999999998777899999999999999999999999   999999999999995   5668999999999876533


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      .  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....       .............   .+..
T Consensus       178 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~---~~~~  244 (486)
T 3mwu_A          178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYA---FDLP  244 (486)
T ss_dssp             ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC---SCSG
T ss_pred             C--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC---CCCc
Confidence            2  2334569999999999875 589999999999999999999999964321       1111111111100   0000


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .    ....+..+.+++.+||+.||++|||+.|++++
T Consensus       245 ~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          245 Q----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             G----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             c----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0    11223678999999999999999999999974

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.2e-40  Score=337.99  Aligned_cols=267  Identities=21%  Similarity=0.267  Sum_probs=202.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC-----Cce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  299 (549)
                      .++|++.+.||+|+||.||+|... +++.||||++...........+.+|++++..++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457899999999999999999975 68899999997544333345789999999999999999999999754     367


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+. |+|.+++... .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            99999997 5899988764 599999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCce--eeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc------
Q 008893          380 CDSHV--TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE------  450 (549)
Q Consensus       380 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  450 (549)
                      .....  .....||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...........+.........+      
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            22211  234469999999998754 458999999999999999999999997544332211111110000000      


Q ss_pred             -----cchhhhcccccc--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          451 -----KKLEMLVDKDLK--NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       451 -----~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                           ........+...  ..........+.+++.+||+.||++|||+.|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 000000000000  00001123678999999999999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.7e-41  Score=331.54  Aligned_cols=251  Identities=20%  Similarity=0.252  Sum_probs=185.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHH-HHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|++.+.||+|+||+||+|... +|+.||+|+++.......... +.++...++.++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467889999999999999999974 689999999976543222233 445555578889999999999999999999999


Q ss_pred             eccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          304 PYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       304 e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ||+++ +|.+++.    ....+++..+..++.|++.||.|||+++  +|+||||||+||+++.++.+||+|||+++....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            99974 8777664    4567999999999999999999999853  899999999999999999999999999987653


Q ss_pred             CCCceeeccccccCccCchhh----ccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          380 CDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      ..  ......||+.|+|||.+    .+..++.++||||||+++|||+||+.||......      ............   
T Consensus       163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---  231 (290)
T 3fme_A          163 DV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------FQQLKQVVEEPS---  231 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------HHHHHHHHHSCC---
T ss_pred             cc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------HHHHHHHhccCC---
Confidence            32  22334699999999996    5567899999999999999999999999642211      111111111110   


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       456 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                            ........+..+.+++.+|++.||++|||+.|+++
T Consensus       232 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 ------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                  00011122367899999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4e-41  Score=368.63  Aligned_cols=250  Identities=23%  Similarity=0.282  Sum_probs=206.4

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCcee
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  300 (549)
                      ..++|++.+.||+|+||.||+|... +++.||||+++...  .......+..|..++..+ +||||+++++++...+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4568999999999999999999976 58899999997432  123345678889998877 7999999999999999999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            9999999999999998877899999999999999999999999   9999999999999999999999999999864332


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                      . .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....       ......+..         ..
T Consensus       496 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~---------~~  558 (674)
T 3pfq_A          496 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIME---------HN  558 (674)
T ss_dssp             T-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHS---------SC
T ss_pred             C-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------HHHHHHHHh---------CC
Confidence            2 234456799999999999999999999999999999999999999974321       111111111         11


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKM-----SEVVR  496 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~  496 (549)
                        ..++...+.++.+++.+||+.||++||++     +||++
T Consensus       559 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence              11223344779999999999999999998     66654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-39  Score=342.73  Aligned_cols=259  Identities=20%  Similarity=0.251  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEE-CCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC-CCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++......   .++..|++++..++| +++..+..++...+..++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            36789999999999999999997 46899999998754432   247789999999987 55566666667788889999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee---cCCCceEEeecccccccCC
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ||+ +++|.+++.. ...+++..++.|+.||+.||.|||++   +|+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999 8999999974 55799999999999999999999999   99999999999999   6889999999999987754


Q ss_pred             CCCc------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccch
Q 008893          380 CDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       380 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      ....      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+....... .....
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~  237 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-VATSI  237 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-HHSCH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-ccccH
Confidence            3322      1224569999999999999999999999999999999999999997543322211111111111 11111


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       454 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      ..+.     ..+    +.++.+++..||+.+|++||++.+|++.|+..
T Consensus       238 ~~l~-----~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          238 EALC-----RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHH-----TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHh-----cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1111     112    36789999999999999999999999888763

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.4e-41  Score=346.06  Aligned_cols=253  Identities=10%  Similarity=0.005  Sum_probs=182.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--CcHHHHHHHHHHHhhc--cCCCccceE-------EEEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA--VHRNLLRLI-------GFCM  294 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~  294 (549)
                      .+|...+.||+|+||+||+|.+. +|+.||||+++.....  .....+.+|+.++..+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888999999999999999976 6899999999875432  2234577885554444  699987754       4444


Q ss_pred             cC-----------------CceeeEeeccCCCchhhhhcc-CCCCCHHHH------HHHHHHHHHHHHHhhhcCCCceEe
Q 008893          295 TT-----------------TERLLVYPYMSNGSVASRLKA-KPSLDWATR------KRIALGAARGLLYLHEQCDPKIIH  350 (549)
Q Consensus       295 ~~-----------------~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~ivH  350 (549)
                      ..                 ...++||||++ |+|.+++.. ...+++..+      ..++.||+.||+|||++   +|+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence            32                 23799999999 899999974 334566667      78889999999999999   9999


Q ss_pred             cccCcCeeeecCCCceEEeecccccccCCCCCceeeccccccCccCchhhcc--CCCCCcccchhHhHHHHHHHhCCccc
Q 008893          351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRAL  428 (549)
Q Consensus       351 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~  428 (549)
                      |||||+|||++.++.+||+|||+++....    ......+|+.|+|||.+.+  ..++.++|||||||++|||+||+.||
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999986542    2224457799999999987  67999999999999999999999999


Q ss_pred             ccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          429 EFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ..........         ......................+..+.+++.+||+.||++|||+.|+++
T Consensus       294 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          294 GLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            7543221100         0000000000111111111223477999999999999999999999974

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.9e-40  Score=327.71  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=200.5

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+....   ....+.+|+.++..++||||+++++++......++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            4568999999999999999999976 58999999997643   2456889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+++++|.+++. ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            9999999999986 456799999999999999999999999   999999999999999999999999999987653322


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......       ..........      .+.. 
T Consensus       181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~------~~~~-  245 (314)
T 3com_A          181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIFMIPTNP------PPTF-  245 (314)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC------CCCC-
T ss_pred             -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCC------Cccc-
Confidence             223446899999999999999999999999999999999999999643211       1111111110      0000 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             011122367899999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-41  Score=338.27  Aligned_cols=259  Identities=27%  Similarity=0.371  Sum_probs=199.1

Q ss_pred             cCHHHHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEe
Q 008893          217 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM  294 (549)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  294 (549)
                      +.+.++....++|++.+.||+|+||.||+|... +|+.||||++....  .....+.+|+.++..+ +||||+++++++.
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            344444556788999999999999999999975 68999999997543  2345788999999998 7999999999997


Q ss_pred             c------CCceeeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCce
Q 008893          295 T------TTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA  366 (549)
Q Consensus       295 ~------~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  366 (549)
                      .      ....++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence            6      46789999999999999999753  4699999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH
Q 008893          367 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML  441 (549)
Q Consensus       367 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~  441 (549)
                      ||+|||++........ ......||+.|+|||.+.     +..++.++||||||+++|+|+||+.||......       
T Consensus       169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------  240 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------  240 (326)
T ss_dssp             EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------
T ss_pred             EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------
Confidence            9999999986643221 223346899999999987     567899999999999999999999999643211       


Q ss_pred             HHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          442 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       442 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..........      .+...   ....+..+.+++.+||+.||++||++.|++++
T Consensus       241 ~~~~~~~~~~------~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          241 RALFLIPRNP------APRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHHHHHHHSC------CCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhcCc------cccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1111111110      01110   11123678999999999999999999999973

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.7e-41  Score=339.09  Aligned_cols=259  Identities=19%  Similarity=0.287  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCc----------------HHHHHHHHHHHhhccCCCccce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG----------------EIQFQTEVEMISLAVHRNLLRL  289 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~----------------~~~~~~e~~~l~~l~h~niv~l  289 (549)
                      .++|.+.+.||+|+||.||+|.. +|+.||||++........                ...+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            35788999999999999999999 899999999864322111                1679999999999999999999


Q ss_pred             EEEEecCCceeeEeeccCCCchhhh------hcc--CCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeee
Q 008893          290 IGFCMTTTERLLVYPYMSNGSVASR------LKA--KPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILL  360 (549)
Q Consensus       290 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~--~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill  360 (549)
                      ++++...+..++||||+++|+|.++      +..  ...+++..+..++.|++.||.|||+ .   +|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence            9999999999999999999999998      665  5689999999999999999999998 8   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCCceeeccccccCccCchhhccC-CCCC-cccchhHhHHHHHHHhCCcccccCccccccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSE-KTDVFGFGILLLELISGLRALEFGKTANQKG  438 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  438 (549)
                      +.++.+||+|||.+......   ......||..|+|||.+.+. .++. ++||||||+++|||+||+.||......    
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            99999999999999876432   33445699999999999887 5666 999999999999999999999754321    


Q ss_pred             cHHHHHHHHhhccc-hhh----hccccc---cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          439 AMLDWVKKIHQEKK-LEM----LVDKDL---KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       439 ~~~~~~~~~~~~~~-~~~----~~d~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        ............ ...    ...+..   ........+..+.+++.+||+.||++|||+.|++++
T Consensus       259 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          259 --VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             --HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             --HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              111111111100 000    000000   000012234678999999999999999999999873

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.9e-41  Score=346.18  Aligned_cols=258  Identities=21%  Similarity=0.317  Sum_probs=194.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCc------ee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE------RL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~  300 (549)
                      .+|...+.||+|+||+||+|....+..||+|++......     ..+|+.+++.++||||+++++++.....      .+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            468889999999999999999987777999988654322     2368999999999999999999864432      78


Q ss_pred             eEeeccCCCchhhhh---ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec-CCCceEEeecccccc
Q 008893          301 LVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKL  376 (549)
Q Consensus       301 lv~e~~~~g~L~~~l---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~  376 (549)
                      +||||++++.+....   .....+++..+..++.||+.||.|||+.   +|+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            999999875443332   2356799999999999999999999999   999999999999999 899999999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc-----
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE-----  450 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  450 (549)
                      ......  .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||........   +...+......     
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ---LVEIIKVLGTPSREQI  266 (394)
T ss_dssp             CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHH
T ss_pred             ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence            643322  2345689999999998765 589999999999999999999999975432221   11111110000     


Q ss_pred             ---------cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          451 ---------KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       451 ---------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                               ..........+...+....+.++.+++.+||+.||++|||+.|++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                     00000000000001112234679999999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.8e-41  Score=332.39  Aligned_cols=254  Identities=29%  Similarity=0.378  Sum_probs=195.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC--CCC--EEEEEEcccCCC--CCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ--DGT--VVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|++.+.||+|+||+||+|.+.  +++  .||||+++....  ......+.+|+.+++.++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            56888999999999999999863  233  689999875432  223457899999999999999999999998754 88


Q ss_pred             eEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          301 LVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      +|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            99999999999999875 35699999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCCce--eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          380 CDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       380 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      .....  .....+|..|+|||.+.+..++.++||||||+++|+|++ |+.||.....       ............    
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~----  242 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEGE----  242 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSCC----
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------HHHHHHHHccCC----
Confidence            43321  223457889999999998889999999999999999999 9999864321       111122211110    


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                           ....+...+..+.+++.+||+.||++|||+.+++++|+.
T Consensus       243 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  281 (291)
T 1u46_A          243 -----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  281 (291)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence                 011122234679999999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.2e-41  Score=365.06  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=204.7

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCce
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER  299 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  299 (549)
                      ...++|++.+.||+|+||.||+|.+..    +..||||.++..........+.+|+.+++.++||||+++++++. .+..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            345678888999999999999999742    46799999876543334467999999999999999999999985 4568


Q ss_pred             eeEeeccCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          300 LLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      ++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            9999999999999999754 4699999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ...........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......       +..........     
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~-----  610 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGER-----  610 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHHTCC-----
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCCC-----
Confidence            443333334457889999999999999999999999999999997 98998643211       11111111111     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                           ...+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       611 -----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          611 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                 11122334678999999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.4e-40  Score=332.11  Aligned_cols=254  Identities=21%  Similarity=0.296  Sum_probs=198.9

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhcc--CCCccceEEEEecCCcee
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV--HRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~  300 (549)
                      ...++|++.+.||+|+||.||++...+++.||||++...... .....+.+|+.++..++  |+||+++++++......+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            345678899999999999999999888999999999754322 23356899999999997  599999999999999999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +||| +.+++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||++++ +.+||+|||+++.....
T Consensus       105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence            9999 56789999998888899999999999999999999999   9999999999999965 89999999999876543


Q ss_pred             CCc-eeeccccccCccCchhhcc-----------CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          381 DSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       381 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      ... ......||+.|+|||.+.+           ..++.++||||||+++|||+||+.||......      ......  
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~--  251 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHA--  251 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHH--
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------HHHHHH--
Confidence            222 2234468999999999875           46888999999999999999999999642211      111111  


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                             ..+......++...+..+.+++.+||+.||++||++.|++++
T Consensus       252 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          252 -------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                   111111112222224678999999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.2e-40  Score=326.97  Aligned_cols=252  Identities=22%  Similarity=0.264  Sum_probs=203.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC--------CcHHHHHHHHHHHhhcc-CCCccceEEEEec
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--------GGEIQFQTEVEMISLAV-HRNLLRLIGFCMT  295 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  295 (549)
                      .++|.+.+.||+|+||.||+|... +|+.||||++......        .....+.+|+.++.++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            467889999999999999999986 5899999999754311        11235788999999995 9999999999999


Q ss_pred             CCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          296 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       296 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      ....++||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchh
Confidence            999999999999999999998777899999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCceeeccccccCccCchhhc------cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          376 LLDHCDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      ......  ......||+.|+|||.+.      ...++.++||||||+++|+|++|+.||.....       .........
T Consensus       173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~  243 (298)
T 1phk_A          173 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIMS  243 (298)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH
T ss_pred             hcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------HHHHHHHhc
Confidence            765432  223456899999999985      45678999999999999999999999964321       111111111


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ... .      .........+..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~-~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          244 GNY-Q------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             TCC-C------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCc-c------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            110 0      000001123467899999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.1e-40  Score=326.90  Aligned_cols=252  Identities=20%  Similarity=0.276  Sum_probs=198.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            467889999999999999999986 58999999987543 3445678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...... ..
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  172 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ  172 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence            9999999998864 55799999999999999999999999   9999999999999999999999999987543211 01


Q ss_pred             eeeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          384 VTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ......||+.|+|||.+.     ...++.++||||||+++|+|+||+.||......       ............ ..  
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-~~--  242 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSDPP-TL--  242 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCC-CC--
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHHhccCCc-cc--
Confidence            122345899999999983     667899999999999999999999998743211       111111111100 00  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                           ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus       243 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          243 -----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -----CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                 0111223678999999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.6e-40  Score=335.24  Aligned_cols=263  Identities=19%  Similarity=0.241  Sum_probs=192.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCC------c
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------E  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  298 (549)
                      ++|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            57889999999999999999975 6889999999754322 22346889999999999999999999997654      6


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++||||+++ +|.+.+..  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       105 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             EEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             eEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            7999999975 78887763  489999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH--------HHH------
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWV------  444 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~------  444 (549)
                      ..  .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...........+.        .+.      
T Consensus       179 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          179 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             cc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            32  22334569999999999999999999999999999999999999997543211100000        000      


Q ss_pred             -HHHhhc-c-----chhhhccccccCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          445 -KKIHQE-K-----KLEMLVDKDLKNN---YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       445 -~~~~~~-~-----~~~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       ...... .     .............   ........+.+++.+||+.||++|||++|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence             000000 0     0000000000000   112335789999999999999999999999874

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-40  Score=346.62  Aligned_cols=197  Identities=22%  Similarity=0.277  Sum_probs=170.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc------cCCCccceEEEEecCCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA------VHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~  298 (549)
                      ..+|++.+.||+|+||+||+|... +++.||||+++...  .....+.+|+.++..+      .|+||+++++++.....
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            356889999999999999999876 58999999997532  2234677888888877      46799999999999999


Q ss_pred             eeeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc--eEEeecccc
Q 008893          299 RLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--AVVGDFGLA  374 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~  374 (549)
                      .++||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.  +||+|||++
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999996 6899888643  3599999999999999999999999   9999999999999999887  999999999


Q ss_pred             cccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCc
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK  432 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~  432 (549)
                      +.....    .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            765432    233468999999999999999999999999999999999999997543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.4e-40  Score=337.02  Aligned_cols=266  Identities=21%  Similarity=0.259  Sum_probs=189.4

Q ss_pred             HHHHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCc-
Q 008893          221 ELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE-  298 (549)
Q Consensus       221 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  298 (549)
                      +.....++|.+.+.||+|+||.||+|... +|+.||||++......  ...+.+++..+..++||||+++++++..... 
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            34566789999999999999999999975 6899999998654322  2346678888889999999999999865433 


Q ss_pred             ------eeeEeeccCCCchh---hhhccCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCceEecccCcCeeeecC-CCce
Q 008893          299 ------RLLVYPYMSNGSVA---SRLKAKPSLDWATRKRIALGAARGLLYLH--EQCDPKIIHRDVKAANILLDE-YYEA  366 (549)
Q Consensus       299 ------~~lv~e~~~~g~L~---~~l~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~Nill~~-~~~~  366 (549)
                            .++||||++++.+.   ........+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence                  78999999875322   23345667999999999999999999999  77   9999999999999996 8999


Q ss_pred             EEeecccccccCCCCCceeeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHH
Q 008893          367 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       367 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  445 (549)
                      ||+|||+++......  ......||+.|+|||.+.+.. ++.++|||||||++|||+||+.||........   +.....
T Consensus       172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~~~  246 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEIVR  246 (360)
T ss_dssp             EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH
T ss_pred             EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHHHH
Confidence            999999998765432  233456899999999986654 89999999999999999999999975432211   111111


Q ss_pred             HHhh-----------ccchhhhccc------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          446 KIHQ-----------EKKLEMLVDK------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       446 ~~~~-----------~~~~~~~~d~------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ....           ........+.      ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1100           0000000000      0001111224578999999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.2e-40  Score=338.90  Aligned_cols=263  Identities=19%  Similarity=0.242  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc--------CCCccceEEEEe--
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--------HRNLLRLIGFCM--  294 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--  294 (549)
                      .++|.+.+.||+|+||+||+|... +++.||||+++...  .....+.+|+.+++.++        |+||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            367899999999999999999865 58899999997432  23456889999999886        788999999987  


Q ss_pred             --cCCceeeEeeccCCCchhhhhc-c-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC------
Q 008893          295 --TTTERLLVYPYMSNGSVASRLK-A-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY------  364 (549)
Q Consensus       295 --~~~~~~lv~e~~~~g~L~~~l~-~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~------  364 (549)
                        .....++||||+. +++.+.+. . ...+++..+..++.||+.||.|||+++  +|+||||||+|||++.++      
T Consensus       114 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          114 GVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             ETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence              5567899999995 55655554 3 256999999999999999999999853  799999999999999775      


Q ss_pred             -------------------------------------------ceEEeecccccccCCCCCceeeccccccCccCchhhc
Q 008893          365 -------------------------------------------EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS  401 (549)
Q Consensus       365 -------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  401 (549)
                                                                 .+||+|||+++.....    .....||+.|+|||++.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence                                                       7999999999876432    23346899999999999


Q ss_pred             cCCCCCcccchhHhHHHHHHHhCCcccccCcccccccc--HHHHHHHHhhc---------cchhhhcccc----------
Q 008893          402 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA--MLDWVKKIHQE---------KKLEMLVDKD----------  460 (549)
Q Consensus       402 ~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~---------~~~~~~~d~~----------  460 (549)
                      +..++.++|||||||++|||+||+.||...........  ....+......         ......+...          
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            99999999999999999999999999975443222111  11111111000         0000000000          


Q ss_pred             ---------ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          461 ---------LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       461 ---------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                               -....+......+.+++.+||+.||++|||+.|++++
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                     0012356677889999999999999999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-40  Score=346.19  Aligned_cols=256  Identities=24%  Similarity=0.324  Sum_probs=192.7

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC----C--cee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT----T--ERL  300 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~--~~~  300 (549)
                      +|+..+.||+|+||.||+|.+. +|+.||||++.....     ...+|+++++.++||||+++++++...    +  ..+
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            5778899999999999999986 599999999875432     134699999999999999999998532    1  357


Q ss_pred             eEeeccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC-CceEEeeccccc
Q 008893          301 LVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAK  375 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~  375 (549)
                      +||||+++ ++.+.+.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 5655543    456799999999999999999999999   99999999999999955 678999999998


Q ss_pred             ccCCCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc--cc
Q 008893          376 LLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE--KK  452 (549)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~  452 (549)
                      .......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......   .+...+......  ..
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence            7653322  2345689999999998765 78999999999999999999999997543221   122222111000  00


Q ss_pred             h-------hhhcccccc-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          453 L-------EMLVDKDLK-----NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       453 ~-------~~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +       .....+.+.     ..+....+.++.+|+.+||+.||++|||+.|++++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            0       000000000     00112234679999999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.4e-40  Score=337.54  Aligned_cols=262  Identities=21%  Similarity=0.250  Sum_probs=182.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecC------Cc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TE  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  298 (549)
                      ++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            57889999999999999999964 689999999975432 22344688999999999999999999998754      56


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            79999999 6899998876 4699999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh-------hc
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH-------QE  450 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~  450 (549)
                      ..    .....||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...........+........       ..
T Consensus       184 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          184 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             cc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            22    234568999999999877 6789999999999999999999999975432211111111000000       00


Q ss_pred             cchhhhccccc-cCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          451 KKLEMLVDKDL-KNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       451 ~~~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ......+.... .....     ......+.+++.+||+.||++|||+.|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00000000000 00000     1123568999999999999999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.2e-41  Score=341.06  Aligned_cols=263  Identities=20%  Similarity=0.254  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC-----Cce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  299 (549)
                      .++|.+.+.||+|+||.||+|... +|+.||||++...........+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467889999999999999999976 68999999997544333345688999999999999999999998754     678


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+. ++|.+++... .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEEEeccC-ccHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            99999997 5899888764 599999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCc---------eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          380 CDSH---------VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       380 ~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      ....         ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........    ...+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~  240 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ----LLLIFGIIG  240 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHC
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhC
Confidence            2211         1123468999999998765 6789999999999999999999999975432111    000000000


Q ss_pred             ccc------------hhhhccccc-cC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 EKK------------LEMLVDKDL-KN-----NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 ~~~------------~~~~~d~~l-~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...            ..+...... ..     ......+..+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000            000000000 00     0001223678899999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.7e-40  Score=333.43  Aligned_cols=264  Identities=23%  Similarity=0.326  Sum_probs=199.9

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEE--CCCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhc---cCCCccceEEEEe----
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYL--QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA---VHRNLLRLIGFCM----  294 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----  294 (549)
                      +.++|++.+.||+|+||.||+|..  .+|+.||+|+++..... .....+.+|+.+++.+   .||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999997  35889999998743321 1223466777777666   8999999999987    


Q ss_pred             -cCCceeeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeec
Q 008893          295 -TTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF  371 (549)
Q Consensus       295 -~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  371 (549)
                       .....++||||+. |+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence             4567899999998 6999998753  3599999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh--
Q 008893          372 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ--  449 (549)
Q Consensus       372 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  449 (549)
                      |+++.....  .......||..|+|||.+.+..++.++||||||+++|||+||+.||........   +.........  
T Consensus       165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~  239 (326)
T 1blx_A          165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG  239 (326)
T ss_dssp             CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred             cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence            999865422  122345689999999999999999999999999999999999999975432211   1111111100  


Q ss_pred             -ccchhh------hcc---ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 -EKKLEM------LVD---KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 -~~~~~~------~~d---~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       ......      ...   ......+....+..+.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             000000      000   000011112234678899999999999999999999863

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9e-40  Score=324.91  Aligned_cols=250  Identities=20%  Similarity=0.299  Sum_probs=197.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC---CCCcHHHHHHHHHHHhhccCCCccceEEEEe--cCCce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN---AIGGEIQFQTEVEMISLAVHRNLLRLIGFCM--TTTER  299 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  299 (549)
                      .++|.+.+.||+|+||.||+|... +++.||+|+++...   .......+.+|+.+++.++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999999999975 68899999997532   1234567999999999999999999999984  44578


Q ss_pred             eeEeeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccccc
Q 008893          300 LLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      ++||||++++ |.+.+..  ...+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 6666643  45699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCC-ceeeccccccCccCchhhccCCC--CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          378 DHCDS-HVTTAVRGTVGHIAPEYLSTGQS--SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       378 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~--~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      ..... .......||+.|+|||.+.+...  +.++||||||+++|||++|+.||.....       ......+....   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~---  229 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFENIGKGS---  229 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCC---
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHHHhcCC---
Confidence            53222 22334569999999999976543  7799999999999999999999974321       11111111110   


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                          ..+    +......+.+++.+|++.||++|||+.|++++
T Consensus       230 ----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ----YAI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----CCC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----CCC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                011    11223678899999999999999999999974

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.5e-40  Score=330.08  Aligned_cols=256  Identities=19%  Similarity=0.262  Sum_probs=201.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEE-C-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCC------ccceEEEEecCCc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYL-Q-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN------LLRLIGFCMTTTE  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  298 (549)
                      ++|++.+.||+|+||+||+|.. . +++.||||+++...  .....+.+|+.++..++|++      ++++++++...+.
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            5788999999999999999987 3 58899999997432  22456889999999887765      9999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC--------------
Q 008893          299 RLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--------------  362 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--------------  362 (549)
                      .++||||+ +++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999987554  689999999999999999999999   9999999999999987              


Q ss_pred             -----CCceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccccc
Q 008893          363 -----YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK  437 (549)
Q Consensus       363 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~  437 (549)
                           ++.+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||+++|||+||+.||.........
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                 678999999999865432    23346899999999999999999999999999999999999999754322111


Q ss_pred             ccHHHHHHHHhhccc-----------------------------hhhhcccc-ccCCCCHHHHHHHHHHHHHhcccCCCC
Q 008893          438 GAMLDWVKKIHQEKK-----------------------------LEMLVDKD-LKNNYDRIELEEMVQVALLCTQYLPSL  487 (549)
Q Consensus       438 ~~~~~~~~~~~~~~~-----------------------------~~~~~d~~-l~~~~~~~~~~~l~~l~~~cl~~dP~~  487 (549)
                          ..+........                             ......+. -...........+.+++.+||+.||++
T Consensus       244 ----~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          244 ----AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             ----HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             ----HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence                11111000000                             00000000 001123345678999999999999999


Q ss_pred             CCCHHHHHH
Q 008893          488 RPKMSEVVR  496 (549)
Q Consensus       488 RPs~~evl~  496 (549)
                      |||+.|+++
T Consensus       320 Rpt~~ell~  328 (339)
T 1z57_A          320 RITLREALK  328 (339)
T ss_dssp             SCCHHHHTT
T ss_pred             ccCHHHHhc
Confidence            999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.2e-39  Score=319.40  Aligned_cols=252  Identities=24%  Similarity=0.338  Sum_probs=204.1

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ..++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++......++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3467999999999999999999976 689999999865432 33456789999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC---CCceEEeecccccccCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~~~  379 (549)
                      |||+++++|.+.+.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.   ++.+||+|||++.....
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            99999999999987767899999999999999999999999   9999999999999975   44799999999987653


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      ..  ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.....       .+...........   .+.
T Consensus       177 ~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~---~~~  243 (287)
T 2wei_A          177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYA---FDL  243 (287)
T ss_dssp             CS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC---CCS
T ss_pred             CC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCC---CCc
Confidence            32  2233458999999999865 489999999999999999999999974321       1111221111100   000


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .....    .+..+.+++.+|++.||++|||+.|+++
T Consensus       244 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          244 PQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             GGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            00111    2367899999999999999999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.7e-40  Score=331.24  Aligned_cols=253  Identities=24%  Similarity=0.319  Sum_probs=178.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHH-HHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|...+.||+|+||.||+|... +|+.||||+++.........++..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            57888999999999999999985 689999999976543333445556665 6777899999999999999999999999


Q ss_pred             ccCCCchhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          305 YMSNGSVASRLK-----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       305 ~~~~g~L~~~l~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      |+++ +|.+++.     ....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||+++....
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            9985 7777765     2567999999999999999999999842  899999999999999999999999999986643


Q ss_pred             CCCceeeccccccCccCchhh----ccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          380 CDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      ..  ......||+.|+|||.+    .+..++.++||||||+++|||+||+.||........      ......      .
T Consensus       179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~------~  244 (327)
T 3aln_A          179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVV------K  244 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCC------C
T ss_pred             cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHHHHh------c
Confidence            22  22333699999999998    456789999999999999999999999974221100      000000      0


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       456 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      -..+.+........+..+.+++.+||+.||++||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00011111111123467999999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=337.78  Aligned_cols=263  Identities=20%  Similarity=0.261  Sum_probs=182.1

Q ss_pred             CCCC-CCeeeeeCCeEEEEEEEC---CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec--CCceee
Q 008893          228 NFSS-KNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLL  301 (549)
Q Consensus       228 ~~~~-~~~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  301 (549)
                      .|++ .++||+|+||+||+|.+.   +++.||||++....   ....+.+|+.+++.++||||+++++++..  ....++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            3555 568999999999999975   47899999997543   23468899999999999999999999954  668899


Q ss_pred             EeeccCCCchhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee----cCCCceEE
Q 008893          302 VYPYMSNGSVASRLKA---------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVV  368 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl  368 (549)
                      ||||+.+ +|.+++..         ...+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999974 78777641         12599999999999999999999999   99999999999999    77899999


Q ss_pred             eecccccccCCCCC--ceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCcccccc------cc
Q 008893          369 GDFGLAKLLDHCDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQK------GA  439 (549)
Q Consensus       369 ~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~------~~  439 (549)
                      +|||+++.......  .......||+.|+|||++.+. .++.++|||||||++|||+||+.||.........      ..
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987653222  223345699999999999874 5899999999999999999999999754321100      01


Q ss_pred             HHHHHHHHhh--ccchhhh------------ccccccCCCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          440 MLDWVKKIHQ--EKKLEML------------VDKDLKNNYDR---------IELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       440 ~~~~~~~~~~--~~~~~~~------------~d~~l~~~~~~---------~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      +...+.....  ......+            +..........         .....+.+|+.+||+.||++|||++|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111110000  0000000            00000000000         01356889999999999999999999997


Q ss_pred             H
Q 008893          497 M  497 (549)
Q Consensus       497 ~  497 (549)
                      +
T Consensus       334 h  334 (405)
T 3rgf_A          334 D  334 (405)
T ss_dssp             S
T ss_pred             C
Confidence            4

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=332.08  Aligned_cols=256  Identities=23%  Similarity=0.374  Sum_probs=199.4

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ...++|++.+.||+|+||.||+|...+  .||+|+++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345688999999999999999999864  499999875432 22234577899999999999999999999999999999


Q ss_pred             eeccCCCchhhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++++|.+++.... .+++..+..++.||+.||.|||+.   +|+||||||+||+++ ++.+||+|||+++......
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            99999999999998644 799999999999999999999999   999999999999998 6799999999987653211


Q ss_pred             C----ceeeccccccCccCchhhcc---------CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHh
Q 008893          382 S----HVTTAVRGTVGHIAPEYLST---------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIH  448 (549)
Q Consensus       382 ~----~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  448 (549)
                      .    .......||+.|+|||.+..         ..++.++||||||+++|||+||+.||......       .......
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~  256 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------AIIWQMG  256 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------HHHHHHH
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHhc
Confidence            1    12233458999999999864         35788999999999999999999999643211       1111111


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          449 QEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       449 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      .. .     .+....   ...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       257 ~~-~-----~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l  300 (319)
T 2y4i_B          257 TG-M-----KPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL  300 (319)
T ss_dssp             TT-C-----CCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred             cC-C-----CCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11 0     111100   01225688999999999999999999999999974

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.5e-39  Score=330.89  Aligned_cols=258  Identities=19%  Similarity=0.255  Sum_probs=195.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCCce-----
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER-----  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-----  299 (549)
                      ++|...+.||+|+||.||+|... +|+.||||++....... ....+.+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            57888999999999999999975 68999999997643222 234688999999999999999999999877654     


Q ss_pred             -eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          300 -LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       300 -~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                       ++||||+. ++|.+.+..  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       122 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             EEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence             99999997 588887754  489999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc--cc---
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE--KK---  452 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---  452 (549)
                      ..    .....||+.|+|||.+.+ ..++.++|||||||++|+|+||+.||........   +..........  ..   
T Consensus       196 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          196 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHTT
T ss_pred             cC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCcHHHHHH
Confidence            32    234568999999999987 6789999999999999999999999975332111   11111100000  00   


Q ss_pred             -----hhhh---ccccccCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          453 -----LEML---VDKDLKNN---YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       453 -----~~~~---~d~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                           ....   ........   ........+.+++.+||+.||++|||+.|++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                 0000   00000000   001124678999999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.1e-39  Score=329.45  Aligned_cols=200  Identities=25%  Similarity=0.311  Sum_probs=169.8

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CC-----CccceEEEEecCC
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HR-----NLLRLIGFCMTTT  297 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~  297 (549)
                      ..++|.+.+.||+|+||+||+|... +++.||||+++...  .....+..|+.++..++ |+     +++++++++...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3578999999999999999999976 58899999997432  22345778888888775 44     4999999999999


Q ss_pred             ceeeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec--CCCceEEeeccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGL  373 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~  373 (549)
                      ..++||||+. |+|.+++...  ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||+
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            9999999996 5999998754  4699999999999999999999952 22899999999999994  578899999999


Q ss_pred             ccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCc
Q 008893          374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK  432 (549)
Q Consensus       374 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~  432 (549)
                      ++.....    .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          208 SCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9876432    233568999999999999999999999999999999999999997543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=328.34  Aligned_cols=245  Identities=24%  Similarity=0.362  Sum_probs=193.4

Q ss_pred             HHHhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-----cHHHHHHHHHHHhhc----cCCCccceEEE
Q 008893          223 QSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLA----VHRNLLRLIGF  292 (549)
Q Consensus       223 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l----~h~niv~l~~~  292 (549)
                      +...++|.+.+.||+|+||.||+|... +++.||||++.......     ....+..|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            344578999999999999999999864 68999999997543221     122356788898888    89999999999


Q ss_pred             EecCCceeeEeec-cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec-CCCceEEee
Q 008893          293 CMTTTERLLVYPY-MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGD  370 (549)
Q Consensus       293 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~D  370 (549)
                      +...+..++|+|| +.+++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||+++ +++.+||+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence            9999999999999 78999999998777899999999999999999999999   999999999999999 889999999


Q ss_pred             cccccccCCCCCceeeccccccCccCchhhccCCCC-CcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh
Q 008893          371 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ  449 (549)
Q Consensus       371 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (549)
                      ||+++......   .....||..|+|||.+.+..+. .++||||||+++|||++|+.||....         .    ...
T Consensus       184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~----~~~  247 (312)
T 2iwi_A          184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------E----ILE  247 (312)
T ss_dssp             CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H----HHH
T ss_pred             cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------H----Hhh
Confidence            99998765322   2345589999999999877764 58999999999999999999986311         0    000


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                               ..  ..++......+.+++.+||+.||++|||+.|++++
T Consensus       248 ---------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          248 ---------AE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ---------TC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---------hc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     00  01112233678999999999999999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.4e-39  Score=319.98  Aligned_cols=251  Identities=25%  Similarity=0.394  Sum_probs=192.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec---------
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT---------  295 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  295 (549)
                      .++|++.+.||+|+||.||+|... +|+.||||++....  .....+.+|+.+++.++||||+++++++.+         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            457889999999999999999975 68999999996432  234568899999999999999999998865         


Q ss_pred             ----CCceeeEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEee
Q 008893          296 ----TTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD  370 (549)
Q Consensus       296 ----~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  370 (549)
                          ....++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence                3467899999999999999974 34688899999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCC-------------CceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccc
Q 008893          371 FGLAKLLDHCD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQ  436 (549)
Q Consensus       371 fg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~  436 (549)
                      ||++.......             ........||+.|+|||.+.+. .++.++||||||+++|||++   ||....    
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~----  232 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM----  232 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch----
Confidence            99998664321             1122344689999999999764 68999999999999999998   443111    


Q ss_pred             cccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          437 KGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        ............       .......++...+..+.+++.+||+.||++|||+.|++++
T Consensus       233 --~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          233 --ERVNILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             --HHHHHHHHHHST-------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --hHHHHHHhcccc-------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence              011111111110       1111122333344678999999999999999999999873

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.5e-39  Score=325.23  Aligned_cols=257  Identities=20%  Similarity=0.269  Sum_probs=196.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEecCCc------
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE------  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------  298 (549)
                      ++|...+.||+|+||.||+|... +|+.||||++....... ....+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888999999999999999975 68999999997643222 23468899999999999999999999987654      


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++||||+. ++|.+.+..  .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            499999997 588888754  489999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh--ccc---
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ--EKK---  452 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~---  452 (549)
                      ..    .....||+.|+|||.+.+ ..++.++||||||+++|||+||+.||........   +.........  ...   
T Consensus       178 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          178 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHHTT
T ss_pred             CC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHH
Confidence            22    233468999999999877 6789999999999999999999999975432111   1111110000  000   


Q ss_pred             ---------hhhhc---cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          453 ---------LEMLV---DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       453 ---------~~~~~---d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                               ...+.   ...+ .......+..+.+++.+|++.||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                     00000   0000 11112335779999999999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.1e-40  Score=332.02  Aligned_cols=243  Identities=23%  Similarity=0.355  Sum_probs=200.5

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-----cHHHHHHHHHHHhhcc--CCCccceEEEEecC
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAV--HRNLLRLIGFCMTT  296 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~  296 (549)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.......     ....+..|+.+++.++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            4567899999999999999999964 68999999997543221     1234678999999996  59999999999999


Q ss_pred             CceeeEeeccCC-CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec-CCCceEEeecccc
Q 008893          297 TERLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLA  374 (549)
Q Consensus       297 ~~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~  374 (549)
                      +..++|+||+.+ ++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++ +++.+||+|||++
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            999999999976 89999998777899999999999999999999999   999999999999999 7899999999999


Q ss_pred             cccCCCCCceeeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccch
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      +.....   ......||+.|+|||.+.+..+ +.++||||||+++|||+||+.||.....             .....  
T Consensus       198 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~~~--  259 (320)
T 3a99_A          198 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQ--  259 (320)
T ss_dssp             EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCC--
T ss_pred             cccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhccc--
Confidence            876532   2234469999999999987765 6789999999999999999999863210             00000  


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       454 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                           ......+    +..+.+++.+||+.||++|||++|++++
T Consensus       260 -----~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          260 -----VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             -----CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----ccccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0011122    3678999999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.4e-39  Score=326.50  Aligned_cols=250  Identities=19%  Similarity=0.241  Sum_probs=172.5

Q ss_pred             hcCCCCC-CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec----CCce
Q 008893          226 TSNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTER  299 (549)
Q Consensus       226 ~~~~~~~-~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  299 (549)
                      .++|.+. +.||+|+||+||+|... +|+.||||++....     ....+....+..+.||||+++++++..    ....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            4577774 46999999999999976 68999999986432     222233334567789999999999875    3457


Q ss_pred             eeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC---CCceEEeecccc
Q 008893          300 LLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA  374 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~  374 (549)
                      ++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            9999999999999999754  3699999999999999999999999   9999999999999975   456999999999


Q ss_pred             cccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      +.....   ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||................   . ..   
T Consensus       179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~-~~---  248 (336)
T 3fhr_A          179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI---R-LG---  248 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh---h-cc---
Confidence            865432   2234468999999999988889999999999999999999999997533221110000000   0 00   


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                         ............+..+.+++.+||+.||++|||+.|+++
T Consensus       249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               000000011123467899999999999999999999997

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.7e-39  Score=337.36  Aligned_cols=249  Identities=24%  Similarity=0.272  Sum_probs=187.6

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEeecc
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      .|...+.||+|+||+||.+...+|+.||||++....    ...+.+|+.++..+ +||||+++++++......++||||+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            344568899999999987777789999999986532    34678899999876 8999999999999999999999999


Q ss_pred             CCCchhhhhccCCCC-------CHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCC-------------Cce
Q 008893          307 SNGSVASRLKAKPSL-------DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-------------YEA  366 (549)
Q Consensus       307 ~~g~L~~~l~~~~~l-------~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-------------~~~  366 (549)
                      . |+|.+++......       ++..+..++.||+.||.|||+.   +|+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 6999999754322       3334578999999999999999   99999999999999754             489


Q ss_pred             EEeecccccccCCCCCc---eeeccccccCccCchhhcc-------CCCCCcccchhHhHHHHHHHh-CCcccccCcccc
Q 008893          367 VVGDFGLAKLLDHCDSH---VTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIS-GLRALEFGKTAN  435 (549)
Q Consensus       367 kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~  435 (549)
                      ||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999877643322   1234569999999999975       568999999999999999999 999986422110


Q ss_pred             ccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                           ......   ....     +..........+.++.+++.+||+.||++|||+.|++++
T Consensus       248 -----~~i~~~---~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 -----SNIIRG---IFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             -----HHHHHT---CCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----HHHhcC---CCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence                 111110   0000     111112245567889999999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=322.76  Aligned_cols=261  Identities=22%  Similarity=0.282  Sum_probs=191.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEe-----------
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM-----------  294 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----------  294 (549)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++.           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            57888999999999999999986 48999999987543 233456889999999999999999999874           


Q ss_pred             ---cCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec-CCCceEEee
Q 008893          295 ---TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGD  370 (549)
Q Consensus       295 ---~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~D  370 (549)
                         .....++||||++ |+|.+++.. ..+++..+..++.|++.||.|||+.   +|+||||||+||+++ +++.+||+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence               3457799999998 699999875 4689999999999999999999999   999999999999997 667999999


Q ss_pred             cccccccCCCCCc--eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHH
Q 008893          371 FGLAKLLDHCDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKI  447 (549)
Q Consensus       371 fg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  447 (549)
                      ||+++........  ......+|..|+|||.+.+ ..++.++||||||+++|||+||+.||........   ........
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~  241 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLILESI  241 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHS
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhc
Confidence            9999876432211  2233457899999998865 6789999999999999999999999975432111   11111000


Q ss_pred             hh--ccchhh-------hcccccc-CC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          448 HQ--EKKLEM-------LVDKDLK-NN-----YDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       448 ~~--~~~~~~-------~~d~~l~-~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ..  .....+       ....... ..     .....+..+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00  000000       0000000 00     00112467899999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.6e-39  Score=329.14  Aligned_cols=261  Identities=20%  Similarity=0.267  Sum_probs=197.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-----------CCCccceEEEEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----------HRNLLRLIGFCM  294 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  294 (549)
                      ++|.+.+.||+|+||+||+|... +++.||||++....  .....+.+|+.++..+.           ||||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            57889999999999999999974 68999999997432  22446888999988876           899999999987


Q ss_pred             cCC----ceeeEeeccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec------C
Q 008893          295 TTT----ERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD------E  362 (549)
Q Consensus       295 ~~~----~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~------~  362 (549)
                      ...    ..+++|||+ +++|.+++..  ...+++..+..++.||+.||.|||+++  +|+||||||+|||++      .
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence            644    689999999 8899999874  345999999999999999999999843  899999999999994      4


Q ss_pred             CCceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccc---c
Q 008893          363 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG---A  439 (549)
Q Consensus       363 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~---~  439 (549)
                      .+.+||+|||+++.....    .....||+.|+|||.+.+..++.++|||||||++|||+||+.||..........   .
T Consensus       174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence            458999999999876432    233468999999999999999999999999999999999999997543221111   1


Q ss_pred             HHHHHHHHhh--------ccchhhhccc-------------------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 008893          440 MLDWVKKIHQ--------EKKLEMLVDK-------------------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMS  492 (549)
Q Consensus       440 ~~~~~~~~~~--------~~~~~~~~d~-------------------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  492 (549)
                      +.........        .......+..                   .-...++......+.+++.+||+.||++|||+.
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            1111110000        0000000000                   001234567788999999999999999999999


Q ss_pred             HHHH
Q 008893          493 EVVR  496 (549)
Q Consensus       493 evl~  496 (549)
                      |+++
T Consensus       330 ell~  333 (373)
T 1q8y_A          330 GLVN  333 (373)
T ss_dssp             HHHT
T ss_pred             HHhh
Confidence            9986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.5e-39  Score=326.00  Aligned_cols=256  Identities=18%  Similarity=0.257  Sum_probs=197.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CC-CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCC------ccceEEEEecCCc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DG-TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN------LLRLIGFCMTTTE  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  298 (549)
                      ++|.+.+.||+|+||+||+|... ++ +.||+|+++...  .....+..|+.+++.++|++      ++.+.+++.....
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            57889999999999999999975 34 689999997432  23456888999999998766      8999999999999


Q ss_pred             eeeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee----------------
Q 008893          299 RLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----------------  360 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----------------  360 (549)
                      .++||||+ ++++.+.+...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||+                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 55666666533  4699999999999999999999999   99999999999999                


Q ss_pred             ---cCCCceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccccc
Q 008893          361 ---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK  437 (549)
Q Consensus       361 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~  437 (549)
                         +.++.+||+|||+++.....    .....||+.|+|||.+.+..++.++|||||||++|||+||+.||........ 
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH-  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred             ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence               67889999999999865432    2334699999999999999999999999999999999999999975332111 


Q ss_pred             ccHHHHHHHHhhcc---------chhhhcc--------------------c-cccCCCCHHHHHHHHHHHHHhcccCCCC
Q 008893          438 GAMLDWVKKIHQEK---------KLEMLVD--------------------K-DLKNNYDRIELEEMVQVALLCTQYLPSL  487 (549)
Q Consensus       438 ~~~~~~~~~~~~~~---------~~~~~~d--------------------~-~l~~~~~~~~~~~l~~l~~~cl~~dP~~  487 (549)
                         ...+.......         .......                    + .............+.+++.+||+.||++
T Consensus       248 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          248 ---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             ---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             ---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence               11111110000         0000000                    0 0000112334568999999999999999


Q ss_pred             CCCHHHHHH
Q 008893          488 RPKMSEVVR  496 (549)
Q Consensus       488 RPs~~evl~  496 (549)
                      |||+.|+++
T Consensus       325 Rpt~~e~l~  333 (355)
T 2eu9_A          325 RITLAEALL  333 (355)
T ss_dssp             SCCHHHHTT
T ss_pred             CcCHHHHhc
Confidence            999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=318.56  Aligned_cols=250  Identities=23%  Similarity=0.320  Sum_probs=179.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHH-HHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|+..+.||+|+||.||+|... +|+.||||++..........+ +.++..+++.++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            56888899999999999999986 689999999976543222233 4445556788899999999999999999999999


Q ss_pred             ccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          305 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       305 ~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |+ ++.+..+.. ....+++..+..++.|++.||.|||+ .   +|+||||||+||+++.++.+||+|||++....... 
T Consensus       105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-  179 (318)
T ss_dssp             CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence            99 445555443 25679999999999999999999998 5   89999999999999999999999999997654322 


Q ss_pred             ceeeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          383 HVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                       ......||+.|+|||.+.     ...++.++||||||+++|||+||+.||......      ............     
T Consensus       180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~-----  247 (318)
T 2dyl_A          180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVLTKVLQEEP-----  247 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHHHSCC-----
T ss_pred             -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHHHHHhccCC-----
Confidence             223446899999999994     456889999999999999999999999742211      111111111110     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                       +.+..  ....+..+.+++.+||+.||.+||++.|+++
T Consensus       248 -~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 -PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             00000  0112367899999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-39  Score=349.12  Aligned_cols=259  Identities=24%  Similarity=0.333  Sum_probs=199.3

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec------CCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT------TTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  298 (549)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|+.+++.++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999975 6899999999765443445578999999999999999999999765      667


Q ss_pred             eeeEeeccCCCchhhhhccCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCc---eEEeecc
Q 008893          299 RLLVYPYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFG  372 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg  372 (549)
                      .++||||+++|+|.+++....   .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999997543   699999999999999999999999   9999999999999997664   9999999


Q ss_pred             cccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccc
Q 008893          373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK  452 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (549)
                      ++.......  ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||......      ..|.........
T Consensus       170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~------~~~~~~i~~~~~  241 (676)
T 3qa8_A          170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP------VQWHGKVREKSN  241 (676)
T ss_dssp             CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH------HHSSTTCC----
T ss_pred             ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch------hhhhhhhhcccc
Confidence            998765432  233456999999999999999999999999999999999999999753211      111111100000


Q ss_pred             hhhhccc------------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 008893          453 LEMLVDK------------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV  495 (549)
Q Consensus       453 ~~~~~d~------------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  495 (549)
                      .......            ..........+..+.+++.+|++.||++|||+.|++
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            0000000            011223445678899999999999999999997743

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-38  Score=329.06  Aligned_cols=248  Identities=23%  Similarity=0.283  Sum_probs=187.0

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .+|...+.||+|+||+||.....+|+.||||++......    .+.+|+.+++.+ +||||+++++++.+....++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            457788999999999976665667999999999654321    246899999998 799999999999999999999999


Q ss_pred             cCCCchhhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-----CCceEEeecccccccCC
Q 008893          306 MSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----YYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       306 ~~~g~L~~~l~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~  379 (549)
                      +. |+|.+++.... ...+..+..++.||+.||.|||+.   +|+||||||+|||++.     ...+||+|||+++....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            96 59999987543 456667789999999999999999   9999999999999942     34688999999987653


Q ss_pred             CCC--ceeeccccccCccCchhhc---cCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccch
Q 008893          380 CDS--HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       380 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      ...  .......||+.|+|||++.   ...++.++|||||||++|||+| |..||......        ...........
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~~~  247 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--------QANILLGACSL  247 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--------HHHHHTTCCCC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--------HHHHHhccCCc
Confidence            322  1234456999999999997   4567889999999999999999 88888532111        01111111100


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       454 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..       ..........+.+++.+||+.||++|||+.|++++
T Consensus       248 ~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          248 DC-------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TT-------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cc-------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            00       01122344568899999999999999999999853

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.6e-38  Score=347.16  Aligned_cols=238  Identities=21%  Similarity=0.286  Sum_probs=191.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC--CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCc-----e
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE-----R  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~  299 (549)
                      ++|.+.+.||+|+||+||+|...  +|+.||||++...........+.+|+.++..++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            57889999999999999999975  5899999999754433344568899999999999999999999987665     6


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+++++|.+++..  .+++..+..++.||+.||.|||++   +|+||||||+|||++.+ .+||+|||+++....
T Consensus       160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence            999999999999988765  699999999999999999999999   99999999999999985 999999999987653


Q ss_pred             CCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          380 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .     ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+........                    .. 
T Consensus       234 ~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------------~~-  286 (681)
T 2pzi_A          234 F-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------------PE-  286 (681)
T ss_dssp             C-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------------CT-
T ss_pred             C-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------------cc-
Confidence            2     3346999999999987754 8899999999999999999888763211100                    00 


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCH-HHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKM-SEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-~evl~~L~~  500 (549)
                         ..........+.+++.+||+.||++||+. +++...|.+
T Consensus       287 ---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          287 ---DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ---TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ---cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence               00001123578899999999999999964 455555543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.1e-37  Score=302.78  Aligned_cols=229  Identities=12%  Similarity=0.053  Sum_probs=181.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|.+.+.||+|+||.||+|... +|+.||||++........  ...+.+|+..+..++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56888999999999999999976 489999999986543222  256899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++++|.+++..+  ....+...++.|++.||.|||+.   +|+||||||+|||++.++.+||+++|           
T Consensus       111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            999999999999654  35567889999999999999999   99999999999999999999997443           


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                                |++       .++.++|||||||++|||+||+.||............         ..........  ..
T Consensus       175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~~--~~  226 (286)
T 3uqc_A          175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------ERDTAGQPIE--PA  226 (286)
T ss_dssp             ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---------CBCTTSCBCC--HH
T ss_pred             ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---------HHHhccCCCC--hh
Confidence                      333       3678999999999999999999999864432210000         0000000000  00


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ......+..+.+++.+||+.||++| |+.|+++.|+.
T Consensus       227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~  262 (286)
T 3uqc_A          227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQ  262 (286)
T ss_dssp             HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred             hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence            0011123678999999999999999 99999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.1e-38  Score=315.03  Aligned_cols=245  Identities=13%  Similarity=0.147  Sum_probs=187.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCC-------CCcHHHHHHHHHHHhhcc---------CCCccce
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAV---------HRNLLRL  289 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~---------h~niv~l  289 (549)
                      .++|++.+.||+|+||+||+|+. +|+.||||+++....       ......+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35678899999999999999998 689999999975532       223367889999988886         8888887


Q ss_pred             EEEEe------------------------------cCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHH
Q 008893          290 IGFCM------------------------------TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY  339 (549)
Q Consensus       290 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~  339 (549)
                      .+++.                              .....++||||+++|++.+.+.. ..+++..+..++.||+.||.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence            77643                              26789999999999987777754 468999999999999999999


Q ss_pred             hh-hcCCCceEecccCcCeeeecCCC--------------------ceEEeecccccccCCCCCceeeccccccCccCch
Q 008893          340 LH-EQCDPKIIHRDVKAANILLDEYY--------------------EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE  398 (549)
Q Consensus       340 LH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE  398 (549)
                      || +.   +|+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+|||
T Consensus       177 lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE  247 (336)
T 2vuw_A          177 AEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred             HHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence            99 88   999999999999999887                    9999999999876532      236999999999


Q ss_pred             hhccCCCCCcccchhHhHH-HHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHH
Q 008893          399 YLSTGQSSEKTDVFGFGIL-LLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVA  477 (549)
Q Consensus       399 ~~~~~~~~~~~Dv~s~G~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  477 (549)
                      ++.+.. +.++||||+|++ .+++++|..||..          ..|.........-................+.++.+++
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli  316 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN----------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFH  316 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH----------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcc----------hhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHH
Confidence            998766 889999998776 7888899988852          1121111100000000011111112345678899999


Q ss_pred             HHhcccCCCCCCCHHHHH-HH
Q 008893          478 LLCTQYLPSLRPKMSEVV-RM  497 (549)
Q Consensus       478 ~~cl~~dP~~RPs~~evl-~~  497 (549)
                      .+||+.|     |++|++ ++
T Consensus       317 ~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          317 RTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHGGGSS-----SHHHHHHHC
T ss_pred             HHHhccC-----CHHHHHhcC
Confidence            9999976     899888 53

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.9e-36  Score=300.20  Aligned_cols=225  Identities=19%  Similarity=0.270  Sum_probs=176.6

Q ss_pred             cCCCCC-CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHH-hhccCCCccceEEEEec----CCce
Q 008893          227 SNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLRLIGFCMT----TTER  299 (549)
Q Consensus       227 ~~~~~~-~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~  299 (549)
                      ++|.+. +.||+|+||.||+|... +++.||+|+++..      ..+.+|+.++ +..+||||+++++++..    ....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            456665 78999999999999974 6899999998642      3567888887 56689999999999876    6678


Q ss_pred             eeEeeccCCCchhhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC---CCceEEeecccc
Q 008893          300 LLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA  374 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~  374 (549)
                      ++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999997543  699999999999999999999999   9999999999999998   789999999998


Q ss_pred             cccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      ....                       +..++.++|||||||++|||+||+.||..........            ....
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------------~~~~  212 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------GMKT  212 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------------CSCC
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------------HHHH
Confidence            7543                       1335678999999999999999999996432211100            0000


Q ss_pred             hhccccccCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 MLVDKDLKNNYD----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .+....  ...+    ...+..+.+++.+||+.||++|||+.|++++
T Consensus       213 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          213 RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000000  0111    1124678999999999999999999999863

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-37  Score=320.37  Aligned_cols=239  Identities=15%  Similarity=0.117  Sum_probs=179.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC--cHHHHHHHHHHHhhccC-CCc---------cceEEE-
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVH-RNL---------LRLIGF-  292 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h-~ni---------v~l~~~-  292 (549)
                      ..|...+.||+|+||+||+|.+. +|+.||||+++......  ....+.+|+.++..++| +|.         +..... 
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45667789999999999999965 69999999987433222  24578999999998877 221         111111 


Q ss_pred             -----------Eec-----CCceeeEeeccCCCchhhhhc-------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceE
Q 008893          293 -----------CMT-----TTERLLVYPYMSNGSVASRLK-------AKPSLDWATRKRIALGAARGLLYLHEQCDPKII  349 (549)
Q Consensus       293 -----------~~~-----~~~~~lv~e~~~~g~L~~~l~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  349 (549)
                                 +..     ....+++|+++ +++|.+++.       ....+++..+..++.||+.||.|||++   +|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                       111     12345666665 679998884       133578899999999999999999999   999


Q ss_pred             ecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccccCccCchhh----------ccCCCCCcccchhHhHHHH
Q 008893          350 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL----------STGQSSEKTDVFGFGILLL  419 (549)
Q Consensus       350 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~G~il~  419 (549)
                      ||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          .+..++.++|||||||++|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            9999999999999999999999998865422    344567 999999999          5556888999999999999


Q ss_pred             HHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          420 ELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       420 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ||+||+.||.........                ..++...  ..+    +..+.+++.+||+.||++||++.|+++
T Consensus       309 elltg~~Pf~~~~~~~~~----------------~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGS----------------EWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCS----------------GGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHCCCCCCCcchhhhH----------------HHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999999753322111                1111110  122    267999999999999999999998875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.2e-30  Score=279.73  Aligned_cols=186  Identities=15%  Similarity=0.053  Sum_probs=132.8

Q ss_pred             eeeeCCeEEEEEEE-CCCCEEEEEEcccCCCC---------CcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeEe
Q 008893          235 VGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI---------GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       235 iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      .+.|++|.+..++. --|+.+++|++......         ...++|.+|+++|+++ .|+||+++++++.++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45566665555442 24888999999754211         1123599999999999 7999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||++|++|.+++...++++..   +|+.||+.||+|+|++   |||||||||+|||+++++.+||+|||+++...... .
T Consensus       322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~  394 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-S  394 (569)
T ss_dssp             ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC----C
T ss_pred             ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC-c
Confidence            999999999999988888765   4889999999999999   99999999999999999999999999998765432 2


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRAL  428 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~  428 (549)
                      .....+||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus       395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            3345679999999999865 4677899999999999887776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=3.4e-27  Score=251.56  Aligned_cols=185  Identities=16%  Similarity=0.190  Sum_probs=145.6

Q ss_pred             CCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCc-------HHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          230 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       230 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ...+.||+|+||+||+|.. .++.+++|+.........       .+++.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 478889998754322111       23479999999999999999777777778888999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||+++++|.+++..        +..++.|++.||.|||++   +|+||||||+|||+++  .+||+|||+++.......
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence            999999999999976        568999999999999999   9999999999999999  999999999998754322


Q ss_pred             ce------eeccccccCccCchhhcc--CCCCCcccchhHhHHHHHHHhCCccc
Q 008893          383 HV------TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRAL  428 (549)
Q Consensus       383 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~  428 (549)
                      ..      .....||+.|+|||++..  ..|+..+|+||..+-..+-+.++.++
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            11      135579999999999976  56788899999998888888776554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=3.4e-24  Score=209.63  Aligned_cols=154  Identities=14%  Similarity=0.077  Sum_probs=122.5

Q ss_pred             HHHHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC-----------------CcHHHHHHHHHHHhhcc
Q 008893          220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-----------------GGEIQFQTEVEMISLAV  282 (549)
Q Consensus       220 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~  282 (549)
                      ..+......|.+.+.||+|+||.||+|...+|+.||||+++.....                 .....+.+|+.+++.++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3444455667778999999999999999977999999999643211                 02346889999999998


Q ss_pred             CCCccceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC
Q 008893          283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE  362 (549)
Q Consensus       283 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  362 (549)
                        | +++.+++.. +..++||||+++++|.+ +..      .....++.|++.||.|||+.   +|+||||||+|||++ 
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-  227 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-
Confidence              4 666665433 56799999999999998 432      23457999999999999999   999999999999999 


Q ss_pred             CCceEEeecccccccCCCCCceeeccccccCccCchhhcc
Q 008893          363 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST  402 (549)
Q Consensus       363 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  402 (549)
                      ++.+||+|||+++              .+..|.|||++..
T Consensus       228 ~~~vkl~DFG~a~--------------~~~~~~a~e~l~r  253 (282)
T 1zar_A          228 EEGIWIIDFPQSV--------------EVGEEGWREILER  253 (282)
T ss_dssp             TTEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred             CCcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence            9999999999986              3445789998743

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=1.1e-19  Score=175.46  Aligned_cols=138  Identities=17%  Similarity=0.162  Sum_probs=107.5

Q ss_pred             CCCCCeeeeeCCeEEEEEEE-CCCCE--EEEEEcccCCCCC-----------------------cHHHHHHHHHHHhhcc
Q 008893          229 FSSKNLVGKGGFGNVYKGYL-QDGTV--VAVKRLKDGNAIG-----------------------GEIQFQTEVEMISLAV  282 (549)
Q Consensus       229 ~~~~~~iG~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~  282 (549)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++......                       ....+.+|+..+..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998 67888  9999975432110                       0125788999999999


Q ss_pred             CCCc--cceEEEEecCCceeeEeeccCC-C----chhhhhccCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCceEecccC
Q 008893          283 HRNL--LRLIGFCMTTTERLLVYPYMSN-G----SVASRLKAKPSLDWATRKRIALGAARGLLYLH-EQCDPKIIHRDVK  354 (549)
Q Consensus       283 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlk  354 (549)
                      |+++  ..++++    ...++||||+.+ |    +|.+....   .++.....++.|++.||.||| +.   +|+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence            8864  344432    367899999942 4    55554432   235577899999999999999 88   99999999


Q ss_pred             cCeeeecCCCceEEeecccccccC
Q 008893          355 AANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       355 p~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      |+|||+++  .++|+|||++....
T Consensus       199 p~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEETT
T ss_pred             HHHEEEcC--cEEEEECcccccCC
Confidence            99999998  99999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=1.3e-17  Score=167.26  Aligned_cols=142  Identities=13%  Similarity=0.106  Sum_probs=101.9

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC-------------CcHHH--------HHHHHHHHhhccCC
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-------------GGEIQ--------FQTEVEMISLAVHR  284 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-------------~~~~~--------~~~e~~~l~~l~h~  284 (549)
                      ..-|.+.+.||+|+||.||+|...+|+.||||+++.....             .....        ...|...|.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            3448899999999999999999989999999997632110             01111        23455556666444


Q ss_pred             CccceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC
Q 008893          285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY  364 (549)
Q Consensus       285 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  364 (549)
                      ++.-..-+..  ...++||||++++.|..+...      +....++.|++.+|.|||+.   |||||||||.|||+++++
T Consensus       174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             TCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred             CCCCCeeeec--cCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence            4322111111  234799999999888765432      23456889999999999998   999999999999998776


Q ss_pred             ----------ceEEeecccccccC
Q 008893          365 ----------EAVVGDFGLAKLLD  378 (549)
Q Consensus       365 ----------~~kl~Dfg~~~~~~  378 (549)
                                .+.|+||+-+....
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CcccccccccceEEEEeCCcccCC
Confidence                      38899999876544

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.56  E-value=6.6e-15  Score=135.17  Aligned_cols=104  Identities=25%  Similarity=0.343  Sum_probs=93.9

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.
T Consensus        35 ~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~  113 (193)
T 2wfh_A           35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGND  113 (193)
T ss_dssp             EEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCC
Confidence            3679999998 788999999999999999999998888889999999999999999998888899999999999999999


Q ss_pred             CCCCCCcccc-----ccccccCCccccCCC
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLICATG  131 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~~~~~  131 (549)
                      |++.++..+.     ..+++++|++.|.+.
T Consensus       114 l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A          114 ISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            9988776543     578999999998753

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.56  E-value=5.4e-15  Score=135.72  Aligned_cols=106  Identities=25%  Similarity=0.363  Sum_probs=94.7

Q ss_pred             hhhhcccCcccccCCc-ccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccC
Q 008893           26 FGRLLQNNNISGHIPT-EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY  104 (549)
Q Consensus        26 ~~l~l~~n~l~~~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~  104 (549)
                      ..++|++|+|++..+. .|+++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus        32 ~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  111 (192)
T 1w8a_A           32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYD  111 (192)
T ss_dssp             SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCS
T ss_pred             CEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence            3467999999977765 589999999999999999988899999999999999999999988888899999999999999


Q ss_pred             CCCCCCCCcccc-----ccccccCCccccCCC
Q 008893          105 NNLSGPVPSFHA-----KTFNITGNSLICATG  131 (549)
Q Consensus       105 N~l~~~~p~~~~-----~~~~l~~N~~~~~~~  131 (549)
                      |+|++.+|..+.     ..+++++|++.|.+.
T Consensus       112 N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A          112 NQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             SCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            999999887553     568999999998753

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.55  E-value=3.9e-15  Score=166.02  Aligned_cols=110  Identities=36%  Similarity=0.563  Sum_probs=99.7

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|+++|.+|..|+++++|+.|+|++|+|+|.+|..|+++++|+.|||++|+++|.+|..|..++.|+.|+|++|+
T Consensus       636 ~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~  715 (768)
T 3rgz_A          636 FLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN  715 (768)
T ss_dssp             EEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE
T ss_pred             EEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc
Confidence            47899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCccc----cccccccCCccccCCCCCCccc
Q 008893          107 LSGPVPSFH----AKTFNITGNSLICATGAEEDCF  137 (549)
Q Consensus       107 l~~~~p~~~----~~~~~l~~N~~~~~~~~~~~c~  137 (549)
                      |+|.+|...    .....+.||+..|+.+.. .|.
T Consensus       716 l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~  749 (768)
T 3rgz_A          716 LSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCD  749 (768)
T ss_dssp             EEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCC
T ss_pred             ccccCCCchhhccCCHHHhcCCchhcCCCCc-CCC
Confidence            999999742    245678899999987543 564

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.54  E-value=1.2e-14  Score=136.45  Aligned_cols=103  Identities=28%  Similarity=0.298  Sum_probs=69.0

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.|
T Consensus        61 L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  140 (220)
T 2v9t_B           61 IDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL  140 (220)
T ss_dssp             EECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcC
Confidence            55677777766666777777777777777777744444456677777777777777766666677777777777777777


Q ss_pred             CCCCCcccc-----ccccccCCccccCC
Q 008893          108 SGPVPSFHA-----KTFNITGNSLICAT  130 (549)
Q Consensus       108 ~~~~p~~~~-----~~~~l~~N~~~~~~  130 (549)
                      ++..+..+.     ..+++++|++.|.+
T Consensus       141 ~~~~~~~~~~l~~L~~L~L~~N~~~c~c  168 (220)
T 2v9t_B          141 QTIAKGTFSPLRAIQTMHLAQNPFICDC  168 (220)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence            766665332     45667777777654

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.52  E-value=2.4e-14  Score=134.41  Aligned_cols=104  Identities=22%  Similarity=0.240  Sum_probs=82.9

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.
T Consensus        61 ~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  140 (220)
T 2v70_A           61 KINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ  140 (220)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSC
T ss_pred             EEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCc
Confidence            35688888887777788888888888888888887777778888888888888888887778888888888888888888


Q ss_pred             CCCCCCcccc-----ccccccCCccccCC
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLICAT  130 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~~~~  130 (549)
                      |++..|..+.     ..+++++|++.|.+
T Consensus       141 l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  169 (220)
T 2v70_A          141 ITTVAPGAFDTLHSLSTLNLLANPFNCNC  169 (220)
T ss_dssp             CCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred             CCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence            8887776543     45788888888764

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.49  E-value=7.6e-14  Score=131.82  Aligned_cols=81  Identities=25%  Similarity=0.246  Sum_probs=44.2

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.|
T Consensus        45 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l  124 (229)
T 3e6j_A           45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL  124 (229)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcc
Confidence            34555555555555555555555555555555533334445555555555555555544444455555555555555555


Q ss_pred             C
Q 008893          108 S  108 (549)
Q Consensus       108 ~  108 (549)
                      +
T Consensus       125 ~  125 (229)
T 3e6j_A          125 T  125 (229)
T ss_dssp             C
T ss_pred             c
Confidence            5

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.47  E-value=1.4e-13  Score=124.46  Aligned_cols=104  Identities=22%  Similarity=0.242  Sum_probs=90.8

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|++++..+..|+++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.
T Consensus        32 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  111 (177)
T 2o6r_A           32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQ  111 (177)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCc
Confidence            46799999997777788999999999999999997666678999999999999999997777778999999999999999


Q ss_pred             CCCCCCcccc-----ccccccCCccccCC
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLICAT  130 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~~~~  130 (549)
                      |++.++..+.     ..+++++|++.|.+
T Consensus       112 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A          112 LKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             ceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence            9988776532     56899999998764

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.47  E-value=1.3e-13  Score=123.82  Aligned_cols=101  Identities=25%  Similarity=0.258  Sum_probs=80.3

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .+++++|.|+ .+|..+.  ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.
T Consensus        13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            4678888887 5676653  788888888888887778888888888888888888886666677888888888888888


Q ss_pred             CCCCCCcccc-----ccccccCCccccCC
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLICAT  130 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~~~~  130 (549)
                      |++.++..+.     ..+++++|++.|.+
T Consensus        90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           90 LKSIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             cCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            8887776442     56788888888765

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.46  E-value=1.6e-13  Score=131.55  Aligned_cols=100  Identities=24%  Similarity=0.254  Sum_probs=61.5

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.|
T Consensus        64 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  143 (251)
T 3m19_A           64 LNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL  143 (251)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcC
Confidence            45666666666666666666666666666666655555566666666666666666644444556666666666666666


Q ss_pred             CCCCCcccc-----ccccccCCccc
Q 008893          108 SGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus       108 ~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      ++.++..+.     ..+++++|.+.
T Consensus       144 ~~~~~~~~~~l~~L~~L~L~~N~l~  168 (251)
T 3m19_A          144 QSIPAGAFDKLTNLQTLSLSTNQLQ  168 (251)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CccCHHHcCcCcCCCEEECCCCcCC
Confidence            655554321     34566666554

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.45  E-value=2.1e-13  Score=122.83  Aligned_cols=101  Identities=28%  Similarity=0.287  Sum_probs=84.0

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.
T Consensus        16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            4678889886 7777664  889999999999998888889999999999999999996666667889999999999999


Q ss_pred             CCCCCCcccc-----ccccccCCccccCC
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLICAT  130 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~~~~  130 (549)
                      |++.++..+.     ..+++++|++.|.+
T Consensus        93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~~  121 (174)
T 2r9u_A           93 LKSIPRGAFDNLKSLTHIYLYNNPWDCEC  121 (174)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred             cceeCHHHhccccCCCEEEeCCCCccccc
Confidence            9987776432     56789999998764

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.42  E-value=6.4e-14  Score=138.93  Aligned_cols=115  Identities=31%  Similarity=0.540  Sum_probs=103.1

Q ss_pred             eeeeeecCCc--eeehhhhcccCcccc--cCCcccCCCCCCCEEEccC-CcCCCCCcccccCCcccCeeeccCcccccCC
Q 008893           13 LIQVICSDGV--FFSFGRLLQNNNISG--HIPTEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYLRLNNNSLTGAI   87 (549)
Q Consensus        13 ~~~~~c~~~~--~~~~~l~l~~n~l~~--~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~   87 (549)
                      |.||.|+...  .++..++|++|.+++  .+|..|+++++|++|+|++ |.+++.+|..|.++++|++|+|++|++++.+
T Consensus        38 w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  117 (313)
T 1ogq_A           38 WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI  117 (313)
T ss_dssp             STTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEEC
T ss_pred             CcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcC
Confidence            7789997533  467788899999999  8999999999999999995 9999999999999999999999999999999


Q ss_pred             CcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           88 PPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        88 p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      |..|..+++|+.|+|++|.+++.+|..+.     +.+++++|.+.
T Consensus       118 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  162 (313)
T 1ogq_A          118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS  162 (313)
T ss_dssp             CGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred             CHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCccc
Confidence            99999999999999999999998887553     56788898874

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.42  E-value=2.9e-13  Score=126.95  Aligned_cols=113  Identities=23%  Similarity=0.234  Sum_probs=96.5

Q ss_pred             eeeecCCceeeh---------hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCccccc
Q 008893           15 QVICSDGVFFSF---------GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG   85 (549)
Q Consensus        15 ~~~c~~~~~~~~---------~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g   85 (549)
                      .+.|++..++.+         .++|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++
T Consensus        15 ~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~   94 (220)
T 2v9t_B           15 IVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE   94 (220)
T ss_dssp             EEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCC
T ss_pred             EEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCc
Confidence            456665443333         36799999998888899999999999999999998889999999999999999999996


Q ss_pred             CCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           86 AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        86 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      ..+..|..+++|+.|+|++|.|++..|..+.     ..+++++|.+.
T Consensus        95 l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  141 (220)
T 2v9t_B           95 LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ  141 (220)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             cCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence            6666688999999999999999999887653     56889999885

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.42  E-value=1.2e-13  Score=136.88  Aligned_cols=124  Identities=20%  Similarity=0.251  Sum_probs=92.5

Q ss_pred             cceeeeeeeeeecC------CceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccC
Q 008893            7 KVLIIVLIQVICSD------GVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN   80 (549)
Q Consensus         7 ~~~~~~~~~~~c~~------~~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~   80 (549)
                      +|+.|++.++....      +......++|++|.+++.+|..|.++++|+.|+|++|++++.+|. +..+++|+.|+|++
T Consensus       175 ~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~  253 (313)
T 1ogq_A          175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRN  253 (313)
T ss_dssp             TCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCS
T ss_pred             cCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcC
Confidence            55666665554431      111233456778888877788888888888888888888866554 77888888888888


Q ss_pred             cccccCCCcccccCCCCceEeccCCCCCCCCCccc----cccccccCCccccCCC
Q 008893           81 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLICATG  131 (549)
Q Consensus        81 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~----~~~~~l~~N~~~~~~~  131 (549)
                      |+|+|.+|..|..+++|+.|+|++|+++|.+|...    ...+++++|+..|+.+
T Consensus       254 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             SCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred             CcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCC
Confidence            88888888888888889999999999888888652    2567888888888753

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.42  E-value=6e-13  Score=123.58  Aligned_cols=102  Identities=24%  Similarity=0.242  Sum_probs=48.6

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+
T Consensus        57 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  136 (208)
T 2o6s_A           57 LYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL  136 (208)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCcc
Confidence            34455555543333445555555555555555533333344555555555555555543333445555555555555555


Q ss_pred             CCCCCcccc-----ccccccCCccccC
Q 008893          108 SGPVPSFHA-----KTFNITGNSLICA  129 (549)
Q Consensus       108 ~~~~p~~~~-----~~~~l~~N~~~~~  129 (549)
                      ++.++..+.     ..+++++|++.|.
T Consensus       137 ~~~~~~~~~~l~~L~~L~l~~N~~~~~  163 (208)
T 2o6s_A          137 KSVPDGVFDRLTSLQYIWLHDNPWDCT  163 (208)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred             ceeCHHHhccCCCccEEEecCCCeecC
Confidence            544443221     3345555555443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.41  E-value=5.3e-13  Score=129.50  Aligned_cols=123  Identities=24%  Similarity=0.223  Sum_probs=76.9

Q ss_pred             cccceeeeeeeeeecCCc-----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDGV-----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +++|+.|+|.++...+-.     .....++|++|.|++..|..|+++++|++|+|++|++++..|..|..+++|+.|+|+
T Consensus        62 l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  141 (272)
T 3rfs_A           62 LPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA  141 (272)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCCcEEECCCCCCCCchhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECC
Confidence            456677777655443210     112235577777776666666777777777777777775555556777777777777


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      +|+|++..|..|..+++|+.|++++|.+++.++..+.     +.+++++|.+.
T Consensus       142 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  194 (272)
T 3rfs_A          142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK  194 (272)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence            7777755555566777777777777777766654322     44566666654

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.41  E-value=4.5e-13  Score=131.26  Aligned_cols=84  Identities=30%  Similarity=0.272  Sum_probs=39.6

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+|+ .+|..+.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus        82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  160 (290)
T 1p9a_G           82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL  160 (290)
T ss_dssp             EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence            344455444 3444444445555555555555433334444445555555555554433333444444444555554444


Q ss_pred             CCCCC
Q 008893          108 SGPVP  112 (549)
Q Consensus       108 ~~~~p  112 (549)
                      ++.++
T Consensus       161 ~~l~~  165 (290)
T 1p9a_G          161 TELPA  165 (290)
T ss_dssp             SCCCT
T ss_pred             CccCH
Confidence            44333

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.41  E-value=2.1e-13  Score=125.00  Aligned_cols=125  Identities=18%  Similarity=0.224  Sum_probs=102.4

Q ss_pred             ccceeeeeeeeeecCCc----e----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            6 EKVLIIVLIQVICSDGV----F----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~~~----~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      .+|+.|+|.++....-.    +    ....++|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus        29 ~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  108 (192)
T 1w8a_A           29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence            47788888777664311    2    223467999999999999999999999999999999988888899999999999


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc----ccccccCCccccCC
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICAT  130 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~~~~  130 (549)
                      |++|+|++..|..|..+++|+.|+|++|++++..+-...    ....+.++...|..
T Consensus       109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~  165 (192)
T 1w8a_A          109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred             CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCC
Confidence            999999999999999999999999999999998774321    22345566666654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.40  E-value=5.4e-13  Score=119.71  Aligned_cols=87  Identities=26%  Similarity=0.290  Sum_probs=79.9

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus        34 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  113 (170)
T 3g39_A           34 VLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNP  113 (170)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCC
Confidence            37799999999889999999999999999999997777778999999999999999997777789999999999999999


Q ss_pred             CCCCCCc
Q 008893          107 LSGPVPS  113 (549)
Q Consensus       107 l~~~~p~  113 (549)
                      +++..+.
T Consensus       114 ~~c~c~~  120 (170)
T 3g39_A          114 WDCACSD  120 (170)
T ss_dssp             BCTTBGG
T ss_pred             CCCCchh
Confidence            9988764

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.39  E-value=9.2e-13  Score=127.64  Aligned_cols=123  Identities=22%  Similarity=0.224  Sum_probs=68.2

Q ss_pred             cccceeeeeeeeeecC---Cc----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSD---GV----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~---~~----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      +.+|+.|+|.++....   +.    .....++|++|.|++..+..|.++++|++|+|++|++++..|..|..+++|+.|+
T Consensus        60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  139 (270)
T 2o6q_A           60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS  139 (270)
T ss_dssp             CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence            3556666665543321   11    1122345666666655555566666666666666666655555566666666666


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      |++|+|++..+..|..+++|+.|+|++|.+++.++..+.     ..+++++|.+.
T Consensus       140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  194 (270)
T 2o6q_A          140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK  194 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCC
Confidence            666666644444456666666666666666655544322     34555555553

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.38  E-value=1e-12  Score=123.96  Aligned_cols=125  Identities=21%  Similarity=0.196  Sum_probs=100.8

Q ss_pred             cccceeeeeeeeeecCCc-------eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSDGV-------FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-------~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      ..+|+.|+|.++..+.-.       .....++|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+
T Consensus        39 ~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~  118 (229)
T 3e6j_A           39 PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF  118 (229)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEe
Confidence            367888888776664311       1233467999999866667789999999999999999976666788999999999


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccccCC
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICAT  130 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~~~~  130 (549)
                      |++|+|+ .+|..+..+++|+.|+|++|.|++.++..+.     ..+++++|++.|.+
T Consensus       119 Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A          119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             CCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred             ccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence            9999999 8898999999999999999999987775443     56789999998875

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.38  E-value=6.6e-13  Score=133.57  Aligned_cols=103  Identities=18%  Similarity=0.248  Sum_probs=91.1

Q ss_pred             hhhcccC-cccccCCcccCCCCCCCEEEccC-CcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccC
Q 008893           27 GRLLQNN-NISGHIPTEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY  104 (549)
Q Consensus        27 ~l~l~~n-~l~~~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~  104 (549)
                      .++++++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            3467777 888 5788 99999999999996 999988788999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCccc----cccccccCCccccCCC
Q 008893          105 NNLSGPVPSFH----AKTFNITGNSLICATG  131 (549)
Q Consensus       105 N~l~~~~p~~~----~~~~~l~~N~~~~~~~  131 (549)
                      |+|++.++..+    ...+++.+|++.|.+.
T Consensus        90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~  120 (347)
T 2ifg_A           90 NALESLSWKTVQGLSLQELVLSGNPLHCSCA  120 (347)
T ss_dssp             SCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred             CccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence            99998887654    3578999999999764

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.37  E-value=5.6e-13  Score=148.53  Aligned_cols=98  Identities=28%  Similarity=0.533  Sum_probs=89.7

Q ss_pred             cccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCCC
Q 008893           30 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG  109 (549)
Q Consensus        30 l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  109 (549)
                      +..|.++|.+|..++++++|+.|||++|+|+|.+|..|+++++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+++|
T Consensus       615 l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g  694 (768)
T 3rgz_A          615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDG  694 (768)
T ss_dssp             TTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEE
T ss_pred             cccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccC
Confidence            44566777777788889999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccc-----ccccccCCccc
Q 008893          110 PVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus       110 ~~p~~~~-----~~~~l~~N~~~  127 (549)
                      .+|..+.     +.+++++|++.
T Consensus       695 ~ip~~l~~l~~L~~L~ls~N~l~  717 (768)
T 3rgz_A          695 RIPQAMSALTMLTEIDLSNNNLS  717 (768)
T ss_dssp             CCCGGGGGCCCCSEEECCSSEEE
T ss_pred             cCChHHhCCCCCCEEECcCCccc
Confidence            9998654     67899999986

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.37  E-value=9e-13  Score=123.57  Aligned_cols=101  Identities=18%  Similarity=0.156  Sum_probs=89.7

Q ss_pred             hhhcccCcccccCC-cccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           27 GRLLQNNNISGHIP-TEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        27 ~l~l~~n~l~~~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .++|++|+|++..| ..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus        36 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  115 (220)
T 2v70_A           36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN  115 (220)
T ss_dssp             EEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTS
T ss_pred             EEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCC
Confidence            36799999998865 46899999999999999999877779999999999999999999888888999999999999999


Q ss_pred             CCCCCCCcccc-----ccccccCCccc
Q 008893          106 NLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus       106 ~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      .|++..|..+.     ..+++++|.+.
T Consensus       116 ~l~~~~~~~~~~l~~L~~L~L~~N~l~  142 (220)
T 2v70_A          116 RITCVGNDSFIGLSSVRLLSLYDNQIT  142 (220)
T ss_dssp             CCCCBCTTSSTTCTTCSEEECTTSCCC
T ss_pred             cCCeECHhHcCCCccCCEEECCCCcCC
Confidence            99999887553     56889999885

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.36  E-value=5e-13  Score=145.40  Aligned_cols=105  Identities=22%  Similarity=0.286  Sum_probs=94.0

Q ss_pred             hhhcccCcc-cccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           27 GRLLQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        27 ~l~l~~n~l-~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .++|++|++ .+.+|..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus       473 ~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N  552 (635)
T 4g8a_A          473 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN  552 (635)
T ss_dssp             EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTS
T ss_pred             hhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCC
Confidence            366888874 4567889999999999999999999989999999999999999999999888889999999999999999


Q ss_pred             CCCCCCCcccc------ccccccCCccccCCC
Q 008893          106 NLSGPVPSFHA------KTFNITGNSLICATG  131 (549)
Q Consensus       106 ~l~~~~p~~~~------~~~~l~~N~~~~~~~  131 (549)
                      +|++.+|..+.      +.+++++|++.|.|.
T Consensus       553 ~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          553 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             cCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            99999987543      468999999999864

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.35  E-value=1.4e-12  Score=117.37  Aligned_cols=87  Identities=24%  Similarity=0.255  Sum_probs=78.4

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus        37 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~  116 (174)
T 2r9u_A           37 RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNP  116 (174)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSC
T ss_pred             EEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCC
Confidence            46799999999989999999999999999999997655667999999999999999996666669999999999999999


Q ss_pred             CCCCCCc
Q 008893          107 LSGPVPS  113 (549)
Q Consensus       107 l~~~~p~  113 (549)
                      |.+.++.
T Consensus       117 ~~c~~~~  123 (174)
T 2r9u_A          117 WDCECRD  123 (174)
T ss_dssp             BCTTBGG
T ss_pred             ccccccc
Confidence            9987764

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.35  E-value=2.4e-12  Score=123.21  Aligned_cols=101  Identities=24%  Similarity=0.211  Sum_probs=91.0

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.
T Consensus        39 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  118 (251)
T 3m19_A           39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQ  118 (251)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCc
Confidence            36799999999888899999999999999999998888889999999999999999997777889999999999999999


Q ss_pred             CCCCCCcccc-----ccccccCCccc
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      |++.++..+.     ..+++++|.+.
T Consensus       119 l~~~~~~~~~~l~~L~~L~Ls~N~l~  144 (251)
T 3m19_A          119 LKSLPSGVFDRLTKLKELRLNTNQLQ  144 (251)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCcChhHhccCCcccEEECcCCcCC
Confidence            9988876542     56889999885

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.34  E-value=9.5e-13  Score=128.56  Aligned_cols=123  Identities=19%  Similarity=0.100  Sum_probs=70.9

Q ss_pred             cccceeeeeeeee-ecCC---c----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCee
Q 008893            5 LEKVLIIVLIQVI-CSDG---V----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL   76 (549)
Q Consensus         5 ~~~~~~~~~~~~~-c~~~---~----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L   76 (549)
                      +++|+.|++.++. ...-   .    .....++|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|+.|
T Consensus        79 l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  158 (285)
T 1ozn_A           79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL  158 (285)
T ss_dssp             CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence            3566666666553 2110   0    112234566677666666666666677777777776665444556666666666


Q ss_pred             eccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           77 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        77 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      +|++|+|++..+..|..+++|+.|+|++|.+++..|..+.     +.+++++|.+.
T Consensus       159 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  214 (285)
T 1ozn_A          159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS  214 (285)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             ECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCC
Confidence            6666666644444566666666666666666655554332     34555555553

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.34  E-value=8.7e-13  Score=133.51  Aligned_cols=84  Identities=29%  Similarity=0.234  Sum_probs=43.1

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.|
T Consensus        69 L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  148 (361)
T 2xot_A           69 LLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI  148 (361)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcC
Confidence            34555555544444555555555555555555544444455555555555555555544444555555555555555555


Q ss_pred             CCCC
Q 008893          108 SGPV  111 (549)
Q Consensus       108 ~~~~  111 (549)
                      ++.+
T Consensus       149 ~~l~  152 (361)
T 2xot_A          149 SRFP  152 (361)
T ss_dssp             CSCC
T ss_pred             CeeC
Confidence            5433

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.33  E-value=1.4e-12  Score=141.88  Aligned_cols=116  Identities=21%  Similarity=0.132  Sum_probs=98.2

Q ss_pred             eeeeecCCceeehh---------hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccc
Q 008893           14 IQVICSDGVFFSFG---------RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT   84 (549)
Q Consensus        14 ~~~~c~~~~~~~~~---------l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~   84 (549)
                      ..+.|+...++.+|         ++|++|+|++..|.+|.+|++|++|||++|+|++..|..|.+|++|++|+|++|+|+
T Consensus        34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~  113 (635)
T 4g8a_A           34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ  113 (635)
T ss_dssp             TEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             CEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence            45789876665554         679999999888889999999999999999999777778999999999999999999


Q ss_pred             cCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccccC
Q 008893           85 GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA  129 (549)
Q Consensus        85 g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~~~  129 (549)
                      +..|..|.++++|+.|+|++|.|++.++..+.     +.+++++|.+...
T Consensus       114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~  163 (635)
T 4g8a_A          114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF  163 (635)
T ss_dssp             EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC
T ss_pred             CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccC
Confidence            76677899999999999999999988776543     5678888887543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.33  E-value=4.2e-12  Score=117.81  Aligned_cols=115  Identities=22%  Similarity=0.196  Sum_probs=95.3

Q ss_pred             eeeeeecCCcee---------ehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCccc
Q 008893           13 LIQVICSDGVFF---------SFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL   83 (549)
Q Consensus        13 ~~~~~c~~~~~~---------~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l   83 (549)
                      +.++.|+...+.         ...++|++|+|++..+..|+++++|++|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus         9 ~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l   88 (208)
T 2o6s_A            9 GTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL   88 (208)
T ss_dssp             TTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcC
Confidence            446677654433         33467999999977777899999999999999999966666789999999999999999


Q ss_pred             ccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           84 TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        84 ~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      ++..+..|..+++|+.|+|++|.|++.++..+.     +.+++++|.+.
T Consensus        89 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  137 (208)
T 2o6s_A           89 QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK  137 (208)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc
Confidence            977677789999999999999999988876443     56889999875

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.32  E-value=1.7e-12  Score=135.55  Aligned_cols=126  Identities=21%  Similarity=0.155  Sum_probs=96.5

Q ss_pred             ccceeeeeeeeeecC-------CceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeec
Q 008893            6 EKVLIIVLIQVICSD-------GVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL   78 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~-------~~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l   78 (549)
                      .+|+.+++.++....       .-.....++|++|.|++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|
T Consensus       275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL  354 (455)
T ss_dssp             SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence            356666665543321       0112234678888888888888888888999999999888777888888899999999


Q ss_pred             cCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccccCCC
Q 008893           79 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG  131 (549)
Q Consensus        79 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~~~~~  131 (549)
                      ++|++++..|..|..+++|+.|+|++|+|++.++..+.     +.+++++|++.|.++
T Consensus       355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            99998888888888888999999999999887765432     567888999888764

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.32  E-value=1.3e-12  Score=128.86  Aligned_cols=100  Identities=20%  Similarity=0.264  Sum_probs=58.1

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCC-CCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      ++|++|.+++..|..|.++++|++|+|++|.+++ .+|..+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.
T Consensus       131 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~  210 (306)
T 2z66_A          131 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN  210 (306)
T ss_dssp             EECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             EECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCc
Confidence            4466666665556666666666666666666654 355556666666666666666665555556666666666666666


Q ss_pred             CCCCCCccc-----cccccccCCccc
Q 008893          107 LSGPVPSFH-----AKTFNITGNSLI  127 (549)
Q Consensus       107 l~~~~p~~~-----~~~~~l~~N~~~  127 (549)
                      +++..+..+     .+.+++++|.+.
T Consensus       211 l~~~~~~~~~~l~~L~~L~L~~N~l~  236 (306)
T 2z66_A          211 FFSLDTFPYKCLNSLQVLDYSLNHIM  236 (306)
T ss_dssp             CSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred             cCccChhhccCcccCCEeECCCCCCc
Confidence            655444322     134555555553

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.31  E-value=4.6e-12  Score=122.80  Aligned_cols=121  Identities=18%  Similarity=0.171  Sum_probs=83.1

Q ss_pred             cccceeeeeeeeeecCC-ce----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDG-VF----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~-~~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +++|+.|++.+....+- .+    ....++|++|.+++.  +.+.++++|++|+|++|+|++..|..|..+++|+.|+|+
T Consensus        40 l~~L~~L~l~~~~i~~~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  117 (272)
T 3rfs_A           40 LNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV  117 (272)
T ss_dssp             HTTCCEEECTTSCCCCCTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             ccceeeeeeCCCCcccccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence            34566666655544321 11    122356788887752  467788888888888888886666667788888888888


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      +|++++..|..|..+++|+.|++++|.+++.++..+.     ..+++++|.+.
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  170 (272)
T 3rfs_A          118 ENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ  170 (272)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC
Confidence            8888866666677888888888888888877765432     55677777765

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.30  E-value=9.4e-13  Score=148.29  Aligned_cols=126  Identities=29%  Similarity=0.331  Sum_probs=101.0

Q ss_pred             cccceeeeeeeeeecCC--------ceeehhhhcccCccc-----ccCCcccCCCCCCCEEEccCCcCCCCCcccccCCc
Q 008893            5 LEKVLIIVLIQVICSDG--------VFFSFGRLLQNNNIS-----GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE   71 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~--------~~~~~~l~l~~n~l~-----~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~   71 (549)
                      +.+|+.|+|.++..+.-        ......++|++|.++     +..|..|.++++|+.|+|++|+|++..|..|..++
T Consensus       425 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  504 (844)
T 3j0a_A          425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT  504 (844)
T ss_dssp             CTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCC
T ss_pred             CCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchh
Confidence            46777888877765421        112334678888887     44556788999999999999999988888899999


Q ss_pred             ccCeeeccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc--ccccccCCccccCCCC
Q 008893           72 TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLICATGA  132 (549)
Q Consensus        72 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~l~~N~~~~~~~~  132 (549)
                      +|+.|+|++|+|++..|..+.  ++|+.|+|++|+|++.+|..+.  ..+++++|++.|.|..
T Consensus       505 ~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          505 ALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             SCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred             hhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence            999999999999976666665  8999999999999999998764  5689999999998753

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.30  E-value=1.1e-12  Score=142.78  Aligned_cols=112  Identities=21%  Similarity=0.272  Sum_probs=99.3

Q ss_pred             eeeeecCCceeehhhhcccCcccccCCcccCCCCCCCEEEccCCc-----------------------------------
Q 008893           14 IQVICSDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNF-----------------------------------   58 (549)
Q Consensus        14 ~~~~c~~~~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~-----------------------------------   58 (549)
                      .||.|+.. .++..++|++|.++|.+|++|++|++|+.|+|++|.                                   
T Consensus        73 ~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~  151 (636)
T 4eco_A           73 PGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVD  151 (636)
T ss_dssp             TTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTC
T ss_pred             CCeEEcCC-CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhc
Confidence            69999654 578899999999999999999999999999999984                                   


Q ss_pred             -------------------------------------------CCCCCcccccCCcccCeeeccCcccccC---------
Q 008893           59 -------------------------------------------FTGPIPSTVSHLETLQYLRLNNNSLTGA---------   86 (549)
Q Consensus        59 -------------------------------------------l~g~~p~~~~~l~~L~~L~l~~N~l~g~---------   86 (549)
                                                                 |+| +|..|+++++|++|+|++|+|+|.         
T Consensus       152 ~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~  230 (636)
T 4eco_A          152 YDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE  230 (636)
T ss_dssp             CCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred             cCchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence                                                       445 888999999999999999999986         


Q ss_pred             --------CCcccc--cCCCCceEeccCCCCCCCCCcccc-----ccccccCCc-cc
Q 008893           87 --------IPPSLS--NMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNS-LI  127 (549)
Q Consensus        87 --------~p~~~~--~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~-~~  127 (549)
                              +|..++  ++++|+.|+|++|.+.|.+|..+.     +.+++++|. +.
T Consensus       231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~  287 (636)
T 4eco_A          231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS  287 (636)
T ss_dssp             TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSC
T ss_pred             ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCc
Confidence                    999999  999999999999999999997654     567889997 53

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.27  E-value=1.6e-11  Score=118.35  Aligned_cols=145  Identities=13%  Similarity=0.070  Sum_probs=112.9

Q ss_pred             HHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeE
Q 008893          224 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       224 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  302 (549)
                      .....|.....++.|+.+.||++... ++.+++|+...... .....+.+|+.+++.+. +..+.++++++...+..++|
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            34457877788888899999999754 68899999865321 11235788999998884 67788999999888889999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ---------------------------------------  343 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------  343 (549)
                      |||++|.+|.+.+.     +......++.+++.+|..||+.                                       
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999887642     1223457888999999999981                                       


Q ss_pred             -----------------CCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          344 -----------------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       344 -----------------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                                       ..+.++|+|++|.||+++++..+.|+||+.+.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             01469999999999999876566799999775

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.27  E-value=5.9e-12  Score=130.97  Aligned_cols=103  Identities=24%  Similarity=0.288  Sum_probs=89.3

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|+|+ .+| .+.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus       189 ~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  266 (440)
T 3zyj_A          189 YLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN  266 (440)
T ss_dssp             EEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSC
T ss_pred             eecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCC
Confidence            3568888887 555 48888999999999999998888999999999999999999998888899999999999999999


Q ss_pred             CCCCCCcccc-----ccccccCCccccCCC
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLICATG  131 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~~~~~  131 (549)
                      |++.++..+.     +.+++++|++.|.|.
T Consensus       267 l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          267 LTLLPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             CCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             CCccChhHhccccCCCEEEcCCCCccCCCC
Confidence            9988876543     578999999999874

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.26  E-value=9.4e-12  Score=121.81  Aligned_cols=119  Identities=24%  Similarity=0.212  Sum_probs=73.8

Q ss_pred             ccceeeeeeeeeecCC-------ceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeec
Q 008893            6 EKVLIIVLIQVICSDG-------VFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL   78 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~~-------~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l   78 (549)
                      ++|+.|+|.++....-       -.....++|++|.|++..+.  +.+++|++|+|++|+|+ .+|..+..+++|+.|+|
T Consensus        31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l  107 (290)
T 1p9a_G           31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV  107 (290)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence            4566666655544211       01122355777777644332  66777777777777776 56666777777777777


Q ss_pred             cCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           79 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        79 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      ++|+|++..|..|..+++|+.|+|++|.|++.++..+.     ..+++++|.+.
T Consensus       108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  161 (290)
T 1p9a_G          108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (290)
T ss_dssp             CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence            77777755556677777777777777777766655432     45666677664

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.25  E-value=8.5e-12  Score=130.23  Aligned_cols=103  Identities=23%  Similarity=0.284  Sum_probs=90.8

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|+|++. | .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.
T Consensus       200 ~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  277 (452)
T 3zyi_A          200 YLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN  277 (452)
T ss_dssp             EEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCc
Confidence            356888888844 4 58889999999999999998889999999999999999999998889999999999999999999


Q ss_pred             CCCCCCcccc-----ccccccCCccccCCC
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLICATG  131 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~~~~~  131 (549)
                      |++.++..+.     ..+++++|++.|.+.
T Consensus       278 l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          278 LSSLPHDLFTPLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             CSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred             CCccChHHhccccCCCEEEccCCCcCCCCC
Confidence            9988876543     568999999999875

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.25  E-value=6.7e-12  Score=126.94  Aligned_cols=101  Identities=22%  Similarity=0.180  Sum_probs=90.3

Q ss_pred             hhcccCcccccCCcccC-CCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           28 RLLQNNNISGHIPTEIG-KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      ++|++|+|++..+..|. ++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.
T Consensus        44 L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  123 (361)
T 2xot_A           44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNH  123 (361)
T ss_dssp             EECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCc
Confidence            67999999988888888 99999999999999997777889999999999999999997777789999999999999999


Q ss_pred             CCCCCCcccc-----ccccccCCcccc
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLIC  128 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~~  128 (549)
                      |++..|..+.     ..+++++|.+..
T Consensus       124 i~~~~~~~~~~l~~L~~L~L~~N~l~~  150 (361)
T 2xot_A          124 IVVVDRNAFEDMAQLQKLYLSQNQISR  150 (361)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred             ccEECHHHhCCcccCCEEECCCCcCCe
Confidence            9988776543     568899998853

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.25  E-value=9.8e-12  Score=123.95  Aligned_cols=97  Identities=21%  Similarity=0.330  Sum_probs=54.9

Q ss_pred             hhcccCcccccCCcccCC---------CCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCc
Q 008893           28 RLLQNNNISGHIPTEIGK---------LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA   98 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~---------l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~   98 (549)
                      ++|++|++.+.+|..++.         +++|++|+|++|+|+ .+|..+.++++|+.|+|++|+++ .+|..+..+++|+
T Consensus       155 L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~  232 (328)
T 4fcg_A          155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE  232 (328)
T ss_dssp             EEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCC
T ss_pred             EECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCC
Confidence            445565555566555443         566666666666665 55555666666666666666665 3444555666666


Q ss_pred             eEeccCCCCCCCCCcccc-----ccccccCCcc
Q 008893           99 FLDLSYNNLSGPVPSFHA-----KTFNITGNSL  126 (549)
Q Consensus        99 ~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~  126 (549)
                      .|+|++|.+.+.+|..+.     +.+++++|.+
T Consensus       233 ~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~  265 (328)
T 4fcg_A          233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSN  265 (328)
T ss_dssp             EEECTTCTTCCBCCCCTTCCCCCCEEECTTCTT
T ss_pred             EEECcCCcchhhhHHHhcCCCCCCEEECCCCCc
Confidence            666666666555554332     3445555544

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.25  E-value=2.5e-12  Score=143.45  Aligned_cols=113  Identities=23%  Similarity=0.263  Sum_probs=99.2

Q ss_pred             eeeeecCCceeehhhhcccCcccccCCcccCCCCCCCEEEc-cCCcCCCC------------------------------
Q 008893           14 IQVICSDGVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDL-SNNFFTGP------------------------------   62 (549)
Q Consensus        14 ~~~~c~~~~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~l-s~N~l~g~------------------------------   62 (549)
                      .||.|+. ..++..++|++|+|+|.+|++|++|++|+.|+| ++|.++|.                              
T Consensus       315 ~GV~C~~-~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~  393 (876)
T 4ecn_A          315 PGVDLDN-NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD  393 (876)
T ss_dssp             TTEEECT-TSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTC
T ss_pred             CceEecC-CCCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhc
Confidence            7899975 456888999999999999999999999999999 78766554                              


Q ss_pred             ----------------------------------------------CcccccCCcccCeeeccCccccc-----------
Q 008893           63 ----------------------------------------------IPSTVSHLETLQYLRLNNNSLTG-----------   85 (549)
Q Consensus        63 ----------------------------------------------~p~~~~~l~~L~~L~l~~N~l~g-----------   85 (549)
                                                                    +|..|++|++|+.|+|++|+|+|           
T Consensus       394 ~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s  473 (876)
T 4ecn_A          394 YDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN  473 (876)
T ss_dssp             CCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTT
T ss_pred             cCcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccc
Confidence                                                          88899999999999999999998           


Q ss_pred             ------CCCcccc--cCCCCceEeccCCCCCCCCCcccc-----ccccccCCc-cc
Q 008893           86 ------AIPPSLS--NMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNS-LI  127 (549)
Q Consensus        86 ------~~p~~~~--~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~-~~  127 (549)
                            .+|..++  ++++|+.|+|++|.+.|.+|..+.     ..+++++|. +.
T Consensus       474 ~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ls  529 (876)
T 4ecn_A          474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS  529 (876)
T ss_dssp             SHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSC
T ss_pred             cccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcc
Confidence                  3999987  999999999999999999997553     567889997 53

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.24  E-value=9.3e-12  Score=114.04  Aligned_cols=108  Identities=24%  Similarity=0.181  Sum_probs=91.1

Q ss_pred             cccceeeeeeeeeecCC--ce----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeec
Q 008893            5 LEKVLIIVLIQVICSDG--VF----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL   78 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~--~~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l   78 (549)
                      ..+|+.|+|.++....-  .+    ....++|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus        30 ~~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           30 PRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             CTTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            35778888877766431  11    2223679999999888889999999999999999999888889999999999999


Q ss_pred             cCcccccCCCcccccCCCCceEeccCCCCCCCCC
Q 008893           79 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP  112 (549)
Q Consensus        79 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p  112 (549)
                      ++|+|++..+..|..+++|+.|+|++|++.+...
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A          110 HGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            9999996666679999999999999999987654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.24  E-value=5.9e-12  Score=110.12  Aligned_cols=101  Identities=19%  Similarity=0.221  Sum_probs=85.3

Q ss_pred             ehhhhcccCccc-ccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEecc
Q 008893           25 SFGRLLQNNNIS-GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLS  103 (549)
Q Consensus        25 ~~~l~l~~n~l~-~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~  103 (549)
                      ...+++++|.++ +.+|..+..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|++++.+|..+..+++|+.|+++
T Consensus        19 l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls   96 (149)
T 2je0_A           19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS   96 (149)
T ss_dssp             CSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECT
T ss_pred             CeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECC
Confidence            445779999998 88899999999999999999999965  788999999999999999997788888889999999999


Q ss_pred             CCCCCCCC-Cccc-----cccccccCCccc
Q 008893          104 YNNLSGPV-PSFH-----AKTFNITGNSLI  127 (549)
Q Consensus       104 ~N~l~~~~-p~~~-----~~~~~l~~N~~~  127 (549)
                      +|.+++.. +..+     ...+++++|.+.
T Consensus        97 ~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~  126 (149)
T 2je0_A           97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVT  126 (149)
T ss_dssp             TSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred             CCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence            99998753 2322     256788898875

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.23  E-value=1.4e-11  Score=111.18  Aligned_cols=109  Identities=19%  Similarity=0.097  Sum_probs=90.7

Q ss_pred             cccceeeeeeeeeecCC------c-eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSDG------V-FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~------~-~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      .++|+.|++.++....-      . .....++|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus        27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  106 (177)
T 2o6r_A           27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA  106 (177)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence            46788888887665421      1 1233467999999977777889999999999999999977777789999999999


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCc
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS  113 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~  113 (549)
                      |++|+|++..+..|..+++|+.|+|++|++++.+|.
T Consensus       107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A          107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            999999966666678899999999999999998874

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.23  E-value=2.3e-11  Score=117.68  Aligned_cols=123  Identities=22%  Similarity=0.219  Sum_probs=98.6

Q ss_pred             ccceeeeeeeeeecCC---ce----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeec
Q 008893            6 EKVLIIVLIQVICSDG---VF----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL   78 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~~---~~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l   78 (549)
                      .+|+.|+|.++....-   .+    ....++|++|.|+...+..|.++++|++|+|++|++++..+..|..+++|+.|+|
T Consensus        37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  116 (270)
T 2o6q_A           37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL  116 (270)
T ss_dssp             TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred             CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence            5678888877665431   11    2234679999999666667899999999999999999766677899999999999


Q ss_pred             cCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCcccc
Q 008893           79 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC  128 (549)
Q Consensus        79 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~~  128 (549)
                      ++|++++..|..|..+++|+.|+|++|.|++.++..+.     +.+++++|.+..
T Consensus       117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  171 (270)
T 2o6q_A          117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR  171 (270)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence            99999987788889999999999999999987776442     567888988754

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.22  E-value=5.6e-12  Score=136.64  Aligned_cols=102  Identities=23%  Similarity=0.285  Sum_probs=50.1

Q ss_pred             hcccCcccc-cCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           29 LLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        29 ~l~~n~l~~-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      +|++|.+++ .+|..|+++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|
T Consensus       454 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l  533 (606)
T 3vq2_A          454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI  533 (606)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCC
T ss_pred             ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcC
Confidence            344555444 2444455555555555555555544444555555555555555555544455555555555555555555


Q ss_pred             CCCCCcc-----ccccccccCCccccCC
Q 008893          108 SGPVPSF-----HAKTFNITGNSLICAT  130 (549)
Q Consensus       108 ~~~~p~~-----~~~~~~l~~N~~~~~~  130 (549)
                      +..++..     ....+++++|++.|.+
T Consensus       534 ~~~p~~~~~l~~~L~~l~l~~N~~~c~c  561 (606)
T 3vq2_A          534 ETSKGILQHFPKSLAFFNLTNNSVACIC  561 (606)
T ss_dssp             CCEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred             cccCHhHhhhcccCcEEEccCCCcccCC
Confidence            5332221     0133455555555544

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.22  E-value=9.7e-12  Score=111.14  Aligned_cols=99  Identities=22%  Similarity=0.250  Sum_probs=59.7

Q ss_pred             hhhcccCccc-ccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           27 GRLLQNNNIS-GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        27 ~l~l~~n~l~-~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .++|++|.++ +.+|..+..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|
T Consensus        28 ~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  105 (168)
T 2ell_A           28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN  105 (168)
T ss_dssp             EEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSS
T ss_pred             EEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCC
Confidence            4556666665 55666666666666666666666643  55666666666666666666556665555666666666666


Q ss_pred             CCCCCCC-ccc-----cccccccCCccc
Q 008893          106 NLSGPVP-SFH-----AKTFNITGNSLI  127 (549)
Q Consensus       106 ~l~~~~p-~~~-----~~~~~l~~N~~~  127 (549)
                      .|++..+ ..+     ...+++++|++.
T Consensus       106 ~l~~~~~~~~l~~l~~L~~L~l~~N~l~  133 (168)
T 2ell_A          106 KLKDISTLEPLKKLECLKSLDLFNCEVT  133 (168)
T ss_dssp             SCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred             ccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence            6665431 111     144566666654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.21  E-value=1.6e-11  Score=112.92  Aligned_cols=77  Identities=22%  Similarity=0.286  Sum_probs=43.0

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      +++++|.++  .++.+.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|.
T Consensus        71 L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~  147 (197)
T 4ezg_A           71 LTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG  147 (197)
T ss_dssp             EEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred             EEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence            345555433  22345555666666666666555455555555666666666666555555555555566666666655

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.21  E-value=9.7e-12  Score=130.69  Aligned_cols=107  Identities=22%  Similarity=0.204  Sum_probs=93.9

Q ss_pred             ehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccC
Q 008893           25 SFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY  104 (549)
Q Consensus        25 ~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~  104 (549)
                      ...++|++|+|++..+..|.++++|+.|+|++|.|++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++
T Consensus       226 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  305 (477)
T 2id5_A          226 LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG  305 (477)
T ss_dssp             CSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCS
T ss_pred             ccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCC
Confidence            34567889999855556899999999999999999987888899999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccc-----ccccccCCccccCCC
Q 008893          105 NNLSGPVPSFHA-----KTFNITGNSLICATG  131 (549)
Q Consensus       105 N~l~~~~p~~~~-----~~~~l~~N~~~~~~~  131 (549)
                      |.|++.++..+.     +.+++++|++.|.+.
T Consensus       306 N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~  337 (477)
T 2id5_A          306 NQLTTLEESVFHSVGNLETLILDSNPLACDCR  337 (477)
T ss_dssp             SCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred             CcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence            999988876543     578999999998753

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.21  E-value=1.4e-11  Score=132.43  Aligned_cols=103  Identities=19%  Similarity=0.306  Sum_probs=74.7

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCC-CCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT-GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      ++|++|.+++..|..|.++++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++..|..|..+++|+.|++++|.
T Consensus       426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  505 (570)
T 2z63_A          426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ  505 (570)
T ss_dssp             EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCc
Confidence            457777777777777777777777777777776 4577777777777777777777777667777777777777777777


Q ss_pred             CCCCCCcccc-----ccccccCCccccCC
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLICAT  130 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~~~~  130 (549)
                      +++.+|..+.     +.+++++|++.|.+
T Consensus       506 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  534 (570)
T 2z63_A          506 LKSVPDGIFDRLTSLQKIWLHTNPWDCSC  534 (570)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred             CCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence            7777665432     45677777777664

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.20  E-value=1.3e-11  Score=110.40  Aligned_cols=121  Identities=23%  Similarity=0.153  Sum_probs=96.4

Q ss_pred             cccceeeeeeeeeecCCce--------eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCee
Q 008893            5 LEKVLIIVLIQVICSDGVF--------FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL   76 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~~--------~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L   76 (549)
                      ..+|+.|++.++...++.+        ....++|++|.|++.  ..++.+++|++|+|++|++++.+|..+.++++|+.|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            4678889998876652221        222367999999966  789999999999999999998788888889999999


Q ss_pred             eccCcccccCC-CcccccCCCCceEeccCCCCCCCCC---ccc-----cccccccCCccc
Q 008893           77 RLNNNSLTGAI-PPSLSNMSQLAFLDLSYNNLSGPVP---SFH-----AKTFNITGNSLI  127 (549)
Q Consensus        77 ~l~~N~l~g~~-p~~~~~l~~L~~l~l~~N~l~~~~p---~~~-----~~~~~l~~N~~~  127 (549)
                      +|++|+|++.. +..+..+++|+.|++++|.+++.++   ..+     ...+++++|...
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            99999999532 2789999999999999999998876   222     245677777664

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.20  E-value=2.5e-11  Score=118.44  Aligned_cols=124  Identities=20%  Similarity=0.197  Sum_probs=101.2

Q ss_pred             cccceeeeeeeeeecC---Cc----eeehhhhcccCc-ccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCee
Q 008893            5 LEKVLIIVLIQVICSD---GV----FFSFGRLLQNNN-ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL   76 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~---~~----~~~~~l~l~~n~-l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L   76 (549)
                      +.+|+.|+|.++....   ..    .....++|++|. ++...|..|.++++|++|+|++|++++..|..|.++++|+.|
T Consensus        55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  134 (285)
T 1ozn_A           55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL  134 (285)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence            4678888887764431   11    123346799997 887778899999999999999999998888899999999999


Q ss_pred             eccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCcccc
Q 008893           77 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC  128 (549)
Q Consensus        77 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~~  128 (549)
                      +|++|++++..+..|..+++|+.|+|++|.+++.++..+.     ..+++++|.+..
T Consensus       135 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (285)
T 1ozn_A          135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (285)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence            9999999977777799999999999999999987775433     568899998753

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.20  E-value=3.8e-11  Score=119.68  Aligned_cols=121  Identities=17%  Similarity=0.198  Sum_probs=98.2

Q ss_pred             cccceeeeeeeeeecCCc----------------eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCccccc
Q 008893            5 LEKVLIIVLIQVICSDGV----------------FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS   68 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~----------------~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~   68 (549)
                      +.+|+.|+|.++......                .....++|++|.|+ .+|..++++++|++|+|++|+++ .+|+.+.
T Consensus       149 l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~  226 (328)
T 4fcg_A          149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH  226 (328)
T ss_dssp             CTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGG
T ss_pred             CcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhc
Confidence            567888888775432211                12233679999998 88888999999999999999999 4777899


Q ss_pred             CCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           69 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        69 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      .+++|+.|+|++|++.+.+|..|..+++|+.|+|++|.+.+.+|..+.     +.+++++|++.
T Consensus       227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~  290 (328)
T 4fcg_A          227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL  290 (328)
T ss_dssp             GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred             cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence            999999999999999999999999999999999999999998887543     56788888774

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.20  E-value=2.2e-11  Score=130.27  Aligned_cols=97  Identities=25%  Similarity=0.335  Sum_probs=86.6

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|+|++ +|. |++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .|..+++|+.|+|++|.
T Consensus       445 ~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~  519 (567)
T 1dce_A          445 VLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR  519 (567)
T ss_dssp             EEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             EEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCC
Confidence            37899999996 676 999999999999999999 899999999999999999999996 77 89999999999999999


Q ss_pred             CCCCC-Ccccc-----ccccccCCcccc
Q 008893          107 LSGPV-PSFHA-----KTFNITGNSLIC  128 (549)
Q Consensus       107 l~~~~-p~~~~-----~~~~l~~N~~~~  128 (549)
                      |++.+ |..+.     ..+++++|++..
T Consensus       520 l~~~~~p~~l~~l~~L~~L~L~~N~l~~  547 (567)
T 1dce_A          520 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ  547 (567)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             CCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence            99986 66543     568999999853

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.19  E-value=3.2e-11  Score=120.32  Aligned_cols=100  Identities=23%  Similarity=0.258  Sum_probs=66.4

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|.+++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|.|
T Consensus       197 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i  275 (330)
T 1xku_A          197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI  275 (330)
T ss_dssp             EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred             EECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcC
Confidence            456677777666667777777777777777777655556777777777777777777 6666677777777777777777


Q ss_pred             CCCCCcccc-----------ccccccCCcccc
Q 008893          108 SGPVPSFHA-----------KTFNITGNSLIC  128 (549)
Q Consensus       108 ~~~~p~~~~-----------~~~~l~~N~~~~  128 (549)
                      ++..+..+.           ..+++++|++.+
T Consensus       276 ~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~  307 (330)
T 1xku_A          276 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY  307 (330)
T ss_dssp             CCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred             CccChhhcCCcccccccccccceEeecCcccc
Confidence            665554331           235566666643

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.19  E-value=4.9e-12  Score=139.50  Aligned_cols=120  Identities=25%  Similarity=0.305  Sum_probs=76.0

Q ss_pred             cccceeeeeeeeeecCC-----c-eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeec
Q 008893            5 LEKVLIIVLIQVICSDG-----V-FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL   78 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~-----~-~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l   78 (549)
                      +.+|+.|+|.++....-     . .....|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|+.|++|+.|+|
T Consensus       223 l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L  300 (727)
T 4b8c_D          223 DQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF  300 (727)
T ss_dssp             CCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred             CCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence            34566666655544310     0 11223567777777 66777777777777777777777 66777777777777777


Q ss_pred             cCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc------ccccccCCccc
Q 008893           79 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLI  127 (549)
Q Consensus        79 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~------~~~~l~~N~~~  127 (549)
                      ++|.|+ .+|..|.++++|+.|+|++|.|++.+|..+.      ..+++.+|.+.
T Consensus       301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~  354 (727)
T 4b8c_D          301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPE  354 (727)
T ss_dssp             CSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             CCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCccc
Confidence            777776 6666677777777777777777776665442      12456666553

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.19  E-value=3.3e-11  Score=115.69  Aligned_cols=137  Identities=15%  Similarity=0.073  Sum_probs=100.4

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCC--ccceEEEEecCCceeeEeec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++....+.+.|..+.||++...+|+.+++|+.....    ...+..|+.+++.+.+.+  +.+++++....+..++||||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            343333334556699999987778889999976531    234778999998886544  45688888877788999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------------
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-----------------------------------------  344 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------------  344 (549)
                      ++|.++.  ...   .+   ...++.+++..|..||+..                                         
T Consensus        97 i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           97 VPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             CSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             cCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            9998884  221   12   2367778888888888742                                         


Q ss_pred             --------------CCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          345 --------------DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       345 --------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                                    .+.++|+|++|.||+++++..+.|+||+.+..
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                          12399999999999998876677999998753

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.18  E-value=2.4e-11  Score=122.07  Aligned_cols=104  Identities=18%  Similarity=0.136  Sum_probs=84.5

Q ss_pred             hhhccc-CcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           27 GRLLQN-NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        27 ~l~l~~-n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .|+|++ |.|++..|..|++|++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|..++ |+.|+|++|
T Consensus        35 ~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N  113 (347)
T 2ifg_A           35 ELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGN  113 (347)
T ss_dssp             EEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSS
T ss_pred             EEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCC
Confidence            467886 999988889999999999999999999998899999999999999999999966666666665 999999999


Q ss_pred             CCCCCCCcccc------ccccccCCccccCCC
Q 008893          106 NLSGPVPSFHA------KTFNITGNSLICATG  131 (549)
Q Consensus       106 ~l~~~~p~~~~------~~~~l~~N~~~~~~~  131 (549)
                      .|.....-...      ....+..+.+.|...
T Consensus       114 ~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~  145 (347)
T 2ifg_A          114 PLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ  145 (347)
T ss_dssp             CCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred             CccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence            99976652211      223345566777653

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.18  E-value=1.1e-11  Score=108.43  Aligned_cols=106  Identities=22%  Similarity=0.173  Sum_probs=89.1

Q ss_pred             cccceeeeeeeeeecCCc--------eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCee
Q 008893            5 LEKVLIIVLIQVICSDGV--------FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL   76 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~--------~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L   76 (549)
                      ..+|+.|++.++...++.        .....++|++|.|++.  ..++++++|++|+|++|++++.+|..+..+++|+.|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            467888888887665211        1223467999999976  789999999999999999998799988889999999


Q ss_pred             eccCcccccC-CCcccccCCCCceEeccCCCCCCCCC
Q 008893           77 RLNNNSLTGA-IPPSLSNMSQLAFLDLSYNNLSGPVP  112 (549)
Q Consensus        77 ~l~~N~l~g~-~p~~~~~l~~L~~l~l~~N~l~~~~p  112 (549)
                      +|++|++++. .|..+..+++|+.|++++|.+++.++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  130 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND  130 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence            9999999963 34889999999999999999998776

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.17  E-value=2.1e-11  Score=120.17  Aligned_cols=124  Identities=20%  Similarity=0.241  Sum_probs=98.8

Q ss_pred             cccceeeeeeeeeecC------CceeehhhhcccCcccccCC-cccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSD------GVFFSFGRLLQNNNISGHIP-TEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~------~~~~~~~l~l~~n~l~~~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      +.+|+.|+|.++....      +-.....++|++|.+++..+ ..+.++++|++|+|++|.+++..|..|..+++|+.|+
T Consensus        77 ~~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  156 (306)
T 2z66_A           77 TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK  156 (306)
T ss_dssp             CSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEE
T ss_pred             ccccCEEECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEE
Confidence            4678888886654421      11122346799999987665 6889999999999999999988888899999999999


Q ss_pred             ccCccccc-CCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCcccc
Q 008893           78 LNNNSLTG-AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC  128 (549)
Q Consensus        78 l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~~  128 (549)
                      |++|++++ .+|..|..+++|+.|++++|.+++..|..+.     +.+++++|.+..
T Consensus       157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  213 (306)
T 2z66_A          157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS  213 (306)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB
T ss_pred             CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc
Confidence            99999986 5888899999999999999999988776543     567889998754

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.17  E-value=2e-11  Score=132.24  Aligned_cols=85  Identities=20%  Similarity=0.223  Sum_probs=44.1

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCC---CcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP---IPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY  104 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~---~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~  104 (549)
                      ++|++|.+++..|..|+++++|++|+|++|.+++.   .+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++
T Consensus       430 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~  509 (606)
T 3t6q_A          430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH  509 (606)
T ss_dssp             EECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             EECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCC
Confidence            44555555555555555555555555555555541   223445555555555555555544455555555555555555


Q ss_pred             CCCCCCCC
Q 008893          105 NNLSGPVP  112 (549)
Q Consensus       105 N~l~~~~p  112 (549)
                      |++++.+|
T Consensus       510 N~l~~~~~  517 (606)
T 3t6q_A          510 NRLTSSSI  517 (606)
T ss_dssp             SCCCGGGG
T ss_pred             CccCcCCh
Confidence            55554444

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.16  E-value=5e-11  Score=129.83  Aligned_cols=98  Identities=21%  Similarity=0.298  Sum_probs=55.3

Q ss_pred             hhcccCcccccCCcccC--CCCCCCEEEccCCcCCCCCcccccCCcccCeeec------cCcccccCCCcccccCCCCce
Q 008893           28 RLLQNNNISGHIPTEIG--KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL------NNNSLTGAIPPSLSNMSQLAF   99 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~--~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l------~~N~l~g~~p~~~~~l~~L~~   99 (549)
                      ++|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+.++++|+.|+|      ++|++.+.+|..|..+++|+.
T Consensus       493 L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~  570 (636)
T 4eco_A          493 IDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQ  570 (636)
T ss_dssp             EECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCE
T ss_pred             EECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCE
Confidence            455566655 4555554  56666666666666664 5556666666666666      345555566666666666666


Q ss_pred             EeccCCCCCCCCCcccc---ccccccCCcccc
Q 008893          100 LDLSYNNLSGPVPSFHA---KTFNITGNSLIC  128 (549)
Q Consensus       100 l~l~~N~l~~~~p~~~~---~~~~l~~N~~~~  128 (549)
                      |+|++|.| +.+|..+.   ..+++++|++.|
T Consensus       571 L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          571 LQIGSNDI-RKVNEKITPNISVLDIKDNPNIS  601 (636)
T ss_dssp             EECCSSCC-CBCCSCCCTTCCEEECCSCTTCE
T ss_pred             EECCCCcC-CccCHhHhCcCCEEECcCCCCcc
Confidence            66666666 34443221   345566665554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.16  E-value=4.7e-11  Score=115.86  Aligned_cols=113  Identities=20%  Similarity=0.131  Sum_probs=93.7

Q ss_pred             eeeecCCceeeh---------hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCccccc
Q 008893           15 QVICSDGVFFSF---------GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG   85 (549)
Q Consensus        15 ~~~c~~~~~~~~---------~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g   85 (549)
                      .+.|++..+..+         .++|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++++
T Consensus        11 ~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~   90 (276)
T 2z62_A           11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS   90 (276)
T ss_dssp             EEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred             eEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCc
Confidence            467766444333         36789999998888899999999999999999997777789999999999999999998


Q ss_pred             CCCcccccCCCCceEeccCCCCCCCCCccc-----cccccccCCccc
Q 008893           86 AIPPSLSNMSQLAFLDLSYNNLSGPVPSFH-----AKTFNITGNSLI  127 (549)
Q Consensus        86 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-----~~~~~l~~N~~~  127 (549)
                      ..|..|.++++|+.|++++|.+++..+..+     .+.+++++|.+.
T Consensus        91 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  137 (276)
T 2z62_A           91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ  137 (276)
T ss_dssp             ECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred             cChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccc
Confidence            888889999999999999999998776433     256788888774

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.16  E-value=3.6e-11  Score=126.33  Aligned_cols=113  Identities=24%  Similarity=0.314  Sum_probs=92.1

Q ss_pred             eeeecCCceeehh---------hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCccccc
Q 008893           15 QVICSDGVFFSFG---------RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG   85 (549)
Q Consensus        15 ~~~c~~~~~~~~~---------l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g   85 (549)
                      .+.|++..+..+|         ++|++|+|++..|..|.++++|++|+|++|.+++..|..|.++++|+.|+|++|+|++
T Consensus        15 ~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~   94 (477)
T 2id5_A           15 AVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL   94 (477)
T ss_dssp             EEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred             EEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCc
Confidence            4667655544433         5789999998888899999999999999999998788899999999999999999996


Q ss_pred             CCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           86 AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        86 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      ..+..|.++++|+.|+|++|.+++.+|..+.     +.+++++|.+.
T Consensus        95 ~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~  141 (477)
T 2id5_A           95 IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV  141 (477)
T ss_dssp             CCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCC
T ss_pred             cCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccc
Confidence            6666788999999999999999888776543     56778888764

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.16  E-value=4.6e-11  Score=129.45  Aligned_cols=113  Identities=21%  Similarity=0.128  Sum_probs=75.0

Q ss_pred             eeeecCCceeehh---------hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCccccc
Q 008893           15 QVICSDGVFFSFG---------RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG   85 (549)
Q Consensus        15 ~~~c~~~~~~~~~---------l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g   85 (549)
                      .+.|++..++.+|         ++|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++
T Consensus        15 ~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~   94 (606)
T 3vq2_A           15 TYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS   94 (606)
T ss_dssp             EEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCC
T ss_pred             ceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccc
Confidence            4566554443333         4577777776666677777777777777777776666677777777777777777776


Q ss_pred             CCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           86 AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        86 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      ..|..|.++++|++|+|++|.+++..|..+.     +.+++++|.+.
T Consensus        95 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  141 (606)
T 3vq2_A           95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH  141 (606)
T ss_dssp             CCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCC
T ss_pred             cChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCccc
Confidence            6677777777777777777777666554332     45566666654

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.14  E-value=4.4e-11  Score=129.57  Aligned_cols=114  Identities=18%  Similarity=0.062  Sum_probs=92.5

Q ss_pred             eeeecCCceeehh---------hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCccccc
Q 008893           15 QVICSDGVFFSFG---------RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG   85 (549)
Q Consensus        15 ~~~c~~~~~~~~~---------l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g   85 (549)
                      .+.|++..+..+|         ++|++|.|++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++
T Consensus        16 ~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~   95 (606)
T 3t6q_A           16 TYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF   95 (606)
T ss_dssp             EEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSE
T ss_pred             eEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccc
Confidence            4667665544444         5788999998888899999999999999999988888889999999999999999988


Q ss_pred             CCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCcccc
Q 008893           86 AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC  128 (549)
Q Consensus        86 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~~  128 (549)
                      ..|..|.++++|+.|++++|.+++..|..+.     +.+++++|.+..
T Consensus        96 ~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~  143 (606)
T 3t6q_A           96 MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS  143 (606)
T ss_dssp             ECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCC
T ss_pred             cChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccc
Confidence            8888899999999999999999886554332     567888887754

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.14  E-value=5.4e-11  Score=124.12  Aligned_cols=110  Identities=21%  Similarity=0.153  Sum_probs=90.2

Q ss_pred             eeeecCCceeehh---------hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCccccc
Q 008893           15 QVICSDGVFFSFG---------RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG   85 (549)
Q Consensus        15 ~~~c~~~~~~~~~---------l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g   85 (549)
                      .+.|++..+..+|         ++|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++
T Consensus        58 ~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~  137 (452)
T 3zyi_A           58 KVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTV  137 (452)
T ss_dssp             EEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSB
T ss_pred             EEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCc
Confidence            4667655444333         6799999998889999999999999999999998888899999999999999999997


Q ss_pred             CCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCC
Q 008893           86 AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGN  124 (549)
Q Consensus        86 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N  124 (549)
                      ..+..|..+++|+.|+|++|.|++.++..+.     ..+++++|
T Consensus       138 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~  181 (452)
T 3zyi_A          138 IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL  181 (452)
T ss_dssp             CCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC
T ss_pred             cChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCC
Confidence            7777799999999999999999876665432     45566664

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.14  E-value=6.9e-11  Score=127.79  Aligned_cols=124  Identities=17%  Similarity=0.092  Sum_probs=94.9

Q ss_pred             cccceeeeeeeeeecCC------c-eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSDG------V-FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~------~-~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      +.+++.+++.+.....-      . .....++|++|.|++..|..|+++++|++|+|++|.|++..|..|+++++|+.|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            45667777766554321      0 1233467889999988888899999999999999999987777888999999999


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCcccc
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC  128 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~~  128 (549)
                      |++|.|++..+..|.++++|+.|+|++|.|++.+|..+.     ..+++++|.+..
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  185 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH  185 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence            999999855555678899999999999999888876543     567888887753

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.13  E-value=4e-11  Score=125.05  Aligned_cols=104  Identities=22%  Similarity=0.205  Sum_probs=94.1

Q ss_pred             ehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccC
Q 008893           25 SFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY  104 (549)
Q Consensus        25 ~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~  104 (549)
                      ...++|++|.+++.+|..|+++++|++|+|++|++++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus       277 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  356 (455)
T 3v47_A          277 VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY  356 (455)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCS
T ss_pred             ceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCC
Confidence            44577999999999999999999999999999999988899999999999999999999988899999999999999999


Q ss_pred             CCCCCCCCcccc-----ccccccCCcccc
Q 008893          105 NNLSGPVPSFHA-----KTFNITGNSLIC  128 (549)
Q Consensus       105 N~l~~~~p~~~~-----~~~~l~~N~~~~  128 (549)
                      |.+++..|..+.     +.+++++|.+..
T Consensus       357 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  385 (455)
T 3v47_A          357 NHIRALGDQSFLGLPNLKELALDTNQLKS  385 (455)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CcccccChhhccccccccEEECCCCcccc
Confidence            999988886543     568999998863

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.13  E-value=6.8e-11  Score=114.73  Aligned_cols=122  Identities=17%  Similarity=0.067  Sum_probs=88.7

Q ss_pred             ccceeeeeeeeeecCC---c----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeec
Q 008893            6 EKVLIIVLIQVICSDG---V----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL   78 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~~---~----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l   78 (549)
                      .+|+.|+|.++....-   .    .....++|++|.|++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            4577777766544310   1    12334668888888777778888888888888888888777778888888888888


Q ss_pred             cCcccccCCCcccccCCCCceEeccCCCCCCC-CCcccc-----ccccccCCccc
Q 008893           79 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP-VPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        79 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~-~p~~~~-----~~~~l~~N~~~  127 (549)
                      ++|++++..+..+..+++|+.|++++|.+++. +|..+.     +.+++++|.+.
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~  162 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ  162 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC
Confidence            88888866666788888888888888888763 355432     45677777664

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=3.2e-10  Score=114.46  Aligned_cols=143  Identities=14%  Similarity=0.183  Sum_probs=107.0

Q ss_pred             CCCeeeeeCCeEEEEEEECCCCEEEEEEcc--cCCCCCcHHHHHHHHHHHhhcc--CCCccceEEEEecC---CceeeEe
Q 008893          231 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLK--DGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGFCMTT---TERLLVY  303 (549)
Q Consensus       231 ~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  303 (549)
                      ..+.++.|.++.||+....+ ..+++|+..  ..........+.+|..+++.+.  +..+.++++++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            34678999999999998764 678888876  3332222346788999999886  45678889988766   3478999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC---------------------------------------  344 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------  344 (549)
                      ||+++..+.+...  ..++...+..++.+++..|..||+..                                       
T Consensus       121 e~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          121 EFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             ECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             EecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            9999988754322  24678888999999999999999730                                       


Q ss_pred             ----------------CCceEecccCcCeeeecCCCc--eEEeecccccc
Q 008893          345 ----------------DPKIIHRDVKAANILLDEYYE--AVVGDFGLAKL  376 (549)
Q Consensus       345 ----------------~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~  376 (549)
                                      .+.++|||+++.||+++.++.  +.|.||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            257999999999999997653  68999998864

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.11  E-value=1.3e-10  Score=118.66  Aligned_cols=123  Identities=17%  Similarity=0.117  Sum_probs=95.1

Q ss_pred             cccceeeeeeeeeecC--C-c----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSD--G-V----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~--~-~----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      +++++.+++.+.....  . .    .....++|++|.|++..|..|+++++|++|+|++|++++..|..|.++++|+.|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            5677888887765532  1 0    1233467889999887788899999999999999999977777889999999999


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      |++|+|+...+..|..+++|+.|++++|.+++..|..+.     +.+++++|.+.
T Consensus       124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  178 (390)
T 3o6n_A          124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT  178 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred             CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence            999999844444468899999999999999887776443     56788888775

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.11  E-value=1e-10  Score=121.47  Aligned_cols=111  Identities=22%  Similarity=0.165  Sum_probs=91.3

Q ss_pred             eeeecCCceeehh---------hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCccccc
Q 008893           15 QVICSDGVFFSFG---------RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG   85 (549)
Q Consensus        15 ~~~c~~~~~~~~~---------l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g   85 (549)
                      .+.|++..+..+|         ++|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++
T Consensus        47 ~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~  126 (440)
T 3zyj_A           47 KVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT  126 (440)
T ss_dssp             EEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSS
T ss_pred             EEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCe
Confidence            5667665555444         5799999998888999999999999999999998778899999999999999999996


Q ss_pred             CCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCc
Q 008893           86 AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNS  125 (549)
Q Consensus        86 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~  125 (549)
                      ..+..|..+++|+.|+|++|.|++.++..+.     +.+++++|.
T Consensus       127 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~  171 (440)
T 3zyj_A          127 IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELK  171 (440)
T ss_dssp             CCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCT
T ss_pred             eCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCC
Confidence            6666899999999999999999877665443     456666643

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.11  E-value=4.2e-11  Score=126.02  Aligned_cols=100  Identities=26%  Similarity=0.227  Sum_probs=77.6

Q ss_pred             hhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCccccc-CCcccCeeeccCcccccCCCcccccCCCCceEeccC
Q 008893           26 FGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS-HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY  104 (549)
Q Consensus        26 ~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~  104 (549)
                      ..++|++|.|++..|..|+++++|+.|+|++|.|++.+|..+. .+++|+.|+|++|.|++. |. +..+++|+.|+|++
T Consensus       123 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~  200 (487)
T 3oja_A          123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSS  200 (487)
T ss_dssp             EEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCS
T ss_pred             CEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCC
Confidence            3467888888888888888888899999999988887787776 688888888888888855 32 34578888888888


Q ss_pred             CCCCCCCCccc----cccccccCCccc
Q 008893          105 NNLSGPVPSFH----AKTFNITGNSLI  127 (549)
Q Consensus       105 N~l~~~~p~~~----~~~~~l~~N~~~  127 (549)
                      |.|++.+|.+.    ...+++++|.+.
T Consensus       201 N~l~~~~~~~~~l~~L~~L~Ls~N~l~  227 (487)
T 3oja_A          201 NKLAFMGPEFQSAAGVTWISLRNNKLV  227 (487)
T ss_dssp             SCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred             CCCCCCCHhHcCCCCccEEEecCCcCc
Confidence            88887766532    256778888775

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.10  E-value=6.7e-11  Score=126.48  Aligned_cols=104  Identities=24%  Similarity=0.236  Sum_probs=88.4

Q ss_pred             cceeeeeeeeeecCC-ce----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCc
Q 008893            7 KVLIIVLIQVICSDG-VF----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN   81 (549)
Q Consensus         7 ~~~~~~~~~~~c~~~-~~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N   81 (549)
                      .|+.|+|.++..+.- .+    ....++|++|.|+ .+|..|++|++|+.|+|++|+|++ +| .|++|++|+.|+|++|
T Consensus       442 ~L~~L~Ls~n~l~~lp~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N  518 (567)
T 1dce_A          442 DVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN  518 (567)
T ss_dssp             TCSEEECTTSCCSSCCCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CceEEEecCCCCCCCcCccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCC
Confidence            466777776655431 11    1223679999999 889999999999999999999996 78 8999999999999999


Q ss_pred             ccccCC-CcccccCCCCceEeccCCCCCCCCCc
Q 008893           82 SLTGAI-PPSLSNMSQLAFLDLSYNNLSGPVPS  113 (549)
Q Consensus        82 ~l~g~~-p~~~~~l~~L~~l~l~~N~l~~~~p~  113 (549)
                      +|++.. |..|..+++|+.|+|++|+|++.+|.
T Consensus       519 ~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          519 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             CCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            999776 99999999999999999999998774

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.10  E-value=1.6e-10  Score=129.00  Aligned_cols=96  Identities=25%  Similarity=0.297  Sum_probs=51.3

Q ss_pred             hhcccCcccccCCcccCC--------CCCCCEEEccCCcCCCCCccccc--CCcccCeeeccCcccccCCCcccccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGK--------LSKLLTLDLSNNFFTGPIPSTVS--HLETLQYLRLNNNSLTGAIPPSLSNMSQL   97 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~--------l~~L~~L~ls~N~l~g~~p~~~~--~l~~L~~L~l~~N~l~g~~p~~~~~l~~L   97 (549)
                      ++|++|+|+ .+|..+..        |++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|
T Consensus       702 L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L  778 (876)
T 4ecn_A          702 IILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQL  778 (876)
T ss_dssp             EECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTC
T ss_pred             EECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCC
Confidence            455566655 44433222        125666666666665 4555554  55666666666666654 55555556666


Q ss_pred             ceEeccC------CCCCCCCCcccc-----ccccccCCcc
Q 008893           98 AFLDLSY------NNLSGPVPSFHA-----KTFNITGNSL  126 (549)
Q Consensus        98 ~~l~l~~------N~l~~~~p~~~~-----~~~~l~~N~~  126 (549)
                      +.|+|++      |.+.+.+|..+.     ..+++++|.+
T Consensus       779 ~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L  818 (876)
T 4ecn_A          779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI  818 (876)
T ss_dssp             CEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred             CEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC
Confidence            6665544      555555554332     3455555555

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.09  E-value=1.5e-10  Score=115.56  Aligned_cols=85  Identities=28%  Similarity=0.338  Sum_probs=54.6

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|.+++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|.|
T Consensus       198 L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l  276 (332)
T 2ft3_A          198 LHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI  276 (332)
T ss_dssp             CBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCC
T ss_pred             EECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCC
Confidence            456666666555566666666666666666666555556666666666666666666 5666666666666666666666


Q ss_pred             CCCCCc
Q 008893          108 SGPVPS  113 (549)
Q Consensus       108 ~~~~p~  113 (549)
                      ++..+.
T Consensus       277 ~~~~~~  282 (332)
T 2ft3_A          277 TKVGVN  282 (332)
T ss_dssp             CBCCTT
T ss_pred             CccChh
Confidence            655443

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.09  E-value=1.1e-10  Score=126.25  Aligned_cols=123  Identities=20%  Similarity=0.136  Sum_probs=100.0

Q ss_pred             cccceeeeeeeeeecCC---ce----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSDG---VF----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~---~~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      +.+|+.|+|.++...+-   .+    ....++|++|.|++..|..|+++++|++|+|++|.|++..+..|.++++|+.|+
T Consensus        74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  153 (597)
T 3oja_B           74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS  153 (597)
T ss_dssp             CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence            46788999877654321   11    233477999999998888999999999999999999965555579999999999


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc--ccccccCCccc
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLI  127 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~l~~N~~~  127 (549)
                      |++|.|++..|..|..+++|+.|+|++|.|++..+..+.  ..+++++|.+.
T Consensus       154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~  205 (597)
T 3oja_B          154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS  205 (597)
T ss_dssp             CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCS
T ss_pred             eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccc
Confidence            999999988888999999999999999999987554433  45677777664

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.08  E-value=6.1e-11  Score=106.82  Aligned_cols=98  Identities=20%  Similarity=0.123  Sum_probs=62.9

Q ss_pred             hhhcccCcccccCCcccCCCC-CCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLS-KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~-~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .++|++|+|+. +|. +..+. +|++|+|++|+|++.  +.|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus        23 ~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N   98 (176)
T 1a9n_A           23 ELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN   98 (176)
T ss_dssp             EEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSC
T ss_pred             EEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCC
Confidence            45677777773 443 44444 777777777777753  56777777777777777777544444577777777777777


Q ss_pred             CCCCCCC-ccc-----cccccccCCcccc
Q 008893          106 NLSGPVP-SFH-----AKTFNITGNSLIC  128 (549)
Q Consensus       106 ~l~~~~p-~~~-----~~~~~l~~N~~~~  128 (549)
                      .|+..++ ..+     ...+++++|++..
T Consensus        99 ~i~~~~~~~~l~~l~~L~~L~l~~N~i~~  127 (176)
T 1a9n_A           99 SLVELGDLDPLASLKSLTYLCILRNPVTN  127 (176)
T ss_dssp             CCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred             cCCcchhhHhhhcCCCCCEEEecCCCCCC
Confidence            7754332 011     2456777777753

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.08  E-value=1.4e-10  Score=123.28  Aligned_cols=102  Identities=21%  Similarity=0.288  Sum_probs=54.8

Q ss_pred             hhcccCcccc--cCCcccCCCCCCCEEEccCCcCCCCCccc-ccCC----------------------cccCeeeccCcc
Q 008893           28 RLLQNNNISG--HIPTEIGKLSKLLTLDLSNNFFTGPIPST-VSHL----------------------ETLQYLRLNNNS   82 (549)
Q Consensus        28 l~l~~n~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l----------------------~~L~~L~l~~N~   82 (549)
                      ++|++|+|++  .+|..++++++|++|+|++|++++.+|.. +..+                      ++|+.|+|++|+
T Consensus       353 L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~  432 (520)
T 2z7x_B          353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNK  432 (520)
T ss_dssp             EECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSC
T ss_pred             EEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEECCCCc
Confidence            4455555554  33444555555555555555555434432 3334                      455555555555


Q ss_pred             cccCCCcccccCCCCceEeccCCCCCCCCCccc-----cccccccCCccccCC
Q 008893           83 LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH-----AKTFNITGNSLICAT  130 (549)
Q Consensus        83 l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-----~~~~~l~~N~~~~~~  130 (549)
                      |+ .+|..+..+++|+.|+|++|+|++.++..+     ...+++++|++.|.+
T Consensus       433 l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c  484 (520)
T 2z7x_B          433 IK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  484 (520)
T ss_dssp             CC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             cc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccC
Confidence            55 555555566666666666666664443312     134566666666553

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.07  E-value=5.4e-11  Score=117.67  Aligned_cols=83  Identities=22%  Similarity=0.223  Sum_probs=57.1

Q ss_pred             hhhcccCcccccCCccc--CCCCCCCEEEccCCcCCCCCcccccCC-----cccCeeeccCcccccCCCcccccCCCCce
Q 008893           27 GRLLQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPSTVSHL-----ETLQYLRLNNNSLTGAIPPSLSNMSQLAF   99 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~--~~l~~L~~L~ls~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~l~~L~~   99 (549)
                      .++|++|+|++.+|..+  +++++|++|+|++|+|++. |..+..+     ++|++|+|++|+|++..|..|..+++|+.
T Consensus        99 ~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  177 (312)
T 1wwl_A           99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST  177 (312)
T ss_dssp             EEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCE
T ss_pred             EEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCE
Confidence            35577777777677665  6777777777777777755 6666665     67777777777777666667777777777


Q ss_pred             EeccCCCCCCC
Q 008893          100 LDLSYNNLSGP  110 (549)
Q Consensus       100 l~l~~N~l~~~  110 (549)
                      |+|++|.+.|.
T Consensus       178 L~Ls~N~l~~~  188 (312)
T 1wwl_A          178 LDLSDNPELGE  188 (312)
T ss_dssp             EECCSCTTCHH
T ss_pred             EECCCCCcCcc
Confidence            77777776553

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.07  E-value=1.9e-10  Score=123.53  Aligned_cols=125  Identities=20%  Similarity=0.253  Sum_probs=66.3

Q ss_pred             cccceeeeeeeeeecCCc-------eeehhhhcccCccccc--CCcccCCCCCCCEEEccCCcCCCCCccc-ccCC----
Q 008893            5 LEKVLIIVLIQVICSDGV-------FFSFGRLLQNNNISGH--IPTEIGKLSKLLTLDLSNNFFTGPIPST-VSHL----   70 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-------~~~~~l~l~~n~l~~~--~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l----   70 (549)
                      +.+|+.|++.++...+..       .....++|++|+|++.  +|..|+++++|+.|+|++|++++.+|.. +..+    
T Consensus       352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~  431 (562)
T 3a79_B          352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL  431 (562)
T ss_dssp             CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred             CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence            455666666555443311       1122244556665542  2344555566666666666555434432 3333    


Q ss_pred             ------------------cccCeeeccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           71 ------------------ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        71 ------------------~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                                        ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++..+.     ..+++++|++.
T Consensus       432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~  510 (562)
T 3a79_B          432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD  510 (562)
T ss_dssp             EEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBC
T ss_pred             EEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcC
Confidence                              45666666666665 5555555666666777777766654443221     34566677766


Q ss_pred             cCC
Q 008893          128 CAT  130 (549)
Q Consensus       128 ~~~  130 (549)
                      |.+
T Consensus       511 c~c  513 (562)
T 3a79_B          511 CTC  513 (562)
T ss_dssp             CCH
T ss_pred             CCc
Confidence            653

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.06  E-value=8.2e-11  Score=116.37  Aligned_cols=123  Identities=16%  Similarity=0.136  Sum_probs=87.7

Q ss_pred             cccceeeeeeeeeecCCc---------eeehhhhcccCcccccCCcccCCC-----CCCCEEEccCCcCCCCCcccccCC
Q 008893            5 LEKVLIIVLIQVICSDGV---------FFSFGRLLQNNNISGHIPTEIGKL-----SKLLTLDLSNNFFTGPIPSTVSHL   70 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~---------~~~~~l~l~~n~l~~~~p~~~~~l-----~~L~~L~ls~N~l~g~~p~~~~~l   70 (549)
                      +++|+.|+|.++...+..         .....++|++|+|++. |..++++     ++|++|+|++|+|++..|..|..+
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  172 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF  172 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence            577888888887765311         1233467888888876 7777776     888888888888887777888888


Q ss_pred             cccCeeeccCcccccC--CCccc--ccCCCCceEeccCCCCCCCC--C-cc-----ccccccccCCcccc
Q 008893           71 ETLQYLRLNNNSLTGA--IPPSL--SNMSQLAFLDLSYNNLSGPV--P-SF-----HAKTFNITGNSLIC  128 (549)
Q Consensus        71 ~~L~~L~l~~N~l~g~--~p~~~--~~l~~L~~l~l~~N~l~~~~--p-~~-----~~~~~~l~~N~~~~  128 (549)
                      ++|+.|+|++|++.|.  +|..+  ..+++|+.|+|++|.|++..  + ..     ..+.+++++|.+..
T Consensus       173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~  242 (312)
T 1wwl_A          173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD  242 (312)
T ss_dssp             SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCS
T ss_pred             CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCc
Confidence            8888888888887765  33334  77888888888888887422  2 11     23567788887753

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.06  E-value=7.7e-11  Score=124.01  Aligned_cols=121  Identities=21%  Similarity=0.111  Sum_probs=94.7

Q ss_pred             cccceeeeeeeeeecCC--ceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcc
Q 008893            5 LEKVLIIVLIQVICSDG--VFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS   82 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~--~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~   82 (549)
                      +.+|+.|+|.++...+-  ......++|++|.|++..+.   .+++|+.|+|++|.|++..|..|+.+++|+.|+|++|.
T Consensus        79 l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  155 (487)
T 3oja_A           79 LSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE  155 (487)
T ss_dssp             CTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSC
T ss_pred             CCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCC
Confidence            56788888877665421  11233467999999877664   45789999999999998888889999999999999999


Q ss_pred             cccCCCcccc-cCCCCceEeccCCCCCCCCCccc---cccccccCCcccc
Q 008893           83 LTGAIPPSLS-NMSQLAFLDLSYNNLSGPVPSFH---AKTFNITGNSLIC  128 (549)
Q Consensus        83 l~g~~p~~~~-~l~~L~~l~l~~N~l~~~~p~~~---~~~~~l~~N~~~~  128 (549)
                      |++..|..|. .+++|+.|+|++|.|++.++...   ...+++++|.+..
T Consensus       156 l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~  205 (487)
T 3oja_A          156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF  205 (487)
T ss_dssp             CCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE
T ss_pred             CCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCC
Confidence            9988888876 78999999999999988755432   3567899998864

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.05  E-value=1.6e-10  Score=106.02  Aligned_cols=81  Identities=25%  Similarity=0.332  Sum_probs=41.7

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      +++++|.|+ .+| .+..+++|++|+|++|.++ . ++.+..+++|+.|+|++|++++..|..|..+++|+.|++++|.+
T Consensus        49 L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i  124 (197)
T 4ezg_A           49 ITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH  124 (197)
T ss_dssp             EEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBC
T ss_pred             EeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCcc
Confidence            345555555 333 3555555555555555444 2 22455555555555555555544455555555555555555555


Q ss_pred             CCCCC
Q 008893          108 SGPVP  112 (549)
Q Consensus       108 ~~~~p  112 (549)
                      ++..|
T Consensus       125 ~~~~~  129 (197)
T 4ezg_A          125 DDSIL  129 (197)
T ss_dssp             BGGGH
T ss_pred             CcHhH
Confidence            54333

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.04  E-value=2.9e-10  Score=124.92  Aligned_cols=83  Identities=29%  Similarity=0.239  Sum_probs=33.8

Q ss_pred             cccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCCC
Q 008893           30 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG  109 (549)
Q Consensus        30 l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  109 (549)
                      |++|.+++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++
T Consensus        56 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  135 (680)
T 1ziw_A           56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS  135 (680)
T ss_dssp             CCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccc
Confidence            44444443334444444444444444444442222234444444444444444443333334444444444444444444


Q ss_pred             CCC
Q 008893          110 PVP  112 (549)
Q Consensus       110 ~~p  112 (549)
                      .+|
T Consensus       136 ~~~  138 (680)
T 1ziw_A          136 TKL  138 (680)
T ss_dssp             CCC
T ss_pred             cCc
Confidence            333

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.04  E-value=3.4e-10  Score=115.61  Aligned_cols=123  Identities=20%  Similarity=0.118  Sum_probs=98.0

Q ss_pred             cccceeeeeeeeeecC---Cc----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSD---GV----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~---~~----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      +++|+.|+|.++...+   ..    .....++|++|.+++..|..|+++++|++|+|++|+|+...+..|.++++|+.|+
T Consensus        68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  147 (390)
T 3o6n_A           68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS  147 (390)
T ss_dssp             CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence            4688899987765432   11    1233467999999988888999999999999999999944444468999999999


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc--ccccccCCccc
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLI  127 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~l~~N~~~  127 (549)
                      |++|++++..|..|..+++|+.|++++|.+++.....+.  ..+++++|.+.
T Consensus       148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~  199 (390)
T 3o6n_A          148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS  199 (390)
T ss_dssp             CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCS
T ss_pred             CCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeeccccccc
Confidence            999999988888899999999999999999976544332  45677777664

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.04  E-value=2.2e-10  Score=126.32  Aligned_cols=97  Identities=29%  Similarity=0.365  Sum_probs=86.2

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .|+|++|.|. .+|..+.+|++|++|+|++|.|+ .+|..|.+|++|+.|+|++|+|+ .+|..|..|++|+.|+|++|.
T Consensus       228 ~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~  304 (727)
T 4b8c_D          228 ALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNM  304 (727)
T ss_dssp             EEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSC
T ss_pred             EEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCC
Confidence            4789999998 78888889999999999999999 89999999999999999999999 889999999999999999999


Q ss_pred             CCCCCCcccc-----ccccccCCccc
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      |+.. |..+.     ..++|++|.+.
T Consensus       305 l~~l-p~~~~~l~~L~~L~L~~N~l~  329 (727)
T 4b8c_D          305 VTTL-PWEFGNLCNLQFLGVEGNPLE  329 (727)
T ss_dssp             CCCC-CSSTTSCTTCCCEECTTSCCC
T ss_pred             CCcc-ChhhhcCCCccEEeCCCCccC
Confidence            9844 54332     56899999885

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.03  E-value=1.5e-10  Score=114.28  Aligned_cols=123  Identities=19%  Similarity=0.146  Sum_probs=90.7

Q ss_pred             cccceeeeeeeeeecCC---c----eeehhhhcccCccccc--C--CcccCCCCCCCEEEccCCcCCCCCcc----cccC
Q 008893            5 LEKVLIIVLIQVICSDG---V----FFSFGRLLQNNNISGH--I--PTEIGKLSKLLTLDLSNNFFTGPIPS----TVSH   69 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~---~----~~~~~l~l~~n~l~~~--~--p~~~~~l~~L~~L~ls~N~l~g~~p~----~~~~   69 (549)
                      +.+|+.|+|.++.....   .    .....++|++|++.+.  +  +..++++++|++|+|++|+|+ .+|.    .+..
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~  222 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA  222 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence            66888999987655321   1    1233477999998753  2  233578899999999999997 4444    2577


Q ss_pred             CcccCeeeccCcccccCCCcccccC---CCCceEeccCCCCCCCCCccc--cccccccCCcccc
Q 008893           70 LETLQYLRLNNNSLTGAIPPSLSNM---SQLAFLDLSYNNLSGPVPSFH--AKTFNITGNSLIC  128 (549)
Q Consensus        70 l~~L~~L~l~~N~l~g~~p~~~~~l---~~L~~l~l~~N~l~~~~p~~~--~~~~~l~~N~~~~  128 (549)
                      +++|+.|+|++|+|++..|..+..+   ++|+.|+|++|.|+..++...  .+.+++++|.+..
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~L~~L~Ls~N~l~~  286 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLPAKLRVLDLSSNRLNR  286 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCCSCCSCEECCSCCCCS
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhcCCCCEEECCCCcCCC
Confidence            8999999999999998878888777   689999999999995433322  3678899998863

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.03  E-value=3.7e-10  Score=112.64  Aligned_cols=98  Identities=31%  Similarity=0.329  Sum_probs=79.7

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|.|++..|..|.++++|++|+|++|++++..|..|.++++|+.|+|++|+++ .+|..+.  ++|+.|++++|.
T Consensus        58 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~  134 (332)
T 2ft3_A           58 LLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNR  134 (332)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSC
T ss_pred             EEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCc
Confidence            4678889888777888899999999999999998777888888999999999999988 6776655  788999999999


Q ss_pred             CCCCCCcccc-----ccccccCCccc
Q 008893          107 LSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus       107 l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      +++.++..+.     +.+++++|.+.
T Consensus       135 i~~~~~~~~~~l~~L~~L~l~~n~l~  160 (332)
T 2ft3_A          135 IRKVPKGVFSGLRNMNCIEMGGNPLE  160 (332)
T ss_dssp             CCCCCSGGGSSCSSCCEEECCSCCCB
T ss_pred             cCccCHhHhCCCccCCEEECCCCccc
Confidence            8877765432     55778888774

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.02  E-value=2.8e-10  Score=125.08  Aligned_cols=114  Identities=20%  Similarity=0.205  Sum_probs=96.3

Q ss_pred             eeeecCCceeeh---------hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCccccc
Q 008893           15 QVICSDGVFFSF---------GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG   85 (549)
Q Consensus        15 ~~~c~~~~~~~~---------~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g   85 (549)
                      .+.|+...++.+         .++|++|.|++..+..|+++++|++|+|++|.+++..|..|.++++|+.|+|++|++++
T Consensus         8 ~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~   87 (680)
T 1ziw_A            8 VADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ   87 (680)
T ss_dssp             EEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCC
T ss_pred             eeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCc
Confidence            366765443333         36799999998888889999999999999999999889999999999999999999996


Q ss_pred             CCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCcccc
Q 008893           86 AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC  128 (549)
Q Consensus        86 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~~  128 (549)
                      ..+..|.++++|+.|+|++|.+++.+|..+.     +.+++++|.+..
T Consensus        88 l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  135 (680)
T 1ziw_A           88 LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS  135 (680)
T ss_dssp             CCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSC
T ss_pred             cChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccc
Confidence            5555799999999999999999988876543     567889988753

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.02  E-value=2.3e-10  Score=115.26  Aligned_cols=85  Identities=25%  Similarity=0.209  Sum_probs=52.5

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+|++..+..|.++++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|++++|.+
T Consensus        57 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l  136 (353)
T 2z80_A           57 LDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY  136 (353)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCC
T ss_pred             EECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCC
Confidence            45666666655555666666666666666666655555666666666666666666633333366666666666666666


Q ss_pred             CCCCC
Q 008893          108 SGPVP  112 (549)
Q Consensus       108 ~~~~p  112 (549)
                      ++.++
T Consensus       137 ~~l~~  141 (353)
T 2z80_A          137 KTLGE  141 (353)
T ss_dssp             SSSCS
T ss_pred             cccCc
Confidence            65443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.02  E-value=2.6e-10  Score=128.35  Aligned_cols=125  Identities=21%  Similarity=0.132  Sum_probs=88.3

Q ss_pred             ccccceeeeeeeeeecC---Cc----eeehhhhcccCcccccC-CcccCCCCCCCEEEccCCcCCCCCcccccCCcccCe
Q 008893            4 LLEKVLIIVLIQVICSD---GV----FFSFGRLLQNNNISGHI-PTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY   75 (549)
Q Consensus         4 ~~~~~~~~~~~~~~c~~---~~----~~~~~l~l~~n~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~   75 (549)
                      +..+|+.|+|.++....   ..    .....++|++|.+.+.+ |..|++|++|++|+|++|+|++..|..|.++++|+.
T Consensus        22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  101 (844)
T 3j0a_A           22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE  101 (844)
T ss_dssp             SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred             CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence            34677788887655432   11    12223567777655555 667888888888888888888777888888888888


Q ss_pred             eeccCcccccCCCcc--cccCCCCceEeccCCCCCCCCCc-cc-----cccccccCCcccc
Q 008893           76 LRLNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLSGPVPS-FH-----AKTFNITGNSLIC  128 (549)
Q Consensus        76 L~l~~N~l~g~~p~~--~~~l~~L~~l~l~~N~l~~~~p~-~~-----~~~~~l~~N~~~~  128 (549)
                      |+|++|++++.+|..  |.++++|+.|+|++|.+++..+. .+     .+.+++++|.+..
T Consensus       102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~  162 (844)
T 3j0a_A          102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL  162 (844)
T ss_dssp             EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred             eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence            888888888766654  78888888888888888876553 22     2557788887643

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.02  E-value=3.7e-10  Score=121.22  Aligned_cols=100  Identities=21%  Similarity=0.092  Sum_probs=64.0

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|.|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|++++|.+
T Consensus        33 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  112 (570)
T 2z63_A           33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL  112 (570)
T ss_dssp             EECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             EEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccccccc
Confidence            45667777666666677777777777777777655556666677777777777776655556666666677777766666


Q ss_pred             CCCCCccc-----cccccccCCccc
Q 008893          108 SGPVPSFH-----AKTFNITGNSLI  127 (549)
Q Consensus       108 ~~~~p~~~-----~~~~~l~~N~~~  127 (549)
                      ++..+..+     .+.+++++|.+.
T Consensus       113 ~~l~~~~~~~l~~L~~L~L~~n~l~  137 (570)
T 2z63_A          113 ASLENFPIGHLKTLKELNVAHNLIQ  137 (570)
T ss_dssp             CCSTTCSCTTCTTCCEEECCSSCCC
T ss_pred             ccCCCccccccccccEEecCCCccc
Confidence            65544222     244566666553

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.01  E-value=2.3e-10  Score=122.34  Aligned_cols=99  Identities=21%  Similarity=0.176  Sum_probs=70.8

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|+|++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|+.|+|++|.
T Consensus        30 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~  109 (549)
T 2z81_A           30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP  109 (549)
T ss_dssp             EEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCC
T ss_pred             EEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCc
Confidence            35677777777777777778888888888888777666777777888888888888776666667777788888888887


Q ss_pred             CCCC-CCccc-----cccccccCCc
Q 008893          107 LSGP-VPSFH-----AKTFNITGNS  125 (549)
Q Consensus       107 l~~~-~p~~~-----~~~~~l~~N~  125 (549)
                      +++. .|..+     .+.+++++|.
T Consensus       110 l~~~~~~~~~~~l~~L~~L~L~~n~  134 (549)
T 2z81_A          110 YQTLGVTSLFPNLTNLQTLRIGNVE  134 (549)
T ss_dssp             CSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred             ccccchhhhhhccCCccEEECCCCc
Confidence            7753 33322     2455666665

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.01  E-value=1.3e-10  Score=114.83  Aligned_cols=81  Identities=15%  Similarity=0.088  Sum_probs=36.6

Q ss_pred             hhcccCcccccCC----cccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccC--C--CcccccCCCCce
Q 008893           28 RLLQNNNISGHIP----TEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA--I--PPSLSNMSQLAF   99 (549)
Q Consensus        28 l~l~~n~l~~~~p----~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~--p~~~~~l~~L~~   99 (549)
                      ++|++|.+++..|    ..+..+++|++|+|++|++++..|..|..+++|++|+|++|++.+.  +  +..+..+++|+.
T Consensus       122 L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~  201 (310)
T 4glp_A          122 LRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQN  201 (310)
T ss_dssp             CEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCS
T ss_pred             EEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCE
Confidence            4455555554333    2233445555555555555544444455555555555555554321  1  111234444444


Q ss_pred             EeccCCCCC
Q 008893          100 LDLSYNNLS  108 (549)
Q Consensus       100 l~l~~N~l~  108 (549)
                      |+|++|.++
T Consensus       202 L~Ls~N~l~  210 (310)
T 4glp_A          202 LALRNTGME  210 (310)
T ss_dssp             CBCCSSCCC
T ss_pred             EECCCCCCC
Confidence            444444443

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=3.5e-10  Score=111.41  Aligned_cols=187  Identities=19%  Similarity=0.186  Sum_probs=122.8

Q ss_pred             CCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCC--ccceEEEEecCC---ceeeEeec
Q 008893          232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRN--LLRLIGFCMTTT---ERLLVYPY  305 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~  305 (549)
                      .+.++.|.+..||+..    ..+++|+....   .....+..|..+++.+. +..  +.+++.......   ..++||+|
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4678999999999863    45888886432   22456889999998873 333  334444433332   34789999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ------------------------------------------  343 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------------  343 (549)
                      ++|.++.+...  ..++..++..++.+++..+..||+.                                          
T Consensus        98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99988865433  2467778888888888888888861                                          


Q ss_pred             -------------CCCceEecccCcCeeeecC--CCceEEeecccccccCCCCCcee-------------eccccccCcc
Q 008893          344 -------------CDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKLLDHCDSHVT-------------TAVRGTVGHI  395 (549)
Q Consensus       344 -------------~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~-------------~~~~gt~~y~  395 (549)
                                   ..+.++|+|++|.||++++  ...+.|+||+.+...........             .......++.
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                         1246899999999999998  55678999999865432100000             0000011122


Q ss_pred             C-chhhccCCCCCcccchhHhHHHHHHHhCCcccc
Q 008893          396 A-PEYLSTGQSSEKTDVFGFGILLLELISGLRALE  429 (549)
Q Consensus       396 a-PE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  429 (549)
                      . |+.....  ....+.|++|.++|.+.+|..++.
T Consensus       256 ~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          256 DIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence            2 2222111  123589999999999999987764

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.01  E-value=3.7e-10  Score=101.64  Aligned_cols=104  Identities=20%  Similarity=0.107  Sum_probs=80.4

Q ss_pred             ccceeeeeeeeeecC-----Cce-eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            6 EKVLIIVLIQVICSD-----GVF-FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~-----~~~-~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      .+|+.|++.++....     ... ....++|++|.|++.  +.|+++++|++|+|++|+|++..|..|..+++|+.|+|+
T Consensus        19 ~~L~~L~l~~n~l~~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   96 (176)
T 1a9n_A           19 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT   96 (176)
T ss_dssp             TSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred             CCceEEEeeCCCCchhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECC
Confidence            466777776665432     111 334467999999975  678999999999999999995544555889999999999


Q ss_pred             CcccccCCCc--ccccCCCCceEeccCCCCCCCCC
Q 008893           80 NNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVP  112 (549)
Q Consensus        80 ~N~l~g~~p~--~~~~l~~L~~l~l~~N~l~~~~p  112 (549)
                      +|+|+ .+|.  .+..+++|+.|++++|.++..++
T Consensus        97 ~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~  130 (176)
T 1a9n_A           97 NNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKH  130 (176)
T ss_dssp             SCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTT
T ss_pred             CCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHh
Confidence            99997 6776  78899999999999999985543

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.01  E-value=3.4e-10  Score=121.51  Aligned_cols=97  Identities=27%  Similarity=0.272  Sum_probs=65.5

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|.|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|..  .+++|+.|+|++|.+
T Consensus        57 L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l  133 (562)
T 3a79_B           57 LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDF  133 (562)
T ss_dssp             EECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCC
T ss_pred             EECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCc
Confidence            557777777666667777777777777777777666777777777777777777777 55655  677777777777777


Q ss_pred             CCC-CCcccc-----ccccccCCccc
Q 008893          108 SGP-VPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus       108 ~~~-~p~~~~-----~~~~l~~N~~~  127 (549)
                      ++. +|..+.     +.+++++|.+.
T Consensus       134 ~~l~~p~~~~~l~~L~~L~L~~n~l~  159 (562)
T 3a79_B          134 DVLPVCKEFGNLTKLTFLGLSAAKFR  159 (562)
T ss_dssp             SBCCCCGGGGGCTTCCEEEEECSBCC
T ss_pred             cccCchHhhcccCcccEEecCCCccc
Confidence            663 333332     45666666653

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.00  E-value=3.8e-10  Score=119.84  Aligned_cols=102  Identities=23%  Similarity=0.250  Sum_probs=83.3

Q ss_pred             hhhhcccCcccccCCcccCCCCCCCEEEccCCcCCC--CCcccccCCcccCeeeccCcccccCCCcc-cccCCCCceEec
Q 008893           26 FGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG--PIPSTVSHLETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDL  102 (549)
Q Consensus        26 ~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~l  102 (549)
                      ..++|++|++++.+|..++++++|++|+|++|++++  .+|..+..+++|+.|+|++|++++.+|.. +..+++|+.|++
T Consensus       327 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L  406 (520)
T 2z7x_B          327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM  406 (520)
T ss_dssp             CEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEEC
T ss_pred             cEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEEC
Confidence            346788999988888888999999999999999986  56677888999999999999998756654 778888999999


Q ss_pred             cCCCCCCCCCccc---cccccccCCccc
Q 008893          103 SYNNLSGPVPSFH---AKTFNITGNSLI  127 (549)
Q Consensus       103 ~~N~l~~~~p~~~---~~~~~l~~N~~~  127 (549)
                      ++|.+++..|..+   .+.+++++|.+.
T Consensus       407 s~N~l~~~~~~~l~~~L~~L~Ls~N~l~  434 (520)
T 2z7x_B          407 SSNILTDTIFRCLPPRIKVLDLHSNKIK  434 (520)
T ss_dssp             CSSCCCGGGGGSCCTTCCEEECCSSCCC
T ss_pred             cCCCCCcchhhhhcccCCEEECCCCccc
Confidence            9999887776543   366788888775

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.99  E-value=3e-10  Score=112.53  Aligned_cols=99  Identities=26%  Similarity=0.240  Sum_probs=62.5

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCccccc-CCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS-HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .++|++|++++..|..++++++|++|+|++|.+++..|..+. .+++|+.|+|++|+|++. |. ...+++|+.|+|++|
T Consensus       124 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N  201 (317)
T 3o53_A          124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSN  201 (317)
T ss_dssp             EEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSS
T ss_pred             EEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCC
Confidence            356777777766666777777777777777777765555553 567777777777777643 32 234666777777777


Q ss_pred             CCCCCCCccc----cccccccCCccc
Q 008893          106 NLSGPVPSFH----AKTFNITGNSLI  127 (549)
Q Consensus       106 ~l~~~~p~~~----~~~~~l~~N~~~  127 (549)
                      .|++.++.+.    ...+++++|.+.
T Consensus       202 ~l~~l~~~~~~l~~L~~L~L~~N~l~  227 (317)
T 3o53_A          202 KLAFMGPEFQSAAGVTWISLRNNKLV  227 (317)
T ss_dssp             CCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred             cCCcchhhhcccCcccEEECcCCccc
Confidence            7766554421    145566666664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.98  E-value=5.6e-10  Score=111.20  Aligned_cols=97  Identities=27%  Similarity=0.282  Sum_probs=73.0

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+|++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|+|+ .+|..+.  ++|+.|++++|.+
T Consensus        57 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l  133 (330)
T 1xku_A           57 LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEI  133 (330)
T ss_dssp             EECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCC
T ss_pred             EECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcc
Confidence            568888888777777888888888888888888777888888888888888888887 6666554  6788888888888


Q ss_pred             CCCCCcccc-----ccccccCCccc
Q 008893          108 SGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus       108 ~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      ++..+..+.     ..+++++|.+.
T Consensus       134 ~~~~~~~~~~l~~L~~L~l~~n~l~  158 (330)
T 1xku_A          134 TKVRKSVFNGLNQMIVVELGTNPLK  158 (330)
T ss_dssp             CBBCHHHHTTCTTCCEEECCSSCCC
T ss_pred             cccCHhHhcCCccccEEECCCCcCC
Confidence            776654332     45677777663

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.98  E-value=2.7e-10  Score=107.90  Aligned_cols=101  Identities=17%  Similarity=0.215  Sum_probs=79.7

Q ss_pred             hhhhcccCcccccCCcccCCCCCCCEEEccCCc-CCCCCcccccCCcccCeeeccC-cccccCCCcccccCCCCceEecc
Q 008893           26 FGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNF-FTGPIPSTVSHLETLQYLRLNN-NSLTGAIPPSLSNMSQLAFLDLS  103 (549)
Q Consensus        26 ~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~  103 (549)
                      ..++|++|+|++..+..|.++++|++|+|++|+ +++..+..|.++++|+.|+|++ |+|++..+..|.++++|+.|+++
T Consensus        34 ~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~  113 (239)
T 2xwt_C           34 QTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF  113 (239)
T ss_dssp             CEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEE
T ss_pred             cEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCC
Confidence            346788999987777788899999999999996 8855566888899999999998 89987666788889999999999


Q ss_pred             CCCCCCCCCccc----cc---cccccCC-ccc
Q 008893          104 YNNLSGPVPSFH----AK---TFNITGN-SLI  127 (549)
Q Consensus       104 ~N~l~~~~p~~~----~~---~~~l~~N-~~~  127 (549)
                      +|.+++. |.+.    ..   .+++++| .+.
T Consensus       114 ~n~l~~l-p~~~~l~~L~~L~~L~l~~N~~l~  144 (239)
T 2xwt_C          114 NTGLKMF-PDLTKVYSTDIFFILEITDNPYMT  144 (239)
T ss_dssp             EECCCSC-CCCTTCCBCCSEEEEEEESCTTCC
T ss_pred             CCCCccc-cccccccccccccEEECCCCcchh
Confidence            9998874 4321    13   6777887 553

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.98  E-value=3.3e-10  Score=114.03  Aligned_cols=122  Identities=20%  Similarity=0.208  Sum_probs=96.4

Q ss_pred             cccceeeeeeeeeecC-------CceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSD-------GVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~-------~~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      .++|+.|++.++....       +-.....++|++|.|++..|..|+++++|++|+|++|+|++..+..|.++++|++|+
T Consensus        51 ~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  130 (353)
T 2z80_A           51 TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLN  130 (353)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEE
T ss_pred             cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEE
Confidence            3578888887665432       111233467999999998899999999999999999999965555599999999999


Q ss_pred             ccCcccccCCCc--ccccCCCCceEeccCCC-CCCCCCcccc-----ccccccCCccc
Q 008893           78 LNNNSLTGAIPP--SLSNMSQLAFLDLSYNN-LSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        78 l~~N~l~g~~p~--~~~~l~~L~~l~l~~N~-l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      |++|+++ .+|.  .|..+++|+.|++++|. +++..+..+.     +.+++++|.+.
T Consensus       131 L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~  187 (353)
T 2z80_A          131 LLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ  187 (353)
T ss_dssp             CTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred             CCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence            9999999 4554  78999999999999994 6666555443     56788888774

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.97  E-value=3.2e-10  Score=121.21  Aligned_cols=123  Identities=20%  Similarity=0.156  Sum_probs=98.8

Q ss_pred             cccceeeeeeeeeecC---Cc----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSD---GV----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~---~~----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      .++|+.|+|.++....   ..    .....++|++|+|++..|..|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus        25 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  104 (549)
T 2z81_A           25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN  104 (549)
T ss_dssp             CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEE
T ss_pred             CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEE
Confidence            3678899998775532   11    1233477999999998899999999999999999999987777799999999999


Q ss_pred             ccCccccc-CCCcccccCCCCceEeccCCCCCCCCC-cccc-----ccccccCCccc
Q 008893           78 LNNNSLTG-AIPPSLSNMSQLAFLDLSYNNLSGPVP-SFHA-----KTFNITGNSLI  127 (549)
Q Consensus        78 l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~~~~p-~~~~-----~~~~l~~N~~~  127 (549)
                      |++|++++ ..|..|.++++|+.|++++|.+.+.+| ..+.     +.+++++|.+.
T Consensus       105 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~  161 (549)
T 2z81_A          105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR  161 (549)
T ss_dssp             CTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred             CCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence            99999986 467789999999999999999655554 3332     56778888764

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.96  E-value=3.8e-10  Score=106.91  Aligned_cols=120  Identities=16%  Similarity=0.170  Sum_probs=89.4

Q ss_pred             ccceeeeeeeeeecC---Cc----eeehhhhcccCc-ccccCCcccCCCCCCCEEEccC-CcCCCCCcccccCCcccCee
Q 008893            6 EKVLIIVLIQVICSD---GV----FFSFGRLLQNNN-ISGHIPTEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYL   76 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~---~~----~~~~~l~l~~n~-l~~~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~~L~~L   76 (549)
                      .+|+.|++.++....   ..    .....++|++|. +++..+..|.++++|++|+|++ |+|++..+..|.++++|+.|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            467777776655431   11    123346788886 8866677888999999999998 88886666788889999999


Q ss_pred             eccCcccccCCCcccccCCCCc---eEeccCC-CCCCCCCcccc-----c-cccccCCccc
Q 008893           77 RLNNNSLTGAIPPSLSNMSQLA---FLDLSYN-NLSGPVPSFHA-----K-TFNITGNSLI  127 (549)
Q Consensus        77 ~l~~N~l~g~~p~~~~~l~~L~---~l~l~~N-~l~~~~p~~~~-----~-~~~l~~N~~~  127 (549)
                      +|++|++++ +|. |..+++|+   .|++++| .+++.++..+.     + .+++++|.+.
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~  169 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT  169 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence            999999885 776 78888887   9999999 88877765443     4 6777788764

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.90  E-value=1.3e-09  Score=106.48  Aligned_cols=118  Identities=26%  Similarity=0.286  Sum_probs=87.7

Q ss_pred             cccceeeeeeeeeecCCc-----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDGV-----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +++|+.|+|.++...+-.     .....++|++|.+++ +| .+.++++|++|+|++|++++ + +.+..+++|+.|+|+
T Consensus        67 l~~L~~L~L~~n~l~~~~~l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~  142 (291)
T 1h6t_A           67 LPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG  142 (291)
T ss_dssp             CTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECC
T ss_pred             CCCCCEEEccCCccCCCcccccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEcc
Confidence            577888888776654321     112236688999885 33 48899999999999999985 4 468888999999999


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCcc---ccccccccCCcccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLIC  128 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~---~~~~~~l~~N~~~~  128 (549)
                      +|++++.  ..+..+++|+.|++++|.+++..|-.   ....+++++|.+..
T Consensus       143 ~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~  192 (291)
T 1h6t_A          143 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD  192 (291)
T ss_dssp             SSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred             CCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC
Confidence            9999854  57888899999999999998876621   12567888887753

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.90  E-value=2.4e-09  Score=104.61  Aligned_cols=117  Identities=21%  Similarity=0.235  Sum_probs=90.4

Q ss_pred             cccceeeeeeeeeecCC-c----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDG-V----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~-~----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +++|+.|++.+....+- .    .....++|++|++++..|  +.++++|++|+|++|++++ +| .+..+++|+.|+|+
T Consensus        45 l~~L~~L~l~~~~i~~~~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~  120 (291)
T 1h6t_A           45 LNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE  120 (291)
T ss_dssp             HHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred             cCcccEEEccCCCcccChhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECC
Confidence            45677777766544321 1    123346799999996554  9999999999999999995 44 59999999999999


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCcc----ccccccccCCcccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNSLIC  128 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~----~~~~~~l~~N~~~~  128 (549)
                      +|+|++ + +.+..+++|+.|++++|.+++. +..    ....+++++|.+..
T Consensus       121 ~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~  170 (291)
T 1h6t_A          121 HNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISD  170 (291)
T ss_dssp             TSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC
T ss_pred             CCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCcccc
Confidence            999995 4 5689999999999999999986 322    12678899998753

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.90  E-value=1.2e-09  Score=107.81  Aligned_cols=118  Identities=25%  Similarity=0.266  Sum_probs=84.9

Q ss_pred             cccceeeeeeeeeecCCc-----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDGV-----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +.+|+.|+|.++...+-.     .....++|++|.|++. |. +.++++|++|+|++|++++ +|. +..+++|+.|+|+
T Consensus        84 l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~  159 (308)
T 1h6u_A           84 LTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIG  159 (308)
T ss_dssp             CCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECC
T ss_pred             CCCCCEEEccCCcCCCchhhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEcc
Confidence            567888888776654311     1222366888988853 43 8888999999999998885 443 8888888999999


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCcc---ccccccccCCcccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLIC  128 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~---~~~~~~l~~N~~~~  128 (549)
                      +|++++ ++. +..+++|+.|++++|.+++..+-.   ....+++++|.+..
T Consensus       160 ~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~  209 (308)
T 1h6u_A          160 NAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISD  209 (308)
T ss_dssp             SSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCB
T ss_pred             CCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCc
Confidence            888884 444 888888888888888888766521   12567788887753

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.88  E-value=2.1e-09  Score=103.40  Aligned_cols=93  Identities=27%  Similarity=0.360  Sum_probs=52.9

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+|++..|  +.++++|++|+|++|+|++ +|.. .. ++|+.|+|++|+|++ +| .+..+++|+.|+|++|.|
T Consensus        68 L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i  140 (263)
T 1xeu_A           68 LHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKL  140 (263)
T ss_dssp             EECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCC
T ss_pred             EECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcC
Confidence            4566666664333  6666666666666666663 3332 22 666666666666663 33 466666666666666666


Q ss_pred             CCCCCcc---ccccccccCCccc
Q 008893          108 SGPVPSF---HAKTFNITGNSLI  127 (549)
Q Consensus       108 ~~~~p~~---~~~~~~l~~N~~~  127 (549)
                      ++..+-.   ....+++++|.+.
T Consensus       141 ~~~~~l~~l~~L~~L~L~~N~i~  163 (263)
T 1xeu_A          141 KSIVMLGFLSKLEVLDLHGNEIT  163 (263)
T ss_dssp             CBCGGGGGCTTCCEEECTTSCCC
T ss_pred             CCChHHccCCCCCEEECCCCcCc
Confidence            6542110   1144566666654

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.88  E-value=7.7e-10  Score=109.58  Aligned_cols=121  Identities=21%  Similarity=0.105  Sum_probs=87.7

Q ss_pred             cccceeeeeeeeeecCC--ceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcc
Q 008893            5 LEKVLIIVLIQVICSDG--VFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS   82 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~--~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~   82 (549)
                      +.+|+.|++.++....-  ......+++++|+|++..+..   +++|+.|+|++|++++..|..+..+++|+.|+|++|+
T Consensus        79 l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  155 (317)
T 3o53_A           79 LSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE  155 (317)
T ss_dssp             CTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSC
T ss_pred             cCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCC
Confidence            46777888876655320  012234668888888665543   5778899999999987777788888999999999999


Q ss_pred             cccCCCcccc-cCCCCceEeccCCCCCCCCCccc---cccccccCCcccc
Q 008893           83 LTGAIPPSLS-NMSQLAFLDLSYNNLSGPVPSFH---AKTFNITGNSLIC  128 (549)
Q Consensus        83 l~g~~p~~~~-~l~~L~~l~l~~N~l~~~~p~~~---~~~~~l~~N~~~~  128 (549)
                      +++..|..+. .+++|+.|+|++|.+++..+...   ...+++++|.+..
T Consensus       156 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~  205 (317)
T 3o53_A          156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF  205 (317)
T ss_dssp             CCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE
T ss_pred             CCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCc
Confidence            8877676664 68889999999998886643322   2567888887753

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.88  E-value=2.7e-09  Score=105.21  Aligned_cols=119  Identities=23%  Similarity=0.288  Sum_probs=93.5

Q ss_pred             ccccceeeeeeeeeecCCc-----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeec
Q 008893            4 LLEKVLIIVLIQVICSDGV-----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL   78 (549)
Q Consensus         4 ~~~~~~~~~~~~~~c~~~~-----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l   78 (549)
                      -+++|+.|+|.++...+-.     .....++|++|.+++. | .+.++++|+.|+|++|++++ +|. +..+++|+.|+|
T Consensus        61 ~l~~L~~L~L~~n~i~~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l  136 (308)
T 1h6u_A           61 YLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL  136 (308)
T ss_dssp             GCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred             ccCCCCEEEccCCcCCCChhHccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence            3578899999877654311     1233467999999853 3 79999999999999999995 554 999999999999


Q ss_pred             cCcccccCCCcccccCCCCceEeccCCCCCCCCCcc---ccccccccCCcccc
Q 008893           79 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLIC  128 (549)
Q Consensus        79 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~---~~~~~~l~~N~~~~  128 (549)
                      ++|++++. +. +..+++|+.|++++|.+++..+-.   ....+++++|.+..
T Consensus       137 ~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~  187 (308)
T 1h6u_A          137 DLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD  187 (308)
T ss_dssp             CSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred             CCCccCcC-cc-ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCc
Confidence            99999954 44 899999999999999999866511   12567899998753

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.87  E-value=2.1e-09  Score=107.76  Aligned_cols=118  Identities=25%  Similarity=0.266  Sum_probs=78.3

Q ss_pred             cccceeeeeeeeeecCCc-----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDGV-----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +++|+.+++.++...+..     .....++|++|.+++..+  +..+++|++|+|++|.+++ + +.+..+++|+.|+|+
T Consensus       198 l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~  273 (347)
T 4fmz_A          198 LTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVG  273 (347)
T ss_dssp             CTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECC
T ss_pred             CCccceeecccCCCCCCchhhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEcc
Confidence            456666666655443211     112235678888774433  7788888888888888874 3 357778888888888


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCccc-----cccccccCCcccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH-----AKTFNITGNSLIC  128 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-----~~~~~l~~N~~~~  128 (549)
                      +|++++ + +.+..+++|+.|++++|.+++..|..+     .+.+++++|++..
T Consensus       274 ~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~  325 (347)
T 4fmz_A          274 SNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD  325 (347)
T ss_dssp             SSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred             CCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence            888874 3 357777888888888888877665532     2556777777653

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.86  E-value=3.7e-09  Score=101.64  Aligned_cols=117  Identities=22%  Similarity=0.233  Sum_probs=91.1

Q ss_pred             cccceeeeeeeeeecCCc-----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDGV-----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +.+|+.|+|.++..++-.     .....++|++|+|++ +|+. .. ++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus        62 l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls  136 (263)
T 1xeu_A           62 FTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIR  136 (263)
T ss_dssp             CTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECT
T ss_pred             CCCCCEEECCCCccCCChhhccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECC
Confidence            567888888877665421     123346799999996 4443 33 999999999999995 44 69999999999999


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCcc----ccccccccCCccccC
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNSLICA  129 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~----~~~~~~l~~N~~~~~  129 (549)
                      +|+|++ +| .+..+++|+.|+|++|.+++. +..    ....+++++|++.+.
T Consensus       137 ~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          137 NNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             TSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred             CCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence            999995 45 699999999999999999987 322    125688999998755

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.86  E-value=2.7e-09  Score=114.82  Aligned_cols=117  Identities=27%  Similarity=0.315  Sum_probs=79.9

Q ss_pred             cccceeeeeeeeeecCCc-e----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDGV-F----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +.+|+.|+|.++..++-. +    ....|+|++|.|++ +| .|.+|++|+.|+|++|+|++ + +.+..|++|+.|+|+
T Consensus        64 l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls  139 (605)
T 1m9s_A           64 LPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG  139 (605)
T ss_dssp             CTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECC
T ss_pred             CCCCCEEEeeCCCCCCChhhccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECC
Confidence            567788888766554311 1    12235688888874 33 67888888888888888884 3 357778888888888


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCcc---ccccccccCCccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLI  127 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~---~~~~~~l~~N~~~  127 (549)
                      +|+|++.  ..|..+++|+.|+|++|.|++.+|-.   ....++|++|.+.
T Consensus       140 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~  188 (605)
T 1m9s_A          140 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS  188 (605)
T ss_dssp             SSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred             CCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCC
Confidence            8888754  56777888888888888887776621   1245677777664

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.85  E-value=2e-09  Score=108.16  Aligned_cols=101  Identities=15%  Similarity=0.153  Sum_probs=81.7

Q ss_pred             eeeecCCceeehh---------hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcc-cccCCcccCe-eeccCccc
Q 008893           15 QVICSDGVFFSFG---------RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQY-LRLNNNSL   83 (549)
Q Consensus        15 ~~~c~~~~~~~~~---------l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~-L~l~~N~l   83 (549)
                      .|.|++..++.+|         ++|++|+|+...+..|.+|++|++|+|++|++.+.+|. .|.+|++|+. +.++.|+|
T Consensus        13 ~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l   92 (350)
T 4ay9_X           13 VFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL   92 (350)
T ss_dssp             EEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTC
T ss_pred             EEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcc
Confidence            4678776555544         57899999966667899999999999999998766664 6788988775 66678999


Q ss_pred             ccCCCcccccCCCCceEeccCCCCCCCCCccc
Q 008893           84 TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH  115 (549)
Q Consensus        84 ~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~  115 (549)
                      ++..|..|..+++|+.|++++|.|++.++..+
T Consensus        93 ~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~  124 (350)
T 4ay9_X           93 LYINPEAFQNLPNLQYLLISNTGIKHLPDVHK  124 (350)
T ss_dssp             CEECTTSBCCCTTCCEEEEEEECCSSCCCCTT
T ss_pred             cccCchhhhhccccccccccccccccCCchhh
Confidence            97778889999999999999999987776544

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.83  E-value=4.4e-09  Score=113.13  Aligned_cols=93  Identities=24%  Similarity=0.364  Sum_probs=59.9

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      |+|++|.|++..|  +.+|++|+.|+|++|.|++ +| .+..|++|+.|+|++|+|++ + +.+..+++|+.|+|++|.|
T Consensus        70 L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l  143 (605)
T 1m9s_A           70 LFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKI  143 (605)
T ss_dssp             EECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCC
T ss_pred             EEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCcc
Confidence            5577777775443  6777777777777777763 33 56777777777777777764 3 3466777777777777777


Q ss_pred             CCCCCcc----ccccccccCCccc
Q 008893          108 SGPVPSF----HAKTFNITGNSLI  127 (549)
Q Consensus       108 ~~~~p~~----~~~~~~l~~N~~~  127 (549)
                      ++. +..    ....++|++|.+.
T Consensus       144 ~~l-~~l~~l~~L~~L~Ls~N~l~  166 (605)
T 1m9s_A          144 TDI-TVLSRLTKLDTLSLEDNQIS  166 (605)
T ss_dssp             CCC-GGGGSCTTCSEEECCSSCCC
T ss_pred             CCc-hhhcccCCCCEEECcCCcCC
Confidence            765 221    1245666666664

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.82  E-value=1.1e-10  Score=107.39  Aligned_cols=99  Identities=22%  Similarity=0.311  Sum_probs=76.8

Q ss_pred             ehhhhcccCcccccCCc------ccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCc
Q 008893           25 SFGRLLQNNNISGHIPT------EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA   98 (549)
Q Consensus        25 ~~~l~l~~n~l~~~~p~------~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~   98 (549)
                      +..++|+.|.++|.+|.      .|+++++|++|+|++|+|++ +| .+..+++|+.|+|++|+|+ .+|..+..+++|+
T Consensus        20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~   96 (198)
T 1ds9_A           20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE   96 (198)
T ss_dssp             CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred             ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence            34466788888888776      78888888888888888885 67 7888888888888888888 7787777788888


Q ss_pred             eEeccCCCCCCCCCcc----ccccccccCCccc
Q 008893           99 FLDLSYNNLSGPVPSF----HAKTFNITGNSLI  127 (549)
Q Consensus        99 ~l~l~~N~l~~~~p~~----~~~~~~l~~N~~~  127 (549)
                      .|+|++|.+++. |..    ....+++++|.+.
T Consensus        97 ~L~L~~N~l~~l-~~~~~l~~L~~L~l~~N~i~  128 (198)
T 1ds9_A           97 ELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT  128 (198)
T ss_dssp             EEEEEEEECCCH-HHHHHHHHSSEEEESEEECC
T ss_pred             EEECcCCcCCcC-CccccCCCCCEEECCCCcCC
Confidence            888888888874 322    1256777887764

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.79  E-value=1.3e-08  Score=108.49  Aligned_cols=108  Identities=19%  Similarity=0.218  Sum_probs=69.4

Q ss_pred             cceeeeeeeeeecCCc----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcc
Q 008893            7 KVLIIVLIQVICSDGV----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS   82 (549)
Q Consensus         7 ~~~~~~~~~~~c~~~~----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~   82 (549)
                      +|+.|+|.++....-.    .....++|++|+|+ .+|   ..+++|+.|+|++|+|++ +|. +.+  +|+.|+|++|+
T Consensus        60 ~L~~L~Ls~n~L~~lp~~l~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~  131 (571)
T 3cvr_A           60 QFSELQLNRLNLSSLPDNLPPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQ  131 (571)
T ss_dssp             TCSEEECCSSCCSCCCSCCCTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSC
T ss_pred             CccEEEeCCCCCCccCHhHcCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCc
Confidence            6677777665553210    12334567788877 566   446778888888888875 666 554  77777777777


Q ss_pred             cccCCCcccccCCCCceEeccCCCCCCCCCccc--cccccccCCccc
Q 008893           83 LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH--AKTFNITGNSLI  127 (549)
Q Consensus        83 l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~--~~~~~l~~N~~~  127 (549)
                      |++ +|.   .+++|+.|+|++|.|++.++ .+  ...+++++|.+.
T Consensus       132 l~~-lp~---~l~~L~~L~Ls~N~l~~lp~-~l~~L~~L~Ls~N~L~  173 (571)
T 3cvr_A          132 LTM-LPE---LPALLEYINADNNQLTMLPE-LPTSLEVLSVRNNQLT  173 (571)
T ss_dssp             CSC-CCC---CCTTCCEEECCSSCCSCCCC-CCTTCCEEECCSSCCS
T ss_pred             CCC-CCC---cCccccEEeCCCCccCcCCC-cCCCcCEEECCCCCCC
Confidence            775 555   56777777777777776333 22  245667777664

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.79  E-value=1.1e-08  Score=109.02  Aligned_cols=109  Identities=23%  Similarity=0.264  Sum_probs=65.0

Q ss_pred             ccceeeeeeeeeecCCc---eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcc
Q 008893            6 EKVLIIVLIQVICSDGV---FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS   82 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~~~---~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~   82 (549)
                      ++|+.|+|.++....-.   .....++|++|+|++ +|. |.+  +|+.|+|++|+|++ +|.   .+++|+.|+|++|+
T Consensus        80 ~~L~~L~Ls~N~l~~ip~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~  151 (571)
T 3cvr_A           80 PQITVLEITQNALISLPELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQ  151 (571)
T ss_dssp             TTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred             CCCCEEECcCCCCcccccccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCc
Confidence            56677777665553210   112235677777775 555 554  67777777777774 555   46677777777777


Q ss_pred             cccCCCcccccCCCCceEeccCCCCCCCCCccc--cccccccCCccc
Q 008893           83 LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH--AKTFNITGNSLI  127 (549)
Q Consensus        83 l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~--~~~~~l~~N~~~  127 (549)
                      |++ +|.   .+++|+.|+|++|.|++. |.+.  ...+++++|.+.
T Consensus       152 l~~-lp~---~l~~L~~L~Ls~N~L~~l-p~l~~~L~~L~Ls~N~L~  193 (571)
T 3cvr_A          152 LTM-LPE---LPTSLEVLSVRNNQLTFL-PELPESLEALDVSTNLLE  193 (571)
T ss_dssp             CSC-CCC---CCTTCCEEECCSSCCSCC-CCCCTTCCEEECCSSCCS
T ss_pred             cCc-CCC---cCCCcCEEECCCCCCCCc-chhhCCCCEEECcCCCCC
Confidence            764 554   456677777777777663 3321  244566666664

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.74  E-value=1e-08  Score=107.29  Aligned_cols=100  Identities=27%  Similarity=0.301  Sum_probs=57.2

Q ss_pred             cccceeeeeeeeeecCCc-----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDGV-----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +.+|+.|++.++...+-.     .....++|++|.+++..|  +..+++|+.|+|++|++++..|  +..+++|+.|+|+
T Consensus       242 l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~  317 (466)
T 1o6v_A          242 LTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLY  317 (466)
T ss_dssp             CTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECC
T ss_pred             CCCCCEEECCCCccccchhhhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECc
Confidence            456666776655443211     112234566776664433  6666666666666666664322  5666666666666


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCC
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP  110 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~  110 (549)
                      +|++++..|  +..+++|+.|++++|.+++.
T Consensus       318 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          318 FNNISDISP--VSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             SSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred             CCcCCCchh--hccCccCCEeECCCCccCCc
Confidence            666665443  55666666666666666554

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.74  E-value=9.8e-11  Score=107.65  Aligned_cols=98  Identities=21%  Similarity=0.299  Sum_probs=83.2

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|.|++ +| .+.++++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +| .+..+++|+.|++++|.
T Consensus        52 ~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~  126 (198)
T 1ds9_A           52 HLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNK  126 (198)
T ss_dssp             EEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEE
T ss_pred             EEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCc
Confidence            46799999996 77 8999999999999999999 789888889999999999999995 56 68899999999999999


Q ss_pred             CCCCCC-cc-----ccccccccCCccccC
Q 008893          107 LSGPVP-SF-----HAKTFNITGNSLICA  129 (549)
Q Consensus       107 l~~~~p-~~-----~~~~~~l~~N~~~~~  129 (549)
                      +++..+ ..     ....+++++|++.|.
T Consensus       127 i~~~~~~~~l~~l~~L~~L~l~~N~l~~~  155 (198)
T 1ds9_A          127 ITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             CCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred             CCchhHHHHHhcCCCCCEEEecCCccccc
Confidence            987543 11     236788999988654

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.72  E-value=1.2e-08  Score=102.09  Aligned_cols=116  Identities=19%  Similarity=0.308  Sum_probs=83.1

Q ss_pred             cccceeeeeeeeeecCCc-e----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDGV-F----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +++|+.|++.++...+-. +    ....+++++|.+++..+  +..+++|+.|+|++|++++ +|. +..+++|+.|+|+
T Consensus       176 l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~  251 (347)
T 4fmz_A          176 LTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIG  251 (347)
T ss_dssp             CTTCSEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECC
T ss_pred             CCCCCEEEccCCcccccccccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECC
Confidence            467777877765543311 1    11225688888885544  8888899999999999884 444 8888999999999


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCcc----ccccccccCCccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNSLI  127 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~----~~~~~~l~~N~~~  127 (549)
                      +|++++ + +.+..+++|+.|++++|.+++. +..    ..+.+++++|.+.
T Consensus       252 ~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~  300 (347)
T 4fmz_A          252 TNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLG  300 (347)
T ss_dssp             SSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC
T ss_pred             CCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCC
Confidence            998884 3 4688888999999999988875 321    1256788888774

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.69  E-value=2.1e-08  Score=104.83  Aligned_cols=78  Identities=37%  Similarity=0.550  Sum_probs=36.2

Q ss_pred             hcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCC
Q 008893           29 LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS  108 (549)
Q Consensus        29 ~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  108 (549)
                      +|++|.+++..|  +.++++|+.|+|++|++++. |. +..+++|+.|+|++|++++..|  +..+++|+.|++++|.++
T Consensus       249 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~  322 (466)
T 1o6v_A          249 DLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS  322 (466)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCS
T ss_pred             ECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCC
Confidence            344444443322  44445555555555554432 22 4445555555555555543222  445555555555555555


Q ss_pred             CCCC
Q 008893          109 GPVP  112 (549)
Q Consensus       109 ~~~p  112 (549)
                      +..|
T Consensus       323 ~~~~  326 (466)
T 1o6v_A          323 DISP  326 (466)
T ss_dssp             CCGG
T ss_pred             Cchh
Confidence            4443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.67  E-value=4.9e-08  Score=101.56  Aligned_cols=114  Identities=19%  Similarity=0.214  Sum_probs=70.3

Q ss_pred             ccceeeeeeeeeecC--Cc-eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcc
Q 008893            6 EKVLIIVLIQVICSD--GV-FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS   82 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~--~~-~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~   82 (549)
                      .+|+.|++.++....  .. .....++|++|++++ +| +|+++++|++|+|++|++++ +|..+   ++|+.|+|++|+
T Consensus       111 ~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~  184 (454)
T 1jl5_A          111 QSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQ  184 (454)
T ss_dssp             TTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSC
T ss_pred             CCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCc
Confidence            445555555443322  00 122345677777775 66 47777777777777777774 55443   477777777777


Q ss_pred             cccCCCcccccCCCCceEeccCCCCCCCCCcc-ccccccccCCccc
Q 008893           83 LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF-HAKTFNITGNSLI  127 (549)
Q Consensus        83 l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~l~~N~~~  127 (549)
                      +++ +| .|.++++|+.|++++|.+++.+... ..+.+++++|.+.
T Consensus       185 l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~~~L~~L~l~~n~l~  228 (454)
T 1jl5_A          185 LEE-LP-ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILE  228 (454)
T ss_dssp             CSS-CC-CCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCS
T ss_pred             CCc-Cc-cccCCCCCCEEECCCCcCCcCCCCcCcccEEECcCCcCC
Confidence            774 55 4777777777777777777632211 2355677777664

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.65  E-value=5.1e-08  Score=101.50  Aligned_cols=115  Identities=23%  Similarity=0.147  Sum_probs=69.5

Q ss_pred             cccceeeeeeeeeecCCce----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccC
Q 008893            5 LEKVLIIVLIQVICSDGVF----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN   80 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~   80 (549)
                      +++|+.|++.++..+.-.+    ....+++++|...+.+  .++.+++|+.|+|++|+|++ +|  +..+++|+.|+|++
T Consensus       126 l~~L~~L~l~~N~l~~l~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~  200 (457)
T 3bz5_A          126 NPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDT  200 (457)
T ss_dssp             CTTCCEEECTTSCCSCCCCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCS
T ss_pred             CCcCCEEECCCCccceeccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcC
Confidence            4566777776554433111    1122456677555455  36677777777777777774 44  66777777777777


Q ss_pred             cccccCCCcccccCCCCceEeccCCCCCCCCCcc--ccccccccCCccc
Q 008893           81 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF--HAKTFNITGNSLI  127 (549)
Q Consensus        81 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~~~l~~N~~~  127 (549)
                      |+|++.   .+..+++|+.|++++|++++.+...  ....+++++|.+.
T Consensus       201 N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip~~~l~~L~~L~l~~N~l~  246 (457)
T 3bz5_A          201 NNITKL---DLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLT  246 (457)
T ss_dssp             SCCSCC---CCTTCTTCSEEECCSSCCSCCCCTTCTTCSEEECCSSCCS
T ss_pred             CcCCee---ccccCCCCCEEECcCCcccccCccccCCCCEEEeeCCcCC
Confidence            777743   2667777777777777777632111  1245667777664

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.62  E-value=4.7e-08  Score=101.75  Aligned_cols=102  Identities=19%  Similarity=0.084  Sum_probs=80.7

Q ss_pred             cccceeeeeeeeeecC-----CceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSD-----GVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~-----~~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +++|+.|++.++....     .-.....++|++|+|++ +|  ++.+++|+.|+|++|+|++.   .+..+++|+.|+|+
T Consensus       147 l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls  220 (457)
T 3bz5_A          147 NTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCS  220 (457)
T ss_dssp             CTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECC
T ss_pred             CCcCCEEECCCCCcccccccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECc
Confidence            4567777776652211     11123346799999996 55  89999999999999999964   38999999999999


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH  115 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~  115 (549)
                      +|+|++ +|  +..+++|+.|++++|.+++.++..+
T Consensus       221 ~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l  253 (457)
T 3bz5_A          221 SNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTL  253 (457)
T ss_dssp             SSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTC
T ss_pred             CCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHC
Confidence            999996 66  8899999999999999999876543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.61  E-value=2e-09  Score=109.71  Aligned_cols=84  Identities=21%  Similarity=0.257  Sum_probs=47.5

Q ss_pred             hhhcccCccc-ccCC---cccCCCCCCCEEEccCCcCC--C---CCcccccCCcccCeeeccCcccc----cCCCccccc
Q 008893           27 GRLLQNNNIS-GHIP---TEIGKLSKLLTLDLSNNFFT--G---PIPSTVSHLETLQYLRLNNNSLT----GAIPPSLSN   93 (549)
Q Consensus        27 ~l~l~~n~l~-~~~p---~~~~~l~~L~~L~ls~N~l~--g---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~   93 (549)
                      .++|++|+|+ +.+|   ..+.++++|+.|+|++|+|+  |   .+|..+..+++|+.|+|++|.|+    +.+|..+..
T Consensus       163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~  242 (386)
T 2ca6_A          163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS  242 (386)
T ss_dssp             EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred             EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence            3556666665 3333   34555666666666666665  2   23335556666666666666664    455555666


Q ss_pred             CCCCceEeccCCCCCCC
Q 008893           94 MSQLAFLDLSYNNLSGP  110 (549)
Q Consensus        94 l~~L~~l~l~~N~l~~~  110 (549)
                      +++|+.|+|++|.|++.
T Consensus       243 ~~~L~~L~L~~n~i~~~  259 (386)
T 2ca6_A          243 WPNLRELGLNDCLLSAR  259 (386)
T ss_dssp             CTTCCEEECTTCCCCHH
T ss_pred             CCCcCEEECCCCCCchh
Confidence            66666666666666543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.58  E-value=1.1e-08  Score=103.11  Aligned_cols=83  Identities=23%  Similarity=0.132  Sum_probs=50.6

Q ss_pred             cccCcccccCCcccCCCCCCCEEEccCCcCCCCCc----ccccCCc-ccCeeeccCcccccCCCcccccC-----CCCce
Q 008893           30 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP----STVSHLE-TLQYLRLNNNSLTGAIPPSLSNM-----SQLAF   99 (549)
Q Consensus        30 l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p----~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l-----~~L~~   99 (549)
                      |+.|+++|.+|..+...++|++|||++|.|++..+    ..|..++ +|+.|+|++|+|++..+..|..+     ++|+.
T Consensus         5 ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~   84 (362)
T 3goz_A            5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTS   84 (362)
T ss_dssp             CCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCE
T ss_pred             cccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccE
Confidence            55666666666655555556666666666664444    4555666 66666666666665555555554     66666


Q ss_pred             EeccCCCCCCCCC
Q 008893          100 LDLSYNNLSGPVP  112 (549)
Q Consensus       100 l~l~~N~l~~~~p  112 (549)
                      |+|++|.+++..+
T Consensus        85 L~Ls~n~l~~~~~   97 (362)
T 3goz_A           85 LNLSGNFLSYKSS   97 (362)
T ss_dssp             EECCSSCGGGSCH
T ss_pred             EECcCCcCChHHH
Confidence            6666666665544

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.57  E-value=1.2e-07  Score=98.53  Aligned_cols=71  Identities=24%  Similarity=0.273  Sum_probs=32.3

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      +++++|++++ +|..+   .+|++|+|++|++++ +| .+.++++|+.|++++|++++ +|...   ++|+.|++++|.+
T Consensus       158 L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l  227 (454)
T 1jl5_A          158 IDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNIL  227 (454)
T ss_dssp             EECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCC
T ss_pred             EECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcC
Confidence            3455555553 33322   345555555555553 33 34555555555555555542 33211   2444444444444


Q ss_pred             C
Q 008893          108 S  108 (549)
Q Consensus       108 ~  108 (549)
                      +
T Consensus       228 ~  228 (454)
T 1jl5_A          228 E  228 (454)
T ss_dssp             S
T ss_pred             C
Confidence            4

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.56  E-value=4.7e-09  Score=106.95  Aligned_cols=123  Identities=17%  Similarity=0.196  Sum_probs=75.6

Q ss_pred             cccceeeeeeeeeecC----------Cc-eeehhhhcccCcccccCCcccC----CC---------CCCCEEEccCCcCC
Q 008893            5 LEKVLIIVLIQVICSD----------GV-FFSFGRLLQNNNISGHIPTEIG----KL---------SKLLTLDLSNNFFT   60 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~----------~~-~~~~~l~l~~n~l~~~~p~~~~----~l---------~~L~~L~ls~N~l~   60 (549)
                      +++|+.|+|.++...+          .. .....++|++|.|++..+..+.    .+         ++|++|+|++|+|+
T Consensus        93 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~  172 (386)
T 2ca6_A           93 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE  172 (386)
T ss_dssp             CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred             CCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence            4667777776665543          01 2333456777777644333333    33         77788888888776


Q ss_pred             -CCCc---ccccCCcccCeeeccCcccc--c---CCCcccccCCCCceEeccCCCCC----CCCCccc-----ccccccc
Q 008893           61 -GPIP---STVSHLETLQYLRLNNNSLT--G---AIPPSLSNMSQLAFLDLSYNNLS----GPVPSFH-----AKTFNIT  122 (549)
Q Consensus        61 -g~~p---~~~~~l~~L~~L~l~~N~l~--g---~~p~~~~~l~~L~~l~l~~N~l~----~~~p~~~-----~~~~~l~  122 (549)
                       +.+|   ..+..+++|+.|+|++|+|+  |   ..|..+..+++|+.|+|++|.++    +.+|..+     ...++++
T Consensus       173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~  252 (386)
T 2ca6_A          173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN  252 (386)
T ss_dssp             GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred             cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence             3444   45667777888888888776  3   34446777777888888888775    3333322     2456777


Q ss_pred             CCccc
Q 008893          123 GNSLI  127 (549)
Q Consensus       123 ~N~~~  127 (549)
                      +|.+.
T Consensus       253 ~n~i~  257 (386)
T 2ca6_A          253 DCLLS  257 (386)
T ss_dssp             TCCCC
T ss_pred             CCCCc
Confidence            77653

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.56  E-value=1.2e-08  Score=102.87  Aligned_cols=102  Identities=22%  Similarity=0.246  Sum_probs=73.4

Q ss_pred             hhhhcccCcccccCC----cccCCCC-CCCEEEccCCcCCCCCcccccCC-----cccCeeeccCcccccCCCccccc--
Q 008893           26 FGRLLQNNNISGHIP----TEIGKLS-KLLTLDLSNNFFTGPIPSTVSHL-----ETLQYLRLNNNSLTGAIPPSLSN--   93 (549)
Q Consensus        26 ~~l~l~~n~l~~~~p----~~~~~l~-~L~~L~ls~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~--   93 (549)
                      ..++|++|.|++..+    ..|.+++ +|++|+|++|+|++..+..+..+     ++|+.|+|++|+|++..+..+..  
T Consensus        25 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l  104 (362)
T 3goz_A           25 TSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTL  104 (362)
T ss_dssp             CEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHH
T ss_pred             eEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHH
Confidence            346788888886666    6677777 78888888888887767777665     78888888888888666654443  


Q ss_pred             --C-CCCceEeccCCCCCCCCCcc----------ccccccccCCccc
Q 008893           94 --M-SQLAFLDLSYNNLSGPVPSF----------HAKTFNITGNSLI  127 (549)
Q Consensus        94 --l-~~L~~l~l~~N~l~~~~p~~----------~~~~~~l~~N~~~  127 (549)
                        + ++|+.|+|++|.|++..+..          ..+.+++++|.+.
T Consensus       105 ~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~  151 (362)
T 3goz_A          105 AAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG  151 (362)
T ss_dssp             HTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred             HhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence              3 78888888888887665532          2345677777664

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.55  E-value=6.3e-08  Score=104.33  Aligned_cols=109  Identities=25%  Similarity=0.255  Sum_probs=70.7

Q ss_pred             ccceeeeeeeeeecC--Cc-eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcc
Q 008893            6 EKVLIIVLIQVICSD--GV-FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS   82 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~--~~-~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~   82 (549)
                      .+|+.|++.++..+.  .. .....+++++|.|+ .+|..   +++|+.|+|++|+|++ +|   ..+++|+.|+|++|+
T Consensus       181 ~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~  252 (622)
T 3g06_A          181 SGLQELSVSDNQLASLPTLPSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNR  252 (622)
T ss_dssp             TTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSC
T ss_pred             CCCcEEECCCCCCCCCCCccchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCC
Confidence            667777777665543  11 11223567777777 45532   4678888888888874 56   445778888888888


Q ss_pred             cccCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           83 LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        83 l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      |+ .+|.   .+++|+.|+|++|.|+. +|..+.     ..+++++|++.
T Consensus       253 L~-~lp~---~~~~L~~L~Ls~N~L~~-lp~~l~~l~~L~~L~L~~N~l~  297 (622)
T 3g06_A          253 LT-SLPM---LPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS  297 (622)
T ss_dssp             CS-CCCC---CCTTCCEEECCSSCCCS-CCGGGGGSCTTCEEECCSCCCC
T ss_pred             CC-cCCc---ccccCcEEeCCCCCCCc-CCHHHhhccccCEEEecCCCCC
Confidence            87 5665   56778888888888873 444322     45677777775

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.51  E-value=1.9e-07  Score=100.56  Aligned_cols=88  Identities=27%  Similarity=0.257  Sum_probs=60.6

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|.|++ +|..   +++|+.|+|++|.|+ .+|..   +++|+.|+|++|+|++ +|   ..+++|+.|+|++|.|
T Consensus       186 L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L  253 (622)
T 3g06_A          186 LSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRL  253 (622)
T ss_dssp             EECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCC
T ss_pred             EECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCC
Confidence            5577777763 4432   367777777777777 45543   3778888888888884 66   3557888888888888


Q ss_pred             CCCCCcc-ccccccccCCccc
Q 008893          108 SGPVPSF-HAKTFNITGNSLI  127 (549)
Q Consensus       108 ~~~~p~~-~~~~~~l~~N~~~  127 (549)
                      ++.++.. ....+++++|.+.
T Consensus       254 ~~lp~~~~~L~~L~Ls~N~L~  274 (622)
T 3g06_A          254 TSLPMLPSGLLSLSVYRNQLT  274 (622)
T ss_dssp             SCCCCCCTTCCEEECCSSCCC
T ss_pred             CcCCcccccCcEEeCCCCCCC
Confidence            8654411 1356788888776

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.50  E-value=1.2e-08  Score=97.45  Aligned_cols=84  Identities=26%  Similarity=0.268  Sum_probs=62.7

Q ss_pred             hhcccCccc---ccCCcccCCCCCCCEEEccCCcCCC--CCcccccCCcccCeeeccCcccccCCCcccccCC--CCceE
Q 008893           28 RLLQNNNIS---GHIPTEIGKLSKLLTLDLSNNFFTG--PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMS--QLAFL  100 (549)
Q Consensus        28 l~l~~n~l~---~~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~--~L~~l  100 (549)
                      ++++.|...   +.++-...++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|+.|
T Consensus       148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L  225 (267)
T 3rw6_A          148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL  225 (267)
T ss_dssp             CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred             ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence            455666332   2222222568899999999999997  4567778899999999999999964  3455555  89999


Q ss_pred             eccCCCCCCCCCc
Q 008893          101 DLSYNNLSGPVPS  113 (549)
Q Consensus       101 ~l~~N~l~~~~p~  113 (549)
                      +|++|++++.+|.
T Consensus       226 ~L~~Npl~~~~~~  238 (267)
T 3rw6_A          226 WLDGNSLCDTFRD  238 (267)
T ss_dssp             ECTTSTTGGGCSS
T ss_pred             EccCCcCccccCc
Confidence            9999999987663

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.42  E-value=2.3e-08  Score=99.57  Aligned_cols=99  Identities=19%  Similarity=0.181  Sum_probs=78.1

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCC-CcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP-IPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .+.+++|.+++..+. +.++++|++|+|++|.+++. +|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|
T Consensus        74 ~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~  152 (336)
T 2ast_B           74 AFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC  152 (336)
T ss_dssp             EEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred             EEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCC
Confidence            456888888877665 56789999999999998865 7888889999999999999998888888888999999999999


Q ss_pred             -CCCCC-CCcc-----ccccccccCC-cc
Q 008893          106 -NLSGP-VPSF-----HAKTFNITGN-SL  126 (549)
Q Consensus       106 -~l~~~-~p~~-----~~~~~~l~~N-~~  126 (549)
                       .+++. ++..     ..+.+++++| .+
T Consensus       153 ~~l~~~~l~~~~~~~~~L~~L~l~~~~~l  181 (336)
T 2ast_B          153 SGFSEFALQTLLSSCSRLDELNLSWCFDF  181 (336)
T ss_dssp             BSCCHHHHHHHHHHCTTCCEEECCCCTTC
T ss_pred             CCCCHHHHHHHHhcCCCCCEEcCCCCCCc
Confidence             67752 3332     1356677777 44

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.41  E-value=2.1e-06  Score=84.25  Aligned_cols=136  Identities=18%  Similarity=0.179  Sum_probs=94.0

Q ss_pred             CCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCC---CccceEEEEe-cCCceeeEeeccC
Q 008893          232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLIGFCM-TTTERLLVYPYMS  307 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~  307 (549)
                      .+.++.|....||+.    |..+++|+...   ......+..|.+++..+.+.   .+.+++.++. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            356788888999988    56688887532   12245688999999998653   2556676664 4456789999999


Q ss_pred             CCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------------
Q 008893          308 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ--------------------------------------------  343 (549)
Q Consensus       308 ~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------  343 (549)
                      |..+.+....  .++...+..++.+++..|..||+.                                            
T Consensus        97 G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           97 GQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             SEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             CeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            9887653211  234455555555555555555532                                            


Q ss_pred             -------------CCCceEecccCcCeeeecC---CCc-eEEeecccccc
Q 008893          344 -------------CDPKIIHRDVKAANILLDE---YYE-AVVGDFGLAKL  376 (549)
Q Consensus       344 -------------~~~~ivH~Dlkp~Nill~~---~~~-~kl~Dfg~~~~  376 (549)
                                   ..+.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         2346799999999999987   455 47999998764

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.39  E-value=3.1e-08  Score=98.62  Aligned_cols=120  Identities=22%  Similarity=0.232  Sum_probs=91.3

Q ss_pred             ccceeeeeeeeeecCC------ceeehhhhcccCccccc-CCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeec
Q 008893            6 EKVLIIVLIQVICSDG------VFFSFGRLLQNNNISGH-IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL   78 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~~------~~~~~~l~l~~n~l~~~-~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l   78 (549)
                      .+++.+++.++...+.      -.....++|++|.+++. +|..+.++++|++|+|++|.+++..|..+..+++|+.|+|
T Consensus        70 ~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L  149 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL  149 (336)
T ss_dssp             TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred             ccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence            5677777766654321      12344577999998866 8888999999999999999999888889999999999999


Q ss_pred             cCc-ccccC-CCcccccCCCCceEeccCC-CCCCC-CCcc------ccccccccCCc
Q 008893           79 NNN-SLTGA-IPPSLSNMSQLAFLDLSYN-NLSGP-VPSF------HAKTFNITGNS  125 (549)
Q Consensus        79 ~~N-~l~g~-~p~~~~~l~~L~~l~l~~N-~l~~~-~p~~------~~~~~~l~~N~  125 (549)
                      ++| .+++. +|..+..+++|+.|++++| .+++. ++..      ..+.+++++|.
T Consensus       150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~  206 (336)
T 2ast_B          150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR  206 (336)
T ss_dssp             TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred             CCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence            999 68753 7777888999999999999 88753 2221      23456666663

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.36  E-value=2.4e-06  Score=82.07  Aligned_cols=135  Identities=19%  Similarity=0.141  Sum_probs=97.2

Q ss_pred             eeeeeCCe-EEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCceeeEeeccCCCc
Q 008893          234 LVGKGGFG-NVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMSNGS  310 (549)
Q Consensus       234 ~iG~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  310 (549)
                      .+..|..| .||+.... ++..+++|+-...    ....+..|...|+.+. +--+-++++++.+.+..++|||++++.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            45556665 68988765 4667889986532    2446788999888774 3336678899988889999999999988


Q ss_pred             hhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------------------
Q 008893          311 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQ-----------------------------------------------  343 (549)
Q Consensus       311 L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------------  343 (549)
                      +.+.....    ......++.+++..|..||+.                                               
T Consensus       107 ~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          107 AFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             ccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            77654321    223345666677777777742                                               


Q ss_pred             --------CCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          344 --------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       344 --------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                              ..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    112489999999999999877777999998753

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.33  E-value=5.9e-07  Score=90.00  Aligned_cols=110  Identities=19%  Similarity=0.126  Sum_probs=73.2

Q ss_pred             cccceeeeeeeeeecC-------Cceeehhhhcc-cCcccccCCcccCCCC-CCCEEEccCCcCCCCCcccccCCcccCe
Q 008893            5 LEKVLIIVLIQVICSD-------GVFFSFGRLLQ-NNNISGHIPTEIGKLS-KLLTLDLSNNFFTGPIPSTVSHLETLQY   75 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~-------~~~~~~~l~l~-~n~l~~~~p~~~~~l~-~L~~L~ls~N~l~g~~p~~~~~l~~L~~   75 (549)
                      +.+|+.|++.++....       .......+++. +|++....+..|..+. .|+.|+|++|+|+ .+|......++|+.
T Consensus       103 l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~  181 (350)
T 4ay9_X          103 LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDE  181 (350)
T ss_dssp             CTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEE
T ss_pred             ccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhH
Confidence            4667777777665532       11122223443 4566655556676664 5788888888888 56666666778888


Q ss_pred             eeccC-cccccCCC-cccccCCCCceEeccCCCCCCCCCcccc
Q 008893           76 LRLNN-NSLTGAIP-PSLSNMSQLAFLDLSYNNLSGPVPSFHA  116 (549)
Q Consensus        76 L~l~~-N~l~g~~p-~~~~~l~~L~~l~l~~N~l~~~~p~~~~  116 (549)
                      |++++ |.++ .+| ..|..+++|+.|+|++|+|+..++..+.
T Consensus       182 l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~  223 (350)
T 4ay9_X          182 LNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLE  223 (350)
T ss_dssp             EECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSSCT
T ss_pred             HhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChhhhc
Confidence            88875 5566 555 4678888888888888888877665543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.31  E-value=1.4e-06  Score=87.45  Aligned_cols=144  Identities=12%  Similarity=0.144  Sum_probs=89.3

Q ss_pred             Cee-eeeCCeEEEEEEEC-------CCCEEEEEEcccCCC--CCcHHHHHHHHHHHhhccC---CCccceEEEEecC---
Q 008893          233 NLV-GKGGFGNVYKGYLQ-------DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVH---RNLLRLIGFCMTT---  296 (549)
Q Consensus       233 ~~i-G~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---  296 (549)
                      +.| +.|....+|+....       +++.+++|+......  ......+..|..+++.+..   -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888999998764       266788998754320  1011346788888887743   3467788887655   


Q ss_pred             CceeeEeeccCCCchhhhhccC------CCCCHHHHHHHHHHHHHHH---------------------------------
Q 008893          297 TERLLVYPYMSNGSVASRLKAK------PSLDWATRKRIALGAARGL---------------------------------  337 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~~i~~~L---------------------------------  337 (549)
                      ...++||||+++..+.+.+...      ..++..++..++.+++..|                                 
T Consensus       106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV  185 (357)
T ss_dssp             SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred             CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence            3568999999987765421000      0122222222222222222                                 


Q ss_pred             ---------------------HHhhhc-------CCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          338 ---------------------LYLHEQ-------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       338 ---------------------~~LH~~-------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                                           .+|.+.       ..+.++|+|+.+.||+++++..+.|+||+.+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence                                 233221       135799999999999999654578999998763

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.21  E-value=5e-07  Score=86.13  Aligned_cols=75  Identities=24%  Similarity=0.300  Sum_probs=62.1

Q ss_pred             ehhhhcccCcccc--cCCcccCCCCCCCEEEccCCcCCCCCcccccCCc--ccCeeeccCcccccCCCc-------cccc
Q 008893           25 SFGRLLQNNNISG--HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--TLQYLRLNNNSLTGAIPP-------SLSN   93 (549)
Q Consensus        25 ~~~l~l~~n~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~--~L~~L~l~~N~l~g~~p~-------~~~~   93 (549)
                      ...|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|+.|+|++|.+++.+|.       .+..
T Consensus       172 L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~  249 (267)
T 3rw6_A          172 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRER  249 (267)
T ss_dssp             CCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHH
T ss_pred             CCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHH
Confidence            3457899999998  5567788999999999999999964  3455555  999999999999988873       4778


Q ss_pred             CCCCceEe
Q 008893           94 MSQLAFLD  101 (549)
Q Consensus        94 l~~L~~l~  101 (549)
                      +++|+.||
T Consensus       250 ~P~L~~LD  257 (267)
T 3rw6_A          250 FPKLLRLD  257 (267)
T ss_dssp             CTTCCEES
T ss_pred             CcccCeEC
Confidence            99999886

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.15  E-value=5.1e-08  Score=101.54  Aligned_cols=122  Identities=26%  Similarity=0.261  Sum_probs=69.4

Q ss_pred             cccceeeeeeeeeecCCc-----------eeehhhhcccCcccccCCccc-CCCC----CCCEEEccCCcCCC----CCc
Q 008893            5 LEKVLIIVLIQVICSDGV-----------FFSFGRLLQNNNISGHIPTEI-GKLS----KLLTLDLSNNFFTG----PIP   64 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-----------~~~~~l~l~~n~l~~~~p~~~-~~l~----~L~~L~ls~N~l~g----~~p   64 (549)
                      +++|+.|+|.++...+..           .....++|++|.+++..+..+ ..++    +|++|+|++|+++.    .+|
T Consensus        27 ~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~  106 (461)
T 1z7x_W           27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS  106 (461)
T ss_dssp             HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             cCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHH
Confidence            456667777655543210           122345677777765433322 2233    57777777777773    456


Q ss_pred             ccccCCcccCeeeccCcccccCCCccccc-----CCCCceEeccCCCCCCCCC----cc-----ccccccccCCcc
Q 008893           65 STVSHLETLQYLRLNNNSLTGAIPPSLSN-----MSQLAFLDLSYNNLSGPVP----SF-----HAKTFNITGNSL  126 (549)
Q Consensus        65 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~-----l~~L~~l~l~~N~l~~~~p----~~-----~~~~~~l~~N~~  126 (549)
                      ..+..+++|+.|+|++|.+++..+..+..     .++|+.|++++|.+++...    ..     ..+.+++++|.+
T Consensus       107 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i  182 (461)
T 1z7x_W          107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI  182 (461)
T ss_dssp             HHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred             HHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCc
Confidence            67777777777777777776443333322     3467777777777765331    11     124566666665

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.10  E-value=8.7e-08  Score=96.82  Aligned_cols=122  Identities=18%  Similarity=0.136  Sum_probs=73.2

Q ss_pred             ccceeeeeeeeeecCCce--------eehhhhcccCcccccCCccc-----CCCCCCCEEEccCCcCCC----CCccccc
Q 008893            6 EKVLIIVLIQVICSDGVF--------FSFGRLLQNNNISGHIPTEI-----GKLSKLLTLDLSNNFFTG----PIPSTVS   68 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~~~~--------~~~~l~l~~n~l~~~~p~~~-----~~l~~L~~L~ls~N~l~g----~~p~~~~   68 (549)
                      ++|+.|+|.++...+...        ....++|++|.|+..-...+     ...++|+.|+|++|.|+.    .++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            456667766655433111        12235677777764433333     245678888888887763    2444556


Q ss_pred             CCcccCeeeccCccccc----CCCcccccCCCCceEeccCCCCCCCCCc---------cccccccccCCccc
Q 008893           69 HLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNLSGPVPS---------FHAKTFNITGNSLI  127 (549)
Q Consensus        69 ~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~~~~p~---------~~~~~~~l~~N~~~  127 (549)
                      .+++|+.|+|++|.|+.    .++..+...++|+.|+|++|.|++....         .....+++++|.+.
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence            67778888888888763    2345566677788888888887643211         11356677777663

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.09  E-value=1.1e-07  Score=98.86  Aligned_cols=123  Identities=17%  Similarity=0.095  Sum_probs=88.8

Q ss_pred             cccceeeeeeeeeecCCc-----------eeehhhhcccCcccccCCcccC-----CCCCCCEEEccCCcCCCC----Cc
Q 008893            5 LEKVLIIVLIQVICSDGV-----------FFSFGRLLQNNNISGHIPTEIG-----KLSKLLTLDLSNNFFTGP----IP   64 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-----------~~~~~l~l~~n~l~~~~p~~~~-----~l~~L~~L~ls~N~l~g~----~p   64 (549)
                      +.+|+.|++.++...+..           .....++|++|.+++..+..+.     ..++|+.|+|++|.+++.    +|
T Consensus       255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  334 (461)
T 1z7x_W          255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS  334 (461)
T ss_dssp             TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence            467888888776554311           1233467899988765444443     236999999999999865    56


Q ss_pred             ccccCCcccCeeeccCcccccCCCccccc-----CCCCceEeccCCCCCC----CCCcc-----ccccccccCCccc
Q 008893           65 STVSHLETLQYLRLNNNSLTGAIPPSLSN-----MSQLAFLDLSYNNLSG----PVPSF-----HAKTFNITGNSLI  127 (549)
Q Consensus        65 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~-----l~~L~~l~l~~N~l~~----~~p~~-----~~~~~~l~~N~~~  127 (549)
                      ..+..+++|+.|+|++|++++..+..+..     .++|+.|+|++|.+++    .+|..     ....+++++|++.
T Consensus       335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~  411 (461)
T 1z7x_W          335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG  411 (461)
T ss_dssp             HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence            77788899999999999998665555543     6799999999999985    44543     2356889998874

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.03  E-value=6.6e-06  Score=81.53  Aligned_cols=88  Identities=14%  Similarity=0.089  Sum_probs=73.5

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccC-eeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ-YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .++|++|+++...+..|.+|++|+.|+|++| ++..-+..|.+|++|+ .|+|.+ +++..-+.+|.+|++|+.|++++|
T Consensus       230 ~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n  307 (329)
T 3sb4_A          230 SLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGD  307 (329)
T ss_dssp             EEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSS
T ss_pred             EEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCC
Confidence            5668899998666778999999999999998 7755667799999999 999988 777566789999999999999999


Q ss_pred             CCCCCCCcccc
Q 008893          106 NLSGPVPSFHA  116 (549)
Q Consensus       106 ~l~~~~p~~~~  116 (549)
                      .++...+..|.
T Consensus       308 ~i~~I~~~aF~  318 (329)
T 3sb4_A          308 KITTLGDELFG  318 (329)
T ss_dssp             CCCEECTTTTC
T ss_pred             ccCccchhhhc
Confidence            99866665554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.02  E-value=3.5e-07  Score=92.39  Aligned_cols=107  Identities=16%  Similarity=0.132  Sum_probs=82.2

Q ss_pred             cccceeeeeeeeeecCCc------------eeehhhhcccCccccc----CCcccCCCCCCCEEEccCCcCCCC----Cc
Q 008893            5 LEKVLIIVLIQVICSDGV------------FFSFGRLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IP   64 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~------------~~~~~l~l~~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p   64 (549)
                      +.+|+.|+|.++...+..            .....++|++|.|+..    ++..+..+++|++|||++|.|+..    ++
T Consensus       125 L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~  204 (372)
T 3un9_A          125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA  204 (372)
T ss_dssp             HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHH
T ss_pred             HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHH
Confidence            567889999887664311            2234577999999742    455667899999999999999842    35


Q ss_pred             ccccCCcccCeeeccCccccc----CCCcccccCCCCceEeccCCCCCCCC
Q 008893           65 STVSHLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNLSGPV  111 (549)
Q Consensus        65 ~~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~~~~  111 (549)
                      ..+...++|+.|+|++|.|+.    .++..+...++|+.|+|++|.|++..
T Consensus       205 ~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g  255 (372)
T 3un9_A          205 AQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEG  255 (372)
T ss_dssp             HHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHH
T ss_pred             HHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHH
Confidence            667888999999999999984    34455667899999999999997543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.98  E-value=3.4e-05  Score=78.47  Aligned_cols=76  Identities=14%  Similarity=0.051  Sum_probs=49.0

Q ss_pred             CCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC------CCcHHHHHHHHHHHhhccC--CC-ccceEEEEecCCceee
Q 008893          232 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA------IGGEIQFQTEVEMISLAVH--RN-LLRLIGFCMTTTERLL  301 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  301 (549)
                      .+.||.|.++.||++... +++.++||.......      ......+..|.+++..+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999754 468899998653211      1122356778888887742  33 3455544  3456789


Q ss_pred             EeeccCCC
Q 008893          302 VYPYMSNG  309 (549)
Q Consensus       302 v~e~~~~g  309 (549)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.89  E-value=5.3e-05  Score=75.13  Aligned_cols=137  Identities=17%  Similarity=0.219  Sum_probs=78.7

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC--CCccceEE------EEecCCceeeEee
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLIG------FCMTTTERLLVYP  304 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e  304 (549)
                      +.|+.|..+.||+....+| .+++|+....     ...+..|..++..+..  -.+.+++.      +....+..+++|+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3456677899999987655 4889988642     2334445555554431  12333332      1123556789999


Q ss_pred             ccCCCchh--------------hhhc---c-C--C--------CCCHHHHH-----------------------------
Q 008893          305 YMSNGSVA--------------SRLK---A-K--P--------SLDWATRK-----------------------------  327 (549)
Q Consensus       305 ~~~~g~L~--------------~~l~---~-~--~--------~l~~~~~~-----------------------------  327 (549)
                      |++|..+.              ..++   . .  .        .-.|....                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              0111   1 0  0        01232110                             


Q ss_pred             --HHHHHHHHHHHHhhh----------cCCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          328 --RIALGAARGLLYLHE----------QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       328 --~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                        .+...+..++.+|++          ...+.++|||+++.||+++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              111123345666653          124589999999999999888899999999775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.80  E-value=0.00013  Score=71.39  Aligned_cols=136  Identities=16%  Similarity=0.148  Sum_probs=90.8

Q ss_pred             CCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc---CCCccceEEEEecCCceeeEeeccC
Q 008893          231 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTTTERLLVYPYMS  307 (549)
Q Consensus       231 ~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~  307 (549)
                      ..+.|+.|.+..+|+.... +..+++|+....    ....+..|...|+.+.   ...+.++++++...+..++||||++
T Consensus        40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3457899999999998864 677888987532    2456888999888874   3567888998887788999999999


Q ss_pred             CCchhh-----------hhcc--C-CC-------------------CCHHHHH---HHHH----------------HHHH
Q 008893          308 NGSVAS-----------RLKA--K-PS-------------------LDWATRK---RIAL----------------GAAR  335 (549)
Q Consensus       308 ~g~L~~-----------~l~~--~-~~-------------------l~~~~~~---~i~~----------------~i~~  335 (549)
                      +..+..           .++.  . ..                   -+|....   ++..                .++.
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            876521           1121  1 10                   1344321   1111                1111


Q ss_pred             H-HHHhhh-cCCCceEecccCcCeeeecCCCceEEeecc
Q 008893          336 G-LLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFG  372 (549)
Q Consensus       336 ~-L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  372 (549)
                      . ...|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 123321 2357899999999999999887 8888874

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.77  E-value=0.00018  Score=69.53  Aligned_cols=79  Identities=19%  Similarity=0.236  Sum_probs=56.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCC---CccceEEEEecCCceeeEee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e  304 (549)
                      .....+.+|.|..+.||+..+.||+.|++|+...... .....|..|...|+.+...   -+.+++++    +..++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence            4455678899999999999999999999998764432 2233578899988887422   24455554    23478999


Q ss_pred             ccCCCch
Q 008893          305 YMSNGSV  311 (549)
Q Consensus       305 ~~~~g~L  311 (549)
                      |++.+..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9886543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.76  E-value=0.00015  Score=74.32  Aligned_cols=79  Identities=11%  Similarity=-0.026  Sum_probs=46.5

Q ss_pred             CCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeeccccccCccCchhhccCC---CCCcccchhHhHHHHHH
Q 008893          345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLEL  421 (549)
Q Consensus       345 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~il~el  421 (549)
                      .+.++|||++|.||+++.++ ++++||+.+..-.....-......-...|++|+......   .....++.+....+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            44899999999999999876 999999988643211000000000113456665543111   11234555777777777


Q ss_pred             HhC
Q 008893          422 ISG  424 (549)
Q Consensus       422 ltg  424 (549)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            765

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.60  E-value=0.00017  Score=71.30  Aligned_cols=15  Identities=0%  Similarity=0.056  Sum_probs=11.9

Q ss_pred             cccceeeeeeeeeec
Q 008893            5 LEKVLIIVLIQVICS   19 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~   19 (549)
                      +.+|+.|||.++.-.
T Consensus        48 l~~L~~LdLs~n~i~   62 (329)
T 3sb4_A           48 FPSLKVLDISNAEIK   62 (329)
T ss_dssp             CTTCCEEEEEEEEEC
T ss_pred             hccCeEEecCcceeE
Confidence            567889999887765

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.57  E-value=3.9e-06  Score=75.75  Aligned_cols=82  Identities=17%  Similarity=0.211  Sum_probs=52.0

Q ss_pred             hhcccC-ccccc----CCcccCCCCCCCEEEccCCcCCCC----CcccccCCcccCeeeccCcccccC----CCcccccC
Q 008893           28 RLLQNN-NISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQYLRLNNNSLTGA----IPPSLSNM   94 (549)
Q Consensus        28 l~l~~n-~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l   94 (549)
                      ++|++| .|...    +...+...++|++|+|++|.|...    +...+...++|+.|+|++|.|+..    +...+...
T Consensus        41 L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n  120 (185)
T 1io0_A           41 VNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSN  120 (185)
T ss_dssp             EECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGC
T ss_pred             EEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhC
Confidence            556666 66532    334455667777777777777621    233455556777777777777632    34556666


Q ss_pred             CCCceEec--cCCCCCC
Q 008893           95 SQLAFLDL--SYNNLSG  109 (549)
Q Consensus        95 ~~L~~l~l--~~N~l~~  109 (549)
                      +.|+.|+|  ++|.|..
T Consensus       121 ~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          121 TSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             SSCCEEECCCCSSCCCH
T ss_pred             CCceEEEecCCCCCCCH
Confidence            77777777  6777763

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.47  E-value=6.3e-06  Score=74.35  Aligned_cols=103  Identities=13%  Similarity=0.159  Sum_probs=76.6

Q ss_pred             ccceeeeeeee-eecC-----------CceeehhhhcccCccccc----CCcccCCCCCCCEEEccCCcCCCC----Ccc
Q 008893            6 EKVLIIVLIQV-ICSD-----------GVFFSFGRLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPS   65 (549)
Q Consensus         6 ~~~~~~~~~~~-~c~~-----------~~~~~~~l~l~~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~   65 (549)
                      .+|+.|+|.++ ...+           .......++|++|.|...    +...+...++|++|+|++|.|+..    +..
T Consensus        36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~  115 (185)
T 1io0_A           36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE  115 (185)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence            56788888776 4332           112334578999998743    345566678999999999999842    456


Q ss_pred             cccCCcccCeeec--cCcccccC----CCcccccCCCCceEeccCCCCC
Q 008893           66 TVSHLETLQYLRL--NNNSLTGA----IPPSLSNMSQLAFLDLSYNNLS  108 (549)
Q Consensus        66 ~~~~l~~L~~L~l--~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~  108 (549)
                      .+...++|+.|+|  ++|.|+..    +...+...+.|+.|+|++|.+.
T Consensus       116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            7788899999999  88999843    4456667789999999999885

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.44  E-value=0.0002  Score=60.16  Aligned_cols=57  Identities=23%  Similarity=0.239  Sum_probs=34.0

Q ss_pred             EEEccCCcCC-CCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCCC
Q 008893           51 TLDLSNNFFT-GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG  109 (549)
Q Consensus        51 ~L~ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  109 (549)
                      .++.++++|+ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+..
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence            5666666665 23454432  356667777777764444556666677777666666653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.39  E-value=0.00049  Score=67.57  Aligned_cols=154  Identities=9%  Similarity=0.044  Sum_probs=84.3

Q ss_pred             CHHHHHHHhcCCCCC-----CeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCC--ccceE
Q 008893          218 HFKELQSATSNFSSK-----NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLI  290 (549)
Q Consensus       218 ~~~~~~~~~~~~~~~-----~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~  290 (549)
                      +.+++......|...     +.|+.|....+|+....+| .+++|+......   ...+..|..++..+....  +.+++
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCccc
Confidence            344555544556542     3456688899999987766 577898865311   124556777776664222  22333


Q ss_pred             EE------EecCCceeeEeeccCCCchhh--------------hhcc---C--CC----C---CHHHHHH----------
Q 008893          291 GF------CMTTTERLLVYPYMSNGSVAS--------------RLKA---K--PS----L---DWATRKR----------  328 (549)
Q Consensus       291 ~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~---~--~~----l---~~~~~~~----------  328 (549)
                      ..      ....+..+++++|++|..+..              .++.   .  .+    .   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      112345689999998865421              0111   0  00    1   1222110          


Q ss_pred             --HHHHHHHHHHHhhhc----CCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          329 --IALGAARGLLYLHEQ----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       329 --i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                        +...+...+.++++.    ...+++|+|+.+.||+++++..+.|+||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              001133445555432    23479999999999999987666899999775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.35  E-value=0.00073  Score=65.71  Aligned_cols=135  Identities=13%  Similarity=0.084  Sum_probs=75.1

Q ss_pred             CCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCc-cceEEEEecCCceeeEeecc-CCC
Q 008893          232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLVYPYM-SNG  309 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g  309 (549)
                      .+.|+.|....+|+.     +.+++|+.......  ......|...++.+....+ .+++++  ..+.-++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence            678889999999998     45888887643211  1123567777777653333 355544  344568899999 554


Q ss_pred             chhh--------h----------hccCC-CC----C-HHHHHHHHHH--------------HHHHHH----Hhhh-cCCC
Q 008893          310 SVAS--------R----------LKAKP-SL----D-WATRKRIALG--------------AARGLL----YLHE-QCDP  346 (549)
Q Consensus       310 ~L~~--------~----------l~~~~-~l----~-~~~~~~i~~~--------------i~~~L~----~LH~-~~~~  346 (549)
                      ++..        .          +|... .+    + +.....+...              +...+.    .+.. ...+
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            4421        0          11111 01    1 1111111110              111111    1111 1234


Q ss_pred             ceEecccCcCeeeecCCCceEEeecccccc
Q 008893          347 KIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       347 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      .++|+|+.+.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            6899999999999 5567789999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.24  E-value=0.00075  Score=66.64  Aligned_cols=139  Identities=15%  Similarity=0.057  Sum_probs=71.2

Q ss_pred             CeeeeeCCeE-EEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC--CCccceEEEEecCCceeeEeeccCCC
Q 008893          233 NLVGKGGFGN-VYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       233 ~~iG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      +.|+.|.... +|+....+|+.+++|.......    ..+..|+.++..+..  -.+.+++.+....  -+++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence            4455555444 6677654467777776543221    123456666666542  2345667664333  37899998765


Q ss_pred             chhhhhc---------------------cC-----CCCCHHHHH-------H-H------------HHHHHHHHHHhhh-
Q 008893          310 SVASRLK---------------------AK-----PSLDWATRK-------R-I------------ALGAARGLLYLHE-  342 (549)
Q Consensus       310 ~L~~~l~---------------------~~-----~~l~~~~~~-------~-i------------~~~i~~~L~~LH~-  342 (549)
                      .+.+.+.                     ..     +.++.....       . +            ...+...+..+.+ 
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            5543221                     10     112111100       0 0            0011112222211 


Q ss_pred             --cCCCceEecccCcCeeeecCC----CceEEeeccccccc
Q 008893          343 --QCDPKIIHRDVKAANILLDEY----YEAVVGDFGLAKLL  377 (549)
Q Consensus       343 --~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~~~~~  377 (549)
                        ...+.++|||+.+.||+++.+    +.+.|+||+.+..-
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence              124589999999999999874    68899999988643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.24  E-value=0.0012  Score=67.54  Aligned_cols=72  Identities=15%  Similarity=0.178  Sum_probs=49.2

Q ss_pred             CeeeeeCCeEEEEEEECC--------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCc-cceEEEEecCCceeeEe
Q 008893          233 NLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLVY  303 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  303 (549)
                      +.|+.|....+|+....+        ++.+++|+....   .....+..|..++..+...++ .++++.+.+    .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            567888889999998753        578999988432   112355578888888754444 566665532    3899


Q ss_pred             eccCCCch
Q 008893          304 PYMSNGSV  311 (549)
Q Consensus       304 e~~~~g~L  311 (549)
                      ||+++.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.22  E-value=0.0017  Score=58.74  Aligned_cols=98  Identities=15%  Similarity=0.117  Sum_probs=63.7

Q ss_pred             Cchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceeec
Q 008893          309 GSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA  387 (549)
Q Consensus       309 g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  387 (549)
                      -+|.+.|. .+.+++++++|.++.|.+.+|.-+-....+  ..+=+.|..|++..+|.+.+.+ +.+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------------
Confidence            47888887 456899999999999999998776211111  1233457889999999988753 1110            


Q ss_pred             cccccCccCchhhccCCCCCcccchhHhHHHHHHHh
Q 008893          388 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS  423 (549)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt  423 (549)
                       .....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence             1223456888763 345678899999999999875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.21  E-value=0.0021  Score=63.12  Aligned_cols=139  Identities=14%  Similarity=0.129  Sum_probs=80.5

Q ss_pred             CeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCC--ccceEEE-----EecCCceeeEeec
Q 008893          233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGF-----CMTTTERLLVYPY  305 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~  305 (549)
                      ..++ |....||+....+|+.+++|+.....  .....+..|..++..+....  +.+++..     ....+..+++|+|
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            3466 88889999887778789999986432  12446677888877764222  3444432     1123455789999


Q ss_pred             cCCCchhh-----------h---hc----c-----CCCCCHHHH----HHH---------------HHHHHHHHHHhhhc
Q 008893          306 MSNGSVAS-----------R---LK----A-----KPSLDWATR----KRI---------------ALGAARGLLYLHEQ  343 (549)
Q Consensus       306 ~~~g~L~~-----------~---l~----~-----~~~l~~~~~----~~i---------------~~~i~~~L~~LH~~  343 (549)
                      ++|..+..           .   ++    .     ....++...    ..+               ...+...+..+.+.
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            98754321           0   11    0     011222211    001               01111122222221


Q ss_pred             ----CCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          344 ----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       344 ----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                          ....++|||+++.||+++ + .+.|+||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                234789999999999999 4 899999987753

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.19  E-value=2.5e-05  Score=83.86  Aligned_cols=96  Identities=10%  Similarity=0.038  Sum_probs=58.6

Q ss_pred             cCccccc-----CCcccCCCCCCCEEEccCC--cCCCCCcccccC-CcccCeeeccCccccc-CCCcccccCCCCceEec
Q 008893           32 NNNISGH-----IPTEIGKLSKLLTLDLSNN--FFTGPIPSTVSH-LETLQYLRLNNNSLTG-AIPPSLSNMSQLAFLDL  102 (549)
Q Consensus        32 ~n~l~~~-----~p~~~~~l~~L~~L~ls~N--~l~g~~p~~~~~-l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l  102 (549)
                      .|.+++.     ++..+.++++|+.|+|++|  .+++..+..+.. +++|+.|+|++|++++ .++..+..+++|+.|+|
T Consensus       416 ~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l  495 (592)
T 3ogk_B          416 EERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEM  495 (592)
T ss_dssp             CSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEE
T ss_pred             CccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeec
Confidence            5666653     3333566777888887643  355444444433 6778888888777765 34445566777888888


Q ss_pred             cCCCCCCCC-Ccc-----ccccccccCCccc
Q 008893          103 SYNNLSGPV-PSF-----HAKTFNITGNSLI  127 (549)
Q Consensus       103 ~~N~l~~~~-p~~-----~~~~~~l~~N~~~  127 (549)
                      ++|.+++.. +..     ..+.+++++|.++
T Consensus       496 ~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it  526 (592)
T 3ogk_B          496 RGCCFSERAIAAAVTKLPSLRYLWVQGYRAS  526 (592)
T ss_dssp             ESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred             cCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence            888775432 111     1255677777753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.14  E-value=0.0026  Score=63.79  Aligned_cols=137  Identities=16%  Similarity=0.158  Sum_probs=81.9

Q ss_pred             CeeeeeCCeEEEEEEEC--------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCC-ccceEEEEecCCceeeEe
Q 008893          233 NLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  303 (549)
                      +.+..|-...+|+....        +++.+++|+....  ......+.+|..+++.+...+ ..++++++.+    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            45667888899998864        2578999986332  223456678999988775333 3556666543    3999


Q ss_pred             eccCCCchhhh-----------------hccC-----CCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 008893          304 PYMSNGSVASR-----------------LKAK-----PSLD--WATRKRIALGAAR-------------------GLLYL  340 (549)
Q Consensus       304 e~~~~g~L~~~-----------------l~~~-----~~l~--~~~~~~i~~~i~~-------------------~L~~L  340 (549)
                      ||++|..+...                 ++..     ....  |.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99997655311                 1111     1122  4455555544322                   12333


Q ss_pred             hh-----cCCCceEecccCcCeeeecCC----CceEEeeccccc
Q 008893          341 HE-----QCDPKIIHRDVKAANILLDEY----YEAVVGDFGLAK  375 (549)
Q Consensus       341 H~-----~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~~~  375 (549)
                      .+     .....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            21     123479999999999999876    789999999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.08  E-value=0.00014  Score=72.67  Aligned_cols=65  Identities=17%  Similarity=0.187  Sum_probs=37.8

Q ss_pred             CCCCCCEEEccC--CcCCCC-----Ccccc--cCCcccCeeeccCcccccCCCcccc---cCCCCceEeccCCCCCC
Q 008893           45 KLSKLLTLDLSN--NFFTGP-----IPSTV--SHLETLQYLRLNNNSLTGAIPPSLS---NMSQLAFLDLSYNNLSG  109 (549)
Q Consensus        45 ~l~~L~~L~ls~--N~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~g~~p~~~~---~l~~L~~l~l~~N~l~~  109 (549)
                      .+++|+.|+|+.  |...|.     +...+  ..+++|+.|+|++|.+.+..+..+.   .+++|+.|+|+.|.|.+
T Consensus       217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d  293 (362)
T 2ra8_A          217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD  293 (362)
T ss_dssp             BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred             cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence            577777777753  221111     11122  2367788888877777643333333   36677888888777765

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.03  E-value=0.00021  Score=76.55  Aligned_cols=99  Identities=8%  Similarity=0.015  Sum_probs=72.3

Q ss_pred             ccceeeeeeeeee-cCCc--------eeehhhhcccCccccc----CCcccCCCCCCCEEEccCCcCCC----CCccccc
Q 008893            6 EKVLIIVLIQVIC-SDGV--------FFSFGRLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTG----PIPSTVS   68 (549)
Q Consensus         6 ~~~~~~~~~~~~c-~~~~--------~~~~~l~l~~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~g----~~p~~~~   68 (549)
                      .+|+.|+|.++.- ++..        .....++|++|.+++.    ++..+.++++|+.|+|++|.+++    .++..+.
T Consensus       138 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~  217 (592)
T 3ogk_B          138 DDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR  217 (592)
T ss_dssp             GGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred             ccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence            3488888876541 1111        1223467899988765    44456678999999999999973    3455567


Q ss_pred             CCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           69 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        69 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      ++++|+.|+|++|.+.+ +|..+..+++|+.|+++++
T Consensus       218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~  253 (592)
T 3ogk_B          218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSL  253 (592)
T ss_dssp             HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBC
T ss_pred             hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhccccc
Confidence            88999999999999985 7788888889999888753

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.97  E-value=0.00085  Score=56.30  Aligned_cols=56  Identities=20%  Similarity=0.194  Sum_probs=44.2

Q ss_pred             hhhcccCccc-ccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccc
Q 008893           27 GRLLQNNNIS-GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT   84 (549)
Q Consensus        27 ~l~l~~n~l~-~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~   84 (549)
                      .++.+++.++ ..+|..+.  ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            4567777775 35565442  47999999999999666667899999999999999886

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.93  E-value=0.0031  Score=63.19  Aligned_cols=73  Identities=10%  Similarity=0.055  Sum_probs=44.2

Q ss_pred             CeeeeeCCeEEEEEEECC---------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCc-cceEEEEecCCceeeE
Q 008893          233 NLVGKGGFGNVYKGYLQD---------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLV  302 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv  302 (549)
                      ..++.|....+|+....+         ++.+++|+......  .......|..++..+...++ .++++..    .-++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence            456788889999998754         26888998754321  11123577888877754343 4666544    23789


Q ss_pred             eeccCCCch
Q 008893          303 YPYMSNGSV  311 (549)
Q Consensus       303 ~e~~~~g~L  311 (549)
                      |||+++..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.91  E-value=0.00014  Score=64.31  Aligned_cols=80  Identities=14%  Similarity=0.052  Sum_probs=32.7

Q ss_pred             hhhhcccCcccccCCcccCCCCCCCEEEccCCc-CCCCCcccccCC----cccCeeeccCcc-cccCCCcccccCCCCce
Q 008893           26 FGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNF-FTGPIPSTVSHL----ETLQYLRLNNNS-LTGAIPPSLSNMSQLAF   99 (549)
Q Consensus        26 ~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~   99 (549)
                      ..++|+++.|+..--..+.+|++|+.|+|+++. |+..--..++.+    ++|+.|+|+++. |+..--..+..+++|+.
T Consensus        64 ~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~  143 (176)
T 3e4g_A           64 QAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKY  143 (176)
T ss_dssp             EEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCE
T ss_pred             eEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCE
Confidence            334444444432222234455555555555542 331111122222    245555555542 44211123444555555


Q ss_pred             EeccCC
Q 008893          100 LDLSYN  105 (549)
Q Consensus       100 l~l~~N  105 (549)
                      |+|++.
T Consensus       144 L~L~~c  149 (176)
T 3e4g_A          144 LFLSDL  149 (176)
T ss_dssp             EEEESC
T ss_pred             EECCCC
Confidence            555543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.87  E-value=0.0074  Score=62.13  Aligned_cols=74  Identities=9%  Similarity=0.063  Sum_probs=47.4

Q ss_pred             CCeeeeeCCeEEEEEEECC-CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCc-cceEEEEecCCceeeEeeccCCC
Q 008893          232 KNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLVYPYMSNG  309 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  309 (549)
                      .+.|+.|-...+|+....+ +..+++|+......  .......|..++..+...++ .++++++.  +  .+|+||+++.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            3567888889999998865 47888998754321  11123578888888865444 46677662  2  3599999875


Q ss_pred             ch
Q 008893          310 SV  311 (549)
Q Consensus       310 ~L  311 (549)
                      ++
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            54

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.62  E-value=0.00011  Score=78.63  Aligned_cols=83  Identities=12%  Similarity=0.115  Sum_probs=59.1

Q ss_pred             cCCCCCCCEEEccCCcCCCCCcccccC-CcccCeeeccCcccccCCCccc-ccCCCCceEeccCCCCCCCCCcc------
Q 008893           43 IGKLSKLLTLDLSNNFFTGPIPSTVSH-LETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPSF------  114 (549)
Q Consensus        43 ~~~l~~L~~L~ls~N~l~g~~p~~~~~-l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~l~l~~N~l~~~~p~~------  114 (549)
                      +.++++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++.....      
T Consensus       428 ~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~  506 (594)
T 2p1m_B          428 VEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLE  506 (594)
T ss_dssp             HHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGG
T ss_pred             HhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCC
Confidence            66788899999977 666555555655 7889999999998876555444 66888999999999885433221      


Q ss_pred             ccccccccCCcc
Q 008893          115 HAKTFNITGNSL  126 (549)
Q Consensus       115 ~~~~~~l~~N~~  126 (549)
                      ..+.+++++|++
T Consensus       507 ~L~~L~l~~~~~  518 (594)
T 2p1m_B          507 TMRSLWMSSCSV  518 (594)
T ss_dssp             GSSEEEEESSCC
T ss_pred             CCCEEeeeCCCC
Confidence            125567777765

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.61  E-value=0.009  Score=59.03  Aligned_cols=32  Identities=22%  Similarity=0.295  Sum_probs=28.0

Q ss_pred             CCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       345 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34799999999999999888899999987754

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.21  E-value=0.00052  Score=73.44  Aligned_cols=79  Identities=18%  Similarity=0.166  Sum_probs=36.3

Q ss_pred             hhcccCcccccCCcccC-CCCCCCEEEccCC-cCCCC-CcccccCCcccCeeeccCcccccCCCcccc----cCCCCceE
Q 008893           28 RLLQNNNISGHIPTEIG-KLSKLLTLDLSNN-FFTGP-IPSTVSHLETLQYLRLNNNSLTGAIPPSLS----NMSQLAFL  100 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~-~l~~L~~L~ls~N-~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~----~l~~L~~l  100 (549)
                      ++|++|.+++..+..+. ++++|+.|+|++| .++.. ++..+.++++|+.|+|++|.+++..+..+.    .+++|+.|
T Consensus       110 L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L  189 (594)
T 2p1m_B          110 IRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL  189 (594)
T ss_dssp             EEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEE
T ss_pred             EEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEE
Confidence            34455555444444443 3555555555555 33311 233333455555555555555433332222    33455555


Q ss_pred             eccCCC
Q 008893          101 DLSYNN  106 (549)
Q Consensus       101 ~l~~N~  106 (549)
                      ++++|.
T Consensus       190 ~l~~~~  195 (594)
T 2p1m_B          190 NISCLA  195 (594)
T ss_dssp             ECTTCC
T ss_pred             EecccC
Confidence            555554

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=96.12  E-value=0.0062  Score=61.68  Aligned_cols=65  Identities=12%  Similarity=0.049  Sum_probs=33.0

Q ss_pred             CcccCCCCCCCEEEccCCcCC-----CCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           40 PTEIGKLSKLLTLDLSNNFFT-----GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        40 p~~~~~l~~L~~L~ls~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      +..|.+|++|+.++|.+|.+.     ..-+..|.+|++|+.++|. |+++..-..+|.+|.+|+.+.|.+|
T Consensus       264 ~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~  333 (401)
T 4fdw_A          264 SRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN  333 (401)
T ss_dssp             TTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred             hhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence            445555555555555555443     1223445555555555555 2344333445555555555555433

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=95.95  E-value=0.0084  Score=60.74  Aligned_cols=80  Identities=9%  Similarity=0.000  Sum_probs=62.9

Q ss_pred             hcccCccc-----ccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEecc
Q 008893           29 LLQNNNIS-----GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLS  103 (549)
Q Consensus        29 ~l~~n~l~-----~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~  103 (549)
                      .+.+|.+.     ...+..|.+|++|+.++|.+ .++-.-...|.+|++|+.|+|.+| ++..-+.+|.++ +|+.|+++
T Consensus       277 ~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~  353 (401)
T 4fdw_A          277 TTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVE  353 (401)
T ss_dssp             EEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEEC
T ss_pred             EeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEc
Confidence            35555543     35567899999999999994 577455678999999999999665 775667789999 99999999


Q ss_pred             CCCCCCCC
Q 008893          104 YNNLSGPV  111 (549)
Q Consensus       104 ~N~l~~~~  111 (549)
                      +|.+....
T Consensus       354 ~n~~~~l~  361 (401)
T 4fdw_A          354 GTTPPQVF  361 (401)
T ss_dssp             CSSCCBCC
T ss_pred             CCCCcccc
Confidence            99776433

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=95.14  E-value=0.0062  Score=53.63  Aligned_cols=71  Identities=14%  Similarity=0.191  Sum_probs=50.9

Q ss_pred             cCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcc-cccCCCcccccC----CCCceEeccCCC-CC
Q 008893           38 HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS-LTGAIPPSLSNM----SQLAFLDLSYNN-LS  108 (549)
Q Consensus        38 ~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~l~l~~N~-l~  108 (549)
                      .+|.....--+|+.|||+++.++..--..+..+++|+.|+|+++. |+..-=..+..+    ++|+.|+|+++. ++
T Consensus        52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT  128 (176)
T 3e4g_A           52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT  128 (176)
T ss_dssp             GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred             cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence            345543333579999999999885434567889999999999995 764322345553    479999999974 65

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.45  E-value=0.22  Score=50.47  Aligned_cols=73  Identities=5%  Similarity=0.011  Sum_probs=47.3

Q ss_pred             CeeeeeCCeEEEEEEECC--------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCC-ccceEEEEecCCceeeEe
Q 008893          233 NLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  303 (549)
                      +.+..|-...+|+....+        ++.+++|+......  ......+|..+++.+...+ ..++++.+.    -+.|+
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~--~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG--KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc--hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            456678889999998763        57899998754321  1112457888887775333 345555332    37899


Q ss_pred             eccCCCch
Q 008893          304 PYMSNGSV  311 (549)
Q Consensus       304 e~~~~g~L  311 (549)
                      ||+++..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=94.42  E-value=0.0057  Score=60.95  Aligned_cols=97  Identities=15%  Similarity=0.183  Sum_probs=60.9

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCccccc--CCcccCeeeccC--cccccC-----CCccc--ccCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS--HLETLQYLRLNN--NSLTGA-----IPPSL--SNMSQ   96 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~--~l~~L~~L~l~~--N~l~g~-----~p~~~--~~l~~   96 (549)
                      |.|++|.-. .+++ +. +++|+.|+|..|.++......+.  .+++|+.|+|+.  |...|.     +...+  ..+++
T Consensus       177 L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~  253 (362)
T 2ra8_A          177 LKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPN  253 (362)
T ss_dssp             EEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTT
T ss_pred             EEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCC
Confidence            446565211 2343 43 89999999999988743333443  789999999864  332222     11223  24789


Q ss_pred             CceEeccCCCCCCCCCcc--------ccccccccCCccc
Q 008893           97 LAFLDLSYNNLSGPVPSF--------HAKTFNITGNSLI  127 (549)
Q Consensus        97 L~~l~l~~N~l~~~~p~~--------~~~~~~l~~N~~~  127 (549)
                      |+.|+|++|.+.+..+..        ..+.++++.|.+.
T Consensus       254 Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~  292 (362)
T 2ra8_A          254 LKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT  292 (362)
T ss_dssp             CCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCB
T ss_pred             cCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCC
Confidence            999999999987433211        2356788888764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=93.84  E-value=0.011  Score=53.08  Aligned_cols=66  Identities=12%  Similarity=0.203  Sum_probs=42.1

Q ss_pred             cCCCCCCCEEEccCC-cCCC----CCcccccCCcccCeeeccCccccc----CCCcccccCCCCceEeccCCCCC
Q 008893           43 IGKLSKLLTLDLSNN-FFTG----PIPSTVSHLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNLS  108 (549)
Q Consensus        43 ~~~l~~L~~L~ls~N-~l~g----~~p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~  108 (549)
                      +.+-+.|++|+|++| +|..    .+-..+..-+.|+.|+|++|+|..    .+...+..-+.|+.|+|++|.|.
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence            344567778888775 6641    123345556778888888887762    23334445567888888888876

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.82  E-value=0.014  Score=37.91  Aligned_cols=31  Identities=29%  Similarity=0.472  Sum_probs=19.1

Q ss_pred             eeeecchhhhHHHHHhhhhheeccccccccc
Q 008893          166 ALALGSSLGCISLLILGFGFLLWWRQRHNQQ  196 (549)
Q Consensus       166 ~~~~~~~~g~i~~~~~~~~~~~~~r~~~~~~  196 (549)
                      .++.+++.|++.++++++++++|+|+|+.++
T Consensus        12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~   42 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVALGIGLFMRRRHIVR   42 (44)
T ss_dssp             SSTHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             eEEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence            3445555556666666666777777766543

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=93.42  E-value=0.028  Score=50.40  Aligned_cols=80  Identities=13%  Similarity=0.115  Sum_probs=56.6

Q ss_pred             hhhcccC-ccccc----CCcccCCCCCCCEEEccCCcCCC----CCcccccCCcccCeeeccCcccccC----CCccccc
Q 008893           27 GRLLQNN-NISGH----IPTEIGKLSKLLTLDLSNNFFTG----PIPSTVSHLETLQYLRLNNNSLTGA----IPPSLSN   93 (549)
Q Consensus        27 ~l~l~~n-~l~~~----~p~~~~~l~~L~~L~ls~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~   93 (549)
                      .++|++| .|...    +...+..-+.|+.|+|++|+|..    .+-..+..-+.|+.|+|++|.|+..    +-.++..
T Consensus        45 ~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~  124 (197)
T 1pgv_A           45 EVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLV  124 (197)
T ss_dssp             EEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTT
T ss_pred             EEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhh
Confidence            3567775 66522    34556677899999999999972    2334455668999999999999832    2334555


Q ss_pred             CCCCceEeccCCC
Q 008893           94 MSQLAFLDLSYNN  106 (549)
Q Consensus        94 l~~L~~l~l~~N~  106 (549)
                      -+.|+.|+|++|.
T Consensus       125 N~tL~~L~L~n~~  137 (197)
T 1pgv_A          125 TQSIVEFKADNQR  137 (197)
T ss_dssp             TCCCSEEECCCCS
T ss_pred             CCceeEEECCCCc
Confidence            6679999998753

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=93.39  E-value=0.068  Score=53.76  Aligned_cols=63  Identities=11%  Similarity=0.035  Sum_probs=40.8

Q ss_pred             cccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           41 TEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        41 ~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      ..|.++.+|+.+.+.++ ++..-...|.++++|+.++|.++ ++..-..+|.+|.+|+.+++..|
T Consensus       291 ~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~  353 (394)
T 4fs7_A          291 KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS  353 (394)
T ss_dssp             TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred             ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence            35667777777777654 44233456777777777777543 55344556777777777777655

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=92.93  E-value=0.092  Score=52.35  Aligned_cols=70  Identities=13%  Similarity=0.097  Sum_probs=50.1

Q ss_pred             ccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           35 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        35 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      ++..-...|.++.+|+.+.+..+ ++..-...|.++++|+.+.+.+|.++..-..+|.+|.+|+.+.|.+|
T Consensus       251 v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~  320 (379)
T 4h09_A          251 VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA  320 (379)
T ss_dssp             CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred             ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence            44334456778888888888654 44234456788888888888888887555667888888888888654

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=92.93  E-value=0.014  Score=37.79  Aligned_cols=31  Identities=26%  Similarity=0.470  Sum_probs=18.5

Q ss_pred             eeeecchhhhHHHHHhhhhheeccccccccc
Q 008893          166 ALALGSSLGCISLLILGFGFLLWWRQRHNQQ  196 (549)
Q Consensus       166 ~~~~~~~~g~i~~~~~~~~~~~~~r~~~~~~  196 (549)
                      .++.+++.|++.+++++.++++|||+|+.++
T Consensus        11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~   41 (44)
T 2l2t_A           11 LIAAGVIGGLFILVIVGLTFAVYVRRKSIKK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             eEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence            3444445556666666666677777766554

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=92.82  E-value=0.13  Score=51.66  Aligned_cols=67  Identities=12%  Similarity=0.138  Sum_probs=45.6

Q ss_pred             CCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCC
Q 008893           39 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS  108 (549)
Q Consensus        39 ~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  108 (549)
                      -...|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-..+|.+|.+|+.+.+..| ++
T Consensus       280 ~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~  346 (394)
T 4gt6_A          280 GTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT  346 (394)
T ss_dssp             CTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC
T ss_pred             cCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC
Confidence            34567778888888886 3455344456778888888888654 55344567888888888887654 44

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.06  E-value=0.67  Score=46.57  Aligned_cols=29  Identities=31%  Similarity=0.441  Sum_probs=24.8

Q ss_pred             ceEecccCcCeeee------cCCCceEEeeccccc
Q 008893          347 KIIHRDVKAANILL------DEYYEAVVGDFGLAK  375 (549)
Q Consensus       347 ~ivH~Dlkp~Nill------~~~~~~kl~Dfg~~~  375 (549)
                      .++|+|+.+.||++      +++..+.++||-+|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            46799999999999      456789999998875

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=90.29  E-value=0.047  Score=35.22  Aligned_cols=29  Identities=17%  Similarity=0.434  Sum_probs=17.7

Q ss_pred             eeecchhhhHHHHHhhhhheecccccccc
Q 008893          167 LALGSSLGCISLLILGFGFLLWWRQRHNQ  195 (549)
Q Consensus       167 ~~~~~~~g~i~~~~~~~~~~~~~r~~~~~  195 (549)
                      .+++.++|++++++++.++++|+|||+.+
T Consensus        13 ~Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           13 SIISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             chHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            35556666555566666666677766544

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=89.45  E-value=0.57  Score=46.86  Aligned_cols=66  Identities=9%  Similarity=0.109  Sum_probs=47.2

Q ss_pred             cCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           38 HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        38 ~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .-..+|.++++|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-..+|.+|.+|+.++|.+|
T Consensus       256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~  321 (394)
T 4gt6_A          256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG  321 (394)
T ss_dssp             ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT
T ss_pred             cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc
Confidence            33456788888888888776544 445667888888888885 4555345567888888888888654

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=88.73  E-value=0.5  Score=46.87  Aligned_cols=79  Identities=11%  Similarity=0.040  Sum_probs=56.7

Q ss_pred             ccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCCCCCCcc
Q 008893           35 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF  114 (549)
Q Consensus        35 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~  114 (549)
                      +...-...|.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-..+|.++.+|+.+.+.+|.++......
T Consensus       228 ~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~a  305 (379)
T 4h09_A          228 VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRV  305 (379)
T ss_dssp             CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTT
T ss_pred             eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhh
Confidence            33334556788899999999876 55344567888899999988654 55344567888999999999888877554444


Q ss_pred             c
Q 008893          115 H  115 (549)
Q Consensus       115 ~  115 (549)
                      |
T Consensus       306 F  306 (379)
T 4h09_A          306 F  306 (379)
T ss_dssp             T
T ss_pred             h
Confidence            4

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.14  E-value=1.5  Score=39.56  Aligned_cols=116  Identities=10%  Similarity=0.057  Sum_probs=78.1

Q ss_pred             cCCCccceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec
Q 008893          282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD  361 (549)
Q Consensus       282 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  361 (549)
                      .||+++.. .+-...+...+.++.-+.+.=...++   .++...+++++.+|+....+++..     +|--|.|+|++++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~  113 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFT  113 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEEC
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEc
Confidence            58888766 45556666666665544222222232   477899999999999888777654     7889999999999


Q ss_pred             CCCceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccc
Q 008893          362 EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE  429 (549)
Q Consensus       362 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  429 (549)
                      .++.+++.-.|+...+.+..                       .++..=.-.+=+++..+++++..|+
T Consensus       114 ~~~~p~i~~RGik~~l~P~~-----------------------~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          114 RDGLPIAKTRGLQNVVDPLP-----------------------VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             TTSCEEESCCEETTTBSCCC-----------------------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCCCEEEEEccCccCCCCCC-----------------------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999998877654332110                       1111123356678888999988876

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.14  E-value=2.1  Score=38.73  Aligned_cols=115  Identities=15%  Similarity=0.098  Sum_probs=77.2

Q ss_pred             cCCCccceEEEEecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCceEecccCcCeeee
Q 008893          282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL-YLHEQCDPKIIHRDVKAANILL  360 (549)
Q Consensus       282 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlkp~Nill  360 (549)
                      .||++  -..+-...+...+.++--+++.=...++   .++...+++++.+|+.... +++..     +|--|+|+|+++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~f  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLMF  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEEE
Confidence            57777  4444466677777776654433333332   4788999999999998777 66654     788899999999


Q ss_pred             cCCCceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE  429 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  429 (549)
                      |.++.++|.-.|+-..+.+..             +.+|-+          .-.+=+++..++.++..|+
T Consensus       118 ~~~~~p~i~hRGi~~~lpP~e-------------~~ee~f----------l~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          118 NRALEPFFLHVGVKESLPPDE-------------WDDERL----------LREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CTTCCEEESCCEETTTBSSCS-------------CCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred             eCCCcEEEEEcCCcccCCCCC-------------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence            999999998887654332111             111211          2355677788888877765

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=87.15  E-value=0.7  Score=46.15  Aligned_cols=64  Identities=14%  Similarity=0.057  Sum_probs=42.7

Q ss_pred             cCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           38 HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        38 ~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .....|.++..|+.+.+..+.+.   ...|..+.+|+.+.+.+| ++..-..+|.++.+|+.++|.++
T Consensus       267 i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~  330 (394)
T 4fs7_A          267 IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL  330 (394)
T ss_dssp             ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred             eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc
Confidence            34456777777877777766543   345677778888877654 55344566777888888877644

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	549
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-65
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-62
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-62
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-60
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-59
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-58
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-57
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-52
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-44
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-04
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-04
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.001
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	4e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 5e-65
 Identities = 73/275 (26%), Positives = 120/275 (43%), Gaps = 24/275 (8%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
                   +G G FG V+ GY    T VAVK LK G+       F  E  ++    H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--LDWATRKRIALGAARGLLYLHEQC 344
           +RL     T     ++  YM NGS+   LK      L       +A   A G+ ++ E+ 
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
               IHRD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G 
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 464
            + K+DV+ FGILL E+++       G+         + ++ + +  ++           
Sbjct: 187 FTIKSDVWSFGILLTEIVTH------GRIPYPGMTNPEVIQNLERGYRMVR--------- 231

Query: 465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                 EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 3e-63
 Identities = 72/279 (25%), Positives = 120/279 (43%), Gaps = 24/279 (8%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRN 285
              +    +G G FG VYKG       VAVK L        ++Q F+ EV ++    H N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQC 344
           +L  +G+  T  +  +V  +    S+   L   +   +      IA   A+G+ YLH + 
Sbjct: 66  ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTG 403
              IIHRD+K+ NI L E     +GDFGLA +      SH    + G++  +APE +   
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 404 QS---SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 460
                S ++DV+ FGI+L EL++G          N +  ++  V + +    L  +    
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSN- 237

Query: 461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                     + M ++   C +     RP   +++  +E
Sbjct: 238 --------CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 1e-62
 Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 22/274 (8%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           S  +    +G G FG V+ GY  +   VA+K +++G     E  F  E E++    H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKL 62

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL-DWATRKRIALGAARGLLYLHEQCD 345
           ++L G C+      LV+ +M +G ++  L+ +  L    T   + L    G+ YL E C 
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
             +IHRD+ A N L+ E     V DFG+ + +       +T  +  V   +PE  S  + 
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 406 SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 465
           S K+DV+ FG+L+ E+ S       GK   +  +  + V+ I    +L            
Sbjct: 180 SSKSDVWSFGVLMWEVFSE------GKIPYENRSNSEVVEDISTGFRLY----------K 223

Query: 466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            R+    + Q+   C +  P  RP  S ++R L 
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (517), Expect = 8e-62
 Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 37/301 (12%)

Query: 217 FHFKELQSATSNFSSK---------NLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGN 263
           F F++   A   F+ +          ++G G FG V  G+L    +    VA+K LK G 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 264 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLD 322
                  F +E  ++    H N++ L G    +T  +++  +M NGS+ S L+       
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
                 +  G A G+ YL +      +HRD+ A NIL++      V DFGL++ L+   S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 383 HVTT----AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG 438
             T       +  +   APE +   + +  +DV+ +GI++ E++S      +G+      
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------YGERPYWDM 237

Query: 439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRML 498
              D +  I Q+ +L   +D              + Q+ L C Q   + RPK  ++V  L
Sbjct: 238 TNQDVINAIEQDYRLPPPMD----------CPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

Query: 499 E 499
           +
Sbjct: 288 D 288

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-60
 Identities = 65/282 (23%), Positives = 123/282 (43%), Gaps = 27/282 (9%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGT-----VVAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           S  + + ++G G FG VYKG L+  +      VA+K LK G      + F  E  ++   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASR-LKAKPSLDWATRKRIALGAARGLLYL 340
            H N++RL G        +++  YM NG++     +            +  G A G+ YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 398
                   +HRD+ A NIL++      V DFGL+++L  D   ++ T+  +  +   APE
Sbjct: 127 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 399 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 458
            +S  + +  +DV+ FGI++ E+++      +  +                  ++   ++
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----------------NHEVMKAIN 227

Query: 459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 500
              +          + Q+ + C Q   + RPK +++V +L+ 
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 5e-60
 Identities = 78/281 (27%), Positives = 120/281 (42%), Gaps = 30/281 (10%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH 283
           +F    ++G+G FG VY G L D        AVK L     IG   QF TE  ++    H
Sbjct: 30  HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 284 RNLLRLIGFCMTT-TERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYLH 341
            N+L L+G C+ +    L+V PYM +G + +       +          L  A+G+    
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---K 144

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD---SHVTTAVRGTVGHIAPE 398
                K +HRD+ A N +LDE +   V DFGLA+ +   +    H  T  +  V  +A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 399 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD 458
            L T + + K+DV+ FG+LL EL++       G          D    + Q ++L     
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTR------GAPPYPDVNTFDITVYLLQGRRLL---- 254

Query: 459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                       + + +V L C      +RP  SE+V  + 
Sbjct: 255 ------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 6e-60
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 27/287 (9%)

Query: 220 KELQSATSNFSSKNLV-GKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEV 275
           K+L     N    ++  G G FG+V +G  +       VA+K LK G       +   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 276 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAA 334
           +++    +  ++RLIG C      +LV      G +   L  K   +  +    +    +
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 335 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTV 392
            G+ YL E+     +HRD+ A N+LL   + A + DFGL+K L   DS+ T  +A +  +
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 393 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
              APE ++  + S ++DV+ +G+ + E +S      +G+   +K    + +  I Q K+
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALS------YGQKPYKKMKGPEVMAFIEQGKR 230

Query: 453 LEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           +E   +             E+  +   C  Y    RP    V + + 
Sbjct: 231 MECPPECP----------PELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 6e-60
 Identities = 55/274 (20%), Positives = 110/274 (40%), Gaps = 22/274 (8%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
            + +    +G G FG V  G  +    VA+K +K+G+    E +F  E +++    H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKL 61

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCD 345
           ++L G C       ++  YM+NG + + L+  +          +       + YL  +  
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120

Query: 346 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 405
              +HRD+ A N L+++     V DFGL++ +   +   +   +  V    PE L   + 
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 406 SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 465
           S K+D++ FG+L+ E+ S  +      T ++                    + + L+   
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRLYR 222

Query: 466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
             +  E++  +   C       RP    ++  + 
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-59
 Identities = 71/275 (25%), Positives = 114/275 (41%), Gaps = 24/275 (8%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
            +   +  +G+G FG V+ G     T VA+K LK G        F  E +++    H  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 74

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQC 344
           ++L     +     +V  YMS GS+   LK +    L       +A   A G+ Y+    
Sbjct: 75  VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
               +HRD++AANIL+ E     V DFGLA+L++  +       +  +   APE    G+
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 464
            + K+DV+ FGILL EL +  R    G                   +++   V++  +  
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMV----------------NREVLDQVERGYRMP 234

Query: 465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                 E +  +   C +  P  RP    +   LE
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (500), Expect = 2e-59
 Identities = 68/313 (21%), Positives = 127/313 (40%), Gaps = 50/313 (15%)

Query: 218 HFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQF 271
               L+   +N      +G+G FG V++         +  T+VAVK LK+  +   +  F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 272 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK--------------- 316
           Q E  +++   + N+++L+G C       L++ YM+ G +   L+               
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 317 ---------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 367
                      P L  A +  IA   A G+ YL E+   K +HRD+   N L+ E     
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180

Query: 368 VGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 426
           + DFGL++ +   D           +  + PE +   + + ++DV+ +G++L E+ S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 427 ALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPS 486
              +G                  E+ +  + D ++    +     E+  +  LC   LP+
Sbjct: 241 QPYYGMA---------------HEEVIYYVRDGNILACPENCP-LELYNLMRLCWSKLPA 284

Query: 487 LRPKMSEVVRMLE 499
            RP    + R+L+
Sbjct: 285 DRPSFCSIHRILQ 297

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 5e-59
 Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 26/290 (8%)

Query: 232 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
           +  +GKG FG V++G    G  VAVK              + E+    +  H N+L  I 
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 64

Query: 292 FCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC--- 344
                  T T+  LV  Y  +GS+   L     +      ++AL  A GL +LH +    
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 345 --DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV---TTAVRGTVGHIAPEY 399
              P I HRD+K+ NIL+ +     + D GLA   D     +        GT  ++APE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 400 LST------GQSSEKTDVFGFGILLLELISGLR---ALEFGKTANQKGAMLDWVKKIHQE 450
           L         +S ++ D++  G++  E+          E  +         D   +  ++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 451 KKLEMLVDKDLKNNYDRIE-LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              E  +  ++ N +   E L  M ++   C     + R     + + L 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  195 bits (496), Expect = 8e-59
 Identities = 69/288 (23%), Positives = 128/288 (44%), Gaps = 24/288 (8%)

Query: 215 KRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT 273
              ++ + +   ++ + K+ +G G +G VY+G  +     VAVK LK+      E  F  
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62

Query: 274 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL--KAKPSLDWATRKRIAL 331
           E  ++    H NL++L+G C       ++  +M+ G++   L    +  +       +A 
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122

Query: 332 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 391
             +  + YL +      IHRD+ A N L+ E +   V DFGL++L+           +  
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 392 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 451
           +   APE L+  + S K+DV+ FG+LL E+ +   +   G   +Q               
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------- 224

Query: 452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            +  L++KD +        E++ ++   C Q+ PS RP  +E+ +  E
Sbjct: 225 -VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 4e-58
 Identities = 68/301 (22%), Positives = 117/301 (38%), Gaps = 44/301 (14%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS- 279
           +  S    +G G FG V +              VAVK LK    +       +E++++S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK------------------PSL 321
           L  H N++ L+G C      L++  Y   G + + L+ K                   +L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 322 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 381
           D       +   A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 382 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           ++ V    R  V  +APE +     + ++DV+ +GI L EL S   +   G         
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-------- 251

Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG 500
                    + K   ++ +  +         EM  +   C    P  RP   ++V+++E 
Sbjct: 252 -------PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 501 D 501
            
Sbjct: 305 Q 305

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-57
 Identities = 59/302 (19%), Positives = 113/302 (37%), Gaps = 32/302 (10%)

Query: 222 LQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 280
           ++    +F   + +G G  G V+K      G V+A K +          Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
                ++   G   +  E  +   +M  GS+   LK    +      ++++   +GL YL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 400
            E+   KI+HRDVK +NIL++   E  + DFG++  L      +  +  GT  +++PE L
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERL 175

Query: 401 STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 460
                S ++D++  G+ L+E+  G   +        +      V+    E          
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235

Query: 461 LKNNYDRIELEEMVQVALL--------------------------CTQYLPSLRPKMSEV 494
             ++Y       M    LL                          C    P+ R  + ++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

Query: 495 VR 496
           + 
Sbjct: 296 MV 297

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 3e-57
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 41/293 (13%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAV 282
           ++   ++++G+G FG V K  ++        A+KR+K+  +      F  E+E++  L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP----------------SLDWATR 326
           H N++ L+G C       L   Y  +G++   L+                   +L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 327 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 386
              A   ARG+ YL +    + IHRD+ A NIL+ E Y A + DFGL++          T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184

Query: 387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK 446
             R  V  +A E L+    +  +DV+ +G+LL E++S       G T  +        +K
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEK 238

Query: 447 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           + Q  +LE  ++ D          +E+  +   C +  P  RP  ++++  L 
Sbjct: 239 LPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 3e-57
 Identities = 68/273 (24%), Positives = 109/273 (39%), Gaps = 26/273 (9%)

Query: 233 NLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLR 288
             +G G FG V KGY Q       VAVK LK+         +   E  ++    +  ++R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 289 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
           +IG C   +  +LV      G +   L+    +       +    + G+ YL E      
Sbjct: 73  MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 128

Query: 349 IHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           +HRD+ A N+LL   + A + DFGL+K L  D       T  +  V   APE ++  + S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188

Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 466
            K+DV+ FG+L+ E  S  +    G   ++                +  +++K  +    
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERMGCP 232

Query: 467 RIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                EM  +  LC  Y    RP  + V   L 
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 6e-57
 Identities = 72/276 (26%), Positives = 115/276 (41%), Gaps = 30/276 (10%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
                   +GKG FG+V  G    G  VAVK +K+         F  E  +++   H NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 62

Query: 287 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQ 343
           ++L+G  +     L +V  YM+ GS+   L+++    L      + +L     + YL   
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
                +HRD+ A N+L+ E   A V DFGL K      S      +  V   APE L   
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREK 175

Query: 404 QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 463
           + S K+DV+ FGILL E+ S       G+    +  + D V ++ +  K++         
Sbjct: 176 KFSTKSDVWSFGILLWEIYSF------GRVPYPRIPLKDVVPRVEKGYKMDAPDGCP--- 226

Query: 464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                    + +V   C     ++RP   ++   LE
Sbjct: 227 -------PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 8e-57
 Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 49/304 (16%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMIS- 279
            N     ++G G FG V                VAVK LK+           +E++M++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 280 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--------------------- 318
           L  H N++ L+G C  +    L++ Y   G + + L++K                     
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 319 --PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 376
               L +      A   A+G+ +L  +     +HRD+ A N+L+       + DFGLA+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 377 LDHCDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN 435
           +    ++V     R  V  +APE L  G  + K+DV+ +GILL E+ S       G   +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVV 495
                               L+    K +      EE+  +   C  +    RP    + 
Sbjct: 274 A---------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

Query: 496 RMLE 499
             L 
Sbjct: 319 SFLG 322

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-55
 Identities = 64/269 (23%), Positives = 114/269 (42%), Gaps = 27/269 (10%)

Query: 235 VGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGF 292
           +G+G F  VYKG   +    VA   L+D      E Q F+ E EM+    H N++R    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 293 CMTTTER----LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 348
             +T +     +LV   M++G++ + LK    +     +       +GL +LH +  P I
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 135

Query: 349 IHRDVKAANILL-DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 407
           IHRD+K  NI +        +GD GLA L     +    AV GT   +APE     +  E
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE-EKYDE 191

Query: 408 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDR 467
             DV+ FG+ +LE+ +                   + +  +  +    +       ++D+
Sbjct: 192 SVDVYAFGMCMLEMATSEYP---------------YSECQNAAQIYRRVTSGVKPASFDK 236

Query: 468 IELEEMVQVALLCTQYLPSLRPKMSEVVR 496
           + + E+ ++   C +     R  + +++ 
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 9e-54
 Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 28/283 (9%)

Query: 224 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLA 281
           S   ++     +G G +G   K     DG ++  K L  G+    E Q   +EV ++   
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 282 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRL----KAKPSLDWATRKRIALGAAR 335
            H N++R     +  T   L  V  Y   G +AS +    K +  LD     R+      
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 336 GLLYLHEQ--CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 393
            L   H +      ++HRD+K AN+ LD      +GDFGLA++L+H D+    A  GT  
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPY 179

Query: 394 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL 453
           +++PE ++    +EK+D++  G LL EL +               +  +   KI + K  
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCA-------LMPPFTAFSQKELAGKIREGKFR 232

Query: 454 EMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
                  +   Y     +E+ ++           RP + E++ 
Sbjct: 233 R------IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-53
 Identities = 61/278 (21%), Positives = 119/278 (42%), Gaps = 25/278 (8%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 282
                   +G+G FG+V++G           VA+K  K+  +     +F  E   +    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLH 341
           H ++++LIG   T     ++    + G + S L+ +  SLD A+    A   +  L YL 
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
            +   + +HRD+ A N+L+       +GDFGL++ ++    +  +  +  +  +APE ++
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 402 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL 461
             + +  +DV+ FG+ + E++        G    Q     D + +I   ++L M  +   
Sbjct: 183 FRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIENGERLPMPPNCP- 235

Query: 462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                      +  +   C  Y PS RP+ +E+   L 
Sbjct: 236 ---------PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 3e-53
 Identities = 62/318 (19%), Positives = 132/318 (41%), Gaps = 26/318 (8%)

Query: 227 SNFSSKNLVGKGGFGNVYKG-YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVEMISLA 281
           + F    ++G G FG VYKG ++ +G      VA+K L++  +     +   E  +++  
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 282 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
            + ++ RL+G C+T+T +L+         +    + K ++         +  A+G+ YL 
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYL 400
           ++   +++HRD+ A N+L+       + DFGLAKLL   +  +     +  +  +A E +
Sbjct: 129 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 401 STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 460
                + ++DV+ +G+ + EL++       G  A++                +  +++K 
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEKG 229

Query: 461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRA 520
            +     I   ++  + + C       RPK  E++         +           R   
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS-KMARDPQRYLVIQGDERMHL 288

Query: 521 NEFSSSERYSDLTDDSSL 538
              + S  Y  L D+  +
Sbjct: 289 PSPTDSNFYRALMDEEDM 306

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 1e-52
 Identities = 58/272 (21%), Positives = 111/272 (40%), Gaps = 21/272 (7%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           ++     +G+G +G V           VAVK +    A+      + E+ +  +  H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           ++  G       + L   Y S G +  R++    +     +R       G++YLH     
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ- 404
            I HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   + 
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 464
            +E  DV+  GI+L  +++G   L + + ++      DW +K       + +        
Sbjct: 183 HAEPVDVWSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEKKTYLNPWKKID------- 233

Query: 465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
                    + +        PS R  + ++ +
Sbjct: 234 ------SAPLALLHKILVENPSARITIPDIKK 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 9e-52
 Identities = 74/273 (27%), Positives = 113/273 (41%), Gaps = 27/273 (9%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVH 283
            +F     +GKG FGNVY     Q   ++A+K L        G E Q + EVE+ S   H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
            N+LRL G+    T   L+  Y   G+V   L+     D           A  L Y H +
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ PE +   
Sbjct: 126 ---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGR 179

Query: 404 QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 463
              EK D++  G+L  E + G    E    AN        + ++  E      V +  ++
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRV--EFTFPDFVTEGARD 233

Query: 464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
                       +     ++ PS RP + EV+ 
Sbjct: 234 ------------LISRLLKHNPSQRPMLREVLE 254

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 2e-51
 Identities = 62/292 (21%), Positives = 124/292 (42%), Gaps = 36/292 (12%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 280
              +    +G+G FG VY+G        +  T VA+K + +  ++   I+F  E  ++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 281 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----------AKPSLDWATRKRIA 330
               +++RL+G        L++   M+ G + S L+                 +   ++A
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 331 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVR 389
              A G+ YL+     K +HRD+ A N ++ E +   +GDFG+ + +   D         
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 449
             V  ++PE L  G  +  +DV+ FG++L E+ +       G +                
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------------N 241

Query: 450 EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD 501
           E+ L  +++  L +  D    + + ++  +C QY P +RP   E++  ++ +
Sbjct: 242 EQVLRFVMEGGLLDKPDNC-PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (445), Expect = 3e-51
 Identities = 71/277 (25%), Positives = 102/277 (36%), Gaps = 30/277 (10%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAV 282
              FS    +G G FG VY    +++  VVA+K++        E       EV  +    
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 283 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 342
           H N ++  G  +      LV  Y    +       K  L       +  GA +GL YLH 
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 343 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 402
                +IHRDVKA NILL E     +GDFG A ++   +S V     GT   +APE +  
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILA 185

Query: 403 ---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK 459
              GQ   K DV+  GI  +EL      L                  ++    L  +   
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLF----------------NMNAMSALYHIAQN 229

Query: 460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
           +          E        C Q +P  RP    +++
Sbjct: 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 1e-50
 Identities = 75/299 (25%), Positives = 109/299 (36%), Gaps = 40/299 (13%)

Query: 210 CLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAI 265
           CL   K     E             +G G FG V +G           VAVK LK     
Sbjct: 3   CLIGEKDLRLLEK------------LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 50

Query: 266 GGEI--QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASR-LKAKPSLD 322
             E    F  EV  +    HRNL+RL G  +T   + +V      GS+  R  K +    
Sbjct: 51  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL 109

Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
             T  R A+  A G+ YL  +     IHRD+ A N+LL       +GDFGL + L   D 
Sbjct: 110 LGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166

Query: 383 H--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
           H  +    +      APE L T   S  +D + FG+ L E+ +  +    G         
Sbjct: 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------- 219

Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
                     + L  +  +  +        +++  V + C  + P  RP    +   L 
Sbjct: 220 --------GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 5e-49
 Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 43/298 (14%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 280
                   +G+G FG V +              VAVK LK+G          +E++++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 281 AVHR-NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLK----------------AKPSLD 322
             H  N++ L+G C      L ++  +   G++++ L+                 K  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 323 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 382
                  +   A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 383 HV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 441
           +V     R  +  +APE +     + ++DV+ FG+LL E+ S   +   G   ++     
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 244

Query: 442 DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           ++ +++ +  ++                  EM Q  L C    PS RP  SE+V  L 
Sbjct: 245 EFCRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 4e-48
 Identities = 72/299 (24%), Positives = 117/299 (39%), Gaps = 45/299 (15%)

Query: 227 SNFSSKNLVGKGGFGNVYKGYL--------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 278
                   +G+G FG V                T VAVK LK            +E+EM+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 279 S-LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS----------------L 321
             +  H+N++ L+G C       ++  Y S G++   L+A+                  L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 322 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 381
                   A   ARG+ YL      K IHRD+ A N+L+ E     + DFGLA+ + H D
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 382 SHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 440
            +  T   R  V  +APE L     + ++DV+ FG+LL E+ +   +   G    +    
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245

Query: 441 LDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
               K + +  +++                 E+  +   C   +PS RP   ++V  L+
Sbjct: 246 --LFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-47
 Identities = 53/271 (19%), Positives = 106/271 (39%), Gaps = 27/271 (9%)

Query: 233 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 291
             +G G FG VYK    +   + A K +   +    E  +  E+++++   H N+++L+ 
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLD 76

Query: 292 FCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
                    ++  + + G+V + + + +  L  +  + +       L YLH+    KIIH
Sbjct: 77  AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 133

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS----- 405
           RD+KA NIL     +  + DFG++           + + GT   +APE +    S     
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 192

Query: 406 SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY 465
             K DV+  GI L+E+          +  + +   +  + KI + +   +          
Sbjct: 193 DYKADVWSLGITLIEMAE-------IEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS--- 242

Query: 466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
                         C +     R   S++++
Sbjct: 243 -----SNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-46
 Identities = 54/272 (19%), Positives = 104/272 (38%), Gaps = 22/272 (8%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
              ++    +G+G  G VY    +  G  VA++++        E     E+ ++    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           N++  +   +   E  +V  Y++ GS+ + +  +  +D      +     + L +LH   
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN- 135

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
             ++IHRD+K+ NILL       + DFG    +    S  +T V GT   +APE ++   
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 464
              K D++  GI+ +E+I G       +        L  +  I      E+   + L   
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG-EPPYLNENP------LRALYLIATNGTPELQNPEKLS-- 243

Query: 465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
                          C       R    E+++
Sbjct: 244 ------AIFRDFLNRCLDMDVEKRGSAKELLQ 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  159 bits (402), Expect = 2e-44
 Identities = 68/353 (19%), Positives = 124/353 (35%), Gaps = 38/353 (10%)

Query: 189 WRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY- 247
           W+Q + Q +     E + + V    L  +   E             +G G FG V++   
Sbjct: 9   WKQYYPQPV-----EIKHDHV----LDHYDIHEE------------LGTGAFGVVHRVTE 47

Query: 248 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 307
              G   A K +   +    E   + E++ +S+  H  L+ L        E +++Y +MS
Sbjct: 48  RATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106

Query: 308 NGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--DEYY 364
            G +  ++      +             +GL ++HE      +H D+K  NI+       
Sbjct: 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSN 163

Query: 365 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           E  + DFGL   LD   S   T   GT    APE          TD++  G+L   L+SG
Sbjct: 164 ELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221

Query: 425 LRALEFGKTANQKGAMLDWVKKIHQE------KKLEMLVDKDL-KNNYDRIELEEMVQVA 477
           L              +      +         +  +  + K L  +   R+ + + ++  
Sbjct: 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281

Query: 478 LLCTQYLPSLRPKMSEVVRMLEGDGLAEKWAASQKAEATRSRANEFSSSERYS 530
            L     P    ++         D +  K+ A  +      R + +SS  ++ 
Sbjct: 282 WLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHR 334

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 5e-44
 Identities = 56/278 (20%), Positives = 101/278 (36%), Gaps = 29/278 (10%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHR 284
           +F    ++G+G F  V     L      A+K L+  + I          E +++S   H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
             ++L        +      Y  NG +   ++   S D    +         L YLH + 
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTG 403
              IIHRD+K  NILL+E     + DFG AK+L          +  GT  +++PE L+  
Sbjct: 129 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 404 QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 463
            + + +D++  G ++ +L++G                        +     ++  K +K 
Sbjct: 186 SACKSSDLWALGCIIYQLVAG--------------------LPPFRAGNEYLIFQKIIKL 225

Query: 464 NYDRIE--LEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
            YD  E    +   +         + R    E+     
Sbjct: 226 EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  153 bits (388), Expect = 1e-42
 Identities = 57/267 (21%), Positives = 101/267 (37%), Gaps = 24/267 (8%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
            +G G FG V++      G V   K +     +      + E+ +++   H  L+ L   
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDA 94

Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
                E +L+  ++S G +  R+ A+   +  A        A  GL ++HE     I+H 
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHL 151

Query: 352 DVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           D+K  NI+ +    + V   DFGLA  L+     +      T    APE +        T
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 410 DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 469
           D++  G+L   L+SGL                D ++ +   K+ +   D+D  ++     
Sbjct: 210 DMWAIGVLGYVLLSGLSPFA----------GEDDLETLQNVKRCDWEFDEDAFSSVS--- 256

Query: 470 LEEMVQVALLCTQYLPSLRPKMSEVVR 496
             E         Q  P  R  + + + 
Sbjct: 257 -PEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (384), Expect = 2e-42
 Identities = 52/279 (18%), Positives = 100/279 (35%), Gaps = 17/279 (6%)

Query: 219 FKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 277
           +K+ +     +  ++++G G F  V      +   +VA+K +      G E   + E+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
           +    H N++ L     +     L+   +S G +  R+  K         R+       +
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
            YLH+        +        LDE  + ++ DFGL+K+ D     V +   GT G++AP
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGYVAP 178

Query: 398 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
           E L+    S+  D +  G++   L+ G         A              Q  K E   
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL----------FEQILKAEYEF 228

Query: 458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
           D    ++      +          +  P  R    + ++
Sbjct: 229 DSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  149 bits (376), Expect = 1e-41
 Identities = 56/285 (19%), Positives = 104/285 (36%), Gaps = 39/285 (13%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI--------GGEIQFQTEVE-M 277
           N+  K ++G+G    V +          AVK +                      EV+ +
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 278 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 337
             ++ H N+++L     T T   LV+  M  G +   L  K +L     ++I       +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 338 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 397
             LH+     I+HRD+K  NILLD+     + DFG +  LD         V GT  ++AP
Sbjct: 124 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYLAP 178

Query: 398 EYLSTGQS------SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK 451
           E +    +       ++ D++  G+++  L++G     + +                Q  
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-SPPFWHR---------------KQML 222

Query: 452 KLEMLVDKDLKNNYDRIEL--EEMVQVALLCTQYLPSLRPKMSEV 494
            L M++  + +      +   + +  +        P  R    E 
Sbjct: 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  151 bits (382), Expect = 1e-41
 Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 13/204 (6%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAV-- 282
           +FS   ++G+GGFG VY       G + A+K L         GE     E  M+SL    
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 283 -HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 341
               ++ +     T  +   +   M+ G +   L        A  +  A     GL ++H
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124

Query: 342 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 401
            +    +++RD+K ANILLDE+    + D GLA        H +    GT G++APE L 
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQ 178

Query: 402 TGQS-SEKTDVFGFGILLLELISG 424
            G +     D F  G +L +L+ G
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRG 202

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  144 bits (365), Expect = 3e-40
 Identities = 56/276 (20%), Positives = 106/276 (38%), Gaps = 27/276 (9%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLRLI 290
           ++G GG   V+    L+    VAVK L+   A       +F+ E +  +   H  ++ + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 291 GFCMTTTERL----LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
                 T       +V  Y+   ++   +  +  +       +   A + L + H+    
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--- 130

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--TTAVRGTVGHIAPEYLSTGQ 404
            IIHRDVK ANI++       V DFG+A+ +    + V  T AV GT  +++PE      
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 464
              ++DV+  G +L E+++G          +         + + ++        + L   
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPPSARHEGLS-- 242

Query: 465 YDRIELEEMVQVALLCTQYLPSLRPK-MSEVVRMLE 499
                  ++  V L      P  R +  +E+   L 
Sbjct: 243 ------ADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 4e-40
 Identities = 60/294 (20%), Positives = 107/294 (36%), Gaps = 26/294 (8%)

Query: 222 LQSATSNFSSKNLVGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMI 278
           L  A   +     +G+G +G V+K       G  VA+KR++      G  +    EV ++
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 279 SLAV---HRNLLRLIGFCMTTTERLLVYPYMSNGSVAS------RLKAKPSLDWATRKRI 329
                  H N++RL   C  +         +    V            +P +   T K +
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 330 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 389
                RGL +LH     +++HRD+K  NIL+    +  + DFGLA++     +  +  V 
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VV 176

Query: 390 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML-------- 441
            T+ + APE L     +   D++  G +  E+             +Q G +L        
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236

Query: 442 -DWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV 494
            DW + +   ++            +     E    + L C  + P+ R      
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 6e-40
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 8/201 (3%)

Query: 228 NFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAV-H 283
           +F    ++GKG FG V+   + +     A+K LK    +  +       E  ++SLA  H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             L  +     T      V  Y++ G +   +++    D +     A     GL +LH +
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               I++RD+K  NILLD+     + DFG+ K     D+   T   GT  +IAPE L   
Sbjct: 123 ---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178

Query: 404 QSSEKTDVFGFGILLLELISG 424
           + +   D + FG+LL E++ G
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIG 199

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (364), Expect = 8e-40
 Identities = 50/278 (17%), Positives = 87/278 (31%), Gaps = 29/278 (10%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
            +G G FG++Y G  +  G  VA+K            Q   E ++  +      +  I +
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 293 CMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
           C    +   +V   +                  T   +A      + Y+H +     IHR
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHR 127

Query: 352 DVKAANIL---LDEYYEAVVGDFGLAKLLDHCDSHV------TTAVRGTVGHIAPEYLST 402
           DVK  N L     +     + DFGLAK      +H          + GT  + +      
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187

Query: 403 GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM-LVDKDL 461
            + S + D+   G +L+           G    Q        +K  +  + +M    + L
Sbjct: 188 IEQSRRDDLESLGYVLMYFN-------LGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
              Y      E       C       +P  S + ++  
Sbjct: 241 CKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  144 bits (363), Expect = 9e-40
 Identities = 49/281 (17%), Positives = 105/281 (37%), Gaps = 15/281 (5%)

Query: 228 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNL 286
            +     +G+G +G VYK     G   A+K+++ +    G       E+ ++    H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 287 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 346
           ++L     T    +LV+ ++           +  L+  T K   L    G+ Y H++   
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--- 119

Query: 347 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 406
           +++HRD+K  N+L++   E  + DFGLA+         T  +           + + + S
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYD 466
              D++  G +  E+++G         A+Q   +   +   + +    +        N+ 
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 467 RIEL-----------EEMVQVALLCTQYLPSLRPKMSEVVR 496
             E            E  + +     +  P+ R    + + 
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 8e-39
 Identities = 49/267 (18%), Positives = 93/267 (34%), Gaps = 25/267 (9%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
            +G+G FG V++            K +K       ++  + E+ ++++A HRN+L L   
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHES 69

Query: 293 CMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
             +  E ++++ ++S   +  R+      L+              L +LH      I H 
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHF 126

Query: 352 DVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 409
           D++  NI+      + +   +FG A+ L   D+           + APE       S  T
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVSTAT 184

Query: 410 DVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIE 469
           D++  G L+  L+SG+                     I      E   D++         
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQI----------IENIMNAEYTFDEEAFKEIS--- 231

Query: 470 LEEMVQVALLCTQYLPSLRPKMSEVVR 496
             E +             R   SE ++
Sbjct: 232 -IEAMDFVDRLLVKERKSRMTASEALQ 257

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 9e-39
 Identities = 52/292 (17%), Positives = 110/292 (37%), Gaps = 25/292 (8%)

Query: 226 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 284
              +++ + +G+G +G V   Y   +   VA+K++          +   E++++    H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 285 NLLRLIGFCMTTTERLLVYPYM----SNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 340
           N++ +       T   +   Y+        +   LK +  L             RGL Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125

Query: 341 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 398
           H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 399 YLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV 457
            +   +  ++  D++  G +L E++S           +Q   +L  +    QE    ++ 
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 458 DKDLKNNYDRIEL-------------EEMVQVALLCTQYLPSLRPKMSEVVR 496
            K                         + + +      + P  R ++ + + 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  140 bits (354), Expect = 2e-38
 Identities = 44/279 (15%), Positives = 88/279 (31%), Gaps = 29/279 (10%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-RLIG 291
            +G+G FG +++G  L +   VA+K     +      Q + E     L      +  +  
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 292 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 351
           F       +LV   +                  T    A      +  +HE+    +++R
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYR 125

Query: 352 DVKAANILLDEYYEAVVG-----DFGLAKLLD------HCDSHVTTAVRGTVGHIAPEYL 400
           D+K  N L+              DFG+ K         H        + GT  +++    
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185

Query: 401 STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD 460
              + S + D+   G + +  + G    +  K A          ++I ++K+   L  ++
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN----KQKYERIGEKKQSTPL--RE 239

Query: 461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE 499
           L   +     EE  +             P    +  +  
Sbjct: 240 LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-38
 Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 20/281 (7%)

Query: 233 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLL 287
           + +G+G F  VYK        +VA+K++K G+      G       E++++    H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
            L+      +   LV+ +M              L  +  K   L   +GL YLH+     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 120

Query: 348 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-S 406
           I+HRD+K  N+LLDE     + DFGLAK     +   T  V  T  + APE L   +   
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYG 179

Query: 407 EKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM--LVDKDLKNN 464
              D++  G +L EL+  +  L      +Q   + + +    +E+  +M  L D     +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 465 YDRIELEEMVQVA------LL--CTQYLPSLRPKMSEVVRM 497
           +  I L  +   A      L+     + P  R   ++ ++M
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (355), Expect = 2e-38
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 10/201 (4%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVH 283
            +F     +G G FG V+      +G   A+K LK    +  +       E  M+S+  H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 284 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 343
             ++R+ G      +  ++  Y+  G + S L+          K  A      L YLH +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 344 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
               II+RD+K  NILLD+     + DFG AK +      VT  + GT  +IAPE +ST 
Sbjct: 124 D---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTK 176

Query: 404 QSSEKTDVFGFGILLLELISG 424
             ++  D + FGIL+ E+++G
Sbjct: 177 PYNKSIDWWSFGILIYEMLAG 197

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 3e-38
 Identities = 54/281 (19%), Positives = 102/281 (36%), Gaps = 17/281 (6%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 285
           NF     +G+G +G VYK      G VVA+K+++ D    G       E+ ++    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           +++L+    T  +  LV+ ++           A   +     K       +GL + H   
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
              ++HRD+K  N+L++      + DFGLA+         T  V           L    
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 405 SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN 464
            S   D++  G +  E+++           +Q   +   +    +     +    D K +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 465 YDRIELEEMVQV---------ALL--CTQYLPSLRPKMSEV 494
           + +   ++  +V         +LL     Y P+ R      
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 2e-36
 Identities = 52/273 (19%), Positives = 103/273 (37%), Gaps = 30/273 (10%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
           ++G G  G V + +  +     A+K L+D      E++          +   +++R++  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDV 73

Query: 293 CMTTTER----LLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDP 346
                      L+V   +  G + SR++ +   +        I       + YLH     
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--- 130

Query: 347 KIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
            I HRDVK  N+L           + DFG AK     +S  T     T  ++APE L   
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188

Query: 404 QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 463
           +  +  D++  G+++  L+ G         +N   A+   +K   +  + E    +  + 
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFY----SNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
           +      EE+  +     +  P+ R  ++E + 
Sbjct: 245 S------EEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-36
 Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 31/289 (10%)

Query: 228 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 286
           +++   ++G G FG VY+  L   G +VA+K++        +     E++++    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75

Query: 287 LRLIGFCMTTTER------LLVYPYMSNG---SVASRLKAKPSLDWATRKRIALGAARGL 337
           +RL  F  ++ E+       LV  Y+            +AK +L     K       R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 338 LYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 396
            Y+H      I HRD+K  N+LLD +     + DFG AK L   + +V+  +        
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191

Query: 397 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD-----------WVK 445
                    +   DV+  G +L EL+ G          +Q   ++             + 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEV 494
             + E K   +        +      E + +     +Y P+ R    E 
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 56/274 (20%), Positives = 101/274 (36%), Gaps = 41/274 (14%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISL--AVHRN 285
           L+G GGFG+VY G  + D   VA+K ++     D   +    +   EV ++    +    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 286 LLRLIGFCMTTTERLLVYPYMSNGS-VASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
           ++RL+ +       +L+         +   +  + +L     +         + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 129

Query: 345 DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
              ++HRD+K  NIL+D    E  + DFG   LL      V T   GT  +  PE++   
Sbjct: 130 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYH 184

Query: 404 Q-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK 462
           +       V+  GILL +++ G     F          + + +++  E   + L+     
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRGQVFFRQRVSSE--CQHLIRW--- 237

Query: 463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
                            C    PS RP   E+  
Sbjct: 238 -----------------CLALRPSDRPTFEEIQN 254

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (326), Expect = 2e-34
 Identities = 48/278 (17%), Positives = 94/278 (33%), Gaps = 17/278 (6%)

Query: 233 NLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLI 290
             +G+G +G V+K    +   +VA+KR++ D +  G       E+ ++    H+N++RL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 291 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 350
               +  +  LV+ +               LD    K       + L  L       ++H
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL---FQLLKGLGFCHSRNVLH 124

Query: 351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 410
           RD+K  N+L++   E  + +FGLA+         +  V                 S   D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184

Query: 411 VFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIEL 470
           ++  G +  EL +  R L  G   + +   +  +     E++   +        Y     
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244

Query: 471 ------------EEMVQVALLCTQYLPSLRPKMSEVVR 496
                            +     +  P  R    E ++
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 5e-34
 Identities = 48/200 (24%), Positives = 76/200 (38%), Gaps = 7/200 (3%)

Query: 228 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHR 284
           +F    L+GKG FG V        G   A+K L+    I  +      TE  ++    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 285 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 344
            L  L     T      V  Y + G +   L  +        +      A  +  L    
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG---AEIVSALEYLH 122

Query: 345 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 404
              +++RD+K  N++LD+     + DFGL K     D        GT  ++APE L    
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 405 SSEKTDVFGFGILLLELISG 424
                D +G G+++ E++ G
Sbjct: 182 YGRAVDWWGLGVVMYEMMCG 201

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 6e-34
 Identities = 56/273 (20%), Positives = 96/273 (35%), Gaps = 29/273 (10%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI-----QFQTEVEMISLAVHRNLL 287
            +G G F  V K      G   A K +K                + EV ++    H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 288 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 347
            L       T+ +L+   ++ G +   L  K SL              G+ YLH      
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 133

Query: 348 IIHRDVKAANILLDEY----YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 403
           I H D+K  NI+L +         + DFGLA  +D    +    + GT   +APE ++  
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEFVAPEIVNYE 191

Query: 404 QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN 463
               + D++  G++   L+SG  +   G T  +    L  V  ++ E + E   +     
Sbjct: 192 PLGLEADMWSIGVITYILLSG-ASPFLGDTKQE---TLANVSAVNYEFEDEYFSNTS--- 244

Query: 464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR 496
                                P  R  + + ++
Sbjct: 245 -------ALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 2e-33
 Identities = 61/303 (20%), Positives = 112/303 (36%), Gaps = 33/303 (10%)

Query: 217 FHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQ 270
           F+ +E+        +       VG G +G V      + G  VA+K+L +   +     +
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 271 FQTEVEMISLAVHRNLLRLIGFCMT------TTERLLVYPYMSNGSVASRLKAKPSLDWA 324
              E+ ++    H N++ L+            T+  LV P+M  G+   +L     L   
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGED 121

Query: 325 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 384
             + +     +GL Y+H      IIHRD+K  N+ ++E  E  + DFGLA+     DS +
Sbjct: 122 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM 175

Query: 385 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 444
           T  V           L+  + ++  D++  G ++ E+I+G    +     +Q   ++   
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235

Query: 445 KKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALL-------------CTQYLPSLRPKM 491
                E    +  D+         ELE+    ++L                     R   
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295

Query: 492 SEV 494
            E 
Sbjct: 296 GEA 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 4e-33
 Identities = 62/300 (20%), Positives = 112/300 (37%), Gaps = 39/300 (13%)

Query: 227 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHR 284
           S +     +G+G FG V+K    + G  VA+K++   N   G  I    E++++ L  H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 285 NLLRLIGFCMTTTER--------LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
           N++ LI  C T             LV+ +  +               +  KR+      G
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS---HVTTAVRGTVG 393
           L   +     KI+HRD+KAAN+L+       + DFGLA+      +   +  T    T+ 
Sbjct: 130 L---YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 394 HIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKK 452
           +  PE L   +      D++G G ++ E+ +    +  G T       L  + ++     
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQH---QLALISQLCGSIT 242

Query: 453 LEMLVDKDLKNNYDRIEL------------------EEMVQVALLCTQYLPSLRPKMSEV 494
            E+  + D    Y+++EL                     + +        P+ R    + 
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (311), Expect = 5e-32
 Identities = 51/232 (21%), Positives = 92/232 (39%), Gaps = 16/232 (6%)

Query: 202 NEQRREEVCLGNLKRFHFKELQSATSNFSSKN------LVGKGGFGNVYKGY-LQDGTVV 254
           +EQ   +  L   K    K+ ++ + N +  +       +G G FG V      + G   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69

Query: 255 AVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVA 312
           A+K L     +  +       E  ++       L++L       +   +V  Y++ G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 313 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 372
           S L+          +  A        YLH      +I+RD+K  N+L+D+     V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186

Query: 373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
            AK          T + GT   +APE + +   ++  D +  G+L+ E+ +G
Sbjct: 187 FAK---RVKGRTWT-LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  120 bits (301), Expect = 9e-31
 Identities = 59/333 (17%), Positives = 116/333 (34%), Gaps = 58/333 (17%)

Query: 196 QIFFDVNEQRREE--------VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY 247
           +++ DVN  R  E        V  GN   +                 +G+G +  V++  
Sbjct: 8   RVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRK------------LGRGKYSEVFEAI 55

Query: 248 -LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERL--LVY 303
            + +   V VK LK       + + + E++ + +L    N++ L         R   LV+
Sbjct: 56  NITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111

Query: 304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-E 362
            +++N       +   +L     +       + L Y H      I+HRDVK  N+++D E
Sbjct: 112 EHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHE 165

Query: 363 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLEL 421
           + +  + D+GLA+       +       +     PE L   Q      D++  G +L  +
Sbjct: 166 HRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223

Query: 422 ISGLRALEFGKTANQKGAML----------DWVKKIHQE--KKLEMLVDKDLKNNYDRIE 469
           I        G     +   +          D++ K + E   +   ++ +  +  ++R  
Sbjct: 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283

Query: 470 LEEMVQVA------LL--CTQYLPSLRPKMSEV 494
             E   +        L    +Y    R    E 
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 1e-29
 Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 20/237 (8%)

Query: 198 FFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTV 253
              V  + R     G+ ++   +       NF    ++G G +G V+          G +
Sbjct: 2   LLTVKHELRTANLTGHAEKVGIE-------NFELLKVLGTGAYGKVFLVRKISGHDTGKL 54

Query: 254 VAVKRLKDGNAIGGEI---QFQTEVEMIS-LAVHRNLLRLIGFCMTTTERLLVYPYMSNG 309
            A+K LK    +         +TE +++  +     L+ L     T T+  L+  Y++ G
Sbjct: 55  YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 114

Query: 310 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 369
            + + L  +          + +     +L L       II+RD+K  NILLD     V+ 
Sbjct: 115 ELFTHLSQRERFTE---HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 171

Query: 370 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS--SEKTDVFGFGILLLELISG 424
           DFGL+K     ++       GT+ ++AP+ +  G S   +  D +  G+L+ EL++G
Sbjct: 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 6e-27
 Identities = 59/303 (19%), Positives = 118/303 (38%), Gaps = 33/303 (10%)

Query: 217 FHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQ 270
           F+ +EL         +    + VG G +G+V   +  + G  VAVK+L +   +I    +
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 271 FQTEVEMISLAVHRNLLRLIGFCMTTT-----ERLLVYPYMSNGSVASRLKAKPSLDWAT 325
              E+ ++    H N++ L+              + +  ++    + + +K +  L    
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122

Query: 326 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 385
            + +     RGL Y+H      IIHRD+K +N+ ++E  E  + DFGLA    H D  +T
Sbjct: 123 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMT 176

Query: 386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVK 445
             V           L+    ++  D++  G ++ EL++G R L  G     +  ++  + 
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLILRLV 235

Query: 446 KIHQEKKLEMLVDKDLKN------NYDRIELEEMVQVA------LL--CTQYLPSLRPKM 491
                + L+ +  +  +N         ++    +   A      LL          R   
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295

Query: 492 SEV 494
           ++ 
Sbjct: 296 AQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 7e-26
 Identities = 45/221 (20%), Positives = 78/221 (35%), Gaps = 22/221 (9%)

Query: 218 HFKELQSATSNFSSKN------LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI- 269
            F  ++   S F+          +G G  G V   Y       VA+K+L           
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 270 QFQTEVEMISLAVHRNLLRLIGFCMTT------TERLLVYPYMSNGSVASRLKAKPSLDW 323
           +   E+ ++    H+N++ L+             +  LV   M                 
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---H 118

Query: 324 ATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 383
                +      G+ +LH      IIHRD+K +NI++       + DFGLA+      S 
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSF 173

Query: 384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 424
           + T    T  + APE +      E  D++  G ++ E++  
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (248), Expect = 1e-23
 Identities = 42/235 (17%), Positives = 81/235 (34%), Gaps = 24/235 (10%)

Query: 234 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 292
            +G G F  V+    + + T VA+K ++           + E++++      +  +    
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 293 CMTTTERLLVY----------------PYMSNGSVASRLKAKPSLDWATRKRIALGAARG 336
                 +LL +                    N     +      +     K+I+     G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 337 LLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDHCDSHVTTA-VRGTVGH 394
           L Y+H +C   IIH D+K  N+L++       +    +A L + C           T  +
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 395 IAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ 449
            +PE L         D++    L+ ELI+G   L      +      D + +I +
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIE 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.0 bits (225), Expect = 9e-22
 Identities = 23/160 (14%), Positives = 48/160 (30%), Gaps = 24/160 (15%)

Query: 233 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA---------IGGEIQFQTEVEMISLAVH 283
            L+G+G    V+  Y +      VK  K G+            G++ F       +    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 284 RNLLRLIGFCMTTT----ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 339
           R L +L G  +          ++   +    +                 +       +  
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAK 118

Query: 340 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 379
            + +    I+H D+   N+L+ E     + DF  +  +  
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGE 154

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 72.7 bits (177), Expect = 2e-14
 Identities = 21/76 (27%), Positives = 40/76 (52%), Gaps = 6/76 (7%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  NNIS   P  +  L+KL  L  +NN  +    S++++L  + +L   +N ++   P 
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP- 368

Query: 90  SLSNMSQLAFLDLSYN 105
            L+N++++  L L+  
Sbjct: 369 -LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 66.6 bits (161), Expect = 2e-12
 Identities = 21/67 (31%), Positives = 31/67 (46%), Gaps = 4/67 (5%)

Query: 46  LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 105
           L  L  L L  N  +   P  VS L  LQ L   NN ++     SL+N++ + +L   +N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361

Query: 106 NLSGPVP 112
            +S   P
Sbjct: 362 QISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 1e-06
 Identities = 12/84 (14%), Positives = 32/84 (38%), Gaps = 6/84 (7%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 88
           + Q+  I+         L++ +   L     T  +  + + L+ +  L+ +   +     
Sbjct: 6   ITQDTPINQIFTDTA--LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI-- 59

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVP 112
             +  ++ L  ++ S N L+   P
Sbjct: 60  DGVEYLNNLTQINFSNNQLTDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.9 bits (110), Expect = 4e-06
 Identities = 27/120 (22%), Positives = 43/120 (35%), Gaps = 27/120 (22%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP- 88
           L  N +       +  L+ L  LDL+NN  +   P  +S L  L  L+L  N ++   P 
Sbjct: 226 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 281

Query: 89  -------------------PSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSL 126
                                +SN+  L +L L +NN+S   P       +      N +
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKV 341

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 8e-06
 Identities = 21/75 (28%), Positives = 35/75 (46%), Gaps = 4/75 (5%)

Query: 38  HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQL 97
              + + KL+ L +L  +NN  +   P  +     L  L LN N L      +L++++ L
Sbjct: 188 SDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNL 243

Query: 98  AFLDLSYNNLSGPVP 112
             LDL+ N +S   P
Sbjct: 244 TDLDLANNQISNLAP 258

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 71.3 bits (173), Expect = 4e-14
 Identities = 20/65 (30%), Positives = 32/65 (49%), Gaps = 2/65 (3%)

Query: 29  LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL-NNNSLTGAI 87
            L+NN I G +P  + +L  L +L++S N   G IP    +L+        NN  L G+ 
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308

Query: 88  PPSLS 92
            P+ +
Sbjct: 309 LPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 63.6 bits (153), Expect = 1e-11
 Identities = 16/55 (29%), Positives = 25/55 (45%), Gaps = 4/55 (7%)

Query: 78  LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNSLIC 128
           L NN + G +P  L+ +  L  L++S+NNL G +P               N  +C
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 39.7 bits (91), Expect = 5e-04
 Identities = 21/66 (31%), Positives = 40/66 (60%), Gaps = 3/66 (4%)

Query: 44  GKLSKLLTLDLSNNFFTG--PIPSTVSHLETLQYLRL-NNNSLTGAIPPSLSNMSQLAFL 100
            +  ++  LDLS        PIPS++++L  L +L +   N+L G IPP+++ ++QL +L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 101 DLSYNN 106
            +++ N
Sbjct: 107 YITHTN 112

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 39.3 bits (90), Expect = 8e-04
 Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 9/120 (7%)

Query: 16  VICSDGVFFSFGRL----LQNNNISG--HIPTEIGKLSKLLTLDLSNN-FFTGPIPSTVS 68
           V+C         R+    L   N+     IP+ +  L  L  L +       GPIP  ++
Sbjct: 41  VLCDTDT--QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 69  HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC 128
            L  L YL + + +++GAIP  LS +  L  LD SYN LSG +P   +   N+ G +   
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 38.6 bits (88), Expect = 0.001
 Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 3/111 (2%)

Query: 53  DLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA--IPPSLSNMSQLAFLDLSYN-NLSG 109
           D  N  + G +  T +    +  L L+  +L     IP SL+N+  L FL +    NL G
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91

Query: 110 PVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMP 160
           P+P   AK   +    +     +       + +     L+ S N+    +P
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 60.4 bits (145), Expect = 1e-10
 Identities = 27/123 (21%), Positives = 42/123 (34%), Gaps = 3/123 (2%)

Query: 38  HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQL 97
            +P ++        LDL NN  T        +L+ L  L L NN ++   P + + + +L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 98  AFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPS 157
             L LS N L   +P    KT           T   +  F      +   L  +P     
Sbjct: 82  ERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140

Query: 158 GMP 160
              
Sbjct: 141 IEN 143

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 57.4 bits (137), Expect = 1e-09
 Identities = 32/170 (18%), Positives = 58/170 (34%), Gaps = 3/170 (1%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           LQNN I+     +   L  L TL L NN  +   P   + L  L+ L L+ N L      
Sbjct: 38  LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK 97

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT-GNSLICATGAEEDCFGTAPMPLSFAL 148
               + +L   +     +   V +   +   +  G + + ++G E   F          +
Sbjct: 98  MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 157

Query: 149 -NNSPNSKPSGMPKG-QKIALALGSSLGCISLLILGFGFLLWWRQRHNQQ 196
            + +  + P G+P    ++ L         +  + G   L       N  
Sbjct: 158 ADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 46.2 bits (108), Expect = 5e-06
 Identities = 25/98 (25%), Positives = 41/98 (41%), Gaps = 2/98 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N I+      +  L+ L  L LS N  +     ++++   L+ L LNNN L   +P 
Sbjct: 178 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPG 236

Query: 90  SLSNMSQLAFLDLSYNNLSG-PVPSFHAKTFNITGNSL 126
            L++   +  + L  NN+S      F    +N    S 
Sbjct: 237 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 274

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 46.2 bits (108), Expect = 6e-06
 Identities = 21/85 (24%), Positives = 34/85 (40%), Gaps = 3/85 (3%)

Query: 31  QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 90
                SG        + KL  + +++   T  IP       +L  L L+ N +T     S
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAAS 190

Query: 91  LSNMSQLAFLDLSYNNLSGPVPSFH 115
           L  ++ LA L LS+N++S       
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSL 215

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 42.7 bits (99), Expect = 7e-05
 Identities = 24/101 (23%), Positives = 40/101 (39%), Gaps = 7/101 (6%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           + + NI+  IP  +     L  L L  N  T    +++  L  L  L L+ NS++     
Sbjct: 157 IADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 213

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 126
           SL+N   L  L L+ N L             +   +  N++
Sbjct: 214 SLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 254

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 25/137 (18%), Positives = 42/137 (30%), Gaps = 29/137 (21%)

Query: 19  SDGVFFSFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 74
            DG F +   L    L NN IS   P     L KL  L LS N            L+ L+
Sbjct: 47  KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELR 106

Query: 75  YLRLNNNSL-----------------------TGAIPPSLSNMSQLAFLDLSYNNLSGPV 111
                   +                       +G    +   M +L+++ ++  N++   
Sbjct: 107 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 166

Query: 112 PSF--HAKTFNITGNSL 126
                     ++ GN +
Sbjct: 167 QGLPPSLTELHLDGNKI 183

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.8 bits (132), Expect = 7e-09
 Identities = 16/83 (19%), Positives = 29/83 (34%), Gaps = 5/83 (6%)

Query: 49  LLTLDLSNNFFT-GPIPSTVSHLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLS 103
           + +LD+     +       +  L+  Q +RL++  LT      I  +L     LA L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 104 YNNLSGPVPSFHAKTFNITGNSL 126
            N L         +        +
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (120), Expect = 2e-07
 Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 9/77 (11%)

Query: 47  SKLLTLDLSNNFFTG----PIPSTVSHLETLQYLRLNNNSLTGAIPPSLS-----NMSQL 97
           S L  L L++   +      + +T+    +L+ L L+NN L  A    L          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 98  AFLDLSYNNLSGPVPSF 114
             L L     S  +   
Sbjct: 429 EQLVLYDIYWSEEMEDR 445

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 3e-07
 Identities = 15/85 (17%), Positives = 26/85 (30%), Gaps = 5/85 (5%)

Query: 30  LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTG----PIPSTVSHLETLQYLRLNNNSLT 84
           +Q   +S     E+   L +   + L +   T      I S +     L  L L +N L 
Sbjct: 9   IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68

Query: 85  GAIPPSLSNMSQLAFLDLSYNNLSG 109
                 +    Q     +   +L  
Sbjct: 69  DVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 9e-06
 Identities = 13/76 (17%), Positives = 25/76 (32%), Gaps = 9/76 (11%)

Query: 30  LQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS-----HLETLQYLRLNN 80
           L + ++S      +   +     L  LDLSNN         +          L+ L L +
Sbjct: 376 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 435

Query: 81  NSLTGAIPPSLSNMSQ 96
              +  +   L  + +
Sbjct: 436 IYWSEEMEDRLQALEK 451

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.3 bits (122), Expect = 1e-08
 Identities = 24/102 (23%), Positives = 40/102 (39%), Gaps = 24/102 (23%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS---------------------TVS 68
           L + +++  +   + +L  +  LDLS+N      P+                      V+
Sbjct: 5   LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62

Query: 69  HLETLQYLRLNNNSLTG-AIPPSLSNMSQLAFLDLSYNNLSG 109
           +L  LQ L L NN L   A    L +  +L  L+L  N+L  
Sbjct: 63  NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.7 bits (92), Expect = 1e-04
 Identities = 16/84 (19%), Positives = 27/84 (32%), Gaps = 2/84 (2%)

Query: 74  QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAE 133
           + L L +  LT  +   L  +  +  LDLS+N L    P+  A        +   A    
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58

Query: 134 EDCFGTAPMPLSFALNNSPNSKPS 157
           +       +      NN      +
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAA 82

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.8 bits (87), Expect = 5e-04
 Identities = 18/79 (22%), Positives = 33/79 (41%), Gaps = 6/79 (7%)

Query: 51  TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN---L 107
            L L++   T  +   +  L  + +L L++N L   +PP+L+ +  L  L  S N    +
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58

Query: 108 SGPVPSFHAKTFNITGNSL 126
            G       +   +  N L
Sbjct: 59  DGVANLPRLQELLLCNNRL 77

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.1 bits (128), Expect = 2e-08
 Identities = 21/80 (26%), Positives = 29/80 (36%), Gaps = 8/80 (10%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
              N  S  I +       L  L++SNN     +P+    LE    L  + N L   +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPE 321

Query: 90  SLSNMSQLAFLDLSYNNLSG 109
              N   L  L + YN L  
Sbjct: 322 LPQN---LKQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.8 bits (91), Expect = 6e-04
 Identities = 12/60 (20%), Positives = 22/60 (36%), Gaps = 12/60 (20%)

Query: 25  SFGRL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 80
              RL       N+++  +P     L     L +  N      P      E+++ LR+N+
Sbjct: 302 LPPRLERLIASFNHLA-EVPELPQNLK---QLHVEYNPLRE-FPD---IPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.3 bits (87), Expect = 0.002
 Identities = 16/69 (23%), Positives = 28/69 (40%), Gaps = 5/69 (7%)

Query: 47  SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN 106
            +   L+L+N   +  +P    HL   + L  + NSLT  +P    ++  L   + +   
Sbjct: 38  RQAHELELNNLGLSS-LPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 107 LSGPVPSFH 115
           LS   P   
Sbjct: 93  LSDLPPLLE 101

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.1 bits (123), Expect = 5e-08
 Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 4/78 (5%)

Query: 32  NNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL 91
            NN+S      +  L  L  L L++N +     +       LQ  R +++ +  ++P  L
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL 268

Query: 92  SNMSQLAFLDLSYNNLSG 109
           +         L+ N+L G
Sbjct: 269 AGRD---LKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.4 bits (103), Expect = 2e-05
 Identities = 23/105 (21%), Positives = 36/105 (34%), Gaps = 4/105 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L  N IS         L  L  L L  N      P     L  L  L L  N+L+     
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219

Query: 90  SLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNSLICAT 130
           +L+ +  L +L L+ N       +       + F  + + + C+ 
Sbjct: 220 ALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (99), Expect = 5e-05
 Identities = 22/98 (22%), Positives = 32/98 (32%)

Query: 31  QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 90
            N  +    P     L +L TL L         P     L  LQYL L +N+L      +
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148

Query: 91  LSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC 128
             ++  L  L L  N +S           ++    L  
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 6e-08
 Identities = 17/105 (16%), Positives = 38/105 (36%), Gaps = 12/105 (11%)

Query: 30  LQNNNISGHIPTEIGK------LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 83
           L +  I+  +PT I +       ++ +  +L     T  +  T + L ++  +  NN+ +
Sbjct: 3   LGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDI 58

Query: 84  TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC 128
                  +  +  +  L L+ N L+   P  + K           
Sbjct: 59  KSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENK 101

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.3 bits (116), Expect = 4e-07
 Identities = 13/65 (20%), Positives = 26/65 (40%), Gaps = 3/65 (4%)

Query: 42  EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLD 101
           E+ K++  L ++      T  +P  +   +    L L+ N L      +L   ++L  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 102 LSYNN 106
           L    
Sbjct: 62  LDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.9 bits (102), Expect = 2e-05
 Identities = 14/53 (26%), Positives = 19/53 (35%), Gaps = 1/53 (1%)

Query: 31  QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 83
            NNN++      +  L  L TL L  N     IP        L +  L+ N  
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.4 bits (85), Expect = 0.003
 Identities = 14/57 (24%), Positives = 22/57 (38%), Gaps = 3/57 (5%)

Query: 66  TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT 122
            VS + +   +  +  +LT A+PP L        L LS N L     +       +T
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLT 58

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.6 bits (109), Expect = 2e-06
 Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 4/61 (6%)

Query: 43  IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDL 102
           +  LSKL TL   +N  +   P  ++ L  L  + L NN ++   P  L+N S L  + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 103 S 103
           +
Sbjct: 225 T 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 1e-05
 Identities = 13/49 (26%), Positives = 22/49 (44%), Gaps = 4/49 (8%)

Query: 32  NNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 80
           +N IS   P  +  L  L+ + L NN  +   P  +++   L  + L N
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 3e-05
 Identities = 13/77 (16%), Positives = 28/77 (36%), Gaps = 6/77 (7%)

Query: 31  QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 90
           Q   I+   P     L+  + +    +  T  +  T + L+ +  L      +T      
Sbjct: 5   QPTAINVIFPDP--ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EG 58

Query: 91  LSNMSQLAFLDLSYNNL 107
           +  ++ L  L+L  N +
Sbjct: 59  VQYLNNLIGLELKDNQI 75

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 7e-06
 Identities = 16/73 (21%), Positives = 29/73 (39%), Gaps = 2/73 (2%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLNNNSLTGAIP 88
              + +   +  E     ++  +DLSN+      +   +S    LQ L L    L+  I 
Sbjct: 30  CPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIV 88

Query: 89  PSLSNMSQLAFLD 101
            +L+  S L  L+
Sbjct: 89  NTLAKNSNLVRLN 101

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (94), Expect = 3e-04
 Identities = 9/73 (12%), Positives = 25/73 (34%), Gaps = 3/73 (4%)

Query: 51  TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG- 109
           TLDL+       +   +     +   R   + +   +    S   ++  +DLS + +   
Sbjct: 4   TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVS 61

Query: 110 PVPSFHAKTFNIT 122
            +    ++   + 
Sbjct: 62  TLHGILSQCSKLQ 74

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 6e-04
 Identities = 15/66 (22%), Positives = 28/66 (42%), Gaps = 3/66 (4%)

Query: 28  RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAI 87
            L +  +I      E+G++  L TL +      G +       E L +L++N +  T   
Sbjct: 206 SLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCSHFTTIA 262

Query: 88  PPSLSN 93
            P++ N
Sbjct: 263 RPTIGN 268

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 1e-05
 Identities = 11/60 (18%), Positives = 22/60 (36%), Gaps = 4/60 (6%)

Query: 31  QNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
            +NN    +P ++    S  + LD+S           + +L+ L+     N      +P 
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.001
 Identities = 8/54 (14%), Positives = 13/54 (24%), Gaps = 2/54 (3%)

Query: 55  SNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 108
            NN                  L ++   +       L N+ +L        NL 
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 4e-05
 Identities = 11/79 (13%), Positives = 30/79 (37%), Gaps = 6/79 (7%)

Query: 31  QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 90
           Q+  I+         L++ +   L     T  +  + + L+ +  L+ +   +       
Sbjct: 4   QDTPINQIFTDT--ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DG 57

Query: 91  LSNMSQLAFLDLSYNNLSG 109
           +  ++ L  ++ S N L+ 
Sbjct: 58  VEYLNNLTQINFSNNQLTD 76

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.2 bits (92), Expect = 2e-04
 Identities = 17/100 (17%), Positives = 30/100 (30%), Gaps = 26/100 (26%)

Query: 31  QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY--------------- 75
             N I          L +L TL+L +N  +  +P +  HL +L                 
Sbjct: 86  GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145

Query: 76  --------LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 107
                     LN  +     P  + ++      DL ++  
Sbjct: 146 WFAEWLRKKSLNGGAARCGAPSKVRDVQ---IKDLPHSEF 182

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 2e-04
 Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 2/90 (2%)

Query: 26  FGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG--PIPSTVSHLETLQYLRLNNNSL 83
              L + ++++  +      + +LL+L+LSNN       + S V     L+ L L+ N L
Sbjct: 44  DVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNEL 103

Query: 84  TGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 113
                       +L  L L  N+LS     
Sbjct: 104 KSERELDKIKGLKLEELWLDGNSLSDTFRD 133

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 3e-04
 Identities = 18/104 (17%), Positives = 33/104 (31%), Gaps = 6/104 (5%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIP 88
              +         +     L  L + N      +       L  L+ L +  + L    P
Sbjct: 15  CTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73

Query: 89  PSLSNMSQLAFLDLSYNNLSGPVP----SFHAKTFNITGNSLIC 128
            +     +L+ L+LS+N L             +   ++GN L C
Sbjct: 74  DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (89), Expect = 5e-04
 Identities = 13/128 (10%), Positives = 34/128 (26%), Gaps = 3/128 (2%)

Query: 46  LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 105
             +   LDL        I +  + L+    +  ++N +          + +L  L ++ N
Sbjct: 17  AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 73

Query: 106 NLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKI 165
            +            ++T   L   +  E           S        +  +     +  
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133

Query: 166 ALALGSSL 173
            +     +
Sbjct: 134 VIYKVPQV 141

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.002
 Identities = 18/79 (22%), Positives = 28/79 (35%), Gaps = 3/79 (3%)

Query: 30  LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 89
           L+   I   I      L +   +D S+N            L  L+ L +NNN +      
Sbjct: 25  LRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRICRIGEG 81

Query: 90  SLSNMSQLAFLDLSYNNLS 108
               +  L  L L+ N+L 
Sbjct: 82  LDQALPDLTELILTNNSLV 100

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.1 bits (82), Expect = 0.004
 Identities = 10/58 (17%), Positives = 20/58 (34%), Gaps = 7/58 (12%)

Query: 50  LTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 107
           LT +L          +  ++    + L L    +   I    + + Q   +D S N +
Sbjct: 3   LTAELIEQ------AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.9 bits (91), Expect = 7e-04
 Identities = 8/65 (12%), Positives = 25/65 (38%), Gaps = 4/65 (6%)

Query: 47  SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDL 102
            K L LD         + + +   ++++ + L+ N++       +  ++++   L   + 
Sbjct: 7   GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 103 SYNNL 107
           S    
Sbjct: 67  SDIFT 71

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 12/93 (12%), Positives = 29/93 (31%), Gaps = 9/93 (9%)

Query: 24  FSF-GRLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQ 74
           FS  G+ L+ + I+      +   + +   +  + LS N         +   ++  + L+
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 75  YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 107
               ++             +  L    L    L
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.002
 Identities = 14/45 (31%), Positives = 18/45 (40%), Gaps = 5/45 (11%)

Query: 69  HLETLQYLRLNNNSLTGAIPPSL-----SNMSQLAFLDLSYNNLS 108
               LQ LRL  N +      +L       M  L FL+L+ N  S
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	549
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.57
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.4
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.38
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.37
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.33
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.33
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.32
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.27
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.21
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.13
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.13
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.1
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.09
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.97
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.92
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.74
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.59
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.57
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.53
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.51
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.5
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.5
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.49
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.45
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.45
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.42
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.35
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.35
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.13
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.97
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.93
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.93
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.85
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.81
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.79
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.37
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.14
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.05
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.03
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.01
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.82
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.66
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.58
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.52
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	95.88
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	94.89
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	91.15
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	88.37

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=413.18  Aligned_cols=253  Identities=27%  Similarity=0.420  Sum_probs=200.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      ++|+..+.||+|+||+||+|.+.+++.||||+++...  ...++|.+|++++++++|||||+++|+|...+..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            4678889999999999999999988999999997543  34567999999999999999999999999999999999999


Q ss_pred             CCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      ++|+|.+++.. ...+++..+..++.|||.||.|||++   +|+||||||+|||+++++.+||+|||+++..........
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence            99999998864 45689999999999999999999999   999999999999999999999999999987765444444


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....||+.|+|||++.+..++.++|||||||++|||+|+..|+.....      .......+....          ....
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~~~----------~~~~  223 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGF----------RLYK  223 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHHTC----------CCCC
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHHhcC----------CCCC
Confidence            456799999999999999999999999999999999996555442221      111122221111          1112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +...++++.+++.+||+.||++|||++||+++|++
T Consensus       224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            22334678999999999999999999999999986

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=413.56  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=205.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||++.........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            46889999999999999999975 69999999997655444445689999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-ce
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  384 (549)
                      +++|+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+|+....... ..
T Consensus        85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            99999999999888899999999999999999999999   999999999999999999999999999987653322 22


Q ss_pred             eeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          385 TTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ....+||+.|+|||++.+..+ +.++|||||||++|||+||+.||.........     + .........         .
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~-~~~~~~~~~---------~  226 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----Y-SDWKEKKTY---------L  226 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----H-HHHHTTCTT---------S
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-----H-HHHhcCCCC---------C
Confidence            345679999999999988876 57899999999999999999999753322110     0 011110000         0


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ......+.++.+++.+||+.||++|||++|+++
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            011122367889999999999999999999865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=413.45  Aligned_cols=253  Identities=29%  Similarity=0.441  Sum_probs=209.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .++|++.+.||+|+||+||+|.+++++.||||+++...  ...+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            45788889999999999999999988999999997543  345679999999999999999999998754 567999999


Q ss_pred             cCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++|+|.+++...  ..+++..+..|+.||+.||.|||++   +|+||||||+|||+++++.+||+|||+++........
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            9999999987643  3699999999999999999999999   9999999999999999999999999999987654444


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......||+.|+|||.+.++.++.++|||||||++|||+||..|+......      .+....+....          ..
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~~i~~~~----------~~  229 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERGY----------RM  229 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTC----------CC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcC----------CC
Confidence            445567999999999999999999999999999999999976665432211      11111211111          11


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..+...+.++.+++.+||+.||++|||++||++.|++
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            1122334678999999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-53  Score=416.90  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=215.1

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||+++...  ...++|.+|+++++.++|||||+++|++.+.+..++||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            3467888999999999999999986 58899999997543  34567999999999999999999999999999999999


Q ss_pred             eccCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          304 PYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       304 e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      ||+++|+|.+++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+++......
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            99999999999864  45789999999999999999999999   99999999999999999999999999999876555


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                      ........||+.|+|||++.+..++.++|||||||++|||+||..|+.......   .+..   ..          ....
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~---~~~~---~i----------~~~~  233 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE---LL----------EKDY  233 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH---HH----------HTTC
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---HHHH---HH----------hcCC
Confidence            555555668999999999999999999999999999999999877765332211   1111   11          1111


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      ....+...++.+.+++.+||+.||++|||++||++.|+..
T Consensus       234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2222333457799999999999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=402.31  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=214.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      ++|+..+.||+|+||+||+|++++++.||||+++...  ....+|.+|+.++++++||||++++|+|.+++..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            5889999999999999999999988899999998654  23567999999999999999999999999999999999999


Q ss_pred             CCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          307 SNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       307 ~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      ++|+|.+++. ....+++..+.+++.||++||.|||++   +|+||||||+|||+++++.+||+|||+++..........
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence            9999999865 445789999999999999999999999   999999999999999999999999999987765544444


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNN  464 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  464 (549)
                      ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......       +....+...          ....
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-------~~~~~i~~~----------~~~~  221 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQG----------LRLY  221 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTT----------CCCC
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-------HHHHHHHhC----------CCCC
Confidence            55679999999999999999999999999999999998 78888643211       111222111          1111


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          465 YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       465 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .+...++.+.+++.+||+.||++|||++|++++|.+
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            222334679999999999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6e-53  Score=415.04  Aligned_cols=254  Identities=28%  Similarity=0.402  Sum_probs=198.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC-C---CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD-G---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|++.+.||+|+||+||+|.++. +   ..||||.+.........+.|.+|+.++++++|||||+++|++...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            345667899999999999999753 3   368999987655444456799999999999999999999999999999999


Q ss_pred             eeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++|+|.+++.. ...++|.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            999999999998875 45799999999999999999999999   99999999999999999999999999998775433


Q ss_pred             Cce----eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          382 SHV----TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       382 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      ...    .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.....       .+....+....     
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-------~~~~~~i~~~~-----  250 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-------QDVINAIEQDY-----  250 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTC-----
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC-----
Confidence            221    123457899999999999999999999999999999998 8999864321       11122222111     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                           ....+...+..+.+++.+||+.||++|||+.||++.|+.
T Consensus       251 -----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         251 -----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                 111223345779999999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=406.42  Aligned_cols=257  Identities=27%  Similarity=0.413  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||+||+|+++  ..||||+++.... ....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467899999999999999999875  3599999975532 3345579999999999999999999998764 56899999


Q ss_pred             ccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-
Q 008893          305 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-  382 (549)
Q Consensus       305 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  382 (549)
                      |+++|+|.+++.. ...+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++....... 
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999964 45699999999999999999999999   999999999999999999999999999987654332 


Q ss_pred             ceeeccccccCccCchhhcc---CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          383 HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||.......   .+...+   ....     ..+
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~~---~~~~-----~~p  229 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMV---GRGY-----LSP  229 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHH---HHTS-----CCC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHHH---hcCC-----CCC
Confidence            23345679999999999864   358999999999999999999999997432211   111111   1110     011


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .+ ...+...++.+.+++.+||+.||++|||++||+++|+.
T Consensus       230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~  269 (276)
T d1uwha_         230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL  269 (276)
T ss_dssp             CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            10 11122234679999999999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=405.15  Aligned_cols=246  Identities=28%  Similarity=0.411  Sum_probs=208.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||+||+|..+ +|+.||+|++....  .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999999999986 68999999986432  2234567899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus        86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred             eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence            9999999999998877899999999999999999999999   9999999999999999999999999999866532   


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....       ...........           .
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~-----------~  221 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVE-----------F  221 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTC-----------C
T ss_pred             cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC-----------C
Confidence            23445799999999999999999999999999999999999999964321       11111111110           1


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      .++...++++.+++.+||+.||++|||++|+++
T Consensus       222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            122223467899999999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=400.43  Aligned_cols=249  Identities=19%  Similarity=0.283  Sum_probs=207.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|+..+.||+|+||+||+|... +|+.||||+++.... ...+.+.+|+.+++.++|||||++++++...+..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            46999999999999999999964 699999999975543 3456799999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +++|+|.+++... .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus        99 ~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~  173 (293)
T d1yhwa1          99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  173 (293)
T ss_dssp             CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred             cCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence            9999999988754 599999999999999999999999   999999999999999999999999999987754332 33


Q ss_pred             eccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          386 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ....||+.|+|||++.+..++.++|||||||++|||+||+.||......       +...........    .    ...
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~~~----~----~~~  238 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTP----E----LQN  238 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSC----C----CSS
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCCC----C----CCC
Confidence            4557999999999999999999999999999999999999999643211       111111111110    0    011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      +...+..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2223467899999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=403.22  Aligned_cols=253  Identities=25%  Similarity=0.358  Sum_probs=194.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-cHHHHHHHHHHHhhccCCCccceEEEEec--CCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  302 (549)
                      ++|++.+.||+|+||+||+|..+ +|+.||||.+....... ....+.+|++++++++|||||++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57899999999999999999975 68999999997654322 23468999999999999999999999865  3567899


Q ss_pred             eeccCCCchhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          303 YPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQC--DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       303 ~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      |||+++|+|.+++.    ....+++..++.++.||+.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999885    3567999999999999999999999871  12499999999999999999999999999998


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      +..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....       .+....+.. ....  
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~-~~~~--  232 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIRE-GKFR--  232 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHH-TCCC--
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------HHHHHHHHc-CCCC--
Confidence            754322 23456799999999999999999999999999999999999999964321       111111111 1111  


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                             ..+...++++.+++.+||+.||++|||+.|++++
T Consensus       233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                   1122234678999999999999999999999863

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-52  Score=404.20  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=206.9

Q ss_pred             cCCCCCCe-eeeeCCeEEEEEEEC---CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNL-VGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~-iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||+++........+.|.+|++++++++|||||+++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            34555564 999999999999864   3557999999866544445679999999999999999999999865 568999


Q ss_pred             eeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+++|+|.+++.. +..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            999999999998764 45799999999999999999999999   99999999999999999999999999999876543


Q ss_pred             Cc--eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          382 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       382 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ..  ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......    .+   ...+....       
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----~~---~~~i~~~~-------  229 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EV---MAFIEQGK-------  229 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HH---HHHHHTTC-------
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH----HH---HHHHHcCC-------
Confidence            32  2234468999999999999999999999999999999998 89999743211    11   11121111       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         ....+...+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus       230 ---~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         230 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               112223344778999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-52  Score=403.91  Aligned_cols=255  Identities=26%  Similarity=0.425  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCC-----CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      +.|+..++||+|+||+||+|.+++.     ..||||+++.........+|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4677889999999999999997642     37999999765544445579999999999999999999999999999999


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ||||+.+|++.+.+.. ...++|..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            9999999999988764 45799999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCc--eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          381 DSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       381 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||+||..|+......      .+....+..         
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~---------  228 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAIND---------  228 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHT---------
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH------HHHHHHHhc---------
Confidence            222  223456899999999999999999999999999999999977776533211      111111111         


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       ......+...+..+.+++.+||+.||++|||+.||++.|+.
T Consensus       229 -~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         229 -GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             -TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence             11122233345779999999999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=415.78  Aligned_cols=266  Identities=21%  Similarity=0.262  Sum_probs=208.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .++|++.+.||+|+||+||+|... +|+.||+|+++..........+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            468999999999999999999975 6899999999866544555679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      |+++|+|.+++.+...+++..+..++.|++.||.|||+ +   +|+||||||+|||+++++.+||+|||+|+.....   
T Consensus        85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  158 (322)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence            99999999999877789999999999999999999997 5   8999999999999999999999999999866422   


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccccccc--------HHHH------HH----
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA--------MLDW------VK----  445 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~--------~~~~------~~----  445 (549)
                      ......||+.|+|||++.+..++.++||||+||++|||+||+.||...........        ....      ..    
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            22345799999999999999999999999999999999999999975432211000        0000      00    


Q ss_pred             HH----hhccchhhh----ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          446 KI----HQEKKLEML----VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       446 ~~----~~~~~~~~~----~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..    .......+.    .............+.++.+++.+||+.||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            00    000000000    00000000001123578899999999999999999999873

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=411.27  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=206.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC-C-----CEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD-G-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  298 (549)
                      .++|++.+.||+|+||+||+|++.. +     ..||+|.+...........+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4678899999999999999999643 2     369999997655445556789999999988 89999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCc
Q 008893          299 RLLVYPYMSNGSVASRLKAK-----------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKA  355 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  355 (549)
                      .++||||+++|+|.++++..                       ..+++..++.++.||+.||.|||++   +|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence            99999999999999999643                       2489999999999999999999999   999999999


Q ss_pred             CeeeecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCcc
Q 008893          356 ANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKT  433 (549)
Q Consensus       356 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~  433 (549)
                      +|||++.++.+||+|||+|+........ ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876544332 2345568999999999999999999999999999999998 8999864322


Q ss_pred             ccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 008893          434 ANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLE  499 (549)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  499 (549)
                      ..   .+..    ...         .......+...++++.+++.+||+.||++|||++||+++|.
T Consensus       273 ~~---~~~~----~~~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DA---NFYK----LIQ---------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SH---HHHH----HHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH---HHHH----HHh---------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            11   1111    111         11111223334478999999999999999999999999996

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=401.15  Aligned_cols=247  Identities=27%  Similarity=0.354  Sum_probs=200.4

Q ss_pred             CeeeeeCCeEEEEEEECC---CCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeeccCC
Q 008893          233 NLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN  308 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  308 (549)
                      +.||+|+||+||+|.+++   ++.||||+++..... ...+.|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999998653   468999999754322 224579999999999999999999999865 467899999999


Q ss_pred             CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce--ee
Q 008893          309 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--TT  386 (549)
Q Consensus       309 g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~  386 (549)
                      |+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.........  ..
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            99999999888899999999999999999999999   99999999999999999999999999998776543332  23


Q ss_pred             ccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccccccCCC
Q 008893          387 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNY  465 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  465 (549)
                      ...||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....       .+....+....          ....
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i~~~~----------~~~~  231 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGE----------RMGC  231 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTC----------CCCC
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHHHHHHcCC----------CCCC
Confidence            4568999999999999999999999999999999998 8999874221       11111111111          1122


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          466 DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       466 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +...+.++.+++.+||+.||++|||+++|++.|+.
T Consensus       232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            23344778999999999999999999999998875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=399.79  Aligned_cols=253  Identities=28%  Similarity=0.388  Sum_probs=203.3

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      .++|++.+.||+|+||+||+|.+++++.||||+++...  ...+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            35788999999999999999999988899999997543  345679999999999999999999999854 568999999


Q ss_pred             cCCCchhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++|+|.+++..  ...++|..+..++.||+.||+|||++   +|+||||||+|||+|+++.+||+|||+++........
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            999999988863  34699999999999999999999999   9999999999999999999999999999877544444


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      ......||+.|+|||++..+.++.++|||||||++|||+||..|+......      ......+...          ...
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~~~----------~~~  233 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERG----------YRM  233 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT----------CCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHhc----------CCC
Confidence            445567999999999999999999999999999999999987776543221      1112111111          111


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..+...++++.+++.+||+.||++||++++|+++|+.
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  270 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  270 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence            2233344679999999999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-51  Score=406.01  Aligned_cols=253  Identities=21%  Similarity=0.312  Sum_probs=193.6

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      .+.|++.+.||+|+||+||+|... +|+.||||++...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356889999999999999999976 6899999999765544445578899999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec---CCCceEEeecccccccCCCC
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~  381 (549)
                      |+++|+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||+.   +++.+||+|||+++......
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            999999999998888899999999999999999999999   999999999999994   57899999999998765322


Q ss_pred             CceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDL  461 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  461 (549)
                        ......||+.|+|||++.+..++.++|||||||++|||+||+.||......       .....+....       ...
T Consensus       165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~-------~~~  228 (307)
T d1a06a_         165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLFEQILKAE-------YEF  228 (307)
T ss_dssp             ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHTTC-------CCC
T ss_pred             --eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHhccC-------CCC
Confidence              233456999999999999999999999999999999999999999743211       1111111111       001


Q ss_pred             cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          462 KNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       462 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ........++++.+++.+||+.||++|||++|++++
T Consensus       229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            111122234678999999999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=400.76  Aligned_cols=251  Identities=20%  Similarity=0.264  Sum_probs=204.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      +.|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+++++.++|||||++++++.+.+..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            45788999999999999999975 68999999997643 33445789999999999999999999999999999999999


Q ss_pred             cCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          306 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       306 ~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      +++|+|.+++.. ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~  166 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR  166 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence            999999998764 55799999999999999999999999   99999999999999999999999999997653211 12


Q ss_pred             eeccccccCccCchhhc-----cCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          385 TTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .....||+.|+|||++.     ...++.++|||||||++|||+||+.||.......    .   ......... ..    
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~---~~~i~~~~~-~~----  234 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----V---LLKIAKSEP-PT----  234 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----H---HHHHHHSCC-CC----
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----H---HHHHHcCCC-CC----
Confidence            23456999999999984     4568999999999999999999999997533211    1   111111110 00    


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                         ...+...+.++.+++.+||+.||++|||++|++++
T Consensus       235 ---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         235 ---LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             ---CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ---CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               01112234678999999999999999999999763

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=403.08  Aligned_cols=249  Identities=21%  Similarity=0.285  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||++....  .......+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56899999999999999999975 69999999986432  2234567999999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC-
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  382 (549)
                      ||+++|+|.+++...+.+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.+..... 
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            9999999999998888899999999999999999999999   999999999999999999999999999998754332 


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      .......||+.|+|||++.+..++.++|||||||++|||+||+.||......       .....+....           
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~-----------  226 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------LIFQKIIKLE-----------  226 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTC-----------
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-------HHHHHHHcCC-----------
Confidence            2334457999999999999999999999999999999999999999743211       1111111110           


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                      ..++...++++.+++.+||+.||++|||++|++.
T Consensus       227 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            0112223467899999999999999999999754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=391.36  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=197.7

Q ss_pred             CCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEec----CCceeeEe
Q 008893          230 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTERLLVY  303 (549)
Q Consensus       230 ~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  303 (549)
                      +..+.||+|+||+||+|... +++.||+|.+...... .....+.+|++++++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            44567999999999999976 5889999998754422 234468999999999999999999999864    34578999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec-CCCceEEeecccccccCCCCC
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      ||+++|+|.+++.....+++..+..++.||+.||+|||++ .++|+||||||+|||++ +++.+||+|||+++.....  
T Consensus        92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--  168 (270)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred             eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence            9999999999998878899999999999999999999998 12299999999999997 5789999999999865432  


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......||+.|+|||++.+ .++.++|||||||++|||+||+.||......      ......+.....     ...+.
T Consensus       169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~-----~~~~~  235 (270)
T d1t4ha_         169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVK-----PASFD  235 (270)
T ss_dssp             -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCC-----CGGGG
T ss_pred             -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCC-----CcccC
Confidence             2345679999999999865 6999999999999999999999999643211      111112211111     01111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..    .++++.+++.+||+.||++|||++|+++|
T Consensus       236 ~~----~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         236 KV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cc----CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            11    23568899999999999999999999863

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.8e-51  Score=401.92  Aligned_cols=247  Identities=28%  Similarity=0.362  Sum_probs=203.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      +.|+..+.||+|+||+||+|+.. +|+.||||+++.......  ...+.+|+.+++.++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            34888899999999999999975 688999999976543222  346889999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|..++.....+++..+..++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+++.....   
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence            9999999988777777899999999999999999999999   9999999999999999999999999999865432   


Q ss_pred             eeeccccccCccCchhhcc---CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccc
Q 008893          384 VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKD  460 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  460 (549)
                        ....||+.|+|||++.+   +.|+.++|||||||++|||++|+.||.....       .+..........      +.
T Consensus       169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~~~~~------~~  233 (309)
T d1u5ra_         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNES------PA  233 (309)
T ss_dssp             --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCC------CC
T ss_pred             --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCC------CC
Confidence              33469999999999864   4589999999999999999999999964321       111111111110      11


Q ss_pred             ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          461 LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       461 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +.   +...++.+.+++.+||+.||++|||++|+++|
T Consensus       234 ~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         234 LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             CS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            11   11223678999999999999999999999863

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=391.77  Aligned_cols=254  Identities=23%  Similarity=0.364  Sum_probs=197.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC----CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      .++|++.+.||+|+||+||+|.+..    +..||||.++..........|.+|+.++++++||||++++|++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3578889999999999999998753    35789999876554444567999999999999999999999986 467899


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999998754 45799999999999999999999999   9999999999999999999999999999887655


Q ss_pred             CCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                      .........||+.|+|||.+.+..++.++|||||||++|||+| |..||......    .+..   .+.....       
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----~~~~---~i~~~~~-------  227 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIG---RIENGER-------  227 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHH---HHHTTCC-------
T ss_pred             cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH----HHHH---HHHcCCC-------
Confidence            4444555678999999999999999999999999999999998 88888643321    1111   1111111       


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         ...+...++.+.+++.+||+.||++|||+.||+++|+.
T Consensus       228 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         228 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               11222334779999999999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-50  Score=399.78  Aligned_cols=261  Identities=25%  Similarity=0.381  Sum_probs=211.4

Q ss_pred             HHHHHhcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEe
Q 008893          221 ELQSATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM  294 (549)
Q Consensus       221 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  294 (549)
                      +++...++|++.+.||+|+||+||+|+++      +++.||||+++.........+|.+|+.+++.++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999864      357899999986554444567999999999999999999999999


Q ss_pred             cCCceeeEeeccCCCchhhhhccC------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEe
Q 008893          295 TTTERLLVYPYMSNGSVASRLKAK------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIH  350 (549)
Q Consensus       295 ~~~~~~lv~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  350 (549)
                      .....+++|||+++|+|.+++...                        ..+++..+..|+.|++.||+|||++   +|+|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence            999999999999999999988532                        2489999999999999999999999   9999


Q ss_pred             cccCcCeeeecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCc-cc
Q 008893          351 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR-AL  428 (549)
Q Consensus       351 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~-p~  428 (549)
                      |||||+|||+|.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|.. ||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            999999999999999999999999876433222 3344568899999999999999999999999999999999964 55


Q ss_pred             ccCccccccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          429 EFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      .....       .+....+... ..         ...+...+.++.+++.+||+.+|++||||.||+++|+..
T Consensus       244 ~~~~~-------~e~~~~v~~~-~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         244 YGMAH-------EEVIYYVRDG-NI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTSCH-------HHHHHHHHTT-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCH-------HHHHHHHHcC-CC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            43211       1111222111 11         112223346789999999999999999999999999863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=388.37  Aligned_cols=250  Identities=20%  Similarity=0.261  Sum_probs=206.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-----CCcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-----IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|++.+.||+|+||+||+|..+ +|+.||||+++....     ....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57899999999999999999975 699999999865422     223567999999999999999999999999999999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC----ceEEeecccccc
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAKL  376 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~~~~  376 (549)
                      +||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++    .+|++|||+++.
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence            9999999999999998877899999999999999999999999   999999999999998776    599999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc-chhh
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK-KLEM  455 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  455 (549)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||+||+.||......       +....+.... ... 
T Consensus       167 ~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~~~~-  236 (293)
T d1jksa_         167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNYEFE-  236 (293)
T ss_dssp             CTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTCCCCC-
T ss_pred             cCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------HHHHHHHhcCCCCC-
Confidence            75432  334456999999999999999999999999999999999999999743211       1111111110 000 


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       456 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                         .....    ..+..+.+++.+||+.||++|||++|+++
T Consensus       237 ---~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         237 ---DEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ---HHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---chhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00001    12367889999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.9e-50  Score=401.34  Aligned_cols=251  Identities=20%  Similarity=0.266  Sum_probs=207.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            57999999999999999999975 689999999975442 3345689999999999999999999999999999999999


Q ss_pred             cCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec--CCCceEEeecccccccCCCCC
Q 008893          306 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       306 ~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      +++|+|.+++. ....+++..+..++.||+.||.|||++   +|+||||||+|||++  .++.+||+|||+++.+.... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            99999999985 455799999999999999999999999   999999999999996  46889999999998776432 


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....       .+....+.....   ..+... 
T Consensus       181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~---~~~~~~-  248 (350)
T d1koaa2         181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDW---NMDDSA-  248 (350)
T ss_dssp             -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC---CSCCGG-
T ss_pred             -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC---CCCccc-
Confidence             33445799999999999999999999999999999999999999964321       111222211110   001111 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                         ....++++.+++.+||+.||++|||++|++++
T Consensus       249 ---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         249 ---FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ---GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ---ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               11223678999999999999999999999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=395.80  Aligned_cols=253  Identities=22%  Similarity=0.392  Sum_probs=201.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCC----EEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL  301 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  301 (549)
                      ++|++.+.||+|+||+||+|.+. +|+    .||+|.++........+.|.+|+.++++++|||||+++|+|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46889999999999999999975 344    68999987665555677899999999999999999999999864 5678


Q ss_pred             EeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          302 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       302 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ++||+.+|+|.+.+.. ...+++..+..++.|||.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            8899999999888764 55799999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcc
Q 008893          381 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVD  458 (549)
Q Consensus       381 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  458 (549)
                      ... ......||+.|+|||.+.++.++.++|||||||++|||+| |..||......    .+...+.   ..        
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~~~~~i~---~~--------  229 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILE---KG--------  229 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----GHHHHHH---HT--------
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----HHHHHHH---cC--------
Confidence            333 2334568999999999999999999999999999999999 77787643211    1221111   11        


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          459 KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       459 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                        .....+...+..+.+++.+||+.||++|||+.||+++|+.
T Consensus       230 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         230 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             --CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence              1112233344779999999999999999999999998875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-49  Score=394.48  Aligned_cols=246  Identities=26%  Similarity=0.339  Sum_probs=208.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||+++...  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46889999999999999999975 69999999996432  2234567899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|..++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence            9999999999999888899999999999999999999999   9999999999999999999999999999876532   


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                       ....+||+.|+|||++.+..++.++|||||||++|||+||+.||.....       ......+....           .
T Consensus       158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~-----------~  218 (316)
T d1fota_         158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAE-----------L  218 (316)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCC-----------C
T ss_pred             -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HHHHHHHHcCC-----------C
Confidence             2345799999999999999999999999999999999999999974321       11111111110           1


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  497 (549)
                      .++...+.++.+++.+|++.||.+||     |++|+++|
T Consensus       219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            11222346789999999999999996     88998864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.8e-49  Score=398.22  Aligned_cols=251  Identities=21%  Similarity=0.278  Sum_probs=207.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||+++.... .....+.+|+.++++++|||||++++++.+.+..++||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999975 699999999976542 2345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec--CCCceEEeecccccccCCCCC
Q 008893          306 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       306 ~~~g~L~~~l~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      +++|+|.+.+... ..+++..+..|+.||+.||.|||++   +|+||||||+|||++  .++.+||+|||+++.+.... 
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            9999999887654 4699999999999999999999999   999999999999998  67899999999999876432 


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......||+.|+|||++.+..++.++|||||||++|||+||+.||......       ..........       ....
T Consensus       184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~-------~~~~  248 (352)
T d1koba_         184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCD-------WEFD  248 (352)
T ss_dssp             -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCC-------CCCC
T ss_pred             -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC-------CCCC
Confidence             334456999999999999999999999999999999999999999743221       1111111111       0011


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .......+.++.+++.+||+.||++|||++|++++
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11112234678999999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-50  Score=383.95  Aligned_cols=246  Identities=28%  Similarity=0.392  Sum_probs=196.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC-CceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-TERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  305 (549)
                      ++|+..+.||+|+||.||+|.++ |+.||||+++...   ..+.|.+|++++++++||||++++|+|.+. +..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            45778899999999999999985 7889999997543   345799999999999999999999999654 568999999


Q ss_pred             cCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          306 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       306 ~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      +++|+|.+++...  ..++|..+++++.||+.||.|||+.   +|+||||||+|||++.++.+|++|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            9999999999643  3589999999999999999999999   9999999999999999999999999999865432   


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       .....+|..|+|||++.++.++.++|||||||++|||+| |+.|+......    .+..++   ...          ..
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----~~~~~i---~~~----------~~  218 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRV---EKG----------YK  218 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHHH---TTT----------CC
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----HHHHHH---HcC----------CC
Confidence             223458899999999999999999999999999999999 67666532211    222222   111          11


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...+...++++.+++.+||+.||++|||+.|++++|+.
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            22233334678999999999999999999999999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-50  Score=394.94  Aligned_cols=260  Identities=26%  Similarity=0.358  Sum_probs=198.0

Q ss_pred             HHHHhcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEe
Q 008893          222 LQSATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM  294 (549)
Q Consensus       222 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  294 (549)
                      ++...++|++.+.||+|+||+||+|.+.      +++.||||+++..........+..|...+.++ +|+||+.+++++.
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            3334567999999999999999999863      24689999998655444455678888887776 6899999999987


Q ss_pred             cCC-ceeeEeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCe
Q 008893          295 TTT-ERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN  357 (549)
Q Consensus       295 ~~~-~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  357 (549)
                      ..+ ..++||||+++|+|.++++..                ..+++..+..++.||+.||.|||++   +|+||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence            654 689999999999999998632                2489999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCc-ccccCcccc
Q 008893          358 ILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR-ALEFGKTAN  435 (549)
Q Consensus       358 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~-p~~~~~~~~  435 (549)
                      ||+++++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||.. ||.......
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999876543332 3344579999999999999999999999999999999999754 564322111


Q ss_pred             ccccHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          436 QKGAMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                         .+.   .......          ....+...++++.+++.+||+.||++|||++||+++|++
T Consensus       245 ---~~~---~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         245 ---EFC---RRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             ---HHH---HHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHH---HHHhcCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               111   1111111          111222234678999999999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=394.55  Aligned_cols=249  Identities=23%  Similarity=0.255  Sum_probs=209.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||+++...  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57899999999999999999975 69999999997432  2334567899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+++|+|.+++.....+++..++.++.||+.||+|||++   +|+||||||+|||++++|.+||+|||+|+...... .
T Consensus        85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~  160 (337)
T d1o6la_          85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A  160 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred             eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC-c
Confidence            9999999999999888899999999999999999999999   99999999999999999999999999998765322 2


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                      .....+||+.|+|||++.+..++.++||||+||++|||+||+.||......       ......... .          .
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~~~~i~~~-~----------~  222 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILME-E----------I  222 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC-C----------C
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-------HHHHHHhcC-C----------C
Confidence            334567999999999999999999999999999999999999999753321       111111111 0          1


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM  497 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  497 (549)
                      .++...+.++.+++.+||++||++||+     ++|+++|
T Consensus       223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            122233467899999999999999995     7777754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=391.43  Aligned_cols=252  Identities=26%  Similarity=0.385  Sum_probs=201.7

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC-CC--EEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD-GT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|++.+.||+|+||+||+|.+++ |.  .||||+++........+.|.+|+++++++ +|||||+++|+|...+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            578888999999999999999763 44  57888886554444455799999999998 799999999999999999999


Q ss_pred             eeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCce
Q 008893          303 YPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA  366 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  366 (549)
                      |||+++|+|.++++..                ..+++..+..++.|||.||.|||+.   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999998643                5799999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcc-cccCccccccccHHHHHH
Q 008893          367 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA-LEFGKTANQKGAMLDWVK  445 (549)
Q Consensus       367 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p-~~~~~~~~~~~~~~~~~~  445 (549)
                      ||+|||+++......  ......||..|+|||.+.++.++.++|||||||++|||++|..| |....       ..+...
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE  237 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHH
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHHH
Confidence            999999998654221  22334589999999999999999999999999999999998654 53221       111112


Q ss_pred             HHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          446 KIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       446 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .+...          .....+...++++.+++.+||+.||++||||+||+++|+.
T Consensus       238 ~i~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         238 KLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             HGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhc----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            22111          1112223344789999999999999999999999999876

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.3e-49  Score=380.23  Aligned_cols=252  Identities=22%  Similarity=0.263  Sum_probs=205.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc--------HHHHHHHHHHHhhcc-CCCccceEEEEecC
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--------EIQFQTEVEMISLAV-HRNLLRLIGFCMTT  296 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--------~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  296 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++.......        ...+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57899999999999999999974 689999999975432211        125889999999997 99999999999999


Q ss_pred             CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          297 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      +..++||||+++|+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence            99999999999999999998888899999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhcc------CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE  450 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (549)
                      .....  ......||+.|+|||.+.+      ..++.++||||+||++|||+||+.||......       .....+...
T Consensus       160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~i~~~  230 (277)
T d1phka_         160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMSG  230 (277)
T ss_dssp             CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHT
T ss_pred             ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHHHHhC
Confidence            75432  2344579999999999863      34688999999999999999999999743211       111111111


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          451 KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       451 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      . ..      .........++++.+++.+||+.||++|||++||+++
T Consensus       231 ~-~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         231 N-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             C-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             C-CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1 00      0011111234679999999999999999999999753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-49  Score=389.44  Aligned_cols=257  Identities=26%  Similarity=0.377  Sum_probs=210.8

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecCCc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  298 (549)
                      .++|++.+.||+|+||.||+|++.      +++.||||+++..........|.+|+.+++.+ +|||||+++|+|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            467888999999999999999852      46789999998765444555799999999998 69999999999999999


Q ss_pred             eeeEeeccCCCchhhhhccC------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee
Q 008893          299 RLLVYPYMSNGSVASRLKAK------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL  360 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  360 (549)
                      .++||||+++|+|.++++..                  ..+++..+..++.||+.||.|||++   +++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence            99999999999999998633                  2589999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCcccccccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGA  439 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~  439 (549)
                      +.++.+|++|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+|++.|+........  .
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--~  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--H
Confidence            99999999999999987654433 33456799999999999999999999999999999999996555543222111  1


Q ss_pred             HHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          440 MLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      +...+.             .......+...+..+.+|+.+||+.||++|||++||+++|+.
T Consensus       257 ~~~~i~-------------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         257 FYKMIK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             HHHHHH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHh-------------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            111111             111122222334779999999999999999999999999985

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=385.31  Aligned_cols=250  Identities=30%  Similarity=0.453  Sum_probs=201.5

Q ss_pred             CCeeeeeCCeEEEEEEECCC----CEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEec-CCceeeEeecc
Q 008893          232 KNLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTERLLVYPYM  306 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  306 (549)
                      .++||+|+||+||+|.+.++    ..||||+++.........+|.+|++++++++||||++++|++.. +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997532    36899999765444445679999999999999999999999875 45789999999


Q ss_pred             CCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc--
Q 008893          307 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--  383 (549)
Q Consensus       307 ~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  383 (549)
                      ++|+|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999998874 44678899999999999999999999   9999999999999999999999999999876543322  


Q ss_pred             -eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          384 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       384 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......      .++..........         
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~------~~~~~~i~~g~~~---------  253 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRRL---------  253 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCC---------
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH------HHHHHHHHcCCCC---------
Confidence             223356899999999999999999999999999999999988887643211      1111222111111         


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                       ..+...++.+.+++.+||+.||++||+|.||+++|+.
T Consensus       254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~  290 (311)
T d1r0pa_         254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  290 (311)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             1122234678999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=382.87  Aligned_cols=254  Identities=29%  Similarity=0.372  Sum_probs=195.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECC--C--CEEEEEEcccCCCC--CcHHHHHHHHHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQD--G--TVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|++.+.||+|+||+||+|.+..  +  ..||||+++.....  ...+.|.+|+.++++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            568888999999999999998642  3  37899998754322  223579999999999999999999999965 4678


Q ss_pred             eEeeccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          301 LVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      +||||+++|++.+.+.. ...+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999999988763 44699999999999999999999999   999999999999999999999999999998755


Q ss_pred             CCCce--eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          380 CDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       380 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      .....  .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||.....       .+.........     
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------~~~~~~i~~~~-----  231 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEG-----  231 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSC-----
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-------HHHHHHHHhCC-----
Confidence            43322  233458889999999999999999999999999999998 8999863221       11122222211     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                          .....+...+..+.+++.+||+.||++|||+.||.+.|++
T Consensus       232 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         232 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                1111222334679999999999999999999999998875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.4e-48  Score=376.25  Aligned_cols=257  Identities=21%  Similarity=0.263  Sum_probs=201.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc--HHHHHHHHHHHhhccCCCccceEEEEecCC----ce
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTT----ER  299 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~  299 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||+++.......  ...+.+|+++++.++||||+++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            57899999999999999999974 699999999976543322  346899999999999999999999987654    37


Q ss_pred             eeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCC
Q 008893          300 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH  379 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  379 (549)
                      ++||||+++++|.+++...+.+++.++..++.||+.||+|||++   +|+||||||+|||++.++..+++|||.+.....
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcc
Confidence            89999999999999998888899999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCC--ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc
Q 008893          380 CDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV  457 (549)
Q Consensus       380 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (549)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||+||+.||......       +............   
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~~~~---  233 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIP---  233 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCC---
T ss_pred             ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcCCCC---
Confidence            322  2334557999999999999999999999999999999999999999743211       1111111111110   


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhc
Q 008893          458 DKDLKNNYDRIELEEMVQVALLCTQYLPSLRP-KMSEVVRMLEG  500 (549)
Q Consensus       458 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~  500 (549)
                      .......    .++.+.+++.+||++||++|| |++++++.|..
T Consensus       234 ~~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 PSARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             GGGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CchhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            0011112    236789999999999999999 89999887754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-49  Score=386.27  Aligned_cols=255  Identities=28%  Similarity=0.396  Sum_probs=203.4

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEECC--------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEecC
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT  296 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  296 (549)
                      .++|++.+.||+|+||.||+|+...        +..||||+++..........+.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3578889999999999999998532        3479999998765444456788899988888 799999999999999


Q ss_pred             CceeeEeeccCCCchhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeee
Q 008893          297 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL  360 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  360 (549)
                      +..++||||+++|+|.+++...                ..+++..++.++.||+.||.|||+.   +|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence            9999999999999999999643                3589999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCCc-eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHh-CCcccccCccccccc
Q 008893          361 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKTANQKG  438 (549)
Q Consensus       361 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  438 (549)
                      +.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+| |..||......    
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----  244 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  244 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence            99999999999999876543322 3344568999999999999999999999999999999998 67777532211    


Q ss_pred             cHHHHHHHHhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          439 AMLDWVKKIHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      .+..   .+...          .....+...++++.+++.+||+.||++|||+.||++.|+.
T Consensus       245 ~~~~---~i~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         245 ELFK---LLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             HHHH---HHHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHH---HHHcC----------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            1111   11111          1111222334679999999999999999999999999975

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-48  Score=387.92  Aligned_cols=245  Identities=21%  Similarity=0.255  Sum_probs=206.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEe
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  303 (549)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++....  .......+.+|+.+++.++||||+++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47899999999999999999975 69999999986432  2234557899999999999999999999999999999999


Q ss_pred             eccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          304 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       304 e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      ||+.+|+|.+.+.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus       121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence            9999999999998877899999999999999999999999   9999999999999999999999999999877532   


Q ss_pred             eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccccccC
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLKN  463 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  463 (549)
                       .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....       ......+....       .    
T Consensus       195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~-------~----  255 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGK-------V----  255 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-------C----
T ss_pred             -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHHHHHhcCC-------C----
Confidence             2345699999999999999999999999999999999999999964321       11111111111       0    


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 008893          464 NYDRIELEEMVQVALLCTQYLPSLRP-----KMSEVVR  496 (549)
Q Consensus       464 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  496 (549)
                      ..+...+.++.+++.+||+.||++|+     |++|+++
T Consensus       256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            11222346789999999999999994     8888876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-48  Score=383.40  Aligned_cols=257  Identities=23%  Similarity=0.381  Sum_probs=209.6

Q ss_pred             HhcCCCCCCeeeeeCCeEEEEEEEC------CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCc
Q 008893          225 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE  298 (549)
Q Consensus       225 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  298 (549)
                      ..++|++.+.||+|+||+||+|.+.      +++.||||+++..........|.+|+.++++++||||++++|++...+.
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            3467888999999999999999863      2578999999865544444569999999999999999999999999999


Q ss_pred             eeeEeeccCCCchhhhhcc----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEE
Q 008893          299 RLLVYPYMSNGSVASRLKA----------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV  368 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  368 (549)
                      .++||||+++|+|.+++..          ...+++..+.+++.|+|+||.|||++   +|+||||||+|||+++++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEE
Confidence            9999999999999998852          13579999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCCce-eeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCC-cccccCccccccccHHHHHHH
Q 008893          369 GDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL-RALEFGKTANQKGAMLDWVKK  446 (549)
Q Consensus       369 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~-~p~~~~~~~~~~~~~~~~~~~  446 (549)
                      +|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||+ .||....       ...+...
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-------~~~~~~~  247 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRF  247 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHHHHHH
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-------HHHHHHH
Confidence            9999998765433222 23345899999999999999999999999999999999986 5554211       1222222


Q ss_pred             HhhccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 008893          447 IHQEKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEGD  501 (549)
Q Consensus       447 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  501 (549)
                      +.....          ...+...+..+.+++.+||+.+|++|||++||+++|+..
T Consensus       248 i~~~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         248 VMEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHhCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            222111          111222346799999999999999999999999999873

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=382.01  Aligned_cols=258  Identities=24%  Similarity=0.276  Sum_probs=197.7

Q ss_pred             CCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCc----HHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeecc
Q 008893          232 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG----EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM  306 (549)
Q Consensus       232 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  306 (549)
                      .++||+|+||+||+|... +|+.||||+++.......    ...+.+|+.+++.++|||||++++++...+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999975 699999999975432211    235889999999999999999999999999999999999


Q ss_pred             CCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCceee
Q 008893          307 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT  386 (549)
Q Consensus       307 ~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  386 (549)
                      .++++.........+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~  158 (299)
T d1ua2a_          83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT  158 (299)
T ss_dssp             SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred             cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence            9998888887777899999999999999999999999   999999999999999999999999999987654332 223


Q ss_pred             ccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhc------cc
Q 008893          387 AVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLV------DK  459 (549)
Q Consensus       387 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------d~  459 (549)
                      ...||+.|+|||.+... .++.++|||||||++|||+||+.||......+.    ...+.............      ..
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~----l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ----LTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH----HHHHHHhcCCCChhhccchhccchh
Confidence            45699999999998754 579999999999999999999999875432211    11111110000000000      00


Q ss_pred             c-c--cCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          460 D-L--KNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       460 ~-l--~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      . .  ....+     ....+++.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            0 0  00011     1123678999999999999999999999863

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=386.86  Aligned_cols=248  Identities=24%  Similarity=0.326  Sum_probs=204.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHHHHHHh-hccCCCccceEEEEecCCceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS-LAVHRNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  302 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...  .......+..|..++. .++||||+++++++.+.+..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999976 69999999996432  1233445666776665 68999999999999999999999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      |||+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            99999999999998888899999999999999999999999   999999999999999999999999999986654322


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                       ......||+.|+|||++.+..++.++|||||||++|||+||+.||......       .........       .+   
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~-------~~---  220 (320)
T d1xjda_         159 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMD-------NP---  220 (320)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC-------CC---
T ss_pred             -cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC-------CC---
Confidence             334457999999999999999999999999999999999999999743221       111111111       11   


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMS-EVVR  496 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~  496 (549)
                       .++...+.++.+++.+||+.||++||++. |+++
T Consensus       221 -~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 -FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence             12222346789999999999999999996 6654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.8e-48  Score=389.21  Aligned_cols=250  Identities=24%  Similarity=0.277  Sum_probs=200.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCC--CCCcHHHHHHH---HHHHhhccCCCccceEEEEecCCcee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTE---VEMISLAVHRNLLRLIGFCMTTTERL  300 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~  300 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....  .......+.+|   +.+++.++|||||++++++...+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57889999999999999999976 69999999985321  11222334444   66677778999999999999999999


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      +||||+++|+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhccc
Q 008893          381 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDK  459 (549)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  459 (549)
                         ......||+.|+|||++.. ..++.++|||||||++|||+||+.||........    ........ .      ...
T Consensus       161 ---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~~~~~~-~------~~~  226 (364)
T d1omwa3         161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTL-T------MAV  226 (364)
T ss_dssp             ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH----HHHHHHSS-S------CCC
T ss_pred             ---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcc-c------CCC
Confidence               2334569999999999975 4689999999999999999999999975432211    11111100 0      001


Q ss_pred             cccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 008893          460 DLKNNYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVRM  497 (549)
Q Consensus       460 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  497 (549)
                          ..+...++++.+++.+||+.||++|||     ++|+++|
T Consensus       227 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         227 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                111223467899999999999999999     5777753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=379.36  Aligned_cols=250  Identities=19%  Similarity=0.244  Sum_probs=205.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||+++...  .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            57899999999999999999976 68899999997643  2344688999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC--CCceEEeecccccccCCCCC
Q 008893          306 MSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKLLDHCDS  382 (549)
Q Consensus       306 ~~~g~L~~~l~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~  382 (549)
                      +++|+|.+++.... .+++.++..++.||+.||.|||++   +|+||||||+|||++.  ...+||+|||+++.....  
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            99999999998654 799999999999999999999999   9999999999999984  458999999999876533  


Q ss_pred             ceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhhcccccc
Q 008893          383 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEMLVDKDLK  462 (549)
Q Consensus       383 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  462 (549)
                      .......+|+.|+|||.+.+..++.++|||||||++|+|+||+.||......       +....+.....   .++....
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------~~~~~i~~~~~---~~~~~~~  227 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEY---TFDEEAF  227 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC---CCCHHHH
T ss_pred             CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC---CCChhhc
Confidence            2334456999999999999999999999999999999999999999743221       11222211110   0001111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          463 NNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       463 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ..    .+.++.+++.+|++.||++|||++|+++|
T Consensus       228 ~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         228 KE----ISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11    23568999999999999999999999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-48  Score=379.76  Aligned_cols=266  Identities=23%  Similarity=0.323  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC----ceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----ERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv  302 (549)
                      ++|...+.||+|+||+||+|++ +|+.||||+++....  ....++.|+..+..++||||++++|++...+    ..++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            4567778999999999999997 488999999864321  1122344555566789999999999998654    57899


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCceEecccCcCeeeecCCCceEEeeccccccc
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ-----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      |||+++|+|.++++.. .++|..+..++.|+|.||.|||+.     ..++|+||||||+||||++++.+||+|||+++..
T Consensus        80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            9999999999999865 599999999999999999999973     1349999999999999999999999999999877


Q ss_pred             CCCCCc---eeeccccccCccCchhhccCC------CCCcccchhHhHHHHHHHhCCcccccCcccccc-------ccHH
Q 008893          378 DHCDSH---VTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELISGLRALEFGKTANQK-------GAML  441 (549)
Q Consensus       378 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-------~~~~  441 (549)
                      ......   ......||+.|+|||++....      ++.++|||||||++|||+||..|+.........       ....
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            544332   223456999999999987643      567899999999999999998887543221110       0111


Q ss_pred             HHHHHHhhccchhhhccccccCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          442 DWVKKIHQEKKLEMLVDKDLKNNY-DRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       442 ~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ..........    ..++.+.... .......+.+++.+||+.||++|||+.||+++|+.
T Consensus       239 ~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         239 EEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             HHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            1111111111    1111111111 22345679999999999999999999999999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=382.10  Aligned_cols=250  Identities=21%  Similarity=0.251  Sum_probs=197.4

Q ss_pred             cCCCCC-CeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhc-cCCCccceEEEEec----CCce
Q 008893          227 SNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMT----TTER  299 (549)
Q Consensus       227 ~~~~~~-~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~  299 (549)
                      ++|.+. +.||+|+||+||+|... +|+.||||+++..      ..+.+|+.++.++ +|||||++++++.+    ....
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            578776 46999999999999974 6899999998642      3577899886554 89999999999865    3568


Q ss_pred             eeEeeccCCCchhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC---CCceEEeecccc
Q 008893          300 LLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA  374 (549)
Q Consensus       300 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~  374 (549)
                      ++|||||++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||+++   ++.+||+|||++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence            9999999999999999753  4699999999999999999999999   9999999999999985   567999999999


Q ss_pred             cccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          375 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      +......  ......||+.|+|||++.+..++.++|||||||++|+|+||+.||..........    .+........  
T Consensus       162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----~~~~~i~~~~--  233 (335)
T d2ozaa1         162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GMKTRIRMGQ--  233 (335)
T ss_dssp             EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCS--
T ss_pred             eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH----HHHHHHhcCC--
Confidence            8765433  2344569999999999999999999999999999999999999997543222111    0000000000  


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                          ..+........++++.+++.+||+.||++|||+.|++++
T Consensus       234 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         234 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                000001112335779999999999999999999999884

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=376.31  Aligned_cols=264  Identities=21%  Similarity=0.282  Sum_probs=199.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++..... ....++.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57899999999999999999974 6999999999754322 234578999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCc
Q 008893          305 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH  383 (549)
Q Consensus       305 ~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  383 (549)
                      |+.++.+..... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence            997654444333 455799999999999999999999999   999999999999999999999999999987654322 


Q ss_pred             eeeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh--ccchhhhc-cc
Q 008893          384 VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ--EKKLEMLV-DK  459 (549)
Q Consensus       384 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-d~  459 (549)
                      ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||........   +.........  +....... .+
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhcccccccc
Confidence            233446999999999987766 57899999999999999999999975432111   1111111000  00000000 00


Q ss_pred             cccCCC-----------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          460 DLKNNY-----------DRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       460 ~l~~~~-----------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .....+           ....+.++.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000000           01123678899999999999999999999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.4e-47  Score=373.71  Aligned_cols=263  Identities=20%  Similarity=0.271  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEeec
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY  305 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  305 (549)
                      ++|++.+.||+|+||+||+|..++|+.||||+++.... .....++.+|+.++++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57889999999999999999999999999999975432 23346799999999999999999999999999999999999


Q ss_pred             cCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCcee
Q 008893          306 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT  385 (549)
Q Consensus       306 ~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  385 (549)
                      +.++.+..+......+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||.+........ ..
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~  157 (286)
T d1ob3a_          82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY  157 (286)
T ss_dssp             CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence            99988888888788899999999999999999999999   999999999999999999999999999987654322 23


Q ss_pred             eccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh--ccch---hhh---
Q 008893          386 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ--EKKL---EML---  456 (549)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~---  456 (549)
                      ....|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+.   +.........  ....   ...   
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhccchhhhhhc
Confidence            344589999999998764 568999999999999999999999975332111   1111111000  0000   000   


Q ss_pred             ------ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          457 ------VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       457 ------~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                            ..+..........+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0000001111223467889999999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-48  Score=374.66  Aligned_cols=241  Identities=23%  Similarity=0.354  Sum_probs=198.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCC-----cHHHHHHHHHHHhhcc--CCCccceEEEEecCCc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAV--HRNLLRLIGFCMTTTE  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  298 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++......     ...++.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57889999999999999999975 68999999986532111     1224678999999986  8999999999999999


Q ss_pred             eeeEeeccCC-CchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-CCceEEeecccccc
Q 008893          299 RLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKL  376 (549)
Q Consensus       299 ~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~  376 (549)
                      .++||||+.+ +++.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++. ++.+||+|||+++.
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence            9999999976 67888888777899999999999999999999999   9999999999999985 57999999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhccCCC-CCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhh
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEM  455 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (549)
                      ....   ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.....             ....     
T Consensus       161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~-----  219 (273)
T d1xwsa_         161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRG-----  219 (273)
T ss_dssp             CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHC-----
T ss_pred             cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhc-----
Confidence            5432   2344579999999999988775 5678999999999999999999963110             0000     


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          456 LVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       456 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        .......+    +.++.+++.+||+.||++|||++|++++
T Consensus       220 --~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         220 --QVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             --CCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --ccCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              00111222    3678999999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-47  Score=373.77  Aligned_cols=267  Identities=23%  Similarity=0.326  Sum_probs=197.5

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-C-CCEEEEEEcccCCCC-CcHHHHHHHHHHHhhc---cCCCccceEEEEec----
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-D-GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA---VHRNLLRLIGFCMT----  295 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  295 (549)
                      .++|++.+.||+|+||+||+|... + ++.||||+++..... .....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 4 668999998653322 2223456777776665   79999999999853    


Q ss_pred             -CCceeeEeeccCCCchhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccc
Q 008893          296 -TTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL  373 (549)
Q Consensus       296 -~~~~~lv~e~~~~g~L~~~l~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  373 (549)
                       ....+++|||+.++++..... ....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence             246789999999887765443 455799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccch
Q 008893          374 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKL  453 (549)
Q Consensus       374 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (549)
                      ++.....  .......||+.|+|||++.+..++.++||||+||++|||+||+.||...........+.............
T Consensus       163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            9865422  23345579999999999999999999999999999999999999997543221111111100000000000


Q ss_pred             h------hhcc---ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          454 E------MLVD---KDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       454 ~------~~~d---~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      .      ....   ......+....++.+.+|+.+||+.||++|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0      0000   000011112234678899999999999999999999864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-45  Score=360.89  Aligned_cols=264  Identities=22%  Similarity=0.310  Sum_probs=198.3

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCC-CCcHHHHHHHHHHHhhccCCCccceEEEEec--------C
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--------T  296 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~  296 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++..... .....++.+|+++++.++|||++++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67889999999999999999975 799999999865432 2334578899999999999999999999865        3


Q ss_pred             CceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccc
Q 008893          297 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       297 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      ...++||||+.++.+.........+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence            45789999999888877777777899999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCc---eeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc-
Q 008893          377 LDHCDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK-  451 (549)
Q Consensus       377 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  451 (549)
                      .......   ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||........    ...+....... 
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~  242 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ----LALISQLCGSIT  242 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCC
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH----HHHHHHhcCCCC
Confidence            6533221   22334699999999998765 689999999999999999999999974322111    11111111000 


Q ss_pred             --chhhhccccc--------cCCCC-H------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          452 --KLEMLVDKDL--------KNNYD-R------IELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       452 --~~~~~~d~~l--------~~~~~-~------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                        ..........        ..... .      .....+.+|+.+||+.||++|||++|+++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence              0000000000        00000 0      113457789999999999999999999964

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-45  Score=365.76  Aligned_cols=260  Identities=23%  Similarity=0.305  Sum_probs=193.8

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecC------Ccee
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TERL  300 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~  300 (549)
                      +|+..++||+|+||+||+|+.. +|+.||||+++.....     ..+|++++++++||||+++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            5777889999999999999975 6999999999765422     24799999999999999999998543      2468


Q ss_pred             eEeeccCCCchhhhh---ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC-ceEEeecccccc
Q 008893          301 LVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKL  376 (549)
Q Consensus       301 lv~e~~~~g~L~~~l---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~  376 (549)
                      +||||++++.+....   .....+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++.
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence            999999876444333   3566799999999999999999999999   999999999999999765 899999999987


Q ss_pred             cCCCCCceeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHH--------HHHHH
Q 008893          377 LDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD--------WVKKI  447 (549)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~  447 (549)
                      .....  ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||...........+..        +....
T Consensus       173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            65432  2334569999999998765 5689999999999999999999999975432221111110        00000


Q ss_pred             hhc---cchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          448 HQE---KKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       448 ~~~---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ...   ...................++++.+|+.+||+.||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000   00000000000111112234678999999999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=363.61  Aligned_cols=265  Identities=19%  Similarity=0.257  Sum_probs=197.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccceEEEEecCC----cee
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----ERL  300 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  300 (549)
                      +++|++.+.||+|+||+||+|+.. +|+.||||++...........+.+|+.+++.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            357889999999999999999964 799999999976543333457889999999999999999999997643    235


Q ss_pred             eEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCC
Q 008893          301 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       301 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  380 (549)
                      ++++|+.+|+|.+++... .+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            566777899999999765 599999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCc--eeeccccccCccCchhhcc-CCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc------
Q 008893          381 DSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK------  451 (549)
Q Consensus       381 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  451 (549)
                      ...  ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||..........   ..........      
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQEDLNC  239 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCHHHHHT
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH---HHhhhccCCChhhhhh
Confidence            221  2244569999999999854 567899999999999999999999997543221110   0000000000      


Q ss_pred             ----chhhhc-cccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          452 ----KLEMLV-DKDLKNNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       452 ----~~~~~~-d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                          ...... ........+     .....++.+++.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                000000 000000000     0112568899999999999999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=354.99  Aligned_cols=264  Identities=20%  Similarity=0.242  Sum_probs=207.5

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  304 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++..... ....++.+|+.+++.++||||+++++++......+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47889999999999999999975 6899999999765433 334679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccCCCCCce
Q 008893          305 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV  384 (549)
Q Consensus       305 ~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  384 (549)
                      ++.++++..++...+.+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.++....... .
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~  157 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C  157 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence            999999999888888899999999999999999999999   999999999999999999999999999987654332 2


Q ss_pred             eeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhc---cch---hhhc
Q 008893          385 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQE---KKL---EMLV  457 (549)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~  457 (549)
                      .....++..|+|||.+.... ++.++|||||||++|||++|+.||..+.....   ...-+......   ...   ....
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH---HHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH---HHHHHHhhcCCCChhhhhhhhhcc
Confidence            33345788999999987665 68999999999999999999999864332211   11111111000   000   0000


Q ss_pred             cc---------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          458 DK---------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       458 d~---------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      +.         .-...........+.+++.+|++.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00         00011112234678899999999999999999999763

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=363.72  Aligned_cols=253  Identities=23%  Similarity=0.295  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC----CCCEEEEEEcccCCC---CCcHHHHHHHHHHHhhccC-CCccceEEEEecCCc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVH-RNLLRLIGFCMTTTE  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  298 (549)
                      ++|++.+.||+|+||+||+|+..    +|+.||||+++....   ......+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56899999999999999999852    488999999864321   1223457899999999977 899999999999999


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .+++|||+.+|+|.+++.....+++.....++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            999999999999999998887889999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCCceeeccccccCccCchhhccC--CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchhhh
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLEML  456 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (549)
                      ...........|++.|+|||.+.+.  .++.++|||||||++|||+||+.||..........   .........      
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~---~i~~~~~~~------  251 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA---EISRRILKS------  251 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH---HHHHHHHHC------
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcccC------
Confidence            4444444556799999999999765  46889999999999999999999997554333211   111111100      


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 008893          457 VDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPK-----MSEVVR  496 (549)
Q Consensus       457 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  496 (549)
                           ...++...+.++.+++.+||++||++|||     ++|+++
T Consensus       252 -----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -----CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                 01122234578999999999999999995     677764

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-43  Score=349.17  Aligned_cols=257  Identities=19%  Similarity=0.210  Sum_probs=196.1

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCccce-EEEEecCCceeeEee
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL-IGFCMTTTERLLVYP  304 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e  304 (549)
                      ++|++.+.||+|+||+||+|... +|+.||||++......   .++..|+++++.++|+|++.. .++....+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            46899999999999999999974 6899999998764422   247789999999987775555 455567778899999


Q ss_pred             ccCCCchhhhh-ccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeec---CCCceEEeecccccccCCC
Q 008893          305 YMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHC  380 (549)
Q Consensus       305 ~~~~g~L~~~l-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  380 (549)
                      |+.+ ++.+.+ .....+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+++.+...
T Consensus        84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            9955 555544 4566799999999999999999999999   999999999999875   4567999999999987543


Q ss_pred             CCc------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhccchh
Q 008893          381 DSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEKKLE  454 (549)
Q Consensus       381 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (549)
                      ...      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..............+...... ... 
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~-  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI-  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCH-
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CCh-
Confidence            322      223456999999999999999999999999999999999999999754332222111111111000 000 


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          455 MLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       455 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                          +.+...+    +.++.+++..|++.+|++||++.++.+.|+.
T Consensus       238 ----~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         238 ----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             ----HHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             ----hHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence                1111122    3678999999999999999999998887765

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4e-44  Score=357.66  Aligned_cols=258  Identities=17%  Similarity=0.244  Sum_probs=197.6

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecC--CceeeE
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTT--TERLLV  302 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  302 (549)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++..    ...++.+|+++++.+. ||||+++++++...  ...++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            57999999999999999999974 6999999998643    3457889999999995 99999999998743  468999


Q ss_pred             eeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCC-ceEEeecccccccCCCC
Q 008893          303 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCD  381 (549)
Q Consensus       303 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  381 (549)
                      |||+.+++|....   ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++ .+||+|||+++......
T Consensus       111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999998764   3589999999999999999999999   999999999999998654 69999999998765432


Q ss_pred             CceeeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccc-cHHH---------HHHHHhhc
Q 008893          382 SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKG-AMLD---------WVKKIHQE  450 (549)
Q Consensus       382 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~-~~~~---------~~~~~~~~  450 (549)
                        ......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||.......... .+..         |.......
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence              234456899999999987754 7999999999999999999999997544321110 1111         11000000


Q ss_pred             --cchhhhcccc--------ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008893          451 --KKLEMLVDKD--------LKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVR  496 (549)
Q Consensus       451 --~~~~~~~d~~--------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  496 (549)
                        ..........        .........+.++.+|+.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0000000000        001111223467899999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-44  Score=359.20  Aligned_cols=259  Identities=23%  Similarity=0.270  Sum_probs=193.0

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecCC------
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------  297 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  297 (549)
                      .++|++.+.||+|+||+||+|... +|+.||||+++..... .....+.+|+++++.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            357889999999999999999975 6999999999754322 22346889999999999999999999997654      


Q ss_pred             ceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeeccccccc
Q 008893          298 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL  377 (549)
Q Consensus       298 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  377 (549)
                      ..++||||+ +.+|....+. ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence            469999999 5577776654 4699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCceeeccccccCccCchhhccC-CCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhh-------
Q 008893          378 DHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQ-------  449 (549)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------  449 (549)
                      ...    .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||........   +.........       
T Consensus       172 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         172 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHH
T ss_pred             CCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH---HHHHHhccCCCcHHHHh
Confidence            532    2345699999999998764 568999999999999999999999975432111   1000000000       


Q ss_pred             ----------ccchhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          450 ----------EKKLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       450 ----------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                                ...........+. .........+.+|+.+||+.||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                      0000000000000 1111223568899999999999999999999974

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.2e-43  Score=342.31  Aligned_cols=258  Identities=17%  Similarity=0.215  Sum_probs=204.1

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC-CCccceEEEEecCCceeeEe
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLIGFCMTTTERLLVY  303 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  303 (549)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++......   ..+.+|++.+..+.| +|++.+++++......++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            357899999999999999999975 6899999998654432   246788888888865 89999999999999999999


Q ss_pred             eccCCCchhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecC-----CCceEEeeccccccc
Q 008893          304 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----YYEAVVGDFGLAKLL  377 (549)
Q Consensus       304 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfg~~~~~  377 (549)
                      ||+ +++|.+++.. ...+++..+..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+++.+
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999 6799888864 44799999999999999999999999   9999999999999974     578999999999876


Q ss_pred             CCCCCc------eeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHHHhhcc
Q 008893          378 DHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKKIHQEK  451 (549)
Q Consensus       378 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (549)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||............ ..+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~~~~~~  235 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQST  235 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHHS
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHhccCCC
Confidence            543221      233457999999999999999999999999999999999999999754433222111 1111111111


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 008893          452 KLEMLVDKDLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSEVVRMLEG  500 (549)
Q Consensus       452 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  500 (549)
                      ...+     +....    ++++.+++..|++.+|++||+++.+.+.|++
T Consensus       236 ~~~~-----l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         236 PLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             CHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ChHH-----hcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            1111     11222    2568899999999999999999988877764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=354.35  Aligned_cols=263  Identities=18%  Similarity=0.234  Sum_probs=190.4

Q ss_pred             cCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEec------CCc
Q 008893          227 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT------TTE  298 (549)
Q Consensus       227 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  298 (549)
                      ++|++.+.||+|+||+||+|.+. +|+.||||+++..... ....++.+|+.+++.++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            47889999999999999999976 6999999999765432 223468899999999999999999999964      357


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .++||||+.++.+ +.+.  ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.+|++|||+++...
T Consensus        97 ~~iv~Ey~~~~l~-~~~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eEEEEeccchHHH-Hhhh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence            8999999976554 4443  3589999999999999999999999   99999999999999999999999999988655


Q ss_pred             CCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccccHH--------HHH------
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML--------DWV------  444 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~------  444 (549)
                      ..  .......||+.|+|||.+.+..+++++||||+||++|||++|+.||...........+.        ++.      
T Consensus       171 ~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            32  23344569999999999999999999999999999999999999997443211110000        000      


Q ss_pred             -HHHhhcc------chhhhccccccCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          445 -KKIHQEK------KLEMLVDKDLKNN---YDRIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       445 -~~~~~~~------~~~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                       .......      .............   .....+..+.+++.+|++.||++|||++|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             0000000      0011111111111   123346788999999999999999999999853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-42  Score=347.46  Aligned_cols=264  Identities=20%  Similarity=0.248  Sum_probs=195.2

Q ss_pred             hcCCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCC-CcHHHHHHHHHHHhhccCCCccceEEEEecC-----Cc
Q 008893          226 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TE  298 (549)
Q Consensus       226 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  298 (549)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++..... ....++.+|+.+++.++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            457999999999999999999964 6999999999755422 2234688999999999999999999998643     34


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecccccccC
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD  378 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  378 (549)
                      .+++++|+.+|+|.+++..+ .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++....
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             eEEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence            57778888999999998654 599999999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCceeeccccccCccCchhhccCC-CCCcccchhHhHHHHHHHhCCcccccCccccccccHHHHHHH----Hhhc---
Q 008893          379 HCDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVKK----IHQE---  450 (549)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~---  450 (549)
                      .    ......||+.|+|||...+.. ++.++|||||||++|+|++|+.||...........+......    ....   
T Consensus       173 ~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         173 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             G----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             c----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            2    233456899999999877654 689999999999999999999999754322111111100000    0000   


Q ss_pred             cchhhhcccccc-CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008893          451 KKLEMLVDKDLK-NNYD-----RIELEEMVQVALLCTQYLPSLRPKMSEVVRM  497 (549)
Q Consensus       451 ~~~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  497 (549)
                      ............ ....     ......+.+++.+||+.||++|||++|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            000000000000 0000     1123568899999999999999999999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.1e-38  Score=317.21  Aligned_cols=261  Identities=19%  Similarity=0.207  Sum_probs=188.5

Q ss_pred             CCCCCCeeeeeCCeEEEEEEEC-CCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-----------CCCccceEEEEec
Q 008893          228 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----------HRNLLRLIGFCMT  295 (549)
Q Consensus       228 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~  295 (549)
                      +|++.+.||+|+||+||+|+.. +|+.||||+++...  .....+.+|+++++.++           |+||+++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            5889999999999999999975 69999999997542  12346778888887775           5789999988764


Q ss_pred             --CCceeeEeeccCCCchhhh---hccCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCC-----
Q 008893          296 --TTERLLVYPYMSNGSVASR---LKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYY-----  364 (549)
Q Consensus       296 --~~~~~lv~e~~~~g~L~~~---l~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~-----  364 (549)
                        ....+++++++..+.....   ......+++..+..++.||+.||.|||+ .   +|+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence              3455666666654433222   2345578999999999999999999998 6   899999999999998654     


Q ss_pred             -ceEEeecccccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHHHHHHHhCCcccccCccccccc---cH
Q 008893          365 -EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKG---AM  440 (549)
Q Consensus       365 -~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~---~~  440 (549)
                       .++++|||.+......    .....||+.|+|||.+....++.++||||+||++++|++|+.||..........   .+
T Consensus       169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence             3899999999865432    234569999999999999999999999999999999999999997543221111   11


Q ss_pred             HHHHHHHhh--------ccchhhhccc-------------------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 008893          441 LDWVKKIHQ--------EKKLEMLVDK-------------------DLKNNYDRIELEEMVQVALLCTQYLPSLRPKMSE  493 (549)
Q Consensus       441 ~~~~~~~~~--------~~~~~~~~d~-------------------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e  493 (549)
                      ...+.....        ........+.                   .............+.+++.+|++.||++|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            111111100        0000000000                   0012234567788999999999999999999999


Q ss_pred             HHHH
Q 008893          494 VVRM  497 (549)
Q Consensus       494 vl~~  497 (549)
                      +++|
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9853

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=5.8e-24  Score=193.58  Aligned_cols=169  Identities=12%  Similarity=0.087  Sum_probs=121.0

Q ss_pred             CCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCC----C-------------cHHHHHHHHHHHhhccCCCccceEEE
Q 008893          230 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI----G-------------GEIQFQTEVEMISLAVHRNLLRLIGF  292 (549)
Q Consensus       230 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~-------------~~~~~~~e~~~l~~l~h~niv~l~~~  292 (549)
                      .+.+.||+|+||+||+|...+|+.||||+++.....    .             .......|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            356899999999999999989999999987532110    0             01234567888889999999988766


Q ss_pred             EecCCceeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEecccCcCeeeecCCCceEEeecc
Q 008893          293 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG  372 (549)
Q Consensus       293 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  372 (549)
                      .    ..+++|||+++..+.+       ++......++.|++.++.|||+.   +|+||||||+|||++++ .++|+|||
T Consensus        83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECC
Confidence            3    3479999998865543       44455678999999999999999   99999999999999965 58999999


Q ss_pred             cccccCCCCCceeeccccccCccCchhhccCCCCCcccchhHhHH
Q 008893          373 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL  417 (549)
Q Consensus       373 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~i  417 (549)
                      .|....+.......  ..+... -.+.+ .+.|+.++|+||..--
T Consensus       148 ~a~~~~~~~~~~~l--~rd~~~-~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         148 QSVEVGEEGWREIL--ERDVRN-IITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TCEETTSTTHHHHH--HHHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred             CcccCCCCCcHHHH--HHHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence            99766533221100  000000 01122 3567889999997543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.57  E-value=1.7e-15  Score=136.90  Aligned_cols=116  Identities=24%  Similarity=0.358  Sum_probs=102.1

Q ss_pred             eeeecCCceeehh---------hhcccCcccccC-CcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccc
Q 008893           15 QVICSDGVFFSFG---------RLLQNNNISGHI-PTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT   84 (549)
Q Consensus        15 ~~~c~~~~~~~~~---------l~l~~n~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~   84 (549)
                      .|.|++..++.+|         ++|++|+|++.+ +..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+|+
T Consensus        12 ~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~   91 (192)
T d1w8aa_          12 TVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK   91 (192)
T ss_dssp             EEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC
T ss_pred             EEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccccc
Confidence            5788876665554         679999998755 567899999999999999999889999999999999999999999


Q ss_pred             cCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccccCC
Q 008893           85 GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICAT  130 (549)
Q Consensus        85 g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~~~~  130 (549)
                      +..|..|.++++|+.|+|++|.|++.+|..+.     ..+++++|++.|.+
T Consensus        92 ~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~  142 (192)
T d1w8aa_          92 EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             ccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence            88888999999999999999999998887654     57899999998864

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.40  E-value=6.1e-14  Score=136.70  Aligned_cols=115  Identities=31%  Similarity=0.537  Sum_probs=102.6

Q ss_pred             eeeeeecC--CceeehhhhcccCcccc--cCCcccCCCCCCCEEEccC-CcCCCCCcccccCCcccCeeeccCcccccCC
Q 008893           13 LIQVICSD--GVFFSFGRLLQNNNISG--HIPTEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYLRLNNNSLTGAI   87 (549)
Q Consensus        13 ~~~~~c~~--~~~~~~~l~l~~n~l~~--~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~   87 (549)
                      |.||.|+.  +..++..++|++|.++|  .+|++|++|++|++|+|++ |+++|.+|++|++|++|++|+|++|+|.+..
T Consensus        38 w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~  117 (313)
T d1ogqa_          38 WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI  117 (313)
T ss_dssp             STTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEEC
T ss_pred             CCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccc
Confidence            67999975  33468889999999998  5899999999999999997 8999999999999999999999999999999


Q ss_pred             CcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           88 PPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        88 p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                      |..+..+..|+.+++++|.+.+.+|..+.     ..+++++|.+.
T Consensus       118 ~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~  162 (313)
T d1ogqa_         118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS  162 (313)
T ss_dssp             CGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred             cccccchhhhcccccccccccccCchhhccCcccceeeccccccc
Confidence            99999999999999999999999987654     45778888774

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.38  E-value=5.5e-13  Score=110.62  Aligned_cols=98  Identities=24%  Similarity=0.353  Sum_probs=82.7

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+|+ .+| .+.++++|++|||++|+|+ .+|+.|..+++|+.|++++|+|+ .+| .+..+++|+.|++++|+|
T Consensus         3 L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i   77 (124)
T d1dcea3           3 LHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL   77 (124)
T ss_dssp             EECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCC
T ss_pred             EEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCcc
Confidence            679999998 555 4899999999999999999 68889999999999999999999 565 489999999999999999


Q ss_pred             CCCCC-ccc-----cccccccCCccccCC
Q 008893          108 SGPVP-SFH-----AKTFNITGNSLICAT  130 (549)
Q Consensus       108 ~~~~p-~~~-----~~~~~l~~N~~~~~~  130 (549)
                      +.... ..+     ...+++++|++....
T Consensus        78 ~~~~~~~~l~~~~~L~~L~l~~N~i~~~~  106 (124)
T d1dcea3          78 QQSAAIQPLVSCPRLVLLNLQGNSLCQEE  106 (124)
T ss_dssp             CSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             CCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence            86553 222     256889999986543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.37  E-value=3.5e-13  Score=121.34  Aligned_cols=125  Identities=19%  Similarity=0.264  Sum_probs=103.2

Q ss_pred             ccceeeeeeeeeecC----Cce----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            6 EKVLIIVLIQVICSD----GVF----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         6 ~~~~~~~~~~~~c~~----~~~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      .+++.|+|.++..+.    ..+    ....++|++|.+.+..+..|..+++|++|+|++|+|++..|..|.++++|+.|+
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence            578889998887742    222    223467999999999999999999999999999999987788899999999999


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCccc----cccccccCCccccCC
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLICAT  130 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~----~~~~~l~~N~~~~~~  130 (549)
                      |++|+|++..|..|..+++|+.|+|++|.+.+..+..+    .....+..|.+.|..
T Consensus       109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~  165 (192)
T d1w8aa_         109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred             cCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCC
Confidence            99999998888899999999999999999987765432    234466677777754

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.33  E-value=4.7e-13  Score=130.29  Aligned_cols=104  Identities=24%  Similarity=0.337  Sum_probs=92.4

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .+++.+|.+.+.+|..++.+++|+.|++++|.+++.+| .+..+++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+
T Consensus       201 ~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~  279 (313)
T d1ogqa_         201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN  279 (313)
T ss_dssp             EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCc
Confidence            35677888888899999999999999999999997655 78999999999999999999999999999999999999999


Q ss_pred             CCCCCCccc----cccccccCCccccCCC
Q 008893          107 LSGPVPSFH----AKTFNITGNSLICATG  131 (549)
Q Consensus       107 l~~~~p~~~----~~~~~l~~N~~~~~~~  131 (549)
                      |+|.+|...    ...++++||+..|+.+
T Consensus       280 l~g~iP~~~~L~~L~~l~l~~N~~l~g~p  308 (313)
T d1ogqa_         280 LCGEIPQGGNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             EEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred             ccccCCCcccCCCCCHHHhCCCccccCCC
Confidence            999999742    2567899999988853

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=1.4e-12  Score=112.86  Aligned_cols=103  Identities=17%  Similarity=0.196  Sum_probs=87.8

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCC-cCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNN-FFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      +.++++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|.+|..+++|+.|+|++|+
T Consensus        13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~   91 (156)
T d2ifga3          13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (156)
T ss_dssp             EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence            456777776 56778899999999999866 5886667789999999999999999998778899999999999999999


Q ss_pred             CCCCCCcccc----ccccccCCccccCCC
Q 008893          107 LSGPVPSFHA----KTFNITGNSLICATG  131 (549)
Q Consensus       107 l~~~~p~~~~----~~~~l~~N~~~~~~~  131 (549)
                      |+...+..+.    ..+++++|++.|.+.
T Consensus        92 l~~l~~~~~~~~~l~~L~L~~Np~~C~C~  120 (156)
T d2ifga3          92 LESLSWKTVQGLSLQELVLSGNPLHCSCA  120 (156)
T ss_dssp             CSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred             CcccChhhhccccccccccCCCcccCCch
Confidence            9977776543    578999999998763

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.32  E-value=6e-13  Score=127.63  Aligned_cols=126  Identities=20%  Similarity=0.198  Sum_probs=106.7

Q ss_pred             cccceeeeeeeeeecC------C-ceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSD------G-VFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~------~-~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      +++|+.|++..+....      + ......+++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus       104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~  183 (284)
T d1ozna_         104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL  183 (284)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence            4678888887765432      1 11223467999999977788899999999999999999988888999999999999


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCccc-----cccccccCCccccCC
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH-----AKTFNITGNSLICAT  130 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-----~~~~~l~~N~~~~~~  130 (549)
                      +++|++++..|..|..+++|+.|++++|.+++.+|..+     .+.+++++|++.|.+
T Consensus       184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C  241 (284)
T d1ozna_         184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC  241 (284)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred             hhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence            99999999999999999999999999999999887654     367899999999875

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.27  E-value=4.7e-12  Score=119.99  Aligned_cols=103  Identities=23%  Similarity=0.215  Sum_probs=75.8

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      +++++|.+.+..+..+..+.+|+.|++++|.+++..+..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|.|
T Consensus       105 L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L  184 (266)
T d1p9ag_         105 LDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL  184 (266)
T ss_dssp             EECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             ccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCC
Confidence            34555555555555556666666666667777755556677788999999999999977777888899999999999999


Q ss_pred             CCCCCccc----cccccccCCccccCC
Q 008893          108 SGPVPSFH----AKTFNITGNSLICAT  130 (549)
Q Consensus       108 ~~~~p~~~----~~~~~l~~N~~~~~~  130 (549)
                      +..+++.+    .+.++++||++.|.|
T Consensus       185 ~~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         185 YTIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             cccChhHCCCCCCCEEEecCCCCCCCc
Confidence            85444433    256889999999875

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.21  E-value=9e-12  Score=103.12  Aligned_cols=99  Identities=24%  Similarity=0.273  Sum_probs=79.1

Q ss_pred             eeeeeeeeeecC-----CceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCccc
Q 008893            9 LIIVLIQVICSD-----GVFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL   83 (549)
Q Consensus         9 ~~~~~~~~~c~~-----~~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l   83 (549)
                      |+|+|.++...+     .-.....++|++|.|+ .+|+.|+.+++|+.|++++|+|+ .+| .+..+++|+.|++++|+|
T Consensus         1 R~L~Ls~n~l~~l~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i   77 (124)
T d1dcea3           1 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL   77 (124)
T ss_dssp             SEEECTTSCCSSCCCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCC
T ss_pred             CEEEcCCCCCCCCcccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCcc
Confidence            356666655542     1112334789999998 67888999999999999999999 556 599999999999999999


Q ss_pred             ccCC-CcccccCCCCceEeccCCCCCCC
Q 008893           84 TGAI-PPSLSNMSQLAFLDLSYNNLSGP  110 (549)
Q Consensus        84 ~g~~-p~~~~~l~~L~~l~l~~N~l~~~  110 (549)
                      +... ...+..+++|+.|++++|++++.
T Consensus        78 ~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          78 QQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             CSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             CCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            8432 25789999999999999999854

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.13  E-value=3.1e-11  Score=114.22  Aligned_cols=111  Identities=22%  Similarity=0.295  Sum_probs=81.1

Q ss_pred             eeeeecCCceeehh---------hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccc
Q 008893           14 IQVICSDGVFFSFG---------RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT   84 (549)
Q Consensus        14 ~~~~c~~~~~~~~~---------l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~   84 (549)
                      ..|.|++..++.+|         ++|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|+.|+|++|+++
T Consensus        13 ~~v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~   90 (266)
T d1p9ag_          13 LEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ   90 (266)
T ss_dssp             CEEECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS
T ss_pred             eEEEccCCCCCeeCcCcCcCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc
Confidence            44678765544443         568888888766678888888888888888888 455 3577888888888888888


Q ss_pred             cCCCcccccCCCCceEeccCCCCCCCCCcccc-----ccccccCCccc
Q 008893           85 GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI  127 (549)
Q Consensus        85 g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~  127 (549)
                       .+|..+..+++|+.|++++|.+.+..+..+.     ..+.+++|.+.
T Consensus        91 -~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~  137 (266)
T d1p9ag_          91 -SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK  137 (266)
T ss_dssp             -SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred             -ccccccccccccccccccccccceeeccccccccccccccccccccc
Confidence             5566788888888888888888776655432     34566666653

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.13  E-value=2.6e-11  Score=105.36  Aligned_cols=98  Identities=20%  Similarity=0.122  Sum_probs=79.6

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|+|+ .+|..+..+++|+.|||++|+|+ .++ .|..+++|+.|+|++|+|+...+..+..+++|+.|++++|+
T Consensus        22 ~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~   98 (162)
T d1a9na_          22 ELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS   98 (162)
T ss_dssp             EEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCC
T ss_pred             EEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccc
Confidence            5789999998 55777788999999999999999 554 58999999999999999995555556789999999999999


Q ss_pred             CCCCCC-ccc-----cccccccCCccc
Q 008893          107 LSGPVP-SFH-----AKTFNITGNSLI  127 (549)
Q Consensus       107 l~~~~p-~~~-----~~~~~l~~N~~~  127 (549)
                      |+.... ..+     ...+++++|++.
T Consensus        99 i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          99 LVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ccccccccccccccccchhhcCCCccc
Confidence            986432 111     256788888874

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.10  E-value=8.2e-11  Score=113.54  Aligned_cols=124  Identities=21%  Similarity=0.206  Sum_probs=99.7

Q ss_pred             cccceeeeeeeeeecC---Cce-eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccC
Q 008893            5 LEKVLIIVLIQVICSD---GVF-FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN   80 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~---~~~-~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~   80 (549)
                      +++|..+++.+.....   ..+ ....+++++|.+++..+..|.+++.++.|++++|.+++..|..+.++++|+.|+|++
T Consensus       149 l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~  228 (305)
T d1xkua_         149 MKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN  228 (305)
T ss_dssp             CTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCS
T ss_pred             ccccCccccccCCccccCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccc
Confidence            4566667765543321   111 233467999999999999999999999999999999988888999999999999999


Q ss_pred             cccccCCCcccccCCCCceEeccCCCCCCCCCccc-----------cccccccCCccccC
Q 008893           81 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH-----------AKTFNITGNSLICA  129 (549)
Q Consensus        81 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-----------~~~~~l~~N~~~~~  129 (549)
                      |+|+ .+|.+|.++++|+.|+|++|+|+......+           ...+++++|++.+.
T Consensus       229 N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~  287 (305)
T d1xkua_         229 NKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  287 (305)
T ss_dssp             SCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             cccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence            9999 789999999999999999999997644332           24578999998654

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.09  E-value=8.4e-11  Score=101.39  Aligned_cols=84  Identities=19%  Similarity=0.136  Sum_probs=71.2

Q ss_pred             hhhcccC-cccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC
Q 008893           27 GRLLQNN-NISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        27 ~l~l~~n-~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      .+++++| .|+...++.|.++++|+.|+|++|+|+...|..|..+++|+.|+|++|+|+ .+|........|+.|+|++|
T Consensus        35 ~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~N  113 (156)
T d2ifga3          35 ELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN  113 (156)
T ss_dssp             EEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSS
T ss_pred             eeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCC
Confidence            3567666 588777788999999999999999999777888999999999999999999 66655445558999999999


Q ss_pred             CCCCCC
Q 008893          106 NLSGPV  111 (549)
Q Consensus       106 ~l~~~~  111 (549)
                      +|....
T Consensus       114 p~~C~C  119 (156)
T d2ifga3         114 PLHCSC  119 (156)
T ss_dssp             CCCCCG
T ss_pred             cccCCc
Confidence            997544

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.97  E-value=1.4e-10  Score=110.79  Aligned_cols=125  Identities=21%  Similarity=0.194  Sum_probs=100.3

Q ss_pred             cccceeeeeeeeeecC---Cce----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeee
Q 008893            5 LEKVLIIVLIQVICSD---GVF----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR   77 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~---~~~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~   77 (549)
                      ..+|..+++.+..-+.   +.+    ....++|++|+|++..|..|.++++|+.|++++|++++..|..|..+++|+.|+
T Consensus       128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~  207 (284)
T d1ozna_         128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY  207 (284)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence            4567777776655532   112    222467999999988899999999999999999999998999999999999999


Q ss_pred             ccCcccccCCCcccccCCCCceEeccCCCCCCCCCcc----ccccccccCCccccC
Q 008893           78 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNSLICA  129 (549)
Q Consensus        78 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~----~~~~~~l~~N~~~~~  129 (549)
                      +++|++++..|..|..+++|+.|+|++|++.+..+..    +...+....+.+.|.
T Consensus       208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~  263 (284)
T d1ozna_         208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS  263 (284)
T ss_dssp             CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred             ccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence            9999999888889999999999999999999877642    223444555556553

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.92  E-value=3.1e-10  Score=98.42  Aligned_cols=102  Identities=21%  Similarity=0.137  Sum_probs=80.8

Q ss_pred             cceeeeeeeeeecC--Cc---e-eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccC
Q 008893            7 KVLIIVLIQVICSD--GV---F-FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN   80 (549)
Q Consensus         7 ~~~~~~~~~~~c~~--~~---~-~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~   80 (549)
                      +++.|+|.++....  +.   + ....++|++|.|+. ++ .|..+++|++|+|++|+|+...+..+..+++|+.|+|++
T Consensus        19 ~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~   96 (162)
T d1a9na_          19 RDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN   96 (162)
T ss_dssp             SCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred             cCcEEECCCCCCCccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccceecc
Confidence            57788888766542  11   1 23347899999994 44 589999999999999999965555567899999999999


Q ss_pred             cccccCCC--cccccCCCCceEeccCCCCCCCC
Q 008893           81 NSLTGAIP--PSLSNMSQLAFLDLSYNNLSGPV  111 (549)
Q Consensus        81 N~l~g~~p--~~~~~l~~L~~l~l~~N~l~~~~  111 (549)
                      |+|+ .++  ..+..+++|+.|++++|+++...
T Consensus        97 N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~  128 (162)
T d1a9na_          97 NSLV-ELGDLDPLASLKSLTYLCILRNPVTNKK  128 (162)
T ss_dssp             CCCC-CGGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred             cccc-ccccccccccccccchhhcCCCcccccc
Confidence            9998 444  46889999999999999997543

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.74  E-value=4.9e-09  Score=100.68  Aligned_cols=104  Identities=17%  Similarity=0.092  Sum_probs=82.6

Q ss_pred             ccccceeeeeeeeeecCC-------ceeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCee
Q 008893            4 LLEKVLIIVLIQVICSDG-------VFFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL   76 (549)
Q Consensus         4 ~~~~~~~~~~~~~~c~~~-------~~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L   76 (549)
                      +..+|..+++.++.....       ......+++++|.+++..+..|.++++|++|+|++|+|+ .+|..|..+++|+.|
T Consensus       169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L  247 (305)
T d1xkua_         169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV  247 (305)
T ss_dssp             CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEE
T ss_pred             cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEE
Confidence            356778888866554321       112223668999999998999999999999999999999 789999999999999


Q ss_pred             eccCcccccCCC------cccccCCCCceEeccCCCCC
Q 008893           77 RLNNNSLTGAIP------PSLSNMSQLAFLDLSYNNLS  108 (549)
Q Consensus        77 ~l~~N~l~g~~p------~~~~~l~~L~~l~l~~N~l~  108 (549)
                      +|++|+|+..-+      ..+..+++|+.|+|++|+++
T Consensus       248 ~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             ECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             ECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence            999999994322      23445778999999999986

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.59  E-value=2.6e-08  Score=98.44  Aligned_cols=66  Identities=32%  Similarity=0.429  Sum_probs=38.3

Q ss_pred             cCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCCCCCC
Q 008893           43 IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP  112 (549)
Q Consensus        43 ~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p  112 (549)
                      +..+++++.|+|++|+|++. + .+..+++|+.|+|++|+|+ .+| .|.++++|+.|++++|+|++.+|
T Consensus       303 ~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~  368 (384)
T d2omza2         303 ISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP  368 (384)
T ss_dssp             GGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred             cchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh
Confidence            45555666666666666642 2 2555666666666666665 333 45666666666666666665544

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.57  E-value=6.2e-08  Score=86.60  Aligned_cols=117  Identities=25%  Similarity=0.305  Sum_probs=77.6

Q ss_pred             cccceeeeeeeeeecC-Cce----eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSD-GVF----FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~-~~~----~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +.+++.|++.+....+ ..+    ....++|++|+|++..|  ++++++|++|++++|.+. .+| .+.+++.|+.|+++
T Consensus        39 l~~l~~L~l~~~~i~~l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~  114 (199)
T d2omxa2          39 LDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLF  114 (199)
T ss_dssp             HTTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECC
T ss_pred             hcCCCEEECCCCCCCCccccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccc
Confidence            3566667665544432 111    12236788998885443  888899999999999887 455 47788888888888


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCcc---ccccccccCCccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLI  127 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~---~~~~~~l~~N~~~  127 (549)
                      +|.+.. + ..+..+++|+.|++++|.+....+-.   ....+++.+|.+.
T Consensus       115 ~~~~~~-~-~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~  163 (199)
T d2omxa2         115 NNQITD-I-DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVT  163 (199)
T ss_dssp             SSCCCC-C-GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCC
T ss_pred             cccccc-c-cccchhhhhHHhhhhhhhhccccccccccccccccccccccc
Confidence            888773 2 34777888888888888887543211   1245667777654

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.53  E-value=5.8e-10  Score=100.09  Aligned_cols=95  Identities=22%  Similarity=0.329  Sum_probs=62.3

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      ++|++|+|+ .++ .|.+|++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+ .++ .+..+++|+.|++++|.|
T Consensus        53 L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i  127 (198)
T d1m9la_          53 LALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKI  127 (198)
T ss_dssp             EECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEEC
T ss_pred             eECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchh
Confidence            567777777 343 4777777777777777777 56655555667777777777777 333 366777777777777777


Q ss_pred             CCCCC-cc-----ccccccccCCccc
Q 008893          108 SGPVP-SF-----HAKTFNITGNSLI  127 (549)
Q Consensus       108 ~~~~p-~~-----~~~~~~l~~N~~~  127 (549)
                      +.... ..     ....+++++|++.
T Consensus       128 ~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         128 TNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             CCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccccccCCCccceeecCCCccc
Confidence            65321 11     1245677777664

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.51  E-value=3.1e-08  Score=97.87  Aligned_cols=73  Identities=26%  Similarity=0.411  Sum_probs=63.7

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      ++|++|+|++..  .+..+++|+.|+|++|+|++ +| .+.+|++|+.|+|++|+|++..|  +.++++|+.|+|++|.
T Consensus       312 L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         312 LTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             EECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             EECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            568899998654  38899999999999999994 55 69999999999999999996544  8999999999999984

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.50  E-value=5.8e-08  Score=89.56  Aligned_cols=85  Identities=18%  Similarity=0.212  Sum_probs=67.2

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCC-cccccCCcccCeeeccC-cccccCCCcccccCCCCceEeccCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPI-PSTVSHLETLQYLRLNN-NSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      ++|++|+|+...+..|.++++|++|+|++|.+...+ +..|..+++++.|++.. |++....+..|..+++|+.|++++|
T Consensus        34 L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~  113 (242)
T d1xwdc1          34 LRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT  113 (242)
T ss_dssp             EEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESC
T ss_pred             EECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchh
Confidence            678888888666667888999999999998887544 44678888888888764 6777677788888899999999998


Q ss_pred             CCCCCCC
Q 008893          106 NLSGPVP  112 (549)
Q Consensus       106 ~l~~~~p  112 (549)
                      .+....+
T Consensus       114 ~l~~~~~  120 (242)
T d1xwdc1         114 GIKHLPD  120 (242)
T ss_dssp             CCCSCCC
T ss_pred             hhccccc
Confidence            8875444

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.50  E-value=7.6e-08  Score=86.81  Aligned_cols=76  Identities=28%  Similarity=0.402  Sum_probs=50.0

Q ss_pred             hhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCC
Q 008893           28 RLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL  107 (549)
Q Consensus        28 l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  107 (549)
                      +++++|.++.. + .+..+++|++|+|++|+|++ ++ .++.+++|+.|++++|+|+ .+| .+.++++|+.|++++|.+
T Consensus        51 L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~  124 (210)
T d1h6ta2          51 IIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGI  124 (210)
T ss_dssp             EECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCC
T ss_pred             EECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccccccc
Confidence            45666766633 2 36667777777777777774 33 3566777777777777776 344 466677777777777776


Q ss_pred             CC
Q 008893          108 SG  109 (549)
Q Consensus       108 ~~  109 (549)
                      ..
T Consensus       125 ~~  126 (210)
T d1h6ta2         125 SD  126 (210)
T ss_dssp             CC
T ss_pred             cc
Confidence            54

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.49  E-value=1.1e-07  Score=84.98  Aligned_cols=95  Identities=24%  Similarity=0.345  Sum_probs=71.4

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .+++++|.|+. ++ .+..|++|++|+|++|+|++ +++ +.++++|+.|++++|.+. .+| .+..++.|+.|++++|.
T Consensus        44 ~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~  117 (199)
T d2omxa2          44 TLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQ  117 (199)
T ss_dssp             EEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSC
T ss_pred             EEECCCCCCCC-cc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-ccccccccccccccccc
Confidence            36688888874 43 47888999999999999985 443 888999999999999887 455 37888899999999988


Q ss_pred             CCCCCCcc---ccccccccCCccc
Q 008893          107 LSGPVPSF---HAKTFNITGNSLI  127 (549)
Q Consensus       107 l~~~~p~~---~~~~~~l~~N~~~  127 (549)
                      +....+-.   ....+++++|.+.
T Consensus       118 ~~~~~~~~~l~~L~~L~l~~n~l~  141 (199)
T d2omxa2         118 ITDIDPLKNLTNLNRLELSSNTIS  141 (199)
T ss_dssp             CCCCGGGTTCTTCSEEECCSSCCC
T ss_pred             cccccccchhhhhHHhhhhhhhhc
Confidence            87654322   1256777777664

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.45  E-value=1.8e-07  Score=84.25  Aligned_cols=117  Identities=21%  Similarity=0.250  Sum_probs=78.5

Q ss_pred             cccceeeeeeeeeecC--C--ce-eehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSD--G--VF-FSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~--~--~~-~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +++|+.|++.+....+  +  .+ ....++|++|.|++. + .+++|++|++|++++|+|+ .+| .+..+++|+.|+++
T Consensus        45 L~~L~~L~l~~~~i~~l~~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~  120 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE  120 (210)
T ss_dssp             HHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred             hcCccEEECcCCCCCCchhHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccccc-ccc-cccccccccccccc
Confidence            3456666666555432  1  11 122367889988854 3 3688899999999999998 455 58888999999999


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCccc---cccccccCCccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH---AKTFNITGNSLI  127 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~---~~~~~l~~N~~~  127 (549)
                      +|.+. .++ .+..++.|+.+++++|.+++..+...   .+.+++++|.+.
T Consensus       121 ~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~  169 (210)
T d1h6ta2         121 HNGIS-DIN-GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS  169 (210)
T ss_dssp             TSCCC-CCG-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCC
T ss_pred             ccccc-ccc-ccccccccccccccccccccccccccccccccccccccccc
Confidence            88876 333 46777777888888777775443221   245666666653

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.45  E-value=2.1e-09  Score=96.35  Aligned_cols=105  Identities=21%  Similarity=0.103  Sum_probs=83.5

Q ss_pred             cccceeeeeeeeeecCC-cee----ehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDG-VFF----SFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~-~~~----~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +++|+.|+|.++..++- .+.    ...++|++|.|+ .+|+.+..+++|+.|++++|+|+ .++ .+..+++|+.|+|+
T Consensus        47 L~~L~~L~Ls~n~I~~i~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~  123 (198)
T d1m9la_          47 LKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMS  123 (198)
T ss_dssp             TTTCCEEECSEEEESCCCCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEES
T ss_pred             ccccceeECcccCCCCcccccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccc
Confidence            67889999988877642 121    223679999998 66766666788999999999999 444 58899999999999


Q ss_pred             CcccccCCC--cccccCCCCceEeccCCCCCCCCCc
Q 008893           80 NNSLTGAIP--PSLSNMSQLAFLDLSYNNLSGPVPS  113 (549)
Q Consensus        80 ~N~l~g~~p--~~~~~l~~L~~l~l~~N~l~~~~p~  113 (549)
                      +|+|+ .++  ..|..+++|+.|+|++|++....+.
T Consensus       124 ~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  158 (198)
T d1m9la_         124 NNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             EEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred             cchhc-cccccccccCCCccceeecCCCccccCccc
Confidence            99998 444  4688999999999999998765543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.42  E-value=5.1e-07  Score=84.06  Aligned_cols=149  Identities=13%  Similarity=0.088  Sum_probs=99.5

Q ss_pred             HHHHHHhcCCCCCCeeeeeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhcc-CCCccceEEEEecCCc
Q 008893          220 KELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTE  298 (549)
Q Consensus       220 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  298 (549)
                      .++...-+.|...+..+-++.+.||+...+ ++.+++|+...... .....+..|...+..+. +--+.+++.+....+.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            345555566665555444455789988654 56677888754332 12224677888877664 3335677888888888


Q ss_pred             eeeEeeccCCCchhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 008893          299 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC----------------------------------  344 (549)
Q Consensus       299 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  344 (549)
                      .++||+++++.++.+.....     .....++.+++..+..||+..                                  
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999998876554321     123334556666666666420                                  


Q ss_pred             ----------------------CCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          345 ----------------------DPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       345 ----------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                                            .+.++|+|+.|.||++++++..-|.||+.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  1248999999999999987667799999875

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.35  E-value=1.7e-07  Score=85.54  Aligned_cols=78  Identities=24%  Similarity=0.440  Sum_probs=63.7

Q ss_pred             hcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCC
Q 008893           29 LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS  108 (549)
Q Consensus        29 ~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  108 (549)
                      .++++.+...  ..+.++++|+.|++++|.+++ .+ .+.++++|+.|+|++|++++ +|+ |.++++|+.|+|++|+|+
T Consensus       135 ~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         135 YLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQIS  208 (227)
T ss_dssp             ECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCC
T ss_pred             hchhhhhchh--hhhcccccccccccccccccc-ch-hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCC
Confidence            4666666543  347888999999999999984 33 48999999999999999984 554 889999999999999999


Q ss_pred             CCCC
Q 008893          109 GPVP  112 (549)
Q Consensus       109 ~~~p  112 (549)
                      +..|
T Consensus       209 ~i~~  212 (227)
T d1h6ua2         209 DVSP  212 (227)
T ss_dssp             BCGG
T ss_pred             CCcc
Confidence            7654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.35  E-value=2.1e-07  Score=84.94  Aligned_cols=117  Identities=25%  Similarity=0.248  Sum_probs=82.8

Q ss_pred             cccceeeeeeeeeecCCc-----eeehhhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeecc
Q 008893            5 LEKVLIIVLIQVICSDGV-----FFSFGRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN   79 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-----~~~~~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~   79 (549)
                      +++++.+++.++...+-.     .....+.++++.+.+.  ..+...+.+..+.++++.+...  ..+.++++|+.|+++
T Consensus        84 l~~l~~l~~~~n~~~~i~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~  159 (227)
T d1h6ua2          84 LTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIG  159 (227)
T ss_dssp             CCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECC
T ss_pred             ccccccccccccccccccccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccccccc
Confidence            456677777665554311     1112245777776543  3477789999999999998843  347788999999999


Q ss_pred             CcccccCCCcccccCCCCceEeccCCCCCCCCCcc---ccccccccCCccc
Q 008893           80 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLI  127 (549)
Q Consensus        80 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~---~~~~~~l~~N~~~  127 (549)
                      +|.+++ .+ .|.++++|+.|+|++|.+++..+-.   ..+.+++++|++.
T Consensus       160 ~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         160 NAQVSD-LT-PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQIS  208 (227)
T ss_dssp             SSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred             cccccc-ch-hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCC
Confidence            999984 33 3889999999999999998754311   2266889999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.13  E-value=5.8e-06  Score=76.21  Aligned_cols=130  Identities=18%  Similarity=0.091  Sum_probs=86.0

Q ss_pred             eeeeeCC-eEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccC--CCccceEEEEecCCceeeEeeccCCCc
Q 008893          234 LVGKGGF-GNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLIGFCMTTTERLLVYPYMSNGS  310 (549)
Q Consensus       234 ~iG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  310 (549)
                      .+..|.. +.||+....++..+++|.......    ..+..|...++.+..  -.+.+++++..+.+..++||+|+++.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3445554 678999988888899998754432    235677777776643  235667888888888999999998866


Q ss_pred             hhhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------------------
Q 008893          311 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQ-----------------------------------------------  343 (549)
Q Consensus       311 L~~~l~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------------  343 (549)
                      +.+..     ..   ....+.+++..|.-||+.                                               
T Consensus        93 ~~~~~-----~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          93 LLSSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTTSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             ccccc-----cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            54321     11   111222333333333321                                               


Q ss_pred             --------CCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          344 --------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       344 --------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                              ..+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                    12348999999999999987667899999775

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.97  E-value=1.1e-05  Score=77.61  Aligned_cols=88  Identities=28%  Similarity=0.321  Sum_probs=53.4

Q ss_pred             hhhcccCcccccCCcccCCCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCC
Q 008893           27 GRLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN  106 (549)
Q Consensus        27 ~l~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  106 (549)
                      .++|++|.|+ .+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++..   .+.|+.|++++|.
T Consensus        42 ~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~  109 (353)
T d1jl5a_          42 ELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQ  109 (353)
T ss_dssp             EEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSC
T ss_pred             EEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccc
Confidence            3567777776 46643   356777777777777 667543   46777777777776 44431   1357777777777


Q ss_pred             CCCCCCccc---cccccccCCcc
Q 008893          107 LSGPVPSFH---AKTFNITGNSL  126 (549)
Q Consensus       107 l~~~~p~~~---~~~~~l~~N~~  126 (549)
                      ++..++...   ...+++++|.+
T Consensus       110 l~~lp~~~~l~~L~~L~l~~~~~  132 (353)
T d1jl5a_         110 LEKLPELQNSSFLKIIDVDNNSL  132 (353)
T ss_dssp             CSSCCCCTTCTTCCEEECCSSCC
T ss_pred             cccccchhhhccceeeccccccc
Confidence            765433211   23455555554

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.93  E-value=7.7e-06  Score=74.73  Aligned_cols=111  Identities=17%  Similarity=0.050  Sum_probs=69.5

Q ss_pred             cccceeeeeeeeeecCCc-------eeehh-hhcccCcccccCCcccCCCC-CCCEEEccCCcCCCCCcccccCCcccCe
Q 008893            5 LEKVLIIVLIQVICSDGV-------FFSFG-RLLQNNNISGHIPTEIGKLS-KLLTLDLSNNFFTGPIPSTVSHLETLQY   75 (549)
Q Consensus         5 ~~~~~~~~~~~~~c~~~~-------~~~~~-l~l~~n~l~~~~p~~~~~l~-~L~~L~ls~N~l~g~~p~~~~~l~~L~~   75 (549)
                      +.+|+.+++.+....+..       +..+. ....++.+....+..|.+++ .++.|++++|+++ .++......++++.
T Consensus       102 l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~  180 (242)
T d1xwdc1         102 LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDE  180 (242)
T ss_dssp             CTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEE
T ss_pred             cccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-ccccccccchhhhc
Confidence            346667777665443211       11111 12345566655566666664 7888888888888 44555445566554


Q ss_pred             e-eccCcccccCCCcccccCCCCceEeccCCCCCCCCCcccc
Q 008893           76 L-RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA  116 (549)
Q Consensus        76 L-~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~  116 (549)
                      + ++++|+|+...+..|..+++|+.|+|++|+|+..++..+.
T Consensus       181 ~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~  222 (242)
T d1xwdc1         181 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE  222 (242)
T ss_dssp             EECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred             cccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHc
Confidence            4 5677888844445678888999999999988866655444

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.93  E-value=1.1e-06  Score=75.31  Aligned_cols=72  Identities=28%  Similarity=0.236  Sum_probs=45.8

Q ss_pred             CcccCCCCCCCEEEccCCcCCCC--CcccccCCcccCeeeccCcccccCCCc-ccccCCCCceEeccCCCCCCCCC
Q 008893           40 PTEIGKLSKLLTLDLSNNFFTGP--IPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVP  112 (549)
Q Consensus        40 p~~~~~l~~L~~L~ls~N~l~g~--~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~~~~p  112 (549)
                      +..+.++++|++|+|++|+|+..  ++..+..+++|+.|+|++|+|+ .+++ .+....+|+.|++++|++++...
T Consensus        58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~  132 (162)
T d1koha1          58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR  132 (162)
T ss_dssp             HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred             HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence            33345677777777777777743  2344566777777777777777 3333 23334467777777777765544

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.85  E-value=1.3e-05  Score=77.08  Aligned_cols=57  Identities=28%  Similarity=0.339  Sum_probs=36.8

Q ss_pred             CCCCCCEEEccCCcCCCCCcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCCCCCC
Q 008893           45 KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG  109 (549)
Q Consensus        45 ~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  109 (549)
                      .+++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|+.|+|++|+|+.
T Consensus       282 ~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         282 LPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS
T ss_pred             cCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC
Confidence            3466777777777776 56643   456777777777776 55542   3467777777777763

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.81  E-value=1.9e-06  Score=73.75  Aligned_cols=78  Identities=24%  Similarity=0.195  Sum_probs=59.8

Q ss_pred             hhhcccCcccccC--CcccCCCCCCCEEEccCCcCCCCCcc-cccCCcccCeeeccCcccccCCCcc-------cccCCC
Q 008893           27 GRLLQNNNISGHI--PTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQYLRLNNNSLTGAIPPS-------LSNMSQ   96 (549)
Q Consensus        27 ~l~l~~n~l~~~~--p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~-------~~~l~~   96 (549)
                      .++|++|+|+..-  +..+..+++|+.|||++|+|+. ++. .+....+|+.|+|++|.+++.....       +..+|+
T Consensus        69 ~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~  147 (162)
T d1koha1          69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPK  147 (162)
T ss_dssp             CCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTT
T ss_pred             EeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCC
Confidence            4679999999543  4557789999999999999994 443 4445568999999999998665532       567899


Q ss_pred             CceEeccCCCC
Q 008893           97 LAFLDLSYNNL  107 (549)
Q Consensus        97 L~~l~l~~N~l  107 (549)
                      |+.||  ++.+
T Consensus       148 L~~LD--g~~v  156 (162)
T d1koha1         148 LLRLD--GHEL  156 (162)
T ss_dssp             CCEET--TEEC
T ss_pred             CCEEC--cCCC
Confidence            99885  4444

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.79  E-value=4.8e-05  Score=74.78  Aligned_cols=76  Identities=16%  Similarity=0.092  Sum_probs=47.1

Q ss_pred             CeeeeeCCeEEEEEEECC-CCEEEEEEccc------CCCCCcHHHHHHHHHHHhhcc-C--CCccceEEEEecCCceeeE
Q 008893          233 NLVGKGGFGNVYKGYLQD-GTVVAVKRLKD------GNAIGGEIQFQTEVEMISLAV-H--RNLLRLIGFCMTTTERLLV  302 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~-g~~vavK~~~~------~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  302 (549)
                      +.||.|....||+....+ ++.++||.-..      ........+...|.+.+..+. +  ..+.+++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998654 67899996432      111112224456777776653 2  334555544  45567899


Q ss_pred             eeccCCCc
Q 008893          303 YPYMSNGS  310 (549)
Q Consensus       303 ~e~~~~g~  310 (549)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.37  E-value=5.4e-06  Score=82.99  Aligned_cols=81  Identities=26%  Similarity=0.297  Sum_probs=46.2

Q ss_pred             hhcccCcccc----cCCcccCCCCCCCEEEccCCcCCCC----Cccccc-CCcccCeeeccCcccccC----CCcccccC
Q 008893           28 RLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IPSTVS-HLETLQYLRLNNNSLTGA----IPPSLSNM   94 (549)
Q Consensus        28 l~l~~n~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~-~l~~L~~L~l~~N~l~g~----~p~~~~~l   94 (549)
                      +.|++|.|+.    .++..+..+++|++|||++|.|+..    +...+. ...+|+.|+|++|+|+..    ++..+..+
T Consensus        32 L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~  111 (460)
T d1z7xw1          32 VRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL  111 (460)
T ss_dssp             EEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSC
T ss_pred             EEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhcc
Confidence            4466666652    2344456667777777777766411    111221 124577777777776532    34455666


Q ss_pred             CCCceEeccCCCCC
Q 008893           95 SQLAFLDLSYNNLS  108 (549)
Q Consensus        95 ~~L~~l~l~~N~l~  108 (549)
                      ++|+.|+|++|.++
T Consensus       112 ~~L~~L~L~~N~i~  125 (460)
T d1z7xw1         112 PTLQELHLSDNLLG  125 (460)
T ss_dssp             TTCCEEECCSSBCH
T ss_pred             ccccccccccccch
Confidence            67777777777665

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.14  E-value=0.00059  Score=64.82  Aligned_cols=133  Identities=15%  Similarity=0.132  Sum_probs=77.1

Q ss_pred             CeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCc--cceEE-----EEecCCceeeEeeccCCCchh
Q 008893          240 FGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL--LRLIG-----FCMTTTERLLVYPYMSNGSVA  312 (549)
Q Consensus       240 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g~L~  312 (549)
                      --.||++..++|+.|++|+.+.+.  ....++..|...+..+....+  +..+.     ........+.++++++|..+.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            468999999999999999987543  235567888888877753322  11111     122345677889998764332


Q ss_pred             h-----h---------hc----c-----CCCCCHH-------------------HHHHHHHHHHHHHHHhh----hcCCC
Q 008893          313 S-----R---------LK----A-----KPSLDWA-------------------TRKRIALGAARGLLYLH----EQCDP  346 (549)
Q Consensus       313 ~-----~---------l~----~-----~~~l~~~-------------------~~~~i~~~i~~~L~~LH----~~~~~  346 (549)
                      .     .         ++    .     ....++.                   .+..+...+...+..+.    +....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            1     0         01    0     0111111                   11112222222223332    22345


Q ss_pred             ceEecccCcCeeeecCCCceEEeecccccc
Q 008893          347 KIIHRDVKAANILLDEYYEAVVGDFGLAKL  376 (549)
Q Consensus       347 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  376 (549)
                      +++|+|+.+.|||++++  ..+.||+.+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            79999999999999753  45889998753

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.05  E-value=2e-05  Score=76.09  Aligned_cols=82  Identities=18%  Similarity=0.174  Sum_probs=45.4

Q ss_pred             hhcccCccccc----CCcccCCCCCCCEEEccCCcCCCC-----CcccccCCcccCeeeccCcccccC----CCcccccC
Q 008893           28 RLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGP-----IPSTVSHLETLQYLRLNNNSLTGA----IPPSLSNM   94 (549)
Q Consensus        28 l~l~~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l   94 (549)
                      +.+++|.++..    +...+..++.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..+
T Consensus       163 l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~  242 (344)
T d2ca6a1         163 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW  242 (344)
T ss_dssp             EECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred             eecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccccc
Confidence            34555555421    223344556667777777666521     223345566667777776666421    33445566


Q ss_pred             CCCceEeccCCCCCC
Q 008893           95 SQLAFLDLSYNNLSG  109 (549)
Q Consensus        95 ~~L~~l~l~~N~l~~  109 (549)
                      ++|+.|+|++|.|++
T Consensus       243 ~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         243 PNLRELGLNDCLLSA  257 (344)
T ss_dssp             TTCCEEECTTCCCCH
T ss_pred             ccchhhhhhcCccCc
Confidence            666777777776653

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.03  E-value=3.6e-05  Score=74.25  Aligned_cols=84  Identities=15%  Similarity=0.156  Sum_probs=56.1

Q ss_pred             CCCCCCCEEEccCCcCCCC----CcccccCCcccCeeeccCcccccC-----CCcccccCCCCceEeccCCCCCCCC---
Q 008893           44 GKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQYLRLNNNSLTGA-----IPPSLSNMSQLAFLDLSYNNLSGPV---  111 (549)
Q Consensus        44 ~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~-----~p~~~~~l~~L~~l~l~~N~l~~~~---  111 (549)
                      ...+.|+.|++++|+++..    +...+..++.|+.|+|++|+|+..     +...+..+++|+.|+|++|.++..-   
T Consensus       155 ~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~  234 (344)
T d2ca6a1         155 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA  234 (344)
T ss_dssp             HTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHH
T ss_pred             ccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccc
Confidence            3567788888888887622    333456678888899988887631     3445677888888999888875321   


Q ss_pred             -C----c-cccccccccCCccc
Q 008893          112 -P----S-FHAKTFNITGNSLI  127 (549)
Q Consensus       112 -p----~-~~~~~~~l~~N~~~  127 (549)
                       .    . .....+++++|.+.
T Consensus       235 L~~~l~~~~~L~~L~Ls~n~i~  256 (344)
T d2ca6a1         235 LAIALKSWPNLRELGLNDCLLS  256 (344)
T ss_dssp             HHHHGGGCTTCCEEECTTCCCC
T ss_pred             ccccccccccchhhhhhcCccC
Confidence             1    1 12246677777663

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.01  E-value=1.1e-05  Score=80.50  Aligned_cols=103  Identities=19%  Similarity=0.161  Sum_probs=72.3

Q ss_pred             ehhhhcccCcccccC-CcccCCCCCCCEEEccCCcCCC----CCcccccCCcccCeeeccCcccccC----CCccccc-C
Q 008893           25 SFGRLLQNNNISGHI-PTEIGKLSKLLTLDLSNNFFTG----PIPSTVSHLETLQYLRLNNNSLTGA----IPPSLSN-M   94 (549)
Q Consensus        25 ~~~l~l~~n~l~~~~-p~~~~~l~~L~~L~ls~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~-l   94 (549)
                      ...+++++|+|++.. ..-+..+++|+.|+|++|+|+-    .+...+..+++|+.|||++|+|+..    +...+.. .
T Consensus         4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~   83 (460)
T d1z7xw1           4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS   83 (460)
T ss_dssp             EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred             CCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCC
Confidence            345678888887532 3345667899999999999882    3455678899999999999998621    2223322 3


Q ss_pred             CCCceEeccCCCCCCCC----Ccc-----ccccccccCCccc
Q 008893           95 SQLAFLDLSYNNLSGPV----PSF-----HAKTFNITGNSLI  127 (549)
Q Consensus        95 ~~L~~l~l~~N~l~~~~----p~~-----~~~~~~l~~N~~~  127 (549)
                      .+|+.|+|++|.+++..    +..     ..+.+++++|.+.
T Consensus        84 ~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          84 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            47999999999997542    211     2356788888764

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.82  E-value=5.5e-05  Score=70.82  Aligned_cols=66  Identities=27%  Similarity=0.258  Sum_probs=48.2

Q ss_pred             cCCCCCCCEEEccCCcCCCC-CcccccCCcccCeeeccCcccccCCCcccccCCCCceEeccCC-CCC
Q 008893           43 IGKLSKLLTLDLSNNFFTGP-IPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN-NLS  108 (549)
Q Consensus        43 ~~~l~~L~~L~ls~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N-~l~  108 (549)
                      .....+|++|||+++.++.. ++.-+.++++|++|+|++|.+++..+..+..+++|+.|+++++ .++
T Consensus        42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~it  109 (284)
T d2astb2          42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS  109 (284)
T ss_dssp             CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred             hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccc
Confidence            33556788888888877643 3445677888888888888887777777778888888888873 554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.66  E-value=0.012  Score=54.94  Aligned_cols=154  Identities=9%  Similarity=0.017  Sum_probs=79.2

Q ss_pred             CHHHHHHHhcCCCCCCeee-----eeCCeEEEEEEECCCCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCc--cceE
Q 008893          218 HFKELQSATSNFSSKNLVG-----KGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL--LRLI  290 (549)
Q Consensus       218 ~~~~~~~~~~~~~~~~~iG-----~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~  290 (549)
                      +-+|++....+|.+.+...     .|---+.|+....+|+ +++|++......   ..+..|++++..+...++  ...+
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH---HHHHHHHHHHHhhhhccccccccc
Confidence            4467777777888765553     4555788999887665 788988654222   234455666665543221  1111


Q ss_pred             E------EEecCCceeeEeeccCCCchhhh--------------hc---cC---C---CCCH------------------
Q 008893          291 G------FCMTTTERLLVYPYMSNGSVASR--------------LK---AK---P---SLDW------------------  323 (549)
Q Consensus       291 ~------~~~~~~~~~lv~e~~~~g~L~~~--------------l~---~~---~---~l~~------------------  323 (549)
                      .      +.........++.+..+......              ++   ..   .   ....                  
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            0      01112344555666554332110              00   00   0   0000                  


Q ss_pred             HHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCeeeecCCCceEEeeccccc
Q 008893          324 ATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK  375 (549)
Q Consensus       324 ~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  375 (549)
                      ......+..+...+...+. ....++||+|+.++||+++++...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0111112222222222221 234589999999999999998777899999875

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.58  E-value=0.00092  Score=62.10  Aligned_cols=61  Identities=21%  Similarity=0.225  Sum_probs=29.2

Q ss_pred             CCCCCCEEEccCC-cCCCCCcccccCCcccCeeeccC-cccccCCCcccccCCCCceEeccCC
Q 008893           45 KLSKLLTLDLSNN-FFTGPIPSTVSHLETLQYLRLNN-NSLTGAIPPSLSNMSQLAFLDLSYN  105 (549)
Q Consensus        45 ~l~~L~~L~ls~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N  105 (549)
                      ++++|++|+|++| .+++..+..+.++++|++|+|++ +.+++.-...++++++|+.|+++++
T Consensus       173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            3455555555543 34434444455555555555555 2344333344445555555555444

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.52  E-value=0.0076  Score=58.50  Aligned_cols=72  Identities=15%  Similarity=0.173  Sum_probs=49.1

Q ss_pred             CeeeeeCCeEEEEEEECC--------CCEEEEEEcccCCCCCcHHHHHHHHHHHhhccCCCc-cceEEEEecCCceeeEe
Q 008893          233 NLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLVY  303 (549)
Q Consensus       233 ~~iG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  303 (549)
                      +.|+.|-.-.+|+....+        .+.|.+++...   ........+|..+++.+.-.++ .++++++.+    .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            567888889999998654        34677776642   2233456788888887754444 467777643    6899


Q ss_pred             eccCCCch
Q 008893          304 PYMSNGSV  311 (549)
Q Consensus       304 e~~~~g~L  311 (549)
                      ||+++..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=95.88  E-value=0.00082  Score=57.02  Aligned_cols=67  Identities=13%  Similarity=0.119  Sum_probs=35.5

Q ss_pred             ccCCCCCCCEEEccCCcCCC----CCcccccCCcccCeeeccCcccccC----CCcccccCCCCceEeccCCCCC
Q 008893           42 EIGKLSKLLTLDLSNNFFTG----PIPSTVSHLETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLS  108 (549)
Q Consensus        42 ~~~~l~~L~~L~ls~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~  108 (549)
                      .+...++|+.|+|++|.++.    .+...+...+.|+.|+|++|.|+..    +-.++...+.|+.|+|++|.+.
T Consensus        39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence            34455566666666666651    1222334455666666666666521    1223444555666666666544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=94.89  E-value=0.0047  Score=52.08  Aligned_cols=66  Identities=12%  Similarity=0.202  Sum_probs=49.9

Q ss_pred             CCCCCCCEEEccCC-cCCCC----CcccccCCcccCeeeccCccccc----CCCcccccCCCCceEeccCCCCCC
Q 008893           44 GKLSKLLTLDLSNN-FFTGP----IPSTVSHLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNLSG  109 (549)
Q Consensus        44 ~~l~~L~~L~ls~N-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~~  109 (549)
                      .+.++|++|+|+++ .++..    +-..+...+.|+.|+|++|.+..    .+...+...+.|+.|+|++|.++.
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~   86 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP   86 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence            45688999999974 56521    23356677899999999999973    233456667899999999999974

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=91.15  E-value=0.03  Score=46.63  Aligned_cols=65  Identities=14%  Similarity=0.137  Sum_probs=36.9

Q ss_pred             CCCCCCCEEEccC-CcCCCC----CcccccCCcccCeeeccCcccccC----CCcccccCCCCceEeccCCCCC
Q 008893           44 GKLSKLLTLDLSN-NFFTGP----IPSTVSHLETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLS  108 (549)
Q Consensus        44 ~~l~~L~~L~ls~-N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~  108 (549)
                      .+.++|++|+|++ |.++..    +-..+...++|+.|+|++|.++..    +-..+...+.|+.+++++|.+.
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            3456677777776 445411    122344566777777777766522    2233445566777777776665

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=88.37  E-value=0.052  Score=45.10  Aligned_cols=82  Identities=17%  Similarity=0.208  Sum_probs=55.7

Q ss_pred             hhhccc-Cccccc----CCcccCCCCCCCEEEccCCcCCCC----CcccccCCcccCeeeccCcccccC----CCccccc
Q 008893           27 GRLLQN-NNISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQYLRLNNNSLTGA----IPPSLSN   93 (549)
Q Consensus        27 ~l~l~~-n~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~   93 (549)
                      .++|++ +.|+..    +-..+...++|++|+|++|.++..    +-..+...++|+.|++++|.++..    +-..+..
T Consensus        21 ~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~  100 (166)
T d1io0a_          21 EVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQS  100 (166)
T ss_dssp             EEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGG
T ss_pred             EEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHh
Confidence            345665 345422    334566889999999999998732    223456679999999999998632    3356777


Q ss_pred             CCCCceEec--cCCCCC
Q 008893           94 MSQLAFLDL--SYNNLS  108 (549)
Q Consensus        94 l~~L~~l~l--~~N~l~  108 (549)
                      .++|+.++|  ++|.+.
T Consensus       101 ~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_         101 NTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             CSSCCEEECCCCSSCCC
T ss_pred             CccccEEeeccCCCcCc
Confidence            888987555  566664